PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Nakamoto, K; Ohtani, T; Kioka, H; Tsukamoto, Y; Taniguchi, T; Yoshioka, D; Yamaguchi, O; Toda, K; Sawa, Y; Sakata, Y				Nakamoto, Kei; Ohtani, Tomohito; Kioka, Hidetaka; Tsukamoto, Yasumasa; Taniguchi, Tatsunori; Yoshioka, Daisuke; Yamaguchi, Osamu; Toda, Koichi; Sawa, Yoshiki; Sakata, Yasushi			Is Extracardiac Dysfunction Reversible in Patients with Advanced Heart Failure?	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakamoto, Kei; Ohtani, Tomohito; Kioka, Hidetaka; Tsukamoto, Yasumasa; Taniguchi, Tatsunori; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 565, Japan; [Yoshioka, Daisuke; Yamaguchi, Osamu; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 565, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP39-1	S191	S191				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100222		
J	Nakamura, T; Ogawa, H				Nakamura, Taishi; Ogawa, Hisao			Paradigm Shift of PKG1 alpha Redox Modulation in the Stressed Heart	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakamura, Taishi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Nakamura, Taishi] Johns Hopkins Med Inst, Dept Med, Devis Cardiol, Baltimore, MD 21205 USA								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA2-1	S147	S147				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100007		
J	Nakano, M; Fukuda, K; Kondo, M; Segawa, M; Hirano, M; Chiba, T; Fukazawa, K; Miki, K; Morosawa, S; Shimokawa, H				Nakano, Makoto; Fukuda, Koji; Kondo, Masateru; Segawa, Masato; Hirano, Michinori; Chiba, Takahiko; Fukazawa, Kyoshiro; Miki, Keita; Morosawa, Susumu; Shimokawa, Hiroaki			Implantable Cardioverter Defibrillator for Primary Prevention Properly Terminated Ventricular Tachycardia in Patient with Cardiac Fabry Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakano, Makoto; Fukuda, Koji; Kondo, Masateru; Segawa, Masato; Hirano, Michinori; Chiba, Takahiko; Fukazawa, Kyoshiro; Miki, Keita; Morosawa, Susumu; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP35-2	S188	S188				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100204		
J	Nakatsukasa, T; Yamamoto, M; Harimura, Y; Ishidu, T; Seo, Y; Aonuma, K				Nakatsukasa, Tomofumi; Yamamoto, Masayoshi; Harimura, Yoshie; Ishidu, Tomoko; Seo, Yoshihiro; Aonuma, Kazutaka			Clinical Significance of Sequential Evaluations of Left Ventricular Ejection Fraction During Hospitalizations for Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakatsukasa, Tomofumi] Hitachinaka Gen Hosp, Dept Cardiol, Hitachinaka, Ibaraki, Japan; [Yamamoto, Masayoshi; Ishidu, Tomoko; Seo, Yoshihiro; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Cardiovasc Devis, Tsukuba, Ibaraki, Japan; [Harimura, Yoshie] Ryugasaki Saiseikai Hosp, Ryugasaki, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP41-3	S193	S193				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100231		
J	Nakayama, H; Kuragaichi, T; Shiba, M; Fukuhara, R; Yoshitani, K; Taniguchi, R; Toma, M; Miyamoto, T; Takatsu, Y; Sato, Y				Nakayama, Hiroyuki; Kuragaichi, Takashi; Shiba, Masayuki; Fukuhara, Rei; Yoshitani, Kazuyasu; Taniguchi, Ryoji; Toma, Masanao; Miyamoto, Tadashi; Takatsu, Yoshiki; Sato, Yukihito			The Prognostic Value of Serum Albumin Changes in Patients with Acute Heart Failure: Rising Pattern Change Predicts Good Long-Term Prognosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakayama, Hiroyuki; Kuragaichi, Takashi; Shiba, Masayuki; Fukuhara, Rei; Yoshitani, Kazuyasu; Taniguchi, Ryoji; Toma, Masanao; Miyamoto, Tadashi; Takatsu, Yoshiki; Sato, Yukihito] Hyogo Kenritsu Amagasaki Hosp, Amagasaki, Hyogo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP2-5	S198	S198				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100262		
J	Nakazat, T; Kin, K; Watanabe, Y; Higuchi, T; Tamaki, S; Yamada, T; Shirakawa, Y				Nakazat, Taro; Kin, Keiwa; Watanabe, Yoshiki; Higuchi, Takuya; Tamaki, Syunsuke; Yamada, Takahisa; Shirakawa, Yukitoshi			A Successful Case of Percutaneous Transluminal Septal Myocardial Ablation for the Left Ventricular Outflow Tract Obstruction after Mitral Valve Replacement	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nakazat, Taro; Kin, Keiwa; Watanabe, Yoshiki; Higuchi, Takuya; Shirakawa, Yukitoshi] Osaka Gen Med Ctr, Dept Cardiovasc Surg, Osaka, Japan; [Tamaki, Syunsuke; Yamada, Takahisa] Osaka Gen Med Ctr, Dept Cardiol, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP35-4	S188	S188				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100206		
J	Namba, T; Kimura, T; Horii, S; Shiraishi, Y; Sato, A; Yasuda, R; Yada, H; Kawamura, A; Hakuno, D; Adachi, T				Namba, Takayuki; Kimura, Toyokazu; Horii, Shunpei; Shiraishi, Yasunaga; Sato, Atsushi; Yasuda, Risako; Yada, Hirotaka; Kawamura, Akio; Hakuno, Daihiko; Adachi, Takeshi			Significance of Plasma Free Fatty Acid and Amino Acid Profile in Obesity-related Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Namba, Takayuki; Kimura, Toyokazu; Horii, Shunpei; Shiraishi, Yasunaga; Sato, Atsushi; Yasuda, Risako; Yada, Hirotaka; Kawamura, Akio; Adachi, Takeshi] Natl Def Med Coll, Dept Cardiol, Tokorozawa, Saitama 359, Japan; [Hakuno, Daihiko] Kyoto Univ, Grad Sch Med, Dept Cardiol, Kyoto, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP44-3	S195	S195				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100245		
J	Nanno, T; Kobayashi, S; Oda, S; Ishiguchi, H; Myoren, T; Oda, T; Okuda, S; Yamada, J; Okamura, T; Yano, M				Nanno, Takuma; Kobayashi, Shigeki; Oda, Seiko; Ishiguchi, Hironori; Myoren, Takeki; Oda, Tetsuro; Okuda, Shinichi; Yamada, Jutaro; Okamura, Takayuki; Yano, Masafumi			Relationship between Cardiac Sympathetic Hyperactivity and Myocardial Oxidative Stress in Patients with Takotsubo Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nanno, Takuma; Kobayashi, Shigeki; Oda, Seiko; Ishiguchi, Hironori; Myoren, Takeki; Oda, Tetsuro; Okuda, Shinichi; Yamada, Jutaro; Okamura, Takayuki; Yano, Masafumi] Yamagata Univ, Grad Sch, Dept Med & Clin Sci, Div Cardiol, Yamagata 990, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA1-5	S146	S146				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100006		
J	Nishihata, Y; Komatsu, I; Asano, T; Mizuno, A; Niwa, K				Nishihata, Yosuke; Komatsu, Ikki; Asano, Taku; Mizuno, Atsushi; Niwa, Koichiro			Adaptive Servo-Ventilation Therapy Reduced Re-hospitalization for Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nishihata, Yosuke; Komatsu, Ikki; Asano, Taku; Mizuno, Atsushi; Niwa, Koichiro] St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP30-5	S185	S185				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100188		
J	Nishizawa, K; Yano, T; Miki, T; Tanno, M; Kuno, A; Kouzu, H; Tobisawa, T; Miura, T				Nishizawa, Keitaro; Yano, Toshiyuki; Miki, Takayuki; Tanno, Masaya; Kuno, Atsushi; Kouzu, Hidemichi; Tobisawa, Toshiyuki; Miura, Tetsuji			Enlargement of Infarct Size by CKD is Preventable by Consistent Activation of the Erythropoietin Receptor	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nishizawa, Keitaro; Yano, Toshiyuki; Miki, Takayuki; Tanno, Masaya; Kouzu, Hidemichi; Tobisawa, Toshiyuki; Miura, Tetsuji] Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Kuno, Atsushi] Sapporo Med Univ, Dept Pharmacol, Sapporo, Hokkaido, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP24-4	S180	S180				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100166		
J	Nogi, S; Fujita, SI; Okamoto, Y; Ito, T; Ishizaka, N				Nogi, Shinpei; Fujita, Shu-Ichi; Okamoto, Yusuke; Ito, Takahide; Ishizaka, Nobukazu			Gender Specific Association between Serum Uric Acid and Diastolic Dysfunction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nogi, Shinpei; Fujita, Shu-Ichi; Okamoto, Yusuke; Ito, Takahide; Ishizaka, Nobukazu] Osaka Med Coll, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP26-1	S182	S182				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100173		
J	Nohara, S; Yasukawa, H; Oba, T; Nagata, T; Takahashi, J; Shimozono, K; Minami, T; Mawatari, K; Sugi, Y; Fukumoto, Y				Nohara, Shoichiro; Yasukawa, Hideo; Oba, Toyoharu; Nagata, Takanobu; Takahashi, Jinya; Shimozono, Koutatsu; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Fukumoto, Yoshihiro			Cardiac-Specific SOCS3 Deficiency Leads to Left Ventricular Dysfunction with Advanced Age through Impaired Autophagy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nohara, Shoichiro; Yasukawa, Hideo; Oba, Toyoharu; Nagata, Takanobu; Takahashi, Jinya; Shimozono, Koutatsu; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP18-4	S175	S175				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100138		
J	Nunoda, S; Sasaoka, T; Sakata, Y; Ono, M; Sawa, Y; Isobe, M				Nunoda, Shinichi; Sasaoka, Taro; Sakata, Yasushi; Ono, Minoru; Sawa, Yoshiki; Isobe, Mitsuaki		Heart Transplantation Comm	Survival of Heart Transplantation Candidates in Japan	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Nunoda, Shinichi] Tokyo Womens Med Univ, Grad Sch Med, Div Severe Heart Failure, Tokyo, Japan; [Sasaoka, Taro; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Sakata, Yasushi] Osaka Univ, Dept Cardiovasc Med, Suita, Osaka 565, Japan; [Ono, Minoru] Univ Tokyo, Dept Cardiac Surg, Tokyo 1138654, Japan; [Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Suita, Osaka 565, Japan; [Heart Transplantation Comm] Japanese Circulat Soc, Heart Transplantat Comm, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY2-1	S150	S151				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100020		
J	Obe, H; Suzuki, H; Ota, H; Aoki, T; Sugimura, K; Matsumoto, Y; Kushimoto, S; Shimokawa, H				Obe, Hiroyuki; Suzuki, Hideaki; Ota, Hideki; Aoki, Tatsuo; Sugimura, Kouichirou; Matsumoto, Yasuharu; Kushimoto, Shigeki; Shimokawa, Hiroaki			Cardiac Magnetic Resonance as an Alternative Diagnostic Method for Takotsubo Cardiomyopathy in a Patient with Allergy to Iodine Contrast Media	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Obe, Hiroyuki; Kushimoto, Shigeki] Tohoku Univ, Grad Sch Med, Div Emergency Med & Crit Care, Sendai, Miyagi 980, Japan; [Suzuki, Hideaki; Aoki, Tatsuo; Sugimura, Kouichirou; Matsumoto, Yasuharu; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Ota, Hideki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol Med, Sendai, Miyagi 980, Japan			Ota, Hideki/A-3717-2012	Ota, Hideki/0000-0002-7239-3152				0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP6-4	S202	S202				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100280		
J	Oga, Y; Kishi, T; Saku, K; Nishizaki, A; Arimura, T; Fujii, K; Tohyama, T; Nishikawa, T; Ide, T; Sunagawa, K				Oga, Yasuhiro; Kishi, Takuya; Saku, Keita; Nishizaki, Akiko; Arimura, Takahiro; Fujii, Kana; Tohyama, Takeshi; Nishikawa, Takuya; Ide, Tomomi; Sunagawa, Kenji			Chronic Heart Failure Markedly Attenuates the Low Pressure Baroreflex in Regulating Sympathetic Function in Rats	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Oga, Yasuhiro; Nishizaki, Akiko; Arimura, Takahiro; Fujii, Kana; Tohyama, Takeshi; Nishikawa, Takuya; Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Kishi, Takuya] Kyushu Univ, Collaborat Res Inst Innovat Therapeut Cardiovasc, Ctr Disrupt Cardiovasc Med, Fukuoka 812, Japan; [Saku, Keita; Sunagawa, Kenji] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Therapeut Regulat Cardiovasc Homeostasis, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP15-5	S172	S172				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100125		
J	Ogawa, M; Izawa, K; Kitamura, A; Kobayashi, S; Tsuboi, Y; Komaki, K; Sawa, T; Hirata, KI; Okita, Y				Ogawa, Masato; Izawa, Kazuhiro; Kitamura, Aki; Kobayashi, Seimi; Tsuboi, Yasunori; Komaki, Kodai; Sawa, Takuma; Hirata, Ken-Ichi; Okita, Yutaka			Poor Exercise Capacity is Associated with the Prevalence of Postoperative Delirium in Elective Cardiac Surgery	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ogawa, Masato; Tsuboi, Yasunori; Komaki, Kodai] Kobe Univ Hosp, Div Rehabil Med, Kobe, Hyogo, Japan; [Ogawa, Masato; Izawa, Kazuhiro] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 657, Japan; [Kitamura, Aki; Okita, Yutaka] Kobe Univ, Dept Surg, Grad Sch Med, Div Cardiovasc Surg, Kobe, Hyogo 657, Japan; [Kobayashi, Seimi; Tsuboi, Yasunori; Sawa, Takuma; Hirata, Ken-Ichi] Kobe Univ, Dept Internal Med, Grad Sch Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP5-3	S165	S165				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100088		
J	Ohta, M				Ohta, Masateru			Structure-Based Drug Design: A Key Technology for Drug Discovery in the Pharmaceutical Industry	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ohta, Masateru] Chugai Pharmaceut, Div Res, Gotemba, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		ES6-1	S160	S160				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100067		
J	Oikawa, M; Sakamoto, N; Kobayashi, A; Suzuki, S; Yoshihisa, A; Yamaki, T; Saitoh, S; Nakano, H; Takeishi, Y				Oikawa, Masayoshi; Sakamoto, Nobuo; Kobayashi, Atsushi; Suzuki, Satoshi; Yoshihisa, Akiomi; Yamaki, Takayoshi; Saitoh, Shuichi; Nakano, Hajime; Takeishi, Yasuchika			Cardiac Fabry Disease Presenting Left Ventricular Outflow Obstruction with E66Q Mutation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Oikawa, Masayoshi; Sakamoto, Nobuo; Kobayashi, Atsushi; Suzuki, Satoshi; Yoshihisa, Akiomi; Yamaki, Takayoshi; Saitoh, Shuichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Nakano, Hajime] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP35-1	S187	S187				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100203		
J	Okada, A; Sugano, Y; Nagai, T; Honda, S; Asaumi, Y; Noguchi, T; Kusano, K; Ogawa, H; Yasuda, S; Anzai, T				Okada, Atsushi; Sugano, Yasuo; Nagai, Toshiyuki; Honda, Satoshi; Asaumi, Yasuhide; Noguchi, Teruo; Kusano, Kengo; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa			Prothrombin Time as a Novel Marker for Congestion in Patients with Acute Decompensated Heart Failure Not Taking Anticoagulants	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Okada, Atsushi; Sugano, Yasuo; Nagai, Toshiyuki; Honda, Satoshi; Asaumi, Yasuhide; Noguchi, Teruo; Kusano, Kengo; Ogawa, Hisao; Yasuda, Satoshi; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP16-1	S172	S173				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100126		
J	Okada, T; Yasuda, Y; Nakamura, T; Endo, A; Tanabe, K				Okada, Taiji; Yasuda, Yu; Nakamura, Taku; Endo, Akihiro; Tanabe, Kazuaki			Influence of Anemia on Clinical Outcome in Octogenarians with Severe Aortic Valve Stenosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Okada, Taiji; Yasuda, Yu; Nakamura, Taku; Endo, Akihiro; Tanabe, Kazuaki] Shimane Univ Hosp, Dept Cardiol, Izumo, Shimane, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP17-4	S174	S174				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100133		
J	Okamoto, N; Shutta, R; Tanaka, A; Mori, N; Makino, N; Egami, Y; Nishino, M; Tanouchi, J				Okamoto, Naotaka; Shutta, Ryu; Tanaka, Akihiro; Mori, Naoki; Makino, Nobuhiko; Egami, Yasuyuki; Nishino, Masami; Tanouchi, Jun			Adding Tolvaptan Instead of Increasing Dose of Furosemide for the Patients Already Received Low-Dose Furosemide May Improve Hospital Mortality	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Okamoto, Naotaka; Shutta, Ryu; Tanaka, Akihiro; Mori, Naoki; Makino, Nobuhiko; Egami, Yasuyuki; Nishino, Masami; Tanouchi, Jun] Osaka Rosai Hosp, Div Cardiol, Sakai, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD1-7	S153	S153				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100032		
J	Okuda, K; Fu, HY; Tsuchida, S; Yamato, M; Araki, R; Matsuzaki, T; Hanawa, H; Sakata, Y; Minamino, T				Okuda, Keiji; Fu, Hai Ying; Tsuchida, Shota; Yamato, Masaki; Araki, Ryo; Matsuzaki, Takashi; Hanawa, Haruo; Sakata, Yasushi; Minamino, Tetsuo			Immunosuppressive Therapy for Giant-Cell Myocarditis with Nanotechnology	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Okuda, Keiji; Fu, Hai Ying; Tsuchida, Shota; Yamato, Masaki; Araki, Ryo; Matsuzaki, Takashi; Sakata, Yasushi; Minamino, Tetsuo] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Hanawa, Haruo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP36-1	S188	S188				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100208		
J	Okuda, S; Kato, T; Sufu, Y; Fukuda, M; Nishimura, S; Oda, T; Kobayashi, S; Yamamoto, T; Yano, M				Okuda, Shinichi; Kato, Takayoshi; Sufu, Yoko; Fukuda, Masakazu; Nishimura, Shigehiko; Oda, Tetsuro; Kobayashi, Shigeki; Yamamoto, Takeshi; Yano, Masafumi			Dantrolene Suppresses Arrhythmogenesis by Inhibition of Aberrant Ca2+Release Mediated by CaMKII and Ca2+Buffering in Troponin T-related Hypertrophic Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Okuda, Shinichi; Kato, Takayoshi; Sufu, Yoko; Fukuda, Masakazu; Nishimura, Shigehiko; Oda, Tetsuro; Kobayashi, Shigeki; Yamamoto, Takeshi; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 755, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP35-5	S188	S188				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100207		
J	Okumura, T; Watanabe, N; Hosokawa, K; Aoki, S; Ichii, T; Sawamura, A; Morimoto, R; Murohara, T				Okumura, Takahiro; Watanabe, Naoki; Hosokawa, Kazuyo; Aoki, Soichiro; Ichii, Takeo; Sawamura, Akinori; Morimoto, Ryota; Murohara, Toyoaki			Polypharmacy, Cognitive Dysfunction and Prognosis in Elderly Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Okumura, Takahiro; Watanabe, Naoki; Aoki, Soichiro; Ichii, Takeo; Sawamura, Akinori; Morimoto, Ryota; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Hosokawa, Kazuyo] Nagoya Univ Hosp, Dept Hosp Pharm, Nagoya, Aichi, Japan			Murohara, Toyoaki/M-4958-2014					0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP40-3	S191	S192				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100226		
J	Omura, K				Omura, Kazuya			Acute Kidney Injury Following Transcatheter Aortic Valve Implantation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Omura, Kazuya] Saiseikai Yokohama Shi Tobu Hosp, Intens Care Ctr, Yokohama, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP7-3	S167	S167				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100097		
J	Ono, K; Ishimaru, G; Murata, K; Hayashi, M; Fujinami, T; Okada, H; Inagaki, H; Toshida, N; Takamoto, T; Isobe, M				Ono, Koya; Ishimaru, Go; Murata, Ken; Hayashi, Miho; Fujinami, Tatsuya; Okada, Hiroyuki; Inagaki, Hiroshi; Toshida, Nobuo; Takamoto, Toshihiko; Isobe, Mitsuaki			The Efficacy of 2D Speckle Tracking Strain Imaging in Diagnosing Cardiac Amyloidosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ono, Koya; Ishimaru, Go; Fujinami, Tatsuya; Okada, Hiroyuki; Inagaki, Hiroshi; Toshida, Nobuo; Takamoto, Toshihiko] Soka Municipal Hosp, Dept Cardiol, Soka, Japan; [Murata, Ken] Soka Municipal Hosp, Dept Hematol, JapanHosp, Soka, Japan; [Hayashi, Miho] JapanMunicipal Hosp, Soka Municipal Hosp, Dept Dermatol, Soka, Japan; [Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP1-4	S162	S162				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100073		
J	Ono, T; Iijima, R; Hara, H; Nakamura, M; Sugi, K				Ono, Tsuyoshi; Iijima, Raisuke; Hara, Hidehiko; Nakamura, Masato; Sugi, Kaoru			Impact of Atrial Fibrillation on the Risk of Readmission after Revascularization in Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ono, Tsuyoshi; Iijima, Raisuke; Hara, Hidehiko; Nakamura, Masato; Sugi, Kaoru] Toho Univ, Ohashi Med Ctr, Dept Cardiol, Shibuya, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP22-3	S178	S179				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100156		
J	Ono, Y; Takamatsu, H				Ono, Yohei; Takamatsu, Hiroto			Characteristics of Takotsubo Cardiomyopathy with Cardiac Complications	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ono, Yohei; Takamatsu, Hiroto] Fujioka Gen Hosp, Dept Cardiol, Fujioka, Gunma, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP10-1	S169	S169				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100109		
J	Onoue, Y; Izumiya, Y; Hanatani, S; Tanaka, T; Yamamura, S; Kimura, Y; Araki, S; Ogawa, H				Onoue, Yoshiro; Izumiya, Yasuhiro; Hanatani, Shinsuke; Tanaka, Tomoko; Yamamura, Satoru; Kimura, Yuichi; Araki, Satoshi; Ogawa, Hisao			Simple Screening Test for Sarcopenia is a Useful Tool to Predict Future Adverse Events in Male Patients with Cardiovascular Risk	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Onoue, Yoshiro; Izumiya, Yasuhiro; Hanatani, Shinsuke; Tanaka, Tomoko; Yamamura, Satoru; Kimura, Yuichi; Araki, Satoshi; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP31-3	S185	S185				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100189		
J	Osakada, K; Kawase, Y; Tada, T; Kadota, K; Iwasaki, K; Hata, R; Mitsudo, K				Osakada, Kohei; Kawase, Yuichi; Tada, Takeshi; Kadota, Kazushige; Iwasaki, Keiichiro; Hata, Reo; Mitsudo, Kazuaki			Effect of Adaptive Servoventilation on Clinical Outcome of Patients Repeating Hospitalization for Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Osakada, Kohei; Kawase, Yuichi; Tada, Takeshi; Kadota, Kazushige; Iwasaki, Keiichiro; Hata, Reo; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP29-2	S183	S184				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100182		
J	Ota, Y; Inoue, K; Toyoshima, Y; Tanaka, K; Oka, T; Tanaka, N; Okada, M; Okamura, A; Iwakura, K; Fujii, K				Ota, Yoshihiro; Inoue, Koichi; Toyoshima, Yuko; Tanaka, Koji; Oka, Takafumi; Tanaka, Nobuaki; Okada, Masato; Okamura, Atsunori; Iwakura, Katsuomi; Fujii, Kenshi			Prediction of Response to Cardiac Resynchronization Therapy by Tissue Mitral Annular Displacement (TMAD)	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ota, Yoshihiro; Inoue, Koichi; Toyoshima, Yuko; Tanaka, Koji; Oka, Takafumi; Tanaka, Nobuaki; Okada, Masato; Okamura, Atsunori; Iwakura, Katsuomi; Fujii, Kenshi] Sakurabashi Watanabe Hosp, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP1-5	S162	S162				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100074		
J	Otomo, F; Endo, M; Akiyama, E; Suzuki, T; Koga, S; Saigo, S; Inoue, M; Himeno, H; Umemura, S; Kimura, K				Otomo, Fumie; Endo, Mitsuaki; Akiyama, Eiichi; Suzuki, Toru; Koga, Shintaro; Saigo, Sae; Inoue, Mitsuho; Himeno, Hideo; Umemura, Satoshi; Kimura, Kazuo			Clinical Characteristics in Patients with Acute Heart Failure Syndromes Requiring Mechanical Ventilation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Otomo, Fumie; Endo, Mitsuaki; Suzuki, Toru; Koga, Shintaro; Saigo, Sae; Inoue, Mitsuho; Himeno, Hideo] Fujisawa City Hosp, Dept Cardiol, Fujisawa, Kanagawa, Japan; [Akiyama, Eiichi; Kimura, Kazuo] Yokohama City Univ, Med Ctr, Div Cardiol, Yokohama, Kanagawa, Japan; [Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP2-2	S198	S198				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100260		
J	Otsuki, T; Satoh, K; Sugimura, K; Aoki, T; Tatebe, S; Miura, M; Yamamoto, S; Yaoita, N; Miyata, S; Shimokawa, H				Otsuki, Tomohiro; Satoh, Kimio; Sugimura, Koichiro; Aoki, Tatsuo; Tatebe, Shunsuke; Miura, Masanobu; Yamamoto, Saori; Yaoita, Nobuhiro; Miyata, Satoshi; Shimokawa, Hiroaki			Prognostic Impacts of Plasma Levels of Cyclophilin A in Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Otsuki, Tomohiro; Satoh, Kimio; Sugimura, Koichiro; Aoki, Tatsuo; Tatebe, Shunsuke; Miura, Masanobu; Yamamoto, Saori; Yaoita, Nobuhiro; Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA1-1	S146	S146				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100002		
J	Rahmawati, A; Chishaki, A; Ohkusa, T; Sawatari, H; Tsuchihashi-Makaya, M; Ohtsuka, Y; Nakai, M; Miyazono, M; Hashiguchi, N; Sakurada, H; Takemoto, M; Mukai, Y; Inoue, S; Chishaki, H				Rahmawati, Anita; Chishaki, Akiko; Ohkusa, Tomoko; Sawatari, Hiroyuki; Tsuchihashi-Makaya, Miyuki; Ohtsuka, Yuko; Nakai, Mori; Miyazono, Mami; Hashiguchi, Nobuko; Sakurada, Harumizu; Takemoto, Masao; Mukai, Yasushi; Inoue, Shujirou; Chishaki, Hiroaki			Psychological Issues in Heart Failure Patients Who Received Implantable Cardioverter-Defibrillator	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Rahmawati, Anita; Takemoto, Masao; Mukai, Yasushi; Inoue, Shujirou] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Chishaki, Akiko; Sawatari, Hiroyuki; Hashiguchi, Nobuko] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 812, Japan; [Ohkusa, Tomoko] Kyushu Univ Hosp, Kirameki Project Carrier Support Ctr, Fukuoka 812, Japan; [Tsuchihashi-Makaya, Miyuki] Kitasato Univ, Sch Nursing, Sagamihara, Kanagawa, Japan; [Ohtsuka, Yuko; Nakai, Mori; Sakurada, Harumizu] Tokyo Metropolitan Hlth & Med Treatment Corp Ooku, Tokyo, Japan; [Miyazono, Mami] Fukuoka Prefectural Univ, Sch Nursing, Fukuoka, Japan; [Chishaki, Hiroaki] Coll Healthcare Management, Dept Healthcare Management, Fukuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP20-1	S176	S176				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100144		
J	Rin, E				Rin, Eisai			Clinical Implications of Pulmonary Hypertension in Patients with Aortic Stenosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Rin, Eisai] Kawachi Gen Hosp, Ctr Cardiovasc, Higashiosaka, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP17-5	S174	S174				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100134		
J	Saito, S; Toda, K; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Yoshioka, D; Kubota, K; Sawa, Y				Saito, Shunsuke; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Kubota, Kaori; Sawa, Yoshiki			Should Destination Therapy with Implantable Left Ventricular Assist Device Replace Heart Transplantation?	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Saito, Shunsuke; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Kubota, Kaori] Osaka Univ Med Hosp, Div Organ Transplantat, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY2-3	S151	S151				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100021		
J	Sakaguchi, T; Hirata, A; Kashiwase, K; Higuchi, Y; Koretsune, Y; Kusuoka, H; Yasumura, Y				Sakaguchi, Taiki; Hirata, Akio; Kashiwase, Kazunori; Higuchi, Yoshiharu; Koretsune, Yukihiro; Kusuoka, Hideo; Yasumura, Yoshio			Right Atrial Pressure Does Not Reflect Body Fluid Status in Repeater Patients with Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sakaguchi, Taiki; Hirata, Akio; Kashiwase, Kazunori; Higuchi, Yoshiharu; Yasumura, Yoshio] Osaka Police Hosp, Div Cardiol, Osaka, Japan; [Koretsune, Yukihiro] Osaka Natl Hosp, Inst Clin Res, Osaka, Japan; [Kusuoka, Hideo] Osaka Natl Hosp, Div Cardiol, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP42-1	S193	S193				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100234		
J	Sakai, T; Kanako, G; Tsukamoto, S; Shoji, M; Kobayashi, Y				Sakai, Tetsuo; Kanako, Gyouiti; Tsukamoto, Shigeto; Shoji, Makoto; Kobayashi, Youichi			Efficacy of Additional Administration of Vasopressin Receptor Antagonist in Acute Decompensated Heart Failure: A Prospective Randomized Study	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sakai, Tetsuo; Kanako, Gyouiti; Tsukamoto, Shigeto; Shoji, Makoto; Kobayashi, Youichi] Showa Univ, Sch Med, Dept Med, Div Cardiol, Tokyo 142, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP9-3	S204	S204				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100291		
J	Sakamoto, T; Abe, K; Hosokawa, K; Oi, K; Mukai, Y; Yamazaki, Y; Nagao, M; Ide, T; Sunagawa, K				Sakamoto, Takafumi; Abe, Kohtaro; Hosokawa, Kazuya; Oi, Keiji; Mukai, Yasushi; Yamazaki, Yuzo; Nagao, Michinobu; Ide, Tomomi; Sunagawa, Kenji			Right Ventricular Pressure-Volume Relationship to Evaluate Right Ventricular-Pulmonary Arterial Coupling and Energetics	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sakamoto, Takafumi; Hosokawa, Kazuya; Oi, Keiji; Mukai, Yasushi; Ide, Tomomi] Kyushu Univ Hosp, Dept Cardiovasc Med, Fukuoka 812, Japan; [Abe, Kohtaro] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Adv Cardiovasc Regulat & Therapeut, Fukuoka 812, Japan; [Yamazaki, Yuzo; Nagao, Michinobu] Kyushu Univ Hosp, Dept Clin Radiol, Fukuoka 812, Japan; [Sunagawa, Kenji] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Therapeut Regulat & Cardiovasc Homeostasis, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY4-4	S152	S152				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100028		
J	Sakamoto, T; Higo, T; Hiasa, K; Fujino, T; Ide, T				Sakamoto, Takafumi; Higo, Taiki; Hiasa, Kenichi; Fujino, Takeo; Ide, Tomomi			A Case of Cardiac Sarcoidosis Presenting Right-Sided Dominant Heart Failure with Low Output Syndrome	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sakamoto, Takafumi; Higo, Taiki; Hiasa, Kenichi; Fujino, Takeo; Ide, Tomomi] Kyushu Univ Hosp, Dept Cardiovasc Dis, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP2-5	S163	S163				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100079		
J	Sakashita, Y; Izutani, H; Namiguchi, K; Kojima, A; Shikata, F; Uchida, S; Yasugi, T				Sakashita, Yuji; Izutani, Hironori; Namiguchi, Kenji; Kojima, Ai; Shikata, Fumiaki; Uchida, Shunji; Yasugi, Takumi			Fatal Right Heart Failure after Left Ventricular Assist Device Implantation for a Patient of Cardiomyopathy Following Fulminant Myocarditis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sakashita, Yuji; Izutani, Hironori; Namiguchi, Kenji; Kojima, Ai; Shikata, Fumiaki; Uchida, Shunji; Yasugi, Takumi] Ehime Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Matsuyama, Ehime 790, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP4-2	S164	S164				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100082		
J	Saku, K; Arimura, T; Kakino, T; Sakamoto, T; Tohyama, T; Nishikawa, T; Akashi, T; Kishi, T; Ide, T; Sunagawa, K				Saku, Keita; Arimura, Takahiro; Kakino, Takamori; Sakamoto, Takafumi; Tohyama, Takeshi; Nishikawa, Takuya; Akashi, Takuya; Kishi, Takuya; Ide, Tomomi; Sunagawa, Kenji			The Neuro-Mechanical Unloading for Acute Myocardial Infarction Markedly Reduces the Infarct Size and Prevents Heart Failure in the Long Term	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Saku, Keita; Akashi, Takuya; Sunagawa, Kenji] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Fukuoka 812, Japan; [Arimura, Takahiro; Sakamoto, Takafumi; Tohyama, Takeshi; Nishikawa, Takuya; Ide, Tomomi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Kakino, Takamori] Kitakyushu Municipal Med Ctr, Dept Cardiovasc Med, Kitakyushu, Fukuoka, Japan; [Kishi, Takuya] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Collaborat Res Inst Innovat Therapeut Cardiovasc, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP8-2	S167	S168				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100101		
J	Sakuragi, S; Ichikawa, K; Nishihara, T; Tsuji, M				Sakuragi, Satoru; Ichikawa, Keishi; Nishihara, Takahiro; Tsuji, Masahiro			Serum Cystatin C is Associated with Left Ventricular Hypertrophy and Impaired Left Ventricular Relaxation in Patients with Chronic Kidney Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sakuragi, Satoru; Ichikawa, Keishi; Nishihara, Takahiro; Tsuji, Masahiro] Iwakuni Clin Ctr, Dept Cardiovasc Med, Iwakuni, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP44-5	S195	S195				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100247		
J	Sasamori, H; Nakamura, T; Adachi, Y; Okada, T; Nakashima, R; Sugamori, T; Takahashi, N; Endo, A; Kitamura, J; Tanabe, K				Sasamori, Hiroki; Nakamura, Taku; Adachi, Yuya; Okada, Taiji; Nakashima, Ryuma; Sugamori, Takashi; Takahashi, Nobuyuki; Endo, Akihiro; Kitamura, Jun; Tanabe, Kazuaki			Licorice-induced Water Retention and Hypokalemia in Elderly Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sasamori, Hiroki] Shimane Univ, Fac Med, Postgrad Clin Traning Ctr, Matsue, Shimane, Japan; [Nakamura, Taku; Okada, Taiji; Nakashima, Ryuma; Sugamori, Takashi; Takahashi, Nobuyuki; Endo, Akihiro; Tanabe, Kazuaki] Shimane Univ, Fac Med, Postgrad Clin Traning Ctr, Matsue, Shimane, Japan; [Adachi, Yuya] Matsue City Hosp, Div Cardiol, Matsue, Shimane, Japan; [Kitamura, Jun] Kobe Kaisei Hosp, Div Internal Med, Kobe, Hyogo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP27-3	S183	S183				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100179		
J	Sato, T; Seguchi, O; Kuroda, K; Hisamatsu, E; Nakajima, S; Sunami, H; Sato, T; Yanase, M; Fukushima, N; Nakatani, T				Sato, Takamasa; Seguchi, Osamu; Kuroda, Kensuke; Hisamatsu, Eriko; Nakajima, Seiko; Sunami, Haruki; Sato, Takuma; Yanase, Masanobu; Fukushima, Norihide; Nakatani, Takeshi			Heart Transplant Recipients for Cardiac Sarcoidosis: 2 Cases with Long-Term Follow-up	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sato, Takamasa; Seguchi, Osamu; Kuroda, Kensuke; Hisamatsu, Eriko; Nakajima, Seiko; Sunami, Haruki; Sato, Takuma; Yanase, Masanobu; Fukushima, Norihide; Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD4-6	S154	S154				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100037		
J	Sato, T; Iino, T; Sato, W; Watanabe, H; Ito, H				Sato, Teruki; Iino, Takako; Sato, Wakana; Watanabe, Hiroyuki; Ito, Hiroshi			Successful Pleuro-Peritoneal Shunting for Refractory Pleural Effusion in the Patient with Severe Right-sided Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sato, Teruki; Iino, Takako; Sato, Wakana; Watanabe, Hiroyuki; Ito, Hiroshi] Akita Univ, Sch Med, Dept Cardiovasc Med, Akita 010, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP32-1	S185	S185				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100190		
J	Sato, T; Yanagisawa, T; Ikeda, Y; Inomata, T; Takano, K; Ako, J				Sato, Toshimitsu; Yanagisawa, Tomoyoshi; Ikeda, Yuki; Inomata, Takayuki; Takano, Koji; Ako, Junya			A Stage D Heart Failure Patient Complicated with Adrenal Insufficiency with Severe Hyponatremia	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sato, Toshimitsu; Yanagisawa, Tomoyoshi; Ikeda, Yuki; Inomata, Takayuki; Ako, Junya] Kitasato Univ, Sch Med, Dept Cardiovasc Med, Sagamihara, Kanagawa 228, Japan; [Takano, Koji] Kitasato Univ, Sch Med, Dept Endocrinol Diabet & Metab, Sagamihara, Kanagawa 228, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP39-2	S191	S191				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100223		
J	Sato, Y; Tanimoto, S; Shinohara, M; Kusuhara, T; Nishimura, T; Oono, T; Fukuda, S; Takamoto, S; Hara, K; Tanabe, K				Sato, Yu; Tanimoto, Shuzou; Shinohara, Masaya; Kusuhara, Takayoshi; Nishimura, Takashi; Oono, Takayuki; Fukuda, Sachito; Takamoto, Shinichi; Hara, Kazuhiro; Tanabe, Kengo			Extracorporeal Biventricular Assist Device and Immunosuppressive Therapy for Eosinophilic Myocarditis with Dilated Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sato, Yu; Tanimoto, Shuzou; Shinohara, Masaya; Tanabe, Kengo] Mitsui Mem Hosp, Div Cardiol, Tokyo 101, Japan; [Kusuhara, Takayoshi; Oono, Takayuki; Fukuda, Sachito; Takamoto, Shinichi] Mitsui Mem Hosp, Div Cardiovasc Surg, Tokyo 101, Japan; [Nishimura, Takashi] Tokyo Metropolitan Geriatr Hosp, Div Cardiac Surg, Tokyo 173, Japan; [Hara, Kazuhiro] Mitsui Mem Hosp, Div Internal Med, Tokyo 101, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP4-3	S164	S164				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100083		
J	Sato, Y; Dohi, K; Takeuchi, T; Tanimura, M; Sugiura, E; Kumagai, N; Nakamori, S; Fujimoto, N; Yamada, N; Ito, M				Sato, Yuichi; Dohi, Kaoru; Takeuchi, Tetsushiro; Tanimura, Muneyoshi; Sugiura, Emiyo; Kumagai, Naoto; Nakamori, Shiro; Fujimoto, Naoki; Yamada, Norikazu; Ito, Masaaki			Clinical and Hemodynamic Effects of Simple Add-on Tolvaptan Therapy and Their Predictors in Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sato, Yuichi; Dohi, Kaoru; Takeuchi, Tetsushiro; Tanimura, Muneyoshi; Sugiura, Emiyo; Kumagai, Naoto; Nakamori, Shiro; Yamada, Norikazu; Ito, Masaaki] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie, Japan; [Fujimoto, Naoki] Mie Univ, Grad Sch Med, Dept Mol & Lab Med, Tsu, Mie, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP25-1	S181	S181				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100168		
J	Satoh, K; Suzuki, K; Sunamura, S; Otsuki, T; Shimizu, T; Ikeda, S; Aoki, T; Tatebe, S; Sugimura, K; Shimokawa, H				Satoh, Kimio; Suzuki, Kota; Sunamura, Shinichiro; Otsuki, Tomohiro; Shimizu, Toru; Ikeda, Shohei; Aoki, Tatsuo; Tatebe, Shunsuke; Sugimura, Koichiro; Shimokawa, Hiroaki			Crucial Roles of Rho-kinase, Cyclophilin A and its Receptor, Basigin, for Cardiac Hypertrophy, Fibrosis and Failure-Novel Therapeutic Targets	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Satoh, Kimio; Suzuki, Kota; Sunamura, Shinichiro; Otsuki, Tomohiro; Shimizu, Toru; Ikeda, Shohei; Aoki, Tatsuo; Tatebe, Shunsuke; Sugimura, Koichiro; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS6-2	S158	S158				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100056		
J	Sawamura, A; Okumura, T; Biraiwa, H; Kondo, T; Watanabe, N; Kano, N; Fukaya, K; Morimoto, R; Bando, Y; Murohara, T				Sawamura, Akinori; Okumura, Takahiro; Biraiwa, Hiroaki; Kondo, Toru; Watanabe, Naoki; Kano, Naoaki; Fukaya, Kenji; Morimoto, Ryota; Bando, Yasuko; Murohara, Tohoaki			Clinical Significance of Lower Total Cholesterol Level in Mild Symptomatic Patients with Nonischemic Dilated Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sawamura, Akinori; Okumura, Takahiro; Biraiwa, Hiroaki; Kondo, Toru; Watanabe, Naoki; Kano, Naoaki; Fukaya, Kenji; Morimoto, Ryota; Bando, Yasuko; Murohara, Tohoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP23-1	S179	S179				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100159		
J	Segawa, M; Fukuda, K; Nakano, M; Kondo, M; Hirano, M; Chiba, T; Miki, K; Morosawa, S; Fukazawa, K; Shimokawa, H				Segawa, Masato; Fukuda, Koji; Nakano, Makoto; Kondo, Masateru; Hirano, Michinori; Chiba, Takahiko; Miki, Keita; Morosawa, Susumu; Fukazawa, Kyosiro; Shimokawa, Hiroaki			The Significance of Advanced Heart Block in Patients with Cardiac Sarcoidosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Segawa, Masato; Fukuda, Koji; Nakano, Makoto; Kondo, Masateru; Hirano, Michinori; Chiba, Takahiko; Miki, Keita; Morosawa, Susumu; Fukazawa, Kyosiro; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP2-1	S163	S163				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100075		
J	Segawa, T				Segawa, Takatusgu			Predictors of Hyperactive Delirium Within 24-Hours after Hospitalization for Acute Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Segawa, Takatusgu] Kure Med Ctr, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP6-1	S166	S166				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100091		
J	Seki, K; Watanabe, H; Suto, Y; Kimura, S; Shimbo, M; Sato, T; Makabe, S; Iino, T; Iino, K; Ito, H				Seki, Katsuhito; Watanabe, Hiroyuki; Suto, Yuta; Kimura, Shunsuke; Shimbo, Mai; Sato, Teruki; Makabe, Shin; Iino, Takako; Iino, Kenji; Ito, Hiroshi			A Right Atrial Giant Lymphoma Causing Right Ventricular Inflow Obstruction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Seki, Katsuhito; Watanabe, Hiroyuki; Suto, Yuta; Kimura, Shunsuke; Shimbo, Mai; Sato, Teruki; Makabe, Shin; Iino, Takako; Iino, Kenji; Ito, Hiroshi] Akita Univ, Grad Sch Med, Dept Cardiovasc Med, Akita 010, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP34-3	S187	S187				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100200		
J	Sekihara, T; Kato, T; Funasako, M; Sasaki, K; Nakane, E; Miyamoto, S; Izumi, T; Haruna, T; Inoko, M				Sekihara, Takayuki; Kato, Takao; Funasako, Moritoshi; Sasaki, Kenichi; Nakane, Eisaku; Miyamoto, Shoichi; Izumi, Toshiaki; Haruna, Tetsuya; Inoko, Moriaki			Echocardiographic Finding of Right Ventricular Overload is the Predictor of the Acute Response to Tolvaptan	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sekihara, Takayuki; Kato, Takao; Funasako, Moritoshi; Sasaki, Kenichi; Nakane, Eisaku; Miyamoto, Shoichi; Izumi, Toshiaki; Haruna, Tetsuya; Inoko, Moriaki] Kitano Hosp, Med Res Inst, Tazuke Kofukai Fdn, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP6-3	S201	S202				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100279		
J	Seno, A; Takeda, Y; Matsui, M; Nakada, Y; Nakagawa, H; Onoue, K; Kawata, H; Kawakami, R; Uemura, S; Saito, Y				Seno, Ayako; Takeda, Yukiji; Matsui, Masaru; Nakada, Yasuki; Nakagawa, Hitoshi; Onoue, Kenji; Kawata, Hiroyuki; Kawakami, Rika; Uemura, Shiro; Saito, Yoshihiko			The PLGF/Flt-1 Signaling Pathway Can be a Novel Mechanism for Cardio-Renal Syndrome	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Seno, Ayako; Takeda, Yukiji; Matsui, Masaru; Nakada, Yasuki; Nakagawa, Hitoshi; Onoue, Kenji; Kawata, Hiroyuki; Kawakami, Rika; Uemura, Shiro; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS2-2	S156	S156				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100044		
J	Seo, Y; Yamamoto, M; Sai, S; Machino, T; Ishizu, T; Aonuma, K				Seo, Yoshihiro; Yamamoto, Masayoshi; Sai, Seika; Machino, Tomoko; Ishizu, Tomoko; Aonuma, Kazutaka			Intra-renal Doppler Profile in Chronic Heart Failure: A Link with Central Venous Pressure and Renal Function	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Seo, Yoshihiro; Yamamoto, Masayoshi; Sai, Seika; Machino, Tomoko; Ishizu, Tomoko; Aonuma, Kazutaka] Univ Tsukuba, Div Cardiovasc, Tsukuba, Ibaraki 305, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS2-3	S156	S156				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100045		
J	Serizawa, N; Nomura, A; Shiga, T; Shoda, M; Hagiwara, N				Serizawa, Naoki; Nomura, Arata; Shiga, Tsuyoshi; Shoda, Morio; Hagiwara, Nobuhisa			Problems and Issues in Practice of Cardiac Sarcoidosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Serizawa, Naoki; Nomura, Arata; Shiga, Tsuyoshi; Shoda, Morio; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD4-3	S154	S154				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100035		
J	Shimizu, I; Yoshida, Y; Minamino, T				Shimizu, Ippei; Yoshida, Yohko; Minamino, Tohru			The Role of Adipose Tissue Dysfunction in Cardio-Metabolic Disorders	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shimizu, Ippei; Yoshida, Yohko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Div Mol Aging & Cell Biol, Niigata, Japan; [Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP37-2	S189	S190				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100214		
J	Shimizu, M; Tanaka, R; Hakuno, D; Kimura, T; Namba, T; Adachi, T				Shimizu, Miki; Tanaka, Ryo; Hakuno, Daihiko; Kimura, Toyokazu; Namba, Takayuki; Adachi, Takeshi			Effects of Febuxostat on Cardiac Fibrosis and Oxidative Stress in Hamsters with Dilated Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shimizu, Miki] Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Diagnost Imaging, Tokyo, Japan; [Tanaka, Ryo] Tokyo Univ Agr & Technol, Fac Agr, Dept Vet Surg, Tokyo, Japan; [Hakuno, Daihiko; Kimura, Toyokazu; Namba, Takayuki; Adachi, Takeshi] Natl Def Med Coll, Dept Internal Med, Tokorozawa, Saitama 359, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP36-5	S189	S189				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100212		
J	Shimizu, T; Yoshihisa, A; Takiguchi, M; Miura, S; Nakamura, Y; Yamauchi, H; Owada, T; Abe, S; Suzuki, S; Takeishi, Y				Shimizu, Takeshi; Yoshihisa, Akiomi; Takiguchi, Mai; Miura, Shunsuke; Nakamura, Yuichi; Yamauchi, Hiroyuki; Owada, Takashi; Abe, Satoshi; Suzuki, Satoshi; Takeishi, Yasuchika			Association between Hyperuricemia and Mortality in Heart Failure Patients with Preserved Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shimizu, Takeshi; Yoshihisa, Akiomi; Takiguchi, Mai; Miura, Shunsuke; Nakamura, Yuichi; Yamauchi, Hiroyuki; Owada, Takashi; Abe, Satoshi; Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP9-5	S169	S169				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100108		
J	Shingu, Y; Wakasa, S; Ooka, T; Tachibana, T; Matsui, Y				Shingu, Yasushige; Wakasa, Satoru; Ooka, Tomonori; Tachibana, Tsuyoshi; Matsui, Yoshiro			Stoke Work Index Predicts Left Ventricular Reverse Remodeling	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shingu, Yasushige; Wakasa, Satoru; Ooka, Tomonori; Tachibana, Tsuyoshi; Matsui, Yoshiro] Dept Cardiovasc & Thorac Surg, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS4-5	S157	S157				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100051		
J	Shinsato, T; Kawabata, T; Hamamoto, Y; Arikawa, T; Shimono, H				Shinsato, Takuro; Kawabata, Takeko; Hamamoto, Yuki; Arikawa, Tomoyoshi; Shimono, Hirokazi			Marked Improvement of Left Ventricular Function after Calcium Supplementation in a Patient with Severe Hypocalcemia Secondly to Idiopathic Hypoparathyroidism	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shinsato, Takuro; Kawabata, Takeko; Hamamoto, Yuki; Arikawa, Tomoyoshi; Shimono, Hirokazi] Sendai Med Assoc Hosp, Dept Cardiol, Sendai, Miyagi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP43-5	S194	S195				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100242		
J	Shiotani, Y; Saitoh, M; Sakamoto, J; Suzuki, H; Nakazawa, M; Watanabe, T; Isege, T; Okamura, D				Shiotani, Yohei; Saitoh, Masakazu; Sakamoto, Junko; Suzuki, Hidetoshi; Nakazawa, Mariko; Watanabe, Takeshi; Isege, Takashi; Okamura, Daisuke			Determinant of Hospital Discharge Destination in Octogenarian Patients with Heart Failure: Multicenter Observation Cohort Study	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shiotani, Yohei; Saitoh, Masakazu] Sakakibara Heart Inst, Tokyo, Japan; [Sakamoto, Junko; Suzuki, Hidetoshi] Mitsui Mem Hosp, Tokyo, Japan; [Nakazawa, Mariko; Watanabe, Takeshi] Ayase Heart Hosp, Tokyo, Japan; [Isege, Takashi] Kawakita Gen Hosp, Tokyo, Japan; [Okamura, Daisuke] St Lukes Int Hosp, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA3-4	S148	S148				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100014		
J	Shioyama, W; Mukai, M; Oka, T; Tone, E; Awata, N; Hori, M				Shioyama, Wataru; Mukai, Mikio; Oka, Toru; Tone, Eirou; Awata, Nobuhisa; Hori, Masatsugu			Cardiotoxicity Associated with Trastuzumab in Breast Cancer Patients: Definition of Cancer Therapeutics-Related Cardiac Dysfunction (CTRCD)	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shioyama, Wataru; Mukai, Mikio; Oka, Toru; Tone, Eirou; Awata, Nobuhisa; Hori, Masatsugu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Cardiol, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP43-1	S194	S194				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100239		
J	Shiraishi, H; Shirayama, T; Nakanishi, N; Nakamura, T; Yamano, T; Matsumuro, A				Shiraishi, Hirokazu; Shirayama, Takeshi; Nakanishi, Naohiko; Nakamura, Takeshi; Yamano, Tetsuhiro; Matsumuro, Akiyoshi			The Evaluation of Nutrition Status and its Relationship to Exercise Tolerance in Heart Failure Patients after Device Implantation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shiraishi, Hirokazu; Shirayama, Takeshi; Nakanishi, Naohiko; Nakamura, Takeshi; Yamano, Tetsuhiro; Matsumuro, Akiyoshi] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY3-5	S151	S151				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100025		
J	Shirakawa, T; Mizoguchi, H; Kikuchi, K; Yoshitatu, M				Shirakawa, Takashi; Mizoguchi, Hiroki; Kikuchi, Kosuke; Yoshitatu, Masao			Morphological Analysis of Double-Chambered Right Ventricle by Using Three-dimensional Printing Technology	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Shirakawa, Takashi; Mizoguchi, Hiroki; Kikuchi, Kosuke; Yoshitatu, Masao] Kansai Rosai Hosp, Dept Cardiovasc Surg, Amagasaki, Hyogo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP32-2	S185	S185				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100191		
J	Suetomi, T; Tamitani, M; Hino, A; Miyazaki, Y; Ono, M; Mochizuki, M; Oda, T; Kobayashi, S; Yamamoto, T; Yano, M				Suetomi, Takeshi; Tamitani, Masaki; Hino, Akihiro; Miyazaki, Yosuke; Ono, Makoto; Mochizuki, Mamoru; Oda, Tetsuro; Kobayashi, Shigeki; Yamamoto, Takeshi; Yano, Masafumi			Tolvaptan Retains Proportion of Body Fluid Compartments during Treatment of Decompensated Heart Failure: Two Case Reports	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Suetomi, Takeshi; Tamitani, Masaki; Hino, Akihiro; Miyazaki, Yosuke; Ono, Makoto; Mochizuki, Mamoru; Oda, Tetsuro; Kobayashi, Shigeki; Yamamoto, Takeshi; Yano, Masafumi] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Div Cardiol, Ube, Yamaguchi 755, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP9-5	S204	S204				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100293		
J	Sugie, M; Takahashi, T; Nara, M; Tanaka, J; Ishikawa, J; Fujimoto, H; Koyama, T; Kyo, S; Harada, K				Sugie, Masamitsu; Takahashi, Tetsuya; Nara, Marina; Tanaka, Jun; Ishikawa, Jouji; Fujimoto, Hajime; Koyama, Teruyuki; Kyo, Shunei; Harada, Kazumasa			Relationship between Skeletal Muscle Mass and Cardiac Function during Exercise in Chronically Ill Older Adults	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sugie, Masamitsu; Takahashi, Tetsuya; Tanaka, Jun; Ishikawa, Jouji; Fujimoto, Hajime; Koyama, Teruyuki; Kyo, Shunei; Harada, Kazumasa] Tokyo Metropolitan Geriatr Hosp, Dept Cardiol, Tokyo, Japan; [Takahashi, Tetsuya] Tokyo Univ Technol, Tokyo, Japan; [Nara, Marina] Ochanomizu Univ, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP33-5	S186	S187				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100198		
J	Sugie, T; Namiuchi, S; Takii, T; Saji, K; Kato, A				Sugie, Tadashi; Namiuchi, Shigeto; Takii, Toru; Saji, Kenya; Kato, Atsushi			A Combination of Anemia and High Levels of BNP is Indicative of In-Hospital Mortality of Patients with Acute Myocardial Infarction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sugie, Tadashi; Namiuchi, Shigeto; Takii, Toru; Saji, Kenya; Kato, Atsushi] Sendai Open Hosp, Dept Cardiovasc Med, Sendai, Miyagi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP24-3	S180	S180				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100165		
J	Sugihara, S; Yamada, K; Natubara, K; Kinugasa, Y; Kato, M; Yamamoto, K				Sugihara, Shinobu; Yamada, Kensaku; Natubara, Kouichi; Kinugasa, Yoshiharu; Kato, Masahiko; Yamamoto, Kazuhiro			High Hyaluronic Acid Level Predicts Adverse Clinical Outcome in Patients with Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sugihara, Shinobu; Yamada, Kensaku; Natubara, Kouichi; Kinugasa, Yoshiharu; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Fac Med, Div Cardiovasc Med, Dept Mol Med & Therapeut, Yonago, Tottori 683, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP16-2	S173	S173				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100127		
J	Sugimura, K; Miura, M; Aoki, T; Tatebe, S; Yamamoto, S; Yaoita, N; Satoh, K; Miyata, S; Sakata, Y; Shimokawa, H				Sugimura, Koichiro; Miura, Masanobu; Aoki, Tatsuo; Tatebe, Shunsuke; Yamamoto, Saori; Yaoita, Nobuhiro; Satoh, Kimio; Miyata, Satoshi; Sakata, Yasuhiko; Shimokawa, Hiroaki			Prognostic Impacts of Diuretics in Japanese Patients with Chronic Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sugimura, Koichiro; Miura, Masanobu; Aoki, Tatsuo; Tatebe, Shunsuke; Yamamoto, Saori; Yaoita, Nobuhiro; Satoh, Kimio; Miyata, Satoshi; Sakata, Yasuhiko; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP9-1	S203	S204				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100289		
J	Sunagawa, Y; Sakurai, R; Funamoto, M; Katanasaka, Y; Asaikawa, T; Kan, T; Murakami, A; Wada, H; Hasegawa, K; Morimoto, T				Sunagawa, Yoichi; Sakurai, Ryoga; Funamoto, Masafumi; Katanasaka, Yasufumi; Asaikawa, Tomohiro; Kan, Toshiyuki; Murakami, Akira; Wada, Hiromichi; Hasegawa, Koji; Morimoto, Tatsuya			A Natural Polymethoxy Flavonoid, Nobiletin, Prevents Pressure-overload Induced Cardiac Hypertrophy in Mice	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sunagawa, Yoichi; Sakurai, Ryoga; Funamoto, Masafumi; Katanasaka, Yasufumi; Morimoto, Tatsuya] Univ Shizuoka, Sch Pharmaceut Sci, Div Mol Med, Shizuoka 4228526, Japan; [Asaikawa, Tomohiro; Kan, Toshiyuki] Univ Shizuoka, Sch Pharmaceut Sci, Synthet Organ & Med Chem, Shizuoka 4228526, Japan; [Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Sunagawa, Yoichi; Katanasaka, Yasufumi; Wada, Hiromichi; Hasegawa, Koji; Morimoto, Tatsuya] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Div Translat Res, Kyoto, Japan; [Morimoto, Tatsuya] Shinonoi Gen Hosp, Shizuoka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP1-5	S197	S198				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100257		
J	Sunamura, S; Satoh, K; Suzuki, K; Omura, J; Kikuchi, N; Satoh, T; Kurosawa, R; Kudo, S; Ikeda, S; Shimokawa, H				Sunamura, Shinichiro; Satoh, Kimio; Suzuki, Kota; Omura, Junichi; Kikuchi, Nobuhiro; Satoh, Taijyu; Kurosawa, Ryo; Kudo, Shun; Ikeda, Shohei; Shimokawa, Hiroaki			ROCK1 Plays a Crucial Role to Maintain Cardiac Function in Response to Pressure-Overload in Mice	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Sunamura, Shinichiro; Satoh, Kimio; Suzuki, Kota; Omura, Junichi; Kikuchi, Nobuhiro; Satoh, Taijyu; Kurosawa, Ryo; Kudo, Shun; Ikeda, Shohei; Shimokawa, Hiroaki] Tohoku Univ, Dept Cardiol, Grad Sch Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP18-5	S175	S175				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100139		
J	Susawa, H; Mikami, S; Takemoto, H; Kobayashi, K; Tanaka, H; Tanaka, K				Susawa, Hitoshi; Mikami, Shinsuke; Takemoto, Hajime; Kobayashi, Kengo; Tanaka, Haruki; Tanaka, Kouichi			Clinical Features of Patients with Acute Decompensated Heart Failure Admitted in Winter Season	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Susawa, Hitoshi; Mikami, Shinsuke; Takemoto, Hajime; Kobayashi, Kengo; Tanaka, Haruki; Tanaka, Kouichi] Miyoshi City Cent Hosp, Dept Cradioligy, Miyoshi City, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP42-4	S194	S194				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100237		
J	Suzuki, A; Shiga, T; Iwanami, Y; Henmi, R; Yagishita, D; Ejima, K; Suzuki, T; Shoda, M; Hagiwara, N				Suzuki, Atsushi; Shiga, Tsuyoshi; Iwanami, Yuji; Henmi, Ryuta; Yagishita, Daigo; Ejima, Koichiro; Suzuki, Tsuyoshi; Shoda, Morio; Hagiwara, Nobuhisa			Implantable Cardioverter Defibrillator in Heart Failure Patients with End-stage Renal Disease on Dialysis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Suzuki, Atsushi; Shiga, Tsuyoshi; Iwanami, Yuji; Henmi, Ryuta; Yagishita, Daigo; Ejima, Koichiro; Suzuki, Tsuyoshi; Shoda, Morio; Hagiwara, Nobuhisa] Tokyo Womens Med Univ Hosp, Dept Cardiol, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS5-5	S158	S158				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100054		
J	Suzuki, C; Shyouin, K; Kato, T; Aizawa, K; Kamiyosi, Y; Aso, S; Aoki, S; Ikeda, U				Suzuki, Chihiro; Shyouin, Kyouko; Kato, Tamon; Aizawa, Katsuyuki; Kamiyosi, Yuichi; Aso, Shinichi; Aoki, Shizue; Ikeda, Uichi			Association between Clinical Features and Prolonged Hospitalization of Heart Failure Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Suzuki, Chihiro; Shyouin, Kyouko; Kato, Tamon; Aizawa, Katsuyuki; Kamiyosi, Yuichi; Aso, Shinichi] Aizawa Hosp, Dept Cardiol, Matsumoto, Nagano, Japan; [Aoki, Shizue] Aizawa Hosp, Med Informat Ctr, Matsumoto, Nagano, Japan; [Ikeda, Uichi] Sinshu Univ, Dept Cardiolohy, Matsumoto, Nagano, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		ES7-4	S161	S161				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100068		
J	Suzuki, H; Matsumoto, Y; Sugimura, K; Takahashi, J; Fukumoto, Y; Shimokawa, H				Suzuki, Hideaki; Matsumoto, Yasuharu; Sugimura, Kouichirou; Takahashi, Jun; Fukumoto, Yoshihiro; Shimokawa, Hiroaki			Evidence for Brain Activation in Patients with Takotsubo Cardiomyopathy A New Finding of Cardio-Cerebral Connection	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Suzuki, Hideaki; Matsumoto, Yasuharu; Sugimura, Kouichirou; Takahashi, Jun; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP10-2	S169	S169				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100110		
J	Suzuki, K; Satoh, K; Omura, J; Satoh, T; Kudo, S; Otsuki, T; Shimokawa, H				Suzuki, Kota; Satoh, Kimio; Omura, Junichi; Satoh, Taijyu; Kudo, Shin; Otsuki, Tomohiro; Shimokawa, Hiroaki			Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure-Overload in Mice	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Suzuki, Kota; Satoh, Kimio; Omura, Junichi; Satoh, Taijyu; Kudo, Shin; Otsuki, Tomohiro; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA2-3	S147	S147				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100009		
J	Suzuki, N; Kida, K; Suzuki, K; Omiya, K; Harada, T; Akashi, Y				Suzuki, Norio; Kida, Keisuke; Suzuki, Kengo; Omiya, Kazuto; Harada, Tomoo; Akashi, Yoshihiro			Malnutrition of Elderly Outpatients with Chronic Heart Failure is a Risk of Frailty	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Suzuki, Norio; Omiya, Kazuto] St Marianna Univ, Sch Med, Yokohama City Seibu Hosp, Div Cardiol,Dept Internal Med, Yokohama, Kanagawa, Japan; [Kida, Keisuke; Suzuki, Kengo; Harada, Tomoo; Akashi, Yoshihiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol, Kawasaki, Kanagawa, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP33-2	S186	S186				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100196		
J	Suzuki, S; Kitamukai, O				Suzuki, Shu; Kitamukai, Osamu			The Evaluation of Cardiac Function on SAS Patient	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Suzuki, Shu; Kitamukai, Osamu] Tohoku Kosai Hosp, Dept Cardiol, Sendai, Miyagi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP11-2	S170	S170				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100115		
J	Takahashi, K; Iino, T; Yamazaki, D; Watanabe, H; Ito, H				Takahashi, Kumiko; IIno, Takako; Yamazaki, Daisuke; Watanabe, Hiroyuki; Ito, Hiroshi			A Case of Spontaneous Submitral Aneurysm in a Patient with End-Stage Renal Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Takahashi, Kumiko; IIno, Takako; Yamazaki, Daisuke; Watanabe, Hiroyuki; Ito, Hiroshi] Akita Univ, Grad Sch Med, Dept Cardiovasc Med, Akita 010, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP4-3	S199	S200				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100267		
J	Takeda, H				Takeda, Hiromi			Cardiac Remodeling and Decreased Ejection Fraction in Hospitalized Patients with Cardiac Readmissions in Heart Failure That has Sleep-Disordered Breathing	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Takeda, Hiromi] Miyoshi Cent Hosp, Med Technol Port Inspect Dept, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP11-5	S171	S171				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100118		
J	Takenaka, R; Ito, K; Ksishi, T; Hirooka, Y				Takenaka, Risa; Ito, Koji; Ksishi, Takuya; Hirooka, Yoshitakaa			Pressure Overload-Induced Cardiac Hypertrophy Increases Brain-Derived Neurotrophic Factor in Nucleus Tractus Solitarius Suggesting Disruption of the Baroreflex Via Heart-to-Brain Axis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Takenaka, Risa] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka 812, Japan; [Ito, Koji] Japan Community Hlth Care Org Kyushu Hosp, Fukuoka, Japan; [Ksishi, Takuya] Kyushu Univ, Collaborat Res Inst Innovat Cardiovasc Dis, Ctr Disrupt Cardiovasc Med, Fukuoka 812, Japan; [Hirooka, Yoshitakaa] Kyushu Univ, Dept Adv Cardiovasc Regulat & Therapeut, Ctr Disrupt Cardiovasc Med, Fukuoka 812, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP21-1	S177	S177				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100149		
J	Takeuchi, H				Takeuchi, Hidekazu			Serum EPA plus DHA Levels Have a Direct Significant Negative Relationship to Serum CRP Levels in Cardiovascular Patients with a Normal Diet	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Takeuchi, Hidekazu] Nagasakiken Tomie Hosp, Nagasaki, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP27-4	S183	S183				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100180		
J	Takeuchi, H				Takeuchi, Hidekazu			Pulmonary Vein Thrombosis Can Potentially Cause Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Takeuchi, Hidekazu] Nagasakiken Tomie Hosp, Nagasaki, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP5-7	S201	S201				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100276		
J	Takeuchi, H				Takeuchi, Hidekazu			The Formation of a Pulmonary Vein Thrombus is Directional	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Takeuchi, Hidekazu] Nagasakiken Tomie Hosp, Nagasaki, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP5-6	S201	S201				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100275		
J	Tamaki, T; Hozumi, T; Shiono, Y; Orii, M; Yamano, T; Matsuo, Y; Ino, Y; Kubo, T; Tanaka, A; Akasaka, T				Tamaki, Tetsuya; Hozumi, Takeshi; Shiono, Yasutsugu; Orii, Makoto; Yamano, Takashi; Matsuo, Yoshiki; Ino, Yasushi; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi			A Case of Heart Failure Due to Increasing of Mitral Regurgitation	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tamaki, Tetsuya; Hozumi, Takeshi; Shiono, Yasutsugu; Orii, Makoto; Yamano, Takashi; Matsuo, Yoshiki; Ino, Yasushi; Kubo, Takashi; Tanaka, Atsushi; Akasaka, Takashi] Wakayama Med Univ, Wakayama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP19-3	S175	S175				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100142		
J	Tanaka, H; Matsumoto, K; Hirata, KI				Tanaka, Hidekazu; Matsumoto, Kensuke; Hirata, Ken-Ichi			Assessment of Bi-ventricular Contractile Reserve for Patients with Left-sided Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tanaka, Hidekazu; Matsumoto, Kensuke; Hirata, Ken-Ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY4-2	S152	S152				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100027		
J	Tanaka, Y; Takaishi, H				Tanaka, Yasushi; Takaishi, Hiroshi			The Impact of Aerobic Exercise Training with Vascular Occlusion in Patients with Chronic Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tanaka, Yasushi; Takaishi, Hiroshi] Yodogawa Christians Hosp, Dept Cardiol, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY3-4	S151	S151				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100024		
J	Taniguchi, T; Ohtani, T; Kioka, H; Tsukamoto, Y; Sakata, Y				Taniguchi, Tatsunori; Ohtani, Tomohito; Kioka, Hidetaka; Tsukamoto, Yasumasa; Sakata, Yasushi			Hepato-renal Interaction in Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Taniguchi, Tatsunori; Ohtani, Tomohito; Kioka, Hidetaka; Tsukamoto, Yasumasa; Sakata, Yasushi] Osaka Univ, Dept Cardiol, Grad Sch Med, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP37-3	S190	S190				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100215		
J	Tanno, M; Kuno, A; Horio, Y; Miura, T				Tanno, Masaya; Kuno, Atsushi; Horio, Yoshiyuki; Miura, Tetsuji			Regulation of Mitochondrial Functions by Sirtuin Proteins in Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tanno, Masaya; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Kuno, Atsushi; Horio, Yoshiyuki] Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS6-4	S158	S159				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100057		
J	Tatsuki, F; Mizuno, T; Oi, K; Yashima, M; Hachimaru, T; Nagaoka, E; Sasaoka, T; Isobe, M; Arai, H				Tatsuki, Fujiwara; Mizuno, Tomohiro; Oi, Keiji; Yashima, Masafumi; Hachimaru, Tsuyoshi; Nagaoka, Eiki; Sasaoka, Taro; Isobe, Mitsuaki; Arai, Hirokuni			The Review of Extracorporeal Ventricular Assist Device Use Post Approval of Implantable Ventricular Assist Device	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tatsuki, Fujiwara; Mizuno, Tomohiro; Oi, Keiji; Yashima, Masafumi; Hachimaru, Tsuyoshi; Nagaoka, Eiki; Arai, Hirokuni] Tokyo Med & Dent Univ, Dept Cardiovasc Surg, Tokyo, Japan; [Sasaoka, Taro; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP8-4	S168	S168				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100103		
J	Tokitsu, T; Yamamoto, E; Hirata, Y; Ogawa, H				Tokitsu, Takanori; Yamamoto, Eiichiro; Hirata, Yoshihiro; Ogawa, Hisao			The Clinical Significance of Pulse Pressure in Patients with Heart Failure with Preserved Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tokitsu, Takanori; Yamamoto, Eiichiro; Hirata, Yoshihiro; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Fac Life Sci, Dept Cardiovasc Med, Kumamoto, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA1-4	S146	S146				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100005		
J	Tokuhisa, T; Tanigawa, T; Harada, M; Moritani, K				Tokuhisa, Takahiro; Tanigawa, Taketo; Harada, Masahiko; Moritani, Koushirou			A Report That Interprofessional Work Could Bail Out Frequent Hospitalization for Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tokuhisa, Takahiro; Tanigawa, Taketo; Harada, Masahiko; Moritani, Koushirou] Ube Kohsan Cent Hospotal, Dept Cardiol, Ube, Yamaguchi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP13-5	S171	S171				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100120		
J	Toma, Y; Aizawa, N; Ikemiyagi, H; Shinzato, T; Ohshiro, K; Iwabuchi, M; Totsuka, Y; Inafuku, H; Kuniyoshi, Y; Ohya, Y				Toma, Yuichiro; Aizawa, Naoki; Ikemiyagi, Hidekazu; Shinzato, Tomoko; Ohshiro, Katsuhiko; Iwabuchi, Masashi; Totsuka, Yuichi; Inafuku, Hitoshi; Kuniyoshi, Yukio; Ohya, Yusuke			Bosentan, Tadarafil and Nitric Monoxide Inhalation Improved Right Heart Failure after Implantation of a Left Ventricular Assist Device	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Toma, Yuichiro; Aizawa, Naoki; Ikemiyagi, Hidekazu; Shinzato, Tomoko; Ohshiro, Katsuhiko; Iwabuchi, Masashi; Ohya, Yusuke] Univ Ryukyus, Dept Cardiovasc Med Nephrol & Neurol, Grad Sch Med, Nishihara, Okinawa 90301, Japan; [Totsuka, Yuichi; Inafuku, Hitoshi; Kuniyoshi, Yukio] Univ Ryukyus, Dept Thorac & Cardiovasc Surg, Grad Sch Med, Nishihara, Okinawa 90301, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP8-3	S168	S168				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100102		
J	Tsuboi, Y; Satomi-Kobayashi, S; Tanaka, H; Nakayama, K; Emoto, N; Hirata, KI				Tsuboi, Yasunori; Satomi-Kobayashi, Seimi; Tanaka, Hidekazu; Nakayama, Kazuhiko; Emoto, Noriaki; Hirata, Ken-Ichi			Cardiopulmonary Exercise Testing is Variable for Assessing Exercise Capacity and Hemodynamic Status in Patients with Chronic Thromboembolic Pulmonary Hypertension	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tsuboi, Yasunori] Kobe Univ, Grad Sch Med, Div Rehabil, Kobe, Hyogo 657, Japan; [Tsuboi, Yasunori; Satomi-Kobayashi, Seimi; Tanaka, Hidekazu; Nakayama, Kazuhiko; Emoto, Noriaki; Hirata, Ken-Ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA3-1	S148	S148				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100012		
J	Tsuchiya, H; Kioka, H; Nakamura, N; Nakamoto, K; Tsukamoto, Y; Ohtani, T; Yamaguchi, O; Sakata, Y				Tsuchiya, Hiromi; Kioka, Hidetaka; Nakamura, Norifumi; Nakamoto, Kei; Tsukamoto, Yasumasa; Ohtani, Tomohito; Yamaguchi, Osamu; Sakata, Yasushi			Bisoprolol Caused Warm Shock and Acute Kidney Injury in a Severe Heart Failure Patient	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tsuchiya, Hiromi; Kioka, Hidetaka; Nakamura, Norifumi; Nakamoto, Kei; Tsukamoto, Yasumasa; Ohtani, Tomohito; Yamaguchi, Osamu; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP39-4	S191	S191				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100225		
J	Tsuda, M; Kinugawa, S; Fukushima, A; Takada, S; Yokota, T; Matsushima, S; Furihata, T; Matsumoto, J; Tsutsui, H				Tsuda, Masaya; Kinugawa, Shintaro; Fukushima, Arata; Takada, Shingo; Yokota, Takashi; Matsushima, Shoji; Furihata, Takaaki; Matsumoto, Junichi; Tsutsui, Hiroyuki			Metabolomic Analysis Reveals New Insights Towards Understanding Skeletal Muscle Mass and Exercise Capacity in Patients with Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tsuda, Masaya; Kinugawa, Shintaro; Fukushima, Arata; Takada, Shingo; Yokota, Takashi; Matsushima, Shoji; Furihata, Takaaki; Matsumoto, Junichi; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP44-4	S195	S195				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100246		
J	Tsujiuchi, M; Ebato, M; Mizukami, T; Tanabe, A; Ikeda, N; Maezawa, H; Suzuki, H				Tsujiuchi, Miki; Ebato, Mio; Mizukami, Takuya; Tanabe, Ayaka; Ikeda, Naoko; Maezawa, Hideyuki; Suzuki, Hiroshi			Different Factors Influence the Left Atrial Longitudinal and Circumferential Strain	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tsujiuchi, Miki; Ebato, Mio; Mizukami, Takuya; Tanabe, Ayaka; Maezawa, Hideyuki; Suzuki, Hiroshi] Showa Univ, Fujigaoka Hosp, Tokyo, Japan; [Ikeda, Naoko] Showa Univ, Koto Toyosu Hosp, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP1-2	S162	S162				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100071		
J	Tsukada, Y; Kubota, Y; Murai, K; Asai, K; Satoh, N; Kusama, Y; Seino, Y; Shimizu, W				Tsukada, Yayoi; Kubota, Yoshiaki; Murai, Kouji; Asai, Kuniya; Satoh, Naoki; Kusama, Yoshiki; Seino, Yoshihiko; Shimizu, Wataru			What is the Best Way of the Medical Coordination to Support Elderly Patients with Chronic Heart Failure in Tokyo Area?	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tsukada, Yayoi; Kubota, Yoshiaki; Murai, Kouji; Asai, Kuniya; Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Satoh, Naoki] Musashi Kosugi Hosp, Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan; [Kusama, Yoshiki] Tama Nagayama Hosp, Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan; [Seino, Yoshihiko] Chiba Hokusou Hosp, Nippon Med Sch, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		ES7-5	S161	S161				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100069		
J	Tsukamoto, Y; Ohtani, T; Kioka, H; Yamaguchi, O; Toda, K; Sawa, Y; Sakata, Y				Tsukamoto, Yasumasa; Ohtani, Tomohito; Kioka, Hidetaka; Yamaguchi, Osamu; Toda, Koichi; Sawa, Yoshiki; Sakata, Yasushi			Therapeutic Strategy for Fulminant Myocarditis in Osaka University Hospital	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Tsukamoto, Yasumasa; Ohtani, Tomohito; Kioka, Hidetaka; Yamaguchi, Osamu; Sakata, Yasushi] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan; [Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Survery, Grad Sch Med, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD5-2	S154	S155				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100039		
J	Uehara, A; Obata, H; Watanabe, H; Izumi, Y; Suzuki, Y; Izumi, T				Uehara, Akifumi; Obata, Hiroaki; Watanabe, Hiroshi; Izumi, Yuki; Suzuki, Yorio; Izumi, Tohru			70% of Elderly Patients Got Total SPPB Score Over 9 Points after Rehabilitation Achieve a 6-min Walk Distance Over 300m	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Uehara, Akifumi; Watanabe, Hiroshi; Izumi, Yuki; Suzuki, Yorio; Izumi, Tohru] Niigataminami Hosp, Niigata, Japan; [Obata, Hiroaki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP33-4	S186	S186				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100197		
J	Uemura, Y; Imai, R; Miura, A; Mitsuda, T; Ishikawa, S; Koyasu, M; Uchikawa, T; Takemoto, K; Watarai, M				Uemura, Yusuke; Imai, Ryo; Miura, Ayako; Mitsuda, Takayuki; Ishikawa, Shinji; Koyasu, Masayoshi; Uchikawa, Tomohiro; Takemoto, Kenji; Watarai, Masato			Effect of Long-term Treatment of Tolvaptan in Patients with Acute Decompensated Heart Failure and Chronic Kidney Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Uemura, Yusuke; Imai, Ryo; Miura, Ayako; Mitsuda, Takayuki; Ishikawa, Shinji; Koyasu, Masayoshi; Uchikawa, Tomohiro; Takemoto, Kenji; Watarai, Masato] Anjo Kosei Hosp, Cardiovasc Ctr, Anjo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP25-4	S181	S181				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100171		
J	Uga, S; Higashi, A; Kinoshita, H; Sada, Y; Dohi, Y; Kihara, Y				Uga, Sayuri; Higashi, Akifumi; Kinoshita, Hiroki; Sada, Yoshiharu; Dohi, Yoshihiro; Kihara, Yasuki			Prognostic Factors for Survival in Patients with Pulmonary Hypertension Due to Left Heart Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Uga, Sayuri; Higashi, Akifumi; Kinoshita, Hiroki; Sada, Yoshiharu; Dohi, Yoshihiro; Kihara, Yasuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Med, Hiroshima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY4-1	S151	S152				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100026		
J	Umeyama, A; Takama, N; Goto, K; Nakajima, M; Higuchi, K; Yamagishi, T; Kurabayashi, M				Umeyama, Atsushi; Takama, Noriaki; Goto, Keita; Nakajima, Masahiro; Higuchi, Kyosuke; Yamagishi, Takahiro; Kurabayashi, Masahiko			Low Integrated Area of Desaturation Index after ASV Therapy is Strong Indicator to Predict Cardiovascular Events in Heart Failure Patients	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Umeyama, Atsushi; Goto, Keita; Nakajima, Masahiro; Higuchi, Kyosuke; Yamagishi, Takahiro] Isesaki City Hosp, Div Cardioligy, Isesaki, Japan; [Umeyama, Atsushi; Takama, Noriaki; Kurabayashi, Masahiko] Gunma Univ, Sch Med, Dept Cardiovasc Med, Maebashi, Gumma 371, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP29-4	S184	S184				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100184		
J	Ushigome, R; Sakata, Y; Nochioka, K; Miyata, S; Miura, M; Tadaki, S; Sato, K; Yamauchi, T; Onose, T; Shimokawa, H				Ushigome, Ryoichi; Sakata, Yasuhiko; Nochioka, Kotaro; Miyata, Satoshi; Miura, Masanobu; Tadaki, Soichiro; Sato, Kenjiro; Yamauchi, Takeshi; Onose, Takeo; Shimokawa, Hiroaki			Temporal Trends in Drug Therapies and Clinical Outcomes in Patients with Symptomatic Heart Failure: Lessons from the CHART Studies	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Ushigome, Ryoichi; Sakata, Yasuhiko; Nochioka, Kotaro; Miura, Masanobu; Tadaki, Soichiro; Sato, Kenjiro; Yamauchi, Takeshi; Onose, Takeo; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Miyata, Satoshi; Miura, Masanobu] Tohoku Univ, Grad Sch Med, Dept Evidence Based Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP37-1	S189	S189				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100213		
J	Wada, Y; Aiba, T; Tsujita, Y; Itoh, H; Anzai, T; Yasuda, S; Horie, M; Ogawa, H; Kusano, K				Wada, Yuko; Aiba, Takeshi; Tsujita, Yasuyuki; Itoh, Hideki; Anzai, Toahihisa; Yasuda, Satoshi; Horie, Minoru; Ogawa, Hisao; Kusano, Kengo			Practical Applicability of Landiolol for Rapid AF and Refractory VT with Advanced LV Dysfunction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Wada, Yuko; Aiba, Takeshi; Anzai, Toahihisa; Yasuda, Satoshi; Ogawa, Hisao; Kusano, Kengo] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan; [Wada, Yuko; Itoh, Hideki; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc Med, Otsu, Shiga 52021, Japan; [Tsujita, Yasuyuki] Shiga Univ Med Sci, Dept Crit & Intensice Care Med, Otsu, Shiga 52021, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS5-2	S158	S158				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100053		
J	Watanabe, N; Okumura, T; Kondo, T; Kano, N; Fukaya, K; Sawamura, A; Morimoto, R; Shintani, S; Bando, Y; Murohara, T				Watanabe, Naoki; Okumura, Takahiro; Kondo, Toru; Kano, Naoaki; Fukaya, Kenji; Sawamura, Akinori; Morimoto, Ryuta; Shintani, Satoshi; Bando, Yasuko; Murohara, Toyoaki			The Nutritional CONUT Score Predicts Short- and Long-Term Prognosis in Super-Elderly Patients with Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Watanabe, Naoki; Okumura, Takahiro; Kondo, Toru; Kano, Naoaki; Fukaya, Kenji; Sawamura, Akinori; Morimoto, Ryuta; Shintani, Satoshi; Bando, Yasuko; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP27-1	S182	S183				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100177		
J	Watanabe, T; Seguchi, O; Fujita, T; Yanase, M; Nishimura, K; Hata, H; Miyamoto, Y; Fukushima, N; Kobayashi, J; Nakatani, T				Watanabe, Takuya; Seguchi, Osamu; Fujita, Tomoyuki; Yanase, Masanobu; Nishimura, Kunihiro; Hata, Hiroki; Miyamoto, Yoshihiro; Fukushima, Norihide; Kobayashi, Junjiro; Nakatani, Takeshi			Poor Flow-Mediated Dilation of Brachial Artery in Heart Transplant Recipients is Associated with Severity of Transplant Coronary Arterial Vasculopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Watanabe, Takuya; Seguchi, Osamu; Fujita, Tomoyuki; Yanase, Masanobu; Nishimura, Kunihiro; Hata, Hiroki; Miyamoto, Yoshihiro; Fukushima, Norihide; Kobayashi, Junjiro; Nakatani, Takeshi] Natl Cerebral & Cardiovasc Ctr, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP5-5	S166	S166				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100090		
J	Watanabe, T; Kashimura, T; Obata, H; Hanawa, H; Mijnamino, T				Watanabe, Tohru; Kashimura, Takeshi; Obata, Hiroaki; Hanawa, Haruo; Mijnamino, Tohru			Rationale for Endomyocardial Biopsy of Heart Failure Patients Who Have Responded to Usual Care	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Watanabe, Tohru; Kashimura, Takeshi; Obata, Hiroaki; Hanawa, Haruo; Mijnamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP4-4	S200	S200				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100268		
J	Yajima, S; Toda, K; Fukushima, S; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Saitou, S; Yoshioka, D; Sawa, Y				Yajima, Shin; Toda, Kouichi; Fukushima, Satsuki; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Saitou, Shunsuke; Yoshioka, Daisuke; Sawa, Yoshiki			Preoperative LV End-diastolic Volume is a Single Predictive Factor of Functional Recovery after Coronary Artery Bypass Grafting for Ischaemic Cardiomyopathy	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yajima, Shin; Toda, Kouichi; Fukushima, Satsuki; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Saitou, Shunsuke; Yoshioka, Daisuke; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP5-1	S165	S165				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100086		
J	Yamada, S				Yamada, Sumio			Starting Process of Large Prospective Rehabilitation Cohort Study. FLAGSHIP	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamada, Sumio] Nagoya Univ, Grad Sch Med, Dept Hlth Sci, Nagoya, Aichi 4648601, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS9-4	S159	S159				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100062		
J	Yamada, Y; Yamamoto, M; Nakagawa, D; Satou, K; Sugano, A; Harimura, Y; Machino, T; Ishidu, T; Seo, Y; Aonuma, K				Yamada, Yu; Yamamoto, Masayoshi; Nakagawa, Daishi; Satou, Kimi; Sugano, Akinori; Harimura, Yoshie; Machino, Tomoko; Ishidu, Tomoko; Seo, Yoshihiro; Aonuma, Kazutaka			Elevated Central Venous Pressure Estimated by Echocardiography Associates with Increased Neurohumoral Activity and Renal Insufficiency in Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamada, Yu; Yamamoto, Masayoshi; Nakagawa, Daishi; Satou, Kimi; Sugano, Akinori; Harimura, Yoshie; Machino, Tomoko; Ishidu, Tomoko; Seo, Yoshihiro; Aonuma, Kazutaka] Univ Tsukuba, Dept Cardiol, Tsukuba, Ibaraki, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP41-1	S192	S192				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100229		
J	Yamaguchi, M; Funimami, T; Shigeta, T; Koura, K; Ishimaru, G; Okada, H; Inagaki, H; Toshida, N; Takamoto, T; Isobe, M				Yamaguchi, Masao; Funimami, Tatsuya; Shigeta, Takatoshi; Koura, Kenji; Ishimaru, Go; Okada, Hiroyuki; Inagaki, Hiroshi; Toshida, Nobuo; Takamoto, Toshihiko; Isobe, Mitsuaki			Two Successful Cases of Tolvaptan Therapy for Water Retention in Patients with Adult Congenital Heart Disease	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamaguchi, Masao; Funimami, Tatsuya; Shigeta, Takatoshi; Koura, Kenji; Ishimaru, Go; Okada, Hiroyuki; Inagaki, Hiroshi; Toshida, Nobuo; Takamoto, Toshihiko] Soka Municipal Hosp, Dept Cardiol, Soka, Japan; [Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP32-4	S186	S186				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100193		
J	Yamaji, M				Yamaji, Masayuki			Impact of Statin Prescription on Cardiac Events in Patients with High CRP after Acute Myocardial Infarction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamaji, Masayuki] Koto Mem Hosp, Dept Cardiol, Higashiohmi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP7-3	S202	S203				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100284		
J	Yamaji, M				Yamaji, Masayuki			A Simple Risk Index is Useful Predictor of In-hospital Mortality after Acute Myocardial Infarction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamaji, Masayuki] Koto Mem Hosp, Dept Cardiol, Higashiohmi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP2-7	S199	S199				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100264		
J	Yamamoto, M; Seo, Y; Aonuma, K				Yamamoto, Masayoshi; Seo, Yoshihiro; Aonuma, Kazutaka			Effects of Cardiac Resynchronization Therapy in Patients with Cardiac Sarcoidosis similar to Insight from J-CRT Registry and START study similar to	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamamoto, Masayoshi; Seo, Yoshihiro; Aonuma, Kazutaka] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Clin Med, Cardiovasc Div, Ibaraki, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PD4-4	S154	S154				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100036		
J	Yamamoto, M; Ishizu, T; Kawamatsu, N; Sato, K; Sai, S; Sugano, A; Kyo, T; Murakoshi, N; Seo, Y; Aonuma, K				Yamamoto, Masayoshi; Ishizu, Tomoko; Kawamatsu, Naoto; Sato, Kimi; Sai, Seika; Sugano, Akinori; Kyo, Tousyu; Murakoshi, Nobuyuki; Seo, Yoshihiro; Aonuma, Kazutaka			Is DPP-4 Inhibitor for Heart Failure Beneficial or Harmful? Research on Teneligliptin in Heart Failure Model Rats	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamamoto, Masayoshi; Ishizu, Tomoko; Kawamatsu, Naoto; Sato, Kimi; Sai, Seika; Sugano, Akinori; Kyo, Tousyu; Murakoshi, Nobuyuki; Seo, Yoshihiro; Aonuma, Kazutaka] Univ Tsukuba, Div Cardiovasc, Inst Clin Med, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP21-4	S177	S178				2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100152		
J	Yamamoto, T; Shinmura, K; Sano, M; Endo, J; Fukuda, K				Yamamoto, Tsunehisa; Shinmura, Ken; Sano, Motoaki; Endo, Jin; Fukuda, Keiichi			Cardiac Sirt1 Mediates the Cardioprotective Effect of Caloric Restriction by Suppressing Local Complement System Activation after Ischemia/Reperfusion	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamamoto, Tsunehisa; Sano, Motoaki; Endo, Jin; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 108, Japan; [Shinmura, Ken] Hyogo Coll Med, Dept Internal Med, Div Gen Med, Nishinomiya, Hyogo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		YA2-2	S147	S147				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100008		
J	Yamamuro, M; Takashio, S; Uemura, T; Kaikita, K; Hokimoto, S; Ogawa, H				Yamamuro, Megumi; Takashio, Seiji; Uemura, Tomoaki; Kaikita, Koichi; Hokimoto, Seiji; Ogawa, Hisao			Cardiac Troponin T Release Level and Coronary Microvascular Dysfunction in Non-Ischemic Heart Failure Patients with Cardiac Fibrosis	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamamuro, Megumi; Uemura, Tomoaki; Kaikita, Koichi; Hokimoto, Seiji; Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 860, Japan; [Takashio, Seiji; Ogawa, Hisao] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		SY4-5	S152	S152				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100029		
J	Yamauchi, T; Sakata, Y; Miura, M; Tadaki, S; Ushigome, R; Sato, K; Onose, T; Tsuji, K; Miyata, S; Shimokawa, H				Yamauchi, Takeshi; Sakata, Yasuhiko; Miura, Masanobu; Tadaki, Soichiro; Ushigome, Ryoichi; Sato, Kenjiro; Onose, Takeo; Tsuji, Kanako; Miyata, Satoshi; Shimokawa, Hiroaki			Prognostic Impact of De-novo Atrial Fibrillation in Patients with Chronic Heart Failure - A Report from the CHART-2 Study	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yamauchi, Takeshi; Sakata, Yasuhiko; Tadaki, Soichiro; Ushigome, Ryoichi; Sato, Kenjiro; Onose, Takeo; Tsuji, Kanako; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Miura, Masanobu; Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Evidenced Based Cardiovasc Med, Sendai, Miyagi 980, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP15-3	S172	S172				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100123		
J	Yano, M; Akazawa, H; Yabumoto, C; Sakata, Y; Komuro, I				Yano, Masamichi; Akazawa, Hiroshi; Yabumoto, Chizuru; Sakata, Yasushi; Komuro, Issei			Monocyte-derived Extracellular Nampt-dependent Biosynthesis of Myocardial NAD plus Protects the Heart against Pressure Overload	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yano, Masamichi; Yabumoto, Chizuru; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Akazawa, Hiroshi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138654, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP21-5	S178	S178				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100153		
J	Yasuda, Y; Okada, T; Endo, A; Tanabe, K				Yasuda, Yu; Okada, Taiji; Endo, Akihiro; Tanabe, Kazuaki			Optimization by QuickOpt (TM) improves Echocardiographic Response to Cardiac Resynchronization Therapy: A Case Report	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yasuda, Yu; Okada, Taiji; Endo, Akihiro; Tanabe, Kazuaki] Shimane Univ, Fac Med, Div Cardiol, Matsue, Shimane, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		PP6-2	S201	S201				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100278		
J	Yasumura, K; Nishino, M; Okamoto, N; Tanaka, A; Mori, N; Yano, M; Makino, N; Egami, Y; Shutta, R; Tanouchi, J				Yasumura, Keisuke; Nishino, Masami; Okamoto, Naotaka; Tanaka, Akihiro; Mori, Naoki; Yano, Masamichi; Makino, Nobuhiko; Egami, Yasuyuki; Shutta, Ryu; Tanouchi, Jun			A Case of Cardiac Sarcoidosis with Severe Mitral Regurgitation Who Underwent Mitral Valve Replacement to Control Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yasumura, Keisuke; Nishino, Masami; Okamoto, Naotaka; Tanaka, Akihiro; Mori, Naoki; Yano, Masamichi; Makino, Nobuhiko; Egami, Yasuyuki; Shutta, Ryu; Tanouchi, Jun] Osaka Rosai Hosp, Div Cardiol, Sakai, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP2-2	S163	S163				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100076		
J	Yasunori, S; Hayashi, T; Asano, Y; Takashima, S				Yasunori, Shintani; Hayashi, Takaharu; Asano, Yoshihiro; Takashima, Seiji			Higd1a Positively Regulates Cytochrome c oxidase	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yasunori, Shintani; Hayashi, Takaharu; Asano, Yoshihiro; Takashima, Seiji] Osaka Univ, Dept Med Biochem, Grad Sch Med, Suita, Osaka, Japan; [Hayashi, Takaharu; Asano, Yoshihiro] Osaka Univ, Dept Cardiol, Grad Sch Med, Suita, Osaka, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP18-1	S174	S174				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100135		
J	Yatsu, S; Kasai, T; Suda, S; Matsumoto, H; Murata, A; Kato, T; Hiki, M; Mitauchi, K; Daida, H				Yatsu, Shoichiro; Kasai, Takatoshi; Suda, Shoko; Matsumoto, Hiroki; Murata, Azusa; Kato, Takao; Hiki, Masaru; Mitauchi, Katsumi; Daida, Hiroyuki			Impact of Periodic Leg Movements during Sleep on Prognosis in Hospitalized Patients Following Acute Decompensated Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yatsu, Shoichiro; Kasai, Takatoshi; Suda, Shoko; Matsumoto, Hiroki; Murata, Azusa; Kato, Takao; Hiki, Masaru; Mitauchi, Katsumi; Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan; [Kasai, Takatoshi; Suda, Shoko; Matsumoto, Hiroki] Juntendo Univ, Grad Sch Med, Cardio Resp Sleep Med, Tokyo, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP6-3	S166	S166				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100093		
J	Yazaki, Y; Ono, T; Iijima, R; Hara, H; Nakamura, M; Sugi, K				Yazaki, Yoshiyuki; Ono, Tsuyoshi; Iijima, Raisuke; Hara, Hidehiko; Nakamura, Masato; Sugi, Kaoru			Overload of Extracellular Water and Clinical Scenario 1 was Associated with Poor Clinical Outcomes in Patients with Acute Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yazaki, Yoshiyuki; Ono, Tsuyoshi; Iijima, Raisuke; Hara, Hidehiko; Nakamura, Masato; Sugi, Kaoru] Toho Univ, Med Ctr, Ohashi Hosp, Dept Cardiol,Meguro Ku, Ohashi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP41-2	S192	S192				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100230		
J	Yokoyama, J; Toda, K; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Saito, S; Yoshioka, D; Sawa, Y				Yokoyama, Junya; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Sawa, Yoshiki			A Surgical Case of Aortic and Mitral Insufficiency, Constrictive Pericarditis and Cardiomyopathy Induced by Radiation Therapy for Esophageal Cancer	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yokoyama, Junya; Toda, Koichi; Nakamura, Teruya; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Yoshioka, Daisuke; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 565, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP5-4	S165	S165				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100089		
J	Yoshida, S; Toda, K; Fukushima, S; Yoshikawa, Y; Nakamura, T; Miyagawa, S; Saito, S; Yoshioka, D; Kuratani, T; Sawa, Y				Yoshida, Shohei; Toda, Koichi; Fukushima, Satsuki; Yoshikawa, Yasushi; Nakamura, Teruya; Miyagawa, Shigeru; Saito, Shunsuke; Yoshioka, Daisuke; Kuratani, Toru; Sawa, Yoshiki			Left Ventricular Anatomy and Geometry by 64-slice Multi-Detector Computed Tomography in Patients with Low Left Ventricular Function	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yoshida, Shohei; Toda, Koichi; Fukushima, Satsuki; Yoshikawa, Yasushi; Nakamura, Teruya; Miyagawa, Shigeru; Saito, Shunsuke; Yoshioka, Daisuke; Kuratani, Toru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 565, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP45-3	S196	S196				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100250		
J	Yoshida, Y; Shimizu, I; Goro, K; Suda, M; Hayashi, Y; Jiao, S; Minamino, T				Yoshida, Yohko; Shimizu, Ippei; Goro, Katsuumi; Suda, Masayoshi; Hayashi, Yuka; Jiao, Shuang; Minamino, Tohru			p53-Induced Inflammation Exacerbates Cardiac Dysfunction during Pressure Overload	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yoshida, Yohko; Shimizu, Ippei; Goro, Katsuumi; Suda, Masayoshi; Hayashi, Yuka; Jiao, Shuang; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Yoshida, Yohko; Shimizu, Ippei] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Niigata, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP21-2	S177	S177				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100150		
J	Yoshihisa, A; Kanno, Y; Shimizu, T; Hiroyuki, Y; Sato, T; Suzuki, S; Oikawa, M; Kobayashi, A; Saitoh, SI; Takeishi, Y				Yoshihisa, Akiomi; Kanno, Yuki; Shimizu, Takeshi; Hiroyuki, Yamauchi; Sato, Takamasa; Suzuki, Satoshi; Oikawa, Masayoshi; Kobayashi, Atsushi; Saitoh, Shu-Ichi; Takeishi, Yasuchika			Beneficial Effects of Positive Airway Pressure Therapy for Sleep-Disordered Breathing in Heart Failure Patients with Preserved Left Ventricular Ejection Fraction	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yoshihisa, Akiomi; Kanno, Yuki; Shimizu, Takeshi; Hiroyuki, Yamauchi; Sato, Takamasa; Suzuki, Satoshi; Oikawa, Masayoshi; Kobayashi, Atsushi; Saitoh, Shu-Ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		WS1-5	S156	S156				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100043		
J	Yoshimura, K; Yuguchi, S; Saito, K; Otsuka, S; Kouchi, Y; Seike, E; Urabe, Y; Maeda, N; Yoshida, T				Yoshimura, Kae; Yuguchi, Satoshi; Saito, Kazuya; Otsuka, Shota; Kouchi, Yuumi; Seike, Eiji; Urabe, Yukio; Maeda, Noriaki; Yoshida, Toshinobu			The Relationship between Grip Strength and Oxygen Consumption during Corridor Walk in Patients with Chronic Heart Failure	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yoshimura, Kae; Yuguchi, Satoshi; Saito, Kazuya; Otsuka, Shota; Kouchi, Yuumi; Seike, Eiji] Sakakibara Heart Inst Okayama, Div Rehabil, Okayama, Japan; [Yoshimura, Kae; Urabe, Yukio; Maeda, Noriaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Yoshida, Toshinobu] Sakakibara Heart Inst Okayama, Div Cardiovasc Med, Okayama, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP3-4	S164	S164				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100081		
J	Yoshioka, S; Shimozato, T; Ohtake, H; Nakamura, M; Tanaka, A; Aoyama, H; Kato, K; Kametani, R				Yoshioka, Shingo; Shimozato, Takashi; Ohtake, Hirotaka; Nakamura, Masayuki; Tanaka, Akimitsu; Aoyama, Hidekazu; Kato, Kazuo; Kametani, Ryosuke			Chronic Heart Failure with Reduced Ejection Fraction Due to Cardiac Sarcoidosis Complicated Coronary Vasospastic Angina	JOURNAL OF CARDIAC FAILURE			English	Meeting Abstract	19th Annual Scientific Meeting of Japanese-Heart-Failure-Society	OCT 22-24, 2015	Osaka, JAPAN	Japanese Heart Failure Soc					[Yoshioka, Shingo; Shimozato, Takashi; Ohtake, Hirotaka; Nakamura, Masayuki; Tanaka, Akimitsu; Aoyama, Hidekazu; Kato, Kazuo; Kametani, Ryosuke] Nagoya Tokushukai Gen Hosp, Dept Cardiol, Kasugai, Aichi, Japan								0	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	1071-9164	1532-8414		J CARD FAIL	J. Card. Fail.	OCT	2015	21	10		S		OP2-4	S163	S163				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CT2HR	WOS:000362623100078		
J	Fuchigami, T; Gabe, A; Takahashi, K; Nishioka, M; Akashige, T; Nagata, N				Fuchigami, Tai; Gabe, Atsushi; Takahashi, Kazuhiro; Nishioka, Masahiko; Akashige, Toru; Nagata, Nobuhiro			Thoracoscopic Surgery for Partial Anomalous Pulmonary Venous Connection with Dual Drainage	JOURNAL OF CARDIAC SURGERY			English	Article							AMPLATZER VASCULAR PLUG; CLOSURE; RETURN	We report our technique for thoracoscopic surgery for a 15-year-old female (body weight, 59kg) diagnosed with partial anomalous pulmonary venous connection with dual drainage. A large anomalous right lower pulmonary vein (RLPV) was drained into the inferior vena cava and left atrium, along with thoracoscopic ligation and clipping of RLPV and some anomalous hepatic veins. doi: 10.1111/jocs.12606 (J Card Surg 2015;30:764-766)	[Fuchigami, Tai; Nishioka, Masahiko; Akashige, Toru; Nagata, Nobuhiro] Okinawa Prefectural Nanbu Med Ctr, Dept Pediat Cardiovasc Surg, Haebaru, Okinawa 9011193, Japan; [Fuchigami, Tai; Gabe, Atsushi; Takahashi, Kazuhiro; Nishioka, Masahiko; Akashige, Toru; Nagata, Nobuhiro] Childrens Med Ctr, Haebaru, Okinawa, Japan; [Gabe, Atsushi] Okinawa Prefectural Nanbu Med Ctr, Thorac Surg, Haebaru, Okinawa 9011193, Japan; [Takahashi, Kazuhiro] Okinawa Prefectural Nanbu Med Ctr, Pediat Cardiol, Haebaru, Okinawa 9011193, Japan	Fuchigami, T (reprint author), Okinawa Prefectural Nanbu Med Ctr, Dept Pediat Cardiovasc Surg, Arakawa 118-1, Haebaru, Okinawa 9011193, Japan.	taifuchigami@yahoo.co.jp					Luciano D, 2013, INT J CARDIOL, V170, P221, DOI 10.1016/j.ijcard.2013.10.061; Patel S, 2014, INT J CARDIOL, V174, P770, DOI 10.1016/j.ijcard.2014.04.075; Guneyli S, 2014, DIAGN INTERV RADIOL, V20, P155, DOI 10.5152/dir.2013.13139; TAKEDA S, 1994, CHEST, V105, P292, DOI 10.1378/chest.105.1.292; Wiegand G, 2013, PEDIATR CARDIOL, V34, P1668, DOI 10.1007/s00246-013-0701-9	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-0440	1540-8191		J CARDIAC SURG	J. Card. Surg.	OCT	2015	30	10					764	766		10.1111/jocs.12606		3	Cardiac & Cardiovascular Systems; Surgery	Cardiovascular System & Cardiology; Surgery	CS9JF	WOS:000362406100006		
J	Krajci, M; Tsai, AP; Hafner, J				Krajci, M.; Tsai, A. -P.; Hafner, J.			Understanding the selectivity of methanol steam reforming on the (111) surfaces of NiZn, PdZn and PtZn: Insights from DFT	JOURNAL OF CATALYSIS			English	Article						Methanol steam reforming; Selectivity; Intermetallic compounds; NiZn; PdZn; PtZn; Density-functional theory	INTERMETALLIC COMPOUND ZNPD; AUGMENTED-WAVE METHOD; CATALYTIC FUNCTIONS; ALLOY CATALYSTS; SUPPORTED PD2GA; IN-SITU; DECOMPOSITION; CU(111); ADSORPTION; PD(111)	This work is focused on better understanding of the origin of CO2/CO selectivity of methanol steam reforming (MSR) catalyzed by three isostructural (L1(0)-type) intermetallic compounds NiZn, PdZn, and PtZn. Following earlier suggestions we assume that the selectivity of MSR arises from the competition between two possible transformations of the reaction intermediate formaldehyde: the reaction of formaldehyde with hydroxyl leading ultimately to the formation of CO2, and the direct dehydrogenation of formaldehyde leading to the production of CO. We have investigated whether the differences in the activation energies for these steps explain the experimentally observed trends in selectivity. Using density-functional theory detailed atomistic scenarios for both reactions have been developed. As in vacuum the reaction of formaldehyde with hydroxyl is non-activated, it does not need the support of a catalyst to proceed. There is a clear correlation between high CO2 selectivities and weak adsorption energies of formaldehyde. On the L1(0)(111) surfaces we have to consider the existence of four inequivalent adsorption sites, caused by the monoclinic shift of subsurface atomic planes resulting from tetragonal deformation of the L10 structure. At PtZn(111) this shift could explain the observed mixed CO2/CO selectivity of the Pan catalyst. The proposed mechanism of selectivity can qualitatively explain the experimentally observed selectivities of the investigated intermetallic compounds. Our results can contribute also to understanding the influence of the ZnO support and the Zn-enriched PdZn surface on the selectivity of the MSR process. The possibilities how to improve the CO2 selectivity of the catalyst are also presented. (C) 2015 Elsevier Inc. All rights reserved.	[Krajci, M.] Slovak Acad Sci, Inst Phys, SK-84511 Bratislava, Slovakia; [Tsai, A. -P.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Hafner, J.] Univ Vienna, Fak Phys, A-1090 Vienna, Austria; [Hafner, J.] Univ Vienna, Ctr Computat Mat Sci, A-1090 Vienna, Austria	Krajci, M (reprint author), Slovak Acad Sci, Inst Phys, Dubravska Cesta 9, SK-84511 Bratislava, Slovakia.				Austrian Ministry for Science through the Center for Computational Materials Science; Grant Agency for Science of Slovakia [2/0189/14]; CEX FUN-MAT; Slovak Research and Development Agency [APVV-0647-10, APVV-0076-11, APVV-0492-11]; Research and Development Operational Programme - ERDF [ITMS 26230120002, 26210120002]	This work has been supported by the Austrian Ministry for Science through the Center for Computational Materials Science. M.K. thanks also for support from the Grant Agency for Science of Slovakia (No. 2/0189/14), from CEX FUN-MAT, and from the Slovak Research and Development Agency (Grants Nos. APVV-0647-10, APVV-0076-11, APVV-0492-11). Part of the calculations were performed in the Computing Centre of the Slovak Academy of Sciences using the supercomputing infrastructure acquired in project ITMS 26230120002 and 26210120002 (Slovak infrastructure for high-performance computing) supported by the Research and Development Operational Programme funded by the ERDF.	Ge Q, 2002, CHEM PHYS LETT, V358, P377, DOI 10.1016/S0009-2614(02)00669-3; Henkelman G, 1999, J CHEM PHYS, V111, P7010, DOI 10.1063/1.480097; Chen ZX, 2004, PHYS CHEM CHEM PHYS, V6, P4499, DOI 10.1039/b407688e; Lorenz H, 2013, J CATAL, V297, P151, DOI 10.1016/j.jcat.2012.10.003; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Krajci M, 2014, J CATAL, V312, P232, DOI 10.1016/j.jcat.2014.02.001; Iwasa N, 2005, APPL CATAL A-GEN, V292, P215, DOI 10.1016/j.apcata.2005.06.019; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Armbruster M, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/3/034803; IWASA N, 1995, APPL CATAL A-GEN, V125, P145, DOI 10.1016/0926-860X(95)00004-6; Chen ZX, 2004, LANGMUIR, V20, P8068, DOI 10.1021/la049377z; Krajci M, 2014, J PHYS CHEM C, V118, P12285, DOI 10.1021/jp5025075; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Greeley J, 2002, J CATAL, V208, P291, DOI 10.1006/jcat.2002.3586; Friedrich M, 2012, J PHYS CHEM C, V116, P14930, DOI 10.1021/jp303174h; Krajci M, 2012, J CATAL, V295, P70, DOI 10.1016/j.jcat.2012.07.025; Lin S, 2011, J PHYS CHEM C, V115, P20583, DOI 10.1021/jp206511q; Neyman KM, 2004, J PHYS CHEM B, V108, P5424, DOI 10.1021/jp049830f; Kim DK, 2008, J PHYS CHEM C, V112, P17235, DOI 10.1021/jp8062178; Smith GK, 2011, SURF SCI, V605, P750, DOI 10.1016/j.susc.2011.01.014; Sheppard D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841941; IWASA N, 1995, REACT KINET CATAL L, V55, P349, DOI 10.1007/BF02073070; Iwasa N, 2003, TOP CATAL, V22, P215, DOI 10.1023/A:1023571819211; Rameshan C, 2010, J CATAL, V276, P101, DOI 10.1016/j.jcat.2010.09.006; Palo DR, 2007, CHEM REV, V107, P3992, DOI 10.1021/cr050198b; Iulianelli A, 2014, RENEW SUST ENERG REV, V29, P355, DOI 10.1016/j.rser.2013.08.032; Gu XK, 2010, J PHYS CHEM C, V114, P21539, DOI 10.1021/jp107678d; Lim KH, 2006, J PHYS CHEM B, V110, P14890, DOI 10.1021/jp061410y; Ota A, 2012, J CATAL, V293, P27, DOI 10.1016/j.jcat.2012.05.020; Zuo ZJ, 2014, INT J HYDROGEN ENERG, V39, P1664, DOI 10.1016/j.ijhydene.2013.11.048; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Armbruster M, 2013, CATAL REV, V55, P289, DOI 10.1080/01614940.2013.796192; Mei DH, 2009, J PHYS CHEM C, V113, P4522, DOI 10.1021/jp808211q; Friedrich M, 2013, ANGEW CHEM INT EDIT, V52, P4389, DOI 10.1002/anie.201209587; Takezawa N, 1997, CATAL TODAY, V36, P45, DOI 10.1016/S0920-5861(96)00195-2; Weilach C, 2012, J PHYS CHEM C, V116, P18768, DOI 10.1021/jp304556s; Sheth PA, 2003, J PHYS CHEM B, V107, P2009, DOI 10.1021/jp021342p; Iwasa N, 1998, CATAL LETT, V54, P119, DOI 10.1023/A:1019056728333; Gomes JRB, 2001, SURF SCI, V471, P59, DOI 10.1016/S0039-6028(00)00881-5; Tsai AP, 2004, J PHYS SOC JPN, V73, P3270, DOI 10.1143/JPSJ.73.3270; Friedrich M, 2012, J CATAL, V285, P41, DOI 10.1016/j.jcat.2011.09.013; Chen ZX, 2005, J PHYS CHEM B, V109, P4568, DOI 10.1021/jp044843e; Nilsson A, 2005, CATAL LETT, V100, P111, DOI 10.1007/s10562-004-3434-9; Heyden A, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2104507; Neyman KM, 2007, PHYS CHEM CHEM PHYS, V9, P3470, DOI 10.1039/b700548b; Frank B, 2007, J CATAL, V246, P177, DOI 10.1016/j.jcat.2006.11.031; Haghofer A, 2012, J CATAL, V286, P13, DOI 10.1016/j.jcat.2011.10.007; Bernardo CGPM, 2001, J MOL STRUC-THEOCHEM, V542, P263, DOI 10.1016/S0166-1280(00)00846-0; Chen ZX, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075417; Friedrich M, 2010, Z ANORG ALLG CHEM, V636, P1735, DOI 10.1002/zaac.201000097; Grimme S., 2000, J COMPUT CHEM, V32, P1456; Krajci M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4795435; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lee JK, 2004, APPL CATAL A-GEN, V278, P25, DOI 10.1016/j.apcata.2004.09.022; Li LD, 2012, CHEMCATCHEM, V4, P1764, DOI 10.1002/cctc.201200268; Lin S, 2012, J MOL CATAL A-CHEM, V356, P165, DOI 10.1016/j.molcata.2012.01.011; Nozawa K., 2011, J PHYS SOC JPN, V80; Sa S, 2010, APPL CATAL B-ENVIRON, V99, P43, DOI 10.1016/j.apcatb.2010.06.015	58	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	OCT	2015	330						6	18		10.1016/j.jcat.2015.06.020		13	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CT2AA	WOS:000362603200002		
J	Song, Y; Xu, YB; Suzuki, Y; Nakagome, H; Ma, XX; Zhang, ZG				Song, Yang; Xu, Yuebing; Suzuki, Yoshizo; Nakagome, Hideki; Ma, Xiaoxun; Zhang, Zhan-Guo			The distribution of coke formed over a multilayer Mo/HZSM-5 fixed bed in H-2 co-fed methane aromatization at 1073 K: Exploration of the coking pathway	JOURNAL OF CATALYSIS			English	Article						Methane dehydroaromatization; Mo/HZSM-5; H-2 addition; Coke distribution; Coking pathways	MO-BASED CATALYSTS; DEHYDRO-AROMATIZATION; ACID SITES; NONOXIDATIVE AROMATIZATION; CARBONACEOUS DEPOSITS; MO/H-ZSM-5 CATALYSTS; ZEOLITE CATALYSTS; DEHYDROAROMATIZATION; CONVERSION; BENZENE	The effects of H-2 concentration on the performance of a three-layer bed of Mo/HZSM-5 catalyst in nonoxidative methane dehydroaromatization at 1073 K and the distribution of coke formed along the bed were investigated systematically. Stepwise increasing the H-2 concentration up to 30% causes stepwise increases in C2H4 selectivity, while having little influence on benzene selectivity. Simultaneously, it also narrows the coke distribution by suppressing the formation of aromatic-type coke inside the zeolite channels and that of graphite-like C on the zeolite surface. The performance and coke distributions of one- and two-layer beds, together with the results obtained over the three-layer bed, showed that the cracking of C2H4 is more likely to dominate the coking process than the polycondensation of formed aromatics. Estimates of C2H4 approach to equilibrium for the reaction CH4 -> 1/2C(2)H(4) + H-2 confirmed that C2H4 always attains its equilibrium concentrations to ensure its availability for cracking. (C) 2015 Elsevier Inc. All rights reserved.	[Song, Yang; Xu, Yuebing; Suzuki, Yoshizo; Zhang, Zhan-Guo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Song, Yang; Nakagome, Hideki] Chiba Univ, Grad Sch Engn, Chiba 2368522, Japan; [Ma, Xiaoxun] NW Univ Xian, Sch Chem Engn, Xian 710069, Shaanxi, Peoples R China	Zhang, ZG (reprint author), Natl Inst Adv Ind Sci & Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	z.zhang@aist.go.jp					Weckhuysen BM, 1998, CATAL LETT, V52, P31, DOI 10.1023/A:1019094630691; Ma HT, 2003, CATAL LETT, V89, P143, DOI 10.1023/A:1024796115700; Ma D, 2002, J CATAL, V208, P260, DOI 10.1006/jcat.2002.3540; Liu Z, 2002, CATAL LETT, V81, P271, DOI 10.1023/A:1016553828814; Liu HM, 2006, J CATAL, V239, P441, DOI 10.1016/j.jcat.2006.02.018; Lacheen HS, 2005, J CATAL, V230, P173, DOI 10.1016/j.jcat.2004.11.037; Hu J, 2014, RSC ADV, V4, P26577, DOI 10.1039/c4ra03945a; Liu ST, 1999, J CATAL, V181, P175, DOI 10.1006/jcat.1998.2310; Tang P, 2014, ENERG ENVIRON SCI, V7, P2580, DOI 10.1039/c4ee00604f; Tessonnier JP, 2008, APPL CATAL A-GEN, V336, P79, DOI 10.1016/j.apcata.2007.08.026; Cui YB, 2011, APPL CATAL A-GEN, V393, P348, DOI 10.1016/j.apcata.2010.12.017; Bedard J, 2013, J CATAL, V306, P58, DOI 10.1016/j.jcat.2013.06.003; CHEN LY, 1995, J CATAL, V157, P190, DOI 10.1006/jcat.1995.1279; Cui YB, 2011, CATAL SCI TECHNOL, V1, P823, DOI 10.1039/c1cy00083g; Xu YB, 2011, CHEM ENG J, V168, P390, DOI 10.1016/j.cej.2011.01.047; Tan PL, 2003, APPL CATAL A-GEN, V253, P305, DOI 10.1016/S0926-860X(03)00541-6; Liu HM, 2001, APPL CATAL A-GEN, V213, P103, DOI 10.1016/S0926-860X(00)00883-8; Cook B, 2009, APPL CATAL A-GEN, V365, P34, DOI 10.1016/j.apcata.2009.05.037; Zhang JZ, 1998, CATAL TODAY, V44, P293, DOI 10.1016/S0920-5861(98)00202-8; Li L, 2001, CHEM ENG SCI, V56, P1869, DOI 10.1016/S0009-2509(00)00465-6; Honda K, 2003, CATAL COMMUN, V4, P21, DOI 10.1016/S1566-7367(02)00242-X; Smieskova A, 2010, APPL CATAL A-GEN, V377, P83, DOI 10.1016/j.apcata.2010.01.021; Solymosi F, 1997, J CATAL, V165, P150, DOI 10.1006/jcat.1997.1478; Ohnishi R, 1999, J CATAL, V182, P92, DOI 10.1006/jcat.1998.2319; Burns S, 2006, J MOL CATAL A-CHEM, V245, P141, DOI 10.1016/j.molcata.2005.09.041; Sarioglan A, 2004, J CATAL, V226, P210, DOI 10.1016/j.jcat.2004.05.029; WANG LS, 1993, CATAL LETT, V21, P35, DOI 10.1007/BF00767368; Bedard J, 2013, PHYS CHEM CHEM PHYS, V15, P12173, DOI 10.1039/c3cp50855b; Solymosi F, 1996, CATAL LETT, V39, P157, DOI 10.1007/BF00805576; Wu YQ, 2015, J CATAL, V323, P100, DOI 10.1016/j.jcat.2014.12.022; Weckhuysen BM, 1998, J CATAL, V175, P338, DOI 10.1006/jcat.1998.2010; Bleken FL, 2013, J CATAL, V307, P62, DOI 10.1016/j.jcat.2013.07.004; Ding WP, 2001, J PHYS CHEM B, V105, P506, DOI 10.1021/jp0030692; Song Y, 2014, APPL CATAL A-GEN, V482, P387, DOI 10.1016/j.apcata.2014.06.018; Larachi F, 2002, CATAL LETT, V84, P183, DOI 10.1023/A:1021475819517; Gimeno MP, 2010, IND ENG CHEM RES, V49, P996, DOI 10.1021/ie900682y; Yao SD, 2009, IND ENG CHEM RES, V48, P713, DOI 10.1021/ie8014582; Ma D, 2000, J CATAL, V189, P314, DOI 10.1006/jcat.1999.2704; Ding WP, 2002, J CATAL, V206, P14, DOI 10.1006/jcat.2001.3457; Abdelsayed V, 2015, FUEL, V139, P401, DOI 10.1016/j.fuel.2014.08.064; Wu P, 2005, CATAL COMMUN, V6, P449, DOI 10.1016/j.catcom.2005.04.002; Tan PL, 2002, APPL CATAL A-GEN, V228, P115, DOI 10.1016/S0926-860X(01)00955-3; Bai J, 2003, CATAL LETT, V90, P123, DOI 10.1023/B:CATL.0000004104.12763.80; Muller S, 2015, J CATAL, V325, P48, DOI 10.1016/j.jcat.2015.02.013; Shu J, 1999, IND ENG CHEM RES, V38, P3860, DOI 10.1021/ie990145i; Liu W, 1999, J CATAL, V185, P386, DOI 10.1006/jcat.1999.2515; Ma HT, 2005, CATAL LETT, V104, P63, DOI 10.1007/s10562-005-7437-y; Iliuta MC, 2002, IND ENG CHEM RES, V41, P2371, DOI 10.1021/ie010977s; Ma D, 2000, J CATAL, V194, P105, DOI 10.1006/jcat.2000.2908; Tshabalala TE, 2014, APPL CATAL A-GEN, V485, P238, DOI 10.1016/j.apcata.2014.07.022; Matus EV, 2007, IND ENG CHEM RES, V46, P4063, DOI 10.1021/ie0609564; Ma H.T., 2005, J NAT GAS CHEM, V14, P129; Osawa T., 2003, CATAL LETT, V83, P57; Sarioglan A., 2008, CATAL LETT, V118, P123; Spivey JJ, 2014, CHEM SOC REV, V43, P792, DOI 10.1039/c3cs60259a; Tempelman CHL, 2015, MICROPOR MESOPOR MAT, V203, P259, DOI 10.1016/j.micromeso.2014.10.020; Xu YB, 2011, APPL CATAL A-GEN, V409, P181, DOI 10.1016/j.apcata.2011.10.003	57	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517	1090-2694		J CATAL	J. Catal.	OCT	2015	330						261	272		10.1016/j.jcat.2015.07.017		12	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CT2AA	WOS:000362603200024		
J	Yang, Y; Xie, SP; Wu, LX; Kosaka, Y; Lau, NC; Vecchi, GA				Yang, Yun; Xie, Shang-Ping; Wu, Lixin; Kosaka, Yu; Lau, Ngar-Cheung; Vecchi, Gabriel A.			Seasonality and Predictability of the Indian Ocean Dipole Mode: ENSO Forcing and Internal Variability	JOURNAL OF CLIMATE			English	Article						Indian Ocean; Atmosphere-ocean interaction; ENSO; Interannual variability	SEA-SURFACE TEMPERATURE; EL-NINO; INTERANNUAL VARIABILITY; COUPLED GCM; PART I; EQUATORIAL PACIFIC; TROPICAL PACIFIC; CLIMATE MODELS; ZONAL MODE; ATMOSPHERE	This study evaluates the relative contributions to the Indian Ocean dipole (IOD) mode of interannual variability from the El Nino-Southern Oscillation (ENSO) forcing and ocean-atmosphere feedbacks internal to the Indian Ocean. The ENSO forcing and internal variability is extracted by conducting a 10-member coupled simulation for 1950-2012 where sea surface temperature (SST) is restored to the observed anomalies over the tropical Pacific but interactive with the atmosphere over the rest of the World Ocean. In these experiments, the ensemble mean is due to ENSO forcing and the intermember difference arises from internal variability of the climate system independent of ENSO. These elements contribute one-third and two-thirds of the total IOD variance, respectively. Both types of IOD variability develop into an east-west dipole pattern because of Bjerknes feedback and peak in September-November. The ENSO forced and internal IOD modes differ in several important ways. The forced IOD mode develops in August with a broad meridional pattern and eventually evolves into the Indian Ocean basin mode, while the internal IOD mode grows earlier in June, is more confined to the equator, and decays rapidly after October. The internal IOD mode is more skewed than the ENSO forced response. The destructive interference of ENSO forcing and internal variability can explain early terminating IOD events, referred to as IOD-like perturbations that fail to grow during boreal summer. The results have implications for predictability. Internal variability, as represented by preseason sea surface height anomalies off Sumatra, contributes to predictability considerably. Including this indicator of internal variability, together with ENSO, improves the predictability of IOD.	[Yang, Yun; Xie, Shang-Ping; Wu, Lixin] Ocean Univ China, Phys Oceanog Lab, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Qingdao, Peoples R China; [Yang, Yun; Xie, Shang-Ping] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Yang, Yun] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Yang, Yun] Joint Ctr Global Studies, Beijing, Peoples R China; [Kosaka, Yu] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Lau, Ngar-Cheung] Inst Environm Energy & Sustainabil, Hong Kong, Hong Kong, Peoples R China; [Lau, Ngar-Cheung] Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Hong Kong, Peoples R China; [Vecchi, Gabriel A.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA	Xie, SP (reprint author), 9500 Gilman Dr,MC 206, La Jolla, CA 92093 USA.	sxie@ucsd.edu	Vecchi, Gabriel/A-2413-2008; Kosaka, Yu/C-2792-2009	Vecchi, Gabriel/0000-0002-5085-224X; 	National Basic Research Program of China [2012CB955600]; China National Natural Science Foundation (NSFC) Key Project [41130859]; NSFC Creative Group Project [40921004]; U.S. National Science Foundation; Chinese Scholarship Council [201306330025]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [15H05466]	This work is supported by the National Basic Research Program of China (2012CB955600), the China National Natural Science Foundation (NSFC) Key Project (41130859), NSFC Creative Group Project (40921004), the U.S. National Science Foundation, a scholarship from the Chinese Scholarship Council to Yun Yang (201306330025), and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan through Grant-in-Aid for Young Scientists to Yu Kosaka (15H05466).	Du Y, 2013, J CLIMATE, V26, P959, DOI 10.1175/JCLI-D-12-00047.1; Annamalai H, 2003, DEEP-SEA RES PT II, V50, P2305, DOI 10.1016/S0967-0645(03)00058-4; Dommenget D, 2002, J CLIMATE, V15, P216, DOI 10.1175/1520-0442(2002)015<0216:ACNOTI>2.0.CO;2; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Annamalai H, 2005, J CLIMATE, V18, P302, DOI 10.1175/JCLI-3268.1; Luo JJ, 2010, J CLIMATE, V23, P726, DOI 10.1175/2009JCLI3104.1; Lau NC, 2004, J CLIMATE, V17, P245, DOI 10.1175/1520-0442(2004)017<0245:CGSOAV>2.0.CO;2; Cai WJ, 2012, J CLIMATE, V25, P6318, DOI 10.1175/JCLI-D-11-00501.1; ROWELL DP, 1995, Q J ROY METEOR SOC, V121, P669, DOI 10.1256/smsqj.52310; Hong CC, 2008, J CLIMATE, V21, P4834, DOI 10.1175/2008JCLI2222.1; Ogata T, 2013, J CLIMATE, V26, P2145, DOI 10.1175/JCLI-D-11-00615.1; Yu LS, 1999, GEOPHYS RES LETT, V26, P735, DOI 10.1029/1999GL900072; Izumo T, 2010, NAT GEOSCI, V3, P168, DOI 10.1038/NGEO760; Luo JJ, 2007, J CLIMATE, V20, P2178, DOI 10.1175/JCLI4132.1; Li T, 2003, J ATMOS SCI, V60, P2119, DOI 10.1175/1520-0469(2003)060<2119:ATFTIO>2.0.CO;2; Saji NH, 2003, J CLIMATE, V16, P2735, DOI 10.1175/1520-0442(2003)016<2735:SOSASW>2.0.CO;2; Shinoda T, 2004, DEEP-SEA RES PT I, V51, P619, DOI 10.1016/j.dsr.2004.01.005; Cai WJ, 2014, NATURE, V510, P254, DOI 10.1038/nature13327; Chang P, 2006, J CLIMATE, V19, P5122, DOI 10.1175/JCLI3903.1; Lau NC, 2003, J CLIMATE, V16, P3, DOI 10.1175/1520-0442(2003)016<0003:AOVITI>2.0.CO;2; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Wajsowicz RC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024169; Liu L, 2014, CLIM DYNAM, V43, P1715, DOI 10.1007/s00382-013-2000-9; Kug JS, 2006, J CLIMATE, V19, P1784, DOI 10.1175/JCLI3660.1; Tozuka T, 2007, J CLIMATE, V20, P2881, DOI 10.1175/JCLI4168.1; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Anderson JL, 2004, J CLIMATE, V17, P4641; Gualdi S, 2003, CLIM DYNAM, V20, P567, DOI 10.1007/s00382-002-0295-z; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Luo JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032793; Song Q, 2007, J CLIMATE, V20, P2895, DOI 10.1175/JCLI4159.1; Baquero-Bernal A, 2002, J CLIMATE, V15, P1358, DOI 10.1175/1520-0442(2002)015<1358:ODVOSS>2.0.CO;2; Zhong AH, 2005, J CLIMATE, V18, P3634, DOI 10.1175/JCLI3493.1; Wang B, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022709; Rao SA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020842; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Du Y, 2009, J CLIMATE, V22, P2023, DOI 10.1175/2008JCLI2590.1; Xie SP, 2002, J CLIMATE, V15, P864, DOI 10.1175/1520-0442(2002)015<0864:SAMOSI>2.0.CO;2; Cai WJ, 2013, GEOPHYS RES LETT, V40, P1200, DOI 10.1002/grl.50208; Luo JJ, 2008, J CLIMATE, V21, P84, DOI 10.1175/2007JCLI1412.1; Yu WD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024327; Lau NC, 2000, J CLIMATE, V13, P4287, DOI 10.1175/1520-0442(2000)013<4287:IOEOTV>2.0.CO;2; Huang BH, 2007, J CLIMATE, V20, P2917, DOI 10.1175/JCLI4151.1; Huang BH, 2007, J CLIMATE, V20, P2937, DOI 10.1175/JCLI4169.1; Li G, 2015, J CLIMATE, V28, P3058, DOI 10.1175/JCLI-D-14-00740.1; Kosaka Y, 2013, P NATL ACAD SCI USA, V110, P7574, DOI 10.1073/pnas.1215582110; Song Q, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031966; Shi L, 2012, MON WEATHER REV, V140, P3867, DOI 10.1175/MWR-D-12-00001.1; Yamagata T, 2004, GEOPHYS MONOGR SER, V147, P189; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; Cai WJ, 2013, J CLIMATE, V26, P2880, DOI 10.1175/JCLI-D-12-00483.1; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Zheng XT, 2010, J CLIMATE, V23, P1240, DOI 10.1175/2009JCLI3326.1; Yu JY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014098; Kug JS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024916; Saji NH, 2003, CLIMATE RES, V25, P151, DOI 10.3354/cr025151; Behera SK, 2006, J CLIMATE, V19, P1688, DOI 10.1175/JCLI3797.1; Drbohlav HKL, 2007, J CLIMATE, V20, P2961, DOI 10.1175/JCLI4153.1; Shinoda T, 2004, J CLIMATE, V17, P362, DOI 10.1175/1520-0442(2004)017<0362:RROTIO>2.0.CO;2; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Chakravorty S, 2014, J GEOPHYS RES-OCEANS, V119, P5105, DOI 10.1002/2013JC009713; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Griffies S., 2003, 5 NOAA GFDL OC GROUP; Hendon H. H., 2009, CLIM DYNAM, V34, P1129, DOI DOI 10.1007/S00382-009-0570-3; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Yu J. -Y., 2004, METEOR ATMOS PHYS, V90, P179, DOI [10.1007/s00703-004-0094-7, DOI 10.1007/S00703-004-0094-7]	67	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	OCT	2015	28	20					8021	8036		10.1175/JCLI-D-15-0078.1		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2VF	WOS:000362661800007		
J	Jiang, CL; Gille, ST; Sprintall, J; Yoshimura, K				Jiang, ChuanLi; Gille, Sarah T.; Sprintall, Janet; Yoshimura, Kei			Spatial variation in turbulent heat fluxes in Drake Passage (vol 25, pg 1470, 2012)	JOURNAL OF CLIMATE			English	Correction						Southern Ocean; Annular mode; Air-sea interaction; Antarctic Oscillation; Climate prediction; Regression analysis			[Jiang, ChuanLi] Earth & Space Res, Seattle, WA 98121 USA; [Gille, Sarah T.; Sprintall, Janet] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Yoshimura, Kei] Univ Tokyo, Kashiwa, Chiba, Japan	Jiang, CL (reprint author), Earth & Space Res, 2101 4th Ave Suite 1310, Seattle, WA 98121 USA.	chjiang@esr.org					Sprintall J, 2003, J MAR RES, V61, P27, DOI 10.1357/002224003321586408; Jiang CL, 2012, J CLIMATE, V25, P1470, DOI 10.1175/2011JCLI4071.1	2	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	OCT	2015	28	20					8283	8285		10.1175/JCLI-D-15-0570.1		3	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CT2VE	WOS:000362661700001		
J	Snow, N				Snow, Nancy			Influence from abroad: Foreign voices, the media and US public opinion	JOURNAL OF COMMUNICATION			English	Book Review									[Snow, Nancy] Keio Univ, Tokyo 108, Japan	Snow, N (reprint author), Keio Univ, Tokyo 108, Japan.						Bumiller E., 2002, NY TIMES; HAYES D, 2013, INFL ABR FOR VOIC, P1; Mowlana H., 1992, TRIUMPH IMAGE MEDIAS	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9916	1460-2466		J COMMUN	J. Commun.	OCT	2015	65	5					E6	E8		10.1111/jcom.12177		3	Communication	Communication	CT1WX	WOS:000362594500002		
J	Saiga, A; Mitsukawa, N; Yamaji, Y				Saiga, Atsuomi; Mitsukawa, Nobuyuki; Yamaji, Yoshihisa			Reconstruction using 'triangular approximation' of bone grafts for orbital blowout fractures	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Blowout fracture; Orbital bone graft; Triangular approximation	CARTILAGE GRAFT; FLOOR; IMPLANT	There are many orbital wall reconstruction materials that can be used in surgery for orbital blowout fractures. We consider autogenous bone grafts to have the best overall characteristics among these materials and use thinned, inner cortical tables of the ilium. A bone bender is normally used to shape the inner iliac table to match the orbital shape. Since orbital walls curve three-dimensionally, processing of bone grafts is not easy and often requires much time and effort. We applied a triangular approximation method to the processing of bone grafts. Triangular approximation is a concept used in computer graphics for polygon processing. In this method, the shape of an object is represented as combinations of polygons, mainly triangles. In this study, the inner iliac table was used as a bone graft, and cuts or scores were made to create triangular sections. These triangular sections were designed three-dimensionally so that the shape of the resulting graft approximated to the three-dimensional orbital shape. This method was used in 12 patients with orbital blowout fractures, which included orbital floor fractures, medial wall fractures, and combined inferior and medial wall fractures. In all patients, bone grafts conformed to the orbital shape and good results were obtained. This simple method uses a reasonable and easy-to-understand approach and is useful in the treatment of bone defects in orbital blowout fractures when using a hard graft material. (C) 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Saiga, Atsuomi] St Marys Hosp, Dept Plast & Reconstruct Surg, Fukuoka, Japan; [Mitsukawa, Nobuyuki; Yamaji, Yoshihisa] Chiba Univ, Dept Plast Reconstruct & Aesthet Surg, Fac Med, Chiba, Chiba 2608670, Japan	Mitsukawa, N (reprint author), Chiba Univ, Dept Plast Reconstruct & Aesthet Surg, Fac Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan.	nmitsu@air.linkclub.or.jp					Bayat M, 2010, BRIT J ORAL MAX SURG, V48, P617, DOI 10.1016/j.bjoms.2009.10.019; Castellani A, 2002, J ORAL MAXIL SURG, V60, P1413, DOI 10.1053/joms.2002.36094; Sakakibara S, 2009, J ORAL MAXIL SURG, V67, P957, DOI 10.1016/j.joms.2008.08.014; Magana FG, 2011, J CRANIOFAC SURG, V22, P1991, DOI 10.1097/SCS.0b013e3182319615; Kyung H, 2013, J CRANIOFAC SURG, V24, P1781, DOI 10.1097/SCS.0b013e3182a21076; Al-Sukhun J, 2011, J CRANIOFAC SURG, V22, P1299, DOI 10.1097/SCS.0b013e31821c6ae9	6	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	OCT	2015	43	8					1369	1373		10.1016/j.jcms.2015.07.002		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	CT2AI	WOS:000362604000009		
J	Furue, M; Kadono, T				Furue, Masutaka; Kadono, Takafumi			New aspects of the clinicopathological features and treatment of mycosis fungoides and Sezary syndrome	JOURNAL OF DERMATOLOGY			English	Editorial Material						chemokine; mycosis fungoides; pathogenesis; Sezary syndrome; treatment	T-CELL LYMPHOMA; ALTERED MICRORNA EXPRESSION; MESSENGER-RNA EXPRESSION; SKIN-CANCER SOCIETY; CUTANEOUS-LYMPHOMAS; EUROPEAN-ORGANIZATION; INTERNATIONAL-SOCIETY; TASK-FORCE; CONSENSUS STATEMENT; LEUKEMIA-LYMPHOMA	Mycosis fungoides and Sezary syndrome are T-helper (Th)2-skewed cutaneous lymphomas. The clinical course of mycosis fungoides is classically indolent, manifesting as patches, plaques and tumors. Along with their progression, Th2 dominance tends to be accelerated. In this review, we discuss the epidemiology, clinicopathogenetic features and therapeutic approaches in mycosis fungoides and Sezary syndrome.	[Furue, Masutaka] Kyushu Univ, Dept Dermatol, Fukuoka 8128582, Japan; [Kadono, Takafumi] St Marianna Univ, Sch Med, Dept Dermatol, Kanagawa, Japan	Furue, M (reprint author), Kyushu Univ, Dept Dermatol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	furue@dermatol.med.kyushu-u.ac.jp					Ahn CS, 2014, AM J DERMATOPATH, V36, P933, DOI 10.1097/DAD.0000000000000207; Trautinger F, 2006, EUR J CANCER, V42, P1014, DOI 10.1016/j.ejca.2006.01.025; VOWELS BR, 1994, J INVEST DERMATOL, V103, P669, DOI 10.1111/1523-1747.ep12398454; Jang MS, 2013, J DERMATOL, V40, P606, DOI 10.1111/1346-8138.12202; Olsen EA, 2011, J CLIN ONCOL, V29, P2598, DOI 10.1200/JCO.2010.32.0630; Gu XG, 2013, J DERMATOL, V40, P596, DOI 10.1111/1346-8138.12160; Magro CM, 2014, J DERMATOL, V41, P609, DOI 10.1111/1346-8138.12458; Xu XL, 2013, J DERMATOL, V40, P844, DOI 10.1111/1346-8138.12253; Asadullah K, 1996, BLOOD, V88, P757; Kim YH, 2007, BLOOD, V110, P479, DOI 10.1182/blood-2006-10-054601; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Jinnin M, 2015, J DERMATOL, V42, P551, DOI 10.1111/1346-8138.12904; Sugaya M, 2015, J DERMATOL, V42, P613, DOI 10.1111/1346-8138.12852; Groves FD, 2000, J NATL CANCER I, V92, P1240, DOI 10.1093/jnci/92.15.1240; Asadullah K, 1996, J INVEST DERMATOL, V107, P833, DOI 10.1111/1523-1747.ep12330869; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Chun P, 2015, ARCH PHARM RES, V38, P933, DOI 10.1007/s12272-015-0571-1; Wada H, 2012, J DERMATOL, V39, P823, DOI 10.1111/j.1346-8138.2012.01554.x; Maj J, 2012, BRIT J DERMATOL, V166, P331, DOI 10.1111/j.1365-2133.2011.10669.x; Moyal L, 2013, EXP DERMATOL, V22, P431, DOI 10.1111/exd.12161; Sugaya M, 2013, J DERMATOL, V40, P2, DOI 10.1111/j.1346-8138.2012.01639.x; Cheng T, 2013, J DERMATOL, V40, P673, DOI 10.1111/1346-8138.12162; Whittaker SJ, 2003, BRIT J DERMATOL, V149, P1095, DOI 10.1111/j.1365-2133.2003.05698.x; Papadavid E, 2003, BRIT J DERMATOL, V148, P709, DOI 10.1046/j.1365-2133.2003.05224.x; Duvic M, 2015, BLOOD, V125, P1883, DOI 10.1182/blood-2014-09-600924; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Marosvari D, 2015, PATHOL ONCOL RES, V21, P821, DOI 10.1007/s12253-015-9897-8; Furue Masutaka, 2011, J Dermatol, V38, P310, DOI 10.1111/j.1346-8138.2011.01209.x; Hamada T, 2014, J DERMATOL, V41, P3, DOI 10.1111/1346-8138.12299; Hsi AC, 2015, J AM ACAD DERMATOL, V72, P159, DOI 10.1016/j.jaad.2014.09.022; Iwatsuki K, 2014, J DERMATOL, V41, P43, DOI 10.1111/1346-8138.12346; Jinno N, 2015, J DERMATOL, V42, P227, DOI 10.1111/1346-8138.12749; Kataoka Y, 2014, J DERMATOL, V41, P221, DOI 10.1111/1346-8138.12440; Matsuzawa T, 2015, J DERMATOL, V42, P108, DOI 10.1111/1346-8138.12738; Miyagaki T, 2014, J DERMATOL, V41, P11, DOI 10.1111/1346-8138.12305; Morimura S, 2014, J DERMATOL, V41, P57, DOI 10.1111/1346-8138.12351; Nakai N, 2014, J DERMATOL, V41, P63, DOI 10.1111/1346-8138.12308; Sugaya M, 2014, J DERMATOL, V41, P50, DOI 10.1111/1346-8138.12341; Sugaya M, 2015, ARCH IMMUNOL THER EX, V63, P109, DOI 10.1007/s00005-014-0313-y; Takahashi T, 2015, J DERMATOL, V42, P327, DOI 10.1111/1346-8138.12766; Tokura Y, 2014, J DERMATOL, V41, P19, DOI 10.1111/1346-8138.12328; vansKester MS, 2011, MOL ONCOL, V5, P273; Willemze R, 2013, ANN ONCOL, V24, P149, DOI 10.1093/annonc/mdt242; Yonekura K, 2014, J DERMATOL, V41, P239, DOI 10.1111/1346-8138.12419	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					941	944		10.1111/1346-8138.13083		4	Dermatology	Dermatology	CS9RR	WOS:000362429600001		
J	Otsuka, M; Yamasaki, O; Kaji, T; Iwatsuki, K; Asagoe, K				Otsuka, Masaki; Yamasaki, Osamu; Kaji, Tatsuya; Iwatsuki, Keiji; Asagoe, Kenji			Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute	JOURNAL OF DERMATOLOGY			English	Article						clinically localized melanoma; disease-free survival; melanoma; melanoma-specific survival; sentinel lymph node biopsy	ACRAL LENTIGINOUS MELANOMA; UNDERGO COMPLETION LYMPHADENECTOMY; PROGNOSTIC-FACTORS; THICK-MELANOMA; UNITED-STATES; MALIGNANT-MELANOMA; SURVIVAL; METAANALYSIS; MULTICENTER; GUIDELINES	Sentinel lymph node biopsy (SLNB) is a widely accepted standard procedure for patients with clinically localized melanoma. Melanoma prevalence and Clark's subtype differ between Asians and Caucasians. Here, we evaluated our experience on SLNB for cutaneous melanoma in a Japanese population. SLNB was performed for patients with melanoma between July 2000 and June 2014. We retrospectively analyzed 102 patients regarding association of clinicopathological features with sentinel lymph node (SLN) status, melanoma-specific survival (MSS) and disease-free survival (DFS). A positive SLN was significantly associated with primary Breslow thickness. Compared with 43 patients with negative SLN, 59 patients with positive SLN had significantly shorter MSS (5-year survival rate, 94.3% vs 63.2%; P=0.0002) and DFS (5-year survival rate, 92.7% vs 63.4%; P=0.0004). According to our subgroup analyses, nine patients with positive non-SLN had significantly shorter MSS compared with 32 patients with negative non-SLN (5-year survival rate, 32.4% vs 68.5%; P=0.0273). The survival of 51 Japanese patients with acral lentiginous melanoma (ALM) was not inferior to the survival of patients with other Clark's subtype. Breslow thickness is an important factor for both MSS and DFS, and the status of SLN is the most predictive prognostic factor in Japanese patients with clinically localized melanomas, as in case of Caucasians. Features of ALM may be different between Asians and Caucasians.	[Otsuka, Masaki; Yamasaki, Osamu; Kaji, Tatsuya; Iwatsuki, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Okayama 7008558, Japan; [Asagoe, Kenji] Natl Hosp Org, Okayama Med Ctr, Dept Dermatol, Okayama, Japan	Otsuka, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dermatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	masaki@cc.okayama-u.ac.jp					Kingham TP, 2010, ANN SURG ONCOL, V17, P514, DOI 10.1245/s10434-009-0836-3; Balch CM, 2001, J CLIN ONCOL, V19, P3622; Namikawa K, 2012, J DERMATOL, V39, P130, DOI 10.1111/j.1346-8138.2011.01318.x; Rondelli F, 2012, J EUR ACAD DERMATOL, V26, P560, DOI 10.1111/j.1468-3083.2011.04109.x; Han DL, 2013, J CLIN ONCOL, V31, P4387, DOI 10.1200/JCO.2013.50.1114; Mozzillo N, 2013, ANN SURG ONCOL, V20, P2780, DOI 10.1245/s10434-012-2826-0; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Ghaferi AA, 2009, ANN SURG ONCOL, V16, P2978, DOI 10.1245/s10434-009-0665-4; Uhara H, 2009, INT J CLIN ONCOL, V14, P490, DOI 10.1007/s10147-009-0941-0; Coit DG, 2013, J NATL COMPR CANC NE, V11, P395; Morton DL, 2012, CLIN EXP METASTAS, V29, P699, DOI 10.1007/s10585-012-9503-3; Bello DM, 2013, ANN SURG ONCOL, V20, P3618, DOI 10.1245/s10434-013-3089-0; Wrightson WR, 2003, ANN SURG ONCOL, V10, P676, DOI 10.1245/ASO.2003.10.001; Nagaraja V, 2013, EJSO-EUR J SURG ONC, V39, P669, DOI 10.1016/j.ejso.2013.02.022; Ariyan C, 2009, ANN SURG ONCOL, V16, P186, DOI 10.1245/s10434-008-0187-5; Valsecchi ME, 2011, J CLIN ONCOL, V29, P1479, DOI 10.1200/JCO.2010.33.1884; Noro S, 2011, J DERMATOL, V38, P76, DOI 10.1111/j.1346-8138.2010.01002.x; Ito T, 2012, MELANOMA RES, V22, P38, DOI 10.1097/CMR.0b013e32834dcfdf; Fujisawa Y, 2012, MELANOMA RES, V22, P362, DOI 10.1097/CMR.0b013e328355e558; Wong SL, 2006, ANN SURG ONCOL, V13, P809, DOI 10.1245/ASO.2006.03.058; Tan KB, 2007, AM J SURG PATHOL, V31, P1902, DOI 10.1097/PAS.0b013e318073c600; Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609; Murali R, 2012, ANN SURG, V255, P128, DOI 10.1097/SLA.0b013e3182306c72; Wu CE, 2015, J FORMOS MED ASSOC, V114, P415, DOI 10.1016/j.jfma.2013.06.018; Yee VSK, 2005, ANN SURG ONCOL, V12, P429, DOI 10.1245/ASO.2005.03.074; Chen YJ, 1999, J AM ACAD DERMATOL, V41, P945, DOI 10.1016/S0190-9622(99)70251-3; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Gajdos C, 2009, CANCER, V115, P5752, DOI 10.1002/cncr.24660; Pollack LA, 2011, J AM ACAD DERMATOL, V65, pS78, DOI 10.1016/j.jaad.2011.05.030; Ribero S, 2015, ANN SURG ONCOL, V22, P1967, DOI 10.1245/s10434-014-4211-7; Muller MGS, 2001, CANCER, V91, P2401; Bamboat ZM, 2014, ANN SURG ONCOL, V21, P3117, DOI 10.1245/s10434-014-3758-7; desVries M, 2006, EUR J SURG ONCOL, V32, P785; Egger ME, 2012, AM J SURG, V204, P874, DOI 10.1016/j.amjsurg.2012.05.013; Egger ME, 2012, AM J SURG, V204, P9; Ito T, 2015, J AM ACAD DERMATOL, V72, P71, DOI 10.1016/j.jaad.2014.10.008; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Wu XC, 2011, J AM ACAD DERMATOL, V65, pS26, DOI 10.1016/j.jaad.2011.05.034	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					954	961		10.1111/1346-8138.12972		8	Dermatology	Dermatology	CS9RR	WOS:000362429600003		
J	Tokura, Y; Ito, T; Kawakami, C; Sugita, K; Kasuya, A; Tatsuno, K; Sawada, Y; Nakamura, M; Shimauchi, T				Tokura, Yoshiki; Ito, Taisuke; Kawakami, Chika; Sugita, Kazunari; Kasuya, Akira; Tatsuno, Kazuki; Sawada, Yu; Nakamura, Motonobu; Shimauchi, Takatoshi			Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8(+) T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma	JOURNAL OF DERMATOLOGY			English	Article						adult T-cell leukemia; lymphoma carrier; CD8(+) T cell; cytotoxic lymphocytes; human T-lymphotropic virus 1-associated myelopathy; human T-lymphotropic virus type 1; lichenoid dermatitis	CHRONIC ACTINIC DERMATITIS; ALOPECIA-AREATA; LEUKEMIA-CELLS; EXPRESSION; LYMPHOCYTES; HAM/TSP; ASSOCIATION; INVOLVEMENT; PATIENT; LESIONS	Human T-lymphotropic virus type 1 (HTLV-1) induces adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and carrier. ATLL is a mature CD4(+)CD25(+)CCR4(+) T-cell neoplasm, and approximately half of patients have direct skin involvement manifesting patch, plaque, tumor, multiple papules, erythroderma and purpura. However, there exist secondary eruptions without tumor cell infiltration in patients with ATLL or HAM/TSP and carriers of HTLV-1. To clarify the presence of reactive skin eruptions in HTLV-1-infected individuals, we reviewed our patients with HTLV-1-associated diseases. In 2002-2012, we saw 50 ATLL or HAM/TSP patients and HTLV-1 carriers presenting with skin lesions. We retrospectively selected cases that histologically showed lichenoid tissue reactions with predominant infiltration of CD8(+) T cells, but not CD4(+) tumor cells. The cases included erythroderma (HTLV-1 carrier), lichen planus (HTLV-1 carrier), alopecia areata (HAM/TSP), chronic actinic dermatitis (HTLV-1 carrier to acute ATLL conversion) and discoid lupus erythematosus (smoldering ATLL). They were graft-versus-host disease-like, major secondary lesions and seen in HTLV-1 carriers and patients with HAM/TSP and smoldering ATLL. We coin the term HTLV-1-associated lichenoid dermatitis (HALD) to encompass the conditions. HALD may occur in association with the elevated immunity toward HTLV-1-infected CD4(+) T cells, thus sharing the pathogenetic role of cytotoxic T cells with HAM/TSP.	[Tokura, Yoshiki; Ito, Taisuke; Kasuya, Akira; Tatsuno, Kazuki] Hamamatsu Univ, Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Kawakami, Chika; Sugita, Kazunari; Sawada, Yu; Nakamura, Motonobu] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka 807, Japan; [Shimauchi, Takatoshi] Cardiff Univ, Sch Med, Dept Dermatol & Wound Healing, Cardiff CF10 3AX, S Glam, Wales	Tokura, Y (reprint author), Hamamatsu Univ, Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	tokura@hama-med.ac.jp			Ministry of Health, Labor and Welfare in Japan	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare in Japan.	Ishida T, 2003, CLIN CANCER RES, V9, P3625; Chen SM, 2006, INT IMMUNOL, V18, P269, DOI 10.1093/intimm/dxh366; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; da Silva JLS, 2013, J CLIN VIROL, V58, P482, DOI 10.1016/j.jcv.2013.07.012; Alli R, 2012, J IMMUNOL, V188, P477, DOI 10.4049/jimmunol.1100657; ROELANDTS R, 1993, J AM ACAD DERMATOL, V28, P240, DOI 10.1016/0190-9622(93)70034-Q; Shimauchi T, 2005, CLIN CANCER RES, V11, P2427, DOI 10.1158/1078-0432.CCR-04-0491; Kozako T, 2011, J MED VIROL, V83, P501, DOI 10.1002/jmv.21985; Shimauchi T, 2007, INT J CANCER, V121, P2585, DOI 10.1002/ijc.23042; UCHIYAMA T, 1977, BLOOD, V50, P481; Bittencourt AL, 2010, INT J DERMATOL, V49, P1099, DOI 10.1111/j.1365-4632.2010.04568.x; Kozako T, 2009, LEUKEMIA, V23, P375, DOI 10.1038/leu.2008.272; Kohno T, 2005, CANCER SCI, V96, P527, DOI 10.1111/j.1349-7006.2005.00080.x; Adachi Y, 2008, PHOTODERMATOL PHOTO, V24, P147, DOI 10.1111/j.1600-0781.2008.00351.x; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; McGill NK, 2012, EXP DERMATOL, V21, P815, DOI 10.1111/exd.12007; Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0; Wenzel J, 2005, BRIT J DERMATOL, V153, P1011, DOI 10.1111/j.1365-2133.2005.06784.x; Araya N, 2014, J CLIN INVEST, V124, P3431, DOI 10.1172/JCI75250; Fuzii HT, 2014, LIFE SCI, V104, P9, DOI 10.1016/j.lfs.2014.03.025; Watanabe T, 1997, INT J HEMATOL, V66, P257; Trevino A, 2013, J NEUROL, V260, P2551, DOI 10.1007/s00415-013-7014-z; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Ito T, 2013, J DERMATOL, V40, P399, DOI 10.1111/1346-8138.12128; Pimentel VN, 2010, J ORAL PATHOL MED, V39, P741, DOI 10.1111/j.1600-0714.2010.00917.x; Araya N, 2011, VIRUSES-BASEL, V3, P1532, DOI 10.3390/v3091532; Buggage Ronald R, 2003, Curr Opin Ophthalmol, V14, P420, DOI 10.1097/00055735-200312000-00016; Kaneko Yasuhiro, 2015, Case Rep Dermatol, V7, P95, DOI 10.1159/000430804; Sawada Y, 2011, BLOOD, V117, P3161; Shirnauchi T, 2008, CANCER SCI, V99, P98; Sugita Kazunari, 2005, J Am Acad Dermatol, V52, P38; Torres-Cabala CA, 2015, J DERMATOL SCI, V77, P150, DOI 10.1016/j.jdermsci.2015.01.003	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					967	974		10.1111/1346-8138.12980		8	Dermatology	Dermatology	CS9RR	WOS:000362429600005		
J	Horiguchi, Y; Takahashi, K; Tanizaki, H; Miyachi, Y				Horiguchi, Yuji; Takahashi, Kenzo; Tanizaki, Hideaki; Miyachi, Yoshiki			Case of bilateral acroangiodermatitis due to symmetrical arteriovenous fistulas of the soles	JOURNAL OF DERMATOLOGY			English	Article						acroangiodermatitis; arteriovenous fistula; bilateral	PSEUDO-KAPOSI SARCOMA	A 58-year-old woman presented painful chronic inflammation of the outside skin of the bilateral soles. A skin biopsy revealed chronic inflammation of the dermis and subcutaneous tissue, as well as the marked dilatation and proliferation of capillaries and veins, and the thick deposition of elastic fibers around the thick-walled veins. 3-D contrasted computed tomography of the lower extremities demonstrated early bilateral imaging of the veins, and fistulas of the peroneal as well as posterior tibial artery and vein of the bilateral soles. On the basis of a diagnosis of bilateral acroangiodermatitis due to symmetrical arteriovenous fistulas, the patient underwent compression therapy using elastic bandages, and the symptoms reduced in several days.	[Horiguchi, Yuji] Horiguchi Clin Dermatol, Hirakata, Osaka 5731121, Japan; [Takahashi, Kenzo] Univ Ryukyus, Dept Dermatol, Naha, Japan; [Tanizaki, Hideaki; Miyachi, Yoshiki] Kyoto Univ, Dept Dermatol, Kyoto, Japan	Horiguchi, Y (reprint author), Horiguchi Clin Dermatol, 11-3-204 Kuzuha Hanazonocho, Hirakata, Osaka 5731121, Japan.	horiguch@fa2.so-net.ne.jp					Alshihry H, 2014, ANN SAUDI MED, V34, P179, DOI 10.5144/0256-4947.2014.179; KOPF AW, 1964, ARCH DERMATOL, V90, P360; BLUEFARB SM, 1967, ARCH DERMATOL, V96, P176; MALI JWH, 1965, ARCH DERMATOL, V92, P515, DOI 10.1001/archderm.92.5.515; Fernández R, 2007, Actas Dermosifiliogr, V98, P268, DOI 10.1016/S0001-7310(07)70061-3; Ghia Deepti H, 2014, Indian J Dermatol, V59, P406, DOI 10.4103/0019-5154.135501; Lugovic L, 2007, ACTA DERMATOVENER CR, V15, P152; Smiddy P, 2001, Australas Radiol, V45, P225, DOI 10.1046/j.1440-1673.2001.00908.x; STEWART W M, 1967, Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie, V74, P664	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					989	991		10.1111/1346-8138.12934		3	Dermatology	Dermatology	CS9RR	WOS:000362429600008		
J	Ishii, K; Ishii, N; Nakanaga, K; Nakano, K; Saito, I; Asahina, A				Ishii, Kentaro; Ishii, Norihisa; Nakanaga, Kazue; Nakano, Kazuaki; Saito, Ikuo; Asahina, Akihiko			Mycobacterium haemophilum infection with prominent facial manifestation mimicking leprosy	JOURNAL OF DERMATOLOGY			English	Article						immunosuppression; leprosy; Mycobacterium haemophilum; potassium iodide; treatment	POTASSIUM-IODIDE; DERMATOLOGY; PATIENT	Mycobacterium haemophilum is a slow-growing non-tuberculous mycobacterium that is rarely known to cause human skin infection, particularly in immunocompromised patients. We recently experienced a 69-year-old Japanese woman with this infection who had been under immunosuppressive treatment for recalcitrant rheumatoid arthritis. The patient showed disseminated erythematous plaques and subcutaneous nodules on the face and extremities, and interestingly, the face manifested with a striking facies leontina appearance. Biopsy revealed abscess and granulomatous dermatitis with the involvement of peripheral nerve bundles and the presence of innumerable acid-fast bacilli, thus necessitating differentiation from lepromatous leprosy. M.haemophilum was identified by molecular characterization as well as by successful culture with iron supplements. Although drug susceptibility testing indicated responsiveness to multiple antibiotics administrated simultaneously for the treatment, it took over 6months to achieve significant improvement, and we also employed concurrent oral potassium iodide administration and repeated surgical excision. This case highlights the importance of continuous combination therapy for successful outcome in this rare infection. Furthermore, application of potassium iodide for mycobacterial infection warrants further evaluation by accumulating more cases.	[Ishii, Kentaro; Asahina, Akihiko] Natl Hosp Org, Sagamihara Natl Hosp, Dept Dermatol, Yokohama, Kanagawa, Japan; [Ishii, Norihisa; Nakanaga, Kazue] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Nakano, Kazuaki] Natl Hosp Org, Sagamihara Natl Hosp, Dept Clin Lab, Yokohama, Kanagawa, Japan; [Saito, Ikuo] Natl Hosp Org, Sagamihara Natl Hosp, Dept Pathol, Yokohama, Kanagawa, Japan; [Asahina, Akihiko] Jikei Univ, Dept Dermatol, Sch Med, Tokyo 1058461, Japan	Asahina, A (reprint author), Jikei Univ, Dept Dermatol, Sch Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	asahina-tky@umin.ac.jp					Kelley CF, 2011, LANCET INFECT DIS, V11, P571, DOI 10.1016/S1473-3099(11)70029-9; Lindeboom JA, 2011, CLIN MICROBIOL REV, V24, P701, DOI 10.1128/CMR.00020-11; Lastoria JC, 2014, AN BRAS DERMATOL, V89, P205, DOI 10.1590/abd1806-4841.20142450; Hassan I, 2012, INDIAN J DERMATOL VE, V78, P390, DOI 10.4103/0378-6323.95472; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Costa RO, 2013, AN BRAS DERMATOL, V88, P396, DOI 10.1590/abd1806-4841.20132377; Takeo N, 2012, J DERMATOL, V39, P968, DOI 10.1111/j.1346-8138.2012.01533.x; Nakanaga K, 2013, J DERMATOL, V40, P151, DOI 10.1111/1346-8138.12047; Arai H, 1983, JPN J CLIN DERMATOL, V37, P249; Copeland NK, 2013, CASE REP DERMATOL ME, V2013; Onouchi H, 2003, RINSHO DERMA TOKYO, V45, P375; SoRelle JA, 2014, DIAGN MICR INFEC DIS, V78, P494, DOI 10.1016/j.diagmicrobio.2013.09.003; Woods GL, 2011, SUSCEPTIBILITY TESTI	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					992	995		10.1111/1346-8138.12948		4	Dermatology	Dermatology	CS9RR	WOS:000362429600009		
J	Nakayama, C; Fujita, Y; Watanabe, M; Shimizu, H				Nakayama, Chihiro; Fujita, Yasuyuki; Watanabe, Mika; Shimizu, Hiroshi			Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab	JOURNAL OF DERMATOLOGY			English	Article						autoimmune bullous diseases; biologic agents; bullous pemphigoid; psoriasis; ustekinumab	PUSTULAR PSORIASIS; DISEASE	Ustekinumab is a human monoclonal antibody that specifically binds to the p40 subunit of interleukin (IL)-12 and IL-23, inhibiting the activity of both cytokines, thereby blocking the T-helper (Th)1 and Th17 inflammatory pathways. While biologic agents have dramatically changed the strategies of psoriasis treatment, increasing cases of autoimmune diseases during the use of such agents have been reported. We experienced a case of bullous pemphigoid occurring during treatment of a rare variant of psoriatic arthritis, psoriatic onycho-pachydermo periostitis with ustekinumab. Only six cases of autoimmune blistering diseases during treatment with biologic agents have ever been reported including our case, and we herein review the published work of these cases. Dermatologists must be attentive to the possibility of autoimmune blistering diseases during ustekinumab treatment.	[Nakayama, Chihiro; Fujita, Yasuyuki; Watanabe, Mika; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan	Fujita, Y (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	yfujita@med.hokudai.ac.jp					Duong TA, 2010, J AM ACAD DERMATOL, V62, P161, DOI 10.1016/j.jaad.2009.02.031; Boussemart L, 2010, DERMATOLOGY, V221, P201, DOI 10.1159/000318008; Ameglio F, 1998, BRIT J DERMATOL, V138, P611; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; Abdelilah SG, 2006, CLIN IMMUNOL, V120, P220, DOI 10.1016/j.clim.2006.03.014; Watanabe M, 2012, CLIN EXP DERMATOL, V37, P683, DOI 10.1111/j.1365-2230.2011.04328.x; Becker JG, 2012, J AM ACAD DERMATOL, V67, P150; DesBandt M, 2005, ARTHRITIS RES THER, V7, pR545; Miyakurai T, 2008, EUR J DERMATOL, V18, P481, DOI 10.1684/ejd.2008.0465; Stausbol-Gron B, 2009, CLIN EXP DERMATOL, V34, P285; Tsuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051819; Wilczek A, 2006, INT J DERMATOL, V45, P1353, DOI 10.1111/j.1365-4632.2006.02861.x	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					996	998		10.1111/1346-8138.12943		3	Dermatology	Dermatology	CS9RR	WOS:000362429600010		
J	Takahashi, C; Kaneta, K; Nomura, W; Ohishi, Y; Uehara, J; Honma, M; Ishida-Yamamoto, A; Sato, H; Takagi, A; Iizuka, H				Takahashi, Chiaki; Kaneta, Kazuhiro; Nomura, Wakana; Ohishi, Yasushi; Uehara, Jiro; Honma, Masaru; Ishida-Yamamoto, Akemi; Sato, Hidetsugu; Takagi, Akiyoshi; Iizuka, Hajime			Cutaneous S100-negative, CD1a-positive histiocytosis successfully treated with combination therapy of oral methotrexate and corticosteroid	JOURNAL OF DERMATOLOGY			English	Article						CD1a; corticosteroid; histiocytosis; methotrexate; S100 protein; ultraviolet therapy	INDETERMINATE CELL HISTIOCYTOSIS; DIFFERENTIATION; EXPRESSION; FEATURES; SKIN	S100-negative, CD1a-positive histiocytosis is a rare histiocytic disorder characterized by proliferation of histiocytic cells possessing a phenotype of epidermal Langerhans cells except for the lack of S100 expression and Birbeck granules. We report the case of a Japanese man suffering from S100-negative, CD1a-positive histiocytosis. The patient showed numerous smooth erythematous 5-10-mm papules/nodules on most of his body. The key histopathological feature was the presence of dermal infiltrates of non-epidermotropic S100-negative CD1a-positive mononuclear cells. No systemic involvement was detected. Initially bath-psoralen plus ultraviolet A therapy was effective, but the lesions became recalcitrant to this treatment. Methylprednisolone pulse therapy followed by low-dose methotrexate (up to 30mg/week) in combination with prednisolone (15mg/day) effectively controlled the skin lesions.	[Takahashi, Chiaki; Kaneta, Kazuhiro; Nomura, Wakana; Ohishi, Yasushi; Uehara, Jiro; Honma, Masaru; Ishida-Yamamoto, Akemi; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Sato, Hidetsugu] Obihiro Kosei Gen Hosp, Dept Dermatol, Obihiro, Hokkaido, Japan; [Takagi, Akiyoshi] Takagi Dermatol Clin, Obihiro, Hokkaido, Japan	Takahashi, C (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	chiaki06@asahikawa-med.ac.jp					Ventarola DJ, 2011, ARCH DERMATOL, V147, P995, DOI 10.1001/archdermatol.2011.219; Tardio JC, 2013, AM J DERMATOPATH, V35, pE57, DOI 10.1097/DAD.0b013e31827adc72; Sidoroff A, 1996, BRIT J DERMATOL, V134, P525; Fournier J, 2011, J DERMATOL, V38, P937, DOI 10.1111/j.1346-8138.2010.01148.x; Ross R, 2000, J INVEST DERMATOL, V115, P658, DOI 10.1046/j.1523-1747.2000.00112.x; Singh A, 2003, DERMATOLOGY, V207, P157, DOI 10.1159/000071786; Bard S, 2011, PEDIATR DERMATOL, V28, P524, DOI 10.1111/j.1525-1470.2011.01305.x; Frater JL, 2006, J CUTAN PATHOL, V33, P437, DOI 10.1111/j.0303-6987.2006.00453.x	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					999	1001		10.1111/1346-8138.12944		3	Dermatology	Dermatology	CS9RR	WOS:000362429600011		
J	Shiiya, C; Hata, H; Inamura, Y; Imafuku, K; Kitamura, S; Fujita, H; Shimizu, H				Shiiya, Chihiro; Hata, Hiroo; Inamura, Yuka; Imafuku, Keisuke; Kitamura, Shinya; Fujita, Hiromi; Shimizu, Hiroshi			Dermoscopic features of hidroacanthoma simplex: Usefulness in distinguishing it from Bowen's disease and seborrheic keratosis	JOURNAL OF DERMATOLOGY			English	Article						Bowen's disease; dermoscopy; diagnosis; hidroacanthoma simplex; seborrheic keratosis		Hidroacanthoma simplex (HAS) is a rare benign eccrine adnexal tumor. HAS is sometimes clinically or pathologically misdiagnosed as squamous cell carcinoma in situ (Bowen's disease; BD), seborrheic keratosis (SK) or other adnexal tumor. To date, there has never been a report focusing on dermoscopic features to distinguish HAS from BD and SK. We found the following dermoscopic findings to be characteristic of HAS: fine black dots/globules (75% of cases) and fine scales arranged annularly (100% of cases). In contrast, glomerular vessels, which are typically observed in BD, were not seen in any of the four cases. Cerebriform appearance and milia-like cysts, which are typically observed in SK, were also not seen in any of the four cases. The existence of scattered fine black dots/globules and fine scales arranged annularly, and the absence of the glomerular vessels, may contribute to precise diagnosis of HAS. Even though HAS resembles BD or SK clinically, it can be distinguished from these by the characteristic dermoscopic features.	[Shiiya, Chihiro; Hata, Hiroo; Inamura, Yuka; Imafuku, Keisuke; Kitamura, Shinya; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan; [Fujita, Hiromi] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan	Hata, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	hata07jp@yahoo.co.jp					Zalaudek I, 2004, BRIT J DERMATOL, V150, P1112, DOI 10.1111/j.1365-2133.2004.05924.x; Sahin MT, 2004, J DERMATOL, V31, P884; Elder DE, 2008, LEVERS HISTOPATHOLOG, P886; Sato Yota, 2014, Case Rep Dermatol, V6, P154, DOI 10.1159/000363369; Zalaudek I, 2010, J AM ACAD DERMATOL, V63, P377, DOI 10.1016/j.jaad.2009.11.697	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1002	1005		10.1111/1346-8138.12945		4	Dermatology	Dermatology	CS9RR	WOS:000362429600012		
J	Shimizu, N; Nakagawa, K; Taguchi, M; Okabayashi, A; Kishida, M; Kinoshita, R; Imanishi, H; Fukai, K; Tsuruta, D				Shimizu, Nami; Nakagawa, Koichi; Taguchi, Mari; Okabayashi, Aya; Kishida, Masaru; Kinoshita, Rie; Imanishi, Hisayoshi; Fukai, Kazuyoshi; Tsuruta, Daisuke			Unusual case of phakomatosis pigmentovascularis in a Japanese female infant associated with three phakomatoses: Port-wine stain, dermal melanocytosis and cutis marmorata telangiectatica congenita	JOURNAL OF DERMATOLOGY			English	Letter									[Shimizu, Nami; Nakagawa, Koichi; Taguchi, Mari; Okabayashi, Aya; Kishida, Masaru; Kinoshita, Rie] Saiseikai Tondabayashi Hosp, Dept Dermatol, Tondabayashi City, Osaka 5840082, Japan; [Imanishi, Hisayoshi; Fukai, Kazuyoshi; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka 558, Japan	Nakagawa, K (reprint author), Saiseikai Tondabayashi Hosp, Dept Dermatol, 1-3-36 Koyodai, Tondabayashi City, Osaka 5840082, Japan.	yama_and_sawa@tonbyo.org					Adachi Koji, 2013, J Med Case Rep, V7, P55, DOI 10.1186/1752-1947-7-55; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Torrelo A, 2003, BRIT J DERMATOL, V148, P342, DOI 10.1046/j.1365-2133.2003.05118.x; Chang BPH, 2007, BRIT J DERMATOL, V156, P1068, DOI 10.1111/j.1365-2133.2007.07798.x; HASEGAWA Y, 1985, ARCH DERMATOL, V121, P651, DOI 10.1001/archderm.121.5.651	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1006	1007		10.1111/1346-8138.13000		2	Dermatology	Dermatology	CS9RR	WOS:000362429600013		
J	Fujita, M; Tanizaki, H; Tanioka, M; Kabashima, K; Miyachi, Y				Fujita, Mafumi; Tanizaki, Hideaki; Tanioka, Miki; Kabashima, Kenji; Miyachi, Yoshiki			Basal cell carcinoma arising within port-wine stains with no preceding radiotherapy	JOURNAL OF DERMATOLOGY			English	Letter									[Fujita, Mafumi; Tanizaki, Hideaki; Tanioka, Miki; Kabashima, Kenji; Miyachi, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan	Tanizaki, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	tanizaki@kuhp.kyoto-u.ac.jp					Lapidoth M, 2006, J EUR ACAD DERMATOL, V20, P1066, DOI 10.1111/j.1468-3083.2006.01701.x; Silapunt S, 2004, DERMATOL SURG, V30, P1241, DOI 10.1111/j.1524-4725.2004.30384.x; MAGANAGARCIA M, 1988, BRIT J DERMATOL, V119, P393, DOI 10.1111/j.1365-2133.1988.tb03234.x; SCOTT IM, 1948, BRIT J DERMATOL SYPH, V60, P69; VansZuuren EJ, 2000, J EUR ACAD DERMATOL, V14, P307	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1007	1008		10.1111/1346-8138.12995		2	Dermatology	Dermatology	CS9RR	WOS:000362429600014		
J	Yoshioka, M; Kambe, N; Yamamoto, Y; Suehiro, K; Matsue, H				Yoshioka, Miri; Kambe, Naotomo; Yamamoto, Yosuke; Suehiro, Keisuke; Matsue, Hiroyuki			Case of respiratory discomfort due to myositis after administration of nivolumab	JOURNAL OF DERMATOLOGY			English	Letter							CANCER		[Yoshioka, Miri; Kambe, Naotomo; Yamamoto, Yosuke; Suehiro, Keisuke; Matsue, Hiroyuki] Chiba Univ, Dept Dermatol, Grad Sch Med, Chiba 2608670, Japan	Kambe, N (reprint author), Chiba Univ, Dept Dermatol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nkambe@faculty.chiba-u.jp					Min L, 2014, CANCER IMMUNOL RES, V2, P15, DOI 10.1158/2326-6066.CIR-13-0146; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; Topalian SL, 2014, J CLIN ONCOL, V32, P986; Yamazaki N, 2013, EUR J CANCER, V48, pS868	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1008	1009		10.1111/1346-8138.12991		2	Dermatology	Dermatology	CS9RR	WOS:000362429600015		
J	Suzuki, S; Yoshida, Y; Shiomi, T; Yanagihara, S; Ito, A; Kimura, R; Yamamoto, O				Suzuki, Shuji; Yoshida, Yuichi; Shiomi, Tatsushi; Yanagihara, Shigeto; Ito, Ayako; Kimura, Ryoko; Yamamoto, Osamu			Squamous cell carcinoma arising on plantar verrucous lesion	JOURNAL OF DERMATOLOGY			English	Letter									[Suzuki, Shuji; Yoshida, Yuichi; Yanagihara, Shigeto; Ito, Ayako; Kimura, Ryoko; Yamamoto, Osamu] Tottori Univ, Div Dermatol, Dept Med Sensory & Motor Organs, Fac Med, Yonago, Tottori 6838504, Japan; [Shiomi, Tatsushi] Tottori Univ, Dept Organ Pathol, Fac Med, Yonago, Tottori 6838504, Japan	Suzuki, S (reprint author), Tottori Univ, Div Dermatol, Dept Med Sensory & Motor Organs, Fac Med, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	drshuji@yahoo.co.jp					Alam M, 2003, J AM ACAD DERMATOL, V48, P385, DOI 10.1067/mjd.2003.184; Nishiwaki M, 2008, J CLIN MICROBIOL, V46, P1161, DOI 10.1128/JCM.00793-07; Sterling JC, 2001, BRIT J DERMATOL, V144, P4, DOI 10.1046/j.1365-2133.2001.04066.x; Joly P, 2010, TRANSPLANTATION, V89, P1224, DOI 10.1097/TP.0b013e3181d7598b; Guadara J, 1992, J Foot Surg, V31, P611	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1010	1011		10.1111/1346-8138.12992		2	Dermatology	Dermatology	CS9RR	WOS:000362429600016		
J	Ohyama, A; Kamo, R; Yanagihara, S; Kimura, Y; Kusutani, N; Ozawa, T; Tsuruta, D				Ohyama, Ayako; Kamo, Riei; Yanagihara, Shigeto; Kimura, Yuka; Kusutani, Nao; Ozawa, Toshiyuki; Tsuruta, Daisuke			Subfascial lipoma in the temporal muscle that extended to under the zygomatic arch	JOURNAL OF DERMATOLOGY			English	Letter									[Ohyama, Ayako; Kamo, Riei; Yanagihara, Shigeto; Kimura, Yuka; Kusutani, Nao; Ozawa, Toshiyuki; Tsuruta, Daisuke] Osaka City Univ, Dept Dermatol, Grad Sch Med, Osaka 5458585, Japan	Kamo, R (reprint author), Osaka City Univ, Dept Dermatol, Grad Sch Med, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	m8701131@med.osaka-cu.ac.jp					SCHERL MP, 1986, ARCH OTOLARYNGOL, V112, P1210; Scolozzi P, 2003, ORAL ONCOL, V39, P316, DOI 10.1016/S1368-8375(02)00117-3; De Riu G, 2011, ORAL SURG ORAL MED O, V111, pE5, DOI 10.1016/j.tripleo.2011.01.005; Larrabee WF, 2004, SURG ANATOMY FACE	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1011	1012		10.1111/1346-8138.12994		2	Dermatology	Dermatology	CS9RR	WOS:000362429600017		
J	Shiohara, J; Ono, S; Endo, T; Kaneko, K				Shiohara, Junko; Ono, Sonoe; Endo, Toshie; Kaneko, Kazuhiko			Impetigo contagiosa with Nikolsky sign in adult patient of advanced malignant melanoma	JOURNAL OF DERMATOLOGY			English	Letter							SKIN SYNDROME		[Shiohara, Junko; Ono, Sonoe] Okaya City Hosp, Dept Dermatol, Nagano 3948512, Japan; [Endo, Toshie; Kaneko, Kazuhiko] Okaya City Hosp, Dept Palliat Care, Nagano 3948512, Japan	Shiohara, J (reprint author), Okaya City Hosp, Dept Dermatol, 4-11-33 Honcho, Nagano 3948512, Japan.	junshio@okaya-hosp.jp					Bourayou R, 2011, J PEDIATR-US, V159, P868, DOI 10.1016/j.jpeds.2011.07.019; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Handler MZ, 2014, J EUR ACAD DERMATOL, V28, P1418, DOI 10.1111/jdv.12541; Pereira LB, 2014, AN BRAS DERMATOL, V89, P293, DOI 10.1590/abd1806-4841.20142283; Kyriakos PK, 2012, INFEZ MED, V20, P105	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1013	1014		10.1111/1346-8138.13003		2	Dermatology	Dermatology	CS9RR	WOS:000362429600018		
J	Matsudate, Y; Tetsutani, M; Fukui, N; Hirose, K; Murao, K; Kubo, Y				Matsudate, Yoshihiro; Tetsutani, Mayu; Fukui, Nozomi; Hirose, Kenji; Murao, Kazutoshi; Kubo, Yoshiaki			Case of nevoid basal cell carcinoma syndrome with multiple cutaneous keratocysts	JOURNAL OF DERMATOLOGY			English	Letter							CYSTS		[Matsudate, Yoshihiro; Tetsutani, Mayu; Fukui, Nozomi; Hirose, Kenji; Murao, Kazutoshi; Kubo, Yoshiaki] Univ Tokushima, Inst Biomed Sci, Dept Dermatol, Grad Sch, Tokushima, Tokushima 7708503, Japan	Kubo, Y (reprint author), Univ Tokushima, Inst Biomed Sci, Dept Dermatol, Grad Sch, 3-15-18 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan.	kubo@tokushima-u.ac.jp					JACKSON R, 1971, CAN MED ASSOC J, V105, P850; GOLDSTEIN AM, 1994, AM J MED GENET, V50, P272, DOI 10.1002/ajmg.1320500311; BARR RJ, 1986, J AM ACAD DERMATOL, V14, P572, DOI 10.1016/S0190-9622(86)70071-6; Motegi SI, 2008, DERMATOLOGY, V216, P159, DOI 10.1159/000111514; Tirado M, 2014, AM J DERMATOPATH, V36, P892, DOI 10.1097/DAD.0000000000000081	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1015	1016		10.1111/1346-8138.13022		2	Dermatology	Dermatology	CS9RR	WOS:000362429600020		
J	Honda, Y; Otsuka, A; Iga, N; Kaku, Y; Sakurai, T; Miyachi, Y; Kabashima, K				Honda, Yuki; Otsuka, Atsushi; Iga, Natsuko; Kaku, Yo; Sakurai, Takaki; Miyachi, Yoshiki; Kabashima, Kenji			Perifollicular elastolysis associated with pseudofolliculitis of Behcet's disease	JOURNAL OF DERMATOLOGY			English	Letter									[Honda, Yuki; Otsuka, Atsushi; Iga, Natsuko; Kaku, Yo; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Dept Dermatol, Grad Sch Med, Kyoto 6068507, Japan; [Sakurai, Takaki] Kyoto Univ, Dept Diagnost Pathol, Grad Sch Med, Kyoto 6068507, Japan	Otsuka, A (reprint author), Kyoto Univ, Dept Dermatol, Grad Sch Med, Sakyo Ku, 54 Shogoin Kawara, Kyoto 6068507, Japan.	otsukamn@kuhp.kyoto-u.ac.jp					Amano H, 2014, J DERMATOL, V41, P231, DOI 10.1111/1346-8138.12388; Gambichler T, 2010, ARCH DERMATOL RES, V302, P85, DOI 10.1007/s00403-009-1004-0; VARADI DP, 1970, BRIT J DERMATOL, V83, P143, DOI 10.1111/j.1365-2133.1970.tb12875.x; Buechner SA, 2002, DERMATOLOGY, V205, P198, DOI 10.1159/000063914; FEIGENBAUM A, 1956, Br J Ophthalmol, V40, P355, DOI 10.1136/bjo.40.6.355	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1017	1018		10.1111/1346-8138.12998		2	Dermatology	Dermatology	CS9RR	WOS:000362429600021		
J	Munemoto, S; Osawa, S; Kurokawa, T; Moriwaki, S				Munemoto, Sawa; Osawa, Saya; Kurokawa, Teruo; Moriwaki, Shinichi			Case of generalized eruptive keratoacanthoma with probable Sjogren's syndrome	JOURNAL OF DERMATOLOGY			English	Letter									[Munemoto, Sawa; Osawa, Saya; Kurokawa, Teruo; Moriwaki, Shinichi] Osaka Med Coll, Dept Dermatol, Osaka, Japan	Moriwaki, S (reprint author), Osaka Med Coll, Dept Dermatol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	der002@poh.osaka-med.ac.jp					Dessoukey MW, 1997, J AM ACAD DERMATOL, V37, P478, DOI 10.1016/S0190-9622(97)70150-6; Consigli JE, 2000, BRIT J DERMATOL, V142, P800, DOI 10.1046/j.1365-2133.2000.03430.x; SNIDER BL, 1981, ARCH DERMATOL, V117, P788, DOI 10.1001/archderm.117.12.788; Haas N, 2002, BRIT J DERMATOL, V147, P793, DOI 10.1046/j.1365-2133.2002.04925.x; Nofal A, 2015, INT J DERMATOL, V54, P160, DOI 10.1111/ijd.12308	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1018	1019		10.1111/1346-8138.13013		2	Dermatology	Dermatology	CS9RR	WOS:000362429600022		
J	Ishibuchi, H; Motegi, S; Amano, H; Ishikawa, O				Ishibuchi, Hirohisa; Motegi, Sei-ichiro; Amano, Hiroo; Ishikawa, Osamu			Successful treatment with dapsone for skin lesions of amyopathic dermatomyositis	JOURNAL OF DERMATOLOGY			English	Letter									[Ishibuchi, Hirohisa; Motegi, Sei-ichiro; Amano, Hiroo; Ishikawa, Osamu] Gunma Univ, Dept Dermatol, Grad Sch Med, Maebashi, Gunma 3718511, Japan	Motegi, S (reprint author), Gunma Univ, Dept Dermatol, Grad Sch Med, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	smotegi@gunma-u.ac.jp					Cohen JB, 2002, INT J DERMATOL, V41, P182, DOI 10.1046/j.1365-4362.2002.01409.x; Kawachi Y, 2012, EUR J DERMATOL, V22, P289, DOI 10.1684/ejd.2012.1669; Abe M, 2008, CLIN EXP DERMATOL, V33, P759, DOI 10.1111/j.1365-2230.2008.02864.x; KONOHANA A, 1994, CLIN EXP DERMATOL, V19, P367, DOI 10.1111/j.1365-2230.1994.tb01220.x; MASCARO JM, 1995, ARCH DERMATOL, V131, P1386, DOI 10.1001/archderm.131.12.1386	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1019	1021		10.1111/1346-8138.12999		3	Dermatology	Dermatology	CS9RR	WOS:000362429600023		
J	Ozaki, S; Funasaka, Y; Tsuruta, K; Kubota, T; Matayoshi, T; Ueno, T; Saeki, H				Ozaki, Saeko; Funasaka, Yoko; Tsuruta, Kyoko; Kubota, Tomoki; Matayoshi, Takemitsu; Ueno, Takashi; Saeki, Hidehisa			Extranodal natural killer/T-cell lymphoma, nasal type, presenting with altered CD56 expression: A case report	JOURNAL OF DERMATOLOGY			English	Letter									[Ozaki, Saeko; Funasaka, Yoko; Tsuruta, Kyoko; Kubota, Tomoki; Matayoshi, Takemitsu; Ueno, Takashi; Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Bunkyo Ku, Tokyo 1138603, Japan	Ozaki, S (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	sae777@nms.ac.jp					Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Chang BH, 2008, PEDIATR DEVEL PATHOL, V11, P50, DOI 10.2350/06-07-0140.1; Chan JKC, 2008, WHO CLASSIFICATION T, P285; Li YX, 2011, LEUKEMIA LYMPHOMA, V52, P417, DOI 10.3109/10428194.2010.543718; Wang L, 2015, TUMOR BIOL, DOI [10.1007/s13277-015-3485-0., DOI 10.1007/S13277-015-3485-0]	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1022	1023		10.1111/1346-8138.13018		2	Dermatology	Dermatology	CS9RR	WOS:000362429600025		
J	Matsuo, R; Honma, M; Komatsu, S; Minami-Hori, M; Ishida-Yamamoto, A; Iizuka, H				Matsuo, Risa; Honma, Masaru; Komatsu, Shigetsuna; Minami-Hori, Masako; Ishida-Yamamoto, Akemi; Iizuka, Hajime			External ear canal lesions of crusted scabies: A pitfall of recurrence?	JOURNAL OF DERMATOLOGY			English	Letter							IVERMECTIN		[Matsuo, Risa; Honma, Masaru; Komatsu, Shigetsuna; Minami-Hori, Masako; Ishida-Yamamoto, Akemi; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan	Matsuo, R (reprint author), Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	mrisa@asahikawa-med.ac.jp					Chosidow O, 2006, NEW ENGL J MED, V354, P1718, DOI 10.1056/NEJMcp052784; Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329; Haas N, 2002, ARCH DERMATOL, V138, P1618, DOI 10.1001/archderm.138.12.1618; Huffam S E, 1998, Int J Infect Dis, V2, P152, DOI 10.1016/S1201-9712(98)90118-7; Ohtaki N, 2003, J DERMATOL, V30, P411	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1023	1024		10.1111/1346-8138.13021		2	Dermatology	Dermatology	CS9RR	WOS:000362429600026		
J	Iijima, S; Okazaki, Y; Watanabe, S; Tsuruta, D; Tateishi, C; Ishii, N; Ohata, C; Hashimoto, T				Iijima, Shigeruko; Okazaki, Yukiko; Watanabe, Shinya; Tsuruta, Daisuke; Tateishi, Chiharu; Ishii, Norito; Ohata, Chika; Hashimoto, Takashi			Case of concurrence of anti-laminin gamma-1 pemphigoid and scabies	JOURNAL OF DERMATOLOGY			English	Letter							ERUPTION		[Iijima, Shigeruko; Okazaki, Yukiko; Watanabe, Shinya] Mito Saiseikai Gen Hosp, Dept Dermatol, Ibaraki, Japan; [Tsuruta, Daisuke; Tateishi, Chiharu] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Ishii, Norito; Ohata, Chika; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan; [Ishii, Norito; Ohata, Chika; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp					Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; OSTLERE LS, 1993, BRIT J DERMATOL, V128, P217, DOI 10.1111/j.1365-2133.1993.tb15155.x; Konishi N, 2000, ACTA DERM-VENEREOL, V80, P281, DOI 10.1080/000155500750012171; Baican A, 2010, J DERMATOL, V37, P280, DOI 10.1111/j.1346-8138.2010.00810.x; Ogata M, 2006, NISHIN J DERMATOL, V68, P375, DOI 10.2336/nishinihonhifu.68.375	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1024	1026		10.1111/1346-8138.13020		3	Dermatology	Dermatology	CS9RR	WOS:000362429600027		
J	Yagami, A; Suzuki, K; Sano, A; Iwata, Y; Arima, M; Moriyama, T; Matsunaga, K				Yagami, Akiko; Suzuki, Kayoko; Sano, Akiyo; Iwata, Yohei; Arima, Masaru; Moriyama, Tatsuya; Matsunaga, Kayoko			Immediate allergy due to raw garlic (Allium sativum L.)	JOURNAL OF DERMATOLOGY			English	Letter							ANAPHYLAXIS		[Yagami, Akiko; Suzuki, Kayoko; Sano, Akiyo; Iwata, Yohei; Arima, Masaru; Matsunaga, Kayoko] Fujita Hlth Univ, Dept Dermatol, Sch Med, Toyoake, Aichi 4701192, Japan; [Moriyama, Tatsuya] Kinki Univ, Dept Appl Biol Chem, Grad Sch Agr, Nara, Japan	Yagami, A (reprint author), Fujita Hlth Univ, Dept Dermatol, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	ayagami@fujita-hu.ac.jp					Ma SK, 2012, FOODBORNE PATHOG DIS, V9, P773, DOI 10.1089/fpd.2012.1133; Vovolis V, 2010, J INVEST ALLERG CLIN, V20, P356; Pires G, 2002, ALLERGY, V57, P957, DOI 10.1034/j.1398-9995.2002.23832_2.x; Perez-Pimiento AJ, 1999, ALLERGY, V54, P626, DOI 10.1034/j.1398-9995.1999.00806.x; Asero R, 1998, J ALLERGY CLIN IMMUN, V101, P427	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1026	1027		10.1111/1346-8138.13025		2	Dermatology	Dermatology	CS9RR	WOS:000362429600028		
J	Nakamura, K; Asano, Y; Shibata, S; Nakao, M; Shida, R; Takahashi, T; Mitsui, A; Araki, M; Yamada, A; Sato, S				Nakamura, Kouki; Asano, Yoshihide; Shibata, Sayaka; Nakao, Momoko; Shida, Rino; Takahashi, Takehiro; Mitsui, Aya; Araki, Mayuko; Yamada, Atsuo; Sato, Shinichi			Case of psoriasis vulgaris developing ulcerative colitis during adalimumab treatment	JOURNAL OF DERMATOLOGY			English	Letter							INFLAMMATORY-BOWEL-DISEASE; GLUCOCORTICOID SYNTHESIS		[Nakamura, Kouki; Asano, Yoshihide; Shibata, Sayaka; Nakao, Momoko; Shida, Rino; Takahashi, Takehiro; Mitsui, Aya; Araki, Mayuko; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Grad Sch Med, Tokyo 1138655, Japan; [Yamada, Atsuo] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo 1138655, Japan	Asano, Y (reprint author), Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasano-tky@umin.ac.jp					Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Toussirot E, 2012, JOINT BONE SPINE, V79, P457, DOI 10.1016/j.jbspin.2011.10.001; Dallocchio A, 2010, RHEUMATOLOGY, V49, P1694, DOI 10.1093/rheumatology/keq136; Huang SC, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004786; vansDijken TD, 2011, J RHEUMATOL, V38, P1441	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-2407	1346-8138		J DERMATOL	J. Dermatol.	OCT	2015	42	10					1029	1030		10.1111/1346-8138.12996		2	Dermatology	Dermatology	CS9RR	WOS:000362429600030		
J	Javidi, B; Martinez-Corral, M; Ferraro, P; Hua, H; Huang, YP; Matoba, O; Son, JY; Stern, A				Javidi, Bahram; Martinez-Corral, Manuel; Ferraro, Pietro; Hua, Hong; Huang, Yi Pai; Matoba, Osamu; Son, Jung Yong; Stern, Adrian			Untitled	JOURNAL OF DISPLAY TECHNOLOGY			English	Editorial Material									[Javidi, Bahram] Univ Connecticut, Storrs, CT 06269 USA; [Martinez-Corral, Manuel] Univ Valencia, E-46100 Burjassot, Spain; [Ferraro, Pietro] Natl Inst Appl Opt, I-80078 Pozzuoli, Italy; [Hua, Hong] Univ Arizona, Coll Opt Sci, Tucson, AZ 85711 USA; [Huang, Yi Pai] Natl Chiao Tung Univ, Hsinchu 300, Taiwan; [Matoba, Osamu] Kobe Univ, Kobe, Hyogo 6578501, Japan; [Son, Jung Yong] Konyang Univ, Nonsan 320711, Chungnam, South Korea; [Stern, Adrian] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel	Javidi, B (reprint author), Univ Connecticut, Storrs, CT 06269 USA.		Ferraro, Pietro/A-5288-2009; Martinez-Corral, Manuel/I-2313-2012	Ferraro, Pietro/0000-0002-0158-3856; Martinez-Corral, Manuel/0000-0002-1449-8976				0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	OCT	2015	11	10					791	791		10.1109/JDT.2015.2472935		1	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CT4HM	WOS:000362767200001		
J	Tahara, T; Takahashi, Y; Komura, T; Kaku, T; Arai, Y				Tahara, Tatsuki; Takahashi, Yuki; Komura, Takuya; Kaku, Toru; Arai, Yasuhiko			Single-Shot Multiwavelength Digital Holography Using Angular Multiplexing and Spatial Bandwidth Enhancement for Extending the Field of View	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Color holography; digital holography; holography	SPECTRAL ESTIMATION TECHNIQUE; FRINGE-PATTERN ANALYSIS; 3-DIMENSIONAL IMAGE; FOURIER-TRANSFORM; PHASE; MICROSCOPY; RECONSTRUCTION; INTERFEROMETRY; RESOLUTION; DISPLAY	Single-shot multiwavelength digital holography using angular multiplexing and spatial bandwidth enhancement is proposed to extend the field of view without the superimposition of undesired images. Angular multiplexing is used to record multiple wavelength information with a single-shot exposure of a monochromatic image sensor. Enlargement of the field of view without the superimposition of undesired images is achieved by designing both the object-wave spectra and angle conditions to obtain wide spatial bandwidths in the respective wavelengths with a high signal-to-noise ratio. Theoretical analyses clarified that the field of view is 1.33 times extended in square by the proposed technique in the case of dual wavelengths. Single-shot, multiple wavelengths, and 3D image recording with both the extended field of view and no superimposition of the zeroth-order diffraction wave is experimentally demonstrated while the zeroth-order wave remains, and the color-synthesized image is degraded in the conventional technique. Experimental results agree well to the theoretical analysis.	[Tahara, Tatsuki; Takahashi, Yuki; Komura, Takuya; Kaku, Toru; Arai, Yasuhiko] Kansai Univ, Fac Engn Sci, Osaka 5648680, Japan	Tahara, T (reprint author), Kansai Univ, Fac Engn Sci, Osaka 5648680, Japan.	tahara@kansai-u.ac.jp			Research Foundation for Opt-Science and Technology; Murata Science Foundation; Japan Society for the Promotion of Science (JSPS) [25886014]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	This work was supported in part by the Research Foundation for Opt-Science and Technology, The Murata Science Foundation, Grant-in-Aid for Research Activity Start-up under Grant 25886014 of the Japan Society for the Promotion of Science (JSPS), and MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Awatsuji Y, 2004, APPL PHYS LETT, V85, P1069, DOI 10.1063/1.1777796; POON TC, 1995, OPT ENG, V34, P1338, DOI 10.1117/12.201662; Javidi B, 2005, OPT EXPRESS, V13, P4492, DOI 10.1364/OPEX.13.004492; Matoba O, 2002, APPL OPTICS, V41, P6187, DOI 10.1364/AO.41.006187; Funamizu H, 2014, OPT COMMUN, V312, P245, DOI 10.1016/j.optcom.2013.09.032; Yamaguchi I, 2002, OPT LETT, V27, P1108, DOI 10.1364/OL.27.001108; Wagner C, 2000, OPT ENG, V39, P79, DOI 10.1117/1.602338; Paturzo M, 2010, OPT EXPRESS, V18, P8806, DOI 10.1364/OE.18.008806; Frauel Y, 2006, P IEEE, V94, P636, DOI 10.1109/JPROC.2006.870704; GREIVENKAMP JE, 1987, APPL OPTICS, V26, P5245, DOI 10.1364/AO.26.005245; Paturzo M, 2009, OPT EXPRESS, V17, P8709, DOI 10.1364/OE.17.008709; ITOH K, 1990, APPL OPTICS, V29, P1625, DOI 10.1364/AO.29.001625; Stern A, 2006, J OPT SOC AM A, V23, P1227, DOI 10.1364/JOSAA.23.001227; ICHIOKA Y, 1972, APPL OPTICS, V11, P1507, DOI 10.1364/AO.11.001507; Stern A, 2007, J OPT SOC AM A, V24, P163, DOI 10.1364/JOSAA.24.000163; Tahara T, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.11.112313; Ferraro P, 2008, J DISP TECHNOL, V4, P97, DOI 10.1109/JDT.2007.900936; Kuhn J, 2007, OPT EXPRESS, V15, P7231, DOI 10.1364/OE.15.007231; Matsushima K, 2011, APPL OPTICS, V50, pH278, DOI 10.1364/AO.50.00H278; Xia P, 2011, APPL OPTICS, V50, pH177, DOI 10.1364/AO.50.00H177; Yokota M, 2011, APPL OPTICS, V50, P3937, DOI 10.1364/AO.50.003937; Khmaladze A, 2008, OPT EXPRESS, V16, P10900, DOI 10.1364/OE.16.010900; Teeranutranont S, 2013, APPL OPTICS, V52, pA388, DOI 10.1364/AO.52.00A388; Xia P, 2014, J DISP TECHNOL, V10, P235, DOI 10.1109/JDT.2014.2298537; Watanabe E, 2013, OPT LETT, V38, P1319, DOI 10.1364/OL.38.001319; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; LEITH EN, 1962, J OPT SOC AM, V52, P1123, DOI 10.1364/JOSA.52.001123; Mori Y, 2013, APPL OPTICS, V52, P3838, DOI 10.1364/AO.52.003838; Wada A, 2008, J OPT SOC AM A, V25, P3013, DOI 10.1364/JOSAA.25.003013; BONE DJ, 1986, APPL OPTICS, V25, P1653; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Hayasaki Y, 2014, OPT COMMUN, V322, P22, DOI 10.1016/j.optcom.2014.02.014; Kakue T, 2010, J DISP TECHNOL, V6, P472, DOI 10.1109/JDT.2010.2046473; Mann CJ, 2005, OPT EXPRESS, V13, P8693, DOI 10.1364/OPEX.13.008693; Stern A, 2008, J OPT SOC AM A, V25, P736, DOI 10.1364/JOSAA.25.000736; Tahara T, 2014, OPT EXPRESS, V22, P29594, DOI 10.1364/OE.22.029594; Horisaki R, 2012, OPT LETT, V37, P2013, DOI 10.1364/OL.37.002013; Takaki Y, 1999, APPL OPTICS, V38, P4990, DOI 10.1364/AO.38.004990; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; Pavillon N, 2009, APPL OPTICS, V48, pH186, DOI 10.1364/AO.48.00H186; Ito Y, 2012, J DISP TECHNOL, V8, P570, DOI 10.1109/JDT.2012.2204956; Javidi B, 2005, OPT LETT, V30, P144, DOI 10.1364/OL.30.000144; Memmolo P, 2012, OPT LETT, V37, P1445, DOI 10.1364/OL.37.001445; Garcia-Sucerquia J, 2012, OPT LETT, V37, P1724, DOI 10.1364/OL.37.001724; Murata S, 2000, OPT LASER TECHNOL, V32, P567, DOI 10.1016/S0030-3992(00)00088-8; Paturzo M, 2008, OPT LETT, V33, P2629, DOI 10.1364/OL.33.002629; Kubota T, 2007, OPT EXPRESS, V15, P14348, DOI 10.1364/OE.15.014348; Senoh T, 2011, J DISP TECHNOL, V7, P382, DOI 10.1109/JDT.2011.2114327; Arazia-Esquivel M. A., 2011, APPL OPTICS, V50, pB96; Javidi B., 2014, MULTIDIMENSIONAL IMA; Schnars U., 2005, DIGITAL HOLOGRAPHY; Tahara T., 2013, APPL PHYS EXPRESS, V6; Xia P, 2014, APPL OPTICS, V53, pG123, DOI 10.1364/AO.53.00G123; Yamaguchi I, 1997, OPT LETT, V22, P1268, DOI 10.1364/OL.22.001268	54	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	OCT	2015	11	10					807	813		10.1109/JDT.2015.2424082		7	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CT4HM	WOS:000362767200004		
J	Yano, S; Suzuki, M; Park, MC				Yano, Sumio; Suzuki, Makoto; Park, Min-Chul			The Effect of Motion Parallax Due to the Difference of Capturing Image Method	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Motion parallax; depth perception; motion perception	DEPTH-PERCEPTION	We evaluated depth perception from motion parallax with capturing natural scene. First, we used two type control methods for the pickup device in capturing the natural scene. One control method was just horizontally repetition motion; another was horizontally repetition motion with heading to a fixation point. As a result, the latter method generated a clearer depth perception than that of the former method. Next, the position of the pickup device and the subject's head was changed for the latter method, when the test image sequences were evaluated. In this case, even when the relationship of the position between the pickup device and the subject's head was correct or opposite, the degree of depth perception was almost the same. These results suggest that the set of fixation point and the natural depth cue are important for depth perception from motion parallax with capturing the natural scene.	[Yano, Sumio; Suzuki, Makoto] Shimane Univ, Dept Mech Elect & Elect Engn, Matsue, Shimane 6908504, Japan; [Park, Min-Chul] Korea Inst Sci & Technol, Sensor Syst Res Ctr, Seoul 136791, South Korea	Yano, S (reprint author), Shimane Univ, Dept Mech Elect & Elect Engn, Matsue, Shimane 6908504, Japan.	yano@ecs.shimane-u.ac.jp		Park, Min-Chul/0000-0002-8575-085X	JSPS KAKENHI [25330196]	This work was supported by JSPS KAKENHI under Grant 25330196.	Yuan HF, 2000, PRESENCE-TELEOP VIRT, V9, P638, DOI 10.1162/105474600300040439; ONO ME, 1986, J EXP PSYCHOL HUMAN, V12, P331, DOI 10.1037//0096-1523.12.3.331; Ujike H, 2001, VISION RES, V41, P2835, DOI 10.1016/S0042-6989(01)00164-X; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; [Anonymous], 2013, BT2020 ITU; Masaoka K., 2007, P SPIE IS T EL IM, V6492; Matsushita S., 2012, JAPANESE J PSYCHONOM, V31, P1; Satoh T., 1991, P SPIE, V1606; Soc. of Motion Pictures and TV Engineers (MPTE), 2014, 28 MPTE EC STUD GROU; Tsushima Y., 2014, P IDW, P1140	10	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	OCT	2015	11	10					821	826		10.1109/JDT.2015.2393360		6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CT4HM	WOS:000362767200006		
J	Mori, Y; Nomura, T				Mori, Yutaka; Nomura, Takanori			Speckle Reduction in Hologram Generation Based on Spherical Waves Synthesis Using Low-Coherence Digital Holography	JOURNAL OF DISPLAY TECHNOLOGY			English	Article						Digital holography; three-dimensional (3D) image; speckle reduction	3-DIMENSIONAL OBJECT RECOGNITION; NOISE-REDUCTION; IMAGE QUALITY; MICROSCOPY; INFORMATION; DISPLAY; IMPROVEMENT; PROJECTION; RESOLUTION; SYSTEM	A speckle reduction method based on a spherical waves synthesis with low-coherence digital holography for hologram generation is proposed. An object information is experimentally obtained from a number of recorded low-coherence digital holograms. A hologram is generated by synthesizing the fields of spherical waves with the obtained information. The performance of the proposed method as hologram generation from a distribution contained spike noises like speckles is confirmed. The image quality is evaluated by the speckle contrast of the reconstructed image.	[Mori, Yutaka] Wakayama Univ, Grad Sch Syst Engn, Wakayama 6408510, Japan; [Nomura, Takanori] Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan	Mori, Y (reprint author), Wakayama Univ, Grad Sch Syst Engn, Wakayama 6408510, Japan.	s112058@sys.wakayama-u.ac.jp; nom@sys.wakayama-u.ac.jp		Mori, Yutaka/0000-0001-7853-9506			Takaki Y, 2011, OPT EXPRESS, V19, P7567, DOI 10.1364/OE.19.007567; Matsushima K, 2009, OPT EXPRESS, V17, P19662, DOI 10.1364/OE.17.019662; Javidi B, 2000, OPT LETT, V25, P28, DOI 10.1364/OL.25.000028; Javidi B, 2000, OPT LETT, V25, P610, DOI 10.1364/OL.25.000610; AMAKO J, 1995, APPL OPTICS, V34, P3165, DOI 10.1364/AO.34.003165; Langehanenberg P, 2008, APPL OPTICS, V47, pD176, DOI 10.1364/AO.47.00D176; Paturzo M, 2010, OPT EXPRESS, V18, P8806, DOI 10.1364/OE.18.008806; Pedrini G, 2002, APPL OPTICS, V41, P4489, DOI 10.1364/AO.41.004489; Makowski M, 2013, OPT EXPRESS, V21, P29205, DOI 10.1364/OE.21.029205; Yokota M, 2011, APPL OPTICS, V50, P3937, DOI 10.1364/AO.50.003937; Gao P, 2013, OPT LETT, V38, P1328, DOI 10.1364/OL.38.001328; Tajahuerce E, 2000, APPL OPTICS, V39, P6595, DOI 10.1364/AO.39.006595; Rong L, 2010, CHIN OPT LETT, V8, P653, DOI 10.3788/COL20100807.0653; Mori Y, 2013, APPL OPTICS, V52, P3838, DOI 10.1364/AO.52.003838; Kozacki T, 2010, OPT EXPRESS, V18, P27118, DOI 10.1364/OE.18.027118; GOODMAN JW, 1967, APPL PHYS LETT, V11, P77, DOI 10.1063/1.1755043; Wang LL, 1998, APPL OPTICS, V37, P1770, DOI 10.1364/AO.37.001770; Tahara T, 2010, BIOMED OPT EXPRESS, V1, P610; Xia P, 2013, APPL OPTICS, V52, pA210, DOI 10.1364/AO.52.00A210; Kuroda K, 2014, OPT REV, V21, P83, DOI 10.1007/s10043-014-0013-1; Mico V, 2006, OPT EXPRESS, V14, P5168, DOI 10.1364/OE.14.005168; Goodman J. W., 2007, SPECKLE PHENOMENA OP, P275; Mori Y, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.12.123101; Nomura T, 2008, APPL OPTICS, V47, pD38, DOI 10.1364/AO.47.000D38; Tajahuerce E, 2001, APPL OPTICS, V40, P3877, DOI 10.1364/AO.40.003877; Yamaguchi I, 1997, OPT LETT, V22, P1268, DOI 10.1364/OL.22.001268; Zheng HD, 2008, PROC SPIE, V7155, DOI 10.1117/12.814510	27	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1551-319X	1558-9323		J DISP TECHNOL	J. Disp. Technol.	OCT	2015	11	10					867	872		10.1109/JDT.2014.2342254		6	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CT4HM	WOS:000362767200013		
J	Shiota, K; Osakai, T				Shiota, Koki; Osakai, Toshiyuki			The effect of supporting electrolyte on the electron transfer at mixed self-assembled monolayers containing ferrocene moieties	JOURNAL OF ELECTROANALYTICAL CHEMISTRY			English	Article						Mixed SAM; Ferrocene; Supporting electrolyte; Interfacial potential distribution	SIMPLE REDOX COUPLE; DOUBLE-LAYER; VOLTAMMETRIC RESPONSE; THIOL MONOLAYERS; GOLD; COADSORPTION; SURFACE; ALKANETHIOLS; DESORPTION; KINETICS	The effect of supporting electrolyte on the apparent redox potential (E-app(center dot)) of ferrocene (Fc) moieties in mixed self-assembled monolayers (SAMs) has been studied by means of cyclic and ac voltammetry. When the Fc moieties are exposed on the surface of the SAM (i.e., for the mixed SAM of Fc(CH2)(6)SH and 1-hexylmercaptan), the E-app(center dot) is little dependent on the supporting electrolytes used, i.e., sodium salts of 4-hydroxybenzenesulfonate (HBS), p-toluenesulfonate (TS), and 2-naphtalenesulfonate (NS). On the other hand, when the Fc moieties are buried in the SAM (i.e., for the mixed SAM of Fc(CH2)(6)SH and 1-octadecylmercaptan), the E-app(center dot) is significantly shifted to more positive potentials and is further affected by the nature of the electrolyte anions. The more hydrophobic the anion becomes in the order HBS <TS <NS, the less positive the E-app(center dot) value. This effect has been successfully explained by the theory proposed by Smith and White (Anal. Chem., 64 (1992) 2398-2405), with an additional consideration on the anions' ability to neutralize the positive charge of oxidized Fc moieties. (C) 2015 Elsevier B.V. All rights reserved.	[Shiota, Koki; Osakai, Toshiyuki] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan	Osakai, T (reprint author), Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan.	osakai@kobe-u.ac.jp					Fernandes FCB, 2013, BIOSENS BIOELECTRON, V50, P437, DOI 10.1016/j.bios.2013.06.043; BAIN CD, 1989, J AM CHEM SOC, V111, P7164, DOI 10.1021/ja00200a040; GRAHAME DC, 1947, CHEM REV, V41, P441, DOI 10.1021/cr60130a002; Eggers PK, 2012, J AM CHEM SOC, V134, P7539, DOI 10.1021/ja301509h; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; ROWE GK, 1991, LANGMUIR, V7, P2307, DOI 10.1021/la00058a055; Valincius G, 2004, LANGMUIR, V20, P6631, DOI 10.1021/la0364800; Sumner JJ, 2001, J PHYS CHEM B, V105, P8739, DOI 10.1021/jp011229j; Laaksonen T, 2007, J AM CHEM SOC, V129, P7732, DOI 10.1021/ja0720107; PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011; CHIDSEY CED, 1990, J AM CHEM SOC, V112, P4301, DOI 10.1021/ja00167a028; Calvente JJ, 2001, J PHYS CHEM B, V105, P9557, DOI 10.1021/jp011990t; BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039; WEBER K, 1994, ANAL CHEM, V66, P3164, DOI 10.1021/ac00091a027; Shiota K, 2015, J ELECTROANAL CHEM, V745, P22, DOI 10.1016/j.jelechem.2015.03.016; Kakiuchi T, 2002, LANGMUIR, V18, P5231, DOI 10.1021/la011560u; Eggers PK, 2009, J PHYS CHEM C, V113, P8964, DOI 10.1021/jp811127f; KOEPP HM, 1960, Z ELEKTROCHEM, V64, P483; Imabayashi S, 1997, LANGMUIR, V13, P4502, DOI 10.1021/la970447u; Creager SE, 1998, ANAL CHEM, V70, P4257, DOI 10.1021/ac980482l; REDEPENNING J, 1993, LANGMUIR, V9, P1404, DOI 10.1021/la00029a039; FAWCETT WR, 1994, J ELECTROANAL CHEM, V378, P117, DOI 10.1016/0022-0728(94)87063-2; SMITH CP, 1992, ANAL CHEM, V64, P2398, DOI 10.1021/ac00044a017; Andreu R, 1997, J PHYS CHEM B, V101, P2884, DOI 10.1021/jp963701k; Ohtani M, 1997, ANAL CHEM, V69, P1045, DOI 10.1021/ac960952g; Bard A.J., 2001, ELECTROCHEMICAL METH; Ho M.Y., 2010, J PHYS CHEM B, V114, P10661; Ho MY, 2014, ANALYST, V139, P6118, DOI 10.1039/c4an01591f; Krysinski P, 1998, ADV MATER OPT ELECTR, V8, P121, DOI 10.1002/(SICI)1099-0712(199805/06)8:3<121::AID-AMO330>3.0.CO;2-W; Naito Y., 2014, REV POLARGOR, V60, P232; SONDAGHUETHORST JAM, 1994, J ELECTROANAL CHEM, V367, P49, DOI 10.1016/0022-0728(93)03006-B; Uosaki K., 1991, ELECTROCHIM ACTA, V36, P1799, DOI 10.1016/0013-4686(91)85047-B; Walczak M.M., 1991, LANGMUIR, V7, P2687	33	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1572-6657	1873-2569		J ELECTROANAL CHEM	J. Electroanal. Chem.	OCT 1	2015	754						75	79		10.1016/j.jelechem.2015.07.004		5	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	CT2GM	WOS:000362620000009		
J	Uematsu, K; Maruyama, C; Hamano, Y; Katano, H				Uematsu, Kohei; Maruyama, Chitose; Hamano, Yoshimitsu; Katano, Hajime			Ion-transfer voltammetry of streptothricin antibiotics with differently sized lysine oligomers at a nitrobenzene vertical bar water interface	JOURNAL OF ELECTROANALYTICAL CHEMISTRY			English	Article						Ion-transfer voltammetry; Streptothricin; Antibiotics; Lysine oligopeptides; Liquid-liquid interface	POLY-L-LYSINE; OIL/WATER INTERFACE; CYCLIC VOLTAMMETRY; GLUCOSE-OXIDASE; DIBENZO-18-CROWN-6; HYDROPHOBICITY; DIPEPTIDES; PROMOTION; ELECTRODE; PROTEINS	The transfer of streptothricin antibiotics containing a beta-lysine monomer (ST-F), trimer (ST-D), and tetramer (ST-C) at a polarizable nitrobenzene (NB) broken vertical bar water (W) interface was studied by cyclic voltammetry. Under acidic conditions, the streptothricins existed in fully protonated forms, as ST-F2+, ST-D4+ and ST-C5+ cationic species. Within the potential range tested, ST-D4+ and ST-C5+ ions gave reversible voltammograms due to their transfer across the NB W interface. The formal potentials, Delta(w)(o)phi(S) (T),(0) (,) of ST-D4+ and ST-C5+ ions were determined. In the presence of a neutral ligand (L), dibenzo-18-crown-6, in NB, ST-F2+, ST-D4+ and ST-C5+ ions gave reversible voltammograms due to their transfer assisted by the formation of ST-FL22+, sr-DL44+ and ST-CL55+ complexes with the ligand in NB. Using the Delta(w)(o)phi(S) (T) (0)-values, association constants between the NH3+-groups of ST-D4+ and ST-C5+ ions and the crown ether in NB were determined. The association constants were in agreement with each other. By assuming that the association constant of ST-F2+ was equal to those of the ST-D4+ and ST-C5+ ions, the Delta(w)(o)phi(S) (0)(T) (,) of the ST-F2+ ion was estimated. Interestingly, the determined Delta(w)(o)phi(S) (0)(T) (,)-value was increasingly negative in the order of ST-F2+ (similar to 0.24 V) > ST-D4+ (0.199 V) > ST-C5+ (0.194 V), indicating that the lysine oligomer affected the phase-transfer characteristics of streptothricin. (C) 2015 Elsevier B.V. All rights reserved.	[Uematsu, Kohei; Maruyama, Chitose; Hamano, Yoshimitsu; Katano, Hajime] Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan	Uematsu, K (reprint author), Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan.	kuematsu@fpu.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [26410226, 25108720, 15K14724]	This work was supported by grant-in-aids from the Ministry of Education, Science, Sports and Culture of Japan (no. 26410226, to H.K.) and (no. 25108720 and 15K14724, to Y.H.).	OSAKAI T, 1983, BUNSEKI KAGAKU, V32, pE81; Arrigan DWM, 2008, ANAL LETT, V41, P3233, DOI 10.1080/00032710802518197; Guo JD, 2005, ANAL CHEM, V77, P5711, DOI 10.1021/ac050833d; Amemiya S, 2003, J AM CHEM SOC, V125, P11832, DOI 10.1021/ja036572b; Zhang LM, 2011, LANGMUIR, V27, P13037, DOI 10.1021/la2028077; Katano H, 2004, TALANTA, V63, P185, DOI 10.1016/j.talanta.2003.10.044; Katano H, 1996, ANAL SCI, V12, P683, DOI 10.2116/analsci.12.683; Hartvig RA, 2010, ANAL CHEM, V82, P7699, DOI 10.1021/ac101528r; Chen Y, 2004, SCI CHINA SER B, V47, P24, DOI 10.1360/03yb0066; KORYTA J, 1977, J ELECTROANAL CHEM, V75, P211, DOI 10.1016/0368-1874(77)80017-8; Trojanek A, 2007, J ELECTROANAL CHEM, V603, P235, DOI 10.1016/j.jelechem.2007.02.006; Samec Z, 2003, ELECTROCHEM COMMUN, V5, P867, DOI 10.1016/j.elecom.2003.08.009; Shinshi M, 2006, LANGMUIR, V22, P5937, DOI 10.1021/la060858n; Yuan Y, 2004, ANAL CHEM, V76, P6877, DOI 10.1021/ac048879e; Uematsu K, 2012, ANAL SCI, V28, P657; Uematsu K, 2014, J ELECTROANAL CHEM, V719, P138, DOI 10.1016/j.jelechem.2014.02.015; NICHOLSON RS, 1964, ANAL CHEM, V36, P706, DOI 10.1021/ac60210a007; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/nchembio.1040, 10.1038/NCHEMBIO.1040]; Katano H, 2004, ANAL SCI, V20, P1581, DOI 10.2116/analsci.20.1581; Herzog G, 2009, ANALYST, V134, P1608, DOI 10.1039/b905441n; Nagatani H, 2010, LANGMUIR, V26, P17686, DOI 10.1021/la1032477; Amemiya S, 2011, ANAL BIOANAL CHEM, V399, P571, DOI 10.1007/s00216-010-4056-2; Osakai T, 2010, LANGMUIR, V26, P11530, DOI 10.1021/la100769q; Sawada S, 1999, PHYS CHEM CHEM PHYS, V1, P4819, DOI 10.1039/a905609b; Katano H, 2014, ANAL SCI, V30, P17; Herzog G, 2012, ANAL CHEM, V84, P5693, DOI 10.1021/ac300856w; Osakai T, 2006, PHYS CHEM CHEM PHYS, V8, P985, DOI 10.1039/b513335a; Matsuda H., B CHEM SOC JPN, P64; Uematsu K, 2014, ANAL SCI, V30, P299	29	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1572-6657	1873-2569		J ELECTROANAL CHEM	J. Electroanal. Chem.	OCT 1	2015	754						143	147		10.1016/j.jelechem.2015.07.003		5	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	CT2GM	WOS:000362620000019		
J	Sameshima, A; Wada, T; Ito, T; Kashimura, A; Sawakawa, K; Yonezawa, R; Tsuneki, H; Ishii, Y; Sasahara, M; Saito, S; Sasaoka, T				Sameshima, Azusa; Wada, Tsutomu; Ito, Tetsuo; Kashimura, Ayaka; Sawakawa, Kanae; Yonezawa, Rika; Tsuneki, Hiroshi; Ishii, Yoko; Sasahara, Masakiyo; Saito, Shigeru; Sasaoka, Toshiyasu			Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity	JOURNAL OF ENDOCRINOLOGY			English	Article						dpp4 inhibitor; adipose tissue macrophage; energy expenditure; insulin resistance	ESTROGEN-RECEPTOR-ALPHA; DIPEPTIDYL-PEPTIDASE-IV; GLUCAGON-LIKE PEPTIDE-1; INSULIN-RESISTANCE; HIGH-FAT; REPLACEMENT THERAPY; HEPATIC STEATOSIS; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; PLUS PROGESTIN	A decrease in serum estrogen levels in menopause is closely associated with the development of visceral obesity and the onset of type 2 diabetes in women. In the present study, we demonstrated the therapeutic effects of the novel DPP4 inhibitor, teneligliptin, on the features of postmenopausal obesity in mice. In the control group, female C57BL/6 mice were sham-operated and maintained on a standard diet. In the postmenopausal obese group, ovariectomized (OVX) mice were maintained on a high-fat diet, and were referred to as OVX-HF. In the treated group, teneligliptin at 60 mg/kg per day was administrated to OVX-HF, and were referred to as Tene. After a 12-week food challenge, the metabolic phenotypes of these mice were analyzed. Body weight, fat accumulation, and glucose intolerance were greater in OVX-HF than in control, while these abnormalities were markedly improved without alterations in calorie intake in Tene. Teneligliptin effectively ameliorated the characteristics of metabolic abnormalities associated with postmenopausal obesity. Regarding chronic inflammation in visceral adipose tissue, the numbers of F4/80(+) CD11c(+) CD206(-) M1-macrophages in flow cytometry, crown-like structure formation in immunohistochemistry, and proinflammatory cytokine expression were significantly attenuated in Tene. Hepatic steatosis was also markedly improved. Furthermore, decreased energy consumption in the dark and light phases, reduced locomotor activity in the dark phase, and lowered core body temperature in OVX-HF were ameliorated in Tene. Since obesity and reduced energy metabolism are a common physiology of menopause, teneligliptin appears to be beneficial as a treatment for type 2 diabetes in postmenopausal obesity.	[Sameshima, Azusa; Yonezawa, Rika; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama 9300194, Japan; [Wada, Tsutomu; Ito, Tetsuo; Kashimura, Ayaka; Sawakawa, Kanae; Tsuneki, Hiroshi; Sasaoka, Toshiyasu] Toyama Univ, Dept Clin Pharmacol, Toyama 9300194, Japan; [Ishii, Yoko; Sasahara, Masakiyo] Toyama Univ, Dept Pathol, Toyama 9300194, Japan	Wada, T (reprint author), Toyama Univ, Dept Clin Pharmacol, 2630 Sugitani, Toyama 9300194, Japan.	twada@pha.u-toyama.ac.jp; tsasaoka@pha.u-toyama.ac.jp			Japan Society for the Promotion of Science [00419334, 25861480, 30175351, 15K15599]	This work was supported in part by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) grant numbers 00419334, 25861480, 30175351, and 15K15599 (to T W, R Y, S S, and T S).	Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; [Anonymous], 2002, JAMA-J AM MED ASSOC, DOI DOI 10.1001/JAMA.288.3.321); Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Meyer MR, 2011, ACTA PHYSIOL, V203, P259, DOI 10.1111/j.1748-1716.2010.02237.x; Takeda K, 2003, J ENDOCRINOL, V176, P237, DOI 10.1677/joe.0.1760237; LEENEN R, 1994, J CLIN ENDOCR METAB, V78, P1515, DOI 10.1210/jc.78.6.1515; DESPRES JP, 1993, NUTRITION, V9, P452; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Sherwin BB, 2009, NAT REV ENDOCRINOL, V5, P620, DOI 10.1038/nrendo.2009.193; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Nagira K, 2006, ENDOCRINOLOGY, V147, P1020, DOI 10.1210/en.2005-0825; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Wada T, 2013, DIABETES, V62, P3996, DOI 10.2337/db13-1325; Fukuda-Tsuru S, 2014, EUR J PHARMACOL, V723, P207, DOI 10.1016/j.ejphar.2013.11.030; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Handgraaf S, 2013, DIABETES, V62, P4098, DOI 10.2337/db13-0282; Resnick SM, 1997, NEUROLOGY, V49, P1491; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Kyle KA, 2011, ENDOCRINOLOGY, V152, P457, DOI 10.1210/en.2010-1098; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Salpeter SR, 2006, DIABETES OBES METAB, V8, P538, DOI 10.1111/j.1463-1326.2006.00545.x; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; Ishikawa S, 2014, AM J CARDIOL, V114, P384, DOI 10.1016/j.amjcard.2014.04.050; Ichihara Y, 2013, J NEUROENDOCRINOL, V25, P372, DOI 10.1111/jne.12014; Arjona FJC, 2013, DIABETES CARE, V36, P1067, DOI [10.2337/dc12-1365, DOI 10.2337/DC12-1365]; Aroor AR, 2015, DIABETES, V64, P1988, DOI 10.2337/db14-0804; Demuth HU, 2005, BBA-PROTEINS PROTEOM, V1751, P33, DOI 10.1016/j.bbapap.2005.05.010; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Heruc GA, 2014, AM J PHYSIOL-ENDOC M, V307, P830, DOI [10.1152/ajpendo.00370.2014, DOI 10.1152/AJPEND0.00370.2014]; Shimasaki T, 2013, PLOS ONE, V8, P63626, DOI [10.1371/journal.pone.0063626, DOI 10.1371/J0URNAL.P0NE.0063626]; Wada TA, 2013, AM J PHYSIOL-ENDOC M, V305, P1415, DOI DOI 10.1152/AJPEND0.00419.2013); Yonezawa R, 2012, AM J PHYSIOL-ENDOC M, V303, P445, DOI 10.1152/ajpendo.00638.2011	46	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0022-0795	1479-6805		J ENDOCRINOL	J. Endocrinol.	OCT	2015	227	1					25	36		10.1530/JOE-15-0239		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CT2YP	WOS:000362673100004		
J	Fujioka, Y; Kikko, T; Saegusa, J; Usuki, T; Ohtsuka, T				Fujioka, Y.; Kikko, T.; Saegusa, J.; Usuki, T.; Ohtsuka, T.			Response of sex ratio to timing of breeding in the small cyprinid Gnathopogon caerulescens	JOURNAL OF FISH BIOLOGY			English	Article						ESD; proportion of males; sex determination; sex ratio; TSD; water temperature	REPRODUCTIVE RHYTHMS; FISH; HONMOROKO; TEMPERATURE; DIFFERENTIATION	The influence of hatching date on the sex ratio of wild Gnathopogon caerulescens was examined. Cohorts reared from eggs collected in the early and middle parts of the spawning season showed almost balanced sex ratios, with female bias in some cohorts. Cohorts born later in the season mostly displayed male bias, and the mean proportion of males later in the season was significantly higher than in early- and mid-season cohorts. These results indicate that the sex ratio of G. caerulescens changes with the time of breeding, increasing along with the ambient water temperature of the lake.	[Fujioka, Y.; Kikko, T.; Saegusa, J.; Usuki, T.] Shiga Prefecture Fisheries Expt Stn, Hikone, Shiga 5220057, Japan; [Fujioka, Y.; Ohtsuka, T.] Lake Biwa Museum, Kusatsu, Shiga 5250001, Japan	Fujioka, Y (reprint author), Shiga Prefecture Fisheries Expt Stn, Hikone, Shiga 5220057, Japan.	yasuhiro@lbm.go.jp					CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; Fujioka Y, 2006, FISHERIES SCI, V72, P1034, DOI 10.1111/j.1444-2906.2006.01253.x; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; OKUZAWA K, 1989, GEN COMP ENDOCR, V75, P139, DOI 10.1016/0016-6480(89)90019-1; Yamahira K, 2003, COPEIA, P155, DOI 10.1643/0045-8511(2003)003[0155:IVITDS]2.0.CO;2; Okuzawa K., 1986, Bulletin of the Japanese Society of Scientific Fisheries, V52, P1957; Fujioka Y, 2013, NIPPON SUISAN GAKK, V79, P31; Fujioka Y, 1998, J FISH BIOL, V52, P430, DOI 10.1111/j.1095-8649.1998.tb00809.x; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Fujioka Y, 2001, J FISH BIOL, V59, P851, DOI 10.1006/jfbi.2001.1700; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; Conover David O., 2004, P11; CONOVER DO, 1984, AM NAT, V123, P297, DOI 10.1086/284205; Fisher R.A., 1930, GENETICAL THEORY NAT; Fujioka Y, 2015, ICHTHYOL RES, V62, P512, DOI 10.1007/s10228-014-0452-5; Fujioka Y, 2011, B SHIGA PREF FISH EX, V54, P167; Fujioka Y, 2014, FISHERIES SCI, V80, P943, DOI 10.1007/s12562-014-0766-2; MAKI I, 1967, Japanese Journal of Ecology, V17, P199; MAKI I, 1968, Japanese Journal of Ecology, V18, P158; MAKI IWAO, 1966, JAP J ECOL, V16, P183; Nakabo T, 2013, FISHES JAPAN PICTORI, P324; Nakamura M, 1949, NIPPON SUISAN GAKK, V15, P88; Oota S., 2004, ANN REPORTS SHIGA PR, V15, P38; Takashima M., 1984, FISH MATURATION SPAW, P76	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	OCT	2015	87	4					958	966		10.1111/jfb.12768		9	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CT0AA	WOS:000362454800009		
J	Morita, K; Nakashima, A				Morita, K.; Nakashima, A.			Temperature seasonality during fry out-migration influences the survival of hatchery-reared chum salmon Oncorhynchus keta	JOURNAL OF FISH BIOLOGY			English	Article						match-mismatch hypothesis; mortality; optimal environmental window	RATES; NORTHERN; RELEASE; OCEAN; AREAS; RIVER; SIZE	Among years, fry-to-adult survival of hatchery-reared chum salmon Oncorhynchus keta was positively correlated with the length (in days) of the fry out-migration period with temperatures suitable for migration. Furthermore, survival decreased with increasing difference in mean temperature between May and June. Thus, prolonged out-migration periods increased the probability of survival from fry to adult, lending support to the hypothesis that long migration periods decrease the risk of mortality (bet-hedging), and increase the probability of migration when environmental conditions in fresh water and the ocean are suitable (match-mismatch).	[Morita, K.; Nakashima, A.] Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Toyohira Ku, Sapporo, Hokkaido 0620922, Japan	Morita, K (reprint author), Fisheries Res Agcy, Hokkaido Natl Fisheries Res Inst, Toyohira Ku, 2-2 Nakanoshima, Sapporo, Hokkaido 0620922, Japan.	moritak@affrc.go.jp	Morita, Kentaro/G-2578-2015	Morita, Kentaro/0000-0002-7803-2438	JSPS KAKENHI [25450293]	Funding was provided by JSPS KAKENHI No. 25450293. We are grateful to the staff of Hokkaido National Fisheries Research Institute for data collection and anonymous reviewers for their constructive comments.	Cole J, 2000, FISH OCEANOGR, V9, P1, DOI 10.1046/j.1365-2419.2000.00118.x; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Mueter FJ, 2002, FISH OCEANOGR, V11, P205, DOI 10.1046/j.1365-2419.2002.00192.x; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670; Jonsson N, 2014, J FISH BIOL, V84, P1457, DOI 10.1111/jfb.12370; Isaak DJ, 2012, CLIMATIC CHANGE, V113, P499, DOI 10.1007/s10584-011-0326-z; CUSHING DH, 1969, J CONSEIL, V33, P81; Volk EC, 1999, FISH RES, V43, P205, DOI 10.1016/S0165-7836(99)00073-9; Langan SJ, 2001, SCI TOTAL ENVIRON, V265, P195, DOI 10.1016/S0048-9697(00)00659-8; Saito T, 2009, FISH RES, V95, P14, DOI 10.1016/j.fishres.2008.07.004; Saito T, 2011, FISH OCEANOGR, V20, P278, DOI 10.1111/j.1365-2419.2011.00583.x; Kasugai K, 2013, FISHERIES SCI, V79, P569, DOI 10.1007/s12562-013-0615-8; Cowan James H. Jr., 2002, P88; Houde Edward D., 2002, P64; Mayama H., 1982, SCI REP HOKKAIDO SAL, V36, P1; Morita K., 2015, ROYAL SOC OPEN SCI, V2, DOI [10.1098/rsos.140312, DOI 10.1098/RSOS.140312]	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1112	1095-8649		J FISH BIOL	J. Fish Biol.	OCT	2015	87	4					1111	1117		10.1111/jfb.12767		7	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CT0AA	WOS:000362454800020		
J	Harada, T; Iguchi, A; Iyoda, S; Seto, K; Taguchi, M; Kumeda, Y				Harada, Tetsuya; Iguchi, Atsushi; Iyoda, Sunao; Seto, Kazuko; Taguchi, Masumi; Kumeda, Yuko			Multiplex Real-Time PCR Assays for Screening of Shiga Toxin 1 and 2 Genes, Including All Known Subtypes, and Escherichia coli O26-, O111-1 and O157-Specific Genes in Beef and Sprout Enrichment Cultures	JOURNAL OF FOOD PROTECTION			English	Article							POLYMERASE-CHAIN-REACTION; O157; FOOD; VARIANTS; OUTBREAK; STRAINS; JAPAN	Shiga toxin family members have recently been classified using a new nomenclature into three Stx1 subtypes (Stx1 a, Stx1c, and Stx1d) and seven Stx2 subtypes (Stx2a, Stx2b, Stx2c, Stx2d, Stx2e, Stx2f, and Stx2g). To develop screening methods for Stx genes, including all of these subtype genes, and Escherichia coli O26-, O111-, and O157-specific genes in laboratory investigations of Shiga toxin producing E. coli (STEC) foodborne cases, we developed multiplex real-time PCR assays and evaluated their specificity and quantitative accuracy using STEC and non-STEC isolates, recombinant plasmids, and food enrichment cultures and by performing STEC spiking experiments with beef and sprout enrichment cultures. In addition, we evaluated the relationship between the recovery rates of the target strains by direct plating and immunomagnetic separation and the cycle threshold (C-T) values of the real-time PCR assays for the Stx subtypes and STEC O26, O111, and O157 serogroups. All three stx(1)- and seven stx(2)-subtype genes were detected by real-time PCR with high sensitivity and specificity, and the quantitative accuracy of this assay was confirmed using control plasmids and STEC spiking experiments. The results of the STEC spiking experiments suggest that it is not routinely possible to isolate STEC from enrichment cultures with real-time PCR C-T values greater than 30 by direct plating on MacConkey agar, although highly selective media and immunomagnetic beads were able to isolate the inoculated strains from the enrichment cultures. These data suggest that C-T values obtained from the highly quantitative real-time PCR assays developed in this study provide useful information to develop effective isolation strategies for STEC from food samples. The real-time PCR assays developed here are expected to aid in investigations of infections or outbreaks caused by STEC harboring any of the stx-subtype genes in the new Stx nomenclature, as well as STEC O26, O111, and O157.	[Harada, Tetsuya; Seto, Kazuko; Taguchi, Masumi; Kumeda, Yuko] Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Osaka 5370025, Japan; [Iguchi, Atsushi] Miyazaki Univ, Dept Anim & Grassland Sci, Fac Agr, Miyazaki 8892192, Japan; [Iyoda, Sunao] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo 1628640, Japan	Harada, T (reprint author), Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Osaka 5370025, Japan.	harada@iph.pref.osaka.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25750069]	This work was partially supported by a Grant-in-Aid for Scientific Research (grant 25750069) in 2013-2015 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Prager R, 2009, INT J MED MICROBIOL, V299, P343, DOI 10.1016/j.ijmm.2008.10.008; Sharma VK, 2002, J FOOD PROTECT, V65, P1371; Kuczius T, 2004, MOL NUTR FOOD RES, V48, P515, DOI 10.1002/mnfr.200400038; Margot H, 2013, J FOOD PROTECT, V76, P871, DOI 10.4315/0362-028X.JFP-12-365; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741; Anklam KS, 2012, J FOOD PROTECT, V75, P643, DOI 10.4315/0362-028X.JFP-11-392; Harada T, 2012, INT J FOOD MICROBIOL, V156, P161, DOI 10.1016/j.ijfoodmicro.2012.03.018; Feng PCH, 2013, APPL ENVIRON MICROB, V79, P6917, DOI 10.1128/AEM.02455-13; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Prager R, 2011, INT J MED MICROBIOL, V301, P181, DOI 10.1016/j.ijmm.2010.06.003; Harada T, 2013, JPN J INFECT DIS, V66, P530; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Fratamico PM, 2010, FOOD ANAL METHOD, V3, P330, DOI 10.1007/s12161-010-9140-x; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Hsu CF, 2005, J CLIN MICROBIOL, V43, P2668, DOI 10.1128/JCM.43.6.2668-2673.2005; Wang F, 2013, FOODBORNE PATHOG DIS, V10, P665, DOI 10.1089/fpd.2012.1448; Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773; Probert WS, 2014, J CLIN MICROBIOL, V52, P2346, DOI 10.1128/JCM.00338-14; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721; Bai X., 2013, CHINA PLOS ONE, V8; Burgos Y., 2012, TRENDS IMMUNOLOBELLE, P29; Fasel D, 2014, J CLIN MICROBIOL, V52, P1301, DOI 10.1128/JCM.03459-13; Gill A, 2014, J MICROBIOL METH, V96, P6, DOI 10.1016/j.mimet.2013.10.022; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; International Organization for Standardization, 2012, ISOTS131362012E; Isobe J, 2014, J CLIN MICROBIOL, V52, P1112, DOI 10.1128/JCM.03469-13; National Institute of Infectious Diseases, 2012, INFECT AGENTS SURVEI, V33, P119; National Institute of Infectious Diseases, 2014, INF DIS WEEKL REP IN; Rozen S, 2000, Methods Mol Biol, V132, P365; U.S. Department of Agriculture, 2012, PRIM PROB SEQ REAG C; World Health Organization Collaborating Centre for Reference and Research on Escherichia and Klebsiella, 2012, ID 3 VTX1 7 VTX2 SUB	34	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	OCT	2015	78	10					1800	1811		10.4315/0362-028X.JFP-15-050		12	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CT2DB	WOS:000362611100004		
J	Sallam, KI; Abd-Elghany, SM; Elhadidy, M; Tamura, T				Sallam, Khalid Ibrahim; Abd-Elghany, Samir Mohammed; Elhadidy, Mohamed; Tamura, Tomohiro			Molecular Characterization and Antimicrobial Resistance Profile of Methicillin-Resistant Staphylococcus aureus in Retail Chicken	JOURNAL OF FOOD PROTECTION			English	Article							RAW CHICKEN; PREVALENCE; MEAT; FOOD; QUANTIFICATION; SUSCEPTIBILITY; ENTEROTOXINS; PRODUCTS; STRAINS; ORIGIN	The emergence of livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) in food-producing animals is of increasing interest, raising questions about the presence of MRSA in food of animal origin and potential sources of transmission to humans via the food chain. In this study, the prevalence, molecular characterization, virulence factors, and antimicrobial susceptibility patterns of MRSA isolates from 200 retail raw chicken samples in Egypt were determined. MRSA was detected by positive amplification of the mecA gene in 38% (76 of 200) of chicken samples analyzed. This represents a potential public health threat in Egypt, as this contamination rate seems to be the highest among other studies reported worldwide. Furthermore, genes encoding alpha-hemolysin (hla) and staphylococcal enterotoxins (sea, seb, and sec) were detected in all of the 288 MRSA isolates. Nonetheless, none of the strains tested carried tst, the gene encoding toxic shock syndrome toxin 1. Antimicrobial resistance of MRSA isolates was most frequently detected against penicillin (93.4%), ampicillin (88.9%), and cloxacillin (83.3%). These results suggest that retail chicken might be a significant potential source for transmission of multidrug-resistant and toxigenic S. aureus in Egypt. This underlines the need for stricter hygienic measures in chicken production in Egypt to minimize the risk of transmission of these strains to consumers. To the best of our knowledge, this is the first study that reports the isolation and molecular characterization of MRSA in retail chicken samples in Egypt.	[Sallam, Khalid Ibrahim; Abd-Elghany, Samir Mohammed] Mansoura Univ, Fac Vet Med, Dept Food Hyg & Control, Mansoura 35516, Egypt; [Elhadidy, Mohamed] Mansoura Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Mansoura 35516, Egypt; [Tamura, Tomohiro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan	Sallam, KI (reprint author), Mansoura Univ, Fac Vet Med, Dept Food Hyg & Control, Mansoura 35516, Egypt.	khsallam@hotmail.com					Alarcon B, 2006, J APPL MICROBIOL, V100, P352, DOI 10.1111/j.1365-2672.2005.02768.x; Sader HS, 2006, CLIN MICROBIOL INFEC, V12, P844, DOI 10.1111/j.1469-0691.2006.01550.x; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; AARESTRUP FM, 1995, CAN J VET RES, V59, P124; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; Lozano C, 2009, J ANTIMICROB CHEMOTH, V64, P1325, DOI 10.1093/jac/dkp378; Lim SK, 2010, J MICROBIOL BIOTECHN, V20, P775, DOI 10.4014/jmb.0912.12022; BERGDOLL MS, 1981, LANCET, V1, P1017; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Sakoulas G, 2001, J CLIN MICROBIOL, V39, P3946, DOI 10.1128/JCM.39.11.3946-3951.2001; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Wang X, 2013, FOOD CONTROL, V29, P103, DOI 10.1016/j.foodcont.2012.06.002; Chen CB, 2010, J HOSP INFECT, V74, P238, DOI 10.1016/j.jhin.2009.10.026; Boost MV, 2013, FOODBORNE PATHOG DIS, V10, P705, DOI 10.1089/fpd.2012.1415; Kitai S, 2005, J VET MED SCI, V67, P269, DOI 10.1292/jvms.67.269; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x; Atanassova V, 2001, INT J FOOD MICROBIOL, V68, P105, DOI 10.1016/S0168-1605(01)00479-2; Bennett R. W., 2001, BACTERIOLOGICAL ANAL; Bergdoll M. S., 1983, STAPHYLOCOCCI STAPHY, P559; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Genigeorgis C. A., 1989, INT J FOOD MICROBIOL, V9, P365; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Huber H, 2010, EUROSURVEILLANCE, V22, P15; Huy Y. H., 1994, FOODBORNE DIS HDB DI; International Commission on Microbiological Specifications for Foods, 1986, MICR FOODS; Jay J. M., 2000, MODERN FOOD MICROBIO, P441; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Mandell G., 1995, MANDELL DOUGLAS BENN; NOTERMANS S, 1988, APPL ENVIRON MICROB, V54, P531; Watanabe S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005714; Winger F., 2008, INT J FOOD MICROBIOL, V126, P302	34	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	OCT	2015	78	10					1879	1884		10.4315/0362-028X.JFP-15-150		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CT2DB	WOS:000362611100014		
J	Teramura, H; Iwasaki, M; Ushiyama, M; Ogihara, H				Teramura, Hajime; Iwasaki, Mihoko; Ushiyama, Masashi; Ogihara, Hirokazu			Evaluation of a Novel Dry Sheet Culture Method for Rapid Enumeration of Total Aerobic Count in Foods	JOURNAL OF FOOD PROTECTION			English	Article							YERSINIA-ENTEROCOLITICA; PLATE-COUNT; BACTERIA; GROWTH	A novel dry sheet culture method (Sanita-kun ACplus; SkACp) for rapid enumeration of total viable count has been developed. This rehydrated plate system comprises an adhesive sheet, nonwoven fabric coated with nutrients, and two types of water absorption polymers. In addition, SkACp facilitates methods for both rapid count (rapid mode: 24-h incubation) and accurate enumeration (standard mode: 48-h incubation) because it not only contains conventional 2,3,5-triphenyltetrazolium chloride but also contains two kinds of new tetrazolium salts for rapid and accurate enumeration of total aerobic count. When SkACp was assessed with 91 microorganisms, 87 strains (95.6%), excluding lactic acid and psychrotrophic bacteria, formed red-colored colonies within 24 h, whereas all microorganisms tested formed colonies within 48 h. The SkACp method, with both 24 and 48 h of incubation, was compared with plate count agar (PCA) and 3M Petrifilm AC (PAC) by using 107 naturally contaminated foods. For all foods tested (n = 107), the linear correlation coefficients of 48-h counts on SkACp compared with PCA and PAC were 0.98 and 0.75, respectively, while the 24-h counts on SkACp compared with PCA and PAC were 0.77 and 0.96, respectively. For foods tested, excluding yogurt and lactic beverages (n = 101), the linear correlation coefficients of 48-h counts on SkACp compared with PCA and PAC were 0.98 and 0.96, respectively, while the 24-h counts on SkACp compared with PCA and PAC were 0.96 and 0.95, respectively. These results demonstrated that SkACp (48 h) is a useful alternative for the enumeration of the total aerobic count for all foods, whereas SkACp (24 h) was also an effective method for rapid enumeration in foods, excluding yogurt and lactic beverages.	[Teramura, Hajime; Iwasaki, Mihoko; Ushiyama, Masashi] JNC Corp, Yokohama Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 2368605, Japan; [Teramura, Hajime; Ogihara, Hirokazu] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa 2520880, Japan	Teramura, H (reprint author), JNC Corp, Yokohama Res Ctr, Kanazawa Ku, 5-1 Ookawa, Yokohama, Kanagawa 2368605, Japan.	h.teramura@jnc-corp.co.jp					Premaratne A, 2012, J MICROBIOL METH, V89, P198, DOI [10.1016/j.mimet.2012.03.008, 10.1016/j.mimet2012.03.008]; Stiles ME, 1997, INT J FOOD MICROBIOL, V36, P1, DOI 10.1016/S0168-1605(96)01233-0; INGHAM SC, 1990, J FOOD PROTECT, V53, P423; DEBOER E, 1992, INT J FOOD MICROBIOL, V17, P75, DOI 10.1016/0168-1605(92)90107-E; Beuchat LR, 1998, J FOOD PROTECT, V61, P14; Oritani T, 2004, INORG CHIM ACTA, V357, P436, DOI 10.1016/j.ica.2003.05.007; Junillon T, 2012, J MICROBIOL METH, V91, P501, DOI 10.1016/j.mimet.2012.09.015; Mizuochi S, 2000, J FOOD PROTECT, V63, P665; Junillon T, 2014, FOOD MICROBIOL, V38, P1, DOI 10.1016/j.fm.2013.07.005; McFarland J., 1907, JAMA-J AM MED ASSOC, V49, P1179; Palleroni N. J., 1984, BERGEYS MANUAL SYSTE, V1, P141; Teramura H, 2015, J MICROBIOL METH, V109, P16, DOI 10.1016/j.mimet.2014.11.017; U. S. Food and Drug Administration, 2014, BACT AN MAN ONL	13	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	OCT	2015	78	10					1885	1890		10.4315/0362-028X.JFP-15-114		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CT2DB	WOS:000362611100015		
J	Hashimoto, K; Kuniyoshi, K; Suzuki, T; Hiwatari, R; Matsuura, Y; Takahashi, K				Hashimoto, Ken; Kuniyoshi, Kazuki; Suzuki, Takane; Hiwatari, Ryo; Matsuura, Yusuke; Takahashi, Kazuhisa			Biomechanical Study of the Digital Flexor Tendon Sliding Lengthening Technique	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Flexor tendon lengthening; sliding lengthening; Z-lengthening	UPPER EXTREMITY; CEREBRAL-PALSY; REPAIRS	Purpose To compare the mechanical properties of sliding lengthening (SL) and Z-lengthening (ZL) for flexor tendon elongation used for conditions such as Volkmann contracture, cerebral palsy, and poststroke spasticity. Methods We harvested 56 flexor tendons, including flexor pollicis longus tendons, flexor digitorum superficialis tendons (zones II to IV), and flexor digitorum profundus tendons (zones II to V) from 24 upper limbs of 12 fresh cadavers. Each tendon was harvested together with its homonymous tendon from the opposite side of the cadaver and paired. We used 28 pairs of tendons and divided them randomly into 4 groups depending on the lengthening distance (20 or 30 mm) and type of stitching (single or double mattress sutures). Then we divided each pair into either the SL or ZL group. Each group was composed of 7 specimens. The same surgeon lengthened all tendons and stitched them with 2-0 polyester sutures. We tested biomechanical tensile strength immediately after completing lengthening and suturing in each group. Results Ultimate tensile strengths were: 23 N for the SL 20-mm lengthening and single mattress suture and 7 N for the ZL; 25 N for the SL 20-mm lengthening and double mattress suture and 10 N for the ZL; 15 N for the SL 30-mm lengthening and single mattress suture and 8 N for the ZL; and 18 N for the SL 30-mm lengthening and double mattress suture and 10 N for the ZL. Conclusions The SL technique may be a good alternative to the ZL technique because it provides higher ultimate tensile strength. Clinical relevance Because of its higher ultimate tensile strength, the SL technique may allow for earlier rehabilitation and reduced risk of postoperative complications. (J Hand Surg Am. 2015;40(10):1981-1985. Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.)	[Hashimoto, Ken; Kuniyoshi, Kazuki; Hiwatari, Ryo; Matsuura, Yusuke; Takahashi, Kazuhisa] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba 2608670, Japan; [Suzuki, Takane] Chiba Univ, Grad Sch Med, Dept Environm Hlth Sci, Chiba 2608670, Japan	Hashimoto, K (reprint author), Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	hkenh@coral.ocn.ne.jp					Aktas S, 2001, ARCH ORTHOP TRAUM SU, V121, P87, DOI 10.1007/s004020000160; Gan AWT, 2012, J HAND SURG-AM, V37A, P1830, DOI 10.1016/j.jhsa.2012.06.008; Farshad M, 2011, J BONE JOINT SURG AM, V93A, P733, DOI 10.2106/JBJS.J.00246; Angeles JG, 2002, J HAND SURG-AM, V27A, P508, DOI 10.1053/jhsu.2002.32619; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P575; Choueka J, 2000, J HAND SURG-AM, V25A, P1127, DOI 10.1053/jhsu.2000.20155; Koman LA, 1990, CLIN ORTHOP RELAT R, P62; Maki Y, 2009, JPN SOC SURG HAND, V25, P763; MATSUO T, 1990, CLIN ORTHOP RELAT R, P185; Shuind F, 1992, J HAND SURG-AM, V17, P291; White JW, 1943, ARCH SURG-CHICAGO, V46, P784	11	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	OCT	2015	40	10					1981	1985		10.1016/j.jhsa.2015.06.120		5	Orthopedics; Surgery	Orthopedics; Surgery	CT2HC	WOS:000362621600006		
J	Kobayashi, T; Yamauchi, K; Matsuura, Y; Kuniyoshi, K; Takahashi, K; Ohtori, S				Kobayashi, Tomoko; Yamauchi, Kazuyo; Matsuura, Yusuke; Kuniyoshi, Kazuki; Takahashi, Kazuhisa; Ohtori, Seiji			The Effects of Generally Administered Anti-Nerve Growth Factor Receptor (p75NTR) Antibody on Pain-Related Behavior, Dorsal Root Ganglia, and Spinal Glia Activation in a Rat Model of Brachial Plexus Avulsion	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Brachial plexus avulsion; DRG; glial cell; neuropathic pain; p75NTR	QUANTITATIVE GAIT ANALYSIS; GENE-RELATED PEPTIDE; PHASE-III TRIAL; NEUROPATHIC PAIN; DOUBLE-BLIND; CELL-PROLIFERATION; SENSORY GANGLIA; SATELLITE CELLS; INJURY MODEL; ADULT-RAT	Purpose To investigate the effect of intraperitoneal administration of an anti-p75 neurotrophin receptor (p75NTR) antibody on reducing neuropathic pain in a rat model of brachial plexus avulsion (BPA). Methods We randomly assigned 40 male Wistar rats to 4 groups. In the BPA group, the C8-T1 roots were avulsed from the spinal cord at the lower trunk level, and saline was administered intraperitoneally. In the anti-p75NTR groups, 1 mu L or 50 mu L anti-p75NTR antibody was administered intraperitoneally after avulsion. In the sham-operated group, the lower trunk level was exposed, and saline was administered intraperitoneally. Mechanical hyperalgesia and pain-induced walking patterns were measured using von Frey filaments and Cat Walk gait analysis at various time points until 15 days after administration. At 3 and 15 days after administration, sensory neurons involved in pain perception and satellite glial cells in the ipsilateral C7 dorsal root ganglia were immunolabeled with antibodies against calcitonin gene-related peptide and glial fibrillary acidic protein (GFAP), respectively. At both time points, microglial and astrocyte activation, indicative of spinal pain transmission, were immunohistochemically examined in the ipsilateral dorsal horn of the spinal cord (C7) using anti-ionized calcium-binding adaptor molecule 1 and anti-GFAP antibodies, respectively. Results The gait pattern was significantly improved in both anti-p75NIR groups compared with the BPA group. There were significantly fewer calcitonin gene-related peptide-immunoreactive (IR) neurons, neurons encircled by GFAP-IR satellite glial cells, and GFAP-IR astrocytes in both anti-p75NTR groups compared with the BPA group at both time points. Fewer ionized calcium-binding adaptor molecule 1-IR microglia were quantified in both anti-p75NTR groups compared with the BPA group, but this was only significant at 15 days after administration. Conclusions Systemic application of the p75NTR inhibitory antibody suppressed neuropathic pain after BPA. Clinical relevance p75NTR may be a potential therapeutic target for the clinical treatment of neuropathic pain in BPA injury. (J Hand Surg Am. 2015;40(10):2017-2025. Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.)	[Kobayashi, Tomoko; Yamauchi, Kazuyo; Matsuura, Yusuke; Kuniyoshi, Kazuki; Takahashi, Kazuhisa; Ohtori, Seiji] Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chiba 2608670, Japan	Kobayashi, T (reprint author), Chiba Univ, Grad Sch Med, Dept Orthoped Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kobayashi.ortho@gmail.com					Amer S, 1988, PAIN, V33, P11; Takahashi Y, 1996, PAIN, V67, P197, DOI 10.1016/0304-3959(96)03116-8; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Liu L, 2000, EXP BRAIN RES, V131, P64, DOI 10.1007/s002219900273; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; HOKFELT T, 1991, NEURON, V7, P867, DOI 10.1016/0896-6273(91)90333-U; Chiang CY, 2014, J NEUROSURG, V120, P250, DOI 10.3171/2013.9.JNS13353; KURAISHI Y, 1989, PEPTIDES, V10, P447, DOI 10.1016/0196-9781(89)90057-0; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Sanga P, 2013, PAIN, V154, P1910, DOI 10.1016/j.pain.2013.05.051; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Echeverry S, 2008, PAIN, V135, P37, DOI 10.1016/j.pain.2007.05.002; Seidel MF, 2013, OSTEOARTHR CARTILAGE, V21, P1223, DOI 10.1016/j.joca.2013.06.004; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Brown MT, 2012, J PAIN, V13, P790, DOI 10.1016/j.jpain.2012.05.006; Tiseo PJ, 2014, PAIN, V155, P1245, DOI 10.1016/j.pain.2014.03.018; Matsuura Y, 2013, SPINE, V38, pE332, DOI 10.1097/BRS.0b013e318285ee20; Evans RJ, 2011, J UROLOGY, V185, P1716, DOI 10.1016/j.juro.2010.12.088; Suter MR, 2007, NEURON GLIA BIOL, V3, P255, DOI 10.1017/S1740925X08000100; Lee SE, 2007, NEUROSCI RES, V58, P245, DOI 10.1016/j.neures.2007.03.004; Berman J, 1996, J BONE JOINT SURG BR, V78B, P759; Pannese E, 2002, J NEUROCYTOL, V31, P755, DOI 10.1023/A:1025708132119; Miyagi M, 2006, EUR SPINE J, V15, P953, DOI 10.1007/s00586-005-1031-2; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Iwakura N, 2010, J HAND SURG-AM, V35A, P267, DOI 10.1016/j.jhsa.2009.10.030; Brown MT, 2013, ARTHRITIS RHEUM-US, V65, P1795, DOI 10.1002/art.37950; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Rodrigues-Filho R, 2004, BRAIN RES, V1018, P159, DOI 10.1016/j.brainres.2004.05.058; Fukui Y, 2010, J ORTHOP RES, V28, P279, DOI 10.1002/jor.20986; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; Pannese E, 2010, NEURON GLIA BIOL, V6, P3, DOI 10.1017/S1740925X10000037; Sah DWY, 2003, NAT REV DRUG DISCOV, V2, P460, DOI 10.1038/nrd1107; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; BRUXELLE J, 1988, CLIN ORTHOP RELAT R, P87; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Galer BS, 1995, NEUROLOGY, V45, pS35; Galer BS, 1995, NEUROLOGY S9, V45, pS17; Huehnchen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076772; Kumar Vinayak, 2012, J Pain Res, V5, P279, DOI 10.2147/JPR.S33408; Paszcuk AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024034; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209	44	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	OCT	2015	40	10					2017	2025		10.1016/j.jhsa.2015.06.008		9	Orthopedics; Surgery	Orthopedics; Surgery	CT2HC	WOS:000362621600012		
J	Ishii, H; Tatebe, M; Hirata, H				Ishii, Hisao; Tatebe, Masahiro; Hirata, Hitoshi			Distal Radius Joint Surface Reconstruction Using a Pedicle Pisiform Osteochondral Transfer	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Distal radius fracture; osteochondral graft; pedicle; pisiform; reconstruction	BONE-GRAFT; FOLLOW-UP; ARTHROPLASTY; FRACTURES; ARTHRITIS; EXCISION; KNEE	Treatment of a large articular cartilage defect in the distal radius poses a significant challenge to hand surgeons. To reduce the development of secondary degenerative arthritis, restoration of the articular surface is preferable. Pedicle pisiform transfer has been reported as a useful treatment option for Kienbock's disease. We describe a surgical technique involving vascularized pisiform transfer for large cartilage defects after intra-articular distal radius fractures and highlight the vascular supply of the pisiform. (J Hand Surg Am. 2015;40(10):2075-2080. Copyright (C) 2015 by the American Society for Surgery of the Hand. All rights reserved.)	[Ishii, Hisao; Tatebe, Masahiro; Hirata, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Tatebe, Masahiro] Anjo Kosei Hosp, Hand & Microsurg Ctr, Anjo, Japan	Ishii, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Hand Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	hisao@med.nagoya-u.ac.jp	Tatebe, Masahiro/Q-1569-2015				Amer M, 1984, SCAND J PLAST RECONS, V18, P241; Lanzetta M, 2009, MICROSURG, V29, P420, DOI 10.1002/micr.20670; Daecke W, 2005, J HAND SURG-AM, V30A, P915, DOI 10.1016/j.jhsa.2005.03.019; Tagil M, 2006, ACTA ORTHOP, V77, P23, DOI 10.1080/17453670610045650; HASEGAWA T, 1992, J HAND SURG-BRIT EUR, V17B, P583, DOI 10.1016/S0266-7681(05)80248-7; TRUMBLE TE, 1994, J HAND SURG-AM, V19A, P325, DOI 10.1016/0363-5023(94)90028-0; KOPYLOV P, 1993, J HAND SURG-BRIT EUR, V18B, P45, DOI 10.1016/0266-7681(93)90195-L; ZAIDEMBERG C, 1991, J HAND SURG-AM, V16A, P474, DOI 10.1016/0363-5023(91)90017-6; Crisco JJ, 2005, J HAND SURG-AM, V30A, P35, DOI 10.1016/j.jhsa.2004.08.012; Lutz M, 2011, ARCH ORTHOP TRAUM SU, V131, P1121, DOI 10.1007/s00402-010-1211-3; Williams RMM, 2003, J HAND SURG-AM, V28A, P856, DOI 10.1053/S0363-5023(03)00304-6; Hugon S, 2010, SURG RADIOL ANAT, V32, P817, DOI 10.1007/s00276-010-0629-1; Canovas F, 1996, ACTA ANAT, V157, P159; Beck E, 1971, Handchirurgie, V3, P64; Capo JT, 2008, J HAND SURG-AM, V33A, P733, DOI 10.1016/j.jhsa.2008.01.012; Capo JT, 2009, J HAND SURG-AM, V34A, P309, DOI 10.1016/j.jhsa.2008.10.001; CARROLL RE, 1985, J HAND SURG-AM, V10A, P703; del Pinal F, 2013, J HAND SURG-AM, V38A, P1883, DOI 10.1016/j.jhsa.2013.07.013; GROSS AE, 1983, CLIN ORTHOP RELAT R, P96; Lo CY, 2003, J HAND SURG-BRIT EUR, V28B, P94, DOI 10.1054/jhsb.2002.0839; MEYERS MH, 1989, J BONE JOINT SURG AM, V71A, P704; O'Keefe KD, 2013, J HAND SURG-AM, V38A, P1913, DOI 10.1016/j.jhsa.2013.07.021; Prommersberger Karl-Josef, 2006, J Bone Joint Surg Am, V88 Suppl 1 Pt 2, P202, DOI 10.2106/JBJS.F.00145; Saffar P, 1982, Ann Chir Main, V1, P276, DOI 10.1016/S0753-9053(82)80027-6	24	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	OCT	2015	40	10					2075	2080		10.1016/j.jhsa.2015.07.019		6	Orthopedics; Surgery	Orthopedics; Surgery	CT2HC	WOS:000362621600022		
J	Gauld, N; Bryant, L; Emmerton, L; Kelly, F; Kurosawa, N; Buetow, S				Gauld, Natalie; Bryant, Linda; Emmerton, Lynne; Kelly, Fiona; Kurosawa, Nahoko; Buetow, Stephen			Why does increasing public access to medicines differ between countries? Qualitative comparison of nine countries	JOURNAL OF HEALTH SERVICES RESEARCH & POLICY			English	Article						access to medicines; community pharmacy services; health policy; nonprescription drugs; self-medication	OVER-THE-COUNTER	Objective To identify factors associated with differences between developed countries in reclassifying (switching) medicines from prescription to non-prescription availability. Methods Cross-national qualitative research using a heuristic approach in the US, UK, Japan, Australia and New Zealand, supplemented by data from Canada, Denmark, the Netherlands and Singapore. In-depth interviews with 80key informants (65 interviews) explored and compared factors in terms of barriers and enablers to reclassification of medicines in each country. Document analysis supplemented interview data. Results Each country had a unique mix of enablers and barriers to reclassification. Enablers included government policy (particularly in UK), pharmacist-only scheduling (particularly in Australia and New Zealand) and large market size (particularly in the US and Europe). Local barriers included limited market potential in small countries, the cost of a reclassification (particularly in the US), competition from distributors of generic medicines, committee inconsistency and consumer behavior. UK had more enablers than barriers, whereas in Australia the opposite was true. Conclusions Different factors limit or enable reclassification, affecting consumer access to medicines in different countries. For countries attempting to reduce barriers to reclassification, solutions may include garnering government support for reclassification, support and flexibility from the medicines regulator, having a pharmacy-only and/or pharmacist-only category, providing market exclusivity, ensuring best practice in pharmacy, and minimizing the cost and delays of reclassification.	[Gauld, Natalie; Bryant, Linda; Buetow, Stephen] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Emmerton, Lynne] Curtin Univ, Sch Pharm, Fac Hlth Sci, Perth, WA 6845, Australia; [Kelly, Fiona] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld 4111, Australia; [Kurosawa, Nahoko] Hokkaido Pharmaceut Univ, Sch Pharm, Otaru, Hokkaido, Japan	Gauld, N (reprint author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Private Bag 92019, Auckland 1, New Zealand.	n.gauld@auckland.ac.nz			New Zealand Pharmacy Education and Research Foundation; University of Auckland	Grants from New Zealand Pharmacy Education and Research Foundation and the University of Auckland contributed to the travel in this study.	Abraham J, 2009, PHARM SOC CRITICAL D, P54; Achanta AS, 2002, THESIS U RHODE ISLAN; AESGP, 2013, EC LEG FRAM NONPR ME; Morse JM, 1998, QUAL HEALTH RES, V8, P733, DOI 10.1177/104973239800800601; Eichler HG, 2013, NAT REV DRUG DISCOV, V12, P907, DOI 10.1038/nrd4129; Jacobs S, 2014, J HEALTH SERV RES PO, V19, P27, DOI 10.1177/1355819613500043; Peck E, 1999, QUAL HEALTH RES, V9, P552, DOI 10.1177/104973299129121965; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; Marston C, 2005, BRIT MED J, V331, P271, DOI 10.1136/bmj.38519.440266.8F; Aronson JK, 2009, BRIT MED BULL, V90, P63, DOI 10.1093/bmb/ldp015; Cohen JP, 2005, BRIT MED J, V330, P39, DOI 10.1136/bmj.330.7481.39; Achanta AS, 2003, CLIN RES REGUL AFF, V20, P1, DOI 10.1081/CRP-120018736; [Anonymous], 2006, INT J PHARM PRACT, DOI 10.1211/ijpp.14.2.0003; Armstrong ME, PLAN B CONTRACEPTIVE; Bond C, 2005, COUNTER MED; Bowden M, 1993, THESIS U SYDNEY SYDN; Cohen Joshua, 2003, Am J Ther, V10, P370, DOI 10.1097/00045391-200309000-00010; Francesco S., 1995, PHARM EXEC, V15, P76; Gauld NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107726; Gauld NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119011; Lyon G, 2001, BRAND MED, P47; Medicines and Healthcare products Regulatory Authority, CHANG LEG CLASS MED; Patton M. Q., 2002, QUALITATIVE RES EVAL; United States Government Accountability Office, NONPR DRUGS CONS REG; World Health Organisation, GUID REG ASS MED PRO; World Health Organisation, ROL PHARM SELF CAR S; World Health Organization, OTT CHART HLTH PROM; World Self-Medication Industries, 2009, SWITCH PRESCR NONPR	28	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1355-8196	1758-1060		J HEALTH SERV RES PO	J. Health Serv. Res. Policy	OCT	2015	20	4					231	239		10.1177/1355819615593302		9	Health Policy & Services	Health Care Sciences & Services	CS9YE	WOS:000362449000008		
J	Takaoka, M				Takaoka, Masaki			Mercury and mercury-containing waste management in Japan	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Mercury-containing waste; Surplus mercury; Long-term storage; Appropriate disposal; Stabilization		Mercury used in products and industrial processes eventually enters the environment via the waste stream. Since the management of mercury waste should prioritize reducing the amount of mercury used in products and industrial processes, this paper first describes the trends in the demand for mercury. Recent mercury demand in Japan is small in comparison to the past and other countries, and is estimated to be 8 tons per year. To manage mercury and its waste stream, it is important to understand the material flow of mercury and the types and quantities of mercury waste. About 80 tons of mercury enter Japan annually, 52 tons are recovered, and 11-24 tons are disposed of in landfill sites. Since environmentally sound treatment and disposal of mercury waste are essential, we discuss the recycling of some mercury-add products and the current state of mercury waste and mercury disposal in Japan. The remaining issue that must be addressed in the management of mercury and mercury waste is its long-term storage or disposal.	Kyoto Univ, Grad Sch Global Environm Studies, Dept Global Ecol, Nishikyo Ku, Kyoto 6158540, Japan	Takaoka, M (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Dept Global Ecol, Nishikyo Ku, Kyoto 6158540, Japan.	takaoka.masaki.4w@kyoto-u.ac.jp			Environment Research and Technology Development Fund [K113001];  [K2006];  [K2147];  [K2262]	This study was supported by a Grant-in-aid for Waste Treatment Research (K2006, K2147, K2262), and by the Environment Research and Technology Development Fund (K113001).	Fitzgerald WF, 1998, ENVIRON SCI TECHNOL, V32, P1, DOI 10.1021/es970284w; Fukuda N, 2014, J HAZARD MATER, V276, P433, DOI 10.1016/j.jhazmat.2014.04.063; Fuhrmann M, 2002, WASTE MANAGE, V22, P327, DOI 10.1016/S0956-053X(01)00057-5; Lopez FA, 2010, SCI TOTAL ENVIRON, V408, P4341, DOI 10.1016/j.scitotenv.2010.07.008; Basel Convention, 2011, TECHN GUID ENV SOUND; Boyle JM, 2010, U.S. Patent, Patent No. [7,691,361, 7691361]; Japan Electric Lamp Manufacturers Association, RESP MIN CONV MERC; Japan Lighting Manufacturers Association, 2013, ANN STAT LAMP PROD S; Japan Waste Management Association, REC RES MERC US DRY; Ministry of the Environment, 2013, MAT FLOW MERC JAP 20; Ministry of the Environment Japan, 2011, LESS MIN DIS MERC MA; Murase J, 2013, J ENV SAF, V4, P107; Takaoka M, 2013, APPROPRIATE MANAGEME; Takaoka M, 2011, STUDY LONG TERM STOR; Tamura N, 2007, J MMIJ, V123, P747, DOI 10.2473/journalofmmij.123.747; UNEP, 2008, REP CURR SUPPL DEM M; UNEP Chemicals, 2006, SUMM SUPPL TRAD DEM	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	OCT	2015	17	4					665	672		10.1007/s10163-014-0325-z		8	Environmental Sciences	Environmental Sciences & Ecology	CT0XI	WOS:000362520800007		
J	Parparita, E; Uddin, MA; Watanabe, T; Kato, Y; Yanik, J; Vasile, C				Parparita, Elena; Uddin, Md. Azhar; Watanabe, Taichi; Kato, Yoshiei; Yanik, Jale; Vasile, Cornelia			Gas production by steam gasification of polypropylene/biomass waste composites in a dual-bed reactor	JOURNAL OF MATERIAL CYCLES AND WASTE MANAGEMENT			English	Article						Polypropylene; Biomass; Composites; Gasification	CATALYTIC DECOMPOSITION; HYDROGEN-PRODUCTION; CO-GASIFICATION; PLASTIC WASTES; FLUIDIZED-BED; BIOMASS TARS; PYROLYSIS; POLYETHYLENE	Polypropylene/biomass waste composites and their constituents were gasified with steam by a two-stage process, in a dual-bed microreactor for the production of fuel gases. Gasification experiments were carried out at 700 A degrees C gasification temperature in absence and presence of Fe2O3/CeO2 catalyst. The gases produced during the process were mainly H-2, CO, CO2, CH4, and some light hydrocarbons. The use of Fe2O3/CeO2 catalyst in the steam gasification of plastic, biomasses, and plastic/biomass composites resulted in the increase in production of gaseous products, indicating that the catalyst accelerated the gasification rate. Moreover, a synergistic effect of combining plastics with biomass was observed since the amount of H-2 production increased in the case of PP/biomass composites compared to the added contribution of production of H-2 from the individual components.	[Parparita, Elena; Vasile, Cornelia] Petru Poni Inst Macromol Chem, Iasi 700487, Romania; [Uddin, Md. Azhar; Watanabe, Taichi; Kato, Yoshiei] Okayama Univ, Dept Energy & Mat, Kita Ku, Okayama 7008530, Japan; [Yanik, Jale] EGE Univ, Dept Chem, Izmir, Turkey	Uddin, MA (reprint author), Okayama Univ, Dept Energy & Mat, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	alazhar@cc.okayama-u.ac.jp			Marie Curie FP7 program [PIRSES GA-2009-247550 BIOFUEL]	The authors are grateful for the financial support received through the Marie Curie FP7 program, grant PIRSES GA-2009-247550 BIOFUEL to perform this research. We also thank Prof. Dr. Yoshiei Kato for his invitation to the Environmental Reaction Engineering Laboratory, Okayama University, and kindly offering us access to modern research devices.	Ranzi E, 1997, J ANAL APPL PYROL, V40-1, P305, DOI 10.1016/S0165-2370(97)00032-6; Pinto F, 2002, FUEL, V81, P291, DOI 10.1016/S0016-2361(01)00164-8; Pinto F, 2003, FUEL, V82, P1967, DOI 10.1016/S0016-2361(03)00160-1; Kim HS, 2004, J THERM ANAL CALORIM, V76, P395; El-Sabbagh A, 2012, J BIOBASED MATER BIO, V6, P346, DOI 10.1166/jbmb.2012.1244; Cozzani V, 1997, IND ENG CHEM RES, V36, P342, DOI 10.1021/ie950779z; Uddin MA, 2008, FUEL, V87, P451, DOI 10.1016/j.fuel.2007.06.021; Wu CF, 2009, APPL CATAL B-ENVIRON, V87, P152, DOI 10.1016/j.apcatb.2008.09.003; Aznar MP, 2006, FUEL PROCESS TECHNOL, V87, P409, DOI 10.1016/j.fuproc.2005.09.006; Wu CF, 2010, INT J HYDROGEN ENERG, V35, P949, DOI 10.1016/j.ijhydene.2009.11.045; Min ZH, 2011, FUEL, V90, P1847, DOI 10.1016/j.fuel.2010.12.039; Parparita E, 2014, POLYM DEGRAD STABIL, V100, P1, DOI 10.1016/j.polymdegradstab.2014.01.005; Gusta E, 2009, ENERG FUEL, V23, P2264, DOI 10.1021/ef8009958; Arena U, 2000, CHEM ENG SCI, V55, P2849, DOI 10.1016/S0009-2509(99)00533-3; Irdem SD, 2014, ENERG FUEL, V28, P3808, DOI 10.1021/ef500238f; Kumar A, 2009, ENERGIES, V2, P556, DOI 10.3390/en20300556; Tchapda AH, 2014, ENERGIES, V7, P1098, DOI 10.3390/en7031098; de Jong E, 2006, P COST E41 M PROGR C; Eltron Research and Development, 2009, CAT MICR ASS GAS REC; Kaminsky W, 1996, RECYCLING RECOVERY P, P435; Kweepa, 2012, REC PLAST BIOC CONS; McKinnon H, 2009, THESIS U CANTERBURY; Nordgreen T, 2011, THESIS KTH; Puls J, 2006, P COST E41 M PROGR C; Taichi W, 2013, THESIS OKAYAMA U; Willfor S, 2006, P COST E41 M PROGR C	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1438-4957	1611-8227		J MATER CYCLES WASTE	J. Mater. Cycles Waste Manag.	OCT	2015	17	4					756	768		10.1007/s10163-014-0308-0		13	Environmental Sciences	Environmental Sciences & Ecology	CT0XI	WOS:000362520800016		
J	Nakamura, M; Kubota, S; Suzuki, H; Haraguchi, T				Nakamura, Masashi; Kubota, Sadayuki; Suzuki, Hideto; Haraguchi, Tadao			Wear and Friction Characteristics of AlN/Diamond-Like Carbon Hybrid Coatings on Aluminum Alloy	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						aluminum alloy; aluminum nitride (AlN); diamondlike carbon (DLC); unbalanced magnetron sputtering (UBMS); wear resistance	NITRIDE FILMS; THIN-FILMS; DEPOSITION; ALN	The use of diamond-like carbon (DLC) coatings has the potential to greatly improve the wear resistance and friction of aluminum alloys, but practical application has so far been limited by poor adhesion due to large difference in hardness and elasticity between the two materials. This study investigates the deposition of DLC onto an Al-alloy using an intermediate AlN layer with a graded hardness to create a hybrid coating. By controlling the hardness of the AlN film, it was found that the wear life of the DLC film could be improved 80-fold compared to a DLC film deposited directly onto Al-alloy. Furthermore, it was demonstrated through finite element simulation that creating a hardness gradient in the AlN intermediate layer reduces the distribution of stress in the DLC film, while also increasing the force of adhesion between the DLC and AlN layers. Given that both the DLC and AlN films were deposited using the same unbalanced magnetron sputtering method, this process is considered to represent a simple and effective means of improving the wear resistance of Al-alloy components commonly used within the aerospace and automotive industries.	[Nakamura, Masashi] Ibaraki Univ, Coll Engn, Dept Intelligence Syst Engn, Hitachi, Ibaraki 3168511, Japan; [Kubota, Sadayuki] Ibaraki Univ, Grad Sch Intelligence Syst Engn, Hitachi, Ibaraki 3168511, Japan; [Suzuki, Hideto; Haraguchi, Tadao] Ibaraki Univ, Hitachi, Ibaraki 3168511, Japan	Nakamura, M (reprint author), Ibaraki Univ, Coll Engn, Dept Intelligence Syst Engn, 4-12-1 Nakanarusawa Cho, Hitachi, Ibaraki 3168511, Japan.	masashi.nakamura.melo@vc.ibaraki.ac.jp; wtmikan6890@gmail.com; pym67691@mvd.biglobe.ne.jp; brkfh104@ybb.ne.jp			JSPS [25420005]	This work was supported by JSPS Grant-in-Aid for Scientific Research(C) Number 25420005.	Kusaka K, 2000, VACUUM, V59, P806, DOI 10.1016/S0042-207X(00)00351-1; Kar JP, 2006, CURR APPL PHYS, V6, P873, DOI 10.1016/j.cap.2005.05.001; Oliveira IC, 2004, VACUUM, V75, P331, DOI 10.1016/j.vacuum.2004.04.001; Schwarz C, 2008, DIAM RELAT MATER, V17, P1685, DOI 10.1016/j.diamond.2008.02.039; Bolelli G, 2011, SURF COAT TECH, V205, P4211, DOI 10.1016/j.surfcoat.2011.03.021; Kar JP, 2005, SURF COAT TECH, V198, P64, DOI 10.1016/j.surfcoat.2004.10.074; Nair R, 2008, SURF COAT TECH, V202, P2935, DOI 10.1016/j.surfcoat.2007.10.038; Horiuchi T, 2012, WEAR, V286, P79, DOI 10.1016/j.wear.2011.07.005; Chiu KH, 2007, THIN SOLID FILMS, V515, P4819, DOI 10.1016/j.tsf.2006.12.181; Figueroa U, 2005, SURF COAT TECH, V200, P1768, DOI 10.1016/j.surfcoat.2005.08.051; Barshiha HC, 2008, THIN SOLID FILMS, V516, P4168, DOI 10.1016/j.tsf.2007.10.129; Cherng J.S., 2010, VACUUM, V84, P653; Knou M., ENG MAT, P36; Lifang X., 2004, WEAR, V257, P599, DOI 10.1016/j.wear.2004.03.009; Nakamori H., 2006, Journal of Japan Institute of Light Metals, V56, DOI 10.2464/jilm.56.77; Nomura H., 2006, T JAPAN SOC MECH E A, V72, P907; Ohira K., 2009, NTN TECH REV, V77, P87; Suzuki H., 2003, JIREI DE MANABU DLC; Xua M., 2008, DIAM RELAT MATER, V17, P1844; Zhaoa X., 2001, MAT SCI ENG A-STRUCT, V528, P1111	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	OCT	2015	24	10					3789	3797		10.1007/s11665-015-1694-8		9	Materials Science, Multidisciplinary	Materials Science	CS7VV	WOS:000362296000012		
J	Jubsilp, C; Taewattana, R; Takeichi, T; Rimdusit, S				Jubsilp, Chanchira; Taewattana, Rapiphan; Takeichi, Tsutomu; Rimdusit, Sarawut			Investigation on Rubber-Modified Polybenzoxazine Composites for Lubricating Material Applications	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						dynamic mechanical; organic matrix composites; polymers and plastics; thermal analysis	TERMINATED POLY(BUTADIENE-CO-ACRYLONITRILE) RUBBER; EPOXY-RESIN FUNCTIONALITY; THERMOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; TRIBOLOGICAL PROPERTIES; FRICTION MATERIALS; MATRIX COMPOSITES; PHENOLIC RESINS; LIQUID RUBBER; PERFORMANCE	Effects of liquid amine-terminated butadiene-acrylonitrile (ATBN) on the properties of bisphenol-A/aniline-based polybenzoxazine (PBA-a) composites were investigated. Liquid ATBN decreased gel time and lowered curing temperature of the benzoxazine resin (BA-a). The PBA-a/ATBN-based self-lubricating composites resulted in substantial enhancement regarding their tribological, mechanical, and thermal properties. The inclusion of the ATBN at 5% by weight was found decreasing the friction coefficient and improved wear resistance of the PBA-a/ATBN composites. Flexural modulus and glass transition temperature of the PBA-a composite samples added the ATBN was constant within the range of 1-5% by weight. A plausible wear mechanism of the composites is proposed based on their worn surface morphologies. Based on the findings in this work, it seems that the obtained PBA-a/ATBN self-lubricating composites would have high potential to be used for bearing materials where low friction coefficient, high wear resistance, and modulus with good thermal property are required.	[Jubsilp, Chanchira] Srinakharinwirot Univ, Fac Engn, Dept Chem Engn, Nakhonnayok 26120, Thailand; [Taewattana, Rapiphan; Rimdusit, Sarawut] Chulalongkorn Univ, Fac Engn, Dept Chem Engn, Polymer Engn Lab, Bangkok 10330, Thailand; [Takeichi, Tsutomu] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Jubsilp, C (reprint author), Srinakharinwirot Univ, Fac Engn, Dept Chem Engn, Nakhonnayok 26120, Thailand.	sarawut.r@chula.ac.th			New Researcher's Grant of Thailand Research Fund-Commission on Higher Education [MRG5580101]; Matching Fund; Strategic Wisdom and Research Institute, Srinakharinwirot University [411/2555]; Srinakharinwirot University Research Fund [171/2556]; National Research University Project, Office of Higher Education Commission, Thailand [WCU-028-AM-57]; Matsumae International Foundation, Japan	This work was supported by a New Researcher's Grant of Thailand Research Fund-Commission on Higher Education (MRG5580101) and Matching Fund, Strategic Wisdom and Research Institute, Srinakharinwirot University 2012-2014 (Contact Grants No. 411/2555), and Srinakharinwirot University Research Fund (Contact Grants No. 171/2556). The authors also greatly acknowledged the National Research University Project, Office of Higher Education Commission, Thailand (WCU-028-AM-57). Additional funding was provided by the Matsumae International Foundation (2012), Japan. Prof. S. Hiziroglu is also acknowledged for his comments on this manuscript.	Xing XS, 2004, WEAR, V256, P21, DOI 10.1016/S0043-1648(03)00220-5; Rimdusit S, 2005, POLYM ENG SCI, V45, P288, DOI 10.1002/pen.20273; Rimdusit S, 2000, POLYMER, V41, P7941, DOI 10.1016/S0032-3861(00)00164-6; Yu SR, 2008, TRIBOL INT, V41, P1205, DOI 10.1016/j.triboint.2008.03.001; Jang J, 1998, J APPL POLYM SCI, V67, P1, DOI 10.1002/(SICI)1097-4628(19980103)67:1<1::AID-APP1>3.0.CO;2-V; Chikhi N, 2002, EUR POLYM J, V38, P251, DOI 10.1016/S0014-3057(01)00194-X; Jubsilp C, 2011, POLYM DEGRAD STABIL, V96, P1047, DOI 10.1016/j.polymdegradstab.2011.03.021; Jubsilp C, 2013, POLYM COMPOSITE, V34, P2067, DOI 10.1002/pc.22615; Agag T, 2001, HIGH PERFORM POLYM, V13, pS327, DOI 10.1088/0954-0083/13/2/328; Grishchuk S, 2012, J APPL POLYM SCI, V124, P2824, DOI 10.1002/app.35302; Bijwe J, 2005, WEAR, V259, P1068, DOI 10.1016/j.wear.2005.01.011; WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853; Thomas R, 2008, POLYMER, V49, P278, DOI 10.1016/j.polymer.2007.11.030; Singh T, 2013, J MATER ENG PERFORM, V22, P796, DOI 10.1007/s11665-012-0325-x; Gopal P, 1996, WEAR, V193, P199, DOI 10.1016/0043-1648(95)06723-X; Thomas R, 2007, POLYMER, V48, P1695, DOI 10.1016/j.polymer.2007.01.018; Xian GJ, 2006, J APPL POLYM SCI, V102, P2391, DOI 10.1002/app.24496; Chonkaew W, 2013, EUR POLYM J, V49, P1461, DOI 10.1016/j.eurpolymj.2013.03.022; Grishchuk S, 2013, J APPL POLYM SCI, V127, P5082, DOI 10.1002/app.38123; Rimdusit S, 2011, POLYM ENG SCI, V51, P1797, DOI 10.1002/pen.21969; Chonkaew W, 2012, J APPL POLYM SCI, V125, P361, DOI 10.1002/app.35580; Davim JP, 2009, WEAR, V266, P795, DOI 10.1016/j.wear.2008.11.003; Saffar A, 2012, WEAR, V274, P286, DOI 10.1016/j.wear.2011.09.012; Li J, 2010, J MATER ENG PERFORM, V19, P1025, DOI 10.1007/s11665-009-9564-x; Wu J, 2006, TRIBOL LETT, V22, P259, DOI 10.1007/s11249-006-9091-y; Blau P.J., 1996, LUBRICATION CONTROL, P285; Demirci M.T., 2010, 10 INT SCI C UNITECH, P249; Hermandez M., 2001, RHEOLOGICAL BEHAV MO, P3554; Ishida H, 2011, HANDBOOK OF BENZOXAZINE RESINS, P1; Ishida H., 2001, U.S. Patent, Patent No. [6,323,270, 6323270]; Jubsilp C, 2008, BIORESOURCE TECHNOL, V99, P8880, DOI 10.1016/j.biortech.2008.04.057; Jubsilp C., 2013, ANILINE BASED POLYBE, P55; Kajohnchaiyagual J, 2014, POLYM COMPOSITE, V35, P2269, DOI 10.1002/pc.22892; Lampman S., 2003, CHARACTERIZATION FAI, P259; Li J, 2010, J MATER ENG PERFORM, V19, P342, DOI 10.1007/s11665-009-9485-8; Ludema K.C., 1996, FRICTION WEAR LUBRIC; Rimdusit S., 2013, ALLOYS COMPOSITES PO; Rimdusit S, 2011, J APPL POLYM SCI, V121, P3669, DOI 10.1002/app.34170; Wang QH, 1996, WEAR, V198, P216, DOI 10.1016/0043-1648(96)07201-8; Xian J., 2004, J MATER ENG PERFORM, V13, P642, DOI 10.1361/10599490420061	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	OCT	2015	24	10					3958	3968		10.1007/s11665-015-1660-5		11	Materials Science, Multidisciplinary	Materials Science	CS7VV	WOS:000362296000031		
J	Nomura, T; Yamamoto, H; Matano, T				Nomura, Takushi; Yamamoto, Hiroyuki; Matano, Tetsuro			LASTING SIV CONTROL BY MULTIPLE GAG, VIF, AND NEF EPITOPE-SPECIFIC CD8+T CELLS	JOURNAL OF MEDICAL PRIMATOLOGY			English	Meeting Abstract									[Nomura, Takushi; Yamamoto, Hiroyuki; Matano, Tetsuro] Natl Inst Infect Dis, Musashimurayama, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2565	1600-0684		J MED PRIMATOL	J. Med. Primatol.	OCT	2015	44	5			SI	O6.04	322	322				1	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CS3IM	WOS:000361966000060		
J	Fujita, T; Burwitz, B; Chew, G; Reed, J; Pathak, R; Seger, E; Clayton, K; Rini, J; Ostrowski, M; Ishii, N; Kuroda, M; Hansen, S; Sacha, J; Ndhlovu, L				Fujita, Tsuyoshi; Burwitz, Benjamin; Chew, Glen; Reed, Jason; Pathak, Reesab; Seger, Elizabeth; Clayton, Kiera; Rini, James; Ostrowski, Mario; Ishii, Naoto; Kuroda, Marcelo; Hansen, Scott; Sacha, Jonah; Ndhlovu, Lishomwa			EXPANSION OF DYSFUNCTIONAL TIM-3 EXPRESSING EFFECTOR MEMORY CD8+T CELLS DURING SIV INFECTION IN RM	JOURNAL OF MEDICAL PRIMATOLOGY			English	Meeting Abstract									[Fujita, Tsuyoshi; Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan; [Burwitz, Benjamin; Reed, Jason; Pathak, Reesab; Seger, Elizabeth; Hansen, Scott; Sacha, Jonah] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Chew, Glen] Univ Hawaii, Dept Trop Med, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Clayton, Kiera; Rini, James; Ostrowski, Mario] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Kuroda, Marcelo] Tulane Natl Primate Res Ctr, Devis Immunol, Covingtom, LA USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2565	1600-0684		J MED PRIMATOL	J. Med. Primatol.	OCT	2015	44	5			SI	P1.05	327	327				1	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CS3IM	WOS:000361966000071		
J	Kuwata, T; Yoshimura, K; Wu, F; Ourmanov, I; Hirsch, VM; Yokoyama, M; Sato, H; Matsushita, S				Kuwata, Takeo; Yoshimura, Kazuhisa; Wu, Fan; Ourmanov, Ilnour; Hirsch, Vanessa M.; Yokoyama, Masaru; Sato, Hironori; Matsushita, Shuzo			MUTATIONS IN GP41 IS CRITICAL TO ESCAPE FROM B404, A BROAD NEUTRALIZING ANTIBODY AGAINST SIV, WHICH RECOGNIZES A V3/V4 CONFORMATIONAL EPITOPE	JOURNAL OF MEDICAL PRIMATOLOGY			English	Meeting Abstract									[Kuwata, Takeo; Matsushita, Shuzo] Kumamoto Univ, Kumamoto, Kumamoto, Japan; [Yoshimura, Kazuhisa; Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Tokyo, Japan; [Wu, Fan; Ourmanov, Ilnour; Hirsch, Vanessa M.] NIAID, NIH, Bethesda, MD 20892 USA								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2565	1600-0684		J MED PRIMATOL	J. Med. Primatol.	OCT	2015	44	5			SI	P3.07	336	336				1	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CS3IM	WOS:000361966000096		
J	Yamamoto, H; Matano, T				Yamamoto, Hiroyuki; Matano, Tetsuro			IN VIVO DISPOSITIONS OF SIVMAC239-NEUTRALIZING ANTIBODY INDUCTION	JOURNAL OF MEDICAL PRIMATOLOGY			English	Meeting Abstract									[Yamamoto, Hiroyuki] Natl Inst Infect Dis, AIDS Res Ctr, Musashi Murayama City, Tokyo, Japan; [Matano, Tetsuro] Univ Tokyo, AIDS Res Ctr, Natl Inst Infect Diseases, Inst Med Sci,Shinjuku Ku Minato Ku, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0047-2565	1600-0684		J MED PRIMATOL	J. Med. Primatol.	OCT	2015	44	5			SI	P3.23	342	342				1	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	CS3IM	WOS:000361966000112		
J	Yamada, S				Yamada, Satoshi			Educational activities in the community and live demonstrations of ultrasonography	JOURNAL OF MEDICAL ULTRASONICS			English	Editorial Material									Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan	Yamada, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan.	syamada@med.hokudai.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					447	448		10.1007/s10396-015-0668-7		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500001		
J	Tachibana, K; Endo, H; Feril, LB; Nejad, SM; Takahashi, H; Narihira, K; Kikuta, T				Tachibana, Katsuro; Endo, Hitomi; Feril, Loreto B.; Nejad, Seyedeh Moosavi; Takahashi, Hiromasa; Narihira, Kyoichi; Kikuta, Toshihiro			Enhanced mechanical damage to in vitro cancer cells by high-intensity-focused ultrasound in the presence of microbubbles and titanium dioxide	JOURNAL OF MEDICAL ULTRASONICS			English	Article						High-intensity-focused ultrasound (HIFU); Titanium dioxide; Microbubbles; Cell damage	CAVITATION BUBBLES; TIO2; NANOPARTICLES; SONOPORATION	To evaluate in vitro the feasibility of therapeutic high-intensity-focused ultrasound (HIFU) combined with microbubbles and titanium dioxide (TiO2). Oral squamous cell carcinoma cells (HSC-2) were sonicated using a HIFU transducer with a resonant frequency of 3.5 MHz, 30 mm in diameter, and focal length of 50 mm. The ultrasound intensity was 210 W/cm(2), and two pulses (0.5 s each) were sonicated for each cell sample (9 x 10(4) cells per well). Immediately after HIFU, the viable cells were measured by an automated cell counter. The survival rate was measured in the presence of microbubbles (Sonazoid) and peroxo titania-silica (R-P-TS) or anatase titania-silica (R-A-TS) TiO2. Cell viability immediately following sonication in the presence of TiO2 (R-A-TS) and TiO2 (R-P-TS) was 65.5 +/- A 0.7 and 59.4 +/- A 3.3 %, respectively. A marked decrease in cell viability was seen when microbubbles were added to the above cell conditions. Specifically, cell viability decreased to 14.0 +/- A 0.1 and 4.4 +/- A 0.9 % when microbubbles were added to samples containing TiO2 (R-A-TS) and TiO2 (R-P-TS), respectively. Immediate in vitro cell killing was observed with short pulsed duration HIFU sonication with a combination of microbubbles and TiO2. This finding suggests that TiO2 could have caused enhanced mechanical cell destruction by microbubbles.	[Tachibana, Katsuro; Endo, Hitomi; Feril, Loreto B.; Nejad, Seyedeh Moosavi] Fukuoka Univ, Dept Anat, Sch Med, Jonan, Fukuoka 8140180, Japan; [Takahashi, Hiromasa; Narihira, Kyoichi; Kikuta, Toshihiro] Fukuoka Univ, Dept Oral Surg, Sch Med, Jonan, Fukuoka 8140180, Japan; [Takahashi, Hiromasa] Self Def Forces Kure Hosp, Dept Dent, Kure, Hiroshima 7370027, Japan	Tachibana, K (reprint author), Fukuoka Univ, Dept Anat, Sch Med, 7-45-1 Nanakuma, Jonan, Fukuoka 8140180, Japan.	k-tachi@fukuoka-u.ac.jp			Japanese Society of Ultrasound in Medicine	This study was supported in part by the Japanese Society of Ultrasound in Medicine 2013 Research Grant.	Tsuang YH, 2008, ARTIF ORGANS, V32, P167, DOI 10.1111/j.1525-1594.2007.00530.x; Wang J, 2011, ULTRASON SONOCHEM, V18, P177, DOI 10.1016/j.ultsonch.2010.05.002; TACHIBANA K, 1995, CIRCULATION, V92, P1148; Shimizu N, 2008, ULTRASON SONOCHEM, V15, P988, DOI 10.1016/j.ultsonch.2008.04.011; Ogino C, 2010, BIOORG MED CHEM LETT, V20, P5320, DOI 10.1016/j.bmcl.2010.06.124; Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI [10.1529/biophysj.105.075366, 10.1529/biophysj.106.075366]; Harada Y, 2011, J CONTROL RELEASE, V149, P190, DOI 10.1016/j.jconrel.2010.10.012; Nejad SM, 2011, BIOCHEM BIOPH RES CO, V413, P218, DOI 10.1016/j.bbrc.2011.08.072; Zhu YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050607; Wu JR, 2007, PROG BIOPHYS MOL BIO, V93, P363, DOI 10.1016/j.pbiomolbio.2006.07.016; Zubkov T, 2005, J PHYS CHEM B, V109, P15454, DOI 10.1021/jp058101c; Abe N, 2014, J MED ULTRASON, V41, P3, DOI 10.1007/s10396-013-0469-9; Chihara Y, 2007, PATHOBIOLOGY, V74, P353, DOI 10.1159/000110029; Esquivel K, 2009, WATER RES, V43, P3593, DOI 10.1016/j.watres.2009.05.035; Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					449	455		10.1007/s10396-015-0626-4		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500002		
J	Ashida, R; Kawabata, K; Maruoka, T; Asami, R; Yoshikawa, H; Takakura, R; Ioka, T; Katayama, K; Tanaka, S				Ashida, Reiko; Kawabata, Ken-ichi; Maruoka, Takashi; Asami, Rei; Yoshikawa, Hideki; Takakura, Rena; Ioka, Tatsuya; Katayama, Kazuhiro; Tanaka, Sachiko			New approach for local cancer treatment using pulsed high-intensity focused ultrasound and phase-change nanodroplets	JOURNAL OF MEDICAL ULTRASONICS			English	Article						HIFU; Drug delivery system; Superheated perfluorocarbon droplet; Histotripsy; Mechanical effect; Cancer	IN-VIVO; CAVITATIONAL ULTRASOUND; TISSUE ABLATION; PROSTATE-CANCER; HISTOTRIPSY; TECHNOLOGY; MODEL; NANOPARTICLES; KIDNEY; TUMORS	The aim of this study was to investigate the combination effects of pulsed HIFU (pHIFU) and phase-change nanodroplets (PCND) as a sensitizer on efficient induction of mechanical effects of pHIFU and chemically enhanced tumor growth inhibition for local anti-tumor therapy. Changes in growth of colon 26 tumor tissue inoculated onto CDF1 mice were evaluated by the following treatments. (1) pHIFU exposure (1.1 MHz, 3.2 kW/cm(2), 300 cycles, and 50 ms interval) for 60 s, (2) PCND (1 %) injection, (3) adriamycin (4 mg/kg) injection, (4) pHIFU exposure after PCND injection, and (5) pHIFU exposure after PCND + adriamycin injection simultaneously. Significant changes in tumor growth were observed in the group with combination of pHIFU and PCND, although single therapy did not show any significant difference. PCND enhanced mechanical tissue fractionation by pHIFU, which was detectable by Real-time tissue elastography. Moreover, the combination of pHIFU and PCND + Adriamycin suppressed the tumor growth for 2 weeks, and 3 of 4 mice did not show any sign of regrowth during the 30-day observation. The combination of pHIFU and PCND exerted a significant anti-tumor effect and may be a new candidate for treatment of locally advanced cancer.	[Ashida, Reiko; Ioka, Tatsuya; Katayama, Kazuhiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Canc Survey & Gastrointestinal Oncol, Osaka, Japan; [Kawabata, Ken-ichi; Maruoka, Takashi; Asami, Rei; Yoshikawa, Hideki] Hitachi Ltd, Res & Dev Grp, Kokubunji, Tokyo 1808601, Japan; [Takakura, Rena; Tanaka, Sachiko] Osaka Ctr Canc & Cardiovasc Dis Prevent, Dept Canc Prevent, Osaka, Japan	Kawabata, K (reprint author), Hitachi Ltd, Res & Dev Grp, 1-280 Higashi Koigakubo, Kokubunji, Tokyo 1808601, Japan.	kenichi.kawabata.ap@hitachi.com			Research and Development Committee Program of the Japan Society of Ultrasound in Medicine and Biology; Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)	This work was supported in part by the Research and Development Committee Program of the Japan Society of Ultrasound in Medicine and Biology, and also by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). The authors deeply thank Prof. Umemura of Tohoku University for discussion and encouragement.	Rebillard X, 2008, BJU INT, V101, P1205, DOI 10.1111/j.1464-410X.2008.07504.x; Hempel CR, 2011, J UROLOGY, V185, P1484, DOI 10.1016/j.juro.2010.11.044; Shanei A, 2012, IRAN J BASIC MED SCI, V15, P759; Styn N, 2011, J ENDOUROL, V25, P1531, DOI 10.1089/end.2010.0648; Liberman A, 2014, J SURG RES, V190, P391, DOI 10.1016/j.jss.2014.05.009; Schade GR, 2012, J UROLOGY, V188, P1957, DOI 10.1016/j.juro.2012.07.006; Hall TL, 2009, UROLOGY, V74, P932, DOI 10.1016/j.urology.2009.03.049; Wang TY, 2009, IEEE T ULTRASON FERR, V56, P995, DOI [10.1109/TUFFC.2009.1131, 10.1109/TUFFC.1131]; Jiang F, 2013, ULTRASONICS, V53, P77, DOI 10.1016/j.ultras.2012.04.001; McDannold N, 1998, JMRI-J MAGN RESON IM, V8, P91, DOI 10.1002/jmri.1880080119; Kang ST, 2014, ULTRASON SONOCHEM, V21, P1866, DOI 10.1016/j.ultsonch.2014.03.007; Vlaisavljevich E, 2013, THERANOSTICS, V3, P851, DOI 10.7150/thno.6717; Rewcastle JC, 2006, TECHNOL CANCER RES T, V5, P619; Lake AM, 2008, UROLOGY, V72, P682, DOI 10.1016/j.urology.2008.01.037; Kawabata K, 2005, JPN J APPL PHYS 1, V44, P4548, DOI 10.1143/JJAP.44.4548; Wang YN, 2013, ULTRASOUND MED BIOL, V39, P424, DOI 10.1016/j.ultrasmedbio.2012.10.012; Kawabata K, 2013, IEEE INT ULTRA SYM, P2106, DOI 10.1109/ULTSYM.2013.0538; Miller RM, 2012, IEEE INT ULTRA SYM, P196, DOI 10.1109/ULTSYM.2012.0049; Yumita N, 2000, J CANCER RES CLIN, V126, P601, DOI 10.1007/PL00008471; Watanabe Y, 2008, CANCER SCI, V99, P2525, DOI 10.1111/j.1349-7006.2008.00989.x; Roberts WW, 2006, J UROLOGY, V175, P734, DOI 10.1016/S0022-5347(05)00141-2; Vlaisavljevich E, 2014, PHYS MED BIOL, V59, P253, DOI 10.1088/0031-9155/59/2/253; Wang TY, 2014, IEEE T ULTRASON FERR, V61, P1137, DOI 10.1109/TUFFC.2014.3013; Xu J, 2013, IEEE T ULTRASON FERR, V60, P1401, DOI 10.1109/TUFFC.2013.2712; Maxwell AD, 2009, ULTRASOUND MED BIOL, V35, P1982, DOI 10.1016/j.ultrasmedbio.2009.07.001; Illing RO, 2005, BRIT J CANCER, V93, P890, DOI 10.1038/sj.bjc.6602803; Asami R, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.07HF16; Dwivedi A, 2010, INDIAN J UROL, V26, P465; Furusawa Hidemi, 2007, Breast Cancer, V14, P55, DOI 10.2325/jbcs.14.55; Kawabata K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.07KF28; Kawabata K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HE06; Xu Z, 2004, IEEE T ULTRASON FERR, V51, P726, DOI 10.1109/TUFFC.2004.1308731; Zhou Yu-Feng, 2011, World J Clin Oncol, V2, P8, DOI 10.5306/wjco.v2.i1.8	33	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					457	466		10.1007/s10396-015-0634-4		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500003		
J	Ogawa, R; Watanabe, A; Morii, A				Ogawa, Ryohei; Watanabe, Akihiko; Morii, Akihiro			Ultrasound up-regulates expression of heme oxygenase-1 gene in endothelial cells	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Ultrasound; Endothelial cells; Heme oxygenase-1; Microarray	INTENSITY PULSED ULTRASOUND; TRANSCRIPTION FACTORS; U937 CELLS; NRF2; IDENTIFICATION; INDUCTION; ACTIVATION; MECHANISM; ARSENITE; CADMIUM	We found heme oxygenase-1 (HO-1) gene up-regulation in response to ultrasound stimulation in endothelial cells. This project was started to explore the mechanism since it could be applied clinically. Quantitative real-time PCR experiments were conducted to determine the appropriate condition to up-regulate HO-1 gene expression. A promoter assay experiment and a microarray analysis were done to analyze signal transduction pathways to be activated in endothelial cells by ultrasound stimulation. Approximately, 33-fold up-regulation of HO-1 mRNA was observed when endothelial cells were exposed to 1-MHz ultrasound at 0.3 W/cm(2) and DF 10 % for 20 s. Data obtained from promoter analysis and microarray analysis suggested that the Nrf2/StRE signal pathway was involved in the up-regulation. In addition, ultrasound stimulation to endothelial cells changed its gene expression profile so that it could modify the anti-inflammatory, antioxidant, and vasodilatory activities in addition to pro-angiogenic and vascular reconstitution activities of endothelial cells. It was suggested that ultrasound stimulation of endothelial cells up-regulated HO-1 expression through intracellular oxidative stress, which subsequently changed the gene expression pattern so that it could modify vascular functions.	[Ogawa, Ryohei] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama 9300194, Japan; [Watanabe, Akihiko; Morii, Akihiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Urol, Toyama 9300194, Japan	Ogawa, R (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, 2630 Sugitani, Toyama 9300194, Japan.	ogawa@med.u-toyama.ac.jp			Research and Development Committee Program of The Japan Society of Ultrasound in Medicine; Ministry of Education, Culture, Sports, Science and Technology [24592442]	The authors are thankful to Prof. Takashi Kondo and Dr. Qing Li Zhao of University of Toyama for their cooperation and support for this research. The present research was supported in part by the Research and Development Committee Program of The Japan Society of Ultrasound in Medicine, and by a Grant-in-Aid for Scientific Research (C) 24592442 from the Ministry of Education, Culture, Sports, Science and Technology.	Aziz MT, 2009, ANDROLOGIA, V41, P176, DOI 10.1111/j.1439-0272.2008.00911.x; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Pae HO, 2010, NITRIC OXIDE-BIOL CH, V23, P251, DOI 10.1016/j.niox.2010.08.002; Kagiya G, 2009, ULTRASOUND MED BIOL, V35, P155, DOI 10.1016/j.ultrasmedbio.2008.07.012; ALAM J, 1995, J BIOL CHEM, V270, P11977; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kagiya G, 2006, ULTRASON SONOCHEM, V13, P388, DOI 10.1016/j.ultsonch.2005.09.004; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; Trigona WL, 2006, BIOCHEM J, V394, P207, DOI 10.1042/BJ20050712; Lin HH, 2008, J MOL CELL CARDIOL, V45, P44, DOI 10.1016/j.yjmcc.2008.04.011; Abdollahi A, 2004, FASEB J, V18, P1413, DOI 10.1096/fj.04-1601fje; Watanabe A, 2009, J MED ULTRASON, V36, P9, DOI 10.1007/s10396-008-0202-2; Feril LB, 2005, CANCER LETT, V221, P145, DOI 10.1016/j.canlet.2004.08.034; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Corbin JD, 2002, UROLOGY, V60, P4, DOI 10.1016/S0090-4295(02)01686-2; Chan KH, 2011, CLIN SCI, V120, P493, DOI 10.1042/CS20100508; Tabuchi Y, 2008, CANCER LETT, V270, P286, DOI 10.1016/j.canlet.2008.05.018; Alam J, 2000, J BIOL CHEM, V275, P27694; MURAOSA Y, 1993, MOL CELL BIOL, V13, P7881; Elbekai RH, 2007, TOXICOL LETT, V172, P106, DOI 10.1016/j.toxlet.2007.05.009; Kagiya G, 2006, J MED ULTRASON, V33, P3, DOI 10.1007/s10396-005-0066-7; Tabuchi Y, 2002, BIOCHEM BIOPH RES CO, V290, P498, DOI 10.1006/bbrc.2001.6203	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					467	475		10.1007/s10396-015-0635-3		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500004		
J	Suzuki, H; Saito, T; Shimomura, Y; Katsuura, T				Suzuki, Hiroyuki; Saito, Takayoshi; Shimomura, Yoshihiro; Katsuura, Tetsuo			Effects of horizontal console position on operator muscular stress during cardiac ultrasonic diagnosis	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Diagnostic ultrasound system; Muscular stress; Console; Working posture; Working environment; Ergonomics		Ultrasound examinations tend to put sonographers in unnatural postures, which may lead to musculoskeletal disorders. In order to address this issue, in this study, we focused on the horizontal position of the console of a diagnostic ultrasound system to quantitatively assess the influence of the work plane position on musculoskeletal stress cardiac ultrasonic diagnosis in the bed-sitting position. Five subjects were asked to simulate a scanning task that involved touching five points on the console, setting the work plane at different positions in the space. Electromyogram of each part of the body indicated that the least stressful position of the left hand was about 350 mm from the center of the trunk in the longitudinal (front-rear) direction and 100 mm left from the center of the trunk in the lateral (left-right) direction. It is necessary to rotate the console in front of the operator for this purpose.	[Suzuki, Hiroyuki; Saito, Takayoshi] Hitachi Aloka Med Ltd, Engn Operat Div, Design Off, Ome, Tokyo 1988577, Japan; [Shimomura, Yoshihiro; Katsuura, Tetsuo] Chiba Univ, Grad Sch Engn, Chiba, Japan	Suzuki, H (reprint author), Hitachi Aloka Med Ltd, Engn Operat Div, Design Off, Imai 3-7-19, Ome, Tokyo 1988577, Japan.	suzu1912@hitachi-aloka.co.jp					Suzuki H, 2014, J MED ULTRASON, V41, P155, DOI 10.1007/s10396-013-0502-z; Magnavita N, 1999, J OCCUP ENVIRON MED, V41, P981, DOI 10.1097/00043764-199911000-00010; Centers for disease control and prevention, 2004, ATLANTA CTR DIS CONT; Eleanor R., 2002, CAUSES MUSCULOSKELET; Joan B, 2004, JDMS, V20, P85; Judy V, 2007, INT J IND ERGO, V37, P781; Lois M W, 1997, INT J IND ERGONOM, V19, P205; Martin N., 1996, J DIAGN MED SONOG, V12, P266	8	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					499	504		10.1007/s10396-015-0639-z		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500007		
J	Matsumoto, N; Ogawa, M; Takayasu, K; Hirayama, M; Miura, T; Shiozawa, K; Abe, M; Nakagawara, H; Moriyama, M; Udagawa, S				Matsumoto, Naoki; Ogawa, Masahiro; Takayasu, Kentaro; Hirayama, Midori; Miura, Takao; Shiozawa, Katsuhiko; Abe, Masahisa; Nakagawara, Hiroshi; Moriyama, Mitsuhiko; Udagawa, Seiichi			Quantitative sonographic image analysis for hepatic nodules: a pilot study	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Quantitative image analysis; Ultrasonography; Hepatocellular carcinoma; Liver hemangioma; Liver metastasis	TEXTURE ANALYSIS; HEPATOCELLULAR-CARCINOMA; ULTRASOUND IMAGES; LIVER-DISEASE; DIFFERENTIATION; CLASSIFICATION; HEMANGIOMAS; LESIONS; TUMORS	The aim of this study was to investigate the feasibility of quantitative image analysis to differentiate hepatic nodules on gray-scale sonographic images. We retrospectively evaluated 35 nodules from 31 patients with hepatocellular carcinoma (HCC), 60 nodules from 58 patients with liver hemangioma, and 22 nodules from 22 patients with liver metastasis. Gray-scale sonographic images were evaluated with subjective judgment and image analysis using ImageJ software. Reviewers classified the shape of nodules as irregular or round, and the surface of nodules as rough or smooth. Circularity values were lower in the irregular group than in the round group (median 0.823, 0.892; range 0.641-0.915, 0.784-0.932, respectively; P = 3.21 x 10(-10)). Solidity values were lower in the rough group than in the smooth group (median 0.957, 0.968; range 0.894-0.986, 0.933-0.988, respectively; P = 1.53 x 10(-4)). The HCC group had higher circularity and solidity values than the hemangioma group. The HCC and liver metastasis groups had lower median, mean, modal, and minimum gray values than the hemangioma group. Multivariate analysis showed circularity [standardized odds ratio (OR), 2.077; 95 % confidential interval (CI) = 1.295-3.331; P = 0.002] and minimum gray value (OR 0.482; 95 % CI = 0.956-0.990; P = 0.001) as factors predictive of malignancy. The combination of subjective judgment and image analysis provided 58.3 % sensitivity and 89.5 % specificity with AUC = 0.739, representing an improvement over subjective judgment alone (68.4 % sensitivity, 75.0 % specificity, AUC = 0.701) (P = 0.008). Quantitative image analysis for ultrasonic images of hepatic nodules may correlate with subjective judgment in predicting malignancy.	[Matsumoto, Naoki; Ogawa, Masahiro; Takayasu, Kentaro; Hirayama, Midori; Miura, Takao; Shiozawa, Katsuhiko; Abe, Masahisa; Nakagawara, Hiroshi; Moriyama, Mitsuhiko] Nihon Univ, Div Gastroenterol & Hepatol, Dept Med, Sch Med,Itabashi Ku, Tokyo 1738610, Japan; [Udagawa, Seiichi] Nihon Univ, Dept Math, Sch Med, Itabashi Ku, Tokyo 1738610, Japan	Matsumoto, N (reprint author), Nihon Univ, Div Gastroenterol & Hepatol, Dept Med, Sch Med,Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	matsumotosg7@gmail.com					Jung EM, 2007, WORLD J GASTROENTERO, V13, P6356, DOI 10.3748/wjg.13.6356; LAYER G, 1991, J CLIN ULTRASOUND, V19, P193, DOI 10.1002/jcu.1870190402; Sujana H, 1996, ULTRASOUND MED BIOL, V22, P1177, DOI 10.1016/S0301-5629(96)00144-5; Virmani J, 2013, J DIGIT IMAGING, V26, P1058, DOI 10.1007/s10278-013-9578-7; Yamada H, 2006, J HEPATOL, V44, P68, DOI 10.1016/j.jhep.2005.08.009; YOSHIDA T, 1987, J CLIN ULTRASOUND, V15, P431, DOI 10.1002/jcu.1870150702; Yoshida H, 2003, PHYS MED BIOL, V48, P3735, DOI 10.1088/0031-9155/48/22/008; MAILLOUX GE, 1984, ULTRASONIC IMAGING, V6, P262, DOI 10.1016/0161-7346(84)90012-9; Badawi AM, 1999, INT J MED INFORM, V55, P135, DOI 10.1016/S1386-5056(99)00010-6; Wakui N, 2012, J ULTRAS MED, V31, P373; MIRK P, 1982, J CLIN ULTRASOUND, V10, P373, DOI 10.1002/jcu.1870100805; KANAI T, 1987, CANCER, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO;2-1; Mitrea D, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/348135; Ito H, 2012, J MED ULTRASON, V39, P61, DOI 10.1007/s10396-011-0339-2; Le Y, 2015, J MED ULTRASON, V42, P25, DOI 10.1007/s10396-014-0559-3; Makuuchi M, 1983, ULTRASOUND 82, P489; Tsujimoto F, 1989, J JPN RADIOL SOC, V49, P574; Wang Y, 2002, J MED ULTRASON, V29, P211, DOI 10.1007/BF02480852	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					505	512		10.1007/s10396-015-0627-3		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500008		
J	Wakui, N; Takeda, Y; Nishinakagawa, S; Ueki, N; Otsuka, T; Oba, N; Hashimoto, H; Kamiyama, N; Sumino, Y; Kojima, T				Wakui, Noritaka; Takeda, Yuki; Nishinakagawa, Shuta; Ueki, Nobuo; Otsuka, Takafumi; Oba, Nobuyuki; Hashimoto, Hiroshi; Kamiyama, Naohisa; Sumino, Yasukiyo; Kojima, Tatsuya			Effect of obstructive jaundice on hepatic hemodynamics: use of Sonazoid-enhanced ultrasonography in a prospective study of the blood flow balance between the hepatic portal vein and hepatic artery	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Obstructive jaundice; Arrival time parametric imaging; Sonazoid; Contrast-enhanced ultrasonography	BUFFER RESPONSE; LIVER; CHOLANGIOCARCINOMA; CIRRHOSIS	To prospectively clarify the effects of obstructive jaundice (OJ) on hepatic hemodynamics using contrast-enhanced ultrasonography (US). Subjects comprised 14 patients admitted to our hospital for OJ between April 2013 and March 2014. Contrast-enhanced US was performed using the LOGIQ E9 ultrasound device during the jaundice phase, before biliary drainage, and again after improvement of jaundice. After injecting the Sonazoid contrast agent, contrast dynamics were recorded in the right kidney and liver segments 5 or 6. Prototype software was used to calculate mean arrival time (AT) of the contrast agent in the liver parenchyma. Statistical analysis was performed to compare the mean AT in the jaundice and improved jaundice phases. We were unable to follow up three of the 14 patients after biliary drainage; thus, we included 11 patients for further analysis. The mean AT of the contrast agent was 2.0 +/- A 1.8 and 6.1 +/- A 2.3 s in the jaundice and improved jaundice phases, respectively, showing significantly shorter AT in the jaundice phase (p = 0.0033). Our findings indicate that OJ may influence the blood flow balance between the hepatic portal vein and hepatic artery.	[Wakui, Noritaka; Takeda, Yuki; Nishinakagawa, Shuta; Ueki, Nobuo; Otsuka, Takafumi; Oba, Nobuyuki; Kojima, Tatsuya] Tokyo Rosai Occupat Dis & Injuries Hosp, Dept Internal Gastroenterol & Hepatol, Tokyo, Japan; [Wakui, Noritaka; Otsuka, Takafumi; Sumino, Yasukiyo] Toho Univ, Div Gastroenterol & Hepatol, Omori Med Ctr, Ota, Tokyo 1438541, Japan; [Hashimoto, Hiroshi; Kamiyama, Naohisa] GE Healthcare, Ultrasound Gen Imaging, Tokyo, Japan	Wakui, N (reprint author), Tokyo Rosai Occupat Dis & Injuries Hosp, Dept Internal Gastroenterol & Hepatol, Tokyo, Japan.	toho_med_wakui@yahoo.co.jp			Japan Labour Health and Welfare Organization [220]	Noritaka Wakui, Yuki Takeda, Shuta Nishinakagawa, Nobuo Ueki, Takafumi Otsuka, Nobuyuki Oba, Hiroshi Hashimoto, Naohisa Kamiyama, Yasukiyo Sumino, and Tatsuya Kojima declare that they have no conflict of interest. Noritaka Wakui received research funds for promoting hospital function from the Japan Labour Health and Welfare Organization (No. 220).	Wakui N, 2013, EXP THER MED, V5, P673, DOI 10.3892/etm.2012.874; Wakui N, 2013, EXP THER MED, V5, P389, DOI 10.3892/etm.2012.814; Kleber G, 1999, GASTROENTEROLOGY, V116, P906, DOI 10.1016/S0016-5085(99)70074-0; Nagino M, 2008, J HEPATO-BILIARY-PAN, V15, P25, DOI 10.1007/s00534-007-1277-7; SUMMERSKILL WHJ, 1959, LANCET, V2, P686; Moriyasu F, 2009, AM J ROENTGENOL, V193, P86, DOI 10.2214/AJR.08.1618; LEEN E, 1993, GUT, V34, P554, DOI 10.1136/gut.34.4.554; PAIN JA, 1985, BRIT J SURG, V72, P942, DOI 10.1002/bjs.1800721203; Wakui N, 2012, J ULTRAS MED, V31, P373; Rocheleau B, 1999, AM J PHYSIOL-GASTR L, V277, pG1000; Miyazaki M, 1999, J AM COLL SURGEONS, V189, P575, DOI 10.1016/S1072-7515(99)00219-7; BLUMGART LH, 1984, LANCET, V1, P66; Ekataksin W, 1999, SEMIN LIVER DIS, V19, P359, DOI 10.1055/s-2007-1007126; NAKATA K, 1960, AM J PHYSIOL, V199, P1181; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549; Matsukiyo Y, 2013, J MED ULTRASON, V40, pS569; Rappaport A M, 1980, Int Rev Physiol, V21, P1; Rappaport AM, 1996, REV INT HEPATOL, V16, P813; RHODIN JAG, 1967, J ULTRA MOL STRUCT R, V18, P181, DOI 10.1016/S0022-5320(67)80239-9; Sasaki S, 2009, ULTRASOUND MED BIOL, V35, P1819; Wakui Noritaka, 2011, Case Rep Gastroenterol, V5, P100, DOI 10.1159/000326951	21	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					513	520		10.1007/s10396-015-0629-1		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500009		
J	Ueno, E; Tohno, E; Morishima, I; Umemoto, T; Waki, K				Ueno, Ei; Tohno, Eriko; Morishima, Isamu; Umemoto, Takeshi; Waki, Koji			A preliminary prospective study to compare the diagnostic performance of assist strain ratio versus manual strain ratio	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Elastography; Strain ratio; FLR; Assist strain ratio; Breast cancer	BREAST; ELASTOGRAPHY; TISSUES; ELASTICITY	The objectives of this study were to demonstrate the non-inferiority of assist strain ratio (ASR)-a newly developed application tool-to manual strain ratio (MSR)-a currently available standard diagnostic tool-and to calculate the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of MSR and ASR. Ninety-eight mass lesions in the mammary gland (30 malignant and 68 benign) were included in the study. Skilled physicians performed the elastography scanning by applying minimal vibration. MSRs were obtained and compared with ASRs calculated from the same elastography image to test the correlation between the two groups of data. Diagnostic performance of MSR at a cut-off of 5.0 showed a sensitivity of 84.4 %, a specificity of 80.4 %, an accuracy of 81.6 %, a PPV of 65.5 %, and an NPV of 92.1 %. Diagnostic performance of ASR at a cut-off of 5.0 showed a sensitivity of 74.4 %, a specificity of 84.3 %, an accuracy of 81.3 %, a PPV of 67.7 %, and an NPV of 88.2 %. The areas under the curve (AUCs) for MSR and ASR were found to be 0.885 and 0.875, respectively. ASR demonstrated excellent diagnostic potential and was highly correlated with MSR performed by skilled physicians (r = 0.69, p < 0.05).	[Ueno, Ei; Morishima, Isamu; Umemoto, Takeshi] Tsukuba Med Ctr Fdn, Dept Senol, Tsukuba, Ibaraki, Japan; [Tohno, Eriko] Tsukuba Med Ctr Fdn, Total Hlth Evaluat Ctr Tsukuba, Tsukuba, Ibaraki, Japan; [Waki, Koji] Hitachi Aloka Med Ltd, Med Syst Engn Div, Kokubunji, Tokyo, Japan	Ueno, E (reprint author), Tsukuba Med Ctr Fdn, Dept Senol, Tsukuba, Ibaraki, Japan.	e-ueno@tmch.or.jp					Thomas A, 2010, ACAD RADIOL, V17, P558, DOI 10.1016/j.acra.2009.12.006; Umemoto T, 2014, ULTRASOUND MED BIOL, V40, P1755, DOI 10.1016/j.ultrasmedbio.2014.02.005; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; UENO E, 1988, ULTRASOUND MED BIOL, V14, P53, DOI 10.1016/0301-5629(88)90047-6; Nakashima K, 2013, J MED ULTRASON, V40, P359, DOI 10.1007/s10396-013-0457-0; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260; Zhi H, 2008, ACAD RADIOL, V15, P1347, DOI 10.1016/j.acra.2008.08.003; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; Baba H, 2013, MEDIX, V58, P42; Murayama N, 2004, J MED ULTRASON, V31, P113; Shiina T, 1996, P IEEE INT ULTR S SA, V4, P1331; Ueno E, 2007, P RAD SOC N AM SCI A, P697; Waki K, P ISICE 2007 1 INT S, P449	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					521	531		10.1007/s10396-015-0633-5		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500010		
J	Kimura, I; Araki, R; Yoshizato, T; Miyamoto, S				Kimura, Ibuki; Araki, Ryota; Yoshizato, Toshiyuki; Miyamoto, Shingo			A case of fetal osteogenesis imperfecta type 2A: longitudinal observation of natural course in utero and pitfalls for prenatal ultrasound diagnosis	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Osteogenesis imperfecta type 2A; Ultrasonography; Prenatal diagnosis	INCREASED NUCHAL TRANSLUCENCY; SKELETAL DYSPLASIAS; 1ST-TRIMESTER DIAGNOSIS; SONOGRAPHIC DIAGNOSIS; PULMONARY HYPOPLASIA; ASSOCIATION; TRIMESTER; SIGN	We present a case of osteogenesis imperfecta (OI) type 2A in which a natural course in utero was observed from 23 weeks' gestation to term. At 23 weeks' gestation, a sonographic examination showed a cloverleaf skull-like head, a narrow thorax, and marked shortening of the long bones with bowing of the femurs and humeri. Follow-up examinations showed that the cloverleaf skull-like head was not evident at 28 weeks' gestation. Discontinuity of the ribs and femurs was observed at 26 and 30 weeks' gestation, respectively. This finding suggested bone fractures, which were confirmed by three-dimensional computed tomography at 32 weeks' gestation. Ultrasonographic findings of bones, including the long bones and calvarium, changed with advancing gestation during the second trimester. Characteristic features of OI type 2A were evident during the late second to early third trimesters. Repeated ultrasonographic examinations together with three-dimensional computed tomography are necessary for the definitive diagnosis of OI type 2A in the second trimester.	[Kimura, Ibuki; Araki, Ryota; Miyamoto, Shingo] Fukuoka Univ, Fac Med, Dept Obstet & Gynecol, Fukuoka 8140180, Japan; [Yoshizato, Toshiyuki] Fukuoka Univ Hosp, Ctr Maternal Fetal & Neonatal Med, Jonan Ku, Fukuoka 8140180, Japan	Yoshizato, T (reprint author), Fukuoka Univ Hosp, Ctr Maternal Fetal & Neonatal Med, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	ty-obgyn@cis.fukuoka-u.ac.jp					Schramm T, 2009, ULTRASOUND OBST GYN, V34, P160, DOI 10.1002/uog.6359; Viora E, 2002, AM J MED GENET, V109, P336, DOI 10.1002/ajmg.10332; Parilla BV, 2003, J ULTRAS MED, V22, P255; Merz E, 1999, PRENATAL DIAG, V19, P614, DOI 10.1002/(SICI)1097-0223(199907)19:7<614::AID-PD595>3.0.CO;2-P; JOHNSON A, 1987, AM J OBSTET GYNECOL, V157, P764; SILLENCE DO, 1984, AM J MED GENET, V17, P407, DOI 10.1002/ajmg.1320170204; Makrydimas G, 2001, AM J MED GENET, V98, P117, DOI 10.1002/1096-8628(20010115)98:2<117::AID-AJMG1018>3.3.CO;2-I; Ruano R, 2003, PRENATAL DIAG, V23, P539, DOI 10.1002/pd.638; McEwing RL, 2003, J ULTRAS MED, V22, P311; Chen CP, 2012, TAIWAN J OBSTET GYNE, V51, P315, DOI 10.1016/j.tjog.2012.04.032; BYERS PH, 1988, AM J HUM GENET, V42, P237; Cho FN, 2005, PRENATAL DIAG, V25, P519, DOI 10.1002/pd.1143; MUNOZ C, 1990, RADIOLOGY, V174, P181; DOTTAVIO G, 1993, AM J OBSTET GYNECOL, V169, P384; Langer L O Jr, 1987, Am J Med Genet Suppl, V3, P167	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					565	570		10.1007/s10396-015-0645-1		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500016		
J	Hosokawa, T; Yamada, Y; Sato, Y; Tanami, Y; Amano, H; Fujiogi, M; Kawashima, H; Oguma, E				Hosokawa, Takahiro; Yamada, Yoshitake; Sato, Yumiko; Tanami, Yutaka; Amano, Hizuru; Fujiogi, Michimasa; Kawashima, Hiroshi; Oguma, Eiji			Five neonatal cases of pyriform sinus fistula with cervical cystic lesion: a comparison between sonography and other modalities	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Pyriform sinus fistula; Sonography; Barium esophagography; Neonatal cases; ALARA	CHILDREN; MANAGEMENT; THYROIDITIS; EXPERIENCE; INFECTION; DIAGNOSIS	Pyriform sinus fistulas are an unusual cause of neck cystic lesions in neonates. A definitive diagnosis requires detection of the fistula, which originates from the pyriform sinus and extends to the cystic lesion. Sonography has been reported to be useful for detecting fistulas. However, there have been no reports of neonatal cases in which sonography could detect fistulas not detected by other modalities, such as barium esophagography, computed tomography (CT), or magnetic resonance imaging (MRI). We describe five neonatal patients with pyriform sinus fistula-appearing cervical cystic lesions. All patients were examined by sonography; of these, three patients were also examined by barium esophagography, two by CT, and one by MRI. The fistula was detected by sonography but not CT in one patient and by barium esophagography but not MRI in one. Two patients whose fistulas were detected by sonography had an oval-shaped and relatively small cystic lesion. One patient whose fistula could be detected only by barium esophagography had a relatively large cystic lesion. In two patients, whose fistulas were not detected by sonography or barium esophagography, sonography revealed air bubbles within the cystic lesions, and a pyriform sinus fistula was suspected. Without requiring ionizing radiation, sonography was thus useful in diagnosing pyriform sinus fistula-appearing cervical cystic lesions in neonatal cases. On the other hand, in two patients whose fistulas were not detected by sonography, the shape of the cystic lesion was polygonal or multicystic. In two of three patients with infectious signs, a fistula could not be detected. The shape and size of the cystic lesion and the presence of infectious signs may be important factors for detecting fistulas.	[Hosokawa, Takahiro; Sato, Yumiko; Tanami, Yutaka; Oguma, Eiji] Saitama Childrens Med Ctr, Dept Radiol, Saitama, Saitama 3398551, Japan; [Yamada, Yoshitake] Keio Univ, Sch Med, Dept Diagnost Radiol, Shinjuku Ku, Tokyo 1608582, Japan; [Amano, Hizuru; Fujiogi, Michimasa; Kawashima, Hiroshi] Saitama Childrens Med Ctr, Dept Surg, Saitama, Saitama 3398551, Japan	Hosokawa, T (reprint author), Saitama Childrens Med Ctr, Dept Radiol, 2100 Magome, Saitama, Saitama 3398551, Japan.	snowglobe@infoseek.jp					Yanai T, 2004, PEDIATR SURG INT, V20, P58, DOI 10.1007/s00383-003-1083-5; Mizuno R, 1998, PEDIATR SURG INT, V14, P82, DOI 10.1007/s003830050442; TYLER D, 1992, J PEDIATR SURG, V27, P1500, DOI 10.1016/0022-3468(92)90483-N; Sheng QF, 2014, J PEDIATR SURG, V49, P455, DOI 10.1016/j.jpedsurg.2013.07.008; Liu Z, 2013, AM J OTOLARYNG, V34, P579, DOI 10.1016/j.amjoto.2013.01.010; Castellote A, 1999, RADIOGRAPHICS, V19, P583; DAVIDSON AJ, 1989, RADIOLOGY, V172, P421; Amano H, 2012, PEDIATR SURG INT, V28, P15, DOI 10.1007/s00383-011-3008-z; MACPHERSON RI, 1993, RADIOGRAPHICS, V13, P1063; Gan YU, 2004, ANN ACAD MED SINGAP, V33, P636; Ahuja AT, 1998, CLIN RADIOL, V53, P209, DOI 10.1016/S0009-9260(98)80102-5; Wang HK, 2003, PEDIATR RADIOL, V33, P328, DOI 10.1007/s00247-003-0887-8; Liberman M, 2002, J PEDIATR SURG, V37, P685, DOI 10.1053/jpsu.2002.32253; Roessingh ASD, 2008, J PEDIATR SURG, V43, DOI 10.1016/j.jpedsurg.2007.12.071; MIYAUCHI A, 1981, ARCH SURG-CHICAGO, V116, P66; Ohno KA, 1989, J JPN SOC PEDIATR SU, V25, P96	16	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					579	585		10.1007/s10396-015-0641-5		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500019		
J	Hosokawa, T; Yamada, Y; Sato, Y; Tanami, Y; Amano, H; Fujiogi, M; Kawashima, H; Oguma, E				Hosokawa, Takahiro; Yamada, Yoshitake; Sato, Yumiko; Tanami, Yutaka; Amano, Hizuru; Fujiogi, Michimasa; Kawashima, Hiroshi; Oguma, Eiji			Lateral cervical sinus: specific sonographic findings in two pediatric cases	JOURNAL OF MEDICAL ULTRASONICS			English	Article						Lateral cervical sinus; Second branchial cleft; Child; Pharyngeal arch; Contrast fistulogram	FISTULA	A lateral cervical sinus, also known as a second pharyngeal or branchial cleft fistula/sinus, occurs when the second pharyngeal arch fails to grow caudally over the third and fourth arches, leaving remnants of the second branchial clefts in contact with the surface of the neck via a narrow canal. This type of sinus is detected on the lateral aspect of the neck directly anterior to the sternocleidomastoid muscle. We report two pediatric cases with lateral cervical sinus, and pathognomonic sonographic findings to confirm the diagnosis. The first case involved a 3-month-old boy with a sinus on the lateral neck and occasional drainage from a cervical sinus opening. Sonography revealed that the sinus tract extended between the external and internal carotid arteries. In case two, a 1-month-old girl presented with a sinus on the lateral neck and signs of acute infection at the site of a pinpoint opening. Sonography revealed an oval-shaped cystic lesion and sinus tract extending between the external and internal carotid arteries. Sonography does not require radiation or sedation for children. The best choice for the first examination for lateral cervical sinus is sonography, rather than CT, MRI, or contrast fistulograms.	[Hosokawa, Takahiro; Sato, Yumiko; Tanami, Yutaka; Oguma, Eiji] Saitama Childrens Med Ctr, Dept Radiol, Iwatsuki, Saitama 3398551, Japan; [Yamada, Yoshitake] Keio Univ, Sch Med, Dept Diagnost Radiol, Shinjuku Ku, Tokyo 1608582, Japan; [Amano, Hizuru; Fujiogi, Michimasa; Kawashima, Hiroshi] Saitama Childrens Med Ctr, Dept Surg, Iwatsuki, Saitama 3398551, Japan	Hosokawa, T (reprint author), Saitama Childrens Med Ctr, Dept Radiol, 2100 Magome, Iwatsuki, Saitama 3398551, Japan.	snowglobe@infoseek.jp					Bajaj Y, 2011, INT J PEDIATR OTORHI, V75, P1020, DOI 10.1016/j.ijporl.2011.05.008; DESCHEPPER AMA, 1988, ANN RADIOL, V31, P141; Kajosaari L, 2014, INT J PEDIATR OTORHI, V78, P1503, DOI 10.1016/j.ijporl.2014.06.020; Guldfred LA, 2012, J LARYNGOL OTOL, V126, P598, DOI 10.1017/S0022215112000473; Keogh I J, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P73; Langman J., 2011, MED EMBRYOLOGY, P270; Moore KL, 2011, DEV HUMAN CLIN ORIEN, P169; O'Rahilly R, 1996, HUMAN EMBRYOLOGY TER, P218; Samareh Sahu Wg Cdr, 2011, MIAFI, V67, P262; Thottam PJ, 2014, ENT-EAR NOSE THROAT, V93, P466	10	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					595	599		10.1007/s10396-015-0650-4		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500022		
J	Inubashiri, E; Watanabe, Y; Akutagawa, N; Sugawara, M; Kuroki, K; Maeda, N				Inubashiri, Eisuke; Watanabe, Yukio; Akutagawa, Noriyuki; Sugawara, Masaki; Kuroki, Katumaru; Maeda, Nobuhiko			Visualization of the spiral artery jet in fetal growth-restricted pregnancy by utilizing spatiotemporal image correlation with high-definition flow	JOURNAL OF MEDICAL ULTRASONICS			English	Editorial Material						Placental lake; STIC; Spiral artery			[Inubashiri, Eisuke; Watanabe, Yukio; Akutagawa, Noriyuki; Sugawara, Masaki; Kuroki, Katumaru; Maeda, Nobuhiko] Sapporo Toho Hosp, Higashi Ku, Sapporo, Hokkaido 0650017, Japan	Inubashiri, E (reprint author), Sapporo Toho Hosp, Higashi Ku, Kita 17,Higashi 15, Sapporo, Hokkaido 0650017, Japan.	reduzierung@yahoo.co.jp					Kudla MJ, 2010, J ULTRAS MED, V29, P1469; Collins SL, 2012, PLACENTA, V33, P782, DOI 10.1016/j.placenta.2012.07.005	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					601	603		10.1007/s10396-015-0623-7		3	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500023		
J	Saijo, Y				Saijo, Yoshifumi			In memory: Floyd Dunn	JOURNAL OF MEDICAL ULTRASONICS			English	Biographical-Item									Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan	Saijo, Y (reprint author), Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan.	saijo@idac.tohoku.ac.jp					SAIJO Y, PUBLICATION LIST	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					605	605		10.1007/s10396-015-0656-y		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500024		
J	Kanai, H				Kanai, Hiroshi			Untitled	JOURNAL OF MEDICAL ULTRASONICS			English	Editorial Material									[Kanai, Hiroshi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Kanai, Hiroshi] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan	Kanai, H (reprint author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan.	kanai@ecei.tohoku.ac.jp						0	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1346-4523	1613-2254		J MED ULTRASON	J. Med. Ultrason.	OCT	2015	42	4					607	607		10.1007/s10396-015-0657-x		1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT0XP	WOS:000362521500025		
J	Li, YF; Sugiyama, M; Toshiyoshi, H; Fujita, H				Li, Yong Fang; Sugiyama, Masakazu; Toshiyoshi, Hiroshi; Fujita, Hiroyuki			Scalable Throughput and Stable Scanning Probe Nanolithography Based on Local Anodic Oxidation by Arrayed Wear-Insensitive Sidewall Microprobes	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						Electrical contact; mechanical contact; sidewall electrode; MEMS cantilevers; scanning probe nanolithography; local anodic oxidation	ATOMIC-FORCE MICROSCOPE; LITHOGRAPHY; SILICON; NANOSTRUCTURES; FABRICATION; NANOFABRICATION; TRANSISTORS; CANTILEVER; SURFACES; CONTACT	In this paper, scalable throughput and stable scanning probe nanolithography is demonstrated using arrayed wear-insensitive sidewall probes (WISPs). Tips of the proposed arrayed probes have a uniform cuboid shape. Each probe tip consists of a microscale mechanical contact and two separated nanoscale electrical contacts (sidewall electrodes) formed on the sidewall of the mechanical contact, and an eave formed at the end. The microscale mechanical contacts reduce the tip wear by dispersing the force applied to the tip, and the nanoscale electrical contacts enable the drawing of nanoscale features. The eaves at the end of the cantilevers play an essential role in preventing metal from being deposited on the mechanical contact, which simplifies the fabrication process. Even when the probe is mechanically worn, the width of the sidewall electrodes does not change; this ensures the wear-insensitive performance of the probe over long drawing distance. A microelectromechanical systems technique is used to fabricate the arrayed probes. Eight linearly arrayed WISPs with an 80-mu m-wide mechanical contact and two 30-nm-thick electrical contacts are fabricated. Using the fabricated probes, eight sets of patterns with a line width of similar to 100 nm and a total drawing distance of 1600 mu m (200 mu m x 8 cycles) are drawn in parallel within the 50 s in contact and vector scan modes. Furthermore, eight sets of multiscale pattern with a line width from 100 nm to several micrometers and a drawing area of 100 mu m x 50 mu m, corresponding to a total distance of 400 mm (50 mmx8 cycles), are stably drawn within 30 min in contact-and raster-scan modes. Better resolution is achieved by increasing the scan rate, as well as by reducing the bias voltage and the environmental humidity. Thus, line patterns with a width of similar to 50 nm are drawn. [2014-0245]	[Li, Yong Fang] Toshiba Co Ltd, Toshiba Corp Res & Dev Ctr, Kawasaki, Kanagawa 2128582, Japan; [Li, Yong Fang] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro 1538904, Japan; [Sugiyama, Masakazu] Univ Tokyo, Sch Engn, Inst Engn Innovat, Tokyo 1138654, Japan; [Toshiyoshi, Hiroshi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro 1538904, Japan; [Fujita, Hiroyuki] Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan	Li, YF (reprint author), Toshiba Co Ltd, Toshiba Corp Res & Dev Ctr, Kawasaki, Kanagawa 2128582, Japan.	yongfang.li@toshiba.co.jp; sugiyama@ee.t.u-tokyo.ac.jp; hiro@iis.u-tokyo.ac.jp; hfujita@iis.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038	New Energy and Industrial Technology Development Organization, Japan	This work was supported by the New Energy and Industrial Technology Development Organization, Japan. Subject Editor M. Wong.	Anggraini L., 2008, P 25 SENS S OCT 22 2, P21; Martinez J, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336773; Chien FSS, 2002, J APPL PHYS, V91, P10044, DOI 10.1063/1.1476072; Li YF, 2013, J MICROELECTROMECH S, V22, P901, DOI 10.1109/JMEMS.2013.2249041; SONG HJ, 1994, J VAC SCI TECHNOL B, V12, P3720, DOI 10.1116/1.587430; DAGATA JA, 1990, APPL PHYS LETT, V56, P2001, DOI 10.1063/1.102999; Snow ES, 1999, APPL PHYS LETT, V75, P1476, DOI 10.1063/1.124730; Minne SC, 1996, J VAC SCI TECHNOL B, V14, P2456, DOI 10.1116/1.588753; Snow ES, 1998, APPL PHYS LETT, V72, P3071, DOI 10.1063/1.121544; Tomizawa Y, 2013, J ADV MECH DES SYST, V7, P15, DOI 10.1299/jamdsm.7.15; Tseng AA, 2005, J VAC SCI TECHNOL B, V23, P877, DOI 10.1116/1.1926293; Snow ES, 1996, APPL PHYS LETT, V69, P269, DOI 10.1063/1.117946; Bhushan B, 2001, WEAR, V251, P1105, DOI 10.1016/S0043-1648(01)00804-3; Quate CF, 1997, SURF SCI, V386, P259, DOI 10.1016/S0039-6028(97)00305-1; Minne SC, 1998, APPL PHYS LETT, V72, P2340, DOI 10.1063/1.121353; Voves J, 2009, MICROELECTRON ENG, V86, P561, DOI 10.1016/j.mee.2008.11.035; Gandjar H, 2008, IEEJ T ELECTR ELECTR, V3, P260, DOI 10.1002/tee.20265; SNOW ES, 1994, APPL PHYS LETT, V64, P1932, DOI 10.1063/1.111746; Shirakashi J, 2010, J NANOSCI NANOTECHNO, V10, P4486, DOI 10.1166/jnn.2010.2359; Salaita K, 2006, ANGEW CHEM INT EDIT, V45, P7220, DOI 10.1002/anie.200603142; MINNE SC, 1995, APPL PHYS LETT, V66, P703, DOI 10.1063/1.114105; Sugimura H, 2002, ADV MATER, V14, P524, DOI 10.1002/1521-4095(20020404)14:7<524::AID-ADMA524>3.3.CO;2-S; MATSUMOTO K, 1995, JPN J APPL PHYS 1, V34, P1387, DOI 10.1143/JJAP.34.1387; SUGIMURA H, 1993, APPL PHYS LETT, V63, P1288, DOI 10.1063/1.110771; Inoue T, 2012, MICROELECTRON ENG, V98, P288, DOI 10.1016/j.mee.2012.05.019; Fuhrer A, 2001, NATURE, V413, P822, DOI 10.1038/35101552; Dagata JA, 1998, J APPL PHYS, V84, P6891, DOI 10.1063/1.368986; Kume W, 2010, J NANOSCI NANOTECHNO, V10, P7239, DOI 10.1166/jnn.2010.2803; Liu C, 2008, MATER TODAY, V11, P22; Garcia R, 1998, APPL PHYS LETT, V72, P2295, DOI 10.1063/1.121340; Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608; Koinuma M, 1996, SURF SCI, V357, P565, DOI 10.1016/0039-6028(96)00224-5; Li YF, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JF04; Matsuzuka N., 2007, P 14 INT C SOL STAT, P1649	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	OCT	2015	24	5					1471	1478		10.1109/JMEMS.2015.2412155		8	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CS8RB	WOS:000362354900026		
J	Kanazawa, M; Nakajima, S; Oshima, T; Whitehead, WE; Sperber, AD; Palsson, OS; Drossman, DA; Miwa, H; Fukudo, S				Kanazawa, Motoyori; Nakajima, Shigemi; Oshima, Tadayuki; Whitehead, William E.; Sperber, Ami D.; Palsson, Olafur S.; Drossman, Douglas A.; Miwa, Hiroto; Fukudo, Shin			Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia	JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						Dyspepsia; Functional gastrointestinal disorders; Irritable bowel syndrome; Japan; Questionnaire; Translations	GASTROINTESTINAL DISORDERS; VALIDATION; CRITERIA; TRANSLATION; AGREEMENT	Background/Aims Reliable diagnostic instruments for measuring the presence of functional gastrointestinal disorders based on the Rome III criteria have been lacking in Japan. The aims of the present study were to translate and validate the Rome III diagnostic questionnaire which was widely used in Western countries. Methods The original version of Rome Ill diignostic questionnaire was translated from English into Japanese through 3 independent forward translations, resolution, back translation and reconciliation of the differences. Forty-nine patients with irritable bowel syndrome (IBS), 32 patients with functional dyspepsia (FD) and 56 subjects without any current GI symptoms as controls were recruited from three hospitals located in different regions of Japan and completed the IBS and FD diagnostic modules twice within 14 days. Kappa statistic was used to assess test-retest reliability. The sensitivity and specificity of each diagnostic module for distinguishing IBS or FD patients from controls was tested. Results Median kappa statistics were 0.63 for the translated IBS diagnostic module and 0.68 for the FD module. The sensitivity, specificity, and positive predict value of the IBS module against physician diagnosis was 61.2%, 100%, and 100% and those of the FD module was 53.2%, 98.2%, and 94.4%, respectively. Meanwhile, IBS patients were significantly more likely to report blood in stools compared to controls (18.4% vs 1.8%, P < 0.01). Conclusions The IBS and FD diagnostic modules on the Japanese version of the Rome III diagnostic questionnaire are valid and reliable. Further studies are warranted to elucidate the diagnostic utility of the red flag questionnaire.	[Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 9808575, Japan; [Nakajima, Shigemi] Shiga Hosp, Japan Community Hlth Care Org, Dept Med Gastroenterol & Hlth Care, Otsu, Shiga, Japan; [Oshima, Tadayuki; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Upper Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Whitehead, William E.; Palsson, Olafur S.; Drossman, Douglas A.] Univ N Carolina, Ctr Funct GI & Motil Disorders, Chapel Hill, NC USA; [Sperber, Ami D.] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Levahim, Israel	Kanazawa, M (reprint author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Aoba Ku, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan.	m-kanazawa@med.tohoku.ac.jp			Ministry of Education, Science, and Culture of Japan; Ministry of Health, Welfare, and Labor of Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, and a Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan.	Whitehead WE, 2010, AM J GASTROENTEROL, V105, P814, DOI 10.1038/ajg.2010.56; Vandvik PO, 2004, SCAND J GASTROENTERO, V39, P448, DOI 10.1080/00365520310008782; Whitehead WE, 2006, ALIMENT PHARM THER, V24, P137, DOI 10.1111/j.1365-2036.2006.02956.x; Miwa H, 2012, NEUROGASTROENT MOTIL, V24, P464, DOI 10.1111/j.1365-2982.2011.01872.x; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; HEATON KW, 1992, GUT, V33, P818, DOI 10.1136/gut.33.6.818; Shinozaki M, 2006, J GASTROENTEROL, V41, P491, DOI 10.1007/s00535-006-1799-9; Nakajima S, 2010, J GASTROEN HEPATOL, V25, pS138, DOI 10.1111/j.1440-1746.2010.06244.x; Lee YY, 2012, J GASTROEN HEPATOL, V27, P746, DOI 10.1111/j.1440-1746.2011.06943.x; Nishino Y, 2004, J EPIDEMIOL, V14, pS7, DOI 10.2188/jea.14.S7; Whitehead WE, 2003, GASTROENTEROLOGY, V124, pA397, DOI 10.1016/S0016-5085(03)82009-7; Spiegel B, 2009, ALIMENT PHARM THER, V30, P1159, DOI 10.1111/j.1365-2036.2009.04144.x; Drossman DA, 2000, ROME 2 FUNCTIONAL GA; Drossman DA, 2006, ROME 3 FUNCTIONAL GA, P835; Drossman DA, 2006, ROME 3 FUNCTIONAL GA; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Goshal UC, 2015, J NEUROGASTROENTEROL, V21, P83; Longstreth GF, 2006, ROME, V3, P487; Reisswitz Pâmela Schitz Von, 2010, Arq Gastroenterol, V47, P354, DOI 10.1590/S0004-28032010000400007; Saigo Tatsuo, 2014, Biopsychosoc Med, V8, P10, DOI 10.1186/1751-0759-8-10; Song KH, 2013, J NEUROGASTROENTEROL, V19, P509, DOI 10.5056/jnm.2013.19.4.509; Tack J, 2006, ROME 3 FUNCTIONAL GA, P419; Toner BB, 2006, ROME 3 FUNCTIONAL GA, P231	24	0	0	KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY	GANGNAM-GU	RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA	2093-0879	2093-0887		J NEUROGASTROENTEROL	J. Neurogastroenterol. Motil.	OCT	2015	21	4					537	544		10.5056/jnm15016		8	Gastroenterology & Hepatology; Clinical Neurology	Gastroenterology & Hepatology; Neurosciences & Neurology	CT3GT	WOS:000362695900011		
J	Taswelll, C; Villemagne, VL; Yates, P; Shimada, H; Leyton, CE; Ballard, KJ; Piguet, O; Burre, JR; Hodges, JR; Rowe, CC				Taswelll, Carl; Villemagne, Victor L.; Yates, Paul; Shimada, Hitoshi; Leyton, Cristian E.; Ballard, Kirrie J.; Piguet, Olivier; Burre, James R.; Hodges, John R.; Rowe, Christopher C.			F-18-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias	JOURNAL OF NUCLEAR MEDICINE			English	Article						Alzheimer disease; focal-onset dementias; C-11-PiB; F-18-FDG; PET brain imaging	PRIMARY PROGRESSIVE APHASIA; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; FDG-PET; FRONTOTEMPORAL DEMENTIA; C-11-PIB PET; BRAIN PET; METAANALYSIS; DEGENERATION	Alzheimer disease is the cause of up to one-third of cases of primary progressive aphasia or corticobasal syndrome. The primary objective of this study was to determine the accuracy of F-18-FDG PET metabolic imaging for the detection of Alzheimer disease in patients with primary progressive aphasia or corticobasal syndrome. Methods: A cohort of patients (n = 94), including those with an expert clinical diagnosis of logopenic (n = 19), nonfluent (n = 16), or semantic (n = 13) variants of primary progressive aphasia, corticobasal syndrome (n = 14), or Alzheimer disease (n = 24), underwent F-18-FDG metabolic and C-11-labeled Pittsburgh compound B (C-11-PiB) amyloid PET brain imaging. F-18-FDG PET scans interpreted with Neurostat and 3D-SSP displays were classified as revealing Alzheimer disease or "other" by interpreters who were unaware of the clinical assessments and C-11-PiB PET results. C-11-PiB PET imaging was considered to be the diagnostic reference standard, with a threshold standardized uptake value ratio of 1.5 being indicative of Alzheimer disease pathology. To address possible bias from subgroup selection for the Alzheimer disease binary classifier, we calculated both conventional and balanced accuracies. Results: Diagnoses of Alzheimer disease based on F-18-FDG PET resulted in 84% accuracy (both conventional and balanced). In comparison, diagnoses based on clinical assessments resulted in 65% conventional accuracy and 67% balanced accuracy. Conclusion: Brain F-18-FDG PET scans interpreted with Neurostat and 3D-SSP displays accurately detected Alzheimer disease in patients with primary progressive aphasia or corticobasal syndrome as focal-onset dementias. In such diagnostically challenging cohorts, F-18-FDG PET imaging can provide more accurate diagnoses, enabling more appropriate therapy.	[Taswelll, Carl] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Villemagne, Victor L.; Yates, Paul; Rowe, Christopher C.] Austin Hlth Dept Mol Imaging, Melbourne, Vic, Australia; [Shimada, Hitoshi] NIRS Mol Imaging Ctr, Chiba, Japan; [Leyton, Cristian E.; Ballard, Kirrie J.] Univ Sydney Hlth Sci, Sydney, NSW, Australia; [Piguet, Olivier; Burre, James R.; Hodges, John R.] Neurosci Res Australia, ARC Ctr Excellence Cognit & Disorders, Sydney, NSW, Australia; [Piguet, Olivier; Burre, James R.; Hodges, John R.] Univ New South Wales Med Sci, Sydney, NSW, Australia	Taswelll, C (reprint author), Univ Calif San Diego, Dept Psychiat, Senior Behav Hlth, 9500 Gilman Dr,MC 0603, La Jolla, CA 92093 USA.	ctaswell@ucsd.edu					Alavi A, 1982, EXP BRAIN RES S5, P187; Bloudek LM, 2011, J ALZHEIMERS DIS, V26, P627, DOI 10.3233/JAD-2011-110458; Bohnen NI, 2012, J NUCL MED, V53, P59, DOI 10.2967/jnumed.111.096578; Bohnen NI, 2012, NEUROLOGY, V79, P1306, DOI 10.1212/WNL.0b013e31826c1be1; Kramer JH, 2000, SEMIN NEUROL, V20, P447, DOI 10.1055/s-2000-13177; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; Josephs KA, 2012, BRAIN, V135, P1522, DOI 10.1093/brain/aws032; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Mesulam M M, 1992, Baillieres Clin Neurol, V1, P583; Rowe CC, 2011, J NUCL MED, V52, P1733, DOI 10.2967/jnumed.110.076315; Rabinovici GD, 2011, NEUROLOGY, V77, P2034, DOI 10.1212/WNL.0b013e31823b9c5e; Hodges JR, 2013, J ALZHEIMERS DIS, V33, pS211, DOI 10.3233/JAD-2012-129038; Yuan Y, 2009, AM J NEURORADIOL, V30, P404, DOI 10.3174/ajnr.A1357; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Wang BW, 2012, CAN J NEUROL SCI, V39, P592; BENSON DF, 1981, T AM NEUROL ASSOC, V106, P68; Jung Y, 2013, SEMIN NEUROL, V33, P342, DOI 10.1055/s-0033-1359317; Silverman DHS, 2002, AM J PSYCHIAT, V159, P1482, DOI 10.1176/appi.ajp.159.9.1482; Silverman DHS, 2002, J NUCL MED, V43, P253; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Herholz K, 2011, J NUCL MED, V52, P1218, DOI 10.2967/jnumed.111.090902; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Mathew R, 2012, J NEUROL NEUROSUR PS, V83, P405, DOI 10.1136/jnnp-2011-300875; Mathis CA, 2002, BIOORG MED CHEM LETT, V12, P295, DOI 10.1016/S0960-894X(01)00734-X; Mesulam MM, 2014, BRAIN, V137, P1176, DOI 10.1093/brain/awu024; Patwardhan MB, 2004, RADIOLOGY, V231, P73, DOI 10.1148/radiol.2311021620; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Risacher SL, 2013, SEMIN NEUROL, V33, P386, DOI 10.1055/s-0033-1359312; Rabinovici GD, 2007, NEUROLOGY, V68, P1205, DOI 10.1212/01.wnl.0000259035.98480.ed; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Brown RKJ, 2014, RADIOGRAPHICS, V34, P684, DOI 10.1148/rg.343135065; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Caroli A, 2012, J NUCL MED, V53, P592; Herholz K, 2013, CLIN TRANSL IMAGING, V1, P261; Kertesz A, 2000, NEUROLOGY, V55, P1368; Nasrallah IM, 2014, J NUCL MED, V55, P2003, DOI 10.2967/jnumed.114.141416; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Rowe Christopher C, 2013, J Nucl Med Technol, V41, P11, DOI 10.2967/jnumed.110.076315	39	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	OCT	2015	56	10					1547	1553		10.2967/jnumed.115.161067		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CS9DF	WOS:000362388600017		
J	Wang, GQ; Tachibana, T; Gilbert, ER; Cline, MA				Wang, Guoqing; Tachibana, Tetsuya; Gilbert, Elizabeth R.; Cline, Mark A.			Dietary Macronutrient Composition Affects the Influence of Exogenous Prolactin-Releasing Peptide on Appetite Responses and Hypothalamic Gene Expression in Chickens	JOURNAL OF NUTRITION			English	Article						prolactin-releasing peptide; macronutrient; food intake; chicken; hypothalamus	NEUROPEPTIDE-Y; FOOD-INTAKE; MESSENGER-RNA; INTRACEREBROVENTRICULAR INJECTION; NEONATAL CHICKS; ARCUATE NUCLEUS; ENERGY-INTAKE; AMINO-ACIDS; BODY-WEIGHT; C-FOS	Background: The interaction between the effects of exogenous neurotransmitters and dietary composition on appetite regulation in nonmammalian species is unclear. Objective: The objective of this study was to determine the effects of exogenous prolactin-releasing peptide (PrRP) and dietary macronutrient composition on food intake regulation in broiler chicks. Methods: Three isocaloric diets were formulated: high-carbohydrate (HC), high-fat (HF; 60% of ME from lard) and highprotein (HP) diets. In Expt. 1, 4-d-old Hubbard x Cobb-500 chicks fed 1 of the 3 diets since hatch were intracerebroventricularly injected with 0 (vehicle), 3, or 188 pmol PrRP (n =10). Food intake was measured for 180 min. In Expt. 2, hypothalamic mRNA abundance of appetite-associated factors was measured in hypothalamus samples obtained 1 h postinjection of 0 or 188 pmol PrF1P. In Expt. 3, chicks were given free access to all diets before and after intracerebroventricular injection and food intake was measured. Results: Three and 188 pmol PrRP increased (P = 0.0008 and 0.04) HP diet intake, but only 188 pmol PrRP was efficacious at increasing HC (P = 0.0011) and HF (P = 0.011 consumption compared with the vehicle. There was a diet effect on mRNA abundance of all genes (P < 0.05), with greater expression in chicks fed the HF or HP than the HC diet. Whereas neuropeptide Y (NPY) mRNA was similar between vehicle- and PrRP-injected chicks that consumed HP or HF diets, expression was greater (P < 0.05) in PrRP- than vehicle-injected chicks that consumed the HC diet. When chicks had access to all diets, 188 pmol PrRP caused preferential (P < 0.0001) intake of the HP over the HC and HF diets. Conclusion: The HP diet enhanced the sensitivity of chicks to the food intake stimulating effects of PrRP, and PrRP in turn increased preference for the HP diet. Thus, dietary macronutrient composition influences PrRP-mediated food intake, and PrRP in turn affects nutrient intake and transcriptional regulation in chicks.	[Wang, Guoqing; Gilbert, Elizabeth R.; Cline, Mark A.] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Tachibana, Tetsuya] Ehime Univ, Fac Agr, Dept Agrobiol Sci, Matsuyama, Ehime 790, Japan	Cline, MA (reprint author), Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA.	macline2@vt.edu			Virginia Agricultural Experiment Station; Hatch Program of the National Institute of Food and Agriculture, USDA	Funding for this work was provided in part by the Virginia Agricultural Experiment Station and the Hatch Program of the National Institute of Food and Agriculture, USDA.	TEMPEL DL, 1988, PEPTIDES, V9, P309, DOI 10.1016/0196-9781(88)90265-3; ANDERSON GH, 1987, INT J OBESITY, V11, P97; GIRAUDO SQ, 1994, AM J PHYSIOL, V266, pR1578; Furuse M, 1999, BRIT POULTRY SCI, V40, P698, DOI 10.1080/00071669987115; Chavez M, 1998, J CLIN INVEST, V102, P340, DOI 10.1172/JCI603; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; van den Heuvel JK, 2014, J NEUROENDOCRINOL, V26, P377, DOI 10.1111/jne.12155; Ando R, 2001, EUR J PHARMACOL, V427, P53, DOI 10.1016/S0014-2999(01)01201-8; Wu YF, 2004, NEUROSCI LETT, V363, P6, DOI 10.1016/j.neulet.2004.02.020; MORLEY JE, 1987, AM J PHYSIOL, V252, pR599; Wang LX, 2002, NEUROSCI LETT, V325, P47; KUENZEL WJ, 1987, PEPTIDES, V8, P823, DOI 10.1016/0196-9781(87)90066-0; Wang J, 1999, BRAIN RES, V848, P124, DOI 10.1016/S0006-8993(99)02040-5; BECK B, 1994, BRAIN RES BULL, V34, P85, DOI 10.1016/0361-9230(94)90002-7; LI ETS, 1982, PHYSIOL BEHAV, V29, P779, DOI 10.1016/0031-9384(82)90324-9; BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Tachibana T, 2001, NEUROSCI LETT, V305, P131, DOI 10.1016/S0304-3940(01)01827-4; Swennen Q, 2007, WORLD POULTRY SCI J, V63, P541, DOI 10.1017/S0043933907001602; WELCH CC, 1994, AM J PHYSIOL, V266, pR426; Noy Y, 2002, POULTRY SCI, V81, P391; Tachibana T, 2011, J NEUROENDOCRINOL, V23, P74, DOI 10.1111/j.1365-2826.2010.02078.x; Bensaid A, 2003, PHYSIOL BEHAV, V78, P311, DOI 10.1016/S0031-9384(02)00977-0; Sun BG, 2005, REGUL PEPTIDES, V126, P27, DOI 10.1016/j.regpep.2004.08.008; Tachibana T, 2004, PHYSIOL BEHAV, V80, P713, DOI 10.1016/j.physbeh.2003.12.005; DAVIS JL, 1979, PHYSIOL BEHAV, V22, P693, DOI 10.1016/0031-9384(79)90233-6; CHRONWALL BM, 1985, NEUROSCIENCE, V15, P1159, DOI 10.1016/0306-4522(85)90260-X; Smith BK, 1997, PEPTIDES, V18, P207, DOI 10.1016/S0196-9781(96)00318-X; Lawrence CB, 2000, NAT NEUROSCI, V3, P645, DOI 10.1038/76597; ANDERSON GH, 1979, CAN J PHYSIOL PHARM, V57, P1043; Hagan MM, 2001, AM J PHYSIOL-REG I, V280, pR814; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; White BD, 2000, PHYSIOL BEHAV, V69, P383, DOI 10.1016/S0031-9384(99)00232-2; Yi JQ, 2015, BEHAV BRAIN RES, V286, P58, DOI 10.1016/j.bbr.2015.02.008; Cobb-Vantress, COBB500 BROIL PERF N; Murray EKI, 2015, THROMB RES, DOI [10.1016/j.thromres.2015.08.011, DOI 10.1016/J.THROMRES.2015.08.011]; Nelson LA, 2015, NEUROSCI LETT, V591, P171, DOI 10.1016/j.neulet.2015.02.017; STANLEY BG, 1989, PHYSIOL BEHAV, V46, P173, DOI 10.1016/0031-9384(89)90251-5; SUTHAMA N, 1991, Japanese Poultry Science, V28, P1	38	0	0	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3166	1541-6100		J NUTR	J. Nutr.	OCT	2015	145	10					2406	2411		10.3945/jn.115.214338		6	Nutrition & Dietetics	Nutrition & Dietetics	CS9CW	WOS:000362387700029		
J	Misawa, K; Hashizume, K; Yamamoto, M; Minegishi, Y; Hase, T; Shimotoyodome, A				Misawa, Koichi; Hashizume, Kojiro; Yamamoto, Masaki; Minegishi, Yoshihiko; Hase, Tadashi; Shimotoyodome, Akira			Ginger extract prevents high-fat diet-induced obesity in mice via activation of the peroxisome proliferator-activated receptor delta pathway	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Energy metabolism; Ginger; Muscle fibers; slow-twitch; Obesity; Oxygen consumption; PPAR delta	SKELETAL-MUSCLE; ZINGIBER-OFFICINALE; METABOLIC SYNDROME; BETA-OXIDATION; ADIPOSE-TISSUE; MESSENGER-RNA; C57BL/6J MICE; WEIGHT-GAIN; PPAR-DELTA; EXPRESSION	The initiation of obesity entails an imbalance wherein energy intake exceeds expenditure. Obesity is increasing in prevalence and is now a worldwide health problem. Food-derived peroxisome proliferator-activated receptor delta (PPAR delta) stimulators represent potential treatment options for obesity. Ginger (Zingiber officinale Roscoe) was previously shown to regulate the PPAR gamma signaling pathway in adipocytes. In this study, we investigated the antiobesity effects of ginger in vivo and the mechanism of action in vitro. Energy expenditure was increased, and diet-induced obesity was attenuated in C57BL/6 J mice treated with dietary ginger extract (GE). GE also increased the number of Type I muscle fibers, improved running endurance capacity and upregulated PPAR delta-targeted gene expression in skeletal muscle and the liver. 6-Shogaol and 6-gingerol acted as specific PPAR delta ligands and stimulated PPAR delta-dependent gene expression in cultured human skeletal muscle myotubes. An analysis of cellular respiration revealed that pretreating cultured skeletal muscle myotubes with GE increased palmitate-induced oxygen consumption rate, which suggested an increase in cellular fatty acid catabolism. These results demonstrated that sustained activation of the PPAR delta pathway with GE attenuated diet-induced obesity and improved exercise endurance capacity by increasing skeletal muscle fat catabolism. 6-Shogaol and 6-gingerol may be responsible for the regulatory effects of dietary ginger on PPAR delta signaling. (C) 2015 Elsevier Inc. All rights reserved.	[Misawa, Koichi; Hashizume, Kojiro; Yamamoto, Masaki; Minegishi, Yoshihiko; Hase, Tadashi; Shimotoyodome, Akira] Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan	Shimotoyodome, A (reprint author), 2606 Akabane, Ichikai, Tochigi 3213497, Japan.	misawa.koichi@kao.co.jp; hashizume.kojiro@kao.co.jp; yamamoto.masaki@kao.co.jp; minegishi.yoshihiko@kao.co.jp; hase.tadashi@kao.co.jp; shimotoyodome.akira@kao.co.jp			Kao Corporation	This study was supported financially by Kao Corporation.	Jeukendrup AE, 1998, INT J SPORTS MED, V19, P371, DOI 10.1055/s-2007-971932; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Shimotoyodome A, 2010, AM J PHYSIOL-ENDOC M, V298, pE652, DOI 10.1152/ajpendo.00468.2009; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Prpic V, 2002, J NUTR, V132, P3325; Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Luquet S, 2004, BIOCHIMIE, V86, P833, DOI 10.1016/j.biochi.2004.09.024; Bremer J, 2001, PROG LIPID RES, V40, P231, DOI 10.1016/S0163-7827(01)00004-2; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Margareto J, 2001, J NUTR BIOCHEM, V12, P130, DOI 10.1016/S0955-2863(00)00131-5; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Malik ZA, 2011, INT J PHARMACOL, V7, P801, DOI 10.3923/ijp.2011.801.812; Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8; Naderi J, 2009, AM J PATHOL, V175, P763, DOI 10.2353/ajpath.2009.081009; Isa Y, 2008, BIOCHEM BIOPH RES CO, V373, P429, DOI 10.1016/j.bbrc.2008.06.046; Tzeng TF, 2013, PHYTOMEDICINE, V20, P481, DOI 10.1016/j.phymed.2012.12.006; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; ASSIMACOPOULOSJEANNET F, 1991, AM J PHYSIOL, V260, pR278; Cho SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033815; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506; Jeukendrup JE, 1998, INT J SPORTS MED, V19, P231; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	OCT	2015	26	10					1058	1067		10.1016/j.jnutbio.2015.04.014		10	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CS9CZ	WOS:000362388000009		
J	Miyamoto, T; Minase, G; Okabe, K; Ueda, H; Sengoku, K				Miyamoto, Toshinobu; Minase, Gaku; Okabe, Kimika; Ueda, Hiroto; Sengoku, Kazuo			Male infertility and its genetic causes	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Review						AURKC; azoospermia factor; KLHL10; male infertility; SPATA16; SYCP3	ROUND-HEADED SPERMATOZOA; CHROMOSOME LONG ARM; AURORA-C KINASE; Y-CHROMOSOME; HOMOZYGOUS MUTATION; MICE LACKING; HUMAN SPERMATOGENESIS; ACROSOME FORMATION; PROTEIN-KINASE; GLOBOZOOSPERMIA	AimInfertility is a serious social problem in advanced nations, with male factor infertility accounting for approximately half of all cases of infertility. Here, we aim to discuss our laboratory results in the context of recent literature on critical genes residing on the Y chromosome or autosomes that play important roles in human spermatogenesis. MethodsThe PubMed database was systematically searched using the following keywords: genetics of male factor infertility'; male infertility genes', genetics of spermatogenesis' to retrieve information for this review. ResultsStriking progress has recently been made in the elucidation of mechanisms of spermatogenesis using knockout mouse models. This information has, in many cases, not been directly translatable to humans. Nevertheless, mutations in several critical genes have been shown to cause male infertility. We discuss here the contribution to male factor infertility of a number of genes identified in the azoospermia factor (AZF) region on the Y chromosome, as well as the autosomally located genes: SYKP3, KLHL10, AURKC and SPATA16. ConclusionsNon-obstructive azoospermia is the most severe form of azoospermia. However, the presence of spermatozoa can only be confirmed through procedures, which may prove to be unnecessary. Elucidation of the genes underlying male factor infertility, and thereby a better understanding of the mechanisms that cause it, will result in more tailored, evidence-based decisions in treatment of patients.	[Miyamoto, Toshinobu; Minase, Gaku; Okabe, Kimika; Ueda, Hiroto; Sengoku, Kazuo] Asahikawa Med Univ, Dept Obstet & Gynecol, Asahikawa, Hokkaido 0788510, Japan	Miyamoto, T (reprint author), Asahikawa Med Univ, Dept Obstet & Gynecol, Higashi Ku, 2-1-1-1 Midorigaoka, Asahikawa, Hokkaido 0788510, Japan.	toshim@asahikawa-med.ac.jp			Japan Society for the Promotion of Science [25462547, 26462469, 24249019]; Ministry of Health, Labour and Welfare of Japan [11105137]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [12024421]; Suhara Memorial Foundation	Our research was supported by Grants-in-Aid for Scientific Research (25462547, 26462469 and 24249019) from the Japan Society for the Promotion of Science, grants from the Ministry of Health, Labour and Welfare of Japan, the Strategic Research Program for Brain Sciences (11105137), a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (12024421) and a Grant-in-Aid for Scientific Research from the Suhara Memorial Foundation.	Elliott DJ, 1997, P NATL ACAD SCI USA, V94, P3848, DOI 10.1073/pnas.94.8.3848; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; Karaca N, 2014, FERTIL STERIL, V102, P103, DOI 10.1016/j.fertnstert.2014.04.002; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Yatsenko AN, 2006, HUM MOL GENET, V15, P3411, DOI 10.1093/hmg/ddl417; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137; Sun C, 1999, NAT GENET, V23, P429; ESCALIER D, 1983, BIOL CELL, V48, P65; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Hvidman HW, 2015, HUM REPROD, V30, P9, DOI 10.1093/humrep/deu305; Bernard M, 1998, GENOMICS, V53, P406, DOI 10.1006/geno.1998.5522; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Ben Khelifa M, 2012, HUM REPROD, V27, P3337, DOI 10.1093/humrep/des296; VOGT P, 1992, HUM GENET, V89, P491; Xu X, 1999, NAT GENET, V23, P118; Ben Khelifa M, 2011, MOL HUM REPROD, V17, P762, DOI 10.1093/molehr/gar050; Simoni M, 2008, REPROD BIOMED ONLINE, V16, P289; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091; Tang CJC, 2001, J BIOL CHEM, V276, P19631, DOI 10.1074/jbc.M100170200; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; DALE B, 1994, FERTIL STERIL, V61, P336; Bolor H, 2009, AM J HUM GENET, V84, P14, DOI 10.1016/j.ajhg.2008.12.002; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Escalier D, 2002, MOL HUM REPROD, V8, P1, DOI 10.1093/molehr/8.1.1; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; DOBSON MJ, 1994, J CELL SCI, V107, P2749; Kilani Z, 2004, FERTIL STERIL, V82, P1436, DOI 10.1016/j.fernstart.2004.03.064; FLORKEGERLOFF S, 1984, ANDROLOGIA, V16, P187; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; NISTAL M, 1977, VIRCHOWS ARCH B, V26, P111; Baird DT, 2010, HUM REPROD UPDATE, V16, P590, DOI 10.1093/humupd/dmq023	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1501	1505		10.1111/jog.12765		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500001		
J	Yamada, T; Cho, K; Morikawa, M; Yamada, T; Minakami, H				Yamada, Takahiro; Cho, Kazutoshi; Morikawa, Mamoru; Yamada, Takashi; Minakami, Hisanori			Intrapartum risk factors for neonatal encephalopathy leading to cerebral palsy in women without apparent sentinel events	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						fetal heart rate tracing; instrumental delivery; macrosomia; non-reassuring fetal status; shoulder dystocia; vacuum delivery	NEWBORN ENCEPHALOPATHY; ABRUPTIO PLACENTAE; SUBGALEAL HEMATOMA; HEMORRHAGE; DELIVERY; INFANTS; BIRTH; CARE	AimTo determine intrapartum factors associated with neonatal encephalopathy leading to cerebral palsy (NE-CP). MethodsA total of 70 NE-CP patients who fulfilled study criteria (cephalic singleton pregnancy with attempted vaginal delivery [AVD] at gestational week [GW] 36; intrapartum occurrence of non-reassuring fetal status without apparent cause following reassuring fetal status on admission; and development of NE-CP) were compared with 210 AVD controls who had 1- and 5-min Apgar score 8 matched for GW, maternal parity, and use of uterotonics. Suboptimal care was defined as delayed reaction due to misinterpretation of fetal heart rate (FHR) tracing, or inappropriate trial of instrumental delivery (TOID). Successful and failed TOID were defined as vaginal and cesarean delivery after TOID, respectively. The 210 controls were assumed not to have had suboptimal care. ResultsThe rates of successful (34% vs 12%) and failed TOID (11% vs 0.0%), cesarean section (34% vs 14%), suboptimal care (57% vs 0.0%), pregnancy-induced hypertension (11% vs 2.4%), birthweight 3800 g (8.6% vs 1.9%), subgaleal hemorrhage (16% vs 0.0%) were significantly higher in NE-CP patients than in controls. Selection with the stepwise method and logistic regression analysis identified four independent risk factors for NE-CP: suboptimal intrapartum care (OR, 2.21; 95%CI: 1.99-2.47), cesarean section (OR, 1.19; 95%CI: 1.08-1.31), successful TOID (OR, 1.14; 95%CI: 1.03-1.25), and hypertension (OR, 1.20; 95%CI: 1.01-1.42). ConclusionsTraining programs for improved interpretation of FHR tracing and appropriate TOID are required to prevent NE-CP among healthy and mature fetuses in Japan.	[Yamada, Takahiro; Cho, Kazutoshi; Morikawa, Mamoru; Minakami, Hisanori] Hokkaido Univ Hosp, Dept Perinatal Med, Sapporo, Hokkaido 060, Japan; [Yamada, Takashi] Japan Community Hlth Care Org Hokkaido Hosp, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan	Yamada, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Obstet, Kita Ku N15 W7, Sapporo, Hokkaido 0608638, Japan.	taka0197@med.hokudai.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [2646246804]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (No. 2646246804).	Yamada T, 2012, EARLY HUM DEV, V88, P861, DOI 10.1016/j.earlhumdev.2012.06.008; Chadwick LM, 1996, J PAEDIATR CHILD H, V32, P228, DOI 10.1111/j.1440-1754.1996.tb01559.x; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Mann JR, 2011, PAEDIATR PERINAT EP, V25, P100, DOI 10.1111/j.1365-3016.2010.01157.x; Badawi N, 1998, BRIT MED J, V317, P1549; Draper ES, 2002, ARCH DIS CHILD, V87, P176; Kadooka M, 2014, EARLY HUM DEV, V90, P431, DOI 10.1016/j.earlhumdev.2014.05.010; Chang HY, 2007, PEDIATR INT, V49, P903, DOI 10.1111/j.1442-200X.2007.02482.x; West CR, 2005, AUST NZ J OBSTET GYN, V45, P207, DOI 10.1111/j.1479-828X.2005.00390.x; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; Badawi N, 1998, BRIT MED J, V317, P1554; GAFFNEY G, 1994, BRIT MED J, V308, P743; BENJAMIN B, 1993, J TRAUMA, V35, P737, DOI 10.1097/00005373-199311000-00015; Jonsson M, 2014, ACTA OBSTET GYN SCAN, V93, P477, DOI 10.1111/aogs.12381; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Morikawa M, 2014, ARCH GYNECOL OBSTET, V289, P987, DOI 10.1007/s00404-013-3101-8; Elvander C, 2013, ACTA OBSTET GYN SCAN, V92, P1175, DOI 10.1111/aogs.12215; Badawi N, 2005, DEV MED CHILD NEUROL, V47, P293, DOI 10.1017/S0012162205000575; Clark SL, 2007, AM J OBSTET GYNECOL, V196; Gilbert WM, 2010, AM J OBSTET GYNECOL, V203, DOI DOI 10.1093/BIOSTATISTICS/KXQ046; [Japan Association of Obstetricians and Gynecologists (JAOG) Japan Society of Obstetrics and Gynecology (JSOG)], 2014, GUID OBST PRACT JAP; PLAUCHE WC, 1980, JAMA-J AM MED ASSOC, V244, P1597, DOI 10.1001/jama.244.14.1597; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; Uchil Dhiraj, 2003, Obstet Gynecol Surv, V58, P687, DOI 10.1097/01.OGX.0000086420.13848.89	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1520	1525		10.1111/jog.12772		6	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500004		
J	Miura, K; Higashijima, A; Murakami, Y; Tsukamoto, O; Hasegawa, Y; Abe, S; Fuchi, N; Miura, S; Kaneuchi, M; Masuzaki, H				Miura, Kiyonori; Higashijima, Ai; Murakami, Yuko; Tsukamoto, Ozora; Hasegawa, Yuri; Abe, Shuhei; Fuchi, Naoki; Miura, Shoko; Kaneuchi, Masanori; Masuzaki, Hideaki			Circulating chromosome 19 miRNA cluster microRNAs in pregnant women with severe pre-eclampsia	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						C19MC; maternal plasma; onset; placenta; pre-eclampsia	PLACENTA-SPECIFIC MICRORNAS; MATERNAL PLASMA; MESSENGER-RNA; CELL-FREE; GROWTH RESTRICTION; EXPRESSION; IDENTIFICATION; FETAL; LABOR; QUANTIFICATION	AimTo clarify the association between circulating chromosome 19 miRNA cluster (C19MC) microRNAs in maternal plasma and severe pre-eclampsia. MethodMaternal blood samples (7mL) at 27-34 weeks of gestation were obtained from 20 pregnant women with severe pre-eclampsia (sPE group) and from 20 uncomplicated pregnant women (NP group). Twenty cases of severe pre-eclampsia were classified into late onset (sPELO group; n = 14) and early onset (sPEEO group; n = 6). Plasma concentration of C19MC microRNAs (miR-518b, -1323, -516b, -516a-5p, -525-5p, -515-5p, -520h, -520a-5p, -519d and -526b) was measured on quantitative real-time reverse transcription-polymerase chain reaction. ResultsThe circulating levels of all 10 C19MC microRNAs in maternal plasma were significantly increased in the sPE group compared with the NP group. Plasma concentration of all 10 C19MC microRNAs tested was significantly increased in the sPEEO group compared with the NP group, while plasma concentration of nine miRNAs, except for miR-519d, was significantly increased in the sPELO group compared with the NP group. Of the 10 C19MC microRNAs measured, plasma concentration of eight miRNAs, except for miR-518b and miR-519d, was significantly increased in the sPEEO group compared with the sPELO group. ConclusionsIncreased levels of C19MC microRNAs in maternal plasma are a characteristic phenomenon of established severe pre-eclampsia, and it has been shown for the first time that the upregulation of C19MC miRNAs occurred as a consequence of, not in advance of, the onset of pre-eclampsia.	[Miura, Kiyonori; Higashijima, Ai; Murakami, Yuko; Tsukamoto, Ozora; Hasegawa, Yuri; Abe, Shuhei; Fuchi, Naoki; Miura, Shoko; Kaneuchi, Masanori; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 8528501, Japan	Miura, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	kiyonori@nagasaki-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [26462495, 24791712, 25462563]; JSPS KAKENHI [26462495, 24791712, 25462563]	The authors would like to thank Drs Atsushi Yoshida and Koh-ichiro Yoshiura for their assistance with the manuscript. We also would like to thank Ayako Ueyama, Shizuka Yoshii, Hiroko Sakakida and Yasuko Noguchi for their technical assistance in sample preparations. This work was supported by the Japan Society for the Promotion of Science KAKENHI grant numbers 26462495, 24791712, and 25462563. K.M., S.M., and H.M. were supported by JSPS KAKENHI, grant numbers 26462495, 24791712, and 25462563, respectively.	Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Prieto DMM, 2011, J REPROD IMMUNOL, V88, P106, DOI 10.1016/j.jri.2011.01.004; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Mendell JT, 2005, CELL CYCLE, V4, P1179; Hromadnikova I, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/186041; Zhao Z, 2013, CLIN BIOCHEM, V46, P953, DOI 10.1016/j.clinbiochem.2013.01.026; Ng EKO, 2002, CLIN CHEM, V48, P1212; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Yang Q, 2011, CLIN CHIM ACTA, V412, P2167, DOI 10.1016/j.cca.2011.07.029; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Kurashina R, 2014, J OBSTET GYNAECOL RE, V40, P650, DOI 10.1111/jog.12217; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Noack F, 2011, J PERINAT MED, V39, P267, DOI 10.1515/JPM.2011.012; Enquobahrie DA, 2011, AM J OBSTET GYNECOL, V204; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Miura K, 2014, PLACENTA, V35, P848, DOI 10.1016/j.placenta.2014.06.002; Morisaki S, 2015, PRENATAL DIAG, V35, P44, DOI 10.1002/pd.4479; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; Pineles BL, 2007, AM J OBSTET GYNECOL, V196; Takahashi H, 2014, MED J OBSTET GYNECOL, V2, P1032; Zhu XM, 2009, AM J OBSTET GYNECOL, V200	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1526	1532		10.1111/jog.12749		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500005		
J	Ishikawa, S; Morikawa, M; Yamada, T; Akaishi, R; Kaneuchi, M; Minakami, H				Ishikawa, Satoshi; Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Kaneuchi, Masanori; Minakami, Hisanori			Prospective risk of stillbirth in women with placental mesenchymal dysplasia	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						antenatal diagnosis; molar pregnancy; perinatal mortality; placenta; prophylactic treatment	BECKWITH-WIEDEMANN-SYNDROME; STEM VILLOUS HYPERPLASIA; OF-THE-LITERATURE; MOLAR PREGNANCY; ANDROGENETIC/BIPARENTAL MOSAICISM; CLINICOPATHOLOGICAL ENTITY; DIFFERENTIAL-DIAGNOSIS; VASCULAR MALFORMATION; GROWTH RESTRICTION; TWIN PREGNANCY	AimThe aim of this study was to provide better counsel to pregnant women with suspected placental mesenchymal dysplasia (PMD) regarding the risks of preterm birth and intrauterine fetal death. Material and MethodsWe reviewed the outcomes of 109 PMD pregnancies with gestational week (GW)24 abstracted from 63 reports in the English-language published reports, including two cases that we encountered recently. The prospective risk of stillbirth at GW N was defined as the number of women with stillbirth at GWN divided by the number of women giving birth at GWN. ResultsA total of 32 (29.4%) women experienced stillbirth at a median GW of 31 (range, 24-38). Preterm birth (GW <37) occurred in 52 (67.5%) of the 77 live-born infants. Only 25 (22.9%) women had full-term (GW37) live-born infants. The prospective risks of stillbirth were 29.4% (32/109), 27.5% (25/91), 20.9% (14/67) and 13.0% (6/46) for women who reached GW 24(+0), 28(+0), 32(+0) and 36(+0) respectively. ConclusionAs women with PMD are at markedly elevated risk of intrauterine fetal death, early admission to the hospital and intensive monitoring of fetal status should be considered, although whether this policy improves outcome has not been validated.	[Ishikawa, Satoshi; Morikawa, Mamoru; Yamada, Takahiro; Akaishi, Rina; Minakami, Hisanori] Hokkaido Univ, Grad Sch Med, Dept Obstet, Sapporo, Hokkaido 0608638, Japan; [Kaneuchi, Masanori] Nagasaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagasaki 852, Japan	Yamada, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Obstet, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	taka0197@med.hokudai.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [2646246804]	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (No. 2646246804).	Akbarzadeh-Jahromi M, 2013, ARCH IRAN MED, V16, P551, DOI 013169/AIM.0013; Chen CP, 1997, HUM REPROD, V12, P2553, DOI 10.1093/humrep/12.11.2553; Ruhland B, 2011, ULTRASOUND OBST GYN, V38, P360, DOI 10.1002/uog.9005; Cohen MC, 2005, PRENATAL DIAG, V25, P187, DOI 10.1002/pd.1103; Starikov R, 2011, OBSTET GYNECOL, V118, P445, DOI 10.1097/AOG.0b013e3182161828; Miliaras D, 2007, BIRTH DEFECTS RES A, V79, P236, DOI 10.1002/bdra.20332; MOSCOSO G, 1991, PATHOL RES PRACT, V187, P324; Zeng X, 2012, ACTA OBSTET GYN SCAN, V91, P754, DOI 10.1111/j.1600-0412.2012.01397.x; Kuwabara Y, 2001, OBSTET GYNECOL, V98, P940, DOI 10.1016/S0029-7844(01)01512-5; Ulker V, 2013, J OBSTET GYNAECOL, V33, P246, DOI 10.3109/01443615.2012.745491; Arigita M, 2010, ULTRASOUND OBST GYN, V36, P644, DOI 10.1002/uog.7666; Kitano Y, 2000, FETAL DIAGN THER, V15, P134, DOI 10.1159/000020992; HOJBERG KE, 1994, PATHOL RES PRACT, V190, P808; Auger N, 2013, CAN MED ASSOC J, V185, pE256, DOI 10.1503/cmaj.120945; Francis B, 2007, PEDIATR DEVEL PATHOL, V10, P50, DOI 10.2350/06-03-0066.1; TAKAYAMA M, 1986, GYNECOL OBSTET INVES, V22, P165; Surti U, 2005, PRENATAL DIAG, V25, P1048, DOI 10.1002/pd.1255; Alwaidh MH, 1997, PEDIATR RADIOL, V27, P247, DOI 10.1007/s002470050113; Jauniaux E, 1997, PLACENTA, V18, P701, DOI 10.1016/S0143-4004(97)90012-6; LEE GK, 1991, AM J CLIN PATHOL, V95, P48; Gizzo S, 2012, ARCH GYNECOL OBSTET, V286, P15, DOI 10.1007/s00404-012-2232-7; Nayeri UA, 2013, ULTRASOUND OBST GYN, V41, P366, DOI 10.1002/uog.12359; Ohira S, 2013, GYNECOL OBSTET INVES, V75, P217, DOI 10.1159/000350661; Gibson BR, 2004, PLACENTA, V25, P671, DOI 10.1016/j.placenta.2003.12.008; Reinhart RD, 1999, ULTRASOUND OBST GYN, V13, P147, DOI 10.1046/j.1469-0705.1999.13020147.x; Papoutsis D, 2011, J MATERN-FETAL NEO M, V24, P1289, DOI 10.3109/14767058.2011.561892; Paradinas FJ, 2001, HISTOPATHOLOGY, V39, P447, DOI 10.1046/j.1365-2559.2001.01256.x; Matsui H, 2003, PATHOL INT, V53, P810, DOI 10.1046/j.1440-1827.2003.01550.x; Ang DC, 2009, ARCH GYNECOL OBSTET, V279, P937, DOI 10.1007/s00404-008-0812-3; Mulch AD, 2006, PRENATAL DIAG, V26, P659, DOI 10.1002/pd.1436; Vaisbuch E, 2009, J ULTRAS MED, V28, P359; Reed RC, 2008, PEDIATR DEVEL PATHOL, V11, P377, DOI 10.2350/07-12-0401.1; Ohyama M, 2000, PATHOL INT, V50, P759, DOI 10.1046/j.1440-1827.2000.01100.x; Laberge JM, 2005, FETAL DIAGN THER, V20, P141, DOI 10.1159/000082439; Furuhashi M, 2000, ARCH GYNECOL OBSTET, V264, P101, DOI 10.1007/s004040000079; Aviram R, 2008, PLACENTA, V29, P646, DOI 10.1016/j.placenta.2008.04.004; Harris K, 2013, FETAL PEDIATR PATHOL, V32, P448, DOI 10.3109/15513815.2013.835893; Kaiser-Rogers KA, 2006, J MED GENET, V43, P187, DOI 10.1136/jmg.2005.033571; Kuwata T, 2014, ULTRASOUND OBST GYN, V43, P355, DOI 10.1002/uog.13230; Takahashi H, 2014, J OBSTET GYNAECOL RE, V40, P1145, DOI 10.1111/jog.12291; SANDER CM, 1993, PEDIATR PATHOL, V13, P621; Robinson WP, 2007, HUM REPROD, V22, P1114, DOI 10.1093/humrep/del462; Robertson M, 2007, J ULTRAS MED, V26, P689; Koga H, 2014, J PEDIAT HEMATOL ONC, V36, pE389, DOI 10.1097/MPH.0b013e31829d4542; Sheeja S, 2013, INDIAN J PATHOL MICR, V56, P57, DOI 10.4103/0377-4929.116153; Robinson WP, 2007, AM J MED GENET A, V143A, P1752, DOI 10.1002/ajmg.a.31800; MINAKAMI H, 1993, LANCET, V341, P1603, DOI 10.1016/0140-6736(93)90746-4; Ventura F, 2013, FORENSIC SCI INT, V229, pE35, DOI 10.1016/j.forsciint.2013.04.002; Kinoshita T, 2007, J OBSTET GYNAECOL RE, V33, P83, DOI 10.1111/j.1447-0756.2007.00480.x; Chan YF, 2003, AUST NZ J OBSTET GYN, V43, P475, DOI 10.1046/j.0004-8666.2003.00130.x; Tortoledo M, 2010, FETAL PEDIATR PATHOL, V29, P261, DOI 10.3109/15513811003782474; Kotani T, 2012, PLACENTA, V33, P888, DOI 10.1016/j.placenta.2012.07.015; Heazell AEP, 2009, PLACENTA, V30, P654, DOI 10.1016/j.placenta.2009.04.004; Lisonkova S, 2012, BJOG-INT J OBSTET GY, V119, P1630, DOI 10.1111/j.1471-0528.2012.03403.x; Jalil SSA, 2009, PRENATAL DIAG, V29, P713, DOI 10.1002/pd.2265; MCCOWAN LME, 1994, OBSTET GYNECOL, V83, P813; Pham T, 2006, AM J CLIN PATHOL, V126, P67, DOI 10.1309/RV45HRD53YQ2YFTP; Arizawa Masayoshi, 2002, Congenital Anomalies, V42, P309, DOI 10.1111/j.1741-4520.2002.tb00897.x; Carta M, 2005, J PEDIATR SURG, V40, DOI 10.1016/j.jpedsurg.2005.02.018; Lokan J, 2002, PATHOLOGY, V34, P75; Morales C, 2009, FERTIL STERIL, V92; Mothers & Childrens Health & Welfare Association, 2007, MAT CHILD HLTH STAT; Qichang W, 2013, CASE REP OBSTET GYNE; Rohilla M, 2012, BMJ CASE REP, DOI [10.1136/bcr-2012-007777, DOI 10.1136/BCR-2012-007777.]; Sudano Maria Chiara, 2013, J Prenat Med, V7, P9; Taga S, 2013, CASE REP OBSTET GYNE; Umazume T, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-38; Umazume T, 2014, THROMB RES, V133, P158, DOI 10.1016/j.thromres.2013.11.004; Woo GW, 2011, AM J OBSTET GYNECOL, V205, pE3, DOI 10.1016/j.ajog.2011.08.019	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1562	1568		10.1111/jog.12757		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500010		
J	Takeda, T; Kondo, A; Koga, S; Hayakawa, J; Hayakawa, K; Hiramatsu, K; Yaegashi, N				Takeda, Takashi; Kondo, Akiko; Koga, Shoko; Hayakawa, Jun; Hayakawa, Kenichi; Hiramatsu, Keizo; Yaegashi, Nobuo			Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open-label pilot study	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						combined oral contraceptive pill; drospirenone; premenstrual dysphoric disorder; premenstrual syndrome	DYSPHORIC DISORDER; DROSPIRENONE; WOMEN	AimA combined oral contraceptive containing ethinylestradiol 20 mu g plus drospirenone 3mg (EE20+DRSP) in a 24/4 regimen has been shown to alleviate the symptoms of premenstrual syndrome and premenstrual dysphoric disorder. This study was conducted to evaluate the efficacy of EE20+DRSP in Japanese patients with premenstrual symptoms. Material and MethodsA multicenter, prospective, open-label, single-arm, phase IV study was performed in Japanese women with dysmenorrhea and premenstrual symptoms. They were treated with EE20+DRSP to alleviate the symptoms of dysmenorrhea for six treatment cycles. Premenstrual symptoms were evaluated using a Premenstrual Symptoms Questionnaire at baseline and after three and six cycles of EE20+DRSP. The degree of dysmenorrhea was also evaluated using a visual analog scale at baseline and after one, three, and six cycles of EE20+DRSP. ResultsForty-eight patients were treated with EE20+DRSP. Most of the premenstrual symptoms were alleviated significantly by three and six cycles of EE20+DRSP treatment. EE20+DRSP treatment significantly improved the severity of premenstrual symptoms. We also confirmed the effectiveness of EE20+DRSP for the treatment for dysmenorrhea. ConclusionThis study showed that EE20+DRSP could be a useful treatment strategy for premenstrual symptoms in Japanese women.	[Takeda, Takashi] Kinki Univ, Sch Med, Res Inst Tradit Asian Med, Div Womens Hlth, Osaka, Osaka 5898511, Japan; [Hayakawa, Jun; Hayakawa, Kenichi] Hayawaka Clin, Osaka, Japan; [Hiramatsu, Keizo] Hiramatsu Womens Clin, Osaka, Japan; [Takeda, Takashi; Kondo, Akiko; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 980, Japan; [Koga, Shoko] Ladys Clin Koga, Sendai, Miyagi, Japan	Takeda, T (reprint author), Kinki Univ, Sch Med, Res Inst Tradit Asian Med, Div Womens Hlth, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.	take@med.kindai.ac.jp			Bayer Yakuhin, Ltd., Osaka, Japan	The study and article processing charges were funded in part by Bayer Yakuhin, Ltd., Osaka, Japan.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Pearlstein TB, 2005, CONTRACEPTION, V72, P414, DOI 10.1016/j.contraception.2005.08.021; Fruzzetti F, 2007, CONTRACEPTION, V76, P190, DOI 10.1016/j.contraception.2007.05.080; Takeda T, 2006, ARCH WOMEN MENT HLTH, V9, P209, DOI 10.1007/s00737-006-0137-9; Yonkers KA, 2005, OBSTET GYNECOL, V106, P492, DOI 10.1097/01.AOG.0000175834.77215.2e; JOHNSON TM, 1987, CULT MED PSYCHIAT, V11, P337, DOI 10.1007/BF00048518; Yonkers KA, 2008, LANCET, V371, P1200, DOI 10.1016/S0140-6736(08)60527-9; Kitamura M, 2012, ARCH WOMEN MENT HLTH, V15, P131, DOI 10.1007/s00737-012-0266-2; Angst J, 2001, ACTA PSYCHIAT SCAND, V104, P110, DOI 10.1034/j.1600-0447.2001.00412.x; Apter D, 2003, EUR J CONTRACEP REPR, V8, P37, DOI 10.1080/713604397; Foidart JM, 2005, CLIMACTERIC, V8, P28, DOI 10.1080/13697130500330309; Sulak PJ, 2000, OBSTET GYNECOL, V95, P261, DOI 10.1016/S0029-7844(99)00524-4; Marr J, 2011, INT J GYNECOL OBSTET, V113, P103, DOI 10.1016/j.ijgo.2010.10.029; Grady-Weliky TA, 2003, NEW ENGL J MED, V348, P433, DOI 10.1056/NEJMcp012067; Mansour D, 2002, EUR J CONTRACEP REPR, V7, P35; Chang A M, 1995, Health Care Women Int, V16, P551; Fu Yi, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P506; Steiner M, 2003, Arch Womens Ment Health, V6, P203, DOI 10.1007/s00737-003-0018-4	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1584	1590		10.1111/jog.12774		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500013		
J	Kiba, A; Banno, K; Yanokura, M; Asada, M; Nakayama, Y; Aoki, D; Watanabe, T				Kiba, Atsushi; Banno, Kouji; Yanokura, Megumi; Asada, Mari; Nakayama, Yusuke; Aoki, Daisuke; Watanabe, Tatsuya			Differential mRNA expression profiling in ovarian endometriotic tissue with versus without leuprolide acetate treatment	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						endometriosis; geneChip; leuprolide acetate	GNRH AGONIST THERAPY; GENE-EXPRESSION; ESTROGEN; APOPTOSIS; RECEPTOR; DATABASE	AimLeuprolide acetate, an analog of gonadotropin-releasing hormone (GnRH), regresses endometriotic tissue and reduces pain, resulting in clinical improvement upon treatment. The molecular mechanisms involved in the regression of endometriotic tissue, however, remain to be elucidated. In this study, we performed genome-wide gene expression profiling of clinical specimens of ovarian endometrioma to obtain insight into the effects of leuprolide acetate treatment. MethodsWe obtained clinical samples from nine normal eutopic endometrium tissues, eight ovarian endometriotic tissues, and 12 leuprolide acetate-treated endometriotic tissues. We compared the gene expression profiles of the three groups using Affymetrix GeneChip Human genome arrays and bioinformatic analysis, including molecular concept analysis. ResultsLeuprolide acetate-treated endometriotic tissue showed downregulated genes associated with the biological functions of steroid hormone regulation, cell proliferation, inflammation, and intracellular signaling. These genes included PTGDS, GRP, APLP2, PLTP, and FGFRL1. In contrast, genes upregulated by leuprolide acetate treatment were associated with cell growth inhibition and apoptosis. These genes included CARD11 and USP18. ConclusionsThese preliminary results based on GeneChip analysis suggest that leuprolide acetate treatment induces a modulation of gene expression that allows for cooperative alterations in disease state. This study gives new insight into the effects of leuprolide acetate treatment. Further investigations with quantitative reverse transcription-polymerase chain reaction and immunohistochemistry are needed to validate this study and to explore new therapeutic targets and biomarkers of endometriosis.	[Kiba, Atsushi; Asada, Mari; Nakayama, Yusuke; Watanabe, Tatsuya] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan; [Banno, Kouji; Yanokura, Megumi; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan	Kiba, A (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	atsushi.kiba@takeda.com			Covidien Company; Japan Vaccine Co., Ltd.; MOCHIDA PHARMACEUTICAL CO., LTD.; Kissei Pharmaceutical Co., Ltd.; Fuji Pharma Co., Ltd.; NIPPON SHINYAKU CO., LTD.; AstraZeneca; Sanofi-Aventis	A.K., M.A., Y.N., and T.W are employees of Takeda Pharmaceutical Company Limited. K.B., an Associate Professor of Keio University, has received: an Advisory fee from Covidien Company and Japan Vaccine Co., Ltd.; a Lecture and Manuscript fee from MOCHIDA PHARMACEUTICAL CO., LTD., Kissei Pharmaceutical Co., Ltd., Fuji Pharma Co., Ltd., and NIPPON SHINYAKU CO., LTD.; a grant for medical research from MOCHIDA PHARMACEUTICAL CO., LTD. and Kissei Pharmaceutical Co., Ltd.; and a grant for research other than this study from Takeda Pharmaceutical Company Limited. D.A., a Professor of Keio University, has received an Advisory fee from AstraZeneca and Kissei Pharmaceutical Co., Ltd.; a Lecture and Manuscript fee from Sanofi-Aventis; and a grant for medical research from Sanofi-Aventis. M.Y. has no conflicts of interest to disclose.	Hu WP, 2006, J CLIN ENDOCR METAB, V91, P228, DOI 10.1210/jc.2004-1594; Kudo K, 2011, LUNG CANCER, V74, P401, DOI 10.1016/j.lungcan.2011.03.019; Cornelio DB, 2007, ANN ONCOL, V18, P1457, DOI 10.1093/annonc/mdm058; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Hull ML, 2008, AM J PATHOL, V173, P700, DOI 10.2353/ajpath.2008.071128; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Meola Juliana, 2010, Fertil Steril, V93, P1750, DOI 10.1016/j.fertnstert.2008.12.058; Forde N, 2009, BIOL REPROD, V81, P784, DOI 10.1095/biolreprod.108.074336; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Mailman MD, 2007, NAT GENET, V39, P1181; Heinrich E, 2011, PROSTATE, V71, P642, DOI 10.1002/pros.21280; Taniguchi F, 2013, GYNECOL OBSTET INVES, V75, P9, DOI 10.1159/000343748; Whitley JC, 2000, J ENDOCRINOL, V166, P649, DOI 10.1677/joe.0.1660649; Roberts M, 2005, MOL HUM REPROD, V11, P751, DOI 10.1093/molehr/gah233; Khan KN, 2010, HUM REPROD, V25, P642, DOI 10.1093/humrep/dep437; Imamura T, 2014, EUR J OBSTET GYN R B, V180, P16, DOI 10.1016/j.ejogrb.2014.06.002; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426; Vouk K, 2011, J STEROID BIOCHEM, V125, P231, DOI 10.1016/j.jsbmb.2011.03.010; Gomes MKO, 2009, HUM REPROD, V24, P2736, DOI 10.1093/humrep/dep288; Van Vaerenbergh I, 2011, REPROD BIOMED ONLINE, V22, P263, DOI 10.1016/j.rbmo.2010.11.002; Eyster KM, 2007, FERTIL STERIL, V88, P1505, DOI 10.1016/j.fertnstert.2007.01.056; Kulak J, 2011, ENDOCRINOLOGY, V152, P3226, DOI 10.1210/en.2010-1010; Cornelio Daniela B, 2007, Recent Pat Antiinfect Drug Discov, V2, P178, DOI 10.2174/157489107782497344; Dorniak P, 2012, BIOL REPROD, V87, P1, DOI [10.1095/biolreprod.112. 101691, DOI 10.1095/BIOLREPROD.112]; Honda H, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-59; Iakovidis Isidoros, 2011, MOL BIOL INT, V2011, P1, DOI DOI 10.4061/2011/594529; Minten MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069444; Weng HN, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0306-y	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1598	1606		10.1111/jog.12768		9	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500015		
J	Matsuura, M; Satohisa, S; Teramoto, M; Tanaka, R; Iwasaki, M; Nishikawa, A; Mizunuma, M; Tanaka, S; Hayakawa, O; Saito, T				Matsuura, Motoki; Satohisa, Seiro; Teramoto, Mizue; Tanaka, Ryoichi; Iwasaki, Masahiro; Nishikawa, Akira; Mizunuma, Masahiro; Tanaka, Satoshi; Hayakawa, Osamu; Saito, Tsuyoshi			Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						carboplatin; dexamethasone; gynecologic cancers; paclitaxel; palonosetron	MODERATELY EMETOGENIC CHEMOTHERAPY; CISPLATIN-INDUCED EMESIS; DOUBLE-BLIND; ONDANSETRON; DOLASETRON; EFFICACY; MODEL	AimChemotherapy-induced nausea and vomiting (CINV) can affect a patient's quality of life, leading to poor compliance with further treatments. Previous studies have provided minimal data about carboplatin-based regimens. Female sex is a known risk factor for CINV. The purpose of this study was to evaluate palonosetron plus single-dose dexamethasone (DEX) for preventing CINV caused by carboplatin plus paclitaxel combination therapy (TC regimen) in patients with gynecologic cancers. Material and MethodsPatients were recruited for this phase-II, multicenter, randomized trial from 12 hospitals in Hokkaido, Japan. Eligible patients were women with uterine cervical, endometrial or ovarian cancer scheduled to receive conventional TC regimen or dose-dense TC regimen; 116 patients were randomly assigned to receive palonosetron in combination with 1-day DEX or 3-day DEX. ResultsDuring the overall period, complete response (CR) was observed in 67.9% (95% confidence interval, 53.7-80.1) of patients in the 3-day DEX arm, and 60.7% (95% confidence interval, 46.8-73.5) of patients in the 1-day DEX arm; CR was significantly lower in the 1-day DEX arm if motion sickness was already present (P=0.0370). In the severe hyperemesis gravidarum cohort, CR in the 1-day DEX arm tended to be lower than in the 3-day DEX arm. ConclusionCombination therapy of palonosetron and 1-day DEX was effective for subjects undergoing a TC regimen for gynecologic cancers. However, the possibility of reduced efficacy of 1-day only DEX therapy in women undergoing a TC regimen could not be refuted and requires further investigation.	[Matsuura, Motoki; Satohisa, Seiro; Teramoto, Mizue; Tanaka, Ryoichi; Iwasaki, Masahiro; Saito, Tsuyoshi] Sapporo Med Univ, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608543, Japan; [Nishikawa, Akira] NTT Sapporo Hosp, Dept Gynecol & Obstet, Sapporo, Hokkaido, Japan; [Matsuura, Motoki] Nikko Mem Hosp, Dept Gynecol & Obstet, Muroran, Hokkaido, Japan; [Mizunuma, Masahiro] Kitami Red Cross Hosp, Dept Gynecol & Obstet, Kitami, Hokkaido, Japan; [Tanaka, Satoshi] Hakodate Goryokaku Hosp, Dept Gynecol & Obstet, Hakodate, Hokkaido, Japan; [Hayakawa, Osamu] Esashi Hosp, Dept Gynecol & Obstet, Esashi, Japan	Matsuura, M (reprint author), Sapporo Med Univ, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608543, Japan.	mmatsuura@sapmed.ac.jp					Hesketh P, 1996, J CLIN ONCOL, V14, P2242; RICHARDSON JL, 1988, J CLIN ONCOL, V6, P1746; Hesketh PJ, 2012, SUPPORT CARE CANCER, V20, P1471, DOI 10.1007/s00520-011-1235-4; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; Saito M, 2009, LANCET ONCOL, V10, P115, DOI 10.1016/S1470-2045(08)70313-9; Aapro M, 2010, ANN ONCOL, V21, P1083, DOI 10.1093/annonc/mdp584; Siddiqui MAA, 2004, DRUGS, V64, P1125, DOI 10.2165/00003495-200464100-00006; Eisenberg P, 2003, CANCER, V98, P2473, DOI 10.1002/cncr.11817; Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI 10.1200/JCO.2010.34.4614; Morita S, 2003, JPN J CLIN ONCOL, V33, P470, DOI 10.1093/jjco/hyg083; Osoba D, 1997, J CLIN ONCOL, V15, P116; Celio L, 2011, SUPPORT CARE CANCER, V19, P1217, DOI 10.1007/s00520-010-0941-7; Gralla R, 2003, ANN ONCOL, V14, P1570, DOI 10.1093/annonc/mdg417; POLLERA CF, 1989, CANCER, V64, P1117, DOI 10.1002/1097-0142(19890901)64:5<1117::AID-CNCR2820640525>3.0.CO;2-R; DUBOIS A, 1992, EUR J CANCER, V28A, P450, DOI 10.1016/S0959-8049(05)80075-9; [ESMO MASCC], MASCC ESMO ANT GUID; Furukawa N, 2014, J CLIN ONCOL, V32, p5s; Hesketh P J, 1999, Oncologist, V4, P191; Isobe H, 2014, SUPPORT CARE CANCER, V22, P102; Lindley C M, 1992, Qual Life Res, V1, P331, DOI 10.1007/BF00434947; National Comprehensive Cancer Network (NCCN), NCCN CLIN PRACT GUID	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1607	1613		10.1111/jog.12748		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500016		
J	Wang, LC; Okubo, T; Shinsaka, M; Kobayashi, A; Ogasawara, M; Sakaguchi, R; Nagai, T; Seki, H				Wang, Liangcheng; Okubo, Takashi; Shinsaka, Mamiko; Kobayashi, Akiko; Ogasawara, Miwa; Sakaguchi, Riko; Nagai, Tomonori; Seki, Hiroyuki			Efficacy and safety of cell-free and concentrated ascites reinfusion therapy (CART) in gynecologic cancer patients with a large volume of ascites	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						ascites; gynecology; neoplasms; paracentesis	MALIGNANT ASCITES; PARACENTESIS; ALBUMIN	AimThe aim of this study was to evaluate the efficacy and safety of cell-free concentrated ascites reinfusion therapy (CART) on a large amount of ascites. Material and MethodsFifty-eight CART procedures were performed in nine patients with ovarian, endometrial, or cervical cancer from February 2013 to September 2014. The medical records were retrospectively reviewed for the amount of collected ascites, vital signs, and laboratory results before and after CART. ResultsNo obvious change in the plasma protein and plasma albumin concentration was found after CART for<5L of ascites; however, obvious increases in both were observed in CART for5L of ascites (P<0.001). The optimum cut-off value for obtaining a positive variant of plasma protein and plasma albumin after CART was 7.9L. CART for5L of ascites did not increase the risk of transient water retention in the body (odds ratio=2.2; 95% confidence interval: 0.35-13.83; P=0.38); however, CART for7.9L of ascites increased the risk of water retention (odds ratio=8.4; 95% confidence interval: 1.91-44.09; P=0.004). The optimal cut-off value of ascites for predicting water retention due to CART was 9.2L. ConclusionMassive ascites collection in CART<9.2L appears to be a safe and effective treatment for improving general condition, plasma protein, and electrolytes in gynecologic cancer patients.	[Wang, Liangcheng; Okubo, Takashi; Shinsaka, Mamiko; Kobayashi, Akiko; Ogasawara, Miwa; Sakaguchi, Riko; Nagai, Tomonori; Seki, Hiroyuki] Sekishindo Hosp, Dept Obstet & Gynecol, Saitama, Japan; [Wang, Liangcheng; Nagai, Tomonori; Seki, Hiroyuki] Saitama Med Univ, Saitama Med Ctr, Dept Obstet & Gynecol, Saitama, Japan	Wang, LC (reprint author), Sekishindo Hosp, Dept Obstet & Gynecol, 25-19 Wakita Honcho, Kawagoe, Saitama 3501123, Japan.	kkscsc@gmail.com					Becker G, 2006, EUR J CANCER, V42, P589, DOI 10.1016/j.ejca.2005.11.018; Parsons SL, 1996, EUR J SURG ONCOL, V22, P237, DOI 10.1016/S0748-7983(96)80009-6; Bernardi M, 2012, HEPATOLOGY, V55, P1172, DOI 10.1002/hep.24786; KAO HW, 1985, HEPATOLOGY, V5, P403, DOI 10.1002/hep.1840050310; Ito T, 2014, THER APHER DIAL, V18, P87, DOI 10.1111/1744-9987.12049; PINTO PC, 1988, HEPATOLOGY, V8, P207, DOI 10.1002/hep.1840080202; Orimi S, 2011, THER APHER DIAL, V15, P411, DOI 10.1111/j.1744-9987.2011.00973.x; Gines A, 1996, GASTROENTEROLOGY, V111, P1002, DOI 10.1016/S0016-5085(96)70068-9; GARRISON RN, 1986, ANN SURG, V203, P644, DOI 10.1097/00000658-198606000-00009; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Inoue N, 1977, Trans Am Soc Artif Intern Organs, V23, P699; Matsusaki K, 2011, INT J CLIN ONCOL, V16, P395; Nasr G, 2010, J Cardiovasc Dis Res, V1, P136, DOI 10.4103/0975-3583.70914; Runyon BA, 1994, NEW ENGL J MED, V330, P7, DOI DOI 10.1056/NEJM199402033300508	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1614	1620		10.1111/jog.12763		7	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500017		
J	Takekuma, M; Kasamatsu, Y; Kado, N; Kuji, S; Tanaka, A; Takahashi, N; Abe, M; Hirashima, Y				Takekuma, Munetaka; Kasamatsu, Yuka; Kado, Nobuhiro; Kuji, Shiho; Tanaka, Aki; Takahashi, Nobutaka; Abe, Masakazu; Hirashima, Yasuyuki			Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						cervical cancer; cisplatin; concurrent chemoradiotherapy; fluorouracil; postoperative adjuvant therapy	RADIATION-THERAPY; ENDOMETRIAL CARCINOMA; PELVIC RADIATION; ONCOLOGY-GROUP; CHEMOTHERAPY; RADIOTHERAPY; TOXICITY	AimThe aim of this retrospective study was to analyze data for patients with stage IB-IIB uterine cervical cancer who were treated with concurrent chemoradiotherapy with fluorouracil (5-FU) and cisplatin (CCRT-FP) as postoperative adjuvant therapy and to re-examine these issues and further treatment. MethodsPatients with high risk for recurrence underwent CCRT-FP as postoperative adjuvant therapy. A total of 73 patients who met these criteria were included in this study. Data related to survival, toxicity, and treatment feasibility were analyzed, and the question of whether there were differences in survival and toxicity according to the number of dissected lymph nodes at surgery was evaluated. ResultsMedian patient age was 45years (range, 24-67 years). Two-thirds of patients had squamous cell histologic type, 41 patients (56.2%) had parametrial invasion, and 60 patients (82.2%) had lymph node metastases. Estimated 4-year progression-free survival, overall survival, and local control rates were 71.8%, 84.1%, and 88.5%, respectively. Sixteen patients (21.9%) had grade 3-4 neutropenia and one of them died of septic shock. Non-hematological toxicities were also common: 13 (17.8%) experienced grade 3-4 nausea, and nine (12.3%) experienced grade 3-4 diarrhea. Ileus occurred in 17 patients (23.3%), and seven of them (9.6%) were not yet cured. One patient experienced gastrointestinal perforation. ConclusionsCCRT-FP in the postoperative setting resulted in good survival outcome but toxicity remained problematic. Development of appropriate treatment for patients with high-risk prognostic factors after radical hysterectomy and lymphadenectomy is required.	[Takekuma, Munetaka; Kasamatsu, Yuka; Kado, Nobuhiro; Kuji, Shiho; Tanaka, Aki; Takahashi, Nobutaka; Abe, Masakazu; Hirashima, Yasuyuki] Shizuoka Canc Ctr, Nagaizumi, Shizuoka, Japan	Takekuma, M (reprint author), 1007 Shimonagakubo,Nagaizumicho, Shizuoka 4118777, Japan.	m.takekuma@scchr.jp					Fata F, 1999, CANCER, V86, P1129, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1129::AID-CNCR5>3.0.CO;2-4; Cragun JM, 2005, J CLIN ONCOL, V23, P3668, DOI 10.1200/JCO.2005.04.144; Folkert MR, 2013, GYNECOL ONCOL, V128, P288, DOI 10.1016/j.ygyno.2012.11.012; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Peters WA, 2000, J CLIN ONCOL, V18, P1606; Chan JK, 2006, CANCER, V107, P1823, DOI 10.1002/cncr.22185; Jhingran A, 2012, INT J RADIAT ONCOL, V84, pE23, DOI 10.1016/j.ijrobp.2012.02.044; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; Klopp AH, 2013, INT J RADIAT ONCOL, V86, P83, DOI 10.1016/j.ijrobp.2013.01.017; Madisch A, 2002, Z GASTROENTEROL, V40, P59, DOI 10.1055/s-2002-20209; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Whitney CW, 1999, J CLIN ONCOL, V17, P1339; Chen MF, 2007, INT J RADIAT ONCOL, V67, P1438, DOI 10.1016/j.ijrobp.2006.11.005; Benedet J L, 2001, J Epidemiol Biostat, V6, P7; Japan Society of Gynecologic Oncology, 2011, TREATM GUID CERV CAN; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Okabayashi H., 1921, SURG GYNECOL OBSTET, V33, P335	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1638	1643		10.1111/jog.12754		6	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500020		
J	Nakakita, B; Mogami, H; Kondoh, E; Tsukamoto, T; Yanagita, M; Konishi, I				Nakakita, Baku; Mogami, Haruta; Kondoh, Eiji; Tsukamoto, Tatsuo; Yanagita, Motoko; Konishi, Ikuo			Case of soluble fms-like tyrosine kinase 1 apheresis in severe pre-eclampsia developed at 15 weeks' gestation	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						apheresis; dextran sulfate cellulose columns; pre-eclampsia; pregnancy; soluble fms-like tyrosine kinase 1	PREGNANCY; SFLT1	Soluble fms-like tyrosine kinase-1 (sFlt1), a circulating vascular endothelial growth factor receptor 1 antagonist, is associated with the pathogenesis of pre-eclampsia. Extracorporeal removal of sFlt1 (sFlt1 apheresis) is emerging as a treatment for pre-eclampsia. We performed sFlt1 apheresis for a patient with very early onset pre-eclampsia, beginning at 15 weeks' gestation. She underwent sFlt1 apheresis 13 times from 19 to 23 weeks' gestation. The series of treatments lowered circulating sFlt1, stabilized blood pressure, reduced urinary protein, and preserved renal function, which contributed to a successful prolongation of pregnancy for 4 weeks and a live birth at 23(+3) weeks' gestation. Further studies are necessary for clinical application of sFlt1 apheresis as sFlt1 might have a protective function for the placenta and fetus in pre-eclampsia.	[Nakakita, Baku; Mogami, Haruta; Kondoh, Eiji; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto 6068507, Japan; [Tsukamoto, Tatsuo; Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto 6068507, Japan	Mogami, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	mogami@kuhp.kyoto-u.ac.jp			JSPS KAKENHI [25861488]; MEXT KAKENHI 'Constructive Developmental Science' [24119004]	We thank Dr Shingo Ukita, Dr Rin Mizuno, and Dr Tsukasa Baba (Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan) for clinical treatment of the patient. This work was supported by JSPS KAKENHI Grant Number 25861488 and MEXT KAKENHI 'Constructive Developmental Science' 24119004.	Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Hazra S, 2003, BJOG-INT J OBSTET GY, V110, P1034; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Bornstein E, 2007, OBSTET GYNECOL, V110, P525, DOI 10.1097/01.AOG.0000268512.26170.ad; Klingel R, 2003, THER APHER DIAL, V7, P359, DOI 10.1046/j.1526-0968.2003.00066.x; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1661	1663		10.1111/jog.12760		3	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500023		
J	Kasai, M; Ichimura, T; Murakami, M; Matsuda, M; Kawamura, N; Sumi, T				Kasai, Mari; Ichimura, Tomoyuki; Murakami, Makoto; Matsuda, Makiko; Kawamura, Naoki; Sumi, Toshiyuki			Two cases of uterine malignant lymphoma diagnosed by needle biopsy	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Article						diagnosis; malignant lymphoma; primary; transcervical needle biopsy; uterine body	B-CELL LYMPHOMA; UTERUS; CERVIX; COMBINATION; SARCOMA; VAGINA	The incidence of primary malignant lymphoma arising in the female genital tract is extremely rare and constitutes approximately 0.05% of malignant tumors. Uterine malignant lymphoma develops in the endometrial stroma, causing minimal necrosis. It is therefore difficult to diagnose malignant lymphoma, as it does not involve genital bleeding or epithelial defects. We have performed transcervical needle biopsies from deep in the myometrium, with the purpose of diagnosing uterine muscle layer lesions, such as leiomyosarcoma, but this is an unusual method. In this report, we suggest that transcervical needle biopsy is useful in the diagnosis of uterine malignant lymphoma.	[Kasai, Mari; Ichimura, Tomoyuki; Murakami, Makoto; Matsuda, Makiko; Kawamura, Naoki; Sumi, Toshiyuki] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Osaka 5458585, Japan	Kasai, M (reprint author), Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	mari_k0410@yahoo.co.jp					Kawamura N, 2002, CANCER, V94, P1713, DOI 10.1002/cncr.10382; STROH EL, 1995, CANCER, V75, P2392, DOI 10.1002/1097-0142(19950501)75:9<2392::AID-CNCR2820750932>3.0.CO;2-Y; Hariprasad R, 2006, AM J OBSTET GYNECOL, V195, P308, DOI 10.1016/j.ajog.2006.04.002; FOX H, 1965, J CLIN PATHOL, V18, P723, DOI 10.1136/jcp.18.6.723; CARR I, 1976, J CLIN PATHOL, V29, P680, DOI 10.1136/jcp.29.8.680; HARRIS NL, 1984, CANCER, V53, P2530, DOI 10.1002/1097-0142(19840601)53:11<2530::AID-CNCR2820531127>3.0.CO;2-J; Cohn DE, 2007, INT J GYNECOL CANCER, V17, P274, DOI 10.1111/j.1525-1438.2006.00747.x; Bull L, 2013, INT J STD AIDS, V24, P587, DOI 10.1177/0956462413476268; Kawamura N, 2002, FERTIL STERIL, V77, P1060, DOI 10.1016/S0015-0282(02)03064-9; Mandato VD, 2014, ANTICANCER RES, V34, P4377; Okamoto Y, 2003, RADIOGRAPHICS, V23, P425, DOI 10.1148/rg.232025065; Younes A, 2014, LANCET ONCOL, V15, P1019, DOI 10.1016/S1470-2045(14)70311-0; Binesh F, 2012, BMJ CASE REP, V6, P2012; Egyed Miklós, 2007, Haematologica, V92, pe26, DOI 10.3324/haematol.08846; Isosaka Mai, 2013, Rinsho Ketsueki, V54, P392; Merritt AJ, 2014, J CLIN PATHOL, V67, P375, DOI 10.1136/jclinpath-2013-202059; Runzhe C, 2015, ONCO TARGETS THERAPY, V8, P265	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1664	1668		10.1111/jog.12759		5	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500024		
J	Matsubara, S; Takahashi, H; Ohkuchi, A				Matsubara, Shigeki; Takahashi, Hironori; Ohkuchi, Akihide			Need for systematic classification of various uterine compression sutures	JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH			English	Letter							POSTPARTUM HEMORRHAGE		[Matsubara, Shigeki; Takahashi, Hironori; Ohkuchi, Akihide] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan	Matsubara, S (reprint author), Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan.	matsushi@jichi.ac.jp					Li GT, 2015, J OBSTET GYNAECOL RE, V41, P993, DOI 10.1111/jog.12705; Matsubara S, 2013, ARCH GYNECOL OBSTET, V288, P1195, DOI 10.1007/s00404-013-2925-6; BLynch C, 1997, BRIT J OBSTET GYNAEC, V104, P372, DOI 10.1111/j.1471-0528.1997.tb11471.x; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P378, DOI 10.1111/aogs.12077	4	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1341-8076	1447-0756		J OBSTET GYNAECOL RE	J. Obstet. Gynaecol. Res.	OCT	2015	41	10					1676	1676		10.1111/jog.12762		1	Obstetrics & Gynecology	Obstetrics & Gynecology	CT3AF	WOS:000362677500026		
J	Shirako, Y; Taya, Y; Sato, K; Chiba, T; Imai, K; Shimazu, Y; Aoba, T; Soeno, Y				Shirako, Youichi; Taya, Yuji; Sato, Kaori; Chiba, Tadashige; Imai, Kazushi; Shimazu, Yoshihito; Aoba, Takaaki; Soeno, Yuuichi			Heterogeneous tumor stromal microenvironments of oral squamous cell carcinoma cells in tongue and nodal metastatic lesions in a xenograft mouse model	JOURNAL OF ORAL PATHOLOGY & MEDICINE			English	Article						metastasis; oral squamous cell carcinoma; tongue; tumor microenvironment; xenograft	INTRATUMORAL LYMPHANGIOGENESIS; MESENCHYMAL TRANSITION; NECK-CANCER; HEAD; EXPRESSION; GROWTH; PROGRESSION; MICE; ANGIOGENESIS; LYMPHATICS	BackgroundOral squamous cell carcinoma exhibits a poor prognosis, caused by aggressive progression and early-stage metastasis to cervical lymph nodes. Here, we developed a xenograft mouse model to explore the heterogeneity of the tumor microenvironment that may govern local invasion and nodal metastasis of tumor cells. MethodsWe transplanted five oral carcinoma cell lines into the tongues of nude mice and determined tongue tumor growth and micrometastatic dissemination by serially sectioning the tongue and lymph node lesions in combination with immunohistochemistry and computer-assisted image analysis. Our morphometric analysis enabled a quantitative assessment of blood and lymphatic endothelial densities in the intratumoral and host stromal regions. ResultsAll cell lines tested were tumorigenic in mouse tongue. The metastatic lesion-derived carcinoma cell lines (OSC19, OSC20, and HSC2) yielded a 100% nodal metastasis rate, whereas the primary tumor-derived cell lines (KOSC2 and HO-1-u-1) showed <40% metastatic potential. Immunohistochemistry showed that the individual cell lines gave rise to heterogeneous tumor architecture and phenotypes and that their micrometastatic lesions assimilated the immunophenotypic properties of the corresponding tongue tumors. Notably, OSC19 and OSC20 cells shared similar aggressive tumorigenicity in both the tongue and lymph node environments but displayed markedly diverse immunophenotypes and gene expression profiles. ConclusionsOur model facilitated comparing the tumor microenvironments in tongue and lymph node lesions. The results support that tumorigenicity and tumor architecture in the host tongue environment depend on the origin and properties of the carcinoma cell lines and that metastatic progression may take place through heterogeneous tumor-host interactions.	[Shirako, Youichi; Taya, Yuji; Sato, Kaori; Shimazu, Yoshihito; Aoba, Takaaki; Soeno, Yuuichi] Nippon Dent Univ Tokyo, Dept Pathol, Sch Life Dent Tokyo, Chiyoda Ku, Tokyo 1028159, Japan; [Chiba, Tadashige; Imai, Kazushi] Nippon Dent Univ Tokyo, Dept Biochem, Sch Life Dent Tokyo, Chiyoda Ku, Tokyo 1028159, Japan; [Shimazu, Yoshihito] Azabu Univ, Sch Life & Environm Sci, Dept Food & Life Sci, Chuo Ku, Sagamihara, Kanagawa, Japan	Soeno, Y (reprint author), Nippon Dent Univ Tokyo, Dept Pathol, Sch Life Dent Tokyo, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1028159, Japan.	soeno-path@tky.ndu.ac.jp			Nippon Dental University at Tokyo	This work was supported in part by a Grant for Research Project from the Nippon Dental University at Tokyo (#2).	Ohno F, 2007, J ORAL PATHOL MED, V36, P281, DOI 10.1111/j.1600-0714.2007.00529.x; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Sleeman JP, 2012, SEMIN CANCER BIOL, V22, P174, DOI 10.1016/j.semcancer.2012.02.007; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Hoon DSB, 2011, J SURG ONCOL, V103, P508, DOI 10.1002/jso.21690; Franchi A, 2004, CANCER, V101, P973, DOI 10.1002/cncr.20454; Sano D, 2011, CLIN CANCER RES, V17, P6658, DOI 10.1158/1078-0432.CCR-11-0046; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Koshida S, 2007, CANCER SCI, V98, P315, DOI 10.1111/j.1349-7006.2006.00383.x; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Zhao D, 2008, J ORAL PATHOL MED, V37, P616, DOI 10.1111/j.1600-0714.2008.00707.x; Beasley NJP, 2002, CANCER RES, V62, P1315; Talmadge JE, 2007, AM J PATHOL, V170, P793, DOI 10.2353/ajpath.2007.060929; Wong SY, 2005, CANCER RES, V65, P9789, DOI 10.1158/0008-5472.CAN-05-0901; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; Miyahara M, 2007, CANCER, V110, P1287, DOI 10.1002/cncr.22900; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kyzas PA, 2005, J PATHOL, V206, P170, DOI 10.1002/path.1776; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Creighton C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r46; Hadler-Olsen E, 2010, VIRCHOWS ARCH, V457, P677, DOI 10.1007/s00428-010-0980-y; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; Ishikawa T, 2006, INT J ONCOL, V28, P61; Luo ZY, 2011, J CANCER RES CLIN, V137, P1713, DOI 10.1007/s00432-011-1042-9; Qiu CP, 2003, J ORAL MAXIL SURG, V61, P696, DOI 10.1053/joms.2003.50139; Maula SM, 2003, CANCER RES, V63, P1920; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Myers JN, 2002, CLIN CANCER RES, V8, P293; de Vicente JC, 2007, J ORAL PATHOL MED, V36, P415, DOI 10.1111/j.1600-0714.2007.00546.x; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Frech S, 2009, ANTICANCER RES, V29, P1675; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Kawashiri S, 1995, Eur J Cancer B Oral Oncol, V31B, P216, DOI 10.1016/0964-1955(95)00027-F; Kudo T, 2013, INT J DENT, V2013; Rousseau A, 2012, ATLAS GENET CYTOGENE, V16, P145; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; YOKOI T, 1990, Tumor Research, V25, P93	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0904-2512	1600-0714		J ORAL PATHOL MED	J. Oral Pathol. Med.	OCT	2015	44	9					656	668		10.1111/jop.12318		13	Dentistry, Oral Surgery & Medicine; Pathology	Dentistry, Oral Surgery & Medicine; Pathology	CT1SQ	WOS:000362581700002		
J	Kubota, T; Yagi, T; Tomonari, H; Ikemori, T; Miyawaki, S				Kubota, T.; Yagi, T.; Tomonari, H.; Ikemori, T.; Miyawaki, S.			Influence of surgical orthodontic treatment on masticatory function in skeletal Class III patients	JOURNAL OF ORAL REHABILITATION			English	Article						orthognathic surgery; masticatory muscles; Angle Class III; electromyography; chewing; mandibular prognathism	ORTHOGNATHIC SURGERY; MUSCLE-ACTIVITY; JAW MOVEMENT; MANDIBULAR PROGNATHISM; CHEWING CYCLES; BITE; CROSSBITE; MASSETER; PATTERNS; REVERSE	Skeletal Class III patients exhibit malocclusion characterised by Angle Class III and anterior crossbite, and their occlusion shows total or partially lateral crossbite of the posterior teeth. Most patients exhibit lower bite force and muscle activity than non-affected subjects. While orthognathic surgery may help improve masticatory function in these patients, its effects have not been fully elucidated. The aims of the study were to evaluate jaw movement and the electromyographic (EMG) activity of masticatory muscles before and after orthognathic treatment in skeletal Class III patients in comparison with control subjects with normal occlusion. Jaw movement variables and EMG data were recorded in 14 female patients with skeletal Class III malocclusion and 15 female controls with good occlusion. Significant changes in jaw movement, from a chopping to a grinding pattern, were observed after orthognathic treatment (closing angle P < 0.01; cycle width P < 0.01), rendering jaw movement in the patient group similar to that of the control group. However, the grinding pattern in the patient group was not as broad as that of controls. The activity indexes, indicating the relative contributions of the masseter and temporalis muscles (where a negative value corresponds to relatively more temporalis activity and vice versa) changed from negative to positive after treatment (P < 0.05), becoming similar to those of control subjects. Our findings suggest that orthognathic treatment in skeletal Class III patients improves the masticatory chewing pattern and muscle activity. However, the chewing pattern remains incomplete compared with controls.	[Kubota, T.; Tomonari, H.; Ikemori, T.; Miyawaki, S.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthodont & Dentofacial Orthoped, Kagoshima 8908520, Japan; [Yagi, T.] Kagoshima Univ, Med & Dent Hosp, Dept Orthodont Dent, Kagoshima 8908520, Japan	Miyawaki, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthodont & Dentofacial Orthoped, Kagoshima 8908520, Japan.	miyawaki@dent.kagoshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23593036, 24593105, 24390464, 24593104, 21592617]	All examinations for this study were performed at Kagoshima University Hospital. All authors declare no potential conflicts of interest with respect to the research, authorship and publication of this article. This study was partially supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) (grant numbers 23593036, 24593105, 24390464, 24593104 and 21592617).	Foster KD, 2006, J NEUROPHYSIOL, V95, P3469, DOI 10.1152/jn.01003.2005; Frongia G, 2013, OR SURG OR MED OR PA, V116, P398, DOI 10.1016/j.oooo.2013.06.008; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Piancino MG, 2009, EUR J ORAL SCI, V117, P122, DOI 10.1111/j.1600-0722.2008.00601.x; Gomes SGF, 2010, J ORAL REHABIL, V37, P813, DOI 10.1111/j.1365-2842.2010.02075.x; Ramieri G, 2011, J CRANIOFAC SURG, V22, P527, DOI 10.1097/SCS.0b013e31820853e8; Trawitzki LVV, 2010, INT J ORAL MAX SURG, V39, P853, DOI 10.1016/j.ijom.2009.03.006; Youssef RE, 1997, J PROSTHET DENT, V78, P179, DOI 10.1016/S0022-3913(97)70123-9; Harzer W, 2007, ORAL SURG ORAL MED O, V104, P486, DOI 10.1016/j.tripleo.2007.01.017; Gjorup H, 2013, ORTHOD CRANIOFAC RES, V16, P246, DOI 10.1111/ocr.12028; Ferrario VF, 2002, CRANIO, V20, P91; Sohn BW, 1997, AM J ORTHOD DENTOFAC, V112, P403, DOI 10.1016/S0889-5406(97)70048-9; Casko JS, 1998, AM J ORTHOD DENTOFAC, V114, P589, DOI 10.1016/S0889-5406(98)70179-9; Tomonari H, 2014, J ORAL REHABIL, V41, P257, DOI 10.1111/joor.12148; Nakata Y, 2007, J ORAL MAXIL SURG, V65, P444, DOI 10.1016/j.joms.2005.12.071; FERRARIO VF, 1993, J ORAL REHABIL, V20, P271, DOI 10.1111/j.1365-2842.1993.tb01609.x; Takeda H, 2009, J ORAL MAXIL SURG, V67, P1844, DOI 10.1016/j.joms.2009.04.027; Louca C, 1996, BRAIN RES, V731, P63, DOI 10.1016/S0006-8993(96)00462-3; Kuninori T, 2014, J ORAL REHABIL, V41, P338, DOI 10.1111/joor.12149; Piancino MG, 2013, OR SURG OR MED OR PA, V115, P328, DOI 10.1016/j.oooo.2012.04.025; Yashiro K, 2013, J ORAL REHABIL, V40, P418, DOI 10.1111/joor.12045; Miyawaki S, 2000, J DENT RES, V79, P1525; Tokiwa H, 2001, J JPN SOC STROMATOGN, V7, P12; Wen-Ching Ko E, 2012, J ORAL MAXILLOFAC SU, V70, P158	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	OCT	2015	42	10					733	741		10.1111/joor.12307		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CT1YP	WOS:000362599500002		
J	Akiyama, M; Yamaoka, M; Mikami-Terao, Y; Yokoi, K; Inoue, T; Hiramatsu, T; Ashizuka, S; Yoshizawa, J; Katagi, H; Ikegami, M; Ida, H; Nakazawa, A; Okita, H; Matsumoto, K				Akiyama, Masaharu; Yamaoka, Masayoshi; Mikami-Terao, Yoko; Yokoi, Kentaro; Inoue, Takashi; Hiramatsu, Tomomasa; Ashizuka, Shuichi; Yoshizawa, Jyoji; Katagi, Hiroaki; Ikegami, Masahiro; Ida, Hiroyuki; Nakazawa, Atsuko; Okita, Hajime; Matsumoto, Kenji			Paraneoplastic Syndrome of Angiomatoid Fibrous Histiocytoma May Be Caused by EWSR1-CREB1 Fusion-induced Excessive Interleukin-6 Production	JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY			English	Article						angiomatoid fibrous histiocytoma; EWSR1-CREB1 fusion gene; interleukin-6; paraneoplastic syndrome	IL-6; PROLIFERATION; CANCER; CELLS; STAT3	We describe a 7-year-old girl with angiomatoid fibrous histiocytoma (AFH) presenting severe inflammatory symptoms. The cytokine/chemokine profile of serum samples before and after surgery demonstrated that interleukin (IL)-6 had decreased by the greatest percentage. The AFH cells were immunopathologically positive for IL-6 and Tyr705-phosphorylation of signal transducer and activator of transcription 3. The EWSR1-CREB1 fusion gene detected in the tumor leads to continuous activation of CREB1 and IL-6 production, because the promoter region of IL-6 has a CREB binding site. Thus, IL-6 plays pivotal roles in both paraneoplastic syndrome and the oncogenesis of AFH.	[Akiyama, Masaharu; Yamaoka, Masayoshi; Mikami-Terao, Yoko; Yokoi, Kentaro; Inoue, Takashi; Ida, Hiroyuki] Jikei Univ, Sch Med, Dept Pediat, Tokyo 1058461, Japan; [Katagi, Hiroaki; Ikegami, Masahiro] Jikei Univ, Sch Med, Dept Pathol, Tokyo 1058461, Japan; [Hiramatsu, Tomomasa; Ashizuka, Shuichi; Yoshizawa, Jyoji] Jikei Univ, Sch Med, Div Pediat Surg, Tokyo 1058461, Japan; [Akiyama, Masaharu] Jikei Univ, Sch Med, Div Mol Genet, Inst DNA Med, Tokyo 1058461, Japan; [Nakazawa, Atsuko] Natl Res Inst Child Hlth & Dev, Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Okita, Hajime] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan	Akiyama, M (reprint author), Jikei Univ, Sch Med, Dept Pediat, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	makiyama@jikei.ac.jp					Nakanishi H, 2004, AM J PATHOL, V165, P471, DOI 10.1016/S0002-9440(10)63312-3; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113; MELHEM MF, 1993, BLOOD, V82, P2038; DAVIES KA, 1995, CLIN EXP IMMUNOL, V99, P117; Thway K, 2012, AM J SURG PATHOL, V36, pE1, DOI 10.1097/PAS.0b013e31825485c5; Matsumura T, 2010, J CLIN PATHOL, V63, P124, DOI 10.1136/jcp.2009.072256; Rossi S, 2007, CLIN CANCER RES, V13, P7322, DOI 10.1158/1078-0432.CCR-07-1744; Thway K, 2008, ARCH PATHOL LAB MED, V132, P273, DOI 10.1043/1543-2165(2008)132[273:AFHARW]2.0.CO;2; Nakanishi H, 2002, INT J CANCER, V99, P167, DOI 10.1002/ijc.10343; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Antonescu CR, 2007, GENE CHROMOSOME CANC, V46, P1051, DOI 10.1002/gec.20491; Shouda T, 2006, CANCER LETT, V231, P176, DOI 10.1016/j.canlet.2005.01.042; HOLLOWOOD K, 1995, SEMIN DIAGN PATHOL, V12, P210; Tawara Ken, 2011, Cancer Manag Res, V3, P177, DOI 10.2147/CMR.S18101	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1077-4114	1536-3678		J PEDIAT HEMATOL ONC	J. Pediatr. Hematol. Oncol.	OCT	2015	37	7					554	559		10.1097/MPH.0000000000000390		6	Oncology; Hematology; Pediatrics	Oncology; Hematology; Pediatrics	CT1GL	WOS:000362545900013		
J	Yoshida, A; Shiotsu-Ogura, Y; Wada-Takahashi, S; Takahashi, SS; Toyama, T; Yoshino, F				Yoshida, Ayaka; Shiotsu-Ogura, Yukako; Wada-Takahashi, Satoko; Takahashi, Shun-suke; Toyama, Toshizo; Yoshino, Fumihiko			Blue light irradiation-induced oxidative stress in vivo via ROS generation in rat gingival tissue	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article						Blue light; N-acetyl-L-cysteine; Reactive oxygen species; Singlet oxygen; Oxidative stress; Gingiva	FLAVIN ADENINE-DINUCLEOTIDE; OXYGEN SPECIES PRODUCTION; ACETYL-L-CYSTEINE; N-ACETYLCYSTEINE; LIPID PEROXIDES; BIOLOGICAL-SYSTEMS; HYDROGEN-PEROXIDE; TEMPERATURE RISE; GLUTATHIONE; MITOCHONDRIA	It has been reported that oxidative stress with reactive oxygen species (ROS) generation is induced by blue light irradiation to a living body. Only limited research has been reported in dental field on the dangers of blue light, mostly focusing on cytotoxicity associated with heat injury of dental pulp. We thus performed an in vivo study on oral tissue exposed to blue light. ROS generated upon blue light irradiation of flavin adenine dinucleotide were measured by electron spin resonance spectroscopy. After blue light irradiation, the palatal gingiva of Wistar rats were isolated. Collected samples were subjected to biochemical analysis of lipid peroxidation and glutathione. Singlet oxygen was generated by blue light irradiation, but was significantly quenched in an N-acetyl-L-cysteine (NAC) concentration-dependent manner. Blue light significantly accelerated oxidative stress and increased the oxidized glutathione levels in gingival tissue. These effects were also inhibited by NAC pre-administration. The results suggest that blue light irradiation at clinical levels of tooth bleaching treatment may enhance lipid peroxidation by the induction of oxidative stress and the consumption of a significant amount of intracellular glutathione. In addition, NAC might be an effective supplement for the protection of oral tissues against blue light irradiation-induced oxidative damage. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshida, Ayaka; Shiotsu-Ogura, Yukako; Yoshino, Fumihiko] Kanagawa Dent Univ, Grad Sch Dent, Div Photomed Dent, Dept Oral Sci, Yokosuka, Kanagawa 2388580, Japan; [Wada-Takahashi, Satoko; Takahashi, Shun-suke] Kanagawa Dent Univ, Grad Sch Dent, Div Dent Circulat Control, Dept Oral Sci, Yokosuka, Kanagawa 2388580, Japan; [Toyama, Toshizo] Kanagawa Dent Univ, Grad Sch Dent, Dept Microbiol, Yokosuka, Kanagawa 2388580, Japan	Yoshino, F (reprint author), Kanagawa Dent Univ, Grad Sch Dent, Div Photomed Dent, Dept Oral Sci, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	yoshino@kdu.ac.jp	Yoshino, Fumihiko/E-5067-2012	Yoshino, Fumihiko/0000-0001-6068-6268	JSPS KAKENHI [24792045, 15K21454]	This study was supported by JSPS KAKENHI Grant-in-Aid for Young Scientists (B), Grant Number 24792045 and 15K21454.	OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Yoshino F, 2012, J PHOTOCH PHOTOBIO B, V114, P73, DOI [10.1016/j.jphotobiol.2012.05.012, 10.1016/j.jphotobio1.2012.05.012]; BARILE M, 1993, ARCH BIOCHEM BIOPHYS, V305, P442, DOI 10.1006/abbi.1993.1444; Yoshida A, 2013, J PHOTOCH PHOTOBIO B, V129, P1, DOI 10.1016/j.jphotobiol.2013.09.003; NAGAO M, 1992, J BIOL CHEM, V267, P17925; Choi EJ, 2006, EUR J PHARMACOL, V542, P162, DOI 10.1016/j.ejphar.2006.05.020; Spooren AAMG, 1997, BLOOD CELL MOL DIS, V23, P323, DOI 10.1006/bcmd.1997.0150; Kobayashi Y, 2014, J ORAL SCI, V56, P35, DOI 10.2334/josnusd.56.35; Sun SY, 2010, CANCER BIOL THER, V9, P109, DOI 10.4161/cbt.9.2.10583; Signorini C, 2014, OXID MED CELL LONGEV, DOI 10.1155/2014/195935; Yagi K, 1998, Methods Mol Biol, V108, P101; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Sparrow JR, 2001, INVEST OPHTH VIS SCI, V42, P1356; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; MURPHY ME, 1990, METHOD ENZYMOL, V186, P595; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; SHEFFNER AL, 1966, BIOCHEM PHARMACOL, V15, P1523, DOI 10.1016/0006-2952(66)90197-3; PATTON S, 1951, J DAIRY SCI, V34, P669; Hahn P, 2013, ODONTOLOGY, V101, P67, DOI 10.1007/s10266-012-0063-4; Andersson H, 1998, J MICROSC-OXFORD, V191, P1; Deng W, 2012, LANGMUIR, V28, P10152, DOI 10.1021/la300332x; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99; Failli P, 2002, NITRIC OXIDE-BIOL CH, V7, P277, DOI 10.1016/S1089-8603(02)00120-9; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Leprince J, 2010, OPER DENT, V35, P220, DOI 10.2341/09-203-L; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Hannig M, 1999, DENT MATER, V15, P275, DOI 10.1016/S0109-5641(99)00047-0; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; SAIJO T, 1995, J BIOL CHEM, V270, P1899; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Margrain TH, 2004, PROG RETIN EYE RES, V23, P523, DOI 10.1016/j.preteyeres.2004.05.001; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Lee MC, 2005, J DENT RES, V84, P178; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Benrahmoune M, 2000, FREE RADICAL BIO MED, V29, P775, DOI 10.1016/S0891-5849(00)00380-4; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; KANOFSKY JR, 1989, CHEM-BIOL INTERACT, V70, P1, DOI 10.1016/0009-2797(89)90059-8; Klaric E., 2013, LASER MED SCI, P1; Krinsky NI, 2002, J NUTR, V132, p540S; MCCORMIC.DB, 1967, EUR J BIOCHEM, V2, P387, DOI 10.1111/j.1432-1033.1967.tb00150.x; Niki Etsuo, 2014, Biomed J, V37, P106, DOI 10.4103/2319-4170.128727; NIKI E, 1987, British Journal of Cancer, V55, P153; Sagrista ML, 2002, FREE RADICAL RES, V36, P329, DOI 10.1080/10715760290019354; Saltveit M.E., 2004, AGR HDB, V66; THOMAS SHL, 1993, PHARMACOL THERAPEUT, V60, P91, DOI 10.1016/0163-7258(93)90023-7	46	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344			J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	OCT	2015	151						48	53		10.1016/j.jphotobiol.2015.07.001		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CT2BT	WOS:000362607700008		
J	Markowska-Szczupak, A; Wang, KL; Rokicka, P; Endo, M; Wei, ZS; Ohtani, B; Morawski, AW; Kowalska, E				Markowska-Szczupak, Agata; Wang, Kunlei; Rokicka, Paulina; Endo, Maya; Wei, Zhishun; Ohtani, Bunsho; Morawski, Antoni W.; Kowalska, Ewa			The effect of anatase and rutile crystallites isolated from titania P25 photocatalyst on growth of selected mould fungi	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article						Antifungal properties; Water activity; Anatase; Rutile; P25; Photocatalysis; Pathogenic fungi	CO-DOPED TIO2; HETEROGENEOUS PHOTOCATALYSIS; AIR PURIFICATION; INDOOR AIR; SURFACE; DISINFECTION; INACTIVATION; DIOXIDE; CELLS; WATER	Antifungal properties of anatase and rutile crystallites isolated from commercial titania P25 photocatalyst were investigated by mycelium growth in the dark and under indoor light. Investigated fungi, i.e., Pseudallescheria boydii, Scedosporium apiospermum, Pseudallescheria ellipsoidea, Scedosporium aurantiacum, Aspergillus versicolor, Aspergillus flavus, Stachybotrys chartarum, Penicillium chrysogenum, Aspergillus melleus, were isolated from air and from moisture condensed on walls. Anatase and rutile were isolated from homogenized P25 (homo-P25) by chemical dissolution, and then purified by washing and thermal treatment. For comparison, homo-P25 was also thermally treated at 200 degrees C and 500 degrees C. Titania samples were characterized by X-ray diffractomety (XRD), X-ray photoelectron spectroscopy (XPS), diffuse reflectance spectroscopy (DRS) and scanning transmission electron microscopy (STEM). It was found that properties of titania, i.e., band-gap energy, impurities adsorbed on the surface, nanoparticle aggregation, and kind of fungal structure, highly influenced resultant antifungal activities. It is proposed that some fungi could uptake necessary water and nutrient from titania surface. It was also found that even when differences in mycelium growth were not significant, the sporulation and mycotoxin generation were highly inhibited by light and presence of titania. (C) 2015 Elsevier B.V. All rights reserved.	[Markowska-Szczupak, Agata; Rokicka, Paulina; Morawski, Antoni W.] West Pomeranian Univ Technol, Inst Chem & Environm Engn, PL-70322 Szczecin, Poland; [Wang, Kunlei; Ohtani, Bunsho; Kowalska, Ewa] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Ohtani, Bunsho; Kowalska, Ewa] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan	Kowalska, E (reprint author), Hokkaido Univ, Catalysis Res Ctr, N21,W10, Sapporo, Hokkaido 0010021, Japan.	agata@erb.pl; kowalska@cat.hokudai.ac.jp	Kowalska, Ewa/D-5540-2009		Bill & Melinda Gates Foundation through Grand Challenges Exploration Initiative [OPP1060234]; Catalysis Research Center through Target Oriented Research Assembly; National Science Centre [DEC-2012/06/A/ST5/00226]	This study was financially supported by Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative (OPP1060234) and Catalysis Research Center through Target Oriented Research Assembly. This work was partly supported by National Science Centre as a scientific Project No. DEC-2012/06/A/ST5/00226.	Ammann H M, 2005, Mycotoxin Res, V21, P157, DOI 10.1007/BF02959254; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211; Rincon AG, 2003, APPL CATAL B-ENVIRON, V44, P263, DOI 10.1016/S0926-3373(03)00076-6; Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a; Hay SO, 2015, MOLECULES, V20, P1319, DOI 10.3390/molecules20011319; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Folli A, 2012, CEMENT CONCRETE RES, V42, P539, DOI 10.1016/j.cemconres.2011.12.001; Kurtoglu ME, 2011, INT J APPL GLASS SCI, V2, P108, DOI 10.1111/j.2041-1294.2011.00040.x; Schnelle-Kreis J, 2000, SCI TOTAL ENVIRON, V256, P125, DOI 10.1016/S0048-9697(00)00476-9; Reszczynska J, 2014, APPL SURF SCI, V307, P333, DOI 10.1016/j.apsusc.2014.03.199; Ohtani B, 2014, PHYS CHEM CHEM PHYS, V16, P1788, DOI 10.1039/c3cp53653j; Zielinska-Jurek A, 2011, APPL CATAL B-ENVIRON, V101, P504, DOI 10.1016/j.apcatb.2010.10.022; Bekbolet M, 1996, CHEMOSPHERE, V32, P959, DOI 10.1016/0045-6535(95)00359-2; Hong JG, 2001, FRESEN J ANAL CHEM, V371, P961, DOI 10.1007/s002160101085; Hurum DC, 2005, J PHYS CHEM B, V109, P977, DOI 10.1021/jp015395d; Mitchell CS, 2007, ENVIRON HEALTH PERSP, V115, P958, DOI 10.1289/ehp.8987; Byrne JA, 2015, MOLECULES, V20, P5574, DOI 10.3390/molecules20045574; Ohno T, 2001, J PHYS CHEM B, V105, P2417, DOI 10.1021/jp003211z; Schneider P, 1999, J EXPO ANAL ENV EPID, V9, P282, DOI 10.1038/sj.jea.7500030; Nakata K, 2012, J PHOTOCH PHOTOBIO C, V13, P169, DOI 10.1016/j.jphotochemrev.2012.06.001; Zubkov T, 2005, J PHYS CHEM B, V109, P15454, DOI 10.1021/jp058101c; Guillard C, 2008, CR CHIM, V11, P107, DOI 10.1016/j.crci.2007.06.007; Allen NS, 2005, PHOTOCHEM PHOTOBIOL, V81, P279, DOI 10.1562/2004-07-01-RA-221.1; Yang GD, 2010, APPL CATAL B-ENVIRON, V96, P458, DOI 10.1016/j.apcatb.2010.03.004; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Pichat P, 2010, J ADV OXID TECHNOL, V13, P238; Pottier A, 2001, J MATER CHEM, V11, P1116, DOI 10.1039/b100435m; Ohtani B, 2010, J PHOTOCH PHOTOBIO A, V216, P179, DOI 10.1016/j.jphotochem.2010.07.024; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; Takeuchi M, 2005, J PHYS CHEM B, V109, P15422, DOI 10.1021/jp058075i; Chen FN, 2009, BUILD ENVIRON, V44, P1088, DOI 10.1016/j.buildenv.2008.07.018; Paz Y, 1997, J MATER RES, V12, P2759, DOI 10.1557/JMR.1997.0367; Thabet S, 2013, APPL CATAL B-ENVIRON, V140, P169, DOI 10.1016/j.apcatb.2013.03.037; Dantigny P, 2005, INT J FOOD MICROBIOL, V100, P187, DOI 10.1016/j.ijfoodmicro.2004.10.013; Maneerat C, 2006, INT J FOOD MICROBIOL, V107, P99, DOI 10.1016/j.ijfoodmicro.2005.08.018; Prieto-Mahaney OO, 2009, CHEM LETT, V38, P238, DOI 10.1246/cl.2009.238; Boumaaza B., 2015, INT J MICROBIOL, V2015; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; Sushma Dubey, 2011, Journal of Phytology, V3, P13; Markowska-Szczupak A., 2011, CATAL TODAY, V161, P249; Markowska-Szczupak A., 2015, CENT EUR J PUBLIC HL, V3; Ohtani B., 2007, T MAT RES SOC JPN, V32, P401; Fujishima A, 1997, P INDIAN AS-CHEM SCI, V109, P471; Thabet S, 2014, APPL ENVIRON MICROB, V80, P7527, DOI 10.1128/AEM.02416-14; Wang K, 2014, THESIS HOKAIDO U; Zhao J, 2003, BUILD ENVIRON, V38, P645, DOI 10.1016/S0360-1323(02)00212-3	47	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344			J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	OCT	2015	151						54	62		10.1016/j.jphotobiol.2015.07.002		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CT2BT	WOS:000362607700009		
J	Adli, HK; Harada, T; Septina, W; Hozan, S; Ito, S; Ikeda, S				Adli, Hasyiya Karimah; Harada, Takashi; Septina, Wilman; Hozan, Shuji; Ito, Seigo; Ikeda, Shigeru			Effects of Porosity and Amount of Surface Hydroxyl Groups of a Porous TiO2 Layer on the Performance of a CH3NH3PbI3 Perovskite Photovoltaic Cell	JOURNAL OF PHYSICAL CHEMISTRY C			English	Article							SENSITIZED SOLAR-CELL; LOW-TEMPERATURE; LOW-COST; EFFICIENCY; STATE; ELECTRON; DEGRADATION; DEPOSITION; LENGTHS	The structural and physicochemcal properties of a porous titanium oxide layer (pTiO(2)) in CH3NH3PbI3 perovskite photovoltaic cells were systematically investigated by Raman spectroscopy, nitrogen sorption, and temperature desorption spectroscopy analyses. When the heat treatment temperature (T-pTO) during the fabrication of pTiO(2) was changed from 400 to 700 degrees C, its porosity and amount of surface hydroxyl groups were varied without alteration of the crystalline structure (anatase). Power conversion efficiencies (PCEs) of solar cells based on pTiO(2) prepared at different temperatures showed a volcanic-like pattern depending on T-pTO of pTiO(2); the highest PCE was obtained by using pTiO(2) prepared at T-pTO of 550 degrees C. Structural analyses of the CH3NH3PbI3 perovskite part performed by X-ray diffraction indicated that formation of CH3NH3PbI3 perovskite was inhibited by the presence of a large amount of surface hydroxyl groups on pTiO(2) prepared at relatively low T-pTO (<550 degrees C). On the other hand, significant reduction of porosity of pTiO(2) occurred when pTiO(2) was prepared at relatively high T-pTO (>550 degrees C) because of extinction of micropores and sintering between the TiO2 particles; such a structural alteration hindered the penetration of CH3NH3I into the pore channel of TiO2 filled by PbI2, resulting in a large amount of PbI2 remaining in the finally obtained photovoltaic cell. Hence, the optimum T-pTO (550 degrees C) for fabrication of pTiO(2) should be determined by its porous nature and sufficient removal of surface hydroxyl groups.	[Adli, Hasyiya Karimah; Harada, Takashi; Septina, Wilman; Hozan, Shuji; Ikeda, Shigeru] Osaka Univ, Res Ctr Solar Energy Chem, Toyonaka, Osaka 5608531, Japan; [Ito, Seigo] Univ Hyogo, Grad Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712280, Japan	Ikeda, S (reprint author), Osaka Univ, Res Ctr Solar Energy Chem, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	sikeda@chem.es.osaka-u.ac.jp			MEXT Japan; Ministry of Education (Malaysia); University Malaysia Kelantan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (All Nippon Artificial Photosynthesis Project for Living Earth), a Grant-in-Aid for Scientific Research (B), and a Grant-in-Aid for Challenging Exploratory Research from MEXT Japan. One of the authors (H.K.A.) thanks Ministry of Education (Malaysia) and University Malaysia Kelantan for providing a scholarship during the study.	Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Habisreutinger SN, 2014, NANO LETT, V14, P5561, DOI 10.1021/nl501982b; Wang Q, 2014, ENERG ENVIRON SCI, V7, P2359, DOI 10.1039/c4ee00233d; You JB, 2014, ACS NANO, V8, P1674, DOI 10.1021/nn406020d; Liu LM, 2009, PROG SURF SCI, V84, P155, DOI 10.1016/j.progsurf.2009.01.002; Lee JW, 2014, J MATER CHEM A, V2, P9251, DOI 10.1039/c4ta01786b; Jeon NJ, 2014, J AM CHEM SOC, V136, P7837, DOI 10.1021/ja502824c; Edri E, 2014, NANO LETT, V14, P1000, DOI 10.1021/nl404454h; Qiu JH, 2013, NANOSCALE, V5, P3245, DOI 10.1039/c3nr00218g; KANEKO K, 1994, J MEMBRANE SCI, V96, P59, DOI 10.1016/0376-7388(94)00126-X; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Etgar L, 2012, J AM CHEM SOC, V134, P17396, DOI 10.1021/ja307789s; Ryu S, 2014, ENERG ENVIRON SCI, V7, P2614, DOI 10.1039/c4ee00762j; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Wojciechowski K, 2014, ENERG ENVIRON SCI, V7, P1142, DOI 10.1039/c3ee43707h; Chen Q, 2014, NANO LETT, V14, P4158, DOI 10.1021/nl501838y; Han Y, 2015, J MATER CHEM A, V3, P8139, DOI 10.1039/c5ta00358j; Kumar MH, 2013, CHEM COMMUN, V49, P11089, DOI 10.1039/c3cc46534a; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Bass KK, 2014, CHEM COMMUN, V50, P15819, DOI 10.1039/c4cc05231e; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Baikie T, 2013, J MATER CHEM A, V1, P5628, DOI 10.1039/c3ta10518k; Dharani S, 2014, NANOSCALE, V6, P1675, DOI 10.1039/c3nr04857h; Mosconi E, 2015, CHEM MATER, V27, P4885, DOI 10.1021/acs.chemmater.5b01991; Kim HS, 2013, NANO LETT, V13, P2412, DOI 10.1021/nl400286w; Hodes G, 2013, SCIENCE, V342, P317, DOI 10.1126/science.1245473; Wang XM, 2014, MAT SCI SEMICON PROC, V27, P569, DOI 10.1016/j.mssp.2014.07.039; Ogomi Y, 2014, J PHYS CHEM C, V118, P16651, DOI 10.1021/jp412627n; Conings B, 2014, ADV MATER, V26, P2041, DOI 10.1002/adma.201304803; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Park NG, 2013, J PHYS CHEM LETT, V4, P2423, DOI 10.1021/jz400892a; Snaith HJ, 2013, J PHYS CHEM LETT, V4, P3623, DOI 10.1021/jz4020162; Christians JA, 2015, J AM CHEM SOC, V137, P1530, DOI 10.1021/ja511132a; Docampo P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3761; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885; Murugadoss G., 2014, APL MATER, V2; National Renewable Energy Laboratory, BEST RES CELL EFF; Smith I. C., 2014, ANGEW CHEM, V126, P11414; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167	44	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1932-7447			J PHYS CHEM C	J. Phys. Chem. C	OCT 1	2015	119	39					22304	22309		10.1021/acs.jpcc.5b05986		6	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CS9CC	WOS:000362385700007		
J	Maeda, H; Sakamoto, R; Nishihara, H				Maeda, Hiroaki; Sakamoto, Ryota; Nishihara, Hiroshi			Rapid Electron Transport Phenomenon in the Bis(terpyridine) Metal Complex Wire: Marcus Theory and Electrochemical Impedance Spectroscopy Study	JOURNAL OF PHYSICAL CHEMISTRY LETTERS			English	Article							SELF-ASSEMBLED MONOLAYERS; MOLECULAR WIRES; PEPTIDE MONOLAYERS; OLIGOMER WIRES; VOLTAMMETRY; CONDUCTION; SURFACE; GOLD	The authors reported previously that bis(terpyiridne)iron(II) complex oligomer wires possess outstanding long-range intrawire electron transport ability. Here, molecular arrays of gold-electrode bis(terpyridine)iron(II) ferrocene are constructed by stepwise coordination as simple models of the oligomer wire system. The fast electron transfer between the terminal ferrocene and the gold electrode through the bis(terpyiridne)iron(II) complex unit is studied by potential step chronoamperometry (PSCA) and electrochemical impedance spectroscopy (EIS). Tafel plots derived from PSCA are analyzed based on Marcus theory. The plots reveal greater first-order electron transfer rate constant, weaker electronic coupling between the terminal ferrocene and the gold electrode, and smaller reorganization energy than shown by a conventional ferrocenylalkanethiol self-assembled monolayer. The electron transfer rate constants estimated by EIS agree with the PSCA results.	[Maeda, Hiroaki; Sakamoto, Ryota; Nishihara, Hiroshi] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Sakamoto, R (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sakamoto@chem.s.u-tokyo.ac.jp; nisihara@chem.s.u-tokyo.ac.jp	Nishihara, Hiroshi/B-4755-2012		MEXT of Japan [25107510, 26708005, 26107510, 26620039, 15H00862, 15K13654]; Ogasawara Foundation for the Promotion of Science & Engineering, Noguchi Institute; Tokuyama Science Foundation; Asahi Glass Foundation; Murata Science Foundation; Iketani Science and Technology Foundation; Japan Prize Foundation; Kao Foundation for Arts and Sciences; Japan Association for Chemical Innovation; MIKIYA Science and Technology Foundation; Yazaki Memorial Foundation for Science and Technology; Shorai Foundation for Science and Technology; Hitachi Global Foundation; Kumagai Foundation for Science and Technology; Foundation for Interaction in Science & Technology (FIST); Foundation for The Promotion of Ion Engineering	The present communication is supported by Grants-in-Aid from MEXT of Japan (Nos. 25107510, 26708005, 26107510, 26620039, 15H00862, 15K13654, areas 2406 [All Nippon Artificial Photosynthesis Project for Living Earth], 2506 [Science of Atomic Layers], and 2509 [Molecular Architectonics]). R.S. is grateful to Ogasawara Foundation for the Promotion of Science & Engineering, Noguchi Institute, Tokuyama Science Foundation, Asahi Glass Foundation, The Murata Science Foundation, Iketani Science and Technology Foundation, The Japan Prize Foundation, Kao Foundation for Arts and Sciences, Japan Association for Chemical Innovation, The MIKIYA Science and Technology Foundation, Yazaki Memorial Foundation for Science and Technology, Shorai Foundation for Science and Technology, The Hitachi Global Foundation, Kumagai Foundation for Science and Technology, Foundation for Interaction in Science & Technology (FIST), and The Foundation for The Promotion of Ion Engineering for financial supports.	Brooksby PA, 2010, LANGMUIR, V26, P1334, DOI 10.1021/la902402t; Katagiri S, 2013, CHEM-EUR J, V19, P5088, DOI 10.1002/chem.201203913; Sikes HD, 2001, SCIENCE, V291, P1519, DOI 10.1126/science.1055745; Hong WJ, 2012, J AM CHEM SOC, V134, P19425, DOI 10.1021/ja307544w; Nishimori Y, 2009, CHEM-ASIAN J, V4, P1361, DOI 10.1002/asia.200900072; CHIDSEY CED, 1991, SCIENCE, V251, P919, DOI 10.1126/science.251.4996.919; Abhayawardhana AD, 2009, J PHYS CHEM C, V113, P4915, DOI 10.1021/jp807287p; Takeda K, 2008, J PHYS CHEM B, V112, P12840, DOI 10.1021/jp805711v; Okamoto S, 2009, LANGMUIR, V25, P3297, DOI 10.1021/la8034962; Morita T, 2003, J AM CHEM SOC, V125, P8732, DOI 10.1021/ja034872n; Sakamoto R, 2015, J AM CHEM SOC, V137, P734, DOI 10.1021/ja509470w; Giacalone F, 2004, J AM CHEM SOC, V126, P5340, DOI 10.1021/ja0318333; WEBER K, 1994, ANAL CHEM, V66, P3164, DOI 10.1021/ac00091a027; Eckermann AL, 2010, COORDIN CHEM REV, V254, P1769, DOI 10.1016/j.ccr.2009.12.023; Sek S, 2002, J PHYS CHEM B, V106, P5907, DOI 10.1021/jp013896i; Li ZH, 2012, NANO LETT, V12, P2722, DOI 10.1021/nl2043216; Kurita T, 2010, J AM CHEM SOC, V132, P4524, DOI 10.1021/ja910462x; Creager SE, 1998, ANAL CHEM, V70, P4257, DOI 10.1021/ac980482l; Yamamoto H, 2002, J PHYS CHEM B, V106, P7469, DOI 10.1021/jp014612x; Boubour E, 2000, J PHYS CHEM B, V104, P9004, DOI 10.1021/jp000151o; Arikuma Y, 2009, J PHYS CHEM B, V113, P6256, DOI 10.1021/jp810200x; Bard AJ, 2001, ELECTROCHEMICAL METH; Li Q, 2012, J PHYS CHEM C, V116; Sakamoto R, 2015, CHEM SOC REV, DOI [10.1039/C5CS00081E, DOI 10.1039/C5CS00081E]	24	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7185			J PHYS CHEM LETT	J. Phys. Chem. Lett.	OCT 1	2015	6	19					3821	3826		10.1021/acs.jpclett.5b01725		6	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Atomic, Molecular & Chemical	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CS9ED	WOS:000362391000008		
J	Enami, S; Hoffmann, MR; Colussi, AJ				Enami, Shinichi; Hoffmann, Michael R.; Colussi, Agustin J.			OH-Radical Specific Addition to Glutathione S-Atom at the Air-Water Interface: Relevance to the Redox Balance of the Lung Epithelial Lining Fluid	JOURNAL OF PHYSICAL CHEMISTRY LETTERS			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FINE PARTICULATE MATTER; SULFENIC ACID FORMATION; THIYL RADICALS; ELECTRON-TRANSFER; ALPHA-TOCOPHEROL; PHYSIOLOGICAL PH; AQUEOUS-SOLUTION; UNITED-STATES; AMBIENT OZONE	Antioxidants in epithelial lining fluids (ELF) prevent inhaled air pollutants from reaching lung tissue. This process, however, may upset ELF's redox balance, which is deemed to be expressed by the ratio of the major antioxidant glutathione (GSH) to its putative oxidation product GSSG. Previously, we found that at physiological pH O-3(g) rapidly oxidizes GS(2-)(aq) (but not GSH(-)) to GSO(3)(-) rather than GSSG. Here, we report that in moderately acidic pH <= 5 media center dot OH(g) oxidizes GSH(-)(aq) to sulfenic GSOH(-), sulfinic GSO(2)(-), and sulfonic GSO(3)(-) acids via center dot OH specific additions to reduced S-atoms. The remarkable specificity of center dot OH on water versus its lack of selectivity in bulk water implicates an unprecedented steering process during [OH...GSH] interfacial encounters. Thus, both O-3 and center dot OH oxidize GSH to GSOH(-) under most conditions, and since GSOH(-) is reduced back to GSH in vivo by NADPH, redox balance may be in fact signaled by GSH/GSOH ratios.	[Enami, Shinichi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068302, Japan; [Enami, Shinichi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji 6110011, Japan; [Enami, Shinichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Hoffmann, Michael R.; Colussi, Agustin J.] CALTECH, Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA	Enami, S (reprint author), Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068302, Japan.	enami.shinichi.3r@kyoto-u.ac.jp; ajcoluss@caltech.edu	Colussi, Agustin/C-6520-2008; ENAMI, SHINICHI/C-6974-2008		National Science Foundation (U.S.A.) [AC-1238977]	We gratefully acknowledge Dr. Tao Cheng and Prof. Bill Goddard of Caltech for helpful discussions. S. E. is grateful to the Research Foundation for Opto-Science and Technology, the Kurita Water and Environment Foundation, and the Japan Science and Technology Agency (JST) PRESTO program. S. E. also thanks Prof. Hiroshi Masuhara for stimulating discussions. M. R. H. and A. J. C. acknowledge support from the National Science Foundation (U.S.A.) Grant AC-1238977.	Poschl U, 2015, CHEM REV, V115, P4440, DOI 10.1021/cr500487s; Amos RIJ, 2015, J PHYS CHEM B, V119, P783, DOI 10.1021/jp505217q; Charrier JG, 2015, ATMOS CHEM PHYS, V15, P2327, DOI 10.5194/acp-15-2327-2015; Enami S, 2009, J PHYS CHEM B, V113, P7977, DOI 10.1021/jp902667x; Enami S, 2015, J PHYS CHEM LETT, V6, P527, DOI 10.1021/jz502432j; Waring C, 2011, PHYS CHEM CHEM PHYS, V13, P8457, DOI 10.1039/c0cp02734k; MCKEE ML, 1993, J PHYS CHEM-US, V97, P10971, DOI 10.1021/j100144a013; Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Merenyi G, 1996, J PHYS CHEM-US, V100, P8875, DOI 10.1021/jp953613k; Dominici F, 2014, SCIENCE, V344, P257, DOI 10.1126/science.1247348; Fiser B, 2011, J PHYS CHEM B, V115, P11269, DOI 10.1021/jp2049525; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; WARREN DL, 1987, TOXICOL APPL PHARM, V88, P203, DOI 10.1016/0041-008X(87)90006-8; Butkovskaya NI, 1999, J PHYS CHEM A, V103, P6921, DOI 10.1021/jp9914828; PRUTZ WA, 1994, BIOPHYS CHEM, V49, P101, DOI 10.1016/0301-4622(93)E0057-C; Vieceli J, 2005, J PHYS CHEM B, V109, P15876, DOI 10.1021/jp051361+; Mezyk SP, 1996, J PHYS CHEM-US, V100, P8861, DOI 10.1021/jp9535553; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Gehling W, 2014, ENVIRON SCI TECHNOL, V48, P4266, DOI 10.1021/es401770y; Ford E, 2002, FREE RADICAL BIO MED, V32, P1314, DOI 10.1016/S0891-5849(02)00850-X; Oakes M, 2012, ENVIRON SCI TECHNOL, V46, P6637, DOI 10.1021/es300701c; Enami S, 2009, J PHYS CHEM A, V113, P7002, DOI 10.1021/jp901712k; Michalek RD, 2007, J IMMUNOL, V179, P6456; Nauser T, 2012, J PHYS CHEM B, V116, P5329, DOI 10.1021/jp210954v; Madej E, 2007, ARCH BIOCHEM BIOPHYS, V462, P94, DOI 10.1016/j.abb.2007.03.002; Pope CA, 2014, AM J RESP CRIT CARE, V190, P485, DOI 10.1164/rccm.201407-1346ED; Hofstetter D, 2010, CHEM RES TOXICOL, V23, P1596, DOI 10.1021/tx100185k; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Zielinski H, 1999, AM J PHYSIOL-LUNG C, V277, pL719; Scheiner S, 2010, J AM CHEM SOC, V132, P16450, DOI 10.1021/ja105204v; Enami S, 2008, P NATL ACAD SCI USA, V105, P7365, DOI 10.1073/pnas.0710791105; Roeselova M, 2004, J AM CHEM SOC, V126, P16308, DOI 10.1021/ja045552m; Franklin M, 2008, ENVIRON HEALTH PERSP, V116, P453, DOI 10.1289/ehp.10777; Muino PL, 2005, J COMPUT CHEM, V26, P612, DOI 10.1002/jcc.20195; Hoffman S, 2015, J CELL BIOCHEM, V116, P884, DOI 10.1002/jcb.25017; Kalyanaraman B, 1996, ANAL BIOCHEM, V241, P75, DOI 10.1006/abio.1996.0380; Schlesinger RB, 2006, INHAL TOXICOL, V18, P95, DOI 10.1080/08958370500306016; Enami S, 2009, CHEM RES TOXICOL, V22, P35, DOI 10.1021/tx800298j; Anglada JM, 2015, ACCOUNTS CHEM RES, V48, P575, DOI 10.1021/ar500412p; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Kameel FR, 2014, J PHYS CHEM C, V118, P29151, DOI 10.1021/jp505010e; SCHONEICH C, 1994, J PHYS CHEM-US, V98, P12613, DOI 10.1021/j100099a026; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Kleinman MT, 2006, INHAL TOXICOL, V18, P295, DOI 10.1080/08958370500444346; MONIG J, 1987, INT J RADIAT BIOL, V52, P589, DOI 10.1080/09553008714552081; Vila-Vicosa D, 2013, J PHYS CHEM B, V117, P7507, DOI 10.1021/jp401066v; Vidrio E, 2009, ENVIRON SCI TECHNOL, V43, P922, DOI 10.1021/es801653u; Enami S, 2009, J PHYS CHEM B, V113, P9356, DOI 10.1021/jp904316n; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152; Bagot PAJ, 2008, J PHYS CHEM C, V112, P10868, DOI 10.1021/jp8024683; STENZEL JD, 1993, FREE RADICAL BIO MED, V14, P531, DOI 10.1016/0891-5849(93)90110-G; Enami S, 2008, J PHYS CHEM B, V112, P4153, DOI 10.1021/jp712010k; Cross CE, 1998, ENVIRON HEALTH PERSP, V106, P1241, DOI 10.2307/3433992; Ricciardolo FLM, 2004, J ALLERGY CLIN IMMUN, V113, P610, DOI 10.1016/j.jaci.2003.12.034; Enami S, 2014, J PHYS CHEM A, V118, P4130, DOI 10.1021/jp503387e; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; Alaghmand M, 2011, TOXICOL ENVIRON CHEM, V93, P955, DOI 10.1080/02772248.2011.571810; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Shen H, 2011, ATMOS CHEM PHYS, V11, P9671, DOI 10.5194/acp-11-9671-2011; SJOBERG L, 1982, RADIAT RES, V89, P255, DOI 10.2307/3575771; ABEDINZADEH Z, 1992, RADIAT PHYS CHEM, V40, P551; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Maynard RL, 2015, CELL BIOL TOXICOL, V31, P131, DOI 10.1007/s10565-015-9296-7; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI 10.1089/ARS.2008.2425; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Enami S, 2014, P NATL ACAD SCI USA, V111, P623, DOI 10.1073/pnas.1314885111; Wessels A, 2010, ENVIRON SCI TECHNOL, V44, P3539, DOI 10.1021/es9036226; Solomon PA, 2011, ATMOS ENVIRON, V45, P7537, DOI 10.1016/j.atmosenv.2011.10.050; Cox LA, 2015, ANN EPIDEMIOL, V25, P162, DOI 10.1016/j.annepidem.2014.11.006; Davidovits P, 2011, CHEM REV, V111, pPR76, DOI 10.1021/cr100360b; Enami S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803652; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-31; Fiser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073652; Flohe L, 2010, METHOD ENZYMOL, V473, P1, DOI 10.1016/S0076-6879(10)73001-9; Gali NK, 2015, ENVIRON POLLUT, V198, P86, DOI 10.1016/j.envpol.2015.01.001; Ghio AJ, 2007, AM J PHYSIOL-LUNG C, V292, pL134, DOI 10.1152/ajplung.00534.2005; Gutteridge J.M.C., 2007, FREE RADICALS BIOL M; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Miyakawa T, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009493; Nauser T, 2015, FREE RADICAL BIO MED, V80, P158, DOI 10.1016/j.freeradbiomed.2014.12.006; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Poole LB, 2015, FREE RADICAL BIO MED, V80, P145, DOI 10.1016/j.freeradbiomed.2015.02.005; Reynaert NL, 2011, BBA-GEN SUBJECTS, V1810, P1045, DOI 10.1016/j.bbagen.2011.01.010; US EPA - National Center Environ Assessment, 2009, INT SCI ASS PART MAT; Winterbourn CC, 2015, FREE RADICAL BIO MED, V80, P164, DOI 10.1016/j.freeradbiomed.2014.08.017; Zhou MG, 2015, ENVIRON RES, V136, P396, DOI 10.1016/j.envres.2014.09.038	90	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7185			J PHYS CHEM LETT	J. Phys. Chem. Lett.	OCT 1	2015	6	19					3935	3943		10.1021/acs.jpclett.5b01819		9	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Atomic, Molecular & Chemical	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CS9ED	WOS:000362391000027		
J	Okayama, A; Miyagi, Y; Oshita, F; Ito, H; Nakayama, H; Nishi, M; Kurata, Y; Kimura, Y; Ryo, A; Hirano, H				Okayama, Akiko; Miyagi, Yohei; Oshita, Fumihiro; Ito, Hiroyuki; Nakayama, Haruhiko; Nishi, Mayuko; Kurata, Yoichi; Kimura, Yayoi; Ryo, Akihide; Hirano, Hisashi			Identification of Tyrosine-Phosphorylated Proteins Upregulated during Epithelial-Mesenchymal Transition Induced with TGF-beta	JOURNAL OF PROTEOME RESEARCH			English	Article						lung adenocarcinoma; tyrosine phosphotylation; epithelial-mesenchymal transition (EMT); transforming growth factor-beta (TGF-beta); tensin-1 (TNS1); hepatocyte growth factor receptor (c-Met); NT-3 growth factor receptor (TrkC); prognostic prediction marker; therapeutic target	HEPATOCYTE GROWTH-FACTOR; CELL LUNG-CANCER; C-MET; FACTOR RECEPTOR; PROTEOMIC ANALYSIS; KINASE; ADENOCARCINOMA; ACTIVATION; MUTATIONS; REVEALS	The epithelial-to-mesenchymal transition (EMT) is a unique process for the phenotypic changes of tumor cells characterized by a transition from polarized rigid epithelial cells to migrant mesenchymal cells, thus conferring the ability of tumor invasion and metastasis. A major challenge in the treatment of lung adenocarcinoma is to identify early stage patients at a high risk of recurrence or metastasis, thereby permitting the best therapeutic strategy and prognosis. In this study, we used a transforming growth factor-beta (TGF-beta)-induced EMT model to quantitatively identify protein tyrosine phosphorylation during the course of EMT in relation to malignant characteristics of lung adeno carcinoma cells. We performed relative quantitation analysis of tyrosine-phosphorylated peptides in TGF-beta-treated and -untreated lung adenocarcinoma cells and identified tyrosine-phosphorylated proteins that were upregulated in TGF-beta-treated cells. These include tensin-1 (TNS1) phosphorylated on Y1404, hepatocyte growth factor receptor (c-Met) phosphorylated on Y1234, and NT-3 growth factor receptor (TrkC) phosphorylated on Y516. We also found that these protein phosphorylation profiles were specifically observed in tissue samples of patients with poor prognostic lung adenocarcinoma. Tyrosine phosphorylations of these proteins represent possible candidates of prognostic prediction markers for lung adenocarcinoma.	[Okayama, Akiko; Kurata, Yoichi; Kimura, Yayoi; Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Miyagi, Yohei] Kanagawa Canc Ctr Res Inst, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Oshita, Fumihiro; Ito, Hiroyuki; Nakayama, Haruhiko] Kanagawa Canc Ctr, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Nishi, Mayuko; Ryo, Akihide] Yokohama City Univ, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Ryo, A (reprint author), Yokohama City Univ, Grad Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp; hirano@yokohama-cu.ac.jp			special coordination funds for promoting science and technology at the "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" in the "Project for Developing Innovation Systems"; Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by special coordination funds for promoting science and technology at the "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" in the "Project for Developing Innovation Systems" to H.H. The depository of frozen cancer tissues used in this study was partially supported by the Scientific Support Programs for Cancer Research, Grant-in-Aid for Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology to Y.M.	Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Nakamura T, 1997, CANCER RES, V57, P3305; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Chen YX, 2010, AM J NEPHROL, V31, P24, DOI 10.1159/000253865; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Hallbook F, 1999, CURR OPIN NEUROBIOL, V9, P616, DOI 10.1016/S0959-4388(99)00011-2; Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885; Wang WL, 2000, ONCOGENE, V19, P3521, DOI 10.1038/sj.onc.1203698; de Caestecker MP, 2000, J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; LONGATI P, 1994, ONCOGENE, V9, P49; Naruke T, 2001, ANN THORAC SURG, V71, P1759, DOI 10.1016/S0003-4975(00)02609-6; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Koga K, 2013, LUNG CANCER, V82, P413, DOI 10.1016/j.lungcan.2013.09.005; Pernemalm M, 2013, J PROTEOME RES, V12, P3934, DOI 10.1021/pr4002096; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Kondo T, 2002, LUNG CANCER-J IASLC, V36, P49, DOI 10.1016/S0169-5002(01)00448-2; Hall EH, 2010, MOL CELL PROTEOMICS, V9, P2853, DOI 10.1074/mcp.M110.003665; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Jin W, 2007, ONCOGENE, V26, P7684, DOI 10.1038/sj.onc.1210571; Tokunou M, 2001, AM J PATHOL, V158, P1451, DOI 10.1016/S0002-9440(10)64096-5; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Domanski D, 2010, ANAL CHEM, V82, P5610, DOI 10.1021/ac1005553; Ali NA, 2011, PROTEOMICS, V11, P3390, DOI 10.1002/pmic.201100036; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kikuchi T, 2012, MOL CELL PROTEOMICS, V11, P916, DOI 10.1074/mcp.M111.015370; Cristiani C, 2005, BIOCHEMISTRY-US, V44, P14110, DOI 10.1021/bi051242k; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Ohtsuki S, 2011, J PHARM SCI-US, V100, P3547, DOI 10.1002/jps.22612; Reka AK, 2014, CARCINOGENESIS, V35, P1292, DOI 10.1093/carcin/bgu041; Nagata K, 2015, J PROTEOMICS, V115, P132, DOI 10.1016/j.jprot.2014.12.012; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Okayama A, 2014, J PROTEOME RES, V13, P4686, DOI 10.1021/pr4012969; Petch Leslie A., 1995, Journal of Cell Science, V108, P1371; Schliekelman M. J., 2015, CANCER RES, V75, P5; Sitek Barbara, 2012, Methods Mol Biol, V893, P241, DOI 10.1007/978-1-61779-885-6_16; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822	48	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	OCT	2015	14	10					4127	4136		10.1021/acs.jproteome.5b00082		10	Biochemical Research Methods	Biochemistry & Molecular Biology	CS9BW	WOS:000362385100004		
J	Hanzawa, H; Sakamoto, T; Kaneko, A; Manri, N; Zhao, Y; Zhao, SJ; Tamaki, N; Kuge, YJ				Hanzawa, Hiroko; Sakamoto, Takeshi; Kaneko, Akihito; Manri, Naomi; Zhao, Yan; Zhao, Songji; Tamaki, Nagara; Kuge, Yuji			Combined Plasma and Tissue Proteomic Study of Atherogenic Model Mouse: Approach To Elucidate Molecular Determinants in Atherosclerosis Development	JOURNAL OF PROTEOME RESEARCH			English	Article						proteomic study; apoE deficient mouse; atherosclerosis; inflammation; complement; coagulation; fibrinolysis; extracellular matrix; macrophage	APOLIPOPROTEIN-E-DEFICIENT; CORONARY-ARTERY-DISEASE; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MICE; BIOMARKERS; COMPLEMENT; HYPERCHOLESTEROLEMIA; INFLAMMATION; COMPONENTS	Atherogenic cardiovascular diseases are the major cause of mortality. Prevention and prediction of incidents is important; however, biomarkers that directly reflect the disease progression remain poorly investigated. To elucidate molecular determinants of atherogenesis, proteomic approaches are advantageous by using model animals for comparing changes occurring systematically (bloodstream) and locally (lesion) in accordance with the disease progression stages. We conducted differential mass spectrometric analysis between apolipoprotein E deficient (apoED) and wild-type (wt) mice using the plasma and arterial tissue of both types of mice obtained at four pathognomonic time points of the disease. A total of 100 proteins in the plasma and 390 in the arterial tissues were continuously detected throughout the four time points; 29 were identified in common. Of those, 13 proteins in the plasma and 36 in the arterial tissues showed significant difference in abundance between the apoED and wt mice at certain time points. Importantly, we found that quantitative variation patterns regarding the pathognomonic time points did not always correspond between the plasma and arterial tissues, resulting in gaining insight into atherosclerotic plaque progression. These characteristic proteins were found to be components of inflammation, thrombus formation, and vascular remodeling, suggesting drastic and integrative alteration in accordance with atherosclerosis development.	[Hanzawa, Hiroko] Hitachi Ltd, Res & Dev Grp, Ctr Exploratory Res, Hatoyama, Saitama 3500395, Japan; [Sakamoto, Takeshi; Kaneko, Akihito; Manri, Naomi] Hitachi Ltd, Res & Dev Grp, Ctr Technol Innovat Healthcare, Kokubunji, Tokyo 1858601, Japan; [Hanzawa, Hiroko; Manri, Naomi; Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido 0600814, Japan; [Sakamoto, Takeshi; Zhao, Yan; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Sapporo, Hokkaido 0608638, Japan; [Zhao, Songji] Hokkaido Univ, Grad Sch Med, Dept Tracer Kinet & Bioanal, Sapporo, Hokkaido 0608638, Japan; [Kuge, Yuji] Hokkaido Univ, Grad Sch Med, Dept Integrated Mol Imaging, Sapporo, Hokkaido 0608638, Japan	Sakamoto, T (reprint author), Hitachi Ltd, Res & Dev Grp, Ctr Technol Innovat Healthcare, Kokubunji, Tokyo 1858601, Japan.	takeshi.sakamoto.yg@hitachi.com			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was supported in part by the grant "The matching program for innovations in future drug discovery and medical care" from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to N.T.). The authors thank Drs. Koichi Kokame, Hiroyasu Inoue, Chiaki Yokota, and Yoichi Shimizu for their valuable discussions, Dr. Hirokazu Nishida for his critical reading of the manuscript, and Yuko Komori, Yumi Yanagiya, and Megumi Hikichi for their technical assistance.	REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Suski M, 2011, J PROTEOMICS, V74, P887, DOI 10.1016/j.jprot.2011.03.003; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Yamada M, 2013, ALCOHOL CLIN EXP RES, V37, pE79, DOI 10.1111/j.1530-0277.2012.01883.x; von zur Muhlen C, 2009, J PROTEOME RES, V8, P335, DOI 10.1021/pr800615t; Zhao Y, 2008, J NUCL MED, V49, P1707, DOI 10.2967/jnumed.108.051847; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Yokosuka T, 2006, RAPID COMMUN MASS SP, V20, P2589, DOI 10.1002/rcm.2595; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133; Jing LH, 2011, PROTEOMICS, V11, P2763, DOI 10.1002/pmic.201000202; Wang XK, 2010, ADV CLIN CHEM, V50, P1, DOI 10.1016/S0065-2423(10)50001-5; Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; AMBROSE JA, 1992, J AM COLL CARDIOL, V19, P1653; Seo D, 2004, ARTERIOSCL THROM VAS, V24, P1922, DOI 10.1161/01.ATV.0000141358.65242.1f; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Speidl WS, 2011, J THROMB HAEMOST, V9, P428, DOI 10.1111/j.1538-7836.2010.04172.x; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Tabibiazar R, 2006, PHYSIOL GENOMICS, V25, P194, DOI 10.1152/physiolgenomics.00240.2005; Mayr M, 2005, ARTERIOSCL THROM VAS, V25, P2135, DOI 10.1161/01.ATV.0000183928.25844.f6; Ritorto MS, 2011, J PROTEOME RES, V10, P3012, DOI 10.1021/pr101207t; Uchida Y, 2011, ARTERIOSCL THROM VAS, V31, P1452, DOI 10.1161/ATVBAHA.110.221671; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Tabibiazar R, 2005, PHYSIOL GENOMICS, V22, P213, DOI 10.1152/physiolgenomics.00001.2005; Clutterbuck AL, 2011, J PROTEOMICS, V74, P704, DOI 10.1016/j.jprot.2011.02.017; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Cimmino Giovanni, 2011, Expert Rev Cardiovasc Ther, V9, P517, DOI 10.1586/erc.11.40; Matsushima Y, 2001, J Atheroscler Thromb, V8, P71; RAO A G, 1984, Complement, V1, P182; Ross R, 1999, NEW ENGL J MED, V340, P115; von zur Muhlen C., 2012, MOL CELL PROTEOMICS, V11, P1; Xu JY, 2014, BBA-MOL BASIS DIS, V1842, P2106, DOI 10.1016/j.bbadis.2014.07.008	41	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	OCT	2015	14	10					4257	4269		10.1021/acs.jproteome.5b00405		13	Biochemical Research Methods	Biochemistry & Molecular Biology	CS9BW	WOS:000362385100015		
J	Yamaguchi, M; Ando, M; Kato, S; Katsuno, T; Kato, N; Kosugi, T; Sato, W; Tsuboi, N; Yasuda, Y; Mizuno, M; Ito, Y; Matsuo, S; Maruyama, S				Yamaguchi, Makoto; Ando, Masahiko; Kato, Sawako; Katsuno, Takayuki; Kato, Noritoshi; Kosugi, Tomoki; Sato, Waichi; Tsuboi, Naotake; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi			Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse	JOURNAL OF RHEUMATOLOGY			English	Article						ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; ANCA-ASSOCIATED VASCULITIS; GRANULOMATOSIS WITH POLYANGIITIS; MICROSCOPIC POLYANGIITIS; ANCA LEVEL; RELAPSE	WEGENERS-GRANULOMATOSIS; DISEASE-ACTIVITY; CRESCENTIC GLOMERULONEPHRITIS; MICROSCOPIC POLYANGIITIS; METHOTREXATE; THERAPY; MYELOPEROXIDASE; CLASSIFICATION; AUTOANTIBODIES; PROTEINASE-3	Objective. The diagnostic values of antiproteinase 3 and antimyeloperoxidase tests using antineutrophil cytoplasmic antibodies (ANCA) are well established. Our study determined whether an increase in ANCA level was a predictor of disease flareup. Methods. Our study included 126 patients with ANCA-associated renal vasculitis treated at 9 nephrology centers in Japan. The relationship between increased ANCA levels and relapse was assessed using time-dependent multivariate Cox regression models adjusted for clinically relevant factors. The outcome of interest was the time from remission to first relapse. Results. During the observation period [median 41 mos, interquartile range (IQR) 23-66 mos], 118 patients (95.8%) achieved remission at least once. After achieving remission, 34 patients relapsed (21.7%). Time-dependent multivariate Cox regression models revealed that lung involvement (adjusted HR 2.29, 95% CI 1.13-4.65, p = 0.022) and increased ANCA levels (adjusted HR 17.4, 95% CI 8.42-36.0, p < 0.001) were significantly associated with relapse. The median time from ANCA level increase to relapse was 0.6 months (IQR 0-2.1 mos). Conclusion. In our study, an increase in ANCA level during remission was associated with a risk of disease relapse. A rise in ANCA level may be useful for guiding treatment decisions in appropriate subsets of patients with ANCA-associated vasculitis.	[Yamaguchi, Makoto; Kato, Sawako; Katsuno, Takayuki; Kato, Noritoshi; Kosugi, Tomoki; Tsuboi, Naotake; Yasuda, Yoshinari; Mizuno, Masashi; Ito, Yasuhiko; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4668550, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Sato, Waichi] Fujita Hlth Univ, Sch Med, Dept Internal Med, Toyoake, Aichi 47011, Japan	Maruyama, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	marus@med.nagoya-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan	Supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labor, and Welfare of Japan.	TERVAERT JWC, 1990, KIDNEY INT, V37, P799, DOI 10.1038/ki.1990.48; Finkielman JD, 2007, ANN INTERN MED, V147, P611; Nachman PH, 1996, J AM SOC NEPHROL, V7, P33; Hogan SL, 2005, ANN INTERN MED, V143, P621; Reinhold-Keller E, 2000, ARTHRITIS RHEUM, V43, P1021, DOI 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J; Boomsma MM, 2000, ARTHRITIS RHEUM, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Hoffman GS, 1998, ARTHRITIS RHEUM, V41, P1521, DOI 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A; TERVAERT JWC, 1990, LANCET, V336, P709; Reinhold-Keller E, 2002, ARTHRIT RHEUM-ARTHR, V47, P326, DOI 10.1002/art.10459; Watts RA, 2008, NEPHROL DIAL TRANSPL, V23, P3928, DOI 10.1093/ndt/gfn354; Koldingsnes W, 2002, RHEUMATOLOGY, V41, P572, DOI 10.1093/rheumatology/41.5.572; Birck R, 2006, AM J KIDNEY DIS, V47, P15, DOI 10.1053/j.ajkd.2005.09.022; de Groot K, 2005, ARTHRITIS RHEUM, V52, P2461, DOI 10.1002/art.21142; Stone JH, 1999, J RHEUMATOL, V26, P1134; SNELLER MC, 1995, ARTHRITIS RHEUM, V38, P608, DOI 10.1002/art.1780380505; SAVAGE COS, 1985, Q J MED, V56, P467; Russell KA, 2001, ARTHRITIS RHEUM, V44, P463, DOI 10.1002/1529-0131(200102)44:2<463::AID-ANR65>3.0.CO;2-9; Chen M, 2008, J RHEUMATOL, V35, P448; Ito-Ihara T, 2008, CLIN EXP RHEUMATOL, V26, P1027; Han WK, 2003, KIDNEY INT, V63, P1079, DOI 10.1046/j.1523-1755.2003.00821.x; Watts Richard, 2007, Ann Rheum Dis, V66, P222, DOI 10.1136/ard.2006.054593; FAUCI AS, 1983, ANN INTERN MED, V98, P76; Weidanz F, 2007, AM J KIDNEY DIS, V50, P36, DOI 10.1053/j.ajkd.2007.04.018; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Goupil R, 2013, CLIN J AM SOC NEPHRO, V8, P416, DOI 10.2215/CJN.07300712; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Savige J, 2000, KIDNEY INT, V57, P846, DOI 10.1046/j.1523-1755.2000.057003846.x; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488; Kemna MJ, 2015, J AM SOC NEPHROL, V26, P537, DOI 10.1681/ASN.2013111233; LUQMANI RA, 1994, Q J MED, V87, P671; Ntatsaki E, 2014, RHEUMATOLOGY, V53, P2306, DOI 10.1093/rheumatology/ket445; Sada KE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4550; Stone JH, 2005, NEW ENGL J MED, V352, P351	34	1	1	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	OCT	2015	42	10					1853	1860		10.3899/jrheum.141622		8	Rheumatology	Rheumatology	CS7AC	WOS:000362234900019		
J	Hotta, T; Nishiguchi, S; Fukutani, N; Tashiro, Y; Adachi, D; Morino, S; Shirooka, H; Nozaki, Y; Hirata, H; Yamaguchi, M; Aoyama, T				Hotta, Takayuki; Nishiguchi, Shu; Fukutani, Naoto; Tashiro, Yuto; Adachi, Daiki; Morino, Saori; Shirooka, Hidehiko; Nozaki, Yuma; Hirata, Hinako; Yamaguchi, Moe; Aoyama, Tomoki			FUNCTIONAL MOVEMENT SCREEN FOR PREDICTING RUNNING INJURIES IN 18-TO 24-YEAR-OLD COMPETITIVE MALE RUNNERS	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						distance runner; screening; dynamic assessment; risk factor	RISK-FACTORS; RELIABILITY; PERFORMANCE; SCORES	Hotta, T, Nishiguchi, S, Fukutani, N, Tashiro, Y, Adachi, D, Morino, S, Shirooka, H, Nozaki, Y, Hirata, H, Yamaguchi, M, and Aoyama, T. Functional movement screen for predicting running injuries in 18- to 24-year-old competitive male runners. J Strength Cond Res 29(10): 2808-2815, 2015The purpose of this study was to investigate whether the functional movement screen (FMS) could predict running injuries in competitive runners. Eighty-four competitive male runners (average age = 20.0 +/- 1.1 years) participated. Each subject performed the FMS, which consisted of 7 movement tests (each score range: 0-3, total score range: 0-21), during the preseason. The incidence of running injuries (time lost because of injury 4 weeks) was investigated through a follow-up survey during the 6-month season. Mann-Whitney U-tests were used to investigate which movement tests were significantly associated with running injuries. The receiver-operator characteristic (ROC) analysis was used to determine the cutoff. The mean FMS composite score was 14.1 +/- 2.3. The ROC analysis determined the cutoff at 14/15 (sensitivity = 0.73, specificity = 0.54), suggesting that the composite score had a low predictability for running injuries. However, the total scores (0-6) from the deep squat (DS) and active straight leg raise (ASLR) tests (DS and ASLR), which were significant with the U-test, had relatively high predictability at the cutoff of 3/4 (sensitivity = 0.73, specificity = 0.74). Furthermore, the multivariate logistic regression analysis revealed that the DS and ASLR scores of 3 significantly influenced the incidence of running injuries after adjusting for subjects' characteristics (odds ratio = 9.7, 95% confidence interval = 2.1-44.4). Thus, the current study identified the DS and ASLR score as a more effective method than the composite score to screen the risk of running injuries in competitive male runners.	[Hotta, Takayuki; Nishiguchi, Shu; Fukutani, Naoto; Tashiro, Yuto; Adachi, Daiki; Morino, Saori; Shirooka, Hidehiko; Nozaki, Yuma; Hirata, Hinako; Yamaguchi, Moe; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth Sci, Kyoto, Japan; [Nishiguchi, Shu] Japan Soc Promot Sci, Tokyo, Japan	Hotta, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth Sci, Kyoto, Japan.	hotta.takayuki36@gmail.com					Agresta C, 2014, INT J SPORTS MED, V35, P1203, DOI 10.1055/s-0034-1382055; Minick KI, 2010, J STRENGTH COND RES, V24, P479, DOI 10.1519/JSC.0b013e3181c09c04; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; O'Connor FG, 2011, MED SCI SPORT EXER, V43, P2224, DOI 10.1249/MSS.0b013e318223522d; LYSHOLM J, 1987, AM J SPORT MED, V15, P168, DOI 10.1177/036354658701500213; Parchmann CJ, 2011, J STRENGTH COND RES, V25, P3378, DOI 10.1519/JSC.0b013e318238e916; Butler RJ, 2013, WORK, V46, P11, DOI 10.3233/WOR-121545; Teyhen DS, 2012, J ORTHOP SPORT PHYS, V42, P530, DOI 10.2519/jospt.2012.3838; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; MESSIER SP, 1988, MED SCI SPORT EXER, V20, P501; Yagi S, 2013, KNEE SURG SPORT TR A, V21, P556, DOI 10.1007/s00167-012-2160-x; Niemuth PE, 2005, CLIN J SPORT MED, V15, P14, DOI 10.1097/00042752-200501000-00004; Di Caprio F, 2010, J SPORT SCI MED, V9, P587; Lisman P, 2013, MED SCI SPORT EXER, V45, P636, DOI 10.1249/MSS.0b013e31827a1c4c; Chapman RF, 2014, INT J SPORT PHYSIOL, V9, P203, DOI [10.1123/ijspp.2012-0329, 10.1123/IJSPP.2012-0329]; Chorba Rita S, 2010, N Am J Sports Phys Ther, V5, P47; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P132; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P62; Gulgin Heather, 2014, Int J Sports Phys Ther, V9, P14; Kiesel Kyle, 2007, N Am J Sports Phys Ther, V2, P147; Loudon JK, 2014, J STRENGTH COND RES, V28, P909, DOI 10.1097/JSC.0000000000000233; Renström A F, 1993, Instr Course Lect, V42, P225; Schneiders Anthony G, 2011, Int J Sports Phys Ther, V6, P75; Warren M, 2014, J SPORT REHABIL	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	OCT	2015	29	10					2808	2815		10.1519/JSC.0000000000000962		8	Sport Sciences	Sport Sciences	CS5HM	WOS:000362108800017		
J	Maeda, K; Wakabayashi, H; Shamoto, H				Maeda, Keisuke; Wakabayashi, Hidetaka; Shamoto, Hiroshi			Angiotensin-Converting Enzyme Inhibitor in Tube-Fed Patients With Stroke History	JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION			English	Letter							DYSPHAGIA; PNEUMONIA		[Maeda, Keisuke] Tamana Reg Hlth Med Ctr, Dept Nutr & Dysphagia Rehabil, Tamana City, Japan; [Wakabayashi, Hidetaka] Yokohama City Univ, Med Ctr, Dept Rehabil Med, Yokohama, Kanagawa 232, Japan; [Shamoto, Hiroshi] Minamisoma Municipal Gen Hosp, Dept Neurosurg, Fukushima, Japan	Maeda, K (reprint author), Tamana Reg Hlth Med Ctr, Dept Nutr & Dysphagia Rehabil, Tamana City, Japan.			Maeda, Keisuke/0000-0001-7132-7818; Wakabayashi, HIdetaka/0000-0002-0364-0818			Lee JSW, 2015, J AM MED DIR ASSOC, V16, P702, DOI 10.1016/j.jamda.2015.05.009; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; Brogan E, 2014, NEUROEPIDEMIOLOGY, V43, P140, DOI 10.1159/000366423; Caldeira D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4260	4	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-8610	1538-9375		J AM MED DIR ASSOC	J. Am. Med. Dir. Assoc.	OCT 1	2015	16	10					896	897		10.1016/j.jamda.2015.07.006		2	Geriatrics & Gerontology	Geriatrics & Gerontology	CS8ZV	WOS:000362379400018		
J	Ohara, T; Iwano, H; Thohan, V; Kitzman, DW; Upadhya, B; Pu, M; Little, WC				Ohara, Takahiro; Iwano, Hiroyuki; Thohan, Vinay; Kitzman, Dalane W.; Upadhya, Bharathi; Pu, Min; Little, William C.			Role of Diastolic Function in Preserved Exercise Capacity in Patients with Reduced Ejection Fractions	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						Heart failure; Echocardiography; Diastole; Exercise	LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; TISSUE DOPPLER; ECHOCARDIOGRAPHIC-ASSESSMENT; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; DYSFUNCTION; RECOMMENDATIONS; DETERMINANTS; PERFORMANCE	Background: Some patients with markedly reduced ejection fractions (EFs) (<35%) have preserved exercise performance greater than predicted for age and gender. Because diastolic function may be a determinant of exercise performance, this study was conducted to test the hypothesis that patients with preserved exercise tolerance despite EFs <35% may have relatively normal diastolic function. Methods: Sixty-five subjects with EFs <35% who underwent exercise Doppler echocardiography and had no inducible ischemia were retrospectively examined. Forty-five subjects with normal EFs (>60%) and preserved exercise capacity were analyzed as a control group. Results: Sixteen of 65 patients with EFs <35% had greater than predicted normal exercise capacity for their age and gender, and the remaining 49 patients had reduced exercise capacity. Patients with reduced EFs and preserved exercise capacity had E/e' ratios (mean, 10 6 4) similar to those of control subjects (mean, 10 6 3) and lower than those with reduced exercise tolerance (mean, 16 6 8) (P < .01). In addition, they had better diastolic filling patterns and smaller left atrial sizes than patients with EFs <35% and reduced exercise capacity. Multivariate logistic regression analyses indicated that E/e' ratio was an independent predictor of preserved exercise capacity in patients with reduced EFs. Conclusions: Relatively intact diastolic function contributes to preserved exercise capacity in patients with reduced EFs (<35%).	[Ohara, Takahiro] Natl Cerebral & Cardiovasc Ctr, Div Cardiol, Suita, Osaka 5658565, Japan; [Ohara, Takahiro] Natl Cerebral & Cardiovasc Ctr, CCU, Suita, Osaka 5658565, Japan; [Iwano, Hiroyuki; Little, William C.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Thohan, Vinay] Aurora Cardiovasc Serv, Milwaukee, WI USA; [Kitzman, Dalane W.; Upadhya, Bharathi; Pu, Min] Wake Forest Sch Med, Cardiol Sect, Winston Salem, NC USA	Ohara, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Cardiol, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	tkohara@ncvc.go.jp			National Institutes of Health [HL106276-01A1]; Wake Forest Translational Science Institute; Medtronic; CVRx; CorrAssist; Cornovus	This work was partially supported by an R21 grant from the National Institutes of Health (HL106276-01A1). Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the National Institutes of Health. The Wake Forest Translational Science Institute also provided financial support.; Dr Little received consulting fees from Medtronic, CVRx, CorrAssist, and Cornovus.	BENGE W, 1980, CIRCULATION, V61, P955; Gilman G, 2007, J AM SOC ECHOCARDIOG, V20, P199, DOI 10.1016/j.echo.2006.08.005; Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1; CHENG CP, 1993, CIRC RES, V72, P795; Terzi S, 2007, HEART VESSELS, V22, P237, DOI 10.1007/s00380-006-0961-x; Masutani S, 2008, CIRCULATION, V117, P1550, DOI 10.1161/CIRCULATIONAHA.107.730564; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; CHENG CP, 1992, CIRC RES, V70, P9; Lapu-Bula R, 2002, CIRCULATION, V106, P1342, DOI 10.1161/01.CIR.0000028812.98083.D9; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Little WC, 2009, CIRCULATION, V120, P802, DOI 10.1161/CIRCULATIONAHA.109.869602; Rovner A, 2005, AM J PHYSIOL-HEART C, V289, pH2081, DOI 10.1152/ajpheart.00951.2005; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; LITTLE WC, 1995, CIRCULATION, V92, P1933; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Haykowsky MJ, 2011, J AM COLL CARDIOL, V58, P265, DOI 10.1016/j.jacc.2011.02.055; Little WC, 2005, CIRCULATION, V112, P2888, DOI 10.1161/CIRCULATIONAHA.105.578161; Hadano Y, 2006, AM J CARDIOL, V97, P1025, DOI 10.1016/j.amjcard.2005.10.044; KELLY RP, 1992, CIRCULATION, V86, P513; Gardin JM, 2009, AM HEART J, V158, pS45, DOI 10.1016/j.ahj.2009.07.015; [Anonymous], 2009, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.109.192064; Grewal J, 2009, JAMA-J AM MED ASSOC, V301, P286, DOI 10.1001/jama.2008.1022; Skaluba SJ, 2004, CIRCULATION, V109, P972, DOI 10.1161/01.CIR.0000117405.74491.D2; Harrington D, 2001, EUR HEART J, V22, P392, DOI 10.1053/euhj.2000.2367; Burke MA, 2014, CIRC-HEART FAIL, V7, P288, DOI 10.1161/CIRCHEARTFAILURE.113.000854; Brubaker PH, 1994, J CARDIOPULM REHABIL, V14, P127, DOI 10.1097/00008483-199403000-00008; Bruce R A, 1978, Adv Cardiol, P6; Pina Ileana L., 2003, Circulation, V107, P1210, DOI 10.1161/01.CIR.0000055013.92097.40; Shvartz E., 1990, AVIATION SPACE ENV M, V61, P3; Sinning D, 2011, CARDIOL RES PRACT, V2011	32	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	OCT	2015	28	10					1184	1193		10.1016/j.echo.2015.06.004		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS9KT	WOS:000362410700008		
J	Hirata, Y; Yamada, H; Kusunose, K; Iwase, T; Nishio, S; Hayashi, S; Bando, M; Amano, R; Yamaguchi, K; Soeki, T; Wakatsuki, T; Sata, M				Hirata, Yukina; Yamada, Hirotsugu; Kusunose, Kenya; Iwase, Takashi; Nishio, Susumu; Hayashi, Shuji; Bando, Mika; Amano, Rie; Yamaguchi, Koji; Soeki, Takeshi; Wakatsuki, Tetsuzo; Sata, Masataka			Clinical Utility of Measuring Epicardial Adipose Tissue Thickness with Echocardiography Using a High-Frequency Linear Probe in Patients with Coronary Artery Disease	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						Epicardial adipose tissue; Echocardiography; Computed tomography; Coronary artery disease; Anterior interventricular groove	CARDIAC COMPUTED-TOMOGRAPHY; VISCERAL ABDOMINAL FAT; PERICARDIAL FAT; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; RISK-FACTORS; ATHEROSCLEROSIS; VOLUME; CALCIFICATION; ASSOCIATION	Background: The relationship between epicardial adipose tissue (EAT) and coronary artery disease (CAD) has recently attracted a great deal of attention in the medical community. The objective of this study was to determine whether measuring EAT thickness in the anterior interventricular groove (AIG) using echocardiography is feasible and whether this index can be a marker of CAD. Methods: A total of 311 patients (mean age, 676 11 years; 208 men) who underwent coronary angiography between December 2011 and December 2013 were prospectively enrolled. EAT-AIG thickness and EAT thickness on the free wall of the right ventricle (RV) were measured in systole using a high-frequency linear probe. Seventy-one patients who underwent multidetector-row computed tomography were enrolled to validate the method for measuring EAT thickness using echocardiography. Subjects were divided into two groups, those with and without significant coronary stenosis, on the basis of findings on coronary angiography (>= 75% luminal narrowing). Results: EAT-AIG thickness measured using echocardiography was validated by computed tomography. EAT-AIG thickness was strongly correlated with EAT volume (r = 0.714, P < .001). The CAD group had thicker EAT-AIG than the non-CAD group (8.3 +/- 3.0 vs 6.3 +/- 2.5 mm, P < .001). EAT-RV thickness was greater in the CAD group than in the non-CAD group (5.0 +/- 2.1 vs 4.4 +/- 2.3 mm, P = .009) as well. The area under the curve on receiver operating characteristic curve analysis of EAT-AIG thickness for predicting CAD was 0.704, which was higher than the EAT-RV thickness. Conclusions: Measuring EAT thickness using echocardiography with a high-frequency linear probe was validated with computed tomography. EAT-AIG was thicker in the CAD group than in the non-CAD group, as was EAT-RV thickness. This noninvasive index may have potential as a diagnostic marker for predicting coronary atherosclerosis.	[Hirata, Yukina; Yamada, Hirotsugu; Kusunose, Kenya; Iwase, Takashi; Nishio, Susumu; Hayashi, Shuji; Bando, Mika; Amano, Rie; Yamaguchi, Koji; Soeki, Takeshi; Wakatsuki, Tetsuzo; Sata, Masataka] Tokushima Univ Hosp, Ultrasound Examinat Ctr, Tokushima 7708503, Japan; [Hirata, Yukina; Yamada, Hirotsugu; Kusunose, Kenya; Iwase, Takashi; Nishio, Susumu; Hayashi, Shuji; Bando, Mika; Amano, Rie; Yamaguchi, Koji; Soeki, Takeshi; Wakatsuki, Tetsuzo; Sata, Masataka] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima 7708503, Japan	Yamada, H (reprint author), Tokushima Univ Hosp, Dept Cardiovasc Med, 2-50-1 Kuramoto, Tokushima 7708503, Japan.	yamadah@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; JSPS KAKENHI [25293184, 25670390, 24659392, 22500437]; Vehicle Racing Commemorative Foundation	This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Knowledge Cluster and New Research Area), JSPS KAKENHI (grants 25293184, 25670390, 24659392, and 22500437), and the Vehicle Racing Commemorative Foundation.	Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; van Taxis CFV, 2013, JACC-CARDIOVASC IMAG, V6, P42, DOI 10.1016/j.jcmg.2012.05.016; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Wong CX, 2011, J AM COLL CARDIOL, V57, P1745, DOI 10.1016/j.jacc.2010.11.045; de Vos AM, 2008, EUR HEART J, V29, P777, DOI 10.1093/eurheartj/ehm564; Sicari R, 2011, J AM SOC ECHOCARDIOG, V24, P1156, DOI 10.1016/j.echo.2011.06.013; Bailey-Downs LC, 2013, J GERONTOL A-BIOL, V68, P780, DOI 10.1093/gerona/gls238; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Wu FZ, 2013, AM J CARDIOL, V112, P943, DOI 10.1016/j.amjcard.2013.05.022; Kim SH, 2014, INT HEART J, V55, P197; Silaghi A, 2008, OBESITY, V16, P2424, DOI 10.1038/oby.2008.379; Lim S, 2013, INT J CARDIOL, V169, P166, DOI 10.1016/j.ijcard.2013.08.077; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Lai YH, 2012, J AM SOC ECHOCARDIOG, V25, P234, DOI 10.1016/j.echo.2011.09.018; Corradi D, 2004, CARDIOVASC PATHOL, V13, P313, DOI 10.1016/j.carpath.2004.08.005; Yudkin JS, 2005, LANCET, V365, P1817, DOI 10.1016/S0140-6736(05)66585-3; Eroglu S, 2009, NUTR METAB CARDIOVAS, V19, P211, DOI 10.1016/j.numecd.2008.05.002; Wang TD, 2010, ATHEROSCLEROSIS, V213, P279, DOI 10.1016/j.atherosclerosis.2010.07.055; Iacobellis G, 2008, OBESITY, V16, P887, DOI 10.1038/oby.2008.6; Gorter PM, 2008, ATHEROSCLEROSIS, V197, P896, DOI 10.1016/j.atherosclerosis.2007.08.016; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; Wang TD, 2009, J CLIN ENDOCR METAB, V94, P662, DOI 10.1210/jc.2008-0834; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Hirata Y, 2011, J AM COLL CARDIOL, V58, P248, DOI 10.1016/j.jacc.2011.01.048; Cho KI, 2014, HEART VESSELS; Dagvasumberel M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-106; Gonzalez GF, 2014, NUTR HOSP, V30, P609, DOI 10.3305/nh.2014.30.3.7129; Iacobellis G, 2009, J AM SOC ECHOCARDIOG, V22, P417; Iacobellis G., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P345, DOI 10.2174/1568006054553408; Iacobellis G, 2009, J AM SOC ECHOCARDIOG, V22, P1311, DOI 10.1016/j.echo.2009.10.013; Jonker Jacqueline T, 2013, Radiology, V269, P434, DOI 10.1148/radiol.13121631; Nelson AJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-15; Wu FZ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-62	34	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	OCT	2015	28	10					1240	+		10.1016/j.echo.2015.07.006		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS9KT	WOS:000362410700014		
J	Pressman, GS; Movva, R; Topilsky, Y; Clavel, MA; Saldanha, JA; Watanabe, N; Enriquez-Sarano, M				Pressman, Gregg S.; Movva, Rajesh; Topilsky, Yan; Clavel, Marie-Annick; Saldanha, Jason A.; Watanabe, Nozomi; Enriquez-Sarano, Maurice			Three-Dimensional Echocardiography: A Powerful New Tool in the Evaluation of Mitral Annular Structure and Dynamics	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Letter							CALCIFICATION; VALVE		[Pressman, Gregg S.; Movva, Rajesh] Albert Einstein Med Ctr, Div Cardiovasc Dis, Philadelphia, PA 19141 USA; [Topilsky, Yan; Clavel, Marie-Annick; Enriquez-Sarano, Maurice] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Saldanha, Jason A.] Dalhousie Univ, Halifax, NS, Canada; [Watanabe, Nozomi] Miyazaki Med Assoc Hosp, Miyazaki, Japan	Pressman, GS (reprint author), Albert Einstein Med Ctr, Div Cardiovasc Dis, Philadelphia, PA 19141 USA.			Pressman, Gregg/0000-0002-0992-1805			Pressman GS, 2015, J AM SOC ECHOCARDIOG, V28, P786, DOI 10.1016/j.echo.2015.03.002; Kohsaka S, 2008, JACC-CARDIOVASC IMAG, V1, P617, DOI 10.1016/j.jcmg.2008.07.006; Movva R, 2013, J AM SOC ECHOCARDIOG, V26, P1135, DOI 10.1016/j.echo.2013.06.014; Carpentier AF, 1996, J THORAC CARDIOV SUR, V111, P718, DOI 10.1016/S0022-5223(96)70332-X; Carpentier AF, 1996, J THORAC CARDIOVASC, V111, P729	5	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	OCT	2015	28	10					1256	1257		10.1016/j.echo.2015.07.020		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS9KT	WOS:000362410700017		
J	Lee, S; Maeda, H; Obata, A; Ueda, K; Narushima, T; Kasuga, T				Lee, Sungho; Maeda, Hirotaka; Obata, Akiko; Ueda, Kyosuke; Narushima, Takayuki; Kasuga, Toshihiro			Structure and dissolution behavior of MgO-P2O5-TiO2/Nb2O5 (Mg/P >= 1) invert glasses	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Biomaterial; Phosphate glass; Invert glass; Magnesium; Niobium; Titanium; Structure	MAGNESIUM PHOSPHATE-GLASSES; X-RAY-DIFFRACTION; ULTRAPHOSPHATE GLASSES; OPTICAL-PROPERTIES; SYSTEM; ZINC; RANGE; IONS; MGO; DEGRADATION	Magnesium phosphate glasses exhibit unusual properties and were classified as 'anomalous phosphate glasses', because magnesium is attributed to a variation of the oxygen coordination number from 6 to 4. Magnesium in phosphate glasses acts as an intermediate oxide and its role was determined, relating to the phosphate chain length. In the present work, MgO-P2O5-TiO2/Nb2O5 glasses with Mg/P ratio between 1.00 and 1.36 were successfully prepared by a melt-quenching method. Magnesium in the glasses worked as a network former to form P-O-Mg bonds, which are cross-linked short phosphate chains that improved the glass-forming ability. Intermediate oxides (i.e., TiO2 and Nb2O5) in the glasses also cross-linked short phosphate chains to form P-O-Ti/Nb bonds. The chemical durability of the glasses decreased with an increase in the Mg/P ratio, because magnesium, which entered the phosphate network, weakened the glass network to induce hydrolysis. The dissolution rate of Ti4+ and Nb5+ ions showed a decreasing tendency with an increase in the Mg/P ratio. The surfaces of the glasses were considered to be covered with gel-like oxide layers containing titanium or niobium and phosphate.	[Lee, Sungho; Maeda, Hirotaka; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Ueda, Kyosuke; Narushima, Takayuki] Tohoku Univ, Grad Sch Engn, Dept Met Mat Sci & Mat Proc, Aoba Ku, Sendai, Miyagi 9808579, Japan	Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	kasuga.toshihiro@nitech.ac.jp			JSPS KAKENHI [25249094, 26289238, 267992]	This work was supported in part by JSPS KAKENHI Grant Numbers 25249094, 26289238, and 267992.	Smith CE, 2014, J NON-CRYST SOLIDS, V390, P51, DOI 10.1016/j.jnoncrysol.2014.02.010; Franks K, 2002, J MATER SCI-MATER M, V13, P549, DOI 10.1023/A:1015122709576; Chu CM, 2011, J NON-CRYST SOLIDS, V357, P939, DOI 10.1016/j.jnoncrysol.2010.12.009; KANAZAWA T, 1982, J NON-CRYST SOLIDS, V52, P187, DOI 10.1016/0022-3093(82)90293-9; Suzuya K, 1999, J PHYS CHEM SOLIDS, V60, P1457, DOI 10.1016/S0022-3697(99)00140-7; Lee IH, 2013, J NON-CRYST SOLIDS, V363, P57, DOI 10.1016/j.jnoncrysol.2012.11.036; Khor SF, 2011, J MATER SCI, V46, P7895, DOI 10.1007/s10853-011-5777-0; Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004; Li YB, 2008, PHYS CHEM GLASSES-B, V49, P41; Kyosuke U, 2007, MATER TRANS, V48, P307; Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a; WALTER G, 1990, PHYS CHEM GLASSES, V31, P188; Flambard A, 2008, J NON-CRYST SOLIDS, V354, P3540, DOI 10.1016/j.jnoncrysol.2008.03.017; Hsu SM, 2012, J NON-CRYST SOLIDS, V358, P14, DOI 10.1016/j.jnoncrysol.2011.08.006; Sene FF, 2004, J NON-CRYST SOLIDS, V348, P30, DOI 10.1016/j.jnoncrysol.2004.08.122; Ahmed I, 2010, J BIOMATER APPL, V24, P555, DOI 10.1177/0885328209102761; Watts SJ, 2010, J NON-CRYST SOLIDS, V356, P517, DOI 10.1016/j.jnoncrysol.2009.04.074; WALTER G, 1994, PHYS CHEM GLASSES, V35, P245; KORDES E, 1953, Z ELEKTROCHEM, V57, P282; Narushima T, 2005, MATER TRANS, V46, P2246, DOI 10.2320/matertrans.46.2246; Karakassides MA, 2004, J NON-CRYST SOLIDS, V347, P69, DOI 10.1016/j.jnoncrysol.2004.08.111; Meyer K, 2001, PHYS CHEM GLASSES, V42, P79; Walter G, 2003, J NON-CRYST SOLIDS, V320, P210, DOI 10.1016/S0022-3093(03)00016-4; HOPPE U, 1992, PHYS CHEM GLASSES, V33, P216; Brow RK, 1997, PHYS CHEM GLASSES, V38, P300; Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2; Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5; Maeda H, 2014, J CERAM SOC JPN, V122, P122, DOI 10.2109/jcersj2.122.122; Kasuga T, 2001, J AM CERAM SOC, V84, P450; Walter G, 2001, J NON-CRYST SOLIDS, V296, P212, DOI 10.1016/S0022-3093(01)00912-7; OKURA T, 1988, PHYS CHEM GLASSES, V29, P13; TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6; BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8; Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220; Mazali IO, 2004, J MATER SCI, V39, P1987, DOI 10.1023/B:JMSC.0000017760.85512.60; OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22; SAKKA S, 1989, J NON-CRYST SOLIDS, V112, P64, DOI 10.1016/0022-3093(89)90494-8; Lee S, 2009, J CERAM SOC JPN, V117, P935, DOI 10.2109/jcersj2.117.935; MATSUBARA E, 1988, J NON-CRYST SOLIDS, V103, P117, DOI 10.1016/0022-3093(88)90423-1; Khor SF, 2013, OPT MATER, V35, P629, DOI 10.1016/j.optmat.2012.10.013; Fayon F, 2001, J NON-CRYST SOLIDS, V283, P88, DOI 10.1016/S0022-3093(01)00357-X; Segawa H, 2010, J CERAM SOC JPN, V118, P278, DOI 10.2109/jcersj2.118.278; Omrani RO, 2015, J ALLOY COMPD, V632, P766, DOI 10.1016/j.jallcom.2015.01.297; Brauer DS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0647; Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713; ELJAZOULI A, 1988, J SOLID STATE CHEM, V73, P433, DOI 10.1016/0022-4596(88)90129-6; HOPPE U, 1995, J NON-CRYST SOLIDS, V193, P28, DOI 10.1016/0022-3093(95)00325-8; Kasuga Toshihiro, 2012, Phosphorus Research Bulletin, V26; Lee S., 2010, BIOCERAM DEV APPL, V1, DOI [10.4303/bda/D110148, DOI 10.4303/BDA/D110148]; Morikawa H, 2013, J NON-CRYST SOLIDS, V380, P53, DOI 10.1016/j.jnoncrysol.2013.08.029; Wolf Federica I., 1999, Frontiers in Bioscience, V4, pd607, DOI 10.2741/Wolf	51	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					942	948		10.2109/jcersj2.123.942		7	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300003		
J	Maeda, K; Hirose, M; Kobayashi, T				Maeda, Kei; Hirose, Motoyuki; Kobayashi, Tomoyuki			High performance transparent glass-ceramics for optical components	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Glass-ceramics; Nepheline; Kalsilite; Band pass filter; Substrate; High thermal expansion; High strength		Glass-ceramics based on nepheline crystal (Na-3(Na, K)[Al4Si4O16]) system was modified to satisfy the thermal and optical properties required for a band-pass filter (BPF) in telecommunication systems using optical fibers. The suitable coefficient of thermal expansion was achieved in a glass-ceramic containing more potassium oxide than the conventional nepheline glass-ceramics, in nepheline-kalsilite (K[AlSiO4]) binary system. An addition of the moderate amount of nucleating agents is a key parameter to obtain high transparency of the glass-ceramics. The optimized nepheline-kalsilite glass-ceramic showed higher mechanical strength as compared with the monolithic glassy material used in the same application. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Maeda, Kei] Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan; [Hirose, Motoyuki] Asahi Glass Co Ltd, Elect Co, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kobayashi, Tomoyuki] Asahi Glass Co Ltd, Business Dev Off, Chiyoda Ku, Tokyo 1000005, Japan	Maeda, K (reprint author), Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, 1150 Hazawa Cho, Yokohama, Kanagawa 2218755, Japan.	kei-maeda@agc.com					DUKE DA, 1967, J AM CERAM SOC, V50, P67, DOI 10.1111/j.1151-2916.1967.tb15041.x; [Anonymous], APPENS COEFFICIENT H, P92; BEALL GH, 1969, J MATER SCI, V4, P340, DOI 10.1007/BF00550404; [Anonymous], Japanese Patent, Patent No. 1483641; DUKE DA, 1968, J AM CERAM SOC, V51, P98, DOI 10.1111/j.1151-2916.1968.tb11845.x; [Anonymous], Japanese Patent, Patent No. 3399883; [Anonymous], Japanese Patent, Patent No. 3243474; Beall G., 1989, REV SOLID STATE SCI, V3, P333; Deer W. A., 1992, INTRO ROCK FORMING M, P473; McMillan P. W., 1979, GLASS CERAM, P162; Scholtz H., 1991, GLASS NATURE STRUCTU, P224; Strnad Z., 1985, GLASS CERAMIC MAT, P85; Strnad Z., 1985, GLASS CERAMIC MAT, P185; TAKASHASHI H, 1995, APPL OPTICS, V34, P667, DOI 10.1364/AO.34.000667	14	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					949	954		10.2109/jcersj2.123.949		6	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300004		
J	Saeki, T; Ohkita, H; Kakuta, N; Mizushima, T				Saeki, Takanori; Ohkita, Hironobu; Kakuta, Noriyoshi; Mizushima, Takanori			Synergistic effects of CeO2-supported bimetallic Ni-Cu, Co-Cu, and Ni-Fe catalysts on steam reforming of ethanol	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Ethanol steam reforming; CeO2-supported catalyst; Bimetallic alloy; Synergistic effect; Carbon deposition	NOBLE-METAL CATALYSTS; SUPPORTED COBALT CATALYSTS; WATER-GAS SHIFT; HYDROGEN-PRODUCTION; LOW-TEMPERATURE; NI/AL2O3 CATALYSTS; FUEL-CELLS; LA; PERFORMANCE; MG	The synergistic effects of CeO2-supported bimetallic Ni-Cu, Co-Cu, and Ni-Fe catalysts on the reduction properties, crystal structure, and catalytic performance during steam reforming of ethanol were investigated. Both metals in the bimetallic catalysts were reduced at lower temperatures than were the metals in the associated monometallic catalysts, and they formed alloy crystallites. It was confirmed from activity tests of the monometallic catalysts that Ni and Co were relatively active components and that Cu and Fe were less active. The combination of Ni and Co with Cu (Ni-Cu/CeO2 and Co-Cu/CeO2) resulted in increases in H-2 and CO2 yields and inhibition of carbon deposition during reactions at 673 K. On the other hand, the incorporation of Ni with Fe (Ni-Fe/CeO2) showed a lower activity than did Ni/CeO2 at 673K but exhibited a higher H-2 yield and higher resistance to carbon deposition at 873 K, in which case NiFe alloys were formed. These results indicate the advantages of alloying a catalytically active metal with a less active metal during steam reforming of ethanol. (C)2015 The Ceramic Society of Japan. All rights reserved.	[Saeki, Takanori; Ohkita, Hironobu; Kakuta, Noriyoshi; Mizushima, Takanori] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan	Mizushima, T (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, 2-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	mizushima@ens.tut.ac.jp					Zhang LF, 2009, J NAT GAS CHEM, V18, P55, DOI 10.1016/S1003-9953(08)60078-X; Cai WJ, 2008, J CATAL, V257, P96, DOI 10.1016/j.jcat.2008.04.009; Haryanto A, 2005, ENERG FUEL, V19, P2098, DOI 10.1021/ef0500538; Chen LW, 2012, INT J HYDROGEN ENERG, V37, P16321, DOI 10.1016/j.ijhydene.2012.02.119; Lin JH, 2010, APPL CATAL A-GEN, V387, P87, DOI 10.1016/j.apcata.2010.08.003; Haga F, 1997, CATAL LETT, V48, P223, DOI 10.1023/A:1019039407126; Ni M, 2007, INT J HYDROGEN ENERG, V32, P3238, DOI 10.1016/j.ijhydene.2007.04.038; Vizcaino AJ, 2007, INT J HYDROGEN ENERG, V32, P1450, DOI 10.1016/j.ijhydene.2006.10.024; Alberton AL, 2007, CATAL TODAY, V123, P257, DOI 10.1016/j.cattod.2007.01.062; Vicente J, 2014, INT J HYDROGEN ENERG, V39, P12586, DOI 10.1016/j.ijhydene.2014.06.093; Trane-Restrup R, 2013, INT J HYDROGEN ENERG, V38, P15105, DOI 10.1016/j.ijhydene.2013.09.027; Wang F, 2009, CATAL TODAY, V146, P31, DOI 10.1016/j.cattod.2009.01.027; Sanchez-Sanchez MC, 2007, INT J HYDROGEN ENERG, V32, P1462, DOI 10.1016/j.ijhydene.2006.10.025; Orucu E, 2008, CATAL LETT, V120, P198, DOI 10.1007/s10562-007-9269-4; Miranda BC, 2015, APPL CATAL B-ENVIRON, V166, P166, DOI 10.1016/j.apcatb.2014.11.019; Li KZ, 2014, APPL SURF SCI, V289, P378, DOI 10.1016/j.apsusc.2013.10.170; Llorca J, 2002, J CATAL, V209, P306, DOI 10.1006/jcat.2002.3643; Basagiannis AC, 2008, TOP CATAL, V51, P2, DOI 10.1007/s11244-008-9130-z; Chen LC, 2011, APPL CATAL B-ENVIRON, V106, P639, DOI 10.1016/j.apcatb.2011.06.028; Casanovas A, 2010, INT J HYDROGEN ENERG, V35, P7690, DOI 10.1016/j.ijhydene.2010.05.099; Shi QJ, 2011, J RARE EARTH, V29, P861, DOI 10.1016/S1002-0721(10)60556-X; Sun J, 2005, INT J HYDROGEN ENERG, V30, P437, DOI 10.1016/j.ijhydene.2004.11.005; Fatsikostas AN, 2002, CATAL TODAY, V75, P145, DOI 10.1016/S0920-5861(02)00057-3; Liguras DK, 2003, APPL CATAL B-ENVIRON, V43, P345, DOI 10.1016/S0926-3373(02)00327-2; Pang XJ, 2012, CHINESE J CATAL, V33, P281, DOI 10.1016/S1872-2067(11)60335-5; Breen JP, 2002, APPL CATAL B-ENVIRON, V39, P65, DOI 10.1016/S0926-3373(02)00075-9; Wang ZJ, 2014, INT J HYDROGEN ENERG, V39, P5644, DOI 10.1016/j.ijhydene.2014.01.151; Furtado AC, 2009, INT J HYDROGEN ENERG, V34, P7189, DOI 10.1016/j.ijhydene.2009.06.060; Erdohelyi A, 2006, CATAL TODAY, V116, P367, DOI 10.1016/j.cattod.2006.05.073; Chakrabarti D. J., 1991, PHASE DIAGRAMS BINAR, P85; da Paz Fiuza Raigenis, 2010, International Journal of Hydrogen Energy, V35, DOI 10.1016/j.ijhydene.2010.07.026; Moraes TS, 2015, CATAL TODAY, V242, P35, DOI 10.1016/j.cattod.2014.05.045; Saeki T., J JPN PETRO IN PRESS; Soyal-Baltacioglu F, 2008, CATAL TODAY, V138, P183, DOI 10.1016/j.cattod.2008.05.035; Swartzendruber L. J., 1991, PHASE DIAGRAMS BINAR, P110	35	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					955	960		10.2109/jcersj2.123.955		6	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300005		
J	Itagaki, Y; Fujihashi, K; Aono, H; Mori, M; Sadaoka, Y				Itagaki, Yoshiteru; Fujihashi, Kenta; Aono, Hiromichi; Mori, Masami; Sadaoka, Yoshihiko			VOC sensing behavior of semiconducting Sm2O3/SmFeO3 mixtures	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						VOC sensor; SmFeO3; Sm2O3 additive; Adsorbed oxygen; Catalytic activity	SMFEO3 GAS SENSOR; OZONE DETECTION; AIR; CATALYSTS; OXIDES; LA; SM; REACTIVITY; ELECTRODES; OXIDATION	Sm2O3/SmFeO3 mixed powders were applied to a chemo-resistive VOC (volatile organic compound) gas sensor. The sensor response to 30 ppm toluene gas increased with increasing the Sm2O3 content up to 30 wt%, but decreased by further adding. The addition of Sm2O3 up to 30 wt% also enhanced the catalytic activity for toluene oxidation, as the result of the sensor response. The amount of toluene adsorption increased with increase in the surface Sm concentration. It was concluded that adding Sm2O3 increased the amount of adsorbed VOCs, resulting in the enhancement of the sensor response and the catalytic activity. Furthermore, adding Sm2O3 remarkably shortened the recovery time from the VOCs to air. For the ethanol sensing, adding Sm2O3 was only effective on shortening the recovery time. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Itagaki, Yoshiteru; Fujihashi, Kenta; Aono, Hiromichi; Mori, Masami] Ehime Univ, Grad Sch Sci, Matsuyama, Ehime 8908577, Japan; [Itagaki, Yoshiteru; Fujihashi, Kenta; Aono, Hiromichi; Mori, Masami] Ehime Univ, Grad Sch Engn, Matsuyama, Ehime 8908577, Japan; [Sadaoka, Yoshihiko] Ehime Univ, Cooperat Ctr Sci & Ind Res, Matsuyama, Ehime 8908577, Japan	Itagaki, Y (reprint author), Ehime Univ, Grad Sch Sci, Matsuyama, Ehime 8908577, Japan.	itagaki.yshiteru.mj@ehime-u.ac.jp					CHE M, 1982, ADV CATAL, V31, P77, DOI 10.1016/S0360-0564(08)60453-8; Tabata K, 1998, APPL CATAL A-GEN, V170, P245, DOI 10.1016/S0926-860X(98)00062-3; Ciambelli P, 2001, APPL CATAL B-ENVIRON, V29, P239, DOI 10.1016/S0926-3373(00)00215-0; YAMAZOE N, 1979, SURF SCI, V86, P335, DOI 10.1016/0039-6028(79)90411-4; Mori M, 2011, J CERAM SOC JPN, V119, P926, DOI 10.2109/jcersj2.119.926; Hosoya Y, 2005, SENSOR ACTUAT B-CHEM, V108, P198, DOI 10.1016/j.snb.2004.10.059; Li XY, 2012, MATER LETT, V85, P25, DOI 10.1016/j.matlet.2012.06.107; Tomoda M, 2004, SENSOR ACTUAT B-CHEM, V97, P190, DOI 10.1016/j.snb.2003.08.013; Mori M, 2012, SENSOR ACTUAT B-CHEM, V161, P471, DOI 10.1016/j.snb.2011.10.063; Mori M, 2012, SENSOR ACTUAT B-CHEM, V163, P44, DOI 10.1016/j.snb.2011.12.047; Mori M, 2014, SENSOR ACTUAT B-CHEM, V191, P351, DOI 10.1016/j.snb.2013.10.005; Mori M, 2008, CATAL TODAY, V139, P125, DOI 10.1016/j.cattod.2008.08.014; TENCH AJ, 1972, J CHEM SOC FARAD T 1, V68, P1169, DOI 10.1039/f19726801169; Aono H, 2003, SENSOR ACTUAT B-CHEM, V94, P132, DOI 10.1016/S0925-4005(03)00328-9; Carotta MC, 1998, SENSOR ACTUAT B-CHEM, V48, P270, DOI 10.1016/S0925-4005(98)00011-2; Elkins TW, 2013, APPL CATAL A-GEN, V454, P100, DOI 10.1016/j.apcata.2013.01.010; Feyzabada S.A., 2013, SENSOR ACTUAT B-CHEM, V181, P910; Levasseur B, 2008, J SOLID STATE CHEM, V181, P2953, DOI 10.1016/j.jssc.2008.07.029	18	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					961	966		10.2109/jcersj2.123.961		6	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300006		
J	Okamoto, Y; Suzuki, Y				Okamoto, Yuji; Suzuki, Yoshikazu			Double-layer dye-sensitized solar cells using SrTiO3 and BaTiO3 second layer with enhanced photovoltaic performance	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						SrTiO3; BaTiO3; Dye-sensitized solar cells; Double-layer electrode; Band-structure matching	12 PERCENT EFFICIENCY; CONVERSION EFFICIENCY; PHOTOELECTROCHEMICAL PROPERTIES; TIO2; FILM; ELECTRODES; CATIO3; 10-PERCENT; NANOWIRES; DESIGN	Double-layer electrodes using TiO2-P25 as the first layer and SrTiO3 or BaTiO3 as the second layer were prepared to improve photovoltaic performance of dye-sensitized solar cells (DSCs), since SrTiO3 and BaTiO3 have more negative conduction bands than that of TiO2. TiO2-anatase second layer with the similar particle size to these double oxides was also prepared as a comparison. Crystal structure, microstructure, film thickness, amount of dye adsorption, J-V curves and IPCE spectra were characterized. Open-circuit voltage (V-OC) of the DSCs with the SrTiO3 or BaTiO3 second layer was improved due to the inhibition of electron-hole recombination by the second layer at the top side of the TiO2 first layer. Elongation of the electron life time due to the band-structure matching might be another reason of the increase in V-OC. By using the second layer, short-circuit current density (J(SC)) was also slightly improved (similar to 4%), possibly due to the increase of electrode thickness and light confinement effect for >similar to 650 nm. As a result, the DSC using BaTiO3 second layer electrode had the largest conversion efficiency of 5.71% with an enhancement of 11.3% compared to that of TiO2-P25 single-layer electrode. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Okamoto, Yuji; Suzuki, Yoshikazu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Suzuki, Yoshikazu] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Suzuki, Y (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	suzuki@ims.tsukuba.ac.jp	Suzuki, Yoshikazu/N-3525-2015				Zhong M, 2011, MATER SCI ENG B-ADV, V176, P1115, DOI 10.1016/j.mseb.2011.05.052; Xu WW, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/1/018401; Kurotobi K, 2013, CHEM-EUR J, V19, P17075, DOI 10.1002/chem.201303460; Kumara GRRA, 2003, SEMICOND SCI TECH, V18, P312, DOI 10.1088/0268-1242/18/4/321; Kumara GRRA, 2001, J PHYS D APPL PHYS, V34, P868, DOI 10.1088/0022-3727/34/6/306; Brennan TP, 2013, J PHYS CHEM C, V117, P24138, DOI 10.1021/jp406789k; Diamant Y, 2003, J PHYS CHEM B, V107, P1977, DOI 10.1021/jp027827v; Wang YF, 2015, ELECTROCHIM ACTA, V151, P399, DOI 10.1016/j.electacta.2014.11.059; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; Kakiage K, 2014, CHEM COMMUN, V50, P6379, DOI 10.1039/c4cc02192d; Burnside S, 1999, J PHYS CHEM B, V103, P9328, DOI 10.1021/jp9913867; Zhang QF, 2009, ADV MATER, V21, P4087, DOI 10.1002/adma.200803827; Zheng HD, 2010, LANGMUIR, V26, P19148, DOI 10.1021/la103692y; Yang SM, 2009, ELECTROCHIM ACTA, V55, P305, DOI 10.1016/j.electacta.2009.08.055; Gubbala S, 2008, ADV FUNCT MATER, V18, P2411, DOI 10.1002/adfm.200800099; Sayama K, 1998, CHEM MATER, V10, P3825, DOI 10.1021/cm980111l; Okamoto Y, 2014, J CERAM SOC JPN, V122, P728, DOI 10.2109/jcersj2.122.728; Nakata K, 2012, J PHOTOCH PHOTOBIO C, V13, P169, DOI 10.1016/j.jphotochemrev.2012.06.001; Gratzel M, 2003, J PHOTOCH PHOTOBIO C, V4, P145, DOI 10.1016/S1389-5567(03)00026-1; Sauvage F, 2010, ACS NANO, V4, P4420, DOI 10.1021/nn1010396; Zhang L, 2008, J PHOTOCH PHOTOBIO A, V197, P260, DOI 10.1016/j.jphotochem.2008.01.002; [Anonymous], 2005, SOLID STATE CHEM, DOI DOI 10.1016/J.JSSC.2004.12.043; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/nchem.1861, 10.1038/NCHEM.1861]; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Bhardwaj A, 2010, J AM CERAM SOC, V93, P4129, DOI 10.1111/j.1551-2916.2010.04002.x; Lu XJ, 2012, DALTON T, V41, P622, DOI 10.1039/c1dt11124h; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Koide N, 2006, J PHOTOCH PHOTOBIO A, V182, P296, DOI 10.1016/j.jphotochem.2006.04.030; Jang JS, 2011, B KOREAN CHEM SOC, V32, P95, DOI 10.5012/bkcs.2011.32.1.95; Wang ZS, 2004, COORDIN CHEM REV, V248, P1381, DOI 10.1016/j.ccr.2004.03.006; Wang YS, 2013, J CHIN CHEM SOC-TAIP, V60, P1437, DOI 10.1002/jccs.201300284; Chiba Y, 2006, JPN J APPL PHYS 2, V45, pL638, DOI 10.1143/JJAP.45.L638	32	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					967	971		10.2109/jcersj2.123.967		5	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300007		
J	Yamatoh, T; Fujimori, H; Arimura, M				Yamatoh, Tomonori; Fujimori, Hirotaka; Arimura, Masashi			Polymerizable complex synthesis of lead-free ferroelectric Na0.5Bi0.5TiO3 suppressing evaporation of sodium and bismuth	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Polymerizable complex method; Sodium bismuth titantate; Lead-free; Ferroelectric; Double-wave method	THIN-FILM; CERAMICS; ROUTE; PEROVSKITE; POWDERS; OXIDES	We present the results of experiments that assess the viability of the polymerizable complex method to synthesize sodium bismuth titanate Na0.5Bi0.5TiO3 (NBT) while preventing sodium and bismuth from evaporating. To synthesize NBT with the stoichiometric composition and no sodium and bismuth deficiencies, it is of vital importance to direct our attention to preventing the evaporation of sodium and bismuth, which can easily occur in high-temperature sintering. X-ray diffraction (XRD) and thermogravimetry-differential thermal analysis (TG-DTA) of precursors synthesized by the polymerizable complex method revealed a crystallization temperature located at a temperature between 300 and 400 degrees C. The C-13 NMR results show the peak intensity derived from residual organics decreased with an increase in the calcining temperature. The complete single phase in NBT was obtained at a temperature higher than 600 degrees C. From ferroelectric hysteresis loops, values of the remanent polarization were larger for the samples synthesized by the polymerizable complex method than for those by the solid-state reaction method. This result indicates that the NBT samples synthesized by the polymerizable complex method retain their stoichiometric compositions even if they are calcined at high temperatures below the melting point of NBT, which is supported by the results of Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-OES). (C)2015 The Ceramic Society of Japan. All rights reserved.	[Yamatoh, Tomonori; Fujimori, Hirotaka] Yamaguchi Univ, Dept Appl Chem, Fac Engn, Ube, Yamaguchi 7558611, Japan; [Arimura, Masashi] Fukuoka Ind Technol Ctr, Chem & Text Res Inst, Chikushino, Fukuoka 8188540, Japan	Fujimori, H (reprint author), Yamaguchi Univ, Dept Appl Chem, Fac Engn, 2-16-1 Tokiwadai, Ube, Yamaguchi 7558611, Japan.	hiro@hiro-fuji.net					Remondiere F, 2007, J EUR CERAM SOC, V27, P4363, DOI 10.1016/j.jeurceramsoc.2007.02.208; West DL, 2003, J AM CERAM SOC, V86, P769; TAKENAKA T, 1991, JPN J APPL PHYS 1, V30, P2236, DOI 10.1143/JJAP.30.2236; Hill NA, 1999, PHYS REV B, V59, P8759, DOI 10.1103/PhysRevB.59.8759; [Anonymous], 1960, SOV PHYS-SOLID STATE; Lu TL, 2010, J ALLOY COMPD, V490, P232, DOI 10.1016/j.jallcom.2009.09.144; Halasyamani PS, 1998, CHEM MATER, V10, P2753, DOI 10.1021/cm980140w; Aksel E, 2010, J AM CERAM SOC, V93, P3012, DOI 10.1111/j.1551-2916.2010.03977.x; Fukunaga M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.064706; FRYE JS, 1982, J MAGN RESON, V48, P125, DOI 10.1016/0022-2364(82)90243-8; Milanova MM, 1996, J ALLOY COMPD, V242, P6, DOI 10.1016/0925-8388(96)02323-7; PARK SE, 1994, J AM CERAM SOC, V77, P2641, DOI 10.1111/j.1151-2916.1994.tb04655.x; DORRIAN JF, 1971, FERROELECTRICS, V3, P17; Panda PK, 2009, J MATER SCI, V44, P5049, DOI 10.1007/s10853-009-3643-0; Kim CY, 2005, J SOL-GEL SCI TECHN, V33, P307, DOI 10.1007/s10971-005-6380-0; Jones GO, 2002, ACTA CRYSTALLOGR B, V58, P168, DOI 10.1107/S0108768101020845; Ranjan R, 2005, SOLID STATE COMMUN, V135, P394, DOI 10.1016/j.ssc.2005.03.053; Xu Q, 2006, J MATER SCI, V41, P6146, DOI 10.1007/s10853-006-0572-z; Yashima M, 1996, J MATER RES, V11, P1410, DOI 10.1557/JMR.1996.0177; Chaouchi A, 2011, J ALLOY COMPD, V509, P9138, DOI 10.1016/j.jallcom.2011.06.085; Wu SJ, 2006, MATER RES BULL, V41, P1345, DOI 10.1016/j.materresbull.2005.12.005; Hiruma Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3115409; Jaffe B, 1971, PIEZOELECTRIC CERAMI, V3; Kakihana M, 1996, J SOL-GEL SCI TECHN, V6, P7, DOI 10.1007/BF00402588; Pechini M. P., 1967, U. S. Pat., Patent No. [3330697, 3 330 697]; Shimada M., 2002, B CERAMID SOC JAPAN, V37, P866	26	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					978	982		10.2109/jcersj2.123.978		5	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300009		
J	Morita, K; Kim, BN; Yoshida, H; Hiraga, K; Sakka, Y				Morita, Koji; Kim, Byung-Nam; Yoshida, Hidehiro; Hiraga, Keijiro; Sakka, Yoshio			Assessment of carbon contamination in MgAl2O4 spinel during spark-plasma-sintering (SPS) processing	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Spark-plasma-sintering; Carbon; Vacancy; Optical properties; Spinel	TRANSPARENT; RAMAN; CONSOLIDATION; POLYCRYSTAL; FABRICATION; PRESSURE; SPECTRA; AL2O3	Carbon contamination caused during spark-plasma-sintering (SPS) processing was investigated in the MgAl2O4 spinel by Raman spectroscopy. Although the carbon contamination became remarkable around the sample surfaces directly contacting the carbon paper, it sensitively changes with the SPS conditions, particularly for the heating rate. For the slow heating rate of 10 degrees C/min, the carbon contamination can be detected around the surface regions rather than inside. For the high heating rate, however, a large amount of the carbon contamination was detected even inside in addition to the significant contamination around the surfaces even though the sintering temperature is the same and the processing time is shorter as compared to those of the slow heating rate. The present results suggest that the carbon contamination is not caused by diffusion processes, but caused by evaporation of the carbon phase from the carbon paper/dies, which were used in the SPS process. For the high heating rates, the carbon evaporation is enhanced due to the rapid heating and goes into the samples through open pore channels. The evaporated carbon is encapsulated into the closed pores during the heating process and remains along the grain junctions as glassy carbon. (C) 2015 The Ceramic Society of Japan. All rights reserved.	[Morita, Koji; Kim, Byung-Nam; Yoshida, Hidehiro; Hiraga, Keijiro; Sakka, Yoshio] Natl Inst Mat Sci, Adv Ceram Grp, Tsukuba, Ibaraki 3050047, Japan; [Hiraga, Keijiro] Kitami Inst Technol, Mat Sci & Engn, Kitami, Hokkaido 0908507, Japan	Morita, K (reprint author), Natl Inst Mat Sci, Adv Ceram Grp, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	MORITA.Koji@nims.go.jp			Amada Foundation [AF-2014020]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [(C)25420700, (C)15K06515]	This study was financially supported by the Amada Foundation (AF-2014020) and the Grant-in-Aid for Scientific Research [(C)25420700 and (C)15K06515] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Grasso S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/5/053001; Morita K, 2009, J MATER RES, V24, P2863, DOI 10.1557/JMR.2009.0335; Ni ZH, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2200353; Ganesh I, 2013, INT MATER REV, V58, P63, DOI 10.1179/1743280412Y.0000000001; Lazzeri M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.140301; Tewell CR, 2002, J PHYS CHEM B, V106, P2946, DOI 10.1021/jp012840l; Krell A, 2009, OPT MATER, V31, P1144, DOI 10.1016/j.optmat.2008.12.009; Kim BN, 2010, J AM CERAM SOC, V93, P2158, DOI 10.1111/j.1551-2916.2010.03699.x; Meir S, 2009, J AM CERAM SOC, V92, P358, DOI 10.1111/j.1551-2916.2008.02893.x; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Frost RL, 2008, J RAMAN SPECTROSC, V39, P374, DOI 10.1002/jrs.1829; Orru R, 2009, MAT SCI ENG R, V63, P127, DOI 10.1016/j.mser.2008.09.003; Zhang HB, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/5/055003; Morita K, 2008, SCRIPTA MATER, V58, P1114, DOI 10.1016/j.scriptamat.2008.02.008; Morita K, 2015, ACTA MATER, V84, P9, DOI 10.1016/j.actamat.2014.10.030; HOWARD WF, 1975, INORG CHEM, V14, P767, DOI 10.1021/ic50146a013; Jiang D, 2008, J AM CERAM SOC, V91, P151, DOI 10.1111/j.1551-2916.2007.02086.x; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; Bernard-Granger G, 2009, SCRIPTA MATER, V60, P164, DOI 10.1016/j.scriptamat.2008.09.027; Krell A, 2009, J EUR CERAM SOC, V29, P275, DOI 10.1016/j.jeurceramsoc.2008.03.024; Morita K, 2009, J AM CERAM SOC, V92, P1208, DOI 10.1111/j.1551-2916.2009.03074.x; Goldstein A, 2013, J AM CERAM SOC, V96, P3523, DOI 10.1111/jace.12525; Krell A, 2010, J AM CERAM SOC, V93, P2656, DOI 10.1111/j.1551-2916.2010.03814.x; Morita K, 2015, J AM CERAM SOC, V98, P378, DOI 10.1111/jace.13309; OHORO MP, 1973, J PHYS CHEM SOLIDS, V34, P23, DOI 10.1016/0022-3697(73)90058-9; Anselmi-Tamburini U, 2007, ADV FUNCT MATER, V17, P3267, DOI 10.1002/adfm.200600959; Gimasekaran S., 2006, J RAMAN SPECTROSC, V37, P892; Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y; Morita K., 2015, J EURO CERAM S UNPUB; Omori M, 2000, MAT SCI ENG A-STRUCT, V287, P183, DOI 10.1016/S0921-5093(00)00773-5; Osada M., 2007, TANSO, V228, P174	31	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					983	988		10.2109/jcersj2.123.983		6	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300010		
J	Kang, YP; Shimokawa, Y; Ishihara, Y; Tsuji, H; Hashimoto, S; Miao, L; Sakae, T; Iwamoto, Y				Kang, Yipu; Shimokawa, Yohei; Ishihara, Yasutaka; Tsuji, Hitoshi; Hashimoto, Shinobu; Miao, Lei; Sakae, Tanemura; Iwamoto, Yuji			Photoluminescence and cathodoluminescence properties of Li+ doped Gd1.88Eu0.12O3	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						Gd2O3:Eu3+:Li+; Photoluminescence; Cathodoluminescence; Dispersion property; Crystallite size; Specific surface area	FIELD-EMISSION DISPLAYS; LUMINESCENCE PROPERTIES; PHOSPHORS; GD2O3-EU3+; DEGRADATION; PARTICLES; FILMS	Li+-doped cubic Gd1.88Eu0.12O3 phosphors were synthesized at 1200 degrees C in air by co-precipitation (CP) and solid state reaction (SS) methods. X-ray diffraction analysis revealed that, regardless of synthetic method, the average crystallite size for Li+-free Gd1.88Eu0.12O3 was approximately 400 nm, then increased with the amount of Li+ and at 20 mol%, reached about 2.3 mu m. Under excitation of the charge transfer band of Eu3+ at 245 nm, Gd1.88Eu0.12O3 exhibited a dominant photoluminescence (PL) red emission peak at 611 nm assigned to the electric dipole transition D-5(0) -> F-7(2) of Eu3+. The red emission peak intensity increased consistently with the amount of Li+-doping, while CP method was found to be effective in improving the red emission intensity at lower amounts of L-i+-doping from 0 to 8 mol%. Cathodoluminescence (CL) property was studied by mounting the synthesized phosphor on a vacuum fluorescent display (VFD) operated at an anode voltage of 50V. The Gd1.88Eu0.12O3 exhibited a similar spectrum with an intense red emission peak at 611 nm, and the highest luminance intensity for the CL red emission was achieved for 8 mol% Li+-doped Gd1.88Eu0.12O3 synthesized by SS method. The evaluation results of PL and CL properties suggested that, besides the crystallite size of Gd1.88Eu0.12O3, dispersion property of Eu3+ ions in the host Gd2O3 was an important factor for improving luminescent properties of Gd1.88Eu0.12O3. Moreover, under the present VFD operating condition at the low excitation voltage, it was thought to be essential for improving CL emission intensity to maintain a sufficient surface area of Gd1.88Eu0.12O3. (C)2015 The Ceramic Society of Japan. All rights reserved.	[Kang, Yipu; Shimokawa, Yohei; Ishihara, Yasutaka; Iwamoto, Yuji] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tsuji, Hitoshi] Noritake Itron Corp, R&D Dept, Taiki, Mie 5192736, Japan; [Hashimoto, Shinobu] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; [Miao, Lei; Sakae, Tanemura] Chinese Acad Sci, Guangzhou Inst Energy Convers, Key Lab Renewable Energy, Guangzhou 510640, Guangdong, Peoples R China	Iwamoto, Y (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	iwamoto.yuji@nitech.ac.jp			Japan Science and Technology Agency (JST) under the Adaptable and Seamless Technology Transfer Program through target-driven RD (A-STEP); Ministry of Education, Culture, Sports, Science and Technology of Japan [20360297]	This work was supported in part by the Japan Science and Technology Agency (JST) under the Adaptable and Seamless Technology Transfer Program through target-driven R&D (A-STEP), and by a Grant-in-Aid for Scientific Research (B) (No. 20360297) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Yang J, 2007, J PHYS CHEM C, V111, P18148, DOI 10.1021/jp0767112; Lin CC, 2007, J LUMIN, V126, P795, DOI 10.1016/j.jlumin.2006.11.014; Wang YG, 2003, J APPL PHYS, V94, P354, DOI 10.1063/1.1577819; Li JG, 2011, ACTA MATER, V59, P3688, DOI 10.1016/j.actamat.2011.03.004; Liu XM, 2007, J ELECTROCHEM SOC, V154, pJ21, DOI 10.1149/1.2364691; Hong M, 1999, SCIENCE, V283, P1897, DOI 10.1126/science.283.5409.1897; Pires AM, 2003, J SOLID STATE CHEM, V171, P420, DOI 10.1016/S0022-4596(02)00224-4; Yang J, 2007, J CRYST GROWTH, V303, P480, DOI 10.1016/j.jcrysgro.2006.12.069; Park JC, 2000, APPL PHYS LETT, V77, P2162, DOI 10.1063/1.1315341; Shin SH, 2005, J LUMIN, V114, P275, DOI 10.1016/j.jlumin.2005.02.002; Nogami M, 2002, J LUMIN, V97, P147, DOI 10.1016/S0022-2313(02)00217-X; Wang X, 2003, ADV MATER, V15, P1442, DOI 10.1002/adma.200305164; Lin KM, 2006, NANOTECHNOLOGY, V17, P4048, DOI 10.1088/0957-4484/17/16/009; Kang YP, 2015, J LUMIN, V166, P238, DOI 10.1016/j.jlumin.2015.05.039; Wang F, 2010, NATURE, V463, P1061, DOI 10.1038/nature08777; Wan JX, 2005, J CRYST GROWTH, V284, P538, DOI 10.1016/j.jcrysgro.2005.07.040; Fitz-Gerald JM, 1998, APPL PHYS LETT, V72, P1838, DOI 10.1063/1.121195; Ko MG, 2003, J LUMIN, V104, P215, DOI 10.1016/S0022-2313(03)00018-8; Swart HC, 1998, J APPL PHYS, V83, P4578, DOI 10.1063/1.367240; FELDMAN C, 1960, PHYS REV, V117, P455, DOI 10.1103/PhysRev.117.455; Tanaka K, 2002, J APPL PHYS, V92, P834, DOI 10.1063/1.1487436; Wang XC, 2015, DALTON T, V44, P11057, DOI 10.1039/c5dt00800j; Jung KY, 2005, ELECTROCHEM SOLID ST, V8, pH17, DOI 10.1149/1.1849111; Xiao HY, 2009, J PHYS CHEM C, V113, P21034, DOI 10.1021/jp905538k; Kumar RGA, 2014, CERAM INT, V40, P2915, DOI 10.1016/j.ceramint.2013.10.020; Rajan G, 2009, APPL SURF SCI, V255, P9112, DOI 10.1016/j.apsusc.2009.06.128; Guo PM, 2003, J LUMIN, V105, P61, DOI 10.1016/S0022-2313(03)00098-X; Ballato J, 1999, MRS BULL, V24, P51; Kano T., 1998, PHOSPHOR HDB, P192; Li H., 2009, MATER SCI ENG, V1, P1; Liu L., 2007, NANOTECHNOLOGY, V18; Tamrakar R., 2015, J BIO CHEM LUMIN, V10, P2913	32	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					989	994		10.2109/jcersj2.123.989		6	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300011		
J	Obukuro, Y; Obata, K; Maeda, R; Matsushima, S; Okuyama, Y; Matsunaga, N; Sakai, G				Obukuro, Yuki; Obata, Kenji; Maeda, Ryosuke; Matsushima, Shigenori; Okuyama, Yuji; Matsunaga, Naoki; Sakai, Go			Formation of CaFe2O4 porous structure by addition of Zr in malic acid complex	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						CaFe2O4; Zr addition; Malic acid complex; Morphology	OXIDATION; HYDROGEN; WATER	The effect of Zr addition into malic acid complex was examined for the purpose of the improvement of microstructure and specific surface area of CaFe2O4. The CaFe2O4 phase could be obtained for both unadded and Zr-added (5 and 10 mol% with respect to Fe) system by calcination of precursor derived from malic acid complex at 700 degrees C which is almost 200 degrees C lower than that of conventional solid-state reaction method. Among the examined products, only the 5 mol% Zr-added product revealed characteristic smaller grains connected three dimensional porous structures resulting in higher specific surface area compared with unadded and 10 mol% Zr-added products. XPS measurements revealed that there are no notable changes in valence state for all constituent elements. The obtained final product of 5 mol% Zr-added CaFe2O4 is worth further investigate for various application from a view point of improved higher specific surface area and characteristic microstructure as well as the functionality of the material itself. (C)2015 The Ceramic Society of Japan. All rights reserved.	[Obukuro, Yuki] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki 8892192, Japan; [Obata, Kenji; Maeda, Ryosuke; Matsushima, Shigenori] Natl Inst Technol, Kitakyushu Coll, Dept Creat Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan; [Okuyama, Yuji] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8892192, Japan; [Matsunaga, Naoki; Sakai, Go] Miyazaki Univ, Dept Environm Robot, Fac Engn, Miyazaki 8892192, Japan	Matsushima, S (reprint author), Natl Inst Technol, Kitakyushu Coll, Dept Creat Engn, Kokuraminami Ku, Kitakyushu, Fukuoka 8020985, Japan.	smatsu@kct.ac.jp; sakai-go@cc.miyazaki-u.ac.jp					Kim ES, 2013, J AM CHEM SOC, V135, P5375, DOI 10.1021/ja308723w; Shizuya M, 2007, J SOLID STATE CHEM, V180, P2550, DOI 10.1016/j.jssc.2007.07.008; Yamashita T, 2008, APPL SURF SCI, V254, P2441, DOI 10.1016/j.apsusc.2007.09.063; Hahn NT, 2010, CHEM MATER, V22, P6474, DOI 10.1021/cm1026078; Shifu C, 2009, J HAZARD MATER, V172, P1415, DOI 10.1016/j.jhazmat.2009.08.007; Miyauchi M, 2013, ACS APPL MATER INTER, V5, P9770, DOI 10.1021/am402929d; MATSUMOTO Y, 1987, J PHYS CHEM-US, V91, P577, DOI 10.1021/j100287a018; Voigts F, 2009, SURF SCI, V603, P40, DOI 10.1016/j.susc.2008.10.016; Pardeshi SK, 2010, MATER RES BULL, V45, P609, DOI 10.1016/j.materresbull.2010.01.011; Kumar P, 2011, INT J HYDROGEN ENERG, V36, P2777, DOI 10.1016/j.ijhydene.2010.11.107; Ida S, 2010, J AM CHEM SOC, V132, P17343, DOI 10.1021/ja106930f; Liu ZF, 2009, J PHYS CHEM C, V113, P17132, DOI 10.1021/jp906195f; Ikenaga N, 2005, ENERG FUEL, V19, P170, DOI 10.1021/ef049907z; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Barunauer S., 1940, J AM CHEM SOC, V62, P1723; Barunauer S., 1938, J AM CHEM SOC, V60, P309; De Bore J. H., 1958, STRUCTURE PROPERTIES, P68; Doi A., 2014, J CERAM SOC JPN, V122, P175; Liu ZF, 2009, CHEM COMMUN, P2002, DOI 10.1039/b819312f; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551	20	0	0	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	OCT	2015	123	1442					995	998		10.2109/jcersj2.123.995		4	Materials Science, Ceramics	Materials Science	CT0SH	WOS:000362506300012		
J	Yada, K; Nogami, K; Takeyama, M; Ogiwara, K; Wakabayashi, H; Shima, M				Yada, K.; Nogami, K.; Takeyama, M.; Ogiwara, K.; Wakabayashi, H.; Shima, M.			Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						blood coagulation factor inhibitors; epitopes; factor VIII; hemophilia A; mutation missense	VON-WILLEBRAND-FACTOR; C2 DOMAIN; BINDING-SITE; FACTOR IXA; FACTOR XA; ACTIVATION; EPITOPES; COMPLEX; MECHANISM; ALLOANTIBODIES	BackgroundIn mild hemophilia A (MHA) patients, the risk of inhibitor development is generally low, but some factor VIII (FVIII) gene missense mutations are associated with a higher inhibitor incidence. ObjectiveTo investigate the mechanism(s) of inhibitor development in MHA. Methods and resultsA patient, HA78, with MHA with a novel P1809L missense mutation in the A3 domain, exhibited significant residual FVIII activity (FVIII:C similar to 10IUdL(-1)), despite the development of an inhibitor (5.6BUmL(-1)). Purified HA78-IgG significantly depressed FVIII:C from normal plasma but not from patient's plasma without inhibitor, indicating that this IgG inhibited allogeneic but not autologous FVIII. The HA78-IgG blocked thrombin and FXa-catalyzed FVIII cleavage but had little effect on FVIII binding to von Willebrand factor and phospholipid. The IgG recognized a C2 epitope close or overlapping the previously described anti-C2 ESH8 epitope. Similarly, a recombinant FVIII-P1809L mutant was little inactivated by HA78-IgG. This mutant demonstrated similar to 3-fold lower binding affinities to von Willebrand factor and phospholipid compared with wild-type, while reactions with thrombin or FXa were not impaired. Reaction of FVIII-P1809L with the alternative anti-C2 ESH4 showed only an similar to 20% inhibition compared with wild-type FVIII but was similar to wild-type after incubation with ESH8. Asurface plasmon resonance-based assay demonstrated that anti-C2 ESH4 bound to FVIII-P1809L with similar to 10(2)-fold lower affinity compared with ESH8. ConclusionThese results indicated that the P1809L mutation in A3 induced the conformational change in the FVIII molecule that hampered antigenic determinant(s) located in the C2 domain and might result in the inhibitor development.	[Yada, K.; Nogami, K.; Takeyama, M.; Ogiwara, K.; Shima, M.] Nara Med Univ, Dept Pediat, Kashihara, Nara 6348522, Japan; [Wakabayashi, H.] Univ Rochester Sch, Dept Biochem & Biophys, Rochester, NY USA	Yada, K (reprint author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp					Soeda T, 2009, J BIOL CHEM, V284, P3379, DOI 10.1074/jbc.M804955200; d'Oiron R, 2004, BLOOD, V103, P155, DOI 10.1182/blood-2003-04-1321; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Nguyen PCT, 2014, BLOOD, V123, P2732, DOI 10.1182/blood-2013-09-527275; Nogami K, 2007, INT J HEMATOL, V85, P317, DOI 10.1532/IJH97.06192; Suzuki H, 1997, THROMB HAEMOSTASIS, V77, P862; GAWRYL MS, 1982, BLOOD, V60, P1103; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; James EA, 2007, J THROMB HAEMOST, V5, P2399, DOI 10.1111/j.1538-7836.2007.02762.x; Nogami K, 2002, THROMB HAEMOSTASIS, V87, P459; Jacquemin M, 2000, BLOOD, V95, P156; Eckhardt CL, 2013, BLOOD, V122, P1954, DOI 10.1182/blood-2013-02-483263; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2005, BLOOD, V105, P4362, DOI 10.1182/blood-2004-10-3939; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Fijnvandraat K, 1997, BLOOD, V89, P4371; Albert T, 2008, THROMB HAEMOSTASIS, V99, P634, DOI 10.1160/TH07-06-0400; Williams IJ, 1998, THROMB HAEMOSTASIS, V79, P723; MANN KG, 1990, BLOOD, V76, P1; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788; Matsumoto T, 2012, THROMB HAEMOSTASIS, V107, P288, DOI 10.1160/TH11-05-0331; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Bloem E, 2013, J BIOL CHEM, V288, P26105, DOI 10.1074/jbc.M113.500884; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Prescott R, 1997, BLOOD, V89, P3663; d'Oiron R, 2008, HAEMOPHILIA, V14, P138, DOI 10.1111/j.1365-2516.2008.01730.x; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Jacquemin M, 2003, BLOOD, V101, P1351, DOI 10.1182/blood-2002-05-1369; Oldenburg Johannes, 2000, Haematologica, V85, P7; Robinson MA, 2014, BLOOD S, V124, P2837	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	OCT	2015	13	10					1843	1853		10.1111/jth.13118		11	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CS9XO	WOS:000362447200014		
J	Ochi, M; Tanaka, Y; Toyoda, H				Ochi, Masanori; Tanaka, Yoshiyuki; Toyoda, Hiromu			Protective effect of N-acetylcysteine against nicardipine hydrochloride-induced autophagic cell death of human vascular endothelial cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Nicardipine hydrochloride; N-acetylcysteine; Autophagy; Cytotoxicity; Vascular injury; Endothelial cells	ISOLATED RAT HEPATOCYTES; LIPIDATION	Nicardipine hydrochloride (NIC) injection has been widely used for emergency treatment of abnormally high blood pressure. However, NIC injection often causes severe peripheral vascular injury. The purpose of the present study was to reduce the NIC-induced cell injury in human vascular endothelial cells by use of clinical agents. The mechanism of NIC-induced cell injury was evaluated by time-lapse microscopic imaging, autophagosome staining with monodansylcadaverine, immunostaining of light chain 3 isoform B (LC-3B) and assessment of cell viability after exposure to NIC with or without an inhibitor of autophagosome formation (3-methyladenine, 3-MA). Results from autophagosome labeling and immunostaining of LC-3B revealed an increase of autophagosomes and LC-3B in NIC-treated cells. NIC-mediated reduction of cell viability was inhibited by 3-methyladenine. Moreover, we found that N-acetylcysteine (NAC) reduced NIC-induced cell injury in human vascular endothelial cells. These findings suggest that NIC causes severe peripheral venous irritation via induction of autophagic cell death and that inhibition of autophagy with NAC could contribute to the reduction of NIC-induced vascular injury.	[Ochi, Masanori; Tanaka, Yoshiyuki; Toyoda, Hiromu] Sawai Pharmaceut Co Ltd, Dept Biol Res, Yodogawa Ku, Osaka, Osaka 5320003, Japan	Ochi, M (reprint author), Sawai Pharmaceut Co Ltd, Dept Biol Res, Yodogawa Ku, 2-30,Miyahara 5 Chome, Osaka, Osaka 5320003, Japan.	m.ochi@sawai.co.jp					Ichimura Y, 2000, NATURE, V408, P488; BRIDGEMAN MME, 1991, THORAX, V46, P39, DOI 10.1136/thx.46.1.39; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Deniel N, 2007, MOL CELL PROTEOMICS, V6, P1671, DOI 10.1074/mcp.M600428-MCP200; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Gurer H, 1998, TOXICOLOGY, V128, P181, DOI 10.1016/S0300-483X(98)00074-2; BRIDGES KR, 1987, J BIOL CHEM, V262, P14773; You BR, 2012, ONCOL REP, V28, P749, DOI 10.3892/or.2012.1852; WALLIN JD, 1988, AM J MED, V85, P331, DOI 10.1016/0002-9343(88)90582-7; Kuo SM, 2001, LIFE SCI, V68, P1751, DOI 10.1016/S0024-3205(01)00970-5; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; Aoki H, 2008, AUTOPHAGY, V4, P467; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yamada T, 2010, FREE RADICAL BIO MED, V48, P120, DOI 10.1016/j.freeradbiomed.2009.10.032; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Chandramani Shivalingappa P, 2012, PARKINSONS DIS, V2012, DOI DOI 10.1155/2012/424285; MEISTER A, 1994, CANCER RES, V54, pS1969; Ochi M, 2015, J TOXICOL SCI, V40, P71, DOI 10.2131/jts.40.71; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Wisnoskey B.J., 2004, AM J PHYSIOL-CELL PH, V287, P345; Yuasa Tetsuya, 1997, Journal of Dermatology (Tokyo), V24, P466	24	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	OCT	2015	40	5					551	558				8	Toxicology	Toxicology	CT2HL	WOS:000362622500002		
J	Win-Shwe, TT; Fujimaki, H				Win-Shwe, Tin-Tin; Fujimaki, Hidekazu			Activation of transcription factors in a mouse lung following exposure to environmental chemical and biological agents	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						TLR4; NF-kappa B; AP-1; Toluene; OVA; LPS	NF-KAPPA-B; LOW-LEVEL TOLUENE; GENETIC SUSCEPTIBILITY; ADAPTIVE IMMUNITY; TLR4; TOLL; INJURY; INFLAMMATION; PATHWAYS; INNATE	Environmental biological and chemical agents can modulate innate and acquired immunity in the lung via the stimulation of Toll-like receptors (TLRs). To investigate the effect of environmental chemical agents on the activation of NF-kappa B and activator protein (AP)-1 subunits and the role of TLR4 signaling in the lung, C3H/HeN and C3H/HeJ (TLR4-defective) mice were exposed to 0 or 50 ppm of toluene for 6 hr/day, 5 days/week for 6 weeks. Some groups of mice were also stimulated with OVA or LPS as a biological agent. The DNA-binding activities of the NF-kappa B subunits (p50, p52, p65 and RelB) and AP-1 family members (FosB, c-Fos, +c-Jun, JunD) were compared using TransAM (TM) ELISA kits. Exposure to toluene alone produced no significant changes in both mice. Although stimulation with OVA or LPS alone significantly increased the DNA binding activities of p50 and p52 in C3H/HeN mice, there were no interactions between biological factors and toluene. In the C3H/HeJ mice, stimulation with OVA or LPS increased p65 and p52 binding activity and the combination of exposure to toluene and OVA significantly increased the DNA binding activities of the p65 and p52 in the lung. During AP-1 activation, co-exposure to toluene and OVA increased JunD binding activity in C3H/HeJ mice, while co-exposure to toluene and LPS influenced c-Fos binding activity in C3H/HeN mice. These results indicate that TLR4 may play an important role in activation of NF-kappa B or AP-1 family following exposure to environmental biological and chemical agents.	[Win-Shwe, Tin-Tin; Fujimaki, Hidekazu] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Win-Shwe, TT (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	tin.tin.win.shwe@nies.go.jp			Ministry of Education, Culture, Sports, Sciences and Technology, Japan [21390198]; National Institute for Environmental Studies [12254]	This research was partly supported by a grant from the Ministry of Education, Culture, Sports, Sciences and Technology, Japan (#21390198 to H.F) and by a grant from National Institute for Environmental Studies (#12254 to T.T.W.S). We thank Drs. Naoki Kunugita, Yasuhiro Yoshida and Keiichi Arashidani (University of Occupational and Environmental Health, Japan) for their excellent support and discussion through this experiment. We also thank Mrs. S. Murakami and K. Ohnishi (National Institute for Environmental Studies) for their excellent technical assistance.	American Conference of Governmental Industrial Hygienists (ACGIH), 2006, THRESH LIM VAL BIOL; Fujimaki H, 2009, TOXICOL LETT, V191, P240, DOI 10.1016/j.toxlet.2009.09.004; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Fujimaki H, 2007, TOXICOL LETT, V168, P132, DOI 10.1016/j.toxlet.2006.11.008; Arguni E, 2006, INT IMMUNOL, V18, P1079, DOI 10.1093/intimm/dxl041; Kleeberger SR, 2000, AM J RESP CELL MOL, V22, P620; Weih F, 1997, J EXP MED, V185, P1359, DOI 10.1084/jem.185.7.1359; Rumchev K, 2004, THORAX, V59, P746, DOI 10.1136/thx.2003.013680; Zhao H, 2010, J IMMUNOL, V184, P5308, DOI 10.4049/jimmunol.1000009; Medzhitov R, 1997, NATURE, V388, P394; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Wright SD, 1999, J EXP MED, V189, P605, DOI 10.1084/jem.189.4.605; Phan HH, 2006, GENE, V371, P121, DOI 10.1016/j.gene.2005.11.019; Hori H, 1999, J OCCUP HEALTH, V41, P149, DOI 10.1539/joh.41.149; Qureshi ST, 2006, J IMMUNOL, V176, P4950; Yang IA, 2008, THORAX, V63, P555, DOI 10.1136/thx.2007.079426; Fujimaki H, 2011, TOXICOLOGY, V286, P28, DOI 10.1016/j.tox.2011.05.002; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Liu JQ, 2010, J APPL TOXICOL, V30, P656, DOI 10.1002/jat.1536; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Japan Society for Occupational Health, 1994, TOLUENE IND MED, V36, P103; Perros F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-125; Tamburlini G., 2002, CHILDRENS HLTH ENV R; Win-Shwe T.T., 2007, TOXICOL APPL PHARM, V222, P17; Zhang XC, 2005, J IMMUNOL, V175, P4834	26	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	OCT	2015	40	5					559	568				10	Toxicology	Toxicology	CT2HL	WOS:000362622500003		
J	Fujimoto, T; Kubo, K; Nishikawa, Y; Aou, S				Fujimoto, Tetsuya; Kubo, Kazuhiko; Nishikawa, Yasuo; Aou, Shuji			Prenatal low-dose bisphenol A enhances behavioral responses induced by a predator odor	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Bisphenol A; Behavioral toxicity; Prenatal exposure; Predator odor; Avoidance response	DEPRESSION-LIKE BEHAVIORS; PERINATAL EXPOSURE; MALE RATS; SEXUAL-DIFFERENTIATION; STRESS; ANXIETY; MICE; MEMORY; TMT; POLYMORPHISM	Bisphenol A (BPA) is an environmental endocrine disrupter (EED). Previous studies by our group showed that pre- and postnatal administration of low-level BPA induced depression-like behavior in rats. In this study, we evaluated the effects of prenatal BPA on behavioral responses to a predator odor by using a novel cross-form apparatus consisting of 4 plastic chambers. On the first day, nothing was placed into the chambers (Session 1). On the second day, a predator odor (fox odor) was located in separate chambers at 2 opposite corners of the apparatus (Session 2). Pregnant Wistar rats were exposed to low-dose BPA (less than the reference dose) during the 7 days just before birth, and the offspring of the treated rats were evaluated as adults. The locomotor activity and avoidance response of each rat on both test days were compared. The control and BPA groups showed reduced locomotor activity in the presence of the predator odor, but the odor-avoidance response was significant only in the BPA rats. The BPA-exposed rats were obviously sensitive to the predator odor. These results suggest that prenatal BPA exposure has an amplifying effect on avoidance responses to predator odor stress.	[Fujimoto, Tetsuya; Nishikawa, Yasuo] Osaka Dent Univ, Dept Physiol, Hirakata, Osaka 5731121, Japan; [Kubo, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Aou, Shuji] Kyushu Inst Technol, Dept Human Intelligence Syst, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan	Fujimoto, T (reprint author), Osaka Dent Univ, Dept Physiol, 8-1 Kuzuha Hanazono Cho, Hirakata, Osaka 5731121, Japan.	tetsu-f@cc.osaka-dent.ac.jp					Kubo K, 2001, NEUROSCI LETT, V304, P73, DOI 10.1016/S0304-3940(01)01760-8; Morrow BA, 2000, BRAIN RES, V864, P146, DOI 10.1016/S0006-8993(00)02174-0; Poimenova A, 2010, NEUROSCIENCE, V167, P741, DOI 10.1016/j.neuroscience.2010.02.051; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Farabollini F, 1999, PHARMACOL BIOCHEM BE, V64, P687, DOI 10.1016/S0091-3057(99)00136-7; Fujimoto T, 2013, J TOXICOL SCI, V38, P539; Brede C, 2003, FOOD ADDIT CONTAM, V20, P684, DOI 10.1080/02652030210134236; Adamec R, 1998, NEUROSCI BIOBEHAV R, V23, P301, DOI 10.1016/S0149-7634(98)00032-3; Xu XH, 2012, HORM BEHAV, V62, P480, DOI 10.1016/j.yhbeh.2012.08.005; Kuwahara R, 2013, J PHARMACOL SCI, V123, P132, DOI 10.1254/jphs.13093FP; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Fendt M, 2008, NEUROSCI BIOBEHAV R, V32, P1259, DOI 10.1016/j.neubiorev.2008.05.010; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; Kang JH, 2003, J FOOD PROTECT, V66, P1444; Jones BA, 2012, HORM BEHAV, V61, P605, DOI 10.1016/j.yhbeh.2012.02.011; Calvo-Torrent A, 1999, PHYSIOL BEHAV, V67, P189, DOI 10.1016/S0031-9384(99)00051-7; Fujimoto T, 2006, BRAIN RES, V1068, P49, DOI 10.1016/j.brainres.2005.11.028; ADAMEC RE, 1993, PHYSIOL BEHAV, V54, P101, DOI 10.1016/0031-9384(93)90050-P; Matsuda S, 2013, HORM BEHAV, V63, P709, DOI 10.1016/j.yhbeh.2013.03.016; Zhou R, 2015, J PSYCHIATR RES, V64, P121, DOI 10.1016/j.jpsychires.2015.02.018; Adamec R, 2006, BEHAV BRAIN RES, V170, P126, DOI 10.1016/j.bbr.2006.02.012; Blanchard DC, 2003, PROG NEURO-PSYCHOPH, V27, P1177, DOI 10.1016/j.pnpbp.2003.09.012; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Patisaul HB, 2008, HORM BEHAV, V53, P580, DOI 10.1016/j.yhbeh.2008.01.008; Xu XH, 2015, CHEMOSPHERE, V120, P258, DOI 10.1016/j.chemosphere.2014.07.021; Olea N, 2000, ENVIRON HEALTH PERSP, V108, pA546, DOI 10.1289/ehp.108-a546a; Weinstein SD, 2013, BRAIN RES, V1529, P56, DOI 10.1016/j.brainres.2013.07.018; Dielenberg RA, 1999, PHARMACOL BIOCHEM BE, V62, P197, DOI 10.1016/S0091-3057(98)00064-1; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Negishi T, 2004, ENVIRON HEALTH PERSP, V112, P1159, DOI 10.1289/ehp.6961; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Kuwahara R, 2014, CELL MOL NEUROBIOL, V34, P333, DOI 10.1007/s10571-013-0017-6; Panagiotidou E, 2014, J ENDOCRINOL, V220, P207, DOI 10.1530/JOE-13-0416; Patisaul HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043890; Suzuki K, 2000, Dent Mater J, V19, P389	37	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	OCT	2015	40	5					569	575				7	Toxicology	Toxicology	CT2HL	WOS:000362622500004		
J	Shinkai, Y; Li, S; Kikuchi, T; Kumagai, Y				Shinkai, Yasuhiro; Li, Song; Kikuchi, Tomohiro; Kumagai, Yoshito			Participation of metabolic activation of 2,4,6-trinitrotoluene to 4-hydroxylamino-2,6-dinitrotoluene in hematotoxicity	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						2,4,6-Trinitrotoluene; Metabolic activation; Hemoglobin; Hematotoxicity; Hydrogen peroxide	INDUCED HEMOLYTIC-ANEMIA; HYDROGEN-PEROXIDE; OXYGEN RADICALS; HEME-SYNTHESIS; HEMOGLOBIN; TRINITROTOLUENE; METHEMOGLOBIN; ERYTHROCYTES; MECHANISM; WORKERS	Exposure to 2,4,6-trinitrotoluene (TNT) causes methemoglobin (metHb) formation, hemolysis and negative heme balance in vivo, but the mechanistic details are poorly understood. In the present study, we examined the participation of metabolic activation in TNT-mediated hematotoxicity. Exposure of rats with TNT (300 mg/kg, i.p.) for 4 days resulted in a decrease of hematocrit value coupled to an increase in metHb formation. The red blood cells treated with 4-hydroxylamino-2,6-dinitrotoluene (HADNT), a metabolite of TNT, underwent readily hemolysis in vitro, whereas such a phenomenon was not seen with TNT. Consistent with this, HADNT is active toward metHb formation and the decrease in thiol content of the globin moiety compared with TNT and its metabolites 4-amino-2,6-dinitrotoluene (ADNT) and 4-acetylamino-2,6-dinitrotoluene (AADNT). Furthermore, interaction of purified rat oxyhemoglobin (oxyHb) with HADNT, but not TNT, ADNT, and AADNT, caused a concentration-dependent production of H2O2 and ferrylhemoglobin (ferry1Hb) which is a highly oxidizing state formed by reaction of oxyHb with H2O2. Notably, hemin was released during interaction of oxyHb with HADNT. Taken together, these findings suggest that HADNT is an active metabolite that mediates TNT-induced hematotoxicity via formation of prooxidants such as H2O2 and ferry1Hb.	[Shinkai, Yasuhiro; Kumagai, Yoshito] Univ Tsukuba, Environm Biol Lab, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Li, Song] Univ Tsukuba, Doctoral Program Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Kikuchi, Tomohiro] Univ Tsukuba, Masters Program Environm Sci, Tsukuba, Ibaraki 3058575, Japan	Kumagai, Y (reprint author), Univ Tsukuba, Environm Biol Lab, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	yk-em-tu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08042]	This work was supported by a Grant-in-Aid (#15K08042 to Y. S.) for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Kovacic P, 2014, J APPL TOXICOL, V34, P810, DOI 10.1002/jat.2980; Kanias T, 2010, FEBS J, V277, P343, DOI 10.1111/j.1742-4658.2009.07472.x; LEUNG KH, 1995, CHEM-BIOL INTERACT, V97, P37, DOI 10.1016/0009-2797(94)03606-9; AHLBORG G, 1988, BRIT J IND MED, V45, P353; CHUA CG, 1975, BIOCHEM J, V149, P259; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265; KAPPUS H, 1986, BIOCHEM PHARMACOL, V35, P1, DOI 10.1016/0006-2952(86)90544-7; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; SAVOLAINEN H, 1985, BRIT J IND MED, V42, P354; Everse J, 1997, FREE RADICAL BIO MED, V22, P1075, DOI 10.1016/S0891-5849(96)00499-6; KIRSCHNERZILBER I, 1982, BIOCHIM BIOPHYS ACTA, V690, P20, DOI 10.1016/0005-2736(82)90234-6; JOLLOW DJ, 1995, DRUG METAB REV, V27, P107, DOI 10.3109/03602539509029818; Evelyn KA, 1938, J BIOL CHEM, V126, P655; GALLO RC, 1967, J CLIN INVEST, V46, P124, DOI 10.1172/JCI105505; KIESE M, 1966, PHARMACOL REV, V18, P1091; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; GROSSMAN SJ, 1992, TOXICOL APPL PHARM, V117, P208, DOI 10.1016/0041-008X(92)90239-O; HEBBEL RP, 1989, SEMIN HEMATOL, V26, P136; Spooren AAMG, 2000, BLOOD CELL MOL DIS, V26, P373, DOI 10.1006/bcmd.2000.0315; TENHUNEN R, 1984, EXP MOL PATHOL, V40, P362, DOI 10.1016/0014-4800(84)90053-4; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; BIAGLOW JE, 1986, BIOCHEM PHARMACOL, V35, P77, DOI 10.1016/0006-2952(86)90561-7; KUMAGAI Y, 1990, J PHARMACOL EXP THER, V255, P504; BEUTLER E, 1969, PHARMACOL REV, V21, P73; LIU SC, 1988, BLOOD, V71, P1755; Stolze K, 1996, BIOCHEM PHARMACOL, V52, P1821, DOI 10.1016/S0006-2952(96)00460-1; HARKONEN H, 1983, AM J OPHTHALMOL, V95, P807, DOI 10.1016/0002-9394(83)90070-3; NEWMAN ESR, 1991, BIOCHEM BIOPH RES CO, V179, P1414, DOI 10.1016/0006-291X(91)91730-Z; DAVIES KJA, 1987, J BIOL CHEM, V262, P9914; HARRISON JH, 1986, J PHARMACOL EXP THER, V238, P1045; Channon HJ, 1944, BIOCHEM J, V38, P70; WOOLLEN BH, 1986, BRIT J IND MED, V43, P465; SATOH H, 1987, BIOCHEM BIOPH RES CO, V146, P618, DOI 10.1016/0006-291X(87)90573-0; KAWANISHI S, 1985, J BIOL CHEM, V260, P4622; Reilly TP, 1999, J PHARMACOL EXP THER, V288, P951; Karuzina II, 1999, FREE RADICAL BIO MED, V26, P620, DOI 10.1016/S0891-5849(98)00252-4; Rossi R, 1997, ANAL BIOCHEM, V254, P215, DOI 10.1006/abio.1997.2424; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Sabbioni G, 2005, CARCINOGENESIS, V26, P1272, DOI 10.1093/carcin/bgi078; DJERASSI LS, 1975, BRIT J IND MED, V32, P54; KARIBIAN D, 1965, BIOCHEM BIOPH RES CO, V18, P243, DOI 10.1016/0006-291X(65)90747-3; LEVINE BS, 1984, TOXICOLOGY, V32, P253, DOI 10.1016/0300-483X(84)90078-7; SCHACTER LP, 1986, EUR J CLIN INVEST, V16, P204, DOI 10.1111/j.1365-2362.1986.tb01330.x; YOSHIDA Y, 1994, BBA-GEN SUBJECTS, V1201, P165, DOI 10.1016/0304-4165(94)90037-X; BERZOFSK.JA, 1971, J BIOL CHEM, V246, P3367; CRAWFORD MAD, 1954, BRIT MED J, V2, P430; HATHAWAY JA, 1977, J OCCUP ENVIRON MED, V19, P341; Li S, 1998, Sangyo Eiseigaku Zasshi, V40, P252; MacGookin A., 1940, J SOC CHEM IND LOND, V59, P92	51	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	OCT	2015	40	5					597	604				8	Toxicology	Toxicology	CT2HL	WOS:000362622500007		
J	Hanagata, N; Morita, H				Hanagata, Nobutaka; Morita, Hiromi			Calcium ions rescue human lung epithelial cells from the toxicity of zinc oxide nanoparticles	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Zinc oxide nanoparticles; Cytotoxicity; Lung epithelial cells; Global gene expression	SILVER NANOPARTICLES; ZNO NANOPARTICLES; OXIDATIVE STRESS; REACTIVE OXYGEN; FUME FEVER; EXPRESSION ANALYSIS; IMMUNE CELLS; CYTOTOXICITY; PARTICLES; MECHANISM	Contradictory results have been reported for in vitro evaluations of whether zinc oxide nanoparticles (ZnO NPs) are cytotoxic. Though there have been reports of ZnO NPs cytotoxicity due to Zn ions released from the nanoparticles, there have also been reports concluding that Zn ions are not cytotoxic. This inconsistency is mostly attributed to the types of cells used. In this research, we investigated the difference in the level of ZnO NPs cytotoxicity due to culturing conditions. The sensitivity of human lung epithelial cells to ZnO NPs cytotoxicity differed depending on the dispersing medium, physiological state of the cells resulting from their growth stage, and composition of the medium. Further, with regard to the toxicity of ZnO NPs, NPs internalized into cells had a greater cytotoxic effect than Zn ions released from ZnO NPs. Instead of inducing cell death, ZnO NPs internalized into cells slowed the rate of cell proliferation. Furthermore, the cytotoxicity of ZnO NPs depended greatly on the concentration of calcium ions (Ca2+) in the medium. When the concentration of Ca2+ was low, the cytotoxicity of ZnO NPs increased markedly. However, the toxicity of ZnO NPs was mitigated by the addition of CaCl2 to the medium. Global gene expression analysis revealed that Ca2+-induced upregulation of cell cycle functions could be attributable to the mitigation of ZnO NP toxicity by Ca2+.	[Hanagata, Nobutaka; Morita, Hiromi] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki 3050047, Japan; [Hanagata, Nobutaka] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hanagata, N (reprint author), Natl Inst Mat Sci, Nanotechnol Innovat Stn, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	HANAGATA.Nobutaka@nims.go.jp			Ministry of Health, Labour, and Welfare of Japan	This work was supported by a Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan.	Agren M S, 2004, J Wound Care, V13, P367; KUSCHNER WG, 1995, J INVEST MED, V43, P371; Liu Y, 2009, J APPL MICROBIOL, V107, P1193, DOI 10.1111/j.1365-2672.2009.04303.x; Turney TW, 2012, CHEM RES TOXICOL, V25, P2057, DOI 10.1021/tx300241q; Donaldson K, 2002, INHAL TOXICOL, V14, P5; Ai HQ, 2003, J CHEM PHYS, V118, P10973, DOI 10.1063/1.1575192; Ji SL, 2008, J MATER SCI TECHNOL, V24, P457; Warheit DB, 2009, ENVIRON SCI TECHNOL, V43, P7939, DOI 10.1021/es901453p; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; Osmond MJ, 2010, NANOTOXICOLOGY, V4, P15, DOI 10.3109/17435390903502028; MOUTIN MJ, 1989, BIOCHIM BIOPHYS ACTA, V984, P289, DOI 10.1016/0005-2736(89)90295-2; Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1; Yang ST, 2010, J NANOSCI NANOTECHNO, V10, P8638, DOI 10.1166/jnn.2010.2491; Prasad AS, 2008, MOL MED, V14, P353, DOI 10.2119/2008-00033.Prasad; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Krezel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P188, DOI 10.1016/j.abb.2007.02.017; Lin WS, 2009, J NANOPART RES, V11, P25, DOI 10.1007/s11051-008-9419-7; Yang H, 2009, J BIOMED NANOTECHNOL, V5, P528, DOI 10.1166/jbn.2009.1061; Hanagata N, 2011, ACS NANO, V5, P9326, DOI 10.1021/nn202966t; Ostrovsky S, 2009, NANO RES, V2, P882, DOI 10.1007/s12274-009-9089-5; Shen CC, 2013, TOXICOL SCI, V136, P120, DOI 10.1093/toxsci/kft187; Newman MD, 2009, J AM ACAD DERMATOL, V61, P685, DOI 10.1016/j.jaad.2009.02.051; LAM HF, 1988, AM IND HYG ASSOC J, V49, P333, DOI 10.1202/0002-8894(1988)049<0333:PFOGPE>2.0.CO;2; Moos PJ, 2010, CHEM RES TOXICOL, V23, P733, DOI 10.1021/tx900203v; Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8; VALLEE BL, 1993, PHYSIOL REV, V73, P79; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; VOGELMEIER C, 1987, CHEST, V92, P946, DOI 10.1378/chest.92.5.946; Xu LM, 2011, MATER EXPRESS, V1, P74, DOI 10.1166/mex.2011.1010; Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; Song WH, 2010, TOXICOL LETT, V199, P389, DOI 10.1016/j.toxlet.2010.10.003; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Goncalves DM, 2014, TOXICOL IN VITRO, V28, P926, DOI 10.1016/j.tiv.2014.03.002; Overbeck S, 2008, J LEUKOCYTE BIOL, V83, P368, DOI 10.1189/jlb.0307148; Fine JM, 1997, J OCCUP ENVIRON MED, V39, P722, DOI 10.1097/00043764-199708000-00006; Xu MS, 2010, BIOMATERIALS, V31, P8022, DOI 10.1016/j.biomaterials.2010.06.022; Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949; AshaRani PV, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-65; BROWN JJL, 1988, BRIT J RADIOL, V61, P327; CONNER MW, 1988, J TOXICOL ENV HEALTH, V25, P57; Deng XY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/11/115101; Hanagata N., 2010, NANO BIOMED, V2, P153; Lu SL, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0082-8; Reddy K. M., 2007, APPL PHYS LETT, V90; Stefanidou M, 2006, ARCH TOXICOL, V80, P1, DOI 10.1007/s00204-005-0009-5; Syama S, 2014, TOXICOL MECH METHOD, V24, P644, DOI 10.3109/15376516.2014.956914; Vandebriel Rob J, 2012, Nanotechnol Sci Appl, V5, P61, DOI 10.2147/NSA.S23932; Zhang Y, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2440-0; Zhuang F., 2012, NANO BIOMED, V4, P90	49	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	OCT	2015	40	5					625	635				11	Toxicology	Toxicology	CT2HL	WOS:000362622500010		
J	Gi, M; Fujioka, M; Yamano, S; Shimomura, EI; Kanki, M; Kawachi, S; Tachibana, H; Tatsumi, K; Fang, H; Ishii, N; Kakehashi, A; Wanibuchi, H				Gi, Min; Fujioka, Masaki; Yamano, Shotaro; Shimomura, En I.; Kanki, Masayuki; Kawachi, Satoko; Tachibana, Hirokazu; Tatsumi, Kumiko; Fang, He; Ishii, Naomi; Kakehashi, Anna; Wanibuchi, Hideki			Modifying effects of 1,2-dichloropropane on N-nitrosobis(2-oxopropyl)amine-induced cholangiocarcinogenesis in male Syrian hamsters	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						1,2-dichloropropane; N-nitrosobis(2-oxopropyl)amine; Cholangiocarcinogenicity; GST-T1; CYP2E1; Hamster	2-YEAR DRINKING-WATER; PANCREATIC CARCINOGENESIS; PRINTING WORKERS; AND/OR DICHLOROMETHANE; TOXICITY; RATS; INHIBITOR; INDUCTION; COMPANY; RODENTS	Based on the findings of epidemiological studies in Japan that occupational exposure to 1,2-dichloropropane (1,2-DCP) was associated with increased cholangiocarcinomas, 1,2-DCP has recently been classified as being carcinogenic to humans (Group 1). However, the cholangiocarcinogenicity of 1,2-DCP has not been demonstrated experimentally, and it was negative for cholangiocarcinogenicity in rats and mice. The present study determined the effects of 1,2-DCP on N-nitrosobis(2-oxopropyl)amine (BOP)-induced cholangiocarcinogenesis in male hamsters. We found that 1,2-DCP did not enhance the development of BOP-induced atypical biliary hyperplasia and did not induce any lesions in liver bile duct when administered alone. Notably, 1,2-DCP had no effect on the proliferative activity of bile duct epithelial cells regardless of BOP-initiation. These results demonstrate that 1,2-DCP lacks promoting effects on BOP-induced cholangiocarcinogenesis and suggest the possibility that 1,2-DCP is not cholangiocarcinogenic to the hamster in the present model. In addition, 1,2-DCP also lacks promoting effects on pancreatic, lung, and renal carcinogenesis. As the occurrence of occupational cholangiocarcinomas in Japan might be attributed to exposure to multiple chemicals, the results of the present study indicate that it will be necessary to determine the cholangiocarcinogenic effects of concurrent exposure of 1,2-DCP and the other halogen solvents to which workers with cholangiocarcinomas were exposed.	[Gi, Min; Fujioka, Masaki; Yamano, Shotaro; Shimomura, En I.; Kanki, Masayuki; Kawachi, Satoko; Tachibana, Hirokazu; Tatsumi, Kumiko; Fang, He; Ishii, Naomi; Kakehashi, Anna; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, Osaka 5458585, Japan	Wanibuchi, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	wani@med.osaka-cu.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [26340042]; Ministry of Health, Labor and Welfare of Japan [25, 20]	The authors gratefully acknowledge the technical assistance of Rie Onodera, Keiko Sakata, Yuko Hisabayashi, Hideki Nakagawa and Yukiko Iura. This work was supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 26340042), and Health Labour Sciences Research Grants (Research on Risk of Chemical Substances H26-#25 and Research on Occupational Safety and Health H26-#20) from the Ministry of Health, Labor and Welfare of Japan.	POUR PM, 1981, CANCER, V47, P1573, DOI 10.1002/1097-0142(19810315)47:6+<1573::AID-CNCR2820471420>3.0.CO;2-K; IMRAY CHE, 1992, EUR J SURG ONCOL, V18, P373; Okamura T, 2013, J AGR FOOD CHEM, V61, P2103, DOI 10.1021/jf3003174; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Gi M, 2015, TOXICOL SCI, V145, P196, DOI 10.1093/toxsci/kfv045; TAKAHASHI M, 1977, LAB ANIM SCI, V27, P336; Takahashi M, 2008, CARCINOGENESIS, V29, P1608, DOI 10.1093/carcin/bgn152; Benbrahim-Tallaa L, 2014, LANCET ONCOL, V15, P924, DOI 10.1016/S1470-2045(14)70316-X; Kumagai S, 2014, J OCCUP HEALTH, V56, P164; Hailey JR, 2014, TOXICOL PATHOL, V42, P844, DOI 10.1177/0192623313499976; Furukawa F, 2003, INT J CANCER, V104, P269, DOI 10.1002/ijc.10965; THAMAVIT W, 1993, CARCINOGENESIS, V14, P2415, DOI 10.1093/carcin/14.11.2415; Guengerich FP, 2003, J BIOCHEM MOL BIOL, V36, P20; Sobue T, 2015, J OCCUP HEALTH, V57, P230, DOI 10.1539/joh.14-0116-OA; SEROTA DG, 1986, FOOD CHEM TOXICOL, V24, P959, DOI 10.1016/0278-6915(86)90324-8; Kubo S, 2014, J HEPATO-BIL-PAN SCI, V21, P479, DOI 10.1002/jhbp.86; Umeda Y, 2010, INHAL TOXICOL, V22, P1116, DOI 10.3109/08958378.2010.526973; SEROTA DG, 1986, FOOD CHEM TOXICOL, V24, P951, DOI 10.1016/0278-6915(86)90323-6; Kitahashi T, 2011, ONCOL LETT, V2, P229, DOI 10.3892/ol.2011.252; POUR PM, 1978, CANCER LETT, V4, P317, DOI 10.1016/S0304-3835(78)95502-7; BUREK JD, 1984, FUND APPL TOXICOL, V4, P30, DOI 10.1016/0272-0590(84)90217-3; Sherratt PJ, 2002, TOXICOL APPL PHARM, V179, P89, DOI 10.1006/taap.2002.9348; Kumagai S, 2013, OCCUP ENVIRON MED, V70, P508, DOI 10.1136/oemed-2012-101246; KURASHINA M, 1988, CANCER, V61, P2469, DOI 10.1002/1097-0142(19880615)61:12<2469::AID-CNCR2820611214>3.0.CO;2-Y; IMBERTI R, 1990, ARCH TOXICOL, V64, P459, DOI 10.1007/BF01977627; Sato Y, 2014, INT J CLIN EXP PATHO, V7, P4745; IARC, 2014, IARC MONOGR IN PRESS; Klaunig I.E., 2008, CASARETT DOULLS TOXI, P329; Nakanuma Y, 2012, INT J HEPATOL, V2012; NTP, 1986, NATL TOX PROGR TECH, V263, P1; NTP, 1986, NATL TOXICOL PROGRAM, V306, P1; Takahashi Mami, 2011, Cancers (Basel), V3, P582, DOI 10.3390/cancers3010582	32	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	OCT	2015	40	5					647	656				10	Toxicology	Toxicology	CT2HL	WOS:000362622500012		
J	Oue, K; Kato, N; Tanaka, S; Noda, Y; Miyake, Y; Higashigawa, T; Okabe, M				Oue, Kensuke; Kato, Noriyuki; Tanaka, Satofumi; Noda, Yoshihiro; Miyake, Yoichiro; Higashigawa, Takatoshi; Okabe, Manabu			Thoracic Endovascular Repair for Chronic Aortic Dissection with Distal Landing in the False Lumen	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Letter									[Oue, Kensuke; Tanaka, Satofumi; Miyake, Yoichiro; Okabe, Manabu] Kochi Hlth Sci Ctr, Dept Cardiovasc Surg, Kochi, Japan; [Noda, Yoshihiro] Kochi Hlth Sci Ctr, Dept Radiol, Kochi, Japan; [Kato, Noriyuki; Higashigawa, Takatoshi] Mie Univ Hosp, Dept Radiol, Tsu, Mie 5148507, Japan	Oue, K (reprint author), Kochi Hlth Sci Ctr, Dept Cardiovasc Surg, Kochi, Japan.						Kang WC, 2011, J THORAC CARDIOV SUR, V142, P1074, DOI 10.1016/j.jtcvs.2011.03.008; Chino S, 2009, ANN THORAC SURG, V88, P2029, DOI 10.1016/j.athoracsur.2009.04.086; Roselli EE, 2011, ANN THORAC SURG, V92, P2078, DOI 10.1016/j.athoracsur.2011.08.018; Kusagawa H, 2005, CIRCULATION, V111, P2951, DOI 10.1161/CIRCULATIONAHA.104.480780	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	OCT	2015	26	10					1574	1576		10.1016/j.jvir.2015.04.018		3	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CT2GT	WOS:000362620700027		
J	Chin, DWL; Watanabe-Okochi, N; Wang, CQ; Tergaonkar, V; Osato, M				Chin, D. W. L.; Watanabe-Okochi, N.; Wang, C. Q.; Tergaonkar, V.; Osato, M.			Mouse models for core binding factor leukemia	LEUKEMIA			English	Review							ACUTE MYELOID-LEUKEMIA; CBF-BETA-SMMHC; HEMATOPOIETIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; AML1-ETO FUSION GENE; MYELOPROLIFERATIVE DISORDER; ADULT HEMATOPOIESIS; IN-VIVO; DEFINITIVE HEMATOPOIESIS	RUNX1 and CBFB are among the most frequently mutated genes in human leukemias. Genetic alterations such as chromosomal translocations, copy number variations and point mutations have been widely reported to result in the malfunction of RUNX transcription factors. Leukemias arising from such alterations in RUNX family genes are collectively termed core binding factor (CBF) leukemias. Although adult CBF leukemias generally are considered a favorable risk group as compared with other forms of acute myeloid leukemia, the 5-year survival rate remains low. An improved understanding of the molecular mechanism for CBF leukemia is imperative to uncover novel treatment options. Over the years, retroviral transduction-transplantation assays and transgenic, knockin and knockout mouse models alone or in combination with mutagenesis have been used to study the roles of RUNX alterations in leukemogenesis. Although successful in inducing leukemia, the existing assays and models possess many inherent limitations. A CBF leukemia model which induces leukemia with complete penetrance and short latency would be ideal as a platform for drug discovery. Here, we summarize the currently available mouse models which have been utilized to study CBF leukemias, discuss the advantages and limitations of individual experimental systems, and propose suggestions for improvements of mouse models.	[Chin, D. W. L.; Watanabe-Okochi, N.; Wang, C. Q.; Osato, M.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Wang, C. Q.; Tergaonkar, V.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Osato, M.] ASTAR, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Osato, M.] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Osato, M.] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan	Osato, M (reprint author), Natl Univ Singapore, Canc Sci Inst Singapore, 14 Med Dr, Singapore 117599, Singapore.	csimo@nus.edu.sg	Osato, Motomi/N-5056-2014; ASTAR, IMCB/E-2320-2012	Osato, Motomi/0000-0003-3982-9054; 	National Medical Research Council; Singapore National Research Foundation; Ministry of Education under the Research Center of Excellence programme; A*STAR (Agency of Science Technology and Research); Biomedical Research Council	This work was supported by National Medical Research Council, Singapore National Research Foundation, Ministry of Education under the Research Center of Excellence programme, A*STAR (Agency of Science Technology and Research) and Biomedical Research Council.	Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Kantner HP, 2013, NEOPLASIA, V15, P1292, DOI 10.1593/neo.131310; Rhoades KL, 2000, BLOOD, V96, P2108; Wang CQ, 2013, BLOOD, V122, P562, DOI 10.1182/blood-2012-10-460618; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; Kuo MC, 2009, LEUKEMIA, V23, P1426, DOI 10.1038/leu.2009.48; Putz G, 2006, ONCOGENE, V25, P929, DOI 10.1038/sj.onc.1209136; Kogan SC, 1998, P NATL ACAD SCI USA, V95, P11863, DOI 10.1073/pnas.95.20.11863; Grisolano JL, 2003, P NATL ACAD SCI USA, V100, P9506, DOI 10.1073/pnas.1531730100; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Okuda T, 1998, BLOOD, V91, P3134; Ng CEL, 2010, STEM CELLS, V28, P1869, DOI 10.1002/stem.507; Schessl C, 2005, J CLIN INVEST, V115, P2159, DOI 10.1172/JCI24225; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Pulikkan JA, 2012, BLOOD, V120, P868, DOI 10.1182/blood-2012-03-414649; Cheng CK, 2008, BLOOD, V112, P3391, DOI 10.1182/blood-2008-02-137083; Kikushige Y, 2010, CELL STEM CELL, V7, P708, DOI 10.1016/j.stem.2010.11.014; Tober J, 2013, DEVELOPMENT, V140, P3765, DOI 10.1242/dev.094961; Andreasson P, 2001, CANCER GENET CYTOGEN, V130, P93, DOI 10.1016/S0165-4608(01)00518-0; Satpathy AT, 2014, BLOOD, V123, P2968, DOI 10.1182/blood-2013-11-539643; Chou FS, 2011, BLOOD, V117, P2237, DOI 10.1182/blood-2010-01-264119; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Kuo YH, 2009, BLOOD, V113, P3323, DOI 10.1182/blood-2008-06-162248; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303; Osato M, 1999, BLOOD, V93, P1817; Mulloy JC, 2003, BLOOD, V102, P4369, DOI 10.1182/blood-2003-05-1762; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298; Basecke J, 2005, LEUKEMIA LYMPHOMA, V46, P265, DOI 10.1080/10428190400010767; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Buchholz F, 2000, EMBO REP, V1, P133, DOI 10.1093/embo-reports/kvd027; Schlenk RF, 2004, J CLIN ONCOL, V22, P3741, DOI 10.1200/JCO.2004.03.012; Castilla LH, 1999, NAT GENET, V23, P144; Krejci O, 2008, BLOOD, V111, P2190, DOI 10.1182/blood-2007-06-093682; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Illendula A, 2015, SCIENCE, V347, P779, DOI 10.1126/science.aaa0314; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Heilman SA, 2006, CANCER RES, V66, P11214, DOI 10.1158/0008-5472.CAN-06-0959; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Castilla LH, 2004, P NATL ACAD SCI USA, V101, P4924, DOI 10.1073/pnas.0400930101; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Watanabe-Okochi N, 2008, BLOOD, V111, P4297, DOI 10.1182/blood-2007-01-068346; Kurosawa S, 2013, HAEMATOLOGICA, V98, P1525, DOI 10.3324/haematol.2012.078030; Matheny CJ, 2007, EMBO J, V26, P1163, DOI 10.1038/sj.emboj.7601568; Yamashita N, 2005, BRIT J HAEMATOL, V131, P495, DOI 10.1111/j.1365-2141.2005.05793.x; Zhao L, 2012, BLOOD, V119, P1511, DOI 10.1182/blood-2011-02-338210; Nishida S, 2006, BLOOD, V107, P3303, DOI 10.1182/blood-2005-04-1656; Wang CQ, 2015, LEUKEMIA, V29, P753, DOI 10.1038/leu.2014.316; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Duque-Afonso J, 2014, CANCER CELL, V25, P265, DOI 10.1016/j.ccr.2014.03.002; Wang CQ, 2010, BLOOD CELL MOL DIS, V44, P275, DOI 10.1016/j.bcmd.2010.01.006; Haferlach C, 2010, LEUKEMIA, V24, P1065, DOI 10.1038/leu.2010.22; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Fischer M, 2005, ONCOGENE, V24, P7579, DOI 10.1038/sj.onc.1208931; Fenske TS, 2004, P NATL ACAD SCI USA, V101, P15184, DOI 10.1073/pnas.0400751101; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Hjalgrim LL, 2002, BRIT J CANCER, V87, P994, DOI 10.1038/sj.bjc.6600601; Tsuzuki S, 2004, P NATL ACAD SCI USA, V101, P8443, DOI 10.1073/pnas.0402063101; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; Song WJ, 1999, NAT GENET, V23, P166; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Kim HG, 2008, BLOOD, V111, P1567, DOI 10.1182/blood-2006-06-030312; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Pearce DJ, 2006, BLOOD, V107, P1166; Dowdy CR, 2010, HUM MOL GENET, V19, P1048, DOI 10.1093/hmg/ddp568; Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610; Chou FS, 2012, BLOOD, V120, P709, DOI 10.1182/blood-2012-01-403212; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; NUCIFORA G, 1993, BLOOD, V82, P712; Yang YD, 2002, CANCER RES, V62, P2232; Wang CQ, 2014, CELL REP, V8, P767, DOI 10.1016/j.celrep.2014.06.046; Kamikubo Y, 2010, CANCER CELL, V17, P455, DOI 10.1016/j.ccr.2010.03.022; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Cabezas-Wallscheid N, 2013, EMBO MOL MED, V5, P1804, DOI 10.1002/emmm.201302661; Hospital MA, 2014, BLOOD, V124, P1312, DOI 10.1182/blood-2014-01-549212; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Shima T, 2014, EXP HEMATOL, V42, pe951; Shima T, 2014, EXP HEMATOL, P955; Xue LT, 2014, BLOOD, V124, P426, DOI 10.1182/blood-2013-12-541730; Yan Ming, 2004, Proceedings of the National Academy of Sciences of the United States of America, V101, P17186, DOI 10.1073/pnas.0406702101	97	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	OCT	2015	29	10					1970	1980		10.1038/leu.2015.181		11	Oncology; Hematology	Oncology; Hematology	CT0ST	WOS:000362507600003		
J	Yayota, M; Kato, A; Ishida, M; Ohtani, S				Yayota, Masato; Kato, Aki; Ishida, Megumi; Ohtani, Shigeru			Ingestive behavior and short-term intake rate of cattle grazing on tall grasses	LIVESTOCK SCIENCE			English	Article						Cattle; Grazing; Ingestive behavior; Jaw movements; Tall grasses	MICRO-SWARD TECHNIQUE; INSTANTANEOUS INTAKE; JAW MOVEMENTS; BITE MASS; PASTURE; DENSITY; HEIGHT; JAPAN	Tall grasses ( > 1 m tall) are an important forage resource for grazing ruminants. Understanding the ingestive behavior and short-term intake rate of cattle grazing on tall grasses will help facilitate grazing management of tall grass pastures. The aim of this study was to determine the allocation of jaw movements in grazing cattle in relation to tall grasses and to assess whether such allocations of jaw movements are effective for maintaining a short-term intake rate. Four plants were used as test plants: bahiagrass (Paspalum notatum Flugge; a short grass), Sudangrass (Sorghum x drummondii; a typical tall grass) and two growth forms of a dwarf bamboo (Sasa senanensis; a semi-woody form of tall grass): a naturally growing form (NGDB, approximately 2 m tall) and a form that is under grazing (DBUG, < 0.8 m). Four Japanese Black cows were allowed to graze each plant in random order. The grazing jaw movements and intake rate were measured using an integrated method with a microsward technique and acoustic monitoring. The cows performed the highest number of total bites (simple bites chew-bites) for bahiagrass, an intermediate number of total bites for Sudangrass and DBUG and the lowest number of total bites for NGDB (P < 0.05). The total number of chews (simple chews chew-bites) was similar among NGDB, DBUG, and Sudangrass, whereas the total number of chews for bahiagrass was less than that for dwarf bamboos. The number of observed chew-bites exhibited an order similar to that observed for the number of total bites. As a result of each jaw movement, cows ingesting the DBUG moved their jaws more frequently among the plants, and cows ingesting the bahiagrass performed the fewest grazing jaw movements. Bite mass was considerably greater in the cows ingesting NGDB than in the cows ingesting other plants. Conversely, the chew mass for bahiagrass was clearly greater than that for the two taller plants. Cows ingesting Sudangrass processed the least amount of forage with each chew (P < 0.05). The intake rate did not significantly differ among the plants (P > 0.05), except for Sudangrass. Cows ingested Sudangrass at a lower intake rate than observed for the other plants (P < 0.05). The results suggest that cattle were able to control their ingestive jaw movements depending on plant characteristics such as height, the spatial arrangement of the leaves and leaf morphology. However, the lower short-term intake. rate for tall grasses implies that there is a limit to the adaptability of grazing jaw movements. (C) 2015 Elsevier B.V. All rights reserved.	[Yayota, Masato; Kato, Aki; Ishida, Megumi; Ohtani, Shigeru] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Yayota, M (reprint author), Gifu Univ, Fac Appl Biol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	yayo@gifu-u.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [21780244]	This work was funded by a Grant-in-Aid for young scientists (B) from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant number 21780244). We are grateful to T. Kato and M. Yokoyama (Field Science Center, Gifu University) for their assistance in animal management. We also thank H. Ikeyama, T. Iwakaji and N. Suzuki for their technical assistance.	Ungar ED, 2006, APPL ANIM BEHAV SCI, V98, P183, DOI 10.1016/j.appkanim.2005.09.001; Hirata M, 2010, J AGR SCI, V148, P615, DOI 10.1017/S0021859610000353; Ungar ED, 2006, APPL ANIM BEHAV SCI, V98, P11, DOI 10.1016/j.applanim.2005.08.011; BLACK JL, 1984, AUST J AGR RES, V35, P565, DOI 10.1071/AR9840565; Fonseca L, 2013, J ANIM SCI, V91, P4357, DOI 10.2527/jas.2012-5602; Orr RJ, 2005, EUPHYTICA, V141, P65, DOI 10.1007/s10681-005-5365-y; Hirata Masahiko, 2007, Grassland Science, V53, P181, DOI 10.1111/j.1744-697X.2007.00091.x; Fonseca L, 2012, LIVEST SCI, V145, P205, DOI 10.1016/j.livsci.2012.02.003; LACA EA, 1994, APPL ANIM BEHAV SCI, V39, P3, DOI 10.1016/0168-1591(94)90011-6; Laca EA, 2000, GRASS FORAGE SCI, V55, P97, DOI 10.1046/j.1365-2494.2000.00203.x; Agreil C, 2004, SMALL RUMINANT RES, V54, P99, DOI 10.1016/j.smallrumres.2003.10.013; Bonnet O, 2011, RANGELAND ECOL MANAG, V64, P366, DOI 10.2111/REM-D-10-00186.1; FLORES ER, 1989, APPL ANIM BEHAV SCI, V23, P285, DOI 10.1016/0168-1591(89)90097-X; Galli JR, 2011, LIVEST SCI, V140, P32, DOI 10.1016/j.livsci.2011.02.007; Benvenutti MA, 2006, GRASS FORAGE SCI, V61, P272, DOI 10.1111/j.1365-2494.2006.00531.x; LACA EA, 1992, GRASS FORAGE SCI, V47, P81, DOI 10.1111/j.1365-2494.1992.tb02250.x; Nakano M, 2015, ANIM SCI J, V86, P689, DOI 10.1111/asj.12348; Hirata M, 2011, LIVEST SCI, V138, P220, DOI 10.1016/j.livsci.2010.12.025; Tani Y, 2013, COMPUT ELECTRON AGR, V92, P54, DOI 10.1016/j.compag.2013.01.001; Soder KJ, 2009, EUPHYTICA, V168, P135, DOI 10.1007/s10681-009-9907-6; AOAC, 2006, OFF METH AN ASS OFF; Aroeira LJM, 2001, PESQUI AGROPECU BRAS, V36, P911, DOI 10.1590/S0100-204X2001000600009; Astigarraga L., 2014, American Journal of Plant Sciences, V5, P955, DOI 10.4236/ajps.2014.57108; Collett I.J., 2004, FORAGE SORGHUM MILLE; HAYASHI K., 1968, Japanese Journal Zootechnical Science, V39, P200; Hirayoshi I., 1969, J JPN SOC GRASSL SCI, V15, P42; Hirayoshi I., 1969, J JPN SOC GRASSL SCI, V15, P155; Kuznetsova A, 2014, IMERTEST TESTS RANDO; R Core Team, 2014, R LANG ENV STAT COMP; SOLLENBERGER L. E., 2001, INT GRASSLAND C, V19, P321; Ungar E.D., 1996, ECOLOGY MANAGEMENT G, P185; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1871-1413	1878-0490		LIVEST SCI	Livest. Sci.	OCT	2015	180						113	120		10.1016/j.livsci.2015.07.024		8	Agriculture, Dairy & Animal Science	Agriculture	CS9AT	WOS:000362382200016		
J	Kato, G; Takano, T; Nishiki, I; Kai, W; Yasuike, M; Nakamura, Y; Fujiwara, A; Sakai, T; Matsuyama, T; Nakayasu, C				Kato, Goshi; Takano, Tomokazu; Nishiki, Issei; Kai, Wataru; Yasuike, Motoshige; Nakamura, Yoji; Fujiwara, Atushi; Sakai, Takamitsu; Matsuyama, Tomomasa; Nakayasu, Chihaya			Expressed sequence tag analyses of three leukocyte subpopulations in ayu Plecoglossus altivelis altivelis, separated by monoclonal antibodies	MARINE GENOMICS			English	Article						Est; Ion Torrent PGM sequencer; Monoclonal antibody; Leukocyte subpopulation; Flow cytometry	FLOUNDER PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; RESPIRATORY BURST; GENE-EXPRESSION; DNA VACCINATION; TELEOST FISH; IMMUNE-RESPONSES; NECROSIS VIRUS; RAINBOW-TROUT; B-LYMPHOCYTES	Ayu Plecogiossus altivelis altivelis are one of the most economically important fish for freshwater aquaculture in Japan. We conducted expressed sequence tag analyses of three leukocyte subpopulations, thrombocytes, neutrophils, and B lymphocytes in ayu using a next generation sequencer. The sequencing and de novo assembly yielded 22,494, 22,733, and 16,505 contigs from the thrombocyte, neutrophil, and B lymphocyte cDNA libraries, respectively. Pathways involving endocytosis, phagosomes, and lysosomes, were found in all three cDNA libraries using pathway analysis. The thrombocyte cDNA library contained 2894 unique sequences, including CXC chemokine receptor 4 and MHC class II. Cytokine and cytokine receptor genes such as interleukin (IL)-1 beta, IL-8, IL-1 receptor (IL-1R), IL-8RA, and IL-8RB were found among the 3056 unique sequences of the neutrophil cDNA library. Typical B lymphocyte related genes such as B cell linker protein, immunoglobulin (Ig) M, IgD and transforming growth factor beta were found in the 1590 unique sequences of the B lymphocyte cDNA library. In summary, a large number of immune-related genes were identified from the three leukocyte cDNA libraries. Our results represent a valuable sequence resource for understanding the immune system function in ayu. (C) 2015 Elsevier B.V. All rights reserved.	[Kato, Goshi; Sakai, Takamitsu; Nakayasu, Chihaya] Fisheries Res Agcy, Tamaki Lab, Natl Res Inst Aquaculture, Tamaki, Mie 5190423, Japan; [Takano, Tomokazu; Matsuyama, Tomomasa] Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie 5160193, Japan; [Nishiki, Issei; Kai, Wataru; Yasuike, Motoshige; Nakamura, Yoji; Fujiwara, Atushi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa 2368648, Japan	Takano, T (reprint author), Fisheries Res Agcy, Natl Res Inst Aquaculture, 422-1 Nakatsuhamaura, Minamiise, Mie 5160193, Japan.	takanoto@fra.affrc.go.jp			Japan Society for the Promotion of Science [12J04812]	This work was supported in part by a Grant-in-Aid (Number 12J04812) for Fellows of the Japan Society for the Promotion of Science.	Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Peatman E, 2007, IMMUNOGENETICS, V59, P613, DOI 10.1007/s00251-007-0228-4; Cuesta A, 2006, MOL IMMUNOL, V43, P1275, DOI 10.1016/j.molimm.2005.07.004; Nakada K, 2014, J VET MED SCI, V76, P693, DOI 10.1292/jvms.13-0584; Moritomo T, 2003, FISH SHELLFISH IMMUN, V15, P29, DOI 10.1016/S1050-4648(02)00136-5; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Matsuyama T, 2009, FISHERIES SCI, V75, P335, DOI 10.1007/s12562-008-0038-0; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Alejo A, 2011, DEV COMP IMMUNOL, V35, P1215, DOI 10.1016/j.dci.2011.03.011; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Ballesteros NA, 2012, FISH SHELLFISH IMMUN, V33, P174, DOI 10.1016/j.fsi.2012.03.016; Zhang J, 2014, FISH SHELLFISH IMMUN, V41, P380, DOI 10.1016/j.fsi.2014.09.022; Lu XJ, 2013, FISH SHELLFISH IMMUN, V34, P497, DOI 10.1016/j.fsi.2012.11.047; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Kato G, 2014, DIS AQUAT ORGAN, V108, P103, DOI 10.3354/dao02679; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Yasuike M, 2007, FISH SHELLFISH IMMUN, V23, P531, DOI 10.1016/j.fsi.2006.12.006; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Serada K, 2005, FISH SHELLFISH IMMUN, V19, P363, DOI 10.1016/j.fsi.2005.01.007; Haugland GT, 2014, FISH SHELLFISH IMMUN, V39, P51, DOI 10.1016/j.fsi.2014.04.023; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P83, DOI 10.1016/j.cimid.2010.02.005; Chu CQ, 2014, GENE, V548, P48, DOI 10.1016/j.gene.2014.07.006; LeBlanc F, 2010, FISH SHELLFISH IMMUN, V29, P217, DOI 10.1016/j.fsi.2010.03.007; WAKABAYASHI H, 1994, FISH PATHOL, V29, P101; Cairns CM, 2001, J IMMUNOL, V167, P57; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P103, DOI 10.1016/j.cimid.2010.03.001; Byon JY, 2005, FISH SHELLFISH IMMUN, V18, P135, DOI 10.1016/j.fsi.2004.06.008; Itou T, 1996, DEV COMP IMMUNOL, V20, P323, DOI 10.1016/S0145-305X(96)00028-6; Uenobe M, 2007, MOL IMMUNOL, V44, P1115, DOI 10.1016/j.molimm.2006.07.281; Kato G, 2010, DEV COMP IMMUNOL, V34, P133, DOI 10.1016/j.dci.2009.08.013; Kato G, 2012, DEV COMP IMMUNOL, V36, P349, DOI 10.1016/j.dci.2011.06.001; Nishimori E, 2000, INT J SYST EVOL MICR, V50, P83; Matsuyama T, 2007, FISH SHELLFISH IMMUN, V22, P598, DOI 10.1016/j.fsi.2006.08.006; Bridle AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040841; Byon JY, 2006, VACCINE, V24, P921, DOI 10.1016/j.vaccine.2005.08.087; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Kato G., 2014, FISH SCI; Kato G., 2014, J FISH DIS; Kolner B., 2004, DEV COMP IMMUNOL, V28, P1049; Martin SAM, 2008, REV FISH SCI, V16, P110; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mourana M., 2008, VET IMMUNOL IMMUNOP, V126, P120; MUROGA K, 1988, Journal of the Faculty of Applied Biological Science Hiroshima University, V27, P1; Nagasawa Takahiro, 2014, Front Immunol, V5, P445, DOI 10.3389/fimmu.2014.00445; Oliveros J., 2007, VENNY INTERACTIVE TO	46	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-7787	1876-7478		MAR GENOM	Mar. Genom.	OCT	2015	23						123	132		10.1016/j.margen.2015.06.011		10	Genetics & Heredity; Marine & Freshwater Biology	Genetics & Heredity; Marine & Freshwater Biology	CT2FS	WOS:000362618000021		
J	Huang, H; Tian, Y; Yuan, GY; Chen, CL; Wang, ZC; Ding, WJ; Inoue, A				Huang, Hua; Tian, Yuan; Yuan, Guangyin; Chen, Chunlin; Wang, Zhongchang; Ding, Wenjiang; Inoue, Akihisa			Secondary phases in quasicrystal-reinforced Mg-3.5Zn-0.6Gd Mg alloy	MATERIALS CHARACTERIZATION			English	Article						Magnesium alloys; Quasictystal; Extrusion; Precipitation; Orientation	ZN-Y ALLOYS; MECHANICAL-PROPERTIES; ICOSAHEDRAL PHASE; HIGH-STRENGTH; DEFORMATION-BEHAVIOR; MAGNESIUM ALLOYS; LAVES PHASES; RE ALLOYS; GD ALLOY; MICROSTRUCTURE	The secondary phases in quasicrystal-reinforced Mg-Zn-Gd alloys are investigated by transmission electron microscopy. The orientation relationships between the dendritic I-phase and the Mg matrix are identified to be [1 1 (2) over bar 0](Mg)parallel to[2-fold](I-phase) and (0001)(Mg)parallel to(5-fold)(I-phase). We also find that the dendritic I-phase is brittle along 2-fold, 5-fold, and 3-fold atomic planes during hot extrusion. Moreover, new orientation relations [(1) over bar 101](Mg)parallel to[mirror 2-fold](I-phase) and (0 (1) over bar 1 1)(Mg)parallel to(5-fold)(I-phase) are found between nanoscale I-phase and Mg matrix. The findings have implications for our understanding of excellent mechanical properties of the I-phase-strengthened Mg alloys. (C) 2015 Elsevier Inc. All rights reserved.	[Huang, Hua; Tian, Yuan; Yuan, Guangyin; Ding, Wenjiang] Shanghai Jiao Tong Univ, Natl Engn Res Ctr Light Alloy Net Forming, Shanghai 200240, Peoples R China; [Huang, Hua; Yuan, Guangyin; Ding, Wenjiang] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composite, Shanghai 200240, Peoples R China; [Huang, Hua; Chen, Chunlin; Wang, Zhongchang] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Inoue, Akihisa] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China; [Inoue, Akihisa] Kings Abudulaziz Univ, Dept Phys, Jeddah 21589, Saudi Arabia	Yuan, GY (reprint author), Shanghai Jiao Tong Univ, Natl Engn Res Ctr Light Alloy Net Forming, Shanghai 200240, Peoples R China.	gyyuan@sjtu.edu.cn; zcwang@wpi-aimr.tohoku.ac.jp	Chen, ChunLin/N-4611-2013		National Nature Science Foundation of China [51174136, 11332013, 51501110]; JSPS [15H04114, 15K14117, 26106503]; CAS under the Japan-China Scientific Cooperation Program; Shorai Foundation for Science and Technology	This work was supported by the National Nature Science Foundation of China (grant nos. 51174136, 11332013 and 51501110). Z.W. thanks financial supports from Scientific Research (B) (grant no. 15H04114), Challenging Exploratory Research (grant no. 15K14117), JSPS Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics" (grant no. 26106503), JSPS and CAS under the Japan-China Scientific Cooperation Program, and Shorai Foundation for Science and Technology.	Abe E, 2004, NAT MATER, V3, P759, DOI 10.1038/nmat1244; Chang HJ, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/31/314001; Bae DH, 2002, ACTA MATER, V50, P2343, DOI 10.1016/S1359-6454(02)00067-8; Wang ZC, 2011, NATURE, V479, P380, DOI 10.1038/nature10593; Xu DK, 2007, SCRIPTA MATER, V57, P285, DOI 10.1016/j.scriptant.2007.03.017; YOKOYAMA Y, 1993, MATER T JIM, V34, P135; Huang H, 2013, INT J MATER RES, V104, P380, DOI 10.3139/146.110880; Goldman AI, 2013, NAT MATER, V12, P714, DOI [10.1038/nmat3672, 10.1038/NMAT3672]; LUO ZP, 1993, SCRIPTA METALL MATER, V28, P1513, DOI 10.1016/0956-716X(93)90584-F; Kim IJ, 2003, MAT SCI ENG A-STRUCT, V359, P313, DOI 10.1016/S0921-5093(03)00352-6; Yuan GY, 2008, MAT SCI ENG A-STRUCT, V474, P348, DOI 10.1016/j.msea.2007.04.017; Huang H, 2012, MATER LETT, V79, P281, DOI 10.1016/j.matlet.2012.04.018; Singh A, 2003, PHIL MAG LETT, V83, P543, DOI 10.1080/09500830310001597027; Somekawa H, 2008, MATER TRANS, V49, P1947, DOI 10.2320/matertrans.MAW200804; Jiang S, 2010, SCRIPTA MATER, V62, P556, DOI 10.1016/j.scriptamat.2009.12.038; Singh A, 2005, ACTA MATER, V53, P4733, DOI 10.1016/j.actamat.2005.06.026; Huang H, 2013, MAT SCI ENG A-STRUCT, V581, P73, DOI 10.1016/j.msea.2013.06.003; Singh A, 2011, SCRIPTA MATER, V64, P661, DOI 10.1016/j.scriptamat.2010.12.016; Kwak TY, 2015, SCRIPTA MATER, V103, P49, DOI 10.1016/j.scriptamat.2015.03.004; Yuan GY, 2008, MAT SCI ENG A-STRUCT, V472, P75, DOI 10.1016/j.msea.2007.03.016; SAINFORT P, 1987, J PHYS-PARIS, V48, P407, DOI 10.1051/jphyscol:1987346; Singh A, 2002, J ALLOY COMPD, V342, P261, DOI 10.1016/S0925-8388(02)00189-5; Huang H, 2014, SCRIPTA MATER, V78-79, P61, DOI 10.1016/j.scriptamat.2014.01.035; Singh A, 2014, METALL MATER TRANS A, V45A, P3232, DOI 10.1007/s11661-013-2056-5; Xu DK, 2012, PROG NAT SCI-MATER, V22, P364, DOI 10.1016/j.pnsc.2012.09.005; Singh A, 2006, PHILOS MAG, V86, P951, DOI 10.1080/14786430500253901; Yuan GY, 2005, J MATER RES, V20, P1278, DOI 10.1557/JMR.2005.0156; Singh A, 2007, SCRIPTA MATER, V56, P935, DOI 10.1016/j.scriptamat.2007.02.015; Shield JE, 1997, J MATER SCI LETT, V16, P2019, DOI 10.1023/A:1018544313643; Singh A, 2003, SCRIPTA MATER, V49, P417, DOI 10.1016/S1359-6462(03)00305-1; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Singh A, 2011, MAGNESIUM TECHNOLOGY, P239; Ohhashi S, 2011, MAT SCI ENG A-STRUCT, V528, P5871, DOI 10.1016/j.msea.2011.04.014; Muller A, 2007, J ALLOY COMPD, V443, pL1, DOI 10.1016/j.jallcom.2006.10.006; Wang ZC, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1111; Wang ZC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4239	36	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1044-5803	1873-4189		MATER CHARACT	Mater. Charact.	OCT	2015	108						132	136		10.1016/j.matchar.2015.09.005		5	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Materials Science, Characterization & Testing	Materials Science; Metallurgy & Metallurgical Engineering	CT2EH	WOS:000362614300016		
J	Taendl, J; Nambu, S; Orthacker, A; Kothleitner, G; Inoue, J; Koseki, T; Poletti, C				Taendl, J.; Nambu, S.; Orthacker, A.; Kothleitner, G.; Inoue, J.; Koseki, T.; Poletti, C.			In-situ observation of recrystallization in an AlMgScZr alloy using confocal laser scanning microscopy	MATERIALS CHARACTERIZATION			English	Article						Recrystallization; Confocal laser scanning microscopy; In-situ characterization; AlSc alloys; Electron backscatter diffraction; Zener pinning	SC-ZR ALLOY; PHASE-TRANSFORMATIONS; AL(SC) ALLOYS; MN STEEL; PRECIPITATION; ALUMINUM; KINETICS; MECHANISMS; EVOLUTION; FERRITE	In this work we present a novel in-situ approach to study the recrystallization behavior of age hardening alloys. We use confocal laser scanning microscopy (CLSM) at 400 degrees C to investigate the static recrystallization of an AlMg4Sc0.4Zr0.12 alloy in-situ. The results are combined with electron backscatter diffraction (EBSD) and transmission electron microscopy (TEM) analyses. It was found that CLSM is a powerful tool to visualize both the local initiation and temporal sequence of recrystallization. After fast nucleation and initial growth, the grain growth rate decreases and the grain boundary migration stops after some minutes due to Zener pinning from Al-3(Sc,Zr) precipitates produced during the heat treatment. EBSD and TEM analyses confirm both the boundary movements and the particle-boundary interactions. (C) 2015 Elsevier Inc. All rights reserved.	[Taendl, J.; Poletti, C.] Graz Univ Technol, Inst Mat Sci & Welding, A-8010 Graz, Austria; [Nambu, S.; Inoue, J.; Koseki, T.] Univ Tokyo, Dept Mat Engn, Tokyo 1138656, Japan; [Orthacker, A.; Kothleitner, G.] Graz Univ Technol, Inst Electron Microscopy & Nanoanal, A-8010 Graz, Austria; [Orthacker, A.; Kothleitner, G.] Graz Ctr Electron Microscopy, Graz, Austria	Taendl, J (reprint author), Graz Univ Technol, Inst Mat Sci & Welding, A-8010 Graz, Austria.	johannes.taendl@tugraz.atl			Austrian Research Promotion Agency FFG project [839002]; Austrian Ministry for Transport, Innovation and Technology; Austrian Cooperative Research	J. Taendl and C. Poletti gratefully acknowledge the financial support by the Austrian Research Promotion Agency FFG project 839002 funded within the program TAKE OFF. A. Orthacker and G. Kothleitner want to thank the Austrian Ministry for Transport, Innovation and Technology and the Austrian Cooperative Research for the financial support.	Field DP, 2007, ACTA MATER, V55, P4233, DOI 10.1016/j.actamat.2007.03.021; Taendl J, 2014, MATER SCI FORUM, V794-796, P1038, DOI 10.4028/www.scientific.net/MSF.794-796.1038; Terasaki H, 2006, METALL MATER TRANS A, V37A, P1261, DOI 10.1007/s11661-006-1077-8; Bozzolo N, 2012, MATER CHARACT, V70, P28, DOI 10.1016/j.matchar.2012.04.020; Royset J, 2005, INT MATER REV, V50, P19, DOI 10.1179/174328005X14311; Benchabane G, 2008, MATER CHARACT, V59, P1425, DOI 10.1016/j.matchar.2008.01.002; Royset J, 2005, MAT SCI ENG A-STRUCT, V396, P409, DOI 10.1016/j.msea.2005.02.015; NES E, 1985, ACTA METALL MATER, V33, P11, DOI 10.1016/0001-6160(85)90214-7; Seidman DN, 2002, ACTA MATER, V50, P4021, DOI 10.1016/S1359-6454(02)00201-X; Chen H, 2013, ACTA MATER, V61, P2414, DOI 10.1016/j.actamat.2013.01.013; Wanjara P, 2005, MATER CHARACT, V54, P254, DOI 10.1016/j.matchar.2004.12.002; Phelan D, 2006, JOM-US, V58, P67, DOI 10.1007/s11837-006-0086-9; Oberdorfer B, 2011, J ALLOY COMPD, V509, pS309, DOI 10.1016/j.jallcom.2010.12.130; Attallah MM, 2011, MATER CHARACT, V62, P760, DOI 10.1016/j.matchar.2011.05.001; Deillon L, 2014, MATER CHARACT, V97, P125, DOI [10.1016/j.matchar.2014.09.004, 10.1016/j.matchar.2014.99.004]; Marquis EA, 2001, ACTA MATER, V49, P1909, DOI 10.1016/S1359-6454(01)00116-1; Jin Y, 2014, MAT SCI ENG A-STRUCT, V597, P295, DOI 10.1016/j.msea.2014.01.018; Hayoune A, 2010, MAT SCI ENG A-STRUCT, V527, P7261, DOI 10.1016/j.msea.2010.08.011; Chao HY, 2011, MATER CHARACT, V62, P312, DOI 10.1016/j.matchar.2011.01.007; Doherty RD, 1997, MAT SCI ENG A-STRUCT, V238, P219, DOI 10.1016/S0921-5093(97)00424-3; Rees DWA, 2012, MATER DESIGN, V39, P495, DOI 10.1016/j.matdes.2012.03.015; Ye WP, 2002, MAT SCI ENG A-STRUCT, V332, P41, DOI 10.1016/S0921-5093(01)01715-4; Taendl J, 2014, KEY ENG MATER, V611-612, P76, DOI 10.4028/www.scientific.net/KEM.611-612.76; Yamamoto A, 2011, MATER TRANS, V52, P876, DOI 10.2320/matertrans.L-MZ201122; Zhang D, 2010, ACTA MATER, V58, P1369, DOI 10.1016/j.actamat.2009.10.043; Nambu S, 2013, ACTA MATER, V61, P4831, DOI 10.1016/j.actamat.2013.04.065; MULLINS WW, 1957, J APPL PHYS, V28, P333, DOI 10.1063/1.1722742; Davis JR, 1993, ALUMINUM ALUMINUM AL; Humphreys F. J., 2004, RECRYSTALLIZATION RE; HUMPHREYS FJ, 1977, ACTA METALL MATER, V25, P1323, DOI 10.1016/0001-6160(77)90109-2; Jones M., ACTA MAT, V51	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1044-5803	1873-4189		MATER CHARACT	Mater. Charact.	OCT	2015	108						137	144		10.1016/j.matchar.2015.09.002		8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Materials Science, Characterization & Testing	Materials Science; Metallurgy & Metallurgical Engineering	CT2EH	WOS:000362614300017		
J	Balogun, OO; Dagvadorj, A; Anigo, KM; Ota, E; Sasaki, S				Balogun, Olukunmi Omobolanle; Dagvadorj, Amarjagal; Anigo, Kola Mathew; Ota, Erika; Sasaki, Satoshi			Factors influencing breastfeeding exclusivity during the first 6 months of life in developing countries: a quantitative and qualitative systematic review	MATERNAL AND CHILD NUTRITION			English	Review						breastfeeding; exclusive breastfeeding; breastfeeding support; barriers; facilitators; developing countries	UNITED-STATES; HEALTH; WOMEN; BARRIERS; DURATION; DISCHARGE; OUTCOMES; RISK; MILK; INTERVENTIONS	Breastfeeding is the most advantageous feeding option for infants, and epidemiological studies provide evidence for its promotion. The objective of this review was to comprehensively delineate the barriers and facilitators of exclusive breastfeeding of infants aged 0-6 months old by mothers in developing countries. A search of CINAHL, MEDLINE and PsycINFO was carried out to retrieve studies from January 2001 to January 2014. Using our inclusion criteria, we selected studies that described barriers and facilitators of exclusive breastfeeding. Qualitative and quantitative studies were considered. Twenty-five studies involving 11025 participants from 19 countries were included. Barriers and facilitators of exclusive/full breastfeeding were identified, analysed tabulated and summarised in this review. Maternal employment was the most frequently cited barrier to exclusive breastfeeding. Maternal perceptions of insufficient breast milk supply was pervasive among studies while medical barriers related to illness of mothers and/or infants as well as breast problems, rather than health care providers. Socio-cultural factors such as maternal and significant other's beliefs about infant nutrition also often constitute strong barriers to exclusive breastfeeding. Despite these barriers, mothers in developing countries often possess certain personal characteristics and develop strategic plans to enhance their success at breastfeeding. Health care providers should be informed about the determinants of exclusive breastfeeding and provide practical anticipatory guidance targeted at overcoming these barriers. In so doing, health care providers in developing countries can contribute to improving maternal and child health outcomes.	[Balogun, Olukunmi Omobolanle; Sasaki, Satoshi] Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Tokyo 1130033, Japan; [Dagvadorj, Amarjagal] Kyoto Univ, Dept Hlth Informat, Kyoto, Japan; [Dagvadorj, Amarjagal] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Anigo, Kola Mathew] Ahmadu Bello Univ, Fac Sci, Dept Biochem, Zaria, Nigeria; [Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo 1130033, Japan	Balogun, OO (reprint author), Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	omobolanle_balogun@yahoo.com					Adam T, 2005, BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Agbo HA, 2013, J MED RES, V2, P112; Agnarsson I, 2001, East Afr Med J, V78, P9; Agunbiade O. M., 2012, INT BREASTFEEDING J, V7, P1; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Horwood LJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e9; Lanting CI, 1996, CURR OPIN LIPIDOL, V7, P43, DOI 10.1097/00041433-199602000-00010; Otoo GE, 2009, J HUM LACT, V25, P34, DOI 10.1177/0890334408325072; Pronyk PM, 2007, JAMA-J AM MED ASSOC, V298, P1925, DOI 10.1001/jama.298.16.1925; Kakute PN, 2005, J MIDWIFERY WOM HEAL, V50, P324, DOI 10.1016/j.jmwh.2005.01.005; Sasaki Y, 2010, J PEDIATR NURS, V25, P463, DOI 10.1016/j.pedn.2009.04.010; Baker M, 2008, J HEALTH ECON, V27, P871, DOI 10.1016/j.jhealeco.2008.02.006; Leatherman S, 2012, HEALTH POLICY PLANN, V27, P85, DOI 10.1093/heapol/czr014; Kwan ML, 2004, PUBLIC HEALTH REP, V119, P521, DOI 10.1016/j.phr.2004.09.002; Gatti L, 2008, J NURS SCHOLARSHIP, V40, P355, DOI 10.1111/j.1547-5069.2008.00234.x; Yanicki S, 2002, CAN J PUBLIC HEALTH, V93, P26; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; WALDENSTROM U, 1987, ACTA PAEDIATR SCAND, V76, P727, DOI 10.1111/j.1651-2227.1987.tb10556.x; Bystrova K, 2009, BIRTH-ISS PERINAT C, V36, P97, DOI 10.1111/j.1523-536X.2009.00307.x; FORD RPK, 1993, INT J EPIDEMIOL, V22, P885, DOI 10.1093/ije/22.5.885; Foster SF, 1996, J PSYCHOSOM RES, V41, P181, DOI 10.1016/0022-3999(96)00035-9; PEREZESCAMILLA R, 1992, EARLY HUM DEV, V31, P25, DOI 10.1016/0378-3782(92)90012-6; LABBOK M, 1990, STUD FAMILY PLANN, V21, P226, DOI 10.2307/1966617; HOWIE PW, 1990, BRIT MED J, V300, P11; Abuidhail J, 2014, MIDWIFERY, V30, P331, DOI 10.1016/j.midw.2013.01.005; MORLEY R, 1988, ARCH DIS CHILD, V63, P1382; Roter DL, 2004, ANNU REV PUBL HEALTH, V25, P497, DOI 10.1146/annurev.publhealth.25.101802.123134; Whalen B, 2010, CURR OPIN PEDIATR, V22, P655, DOI 10.1097/MOP.0b013e32833c8996; Jones JR, 2011, PEDIATRICS, V128, P1117, DOI 10.1542/peds.2011-0841; Al-Sahab B, 2008, PUBLIC HEALTH NUTR, V11, P1350, DOI 10.1017/S1368980008003005; Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005; Winterburn S, 2000, J ADV NURS, V32, P1152, DOI 10.1046/j.1365-2648.2000.01586.x; Renfrew MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub4; Bashour HN, 2008, PUBLIC HEALTH NURS, V25, P115, DOI 10.1111/j.1525-1446.2008.00688.x; Hannula L, 2008, J CLIN NURS, V17, P1132, DOI 10.1111/j.1365-2702.2007.02239.x; Karacam Z, 2008, J CLIN NURS, V17, P341, DOI 10.1111/j.1365-2702.2007.01936.x; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Kramer MS, 2003, AM J CLIN NUTR, V78, P291; Vaahtera M, 2001, ACTA PAEDIATR, V90, P328, DOI 10.1080/080352501300067730; Heck KE, 2003, BIRTH-ISS PERINAT C, V30, P153, DOI 10.1046/j.1523-536X.2003.00239.x; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Hruschka DJ, 2003, J NUTR, V133, P2592; Johnston ML, 2007, JOGNN-J OBST GYN NEO, V36, P9, DOI 10.1111/J.1552-6909.2006.00109.x; Barnes J, 1997, J ROY SOC MED, V90, P551; Arusei RJ, 2011, FOOD NUTR BULL, V32, P307; BURR ML, 1993, ARCH DIS CHILD, V68, P724; Cambonie G, 2010, PEDIATR INT, V52, P180, DOI 10.1111/j.1442-200X.2009.02942.x; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; [Anonymous], 2013, HLTH PEOPL 2020; Chandrashekhar TS, 2007, PUBLIC HEALTH NUTR, V10, P192, DOI 10.1017/S1368980007248475; Santo LCD, 2007, BIRTH-ISS PERINAT C, V34, P212, DOI 10.1111/j.1523-536X.2007.00173.x; Arthur E. I., 2012, PEDIATRICS, V129, pe827; Australian Government Department of Health and Ageing, 2009, AUSTR HLTH MIN C 200; Barennes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030634; Dennis CL, 2002, JOGNN, V31, P12, DOI 10.1111/j.1552-6909.2002.tb00019.x; dosNascimento M. B. R., 2010, BREASTFEED MED, V5, P79; Ettarh R., 2014, PREVENTING CHRONIC D, V11, pE212; Fisher J, 2013, ACTA PAEDIATR, V102, P970, DOI 10.1111/apa.12336; Horta B. L, 2007, EVIDENCE LONG TERM E; Inoue Madoka, 2012, Int Breastfeed J, V7, P15, DOI 10.1186/1746-4358-7-15; International Labor Organization, 1998, MOR 120 NAT PROV PAI; Ip S, 2007, EVID REP TECHNOL ASS, V153, P1, DOI DOI 10.1542/GR.18-2-15; Labbok M. H., 2008, ACHIEVING EXCLUSIVE; Lim SS, 2013, LANCET, V380, P2224, DOI DOI 10.1016/S0140-6736(12)61766-8; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Sadauskaite-Kuehne Vaiva, 2004, Diabetes-Metabolism Research and Reviews, V20, P150, DOI 10.1002/dmrr.425; Margolis L H, 2000, J Hum Lact, V16, P121, DOI 10.1177/089033440001600207; McAndrew Fiona, 2012, INFANT FEEDING SURVE; Ministry of Health Labour and Welfare, 2013, PROM COMM HLTH FAM S; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Morley R., 1996, SEMIN NEONATOL, V1, P27, DOI 10.1016/S1084-2756(96)80018-2; Nabulsi Mona, 2011, BMC Pediatr, V11, P75, DOI 10.1186/1471-2431-11-75; Nawaz Rab, 2009, J Ayub Med Coll Abbottabad, V21, P93; Oakley L. L., 2013, BMJ OPEN, V3, P1; Okafor I., 2013, NIGERIAN J PAEDIAT, V41, P43; Perera Priyantha J, 2012, Int Breastfeed J, V7, P21, DOI 10.1186/1746-4358-7-21; Quan L. N., 2002, FOOD NUTR BULL, V23, P99; Rguibi Mohamed, 2006, Body Image, V3, P395, DOI 10.1016/j.bodyim.2006.07.007; Mlay Rose Shao, 2004, Health Care Women Int, V25, P242; Singh J, 2013, J PHARM PHARMACOTHER, V4, P76; Tamiru D., 2013, INT J FOOD SCI NUTR, V2, P77; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Ulak Manjeswori, 2012, Int Breastfeed J, V7, P1, DOI 10.1186/1746-4358-7-1; United Nations, 2010, WORLDS WOM 2010 TREN; World Bank, 2014, WORLD BANK LIST EC 2; World Health Organization, 2003, GLOB STRAT INF YOUNG	86	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1740-8695	1740-8709		MATERN CHILD NUTR	Matern. Child Nutr.	OCT	2015	11	4					433	451		10.1111/mcn.12180		19	Nutrition & Dietetics; Pediatrics	Nutrition & Dietetics; Pediatrics	CS6NR	WOS:000362197100002		
J	Shiraishi, M; Haruna, M; Matsuzaki, M; Murayama, R; Kitanaka, S; Sasaki, S				Shiraishi, Mie; Haruna, Megumi; Matsuzaki, Masayo; Murayama, Ryoko; Kitanaka, Sachiko; Sasaki, Satoshi			Validity of a self-administered diet history questionnaire for estimating vitamin D intakes of Japanese pregnant women	MATERNAL AND CHILD NUTRITION			English	Article						diet history questionnaire; pregnancy; serum marker; validation; vitamin D	25-HYDROXYVITAMIN D CONCENTRATIONS; FOOD-FREQUENCY QUESTIONNAIRES; ENERGY-INTAKE; D DEFICIENCY; PREVALENCE; VALIDATION	Maternal vitamin D status is important for fetal development and the prevention of pregnancy complications. Mothers require both sufficient intakes and skin production of this vitamin. We investigated the validity and test-retest reliability of a self-administered diet history questionnaire (DHQ) to establish a method of assessing vitamin D intakes of Japanese pregnant women, using a serum marker. A total of 245 healthy pregnant women in the second trimester, who were not taking vitamin D supplements, were recruited at a university hospital in Tokyo between June 2010 and July 2011. Serum 25-hydroxyvitamin D [25(OH)D] concentrations were measured as an indicator of vitamin D status. To assess the test-retest reliability of the DHQ, 58 pregnant women completed it twice within a 4-5-week interval. Significant positive correlations between intakes and serum concentrations of vitamin D were found (r=0.266 for daily intakes and r=0.249 for energy-adjusted intakes). In the winter investigation in which the serum 25(OH)D concentrations were less likely to be affected by sunlight exposure, the correlation coefficients were 0.304 for both daily and energy-adjusted intakes. After excluding participants with pregnancy-associated nausea, the coefficients increased. The intraclass correlation coefficient between vitamin D intakes estimated from the two-time DHQ was 0.638. The DHQ provides an acceptable validity and reliability of the vitamin D intake of Japanese pregnant women. However, the data of women with nausea should be interpreted with caution. We believe that the DHQ is a useful questionnaire to grasp and improve vitamin D intakes during pregnancy.	[Shiraishi, Mie; Haruna, Megumi; Matsuzaki, Masayo; Murayama, Ryoko] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Midwifery & Womens Hlth,Bunkyo Ku, Tokyo 1130033, Japan; [Kitanaka, Sachiko] Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 1130033, Japan; [Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, Tokyo 1130033, Japan	Shiraishi, M (reprint author), Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Midwifery & Womens Hlth,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mi-shi@umin.ac.jp			Institute for Food and Health Science; Yazuya Co Ltd; Fumiko Yamaji Professional Nursing Education	This work was supported by Institute for Food and Health Science, Yazuya Co Ltd, 2009 and Fumiko Yamaji Professional Nursing Education, 2011.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Grant WB, 2011, BIOL RES NURS, V13, P120, DOI 10.1177/1099800410391243; Moon HW, 2012, CLIN BIOCHEM, V45, P326, DOI 10.1016/j.clinbiochem.2011.12.025; Nakamura K, 2000, INT J BIOMETEOROL, V44, P186, DOI 10.1007/s004840000067; Miyake Y, 2012, INT J TUBERC LUNG D, V16, P255, DOI 10.5588/ijtld.11.0173; Shibata M, 2011, J BONE MINER METAB, V29, P615, DOI 10.1007/s00774-011-0264-x; Sasaki S, 2003, INT J OBESITY, V27, P1405, DOI 10.1038/sj.ijo.0802425; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Nanri A, 2011, J EPIDEMIOL, V21, P346, DOI 10.2188/jea.JE20100161; Brantsaeter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; Nakamura K, 2002, NUTRITION, V18, P415, DOI 10.1016/S0899-9007(02)00751-7; [Anonymous], 2011, DIETARY REFERENCE IN; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Lewis S, 2010, MOL NUTR FOOD RES, V54, P1092, DOI 10.1002/mnfr.201000044; Winkvist A, 2002, PUBLIC HEALTH NUTR, V5, P523, DOI 10.1079/PHN2001317; Ohta H, 2009, J BONE MINER METAB, V27, P682, DOI 10.1007/s00774-009-0095-1; BRUINSE HW, 1995, EUR J OBSTET GYN R B, V61, P31, DOI 10.1016/0028-2243(95)02150-Q; Nakamura K, 2000, AM J CLIN NUTR, V71, P1161; Sasaki S, 1998, JPN CIRC J, V62, P431, DOI 10.1253/jcj.62.431; Health Canada, 2010, VIT D CALC UPD DIET; Kovacs CS, 2008, AM J CLIN NUTR, V88, p520S; Ministry of Education Culture Sports Science and Technology, 2005, STAND TABL FOOD COMP; Ministry of Health Labour and Welfare, 2010, NAT HLTH NUTR SURV J; Ministry of Health Labour and Welfare of Japan, 2010, POP SURV REP 2010; Ministry of Health Labour and Welfare of Japan, 2009, DIET REF INT JAP PEO; Ministry of the Environment, 2008, HLTH CAR MAN UV; Ortiz-Andrellucchi A, 2009, BRIT J NUTR, V102, pS87, DOI 10.1017/S0007114509993163; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sasaki S, 1998, J Epidemiol, V8, P203; Shiraishi M, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-15; Shiraishi M., 2013, INT J FOOD IN PRESS; Thompson F. E, 2008, NUTR PREVENTION TREA, V2, P3; Watanabe T., 2001, CHIBA COLL HLTH SCI, V20, P23; Willett WC, 1997, AM J CLIN NUTR, V65, P1220; Young V., 1997, DIET REF INT CALC PH, P250	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1740-8695	1740-8709		MATERN CHILD NUTR	Matern. Child Nutr.	OCT	2015	11	4					525	536		10.1111/mcn.12063		12	Nutrition & Dietetics; Pediatrics	Nutrition & Dietetics; Pediatrics	CS6NR	WOS:000362197100007		
J	Sawano, Y; Hakim, DI; Gunawan, H				Sawano, Yoshihiro; Hakim, Denny Ivanal; Gunawan, Hendra			Non-smooth atomic decomposition for generalized Orlicz-Morrey spaces	MATHEMATISCHE NACHRICHTEN			English	Article						Generalized Orlicz-Morrey spaces; atomic decomposition; maximal operators	LIZORKIN-TYPE SPACES; FRACTIONAL INTEGRAL-OPERATORS; BESOV-MORREY; HARDY-SPACES; MAXIMAL INEQUALITIES; VARIABLE EXPONENTS; HAUSDORFF SPACES; WEAK SOLUTIONS; LOCAL MEANS; TRIEBEL	In the present paper, we consider the non-smooth atomic decomposition of generalized Orlicz-Morrey spaces. The result will be sharper than the existing results. As an application, we consider the boundedness of the bilinear operator, which is called the Olsen inequality nowadays. To obtain a sharp norm estimate, we first investigate their predual space, which is even new, and we make full advantage of the vector-valued inequality for the Hardy-Littlewood maximal operator. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Sawano, Yoshihiro; Hakim, Denny Ivanal] Tokyo Metropolitan Univ, Dept Math & Informat Sci, Hachioji, Tokyo 1920397, Japan; [Gunawan, Hendra] Bandung Inst Technol, Fac Math & Nat Sci, Bandung 40116, Indonesia	Sawano, Y (reprint author), Tokyo Metropolitan Univ, Dept Math & Informat Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	ysawano@tmu.ac.jp; dennyivanalhakim@gmail.com; hqunawan@math.itb.ac.id			Japan Society for the Promotion of Science [24740085]; ITB Research Program	The first author is supported by Grant-in-Aid for Young Scientists (B) No. 24740085 Japan Society for the Promotion of Science. This work is written during the stay of the second author in Tokyo Metropolitan University with the help of Young Scientists (B) No. 24740085 Japan Society for the Promotion of Science. The third author is supported by ITB Research Program 2014. The authors are thankful to the anonymous referees for their careful reading of this paper, which increases its readability.	Yang DC, 2011, Z ANAL ANWEND, V30, P29, DOI 10.4171/ZAA/1422; Kruglyak N, 2005, J FOURIER ANAL APPL, V11, P697, DOI 10.1007/s00041-005-5032-7; Sawano Y, 2012, POTENTIAL ANAL, V36, P517, DOI 10.1007/s11118-011-9239-8; Nakai E, 2012, J FUNCT ANAL, V262, P3665, DOI 10.1016/j.jfa.2012.01.004; Tang L, 2005, MATH NACHR, V278, P904, DOI 10.1002/mana.200310281; Morrey CB, 1938, T AM MATH SOC, V43, P126, DOI 10.2307/1989904; Ho KP, 2012, ANN ACAD SCI FENN-M, V37, P375, DOI 10.5186/aasfm.2012.3746; Gala S, 2015, J APPROX THEORY, V198, P1, DOI 10.1016/j.jat.2015.04.001; Haroske DD, 2012, ACTA MATH SIN, V28, P1307, DOI 10.1007/s10114-012-1119-7; Jia HY, 2009, J MATH ANAL APPL, V354, P99, DOI 10.1016/j.jmaa.2008.12.051; Nakai E, 2008, STUD MATH, V188, P193, DOI 10.4064/sm188-3-1; Rauhut H, 2011, J FUNCT ANAL, V260, P3299, DOI 10.1016/j.jfa.2010.12.006; Sawano Y, 2009, ACTA MATH SIN, V25, P1223, DOI 10.1007/s10114-009-8247-8; Sawano Y, 2007, MATH Z, V257, P871, DOI 10.1007/s00209-007-0150-3; Sawano Y, 2011, T AM MATH SOC, V363, P6481; Haroske DD, 2013, STUD MATH, V218, P119, DOI 10.4064/sm218-2-2; Sugano S, 2011, MATH INEQUAL APPL, V14, P849; Yang DC, 2008, J FUNCT ANAL, V255, P2760, DOI 10.1016/j.jfa.2008.09.005; Iida T, 2014, Z ANAL ANWEND, V33, P149, DOI 10.4171/ZAA/1504; Kalita EA, 1998, DOKL AKAD NAUK+, V361, P447; Gala S, 2012, MATH METHOD APPL SCI, V35, P1321, DOI 10.1002/mma.2535; Mazzucato AL, 2003, CONTEMP MATH, V320, P279; Yang DC, 2010, MATH Z, V265, P451, DOI 10.1007/s00209-009-0524-9; Zhuo CQ, 2014, J MATH ANAL APPL, V412, P998, DOI 10.1016/j.jmaa.2013.10.084; Gogatishvili A, 2013, J MATH ANAL APPL, V397, P678, DOI 10.1016/j.jmaa.2012.08.025; ZORKO CT, 1986, P AM MATH SOC, V98, P586, DOI 10.2307/2045731; Tanaka H, 2010, J AUST MATH SOC, V88, P247, DOI 10.1017/S1446788709000457; Liang YY, 2012, J FOURIER ANAL APPL, V18, P1067, DOI 10.1007/s00041-012-9234-5; Gala S, 2013, APPL ANAL, V92, P776, DOI 10.1080/00036811.2011.636357; Ho KP, 2011, MATH SCAND, V108, P77; Sawano Y, 2010, J MATH ANAL APPL, V363, P73, DOI 10.1016/j.jmaa.2009.08.002; Nakai E, 2014, SCI CHINA MATH, V57, P903, DOI 10.1007/s11425-014-4798-y; Sawano Y, 2013, J FOURIER ANAL APPL, V19, P20, DOI 10.1007/s00041-012-9223-8; Yuan W, 2010, J MATH ANAL APPL, V369, P736, DOI 10.1016/j.jmaa.2010.04.021; Sawano Y, 2005, ACTA MATH SIN, V21, P1535, DOI 10.1007/s10114-005-0660-z; Rosenthal M, 2013, MATH NACHR, V286, P59, DOI 10.1002/mana.201200020; Gala S, 2014, APPL ANAL, V93, P356, DOI 10.1080/00036811.2013.772582; Yang DC, 2013, APPL ANAL, V92, P549, DOI 10.1080/00036811.2011.629610; Yang DC, 2010, NONLINEAR ANAL-THEOR, V73, P3805, DOI 10.1016/j.na.2010.08.006; Ho KP, 2012, ANAL MATH, V38, P173, DOI 10.1007/s10476-012-0302-5; Blasco O., 1999, ANN SCUOLA NORM SU S, V28, P31; Duoandikoetxea J., 2001, GRADUATE STUDIES MAT, V29; FEFFERMA.C, 1971, AM J MATH, V93, P107, DOI 10.2307/2373450; Gunawan Eridani H., 2014, MATH INEQUAL APPL, V17, P761; Gunawan Eridani H., 2012, ANAL THEORY APPL, V28, P263; Gunawan H., 2013, J FUNCT SPACES APPL, V2013; Ho KP, 2013, TOKYO J MATH, V36, P499; Iida T, 2014, TAIWAN J MATH, V18, P147; Liang YY, 2013, DISS MATH, P1, DOI 10.4064/dm489-0-1; Nakai E., 2004, BANACH FUNCTION SPAC, P323; Nakai E., 2011, BANACH FUNCTION SPAC, P187; NAKAI E, 1994, MATH NACHR, V166, P95, DOI 10.1002/mana.19941660108; Netrusov Y., 2007, MEM AM MATH SOC, V188; OLSEN PA, 1995, COMMUN PART DIFF EQ, V20, P2005, DOI 10.1080/03605309508821161; Sawano Y., 2010, MATH NACHR, V283, p1 ; Sawano Y., 2011, SUURIKAISEKI KOKYU B, V26, P51; Sawano Y., 2008, FUNCT APPROX COMMENT, V38, P93; Sawano Y, 2013, INTEGR EQUAT OPER TH, V77, P123, DOI 10.1007/s00020-013-2073-1; Sihwaningrum I., 2010, AUST J MATH ANAL APP, V7, P6; Stein E., 1993, HARMONIC ANAL REAL V; SUGANO S., 2003, SCI MATH JPN, V58, p[531, 233]; Ullrich T., J FUNCT SPACE APPL; Utoyo M. I., 2012, INT J MATH ANAL RUSE, V6, P1501; Viviani B. E., 1987, REV MAT IBEROAM, V3, P401; Yuan W, 2010, LECT NOTES MATH, V2005, P1, DOI 10.1007/978-3-642-14606-0_1	65	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0025-584X	1522-2616		MATH NACHR	Math. Nachr.	OCT	2015	288	14-15					1741	1775		10.1002/mana.201400138		35	Mathematics	Mathematics	CT1IP	WOS:000362552300013		
J	Liu, HQ; Wu, XZ; Xiao, TQ				Liu, Huiqiang; Wu, Xizeng; Xiao, Tiqiao			Technical Note: Synchrotron-based high-energy x-ray phase sensitive microtomography for biomedical research	MEDICAL PHYSICS			English	Article						X-ray imaging; phase contrast; phase retrieval; tomography; synchrotron radiation	ATTENUATION DUALITY; CONTRAST TOMOGRAPHY; FRESNEL REGION; SOFT-TISSUE; RETRIEVAL; HOLOTOMOGRAPHY; INTERFEROMETER; OBJECT; IMAGE	Purpose: Propagation-based phase-contrast CT (PPCT) utilizes highly sensitive phase-contrast technology applied to x-ray microtomography. Performing phase retrieval on the acquired angular projections can enhance image contrast and enable quantitative imaging. In this work, the authors demonstrate the validity and advantages of a novel technique for high-resolution PPCT by using the generalized phase-attenuation duality (PAD) method of phase retrieval. Methods: A high-resolution angular projection data set of a fish head specimen was acquired with a monochromatic 60-keV x-ray beam. In one approach, the projection data were directly used for tomographic reconstruction. In two other approaches, the projection data were preprocessed by phase retrieval based on either the linearized PAD method or the generalized PAD method. The reconstructed images from all three approaches were then compared in terms of tissue contrast-to-noise ratio and spatial resolution. Results: The authors' experimental results demonstrated the validity of the PPCT technique based on the generalized PAD-based method. In addition, the results show that the authors' technique is superior to the direct PPCT technique as well as the linearized PAD-based PPCT technique in terms of their relative capabilities for tissue discrimination and characterization. Conclusions: This novel PPCT technique demonstrates great potential for biomedical imaging, especially for applications that require high spatial resolution and limited radiation exposure. (C) 2015 American Association of Physicists in Medicine.	[Liu, Huiqiang] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Wu, Xizeng] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35249 USA; [Xiao, Tiqiao] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China	Wu, XZ (reprint author), Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35249 USA.	xwu@uabmc.edu; tqxiao@sinap.ac.cn			External Cooperation Program of Chinese Academy of Science [GJHZ09058]; National Natural Science Foundation of China [11105213]; NIH [R01CA142587, R01CA193378]	The experiment was performed at the BL13W1 of the Shanghai Synchrotron Radiation Facility (SSRF), and this work was supported by the External Cooperation Program of Chinese Academy of Science (Grant No. GJHZ09058) and the National Natural Science Foundation of China (Grant No. 11105213). X. Wu was supported in part by the NIH Grant Nos. R01CA142587 and R01CA193378. The authors are grateful to Dr. Molly Wong for her meticulous help in editing the paper.	Lewis RA, 2003, BRIT J RADIOL, V76, P301, DOI 10.1529/bjr/32889803; Wu XZ, 2004, J X-RAY SCI TECHNOL, V12, P273; Sera T, 2005, MED PHYS, V32, P2787, DOI 10.1118/1.2008429; Kitchen MJ, 2004, PHYS MED BIOL, V49, P4335, DOI 10.1088/0031-9155/49/18/010; Burvall A, 2011, OPT EXPRESS, V19, P10359, DOI 10.1364/OE.19.010359; Wu XZ, 2004, MED PHYS, V31, P2378, DOI 10.1118/1.1776672; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Gureyev TE, 2004, OPT COMMUN, V231, P53, DOI 10.1016/j.optcom.2003.12.020; Wu XZ, 2007, J X-RAY SCI TECHNOL, V15, P85; Wu XZ, 2008, APPL OPTICS, V47, pE44, DOI 10.1364/AO.47.000E44; Guigay JP, 2007, OPT LETT, V32, P1617, DOI 10.1364/OL.32.001617; Suzuki Y, 2002, J SYNCHROTRON RADIAT, V9, P160, DOI 10.1107/S090904950200554X; Gureyev TE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226794; Zanette I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4848595; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Gureyev TE, 2004, APPL OPTICS, V43, P2418, DOI 10.1364/AO.43.002418; Zabler S, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1960797; Wu XZ, 2009, OPT EXPRESS, V17, P11187, DOI 10.1364/OE.17.011187; Bronnikov AV, 1999, OPT COMMUN, V171, P239, DOI 10.1016/S0030-4018(99)00575-1; Chen RC, 2011, OPT LETT, V36, P1719, DOI 10.1364/OL.36.001719; Groso A, 2006, OPT EXPRESS, V14, P8103, DOI 10.1364/OE.14.008103; Wu XZ, 2003, J X-RAY SCI TECHNOL, V11, P33; Wu XZ, 2005, OPT LETT, V30, P379, DOI 10.1364/OL.30.000379; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Wu XZ, 2008, EUR J RADIOL, V68, pS8, DOI 10.1016/j.ejrad.2008.04.027; Langer M, 2010, IEEE T IMAGE PROCESS, V19, P2428, DOI 10.1109/TIP.2010.2048608; Guan HF, 2015, PHYS MED BIOL, V60, pN151, DOI 10.1088/0031-9155/60/8/N151; Gureyev T. E., 2009, J APPL PHYS, V105; Liu H., 2012, CHIN OPT LETT, V10; WHITE DR, 1987, BRIT J RADIOL, V60, P907	32	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	OCT	2015	42	10					5595	5603		10.1118/1.4929551		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT1OY	WOS:000362570100003		
J	Righter, K; Abell, P; Agresti, D; Berger, EL; Burton, AS; Delaney, JS; Fries, MD; Gibson, EK; Haba, MK; Harrington, R; Herzog, GF; Keller, LP; Locke, D; Lindsay, FN; Mccoy, TJ; Morris, RV; Nagao, K; Nakamura-Messenger, K; Niles, PB; Nyquist, LE; Park, J; Peng, ZX; Shih, CY; Simon, JI; Swisher, CC; Tappa, MJ; Turrin, BD; Zeigler, RA				Righter, K.; Abell, P.; Agresti, D.; Berger, E. L.; Burton, A. S.; Delaney, J. S.; Fries, M. D.; Gibson, E. K.; Haba, M. K.; Harrington, R.; Herzog, G. F.; Keller, L. P.; Locke, D.; Lindsay, F. N.; McCoy, T. J.; Morris, R. V.; Nagao, K.; Nakamura-Messenger, K.; Niles, P. B.; Nyquist, L. E.; Park, J.; Peng, Z. X.; Shih, C. -Y.; Simon, J. I.; Swisher, C. C., III; Tappa, M. J.; Turrin, B. D.; Zeigler, R. A.			Mineralogy, petrology, chronology, and exposure history of the Chelyabinsk meteorite and parent body	METEORITICS & PLANETARY SCIENCE			English	Article							HIGH-VELOCITY RESOLUTION; IMPACT-MELT BRECCIA; RUTHENIUM TETROXIDE OXIDATION; ITOKAWA DUST PARTICLES; NEAR-EARTH ASTEROIDS; EARLY SOLAR-SYSTEM; ORDINARY CHONDRITES; MOSSBAUER-SPECTROSCOPY; LL5 METEORITE; COMPOSITIONAL CLASSIFICATION	Three masses of the Chelyabinsk meteorite have been studied with a wide range of analytical techniques to understand the mineralogical variation and thermal history of the Chelyabinsk parent body. The samples exhibit little to no postentry oxidation via M_ ossbauer and Raman spectroscopy indicating their fresh character, but despite the rapid collection and care of handling some low levels of terrestrial contamination did nonetheless result. Detailed studies show three distinct lithologies, indicative of a genomict breccia. A light-colored lithology is LL5 material that has experienced thermal metamorphism and subsequent shock at levels near S4. The second lithology is a shock-darkened LL5 material in which the darkening is caused by melt and metal-troilite veins along grain boundaries. The third lithology is an impact melt breccia that formed at high temperatures (similar to 1600 degrees C), and it experienced rapid cooling and degassing of S2 gas. Portions of light and dark lithologies from Chel-101, and the impact melt breccias (Chel-102 and Chel-103) were prepared and analyzed for Rb-Sr, Sm-Nd, and Ar-Ar dating. When combined with results from other studies and chronometers, at least eight impact events (e.g., similar to 4.53 Ga, similar to 4.45 Ga, similar to 3.73 Ga, similar to 2.81 Ga, similar to 1.46 Ga, similar to 852 Ma, similar to 312 Ma, and similar to 27 Ma) are clearly identified for Chelyabinsk, indicating a complex history of impacts and heating events. Finally, noble gases yield young cosmic ray exposure ages, near 1 Ma. These young ages, together with the absence of measurable cosmogenic derived Sm and Cr, indicate that Chelyabinsk may have been derived from a recent breakup event on an NEO of LL chondrite composition.	[Righter, K.; Abell, P.; Burton, A. S.; Fries, M. D.; Gibson, E. K.; Keller, L. P.; Morris, R. V.; Nakamura-Messenger, K.; Niles, P. B.; Nyquist, L. E.; Simon, J. I.; Zeigler, R. A.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Agresti, D.] Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; [Berger, E. L.] NASA, Lyndon B Johnson Space Ctr, GeoControl Syst Inc, Jacobs JETS Contract, Houston, TX 77058 USA; [Delaney, J. S.; Herzog, G. F.; Lindsay, F. N.; Park, J.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Harrington, R.] NASA, Lyndon B Johnson Space Ctr, UTAS, Jacobs JETS Contract, Houston, TX 77058 USA; [Locke, D.] NASA, Lyndon B Johnson Space Ctr, HX5, Jacobs JETS Contract, Houston, TX 77058 USA; [McCoy, T. J.] Smithsonian Inst, Dept Mineral Sci, Natl Museum Nat Hist, Washington, DC 20560 USA; [Haba, M. K.; Nagao, K.] Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Peng, Z. X.] NASA, Lyndon B Johnson Space Ctr, Barrios Tech, Jacobs JETS Contract, Houston, TX 77058 USA; [Shih, C. -Y.] NASA, Lyndon B Johnson Space Ctr, Jacobs JETS Contract, Houston, TX 77058 USA; [Swisher, C. C., III; Turrin, B. D.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Tappa, M. J.] NASA, Lyndon B Johnson Space Ctr, Aerodyne Ind, Jacobs JETS Contract, Houston, TX 77058 USA	Righter, K (reprint author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	kevin.righter-1@nasa.gov			RTOP; Cosmochemistry program [11-COS11-0066]; NASA Lunar Advanced Science Exploration Research (LASER) Program [10-LASER10-0054]	We thank T. Kryachko for donating Chel-101 and -102 to NASA, L. Johnson and R. Landis for facilitating delivery of samples from Russia to Houston, and M. Farmer for the Chel-103 sample. Rhian Jones kindly shared Chelyabinsk samples (UNM 001h and 020) with us for the Ar dating. This research was supported by an RTOP to K. Righter and 11-COS11-0066 to J.I. Simon from the Cosmochemistry program, financial support for L.E. Nyquist and C.-Y. Shih was provided by the NASA Lunar Advanced Science Exploration Research (LASER) Program via proposal number 10-LASER10-0054. Journal reviews of K. Welten and L. Folco helped improve the presentation of this work.	WASSERBURG GJ, 1981, GEOCHIM COSMOCHIM AC, V45, P2311, DOI 10.1016/0016-7037(81)90085-5; Nakamura E, 2012, P NATL ACAD SCI USA, V109, pE624, DOI 10.1073/pnas.1116236109; CRONIN JR, 1990, GEOCHIM COSMOCHIM AC, V54, P2859, DOI 10.1016/0016-7037(90)90020-L; Rubin AE, 2011, METEORIT PLANET SCI, V46, P587, DOI 10.1111/j.1945-5100.2011.01176.x; MINSTER JF, 1982, NATURE, V300, P414, DOI 10.1038/300414a0; KATTAMIS TZ, 1965, T METALL SOC AIME, V233, P992; KALLEMEYN GW, 1989, GEOCHIM COSMOCHIM AC, V53, P2747, DOI 10.1016/0016-7037(89)90146-4; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; Folco L, 2006, METEORIT PLANET SCI, V41, P343; Vernazza P, 2008, NATURE, V454, P858, DOI 10.1038/nature07154; Menzies ON, 2005, METEORIT PLANET SCI, V40, P1023; Dixon ET, 2004, GEOCHIM COSMOCHIM AC, V68, P3779, DOI 10.1016/j.gca.2004.02.023; KALLEMEYN GW, 1978, GEOCHIM COSMOCHIM AC, V42, P507, DOI 10.1016/0016-7037(78)90200-4; Bogomolov ES, 2013, DOKL EARTH SCI, V452, P1034, DOI 10.1134/S1028334X13100097; [Anonymous], 2013, METEORITICAL B, V102; Trinquier A, 2008, GEOCHIM COSMOCHIM AC, V72, P5146, DOI 10.1016/j.gca.2008.03.023; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; AUDISIO G, 1992, J ANAL APPL PYROL, V24, P61, DOI 10.1016/0165-2370(92)80005-7; Sephton MA, 2001, PRECAMBRIAN RES, V106, P47, DOI 10.1016/S0301-9268(00)00124-8; Sephton MA, 2000, GEOCHIM COSMOCHIM AC, V64, P321, DOI 10.1016/S0016-7037(99)00282-3; Leya I, 2009, METEORIT PLANET SCI, V44, P1061, DOI 10.1111/j.1945-5100.2009.tb00788.x; Folco L, 2004, GEOCHIM COSMOCHIM AC, V68, P2379, DOI 10.1016/j.gca.2003.11.023; Oshtrakh MI, 2014, HYPERFINE INTERACT, V226, P559, DOI 10.1007/s10751-013-0951-1; Dunn TL, 2013, ICARUS, V222, P273, DOI 10.1016/j.icarus.2012.11.007; Simon JI, 2009, ASTROPHYS J, V702, P707, DOI 10.1088/0004-637X/702/1/707; Bennett ME, 1996, METEORIT PLANET SCI, V31, P783; KALLEMEYN GW, 1991, GEOCHIM COSMOCHIM AC, V55, P881, DOI 10.1016/0016-7037(91)90348-9; Brown PG, 2013, NATURE, V503, P238, DOI 10.1038/nature12741; BOGARD DD, 1995, J GEOPHYS RES-PLANET, V100, P9401, DOI 10.1029/95JE00663; WOOD JA, 1967, ICARUS, V6, P1, DOI 10.1016/0019-1035(67)90002-4; HEYMANN D, 1967, GEOCHIM COSMOCHIM AC, V31, P1793, DOI 10.1016/0016-7037(67)90123-8; Rubin AE, 2014, METEORIT PLANET SCI, V49, P1057, DOI 10.1111/maps.12315; Yokoyama T, 2013, EARTH PLANET SC LETT, V366, P38, DOI 10.1016/j.epsl.2013.01.037; Bischoff A, 2010, METEORIT PLANET SCI, V45, P1638, DOI 10.1111/j.1945-5100.2010.01108.x; Rubin AE, 2003, METEORIT PLANET SCI, V38, P1507; Kohout T, 2014, ICARUS, V228, P78, DOI 10.1016/j.icarus.2013.09.027; DONALDSON CH, 1975, LITHOS, V8, P163, DOI 10.1016/0024-4937(75)90023-7; Rubin AE, 2004, GEOCHIM COSMOCHIM AC, V68, P673, DOI 10.1016/S0016-7037(00)00452-6; HUSTON TJ, 1984, GEOCHIM COSMOCHIM AC, V48, P1319, DOI 10.1016/0016-7037(84)90065-6; PODOSEK FA, 1991, METEORITICS, V26, P145; Qin LP, 2010, GEOCHIM COSMOCHIM AC, V74, P1122, DOI 10.1016/j.gca.2009.11.005; CRESSY PJ, 1976, GEOCHIM COSMOCHIM AC, V40, P749, DOI 10.1016/0016-7037(76)90028-4; Horz F, 2005, METEORIT PLANET SCI, V40, P1329; Romanovskaya GI, 2013, GEOCHEM INT+, V51, P590, DOI 10.1134/S0016702913070148; GARRISON DH, 1992, METEORITICS, V27, P371; NYQUIST LE, 1990, GEOCHIM COSMOCHIM AC, V54, P2195, DOI 10.1016/0016-7037(90)90045-M; JACOBSEN SB, 1980, EARTH PLANET SC LETT, V50, P139, DOI 10.1016/0012-821X(80)90125-9; Pillinger CT, 2013, GEOCHEM INT+, V51, P540, DOI 10.1134/S0016702913070136; Mittlefehldt DW, 2005, GEOL SOC AM SPEC PAP, V384, P367, DOI 10.1130/0-8137-2384-1.367; BROOKS C, 1972, REV GEOPHYS SPACE GE, V10, P551, DOI 10.1029/RG010i002p00551; WALSH TM, 1982, GEOCHIM COSMOCHIM AC, V46, P2491, DOI 10.1016/0016-7037(82)90372-6; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; BOUCHER RJ, 1991, FUEL, V70, P695, DOI 10.1016/0016-2361(91)90064-H; Nesvorny D, 2002, ICARUS, V157, P155, DOI 10.1006/icar.2002.6830; Ganguly J, 2013, GEOCHIM COSMOCHIM AC, V105, P206, DOI 10.1016/j.gca.2012.11.024; Remusat L, 2005, GEOCHIM COSMOCHIM AC, V69, P4377, DOI 10.1016/j.gca.2005.05.003; Galimov EM, 2013, GEOCHEM INT+, V51, P522, DOI 10.1134/S0016702913070100; Turrin BD, 2007, QUATERNARY RES, V68, P96, DOI 10.1016/j.yqres.2007.02.004; Rubin AE, 2011, METEORIT PLANET SCI, V46, P737, DOI 10.1111/j.1945-5100.2011.01187.x; Yang J, 2008, GEOCHIM COSMOCHIM AC, V72, P3043, DOI 10.1016/j.gca.2008.04.009; Fabbri D, 1998, J CHROMATOGR SCI, V36, P600; Benedix GK, 2008, GEOCHIM COSMOCHIM AC, V72, P2417, DOI 10.1016/j.gca.2008.02.010; Popova OP, 2013, SCIENCE, V342, P1069, DOI 10.1126/science.1242642; BLAU PJ, 1975, GEOCHIM COSMOCHIM AC, V39, P305, DOI 10.1016/0016-7037(75)90199-4; Reddy V, 2014, ICARUS, V237, P116, DOI 10.1016/j.icarus.2014.04.027; Oshtrakh MI, 2008, METEORIT PLANET SCI, V43, P941; KALLEMEYN GW, 1994, GEOCHIM COSMOCHIM AC, V58, P2873, DOI 10.1016/0016-7037(94)90121-X; Turrin BD, 1998, GEOL SOC AM BULL, V110, P931, DOI 10.1130/0016-7606(1998)110<0931:AOLPCA>2.3.CO;2; Borovicka J, 2013, NATURE, V503, P235, DOI 10.1038/nature12671; Rubin AE, 2002, GEOCHIM COSMOCHIM AC, V66, P699, DOI 10.1016/S0016-7037(01)00799-2; Armstrong T. W., 1971, P LUNAR PLANET SCI C, P1729; Beard S.P., 2014, LUNAR PLANET SCI, VXLV, P1807; Bottke W.F., 2002, ASTEROIDS, VIII, P395; Bouvier A., 2013, LPI CONTRIBUTIONS, V1737, P3087; Buhl S., 2013, TRAJECTORY PROJECTIO; Busemann H., 2014, 45 LUN PLAN SCI C; Corrigan C. M., 2014, AGU SPECIAL PUBLICAT, V68, P173; DALRYMPL.GB, 1974, GEOCHIM COSMOCHIM AC, V38, P715; Eugster O., 2006, METEORITES EARLY SOL, P829; Fleck J., 1977, GEOCHIM COSMOCHIM AC, V41, P15; Galimov E. M., 2013, GEOKHIMIYA, V51, P580; Garrison D. H., 1991, P 12 LUN PLAN SCI C, P429; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Haba M. K., 2014, 45 LUN PLAN SCI C; Hays J. M., 1968, GEOCHIMICA COSMOCHIM, V32, P239; Herzog G. F., 2014, TREATISE GEOCHEMISTR, V1, P419; Ivanova M. A., 2013, METEORITICS PLANET S; Keller L. P., 2013, 44 LUN PLAN SCI C; Kring D. A., 2015, PHYS TODAY, V67, P32; Lanphere M.A., 1969, POTASSIUM ARGON DATI; Lapen T. J., 2014, 45 LUN PLAN SCI C; Lindsay F. N., 2015, 46 LUN PLAN SCI C; Maksimova AA, 2014, AIP CONF PROC, V1622, DOI 10.1063/1.4898607; Meier M. M. M., 2014, 45 LUN PLAN SCI C; Nagao K., 2013, 44 LUN PLAN SCI C; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nakamura E., 2015, 46 LUN PLAN SCI C; Newsom H. E., 1995, AGU REF SHELF, V1, P159; Nishiizumi K., 2013, METEORITICS PLANETAR, P48; Park J., 2015, 46 LUN PLAN SCI C; Povinec PP, 2015, METEORIT PLANET SCI, V50, P273, DOI 10.1111/maps.12419; Righter K., 2014, 2014 GOLDSCHM C 8 13; SCOTT ERD, 1982, GEOCHIM COSMOCHIM AC, V46, P813, DOI 10.1016/0016-7037(82)90032-1; Sharp T.G., 2006, METEORITES EARLY SOL, VII, P653; Swindle T. D., 2013, SPECIAL PUBLICATIONS, V378, P333; Taylor J.R., 1997, INTRO ERROR ANAL; Wittmann A, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003433	108	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	OCT	2015	50	10					1790	1819		10.1111/maps.12511		30	Geochemistry & Geophysics	Geochemistry & Geophysics	CT1JN	WOS:000362554700009		
J	Zhu, SW; Kumar, A; Kojima, S; Homma, M				Zhu, Shiwei; Kumar, Ananthanarayanan; Kojima, Seiji; Homma, Michio			FliL associates with the stator to support torque generation of the sodium-driven polar flagellar motor of Vibrio	MOLECULAR MICROBIOLOGY			English	Article							C-TERMINAL REGION; PROTEUS-MIRABILIS; CONFORMATIONAL-CHANGE; PERIPLASMIC REGION; ESCHERICHIA-COLI; GENE-EXPRESSION; ROTOR COMPONENT; BASAL BODY; ALGINOLYTICUS; SALMONELLA	Flagellar motors generate torque to rotate flagellar filaments and drive bacterial cells. Each motor is composed of a rotor and many stators. The stator is a force-generating complex that converts ion flux into torque. Previous reports have suggested that the membrane protein FliL is located near the stator and is involved in torque generation. We investigated the role of FliL in the sodium-driven polar flagellar motor of Vibrio alginolyticus. Our results revealed that FliL is a cytoplasmic membrane protein and is located at the base of flagellum. The deletion of fliL did not affect the cell morphology or flagellation but resulted in a significant decrease of swimming speed, especially at a higher load thus suggesting that FliL is important for torque generation at high load conditions. Furthermore, the polar localization of the stator was decreased in a Delta fliL mutant, but the sodium-dependent assembly of the stator complex was still retained. The polar localization of FliL was lost in the absence of the stator complex, indicating that FliL interacts directly or indirectly with the stator. Our results suggest that FliL is localized along with the stator in order to support the motor functioning for swimming at high load conditions by maintaining the stator assembly.	[Zhu, Shiwei; Kumar, Ananthanarayanan; Kojima, Seiji; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Homma, M (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44416a@cc.nagoya-u.ac.jp			Japan Society for the Promotion of Science [24117004, 23247024, 24657087]; Integrative Graduate Education and Research program (Green Natural Sciences) of Nagoya University	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24117004 and 23247024 to M.H., or 24657087 to S.K.). S.Z. was partly supported by the Integrative Graduate Education and Research program (Green Natural Sciences) of Nagoya University.	Sowa Y, 2003, J MOL BIOL, V327, P1043, DOI 10.1016/S0022-2836(03)00176-1; Kojima S, 2001, BIOCHEMISTRY-US, V40, P13041, DOI 10.1021/bi011263o; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Zhu SW, 2012, J BACTERIOL, V194, P6728, DOI 10.1128/JB.01132-12; Attmannspacher U, 2008, MOL MICROBIOL, V68, P328, DOI 10.1111/j.1365-2958.2008.06170.x; Lele PP, 2013, P NATL ACAD SCI USA, V110, P11839, DOI 10.1073/pnas.1305885110; Li N, 2011, GENES CELLS, V16, P985, DOI 10.1111/j.1365-2443.2011.01545.x; Kojima S, 2011, J MOL BIOL, V414, P62, DOI 10.1016/j.jmb.2011.09.019; Li N, 2011, J BACTERIOL, V193, P3773, DOI 10.1128/JB.00113-11; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Cusick K, 2012, J BACTERIOL, V194, P437, DOI 10.1128/JB.05998-11; Gohara M, 2014, J BIOCHEM, V155, P83, DOI 10.1093/jb/mvt100; Suaste-Olmos F, 2010, J BACTERIOL, V192, P6230, DOI 10.1128/JB.00655-10; Yorimitsu T, 1999, J BACTERIOL, V181, P5103; Okunishi I, 1996, J BACTERIOL, V178, P2409; Atsumi T, 1996, J BACTERIOL, V178, P5024; Partridge JD, 2013, J BACTERIOL, V195, P919, DOI 10.1128/JB.02064-12; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Terauchi T, 2011, MICROBIOL-SGM, V157, P2422, DOI 10.1099/mic.0.048488-0; Liu RY, 2007, J BACTERIOL, V189, P7098, DOI 10.1128/JB.00643-07; Fukuoka H, 2005, J MOL BIOL, V351, P707, DOI 10.1016/j.jmb.2005.06.037; Motaleb MA, 2011, J BACTERIOL, V193, P3324, DOI 10.1128/JB.00202-11; Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; RAHA M, 1994, J BACTERIOL, V176, P2308; Zhu SW, 2014, P NATL ACAD SCI USA, V111, P13523, DOI 10.1073/pnas.1324201111; Braun TF, 2004, BIOCHEMISTRY-US, V43, P35, DOI 10.1021/bi035406d; Fukuoka H, 2009, MOL MICROBIOL, V71, P825, DOI 10.1111/j.1365-2958.2008.06569.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121; Sato K, 2000, J BIOL CHEM, V275, P20223, DOI 10.1074/jbc.M002236200; Belas R, 2005, J BACTERIOL, V187, P6789, DOI 10.1128/JB.187.19.6789-6803.2005; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Yorimitsu T, 2003, J MOL BIOL, V334, P567, DOI 10.1016/j.jmb.2003.09.052; Che YS, 2014, MOL MICROBIOL, V91, P175, DOI 10.1111/mmi.12453; Yorimitsu T, 2000, J BIOL CHEM, V275, P31387, DOI 10.1074/jbc.M000848200; Lee YY, 2013, J BACTERIOL, V195, P823, DOI [10.1128/JB.02024-12, 10.1128/JB.02024.12]; KAWAGISHI I, 1994, MICROBIOL-UK, V140, P2355; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Schoenhals GJ, 1999, MICROBIOL-UK, V145, P1769; Belas R, 2014, TRENDS MICROBIOL, V22, P517, DOI 10.1016/j.tim.2014.05.002; JENAL U, 1994, J MOL BIOL, V243, P227, DOI 10.1006/jmbi.1994.1650; Lee YY, 2015, J BACTERIOL, V197, P159, DOI 10.1128/JB.02235-14; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Partridge J.D., 2015, MBIO, V6; Tipping MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00551-13; Val ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002472	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	OCT	2015	98	1					101	110		10.1111/mmi.13103		10	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CT3RY	WOS:000362725800008		
J	Ono, H; Takashima, A; Hirata, H; Homma, M; Kojima, S				Ono, Hiroki; Takashima, Akari; Hirata, Hikaru; Homma, Michio; Kojima, Seiji			The MinD homolog FlhG regulates the synthesis of the single polar flagellum of Vibrio alginolyticus	MOLECULAR MICROBIOLOGY			English	Article							SIGNAL-RECOGNITION PARTICLE; PSEUDOMONAS-AERUGINOSA; BACTERIAL FLAGELLA; ESCHERICHIA-COLI; MOLECULAR EVOLUTION; PROTEIN; ATPASE; NUMBER; LOCALIZATION; REVEALS	FlhG, a MinD homolog and an ATPase, is known to mediate the formation of the single polar flagellum of Vibrio alginolyticus together with FlhF. FlhG and FlhF work antagonistically, with FlhF promoting flagellar assembly and FlhG inhibiting it. Here, we demonstrate that purified FlhG exhibits a low basal ATPase activity. As with MinD, the basal ATPase activity of FlhG can be activated and the D171A residue substitution enhances its ATPase activity sevenfold. FlhG-D171A localizes strongly at the cell pole and severely inhibits motility and flagellation, whereas the FlhG K31A and K36Q mutants, which are defective in ATP binding, do not localize to the poles, cannot complement a flhG mutant and lead to hyperflagellation. A strong polar localization of FlhF is observed with the K36Q mutant FlhG but not with the wild-type or D171A mutant FlhG. Unexpectedly, an Ala substitution at the catalytic residue (D60A), which abolishes ATPase activity but still allows ATP binding, only slightly affects FlhG functions. These results suggest that the ATP-dependent polar localization of FlhG is crucial for its ability to downregulate the number of polar flagella. We speculate that ATP hydrolysis by FlhG is required for the fine tuning of the regulation.	[Ono, Hiroki; Takashima, Akari; Hirata, Hikaru; Homma, Michio; Kojima, Seiji] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Homma, M (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44416a@cc.nagoya-u.ac.jp; z47616a@cc.nagoya-u.ac.jp			MEXT/JSPS KAKENHI [24117004, 23247024, 24115506, 26115705]	We thank Akari Shinohara for construction of the plasmid pTrc-flhG, and Akiko Abe for technical assistance. We thank Dr. Mike Manson for critically reading the manuscript. This work was supported in by MEXT/JSPS KAKENHI Grant Numbers 24117004, 23247024 (to M.H), 24115506 and 26115705 (to S.K.).	Altegoer F, 2014, BIOTECHNOL GENET ENG, V30, P49, DOI 10.1080/02648725.2014.921500; Green JCD, 2009, J MOL BIOL, V391, P679, DOI 10.1016/j.jmb.2009.05.075; Schniederberend M, 2013, J BACTERIOL, V195, P1051, DOI 10.1128/JB.02013-12; Zhou HJ, 2005, J BACTERIOL, V187, P629, DOI 10.1128/JB.187.2.629-638.2005; Kusumoto A, 2006, J BIOCHEM, V139, P113, DOI 10.1093/jb/mvj010; Kusumoto A, 2008, MICROBIOL-SGM, V154, P1390, DOI 10.1099/mic.0.2007/012641-0; Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; Bange G, 2007, P NATL ACAD SCI USA, V104, P13621, DOI 10.1073/pnas.0702570104; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Yamaichi Y, 2012, GENE DEV, V26, P2348, DOI 10.1101/gad.199869.112; DEBOER PAJ, 1991, EMBO J, V10, P4371; Okunishi I, 1996, J BACTERIOL, V178, P2409; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; Kazmierczak BI, 2013, MOL MICROBIOL, V88, P655, DOI 10.1111/mmi.12221; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Park KT, 2012, MOL MICROBIOL, V85, P271, DOI 10.1111/j.1365-2958.2012.08110.x; Balaban M, 2009, J BACTERIOL, V191, P6602, DOI 10.1128/JB.00884-09; GUZMAN LM, 1995, J BACTERIOL, V177, P4121; Schuhmacher JS, 2015, P NATL ACAD SCI USA, V112, P3092, DOI 10.1073/pnas.1419388112; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; KAWAGISHI I, 1994, MICROBIOL-UK, V140, P2355; Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Bange G, 2011, NAT STRUCT MOL BIOL, V18, P1376, DOI 10.1038/nsmb.2141; Pandza S, 2000, MOL MICROBIOL, V36, P414, DOI 10.1046/j.1365-2958.2000.01859.x; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; Kitaoka M, 2013, J BACTERIOL, V195, P816, DOI 10.1128/JB.01850-12; Balaban M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002420	34	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	OCT	2015	98	1					130	141		10.1111/mmi.13109		12	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	CT3RY	WOS:000362725800010		
J	Cherasse, Y; Saito, H; Nagata, N; Aritake, K; Lazarus, M; Urade, Y				Cherasse, Yoan; Saito, Hitomi; Nagata, Nanae; Aritake, Kosuke; Lazarus, Michael; Urade, Yoshihiro			Zinc-containing yeast extract promotes nonrapid eye movement sleep in mice	MOLECULAR NUTRITION & FOOD RESEARCH			English	Article						Electroencephalogram; Food supplement; Locomotor activity; Sleep; Zinc-containing yeast	BASAL GANGLIA; BRAIN; RAT; DEFICIENCY; BEHAVIOR; SYSTEM; HEALTH	Zinc is an essential trace element for humans and animals, being located, among other places, in the synaptic vesicles of cortical glutamatergic neurons and hippocampal mossy fibers in the brain. Extracellular zinc has the potential to interact with and modulate many different synaptic targets, including glutamate and GABA receptors. Because of the central role of these neurotransmitters in brain activity, we examined in this study the sleep-promoting activity of zinc by monitoring locomotor activity and electroencephalogram after its administration to mice. Zinc-containing yeast extract (40 and 80 mg/kg) dose dependently increased the total amount of nonrapid eye movement sleep and decreased the locomotor activity. However, this preparation did not change the amount of rapid eye movement sleep or show any adverse effects such as rebound of insomnia during a period of 24 h following the induction of sleep; whereas the extracts containing other divalent cations (manganese, iron, and copper) did not decrease the locomotor activity. This is the first evidence that zinc can induce sleep. Our data open the way to new types of food supplements designed to improve sleep.	[Cherasse, Yoan; Saito, Hitomi; Nagata, Nanae; Aritake, Kosuke; Lazarus, Michael; Urade, Yoshihiro] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Saito, Hitomi] Fujifilm Corp, Tokyo, Japan	Cherasse, Y (reprint author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan.	cherasse.yoan.fm@u.tsukuba.ac.jp			National Agriculture and Food Research Organization Research Project on Development of Agricultural Products and Foods with Health-promoting benefits; Cross-ministerial Strategic Innovation Promotion Program [14533235]; Japan Society for the Promotion of Science KAKENHI [25871082, 25670047]; Nestle Nutrition Council, Japan; World Premier International Research Center Initiative (WPI) from Ministry of Education, Culture, Sports, Science and Technology	This work was supported by grants from the National Agriculture and Food Research Organization Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (H.S., M.L., Y.U.) and Cross-ministerial Strategic Innovation Promotion Program Grant Number 14533235 (Y.C., N.N., K.A., Y.U.), Japan Society for the Promotion of Science KAKENHI grants, number 25871082 (Y.C.) and 25670047 (K.A.), the Nestle Nutrition Council, Japan (to M.L.) and the World Premier International Research Center Initiative (WPI) from Ministry of Education, Culture, Sports, Science and Technology.	Hotz C, 2007, FOOD NUTR BULL, V28, pS430; GORDON EF, 1982, PHYSIOL BEHAV, V28, P893, DOI 10.1016/0031-9384(82)90210-4; Kohtoh S, 2008, SLEEP BIOL RHYTHMS, V6, P163, DOI 10.1111/j.1479-8425.2008.00355.x; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Prasad AS, 2013, ADV NUTR, V4, P176, DOI 10.3945/an.112.003210; Watson CJ, 2011, J NEUROCHEM, V118, P571, DOI 10.1111/j.1471-4159.2011.07350.x; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Penny ME, 2013, ANN NUTR METAB, V62, P31, DOI 10.1159/000348263; Lazarus M, 2012, TRENDS NEUROSCI, V35, P723, DOI 10.1016/j.tins.2012.07.001; Hayaishi O, 2004, DRUG NEWS PERSPECT, V17, P105, DOI 10.1358/dnp.2004.17.2.829043; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; TAKEDA A, 1994, BRAIN RES, V640, P341, DOI 10.1016/0006-8993(94)91891-0; KASARSKIS EJ, 1984, EXP NEUROL, V85, P114, DOI 10.1016/0014-4886(84)90166-3; FORMAN WB, 1990, WESTERN J MED, V152, P190; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Takeda A, 1997, BRAIN RES, V769, P193, DOI 10.1016/S0006-8993(97)00852-4; Stathopoulou MG, 2012, PROG MOL BIOL TRANSL, V108, P201, DOI 10.1016/B978-0-12-398397-8.00009-5; PULLEN RGL, 1990, NEUROCHEM RES, V15, P1003, DOI 10.1007/BF00965746; Nakashima Y, 2011, J NUTR SCI VITAMINOL, V57, P42, DOI 10.3177/jnsv.57.42; Xu Q, 2014, PHARMACOL BIOCHEM BE, V116, P129, DOI 10.1016/j.pbb.2013.11.029; Avila Daiana Silva, 2013, Met Ions Life Sci, V13, P199, DOI 10.1007/978-94-007-7500-8_7; Colavito Valeria, 2013, Front Syst Neurosci, V7, P106, DOI 10.3389/fnsys.2013.00106; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; Massaro T. F., 1982, PHYSIOL BEHAV, V25, P117; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1613-4125	1613-4133		MOL NUTR FOOD RES	Mol. Nutr. Food Res.	OCT	2015	59	10					2087	2093		10.1002/mnfr.201500082		7	Food Science & Technology	Food Science & Technology	CT1HZ	WOS:000362550700019		
J	Tang, SC; Kort, A; Cheung, KL; Rosing, H; Fukami, T; Durmus, S; Wagenaar, E; Hendrikx, JJMA; Nakajima, M; van Vlijmen, BJM; Beijnen, JH; Schinkel, AH				Tang, Seng Chuan; Kort, Anita; Cheung, Ka Lei; Rosing, Hilde; Fukami, Tatsuki; Durmus, Selvi; Wagenaar, Els; Hendrikx, Jeroen J. M. A.; Nakajima, Miki; van Vlijmen, Bart J. M.; Beijnen, Jos H.; Schinkel, Alfred H.			P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in Mice	MOLECULAR PHARMACEUTICS			English	Article						cabazitaxel; carboxylesterase; pharmacokinetics; P-glycoprotein; brain accumulation	ADVANCED SOLID TUMORS; EVERY 3 WEEKS; MULTIDRUG-RESISTANCE; IN-VIVO; ANTITUMOR-ACTIVITY; PROSTATE-CANCER; HUMAN OATP1B1; MRP2 ABCC2; PHASE-I; PACLITAXEL	We aimed to clarify the roles of the multidrug-detoxifying proteins ABCB1, ABCG2, ABCC2, and CYP3A in oral availability and brain accumulation of cabazitaxel, a taxane developed for improved therapy of docetaxel-resistant prostate cancer. Cabazitaxel pharmacokinetics were studied in Abcb1a/1b, Abcg2, Abcc2, Cyp3a, and combination knockout mice. We found that human ABCB1, but not ABCG2, transported cabazitaxel in vitro. Upon oral cabazitaxel administration, total plasma levels were greatly increased due to binding to plasma carboxylesterase Ces1c, which is highly upregulated in several knockout strains. Ces1c inhibition and in vivo hepatic Ces1c knockdown reversed these effects. Correcting for Ces1c effects, Abcb1a/1b, Abcg2, and Abcc2 did not restrict cabazitaxel oral availability, whereas Abcb1a/1b, but not Abcg2, dramatically reduced cabazitaxel brain accumulation (>10-fold). Coadministration of the ABCB1 inhibitor elacridar completely reversed this brain accumulation effect. After correction for Ces1c effects, Cyp3a knockout mice demonstrated a strong (six-fold) increase in cabazitaxel oral availability, which was completely reversed by transgenic human CYP3A4 in intestine and liver. Cabazitaxel markedly inhibited mouse Ces1c, but human CES1 and CES2 only weakly. Ces1c upregulation can thus complicate preclinical cabazitaxel studies. In summary, ABCB1 limits cabazitaxel brain accumulation and therefore potentially therapeutic efficacy against (micro)metastases or primary tumors positioned wholly or partly behind a functional blood brain barrier. This can be reversed with elacridar coadministration, and similar effects may apply to ABCB1-expressing tumors. CYP3A4 profoundly reduces the oral availability of cabazitaxel. This may potentially be greatly improved by coadministering ritonavir or other CYP3A inhibitors, suggesting the option of patient-friendly oral cabazitaxel therapy.	[Tang, Seng Chuan; Kort, Anita; Durmus, Selvi; Wagenaar, Els; Schinkel, Alfred H.] Netherlands Canc Inst, Dept Mol Oncol, NL-1066 CX Amsterdam, Netherlands; [Kort, Anita; Rosing, Hilde; Hendrikx, Jeroen J. M. A.; Beijnen, Jos H.] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Pharm & Pharmacol, NL-1066 CX Amsterdam, Netherlands; [Cheung, Ka Lei; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, NL-2333 ZA Leiden, Netherlands; [Fukami, Tatsuki; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan; [Beijnen, Jos H.] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, NL-3512 JE Utrecht, Netherlands	Schinkel, AH (reprint author), Netherlands Canc Inst, Dept Mol Oncol, NL-1066 CX Amsterdam, Netherlands.	a.schinkel@nki.nl			Malaysian Ministry of Science, Technology, and Innovation; Dutch Cancer Society [NKI 2007-3764]	This work was supported in part by an academic staff training scheme fellowship from the Malaysian Ministry of Science, Technology, and Innovation to S.C.T., and by Dutch Cancer Society Grant No. NKI 2007-3764 to A.H.S. and J.H.B. We thank Olaf van Tellingen for the assistance with HPLC analysis of irinotecan and SN-38.	Nishimuta H, 2014, DRUG METAB DISPOS, V42, P1522, DOI 10.1124/dmd.114.057372; Vrignaud P, 2013, CLIN CANCER RES, V19, P2973, DOI 10.1158/1078-0432.CCR-12-3146; Koolen SLW, 2010, CLIN PHARMACOL THER, V87, P126, DOI 10.1038/clpt.2009.233; van de Steeg E, 2013, CLIN CANCER RES, V19, P821, DOI 10.1158/1078-0432.CCR-12-2080; Pivot X, 2008, ANN ONCOL, V19, P1547, DOI 10.1093/annonc/mdn171; Vlaming MLH, 2006, J PHARMACOL EXP THER, V318, P319, DOI 10.1124/jpet.106.101774; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Schoemaker NE, 2003, THER DRUG MONIT, V25, P120, DOI 10.1097/00007691-200302000-00020; Yared JA, 2012, DRUG DES DEV THER, V6, P371, DOI 10.2147/DDDT.S28997; Lagas JS, 2010, CLIN CANCER RES, V16, P130, DOI 10.1158/1078-0432.CCR-09-1321; Tang SC, 2012, INT J CANCER, V130, P223, DOI 10.1002/ijc.26000; Morton CL, 2005, CANCER CHEMOTH PHARM, V56, P629, DOI 10.1007/s00280-005-1027-y; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Ballatore C, 2011, CURR TOP MED CHEM, V11, P317, DOI 10.2174/156802611794072605; Tang SC, 2014, CLIN CANCER RES, V20, P3133, DOI 10.1158/1078-0432.CCR-13-1759; Mita AC, 2009, CLIN CANCER RES, V15, P723, DOI 10.1158/1078-0432.CCR-08-0596; van Waterschoot RAB, 2010, INT J CANCER, V127, P2959, DOI 10.1002/ijc.25279; Lagas JS, 2006, CLIN CANCER RES, V12, P6125, DOI 10.1158/1078-0432.CCR-06-1352; van Herwaarden AE, 2007, J CLIN INVEST, V117, P3583, DOI 10.1172/JC133435; Moes J, 2013, EUR J PHARM BIOPHARM, V83, P87, DOI 10.1016/j.ejpb.2012.09.016; Bardelmeijer HA, 2002, CANCER RES, V62, P6158; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Lagas JS, 2012, MOL PHARMACOL, V82, P636, DOI 10.1124/mol.111.077099; Hendrikx JJMA, 2013, INT J CANCER, V132, P2439, DOI 10.1002/ijc.27912; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Stuurman FE, 2013, CLIN PHARMACOKINET, V52, P399, DOI 10.1007/s40262-013-0040-2; Kemper EM, 2004, EUR J CANCER, V40, P1269, DOI 10.1016/j.ejca.2004.01.024; van Waterschoot RAB, 2009, CANCER RES, V69, P8996, DOI 10.1158/0008-5472.CAN-09-2915; van Asperen J, 1998, CLIN CANCER RES, V4, P2293; Bahar FG, 2012, J PHARM SCI-US, V101, P3979, DOI 10.1002/jps.23258; Center for Drug Evaluation and Research of the US Department of Health and Human Services, 2010, CLIN PHARM BIOPH REV; Cisternino S, 2003, BRIT J PHARMACOL, V138, P1367, DOI 10.1038/sj.bjp.0705150; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; Duran GE, 2015, MOL CANCER THER, V14, P193, DOI 10.1158/1535-7163.MCT-14-0155; European Medicines Agency, 2011, ASS REP JEVT; Hendrikx JJMA, 2014, BRIT J CANCER, V110, P2669, DOI 10.1038/bjc.2014.222; Iusuf D, 2015, INT J CANCER, V136, P225, DOI 10.1002/ijc.28970; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Sarantopoulos J, 2014, CANCER CHEMOTH PHARM, V74, P1113, DOI 10.1007/s00280-014-2572-z; Sparreboom A, 1997, P NATL ACAD SCI USA, V94, P2031, DOI 10.1073/pnas.94.5.2031	42	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	OCT	2015	12	10					3714	3723		10.1021/acs.molpharmaceut.5b00470		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CT0CC	WOS:000362460500020		
J	Thakral, NK; Yamada, H; Stephenson, GA; Suryanarayanan, R				Thakral, Naveen K.; Yamada, Hiroyuki; Stephenson, Gregory A.; Suryanarayanan, Raj			Spatial Distribution of Trehalose Dihydrate Crystallization in Tablets by X-ray Diffractometry	MOLECULAR PHARMACEUTICS			English	Article						amorphous; crystallization; X-ray powder diffractometry; tablet; physical characterization	ACTIVE INGREDIENT; DIFFRACTION; WATER; QUANTIFICATION; FORMULATION; DEPTH; PHASE; FILMS; FORM	Crystallization of trehalose dihydrate (C12H22O11 center dot 2H(2)O) was induced by storing tablets of amorphous anhydrous trehalose (C12H22O11) at 65% RH (RT). Our goal was to evaluate the advantages and limitations of two approaches of profiling spatial distribution of drug crystallization in tablets. The extent of crystallization, as a function of depth, was determined in tablets stored for different time-periods. The first approach was glancing angle X-ray diffractometry, where the penetration depth of X-rays was modulated by the incident angle. Based on the mass attenuation coefficient of the matrix, the depth of X-ray penetration was calculated as a function of incident angle, which in turn enabled us to "calculate" the extent of crystallization to different depths. In the second approach, the tablets were split into halves and the split surfaces were analyzed directly. Starting from the tablet surface and moving toward the midplane, XRD patterns were collected in 36 "regions", in increments of 0.05 mm. The results obtained by the two approaches were, in general, in good agreement. Additionally, the results obtained were validated by determining the "average" crystallization in the entire tablet by using synchrotron radiation in the transmission mode. The glancing angle method could detect crystallization up to similar to 650 mu m and had a "surface bias". Being a nondestructive technique, this method will permit repeated analyses of the same tablet at different time points, for example, during a stability study. However, split tablet analyses, while a "destructive" technique, provided comprehensive and unbiased depth profiling information.	[Thakral, Naveen K.; Stephenson, Gregory A.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Thakral, Naveen K.; Suryanarayanan, Raj] Univ Minnesota, Coll Pharm, Dept Pharmaceut, Minneapolis, MN 55455 USA; [Yamada, Hiroyuki] Mitsubishi Tanabe Pharma Co, Yodogawa Ku, Osaka 5328505, Japan	Suryanarayanan, R (reprint author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.	surya001@umn.edu			Lilly Innovation Fellowship Award; William and Mildred Peters Endowment Fund; U.S. Department of Energy, Office of Science, Office of Basic Energy Science [DE-AC02-06CH11357]; NSF through the MRSEC program	N.K.T. was sponsored by the Lilly Innovation Fellowship Award. The authors thank Bob He (Bruker) and Gregory Halder (Argonne National Laboratory) for their help and for the enlightening discussions. The work was partially supported by the William and Mildred Peters Endowment Fund. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Science, under contract No. DE-AC02-06CH11357. Parts of this work were carried out in the Characterization Facility, University of Minnesota, which receives partial support from NSF through the MRSEC program.	Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Nagase H, 2008, J PHYS CHEM B, V112, P9105, DOI 10.1021/jp800936z; Cooper VB, 2003, J PHARM PHARMACOL, V55, P1323, DOI 10.1211/0022357021675; Akao K, 2002, CARBOHYD RES, V337, P1729, DOI 10.1016/S0008-6215(02)00284-7; CHAUDHURI J, 1991, J APPL PHYS, V69, P499, DOI 10.1063/1.347691; Yamada H, 2006, PHARM RES, V23, P2149, DOI 10.1007/s11095-006-9070-x; Surana R, 2004, PHARM RES, V21, P1167, DOI 10.1023/B:PHAM.0000033003.17251.c3; Wu HQ, 2002, SURF COAT TECH, V149, P198, DOI 10.1016/S0257-8972(01)01442-6; SURYANARAYANAN R, 1991, INT J PHARM, V77, P287, DOI 10.1016/0378-5173(91)90329-M; Kawabata Y, 2011, INT J PHARMACEUT, V420, P1, DOI 10.1016/j.ijpharm.2011.08.032; He BBP, 2003, POWDER DIFFR, V18, P71, DOI 10.1154/1.1577355; Thakral NK, 2013, MOL PHARMACEUT, V10, P3128, DOI 10.1021/mp400180n; He BB, 2004, POWDER DIFFR, V19, P110, DOI 10.1154/1.1752948; Koradia V, 2012, PHARM RES-DORDR, V29, P134, DOI 10.1007/s11095-011-0520-8; Cullity B.D., 2001, ELEMENTS XRAY DIFFRA; Hammersley A.P., 1997, ESRF97HA02T; Thakral N. K., 2014, MOL PHARM, V12, P253; Yu L, 2001, ADV DRUG DELIVER REV, V48, P27, DOI 10.1016/S0169-409X(01)00098-9	18	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1543-8384			MOL PHARMACEUT	Mol. Pharm.	OCT	2015	12	10					3766	3775		10.1021/acs.molpharmaceut.5b00567		10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CT0CC	WOS:000362460500025		
J	Lee, NC; Muramatsu, S; Chien, YH; Liu, WS; Wang, WH; Cheng, CH; Hu, MK; Chen, PW; Tzen, KY; Byrne, BJ; Hwu, WL				Lee, Ni-Chung; Muramatsu, Shin-ichi; Chien, Yin-Hsiu; Liu, Wen-Shin; Wang, Wei-Hua; Cheng, Chia-Hao; Hu, Meng-Kai; Chen, Pin-Wen; Tzen, Kai-Yuan; Byrne, Barry J.; Hwu, Wuh-Liang			Benefits of Neuronal Preferential Systemic Gene Therapy for Neurotransmitter Deficiency	MOLECULAR THERAPY			English	Article							ACID DECARBOXYLASE DEFICIENCY; ADENOASSOCIATED VIRAL VECTORS; ELEVATED PLUS-MAZE; CLINICAL-FEATURES; MICE; MODEL; ANTIDEPRESSANTS; TRANSDUCTION; INJECTION; DIAGNOSIS	Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive disease that impairs synthesis of dopamine and serotonin. Children with AADC deficiency exhibit severe motor, behavioral, and autonomic dysfunctions. We previously generated an IVS6+4A>T knock-in mouse model of AADC deficiency (Ddc(KI) mice) and showed that gene therapy at the neonatal stage can rescue this phenotype. In the present study, we extended this treatment to systemic therapy on young mice. After intraperitoneal injection of AADC viral vectors into 7-day-old DdcKI mice, the treated mice exhibited improvements in weight gain, survival, motor function, autonomic function, and behavior. The yfAAV9/3-Syn-I-mAADC-treated mice showed greater neuronal transduction and higher brain dopamine levels than AAV9-CMV-hAADC-treated mice, whereas AAV9-CMV-hAADC-treated mice exhibited hyperactivity. Therefore, neurotransmitter-deficient animals can be rescued at a young age using systemic gene therapy, although a vector for preferential neuronal expression may be necessary to avoid hyperactivity caused by this treatment.	[Lee, Ni-Chung; Chien, Yin-Hsiu; Liu, Wen-Shin; Wang, Wei-Hua; Cheng, Chia-Hao; Hu, Meng-Kai; Chen, Pin-Wen; Hwu, Wuh-Liang] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei 10041, Taiwan; [Lee, Ni-Chung; Chien, Yin-Hsiu; Liu, Wen-Shin; Wang, Wei-Hua; Cheng, Chia-Hao; Hu, Meng-Kai; Chen, Pin-Wen; Tzen, Kai-Yuan; Hwu, Wuh-Liang] Natl Taiwan Univ, Coll Med, Taipei 10041, Taiwan; [Lee, Ni-Chung; Chien, Yin-Hsiu; Hwu, Wuh-Liang] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10041, Taiwan; [Muramatsu, Shin-ichi] Jichi Med Univ, Div Neurol, Dept Med, Shimotsuke, Japan; [Muramatsu, Shin-ichi] Univ Tokyo, Inst Med Sci, Div Genet Therapeut, Tokyo, Japan; [Tzen, Kai-Yuan] Natl Taiwan Univ, Mol Imaging Ctr, Taipei 10041, Taiwan; [Tzen, Kai-Yuan] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei 10041, Taiwan; [Byrne, Barry J.] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL USA	Hwu, WL (reprint author), Natl Taiwan Univ Hosp, Dept Med Genet, Room 19005,19F,Childrens Hosp Bldg, Taipei 10041, Taiwan.	hwuwlntu@ntu.edu.tw					Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Iida A, 2013, BIOMED RES INT, DOI 10.1155/2013/974819; Lee NC, 2014, HUM GENE THER, V25, P189, DOI 10.1089/hum.2013.170; Hascoet M, 2009, NEUROMETHODS, V42, P85, DOI 10.1007/978-1-60761-303-9_6; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7; Walf AA, 2009, NEUROMETHODS, V42, P225, DOI 10.1007/978-1-60761-303-9_12; HYLAND K, 1992, NEUROLOGY, V42, P1980; Gholizadeh S, 2013, HUM GENE THER METHOD, V24, P205, DOI 10.1089/hgtb.2013.076; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Verbeek MM, 2007, MOL GENET METAB, V90, P363, DOI 10.1016/j.ymgme.2006.12.001; Manegold C, 2009, J INHERIT METAB DIS, V32, P371, DOI 10.1007/s10545-009-1076-1; Lipshutz GS, 2003, MOL THER, V8, P90, DOI 10.1016/S1525-0016(03)00132-1; Chen PW, 2014, CLIN CHIM ACTA, V431, P19, DOI 10.1016/j.cca.2014.01.034; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Brun L, 2010, NEUROLOGY, V75, P64, DOI 10.1212/WNL.0b013e3181e620ae; Lee NC, 2013, NEUROBIOL DIS, V52, P177, DOI 10.1016/j.nbd.2012.12.005; Patel BA, 2005, J CHROMATOGR B, V818, P269, DOI 10.1016/j.jchromb.2005.01.008; Wu WL, 2010, GENES BRAIN BEHAV, V9, P603, DOI 10.1111/j.1601-183X.2010.00591.x; Ciesielska A, 2013, MOL THER, V21, P158, DOI 10.1038/mt.2012.167; Arnoux JB, 2013, J CLIN ENDOCR METAB, V98, P4279, DOI 10.1210/jc.2013-2740; HYLAND K, 1990, J INHERIT METAB DIS, V13, P301, DOI 10.1007/BF01799380; Fumoto S, 2013, NOVEL GENE THERAPY A, P3; Hwu WL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003640; Swoboda KJ, 2003, ANN NEUROL, V54, pS49, DOI 10.1002/ana.10631	26	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	OCT	2015	23	10					1572	1581		10.1038/mt.2015.122		10	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CT0SX	WOS:000362508100005		
J	Usui, N; Fujii, Y; Sakamoto, K; Kamachi, M				Usui, Norihisa; Fujii, Yosuke; Sakamoto, Kei; Kamachi, Masafumi			Development of a Four-Dimensional Variational Assimilation System for Coastal Data Assimilation around Japan	MONTHLY WEATHER REVIEW			English	Article						Sea level; Data assimilation; Model evaluation; performance; Ocean models	GENERAL-CIRCULATION MODEL; 4DVAR DATA ASSIMILATION; TROPICAL PACIFIC-OCEAN; SEA-ICE DYNAMICS; PART I; FREE-SURFACE; ROMS; TEMPERATURE; FORMULATION; SALINITY	The authors have developed an assimilation system toward coastal data assimilation around Japan, which consists of a four-dimensional variational (4DVAR) assimilation scheme with an eddy-resolving model in the western North Pacific (MOVE-4DVAR-WNP) and a fine-resolution coastal model covering the western part of the Japanese coastal region around the Seto Inland Sea (MOVE-Seto). The 4DVAR scheme is developed as a natural extension of the 3DVAR scheme used in the Meteorological Research Institute Multivariate Ocean Variational Estimation (MOVE) system. An initialization scheme of incremental analysis update (IAU) is incorporated into MOVE-4DVAR-WNP to filter out high-frequency noises. During the backward integration of the adjoint model, it works as an incremental digital filtering. MOVE-Seto, which is nested within MOVE-4DVAR-WNP, also employs IAU to initialize the interior of the coastal model using MOVE-4DVAR-WNP analysis fields. The authors conducted an assimilation experiment using MOVE-4DVAR-WNP, and results were compared with an additional experiment using the 3DVAR scheme. The comparison reveals that MOVE-4DVAR-WNP improves mesoscale variability. In particular, short-term variability such as small-scale Kuroshio fluctuations is much enhanced. Using MOVE-Seto and MOVE-4DVAR-WNP, the authors also performed a case study focused on an unusual tide event that occurred at the south coast of Japan in September 2011. MOVE-Seto succeeds in reproducing a significant sea level rise associated with this event, indicating the effectiveness of the newly developed system for coastal sea level variability.	[Usui, Norihisa; Fujii, Yosuke; Sakamoto, Kei; Kamachi, Masafumi] Meteorol Res Inst, Oceanog & Geochem Res Dept, Tsukuba, Ibaraki 3050052, Japan	Usui, N (reprint author), Meteorol Res Inst, Oceanog & Geochem Res Dept, Nagamine 1-1, Tsukuba, Ibaraki 3050052, Japan.	nusui@mri-jma.go.jp			Meteorological Research Institute; JSPS KAKENHI [22106006, 26400472]; Research Program on Climate Change Adaptation (RECCA) of MEXT	The authors thank the members of the ocean modeling and assimilation group at the Meteorological Research Institute for fruitful discussions. Comments from anonymous reviewers greatly improved the earlier version of the manuscript. This work was funded by the Meteorological Research Institute, and was partly supported by JSPS KAKENHI Grants 22106006 and 26400472 and by Research Program on Climate Change Adaptation (RECCA) of MEXT.	Noh Y, 1999, J GEOPHYS RES-OCEANS, V104, P15621, DOI 10.1029/1999JC900068; Bloom SC, 1996, MON WEATHER REV, V124, P1256, DOI 10.1175/1520-0493(1996)124<1256:DAUIAU>2.0.CO;2; MELLOR GL, 1989, J GEOPHYS RES-OCEANS, V94, P10937, DOI 10.1029/JC094iC08p10937; Fujii Y, 2003, J OCEANOGR, V59, P173, DOI 10.1023/A:1025539104750; Griffies SM, 2000, MON WEATHER REV, V128, P2935, DOI 10.1175/1520-0493(2000)128<2935:BFWASL>2.0.CO;2; Zhang WFG, 2010, OCEAN MODEL, V35, P119, DOI 10.1016/j.ocemod.2010.08.003; KILLWORTH PD, 1991, J PHYS OCEANOGR, V21, P1333, DOI 10.1175/1520-0485(1991)021<1333:TDOAFS>2.0.CO;2; COURTIER P, 1994, Q J ROY METEOR SOC, V120, P1367, DOI 10.1002/qj.49712051912; Weaver AT, 2003, MON WEATHER REV, V131, P1360, DOI 10.1175/1520-0493(2003)131<1360:TAFVAW>2.0.CO;2; Moore AM, 2011, PROG OCEANOGR, V91, P34, DOI 10.1016/j.pocean.2011.05.004; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Talagrand O, 1997, J METEOROL SOC JPN, V75, P191; Powell BS, 2008, OCEAN MODEL, V23, P130, DOI 10.1016/j.ocemod.2008.04.008; Polavarapu S, 2004, MON WEATHER REV, V132, P2495, DOI 10.1175/1520-0493(2004)132<2495:OTRBIA>2.0.CO;2; Hurlburt HE, 2009, OCEANOGRAPHY, V22, P110; Kuragano T, 2000, J GEOPHYS RES-OCEANS, V105, P955, DOI 10.1029/1999JC900247; GHIL M, 1991, ADV GEOPHYS, V33, P141, DOI 10.1016/S0065-2687(08)60442-2; Fujii Y, 2005, J OCEANOGR, V61, P655, DOI 10.1007/s10872-005-0073-8; Ishikawa Y, 2009, J MARINE SYST, V78, P237, DOI 10.1016/j.jmarsys.2009.02.016; Fujii Y, 2005, J OCEANOGR, V61, P167, DOI 10.1007/s10872-005-0029-z; Usui N, 2006, ADV SPACE RES, V37, P806, DOI 10.1016/j.asr.2005.09.022; Kurapov AL, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006909; Kuragano T, 2014, J OCEANOGR, V70, P45, DOI 10.1007/s10872-013-0211-7; Cummings J, 2009, OCEANOGRAPHY, V22, P96; Dombrowsky E, 2009, OCEANOGRAPHY, V22, P80; Hunke EC, 1997, J PHYS OCEANOGR, V27, P1849, DOI 10.1175/1520-0485(1997)027<1849:AEVPMF>2.0.CO;2; Fujii Y, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004476; Fukumori I, 2002, MON WEATHER REV, V130, P1370, DOI 10.1175/1520-0493(2002)130<1370:APKFAS>2.0.CO;2; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Vialard J, 2003, MON WEATHER REV, V131, P1379, DOI 10.1175/1520-0493(2003)131<1379:TAFVAW>2.0.CO;2; Zhu J, 2000, TELLUS A, V52, P265, DOI 10.1034/j.1600-0870.2000.d01-3.x; Fujii Y, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001745; Broquet G, 2009, DYNAM ATMOS OCEANS, V48, P69, DOI 10.1016/j.dynatmoce.2009.03.001; THOMPSON RORY, 1983, J PHYS OCEANOGR, V13, P1077, DOI 10.1175/1520-0485(1983)013<1077:LPFTSI>2.0.CO;2; Tsujino H, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003118; Fujii Y, 2013, J GEOPHYS RES-OCEANS, V118, P2035, DOI 10.1002/jgrc.20094; Chua BS, 2001, OCEAN MODEL, V3, P137, DOI 10.1016/S1463-5003(01)00006-3; Hunke EC, 2002, MON WEATHER REV, V130, P1848, DOI 10.1175/1520-0493(2002)130<1848:TEVPSI>2.0.CO;2; Bennett A F, 2002, INVERSE MODELING OCE; Bennett A. F., 1992, INVERSE METHODS PHYS; CLS, 2004, CLSDOSNT04103; Conkright M., 2002, INTRODUCTION, V1; Evensen G., 2007, DATA ASSIMILATION EN; Hamilton D., 1994, EARTH SYST MONIT, V4, P4; Hanawa K., 1985, B COAST OCEANOGR, V23, P4; Kawabe M., 1980, J OCEANOGR SOC JAPAN, V36, P97, DOI [10.1007/BF02312095, DOI 10.1007/BF02070336]; Kondo J., 1975, Boundary-Layer Meteorology, V9; Kourafalou V., 2015, J OPER OCEANOGR, V8, ps127, DOI [10.1080/1755876X.2015.1022336, DOI 10.1080/1755876X.2015.1022336]; Kurihara Y., 2000, WEATHER B, V73, pS1; Lewis J. M., 2006, DYNAMIC DATA ASSIMIL; Madec G, 1998, NOTE POLE MODELISATI, V11, P91; PRATHER MJ, 1986, J GEOPHYS RES-ATMOS, V91, P6671, DOI 10.1029/JD091iD06p06671; Senjyu T, 1999, J OCEANOGR, V55, P619, DOI DOI 10.1023/A:1007844903204; Tsujino H., 2010, 59 MET RES I, P241; Ueno H, 2000, J GEOPHYS RES-OCEANS, V105, P16885, DOI 10.1029/2000JC900020; Usui N, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007009; Weatherly G. L., 1972, Journal of Physical Oceanography, V2; Wunsch C., 1996, OCEAN CIRCULATION IN	58	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	OCT	2015	143	10					3874	3892		10.1175/MWR-D-14-00326.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CS6VK	WOS:000362220800002		
J	Hirata, H; Kawamura, R; Kato, M; Shinoda, T				Hirata, Hidetaka; Kawamura, Ryuichi; Kato, Masaya; Shinoda, Taro			Influential Role of Moisture Supply from the Kuroshio/Kuroshio Extension in the Rapid Development of an Extratropical Cyclone	MONTHLY WEATHER REVIEW			English	Article						Atmosphere-ocean interaction; Extratropical cyclones; Boundary currents; Latent heating; cooling; Surface fluxes; Cloud resolving models	POTENTIAL-VORTICITY DIAGNOSIS; WARM CONVEYOR BELTS; NORTHWESTERN PACIFIC REGION; SEA-SURFACE TEMPERATURE; ERICA IOP-5 STORM; MARINE CYCLONE; EXPLOSIVE CYCLONES; FRONTAL-CYCLONE; MESOSCALE MODEL; NORTH-ATLANTIC	This study focused on an explosive cyclone migrating along the southern periphery of the Kuroshio/Kuroshio Extension in the middle of January 2013 and examined how those warm currents played an active role in the rapid development of the cyclone using a high-resolution coupled atmosphere-ocean regional model. The evolutions of surface fronts of the simulated cyclone resemble the Shapiro-Keyser model. At the time of the maximum deepening rate, strong mesoscale diabatic heating areas appear over the bent-back front and the warm front east of the cyclone center. Diabatic heating over the bent-back front and the eastern warm front is mainly induced by the condensation of moisture imported by the cold conveyor belt (CCB) and the warm conveyor belt (WCB), respectively. The dry air parcels transported by the CCB can receive large amounts of moisture from the warm currents, whereas the very humid air parcels transported by the WCB can hardly be modified by those currents. The well-organized nature of the CCB plays a key role not only in enhancing surface evaporation from the warm currents but also in importing the evaporated vapor into the bent-back front. The imported vapor converges at the bent-back front, leading to latent heat release. The latent heating facilitates the cyclone's development through the production of positive potential vorticity in the lower troposphere. Its deepening can, in turn, reinforce the CCB. In the presence of a favorable synoptic-scale environment, such a positive feedback process can lead to the rapid intensification of a cyclone over warm currents.	[Hirata, Hidetaka; Kawamura, Ryuichi] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan; [Kato, Masaya; Shinoda, Taro] Nagoya Univ, Hydrospher Atmospher Res Ctr, Nagoya, Aichi 4648601, Japan	Hirata, H (reprint author), Kyushu Univ, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	h.hirata17@gmail.com			JSPS KAKENHI [14J04241, 25242038]; MEXT KAKENHI [22106005]	We wish to thank Kazuhisa Tsuboki, Hidenori Aiki, and Mayumi Yoshioka for their kind support and for the use of a coupled atmosphere-ocean regional model, CReSS-NHOES. We would also like to thank Tetsuya Kawano, Satoshi Iizuka, and Eigo Tochimoto for their many helpful suggestions and Chris Davis for his kindness and for the use of the original PV inversion program. Comments by the editor and two anonymous reviewers were extremely helpful. This work was supported by JSPS KAKENHI Grants 14J04241 and 25242038 and MEXT KAKENHI Grant 22106005.	Aiki H., 2015, B COASTAL OCEANOGR, V52, P139; CARLSON TN, 1980, MON WEATHER REV, V108, P1498, DOI 10.1175/1520-0493(1980)108<1498:ATMCAT>2.0.CO;2; Schemm S, 2014, J ATMOS SCI, V71, P1443, DOI 10.1175/JAS-D-13-0177.1; Schemm S, 2013, J ATMOS SCI, V70, P627, DOI 10.1175/JAS-D-12-0147.1; Takayabu I, 1996, METEOROL ATMOS PHYS, V61, P39, DOI 10.1007/BF01029710; Wang CC, 2001, MON WEATHER REV, V129, P1481, DOI 10.1175/1520-0493(2001)129<1481:ACSOEC>2.0.CO;2; Aiki H, 2006, CONT SHELF RES, V26, P1448, DOI 10.1016/j.csr.2006.02.017; CHEN SJ, 1992, MON WEATHER REV, V120, P3029, DOI 10.1175/1520-0493(1992)120<3029:COECOT>2.0.CO;2; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; Aiki H, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006589; Korner SO, 2000, MON WEATHER REV, V128, P1266, DOI 10.1175/1520-0493(2000)128<1266:PFFAPV>2.0.CO;2; TAKAYABU I, 1991, J METEOROL SOC JPN, V69, P609; REED RJ, 1992, MON WEATHER REV, V120, P893, DOI 10.1175/1520-0493(1992)120<0893:AMASOT>2.0.CO;2; GYAKUM JR, 1989, MON WEATHER REV, V117, P1141, DOI 10.1175/1520-0493(1989)117<1141:NPCSSC>2.0.CO;2; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; REED RJ, 1994, MON WEATHER REV, V122, P2688, DOI 10.1175/1520-0493(1994)122<2688:AASOTE>2.0.CO;2; Pfahl S, 2014, J CLIMATE, V27, P27, DOI 10.1175/JCLI-D-13-00223.1; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Kuo YH, 1996, MON WEATHER REV, V124, P1409, DOI 10.1175/1520-0493(1996)124<1409:TEISPI>2.0.CO;2; Donelan MA, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007787; BROWNING KA, 1994, Q J ROY METEOR SOC, V120, P1535, DOI 10.1002/qj.49712052006; KUO YH, 1991, MON WEATHER REV, V119, P368, DOI 10.1175/1520-0493(1991)119<0368:TIBBAD>2.0.CO;2; DAVIS CA, 1991, MON WEATHER REV, V119, P1929, DOI 10.1175/1520-0493(1991)119<1929:PVDOC>2.0.CO;2; Wu LT, 2011, TELLUS A, V63, P198, DOI 10.1111/j.1600-0870.2011.00511.x; Martin JE, 2002, MON WEATHER REV, V130, P1264, DOI 10.1175/1520-0493(2002)130<1264:SCITNP>2.0.CO;2; REED RJ, 1993, MON WEATHER REV, V121, P1595, DOI 10.1175/1520-0493(1993)121<1595:TEISPI>2.0.CO;2; Ahmadi-Givi F, 2004, Q J ROY METEOR SOC, V130, P295, DOI 10.1256/qj.02.226; Zhang WQ, 2006, MON WEATHER REV, V134, P2418, DOI 10.1175/MWR3191.1; Miyazawa Y, 2009, J OCEANOGR, V65, P737; Kelly KA, 2010, J CLIMATE, V23, P5644, DOI 10.1175/2010JCLI3346.1; Madonna E, 2014, J CLIMATE, V27, P3, DOI 10.1175/JCLI-D-12-00720.1; Hart RE, 2003, MON WEATHER REV, V131, P585, DOI 10.1175/1520-0493(2003)131<0585:ACPSDF>2.0.CO;2; Kuwano-Yoshida A, 2013, MON WEATHER REV, V141, P3769, DOI 10.1175/MWR-D-12-00161.1; Yoshiike S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011820; DOYLE JD, 1995, TELLUS A, V47, P766, DOI 10.1034/j.1600-0870.1995.00119.x; KUO YH, 1991, MON WEATHER REV, V119, P457, DOI 10.1175/1520-0493(1991)119<0457:EOSEFD>2.0.CO;2; DAVIS CA, 1993, MON WEATHER REV, V121, P2309, DOI 10.1175/1520-0493(1993)121<2309:TIEOCI>2.0.CO;2; Fu SM, 2014, TELLUS A, V66, DOI 10.3402/tellusa.v66.23210; NUSS WA, 1990, MON WEATHER REV, V118, P755, DOI 10.1175/1520-0493(1990)118<0755:DABLPI>2.0.CO;2; Booth JF, 2012, MON WEATHER REV, V140, P1241, DOI 10.1175/MWR-D-11-00195.1; SANDERS F, 1980, MON WEATHER REV, V108, P1589, DOI 10.1175/1520-0493(1980)108<1589:SDCOT>2.0.CO;2; Yoshida A, 2004, MON WEATHER REV, V132, P1121, DOI 10.1175/1520-0493(2004)132<1121:SAEOED>2.0.CO;2; NEIMAN PJ, 1993, MON WEATHER REV, V121, P2177, DOI 10.1175/1520-0493(1993)121<2177:TLCOAE>2.0.CO;2; Kuwano-Yoshida A, 2008, MON WEATHER REV, V136, P712, DOI 10.1175/2007MWR2111.1; NEIMAN PJ, 1993, MON WEATHER REV, V121, P2153, DOI 10.1175/1520-0493(1993)121<2153:TLCOAE>2.0.CO;2; Liu CH, 1997, MON WEATHER REV, V125, P341, DOI 10.1175/1520-0493(1997)125<0341:OOMCWE>2.0.CO;2; Iizuka S, 2013, SOLA, V9, P1, DOI 10.2151/sola.2013-001; Schultz DM, 2001, MON WEATHER REV, V129, P2205, DOI 10.1175/1520-0493(2001)129<2205:RTCCB>2.0.CO;2; Furuichi N, 2012, J OCEANOGR, V68, P285, DOI 10.1007/s10872-011-0095-3; Davis CA, 1996, MON WEATHER REV, V124, P3, DOI 10.1175/1520-0493(1996)124<0003:TBDNOA>2.0.CO;2; REED RJ, 1993, MON WEATHER REV, V121, P1577, DOI 10.1175/1520-0493(1993)121<1577:TEISPI>2.0.CO;2; HOSKINS BJ, 1985, Q J ROY METEOR SOC, V111, P877, DOI 10.1256/smsqj.47001; Kwon YO, 2010, J CLIMATE, V23, P3249, DOI 10.1175/2010JCLI3343.1; Powers JG, 2000, MON WEATHER REV, V128, P208, DOI 10.1175/1520-0493(2000)128<0208:ACASMM>2.0.CO;2; DAVIS CA, 1992, MON WEATHER REV, V120, P2409, DOI 10.1175/1520-0493(1992)120<2409:APVDOT>2.0.CO;2; Japan Meteorological Agency, 2013, OUTLINE OF THE OPERA; ROEBBER PJ, 1984, MON WEATHER REV, V112, P1577, DOI 10.1175/1520-0493(1984)112<1577:SAAUCO>2.0.CO;2; Shapiro M. A., 1999, THE LIFE CYCLES OF E, P139; SHAPIRO MA, 1990, EXTRATROPICAL CYCLONES, P167; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Tsuboki K., 2002, High Performance Computing. 4th International Symposium, ISHPC 2002. Proceedings (Lecture Notes in Computer Science Vol.2327), DOI 10.1007/3-540-47847-7_21; Tsuboki K., 2007, NUMERICAL PREDICTION	62	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	OCT	2015	143	10					4126	4144		10.1175/MWR-D-15-0016.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CS6VK	WOS:000362220800016		
J	Cmokova, A; Kolarik, M; Vetrovsky, T; Dobiasova, S; Dobias, R; Stubbe, D; Skorepova, M; Lyskova, P; Hoyer, L; Mallatova, N; Kano, R; Nenoff, P; Uhrlass, S; Peano, A; Koubkova, J; Mencl, K; Janouskovcova, H; Hubka, V				Cmokova, A.; Kolarik, M.; Vetrovsky, T.; Dobiasova, S.; Dobias, R.; Stubbe, D.; Skorepova, M.; Lyskova, P.; Hoyer, L.; Mallatova, N.; Kano, R.; Nenoff, P.; Uhrlass, S.; Peano, A.; Koubkova, J.; Mencl, K.; Janouskovcova, H.; Hubka, V.			Molecular typization of Arthroderma benhamiae, a zoonotic agent of epidemic dermatophytosis in Central Europe	MYCOSES			English	Meeting Abstract									[Cmokova, A.; Hubka, V.] Charles Univ Prague, Prague, Czech Republic; [Kolarik, M.] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Vetrovsky, T.] AS CR, Inst Microbiol, Prague, Czech Republic; [Dobiasova, S.] Inst Publ Hlth, Ostrava, Czech Republic; [Dobias, R.] Inst Hlth Ostrava, Ostrava, Czech Republic; [Stubbe, D.] Sci Inst Publ Hlth, Brussels, Belgium; [Skorepova, M.] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Lyskova, P.] Inst Hlth Usti Labem, Prague, Czech Republic; [Hoyer, L.] Univ Illinois, Coll Vet Med, Prague, Czech Republic; [Mallatova, N.] Hosp Ceske Budejovice, Ceske Budejovice, Czech Republic; [Kano, R.] Nihon Univ, Sch Vet Med, Fujisawa, Kanagawa, Japan; [Nenoff, P.; Uhrlass, S.] Lab Med Microbiol, Molbis, Germany; [Peano, A.] Univ Turin, Fac Med Vet, Turin, Italy; [Koubkova, J.] Clin Vet Lab Labvet, Prague, Czech Republic; [Mencl, K.; Janouskovcova, H.] Pardubice Reg Hosp Inc, Pardubice, Czech Republic								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0933-7407	1439-0507		MYCOSES	Mycoses	OCT	2015	58			4	SI	P206	124	124				1	Dermatology; Mycology	Dermatology; Mycology	CT4SF	WOS:000362796800271		
J	Passos, AIM; Dertkigil, RP; Busso, A; Ribeiro, EO; Trabasso, P; Matsuzawa, T; Mikami, Y; Toro, IC; Schreiber, AZ; Kamei, K; Moretti, ML				Passos, A. I. M.; Dertkigil, R. P.; Busso, A.; Ribeiro, E. O.; Trabasso, P.; Matsuzawa, T.; Mikami, Y.; Toro, I. C.; Schreiber, A. Z.; Kamei, K.; Moretti, M. L.			Investigation of pulmonary fungal infections leading to hospitalization in HIV-infected adult patients	MYCOSES			English	Meeting Abstract									[Passos, A. I. M.; Dertkigil, R. P.; Busso, A.; Ribeiro, E. O.; Trabasso, P.; Toro, I. C.; Schreiber, A. Z.; Moretti, M. L.] Univ Estadual Campinas, Sao Paulo, Brazil; [Matsuzawa, T.; Mikami, Y.; Kamei, K.] Chiba Univ, Chiba, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0933-7407	1439-0507		MYCOSES	Mycoses	OCT	2015	58			4	SI	P313	167	167				1	Dermatology; Mycology	Dermatology; Mycology	CT4SF	WOS:000362796800363		
J	Mira, NP; Bernardo, R; Cunha, D; Wang, CAN; JChibana, HIRO; Silva, S; Sa-Correia, I; Azeredo, J; Butler, G				Mira, N. P.; Bernardo, R.; Cunha, D.; Wang, C. A. N.; JChibana, H. I. R. O.; Silva, S.; Sa-Correia, I.; Azeredo, J.; Butler, G.			Genetic adaptive mechanisms mediating response and tolerance to acetic acid stress in the human pathogen Candida glabrata: role of the CgHaa1-dependent signaling pathway	MYCOSES			English	Meeting Abstract									[Mira, N. P.; Bernardo, R.; Cunha, D.; Sa-Correia, I.] Inst Bioengn & Biosci, Lisbon, Portugal; [Wang, C. A. N.; Butler, G.] Conway Inst, Sch Biomol & Biomed Sci, Dublin, Ireland; [JChibana, H. I. R. O.] Med Mycol Res Ctr, Chiba, Japan; [Silva, S.] Ctr Biol Engn, CEB, Braga, Portugal; [Azeredo, J.] Univ Minho, Braga, Portugal			Sa-Correia, Isabel/H-4054-2011	Sa-Correia, Isabel/0000-0003-2208-5183				0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0933-7407	1439-0507		MYCOSES	Mycoses	OCT	2015	58			4	SI	P381	188	189				2	Dermatology; Mycology	Dermatology; Mycology	CT4SF	WOS:000362796800413		
J	Hubka, V; Dudova, Z; Yaguchi, T; Horie, Y; Matsuzawa, T; Novakova, A; Svobodova, L; Hamal, P; Kolarik, M				Hubka, V.; Dudova, Z.; Yaguchi, T.; Horie, Y.; Matsuzawa, T.; Novakova, A.; Svobodova, L.; Hamal, P.; Kolarik, M.			Insight into the intricate taxonomy of Aspergillus viridinutans complex (section Fumigati) comprising opportunistic human and animal pathogens	MYCOSES			English	Meeting Abstract									[Hubka, V.; Dudova, Z.] Charles Univ Prague, Prague, Czech Republic; [Yaguchi, T.; Matsuzawa, T.] Chiba Univ, Chiba, Japan; [Horie, Y.] Nat Hist Museum & Inst, Chiba, Japan; [Novakova, A.; Kolarik, M.] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Svobodova, L.] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Hamal, P.] Palacky Univ, Fac Med & Dent, CR-77147 Olomouc, Czech Republic								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0933-7407	1439-0507		MYCOSES	Mycoses	OCT	2015	58			4	SI	P491	225	226				2	Dermatology; Mycology	Dermatology; Mycology	CT4SF	WOS:000362796800497		
J	El-Safty, SA; Khairy, M; Shenashen, MA; Elshehy, E; Warkocki, W; Sakai, M				El-Safty, Sherif A.; Khairy, Mohamed; Shenashen, Mohamed A.; Elshehy, Emad; Warkocki, Wojciech; Sakai, Masaru			Optical mesoscopic membrane sensor layouts for water-free and blood-free toxicants	NANO RESEARCH			English	Article						health risks; optical sensor; mesoscopic nanotubes; toxins; blood	METAL-IONS; II IONS; LEAD; CHEMOSENSORS; ADSORBENTS; REMOVAL; CADMIUM; ALUMINA; MESOSTRUCTURES; NANOPARTICLES	Advances in fabrication of mesoscopic membrane sensors with unique structures and morphologies inside anodic alumina membrane (AAM) nanochannels have led to the development of various methods for detecting, visualizing, adsorbing, filtering, and recovering ultra-trace concentrations of toxic metal ions, such as Hg2+ and Pb2+, in water and blood. These often "one-pot" screening methods offer advantages over conventional methods in that they do not require sophisticated instruments or laborious sample preparation. In the present study, we fabricated two mesoscopic membrane sensors for naked-eye detection, recognition, filtration, and recovery of Hg2+ and Pb2+ in biological and environmental samples. These sensors were characterized by the dense immobilization of organic colorants on the mesopore surfaces of silica nanotubes that were constructed using the nanochannels of an AAM as a scaffold. We confirmed that the nanotubes were oriented along the long axis of the AAM nanochannels, open at both ends, and completely and uniformly filled with organic colorants; also, the dense immobilization of the organic colorants did not affect the speed of ion-to-ligand binding events. We used simple, desk-top, flow-through assays to assess the suitability of the developed membrane sensors for detection, removal, and filtration of Hg2+ and Pb2+ with respect to recyclability and continuous monitoring. Removal of the target ions from biological fluids was assessed by means of flow cytometric analysis. Our results demonstrate the potential of our membrane sensors to be used for preventing the health risks associated with exposure to toxic metal ions in the environment and blood.	[El-Safty, Sherif A.; Khairy, Mohamed; Shenashen, Mohamed A.; Elshehy, Emad; Warkocki, Wojciech] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [El-Safty, Sherif A.] Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Sakai, Masaru] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki 3058572, Japan	El-Safty, SA (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.	sherif.elsafty@nims.go.jp	Khairy, Mohamed /O-2431-2015				Afal A., 2014, METAL TOXICITY; Platschek B, 2006, ANGEW CHEM INT EDIT, V45, P1134, DOI 10.1002/anie.200503301; Meoto S, 2014, J MATER CHEM A, V2, P5640, DOI 10.1039/c3ta15330d; Jung JH, 2011, CHEM SOC REV, V40, P4464, DOI 10.1039/c1cs15051k; Shenashen MA, 2014, ANALYST, V139, P6393, DOI [10.1039/c4an00980k, 10.1039/C4AN00980K]; Pikus S, 2007, APPL SURF SCI, V253, P5682, DOI 10.1016/j.apsusc.2006.12.043; Shenashen MA, 2013, SEP PURIF TECHNOL, V116, P73, DOI 10.1016/j.seppur.2013.05.011; Das SK, 2013, CHEMCATCHEM, V5, P3050, DOI 10.1002/cctc.201300192; El-Safty SA, 2008, ADV FUNCT MATER, V18, P1485, DOI 10.1002/adfm.200701059; Duan JL, 2009, NANO RES, V2, P61, DOI 10.1007/s12274-009-9004-0; El-Safty SA, 2013, ADV HEALTHC MATER, V2, P854, DOI 10.1002/adhm.201200326; Lee HY, 2009, ANGEW CHEM INT EDIT, V48, P1239, DOI 10.1002/anie.200804714; Ros-Lis JV, 2008, CHEM-EUR J, V14, P8267, DOI 10.1002/chem.200800632; Locatelli C, 2005, ANAL BIOANAL CHEM, V382, P1567, DOI 10.1007/s00216-005-3356-4; El-Safty SA, 2011, SMALL, V7, P62, DOI 10.1002/smll.201001303; Balaji T, 2006, ANGEW CHEM INT EDIT, V45, P7202, DOI 10.1002/anie.200602453; El-Safty S, 2011, J MATER CHEM, V21, P5593, DOI 10.1039/c0jm03269g; El-Safty SA, 2008, CHEM MATER, V20, P2644, DOI 10.1021/cm701966c; Townsend AT, 1998, J ANAL ATOM SPECTROM, V13, P1213, DOI 10.1039/a805021j; El-Safty SA, 2013, ENVIRON SCI POLLUT R, V20, P3863, DOI 10.1007/s11356-012-1309-y; El-Safty SA, 2012, CHEM COMMUN, V48, P6708, DOI 10.1039/c2cc30725a; El-Safty SA, 2008, J PHYS CHEM C, V112, P4825, DOI 10.1021/jp0764283; Hoa ND, 2011, CHEM-EUR J, V17, P12896, DOI 10.1002/chem.201101122; Khairy M, 2014, CHEM COMMUN, V50, P1356, DOI 10.1039/c3cc48155g; El-Safty S, 2011, ANAL CHIM ACTA, V694, P151, DOI 10.1016/j.aca.2011.03.035; El-Safty SA, 2012, ADV FUNCT MATER, V22, P3013, DOI 10.1002/adfm.201200393; MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Khairy M, 2013, NANOSCALE, V5, P7920, DOI 10.1039/c3nr02403b; El-Safty SA, 2008, ADV FUNCT MATER, V18, P1739, DOI 10.1002/adfm.200800035; Forde MS, 2014, ENVIRON SCI-PROC IMP, V16, P2184, DOI [10.1039/c4em00239c, 10.1039/C4EM00239C]; El-Safty SA, 2013, SMALL, V9, P2288, DOI 10.1002/smll.201202407; Li F, 2010, CHEM MATER, V22, P3790, DOI 10.1021/cm100932j; El-Safty SA, 2013, SENSOR ACTUAT B-CHEM, V183, P58, DOI 10.1016/j.snb.2013.03.041; Aragay G, 2011, CHEM REV, V111, P3433, DOI 10.1021/cr100383r; Kang DY, 2010, ACS NANO, V4, P4897, DOI 10.1021/nn101211y; Shenashen MA, 2013, J HAZARD MATER, V260, P833, DOI 10.1016/j.jhazmat.2013.06.025; El-Safty SA, 2012, CHEM COMMUN, V48, P9652, DOI 10.1039/c2cc34788a; Banfalvi G., 2011, CELLULAR EFFECTS HEA, P3, DOI 10.1007/978-94-007-0428-2_1; Barbosa J F, 2005, ENV HLTH PERSPECT, V113, P1669; Blannn A., 2014, BLOOD SCI PRINCIPLES; Dufault R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-2; El-Safty A. S., 2012, TRAC-TREND ANAL CHEM, V38, P98; El-Safty A. S., 2010, CHEM COMMUN, V46, P3917; El-Safty SA, 2011, TRAC-TREND ANAL CHEM, V30, P447, DOI 10.1016/j.trac.2011.01.004; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Jiang S, 2015, NANO RES, V8, P257, DOI 10.1007/s12274-014-0658-x; Kebbekus BB., 2003, SAMPLE PREPARATION T, P227; Khairy M, 2014, TRAC-TREND ANAL CHEM, V62, P56, DOI 10.1016/j.trac.2014.06.013; Lee SJ, 2008, EUR J INORG CHEM, P1559, DOI 10.1002/ejic.200701073; Nielen MWF, 2008, COMP ANAL C, V51, P1, DOI 10.1016/S0166-526X(08)00001-9; Ruprich J., 2013, TOTAL DIET STUDIES, P513; Shenashen MA, 2015, EUR J INORG CHEM, P179, DOI 10.1002/ejic.201402756; World Health Organization, STOP LEAD POIS CHILD	54	1	1	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	OCT	2015	8	10					3150	3163		10.1007/s12274-015-0815-x		14	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT1US	WOS:000362588100004		
J	Kobayashi, Y; Mori, S; Maniwa, Y; Miyata, Y				Kobayashi, Yu; Mori, Shohei; Maniwa, Yutaka; Miyata, Yasumitsu			Bandgap-tunable lateral and vertical heterostructures based on monolayer Mo1-x W (x) S-2 alloys	NANO RESEARCH			English	Article						transition metal dichalcogenide; Mo1-xWxS2; alloy; heterostructure; thin-film sulfurization; photoluminescence; stability	HEXAGONAL BORON-NITRIDE; CHEMICAL-VAPOR-DEPOSITION; INPLANE HETEROSTRUCTURES; GRAPHENE; PHOTOLUMINESCENCE; GROWTH; ELECTRONICS; WS2; HETEROJUNCTIONS; SEMICONDUCTORS	The fabrication of heterostructures of two-dimensional semiconductors with specific bandgaps is an important approach to realizing the full potential of these materials in electronic and optoelectronic devices. Several groups have recently reported the direct growth of lateral and vertical heterostructures based on monolayers of typical semiconducting transition metal dichalcogenides (TMDCs) such as WSe2, MoSe2, WS2, and MoS2. Here, we demonstrate the single-step direct growth of lateral and vertical heterostructures based on bandgap-tunable Mo1-x W (x) S-2 alloy monolayers by the sulfurization of patterned thin films of WO3 and MoO3. These patterned films are capable of generating a wide variety of concentration gradients by the diffusion of transition metals during the crystal growth phase. Under high temperatures, this leads to the formation of monolayer crystals of Mo1-x W (x) S-2 alloys with various compositions and bandgaps, depending on the positions of the crystals on the substrates. Heterostructures of these alloys are obtained through stepwise changes in the ratio of W/Mo within a single domain during low-temperature growth. The stabilization of the monolayer Mo1-x W (x) S-2 alloys, which often degrade even under gentle conditions, was accomplished by coating the alloys with other monolayers. The present findings demonstrate an efficient means of both studying and optimizing the optical and electrical properties of TMDC-based heterostructures to allow use of the materials in future device applications.	[Kobayashi, Yu; Mori, Shohei; Maniwa, Yutaka; Miyata, Yasumitsu] Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan; [Miyata, Yasumitsu] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Miyata, Y (reprint author), Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan.	ymiyata@tmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [15H05412, 26107530]; Izumi Science and Technology Foundation	This work was supported by a Grant-in-Aid for Young Scientist (A) (No. 15H05412) and for Scientific Research on Innovative Areas (No. 26107530) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by the Izumi Science and Technology Foundation.	Han GH, 2013, ACS NANO, V7, P10129, DOI 10.1021/nn404331f; Gao YB, 2013, NANO LETT, V13, P3439, DOI 10.1021/nl4021123; Ren YJ, 2012, NANO, V7, DOI 10.1142/S1793292011500019; Zhao WJ, 2013, ACS NANO, V7, P791, DOI 10.1021/nn305275h; Havener RW, 2013, NANO LETT, V13, P3942, DOI 10.1021/nl402062j; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/nnano.2012.224, 10.1038/NNANO.2012.224]; Levendorf MP, 2012, NATURE, V488, P627, DOI 10.1038/nature11408; Gong YJ, 2014, NANO LETT, V14, P442, DOI 10.1021/nl4032296; Sutter P, 2012, NANO LETT, V12, P4869, DOI 10.1021/nl302398m; Liu L, 2014, SCIENCE, V343, P163, DOI 10.1126/science.1246137; Zhou HQ, 2013, NANO RES, V6, P703, DOI 10.1007/s12274-013-0346-2; Liu Z, 2013, NAT NANOTECHNOL, V8, P119, DOI [10.1038/nnano.2012.256, 10.1038/NNANO.2012.256]; Yu YF, 2015, NANO LETT, V15, P486, DOI 10.1021/nl5038177; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/nmat4091, 10.1038/NMAT4091]; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Dean C, 2012, SOLID STATE COMMUN, V152, P1275, DOI 10.1016/j.ssc.2012.04.021; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Roy K, 2013, NAT NANOTECHNOL, V8, P826, DOI [10.1038/nnano.2013.206, 10.1038/NNANO.2013.206]; Chen YF, 2013, ACS NANO, V7, P4610, DOI 10.1021/nn401420h; Orofeo CM, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893978; Bissett MA, 2013, ACS NANO, V7, P10335, DOI 10.1021/nn404746h; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/nmat3010, 10.1038/NMAT3010]; Zhang XQ, 2015, NANO LETT, V15, P410, DOI 10.1021/nl503744f; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/nchem.1589, 10.1038/NCHEM.1589]; Lee GH, 2013, ACS NANO, V7, P7931, DOI 10.1021/nn402954e; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Kobayashi Y, 2015, ACS NANO, V9, P4056, DOI 10.1021/acsnano.5b00103; Huang CM, 2014, NAT MATER, V13, P1096, DOI [10.1038/nmat4064, 10.1038/NMAT4064]; Chen Y. F., 2013, NANOSCALE, V6, P2833; Duan XD, 2014, NAT NANOTECHNOL, V9, P1024, DOI [10.1038/nnano.2014.222, 10.1038/NNANO.2014.222]; Gorbachev RV, 2014, SCIENCE, V346, P448, DOI 10.1126/science.1254966; Gutierrez HR, 2013, NANO LETT, V13, P3447, DOI 10.1021/nl3026357; Miyata Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.085102; Tongay S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02657	38	2	2	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	OCT	2015	8	10					3261	3271		10.1007/s12274-015-0826-7		11	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT1US	WOS:000362588100014		
J	Noh, SH; Han, B; Ohsaka, T				Noh, Seung Hyo; Han, Byungchan; Ohsaka, Takeo			First-principles computational study of highly stable and active ternary PtCuNi nanocatalyst for oxygen reduction reaction	NANO RESEARCH			English	Article						density functional theory; ternary alloy; nanoparticle; durability; stability; alloy	SURFACE-COMPOSITION; HYDROGEN EVOLUTION; ENHANCED ACTIVITY; 1ST PRINCIPLES; PT-ALLOY; ELECTROCATALYSTS; NANOPARTICLES; CATALYSTS; STABILITY; FE	Using density functional theory (DFT) calculations, we rationally designed metallic nanocatalysts with ternary transition metals for oxygen reduction reactions (ORRs) in fuel cell applications. We surrounded binary core-shell nanoparticles with a Pt skin layer. To overcome surface segregation of the core 3-d transition metal, we identified the binary alloy Cu0.76Ni0.24 as having strongly attractive atomic interactions by computationally screening 158 different alloy configurations using energy convex hull theory. The PtskinCu0.76Ni0.24 nanoparticle showed better electrochemical stability than pure Pt nanoparticles similar to 3 nm in size. We propose that the underlying mechanism originates from favorable compressive strain on Pt for ORR catalysis and atomic interactions among the nanoparticle shells for electrochemical stability. Our results will contribute to accurate identification and innovative design of promising nanomaterials for renewable energy systems.	[Noh, Seung Hyo; Ohsaka, Takeo] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Han, Byungchan] Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea	Ohsaka, T (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, 4259-G1-5 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	bchan@yonsei.ac.kr; ohsaka.t.aa@m.titech.ac.jp			Global Frontier Program through the Global Frontier Hybrid Interface Materials (GFHIM) of the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning [2013M3A6B1078882]; New and Renewable Energy R&D Program under the Ministry of Knowledge Economy, Republic of Korea [20113020030020]; HPCI systems [hp140038]; Government of Japan	This research was supported by Global Frontier Program through the Global Frontier Hybrid Interface Materials (GFHIM) of the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2013M3A6B1078882). The New and Renewable Energy R&D Program (No. 20113020030020) under the Ministry of Knowledge Economy, Republic of Korea partially supported this work. This research was performed using Tsubame 2.5 at the Global Scientific Information and Computing Center of the Tokyo Institute of Technology as a Research Project of HPCI systems (Project ID: hp140038). Author, Seunghyo Noh, also appreciates the Government of Japan for MEXT scholarship.	Hansen HA, 2008, PHYS CHEM CHEM PHYS, V10, P3722, DOI 10.1039/b803956a; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Wei GF, 2011, ENERG ENVIRON SCI, V4, P1268, DOI 10.1039/c0ee00762e; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Greeley J, 2007, ELECTROCHIM ACTA, V52, P5829, DOI 10.1016/j.electacta.2007.02.082; Toda T, 1999, J ELECTROANAL CHEM, V460, P258, DOI 10.1016/S0022-0728(98)00361-1; Escano MCS, 2014, J POWER SOURCES, V247, P562, DOI 10.1016/j.jpowsour.2013.09.013; Hammer B, 2000, ADV CATAL, V45, P71; METHFESSEL M, 1989, PHYS REV B, V40, P3616, DOI 10.1103/PhysRevB.40.3616; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/nchem.367, 10.1038/NCHEM.367]; Zheng FL, 2014, NANO RES, V7, P410, DOI 10.1007/s12274-014-0407-1; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/nchem.623, 10.1038/NCHEM.623]; Cao X, 2014, NANO ENERGY, V9, P301, DOI 10.1016/j.nanoen.2014.08.008; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Wu JB, 2012, J AM CHEM SOC, V134, P11880, DOI 10.1021/ja303950v; Tsai HC, 2014, J PHYS CHEM C, V118, P26703, DOI 10.1021/jp507103c; Arumugam B, 2014, RSC ADV, V4, P27510, DOI 10.1039/c4ra04744c; Cui CH, 2012, NANO LETT, V12, P5885, DOI 10.1021/nl3032795; Neyerlin KC, 2009, J POWER SOURCES, V186, P261, DOI 10.1016/j.jpowsour.2008.10.062; He T, 2006, J ELECTROCHEM SOC, V153, pA1637, DOI 10.1149/1.2213387; Chen S, 2008, J AM CHEM SOC, V130, P13818, DOI 10.1021/ja802513y; Wei GF, 2015, CHEM SCI, V6, P1485, DOI 10.1039/c4sc02806f; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Vitos L, 1998, SURF SCI, V411, P186, DOI 10.1016/S0039-6028(98)00363-X; TSAI AP, 1988, J MATER SCI LETT, V7, P322, DOI 10.1007/BF01730730; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Stamenkovic VR, 2006, J AM CHEM SOC, V128, P8813, DOI 10.1021/ja0600476; Kang HC, 2013, NANOSCALE, V5, P7184, DOI 10.1039/c3nr00396e; Wei GF, 2012, J PHYS CHEM C, V116, P12696, DOI 10.1021/jp3034616; Noh SH, 2013, NANOSCALE, V5, P8625, DOI 10.1039/c3nr02611f; Liu LC, 2014, J POWER SOURCES, V253, P1, DOI 10.1016/j.jpowsour.2013.12.028; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Bligaard T, 2007, ELECTROCHIM ACTA, V52, P5512, DOI 10.1016/j.electacta.2007.02.041; Wang DL, 2013, NAT MATER, V12, P81, DOI [10.1038/nmat3458, 10.1038/NMAT3458]; Ling T, 2009, NANO LETT, V9, P1572, DOI 10.1021/nl8037294; Noh SH, 2014, ELECTROCHIM ACTA, V140, P225, DOI 10.1016/j.electacta.2014.03.076; Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840; Hammer B, 1995, SURF SCI, V343, P211, DOI 10.1016/0039-6028(96)80007-0; Cao XR, 2014, PHYS CHEM CHEM PHYS, V16, P8367, DOI 10.1039/c4cp00399c; Toda T, 1999, J ELECTROCHEM SOC, V146, P3750, DOI 10.1149/1.1392544; Li HY, 2014, NANO RES, V7, P1007, DOI 10.1007/s12274-014-0464-5; Dubau L, 2011, ELECTROCHIM ACTA, V56, P10658, DOI 10.1016/j.electacta.2011.03.073; Mani P, 2011, J POWER SOURCES, V196, P666, DOI 10.1016/j.jpowsour.2010.07.047; Balbuena PB, 2012, TOP CATAL, V55, P322, DOI 10.1007/s11244-012-9800-8; WINTER BJ, 1991, Z PHYS D ATOM MOL CL, V19, P375; Escano MCS, 2015, NANO RES, V8, P1689, DOI 10.1007/s12274-014-0670-1; Han BC, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075410; Han BC, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205409; Haynes W.M., 2013, CRC HDB CHEM PHYS; He C., 2005, INTERFACE, V14, P41, DOI DOI 10.1149/1.2388863; Kaminskii P. P., 1987, Soviet Physics Journal, V30, DOI 10.1007/BF00914832; Li JY, 2014, NANO RES, V7, P1519, DOI 10.1007/s12274-014-0513-0; Pourbaix M., 1974, ATLAS ELECTROCHEMICA; Srivastava R., 2007, ANGEW CHEM, V119, P9146, DOI 10.1002/ange.200703331; Stolten D, 2013, TRANSITION TO RENEWABLE ENERGY SYSTEMS, pXXIX; Takahashi R, 2015, ECS TRANSACTIONS, V65, P175, DOI 10.1149/06501.0175ecst; Tang L., 2009, J AM CHEM SOC, V132, P596; van der Vliet D. F, 2012, ANGEW CHEM INT EDIT, VI24, P3193	58	1	1	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	OCT	2015	8	10					3394	3403		10.1007/s12274-015-0839-2		10	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CT1US	WOS:000362588100026		
J	Kimura, T; Kitaura, H; Masuda, H; Kameyama, S; Saito, Y; Sugai, K; Otsuki, T; Nakazawa, A; Morota, N; Yamamoto, T; Iida, K; Nakagawa, M; Mizuno, T; Takahashi, H; Kakita, A				Kimura, Tadashi; Kitaura, Hiroki; Masuda, Hiroshi; Kameyama, Shigeki; Saito, Yuko; Sugai, Kenji; Otsuki, Taisuke; Nakazawa, Atsuko; Morota, Nobuhito; Yamamoto, Takamichi; Iida, Kouji; Nakagawa, Masanori; Mizuno, Toshiki; Takahashi, Hitoshi; Kakita, Akiyoshi			Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia	NEUROPATHOLOGY			English	Article						balloon cell; focal cortical dysplasia; hemimegalencephaly; p57; Kip2; tuberous sclerosis	TUBEROUS SCLEROSIS COMPLEX; KINASE INHIBITORS; DIFFERENTIATION; MALFORMATIONS; ACTIVATION; NEOCORTEX; ROLES; P57; IIB	Balloon cells are a pathognomonic cellular feature of various cortical malformations, including focal cortical dysplasia type IIb (FCD IIb), cortical tubers of tuberous sclerosis (TSC) and hemimegalencephaly (HME). In the present study, we investigated the immunohistochemical expression of p57/Kip2, a member of the Cip/Kip family of cyclin-dependent kinase inhibitory proteins, in balloon cells in surgical specimens taken from 26, 17 and six patients with FCD IIb, TSC and HME, respectively. Characteristic dot-like reactivity with a faint, intense, reticular and process-like pattern was confined to the proximal portion of the cytoplasmic processes of the cells. Immunoelectron microscopy revealed the p57/Kip2 reactivity on intermediate filaments in the proximal portion of the processes. The immunohistochemical profile appeared similar to that of CD34; however, a double immunofluorescence study demonstrated that no cells showed reactivity for both p57/Kip2 and CD34. The frequencies of the p57/Kip2-positive cells in FCD IIb and HME were significantly higher than those in TSC, suggesting that the balloon cells may be heterogeneous. These findings suggest some functional significance of the protein on the cytoplasmic processes of balloon cells and appear consistent with the notion that the cells are abnormally differentiated progenitor cells.	[Kimura, Tadashi; Kitaura, Hiroki; Takahashi, Hitoshi; Kakita, Akiyoshi] Niigata Univ, Dept Pathol, Brain Res Inst, Niigata 9518585, Japan; [Masuda, Hiroshi; Kameyama, Shigeki] Nishi Niigata Chuo Natl Hosp, Epilepsy Ctr, Dept Funct Neurosurg, Niigata, Japan; [Saito, Yuko; Sugai, Kenji; Otsuki, Taisuke] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Nakazawa, Atsuko; Morota, Nobuhito] Natl Ctr Child Hlth & Dev, Natl Med Ctr Children & Mothers, Tokyo, Japan; [Yamamoto, Takamichi] Seirei Hamamatsu Gen Hosp, Comprehens Epilepsy Ctr, Hamamatsu, Shizuoka, Japan; [Iida, Kouji] Hiroshima Univ, Dept Neurosurg, Hiroshima, Japan; [Nakagawa, Masanori; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Neurol, Kyoto, Japan	Kakita, A (reprint author), Niigata Univ, Dept Pathol, Brain Res Inst, Chuo Ku, 1-757 Asahimachi, Niigata 9518585, Japan.	kakita@bri.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [25250008, 25640027]; Ministry of Health, Labor and Welfare, Japan [24-7, H26-052]	This work was supported by a Grant-in-Aid for Scientific Research (no. 25250008) and Exploratory Research (no. 25640027) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and a grant (24-7) for Nervous and Mental Disorders and a Health Labour Sciences Research Grant (H26-052) from the Ministry of Health, Labor and Welfare, Japan.	Cepeda C, 2012, NEUROBIOL DIS, V45, P310, DOI 10.1016/j.nbd.2011.08.015; Tan CF, 2009, ACTA NEUROPATHOL, V118, P553, DOI 10.1007/s00401-009-0552-x; Fauser S, 2004, ACTA NEUROPATHOL, V108, P272, DOI 10.1007/s00401-004-0889-0; Alonso-Nanclares L, 2005, BRAIN, V128, P158, DOI 10.1093/brain/awh331; Ying Z, 2005, EPILEPSIA, V46, P1716, DOI 10.1111/j.1528-1167.2005.00276.x; Vlachos P, 2009, ONCOGENE, V28, P4175, DOI 10.1038/onc.2009.269; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Miyahara H, 2013, BRAIN PATHOL, V23, P254, DOI 10.1111/j.1750-3639.2012.00634.x; Gui HX, 2007, DEV BIOL, V301, P14, DOI 10.1016/j.ydbio.2006.10.035; LIN GS, 1995, EUR J IMMUNOL, V25, P1508, DOI 10.1002/eji.1830250606; Garbelli R, 1999, BRAIN PATHOL, V9, P445; Lamparello P, 2007, BRAIN, V130, P2267, DOI 10.1093/brain/awm175; Blumcke I, 2014, ACTA NEUROPATHOL, V128, P39, DOI 10.1007/s00401-014-1288-9; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Crino PB, 1997, ACTA NEUROPATHOL, V93, P619; Oh HS, 2008, CHILD NERV SYST, V24, P175, DOI 10.1007/s00381-007-0453-z; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Englund C, 2005, ACTA NEUROPATHOL, V109, P519, DOI 10.1007/s00401-005-1005-9; Schick V, 2007, BRAIN PATHOL, V17, P165, DOI 10.1111/j.1750-3639.2007.00059.x; Cepeda C, 2006, EPILEPSY BEHAV, V9, P219, DOI 10.1016/j.yebeh.2006.05.012; Tury A, 2012, DEV NEUROBIOL, V72, P821, DOI 10.1002/dneu.20999; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Yasin SA, 2010, ACTA NEUROPATHOL, V120, P85, DOI 10.1007/s00401-010-0677-y; Thom M, 2005, NEUROPATH APPL NEURO, V31, P580, DOI 10.1111/j.1365-2990.2005.00651.x; Thom M, 2007, J NEUROPATH EXP NEUR, V66, P1045, DOI 10.1097/nen.0b013e3181598d23; Kavanagh E, 2011, BBA-REV CANCER, V1816, P50, DOI 10.1016/j.bbcan.2011.03.002; Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028; Thom M., 2004, PATHOLOGY GENETICS D, P67; Tury A, 2011, CEREB CORTEX, V15, P1343; Vinters HV, 2004, PATHOLOGY GENETICS D, P79	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2015	35	5					401	409		10.1111/neup.12199		9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CT1NM	WOS:000362565300001		
J	Nakamura, K; Mori, F; Tanji, K; Miki, Y; Yamada, M; Kakita, A; Takahashi, H; Utsumi, J; Sasaki, H; Wakabayashi, K				Nakamura, Keiko; Mori, Fumiaki; Tanji, Kunikazu; Miki, Yasuo; Yamada, Masahito; Kakita, Akiyoshi; Takahashi, Hitoshi; Utsumi, Jun; Sasaki, Hidenao; Wakabayashi, Koichi			Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies	NEUROPATHOLOGY			English	Article						alpha-synuclein; cholesterol; isopentenyl diphosphate isomerase; Lewy body; Parkinson's disease	SPORADIC PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISORDERS; MARINESCO BODIES; BODY DISEASE; IN-VITRO; EXPRESSION; BRAIN; HOMEOSTASIS	Isopentenyl diphosphate isomerase (IDI) is a cytoplasmic enzyme involved in the biosynthesis of isoprenoids including cholesterols. IDI has two isoforms in humans: IDI1 and IDI2. Since lipids are known to be a component of Lewy bodies (LBs), we investigated the immunohistochemical localization of IDI1 and IDI2 in the brain of patients with LB disease and multiple system atrophy (MSA) and normal control subjects. In normal controls, the cytoplasm of neurons was weakly immunostained with anti-IDI1 and anti-IDI2 antibodies throughout the nervous system. In LB disease, brainstem-type LBs were strongly positive for IDI1 and IDI2, and cortical LBs were unstained or barely immunolabeled. Double immunofluorescence staining revealed co-localization of phosphorylated -synuclein with IDI1 or IDI2. Glial cytoplasmic inclusions in MSA were unstained. Previous studies have shown that levels of cholesterol metabolites are increased in the cerebral cortex of patients with LB disease, and that these metabolites accelerate -synuclein aggregation. The present findings suggest that IDI1 and IDI2 may be associated with the production of cholesterol metabolites in neurons, leading to -synuclein aggregation during the process of LB formation.	[Nakamura, Keiko; Mori, Fumiaki; Tanji, Kunikazu; Miki, Yasuo; Wakabayashi, Koichi] Hirosaki Univ, Grad Sch Med, Dept Neuropathol, Hirosaki, Aomori 0368562, Japan; [Nakamura, Keiko; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Ageing, Kanazawa, Ishikawa, Japan; [Kakita, Akiyoshi] Niigata Univ, Dept Pathol Neurosci, Ctr Bioresourcebased Res, Niigata, Japan; [Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Utsumi, Jun; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan	Mori, F (reprint author), Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Neuropathol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	neuropal@hirosaki-u.ac.jp			JSPS [26430049, 26430050, 26860655, 24300131]; Brain Research Institute, Niigata University [2014-2508]; Research Committee for Ataxic Disease from the Ministry of Health, Labor and Welfare, Japan; NCNP [24-5]	This work was supported by JSPS KAKENHI Grant Numbers 26430049 (F.M.), 26430050 (K.T.), 26860655 (Y.M.) and 24300131 (K.W.), a Grant for Hirosaki University Institutional Research (K.W.), the Collaborative Research Project (2014-2508) of the Brain Research Institute, Niigata University (F.M.), Grants-in Aid from the Research Committee for Ataxic Disease from the Ministry of Health, Labor and Welfare, Japan (H.S., K.W.) and an Intramural Research Grant (24-5) for Neurological and Psychiatric Disorders from NCNP (K.W.). The authors wish to express their gratitude to M. Nakata and A. Ono for their technical assistance.	Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; YUEN P, 1963, J NEUROL NEUROSUR PS, V26, P178, DOI 10.1136/jnnp.26.2.178; ISSIDORIDES MR, 1990, PATHOL RES PRACT, V186, P473; Wakabayashi K, 2002, ACTA NEUROPATHOL, V103, P209, DOI 10.1007/s004010100451; Clizbe DB, 2007, J BIOL CHEM, V282, P6668, DOI 10.1074/jbc.M610922200; Breitling R, 2003, J MOL EVOL, V57, P282, DOI 10.1007/s00239-003-2476-8; Baba M, 1998, AM J PATHOL, V152, P879; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; AGRANOFF BW, 1959, J AM CHEM SOC, V81, P1254, DOI 10.1021/ja01514a059; Cheng D, 2008, NEUROREPORT, V19, P1685, DOI 10.1097/WNR.0b013e32831578b2; KATO S, 1991, ACTA NEUROPATHOL, V82, P488; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Hahn FM, 1996, ARCH BIOCHEM BIOPHYS, V332, P30, DOI 10.1006/abbi.1996.0312; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Vaya J, 2007, FREE RADICAL BIO MED, V42, P864, DOI 10.1016/j.freeradbiomed.2006.12.022; Paton VG, 1997, J BIOL CHEM, V272, P18945, DOI 10.1074/jbc.272.30.18945; BOERNER D, 1952, PROTOPLASMA, V41, P168, DOI 10.1007/BF01248220; Pfister S, 2011, INT J DEV BIOL, V55, P45, DOI 10.1387/ijdb.103158sp; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Odagiri S, 2012, NEUROPATHOLOGY, V32, P261, DOI 10.1111/j.1440-1789.2011.01267.x; Valdez CM, 2011, MOL BIOSYST, V7, P1891, DOI 10.1039/c0mb00282h; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Kato T, 2010, BIOCHEM BIOPH RES CO, V402, P438, DOI 10.1016/j.bbrc.2010.10.056; Morihara T, 1999, MOL BRAIN RES, V67, P231, DOI 10.1016/S0169-328X(99)00065-0; DUFFY PE, 1965, J NEUROPATH EXP NEUR, V24, P398, DOI 10.1097/00005072-196507000-00003; Malik B, 2012, NEUROCHEM INT, V61, P321, DOI 10.1016/j.neuint.2012.05.006; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Davison AN, 1970, HANDBOOK NEUROCHEMIS, V3, P547; JAGER WAD, 1969, ARCH NEUROL-CHICAGO, V21, P615; Ikeda K, 1974, Seishin Shinkeigaku Zasshi, V76, P778; Porter JW, 1981, BIOSYNTHESIS ISOPREN, V1	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2015	35	5					432	440		10.1111/neup.12204		9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CT1NM	WOS:000362565300004		
J	Homma, T; Mochizuki, Y; Takahashi, K; Komori, T				Homma, Taku; Mochizuki, Yoko; Takahashi, Kazushi; Komori, Takashi			Medial temporal regional argyrophilic grain as a possible important factor affecting dementia in Parkinson's disease	NEUROPATHOLOGY			English	Article						argyrophilic grain; cerebral limbic system; dementia; Parkinson's disease; spongiform change	LEWY BODY DISEASE; VISUAL HALLUCINATIONS; SPONGIFORM CHANGE; ONSET DEMENTIA; PATHOLOGY; NEUROPATHOLOGY; CONSORTIUM; FREQUENCY; DIAGNOSIS; BODIES	Argyrophilic grain (ArG) is the main pathological feature of argyrophilic grain disease (AGD) and is clinically characterized by cognitive impairment, behavioral abnormalities, personality changes, and emotional imbalances. However, ArG can not only be found in AGD but also in various other neurological disorders, including Parkinson's disease (PD). The association of ArG with psychosis and/or dementia in various neurological disorders remains unknown; in this study, we have investigated this in PD. The distribution and degree of ArG deposition, spongiform change in the transentorhinal cortex (TER SpC), and phosphorylated alpha-synuclein-positive neurites in CA2/3 were assessed, and we used formalin-fixed, paraffin-embedded specimens obtained from the anterior/posterior medial temporal region of 20 autopsy cases diagnosed as PD. These cases were clinically divided into two groups: PD without dementia (PDND) and PD with dementia (PDD). Most PDD cases revealed scattered to numerous ArG or moderate to severe TER SpC, both of which were rarely observed in the PDND group. Furthermore, by the degree of ArG density and TER SpC, the PDD group was further divided into three subtypes: PDD with ArG, with TER SpC and without ArG/TER SpC. Scattered-to-numerous ArG and/or moderate-to-severe TER SpC were observed only in PDD, which suggested that both ArG and TER SpC could be important factors affecting dementia in PD and that their distribution and degree are equally important.	[Homma, Taku; Mochizuki, Yoko; Komori, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Pathol, Fuchu, Tokyo 1830042, Japan; [Takahashi, Kazushi] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Fuchu, Tokyo 1830042, Japan; [Homma, Taku] Nihon Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Mochizuki, Yoko] Tokyo Metropolitan Kita Med & Rehabil Ctr Disable, Dept Neurol, Tokyo, Japan; [Takahashi, Kazushi] Saitama Med Univ, Dept Neurol, Saitama, Japan	Homma, T (reprint author), Tokyo Metropolitan Neurol Hosp, Dept Pathol, 2-6-1 Musashi Dai, Fuchu, Tokyo 1830042, Japan.	homma.taku@gmail.com					Seno H, 2000, J NEUROL SCI, V178, P70, DOI 10.1016/S0022-510X(00)00359-2; McKeith IG, 1996, NEUROLOGY, V47, P1113; Ferrer I, 2008, BRAIN, V131, P1416, DOI 10.1093/brain/awm305; IKEDA K, 1995, ACTA NEUROPATHOL, V89, P409; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Togo T, 2002, BRAIN PATHOL, V12, P45; Kosaka K, 2000, NEUROPATHOLOGY, V20, P1, DOI 10.1046/j.1440-1789.2000.00269.x; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; DICKSON DW, 1994, ACTA NEUROPATHOL, V87, P269; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Grau-Rivera O, 2013, J NEUROL, V260, P3002, DOI 10.1007/s00415-013-7101-1; Papapetropoulos S, 2006, PARKINSONISM RELAT D, V12, P253, DOI 10.1016/j.parkreldis.2005.10.005; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; HANSEN LA, 1989, ACTA NEUROPATHOL, V78, P194; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911; Braak H, 1998, J NEURAL TRANSM, V105, P801, DOI 10.1007/s007020050096; Soma K, 2012, NEUROPATH APPL NEURO, V38, P54, DOI 10.1111/j.1365-2990.2011.01175.x; Horvath J, 2013, PARKINSONISM RELAT D, V19, P864, DOI 10.1016/j.parkreldis.2013.05.010; Tolnay M, 1997, ACTA NEUROPATHOL, V94, P353; BRAAK H, 1987, NEUROSCI LETT, V76, P124, DOI 10.1016/0304-3940(87)90204-7; Tolnay M, 2004, NEUROPATHOLOGY, V24, P269, DOI 10.1111/j.1440-1789.2004.00591.x; Compta Y, 2014, NEURODEGENER DIS, V13, P154, DOI 10.1159/000354670; Kalaitzakis ME, 2009, PARKINSONISM RELAT D, V15, P196, DOI 10.1016/j.parkreldis.2008.05.007; Iseki E, 1997, J NEUROL SCI, V146, P53, DOI 10.1016/S0022-510X(96)00282-1; Grinberg LT, 2009, DEMENT NEUROPSYCHOL, V3, P2	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2015	35	5					441	451		10.1111/neup.12208		11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CT1NM	WOS:000362565300005		
J	Okamoto, K; Fujita, Y; Hoshino, E; Tamura, Y; Fukuda, T; Hasegawa, M; Takatama, M				Okamoto, Koichi; Fujita, Yukio; Hoshino, Eri; Tamura, Yuhji; Fukuda, Toshio; Hasegawa, Masato; Takatama, Masamitsu			An autopsy case of familial amyotrophic lateral sclerosis with a TARDBP Q343R mutation	NEUROPATHOLOGY			English	Article						amyotrophic lateral sclerosis; p62; pathology; TARDBPQ343R mutation; TDP-43	FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; ANTERIOR HORN CELLS; TDP-43 PROTEINOPATHY; BUNINA BODIES; JAPANESE FAMILY; BINDING PROTEIN; INCLUSIONS; CLASSIFICATION; IMMUNOREACTIVITIES	We describe a Japanese autopsy case of familial amyotrophic lateral sclerosis (FALS) with a TARDBPQ343R mutation. This male patient developed dysarthria at the age of 52 years, and bulbar symptoms progressed, with weakness and atrophy in the extremities. His mental status was normal, but he became bedridden, received artificial respiratory support at 54 years of age, and gradually acquired a locked-in state and died at 58 years of age. Microscopically, marked diffuse myelin pallor was observed in the anterolateral columns of the spinal cord. The remaining anterior horn cells contained Bunina bodies and phosphorylation-dependent transactivation response DNA-binding protein of 43kDa (pTDP-43)-positive neuronal cytoplasmic inclusions (NCIs). Glial cytoplasmic inclusions (GCIs) were also observed. The number of ubiquitin- and p62-positive inclusions was markedly lower than that of pTDP-43-positive inclusions. NCIs and many fine dot-like pTDP-43-positive granules in the neuropil were mainly seen in the temporal and motor cortices, and striatum. NCIs were rare in hippocampal granular cells. Immunoblotting of samples from the cerebral cortex using an anti-pTDP-43 antibody was slightly different from previous TDP-43 pathological subtypes.	[Okamoto, Koichi] Geriatr Res Inst & Hosp, Dept Neurol, Maebashi, Gumma 3710847, Japan; [Fujita, Yukio; Hoshino, Eri] Gunma Univ, Dept Neurol, Sch Med, Maebashi, Gumma 371, Japan; [Fukuda, Toshio] Gunma Univ, Dept Histopathol & Cytopathol, Grad Sch Hlth Sci, Maebashi, Gumma 371, Japan; [Takatama, Masamitsu] Geriatr Res Inst & Hosp, Dept Internal Med, Maebashi, Gumma 3710847, Japan; [Tamura, Yuhji] Kiboukan Hosp, Dept Internal Med, Takasaki, Gumma, Japan; [Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Neuropathol & Cell Biol, Tokyo 113, Japan	Okamoto, K (reprint author), Geriatr Res Inst & Hosp, Dept Neurol, 3-26-8 Otomo Machi, Maebashi, Gumma 3710847, Japan.	okamotok@ronenbyo.or.jp			Ministry of Health, Labour and Welfare of Japan	We are very grateful to Drs A. Yokoseki and O. Onodera, Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute (A.Y.), and Department of Molecular Neuroscience, Resource Branch for Brain Disease, Brain Research Institute (O.O.), Niigata University, for TARDBP analysis. This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan. The authors express their appreciation to Ms Kunie Watanabe for her excellent technical assistance.	Borroni B, 2009, HUM MUTAT, V30, pE974, DOI 10.1002/humu.21100; Fujita Y, 2008, J NEUROL SCI, V269, P30, DOI 10.1016/j.jns.2007.12.016; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Kadokura A, 2009, NEUROSCI LETT, V463, P87, DOI 10.1016/j.neulet.2009.06.024; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Mizuno Y, 2006, J NEUROL SCI, V249, P13, DOI 10.1016/j.jns.2006.05.060; Braak H, 2010, ACTA NEUROPATHOL, V120, P67, DOI 10.1007/s00401-010-0683-0; Cairns NJ, 2010, NEUROPATH APPL NEURO, V36, P673, DOI 10.1111/j.1365-2990.2010.01121.x; Giordana MT, 2010, BRAIN PATHOL, V20, P351, DOI 10.1111/j.1750-3639.2009.00284.x; Nishihira Y, 2009, ACTA NEUROPATHOL, V117, P45, DOI 10.1007/s00401-008-0443-6; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Tagawa A, 2007, ACTA NEUROPATHOL, V113, P205, DOI 10.1007/s00401-006-0151-z; Arai T, 2014, NEUROPATHOLOGY, V34, P578, DOI 10.1111/neup.12138; Nakano I, 2000, NEUROPATHOLOGY, V20, P68, DOI 10.1046/j.1440-1789.2000.00272.x; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Fujita Y, 2011, NEUROLOGY, V77, P1427, DOI 10.1212/WNL.0b013e318232ab87; Okamoto K, 2010, NEUROPATHOLOGY, V30, P486, DOI 10.1111/j.1440-1789.2010.01121.x; Tamaoka A, 2010, INTERNAL MED, V49, P331, DOI 10.2169/internalmedicine.49.2915; Pamphlett R, 2009, NEUROPATH APPL NEURO, V35, P222, DOI 10.1111/j.1365-2990.2008.00982.x; Maekawa S, 2009, NEUROPATHOLOGY, V29, P672, DOI 10.1111/j.1440-1789.2009.01029.x; Tsuchiya K, 2000, ACTA NEUROPATHOL, V100, P603; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Okamoto K, 2008, NEUROPATHOLOGY, V28, P109, DOI 10.1111/j.1440-1789.2007.00873.x; Homma T, 2014, NEUROPATH APPL NEURO, V40, P231, DOI 10.1111/nan.12090; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Egawa N., 2012, SCI TRANSL MED, V4, P1, DOI DOI 10.1126/SCITRANSLMED.3004052	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2015	35	5					462	468		10.1111/neup.12209		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CT1NM	WOS:000362565300008		
J	Masaki, K				Masaki, Katsuhisa			Early disruption of glial communication via connexin gap junction in multiple sclerosis, Balo's disease and neuromyelitis optica	NEUROPATHOLOGY			English	Article						aquaporin-4; Balo's disease; connexin; multiple sclerosis; neuromyelitis optica	MARIE-TOOTH-DISEASE; MERZBACHER-LIKE-DISEASE; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; WHITE-MATTER LESIONS; OCULODENTODIGITAL DYSPLASIA; DEMYELINATING DISEASE; CULTURED ASTROCYTES; NEURONAL-ACTIVITY; MUTATIONS CAUSE	Multiple sclerosis (MS), neuromyelitis optica (NMO), and Balo's disease (BD) are inflammatory demyelinating diseases of the CNS. We previously reported anti-aquaporin-4 (anti-AQP4) antibody-dependent AQP4 loss occurs in some NMO patients, while antibody-independent AQP4 astrocytopathy can occur in heterogeneous demyelinating conditions, including MS, NMO and BD. To investigate the relationship between astrocytopathy and demyelination, we focused on connexins (Cxs), which form gap junctions (GJs) between astrocytes and oligodendrocytes and maintain homeostasis in the CNS. We evaluated expression of astrocytic Cx43/Cx30 and oligodendrocytic Cx47/Cx32 in autopsied materials from MS, NMO and BD patients. Astrocytic Cx43 and oligodendrocytic Cx32/Cx47 expressions were significantly diminished in both demyelinated and preserved myelin layers in all BD samples. In the leading edge of BD lesions, Cx43 and AQP4 loss preceded Cx32/Cx47 loss. Half of the NMO and MS samples showed preferential loss of astrocytic Cx43 expression in actively demyelinating and chronic active lesions, where heterotypic Cx43/Cx47 astrocyte-oligodendrocyte GJs were lost. Cases with Cx43 loss were significantly associated with rapid disease progression, regardless of the disease phenotype. Pathologically, Cx43 loss was frequently accompanied by distal oligodendrogliopathy. Our findings suggest that Cx43 astrocytopathy can occur in MS, BD and NMO. Moreover, astrocytic Cx43 loss may be associated with disease aggressiveness and distal oligodendrogliopathy in demyelinating conditions. Early disruption of glial communications via GJs may cause loss of glia syncytium, thereby inducing oligodendroglial damage and myelin loss. Inhibition of Cx hemichannels and restoration of GJs may be a possible therapeutic target for demyelinating disorders.	Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol,Higashi Ku, Fukuoka 8128582, Japan	Masaki, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kmasaki@neuro.med.kyushu-u.ac.jp			Japanese Ministry of Health, Labour and Welfare [H26-Nanchi-Ippan-074]; Japanese Ministry of Education, Culture, Sports, Science and Technology [25293204, 26461295]	I acknowledge Prof. Jun-ichi Kira for his helpful comments. I also thank Drs Satoshi O Suzuki, Shotaro Hayashida, Hayato Une, Mitsuru Watanabe, Yiwen Cui, Yuko Kobayakawa, Takuya Matsushita, Ryo Yamasaki, Hiroo Yamaguchi and Toru Iwaki for their help with neuropathological and connexin examinations. This work was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases (H26-Nanchi-Ippan-074) from the Japanese Ministry of Health, Labour and Welfare, by a Scientific Research B Grant (No. 25293204), and a Scientific Research C Grant (No. 26461295) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. I thank Ms. Sachiko Koyama and Mr. Takaaki Kanemaru from the Department of Neuropathology and Morphology Core Unit, Kyushu University, for their excellent technical assistance.	Lutz SE, 2009, J NEUROSCI, V29, P7743, DOI 10.1523/JNEUROSCI.0341-09.2009; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Sugiura K, 2013, JAMA DERMATOL, V149, P1350, DOI 10.1001/jamadermatol.2013.4766; Parman Y, 2007, J NEUROL, V254, P953, DOI 10.1007/s00415-006-0324-7; Meyer E, 2011, MOL GENET METAB, V104, P637, DOI 10.1016/j.ymgme.2011.08.032; Menichella DM, 2006, J NEUROSCI, V26, P10984, DOI 10.1523/JNEUROSCI.0304-06.2006; YAO DL, 1994, ANN NEUROL, V35, P18, DOI 10.1002/ana.410350105; Kleopa KA, 2011, J NEUROSCI, V31, P17753, DOI 10.1523/JNEUROSCI.4824-11.2011; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Lamartine J, 2000, NAT GENET, V26, P142; MASSA PT, 1982, NEUROSCIENCE, V7, P523; Kleopa KA, 2004, GLIA, V47, P346, DOI 10.1002/glia.20043; Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Rash JE, 2001, J NEUROSCI, V21, P1983; Orthmann-Murphy JL, 2009, BRAIN, V132, P426, DOI 10.1093/brain/awn328; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Hanemann CO, 2003, ARCH NEUROL-CHICAGO, V60, P605, DOI 10.1001/archneur.60.4.605; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Lutz SE, 2012, J NEUROIMMUNOL, V245, P8, DOI 10.1016/j.jneuroim.2012.01.007; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Odermatt B, 2003, J NEUROSCI, V23, P4549; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Tabernero A, 2006, J NEUROCHEM, V99, P1049, DOI 10.1111/j.1471-4159.2006.04088.x; Markoullis K, 2012, ACTA NEUROPATHOL, V123, P873, DOI 10.1007/s00401-012-0978-4; PAUL DL, 1995, CURR OPIN CELL BIOL, V7, P665, DOI 10.1016/0955-0674(95)80108-1; WALZ W, 1983, PROG NEUROBIOL, V20, P133, DOI 10.1016/0301-0082(83)90013-8; Fusco C, 2010, J CHILD NEUROL, V25, P759, DOI 10.1177/0883073809344119; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Ye ZC, 2003, J NEUROSCI, V23, P3588; YAMAMOTO T, 1990, BRAIN RES, V508, P313, DOI 10.1016/0006-8993(90)90415-8; Menichella DM, 2003, J NEUROSCI, V23, P5963; Srinivasan J, 2008, PEDIATR NEUROL, V38, P293, DOI 10.1016/j.pediatrneurol.2007.12.003; Anderson CM, 2000, GLIA, V32, P1; Simard M, 2003, J NEUROSCI, V23, P9254; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Bruck W, 2012, ANN NEUROL, V72, P385, DOI 10.1002/ana.23621; Kira J, 2011, MULT SCLER J, V17, P771, DOI 10.1177/1352458511400475; Matsuoka T, 2010, ACTA NEUROPATHOL, V120, P651, DOI 10.1007/s00401-010-0733-7; Markoullis K, 2012, GLIA, V60, P1053, DOI 10.1002/glia.22334; Ahn M, 2008, J NEUROSCI RES, V86, P992, DOI 10.1002/jnr.21561; Scherer SS, 1997, NEURON, V18, P13, DOI 10.1016/S0896-6273(01)80042-8; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/aw1371; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; Schelhaas HJ, 2002, NEUROLOGY, V59, P2007; Taylor RA, 2003, NEUROLOGY, V61, P1475; Loddenkemper T, 2002, J NEUROL, V249, P584, DOI 10.1007/s004150200068; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Charles A, 1998, GLIA, V24, P39, DOI 10.1002/(SICI)1098-1136(199809)24:1<39::AID-GLIA5>3.0.CO;2-W; Roscoe WA, 2007, J NEUROSCI RES, V85, P945, DOI 10.1002/jnr.21194; Masaki K, 2012, ACTA NEUROPATHOL, V123, P887, DOI 10.1007/s00401-012-0972-x; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; Zhang FL, 2013, GLIA, V61, P1261, DOI 10.1002/glia.22513; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Markoullis K, 2014, J NEUROPATH EXP NEUR, V73, P865, DOI 10.1097/NEN.0000000000000106; Scherer SS, 1995, J NEUROSCI, V15, P8281; Nagy JI, 2003, GLIA, V44, P205, DOI 10.1002/glia.10278; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Isoardo G, 2005, NEUROLOGY, V65, P1672, DOI 10.1212/01.wnl.0000186032.06791.94; Misu T, 2013, ACTA NEUROPATHOL, V125, P815, DOI 10.1007/s00401-013-1116-7; Nelles E, 1996, P NATL ACAD SCI USA, V93, P9565, DOI 10.1073/pnas.93.18.9565; Altevogt BM, 2002, J NEUROSCI, V22, P6458; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Osaka H, 2010, ANN NEUROL, V68, P250, DOI 10.1002/ana.22022; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Anzini P, 1997, J NEUROSCI, V17, P4545; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Giaume C, 1997, GLIA, V21, P114; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Paulson HL, 2002, ANN NEUROL, V52, P429, DOI 10.1002/ana.10305; Sutor B, 2000, CEREB CORTEX, V10, P684, DOI 10.1093/cercor/10.7.684; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Cui YW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-42; Endong Li, 2011, J Neuroimmunol, V240-241, P58, DOI 10.1016/j.jneuroim.2011.09.012; Kira J, 2011, J NEUROL SCI, V311, P69, DOI 10.1016/j.jns.2011.08.043; Kleopas K., 2013, CLIN EXP NEUROIM SS1, V4, P45; Masaki K, 2013, CLIN EXP NEUROIM SS1, V4, P36; Masaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072919; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Shijie Jin, 2009, Tohoku J Exp Med, V217, P87; Takeuchi H, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fncel.2014.00189, 10.3389/fnce1.2014.00189]; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050	91	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2015	35	5					469	480		10.1111/neup.12211		12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CT1NM	WOS:000362565300009		
J	Kawachi, I; Nishizawa, M				Kawachi, Izumi; Nishizawa, Masatoyo			Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica	NEUROPATHOLOGY			English	Article						gray matter lesions; neurodegeneration; neuromyelitis optica; multiple sclerosis; white matter lesions	CORTICAL DEMYELINATION; COGNITIVE IMPAIRMENT; GREY-MATTER; INTRACORTICAL LESIONS; MR; INFLAMMATION; PATHOLOGY; PATHOGENESIS; AQUAPORIN-4; DAMAGE	Multiple sclerosis (MS) and neuromyelitis optica (NMO) are the two main autoimmune diseases of the CNS. In patients with NMO, the target antigen is aquaporin-4 (AQP4), the most abundant water channel protein in the CNS. AQP4 is mainly expressed on astrocytic endfoot processes at the blood-brain barrier and in subpial and subendymal regions. MS and NMO are distinct diseases, but they have some common clinical features: both have long been considered autoimmune diseases that primarily affect the white matter (WM). However, because WM demyelination by itself cannot explain the full extent of the clinical disabilities, including cognitive decline in patients with MS and NMO, renewed interest in gray matter (GM) pathology in MS and NMO is emerging. Important hallmarks of WM and GM lesions in MS and NMO may differentially influence neuronal degeneration and demyelination in the brain and spinal cord, given different detrimental effects, including cytokine diffusion, disruption of water homeostasis associated with or without AQP4 (the target antigen in NMO) dynamics, or other unidentified mechanisms. An increase in knowledge of the structure of GM and WM lesions in MS and NMO will result in more targeted therapeutic approaches to these two diseases.	[Kawachi, Izumi; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan	Kawachi, I (reprint author), Niigata Univ, Brain Res Inst, Dept Neurol, Chuo Ku, 1-757 Asahimachi, Niigata 9518585, Japan.	ikawachi@bri.niigata-u.ac.jp			JSPS [26461289]; Ministry of Health, Labour and Welfare of Japan	This work was supported in part by JSPS KAKENHI Grant Number 26461289 (IK), and a Health and Labour Sciences Research Grant on Rare and Intractable Diseases (Evidence-based Early Diagnosis and Treatment Strategies for Neuroimmunological Diseases) from the Ministry of Health, Labour and Welfare of Japan (MN).	Calabrese M, 2012, NEUROLOGY, V79, P1671, DOI 10.1212/WNL.0b013e31826e9a96; Rocca MA, 2004, NEUROLOGY, V62, P476; Calabrese M, 2009, NEUROLOGY, V72, P1330, DOI 10.1212/WNL.0b013e3181a0fee5; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Piras MR, 2003, J NEUROL NEUROSUR PS, V74, P878, DOI 10.1136/jnnp.74.7.878; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Geurts JJG, 2009, J NEUROL SCI, V282, P12, DOI 10.1016/j.jns.2009.01.018; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Popescu BFG, 2011, NEUROLOGY, V76, P1229, DOI 10.1212/WNL.0b013e318214332c; Yanagawa K, 2009, NEUROLOGY, V73, P1628, DOI 10.1212/WNL.0b013e3181c1deb9; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Pichiecchio A, 2012, MULT SCLER J, V18, P817, DOI 10.1177/1352458511431072; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; Pouwels PJW, 2006, RADIOLOGY, V241, P873, DOI 10.1148/radiol.2413051182; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Yu CS, 2008, RADIOLOGY, V246, P222; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Kutzelnigg A, 2006, J NEUROL SCI, V245, P123, DOI 10.1016/j.jns.2005.09.021; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/aw1371; Christodoulou C, 2003, NEUROLOGY, V60, P1793; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107; Popescu BFG, 2010, NEUROLOGY, V75, P2103, DOI 10.1212/WNL.0b013e318200d80c; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Bagnato F, 2006, AM J NEURORADIOL, V27, P2161; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Lucchinetti CF, 2014, BRAIN PATHOL, V24, P83, DOI 10.1111/bpa.12099; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723; Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Vercellino M, 2009, J NEUROPATH EXP NEUR, V68, P489, DOI 10.1097/NEN.0b013e3181a19a5a; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Mike A, 2011, AM J NEURORADIOL, V32, P515, DOI 10.3174/ajnr.A2340; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Nelson F, 2011, MULT SCLER J, V17, P1122, DOI 10.1177/1352458511405561; Brink BP, 2005, J NEUROPATH EXP NEUR, V64, P147; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Haider L, 2014, J NEUROL NEUROSUR PS, V85, P1386, DOI 10.1136/jnnp-2014-307712; Kawachi I, 2014, CLIN EXP NEUROIMMUNO, V5, P69; Kawachi I, 2014, J NEUROL NEUROSURG P; vansHorssen J, 2007, J NEUROPATH EXP NEUR, V66, P321	52	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2015	35	5					481	486		10.1111/neup.12216		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CT1NM	WOS:000362565300010		
J	Shishido-Hara, Y				Shishido-Hara, Yukiko			Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions	NEUROPATHOLOGY			English	Article						IRIS; JC virus; natalizumab; PML; progressive multifocal leukoencephalopathy	RECONSTITUTION INFLAMMATORY SYNDROME; CYTOTOXIC T-LYMPHOCYTES; NATALIZUMAB-ASSOCIATED PML; JC-VIRUS; MULTIPLE-SCLEROSIS; TOKYO-1 STRAIN; BRAIN-TUMORS; RISK STRATIFICATION; PROLONGED SURVIVAL; THERAPY	Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease caused by reactivation of the asymptomatic persistent pathogen human polyomavirus JC (JC virus). The pathology of affected brain tissues demonstrates oligodendroglia-like cells with viral inclusions in their enlarged nuclei, a diagnostic hallmark of this disease. Today, the pathological features of this disease are expanding, partly due to an unsteady balance between viral virulence and host immunity. Intranuclear viral inclusions were initially thought to be amphophilic materials comprising the entire enlarged nucleus, based on HE staining (full inclusions). Howevewr, recent immunohistochemical analyses detected the presence of intranuclear viral inclusions in dots (dot-shaped inclusions). The dot-shaped inclusions reflect clustered progeny virions at punctuated subnuclear domains called promyelocytic leukemia nuclear bodies, and are indicative of early-stage viral infection or suppressed viral proliferation. Second, the JC virus is usually reactivated in patients with impaired immunity, and therefore the inflammatory reactions are poor. However, the causes of immunosuppression are divergent, as seen with the frequent use of immunosuppressive drugs, including natalizumab. Therefore, the degree of host immunity is variable; some patients show marked anti-viral inflammatory reactions and a good prognosis, indicating that a strong resistance against viral infection remains. Recovery of the immune system may also induce paradoxical clinical worsening, known as immune reconstitution inflammatory syndrome, the mechanism of which has not been clarified. The virus-host interactions have increased in complexity, and the pathology of PML is diverging. In this review, the pathology of PML will be described, with a focus on the intranuclear target of JC virus infection and host inflammatory reactions.	[Shishido-Hara, Yukiko] Kyorin Univ, Sch Med, Dept Pathol, Mitaka, Tokyo 1818611, Japan; [Shishido-Hara, Yukiko] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Tokyo 113, Japan	Shishido-Hara, Y (reprint author), Kyorin Univ, Fac Med, Dept Pathol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	yhara@ks.kyorin-u.ac.jp			Research Committee of Prion Disease and Slow Virus Infection, Ministry of Health, Labour and Welfare, Japan; Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection, The Ministry of Health, Labour and Welfare, Japan	I thank Drs. Hiroshi Kamma (Department of Pathology, Kyorin University School of Medicine) and Toshiki Uchihara (Laboratory of Structural Neuropathology, Tokyo Metropolitan Institute of Medical Science) for their continuous support of this research. This work is supported, in part, by the Research Committee of Prion Disease and Slow Virus Infection and by the Research Committee of Molecular Pathogenesis and Therapies for Prion Disease and Slow Virus Infection, The Ministry of Health, Labour and Welfare, Japan.	Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jmci/djh043; NAGASHIMA K, 1982, ACTA PATHOL JAPON, V32, P333; Shishido-Hara Y, 2010, ACTA NEUROPATHOL, V120, P403, DOI 10.1007/s00401-010-0694-x; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; Shishido-Hara Y, 2000, J VIROL, V74, P1840, DOI 10.1128/JVI.74.4.1840-1853.2000; Tan IL, 2011, NEUROLOGY, V77, P1061, DOI 10.1212/WNL.0b013e31822e55e7; Koralnik IJ, 2001, J VIROL, V75, P3483, DOI 10.1128/JVI.75.7.3483-3487.2001; Gheuens S, 2011, J VIROL, V85, P7256, DOI 10.1128/JVI.02506-10; PADGETT BL, 1977, CANCER RES, V37, P718; CAVANAGH JB, 1959, LANCET, V2, P524; ZOCHODNE DW, 1987, CAN J NEUROL SCI, V14, P603; Salomoni P, 2011, MOL NEUROBIOL, V43, P114, DOI 10.1007/s12035-010-8156-y; Shishido-Hara Y, 2004, J VIROL, V78, P9890, DOI 10.1128/JVI.78.18.9890-9903.2004; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Shishido Y, 1997, J MED VIROL, V51, P265; Shishido-Hara Y, 2008, J NEUROPATH EXP NEUR, V67, P299, DOI 10.1097/NEN.0b013e31816a1dd3; Blair NF, 2012, NEUROLOGY, V78, P507, DOI 10.1212/WNL.0b013e318246d6d8; Metz I, 2012, ACTA NEUROPATHOL, V123, P235, DOI 10.1007/s00401-011-0900-5; PADGETT BL, 1971, LANCET, V1, P1257; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; FRISQUE RJ, 1983, J VIROL, V46, P170; Gasparovic ML, 2009, VIROLOGY, V390, P279, DOI 10.1016/j.virol.2009.05.017; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; NAGASHIMA K, 1981, ACTA PATHOL JAPON, V31, P953; Lee P, 2013, J CLIN VIROL, V57, P141, DOI 10.1016/j.jcv.2013.02.002; NAGASHIMA K, 1984, AM J PATHOL, V116, P455; ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; Shishido-Hara Y, 2014, J NEUROPATH EXP NEUR, V73, P442, DOI 10.1097/NEN.0000000000000066; Phan-Ba R, 2012, J NEUROL NEUROSUR PS, V83, P224, DOI 10.1136/jnnp-2011-300511; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Rice GPA, 2005, NEUROLOGY, V64, P1336; Gheuens S, 2010, J NEUROL NEUROSUR PS, V81, P247, DOI 10.1136/jnnp.2009.187666; Aly L, 2011, BRAIN, V134, P2687, DOI 10.1093/brain/awr206; Du Pasquier RA, 2004, BRAIN, V127, P1970, DOI 10.1093/brain/awh215; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Du Pasquier RA, 2004, J VIROL, V78, P10206, DOI 10.1128/JVI.78.18.10206-10210.2004; Chaudhuri A, 2006, BRIT MED J, V332, P416, DOI 10.1136/bmj.332.7538.416; Vendrely A, 2005, ACTA NEUROPATHOL, V109, P449, DOI 10.1007/s00401-005-0983-y; Weber T, 1997, J INFECT DIS, V176, P250, DOI 10.1086/514032; Shishido-Hara Y, 2012, AM J PATHOL, V180, P1095, DOI 10.1016/j.ajpath.2011.11.036; Tan IL, 2011, NEUROLOGY, V77, P297, DOI 10.1212/WNL.0b013e318225ab3f; LOEBER G, 1988, J VIROL, V62, P1730; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; WALKER DL, 1973, SCIENCE, V181, P674, DOI 10.1126/science.181.4100.674; SCHLITT M, 1986, NEUROSURGERY, V18, P407; Rabellino Andrea, 2013, Front Oncol, V3, P60, DOI 10.3389/fonc.2013.00060; Miravalle A, 2011, ARCH NEUROL-CHICAGO, V68, P186, DOI 10.1001/archneurol.2010.257; Koralnik IJ, 2006, ANN NEUROL, V60, P162, DOI 10.1002/ana.20933; LONDON WT, 1978, SCIENCE, V201, P1246, DOI 10.1126/science.211583; Ayzenberg I, 2012, J NEUROL, V259, P1732, DOI 10.1007/s00415-012-6426-5; Marzocchetti A, 2009, NEUROLOGY, V73, P1551, DOI 10.1212/WNL.0b013e3181c0d4a1; Du Pasquier RA, 2003, J VIROL, V77, P11918, DOI 10.1128/JVI.77.22.11918-11926.2003; Koralnik IJ, 2002, J IMMUNOL, V168, P499; MATSUDA M, 1987, VIRUS RES, V7, P159; Berger Joseph R, 2011, Cleve Clin J Med, V78 Suppl 2, pS8, DOI 10.3949/ccjm.78.s2.03; ZU RHEIN GABRIELE M., 1965, SCIENCE, V148, P1477, DOI 10.1126/science.148.3676.1477; desThe H, 2012, J CELL BIOL, V198, P11; Kleinschmidt-DeMasters BK, 2012, J NEUROPATH EXP NEUR, V71, P604, DOI 10.1097/NEN.0b013e31825caf2c; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Martin-Blondel Guillaume, 2013, F1000Res, V2, P283, DOI 10.12688/f1000research.2-283.v1; Mazza Massimiliano, 2013, Front Oncol, V3, P174, DOI 10.3389/fonc.2013.00174; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Richardson E P Jr, 1975, Acta Neuropathol Suppl, VSuppl 6, P247; Rivera-Molina Yisel A, 2013, World J Virol, V2, P110, DOI 10.5501/wjv.v2.i3.110; SILVERMAN LLOYD, 1965, ACTA NEUROPATHOL, V5, P215	67	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	OCT	2015	35	5					487	496		10.1111/neup.12203		10	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CT1NM	WOS:000362565300011		
J	Nitta, M				Nitta, Muneto			Josephson junction of non-Abelian superconductors and non-Abelian Josephson vortices	NUCLEAR PHYSICS B			English	Article							NONLINEAR SIGMA-MODELS; Q-KINKS; SOLITONS; WALLS; MONOPOLES; KAHLER; PHASE; WEBS	A Josephson junction is made of two superconductors sandwiching an insulator, and a Josephson vortex is a magnetic vortex (flux tube) absorbed into the Josephson junction, whose dynamics can be described by the sine-Gordon equation. In a field theory framework, a flexible Josephson junction was proposed, in which the Josephson junction is represented by a domain wall separating two condensations and a Josephson vortex is a sine-Gordon soliton in the domain wall effective theory. In this paper, we propose a Josephson junction of non-Abelian color superconductors and show that a non-Abelian vortex (color magnetic flux tube) absorbed into it is a non-Abelian Josephson vortex represented as a non-Abelian sine-Gordon soliton in the domain wall effective theory, that is the U(N) principal chiral model. (C) 2015 The Author. Published by Elsevier B.V.	[Nitta, Muneto] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238521, Japan; [Nitta, Muneto] Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 2238521, Japan	Nitta, M (reprint author), Keio Univ, Dept Phys, Hiyoshi 4-1-1, Yokohama, Kanagawa 2238521, Japan.	nitta@phys-h.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23740198, 23103515]	This work is supported in part by Grant-in-Aid for Scientific Research (No. 23740198) and by the "Topological Quantum Phenomena" Grant-in-Aid for Scientific Research on Innovative Areas (No. 23103515) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	ABRIKOSOV AA, 1957, SOV PHYS JETP-USSR, V5, P1174; Eto M, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.125008; Eto M, 2009, NUCL PHYS B, V815, P495, DOI 10.1016/j.nuclphysb.2009.01.019; Eto M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.125011; Eto M, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.105009; Eto M, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.125006; Eto M, 2008, PHYS LETT B, V669, P98, DOI 10.1016/j.physletb.2008.09.007; Isozumi Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.161601; Eto M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.161601; Eto M, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.065021; Auzzi R, 2003, NUCL PHYS B, V673, P187, DOI 10.1016/j.nuclphysb.2003.09.029; Auzzi R, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.045007; Shifman M, 2007, REV MOD PHYS, V79, P1139, DOI 10.1103/RevModPhys.79.1139; Eto M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.125007; Nakano E, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.045002; NIELSEN HB, 1973, NUCL PHYS B, VB 61, P45, DOI 10.1016/0550-3213(73)90350-7; Shifman M, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.125012; Eto M, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.125025; Gudnason SB, 2015, PHYS LETT B, V747, P173, DOI 10.1016/j.physletb.2015.05.062; Higashijima K, 2000, PROG THEOR PHYS, V103, P635, DOI 10.1143/PTP.103.635; Ustinov AV, 1998, PHYSICA D, V123, P315, DOI 10.1016/S0167-2789(98)00131-6; Tanaka Y, 2001, J PHYS SOC JPN, V70, P2844, DOI 10.1143/JPSJ.70.2844; Nitta M, 2015, NUCL PHYS B, V895, P288, DOI 10.1016/j.nuclphysb.2015.04.006; MANTON NS, 1982, PHYS LETT B, V110, P54, DOI 10.1016/0370-2693(82)90950-9; ABRAHAM ERC, 1992, PHYS LETT B, V291, P85, DOI 10.1016/0370-2693(92)90122-K; Isozumi Y, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.125014; Balachandran AP, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.074009; Eto M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.025011; Arai M, 2003, NUCL PHYS B, V652, P35, DOI 10.1016/S0550-3213(03)00009-9; Shifman M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.045004; Gudnason SB, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.085022; Alford MG, 2008, REV MOD PHYS, V80, P1455, DOI 10.1103/RevModPhys.80.1455; Shifman M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.025013; Gurevich A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047004; Arai M, 2005, PROG THEOR PHYS, V113, P657, DOI 10.1143/PTP.113.657; Ferretti L, 2008, NUCL PHYS B, V789, P84, DOI 10.1016/j.nuclphysb.2007.07.021; Eto M, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.105002; Eto M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.085004; Nitta M, 2013, NUCL PHYS B, V872, P62, DOI 10.1016/j.nuclphysb.2013.03.003; Eto M, 2006, PHYS LETT B, V632, P384, DOI 10.1016/j.physletb.2005.10.017; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Eto M, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.045010; Agterberg DF, 1998, PHYS REV LETT, V80, P5184, DOI 10.1103/PhysRevLett.80.5184; Eto M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.161601; ABRAHAM ERC, 1992, PHYS LETT B, V295, P225, DOI 10.1016/0370-2693(92)91558-Q; Eto M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.091602; Arai M., 2003, ARXIVHEPTH0302028, P299; Eto M, 2005, AIP CONF PROC, V805, P354; Eto M, 2006, PHYS REV D, V73, DOI [10.1103/PhysRevD.73.125008, 10.1103/PhysRevD.73.085008]; Eto M, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.085044; Eto M, 2006, J PHYS A-MATH GEN, V39, pR315, DOI 10.1088/0305-4470/39/26/R01; Eto M., 2014, PTEP, V2014; Eto M, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.045015; Eto M, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2011)017; Eto M., 2014, PTEP; Eto M., 2009, J HIGH ENERGY PHYS, V0906, P004; Eto M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.252003; Garaud J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060514; Gauntlett JP, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.085002; Goryo J, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/17002; Gudnason SB, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.025012; Gudnason SB, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.085007; Gudnason SB, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.045018; Hanany A, 2003, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2003/07/037; Hanany A, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/04/066; Isozumi Y, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.065018; Kaurov VM, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011601; Kaurov VM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.013627; Kobayashi M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.120403; Kobayashi M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.085003; Kudryavtsev AE, 2000, PHYS REV D, V61; Nitta M., 2015, PHYS REV D IN PRESS; Nitta M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.025013; Nitta M, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.125004; Shifman M, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.125007; Shifman M, 2009, CAM M MATH, P1, DOI 10.1017/CBO9780511575693; Tanaka Y, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/3/034002; Tong D., ARXIVHEPTH0509216	78	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	OCT	2015	899						78	90		10.1016/j.nuclphysb.2015.07.027		13	Physics, Particles & Fields	Physics	CT2AJ	WOS:000362604100005		
J	Gehrlein, J; Petcov, ST; Spinrath, M; Zhang, XY				Gehrlein, Julia; Petcov, S. T.; Spinrath, Martin; Zhang, Xinyi			Leptogenesis in an SU(5) x A(5) golden ratio flavour model (vol 896, pg 311, 2015)	NUCLEAR PHYSICS B			English	Correction							VIOLATION	We derive and discuss the solution of the Boltzmann equations for leptogenesis in a phenomenologically viable SU(5) x A(5) golden ratio flavour model proposed in [1,2]. The model employs, in particular, the seesaw mechanism of neutrino mass generation. We find that the results on the baryon asymmetry of the Universe, obtained earlier in [2] using approximate analytic expressions for the relevant CP violating asymmetry and efficiency factors, are correct, as was expected, up to 20-30%. The phenomenological predictions for the low energy neutrino observables, derived using values of the parameters of the model for which we reproduce the observed value of the baryon asymmetry, change little with respect to those presented in [2]. Among the many predictions of the model we find, for instance, that the neutrinoless double beta decay effective Majorana mass m(ee) lies between 3.3 meV and 14.3 meV. (C) 2015 The Authors. Published by Elsevier B.V.	[Gehrlein, Julia; Spinrath, Martin] Karlsruhe Inst Technol, Inst Theoret Teilchenphys, D-76131 Karlsruhe, Germany; [Petcov, S. T.] SISSA INFN, I-34136 Trieste, Italy; [Petcov, S. T.] Univ Tokyo, Kavli IPMU WPI, Tokyo, Japan; [Zhang, Xinyi] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Zhang, Xinyi] Peking Univ, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China	Gehrlein, J (reprint author), Karlsruhe Inst Technol, Inst Theoret Teilchenphys, Engesserstr 7, D-76131 Karlsruhe, Germany.	julia.gehrlein@student.kit.edu; martin.spinrath@kit.edu; xinyizhang18@gmail.com					Abada A., 2006, JCAP, V0604, P004; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Angrik J., FZKA7090 KATRIN COLL; Meroni A, 2012, PHYS LETT B, V710, P435, DOI 10.1016/j.physletb.2012.03.006; FUKUGITA M, 1986, PHYS LETT B, V174, P45, DOI 10.1016/0370-2693(86)91126-3; Kajiyama Y, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.117301; Datta A, 2003, NUCL PHYS B, V671, P383, DOI 10.1016/jnuclphysb.2003.08.026; Pascoli S, 2007, NUCL PHYS B, V774, P1, DOI 10.1016/j.nuclphysb.2007.02.019; SAKHAROV AD, 1991, USP FIZ NAUK+, V161, P61; Giudice GF, 2004, NUCL PHYS B, V685, P89, DOI 10.1016/j.nuclphysb.2004.02.01; Davidson S, 2008, PHYS REP, V466, P105, DOI 10.1016/j.physrep.2008.06.002; Antusch S, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.075020; Albert JB, 2014, NATURE, V510, P229, DOI 10.1038/nature13432; Albright CH, 2010, EUR PHYS J C, V70, P1099, DOI 10.1140/epjc/s10052-010-1492-2; Gehrlein J, 2015, NUCL PHYS B, V890, P539, DOI 10.1016/j.nuclphysb.2014.11.023; Antusch S, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.095004; KRASTEV PI, 1988, PHYS LETT B, V205, P84, DOI 10.1016/0370-2693(88)90404-2; Cooper IK, 2013, NUCL PHYS B, V875, P650, DOI 10.1016/j.nuclphysb.2013.07.027; Antusch S, 2013, NUCL PHYS B, V866, P255, DOI 10.1016/j.nuclphysb.2012.09.002; King SF, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/5/056201; Antusch S., 2013, J HIGH ENERGY PHYS, V1301, P187; Antusch S., 2005, JHEP, V0503, P024; Antusch S., 2006, JCAP, V0611; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Everett LL, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.085005; Feruglio F., 2011, JHEP, V1103, P101; Fong C.S., 2010, J COSMOL ASTROPART P, V1012; Forero DV, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.093006; Gehrlein J., ARXIV150200110HEPPH; Gonzalez-Garcia M. C., 2014, J HIGH ENERGY PHYS, V1411, P052; Nardi E., 2006, JHEP, V0601, P164; Smolnikov A. A., ARXIV08124194NUCLEX	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	OCT	2015	899						617	630		10.1016/j.nuclphysb.2015.08.019		14	Physics, Particles & Fields	Physics	CT2AJ	WOS:000362604100031		
J	Hanada, M; Matsuo, Y; Morita, T				Hanada, Masanori; Matsuo, Yoshinori; Morita, Takeshi			Instanton dynamics in finite temperature QCD via holography	NUCLEAR PHYSICS B			English	Article							LARGE-N; GAUGE-THEORY; PHASE-TRANSITION; BLACK STRINGS; T-C; MODEL	We investigate instantons in finite temperature QCD via Witten's holographic QCD. To study the deconfinement phase, we use the setup proposed in [1]. We find that the sizes of the instantons are stabilized at certain values both in the confinement and deconfinement phases. This agrees with the numerical result in the lattice gauge theory. Besides we find that the gravity duals of the large and small instantons in the deconfinement phase have different topologies. We also argue that the fluctuation of the topological charges is large in confinement phase while it is exponentially suppressed in deconfinement phase, and a continuous transition occurs at the Gross-Witten-Wadia (GWW) point. It would be difficult to observe the counterpart of this transition in lattice QCD, since the GWW point in QCD may stay at an unstable branch. (C) 2015 The Authors. Published by Elsevier B.V.	[Hanada, Masanori] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan; [Hanada, Masanori] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Hanada, Masanori] Stanford Univ, Stanford Inst Theoret Phys, Dept Phys, Stanford, CA 94305 USA; [Matsuo, Yoshinori] Univ Crete, Dept Phys, Crete Ctr Theoret Phys, Iraklion 71003, Greece; [Matsuo, Yoshinori] Univ Crete, Dept Phys, Crete Ctr Quantum Complex & Nanotechnol, Iraklion 71003, Greece; [Morita, Takeshi] Shizuoka Univ, Dept Phys, Suruga Ku, Shizuoka 4228529, Japan	Morita, T (reprint author), Shizuoka Univ, Dept Phys, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	hanada@yukawa.kyoto-u.ac.jp; matsuo@physics.uoc.gr; morita.takeshi@shizuoka.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) for Scientific Research [25287046]; European Union [316165]; EU program "Thales" [MIS 375734]; European Union (European Social Fund, ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) under "Funding of proposals that have received a positive evaluation in the 3rd and 4th Call of ERC Grant Schemes"; JSPS [15K17643]	The authors would like to thank Robert Pisarski and Edward Shuryak for stimulating discussions and comments. The authors also would like to thank Tatsuo Azeyanagi and Shotaro Shiba for collaboration in the initial stages of this project. T.M. would like to thank Yukawa Institute for hospitality where part of the work was done. The work of M.H. is supported in part by the Grant-in-Aid of the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) for Scientific Research (No. 25287046). The work of Y.M. is supported in part by European Union's Seventh Framework Programme under grant agreements (FP7-REGPOT-2012-2013-1) No. 316165, the EU program "Thales" MIS 375734 and was also cofinanced by the European Union (European Social Fund, ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) under "Funding of proposals that have received a positive evaluation in the 3rd and 4th Call of ERC Grant Schemes." The work of T.M. is supported in part by Grant-in-Aid for Scientific Research (No. 15K17643) from JSPS.	Aharony O., 2004, QUANTUM GRAVITY, V21, P5169; WADIA SR, 1980, PHYS LETT B, V93, P403, DOI 10.1016/0370-2693(80)90353-6; GOCKSCH A, 1983, PHYS REV LETT, V50, P1099, DOI 10.1103/PhysRevLett.50.1099; Semenoff GW, 1996, PHYS REV LETT, V77, P2174, DOI 10.1103/PhysRevLett.77.2174; Aharony O, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.125018; GROSS DJ, 1980, PHYS REV D, V21, P446, DOI 10.1103/PhysRevD.21.446; GROSS DJ, 1981, REV MOD PHYS, V53, P43, DOI 10.1103/RevModPhys.53.43; Gubser SS, 1998, PHYS LETT B, V428, P105, DOI 10.1016/S0370-2693(98)00377-3; Aharony O, 2007, ANN PHYS-NEW YORK, V322, P1420, DOI 10.1016/j.aop.2006.11.002; Peet AW, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.065011; Kogan II, 1999, NUCL PHYS B, V539, P121, DOI 10.1016/S0550-3213(98)00760-3; Witten E, 1998, PHYS REV LETT, V81, P2862, DOI 10.1103/PhysRevLett.81.2862; Wu C, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.026016; EGUCHI T, 1982, PHYS REV LETT, V48, P1063, DOI 10.1103/PhysRevLett.48.1063; Chu CS, 1999, NUCL PHYS B, V541, P179, DOI 10.1016/S0550-3213(98)00802-5; Alvarez-Gaume L, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.124023; Gattringer C, 2002, PHYS LETT B, V535, P358, DOI 10.1016/S0370-2693(02)01757-4; Aharony O, 2000, PHYS REP, V323, P183, DOI 10.1016/S0370-1573(99)00083-6; Sakai T, 2005, PROG THEOR PHYS, V113, P843, DOI 10.1143/PTP.113.843; Azuma T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.091603; GREGORY R, 1994, NUCL PHYS B, V428, P399, DOI 10.1016/0550-3213(94)90206-2; Lucini B, 2005, NUCL PHYS B, V715, P461, DOI 10.1016/j.nuclphysb.2005.02.037; Kol B, 2006, PHYS REP, V422, P119, DOI 10.1016/j.physrep.2005.10.001; Barbon JLF, 1999, PHYS LETT B, V458, P288, DOI 10.1016/S0370-2693(99)00607-3; Hanada M, 2007, J HIGH ENERGY PHYS; Kim Y, 2013, PROG PART NUCL PHYS, V68, P55, DOI 10.1016/j.ppnp.2012.09.002; Azeyanagi T., 2009, JHEP, V0903, P121; Azuma T., 2012, J HIGH ENERGY PHYS, V1210; Balasubramanian V, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.104021; Bergman O., 2007, JHEP, V0704; Berkowitz E., ARXIV150507455HEPPH; Bianchi M., 1998, J HIGH ENERGY PHYS, V9808; Catterall S., 2010, J HIGH ENERGY PHYS, V1012; Gorbonos D., J HIGH ENERGY PHYS, V0406; Gross DJ, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.106002; Harmark T., 2007, CLASS QUANTUM GRAVIT, V24; Harmark T, 2004, J HIGH ENERGY PHYS; Harmark T., 2002, JHEP, V0205; Itzhaki N, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.046004; Kawahara N., 2007, JHEP, V0710; Kitano R., ARXIV150600370HEPPH; Kruczenski M, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/05/041; Kudoh H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.161102; Maldacena J M, 1998, ADV THEOR MATH PHYS, V2, P231, DOI DOI 10.1023/A:1026654312961; Mandal G., 2011, J HIGH ENERGY PHYS, V1109; Mandal G., 2010, JHEP, V1002; Mateos D., 2007, JHEP, V0705; Morita T., ARXIV14123939HEPTH; Seki S., 2013, J HIGH ENERGY PHYS, V1310, P223; Sorkin E, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.104027; Susskind L., ARXIVHEPTH9805114; Wadia S.R., ARXIV12122906HEPTH; WITTEN E, 1980, ANN PHYS-NEW YORK, V128, P363, DOI 10.1016/0003-4916(80)90325-5; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI DOI 10.1016/S0370-1573(99)00083-6	54	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	OCT	2015	899						631	650		10.1016/j.nuclphysb.2015.08.018		20	Physics, Particles & Fields	Physics	CT2AJ	WOS:000362604100032		
J	Ito, H; Kawamura, M; Badhwar, N; Vedantham, V; Tseng, ZH; Lee, BK; Lee, RJ; Marcus, GM; Gerstenfeld, EP; Scheinman, MM				Ito, Hiroyuki; Kawamura, Mitsuharu; Badhwar, Nitish; Vedantham, Vasanth; Tseng, Zian H.; Lee, Byron K.; Lee, Randall J.; Marcus, Gregory M.; Gerstenfeld, Edward P.; Scheinman, Melvin M.			The Effect of Direct Current Stimulation versus T-Wave Shock on Defibrillation Threshold Testing	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						defibrillation threshold testing; shock on T; direct current voltage; tachycardia cycle length; electromechanical dissociation	IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CHRONIC AMIODARONE THERAPY; SUDDEN CARDIAC DEATH; VENTRICULAR-FIBRILLATION; CLINICAL PREDICTORS; INDUCTION; INSERTION; VOLTAGE	IntroductionThere are several methods to induce ventricular fibrillation (VF) during defibrillation threshold (DFT) testing. Delivering a shock at a critical time during the T wave (T-shock) is the conventional approach, while delivering a constant direct current voltage (DC stim) from the implantable cardioverter defibrillator is an alternative method. Only a few reports compare VF induction methods. The purpose of this study was to evaluate the effects and safety of DC stim versus T-shock. MethodsWe retrospectively investigated 414 consecutive patients undergoing DFT testing. We compared the two groups (DC stim and T-shock) with respect to clinical characteristics, electrocardiogram (ECG) changes, and complications. ResultsVentricular arrhythmia, including ventricular tachycardia (VT) and VF, was induced by DC stim in 93 patients or T-shock in 321 patients. No more than three attempts were performed during one procedure. There was no significant difference in the baseline ECG, induced tachycardia cycle length (TCL), or complications between the two groups. However, the induced TCL was significantly shorter than the clinical TCL regardless of induction method (P = 0.001). Five patients suffered major complications (i.e., electromechanical dissociation or incessant VT). A history of atrial fibrillation was significantly greater in patients with major complications than the others (80% vs 24%, P = 0.004), and was an independent predictor on multivariate analysis. ConclusionsThere is no significant difference in induced TCL or complications between the DC stim and T-shock. The induced TCL is significantly shorter than clinical TCL regardless of induction method.	[Ito, Hiroyuki; Badhwar, Nitish; Vedantham, Vasanth; Tseng, Zian H.; Lee, Byron K.; Lee, Randall J.; Marcus, Gregory M.; Gerstenfeld, Edward P.; Scheinman, Melvin M.] Univ Calif San Francisco, Div Cardiac Electrophysiol, San Francisco, CA 94143 USA; [Kawamura, Mitsuharu] Showa Univ, Dept Med, Div Cardiol, Tokyo, Japan	Ito, H (reprint author), Univ Calif San Francisco, Div Cardiac Electrophysiol, 500 Parnassus Ave,MUE 434, San Francisco, CA 94143 USA.	hiroic2004@yahoo.co.jp			Japanese Heart Rhythm Society; Medtronic	Dr. Ito reports a fellowship from the Japanese Heart Rhythm Society. Dr. Byron Lee reports a research support from Medtronic and speaking honoraria from Biotronik. Dr. Marcus reports a research support from Medtronic. Other authors: no disclosures.	Rubenstein JC, 2013, J INTERV CARD ELECTR, V38, P137, DOI 10.1007/s10840-013-9819-1; Swerdlow CD, 2007, PACE, V30, P675, DOI 10.1111/j.1540-8159.2007.00730.x; Hammill SC, 2010, HEART RHYTHM, V7, P1340, DOI 10.1016/j.hrthm.2010.07.015; Chen J, 2013, J AM COLL CARDIOL, V61, P2161, DOI 10.1016/j.jacc.2013.02.046; Sharma AD, 2004, PACE, V27, P89, DOI 10.1111/j.1540-8159.2004.00391.x; Mitchell LB, 2002, J AM COLL CARDIOL, V39, P1323, DOI 10.1016/S0735-1097(02)01784-9; Russo AM, 2014, CARDIOL CLIN, V32, P211, DOI 10.1016/j.ccl.2014.01.003; Russo AM, 2005, HEART RHYTHM, V2, P456, DOI 10.1016/j.hrthm.2005.01.015; Murakawa Y, 1999, PACE, V22, P302, DOI 10.1111/j.1540-8159.1999.tb00442.x; Shukla HH, 2003, PACE, V26, P44; Taneja T, 2000, J CARDIOVASC ELECTR, V11, P1355, DOI 10.1046/j.1540-8167.2000.01355.x; Pelosi F, 2000, J CARDIOVASC ELECTR, V11, P736, DOI 10.1111/j.1540-8167.2000.tb00043.x; PINSKI SL, 1991, AM HEART J, V122, P89, DOI 10.1016/0002-8703(91)90763-8; Smits K, 2011, PACE, V34, P1515, DOI 10.1111/j.1540-8159.2011.03166.x; Bhandari AK, 1998, J ELECTROCARDIOL, V31, P31, DOI 10.1016/S0022-0736(98)90004-8; Lin EF, 2013, PACE, V36, P231, DOI 10.1111/pace.12039; Euler DE, 1999, PACE, V22, P908, DOI 10.1111/j.1540-8159.1999.tb06815.x; Lever NA, 2007, EUROPACE, V9, P1054, DOI 10.1093/europace/eum194; Mainigi SK, 2006, HEART RHYTHM, V3, P1010, DOI 10.1016/j.hrthm.2006.05.028; Birnie D, 2008, HEART RHYTHM, V5, P387, DOI 10.1016/j.hrthm.2007.11.018; Ideker RE, 2005, HEART RHYTHM, V2, P462, DOI 10.1016/j.hrthm.2005.02.004; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Josephson ME, 2000, ANN INTERN MED, V133, P901; STROHMENGER HU, 1994, ANESTH ANALG, V79, P434; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Gold MR, 1997, AM J CARDIOL, V79, P1623; Niemann JT, 2007, CRIT CARE MED, V35, P1356, DOI 10.1097/01.CCM.0000261882.47616.7D; JUNG W, 1992, AM J CARDIOL, V70, P1023, DOI 10.1016/0002-9149(92)90354-2; SINGER I, 1987, J AM COLL CARDIOL, V10, P382; Zima E, 2006, J CARDIOVASC ELECTR, V17, P377, DOI 10.1111/j.1540-8167.2006.00352.x	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	OCT	2015	38	10					1173	1180		10.1111/pace.12684		8	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	CT1MZ	WOS:000362563900006		
J	Ehiro, M; Sasaki, O; Kano, H; Nemoto, J; Kato, H				Ehiro, Masayuki; Sasaki, Osamu; Kano, Harumasa; Nemoto, Jun; Kato, Hisayoshi			Thylacocephala (Arthropoda) from the Lower Triassic of the South Kitakami Belt, Northeast Japan	PALEONTOLOGICAL RESEARCH			English	Article						Arthropoda; Early Triassic; Osawa Formation; South Kitakami Belt; Thylacocephala	OSAWA FORMATION; CRUSTACEA; FOSSIL; LAGERSTATTE	A thylacocephalan fauna from the upper Olenekian (Lower Triassic) Osawa Formation in the South Kitakami Belt, Northeast Japan, is described. The fauna comprises three species belonging to three genera: Ankitokazocaris bandoi Ehiro and Kato sp. nov., Kitakamicaris utatsuensis Ehiro and Kato gen. et sp. nov., and Ostenocaris sp. This is the first report of fossils belonging to the class Thylacocephala from Japan, and it expands their paleogeographic distribution. As almost all genera of Thylacocephala inhabited low-latitude areas in each relevant geological time, their occurrence from the Osawa Formation supports previous opinions that the South Kitakami Belt was located in the equatorial region during the Triassic.	[Ehiro, Masayuki; Sasaki, Osamu; Kano, Harumasa; Nemoto, Jun] Tohoku Univ, Tohoku Univ Museum, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kato, Hisayoshi] Nat Hist Museum & Inst, Chuo Ku, Chiba 2608682, Japan	Ehiro, M (reprint author), Tohoku Univ, Tohoku Univ Museum, Aoba Ku, 6-3 Aramaki Aoba, Sendai, Miyagi 9808578, Japan.	ehiro@m.tohoku.ac.jp					Vannier J, 2006, ACTA PALAEONTOL POL, V51, P201; Brayard A, 2009, J ASIAN EARTH SCI, V36, P420, DOI 10.1016/j.jseaes.2008.05.004; Forchielli A, 2013, AUSTRIAN J EARTH SCI, V106, P46; Nakajima Y, 2014, PALAEOGEOGR PALAEOCL, V414, P225, DOI 10.1016/j.palaeo.2014.08.014; Hegna TA, 2014, J PALEONTOL, V88, P606, DOI 10.1666/13-131; Lange S, 2001, PALAEONTOLOGY, V44, P905, DOI 10.1111/1475-4983.00207; Schram FR, 2014, CRUSTACEANA, V87, P340, DOI 10.1163/15685403-00003289; ARDUINI P, 1984, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V125, P48; ARDUINI P, 1988, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V129, P159; Arduini P., 1992, ATTI SOC ITALIANA SC, V132, P265; ARDUINI P, 1984, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V125, P87; ARDUINI P, 1980, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V121, P360; ARDUINI P, 1990, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V131, P197; Arthaber G. V., 1911, BEITRAGE PALAONTOLOG, V24, P169; BANDO Y, 1982, Transactions and Proceedings of the Palaeontological Society of Japan New Series, P375; BANDO Y, 1974, Transactions and Proceedings of the Palaeontological Society of Japan New Series, P293; Briggs D.E.G., 1983, SPEC PAP PALAEONTOL, V30, P249; Calzada Sebastian, 1993, Trabajos del Museo Geologico del Seminario de Barcelona, V224, P13; dalla Vecchia F.M., 1990, Bollettino della Societa Paleontologica Italiana, V29, P39; Dalla Vecchia F. M., 1993, GORTANIA ATTI MUSEO, V14, P59; Dames W., 1886, Z DTSCH GEOLOGISCHEN, V38, P551; Ehiro M, 1999, GONDWANA DISPERSION AND ASIAN ACCRETION, P283; Ehiro M., 2001, EARTH SCI, V55, P71; Ehiro Masayuki, 1993, Transactions and Proceedings of the Palaeontological Society of Japan New Series, V171, P229; Ehiro M., 1997, PALAEONTOLOGY HIST G, V12, P18; GLAESSNER MARTIN F., 1931, JAHRB GEOL BUNDESANST [WIEN], V81, P467; Guex Jean, 2005, Bulletin de Geologie Lausanne, V363, P1; Haug C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0159-2; Hyatt A., 1905, US GEOL SURV PROF PA, P1; Kamada K., 1991, SAITO HO ON KAI SPEC, V3, P423; Kato Takafumi, 1995, Journal of the Geological Society of Japan, V101, P466; Keyserling A., 1845, B ACAD IMPER SCI ST, V5, P161; KON'NO E, 1973, Science Reports of the Tohoku University Second Series (Geology), V43, P99; Kriznar Matija, 2010, Scopolia, P91; Meek F. B., 1868, AM J SCI 2, V46, P22; Murata M., 1973, SCI REP TOHOKU U, P267; Murata M., 1978, KUMAMOTO J SCI GEOLO, V11, P5; Onuki Y., 1959, CONTRIBUTIONS I GEOL, P1; Pinna G., 1974, AT SOC IT SC NAT, V21, P7; PINNA G, 1982, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V123, P469; Pinna G., 1976, Natura Bresciana, V13, P33; Rolfe W. D. I., 1969, TREATISE INVERTEBR R, P296; Rolfe W.D.I., 1985, Transactions of the Royal Society of Edinburgh Earth Sciences, V76, P391; Scotese C. R., 2002, PALEOMAP PROJECT; SECRETAN S, 1983, CR ACAD SCI II, V296, P741; Shen Y.-b., 1983, Acta Palaeontologica Sinica, V22, P346; Shikama T., 1978, SCI REP TOHOKU U, V48, P77; SPATH L. F., 1930, MEDDEL OM GRONLAND, V83, P1; Sugiyama T., 1942, J GEOLOGICAL SOC JAP, V49, P390; Takahashi Y, 2014, PALEONTOL RES, V18, P258, DOI 10.2517/2014PR023; Van Straelen V., 1923, B SOC GEOLOGIQUE FRA, V23, P431; Arthaber Gustav von., 1908, Mitteilungen der Geologischen Gesellschaft in Wien, V1	52	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	OCT	2015	19	4					269	282		10.2517/2015PR010		14	Paleontology	Paleontology	CT3BV	WOS:000362681900001		
J	Shiino, Y; Suzuki, Y				Shiino, Yuta; Suzuki, Yutaro			A rectifying effect by internal structures for passive feeding flows in a concavo-convex productide brachiopod	PALEONTOLOGICAL RESEARCH			English	Article						biophysiology; Echinoconchoidea; functionality; hydrodynamics; Strophomenata; suspension feeder	PARASPIRIFER; MORPHOLOGY	It has been experimentally shown that the shell morphology of concavo-convex productide brachiopods has the potential to generate passive flows for feeding. However, there still remains the problem of how the presence of internal soft parts influences the course and pattern of the flows. To clarify the effect of soft parts, we performed additional experiments of fluid visualisation using a flow tank and a transparent, polyhedral model with supposed soft parts in a postero-median region. Regardless of the ambient flow directions, the experimental results showed that inflows through ear gapes turned into symmetrical vortices inside the model. The soft parts altered the course of internal flows and interfered with the vortices entering the median region. Therefore, stepwise inflows pushed the precedent vortices forward as the rotational speed decreased. As a result, the slower vortices aligned with the brachial ridges on which the lophophore was arranged. Morphologically, productide brachial ridges tend to lie in the antero-lateral corners of the dorsal disc. The rectifying effect by means of soft parts, though consequential, would enable productides to sieve food particles from gentle vortices rather than from swift vortices just after the inflow through the ear gapes.	[Shiino, Yuta] Niigata Univ, Inst Sci & Technol, Acad Assembly, Nishi Ku, Niigata 9502181, Japan; [Suzuki, Yutaro] Shizuoka Univ, Inst Geosci, Suruga Ku, Shizuoka 4228529, Japan	Shiino, Y (reprint author), Niigata Univ, Inst Sci & Technol, Acad Assembly, Nishi Ku, 8050,Ikarashi 2 Cho, Niigata 9502181, Japan.	y-shiino@geo.sc.niigata-u.ac.jp			Uchida Energy Science Promotion Foundation; Sasakawa Scientific Research Grant from The Japan Science Society; JSPS KAKENHI Grant [25630047, 26400503, 25400496]	We thank reviewers Guang R. Shi (Deakin University) and Takao Ubukata (Kyoto University) for their helpful comments and constructive suggestions. This study was supported in part by the Uchida Energy Science Promotion Foundation, by the Sasakawa Scientific Research Grant from The Japan Science Society and by JSPS KAKENHI Grant numbers 25630047, 26400503 and 25400496.	Tomasovych A, 2008, PALAEONTOLOGY, V51, P1471, DOI 10.1111/j.1475-4983.2008.00809.x; Shiino Y, 2009, J THEOR BIOL, V259, P132, DOI 10.1016/j.jtbi.2009.02.018; Shiino Y, 2011, LETHAIA, V44, P329, DOI 10.1111/j.1502-3931.2010.00243.x; Shiino Y, 2011, J THEOR BIOL, V276, P192, DOI 10.1016/j.jtbi.2011.02.004; JAMES MA, 1992, ADV MAR BIOL, V28, P175, DOI 10.1016/S0065-2881(08)60040-1; Leighton LR, 2000, PALAIOS, V15, P184, DOI 10.2307/3515641; Shiino Yuta, 2007, Paleontological Research, V11, P265, DOI 10.2517/1342-8144(2007)11[265:AAMSIA]2.0.CO;2; Dhar SR, 1997, INVERTEBR BIOL, V116, P142, DOI 10.2307/3226978; Shiino Y, 2014, LETHAIA, V47, P216, DOI 10.1111/let.12052; Shiino Y, 2010, LETHAIA, V43, P223, DOI 10.1111/j.1502-3931.2009.00185.x; Shiino Y, 2010, J EVOLUTION BIOL, V23, P1547, DOI 10.1111/j.1420-9101.2010.02024.x; Shiino Y, 2011, ISL ARC, V20, P203, DOI 10.1111/j.1440-1738.2011.00760.x; Brunton C. H. C., 2000, TREATISE INVERTEBR H, V2, P350; Carlson S. J., 2001, BRACHIOPODS ANCIENT, P89; Curry G. B., 2007, TREATISE INVERTEBR H, V6, P2901; GRANT RICHARD E., 1968, J PALEONTOL, V42, P1; GRANT R E, 1976, Paleontological Society Memoir, V9, P1; GRANT RE, 1976, J PALEONTOL, V50, P1; Hjulstrom F., 1935, B GEOLOGICAL I U UPS, V25, P222; Prendergast K. L., 1935, Journal of the Royal Society of Western Australia, V21, P9; Rudwick M. J. S., 1970, LIVING FOSSIL BRACHI; Williams Alwyn, 1997, P321; Williams A, 1997, TREATISE INVERTEBRAT, V1, P7	23	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	OCT	2015	19	4					283	287		10.2517/2015PR011		5	Paleontology	Paleontology	CT3BV	WOS:000362681900002		
J	Niko, S; Sone, M				Niko, Shuji; Sone, Masatoshi			Gondwanan nautiloid cephalopods from the Ordovician of Myanmar	PALEONTOLOGICAL RESEARCH			English	Article						Darriwilian (Middle Ordovician); northern Gondwana; Sibumasu Block; Sibumasuoceras gen. nov.; Tasmanoceras		Two species of Darriwilian (late Middle Ordovician) nautiloid cephalopods are described from the Wunbye Formation and its equivalent strata in the Shan Plateau of Myanmar (Sibumasu Block). They are the orthocerid Sibumasuoceras langkawiense (Kobayashi) and the discosorid Tasmanoceras sp. First, Sibumasuoceras is proposed for a new genus of the cayutoceratin pseudorthoceratids. Sibumasuoceras langkawiense [originally Ormoceras langkawiense, the type species of the genus] was previously assigned either to the Actinocerida or the Discosorida. However, the present investigations reveal that it possesses thin connecting rings and differentiated endosiphuncular deposits and lacks a detailed endosiphuncular canal system, all suggestive of a relationship to the Orthocerida. Sibumasuoceras is known to occur so far from Malaysia and Myanmar of the Sibumasu Block, which was part of northern Gondwana during the early Palaeozoic. Second, the rare genus Tasmanoceras, which was previously known only in Tasmania, is confirmed in Southeast Asia for the first time; this implies an Ordovician marine biotic linkage between Sibumasu and Tasmania over northern Gondwana.	[Niko, Shuji] Hiroshima Univ, Fac Integrated Arts & Sci, Dept Environm Studies, Higashihiroshima, Hiroshima 7398521, Japan; [Sone, Masatoshi] Univ Malaya, Fac Sci, Dept Geol, Kuala Lumpur 50603, Malaysia	Niko, S (reprint author), Hiroshima Univ, Fac Integrated Arts & Sci, Dept Environm Studies, 1-7-1 Kagamiyama, Higashihiroshima, Hiroshima 7398521, Japan.	niko@hiroshima-u.ac.jp			High Impact Research Grant [UM.C/625/1/HIR/140]; UM Research Grant from the University of Malaya [RG146-11AFR]	We thank Aye Ko Aung (University of Malaya) for providing opportunities to examine the specimens kept in Dagon University and information on regional stratigraphy of Shan Plateau, Myanmar. The manuscript benefited from comments of the two anonymous reviewers. This study was supported by a High Impact Research Grant UM.C/625/1/HIR/140 and a UM Research Grant RG146-11AFR from the University of Malaya.	Agassiz L., 1847, INTRO STUDY NATURAL; STAIT B, 1980, J PALEONTOL, V54, P1113; Niko S, 2014, PALEONTOL RES, V18, P94, DOI 10.2517/2014PR010; ZHURAVLEVA FA, 1957, DOKL AKAD NAUK SSSR+, V116, P677; Aung Aye Ko, 2012, J MYANMAR GEOSCIENCE, V5, P1; Chen Junyuan, 1976, Acta Palaeontologica Sinica, V15, P55; Chen J., 1984, MEMOIRS NANJING I GE, V20, P33; Chen J., 1981, Memoirs of Nanjing Institute of Geology and Palaeontology, V13, P1; Flower R. H., 1968, Bulletin Geological Survey of Canada, VNo. 164, P1; Flower R. H., 1935, B AM PALEONTOL, V22, P199; Flower R. H., 1939, Palaeontographica Americana, V2, P1; FLOWER ROUSSEAU H., 1950, JOUR PALEONTOL, V24, P604; Jones C. R., 1981, GEOLOGICAL SURVEY MA, V17, P1; KOBAYASHI TEHCHI, 1958, JAPANESE JOUR GEOL AND GEOGR, V29, P223; Kobayashi T., 1959, J FAC SCI U TOKYO, V11, P387; Kuhn O., 1940, PALAOZOOLOGIE TABELL; Lai C.-g., 1986, Acta Palaeontologica Sinica, V25, P248; SCOTESE C. R., 1991, ADV ORDOVICIAN GEOLO, P271; Stait B., 1987, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V174, P373; STAIT B, 1984, Proceedings of the Royal Society of Victoria, V96, P187; TEICHERT CURT, 1952, JOUR PALEONTOL, V26, P730; Teichert C., 1954, Bulletins of American Paleontology, V34, P1; Thein M. L., 1973, GEOLOGICAL SURVEY MA, V6, P67; Zhuravleva F. A., 1961, PALEONTOL ZH, V1961, P55	24	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	OCT	2015	19	4					288	293		10.2517/2015PR008		6	Paleontology	Paleontology	CT3BV	WOS:000362681900003		
J	Tomida, S; Hosoda, E				Tomida, Susumu; Hosoda, Eisaku			Discovery of Turbo (Marmarostoma) matsuzakiensis Tomida and Kadota with an in situ operculum from the middle Miocene Yugashima Group of Izu Peninsula, central Japan	PALEONTOLOGICAL RESEARCH			English	Article						in situ operculum; middle Miocene; Shikura Limestone; Shizuoka Prefecture; Turbo (Marmarostoma) matsuzakiensis; Yugashima Group	GASTROPODA TURBINIDAE	Turbo (Marmarostoma) matsuzakiensis Tomida and Kadota with an in situ operculum was found in limestone within the tuffaceous sandstone of the middle Miocene Yugashima Group, at Shikura, Shizuoka Prefecture, Japan. The presence of an operculum on T. (M.) matsuzakiensis Tomida and Kadota is confirmed and described in this paper, and demonstrates the autochthonous occurrence of the fossil.	[Tomida, Susumu] Paleonto, Tajimi, Gifu, Japan	Tomida, S (reprint author), Paleonto, 2-20-63,Hime Cho, Tajimi, Gifu, Japan.	t_susumu@ob.aitai.ne.jp					LINSLEY RM, 1989, J PALEONTOL, V63, P206; Peel JS, 1996, PALAEONTOLOGY, V39, P709; Tomida S, 2014, PALEONTOL RES, V18, P67, DOI 10.2517/2014PR007; GORDON M, 1982, J PALEONTOL, V56, P260; Tomida Susumu, 2012, Venus (Tokyo), V70, P53; Rohr DM, 2008, J PALEONTOL, V82, P604, DOI 10.1666/07-006.1; OKADA H, 1980, MAR MICROPALEONTOL, V5, P321, DOI 10.1016/0377-8398(80)90016-X; Bruguiere J. G., 1789, ENCY METHODIQUE ORDR, VPremier, p[iii, xviii, 758]; Gradstein F. M., 2004, GEOLOGIC TIME SCALE; Guvanov A. P., 1994, J PALEONTOL, V68, P486; Hirooka K., 1985, FORMATION ACTIVE OCE, P775; Horny Radvan J., 1995, Journal of the Czech Geological Society, V40, P79; Iwasaki Y., 1980, KUMAMOTO J SCI GEOLO, V12, P11; Kase T., 1980, T P PALAEONTOLOGICAL, P361; Koyama M., 1986, CHIKYU MONTHLY, V8, P743; Lightfoot R. J., 1786, CATALOGUE PORTLAND M; Linnaeus C., 1758, SYSTEMA NATURAE REGN; Majima R., 1986, GEOLOGICAL NEWS, P14; MAJIMA R, 1984, Transactions and Proceedings of the Palaeontological Society of Japan New Series, P361; Matsuoka K., 1981, B MIZUNAMI FOSSIL MU, V8, P105; Noda H., 1980, VENUS JAPANESE J MAL, V39, P53; Okada H., 1987, FOSSILS, P5; Okada H., 1986, INT KAIK C TOK; Rafinesque C.S., 1815, ANAL NATURE TABLEAU; Saito T., 1999, J JAPANESE ASS PETRO, V64, P2; Sasaki T., 2000, MARINE MOLLUSKS JAPA, P88; Swainson W., 1829, ZOOLOGICAL ILLUSTRAT, V1; Uno Y., 1962, J TOKYO U FISH, V6, P1; Vermej GJ, 2007, J MOLLUS STUD, V73, P67, DOI 10.1093/mollus/eyl032; Yabe H., 1906, J GEOLOGICAL SOC JAP, V13, P317	30	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	OCT	2015	19	4					294	298		10.2517/2015PR012		5	Paleontology	Paleontology	CT3BV	WOS:000362681900004		
J	Kase, T; Kurihara, Y; Aguilar, YM; Pandita, H; Fernando, AGS; Hayashi, H				Kase, Tomoki; Kurihara, Yukito; Aguilar, Yolanda M.; Pandita, Hita; Fernando, Allan Gil S.; Hayashi, Hiroki			A new cerithioidean genus Megistocerithium (Gastropoda; Mollusca) from the Miocene of Southeast Asia: a possible relict of Mesozoic "Eustomatidae"	PALEONTOLOGICAL RESEARCH			English	Article						Cerithioidea; Gastropoda; Java; Megistocerithium; Miocene; Philippines	CERITHIFORM GASTROPODS; MANGROVE FOREST; LEAF-LITTER; POTAMIDIDAE; TEREBRALIA; CAENOGASTROPODA; PROSOBRANCHIA; MORPHOLOGY; EVOLUTION; PACIFIC	Based upon large cerithiform gastropod specimens from the middle Miocene beds of Java, Indonesia and the Philippines, a new genus and new species, Megistocerithium magoi, is described herein. Ten fragmentary specimens from the lower and upper Miocene beds of the Philippines are tentatively referred to this species. M. magoi Kase sp. nov. is amongst the largest fossil cerithioidean gastropods (except for Turritellidae). It was a dweller in intertidal sandy mudflats, probably in close proximity to mangrove forests. No species considered to be congeneric with this species have been found in the Cenozoic. On the other hand, M. magoi Kase gen. et sp. nov. shares apertural characters with the Middle Jurassic species Eustoma tuberculosa, the type species of a genus belonging to the yet to be well-recognized family Eustomatidae. M. magoi Kase gen. et sp. nov. is possibly a relict of the Mesozoic Eustomatidae. It is assumed to have been a grazer on mangrove litter like the potamidid genera Terebralia and Telescopium in modern mangrove swamps.	[Kase, Tomoki] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Kurihara, Yukito] Mie Univ, Fac Educ, Dept Geol, Tsu, Mie 5148507, Japan; [Aguilar, Yolanda M.] Mines & Geosci Bur, Marine Geol Survey, Quezon City 1101, Philippines; [Pandita, Hita] Sekolah Tinggi Teknol Nas Yogyakarta, Tekn Geol, Depok Sleman 55281, Yogyakarta, Indonesia; [Fernando, Allan Gil S.] Univ Philippines, Natl Inst Geol Sci, Quezon City 1101, Philippines; [Hayashi, Hiroki] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Dept Geosci, Matsue, Shimane 6908504, Japan	Kase, T (reprint author), Natl Museum Nat & Sci, Dept Geol & Paleontol, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan.	kase@kahaku.go.jp			National Museum of Nature and Science, Tokyo; Japan Society for the Promotion of Science (JSPS) [18253007]	We would like to thank L. L. Jasareno (Director, Mines and Geosciences Bureau, Philippines) for a research permit, and W. Mago and E. Azurin (Mines and Geosciences Bureau, Philippines) for their assistance during fieldwork. We also thank C. Skovsted (Swedish Museum of Natural History), T. Sasaki (University Museum, the University of Tokyo), and Y. Kobayashi (Hokkaido University Museum, Hokkaido University) for the loan of the specimens under their care, E. Robert (University of Lyon 1, France), who provided high-resolution images of the syntypes of Eustoma tuberculosus, and R. Nakashima, who provided us with one of the references. Thanks are also due to A. Kaim (Polish Academy of Sciences, Poland), an anonymous reviewer for their helpful comments on the manuscript and A. G. Beu (Institute of Geological and Nuclear Sciences, New Zealand) for his improvement of the English text. This study was funded by the National Museum of Nature and Science, Tokyo and a Grant-In-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (no. 18253007).	Akopjan V. T., 1976, LATE CRETACEOUS GAST; Akopjan V. T., 1972, IZVESTIIA AKAD NAUK, V25, P3; [Anonymous], 1998, MOLLUSCA SO SYNTHESI; HASZPRUNAR G, 1988, J MOLLUS STUD, V54, P367, DOI 10.1093/mollus/54.4.367; Batenburg SJ, 2011, PALAEOGEOGR PALAEOCL, V306, P75, DOI 10.1016/j.palaeo.2011.03.031; RODELLI MR, 1984, OECOLOGIA, V61, P326, DOI 10.1007/BF00379629; Vermeij GJ, 2012, BIOL J LINN SOC, V106, P776, DOI 10.1111/j.1095-8312.2012.01897.x; Hikuroa DCH, 2007, ANTARCT SCI, V19, P115, DOI 10.1017/S0954102007000168; Inoue Keisuke, 2007, Paleontological Research, V11, P277, DOI 10.2517/1342-8144(2007)11[277:BAPGFT]2.0.CO;2; Salgeback Jenny, 2006, Paleontological Research, V10, P233, DOI 10.2517/prpsj.10.233; ALEXANDER CG, 1979, COMP BIOCHEM PHYS B, V64, P83, DOI 10.1016/0305-0491(79)90187-1; Saul LR, 2003, J PALEONTOL, V77, P442, DOI 10.1666/0022-3360(2003)077<0442:NCCGFT>2.0.CO;2; CHINZEI K, 1978, VELIGER, V21, P155; Fratini S, 2004, MAR BIOL, V144, P1173, DOI 10.1007/s00227-003-1282-6; Bachok Z, 2003, J EXP MAR BIOL ECOL, V292, P187, DOI 10.1016/S0022-0981(03)00160-6; Lesport JF, 2002, NEUES JAHRB GEOL P-A, V223, P1; Vermeij GJ, 2011, P ROY SOC B-BIOL SCI, V278, P2362, DOI 10.1098/rspb.2010.2362; HOUBRICK RS, 1991, MALACOLOGIA, V33, P289; Bouillon S, 2004, MAR ECOL PROG SER, V278, P77, DOI 10.3354/meps278077; HOUBRICK RS, 1981, MALACOLOGIA, V21, P263; Slim FJ, 1997, J EXP MAR BIOL ECOL, V215, P35, DOI 10.1016/S0022-0981(97)00029-4; Colgan DJ, 2007, MOL PHYLOGENET EVOL, V42, P717, DOI 10.1016/j.ympev.2006.10.009; Harzhauser M, 2007, PALAEONTOGR ABT A, V280, P75; Archiac A. d', 1851, HIST PROGRES GEOLOGI, V3; Archiac A. d', 1853, DESCRIPTION ANIMAUX; Brander G., 1766, FOSSILIA HANTONIENSI; Bruguiere J. G., 1789, ENCY METHODIQUE ORDR, VPremier, p[iii, xviii, 758]; Cossmann M., 1906, ESSAIS PALEOCONCHOLO, V7; de Grateloup J.-P. S., 1847, CONCHYLIOLOGIE FOSSI, V1; de Lamarck J. B. P. D. de M., 1804, ANN MUSEUM NATL HIST, V3, P436; Dharma B, 2005, RECENT FOSSIL INDONE; Egojan V. L., 1955, UPPER CRETACEOUS DEP; Fernando Allan Gil S., 2008, Bulletin of the National Museum of Nature and Science Series C Geology & Paleontology, V34, P27; Fryda Jiri, 2003, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V87, P47; Harris G. F., 1897, CATALOGUE TERTIARY 1; Heilprin A., 1887, Transactions of the Wagner Institute, Vi, P1; Hilgen F.J., 2012, GEOLOGIC TIME SCALE, V2, P923, DOI DOI 10.1016/B978-0-444-59425-9.00029-9; Houbrick R.S., 1978, Monographs of Marine Mollusca, P1; HOUBRICK R.S., 1992, SMITHSONIAN CONTRIBU, V510, P1; Houbrick R.S., 1984, P232; International Commission on Zoological Nomenclature, 1999, INT TRUST ZOOLOGICAL; Iredale T., 1917, Proceedings of the Malacological Society of London, V12; Itoigawa J., 1978, B MIZUNAMI FOSSIL MU, P7; Iwasaki Y., 1970, T P PALAEONTOLOGICAL, P205; Kanno S., 1986, B JOETSU U ED, V5, P31; Kanno S., 1980, Geology and Palaeontology of Southeast Asia, V21, P135; Kase T., 1984, EARLY CRETACEOUS MAR; Kowalke T., 2001, B CZECH GEOLOGICAL S, V76, P253; Kowalke T, 2003, NEUES JAHRB GEOL P-A, V227, P301; Leidy J., 1851, P ACAD NAT SCI PHILA, V5, P349; LUDBROOK N H, 1971, Transactions of the Royal Society of South Australia, V95, P29; Martin K., 1890, TIJDSCHR KON NED AAR, V7, P241; Martin K., 1890, SAMMLUNGEN GEOLOGISC, V4, P232; Martin K., 1899, SAMMLUNGEN GEOLOGISC, V1, P133; Martini E., 1971, P 2 PLANKT C ROM 197, V2, P739; Mines and Geosciences Bureau, 2010, GEOL PHIL; Nagao T., 1934, J Fac Sci Univ Hokkaido Geol & Min, V2, P177; Nishihira M., 1983, Galaxea, V2, P45; Oostingh C. H., 1938, HANDELINGEN ACHTSTE, P508; Oyama K., 1950, REPORT GEOLOGICAL SU, P1; Ozawa T., 1986, PALAEONTOLOGICAL SOC, P133; Piette E., 1856, B SOC GEOLOGIQUE FRA, V13, P85; Piette E., 1855, B SOC GEOLOGIQUE F 2, V12, P1083; Plaziat Jean-Claude, 2001, Wetlands Ecology and Management, V9, P161, DOI 10.1023/A:1011118204434; Plaziat J.-C., 1995, SPECIAL PUBLICATIONS, V83, P73; Plaziat J.C., 1984, Developments in Hydrobiology, V20, P111; Sayn G., 1932, TRAVAUX LAB GEOLOGIE, P1; Schlotheim E. F., 1820, PETREFACTENKUNDE IHR; Shuto T., 1978, Geology and Palaeontology of Southeast Asia, V19, P113; Smith Warren D., 1913, Philippine Journal of Science, V8; Sowerby G. B., 1855, JAPANESE J GEOLOGY G, V2, P847; TAKEYAMA TOSHIO, 1933, JAPANESE JOUR GEOL AND GEOGR, V10, P129; Tate R., 1899, T ROYAL SOC S AUSTR, V23, P102; Tenison-Woods J. E., 1879, P LINNEAN SOC NEW S, V3, P222; Tian J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001552; Tojo Bunji, 1999, Paleontological Research, V3, P193; TSUDA K, 1986, Palaeontological Society of Japan Special Papers, P129; van Bemmelen R. W., 1972, GEOLOGY INDONESIA A, V1A; VREDENBURG E., 1928, MEM GEOL SURV INDIA, V50, P351; Wenz W., 1940, Handbuch der Palaeozoologie, V6, P721; WILLIAMS H H, 1968, Journal of Helminthology, V42, P199	81	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	OCT	2015	19	4					299	311		10.2517/2015PR013		13	Paleontology	Paleontology	CT3BV	WOS:000362681900005		
J	Maekawa, T; Komatsu, T; Shigeta, Y; Huyen, DT; Tien, DC				Maekawa, Takumi; Komatsu, Toshifumi; Shigeta, Yasunari; Dang Tran Huyen; Dinh Cong Tien			First occurrence of Early Triassic conodonts from the Lang Son Formation, northeastern Vietnam	PALEONTOLOGICAL RESEARCH			English	Article						An Chau sedimentary basin; conodont; Early Triassic; Induan-Olenekian boundary; Vietnam	NORTH VIETNAM; TAXONOMY; FAUNAS; SPITI; INDIA	The Early Triassic conodonts Eurygnathodus costatus Staesche, E. hamadai (Koike), Neospathodus cristagalli (Huckriede), and Ns. pakistanensis Sweet are newly reported from the upper part of the Lang Son Formation in Lang Son City, northeastern Vietnam. This association and particularly E. costatus and E. hamadai indicate the lower Smithian (lower lower Olenekian). Thus, the geological age of the upper part of the Lang Son Formation ranges from Induan to early Olenekian, and the stage boundary lies within the upper part of the formation.	[Maekawa, Takumi; Komatsu, Toshifumi] Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, Kumamoto 8608555, Japan; [Shigeta, Yasunari] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Dang Tran Huyen; Dinh Cong Tien] Minist Ind, Res Inst Geol & Mineral Resources, Dept Paleontol & Stratig, Hanoi, Vietnam	Maekawa, T (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	komatsu@sci.kumamoto-u.ac.jp			JSPS-VAST Joint Research Program; Japan Society for Promotion of Science [25400500]	We are grateful to Michael J. Orchard (Geological Survey of Canada) for his critical reading of the manuscript, and also thank two reviewers, Sachiko Agematsu of the Graduate School of Life and Environmental Sciences, Tsukuba University and Nicolas Goudemand of the Paleontological Institute and Museum, University of Zurich. This study was financially supported by the JSPS-VAST Joint Research Program and a Grant-in-Aid from the Japan Society for Promotion of Science (25400500 to Komatsu).	Komatsu Toshifumi, 2007, Paleontological Research, V11, P135, DOI 10.2517/1342-8144(2007)11[135:LTBFFT]2.0.CO;2; Komatsu T, 2013, PALEONTOL RES, V17, P1, DOI 10.2517/1342-8144-17.1.1; Krystyn L., 2007, Albertiana, V36, P33; Orchard MJ, 2008, POLAR RES, V27, P393, DOI 10.1111/j.1751-8369.2008.00072.x; Komatsu T, 2008, PALEONTOL RES, V12, P119, DOI 10.2517/1342-8144(2008)12[119:LTBAAT]2.0.CO;2; Komatsu T, 2014, SEDIMENT GEOL, V300, P28, DOI 10.1016/j.sedgeo.2013.10.009; Bruhwiler T, 2010, J ASIAN EARTH SCI, V39, P724, DOI 10.1016/j.jseaes.2010.04.032; Komatsu T, 2010, PALAEOGEOGR PALAEOCL, V291, P190, DOI 10.1016/j.palaeo.2010.02.026; Orchard M.J., 2007, Albertiana, V36, P46; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; [Anonymous], 2005, SPEC PAP PALAEONTOL; Beyers J. N., 1991, GEOLOGICAL SURVEY CA, V417, P269; Budurov K., 1973, B GEOL I SER PALEONT, V22, P49; Bui D. T., 1989, ACTA PALAEONTOLOGICA, V34, P391; Buryi G. I., 1979, LOWER TRIASSIC CONOD, V412; Buryi Galina I., 1997, Memoires de Geologie (Lausanne), V30, P35; Cao Y., 1993, CONODONTS LOWER YANG, P103; Dang T. H., 2006, STRATIGRAPHIC UNITS, P245; DUAN J-Y, 1987, Acta Micropalaeontologica Sinica, V4, P351; DZIK J, 1976, Acta Palaeontologica Polonica, V21, P395; GOEL RK, 1977, J PALEONTOL, V51, P1085; Goudemand N., 2014, ALBERTIANA, V42, P49; Hatleberg E. W., 1984, GEOL PALEONT, V18, P101; Hauer F., 1865, SITZUNGSBERICHTE MN, V52, P605; Hirsch F., 1994, Canadian Society of Petroleum Geologists Memoir, V17, P949; Huckriede R., 1958, Palaeontologische Zeitschrift, V32, P141; Ichikawa K., 1966, Journal of Geosciences Osaka University, V9, P101; Igo H., 2009, NAT MUS NATURE SCI M, V38, P181; Khuc Vu, 1991, PALEONTOLOGICAL ATLA, V3; Koike T., 1982, Geology and Palaeontology of Southeast Asia, V23, P9; Koike T., 1988, SCI REPTS YOKOHAMA N, V35, P61; Komatsu T., 2011, 2011 ANN M PAL SOC J, P26; LINDSTRO.M, 1970, LETHAIA, V3, P427, DOI 10.1111/j.1502-3931.1970.tb00834.x; Maekawa T., 2012, 2012 ANN M PAL SOC J, P35; Maekawa T., 2014, NAT MUS NATURE SCI M, V45, P190; MATSUDA T, 1984, Journal of Geosciences Osaka City University, V27, P119; MATSUDA T, 1982, Journal of Geosciences Osaka City University, V25, P87; MATSUDA T, 1983, Journal of Geosciences Osaka City University, V26, P87; McTavish B. R., 1973, NUEES JB GEOLOGIE PA, V143, P275; MOSHER L C, 1968, Journal of Paleontology, V42, P895; MOSHER L C, 1973, Geological Survey of Canada Bulletin, V222, P141; Orchard M.J., 2007, Albertiana, V35, P30; ORCHARD MJ, 1995, J PALEONTOL, V69, P110; Orchard MJ, 2010, GEOL SOC SPEC PUBL, V334, P139, DOI 10.1144/SP334.7; Shigeta Y., 2009, NATL MUSEUM NATURE S, V38, P29; Shigeta Y., 2014, NATL MUSEUM NATURE S, V45, P65; SOLIEN MA, 1979, J PALEONTOL, V53, P276; Staesche U., 1964, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V119, P247; Sweet W. C., 1970, 49 U KANS PAL CONTR, P1; Sweet W. C., 1970, U KANSAS SPECIAL PUB, V4, P207; Tian C., 1983, PALEONTOLOGICAL ATLA, P345; Vu Khuc, 1965, CHARACTERISTIC FOSSI; Wang Zhi-Hao, 1994, Acta Micropalaeontologica Sinica, V11, P379; Wang Z.-h., 1981, Acta Palaeontologica Sinica, V20, P363; YABE HISAKATSU, 1928, JAPANESE JOUR GEOL & GEOGR, V6, P19; Zhao L., 2007, PALAEOGEOGR PALAEOCL, V252, P24	56	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	OCT	2015	19	4					312	320		10.2517/2015PR014		9	Paleontology	Paleontology	CT3BV	WOS:000362681900006		
J	Tsubamoto, T; Kunimatsu, Y; Nakatsukasa, M				Tsubamoto, Takehisa; Kunimatsu, Yutaka; Nakatsukasa, Masato			A lower molar of a primitive, large hippopotamus from the lower Miocene of Kenya	PALEONTOLOGICAL RESEARCH			English	Article						Hippopotamidae; Kenyapotaminae; Kulutherium; Mfwangano; Morotochoerinae; Rusinga Group	EAST-AFRICA; CETARTIODACTYLA; KENYAPOTAMUS; EMERGENCE; EVOLUTION; MAMMALIA; ORIGINS; FAUNAS	A trigonid of a lower molar of a primitive, large hippopotamus from the upper lower Miocene of Mfwangano Island in southwestern Kenya is described. The molar trigonid is similar in size to that of living hippopotamuses, and is comparable in morphology to that of kenyapotamine hippopotamids (Mammalia, Cetartiodactyla) in having a brachyodont crown, bunodont cusps, an M-like structure on the distal trigonid wall, a single-ridged premetacristid, and a buccolingually bifurcate mesial root, and in lacking a paraconid. On the basis of its size and morphology, the specimen appears to be assignable to Kulutherium, which is a putative kenyapotamine previously known from the upper lower Miocene of Kenya and is so far represented only by the upper dentition. The present specimen provides additional evidence that a hippopotamus-sized, large hippopotamid was already living during the early Miocene. If it proves to be Kulutherium, it provides additional evidence that Kulutherium should be assigned to the Kenyapotaminae.	[Tsubamoto, Takehisa] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Kunimatsu, Yutaka] Ryukoku Univ, Fac Business Adm, Fushimi Ku, Kyoto 6128577, Japan; [Nakatsukasa, Masato] Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Tsubamoto, T (reprint author), Ehime Univ, Grad Sch Sci & Engn, 2-5 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	tsubamoto@sci.ehime-u.ac.jp			JSPS KAKENHI Grant [25257408]	We are grateful to the Government of Kenya for research permission at the National Museums of Kenya (Nairobi, Kenya). We also thank Emma Mbua, Fredrick Kyalo Manthi, Mary Muungu, and Francis Ndiritu (National Museums of Kenya) for graciously providing access to the specimens examined. This research was supported by JSPS KAKENHI Grant Number 25257408 (to M. Nakatsukasa).	Peppe DJ, 2009, J HUM EVOL, V56, P447, DOI 10.1016/j.jhevol.2009.02.006; Peppe DJ, 2011, AM J PHYS ANTHROPOL, V144, P237; Boisserie JR, 2011, BIOL REV, V86, P601, DOI 10.1111/j.1469-185X.2010.00162.x; [Anonymous], 2015, J GEOL SOC JPN, DOI DOI 10.5575/geosoc.2015.0004; Tsubamoto Takehisa, 2002, Paleontological Research, V6, P363; Pickford Martin, 2007, Paleontological Research, V11, P85, DOI 10.2517/1342-8144(2007)11[85:SAHFTM]2.0.CO;2; Alloing-Seguier L, 2014, ZOOL J LINN SOC-LOND, V171, P668, DOI 10.1111/zoj.12143; Boisserie JR, 2006, CR PALEVOL, V5, P749, DOI 10.1016/j.crpv.2005.11.004; Orliac M, 2010, P NATL ACAD SCI USA, V107, P11871, DOI 10.1073/pnas.1001373107; Pickford M, 2007, CR PALEVOL, V6, P221, DOI 10.1016/j.crpv.2006.11.002; Pickford Martin, 2008, Revista Espanola de Paleontologia, V23, P31; Pickford M, 2011, ESTUD GEOL-MADRID, V67, P523, DOI 10.3989/egeol.40393.205; Boisserie JR, 2010, ZOOL J LINN SOC-LOND, V158, P325, DOI 10.1111/j.1096-3642.2009.00548.x; DRAKE RE, 1988, J GEOL SOC LONDON, V145, P479, DOI 10.1144/gsjgs.145.3.0479; Boisserie Jean-Renaud, 2007, P106; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; Lihoreau F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7264; Pickford Martin, 1998, Annales de Paleontologie, V84, P275, DOI 10.1016/S0753-3969(99)80003-2; PICKFORD M, 1983, GEOBIOS-LYON, V16, P193, DOI 10.1016/S0016-6995(83)80019-9; Ride W. D. L., 1999, INT CODE ZOOLOGICAL; Tsubamoto T., 2006, ASIAN PALEOPRIMATOLO, V4, P1; Tsubamoto Takehisa, 2011, Vertebrata Palasiatica, V49, P85; Werdelin Lars, 2010, P27; Weston Eleanor, 2010, P853	24	0	0	PALAEONTOLOGICAL SOC JAPAN	TOKYO	MT BLDG 4F, 7-2-2, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	1342-8144			PALEONTOL RES	Paleontol. Res.	OCT	2015	19	4					321	327		10.2517/2015PR015		7	Paleontology	Paleontology	CT3BV	WOS:000362681900007		
J	Miyata, K; Suzuki, T; Hayashi, S; Miyashita, SI; Ohyama, T; Niwa, K; Watanabe, T; Sagane, Y				Miyata, Keita; Suzuki, Tomonori; Hayashi, Shintaro; Miyashita, Shin-Ichiro; Ohyama, Tohru; Niwa, Koichi; Watanabe, Toshihiro; Sagane, Yoshimasa			Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex	PATHOGENS AND DISEASE			English	Article						Clostridium botulinum; hemagglutinin; sialo-oligosaccharide; gene shuffling; food borne botulism; botulinum toxin	INTESTINAL EPITHELIAL-CELLS; PROGENITOR TOXIN; SIALIC-ACID; MOSAIC NEUROTOXIN; PHAGE-CONVERSION; BINDING SITES; COMPONENT; SUBCOMPONENT; HA1; IDENTIFICATION	Clostridium botulinum strains produce a large-sized toxin complex (TC) that is composed of botulinum neurotoxin (BoNT), non-toxic non-hemagglutinin and three different hemagglutinins (HA-70, HA-33 and HA-17). HA components enhance toxin delivery across the intestinal cell wall in a sugar chain-dependent manner. Here we characterized the sugar recognition of serotype D strain 1873 (D-1873) botulinum L-TC. Most L-TCs produced by serotype C and D strains bind to cells via interactions between HA-33 and cell surface sialo-oligosaccharides. However, like the previously reported L-TC produced by serotype C strain Yoichi (C-Yoichi), D-1873 L-TC binds only to cells that have been treated with neuraminidase, indicating that they recognize asialo-oligosaccharides. The D-1873 HA-33 amino acid sequence is similar to that of C-Yoichi, but had lower similarity to the majority of serotype C and D HA-33s. A comparison of TC component primary structures for 12 serotype C and D strains suggested that at least three types of HA-33 genes exist, and these are shuffled among the serotype C and D strains independently of BoNT serotype. This shuffling produces the distinct sugar recognition of serotype C and D botulinum TCs.	[Miyata, Keita; Hayashi, Shintaro; Miyashita, Shin-Ichiro; Niwa, Koichi; Watanabe, Toshihiro; Sagane, Yoshimasa] Tokyo Univ Agr, Fac Bioind, Dept Food & Cosmet Sci, Abashiri, Hokkaido 0992493, Japan; [Suzuki, Tomonori] Tokyo Univ Agr, Fac Appl Biol Sci, Dept Nutr Sci & Food Safety, Setagaya Ku, Tokyo 1568502, Japan; [Ohyama, Tohru] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Hlth & Nutr, Eniwa 0611449, Japan	Sagane, Y (reprint author), Tokyo Univ Agr, Fac Bioind, Dept Food & Cosmet Sci, 196 Yasaka, Abashiri, Hokkaido 0992493, Japan.	y3sagane@bioindustry.nodai.ac.jp					Hayashi S, 2014, ACTA CRYSTALLOGR F, V70, P370, DOI 10.1107/S2053230X14003094; OGUMA K, 1976, INFECT IMMUN, V14, P597; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Arimitsu H, 2008, MICROB PATHOGENESIS, V45, P142, DOI 10.1016/j.micpath.2008.04.007; Nakamura T, 2011, ARCH BIOCHEM BIOPHYS, V512, P69, DOI 10.1016/j.abb.2011.05.012; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Nakamura K, 2012, INFECT IMMUN, V80, P2886, DOI 10.1128/IAI.00302-12; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Sagane Y, 2001, BIOCHEM BIOPH RES CO, V288, P650, DOI 10.1006/bbrc.2001.5820; Niwa K, 2010, VET MICROBIOL, V141, P312, DOI 10.1016/j.vetmic.2009.09.008; Kouguchi H, 2001, EUR J BIOCHEM, V268, P4019, DOI 10.1046/j.1432-1327.2001.02317.x; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Takeda M, 2006, J VET MED SCI, V68, P325, DOI 10.1292/jvms.68.325; Moriishi K, 1996, APPL ENVIRON MICROB, V62, P662; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Nakamura T, 2007, BBA-GEN SUBJECTS, V1770, P551, DOI 10.1016/j.bbagen.2006.11.006; Inoue K, 1999, MICROBIOL-UK, V145, P2533; OHYAMA T, 1995, MICROBIOL IMMUNOL, V39, P457; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Inui K, 2010, J VET MED SCI, V72, P1251, DOI 10.1292/jvms.10-0090; Miyata K, 2009, BIOCHEM BIOPH RES CO, V384, P126, DOI 10.1016/j.bbrc.2009.04.095; INOUE K, 1971, JPN J MED SCI BIOL, V24, P53; Li L, 1999, J TOXICOL-TOXIN REV, V18, P95; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; SUGII S, 1977, INFECT IMMUN, V17, P491; Yoneyama T, 2008, FEMS IMMUNOL MED MIC, V54, P290, DOI 10.1111/j.1574-695X.2008.00475.x; Matsuo T, 2011, FEMS IMMUNOL MED MIC, V63, P35, DOI 10.1111/j.1574-695X.2011.00825.x; Drummond AJ, 2011, GENEIOUS V5 5 3; Matsumura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7255; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2049-632X			PATHOG DIS	Pathog. Dis.	OCT	2015	73	7								10.1093/femspd/ftv054		9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CT1QG	WOS:000362574700010		
J	Tateishi, Y; Okudela, K; Mitsui, H; Umeda, S; Suzuki, T; Kojima, Y; Watanabe, K; Kawano, N; Endo, I; Ohashi, K				Tateishi, Yoko; Okudela, Koji; Mitsui, Hideaki; Umeda, Shigeaki; Suzuki, Takehisa; Kojima, Yoko; Watanabe, Kazuteru; Kawano, Naomi; Endo, Itaru; Ohashi, Kenichi			The potential role of microRNA-31 expression in early colorectal cancer	PATHOLOGY INTERNATIONAL			English	Article						early colorectal cancers; microRNA-31; real-time quantitative reverse transcription-polymerase chain reaction	LYMPH-NODE METASTASIS; CARCINOMA; MIR-31; PATHWAY; CARCINOGENESIS; MIR-125B; CELLS; HEAD; NECK	The expression of microRNA-31 (miR-31) has been implicated in the progression of some human malignancies including colorectal cancer. However, the clinical significance of the expression of miR-31 in submucosally invasive (T1) colorectal cancer remains unclear. The aim of the present study was to delineate the relationship between clinicopathological features and the oncogenic modulator miR-31 in submucosally invasive colorectal cancer. We investigated the expression of miR-31 in 50 submucosally invasive colorectal cancer specimens, along with the corresponding non-tumoral mucosa specimens, using a real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The relationships between miR-31 expression levels and clinicopathological characteristics were assessed. The miR-31 host gene locus was investigated using fluorescence in situ hybridization. qRT-PCR revealed that the expression of miR-31 was higher in colorectal cancer tissue than in non-tumoral tissue (P = 0.0002). The up-regulated expression of miR-31 may play an oncogenic role in the early stage of carcinogenesis in colorectal cancers.	[Tateishi, Yoko; Okudela, Koji; Mitsui, Hideaki; Umeda, Shigeaki; Suzuki, Takehisa; Kojima, Yoko; Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 2360004, Japan; [Watanabe, Kazuteru; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 2360004, Japan; [Kawano, Naomi] Yokohama Minami Kyousai Hosp, Dept Pathol, Yokohama, Kanagawa, Japan	Tateishi, Y (reprint author), Yokohama City Univ, Grad Sch Med, Dept Pathol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ytateish@yokohama-cu.ac.jp			Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan); Yokohama Medical Facility (Yokohama, Japan)	This work was supported by the Japanese Ministry of Education, Culture, Sports, and Science (Tokyo Japan), and by a grant from Yokohama Medical Facility (Yokohama, Japan).	Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Tateishi Y, 2010, MODERN PATHOL, V23, P1068, DOI 10.1038/modpathol.2010.88; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x; Kambara T, 2001, CANCER RES, V61, P7743; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Odar K, 2012, HISTOPATHOLOGY, V61, P257, DOI 10.1111/j.1365-2559.2012.04242.x; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Okudela K, 2009, AM J PATHOL, V175, P867, DOI 10.2353/ajpath.2009.080489; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Nosho K, 2014, CARCINOGENESIS, V35, P776, DOI 10.1093/carcin/bgt374; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Arai T, 1998, INT J CANCER, V79, P418, DOI 10.1002/(SICI)1097-0215(19980821)79:4<418::AID-IJC18>3.0.CO;2-0; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bosman FT, 2010, WHO CLASSIFICATION T; Lei SL, 2014, ONCOL LETT, V8, P1768, DOI 10.3892/ol.2014.2328; Li T, 2015, BIOTECHNOL LETT, V37, P523, DOI 10.1007/s10529-014-1715-y; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Okudela K, 2014, ONCOL REP, V32, P1374, DOI 10.3892/or.2014.3339; Okudela K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100581; Saad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064463; Stewart BW, 2014, WORLD CANC REPORT 20, P393	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					513	518		10.1111/pin.12334		6	Pathology	Pathology	CT1JB	WOS:000362553500001		
J	Yoshida, M; Ichikawa, A; Miyoshi, H; Kiyasu, J; Kimura, Y; Arakawa, F; Niino, D; Ohshima, K				Yoshida, Maki; Ichikawa, Ayako; Miyoshi, Hiroaki; Kiyasu, Junichi; Kimura, Yoshizo; Arakawa, Fumiko; Niino, Daisuke; Ohshima, Koichi			Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements	PATHOLOGY INTERNATIONAL			English	Article						B-cell lymphoma; BCL2; double-hit lymphoma; follicular lymphoma; MYC; unclassifiable with features intermediate between DLBCL and Burkitt lymphoma	FOLLICULAR LYMPHOMA; IMMUNOPHENOTYPE; TRANSFORMATION; ONCOGENE	Double-hit (DH) lymphomas are B-cell lymphomas characterized by chromosomal rearrangements, specifically of MYC and either BCL2, BCL6 or CCND1. We reviewed 22 cases of DH lymphomas. BCL2/MYCDH lymphomas constituted the majority of these DH lymphomas (17 cases; 77%), followed by BCL6/MYC (2 cases; 9%) lymphomas. Assessing morphological features using the 2008 World Health Organization classification system, 15 cases (68%) were determined to be B-cell lymphoma, unclassifiable with features intermediate between diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BCLU) (10 cases; 45%), or as DLBCL (5 cases; 23%), and 2 cases (9%) were classified as morphologically untransformed follicular lymphoma. Burkitt lymphoma was rare (1 case; 5%) among DH lymphomas. Nineteen cases were treated with R-CHOP or a high dose chemotherapy regimen. After a median follow-up of 11 months, 7 patients had died, and the 1-year survival rate was 62.5%. High dose chemotherapy did not improve the outcome. We suggest that screening of genetic variations to detect DH lymphomas is required in diagnosing all lymphomas, even those determined morphologically to be follicular lymphoma.	[Yoshida, Maki; Ichikawa, Ayako; Miyoshi, Hiroaki; Kiyasu, Junichi; Kimura, Yoshizo; Arakawa, Fumiko; Niino, Daisuke; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan	Yoshida, M (reprint author), Kurume Univ, Sch Med, Dept Pathol, Asahimachi 67, Kurume, Fukuoka 8300011, Japan.	yoshida_maki@med.kurume-u.ac.jp					Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Young KH, 2008, AM J CLIN PATHOL, V129, P157, DOI 10.1309/NKK3FEX2BE5L7EKB; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Voorhees PM, 2004, ARCH PATHOL LAB MED, V128, P210; Federico M, 2009, J CLIN ONCOL, V27, P4555, DOI 10.1200/JCO.2008.21.3991; Tomita N, 2009, HAEMATOL-HEMATOL J, V94, P935, DOI 10.3324/haematol.2008.005355; Li SY, 2012, MODERN PATHOL, V25, P145, DOI 10.1038/modpathol.2011.147; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Lin P, 2007, HAEMATOL-HEMATOL J, V92, P1297, DOI 10.3324/haematol.11263; LEE JT, 1989, J CLIN INVEST, V84, P1454, DOI 10.1172/JCI114320; Xu XX, 2013, INT J CLIN EXP PATHO, V6, P788; Boerma GE, 2009, LEUKEMIA, V23, P225; DEJONG D, 1988, NEW ENGL J MED, V318, P1373, DOI 10.1056/NEJM198805263182106; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Kluin PM, 2008, WHO CLASSIFICATION T, P265; Li S, 2013, ADV ANAT PATHOL, V5, P315; Tomita Naoto, 2011, J Clin Exp Hematop, V51, P7; Weremowicz S, 2007, CURR PROTOC HUM GENE, pChapter 8	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					519	527		10.1111/pin.12335		9	Pathology	Pathology	CT1JB	WOS:000362553500002		
J	Oishi, N; Kondo, T; Nakazawa, T; Mochizuki, K; Tanioka, F; Oyama, T; Yamamoto, T; Iizuka, J; Tanabe, K; Shibata, N; Kirito, K; Katoh, R				Oishi, Naoki; Kondo, Tetsuo; Nakazawa, Tadao; Mochizuki, Kunio; Tanioka, Fumihiko; Oyama, Toshio; Yamamoto, Tomoko; Iizuka, Junpei; Tanabe, Kazunari; Shibata, Noriyuki; Kirito, Keita; Katoh, Ryohei			High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses	PATHOLOGY INTERNATIONAL			English	Article						diffuse large B-cell lymphoma; gene amplification; immunohistochemistry; mutation; MYD88; testis	B-CELL LYMPHOMA; NERVOUS-SYSTEM LYMPHOMAS; IMMUNOPHENOTYPE MIGHT; EXTRANODAL LYMPHOMA; CD79B MUTATIONS; ONCOGENIC MYD88; POOR-PROGNOSIS; TESTIS; CLASSIFICATION; EXPRESSION	The activating mutation of MYD88 has been identified in diffuse large B-cell lymphoma (DLBCL). We investigated the mutational status and both the gene amplification and protein expression of MYD88 in 23 cases of testicular DLBCL. To detect the MYD88 mutations, we employed the allele-specific PCR and Sanger sequencing. MYD88 gene amplification and protein expression were analyzed by quantitative PCR and by immunohistochemistry, respectively. There were 17 cases of primary testicular DLBCL: 94% (16/17) exhibited a non-Germinal center B-cell (non-GCB) subtype, 82% (14/17) showed the MYD88L265P, and 65% (11/17) had intense expression of MYD88. When compared with normal lymph nodes, the MYD88 is significantly amplified in primary testicular DLBCL. However, the amplification status showed no correlation with its mutational status or protein expression. Moreover, neither the MYD88 mutational status nor the expression pattern affected overall survival. Six cases were secondary testicular DLBCL with an 83% (5/6) and an 80% (4/5) incidence of the non-GCB subtype and of the MYD88L265P, respectively. In conclusion, we demonstrated a high prevalence of the non-GCB subtype and the common MYD88L265P in both primary and secondary testicular DLBCL. Our data suggest that the MYD88 mutation is a fairly consistent genetic feature in testicular DLBCL.	[Oishi, Naoki; Kondo, Tetsuo; Nakazawa, Tadao; Mochizuki, Kunio; Katoh, Ryohei] Univ Yamanashi, Dept Pathol, Chuo Ku, Yamanashi 4093898, Japan; [Kirito, Keita] Univ Yamanashi, Dept Hematol & Oncol, Chuo, Japan; [Tanioka, Fumihiko] Iwata City Hosp, Div Pathol, Iwata, Japan; [Oyama, Toshio] Yamanashi Prefectural Cent Hosp, Dept Diagnost Pathol, Kofu, Yamanashi, Japan; [Yamamoto, Tomoko; Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Iizuka, Junpei; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan	Kondo, T (reprint author), Univ Yamanashi, Dept Pathol, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	ktetsuo@yamanashi.ac.jp					Zucca E, 2003, J CLIN ONCOL, V21, P20, DOI 10.1200/JCO.2003.11.141; Gonzalez-Aguilar A, 2012, CLIN CANCER RES, V18, P5203, DOI 10.1158/1078-0432.CCR-12-0845; Schlegel U, 2000, J NEUROL SCI, V181, P1, DOI 10.1016/S0022-510X(00)00385-3; Al-Abbadi MA, 2006, MODERN PATHOL, V19, P1521, DOI 10.1038/modpathol.3800691; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Ahmad SS, 2012, CLIN ONCOL-UK, V24, P358, DOI 10.1016/j.clon.2012.02.005; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Fonseca R, 2000, CANCER, V88, P154, DOI 10.1002/(SICI)1097-0142(20000101)88:1<154::AID-CNCR21>3.0.CO;2-T; Xu L, 2013, BLOOD, V121, P2051, DOI 10.1182/blood-2012-09-454355; Bhagavathi S, 2008, CLIN NEUROPATHOL, V27, P13; Booman M, 2006, J PATHOL, V210, P163, DOI 10.1002/path.2033; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Choi JW, 2013, HUM PATHOL, V44, P1375, DOI 10.1016/j.humpath.2012.10.026; Pham-Ledard A, 2014, MODERN PATHOL, V27, P402, DOI 10.1038/modpathol.2013.156; Li D, 2010, PATHOL RES PRACT, V206, P611, DOI 10.1016/j.prp.2010.04.005; Horne MJ, 2011, ARCH PATHOL LAB MED, V135, P1363, DOI 10.5858/arpa.2010-0158-RS; Zucca E, 2008, ANN ONCOL, V19, P77, DOI 10.1093/annonc/mdn204; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Camilleri-Broet S, 2006, BLOOD, V107, P190, DOI 10.1182/blood-2005-03-1024; Kraan W, 2014, LEUKEMIA, V28, P719, DOI 10.1038/leu.2013.348; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Kraan W, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.28; Montesinos-Rongen M, 2011, ACTA NEUROPATHOL, V122, P791, DOI 10.1007/s00401-011-0891-2; Ngo V.N, 2010, NATURE, V470, P115; Swerdlow S, 2008, WHO CLASSIFICATION T	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					528	535		10.1111/pin.12336		8	Pathology	Pathology	CT1JB	WOS:000362553500003		
J	Imada, H; Sakatani, T; Sawada, M; Matsuura, T; Fukushima, N; Nakano, I				Imada, Hiroki; Sakatani, Takashi; Sawada, Mikio; Matsuura, Tohru; Fukushima, Noriyoshi; Nakano, Imaharu			A lethal intracranial Rosai-Dorfman disease of the brainstem diagnosed at autopsy	PATHOLOGY INTERNATIONAL			English	Article						autopsy; central nervous system; extra-nodal; intraparenchymal; Rosai-Dorfman disease	SINUS HISTIOCYTOSIS; MASSIVE LYMPHADENOPATHY; ENTITY	Rosai-Dorfman disease (RDD) is a benign histiocytic proliferative disorder characterized by the accumulation of histiocytes in lymph nodes and various other organs. RDD seldom involves the central nervous system, and cases of purely intracranial RDD are particularly rare. We report a case of purely intracranial RDD involving the brainstem that was diagnosed at autopsy. A 68-year-old woman visited our hospital because of visual disturbances and loss of energy. Magnetic resonance imaging revealed an obscure mass in the brainstem. Despite exhaustive work-ups, the etiology of the intracranial mass remained unclear. The patient died of respiratory depression, and an autopsy was performed for pathological investigation. Macroscopically, a pink pale mass 2.5cm in diameter was found in the brainstem, with no attachment to the dura. Histologically, it was composed of histiocytic cells with incorporation of small lymphocytes (emperipolesis). Immunohistochemical staining revealed that the cells were positive for CD68 and S100 and negative for CD1a, consistent with a diagnosis of RDD. Purely intracranial RDD is extremely rare and considered benign. To date, nine cases (including ours) have been reported. To our knowledge, this is the first case of intracranial RDD with autopsy. Although generally considered benign, RDD involving the brainstem might be lethal.	[Imada, Hiroki; Sakatani, Takashi; Fukushima, Noriyoshi] Jichi Med Univ Hosp, Dept Pathol, Shimotsuke, Japan; [Sawada, Mikio; Matsuura, Tohru; Nakano, Imaharu] Jichi Med Univ, Sch Med, Dept Internal Med, Div Neurol, Shimotsuke, Tochigi 3290498, Japan	Sakatani, T (reprint author), Jichi Med Univ, Dept Pathol, Yakushiji 3311-1, Shimotsuke, Tochigi 3290498, Japan.	takashi-sakatani@nms.ac.jp					Andriko JAW, 2001, MODERN PATHOL, V14, P172, DOI 10.1038/modpathol.3880278; Juric G, 2003, ACTA NEUROCHIR, V145, P145, DOI 10.1007/s00701-002-1031-5; Natarajan S, 2000, J NEURO-ONCOL, V47, P73, DOI 10.1023/A:1006435220380; Camp SJ, 2012, J CLIN NEUROSCI, V19, P1308, DOI 10.1016/j.jocn.2012.01.011; ROSAI J, 1969, ARCH PATHOL, V87, P63; Morandi X, 2000, J NEUROSURG, V92, P890, DOI 10.3171/jns.2000.92.5.0890; Gaetani P, 2000, NEUROSURGERY, V46, P479, DOI 10.1097/00006123-200002000-00041; O'Malley DP, 2013, SEMIN DIAGN PATHOL, V30, P137, DOI 10.1053/j.semdp.2012.08.007; FOUCAR E, 1990, SEMIN DIAGN PATHOL, V7, P19; Fukushima T, 2011, NEUROL MED-CHIR, V51, P136, DOI 10.2176/nmc.51.136; Mahzoni P, 2012, J RES MED SCI, V17, P304; David NL, 2010, NONNEOPLASTIC DIS CE; Leboit PE, 2006, WHO CLASSIFICATION T; Symss Nigel Peter, 2010, Asian J Neurosurg, V5, P19	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					549	553		10.1111/pin.12331		5	Pathology	Pathology	CT1JB	WOS:000362553500006		
J	Tanaka, H; Yorita, K; Takahashi, N; Usuma, Y; Nakamura, K; Kataoka, H				Tanaka, Hiroyuki; Yorita, Kenji; Takahashi, Nobuyasu; Usuma, Yasuhiro; Nakamura, Kunihide; Kataoka, Hiroaki			Primary pulmonary angiosarcoma: A case report	PATHOLOGY INTERNATIONAL			English	Article						angiosarcoma; lung cancer; pulmonary sarcoma		Primary sarcoma is uncommon in the lung, and primary angiosarcoma is exceedingly rare. We report a case of primary pulmonary angiosarcoma of the left lung with emphasis on its growth pattern in the lung. A 48-year-old Japanese man was admitted to our hospital because of dyspnea on exertion. He was subsequently found to have left pleural effusion. Computed tomography shows a nodular lesion measuring 7 x 4cm in his left lung. Obstruction of the left inferior lobar bronchus was observed, and endobronchial biopsy suggested angiosarcoma. Left pneumonectomy was performed. On macroscopic examination of the cut surface, multiple nodular lesions were observed particularly in portions around branches of pulmonary artery along bronchioles. Histological examination revealed vascular channel-like structure with vague lumen formations by atypical polygonal or spindle-shaped neoplastic cells. Immunohistochemically, the neoplastic cells are positive for FLI-1, ERG, CD31 and von Willebrand factor/factor VIII-related antigen, but not CD34. Angiosarcoma is a particularly rare form of primary pulmonary tumors, and this case report describes its unique macroscopic growth pattern in the lung.	[Tanaka, Hiroyuki; Yorita, Kenji; Kataoka, Hiroaki] Miyazaki Univ, Dept Pathol, Sect Oncopathol & Regenerat Biol, Miyazaki, Japan; [Takahashi, Nobuyasu] Miyazaki Univ, Dept Anat, Ultrastruct Cell Biol, Miyazaki, Japan; [Nakamura, Kunihide] Miyazaki Univ, Fac Med, Dept Surg 2, Miyazaki, Japan; [Usuma, Yasuhiro] Natl Hosp Org, Miyazaki Higashi Hosp, Dept Surg, Miyazaki, Japan	Tanaka, H (reprint author), Miyazaki Univ, Fac Med, Dept Pathol, Sect Oncopathol & Regenerat Biol, Kiyotake, Miyazaki 8891692, Japan.	hiroyuki_tanaka@med.miyazaki-u.ac.jp					Anderson T, 2015, AM J SURG PATHOL, V39, P132, DOI 10.1097/PAS.0000000000000346; Kojima K, 2003, CHEST, V124, P2397, DOI 10.1378/chest.124.6.2397; Weissferdt A, 2010, ANN DIAGN PATHOL, V14, P296, DOI 10.1016/j.anndiagpath.2010.03.001; Rosado FGN, 2012, ARCH PATHOL LAB MED, V136, P301, DOI 10.5858/arpa.2011-0213-OA; Meis-Kindblom JM, 1998, AM J SURG PATHOL, V22, P683, DOI 10.1097/00000478-199806000-00005; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016/S1470-2045(10)70023-1; Chen YB, 2010, LUNG CANCER, V70, P352, DOI 10.1016/j.lungcan.2010.09.002; Gladish GW, 2002, RADIOGRAPHICS, V22, P621; Lahat G, 2010, ANN SURG, V251, P1098, DOI 10.1097/SLA.0b013e3181dbb75a; Flucke U, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-131; Lund Lidiya, 2005, Arch Pathol Lab Med, V129, pe7; Obeso Carillo GA, 2013, GEN THORAC CARDIOVAS, V61, P643; Pandit Sameer A, 2005, Ann Diagn Pathol, V9, P302, DOI 10.1016/j.anndiagpath.2005.04.001	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					554	557		10.1111/pin.12341		4	Pathology	Pathology	CT1JB	WOS:000362553500007		
J	Yorita, K; Ayabe, T; Chosa, E; Uchino, N; Nagatomo, Y; Yamaguchi, T; Nakatani, Y; Kataoka, H				Yorita, Kenji; Ayabe, Takanori; Chosa, Eiichi; Uchino, Noriko; Nagatomo, Yasuhiro; Yamaguchi, Tetsuro; Nakatani, Yukio; Kataoka, Hiroaki			Unusual cystic hamartomatous lung lesion with clinical manifestation of subpleural bullae in a woman of reproductive age: A case report	PATHOLOGY INTERNATIONAL			English	Article						giant bulla; pulmonary hamartoma; reproductive age; subpleural bulla		Pulmonary hamartoma is a common benign lung disorder, and most cases show solid nodules. Here, we documented the clinicopathological features of a growing, bulla-like, multilocular hamartomatous lung lesion in a woman of reproductive age. To the best of our knowledge, this disorder has not been reported in the literature to date. An asymptomatic 29-year-old Japanese woman with no significant past medical history was referred to our institution for surgical treatment of a bullous lesion in the right upper lobe because the pulmonary lesion had enlarged to multilocular cysts, including a giant bulla, within 1 year, leading to compression of the right lung. The bullous lesion, which was projected from the apex of the lung via a narrow stalk, showed nonemphysematous, multiloculated tissue. The wall mimicked a bronchiolar structure with ciliated, nonatypical epithelium and layers of nonatypical spindle cells that were positive for smooth muscle markers and sex steroid hormone receptors. No cartilage was included in the lesion. We believe that this may be a novel form of hamartoma. This disorder may be included in a differential diagnosis of subpleural bullous diseases in women of reproductive age.	[Yorita, Kenji; Kataoka, Hiroaki] Miyazaki Univ, Dept Pathol, Fac Med, Sect Oncopathol & Regenerat Biol, Kiyotake, Miyazaki 8891692, Japan; [Ayabe, Takanori; Chosa, Eiichi] Miyazaki Univ, Fac Med, Dept Cardiovasc Thorac & Gen Surg, Kiyotake, Miyazaki 8891692, Japan; [Uchino, Noriko] Miyazaki Univ, Fac Med, Dept Radiol, Kiyotake, Miyazaki 8891692, Japan; [Nagatomo, Yasuhiro] Miyazaki Univ, Fac Med, Dept Rheumatol Infect Dis & Lab Med, Kiyotake, Miyazaki 8891692, Japan; [Yamaguchi, Tetsuro] Miyazaki Prefectural Nobeoka Hosp, Dept Internal Med, Miyazaki, Japan; [Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba, Japan	Yorita, K (reprint author), Miyazaki Univ, Dept Pathol, Fac Med, Sect Oncopathol & Regenerat Biol, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	kenjiyorita@gmail.com					Abbott GF, 2004, RADIOGRAPHICS, V24, P821, DOI 10.1148/rg.243045005; Steiner PE, 1939, AM J PATHOL, V15, P89; Pelosi G, 2006, AM J SURG PATHOL, V30, P819, DOI 10.1097/01.pas.0000208898.38730.36; PETERS P, 1992, THORAX, V47, P393, DOI 10.1136/thx.47.5.393; Sugawara M, 2009, PATHOL INT, V59, P828, DOI 10.1111/j.1440-1827.2009.02453.x; STERN EJ, 1994, AM J ROENTGENOL, V162, P279; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; WILLIAMS RB, 1950, J THORAC SURG, V19, P806; Itoh H, 2001, PATHOL INT, V51, P661, DOI 10.1046/j.1440-1827.2001.01245.x; Takeshima Y, 2000, PATHOL INT, V50, P984, DOI 10.1046/j.1440-1827.2000.01136.x; CRUICKSHANK DB, 1953, THORAX, V8, P316, DOI 10.1136/thx.8.4.316; Narita T, 1996, HISTOPATHOLOGY, V28, P285, DOI 10.1046/j.1365-2559.1996.d01-422.x; TOOMES H, 1983, CANCER, V51, P534, DOI 10.1002/1097-0142(19830201)51:3<534::AID-CNCR2820510328>3.0.CO;2-B; Chida Masayuki, 2009, Gen Thorac Cardiovasc Surg, V57, P166, DOI 10.1007/s11748-008-0333-9; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kitaichi M, 2002, HISTOPATHOLOGY, V41, P424; MARK EJ, 1986, NEW ENGL J MED, V315, P1255, DOI 10.1056/NEJM198611133152004; Okudela K, 2014, PATHOL INT, V64, P618, DOI 10.1111/pin.12222; Reid L, 1967, PATHOLOGY EMPHYSEMA	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					558	562		10.1111/pin.12342		5	Pathology	Pathology	CT1JB	WOS:000362553500008		
J	Kihara, A; Iihara, K; Murata, K; Kitagawa, M; Horiuchi, H				Kihara, Atsushi; Iihara, Kuniko; Murata, Kenichiro; Kitagawa, Masanobu; Horiuchi, Hajime			Choroid plexus papilloma arising in a mature cystic teratoma of the ovary: A short case report and literature review	PATHOLOGY INTERNATIONAL			English	Letter							TUMORS		[Kihara, Atsushi; Kitagawa, Masanobu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan; [Iihara, Kuniko] Tokyo Yamate Med Ctr, Dept Pathol, Tokyo, Japan; [Horiuchi, Hajime] NTT Med Ctr, Dept Diagnost Pathol, Tokyo, Japan; [Murata, Kenichiro] Kokura Kinen Hosp, Dept Diagnost Pathol, Fukuoka, Japan	Kihara, A (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Comprehens Pathol, Tokyo, Japan.						Terada T, 2010, INT J GYNECOL CANCER, V20, P1101, DOI 10.1111/IGC.0b013e3181a831b0; Quadri AM, 2011, INT J SURG PATHOL, V19, P718, DOI 10.1177/1066896909353601; WATANABE K, 1995, CLIN NEUROPATHOL, V14, P159; REIMUND EL, 1990, ARCH PATHOL LAB MED, V114, P902; Morovic A, 2008, HISTOL HISTOPATHOL, V23, P765; Gyure KA, 2000, MODERN PATHOL, V13, P638, DOI 10.1038/modpathol.3880111; KLEINMAN GM, 1993, AM J SURG PATHOL, V17, P764, DOI 10.1097/00000478-199308000-00002; Dessauvagie BF, 2013, PATHOLOGY, V45, P88, DOI 10.1097/PAT.0b013e32835b6855; Fullar GN, 2012, HISTOLOGY PATHOLOGIS, P295; vonsGunten M, 2006, HISTOPATHOLOGY, V49, P204	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					563	565		10.1111/pin.12301		3	Pathology	Pathology	CT1JB	WOS:000362553500009		
J	Ide, F; Kikuchi, K; Kusama, K				Ide, Fumio; Kikuchi, Kentaro; Kusama, Kaoru			Anastomosing or plexiform ameloblastoma?	PATHOLOGY INTERNATIONAL			English	Letter							GRANULAR-CELL AMELOBLASTOMA		[Ide, Fumio; Kikuchi, Kentaro; Kusama, Kaoru] Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral Pathol, Sakado, Saitama 35002, Japan	Ide, F (reprint author), Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Oral Pathol, Sakado, Saitama 35002, Japan.						SHAFER WG, 1954, ORAL SURG ORAL MED O, V7, P32, DOI 10.1016/0030-4220(54)90249-2; ALTINI M, 1986, ORAL SURG ORAL MED O, V61, P163, DOI 10.1016/0030-4220(86)90180-5; Hunt KT, 2011, J ORAL MAXIL SURG, V69, P3001, DOI 10.1016/j.joms.2010.12.034; NASU M, 1984, J ORAL PATHOL MED, V13, P448, DOI 10.1111/j.1600-0714.1984.tb01445.x; CERNEA P, 1953, Actual Odontostomatol (Paris), V7, P129; Kim NR, 2004, KOREAN J PATHOL, V38, P116; Matsushita Y, 2015, PATHOL INT, V65, P43, DOI 10.1111/pin.12231; Praetorius F., 2009, SURG PATHOLOGY HEAD, V3, P1206; TO EWH, 1990, J CRANIO MAXILL SURG, V18, P122, DOI 10.1016/S1010-5182(05)80328-2; Yaoi H, 1964, J JPN STOMATOL SOC, V13, P174	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					566	566		10.1111/pin.12309		1	Pathology	Pathology	CT1JB	WOS:000362553500010		
J	Matsushita, Y; Fujita, S; Kawasaki, G; Rokutanda, S; Yamashita, K; Yanamoto, S; Ikeda, T; Umeda, M				Matsushita, Yuki; Fujita, Shuichi; Kawasaki, Goro; Rokutanda, Satoshi; Yamashita, Kentaro; Yanamoto, Souichi; Ikeda, Tohru; Umeda, Masahiro			Anastomosing or plexiform ameloblastoma? Reply	PATHOLOGY INTERNATIONAL			English	Letter							GRANULAR-CELL AMELOBLASTOMA; ODONTOGENIC-TUMOR		[Matsushita, Yuki; Kawasaki, Goro; Rokutanda, Satoshi; Yamashita, Kentaro; Yanamoto, Souichi; Umeda, Masahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Unit Translat Med, Nagasaki 852, Japan; [Fujita, Shuichi; Ikeda, Tohru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Pathol & Bone Metab, Unit Basic Med Sci,Course Med & Dent Sci, Nagasaki 852, Japan	Matsushita, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Unit Translat Med, Nagasaki 852, Japan.						RAUBENHEIMER EJ, 1995, J ORAL PATHOL MED, V24, P227, DOI 10.1111/j.1600-0714.1995.tb01172.x; ALTINI M, 1986, ORAL SURG ORAL MED O, V61, P163, DOI 10.1016/0030-4220(86)90180-5; SIAR CH, 1991, ORAL SURG ORAL MED O, V72, P82, DOI 10.1016/0030-4220(91)90194-H; NASU M, 1984, J ORAL PATHOL MED, V13, P448, DOI 10.1111/j.1600-0714.1984.tb01445.x; Ide F, 2015, PATHOL INT, V65, P566, DOI 10.1111/pin.12309; Matsushita Y, 2015, PATHOL INT, V65, P43, DOI 10.1111/pin.12231	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5463	1440-1827		PATHOL INT	Pathol. Int.	OCT	2015	65	10					567	567		10.1111/pin.12330		1	Pathology	Pathology	CT1JB	WOS:000362553500011		
J	Saito, Y; Fons, P; Kolobov, AV; Tominaga, J				Saito, Yuta; Fons, Paul; Kolobov, Alexander V.; Tominaga, Junji			Self-organized van der Waals epitaxy of layered chalcogenide structures	PHYSICA STATUS SOLIDI B-BASIC SOLID STATE PHYSICS			English	Article						layered chalcogenides; Sb2Te3; Self-organized growth; sputtering; topological insulators; van der Waals epitaxy	TRANSITION-METAL DICHALCOGENIDES; TOPOLOGICAL INSULATOR; THIN-FILMS; TELLURIDE; SURFACE; SB2TE3; GROWTH; MOS2; HETEROSTRUCTURES; SUBSTRATE	Highly oriented Sb2Te3 films were successfully deposited by RF-magnetron sputtering on both crystalline and amorphous substrates. A novel deposition mechanism and method are proposed based on van der Waals epitaxy. Due to the selective reactivity of the top surface atoms of the substrate with sputtered atoms, a Te monolayer is the first layer formed on the substrate, resulting in the subsequent layer-by-layer growth of the Sb2Te3 film independent of the crystallinity of the substrates. We believe that this method can be applied to the mass production of a wide range of various van der Waals solids, such as transition metal dichalcogenides and topological insulators for future electronics devices.	[Saito, Yuta; Fons, Paul; Kolobov, Alexander V.; Tominaga, Junji] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Saito, Yuta; Fons, Paul; Kolobov, Alexander V.; Tominaga, Junji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Saito, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba Cent 4, Tsukuba, Ibaraki 3058562, Japan.	yuta-saito@aist.go.jp	Saito, Yuta/H-7119-2014	Saito, Yuta/0000-0002-9576-1560	CREST, JST	This research was supported by CREST, JST. We thank Ms Reiko Kondou in AIST for her assistance in fabrication of samples and Mr Kosuke Kurushima and Ms Yasue Oogi in TORAY for their assistance in TEM observations.	ANDERSON TL, 1974, ACTA CRYSTALLOGR B, V30, P1307, DOI 10.1107/S0567740874004729; Li HD, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103038; WRIGHT DA, 1958, NATURE, V181, P834, DOI 10.1038/181834a0; Bendt G, 2014, J MATER CHEM A, V2, P8215, DOI 10.1039/c4ta00707g; VERBLE JL, 1972, SOLID STATE COMMUN, V11, P941, DOI 10.1016/0038-1098(72)90294-3; Huang BL, 2008, J APPL PHYS, V104, DOI 10.1063/1.3033381; KNOP O, 1956, CAN J CHEM, V34, P1142, DOI 10.1139/v56-149; Simpson RE, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3675635; Zhang GH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3200237; KOMA A, 1992, THIN SOLID FILMS, V216, P72, DOI 10.1016/0040-6090(92)90872-9; He L, 2013, PHYS STATUS SOLIDI-R, V7, P50, DOI 10.1002/pssr.201307003; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Boschker JE, 2014, NANO LETT, V14, P3534, DOI 10.1021/nl5011492; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Hsieh D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.146401; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Wang RN, 2014, J PHYS CHEM C, V118, P29724, DOI 10.1021/jp507183f; Bernardi M, 2013, NANO LETT, V13, P3664, DOI 10.1021/nl401544y; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Jiang YP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.016401; YAMADA N, 1991, J APPL PHYS, V69, P2849, DOI 10.1063/1.348620; Winkler M, 2012, Z ANORG ALLG CHEM, V638, P2441, DOI 10.1002/zaac.201200305; Ando Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.102001; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Saito Y, 2014, PHYS STATUS SOLIDI-R, V8, P302, DOI 10.1002/pssr.201409013; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; THURMOND CD, 1960, AT&T TECH J, V39, P169; He KL, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.026803; Cunningham G, 2012, ACS NANO, V6, P3468, DOI 10.1021/nn300503e; Wang HH, 2012, INT J GERONTOL, V6, P1, DOI 10.1016/j.ijge.2011.09.015; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Miro P, 2014, CHEM SOC REV, V43, P6537, DOI 10.1039/c4cs00102h; Shi YM, 2012, NANO LETT, V12, P2784, DOI [10.1021/nl204562j, 10.1021/nl204562J]; You H, 2011, J ELECTRON MATER, V40, P635, DOI 10.1007/s11664-010-1490-z; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Wang ZY, 2011, J CRYST GROWTH, V334, P96, DOI 10.1016/j.jcrysgro.2011.08.029; BAILEY LG, 1966, J PHYS CHEM SOLIDS, V27, P1593, DOI 10.1016/0022-3697(66)90237-X; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Simpson RE, 2011, NAT NANOTECHNOL, V6, P501, DOI [10.1038/nnano.2011.96, 10.1038/NNANO.2011.96]; Chernikov A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076802; Benjamin SL, 2015, J MATER CHEM C, V3, P423, DOI 10.1039/c4tc02327g; Boller H., 1964, MONATSH CHEM, V95, P1272, DOI 10.1007/BF00904725; Koma A., 1984, Microelectronic Engineering, V2, DOI 10.1016/0167-9317(84)90057-1; Massalski T. B., 1990, BINARY ALLOY PHASE D; Plechinger G, 2014, SEMICOND SCI TECH, V29, DOI 10.1088/0268-1242/29/6/064008; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012	49	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0370-1972	1521-3951		PHYS STATUS SOLIDI B	Phys. Status Solidi B-Basic Solid State Phys.	OCT	2015	252	10					2151	2158		10.1002/pssb.201552335		8	Physics, Condensed Matter	Physics	CT3QQ	WOS:000362722300001		
J	Sharma, KR; Adhikari, A; Hafizur, RM; Hameed, A; Raza, SA; Kalauni, SK; Miyazaki, J; Choudhary, MI				Sharma, Khaga Raj; Adhikari, Achyut; Hafizur, Rahman M.; Hameed, Abdul; Raza, Sayed Ali; Kalauni, Surya Kant; Miyazaki, Jun-Ichi; Choudhary, M. Iqbal			Potent Insulin Secretagogue from Scoparia dulcis Linn of Nepalese Origin	PHYTOTHERAPY RESEARCH			English	Article						Scoparia dulcis; coixol; insulin secretion; isolated islets; MIN-6 cells	ACID; RATS; CELL	Ethno-botanical inspired isolation from plant Scoparia dulcis Linn. (Sweet Broomweed) yielded six compounds, coixol (1), glutinol (2), glutinone (3), friedelin (4), betulinic acid (5), and tetratriacontan-1-ol (6). There structures were identified using mass and 1D- and 2D-NMR spectroscopy techniques. Compounds 1-6 were evaluated for their insulin secretory activity on isolated mice islets and MIN-6 pancreatic -cell line, and compounds 1 and 2 were found to be potent and mildly active, respectively. Compound 1 was further evaluated for insulin secretory activity on MIN-6 cells. Compound 1 was subjected to in vitro cytotoxicity assay against MIN-6, 3T3 cell lines, and islet cells, and in vivo acute toxicity test in mice that was found to be non-toxic. The insulin secretory activity of compounds 1 and 2 supported the ethno-botanic uses of S. dulcis as an anti-diabetic agent. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Sharma, Khaga Raj; Adhikari, Achyut; Choudhary, M. Iqbal] Univ Karachi, HEJ Res Inst Chem, ICCBS, Karachi 75270, Pakistan; [Sharma, Khaga Raj; Kalauni, Surya Kant] Tribhuvan Univ, Cent Dept Chem, Kathmandu, Nepal; [Hafizur, Rahman M.; Hameed, Abdul; Raza, Sayed Ali] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, ICCBS, Karachi 75270, Pakistan; [Miyazaki, Jun-Ichi] Osaka Univ, Grad Sch Med, Div Med, Osaka, Japan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah 21412, Saudi Arabia	Adhikari, A (reprint author), Univ Karachi, HEJ Res Inst Chem, ICCBS, Karachi 75270, Pakistan.	adhikarimine@yahoo.com			Higher Education Commission (HEC), Pakistan [20-1963/RD/10/9164]	We are thankful to the Nepal Academy of Science and Technology, Nepal, for providing Ph. D. fellowship to Mr. Khaga Raj Sharma. This work was partially supported by a grant (no. 20-1963/R&D/10/9164) to M. Hafizur Rahman from Higher Education Commission (HEC), Pakistan.	Latha M, 2009, NAT PROD RES, V23, P1528, DOI 10.1080/14786410902726126; NAGAO T, 1985, PHYTOCHEMISTRY, V24, P2959, DOI 10.1016/0031-9422(85)80035-2; Latha M, 2004, LIFE SCI, V75, P2003, DOI 10.1016/j.lfs.2004.05.012; HAYASHI T, 1994, PHYTOCHEMISTRY, V37, P1611, DOI 10.1016/S0031-9422(00)89576-X; Siddiqui BS, 2014, J ETHNOPHARMACOL, V152, P561, DOI 10.1016/j.jep.2014.02.002; Beh JE, 2010, J ETHNOPHARMACOL, V129, P23, DOI 10.1016/j.jep.2010.02.009; Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088; Susidarti RA, 2006, NAT PROD RES, V20, P145, DOI 10.1080/14786410500046042; KAWASAKI M, 1988, PHYTOCHEMISTRY, V27, P3709, DOI 10.1016/0031-9422(88)80811-2; FREIRE SMF, 1991, MEM I OSWALDO CRUZ, V86, P149; Mishra MR, 2013, INDIAN J PHARM SCI, V75, P610; Chauhan SMS, 2002, INDIAN J CHEM B, V41, P1097; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126; PIPELEERS DG, 1981, DIABETOLOGIA, V20, P654; Arulselvana P, 2014, BIOMED PREV NUTR, V4, P607; Declaration K, 2013, J DIABETES INVESTIG, V4, P222; Girach R. D., 1994, International Journal of Pharmacognosy, V32, P274; Jain S. P., 1994, J ETHNOPHARMACOL, V3, P44; Mahabir D, 1997, Rev Panam Salud Publica, V1, P174, DOI 10.1590/S1020-49891997000300002; Mahmood K, 1995, PERTANIKA J SCI TECH, V3, P197; Manandhar N. P., 1993, Fitoterapia, V64, P266; Mishra M. R., 2011, International Journal of Phytomedicine, V3, P422; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Saikia R, 2012, ASIAN J PHARM CLIN R, V5, P765; SATYANAR.K, 1969, J INDIAN CHEM SOC, V46, P765; Wang YS, 1983, PHARM APPL CHINESE M, VII; [邢贤冬 Xing Xiandong], 2012, [中药材, Journal of Chinese Medicinal Materials], V35, P1429; Zhu YP, 1998, CHINESE MATERIA MED, P321; Zulfiker A.H.M., 2010, INT J PHARMTECH RES, V2, P2527	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	OCT	2015	29	10					1672	1675		10.1002/ptr.5412		4	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CT4QX	WOS:000362792900031		
J	Tsuji, M; Ohta, K; Tanaka, K; Takikawa, Y				Tsuji, M.; Ohta, K.; Tanaka, K.; Takikawa, Y.			First Report of Knot Disease on Olive (Olea europaea) in Japan Caused by Pseudomonas savastanoi pv. savastanoi.	PLANT DISEASE			English	News Item									[Tsuji, M.; Takikawa, Y.] Shizuoka Univ, Grad Sch Sci & Technol, Shizuoka 4228529, Japan; [Ohta, K.] Nissei Sekiyu Co Ltd, Shizuoka 4228616, Japan; [Tanaka, K.] Shizuoka Plant Protect Off, Iwata, Shizuoka 4380803, Japan	Tsuji, M (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, 836 Ohya, Shizuoka 4228529, Japan.						Penyalver R, 2000, APPL ENVIRON MICROB, V66, P2673, DOI 10.1128/AEM.66.6.2673-2677.2000; Marchi G, 2005, EUR J PLANT PATHOL, V112, P101, DOI 10.1007/s10658-005-0804-0; LELLIOTT RA, 1966, J APPL BACTERIOL, V29, P470, DOI 10.1111/j.1365-2672.1966.tb03499.x; Ausubel FM, 1987, CURRENT PROTOCOLS MO	4	0	0	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0191-2917	1943-7692		PLANT DIS	PLANT DIS.	OCT	2015	99	10					1445	1445		10.1094/PDIS-12-14-1318-PDN		1	Plant Sciences	Plant Sciences	CS9CK	WOS:000362386500021		
J	Inaba, S; Kurata, R; Kobayashi, M; Yamagishi, Y; Mori, I; Ogata, Y; Fukao, Y				Inaba, Shoko; Kurata, Rie; Kobayashi, Mami; Yamagishi, Yoko; Mori, Izumi; Ogata, Yoshiyuki; Fukao, Yoichiro			Identification of putative target genes of bZIP19, a transcription factor essential for Arabidopsis adaptation to Zn deficiency in roots	PLANT JOURNAL			English	Article						zinc deficiency; bZIP transcription factor; ZIP family transporter; Arabidopsis thaliana; quantitative proteomics; quantitative real-time PCR	METAL HOMEOSTASIS; ZINC HOMEOSTASIS; PLANT DEFENSINS; ZIP FAMILY; EXPRESSION; THALIANA; TRANSPORTER; PEPTIDES; HALLERI; PROTEIN	Zinc (Zn) depletion adversely affects plant growth. To avoid lethal depletion of cellular Zn, plants have evolved mechanisms to adjust the expression of genes associated with Zn homeostasis, the details of which are poorly understood. In the present study, we isolated an Arabidopsis thaliana T-DNA insertion mutant that exhibited hypersensitivity to Zn depletion. By monitoring root development under Zn-deficient conditions, we isolated a single mutant lacking the basic-region leucine-zipper transcription factor gene bZIP19. To identify proteins whose expression is affected by bZIP19, an iTRAQ-based quantitative proteomics analysis was performed using microsomal proteins from wild-type and the bzip19 mutant A.thaliana roots grown on Basal and Zn-deficient media. Of the 797 proteins identified, expression of two members of the Zrt- and Irt-related protein family, ZIP3 and ZIP9, and three defensin-like family proteins was markedly induced in wild-type but not in the bzip19 mutant under Zn-deficient conditions. Furthermore, selected reaction monitoring and quantitative real-time PCR revealed that ZIP9 expression is mediated by bZIP19 and may be partly supported by bZIP23, a homolog of bZIP19. Mutant analysis revealed that ZIP9 is involved in uptake of Zn by the roots, and the mutant lacking ZIP9 was significantly more sensitive to Zn depletion than the wild-type. These results demonstrate that bZIP19 mainly contributes to expression of genes, such as ZIP9, under Zn-deficient conditions. Significance Statement Zinc homeostasis is important for plant growth, but how plants cope with zinc deficiencies is poorly understood. We show that the Arabidopsis transcription factor bZIP19 predominantly contributes zinc deficiency adaptation, in part by affecting expression of the Zrt- and Irt-related protein 9 (ZIP9) Zn transporters.	[Inaba, Shoko; Fukao, Yoichiro] Ritsumeikan Univ, Dept Bioinformat, Shiga 5258577, Japan; [Inaba, Shoko; Kurata, Rie; Kobayashi, Mami; Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Yamagishi, Yoko] Thermo Fisher Sci, Yokohama, Kanagawa 2210022, Japan; [Mori, Izumi] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan; [Ogata, Yoshiyuki] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka 5998531, Japan	Fukao, Y (reprint author), Ritsumeikan Univ, Dept Bioinformat, Shiga 5258577, Japan.	y-fukao@fc.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26450080]; Nara Institute of Science and Technology - Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Advanced Plant Science Network	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (number 26450080 to Y.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Scientific Research from Nara Institute of Science and Technology supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Tsuyoshi Nakagawa (Shimane University, Depaertment of Molecular and Functional Genomics, Matsue, Japan) for kindly providing the Gateway binary vectors (pGWBs). This research was supported by the Japan Advanced Plant Science Network.	Alloway B. J., 2008, ZINC SOILS CROP NUTR, P44; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; van de Mortel JE, 2006, PLANT PHYSIOL, V142, P1127, DOI 10.1104/pp.106.082073; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Grotz N, 2006, BBA-MOL CELL RES, V1763, P595, DOI 10.1016/j.bbamcr.2006.05.014; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Lee S, 2010, PLANT MOL BIOL, V73, P507, DOI 10.1007/s11103-010-9637-0; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Lopez-Millan AF, 2004, PLANT MOL BIOL, V54, P583, DOI 10.1023/B:PLAN.0000038271.96019.aa; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Jain A, 2013, ENVIRON SCI TECHNOL, V47, P5327, DOI 10.1021/es400113y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ramesh SA, 2003, PLANT PHYSIOL, V133, P126, DOI 10.1104/pp.103.026815; Lin YF, 2009, NEW PHYTOL, V182, P392, DOI 10.1111/j.1469-8137.2009.02766.x; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Ishimaru Y, 2005, J EXP BOT, V56, P3207, DOI 10.1093/jxb/eri317; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Waters BM, 2011, PLANT SCI, V180, P562, DOI 10.1016/j.plantsci.2010.12.003; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; VALLEE BL, 1993, PHYSIOL REV, V73, P79; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Jain A, 2009, PLANT PHYSIOL, V150, P1033, DOI 10.1104/pp.109.136184; Lee S, 2010, MOL CELLS, V29, P551, DOI 10.1007/s10059-010-0069-0; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; [Anonymous], 1962, PHYSIOL PLANTARUM, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Randhawa N. S., 1983, MICRONUTRIENTS, P4; RHODES D, 1993, SCI AM, V268, P56; Tesfaye M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058992	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	OCT	2015	84	2					323	334		10.1111/tpj.12996		12	Plant Sciences	Plant Sciences	CT3FG	WOS:000362692000006		
J	Sasaki, A; Yamaji, N; Mitani-Ueno, N; Kashino, M; Ma, JF				Sasaki, Akimasa; Yamaji, Naoki; Mitani-Ueno, Namiki; Kashino, Miho; Ma, Jian Feng			A node-localized transporter OsZIP3 is responsible for the preferential distribution of Zn to developing tissues in rice	PLANT JOURNAL			English	Article						zinc; ZIP; transporter; distribution; node; rice	ZINC TRANSPORTER; ARABIDOPSIS-THALIANA; ZIP FAMILY; EXPRESSION; TRANSLOCATION; MANGANESE; CADMIUM; PROTEIN; OSHMA2; PLANTS	Developing tissues such as meristem with low transpiration require high Zn levels for their active growth, but the molecular mechanisms underlying the preferential distribution to these tissues are poorly understood. We found that a member of the ZIP (ZRT, IRT-like protein), OsZIP3, showed high expression in the nodes of rice (Oryza sativa). Immunostaining revealed that OsZIP3 was localized at the xylem intervening parenchyma cells and xylem transfer cells of the enlarged vascular bundle in both basal and upper nodes. Neither OsZIP3 gene expression nor encoded protein was affected by either deficiency or toxic levels of Zn. Knockdown of OsZIP3 resulted in significantly reduced Zn levels in the shoot basal region containing the shoot meristem and elongating zone, but increased Zn levels in the transpiration flow. A short-term experiment with the Zn-67 stable isotope showed that more Zn was distributed to the lower leaves, but less to the shoot elongating zone and nodes in the knockdown lines compared with the wild-type rice at both the vegetative and reproductive growth stages. Taken together, OsZIP3 located in the node is responsible for unloading Zn from the xylem of enlarged vascular bundles, which is the first step for preferential distribution of Zn to the developing tissues in rice. Significance Statement Zinc homeostasis is achieved by regulating diverse zinc transporters. Here we show that the zinc transporter OsZIP3 mediates the first step leading to preferential distribution of zinc in developing tissues, by unloading zinc from the xylem of enlarged vascular bundles.	[Sasaki, Akimasa; Yamaji, Naoki; Mitani-Ueno, Namiki; Kashino, Miho; Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama 7100046, Japan	Ma, JF (reprint author), Okayama Univ, Inst Plant Sci & Resources, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	maj@rib.okayama-u.ac.jp	YAMAJI, Naoki/B-2524-2011	YAMAJI, Naoki/0000-0002-7499-3004	Ministry of Education, Culture, Sports, Science and Technology of Japan [22119002, 24248014]	The research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 22119002 and 24248014 to J.F.M.) and a Grant-in-Aid for JSPS Fellows to A.S. We thank Akemi Morita, Kaoru Ishii and Tomoko Haruna for their technical assistance.	KUPPELWIESER H, 1991, PLANT SOIL, V132, P281; Astudillo C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00286; Takahashi H, 2010, J PLANT RES, V123, P807, DOI 10.1007/s10265-010-0319-4; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Chen WR, 2008, RUSS J PLANT PHYSL+, V55, P400, DOI 10.1134/S1021443708030175; Moore KL, 2014, NEW PHYTOL, V201, P104, DOI 10.1111/nph.12497; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Lee S, 2010, PLANT MOL BIOL, V73, P507, DOI 10.1007/s11103-010-9637-0; Yamaji N, 2009, PLANT CELL, V21, P2878, DOI 10.1105/tpc.109.069831; Satoh-Nagasawa N, 2012, PLANT CELL PHYSIOL, V53, P213, DOI 10.1093/pcp/pcr166; Sasaki A, 2014, J EXP BOT, V65, P6013, DOI 10.1093/jxb/eru340; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Takahashi R, 2012, PLANT CELL ENVIRON, V35, P1948, DOI 10.1111/j.1365-3040.2012.02527.x; Ramesh SA, 2003, PLANT PHYSIOL, V133, P126, DOI 10.1104/pp.103.026815; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Bashir K, 2012, PLANT SOIL, V361, P189, DOI 10.1007/s11104-012-1240-5; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Ishimaru Y, 2005, J EXP BOT, V56, P3207, DOI 10.1093/jxb/eri317; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Waters BM, 2011, PLANT SCI, V180, P562, DOI 10.1016/j.plantsci.2010.12.003; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Lee S, 2010, MOL CELLS, V29, P551, DOI 10.1007/s10059-010-0069-0; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Yamaji N, 2007, PLANT PHYSIOL, V143, P1306, DOI 10.1104/pp.106.093005; Yamaguchi N, 2012, J EXP BOT, V63, P2729, DOI 10.1093/jxb/err455; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Broadley M., 2011, MARSCHNERS MINERAL N, P212; KITAGISHI K, 1986, SOIL SCI PLANT NUTR, V32, P397; Obata H., 1980, JPN J SOIL SCI PLANT, V51, P285; Olsen LI, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00030; Yamaji N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3442; Yamaji N, 2014, TRENDS PLANT SCI, V19, P556, DOI 10.1016/j.tplants.2014.05.007	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	OCT	2015	84	2					374	384		10.1111/tpj.13005		11	Plant Sciences	Plant Sciences	CT3FG	WOS:000362692000010		
J	Fukuhara, G				Fukuhara, Gaku			Polymer-based supramolecular sensing and application to chiral photochemistry	POLYMER JOURNAL			English	Review							SINGLE-STRANDED RNA; MOLECULAR RECOGNITION; HELICAL POLYMERS; DIASTEREODIFFERENTIATING PHOTOCYCLODIMERIZATION; POLYTHIOPHENE CONJUGATE; CHEMICAL SENSORS; COMPLEXES; AMPLIFICATION; SYSTEMS; 2-ANTHRACENECARBOXYLATE	Supramolecular sensing using polymers is of particular significance not only for fundamental science but also for a number of practical diagnostic applications because, upon interaction with target analytes, polymers are capable of amplifying the binding events and thus greatly enhance the signal gain. Hence, we proposed the construction of supramolecular sensors based on chiral functional polymers, such as synthetic conjugated polymers and modified polysaccharides, which are responsive to biologically important chiral materials and saccharides. The present strategy using polymer hosts that behave very differently from those commonly employed in conventional chemosensors is based on the chirality or molecular information propagation and amplification in the polymer chains. By exploiting the knowledge and techniques obtained from the polymer-based supramolecular sensing of bio-related materials, we have expanded the research to photochemical asymmetric synthesis, or 'photochirogenesis,' which provides ecologically benign yet versatile routes to optically active compounds via electronically excited states and is also one of the most attractive and challenging topics in current chemistry. In this review, the author highlights polymer-based supramolecular sensing and application to photochirogenesis with recent examples.	Osaka Univ, Dept Appl Chem, Suita, Osaka 5650871, Japan	Fukuhara, G (reprint author), Osaka Univ, Dept Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	gaku@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [20850023, 23750129, 26620061]; Nikko Memorial Foundation; Nikki-Saneyoshi (JGC-S) Scholarship Foundation; Shorai Foundation for Science and Technology; Ogasawara Foundation for the Promotion of Science Engineering; Nakatani Foundation	I am deeply grateful to Prof. Yoshihisa Inoue of Osaka University for his appropriate guidance and continuous encouragement throughout these works, to all the collaborators for developing the studies and to the financial support by the Japan Society for the Promotion of Science (JSPS) (nos. 20850023, 23750129 and 26620061) and by research grants from the Nikko Memorial Foundation, the Nikki-Saneyoshi (JGC-S) Scholarship Foundation, the Shorai Foundation for Science and Technology, the Ogasawara Foundation for the Promotion of Science & Engineering and the Nakatani Foundation.	Fukuhara G, 2010, J ORG CHEM, V75, P4307, DOI 10.1021/jo100596n; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; Bunz UHF, 2000, CHEM REV, V100, P1605, DOI 10.1021/cr990257j; MARSELLA MJ, 1994, J AM CHEM SOC, V116, P9347, DOI 10.1021/ja00099a069; Pu L, 1998, CHEM REV, V98, P2405, DOI 10.1021/cr970463w; Li C, 2005, J AM CHEM SOC, V127, P4548, DOI 10.1021/ja050168q; Mazik M, 2012, RSC ADV, V2, P2630, DOI 10.1039/c2ra01138g; Nakano T, 2001, CHEM REV, V101, P4013, DOI 10.1021/cr0000978; CRAM DJ, 1988, SCIENCE, V240, P760, DOI 10.1126/science.3283937; Fukuhara G, 2010, CHEM-EUR J, V16, P7859, DOI 10.1002/chem.200903545; Cornelissen JJLM, 2001, CHEM REV, V101, P4039, DOI 10.1021/cr990126i; Haraguchi S, 2009, CHEM-EUR J, V15, P11221, DOI 10.1002/chem.200901003; Yashima E, 2009, CHEM REV, V109, P6102, DOI 10.1021/cr900162q; Fukuhara G, 2010, ORG LETT, V12, P3510, DOI 10.1021/ol101362s; Rochat S, 2013, ACS APPL MATER INTER, V5, P4488, DOI 10.1021/am400939w; Oliveri CG, 2008, ACCOUNTS CHEM RES, V41, P1618, DOI 10.1021/ar800025w; Green MM, 2001, ACCOUNTS CHEM RES, V34, P672, DOI 10.1021/ar010009l; Nakamura A, 2003, J AM CHEM SOC, V125, P966, DOI 10.1021/ja016238k; Sada K, 2007, CHEM SOC REV, V36, P415, DOI 10.1039/b603555h; Shinkai S, 2001, ACCOUNTS CHEM RES, V34, P494, DOI 10.1021/ar000177y; MARSELLA MJ, 1993, J AM CHEM SOC, V115, P12214, DOI 10.1021/ja00078a090; Hoeben FJM, 2005, CHEM REV, V105, P1491, DOI 10.1021/cr030070z; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Fukuhara G, 2010, CHEM COMMUN, V46, P9128, DOI 10.1039/c0cc02568b; Griesbeck AG, 2002, ANGEW CHEM INT EDIT, V41, P3147, DOI 10.1002/1521-3773(20020902)41:17<3147::AID-ANIE3147>3.0.CO;2-V; Davis AP, 1999, ANGEW CHEM INT EDIT, V38, P2978; Yashima E, 2004, CHEM-EUR J, V10, P42, DOI 10.1002/chem.200305295; Yang C, 2014, CHEM SOC REV, V43, P4123, DOI 10.1039/c3cs60339c; Inoue Y, 1997, J AM CHEM SOC, V119, P472, DOI 10.1021/ja963160c; CRAM DJ, 1978, ACCOUNTS CHEM RES, V11, P8, DOI 10.1021/ar50121a002; OGAWA K, 1973, CHEM LETT, P943, DOI 10.1246/cl.1973.943; Fukuhara G, 2012, CHEM-EUR J, V18, P11459, DOI 10.1002/chem.201201294; Sakurai K, 2000, J AM CHEM SOC, V122, P4520, DOI 10.1021/ja0000145; DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020; Hembury GA, 2008, CHEM REV, V108, P1, DOI 10.1021/cr050005k; Fukuhara G, 2011, ORG LETT, V13, P1856, DOI 10.1021/ol2003644; Muller C, 2008, AUST J CHEM, V61, P557, DOI 10.1071/CH08195; OGAWA K, 1972, CARBOHYD RES, V23, P399, DOI 10.1016/S0008-6215(00)82709-3; Fukuhara G, 2012, CHEM COMMUN, V48, P1641, DOI 10.1039/c2cc17007h; Kovbasyuk L, 2004, CHEM REV, V104, P3161, DOI 10.1021/cr030673a; Mateos-Timoneda MA, 2004, CHEM SOC REV, V33, P363, DOI 10.1039/b305550g; Maeda K, 2006, TOP CURR CHEM, V265, P47, DOI 10.1007/128_035; Numata M, 2011, CHEM COMMUN, V47, P1961, DOI 10.1039/c0cc03133j; Fukuhara G, 2011, J AM CHEM SOC, V133, P768, DOI 10.1021/ja110075p; Eleftheriadou Ioanna, 2008, Curr Diabetes Rev, V4, P340, DOI 10.2174/157339908786241133; Inoue Y., 2004, CHIRAL PHOTOCHEMISTR; Kimura T, 2000, CHEM LETT, P1242, DOI 10.1246/cl.2000.1242; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Palmans ARA, 2007, ANGEW CHEM INT EDIT, V46, P8948, DOI 10.1002/anie.200701285; Ramamurthy V., 2011, SUPRAMOLECULAR PHOTO; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339	51	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	OCT	2015	47	10					649	655		10.1038/pj.2015.52		7	Polymer Science	Polymer Science	CS9YB	WOS:000362448600001		
J	Jikei, M; Takeyama, Y; Yamadoi, Y; Shinbo, N; Matsumoto, K; Motokawa, M; Ishibashi, K; Yamamoto, F				Jikei, Mitsutoshi; Takeyama, Yuuki; Yamadoi, Yuta; Shinbo, Natsumi; Matsumoto, Kazuya; Motokawa, Mamika; Ishibashi, Kazuyuki; Yamamoto, Fumio			Synthesis and properties of Poly(L-lactide)-Poly(epsilon-caprolactone) multiblock copolymers by the self-polycondensation of diblock macromonomers	POLYMER JOURNAL			English	Article							LACTIC-ACID; THERMOPLASTIC ELASTOMERS; MELTING BEHAVIOR; CRYSTALLIZATION; POLY(L-LACTIDE); BLENDS; POLY(L-LACTIDE)-CO-POLY(EPSILON-CAPROLACTONE); POLY(EPSILON-CAPROLACTONE); POLYESTERS; PREVENTION	Poly(L-lactide) (PLLA)-poly(epsilon-caprolactone) (PCL) multiblock copolymers (MBCs) were synthesized by the self-polycondensation of PLLA-PCL diblock copolymers. We synthesized three types of MBCs with degrees of polymerization of the lactide-caprolactone segments of 12-15 (MBC1), 24-26 (MBC2) and 49-50 (MBC3) to investigate the effect of the segment length on the properties. The strict control over the terminal functional groups of the diblock copolymers resulted in the formation of high-molecular weight MBCs (M-w=(2.4-4.9) x 10(5) g mol(-1)). Differential scanning calorimetry (DSC) measurements suggest the phase mixing of PLLA and PCL segments in amorphous region and that the MBCs contain PCL-rich regions, the extent of which is influenced by the segment length. The X-ray diffraction patterns of the MBCs contain diffraction peaks originating from lactide segment crystals. High moduli (95-43 MPa) and elongation at break (similar to 500%) were observed for all the MBC films. The MBCs hydrolyzed slowly in comparison with PLLA, and the hydrophilic porous films of MBC2 were obtained. To estimate their potential as adhesion barrier films, the hydrophilic porous MBC films were implanted onto the abdominal side walls of rats. The MBC films effectively prevented the adhesion at the target site, but intermediate adhesion was observed at the suture site where the MBC film was fixed.	[Jikei, Mitsutoshi; Takeyama, Yuuki; Yamadoi, Yuta; Shinbo, Natsumi; Matsumoto, Kazuya] Akita Univ, Dept Appl Chem, Akita, Akita 0108502, Japan; [Motokawa, Mamika; Ishibashi, Kazuyuki; Yamamoto, Fumio] Akita Univ, Grad Sch Med, Akita, Akita 0108502, Japan	Jikei, M (reprint author), Akita Univ, Dept Appl Chem, 1-1 Tegatagakuen Machi, Akita, Akita 0108502, Japan.	mjikei@gipc.akita-u.ac.jp			Feasibility Study of Akita prefecture, Japan	This work was partially supported by Feasibility Study of Akita prefecture, Japan. We appreciate the kind donation of a random copolymer of poly(L-lactide)-co-poly(epsilon-caprolactone) (LCL) from BMG, Inc. (Kyoto, Japan).	Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Diamond MP, 1996, FERTIL STERIL, V66, P904; MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013; Nakayama Y, 2007, REACT FUNCT POLYM, V67, P798, DOI 10.1016/j.reactfunctpolym.2006.12.006; Park SN, 2007, J MATER SCI-MATER M, V18, P475, DOI 10.1007/s10856-007-2007-z; Suh H, 2003, MATER SCI FORUM, V426-4, P3255; Fernandez J, 2013, POLYMER, V54, P2621, DOI 10.1016/j.polymer.2013.03.009; Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149; Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052; DeCherney AH, 1997, SURG CLIN N AM, V77, P671, DOI 10.1016/S0039-6109(05)70574-0; Yang JM, 1997, POLYM J, V29, P657, DOI 10.1295/polymj.29.657; Nagata M, 2005, J POLYM SCI POL CHEM, V43, P2426, DOI 10.1002/pola.20718; Mulhaupt R, 2013, MACROMOL CHEM PHYS, V214, P159, DOI 10.1002/macp.201200439; Lopez-Rodriguez N, 2006, POLYM ENG SCI, V46, P1299, DOI 10.1002/pen.20609; Zhang JH, 2009, MAT SCI ENG C-BIO S, V29, P889, DOI 10.1016/j.msec.2008.08.002; Zhang J, 2008, MACROMOLECULES, V41, P1352, DOI 10.1021/ma0706071; Li Y, 2012, RSC ADV, V2, P8229, DOI 10.1039/c2ra20736b; Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6; Tsuji H, 1998, J APPL POLYM SCI, V67, P405; Jeon O, 2003, MACROMOLECULES, V36, P5585, DOI 10.1021/ma034006v; Saeidlou S, 2012, PROG POLYM SCI, V37, P1657, DOI 10.1016/j.progpolymsci.2012.07.005; Shi R, 2009, INT J MOL SCI, V10, P4223, DOI 10.3390/ijms10104223; Brostrom J, 2004, BIOMACROMOLECULES, V5, P1124, DOI 10.1021/bm049920q; Moller M, 2000, J POLYM SCI POL CHEM, V38, P2067, DOI 10.1002/(SICI)1099-0518(20000601)38:11<2067::AID-POLA150>3.0.CO;2-1; Kawai T, 2007, MACROMOLECULES, V40, P9463, DOI 10.1021/ma070082c; Arimura H., 2009, JAPAN TOKKYO KOKAI; Burns JW, 1997, EUR J SURG S, V57, P40; Dorgan J. R., 2006, ACS SYM SER, V939, P102; Sakuma K., 2000, Japanese Journal of Artificial Organs, V29, P233; Santis P. D., 1968, BIOPOLYMERS, V6, P299	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	OCT	2015	47	10					657	665		10.1038/pj.2015.49		9	Polymer Science	Polymer Science	CS9YB	WOS:000362448600002		
J	Terashima, T; Sugita, T; Sawamoto, M				Terashima, Takaya; Sugita, Takanori; Sawamoto, Mitsuo			Single-chain crosslinked star polymers via intramolecular crosslinking of self-folding amphiphilic copolymers in water	POLYMER JOURNAL			English	Article							LIVING RADICAL POLYMERIZATION; UNIMOLECULAR MICELLES; RUTHENIUM CATALYSTS; NANOPARTICLES; RECOGNITION; CHEMISTRY; VERSATILE; COLLAPSE; DESIGN	Single-chain crosslinked star polymers with multiple hydrophilic short arms and a hydrophobic core were created as novel microgel star polymers of single polymer chains. The synthetic process involves the intramolecular crosslinking of self-folding amphiphilic random copolymers in water. For this process, amphiphilic random copolymers bearing hydrophilic poly(ethylene glycol) (PEG) and hydrophobic olefin pendants were synthesized by ruthenium-catalyzed living radical copolymerization of PEG methyl ether methacrylate, dodecyl methacrylate and hydroxyl-functionalized methacrylates, and the in situ or postesterification of the hydroxyl pendants of the resulting copolymers with methacryloyl chloride. The olefin-bearing copolymers with 20-40 mol% hydrophobic units efficiently self-folded because of hydrophobic interactions in water. These folded structures were then crosslinked intramolecularly using a free radical initiator or a ruthenium catalyst to selectively yield single-chain crosslinked star polymers, whereas a counterpart containing 50 mol% hydrophobic units induced bimolecular aggregation in water to give double-chain crosslinked star polymers. The primary structure of the star polymers can be precisely controlled with random copolymer precursors. Owing to the PEG arm units, the star polymers further showed thermosensitive solubility in water.	[Terashima, Takaya; Sugita, Takanori; Sawamoto, Mitsuo] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6158510, Japan	Terashima, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan.	terashima@living.polym.kyoto-u.ac.jp; sawamoto@star.polym.kyoto-u.ac.jp			Ministry of Education, Science, Sports and Culture [24245026, 26410134, 24750104]	This research was supported by the Ministry of Education, Science, Sports and Culture through Grant-in-Aids for Scientific Research (A: 24245026, C: 26410134) and Young Scientist (B: 24750104). We also thank Mr Akihiro Uesaka and Professor Syunsaku Kimura (Department of Material Chemistry, Kyoto University) for transmission electron microscopy measurements.	Altintas O, 2012, MACROMOL RAPID COMM, V33, P958, DOI 10.1002/marc.201200049; Terashima T, 2014, MACROMOLECULES, V47, P589, DOI 10.1021/ma402355v; Ouchi M, 2009, CHEM REV, V109, P4963, DOI 10.1021/cr900234b; Blencowe A, 2009, POLYMER, V50, P5, DOI 10.1016/j.polymer.2008.09.049; Terashima T, 2011, POLYM J, V43, P770, DOI 10.1038/pj.2011.52; Sanchez-Sanchez A, 2013, MOLECULES, V18, P3339, DOI 10.3390/molecules18033339; Ouchi M, 2012, POLYM J, V44, P51, DOI 10.1038/pj.2011.59; Terashima T, 2011, J AM CHEM SOC, V133, P4742, DOI 10.1021/ja2004494; Kanaoka S, 2007, J AM CHEM SOC, V129, P12060, DOI 10.1021/ja0735599; Mes T, 2011, ANGEW CHEM INT EDIT, V50, P5085, DOI 10.1002/anie.201100104; Croce TA, 2007, MACROMOLECULES, V40, P6028, DOI 10.1021/ma071111m; Chi YG, 2008, J AM CHEM SOC, V130, P6322, DOI 10.1021/ja8013456; Foster EJ, 2009, J AM CHEM SOC, V131, P6964, DOI 10.1021/ja901687d; Terashima T, 2011, ANGEW CHEM INT EDIT, V50, P7892, DOI 10.1002/anie.201101381; Terashima T, 2010, MACROMOLECULES, V43, P8218, DOI 10.1021/ma101235j; Sugita T, 2015, MACROMOL SYMP, V350, P76, DOI 10.1002/masy.201400027; Koda Y, 2014, J AM CHEM SOC, V136, P15742, DOI 10.1021/ja508818j; Yoda H, 2010, MACROMOLECULES, V43, P5595, DOI 10.1021/ma100589b; Cherian AE, 2007, J AM CHEM SOC, V129, P11350, DOI 10.1021/ja074301l; Ouchi M, 2008, CHEM-ASIAN J, V3, P1358, DOI 10.1002/asia.200800142; Altintas O, 2012, POLYM CHEM-UK, V3, P640, DOI 10.1039/c1py00392e; REICHARDT C, 1994, CHEM REV, V94, P2319, DOI 10.1021/cr00032a005; Elsabahy M, 2012, J POLYM SCI POL CHEM, V50, P1869, DOI 10.1002/pola.25955; Terashima T, 2012, ACS SYM SER, V1101, P65; Lyon CK, 2015, POLYM CHEM-UK, V6, P181, DOI 10.1039/c4py01217h; Yusa S, 2002, MACROMOLECULES, V35, P10182, DOI 10.1021/ma0212947; Terashima T, 2014, J AM CHEM SOC, V136, P10254, DOI 10.1021/ja505646p; Chao DM, 2013, CHEM COMMUN, V49, P4178, DOI 10.1039/c2cc37157j; Hosono N, 2013, J AM CHEM SOC, V135, P501, DOI 10.1021/ja310422w; Ouchi M, 2011, NAT CHEM, V3, P917, DOI [10.1038/nchem.1175, 10.1038/NCHEM.1175]; Gao HF, 2012, MACROMOL RAPID COMM, V33, P722, DOI 10.1002/marc.201200005; Li LY, 2014, CHEM COMMUN, V50, P13417, DOI 10.1039/c4cc03688c; Gillissen MAJ, 2013, MACROMOLECULES, V46, P4120, DOI 10.1021/ma4006846; Artar M, 2014, ACS SYM SER, V1170, P313; Arter M., 2014, J POLYM SCI A, V52, P12; Lutz J.-F., 2008, POLYM SCI SER A, V46, P3459; MORISHIMA Y, 1995, MACROMOLECULES, V28, P2874, DOI 10.1021/ma00112a037; Murray BS, 2011, MACROMOLECULES, V44, P7242, DOI 10.1021/ma201331f; Terashima T, 2014, ACS SYM SER, V1170, P255; Terashima T, 2014, POLYM J, V46, P664, DOI 10.1038/pj.2014.57	40	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	OCT	2015	47	10					667	677		10.1038/pj.2015.54		11	Polymer Science	Polymer Science	CS9YB	WOS:000362448600003		
J	Ida, D				Ida, Daichi			Translational diffusion coefficient of wormlike regular three-arm stars	POLYMER JOURNAL			English	Article							PLANE-POLYGONAL POLYMER; HYDRODYNAMIC PROPERTIES; INTRINSIC-VISCOSITY; DILUTE-SOLUTION; MONTE-CARLO; DYNAMICS; CHAINS; MOLECULES; MODEL	Effects of chain stiffness on the translational diffusion coefficient D or (effective) hydrodynamic radius R-H (proportional to D-1) are examined theoretically for the regular three-arm star polymers on the basis of the Kratky-Porod (KP) wormlike chain model. The ratio g(H) of R-H of the regular KP three-arm star touched-bead model to that of the KP linear one, both having the same (reduced) total contour length L and (reduced) bead diameter d(b), is numerically evaluated on the basis of the Kirkwood formula and/or the Kirkwood-Riseman (KR) hydrodynamic equation. From an examination of the behavior of the Kirkwood value g(H)((K)) and the KR one g(H)((KR)) of g(H) as a function of L and d(b), it is found that both of g(H)((K)) and g(H)((KR)) are insensitive to change in L irrespective of the value of d(b) and that g(H)((KR)) is slightly larger than g(H)((K)) in the ranges of L and d(b) investigated. An empirical interpolation formula is constructed for g(H)((K)), which reproduces the asymptotic values root 3/(2 root 2 - 1) (= 0.947) in the random-coil limit and 1 in the thin-rod limit.	Kyoto Univ, Dept Polymer Chem, Kyoto 6158510, Japan	Ida, D (reprint author), Kyoto Univ, Dept Polymer Chem, Kyoto 6158510, Japan.	ida@molsci.polym.kyoto-u.ac.jp					YAMAKAWA H, 1981, J CHEM PHYS, V75, P1016, DOI 10.1063/1.442065; KURATA M, 1964, J CHEM PHYS, V41, P2934, DOI 10.1063/1.1726377; ZWANZIG R, 1966, J CHEM PHYS, V45, P1858, DOI 10.1063/1.1727857; Ida D, 2008, POLYM J, V40, P1074, DOI 10.1295/polymj.PJ2008160; KIRKWOOD JG, 1954, J POLYM SCI, V12, P1, DOI 10.1002/pol.1954.120120102; YAMAKAWA H, 1983, MACROMOLECULES, V16, P1928, DOI 10.1021/ma00246a023; HUBER K, 1984, MACROMOLECULES, V17, P541, DOI 10.1021/ma00134a006; Ida D, 2008, POLYM J, V40, P256, DOI 10.1295/polymj.PJ2007205; ZIMM BH, 1956, J CHEM PHYS, V24, P269, DOI 10.1063/1.1742462; PAUL E, 1969, J CHEM PHYS, V51, P1102, DOI 10.1063/1.1672109; YAMAKAWA H, 1972, J CHEM PHYS, V57, P1542, DOI 10.1063/1.1678435; NORISUYE T, 1982, POLYM J, V14, P143, DOI 10.1295/polymj.14.143; Ida D, 2007, POLYM J, V39, P1373, DOI 10.1295/polymj.PJ2007121; KURATA M, 1958, J CHEM PHYS, V29, P311, DOI 10.1063/1.1744479; PAUL E, 1968, J CHEM PHYS, V48, P2378, DOI 10.1063/1.1669446; RISEMAN J, 1950, J CHEM PHYS, V18, P512, DOI 10.1063/1.1747672; STOCKMAYER WH, 1953, ANN NY ACAD SCI, V57, P334, DOI 10.1111/j.1749-6632.1953.tb36408.x; TCHEN CM, 1954, J APPL PHYS, V25, P463, DOI 10.1063/1.1721663; MANSFIELD ML, 1980, MACROMOLECULES, V13, P1713, DOI 10.1021/ma60078a064; ZIMM BH, 1949, J CHEM PHYS, V17, P1301, DOI 10.1063/1.1747157; YAMAKAWA H, 1989, J CHEM PHYS, V91, P7900, DOI 10.1063/1.457206; HUBER K, 1985, MACROMOLECULES, V18, P1461, DOI 10.1021/ma00149a017; YAMADA T, 1992, MACROMOLECULES, V25, P377, DOI 10.1021/ma00027a058; KIRKWOOD JG, 1948, J CHEM PHYS, V16, P565, DOI 10.1063/1.1746947; Irurzun IM, 1997, J POLYM SCI POL PHYS, V35, P563, DOI 10.1002/(SICI)1099-0488(199703)35:4<563::AID-POLB4>3.0.CO;2-R; KIRKWOOD JG, 1949, RECL TRAV CHIM PAY B, V68, P649; Yamakawa H., 1997, HELICAL WORMLIKE CHA; Yamakawa H., 1971, MODERN THEORY POLYM	28	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	OCT	2015	47	10					679	685		10.1038/pj.2015.44		7	Polymer Science	Polymer Science	CS9YB	WOS:000362448600004		
J	Sasaki, T; Ichimura, M; Irie, S				Sasaki, Takashi; Ichimura, Mizuki; Irie, Satoshi			Correlation between fragility and cooperativity in segmental dynamics of glass-forming para-substituted polystyrenes	POLYMER JOURNAL			English	Article							HEAT-CAPACITY SPECTROSCOPY; SHORT-RANGE ORDER; X-RAY-SCATTERING; SUPERCOOLED LIQUIDS; ATACTIC POLYSTYRENE; TRANSITION TEMPERATURE; LENGTH SCALE; FLUORESCENCE DEPOLARIZATION; AMORPHOUS POLYSTYRENE; NEUTRON-SCATTERING	To understand the mechanism of the viscous slowdown in supercooled liquids that is responsible for glass transition, we investigate the interrelation between glass transition temperature T-g, fragility and cooperativity in segmental dynamics. Polymeric glass formers having a similar chemical structure are expected to exhibit clear correlations between the above parameters. In this paper, polystyrene (PS) derivatives possessing various para-substituents are studied using calorimetry with regard to the fragility parameter m, dynamic length scale. and the number of cooperatively rearranging segments N-CRR at T-g. Positive correlations were revealed for both N-CRR(T-g) vs m and xi(3)(T-g) vs m. Both fragility and cooperativity were found to increase as the bulkiness of the substituent increases. Wide-angle X-ray scattering measurements revealed that the structural correlation between backbone chains is reduced as the bulkiness increases. This may be responsible for the reduced cooperativity. In contrast, for poly(methacrylic acid ester)s, the relations between the above parameters appeared to be less clear. The clear trend observed for the PS system may be due to the rigidity of the phenylene unit, through which the substituent directly affects the backbone dynamics. The estimated activation energy per segment increased consistently with an increase in the para-substituent's bulkiness.	[Sasaki, Takashi; Ichimura, Mizuki] Univ Fukui, Dept Mat Sci & Engn, Fukui 9108507, Japan; [Irie, Satoshi] Univ Fukui, Dept Frontier Fiber Technol & Sci, Fukui 910, Japan	Sasaki, T (reprint author), Univ Fukui, Dept Mat Sci & Engn, 3-9-1 Bunkyo, Fukui 9108507, Japan.	sasaki@matse.u-fukui.ac.jp					MOYNIHAN CT, 1976, J AM CERAM SOC, V59, P12, DOI 10.1111/j.1151-2916.1976.tb09376.x; BENGTZELIUS U, 1984, J PHYS C SOLID STATE, V17, P5915, DOI 10.1088/0022-3719/17/33/005; YAMAKAWA H, 1977, MACROMOLECULES, V10, P692, DOI 10.1021/ma60057a039; Huth H, 2000, PHYS REV B, V61, P15092, DOI 10.1103/PhysRevB.61.15092; Donth E, 1997, THERMOCHIM ACTA, V305, P239; YAMAKAWA H, 1986, J CHEM PHYS, V84, P4693, DOI 10.1063/1.449997; Lubchenko V, 2007, ANNU REV PHYS CHEM, V58, P235, DOI 10.1146/annurev.physchem.58.032806.104653; Agapov AL, 2012, MACROMOLECULES, V45, P8430, DOI 10.1021/ma301489c; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Casalini R, 2014, MACROMOLECULES, V47, P4087, DOI 10.1021/ma5008495; Hu YF, 2010, MACROMOLECULES, V43, P7391, DOI 10.1021/ma101662e; GOTZE W, 1992, REP PROG PHYS, V55, P241, DOI 10.1088/0034-4885/55/3/001; Sasaki T, 2005, J POLYM SCI POL PHYS, V43, P115, DOI 10.1002/polb.20314; Matsuoka S, 1997, J RES NATL INST STAN, V102, P213, DOI 10.6028/jres.102.017; Kanaya T, 1996, J CHEM PHYS, V104, P3841, DOI 10.1063/1.471037; Roland CM, 2010, MACROMOLECULES, V43, P7875, DOI 10.1021/m101649u; Tracht U, 1999, J MAGN RESON, V140, P460, DOI 10.1006/jmre.1999.1854; Ayyagari C, 2000, MACROMOLECULES, V33, P6194, DOI 10.1021/ma0003553; Sasaki T, 2006, J POLYM SCI POL PHYS, V44, P1958, DOI 10.1002/polb.20852; Hempel E, 2003, THERMOCHIM ACTA, V403, P105, DOI 10.1016/S0040-6031(03)00098-4; Kunal K, 2008, MACROMOLECULES, V41, P7232, DOI 10.1021/ma801155c; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; MITCHELL GR, 1984, POLYMER, V25, P906, DOI 10.1016/0032-3861(84)90073-9; SASAKI T, 1991, POLYM J, V23, P103, DOI 10.1295/polymj.23.103; Schweizer KS, 2004, J PHYS CHEM B, V108, P19729, DOI 10.1021/jp047763j; BOHMER R, 1993, J CHEM PHYS, V99, P4201; Dudowicz J, 2005, J PHYS CHEM B, V109, P21350, DOI 10.1021/jp053693k; Qin Q, 2006, J NON-CRYST SOLIDS, V352, P2977, DOI 10.1016/j.jnoncrysol.2006.04.014; Katz JR, 1936, T FARADAY SOC, V32, P0077, DOI 10.1039/tf9363200077; Hong L, 2011, J NON-CRYST SOLIDS, V357, P351, DOI 10.1016/j.jnoncrysol.2010.06.071; Capaccioli S, 2008, J PHYS CHEM B, V112, P10652, DOI 10.1021/jp802097u; FURUYA H, 1994, MACROMOLECULES, V27, P5674, DOI 10.1021/ma00098a022; Dudowicz J, 2008, ADV CHEM PHYS, V137, P125; SONG HH, 1987, MACROMOLECULES, V20, P2723, DOI 10.1021/ma00177a016; Dudowicz J, 2005, J PHYS CHEM B, V109, P21285, DOI 10.1021/jp0523266; ROE RJ, 1995, MACROMOLECULES, V28, P2807, DOI 10.1021/ma00112a028; LEUTHEUSSER E, 1984, PHYS REV A, V29, P2765, DOI 10.1103/PhysRevA.29.2765; Huang DH, 2001, J CHEM PHYS, V114, P5621, DOI 10.1063/1.1348029; Xia XY, 2000, P NATL ACAD SCI USA, V97, P2990, DOI 10.1073/pnas.97.7.2990; SCHUBACH HR, 1981, COLLOID POLYM SCI, V259, P789, DOI 10.1007/BF01388082; ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; Evans CM, 2013, MACROMOLECULES, V46, P6091, DOI 10.1021/ma401017n; Ellison CJ, 2005, MACROMOLECULES, V38, P1767, DOI 10.1021/ma047846y; Tracht U, 1998, PHYS REV LETT, V81, P2727, DOI 10.1103/PhysRevLett.81.2727; Schawe JEK, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4900961; Casalini R, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4907371; Chua YZ, 2014, COLLOID POLYM SCI, V292, P1893, DOI 10.1007/s00396-014-3280-2; Dalle-Ferrier C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041510; Di XJ, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4779057; Donth E, 1996, J POLYM SCI POL PHYS, V34, P2881; Ediger MD, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747326; Elfadl A. A., 2009, MACROMOLECULES, V42, P6816; Freed KF, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897973; Hemmpel E., 2000, J PHYS CHEM B, V104, P2460; Hong L, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3266508; MONDELLO M, 1994, MACROMOLECULES, V27, P3566, DOI 10.1021/ma00091a018; Pyda M., ATHAS DATA BANK; Roland CM, 2005, REP PROG PHYS, V68, P1405, DOI 10.1088/0034-4885/68/6/R03; Xu WS, 2014, MACROMOLECULES, V47, P6990, DOI 10.1021/ma501581u	59	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	OCT	2015	47	10					687	694		10.1038/pj.2015.50		8	Polymer Science	Polymer Science	CS9YB	WOS:000362448600005		
J	Horii, T; Li, YC; Mori, Y; Okuzaki, H				Horii, Tatsuhiro; Li, Yuechen; Mori, Yusaku; Okuzaki, Hidenori			Correlation between the hierarchical structure and electrical conductivity of PEDOT/PSS	POLYMER JOURNAL			English	Article							THIN-FILMS; POLYMER-FILMS; SOLVENT; POLY(3,4-ETHYLENEDIOXYTHIOPHENE)/POLY(4-STYRENE-SULFONATE)	The correlation between the hierarchical structure and electrical conductivity of poly(3,4-ethylenedioxythiophene) doped with poly(4-styrenesulfonate) (PEDOT/PSS) was investigated by means of X-ray photoelectron spectroscopy, wide-angle X-ray diffraction, conductive atomic force microscopy and the temperature dependence of the electrical conductivity. Upon adding 3% ethylene glycol (EG), the electrical conductivity at room temperature significantly increased from 3 to 175 S cm(-1), while a further increase in EG up to 20% resulted in a decrease in the electrical conductivity to 117 S cm(-1). It was found that the improvement in the electrical conductivity could be explained from the changes in the hierarchical structure; a decrease in the insulating PSS shell, crystallization of the PEDOT and aggregation of the PEDOT/PSS particles, which affect both the intra-and interparticle transport of charge carriers.	[Horii, Tatsuhiro; Li, Yuechen; Mori, Yusaku; Okuzaki, Hidenori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008511, Japan	Okuzaki, H (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, 4-4-37 Takeda, Kofu, Yamanashi 4008511, Japan.	okuzaki@yamanashi.ac.jp			Industrial Technology Research Grant Program; Practical Application of University R&D Results under the Matching Fund Method from New Energy and the Industrial Technology Development Organization (NEDO, Japan); Ministry of Education, Science, Sports and Culture of Japan	This work was supported in part by the Industrial Technology Research Grant Program in 2008, the Practical Application of University R&D Results under the Matching Fund Method from New Energy and the Industrial Technology Development Organization (NEDO, Japan) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan.	Yan H, 2009, THIN SOLID FILMS, V517, P3299, DOI 10.1016/j.tsf.2009.01.004; Greczynski G, 2001, J ELECTRON SPECTROSC, V121, P1, DOI 10.1016/S0368-2048(01)00323-1; Nardes AM, 2008, ADV FUNCT MATER, V18, P865, DOI 10.1002/adfm.200700796; Kirchmeyer S, 2005, J MATER CHEM, V15, P2077, DOI 10.1039/b417803n; Jonsson SKM, 2003, SYNTHETIC MET, V139, P1, DOI 10.1016/S0379-6779(02)01259-6; Hohnholz D, 2005, ADV FUNCT MATER, V15, P51, DOI 10.1002/adfm.200400241; Okuzaki H, 2003, MACROMOL RAPID COMM, V24, P261, DOI 10.1002/marc.200390038; Crispin X, 2006, CHEM MATER, V18, P4354, DOI 10.1021/cm061032+; Ouyang J, 2004, POLYMER, V45, P8443, DOI 10.1016/j.polymer.2004.10.001; Okuzaki H, 2009, J PHYS CHEM B, V113, P11378, DOI 10.1021/jp902845x; Okuzaki H, 2013, REACT FUNCT POLYM, V73, P986, DOI 10.1016/j.reactfunctpolym.2012.10.013; Okuzaki H, 2009, EUR POLYM J, V45, P256, DOI 10.1016/j.eurpolymj.2008.10.027; Aasmundtveit KE, 1999, SYNTHETIC MET, V101, P561, DOI 10.1016/S0379-6779(98)00315-4; Yan H, 2011, POLYM J, V43, P662, DOI 10.1038/pj.2011.32; Takano T, 2012, MACROMOLECULES, V45, P3859, DOI 10.1021/ma300120g; Ashizawa S, 2005, SYNTHETIC MET, V153, P5, DOI 10.1016/j.synthmet.2005.07.214; Elschner A., 2011, PEDOT PRINCIPLES APP; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Mott N.F., 1979, ELECT PROCESSES NONC; Okuzaki H., 2012, PEDOT MAT PROPERTIES; Ouyang J., 2005, ADV FUNCT MATER, V15, P203, DOI DOI 10.1002/ADFM.200400016; Yamashita M., 2011, APPL PHYS LETT, V99	22	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	OCT	2015	47	10					695	699		10.1038/pj.2015.48		5	Polymer Science	Polymer Science	CS9YB	WOS:000362448600006		
J	Tamesue, S; Hasegawa, S; Ishizaki, R; Hashimoto, K; Mitsumata, T; Tsubokawa, N; Yamauchi, T				Tamesue, Shingo; Hasegawa, Suguru; Ishizaki, Ryota; Hashimoto, Kumi; Mitsumata, Tetsu; Tsubokawa, Norio; Yamauchi, Takeshi			Preparation of poly(N-isopropylacrylamide)-terminated carbon nanotubes and determining their aggregation properties in response to infrared light and heating	POLYMER JOURNAL			English	Article							POLYMER; DELIVERY		[Tamesue, Shingo; Hashimoto, Kumi; Mitsumata, Tetsu; Tsubokawa, Norio; Yamauchi, Takeshi] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Tamesue, Shingo; Hasegawa, Suguru; Ishizaki, Ryota; Mitsumata, Tetsu; Yamauchi, Takeshi] Niigata Univ, Fac Engn, Dept Mat Sci & Engn, Niigata 9502181, Japan	Yamauchi, T (reprint author), Niigata Univ, Grad Sch Sci & Technol, Fac Engn, Nishi Ku, 8050,Ikarashi 2 No Cho, Niigata 9502181, Japan.	yamauchi@gs.niigata-u.ac.jp	Tamesue, Shingo/D-9009-2013		JSPS Kakenhi from the MEXT in Japan [2412001]	We appreciate the kind help from Dr T Kawahara, Niigata University. This work was supported by JSPS Kakenhi (Grant Number: 2412001) from the MEXT in Japan.	Pelah A, 2007, J AM CHEM SOC, V129, P468, DOI 10.1021/ja067171+; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Fujigaya T, 2008, ADV MATER, V20, P3610, DOI 10.1002/adma.200800494; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Zydziak N, 2013, POLYM CHEM-UK, V4, P1525, DOI 10.1039/c2py20928d; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Shiraki T, 2011, CHEM COMMUN, V47, P7065, DOI 10.1039/c1cc11288k; Nishihama S, 2012, REACT FUNCT POLYM, V72, P142, DOI 10.1016/j.reactfunctpolym.2011.12.001; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; Fan X, 2000, PHYS REV LETT, V84, P4621, DOI 10.1103/PhysRevLett.84.4621; STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0; Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P4663, DOI 10.1002/anie.200460774; Kong H, 2004, MACROMOLECULES, V37, P6683, DOI 10.1021/ma048682o; Soppimath KS, 2005, ADV MATER, V17, P318, DOI 10.1002/adma.200401057; HAYASHI S, 1995, POLYM J, V27, P623, DOI 10.1295/polymj.27.623; Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565; Sun BY, 2005, J AM CHEM SOC, V127, P17972, DOI 10.1021/ja056238a; Etika K. C., 2000, MACROMOL RAPID COMM, V31, P1368; Shekhar S., 2012, ADV MAT RES, V1, P269; Tsubokawa N., 2010, NIPPON GOMU KYOKAISH, V83, P361	20	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	OCT	2015	47	10					709	712		10.1038/pj.2015.47		4	Polymer Science	Polymer Science	CS9YB	WOS:000362448600008		
J	Dharajiya, NG; Namba, A; Horiuchi, I; Miyai, S; Farkas, DH; Almasri, E; Saldivar, JS; Takagi, K; Kamei, Y				Dharajiya, Nilesh G.; Namba, Akira; Horiuchi, Isao; Miyai, Shunsuke; Farkas, Daniel H.; Almasri, Eyad; Saldivar, Juan-Sebastian; Takagi, Kenjiro; Kamei, Yoshimasa			Uterine leiomyoma confounding a noninvasive prenatal test result	PRENATAL DIAGNOSIS			English	Article							CYTOGENETIC ABNORMALITIES; MATERNAL PLASMA; DNA		[Dharajiya, Nilesh G.; Almasri, Eyad; Saldivar, Juan-Sebastian] Sequenom Labs, San Diego, CA 92121 USA; [Namba, Akira; Kamei, Yoshimasa] Saitama Med Univ Hosp, Dept Obstet & Gynecol, Saitama, Japan; [Horiuchi, Isao; Takagi, Kenjiro] Jichi Med Univ, Saitama Med Ctr, Perinatal Med Ctr, Saitama, Japan; [Miyai, Shunsuke] GeneTech Inc, Tokyo, Japan; [Farkas, Daniel H.] Sequenom Labs, Grand Rapids, MI USA; [Farkas, Daniel H.] Michigan State Univ, Dept Obstet Gynecol & Reprod Med, E Lansing, MI 48824 USA	Dharajiya, NG (reprint author), Sequenom Labs, San Diego, CA 92121 USA.	ndharajiya@sequenom.com					American college of Obstetricians and gynecologists committee on Genetics, 2012, OBSTET GYNECOL, V120, P1532, DOI DOI 10.1056/NEJMC1311604; MELONI AM, 1991, CANCER GENET CYTOGEN, V53, P199, DOI 10.1016/0165-4608(91)90096-D; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; REIN MS, 1991, OBSTET GYNECOL, V77, P923; Osborne CM, 2013, PRENATAL DIAG, V33, P609, DOI 10.1002/pd.4100; Bowden W, 2009, MOL HUM REPROD, V15, P563, DOI 10.1093/molehr/gap050; Harada N, 2002, AM J MED GENET, V111, P285, DOI 10.1002/ajmg.10584; Ligon AH, 2000, GENE CHROMOSOME CANC, V28, P235, DOI 10.1002/1098-2264(200007)28:3<235::AID-GCC1>3.0.CO;2-7; Rein MS, 1998, MOL HUM REPROD, V4, P83, DOI 10.1093/molehr/4.1.83; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Laughlin SK, 2009, OBSTET GYNECOL, V113, P630, DOI 10.1097/AOG.0b013e318197bbaf; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Chan RWY, 2014, P NATL ACAD SCI USA, V111, pE5302, DOI 10.1073/pnas.1421126111; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; McCullough RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109173	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-3851	1097-0223		PRENATAL DIAG	Prenat. Diagn.	OCT	2015	35	10			SI		990	993		10.1002/pd.4629		4	Genetics & Heredity; Obstetrics & Gynecology	Genetics & Heredity; Obstetrics & Gynecology	CT2RH	WOS:000362650700012		
J	Kee, NLA; Krause, J; Blatch, GL; Muramoto, K; Sakka, K; Sakka, M; Naude, RJ; Wagner, L; Wolf, R; Rahfeld, JU; Demuth, HU; Mielicki, WP; Frost, CL				Kee, Nalise Low Ah; Krause, Jason; Blatch, Gregory L.; Muramoto, Koji; Sakka, Kazuo; Sakka, Makiko; Naude, Ryno J.; Wagner, Leona; Wolf, Raik; Rahfeld, Jens-Ulrich; Demuth, Hans-Ulrich; Mielicki, Wojciech P.; Frost, Carminita L.			The Proteolytic Profile of Human Cancer Procoagulant Suggests That It Promotes Cancer Metastasis at the Level of Activation Rather Than Degradation	PROTEIN JOURNAL			English	Article						Factor X; Fibronectin; CP assay; Peptide substrates; Kinetics; Extracellular matrix	FACTOR-X ACTIVATOR; PLATELET-AGGREGATION; SNAKE-VENOM; FIBRONECTIN; EXPRESSION; RECEPTOR-4; ADHESION; TISSUES; FIBRINOGEN; SUBSTRATE	Proteases are essential for tumour progression and many are over-expressed during this time. The main focus of research was the role of these proteases in degradation of the basement membrane and extracellular matrix (ECM), thereby enabling metastasis to occur. Cancer procoagulant (CP), a protease present in malignant tumours, but not normal tissue, is a known activator of coagulation factor X (FX). The present study investigated the function of CP in cancer progression by focussing on its enzymatic specificity. FX cleavage was confirmed using SDS-PAGE and MALDI-TOF MS and compared to the proteolytic action of CP on ECM proteins, including collagen type IV, laminin and fibronectin. Contrary to previous reports, CP cleaved FX at the conventional activation site (between Arg-52 and Ile-53). Additionally, degradation of FX by CP occurred at a much slower rate than degradation by conventional activators. Complete degradation of the heavy chain of FX was only visible after 24 h, while degradation by RVV was complete after 30 min, supporting postulations that the procoagulant function of CP may be of secondary importance to its role in cancer progression. Of the ECM proteins tested, only fibronectin was cleaved. The substrate specificity of CP was further investigated by screening synthetic peptide substrates using a novel direct CP assay. The results indicate that CP is not essential for either cancer-associated blood coagulation or the degradation of ECM proteins. Rather, they suggest that this protease may be required for the proteolytic activation of membrane receptors.	[Kee, Nalise Low Ah; Krause, Jason; Naude, Ryno J.; Frost, Carminita L.] Nelson Mandela Metropolitan Univ, Dept Biochem & Microbiol, ZA-6031 Port Elizabeth, South Africa; [Blatch, Gregory L.] Rhodes Univ, Biomed Biotechnol Res Unit, Dept Biochem Microbiol & Biotechnol, ZA-6140 Grahamstown, South Africa; [Mielicki, Wojciech P.] Med Univ Lodz, Dept Pharmaceut Biochem, PL-90151 Lodz, Poland; [Wagner, Leona; Wolf, Raik] Probiodrug AG, D-06120 Halle, Germany; [Muramoto, Koji] Tohoku Univ, Grad Sch Life Sci, Lab Biomol Funct, Sendai, Miyagi 9818555, Japan; [Sakka, Kazuo; Sakka, Makiko] Mie Univ, Dept & Grad Sch Sustainable Resource Sci, Tsu, Mie 5148507, Japan; [Blatch, Gregory L.] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis, Melbourne, Vic 8001, Australia; [Rahfeld, Jens-Ulrich; Demuth, Hans-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Drug Design & Target Validat, D-06120 Halle, Germany	Frost, CL (reprint author), Nelson Mandela Metropolitan Univ, Dept Biochem & Microbiol, POB 77000, ZA-6031 Port Elizabeth, South Africa.	carminita.frost@nmmu.ac.za			South African Medical Research Council; National Research Foundation Research Niche Area programme of South Africa	The authors wish to thank: Prof. W. Mielicki (Medical University of Lodz, Poland) for help with the purification of CP; nursing staff of the maternity unit of Greenacres Hospital (Port Elizabeth, South Africa) for the collection of tissue samples; Prof. K. Sakka and Dr M. Sakka (Mie University, Tsu, Japan) for N-terminal sequence analysis of FX fragments; and Prof. T. Coetzer (University of KwaZulu-Natal, Pietermaritzburg, South Africa) for MCA standard. This research was funded by the South African Medical Research Council and the National Research Foundation Research Niche Area programme of South Africa. The authors would like to thank the reviewers for their valuable input.	Ando S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-31; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Kee NLA, 2012, BIOL CHEM, V393, P113, DOI 10.1515/hsz-2011-0177; Naldini A, 2009, EUR J CANCER, V45, P454, DOI 10.1016/j.ejca.2008.10.012; Mielicki WP, 1997, THROMB RES, V87, P251, DOI 10.1016/S0049-3848(97)00125-4; Olas B, 2000, THROMB RES, V97, P169, DOI 10.1016/S0049-3848(99)00129-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Franco E, 1997, J INFECT DIS, V176, P1597; Kaplinska K, 2009, BLOOD COAGUL FIBRIN, V20, P315, DOI 10.1097/MBC.0b013e32831bc2c5; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com; GORDON SG, 1994, METHOD ENZYMOL, V244, P568; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Olas B, 2001, CANCER LETT, V169, P165, DOI 10.1016/S0304-3835(01)00545-6; MIELICKI WP, 1993, BLOOD COAGUL FIBRIN, V4, P441, DOI 10.1097/00001721-199306000-00008; Tsuruo T, 2008, P JPN ACAD A-MATH, V84, P189, DOI 10.2183/pjab/84.189; Ramani VC, 2008, BIOCHEM BIOPH RES CO, V369, P1169, DOI 10.1016/j.bbrc.2008.03.021; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Hansen KK, 2008, N-S ARCH PHARMACOL, V377, P377, DOI 10.1007/s00210-007-0194-2; BUCK MR, 1992, BIOCHEM J, V282, P273; Gratio V, 2009, INT J CANCER, V124, P1517, DOI 10.1002/ijc.24070; Olas B, 2001, PLATELETS, V12, P431, DOI 10.1080/09537100120085469; Gebbink MFBG, 2009, FEBS LETT, V583, P2691, DOI 10.1016/j.febslet.2009.06.013; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Gordon SG, 1997, BLOOD COAGUL FIBRIN, V8, P73, DOI 10.1097/00001721-199703000-00001; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; DAVID L, 1994, CANCER, V73, P518, DOI 10.1002/1097-0142(19940201)73:3<518::AID-CNCR2820730305>3.0.CO;2-T; Olas B, 1999, THROMB RES, V94, P199, DOI 10.1016/S0049-3848(98)00214-X; Tans G, 2001, HAEMOSTASIS, V31, P225; GORDON SG, 1991, BLOOD COAGUL FIBRIN, V2, P735, DOI 10.1097/00001721-199112000-00007; Kabuto S, 2000, COMP BIOCHEM PHYS B, V127, P481, DOI 10.1016/S0305-0491(00)00282-0; Yin YJ, 2003, ARTERIOSCL THROM VAS, V23, P940, DOI 10.1161/01.ATV.0000066878.27340.22; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Siigur E, 2001, BBA-GEN SUBJECTS, V1568, P90, DOI 10.1016/S0304-4165(01)00206-9; Chin D, 2005, BRIT J PLAST SURG, V58, P466, DOI 10.1016/j.bjps.2004.12.025; Armstrong PB, 2000, BBA-REV CANCER, V1470, pO9, DOI 10.1016/S0304-419X(00)00003-2; Dixon M, 1979, ENZYMES, P344	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1572-3887	1573-4943		PROTEIN J	Protein J.	OCT	2015	34	5					338	348		10.1007/s10930-015-9628-8		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT1SM	WOS:000362581200003		
J	Nilsson, P; Loganathan, K; Sekiguchi, M; Winblad, B; Iwata, N; Saido, TC; Tjernberg, LO				Nilsson, Per; Loganathan, Krishnapriya; Sekiguchi, Misaki; Winblad, Bengt; Iwata, Nobuhisa; Saido, Takaomi C.; Tjernberg, Lars O.			Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice	PROTEOMICS			English	Article						AD mouse model; Alzheimer's disease; Animal proteomics; Ingenuity Pathway Analysis; Neprilysin knockout mouse; O-18-labeling	AMYLOID-BETA PEPTIDE; NEURONS	Alzheimer's disease (AD) is a neurodegenerative disease displaying extracellular plaques formed by the neurotoxic amyloid -peptide (A), and intracellular neurofibrillary tangles consisting of protein tau. However, how these pathologies relate to the massive neuronal death that occurs in AD brains remain elusive. Neprilysin is the major A-degrading enzyme and a lack thereof increases A levels in the brain twofold. To identify altered protein expression levels induced by increased A levels, we performed a proteomic analysis of the brain of the AD mouse model APPsw and compared it to that of APPsw mice lacking neprilysin. To this end we established an LC-MS/MS method to analyze brain homogenate, using an O-18-labeled internal standard to accurately quantify the protein levels. To distinguish between alterations in protein levels caused by increased A levels and those induced by neprilysin deficiency independently of A, the brain proteome of neprilysin deficient APPsw mice was also compared to that of neprilysin deficient mice. By this approach we identified approximately 600 proteins and the levels of 300 of these were quantified. Pathway analysis showed that many of the proteins with altered expression were involved in neurological disorders, and that tau, presenilin and APP were key regulators in the identified networks. The data have been deposited to the ProteomeXchange Consortium with identifiers PXD000968 and PXD001786 ( and (). Interestingly, the levels of several proteins, including some not previously reported to be linked to AD, were associated with increased A levels.	[Nilsson, Per; Loganathan, Krishnapriya; Sekiguchi, Misaki; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Saitama, Japan; [Nilsson, Per; Loganathan, Krishnapriya; Winblad, Bengt; Tjernberg, Lars O.] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Huddinge, Sweden; [Loganathan, Krishnapriya] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Biotechnol, Nagasaki 852, Japan	Nilsson, P (reprint author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Saitama, Japan.	per-nilsson@brain.riken.jp			Alzheimerfonden; Swedish Research Council, Sweden; RIKEN Brain Science Institute, Japan; Ministry of Education, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	We thank Yuya Tomita for the mass sorting software, and all the other members of the PNS laboratory and WaltteriHosia, HedvigWelander, Ji-YeunHur, BirgittaWiehager, Masakazu Hashimoto and Sophia Schedin Weiss at KI-ADRC at Karolinska Institutet for fruitful discussions. We are grateful to the Support Unit for Bio-Material Analysis in RIKEN BSI Research Resources Center, with special thanks to Kaori Otsuki, Masaya Usui and Aya Abe for the help with the MS/MS analysis. This project was financially supported by research grants from Alzheimerfonden and the Swedish Research Council, Sweden; RIKEN Brain Science Institute, Japan; Ministry of Education, Sports, Science and Technology, Japan; and Ministry of Health, Labour and Welfare, Japan. The MS proteomics data in this paper have been deposited in the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository [19]: dataset identifiers PXD000968 and PXD001786.	Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103; Thal DR, 2002, BRAIN PATHOL, V12, P405; Popovics P, 2012, J ALZHEIMERS DIS, V30, P737, DOI 10.3233/JAD-2012-120241; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Hashimoto M, 2012, J CELL MOL MED, V16, P1686, DOI 10.1111/j.1582-4934.2011.01441.x; Woltjer RL, 2010, J NEUROPATH EXP NEUR, V69, P667, DOI 10.1097/NEN.0b013e3181e24adb; Iwata N, 2000, NAT MED, V6, P143; Guix FX, 2009, BRAIN, V132, P1335, DOI 10.1093/brain/awp023; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; George AJ, 2010, NEUROTOX RES, V17, P360, DOI 10.1007/s12640-009-9112-3; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Thorsell A, 2010, BRAIN RES, V1362, P13, DOI 10.1016/j.brainres.2010.09.073; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Haass C., 2012, COLD SPRING HARB PER, V2, P1; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	OCT	2015	15	19					3349	3355		10.1002/pmic.201400211		7	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CT0RP	WOS:000362504300009		
J	Shi, ZQ; Yang, QL; Ono, Y; Funahashi, R; Saito, T; Isogai, A				Shi, Zhuqun; Yang, Quanling; Ono, Yuko; Funahashi, Ryunosuke; Saito, Tsuguyuki; Isogai, Akira			Creation of a new material stream from Japanese cedar resources to cellulose nanofibrils	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Japanese cedar; Cellulose nanofibril; TEMPO-mediated oxidation; Nanofibrillation; Sugar composition	TEMPO-MEDIATED OXIDATION; OXIDIZED CELLULOSES; NATIVE CELLULOSE; NMR; NANODISPERSIBILITY; NANOCELLULOSES; TRANSPARENT; COMPOSITES; SOFTWOOD; LENGTH	Japanese cedar is one of the most abundant plantation softwoods in Japan, although it is not effectively utilized as a wood resource. Japanese cedar cellulose was isolated and subjected to one-pot catalytic oxidation and reduction with 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) and NaBH4, respectively. The TEMPO-oxidized and NaBH4-reduced Japanese cedar celluloses (TOCs-NaBH4) had carboxylate content of up to 1.4 mmol/g and viscosity-average degrees of polymerization from 2000 to 3000. The X-ray diffraction patterns of the TOCs-NaBH4 showed that the crystal widths were similar to 3 nm, indicating that the C6-OH groups present on the crystalline cellulose microfibril surfaces were selectively oxidized to C6-carboxylate groups. When the TOCs-NaBH4 with carboxylate content of 0.9-1.4 mmol/g were mechanically disintegrated in water, transparent TEMPO-oxidized cellulose nanofibril (TOCN) dispersions were obtained. The lengths of the TOCNs, determined from their atomic force microscopy images, varied from 800 to 1500 nm, depending on the oxidation conditions. The TOCNs prepared from Japanese cedar cellulose have an average of high aspect ratios (>300), which is greater than that (similar to 150) prepared from wood pulp and thus advantageous. (C) 2015 Elsevier B.V. All rights reserved.	[Shi, Zhuqun; Yang, Quanling; Ono, Yuko; Funahashi, Ryunosuke; Saito, Tsuguyuki; Isogai, Akira] Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Isogai, A (reprint author), Univ Tokyo, Dept Biomat Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aisogai@mail.ecc.u-tokyo.ac.jp	Yang, Quanling/J-8420-2014		National Agriculture and Food Research Organization (NARO); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	This study was supported by the National Agriculture and Food Research Organization (NARO) and the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST).	Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970; Saito T, 2013, BIOMACROMOLECULES, V14, P248, DOI 10.1021/bm301674e; Paul DR, 2008, POLYMER, V49, P3187, DOI 10.1016/j.polymer.2008.04.017; GIERER J, 1980, WOOD SCI TECHNOL, V14, P241; Saito T, 2011, SOFT MATTER, V7, P8804, DOI 10.1039/c1sm06050c; GUSTAFSON RR, 1983, IND ENG CHEM PROC DD, V22, P87, DOI 10.1021/i200020a016; Hiraoki R, 2015, BIOMACROMOLECULES, V16, P675, DOI 10.1021/bm501857c; Puangsin B, 2013, J POLYM ENVIRON, V21, P555, DOI 10.1007/s10924-012-0548-9; Tanaka R, 2014, CELLULOSE, V21, P1581, DOI 10.1007/s10570-014-0196-4; TEEAAR R, 1987, POLYM BULL, V17, P231; Shimizu M, 2014, BIOMACROMOLECULES, V15, P1904, DOI 10.1021/bm500384d; Fujisawa S, 2013, BIOMACROMOLECULES, V14, P1541, DOI 10.1021/bm400178m; Isogai A, 2013, J WOOD SCI, V59, P449, DOI 10.1007/s10086-013-1365-z; Maunu SL, 2002, PROG NUCL MAG RES SP, V40, P151, DOI 10.1016/S0079-6565(01)00041-3; Wikberg H, 2004, CARBOHYD POLYM, V58, P461, DOI 10.1016/j.carbpol.2004.08.008; Liu DG, 2010, BIORESOURCE TECHNOL, V101, P2529, DOI 10.1016/j.biortech.2009.11.058; Kimura M, 2014, CELLULOSE, V21, P3193, DOI 10.1007/s10570-014-0342-z; Koga H, 2013, BIOMACROMOLECULES, V14, P1160, DOI 10.1021/bm400075f; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; KLEPPE PJ, 1970, TAPPI, V53, P35; Shinoda R, 2012, BIOMACROMOLECULES, V13, P842, DOI 10.1021/bm2017542; Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u; Takaichi S, 2014, CELLULOSE, V21, P4093, DOI 10.1007/s10570-014-0444-7; Kuramae R, 2014, REACT FUNCT POLYM, V85, P126, DOI 10.1016/j.reactfunctpolym.2014.06.011; Wada M, 2004, BIOMACROMOLECULES, V5, P1385, DOI 10.1021/bm0345357; Kobayashi Y, 2014, ANGEW CHEM, V126, P10562; Mushtaq M., 2014, J LIB INF SCI, V4, P431; Sahoo H., 2011, ASIAN J SOC SCI, V30, P263; Shinrin-Ringyou, SCI ED CTR ATT HOKK; Wise L. E., 1946, Paper Trade Journal, V122, P35; Wu C.-N., 2012, BIOMACROMOLECULES, V13, P2188	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	OCT	2015	95						19	24		10.1016/j.reactfunctpolym.2015.08.005		6	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	CT2BY	WOS:000362608200003		
J	Wang, T; Tian, X; Hashimoto, S; Tanikawa, H				Wang, Tao; Tian, Xin; Hashimoto, Seiji; Tanikawa, Hiroki			Concrete transformation of buildings in China and implications for the steel cycle	RESOURCES CONSERVATION AND RECYCLING			English	Article						Buildings; Dynamic stock and flow analysis; Steel Intensity in buildings; Steel cycle; Monte Carlo simulation	MATERIAL FLOW-ANALYSIS; RESIDENTIAL BUILDINGS; URBAN CONSTRUCTION; WASTE MANAGEMENT; MATERIALS DEMAND; LIFE-CYCLE; ENERGY; STOCK; CONSUMPTION; ENVIRONMENT	Urbanization and real estate development are two mighty impetuses for the growth of China. An enhanced dynamic modeling has been devised to explore stocks and flows of buildings in the country and to quantify the related steel cycle. The uncertainties of the variables and results are investigated by the means of Monte Carlo method and sampling analysis. The building stocks are expected to increase to some 85-130 billion m(2) in the mid-century, about 40-100% up from the current level. Throughout China but in urban areas in particular, concrete structures are replacing the buildings made of wood, clay brick, and primitive materials. By 2050 every two out of three buildings in China will be reinforced concrete- or steel-framed, leading to substantial demand for ferrous metals. Scenarios analysis shows that a slowing down in the building stock expansion will likely occur in China in no more than ten years. This may open up a transition with profound industrial and resource implications. Increasing businesses for the construction industry may emerge from maintenance, retrofitting, and end-of-life management of existing buildings. The steel industry shall reform its capacity to conform to the growingly available secondary resources and the declining requirement for construction steel. Efficient and appropriate recycling of steel content from waste concrete will play an important role in material conservation. A collaboration of improvements in process material efficiency with lifetime extension and application of high-strength steel may save nearly 40% of primary iron ores for building use in the coming four decades. (C) 2015 Elsevier B.V. All rights reserved.	[Wang, Tao] Ritsumeikan Univ, Global Innovat Res Org, Kyoto, Japan; [Tian, Xin; Tanikawa, Hiroki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Hashimoto, Seiji] Ritsumeikan Univ, Coll Sci & Engn, Dept Environm Syst Engn, Kyoto, Japan	Wang, T (reprint author), 1-1-1 Noji Higashi, Kusatsu, Shiga, Japan.	a.t.wang@gmail.com			Ministry of the Environment, Japan [S-6-4, 1-1402]	This research was supported by the Environment Research and Technology Development Fund (S-6-4 and 1-1402) of the Ministry of the Environment, Japan. Helpful discussions were made with Prof. Wei Yang at Tianjin University, Dr. Mingming Hu at Leiden University, and Dr. Feng Shi at Institute of Science and Technology for Development of Shandong, China. We gratefully thank many experts from the industries and academia for their data provision and advice, and thank three anonymous referees for their valuable feedback.	Allwood J.M., 2012, SUSTAINABLE MAT BOTH; Yuan HP, 2013, PROJ MANAG J, V44, P101, DOI 10.1002/pmj.21349; Huang T, 2013, RESOUR CONSERV RECY, V72, P91, DOI 10.1016/j.resconrec.2012.12.013; Warren-Rhodes K, 2001, AMBIO, V30, P429, DOI 10.1639/0044-7447(2001)030[0429:ETITUM]2.0.CO;2; Hu D, 2010, RESOUR CONSERV RECY, V54, P1177, DOI 10.1016/j.resconrec.2010.03.011; You F, 2011, ECOL COMPLEX, V8, P201, DOI 10.1016/j.ecocom.2011.02.003; Hatayama H, 2010, ENVIRON SCI TECHNOL, V44, P6457, DOI 10.1021/es100044n; Shi JG, 2006, RESOUR CONSERV RECY, V49, P147, DOI 10.1016/j.resconrec.2006.03.011; Yang W, 2008, BUILD RES INF, V36, P1, DOI 10.1080/09613210701702883; Huang SL, 2003, LANDSCAPE URBAN PLAN, V63, P61, DOI 10.1016/S0169-2046(02)00152-4; Wang T, 2007, ENVIRON SCI TECHNOL, V41, P5120, DOI 10.1021/es062761t; Pauliuk S, 2012, ENVIRON SCI TECHNOL, V46, P148, DOI 10.1021/es201904c; Lu WS, 2011, WASTE MANAGE, V31, P1252, DOI 10.1016/j.wasman.2011.01.018; Muller DB, 2006, ECOL ECON, V59, P142, DOI 10.1016/j.ecolecon.2005.09.025; Evans M, 2014, ENERG POLICY, V64, P243, DOI 10.1016/j.enpol.2013.06.040; Krausmann F, 2008, J IND ECOL, V12, P637, DOI 10.1111/j.1530-9290.2008.00065.x; Chang Y, 2013, ENERG POLICY, V62, P656, DOI 10.1016/j.enpol.2013.07.053; Glicksman LR, 2001, ANNU REV ENERG ENV, V26, P83, DOI 10.1146/annurev.energy.26.1.83; He XS, 2013, BUILD ENVIRON, V64, P130, DOI 10.1016/j.buildenv.2013.03.013; WERNICK IK, 1995, ANNU REV ENERG ENV, V20, P463; Fernandez JE, 2007, J IND ECOL, V11, P99, DOI 10.1162/jie.2007.1199; Hu MM, 2010, RESOUR CONSERV RECY, V54, P591, DOI 10.1016/j.resconrec.2009.10.016; Hu MM, 2010, J IND ECOL, V14, P440, DOI 10.1111/j.1530-9290.2010.00245.x; Li BZ, 2009, RENEW ENERG, V34, P1994, DOI 10.1016/j.renene.2009.02.015; Shi F, 2012, J IND ECOL, V16, P493, DOI 10.1111/j.1530-9290.2012.00523.x; Chen SQ, 2008, ENERG BUILDINGS, V40, P654, DOI 10.1016/j.enbuild.2007.04.022; Wang HM, 2012, J IND ECOL, V16, P481, DOI 10.1111/j.1530-9290.2012.00484.x; Li JR, 2013, RESOUR CONSERV RECY, V74, P20, DOI 10.1016/j.resconrec.2013.02.015; CISA (China Iron and Steel Association), 2013, CHIN STEEL YB 2012; CSCS (China Steel Construction Society), 2006, CHIN STEEL CONSTR YB; Han Y., 2012, COMMUNICATION; He W., 2012, COMMUNICATION; Huang W., 2006, DEV SMALL CITIES, P18; IISI (International Iron and Steel Institute), 2001, STEEL STAT YB 2001; Li MS, 2012, INT ADV EDU-GLOB, P103; Li Z., 1985, RURAL BUILDING ARCHI; MOCC, 2007, STAT B URB RUR CONST, V2006; MOCC (Ministry of Construction of China), 2005, TARG HOUS FAIRL WELL; MOHURD (Ministry of Housing and Urban-Rural Development of China), 2010, COD DES CONCR STRUCT; NBSC, 2013, CHIN STAT YB 2013; NBSC, 2010, CHIN COMP STAT 1949; NBSC, NAT DAT; NBSC, 2015, STAT COMM PEOPL REP; NBSC (National Bureau of Statistics of China), 2012, TAB 2010 POP CENS PE; NBSC (National Bureau of Statistics of China), 2002, TAB 2000 POP CENS PE; NBSC (National Bureau of Statistics of China), 1991, CHIN STAT YB 1991; Ouyang J., 2007, THESIS XIAN U ARCHIT; Qin L., 2012, COMMUNICATION; Shangguan F., 2012, COMMUNICATION; Song C., 2004, URBAN DEV, P4; Song Y., 2012, COMMUNICATION; State Council of China, 1990, INT REG PEOPL REP CH; United Nations Population Division (UNPD), 2013, WORLD POP PROSP 2012; United Nations Population Division (UNPD), 2012, WORLD URB PROSP 2011; USBM, 1993, MIN YB 1990, V1; USBM (U.S. Bureau of Mines), 1986, MIN YB 1986, V1; USGS, 2013, MIN COMM SUMM 2013; WSA (World Steel Association), 2013, STEEL STAT YB 2013; Yang W., 2010, MODELING EVOLUTION C; Zhang JB, 2010, CONFERENCE ON ENVIRONMENTAL POLLUTION AND PUBLIC HEALTH, VOL 1-2, P21	60	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-3449	1879-0658		RESOUR CONSERV RECY	Resour. Conserv. Recycl.	OCT	2015	103						205	215		10.1016/j.resconrec.2015.07.021		11	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CT2FY	WOS:000362618600018		
J	Ardaravicius, L; Kiprijanovic, O; Liberis, J; Sermuksnis, E; Matulionis, A; Ferreyra, A; Avrutin, V; Ozgur, U; Morkoc, H				Ardaravicius, L.; Kiprijanovic, O.; Liberis, J.; Sermuksnis, E.; Matulionis, A.; Ferreyra, A.; Avrutin, V.; Oezguer, Ue; Morkoc, H.			Threshold field for soft damage and electron drift velocity in InGaN two-dimensional channels	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article						high-field transport; threshold field; drift velocity; InGaN; hot-phonon lifetime; electron density	GAN	Experimental investigation of electron transport along a two-dimensional channel confined in an InGaN alloy of Al0.82In0.18N/AlN/In0.1Ga0.9N/GaN structure was performed at room temperature under near-equilibrium thermal-bath temperature. A soft damage was observed at a threshold electric field applied in the channel plane. The threshold current for soft damage and the supplied electric power were lower in the channels with a higher electron density. The results are interpreted in terms of plasmon-assisted heat dissipation. In agreement with ultra-fast decay of hot phonons in the vicinity of the resonance with plasmons, the electron drift velocity acquires a highest value of similar to 2 x 10(7) cm s(-1) at 180 kV cm(-1) in channels with 1 x 10(13) cm(-2) and decreases as the electron density increases. No negative differential resistance is observed. The effective hot-phonon lifetime is estimated as similar to 2 ps at 1.6 x 10(13) cm(-2) at low electric fields and is found to decrease as the field increases.	[Ardaravicius, L.; Kiprijanovic, O.; Liberis, J.; Sermuksnis, E.; Matulionis, A.] Ctr Phys Sci & Technol, Inst Semicond Phys, LT-01108 Vilnius, Lithuania; [Ferreyra, A.] Kyoto Inst Technol, Nano Mat & Device Res Ctr, Kyoto 606, Japan; [Ferreyra, A.; Avrutin, V.; Oezguer, Ue] Virginia Commonwealth Univ, Dept Elect & Comp Engn, Richmond, VA 23284 USA	Ardaravicius, L (reprint author), Ctr Phys Sci & Technol, Inst Semicond Phys, A Gostauto 11, LT-01108 Vilnius, Lithuania.	linas.ardaravicius@ftmc.lt			European Social Fund under global grant measure [VP1-3.1-SMM-07-K-03-038]	This research was funded by the European Social Fund under global grant measure (VP1-3.1-SMM-07-K-03-038).	Matulionis A, 2008, SEMICOND SCI TECH, V23, DOI 10.1088/0268-1242/23/7/075048; Khurgin J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824872; Kayis C, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3624702; O'Leary SK, 2006, J MATER SCI-MATER EL, V17, P87, DOI 10.1007/s10854-006-5624-2; Smorchkova IP, 2001, J APPL PHYS, V90, P5196, DOI 10.1063/1.1412273; Polyakov VM, 2009, J APPL PHYS, V106, DOI 10.1063/1.3174441; Wang Z, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.037403; Matulionis A, 2010, P IEEE, V98, P1118, DOI 10.1109/JPROC.2009.2029877; Liberis J, 2009, PHYS STATUS SOLIDI A, V206, P1385, DOI 10.1002/pssa.200824287; Matulionis A, 2011, PHYS STATUS SOLIDI A, V208, P30, DOI 10.1002/pssa.201026361; Ardaravicius L, 2003, APPL PHYS LETT, V83, P4038, DOI 10.1063/1.1626258; Xie JQ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794419; Guo L, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904418; Kuzmik J, 2001, IEEE ELECTR DEVICE L, V22, P510, DOI 10.1109/55.962646; Ardaravicius L, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236569; Dyson A, 2010, J APPL PHYS, V108, DOI 10.1063/1.3500329; Ardaravicius L, 2011, PHYS STATUS SOLIDI-R, V5, P65, DOI 10.1002/pssr.201004502; Matulionis A, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/7/074007; Leach JH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3271183; Butte R, 2007, J PHYS D APPL PHYS, V40, P6328, DOI 10.1088/0022-3727/40/20/S16; Liberis J, 2014, SEMICOND SCI TECH, V29, DOI 10.1088/0268-1242/29/4/045018; Kash J A, 1992, MODERN PROBLEMS COND, V35, P113; Lee DS, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.100212; Matulionis A, 2003, PHYS REV B, V68, DOI [10.1103/PhysRevB.68.035338, 10.1103/PhysRevB.68.0353XX]; Morkoc H, 2008, HDB NITRIDE SEMICOND; Sarikavak-Lisesivdin B, 2015, METALL MATER TRANS A, V46A, P1565, DOI 10.1007/s11661-015-2762-2	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	OCT	2015	30	10							105016	10.1088/0268-1242/30/10/105016		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	CT1ZR	WOS:000362602300024		
J	Sugimoto, K; Tanino, H; Kobayashi, J				Sugimoto, Koh-ichi; Tanino, Hikaru; Kobayashi, Junya			Impact Toughness of Medium-Mn Transformation-Induced Plasticity-Aided Steels	STEEL RESEARCH INTERNATIONAL			English	Article						impact toughness; MA-like phase; martensite; medium-Mn TRIP-aided steel; retained austenite	STRETCH-FLANGEABILITY; MECHANICAL-PROPERTIES; RETAINED AUSTENITE; MARTENSITIC STEEL; SHEET STEELS; STRENGTH; AHSS; 3RD-GENERATION	The impact toughness of 0.2% C-1.5% Si-(1.5-5.0)% Mn (mass%) transformation-induced plasticity (TRIP)-aided steels with bainitic ferrite and/or martensite structure matrices produced by isothermal transformation process is investigated for automotive body applications. The highest impact toughness, highest Charpy impact absorbed value (CIAV) at 298 K (130 J cm(-2)), and lowest ductile-brittle transformation temperature (DBTT, 203 K) is achieved in 1.5% Mn steel subjected to an isothermal transformation process at a temperature below the martensite start temperature M-S - (50-100) K. An increase in the Mn content results in a small decrease in the CIAV (5-40 J cm(-2)) and an increase in the DBTT (20 K). The highest CIAV of 1.5% Mn steel compared with steels containing higher Mn content is mainly caused by (i) a more softened matrix structure consisting of wide lath-martensite and bainitic ferrite, (ii) a smaller amount of the narrow-lath martensite-retained austenite-like phase, and (iii) more stable retained austenite. The lowest DBTT of 1.5% Mn steel compared with the other steel compositions is mainly associated with the low Mn concentration of the matrix in this steel.	[Sugimoto, Koh-ichi; Tanino, Hikaru] Shinshu Univ, Dept Mech Syst Engn, Nagano 3808553, Japan; [Kobayashi, Junya] Ibaraki Univ, Dept Mech Engn, Hitachi, Ibaraki 3168511, Japan	Sugimoto, K (reprint author), Shinshu Univ, Dept Mech Syst Engn, 4-17-1 Wakasato, Nagano 3808553, Japan.	sugimot@shinshu-u.ac.jp					Sugimoto K, 2007, ISIJ INT, V47, P1357, DOI 10.2355/isijinternational.47.1357; Aydin H, 2013, MAT SCI ENG A-STRUCT, V564, P501, DOI 10.1016/j.msea.2012.11.113; Kobayashi J, 2013, METALL MATER TRANS A, V44A, P5006, DOI 10.1007/s11661-013-1882-9; De Cooman BC, 2006, STEEL RES INT, V77, P634; Suh DW, 2010, METALL MATER TRANS A, V41A, P397, DOI 10.1007/s11661-009-0124-7; Wang XD, 2009, J MATER RES, V24, P260, DOI 10.1557/JMR.2009.0029; Pham DV, 2014, ISIJ INT, V54, P1943, DOI 10.2355/isijinternational.54.1943; FURUKAWA T, 1994, MATER SCI TECH SER, V10, P964; Sugimoto K, 2002, ISIJ INT, V42, P450, DOI 10.2355/isijinternational.42.450; Hanamura T, 2011, ISIJ INT, V51, P685, DOI 10.2355/isijinternational.51.685; Grajcar A, 2012, ARCH CIV MECH ENG, V12, P334, DOI 10.1016/j.acme.2012.06.011; Sugimoto K, 2000, ISIJ INT, V40, P920, DOI 10.2355/isijinternational.40.920; DYSON DJ, 1970, J IRON STEEL I, V208, P469; Grassel O, 2000, INT J PLASTICITY, V16, P1391, DOI 10.1016/S0749-6419(00)00015-2; Grassel O, 1998, MATER SCI TECH SER, V14, P1213; Haung H., 1994, MAT SCI TECH, V10, P621; Kobayashi J., 2011, STEEL RES INT, P598; Kunitake T., 1971, IMPROVED DUCTILITY T, P83; Maruyama H., 1977, J JPN SOC HEAT TREAT, V17, P198; MCCLINTO.FA, 1968, J APPL MECH, V35, P363; Speer J. G., 2004, SOLID STATE MAT SCI, V8, P219; Tanaka M, 2014, TETSU TO HAGANE, V100, P1267, DOI 10.2355/tetsutohagane.100.1267; Zacky V. F., 1967, T AM SOC MET, V60, P252; Zhong N., 2009, MAT SCI ENG A-STRUCT, V509, P111	24	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1611-3683	1869-344X		STEEL RES INT	Steel Res. Int.	OCT	2015	86	10					1151	1160		10.1002/srin.201400585		10	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CT1ML	WOS:000362562400004		
J	Colvin, H; Yamamoto, K; Wada, N; Mori, M				Colvin, Hugh; Yamamoto, Ken; Wada, Noriko; Mori, Masaki			Hereditary Gastric Cancer Syndromes	SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Hereditary gastric cancer syndromes; Diagnosis; Management; Genetic counseling; Gastrectomy; Hereditary diffuse gastric cancer; Familial intestinal gastric cancer; Gastric adenocarcinoma and proximal polyposis of the stomach	PEUTZ-JEGHERS SYNDROME; OPEN TOTAL GASTRECTOMY; E-CADHERIN MUTATIONS; CLINICAL MANAGEMENT; CELL POLARITY; BREAST-CANCER; DIFFUSE; CDH1; FAMILIES; RISK	Hereditary gastric cancer syndromes are a rare but distinct cause of gastric cancers. The genetic mutations underlying most affected families are unknown. Mutations of CDH1 occur in some patients affected by hereditary diffuse gastric cancer, and is the only practical marker for guiding management. Carriers of CDH1 mutations are at risk for a highly penetrant, aggressive and early-onset diffuse-type gastric cancer, and these individuals are usually offered prophylactic total gastrectomy. Further research is required to identify other genetic mutations responsible for these syndromes to improve our understanding of the underlying disease mechanisms and optimize the clinical management of affected individuals.	[Colvin, Hugh; Wada, Noriko; Mori, Masaki] Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yamamoto, Ken] Kurume Univ, Dept Med Chem, Sch Med, Kurume, Fukuoka 8300011, Japan	Colvin, H (reprint author), Osaka Univ, Dept Surg Gastroenterol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hcolvin@gesurg.med.osaka-u.ac.jp					Worthley DL, 2012, GUT, V61, P774, DOI 10.1136/gutjnl-2011-300348; Shinohara T, 2013, SURG ENDOSC, V27, P286, DOI 10.1007/s00464-012-2442-x; Lim YC, 2014, GASTROINTEST ENDOSC, V80, P78, DOI 10.1016/j.gie.2013.11.040; Barber M, 2008, J PATHOL, V216, P295, DOI 10.1002/path.2426; Blair V, 2006, CLIN GASTROENTEROL H, V4, P262, DOI 10.1016/j.cgh.2005.12.003; Yamada H, 2011, CANCER SCI, V102, P1782, DOI 10.1111/j.1349-7006.2011.02038.x; Lee MS, 2013, SURG ENDOSC, V27, P2598, DOI 10.1007/s00464-013-2796-8; Guilford P, 2007, HERED CANCER CLIN PR, V5, P183, DOI 10.1186/1897-4287-5-4-183; Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Yanaru-Fujisawa R, 2012, GUT, V61, P1103, DOI 10.1136/gutjnl-2011-301384; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Humar B, 2009, CANCER RES, V69, P2050, DOI 10.1158/0008-5472.CAN-08-2457; Charlton A, 2004, GUT, V53, P814, DOI 10.1136/gut.2003.010447; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Gayther SA, 1998, CANCER RES, V58, P4086; Keller G, 1999, AM J PATHOL, V155, P337, DOI 10.1016/S0002-9440(10)65129-2; Oliveira C, 2005, VIRCHOWS ARCH, V446, P181, DOI 10.1007/s00428-004-1156-4; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Humar B, 2009, CANCER SCI, V100, P1151, DOI 10.1111/j.1349-7006.2009.01163.x; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Carneiro F, 2008, J CLIN PATHOL, V61, P25, DOI 10.1136/jcp.2006.043679; Figueiredo J, 2013, EUR J HUM GENET, V21, P301, DOI 10.1038/ejhg.2012.159; Xie ZM, 2011, CANCER-AM CANCER SOC, V117, P3112, DOI 10.1002/cncr.25876; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Kim HS, 2013, J LAPAROENDOSC ADV S, V23, P323, DOI 10.1089/lap.2012.0389; Lynch HT, 2008, SURG CLIN N AM, V88, P759, DOI 10.1016/j.suc.2008.04.006; Bakkelund KE, 2012, GASTROENT RES PRACT, DOI 10.1155/2012/457831; van Lier MGF, 2011, GUT, V60, P141, DOI 10.1136/gut.2010.223750; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Oliveira C, 2009, GASTROENTEROLOGY, V136, P2137, DOI 10.1053/j.gastro.2009.02.065; Majewski IJ, 2013, J PATHOL, V229, P621, DOI 10.1002/path.4152; PECK DA, 1964, AM J OBSTET GYNECOL, V90, P517; Caldas C, 1999, J MED GENET, V36, P873; Hansford Samantha, 2015, JAMA Oncol, V1, P23, DOI 10.1001/jamaoncol.2014.168; Kaurah P, 2007, JAMA-J AM MED ASSOC, V297, P2360, DOI 10.1001/jama.297.21.2360; Corso G, 2007, EJSO-EUR J SURG ONC, V33, P1061, DOI 10.1016/j.ejso.2007.03.001; Grunwald GB, 1993, CURR OPIN CELL BIOL, V5, P797, DOI 10.1016/0955-0674(93)90028-O; Capelle LG, 2010, GASTROENTEROLOGY, V138, P487, DOI 10.1053/j.gastro.2009.10.051; Suriano G, 2006, J MOL MED-JMM, V84, P1023, DOI 10.1007/s00109-006-0091-z; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/jic.11426; Grady WM, 2000, NAT GENET, V26, P16; Kluijt I, 2012, FAM CANCER, V11, P363, DOI 10.1007/s10689-012-9521-y; Chen YJ, 2011, ANN SURG ONCOL, V18, P2594, DOI 10.1245/s10434-011-1648-9; Oliveira C, 2009, HUM MOL GENET, V18, P1545, DOI 10.1093/hmg/ddp046; Kaurah P, 2010, FAM CANCER, V9, P331, DOI 10.1007/s10689-009-9316-y; PISANI BJ, 1958, J AM GERIATR SOC, V6, P99; Gertler R, 2009, AM J GASTROENTEROL, V104, P2838, DOI 10.1038/ajg.2009.456; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; Brosens LAA, 2011, WORLD J GASTROENTERO, V17, P4839, DOI 10.3748/wjg.v17.i44.4839; Fein M, 2008, ANN SURG, V247, P759, DOI 10.1097/SLA.0b013e318167748c; Corso G, 2013, BIOMED RES INT, DOI 10.1155/2013/385132; Shaw D, 2005, GUT, V54, P461, DOI 10.1136/gut.2004.049171; Brennan MF, 2003, BRIT J SURG, V90, P3, DOI 10.1002/bjs.4001; Fitzgerald RC, 2004, GUT, V53, P775, DOI 10.1136/gut.2003.022061; Masciari S, 2011, GENET MED, V13, P651, DOI 10.1097/GIM.0b013e31821628b6; Wood LD, 2014, AM J SURG PATHOL, V38, P389, DOI 10.1097/PAS.0000000000000146; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Mimata A, 2011, CANCER SCI, V102, P942, DOI 10.1111/j.1349-7006.2011.01890.x; Friedenson Bernard, 2005, MedGenMed, V7, P60; Howlader N, 2014, SEER CANC STAT REV; IARC, 1994, IARC MONOGR EVAL CAR, V61, P121; Jemal A, 2011, CA-CANCER J CLIN, V61, P2011, DOI DOI 10.3322/CAAC.20107; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Oliveira C, 2015, LANCET ONCOL, V16, pE60, DOI 10.1016/S1470-2045(14)71016-2; Peyre CG, 2007, ANN SURG, V246, P665, DOI 10.1097/SLA.0b013e318155a7a1; Peyre CG, 2007, ANN SURG, V246, P671; SANO T, 1992, BRIT J SURG, V79, P241, DOI 10.1002/bjs.1800790319; Simoes-Correia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033783; Ukleja Andrew, 2005, Nutr Clin Pract, V20, P517, DOI 10.1177/0115426505020005517	73	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1055-3207	1558-5042		SURG ONCOL CLIN N AM	Surg. Oncol. Clin. N. Am.	OCT	2015	24	4					765	+		10.1016/j.soc.2015.06.002		14	Oncology; Surgery	Oncology; Surgery	CT3GA	WOS:000362694000010		
J	Takale, BS; Bao, M; Yamamoto, Y; Almansour, AI; Arumugam, N; Kumar, RS				Takale, Balaram S.; Bao, Ming; Yamamoto, Yoshinori; Almansour, Abdulrahman I.; Arumugam, Natarajan; Kumar, Raju Suresh			Applications of Metal Nanopore Catalysts in Organic Synthesis	SYNLETT			English	Article						metal nanoparticle catalysts; metal nanopore catalysts; nanoparticles; nanopores; heterogeneous; homogeneous; oxidation; reduction	DEHYDROGENATIVE AMIDE SYNTHESIS; HIGHLY SELECTIVE HYDROGENATION; SUPPORTED GOLD NANOPARTICLES; DIRECT REDUCTIVE AMINATION; SUZUKI COUPLING REACTIONS; TEMPERATURE CO OXIDATION; TERMINAL ALKYNES; CLICK CHEMISTRY; PALLADIUM NANOPARTICLES; CARBONYL-COMPOUNDS	Reducing the size of bulk metals to nanometer scale can result in the display of extraordinary physical and chemical properties. Typically, metal nanoparticles (MNPs) are prepared from metal atoms or metal salts and show remarkable catalytic properties. Metal nanopores (MNPores) are prepared through a totally reverse approach (from bulk metal to nanosized metal): alloy (MM2)-M-1 is fabricated from metal M-1 and metal M-2, and then dealloying of M-2 results in a nanoporous framework of metal M-1. This account summarizes MNPore-catalyzed reactions developed in our group, and their comparison with other representative catalytic reactions. 1 Introduction 1.1 Fabrication and Structural Characteristics of Nanoporous Gold 2 Oxidation Reactions 2.1 Oxidation of Alcohols 2.2 Synthesis of Formamides Through Oxidative Coupling of Methanol with Amines 2.3 Oxidation of Silanes 3 Reduction Reactions 3.1 Semihydrogenation of Alkynes 3.2 Reduction of Quinoline 3.3 Reduction of Imines and Reductive Amination of Carbonyls 3.4 Reduction of ,-Unsaturated Aldehydes 3.5 1,4-Hydrosilylation of Cyclic Enones 4 Formation of C-Si, C-B, and C-C Bonds Using Alkynes 4.1 Hydrosilylation of Alkynes 4.2 Diboration of Alkynes 4.3 Benzannulation Reaction 5 CuNPore-Catalyzed Click Reaction 6 Suzuki, Negishi and Heck Coupling Reactions 7 Concluding Remarks	[Takale, Balaram S.; Bao, Ming; Yamamoto, Yoshinori] Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116023, Peoples R China; [Yamamoto, Yoshinori] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Almansour, Abdulrahman I.; Arumugam, Natarajan; Kumar, Raju Suresh] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11451, Saudi Arabia	Bao, M (reprint author), Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116023, Peoples R China.	mingbao@dlut.edu.cn; yoshi@dlut.edu.cn			Deanship of Scientific Research at King Saud University [RGP-VPP-026]	The authors acknowledge the Deanship of Scientific Research at King Saud University for the Research Grant, RGP-VPP-026.	Hu JC, 2007, CATAL TODAY, V122, P277, DOI 10.1016/j.cattod.2007.01.012; Ren D, 2012, J AM CHEM SOC, V134, P17592, DOI 10.1021/ja3066978; Kim JY, 2010, CHEM COMMUN, V46, P439, DOI 10.1039/b917781g; Jin T, 2011, ADV SYNTH CATAL, V353, P3095, DOI 10.1002/adsc.201100760; Mitsudome T, 2008, ANGEW CHEM INT EDIT, V47, P7938, DOI 10.1002/anie.200802761; Chandrasekhar S, 2004, TETRAHEDRON LETT, V45, P2421, DOI 10.1016/j.tetlet.2004.01.097; Yamada YMA, 2012, J AM CHEM SOC, V134, P9285, DOI 10.1021/ja3036543; LINDLAR H, 1952, HELV CHIM ACTA, V35, P446, DOI 10.1002/hlca.19520350205; Asao N, 2012, SYNLETT, V23, P66, DOI 10.1055/s-0031-1289527; Richardson RD, 2006, ANGEW CHEM INT EDIT, V45, P4402, DOI 10.1002/anie.200601817; BARAK G, 1988, J ORG CHEM, V53, P3553, DOI 10.1021/jo00250a025; Li G, 2014, J AM CHEM SOC, V136, P11347, DOI 10.1021/ja503724j; Li ZW, 2014, CATAL COMMUN, V53, P53, DOI 10.1016/j.catcom.2014.04.009; Chandrasekhar V, 2004, CHEM REV, V104, P5847, DOI 10.1021/cr0306135; Yamamoto Y, 2014, TETRAHEDRON, V70, P2305, DOI 10.1016/j.tet.2013.09.065; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Mitsudome T, 2013, ANGEW CHEM INT EDIT, V52, P1481, DOI 10.1002/anie.201207845; Della Pina C, 2012, CHEM SOC REV, V41, P350, DOI 10.1039/c1cs15089h; Takale BS, 2015, TETRAHEDRON, V71, P7154, DOI 10.1016/j.tet.2014.11.023; Niembro S, 2008, ORG LETT, V10, P3215, DOI 10.1021/ol801091u; Asao N, 2004, J AM CHEM SOC, V126, P7458, DOI 10.1021/ja0477367; Chen Z, 2012, J PHYS CHEM C, V116, P14986, DOI 10.1021/jp303992g; Alonso F, 2009, TETRAHEDRON LETT, V50, P2358, DOI 10.1016/j.tetlet.2009.02.220; Raj KJA, 2012, CATAL LETT, V142, P87, DOI 10.1007/s10562-011-0693-0; Wagh YS, 2015, J ORG CHEM, V80, P847, DOI 10.1021/jo502313d; Rueping M, 2011, CHEM MATER, V23, P2008, DOI 10.1021/cm1032578; Asao N, 2002, J AM CHEM SOC, V124, P12650, DOI 10.1021/ja028128z; Yoshida H, 2012, ANGEW CHEM INT EDIT, V51, P235, DOI 10.1002/anie.201106706; Zhang ZH, 2006, J ORG CHEM, V71, P7485, DOI 10.1021/jo061179k; Tararov VI, 2004, ORG PREP PROCED INT, V36, P99; Qi XQ, 2014, DALTON T, V43, P9283, DOI 10.1039/c3dt53539h; Hvolbaek B, 2007, NANO TODAY, V2, P14, DOI 10.1016/S1748-0132(07)70113-5; Milone C, 2007, CATAL TODAY, V122, P341, DOI 10.1016/j.cattod.2007.01.011; Schubert U, 1997, INORG CHEM, V36, P1258, DOI 10.1021/ic961134+; Tanaka S, 2011, CHEM COMMUN, V47, P5985, DOI 10.1039/c1cc10710k; Soule JF, 2011, J AM CHEM SOC, V133, P18550, DOI 10.1021/ja2080086; Lei Q, 2013, CHEM-EUR J, V19, P4021, DOI 10.1002/chem.201204194; Tsukuda T, 2011, CHEM-ASIAN J, V6, P736, DOI 10.1002/asia.201000611; Chen Q, 2014, CHEM COMMUN, V50, P3344, DOI 10.1039/c3cc49524h; Geukens I, 2014, APPL CATAL A-GEN, V469, P373, DOI 10.1016/j.apcata.2013.09.044; Zeng MF, 2014, IND ENG CHEM RES, V53, P10041, DOI 10.1021/ie501315a; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Molina LM, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155424; Alonso F, 2011, J ORGANOMET CHEM, V696, P368, DOI 10.1016/j.jorganchem.2010.09.068; Ma CY, 2009, APPL CATAL B-ENVIRON, V92, P202, DOI 10.1016/j.apcatb.2009.07.007; Takale BS, 2014, ORG LETT, V16, P2558, DOI 10.1021/ol500958p; Kumar NU, 2012, TETRAHEDRON LETT, V53, P4354, DOI 10.1016/j.tetlet.2012.06.018; Aida T, 2005, TETRAHEDRON LETT, V46, P1667, DOI 10.1016/j.tetlet.2005.01.058; Abad A, 2007, TOP CATAL, V44, P237, DOI 10.1007/s11244-007-0296-6; Takaya J, 2012, ACS CATAL, V2, P1993, DOI 10.1021/cs300320u; Chen Q, 2013, ORG LETT, V15, P5766, DOI 10.1021/ol4028013; Wang MM, 2011, GREEN CHEM, V13, P602, DOI 10.1039/c0gc00937g; Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591; DESS DB, 1983, J ORG CHEM, V48, P4155, DOI 10.1021/jo00170a070; Lopez N, 2004, J CATAL, V223, P232, DOI 10.1016/j.jcat.2004.01.001; Sheldon RA, 2000, CATAL TODAY, V57, P157, DOI 10.1016/S0920-5861(99)00317-X; Chen XC, 2008, J PHYS CHEM C, V112, P8172, DOI 10.1021/jp800610q; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Aronica LA, 2009, J CATAL, V266, P250, DOI 10.1016/j.jcat.2009.06.012; Zielasek V, 2006, ANGEW CHEM INT EDIT, V45, P8241, DOI 10.1002/anie.200602484; Asao N, 2012, PURE APPL CHEM, V84, P1771, DOI 10.1351/PAC-CON-11-10-28; ISHIYAMA T, 1993, J AM CHEM SOC, V115, P11018, DOI 10.1021/ja00076a081; Wu WY, 2013, CHEMCATCHEM, V5, P1011, DOI 10.1002/cctc.201200388; Zhu MY, 2011, J PHYS CHEM C, V115, P24743, DOI 10.1021/jp206116e; Moglie Y, 2006, TETRAHEDRON, V62, P2812, DOI 10.1016/j.tet.2006.01.006; Naota T, 1998, CHEM REV, V98, P2599, DOI 10.1021/cr9403695; Chassaing S, 2007, ORG LETT, V9, P883, DOI 10.1021/ol0631152; Gallezot P, 1998, CATAL REV, V40, P81, DOI 10.1080/01614949808007106; Yan M, 2013, ORG LETT, V15, P1484, DOI 10.1021/ol400229z; Asao N, 2005, J ORG CHEM, V70, P3682, DOI 10.1021/jo0500434; Li SS, 2014, CHEM COMMUN, V50, P5626, DOI 10.1039/c4cc01595a; Nasrollahzadeh M, 2014, NEW J CHEM, V38, P5544, DOI 10.1039/c4nj01440e; Hashimoto N, 2010, CHEM LETT, V39, P832, DOI 10.1246/cl.2010.832; Ishikawa Y, 2013, CATAL SCI TECHNOL, V3, P2902, DOI 10.1039/c3cy00242j; Liu YM, 2009, J PHYS CHEM C, V113, P13457, DOI 10.1021/jp904700p; Della Pina C, 2011, CATAL SCI TECHNOL, V1, P1564, DOI 10.1039/c1cy00283j; Liu J, 2008, ORG LETT, V10, P2661, DOI 10.1021/ol8007342; Shi H, 2008, CATAL COMMUN, V9, P1949, DOI 10.1016/j.catcom.2008.03.025; Mirza-Aghayan M, 2014, APPL ORGANOMET CHEM, V28, P113, DOI 10.1002/aoc.3090; Lemire C, 2004, ANGEW CHEM INT EDIT, V43, P118, DOI 10.1002/anie.200352538; Maki-Arvela P, 2005, APPL CATAL A-GEN, V292, P1, DOI 10.1016/j.apcata.2005.05.045; Ison EA, 2005, J AM CHEM SOC, V127, P11938, DOI 10.1021/ja053860u; Chauhan BPS, 2009, APPL ORGANOMET CHEM, V23, P385, DOI 10.1002/aoc.1528; Pournara A, 2014, CATAL COMMUN, V43, P57, DOI 10.1016/j.catcom.2013.09.008; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Grirrane A, 2011, CHEM-EUR J, V17, P2467, DOI 10.1002/chem.201002777; Della Pina C, 2008, CHEM SOC REV, V37, P2077, DOI 10.1039/b707319b; Hori J, 2009, ADV SYNTH CATAL, V351, P3143, DOI 10.1002/adsc.200900721; Cook TL, 2013, GREEN CHEM, V15, P617, DOI 10.1039/c3gc36720g; Takale BS, 2014, ORG BIOMOL CHEM, V12, P2005, DOI 10.1039/c3ob42207k; John J, 2011, ANGEW CHEM INT EDIT, V50, P7533, DOI 10.1002/anie.201101993; Liu ZL, 2013, J ORG CHEM, V78, P7436, DOI 10.1021/jo400803s; Blackwell JM, 2002, TETRAHEDRON, V58, P8247, DOI 10.1016/S0040-4020(02)00974-2; Gao Z, 2011, J MOL CATAL A-CHEM, V336, P51, DOI 10.1016/j.molcata.2010.12.009; Cano R, 2012, ACS CATAL, V2, P1070, DOI 10.1021/cs300056e; Bhor MD, 2008, TETRAHEDRON LETT, V49, P965, DOI 10.1016/j.tetlet.2007.12.023; Li J, 2011, CHEM-EUR J, V17, P8462, DOI 10.1002/chem.201003662; Zhang Y, 2012, CHEM REV, V112, P2467, DOI 10.1021/cr200260m; Zhdankin VV, 2011, J ORG CHEM, V76, P1185, DOI 10.1021/jo1024738; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Tanaka S, 2013, CHEM-EUR J, V19, P11832, DOI 10.1002/chem.201302396; Benohoud M, 2011, CHEM-EUR J, V17, P8404, DOI 10.1002/chem.201100655; Asao N, 2003, J AM CHEM SOC, V125, P10921, DOI 10.1021/ja036927r; Asao N, 2012, CHEM COMMUN, V48, P4540, DOI 10.1039/c2cc17245c; Tuokko S, 2014, ORG PROCESS RES DEV, V18, P1740, DOI 10.1021/op5003209; Lee Y, 2004, J ORG CHEM, V69, P1741, DOI 10.1021/jo035647r; Caporusso AM, 2005, J ORGANOMET CHEM, V690, P1063, DOI 10.1016/j.jorganchem.2004.10.051; Lipshutz BH, 1999, J AM CHEM SOC, V121, P5819, DOI 10.1021/ja990432d; Whittaker AM, 2013, ORG LETT, V15, P1112, DOI 10.1021/ol4001679; Yan M, 2012, J AM CHEM SOC, V134, P17536, DOI 10.1021/ja3087592; Shimizu K, 2009, CHEM-EUR J, V15, P9977, DOI 10.1002/chem.200901896; Ramos-Fernandez EV, 2011, APPL CATAL A-GEN, V402, P50, DOI 10.1016/j.apcata.2011.05.020; Kaneko T, 2011, ADV SYNTH CATAL, V353, P2927, DOI 10.1002/adsc.201100358; Abdel-Magid AF, 2006, ORG PROCESS RES DEV, V10, P971, DOI 10.1021/op0601013; Zhang Y, 2010, ORGANOMETALLICS, V29, P1374, DOI 10.1021/om901020h; Fujita T, 2012, NAT MATER, V11, P775, DOI [10.1038/nmat3391, 10.1038/NMAT3391]; Xu CX, 2007, J AM CHEM SOC, V129, P42, DOI 10.1021/ja0675503; Farmer V, 2002, GREEN CHEM, V4, P97, DOI 10.1039/b109851a; Misumi Y, 2009, J AM CHEM SOC, V131, P14636, DOI 10.1021/ja905835u; Alonso F, 2007, TETRAHEDRON, V63, P93, DOI 10.1016/j.tet.2006.10.043; Dobereiner GE, 2011, J AM CHEM SOC, V133, P7547, DOI 10.1021/ja2014983; Cho BT, 2005, TETRAHEDRON, V61, P5725, DOI 10.1016/j.tet.2005.04.039; Zhu JL, 2012, TETRAHEDRON LETT, V53, P3178, DOI 10.1016/j.tetlet.2012.04.048; Nordstrom LU, 2008, J AM CHEM SOC, V130, P17672, DOI 10.1021/ja808129p; Lipshutz BH, 2006, ANGEW CHEM INT EDIT, V45, P8235, DOI 10.1002/anie.200603726; Sato K, 2005, J ORG CHEM, V70, P8977, DOI 10.1021/jo051444m; Ogasawara S, 2010, J AM CHEM SOC, V132, P4608, DOI 10.1021/ja9062053; Asao N, 2010, ANGEW CHEM INT EDIT, V49, P10093, DOI 10.1002/anie.201005138; Bailie JE, 1999, CHEM COMMUN, P2151, DOI 10.1039/a906538e; Cainelli G, 1984, CHROMIUM OXIDATIONS; Dubuis R, 1966, ORG SYNTH, V46, P89; Guo WS, 2015, ADV SYNTH CATAL, V357, P89, DOI 10.1002/adsc.201400740; Jin TN, 2012, CHEMCATCHEM, V4, P1217, DOI 10.1002/cctc.201200193; Katritzky AR, 1996, TETRAHEDRON, V52, P15031, DOI 10.1016/S0040-4020(96)00911-8; Lickiss P. D., 1995, ADV INORG CHEM, V42, P147; Mahoney W S, 1988, J AM CHEM SOC, V110, P293; Marciniec B, 1996, APPL HOMOGENEOUS CAT; Marciniec B., 1992, COMPREHENSIVE HDB HY; Mitsudome T, 2009, CHEM COMMUN, P5302, DOI 10.1039/b910208f; Mori K, 2002, J CHEM, V26, P1536; Muetterties E L, 1967, CHEM BORON ITS COMPO, P398; Ochiai M, 2008, EUR J ORG CHEM, P4229, DOI 10.1002/ejoc.200800416; Ojima I., 1998, CHEM ORGANIC SILICON; Onak T, 1975, ORGANOBORANE CHEM, P38; Parida S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.035504; Pascu O, 2014, RSC ADV, V4, P59953, DOI 10.1039/c4ra09881a; Petegem S.V., 2009, NANO LETT, V9, P1158; Preedasuriyachai P, 2010, CHEM LETT, V39, P1174, DOI 10.1246/cl.2010.1174; RASMUSSEN JK, 1977, SYNTHESIS-STUTTGART, P91; Saxena I, 2000, J CHEM SOC P1, V1, P503; SHIBATA M, 1988, J CHEM SOC CHEM COMM, P154, DOI 10.1039/c39880000154; Singh UK, 2001, APPL CATAL A-GEN, V213, P1, DOI 10.1016/S0926-860X(00)00885-1; Takale BS, 2014, CHEM COMMUN, V50, P14401, DOI 10.1039/c4cc07068b; Takale B S, 2015, REFERENCE MODULE CHE, DOI [10.1016/B978-0-12-409547-2.11037-6, DOI 10.1016/B978-0-12-409547-2.11037-6]; Uyanik M, 2009, CHEM COMMUN, P2086, DOI 10.1039/b823399c; Vanysek P, 2012, HDB CHEM PHYS, P580; Vasilikogiannaki E, 2015, CHEM COMMUN, V51, P2384, DOI 10.1039/c4cc08163c	158	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	17					2355	2380		10.1055/s-0034-1380867		26	Chemistry, Organic	Chemistry	CT2VZ	WOS:000362664300005		
J	Shimada, Y; Haraguchi, R; Matsubara, S				Shimada, Yukako; Haraguchi, Ryosuke; Matsubara, Seijiro			Preparation of an Arenylmethylzinc Reagent with Functional Groups by Chemoselective Cross-Coupling Reaction of Bis(iodozincio)methane with Iodoarenes	SYNLETT			English	Article						arenylmethylzinc; organozinc; cross-coupling; palladium; nickel		Palladium-catalyzed cross-coupling reaction of bis(iodozincio)methane with iodoarenes carrying various functionalities such as ester, boryl, cyano, and halo groups proceeded chemoselectively to give the corresponding arenylmethylzinc species efficiently. The moderate reactivity of the gem-dizinc reagent imparted functional group tolerance to the process. The transformations from iodoheteroarenes were also performed; in the case of iodopyridine derivatives, the nickel-catalyzed reaction gave the corresponding organozinc species efficiently. The obtained arenylmethylzinc species underwent the copper-mediated coupling reaction with a range of organic halides.	[Shimada, Yukako; Haraguchi, Ryosuke; Matsubara, Seijiro] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan	Matsubara, S (reprint author), Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan.	matsubara.seijiro.2e@kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported financially by the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Braendvang M, 2009, BIOORGAN MED CHEM, V17, P6512, DOI 10.1016/j.bmc.2009.08.012; Boudier A, 2000, ANGEW CHEM INT EDIT, V39, P4414, DOI 10.1002/1521-3773(20001215)39:24<4414::AID-ANIE4414>3.0.CO;2-C; Murakami K, 2010, CHEM-EUR J, V16, P7688, DOI 10.1002/chem.201001061; Krasovskiy A, 2004, ANGEW CHEM INT EDIT, V43, P3333, DOI 10.1002/anie.200454084; Sada M, 2010, J AM CHEM SOC, V132, P17452, DOI 10.1021/ja104439w; Yoshino H, 2006, CHEM-EUR J, V12, P721, DOI 10.1002/chem.200500767; Nishida Y, 2015, J AM CHEM SOC, V137, P114, DOI 10.1021/ja5114535; GOLIASZEWSKI A, 1985, ORGANOMETALLICS, V4, P417, DOI 10.1021/om00121a047; Haraguchi R, 2014, SYNTHESIS-STUTTGART, V46, P2272, DOI 10.1055/s-0034-1378514; Barl NM, 2014, ORG LETT, V16, P2422, DOI 10.1021/ol500790p; Baba Y, 2008, SYNLETT, P2061, DOI 10.1055/s-2008-1077960; KANEMOTO S, 1987, CHEM LETT, P5, DOI 10.1246/cl.1987.5; Sada M, 2014, SYNLETT, V25, P2831, DOI 10.1055/s-0034-1379250; Schlosser M., 2002, ORGANOMETALLICS SYNT, P1; Schlosser M, 2005, ANGEW CHEM INT EDIT, V44, P376, DOI 10.1002/anie.200300645; Shimada Y., 2015, P 95 CSJ ANN M CHIB, p2EA	16	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	17					2395	2398		10.1055/s-0034-1381044		4	Chemistry, Organic	Chemistry	CT2VZ	WOS:000362664300009		
J	Kitazawa, Y; Otsuka, M; Kanazawa, J; Takita, R; Uchiyama, M				Kitazawa, Yu; Otsuka, Mai; Kanazawa, Junichiro; Takita, Ryo; Uchiyama, Masanobu			Palladium-Catalyzed Cross-Coupling Reaction of Lithiated Monocarba-closo-dodecaborate at the Carbon Vertex	SYNLETT			English	Article						monocarba-closo-dodecaborate; cross-coupling; lithium; transmetalation	ANIONS; CHEMISTRY; ION; SUBSTITUTION; CATIONS; ALKENES; CB11H12	A cross-coupling reaction of lithium species of monocarba-closo-dodecaborate {[closo-CHB11H11](-)} at the carbon vertex under palladium catalysis was developed. The properties of a metal-carborate complex in a transmetalation step were important to achieve the cross-coupling process with aryl halides, and the use of lithiated monocarba-closo-dodecaborate was found to promote the carbon-carbon bond formation to provide a series of C-arylated monocarba-closo-dodecaborate derivatives. Mechanistic investigations with DFT calculations suggested the efficient transmetalation with the lithium reagent.	[Kitazawa, Yu; Otsuka, Mai; Kanazawa, Junichiro; Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kitazawa, Yu; Takita, Ryo; Uchiyama, Masanobu] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan	Takita, R (reprint author), RIKEN Ctr Sustainable Resource Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ryo.takita@riken.jp; uchiyama@mol.f.u-tokyo.ac.jp			JSPS [25713001]; JSPS KAKENHI [24229011]	This work was partly supported by JSPS Grant-in-Aid for Young Scientists (A) (to R.T.) (No. 25713001), and JSPS KAKENHI (S) (No. 24229011), T (to M.U.). Y.K. thanks RIKEN Junior Research Associate program (until March 2015) and the JSPS Research Fellowship for Young Scientists (from April 2015). The calculations were performed on the RIKEN Integrated Cluster of Clusters (RICC). We gratefully acknowledge the Advanced Center for Computing and Communication, RIKEN for providing computational resources.	MURAHASHI SI, 1979, J ORG CHEM, V44, P2408, DOI 10.1021/jo01328a016; Jankowiak A, 2013, J ORGANOMET CHEM, V747, P195, DOI 10.1016/j.jorganchem.2013.05.034; Xie ZW, 1998, INORG CHEM, V37, P6444, DOI 10.1021/ic9805628; Kanazawa J, 2013, ANGEW CHEM INT EDIT, V52, P8017, DOI 10.1002/anie.201302448; Vyakaranam K, 2007, J AM CHEM SOC, V129, P4172, DOI 10.1021/ja066520x; Franken A, 2002, J ORGANOMET CHEM, V657, P176, DOI 10.1016/S0022-328X(02)01539-5; King BT, 2007, J AM CHEM SOC, V129, P12960, DOI 10.1021/ja066247z; Kim KC, 2002, J AM CHEM SOC, V124, P7662, DOI 10.1021/ja0259990; Reed CA, 2000, SCIENCE, V289, P101, DOI 10.1126/science.289.5476.101; Stoyanov ES, 2010, J AM CHEM SOC, V132, P4062, DOI 10.1021/ja100297b; Korbe S, 2006, CHEM REV, V106, P5208, DOI 10.1021/cr050548u; Shoji Y, 2014, NAT CHEM, V6, P498, DOI [10.1038/nchem.1948, 10.1038/NCHEM.1948]; Giannerini M, 2013, NAT CHEM, V5, P667, DOI [10.1038/nchem.1678, 10.1038/NCHEM.1678]; Nava M, 2014, ANGEW CHEM INT EDIT, V53, P1131, DOI 10.1002/anie.201308586; Kobayashi Y, 2013, ANGEW CHEM INT EDIT, V52, P10740, DOI 10.1002/anie.201304770; Korbe S, 2004, INORG CHEM, V43, P8158, DOI 10.1021/ic049255u; Kim KC, 2002, SCIENCE, V297, P825, DOI 10.1126/science.1073540; Wright JH, 2010, ORGANOMETALLICS, V29, P4066, DOI 10.1021/om100662r; Eriksson L, 2007, J ORG CHEM, V72, P2351, DOI 10.1021/jo0618371; Nava MJ, 2010, INORG CHEM, V49, P4726, DOI 10.1021/ic100053u; Stoyanov ES, 2012, J AM CHEM SOC, V134, P707, DOI 10.1021/ja209942s; Tsurumaki E, 2011, J AM CHEM SOC, V133, P11956, DOI 10.1021/ja2056566; JELINEK T, 1993, INORG CHEM, V32, P1982, DOI 10.1021/ic00062a018; Douvris C., 2013, J CHEM REV, V113, pPR179; Franken A, 2006, DALTON T, P5753, DOI 10.1039/b609908d; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Janousek Z., 2001, 2 EUR S BOR CHEM EUR; Jelinek T, 2001, CHEM COMMUN, P1790, DOI 10.1039/b105645j; Reed CA, 2010, ACCOUNTS CHEM RES, V43, P121, DOI 10.1021/ar900159e	29	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	17					2403	2407		10.1055/s-0034-1378833		5	Chemistry, Organic	Chemistry	CT2VZ	WOS:000362664300011		
J	Ryu, I; Yamamura, G; Minakata, S; Komatsu, M; Kubo, H; Ueda, M				Ryu, Ilhyong; Yamamura, Go-hei; Minakata, Satoshi; Komatsu, Mitsuo; Kubo, Haruka; Ueda, Mitsuhiro			Intramolecular Carbolithiation of 3-Lithioxy-5-alkenyllithiums as a Platform for Cyclopentanols and Cyclopentanones	SYNLETT			English	Article						intramolecular carbolithiation; dianion; cyclopentanols; cyclopentanones	KETONE DILITHIO ALPHA,BETA-DIANIONS; RING-CLOSURE; SUBSTITUTED 5-HEXENYLLITHIUMS; CONJUGATE ADDITION; CARBON-MONOXIDE; CYCLIZATION; GENERATION; STEREOCHEMISTRY; ORGANOLITHIUMS; ELECTROPHILES	Intramolecular carbolithiation of 3-lithioxy-5-hexenyllithiums was studied. Unlike the case of 5-hexenyllithium, the cyclization of 3-lithioxy-5-hexenyllithium was very sluggish. Acceleration was observed when lithium chloride was added, suggesting that intramolecular lithioxy coordination would hinder the cyclization. Introduction of a silyl or thiophenyl group at the olefin terminus caused smooth cyclization. The resulting dianions having a cyclopentane framework are subjected to C-C bond-forming reaction with electrophiles to give 3-substituted cyclopentanols. Coupled with the Swern oxidation, the overall protocol served as a platform for 3-substituted cyclopentanones.	[Ryu, Ilhyong; Kubo, Haruka; Ueda, Mitsuhiro] Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Sakai, Osaka 5998531, Japan; [Yamamura, Go-hei; Minakata, Satoshi; Komatsu, Mitsuo] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Ryu, I (reprint author), Osaka Prefecture Univ, Grad Sch Sci, Dept Chem, Sakai, Osaka 5998531, Japan.	ryu@c.s.osakafu-u.ac.jp			JSPS; MEXT, Japan	This work was supported by a Grant-in-Aid for Scientific Research from the JSPS and the MEXT, Japan.	Ryu I, 1996, ORGANOMETALLICS, V15, P5459, DOI 10.1021/om9608014; Fukuyama T, 2014, ORG LETT, V16, P5632, DOI 10.1021/ol5026958; Mealy MJ, 2002, J ORGANOMET CHEM, V646, P59, DOI 10.1016/S0022-328X(01)01244-X; Ryu I, 2006, TETRAHEDRON LETT, V47, P2283, DOI 10.1016/j.tetlet.2006.02.026; Yamato SY, 2005, ORG LETT, V7, P2489, DOI 10.1021/ol050813y; Bailey WF, 2013, J ORG CHEM, V78, P3493, DOI 10.1021/jo4002118; Bailey WF, 2005, TETRAHEDRON, V61, P3183, DOI 10.1016/j.tet.2005.01.042; Ryu I, 2002, TETRAHEDRON LETT, V43, P1257, DOI 10.1016/S0040-4039(01)02346-2; Mehta G, 1997, CHEM REV, V97, P671, DOI 10.1021/cr9403650; NAKAHIRA H, 1991, ANGEW CHEM INT EDIT, V30, P177, DOI 10.1002/anie.199101771; Bailey WF, 2013, BEILSTEIN J ORG CHEM, V9, P537, DOI 10.3762/bjoc.9.59; Das S, 2007, CHEM REV, V107, P3286, DOI 10.1021/cr068365a; BAILEY WF, 1994, TETRAHEDRON, V50, P5957, DOI 10.1016/S0040-4020(01)90450-8; Gomez-SanJuan A, 2013, BEILSTEIN J ORG CHEM, V9, P313, DOI 10.3762/bjoc.9.36; Ryu I, 2000, J AM CHEM SOC, V122, P1219, DOI 10.1021/ja993577t; Rodriguez C, 2014, J PHYS ORG CHEM, V27, P322, DOI 10.1002/poc.3259; Tian LX, 2014, CHINESE J ORG CHEM, V34, P507, DOI 10.6023/cjoc201310046; RYU I, 1990, J AM CHEM SOC, V112, P7061, DOI 10.1021/ja00175a051; Komine N, 2000, HETEROCYCLES, V52, P1071; Biellmann JF, 2003, CHEM REV, V103, P2019, DOI 10.1021/cr020071b; BAILEY WF, 1985, J ORG CHEM, V50, P1999, DOI 10.1021/jo00211a050; ROSS GA, 1985, J AM CHEM SOC, V107, P6742, DOI 10.1021/ja00309a071; MURAI S, 1984, J AM CHEM SOC, V106, P2440, DOI 10.1021/ja00320a039; Fressigne C, 2013, J ORG CHEM, V78, P9659, DOI 10.1021/jo4012893; Ryu I, 2000, TETRAHEDRON LETT, V41, P5689, DOI 10.1016/S0040-4039(00)00925-4; Nakahira H, 2005, TETRAHEDRON, V61, P3383, DOI 10.1016/j.tet.2005.01.047; Bailey WF, 2005, ARKIVOC, P25; Clayden J., 2002, ORGANOLITHIUMS SELEC, P273; Fananas F. J., 2006, CHEM ORGANOLITHIUM C, V2, P295, DOI DOI 10.1002/0470023236.CH4; Girard AL, 2012, EUR J ORG CHEM, P2895, DOI 10.1002/ejoc.201101777; Hogan AML, 2008, CHEM COMMUN, P3839, DOI 10.1039/b805595e; Manna MS, 2015, ORG BIOMOL CHEM, V13, P18, DOI 10.1039/c4ob01649a; Marek I, 1999, J CHEM SOC PERK T 1, P535, DOI 10.1039/a807060a; Normant J. F., 2003, ORGANOLITHIUMS ENANT, V5, P287, DOI 10.1007/3-540-36117-0_9; Rodriguez C, 2014, SYNTHETIC COMMUN, V44, P772, DOI 10.1080/00397911.2013.830132	35	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	17					2413	2417		10.1055/s-0035-1560170		5	Chemistry, Organic	Chemistry	CT2VZ	WOS:000362664300013		
J	Murakoshi, S; Hosokawa, S				Murakoshi, Sawato; Hosokawa, Seijiro			Stereoselective Synthesis of the C27-C48 Moiety of Aflastatin A by a Carbohydrate Strategy Using a Tin(II)-Mediated Aldol Reaction	SYNLETT			English	Article						stereoselectivity; aflastatin A; aldol reactions; polyols; carbohydrates	AFLATOXIN PRODUCTION; ERYTHRULOSE DERIVATIVES; ASPERGILLUS-PARASITICUS; ABSOLUTE-CONFIGURATION; DIRECTED REDUCTION; INHIBITOR; MACROLIDE; POLYOL; STREPTOMYCES; ACULEXIMYCIN	The C27-C48 segment of aflastatin A was synthesized by using d-mannoside and l-erythrulose derivatives as chiral building blocks. The aldol reaction of undecan-2-one with mannolactone and a subsequent reduction gave the C37 and C39 stereogenic centers with high selectivity. Another aldol reaction of a tin(II) enolate of a protected erythrulose (C27-C30 segment) with a C31-C48 aldehyde segment gave the C30,C31-syn adduct with the desired stereochemistry. Deprotection of the assembled product proceeded smoothly to give the C27-C48 segment of aflastatin A containing a contiguous polyol moiety.	[Murakoshi, Sawato; Hosokawa, Seijiro] Waseda Univ, Fac Sci & Engn, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan	Hosokawa, S (reprint author), Waseda Univ, Fac Sci & Engn, Dept Appl Chem, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.	e-mail_seijiro@waseda.jp			Kurata Memorial Hitachi Science; Naito Foundation; Technology Foundation, Scientific Research on Innovative Areas of The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24102531]	The authors are grateful for financial support from The Kurata Memorial Hitachi Science, The Naito Foundation, and the Technology Foundation, Scientific Research on Innovative Areas #24102531 of The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Evans DA, 2005, ORG LETT, V7, P3335, DOI 10.1021/ol051225n; Ikeda H, 2000, J ORG CHEM, V65, P438, DOI 10.1021/jo991284c; NERZSTORMES M, 1986, TETRAHEDRON LETT, V27, P897, DOI 10.1016/S0040-4039(00)84131-3; EVANS DA, 1988, J AM CHEM SOC, V110, P3560, DOI 10.1021/ja00219a035; Evans DA, 2005, ORG LETT, V7, P3331, DOI 10.1021/ol051226f; Mikkelsen LM, 2002, J ORG CHEM, V67, P6297, DOI 10.1021/jo020339z; Murata Y, 2004, ANGEW CHEM INT EDIT, V43, P3175, DOI 10.1002/anie.200454212; Gribble GW, 2006, ORG PROCESS RES DEV, V10, P1062, DOI 10.1021/op060107s; Marco JA, 2003, J ORG CHEM, V68, P8577, DOI 10.1021/jo035159j; Murata Y, 2002, TETRAHEDRON LETT, V43, P8121, DOI 10.1016/S0040-4039(02)01946-9; Narute SB, 2013, TETRAHEDRON, V69, P1830, DOI 10.1016/j.tet.2012.12.065; MURATA H, 1995, J ANTIBIOT, V48, P850; Hosokawa S, 2009, TETRAHEDRON LETT, V50, P6701, DOI 10.1016/j.tetlet.2009.09.089; Hobley G, 2003, TETRAHEDRON, V59, P4739, DOI 10.1016/S0040-4020(03)00692-6; Narute SB, 2011, ORG BIOMOL CHEM, V9, P5469, DOI 10.1039/c1ob05251a; Robles O, 2008, ORG LETT, V10, P1811, DOI [10.1021/ol800659z, 10.1021/o1800659z]; Ono M, 1997, J ANTIBIOT, V50, P111; Sakuda S, 2007, TETRAHEDRON LETT, V48, P2527, DOI 10.1016/j.tetlet.2007.02.024; Murga J, 2002, TETRAHEDRON, V58, P9697, DOI 10.1016/S0040-4020(02)01279-6; Miquel N, 2000, ANGEW CHEM INT EDIT, V39, P4111, DOI 10.1002/1521-3773(20001117)39:22<4111::AID-ANIE4111>3.0.CO;2-C; Mukherjee C, 2010, EUR J MED CHEM, V45, P6012, DOI 10.1016/j.ejmech.2010.09.069; EVANS DA, 1986, TETRAHEDRON LETT, V27, P5939, DOI 10.1016/S0040-4039(00)85367-8; ASPINALL GO, 1994, CAN J CHEM, V72, P247; Hosokawa S, 2010, TETRAHEDRON LETT, V51, P5532, DOI 10.1016/j.tetlet.2010.07.153; Kawahara T, 2012, ORG LETT, V14, P4434, DOI 10.1021/ol301940q; Sakuda S, 1996, J AM CHEM SOC, V118, P7855, DOI 10.1021/ja960899d; Kato T, 2015, ORG LETT, V17, P2274, DOI 10.1021/acs.orglett.5b00965; Kondo T, 2001, J ANTIBIOT, V54, P650; Kamino T, 2001, TETRAHEDRON LETT, V42, P5249, DOI 10.1016/S0040-4039(01)00818-8; Takahashi Y, 2014, ORG LETT, V16, P4106, DOI 10.1021/ol501805j; Nakamura T, 2013, ORG LETT, V15, P3170, DOI 10.1021/ol401406m; Beiger J. J., 2013, THESIS HARVARD U US; Hedenstrom E, 2000, J CHEM SOC PERK T 1, P1513, DOI 10.1039/b001730m; Hosokawa S., 2009, YUKI GOSEI KAGAKU KY, V67, P24; Hosokawa S, 2008, MINI-REV ORG CHEM, V5, P1, DOI 10.2174/157019308783498197; Mikami Y, 2000, J ANTIBIOT, V53, P70; TAKANO S, 1986, SYNTHESIS-STUTTGART, P811; Yasuda M, 2001, CHEM COMMUN, P157, DOI 10.1039/b008493j	38	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	17					2437	2441		10.1055/s-0035-1560572		5	Chemistry, Organic	Chemistry	CT2VZ	WOS:000362664300018		
J	Sekine, K; Mawatari, T; Yamada, T				Sekine, Kohei; Mawatari, Takanori; Yamada, Tohru			Synthesis of Oxazolidin-2-ones by Tandem Cyclization of Propargylic Alcohols and Phenyl Isocyanate Promoted by Silver Catalysts as -Lewis Acids	SYNLETT			English	Article						silver; catalysis; cyclizations; oxazolidinones; tandem reactions; isocyanates	CARBON-DIOXIDE INCORPORATION; O-ALKYNYLANILINE DERIVATIVES; EFFICIENT SYNTHESIS; INTRAMOLECULAR REARRANGEMENT; CONVENIENT SYNTHESIS; BOND FORMATION; PYRROLES; 4-ALKYLIDENE-2-OXAZOLIDINONES; CYCLOADDITION; ALKYNES	Highly Z-selective syntheses of oxazolidin-2-ones from propargylic alcohols containing internal alkynes and phenyl isocyanate were achieved by using a combination of silver acetate and N,N-dimethylaminopyridine. The catalytic system was applied to propargylic alcohols containing alkyl-substituted alkyne groups. By considering the results in the presence and absence of an electron-withdrawing group on the aromatics, it was shown that the silver catalyst effectively activates the CC triple bond by acting as a -Lewis acid to produce the corresponding oxazolidinones with high Z-selectivities.	[Sekine, Kohei; Mawatari, Takanori; Yamada, Tohru] Keio Univ, Dept Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Yamada, T (reprint author), Keio Univ, Dept Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.	yamada@chem.keio.ac.jp					Alamsetti SK, 2013, ANGEW CHEM INT EDIT, V52, P13745, DOI 10.1002/anie.201307471; Gao M, 2013, ANGEW CHEM INT EDIT, V52, P6958, DOI 10.1002/anie.201302604; Ishida T, 2013, ORG LETT, V15, P3710, DOI 10.1021/ol401571r; Jo KA, 2012, J ORG CHEM, V77, P2924, DOI 10.1021/jo202102y; Wang Y, 2011, ANGEW CHEM INT EDIT, V50, P2787, DOI 10.1002/anie.201005833; Ramesh R, 2007, TETRAHEDRON, V63, P9153, DOI 10.1016/j.tet.2007.06.066; Wong VHL, 2013, CHEM COMMUN, V49, P9272, DOI 10.1039/c3cc45500a; Liu JQ, 2013, ANGEW CHEM INT EDIT, V52, P6953, DOI 10.1002/anie.201302024; Yamamoto Y, 2008, CHEM REV, V108, P3199, DOI 10.1021/cr078359u; Hu YC, 2013, J ORG CHEM, V78, P7714, DOI 10.1021/jo401330t; Kikuchi S, 2011, B CHEM SOC JPN, V84, P698, DOI 10.1246/bcsj.20110078; TAMARU Y, 1994, B CHEM SOC JPN, V67, P2838, DOI 10.1246/bcsj.67.2838; Kikuchi S, 2012, ANGEW CHEM INT EDIT, V51, P6989, DOI 10.1002/anie.201201399; Alvarez-Corral M, 2008, CHEM REV, V108, P3174, DOI 10.1021/cr078361l; Yang L, 2014, CHEM COMMUN, V50, P3024, DOI 10.1039/c3cc49851d; Ugajin R, 2014, SYNLETT, V25, P1178, DOI 10.1055/s-0033-1341047; KIMURA M, 1990, TETRAHEDRON LETT, V31, P4887, DOI 10.1016/S0040-4039(00)97760-8; Brioche J, 2013, ORG LETT, V15, P1626, DOI 10.1021/ol400402n; Ishida T, 2013, ORG LETT, V15, P848, DOI 10.1021/ol303534w; Sekine K, 2013, CHEM COMMUN, V49, P11320, DOI 10.1039/c3cc47221c; Sheng J, 2014, CHEM COMMUN, V50, P4188, DOI 10.1039/c4cc00691g; Gronnier C, 2014, ORG LETT, V16, P2092, DOI 10.1021/ol500939v; OHE K, 1991, J ORG CHEM, V56, P2267, DOI 10.1021/jo00006a062; Naodovic M, 2008, CHEM REV, V108, P3132, DOI 10.1021/cr068413r; Ishida T, 2014, ORG LETT, V16, P2430, DOI 10.1021/ol500806u; Sai M, 2011, ORG LETT, V13, P4676, DOI 10.1021/ol201895s; SHACHAT N, 1963, J ORG CHEM, V28, P991, DOI 10.1021/jo01039a028; Kim WS, 2011, B KOREAN CHEM SOC, V32, P3158, DOI 10.5012/bkcs.2011.32.8.3158; Weibel JM, 2008, CHEM REV, V108, P3149, DOI 10.1021/cr078365q; Liu J, 2013, CHEM COMMUN, V49, P11794, DOI 10.1039/c3cc46524a; STOFFEL PJ, 1963, J ORG CHEM, V28, P2814, DOI 10.1021/jo01045a079; Wang Y, 2012, J AM CHEM SOC, V134, P4096, DOI 10.1021/ja300453u; Zhang X, 2011, GREEN CHEM, V13, P397, DOI 10.1039/c0gc00668h; Breman AC, 2014, EUR J ORG CHEM, P7413, DOI 10.1002/ejoc.201403099; Chioua M, 2013, EUR J ORG CHEM, P35, DOI 10.1002/ejoc.201201258; Yoshida S, 2010, J AM CHEM SOC, V132, P4072, DOI 10.1021/ja1007118; Harmata M., 2010, SILVER ORGANIC CHEM; Li DY, 2015, ADV SYNTH CATAL, V357, P1193, DOI 10.1002/adsc.201401039; Meng XY, 2014, CHEM COMMUN, V50, P11837, DOI 10.1039/c4cc04905e; Ritter S, 2006, SYNLETT, P3309, DOI 10.1055/s-2006-951555; Verma K. A. K., 2013, J ORG CHEM, V78, P6657; Yamada W, 2007, EUR J ORG CHEM, P2604, DOI 10.1002/ejoc.200700169	42	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	17					2447	2450		10.1055/s-0035-1560263		4	Chemistry, Organic	Chemistry	CT2VZ	WOS:000362664300020		
J	Yanai, H; Sasaki, Y; Yamamoto, Y; Matsumoto, T				Yanai, Hikaru; Sasaki, Yuichi; Yamamoto, Yuki; Matsumoto, Takashi			Chemoselective Two-Directional Reaction of Bifunctionalized Substrates: Formal Ketal-Selective Mukaiyama Aldol Type Reaction	SYNLETT			English	Article						acid catalysis; zwitterion; carbanion; chemoselectivity; Mukaiyama aldol reaction	BRONSTED ACID CATALYST; ACTIVATION; LACTONES; CARBONYL; ECONOMY; ACETALS; KETONES; DESIGN; ETHERS	In the presence of an acidic zwitterion bearing a highly stabilized carbanion, reactions of ,-dialkoxy carbonyl compounds with ketene silyl acetals (KSA) resulted in an unusual molecular transformation; substitution reaction with the KSA at the ketal moiety and simultaneous silylative acetalization of the ketone moiety.	[Yanai, Hikaru; Sasaki, Yuichi; Yamamoto, Yuki; Matsumoto, Takashi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan	Yanai, H (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yanai@toyaku.ac.jp; tmatsumo@toyaku.ac.jp			MEXT; Mitsubishi Gas Chemical Co. Ltd.; Kurata Memorial Hitachi Science and Technology Foundation	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Advanced Molecular Transformations by Organocatalysts' from the MEXT, Mitsubishi Gas Chemical Co. Ltd., and the Kurata Memorial Hitachi Science and Technology Foundation	Wender PA, 2008, ACCOUNTS CHEM RES, V41, P40, DOI 10.1021/ar700155p; Newhouse T, 2009, CHEM SOC REV, V38, P3010, DOI 10.1039/b821200g; Saadi J, 2011, J AM CHEM SOC, V133, P14248, DOI 10.1021/ja2066169; Vrettou M, 2007, TETRAHEDRON, V63, P1487, DOI 10.1016/j.tet.2006.09.109; Olah GA, 1996, MACROMOLECULES, V29, P1857, DOI 10.1021/ma951283w; Li WDZ, 2002, ORG LETT, V4, P3485, DOI 10.1021/ol026585e; Oisaki K, 2006, J AM CHEM SOC, V128, P7164, DOI 10.1021/ja061815w; Yanai H, 2013, ASIAN J ORG CHEM, V2, P989, DOI 10.1002/ajoc.201300157; Ishihara K, 2001, ANGEW CHEM INT EDIT, V40, P4077, DOI 10.1002/1521-3773(20011105)40:21<4077::AID-ANIE4077>3.0.CO;2-1; Denmark SE, 2002, J AM CHEM SOC, V124, P4233, DOI 10.1021/ja025670e; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Fujioka H, 2005, ANGEW CHEM INT EDIT, V44, P734, DOI 10.1002/anie.200461584; MAGNUSON SR, 1995, TETRAHEDRON, V51, P2167, DOI 10.1016/0040-4020(94)01070-G; POSS CS, 1994, ACCOUNTS CHEM RES, V27, P9, DOI 10.1021/ar00037a002; Garcia-Garcia P, 2009, ANGEW CHEM INT EDIT, V48, P4363, DOI 10.1002/anie.200901768; Yanai H, 2010, CHEM COMMUN, V46, P8728, DOI 10.1039/c0cc02438d; Boxer MB, 2006, J AM CHEM SOC, V128, P48, DOI 10.1021/ja054725k; Hasegawa A, 2006, ORG LETT, V8, P3175, DOI 10.1021/ol060939a; STERN A, 1987, J ORG CHEM, V52, P2763, DOI 10.1021/jo00389a023; Ooi T, 1997, TETRAHEDRON LETT, V38, P7403, DOI 10.1016/S0040-4039(97)01735-8; Hiraiwa Y., 2006, EUR J ORG CHEM, P1837; Inagawa K., 2005, J AM CHEM SOC, V127, P3668; Matsuo J, 2013, ANGEW CHEM INT EDIT, V52, P9109, DOI 10.1002/anie.201303192; MUKAIYAM.T, 1973, CHEM LETT, P1011, DOI 10.1246/cl.1973.1011; MUKAIYAMA T, 1991, CHEM LETT, P949, DOI 10.1246/cl.1991.949; NOYORI R, 1977, J AM CHEM SOC, V99, P1265, DOI 10.1021/ja00446a049; Otera J., 1996, SYNLETT, P321; Takahashi A, 2008, CHEM COMMUN, P2385, DOI 10.1039/b800815a; Yanai H, 2013, ANGEW CHEM INT EDIT, V52, P1560, DOI 10.1002/anie.201208809; Yanai H, 2011, CHEM-EUR J, V17, P11747, DOI 10.1002/chem.201102023; Zhang M, 2015, J PHYS ORG CHEM, V28, P181, DOI 10.1002/poc.3304	31	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	OCT	2015	26	17					2457	2461		10.1055/s-0035-1560478		5	Chemistry, Organic	Chemistry	CT2VZ	WOS:000362664300022		
J	Okuma, K; Horigami, K; Nagahora, N; Shioji, K				Okuma, Kentaro; Horigami, Kenta; Nagahora, Noriyoshi; Shioji, Kosei			Enantioselective Synthesis of 4,4 '-Biaryl-BINOLs from Arynes and beta-Diketones	SYNTHESIS-STUTTGART			English	Article						aryne; beta-diketone; carbon-carbon bond insertion; 4-aryl-2-naphthol; BINOL	MILD CONDITIONS; DERIVATIVES; BENZYNE; 2-NAPHTHOLS; ALKYLATION; COMPLEXES; ARYLATION; INSERTION; CATALYST; KETONES	The reaction of 2-(trimethylsilyl) phenyl triflate with aroylacetones in the presence of CsF gave the corresponding 4-aryl-2-naphthols. Substituted triflates also reacted with aroylacetones to afford 4-aryl-2-naphthols regioselectively. The enantioselective oxidation of 4aryl-2-naphthols with a chiral tridentate oxovanadium(IV) complex furnished the corresponding 4,4'-biaryl-1,1'-binaphthols in good yields.	[Okuma, Kentaro; Horigami, Kenta; Nagahora, Noriyoshi; Shioji, Kosei] Fukuoka Univ, Dept Chem, Jonan Ku, Fukuoka 8140180, Japan	Okuma, K (reprint author), Fukuoka Univ, Dept Chem, Jonan Ku, Fukuoka 8140180, Japan.	kokuma@fukuoka-u.ac.jp					Yoshida H, 2006, J AM CHEM SOC, V128, P11040, DOI 10.1021/ja064157o; NISHII Y, 1995, TETRAHEDRON LETT, V36, P8803, DOI 10.1016/0040-4039(95)01866-G; Qian XH, 2010, CHEM COMMUN, V46, P6418, DOI 10.1039/c0cc00686f; Hon SW, 2001, ORG LETT, V3, P869, DOI 10.1021/ol015505o; Chow HF, 2001, J ORG CHEM, V66, P5042, DOI 10.1021/jo0100289; Wentrup C, 2010, AUST J CHEM, V63, P979, DOI 10.1071/CH10179; Hashimoto T, 2003, TETRAHEDRON-ASYMMETR, V14, P1599, DOI 10.1016/S0957-4166(03)00271-4; Kitamura T, 2010, AUST J CHEM, V63, P987, DOI 10.1071/CH10072; Jin T, 2007, ORG LETT, V9, P5259, DOI 10.1021/ol702455v; Gilmore CD, 2008, J AM CHEM SOC, V130, P1558, DOI 10.1021/ja0780582; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; BRUSSEE J, 1985, TETRAHEDRON, V41, P3313, DOI 10.1016/S0040-4020(01)96682-7; Tambar UK, 2005, J AM CHEM SOC, V127, P5340, DOI 10.1021/ja050859m; Cai YS, 2010, NAT PROD REP, V27, P1840, DOI 10.1039/c0np00031k; Karady S, 1996, TETRAHEDRON LETT, V37, P8277, DOI 10.1016/0040-4039(96)01936-3; Ma LQ, 2009, J AM CHEM SOC, V131, P4610, DOI 10.1021/ja809590n; Redic R, 2006, J PHOTOCH PHOTOBIO A, V179, P66, DOI 10.1016/j.jphotochem.2005.07.014; Bolm C, 2001, ANGEW CHEM INT EDIT, V40, P3285; Kilian P, 2011, CHEM-EUR J, V17, P2302, DOI 10.1002/chem.201001750; Okuma K, 2001, J AM CHEM SOC, V123, P7166, DOI 10.1021/ja010640h; RUPARD JH, 1989, J MED CHEM, V32, P2261, DOI 10.1021/jm00130a006; Lou ZB, 2014, ADV SYNTH CATAL, V356, P153, DOI 10.1002/adsc.201300728; Hu XY, 2012, TETRAHEDRON-ASYMMETR, V23, P1327, DOI 10.1016/j.tetasy.2012.08.014; Okuma K, 2012, CHEM COMMUN, V48, P11145, DOI 10.1039/c2cc36128k; MIKAMI K, 1992, CHEM REV, V92, P1021, DOI 10.1021/cr00013a014; Yoshida H, 2002, ANGEW CHEM INT EDIT, V41, P3247, DOI 10.1002/1521-3773(20020902)41:17<3247::AID-ANIE3247>3.0.CO;2-P; Frigoli M, 2003, EUR J ORG CHEM, P2799, DOI 10.1002/ejoc.200300033; Hart H., 1994, CHEM TRIPLE BOND SC2, DOI DOI 10.1002/0470024771.CH18; HIMESHIMA Y, 1983, CHEM LETT, P1211, DOI 10.1246/cl.1983.1211; Hoffman R. W., 1967, DEHYDROBENZENE CYCLO; Irie R, 2000, SYNLETT, P1433; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME; Kessar S.V., 1991, COMPREHENSIVE ORGANI, V4, P483; Kim HY, 2014, ORG LETT, V16, P5934, DOI 10.1021/ol502951v; Koptyug V. A., 1972, CHEM ABSTR, V76; KOPTYUG VA, 1971, ZH ORG KHIM+, V7, P2398; Rauniyar V, 2007, SYNTHESIS-STUTTGART, P3421, DOI 10.1055/s-2007-983832; Tashiro A, 2003, SYNLETT, P1868; Wieting JM, 2015, EUR J ORG CHEM, P525, DOI 10.1002/ejoc.201403441; Yoshida H, 2005, CHEM COMMUN, P3292, DOI 10.1039/b505392g; Zhang JC, 2015, CHEM COMMUN, V51, P1297, DOI 10.1039/c4cc07997c; Zhang XX, 2006, J ORG CHEM, V71, P236, DOI 10.1021/jo051948k	42	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	19					2937	2944		10.1055/s-0034-1380452		8	Chemistry, Organic	Chemistry	CT1OO	WOS:000362568400010		
J	Aoyama, T; Hayakawa, M; Kubota, S; Ogawa, S; Nakajima, E; Mitsuyama, E; Iwabuchi, T; Kaneko, H; Obara, R; Takido, T; Kodomari, M; Ouchi, A				Aoyama, Tadashi; Hayakawa, Mamiko; Kubota, Sho; Ogawa, Sumire; Nakajima, Erika; Mitsuyama, Emi; Iwabuchi, Taku; Kaneko, Haruki; Obara, Rina; Takido, Toshio; Kodomari, Mitsuo; Ouchi, Akihiko			Simple Method for sp(2)-sp(3) and sp(3)-sp(3) Carbon-Carbon Bond Activation in 2-Substituted 1,3-Diketones	SYNTHESIS-STUTTGART			English	Article						bond activation; alkylations; deacylations; heterogeneous reactions	C-C BOND; SILICA SULFURIC-ACID; CATALYZED SYNTHESIS; BETA-DIKETONES; 3-SUBSTITUTED ISOCOUMARINS; RHODIUM(I) COMPLEX; AROMATIC-COMPOUNDS; TRANSITION-METALS; ALPHA-BROMOESTERS; LEAVING GROUPS	Simple and efficient methods were developed for sp(2)-sp(3) and sp(3)-sp(3) C-C bond-activation reactions of 2-substituted 1,3-diketones. 3-Substituted 3-bromopentane-2,4-diones were deacylated in the presence of an aromatic compound and a silica gel supported Bronsted acid containing sulfonic groups. The carbocation formed by cleavage of the sp(3)-sp(3) C-C bond of the dione alkylated the aromatic compound.	[Aoyama, Tadashi; Hayakawa, Mamiko; Kubota, Sho; Ogawa, Sumire; Nakajima, Erika; Mitsuyama, Emi; Iwabuchi, Taku; Kaneko, Haruki; Obara, Rina; Takido, Toshio; Ouchi, Akihiko] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ku, Tokyo 1018308, Japan; [Aoyama, Tadashi] Nihon Univ, Coll Sci & Technol, Ctr Creat Mat Res,Res Inst Sci & Technol, Chiyoda Ku, Tokyo 1018308, Japan; [Kodomari, Mitsuo] Nihon Univ, Coll Humanities & Sci, Inst Nat Sci, Setagaya Ku, Tokyo 1568550, Japan	Aoyama, T (reprint author), Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Chiyoda Ku, Tokyo 1018308, Japan.	aoyama.tadashi@nihon-u.ac.jp					Aoyama T, 2004, TETRAHEDRON LETT, V45, P1873, DOI 10.1016/j.tetlet.2004.01.014; Sun X, 2013, GREEN CHEM, V15, P3289, DOI 10.1039/c3gc41260a; Park YJ, 2008, ACCOUNTS CHEM RES, V41, P222, DOI 10.1021/ar700133y; Gandelman M, 2000, CHEM COMMUN, P1603, DOI 10.1039/b004820h; Bray DJ, 2007, TETRAHEDRON, V63, P1953, DOI 10.1016/j.tet.2006.12.071; Pohlhaus PD, 2004, J AM CHEM SOC, V126, P2294, DOI 10.1021/ja0397963; Li HR, 2011, ANGEW CHEM INT EDIT, V50, P2975, DOI 10.1002/anie.201006779; Adkins H, 1930, J AM CHEM SOC, V52, P3212, DOI 10.1021/ja01371a029; Amijs CHM, 2008, J ORG CHEM, V73, P7721, DOI 10.1021/jo8014769; Li WJ, 2013, ADV SYNTH CATAL, V355, P181, DOI 10.1002/adsc.201200324; Rong ZQ, 2011, ORG LETT, V13, P4080, DOI 10.1021/ol201595f; Sun X, 2014, ORG LETT, V16, P2126, DOI 10.1021/ol500546p; MIGNANI G, 1987, TETRAHEDRON LETT, V28, P5505, DOI 10.1016/S0040-4039(00)96765-0; Jun CH, 2004, CHEM SOC REV, V33, P610, DOI 10.1039/b308864m; Matsumura S, 2003, J AM CHEM SOC, V125, P8862, DOI 10.1021/ja035293l; Beckham LJ, 1934, J AM CHEM SOC, V56, P1119, DOI 10.1021/ja01320a035; Kondo T, 2002, J AM CHEM SOC, V124, P6824, DOI 10.1021/ja0260521; Zhao J, 2012, ORG LETT, V14, P2710, DOI 10.1021/ol300908g; Najera C, 2009, ANGEW CHEM INT EDIT, V48, P2452, DOI 10.1002/anie.200805601; Jun CH, 2001, ORGANOMETALLICS, V20, P2928, DOI 10.1021/om010087c; Murakami M, 2006, B CHEM SOC JPN, V79, P1315, DOI 10.1246/bcsj.79.1315; Xu QF, 2009, ORG LETT, V11, P4136, DOI 10.1021/ol901608k; Takahashi T, 2008, J AM CHEM SOC, V130, P15236, DOI 10.1021/ja805352z; Rezgui F, 1997, TETRAHEDRON, V53, P15711, DOI 10.1016/S0040-4020(97)10023-0; Kawata A, 2007, ANGEW CHEM INT EDIT, V46, P7793, DOI 10.1002/anie.200702798; Winter C, 2009, ANGEW CHEM INT EDIT, V48, P2460, DOI 10.1002/anie.200805578; Kim S, 2002, J AM CHEM SOC, V124, P762, DOI 10.1021/ja017460s; Perthuisot C, 2002, J MOL CATAL A-CHEM, V189, P157, DOI 10.1016/S1381-1169(02)00203-0; Jun CH, 2000, ANGEW CHEM INT EDIT, V39, P3070, DOI 10.1002/1521-3773(20000901)39:17<3070::AID-ANIE3070>3.0.CO;2-G; HAYASHI T, 1986, J ORG CHEM, V51, P723, DOI 10.1021/jo00355a025; Cai SJ, 2012, J ORG CHEM, V77, P2331, DOI 10.1021/jo2026433; Zhang XB, 2013, RSC ADV, V3, P1311, DOI 10.1039/c2ra22116k; Jun CH, 2001, J AM CHEM SOC, V123, P751, DOI 10.1021/ja0033537; Liu WP, 2011, ORG LETT, V13, P6272, DOI 10.1021/ol202749x; Hajipour AR, 2004, TETRAHEDRON LETT, V45, P6607, DOI 10.1016/j.tetlet.2004.07.023; Lee DY, 2002, ANGEW CHEM INT EDIT, V41, P3031, DOI 10.1002/1521-3773(20020816)41:16<3031::AID-ANIE3031>3.0.CO;2-X; Kavala V, 2012, J ORG CHEM, V77, P5022, DOI 10.1021/jo300501j; Lundin PM, 2009, ANGEW CHEM INT EDIT, V48, P154, DOI 10.1002/anie.200804888; Aoyama T, 2011, CHEM LETT, V40, P484, DOI 10.1246/cl.2011.484; Kuninobu Y, 2008, ORG LETT, V10, P3133, DOI 10.1021/ol801226t; Bonesi SM, 2010, CHEM-EUR J, V16, P13572, DOI 10.1002/chem.201001478; Sugiishi T, 2010, J AM CHEM SOC, V132, P5332, DOI 10.1021/ja9109055; Kogan K, 2009, J ORG CHEM, V74, P7172, DOI 10.1021/jo901450x; Tobisu M, 2008, CHEM SOC REV, V37, P300, DOI 10.1039/b702940n; Bart SC, 2003, J AM CHEM SOC, V125, P886, DOI 10.1021/ja028912j; Seiser T, 2010, J AM CHEM SOC, V132, P5340, DOI 10.1021/ja101469t; Liu H, 2014, CHEM-ASIAN J, V9, P3360, DOI 10.1002/asia.201402591; He CA, 2010, J AM CHEM SOC, V132, P8273, DOI 10.1021/ja1033777; Schmink JR, 2009, ORG LETT, V11, P2575, DOI 10.1021/ol900874z; Aoyama T, 2014, SYNLETT, V25, P2493, DOI 10.1055/s-0034-1378650; BELLESIA F, 1986, J CHEM RES-S, P428; Biswas S, 2010, EUR J ORG CHEM, P2861, DOI 10.1002/ejoc.201000128; Fan XS, 2012, EUR J ORG CHEM, P673, DOI 10.1002/ejoc.201101559; Jun Chul-Ho, 2002, Chemistry, V8, P2422, DOI 10.1002/1521-3765(20020603)8:11<2422::AID-CHEM2422>3.0.CO;2-B; Klimkin M. A., 2001, CHEM NAT COMPD, V36, P609; Liu Y., 2012, ORG CHEM, V77, P1191; STOTTER PL, 1972, TETRAHEDRON LETT, P4067; Xie H., 2012, CHEM COMMUN, V48, P979	58	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	19					2945	2956		10.1055/s-0034-1378862		12	Chemistry, Organic	Chemistry	CT1OO	WOS:000362568400011		
J	Uenishi, J; Hirano, H; Ueda, T; Hoshiya, N; Ii, H; Yoshiki, T				Uenishi, Jun'ichi; Hirano, Hirokazu; Ueda, Tsuyoshi; Hoshiya, Naoyuki; Ii, Hiromi; Yoshiki, Tatsuhiro			Synthesis and Cytotoxic Activity of N,N '-(Arylmethylene)bisamides	SYNTHESIS-STUTTGART			English	Article						amides; medicinal chemistry; cytotoxins; condensation; bisamides	SYMMETRICAL BISAMIDES; (-)-DACTYLOLIDE; ZAMPANOLIDE; ACID; (-)-ZAMPANOLIDE; DERIVATIVES; ALDEHYDES; SPONGE	N,N'-(Arylmethylene) bisamides were prepared by an acidcatalyzed reaction of arylaldehydes with cinnamamide or acrylamides. The reaction was carried out in refluxing toluene for a few hours, and simple collection of the precipitate gave the desired products. The bisamides were designed as cytotoxic molecules based on the structure of the potently cytotoxic marine natural product (-)-zampanolide. The activities of the bisamides against two cancer cell lines were evaluated, and several compounds were found to show medium potency with IC50 values in the lower micromolar level.	[Uenishi, Jun'ichi; Hirano, Hirokazu; Ueda, Tsuyoshi; Hoshiya, Naoyuki] Kyoto Pharmaceut Univ, Dept Pharmaceut Chem, Yamashina, Kyoto 6078412, Japan; [Ii, Hiromi; Yoshiki, Tatsuhiro] Kyoto Pharmaceut Univ, Dept Clin Oncol, Yamashina, Kyoto 6078412, Japan	Uenishi, J (reprint author), Kyoto Pharmaceut Univ, Dept Pharmaceut Chem, Yamashina, Kyoto 6078412, Japan.	juenishi@mb.kyoto-phu.ac.jp; yoshiki@mb.kyoto-phu.ac.jp			Ministry of Education, Science, and Culture of Japan	This work was supported by the Ministry of Education, Science, and Culture of Japan.	Anary-Abbasinejad M, 2010, SYNTHETIC COMMUN, V40, P2209, DOI 10.1080/00397910903219617; Anary-Abbasinejad M, 2009, J CHEM RES, P218, DOI 10.3184/030823409X435937; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Schafer G, 2015, HETEROCYCLES, V90, P1375, DOI 10.3987/COM-14-S(K)89; Chen QH, 2014, NAT PROD REP, V31, P1202, DOI 10.1039/c4np00024b; Hoye TR, 2003, J AM CHEM SOC, V125, P9576, DOI 10.1021/ja035579q; Field JJ, 2009, J MED CHEM, V52, P7328, DOI 10.1021/jm901249g; PALLAI PV, 1985, BIOCHEMISTRY-US, V24, P1933, DOI 10.1021/bi00329a020; Fletcher MD, 1998, CHEM REV, V98, P763, DOI 10.1021/cr970468t; Uenishi J, 2009, ORG LETT, V11, P3262, DOI 10.1021/ol901167g; CHOREV M, 1977, J AM CHEM SOC, V99, P8075, DOI 10.1021/ja00466a064; Zurwerra D, 2012, CHEM-EUR J, V18, P16868, DOI 10.1002/chem.201202553; RODRIGUEZ M, 1987, J MED CHEM, V30, P758, DOI 10.1021/jm00388a002; Karimi-Jaberi Z, 2013, MONATSH CHEM, V144, P659, DOI 10.1007/s00706-012-0848-8; Tanaka J, 1996, TETRAHEDRON LETT, V37, P5535, DOI 10.1016/0040-4039(96)01149-5; Zhu SZ, 1999, J FLUORINE CHEM, V93, P69, DOI 10.1016/S0022-1139(98)00286-3; Field JJ, 2012, CHEM BIOL, V19, P686, DOI 10.1016/j.chembiol.2012.05.008; Fernandez AH, 1996, SYNTHESIS-STUTTGART, P1299; Ghosh AK, 2012, EUR J ORG CHEM, P4130, DOI 10.1002/ejoc.201200286; Ghosh A. K., 2013, ORG LETT, V13, P4108; GILBERT EE, 1972, SYNTH-INT J METHODS, P30, DOI 10.1055/s-1972-21820; PERNAK J, 1994, SYNTHESIS-STUTTGART, P1415	22	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	19					2976	2984		10.1055/s-0034-1380437		9	Chemistry, Organic	Chemistry	CT1OO	WOS:000362568400016		
J	Seki, M				Seki, Masahiko			2,4-Dimethoxybenzyl Group for the Protection of Tetrazole: An Efficient Synthesis of Olmesartan Medoxomil through C-H Arylation	SYNTHESIS-STUTTGART			English	Article						protecting groups; arylations; heterocycles; biaryls; drugs; tetrazoles	II RECEPTOR ANTAGONISTS; CATALYTIC-SYSTEM; PRACTICAL SYNTHESIS; ACTIVATION; FUNCTIONALIZATION; BLOCKERS; POTENT; SERIES; ARENES; BONDS	The 2,4-dimethoxybenzyl (DMB) group was found to be effective for protecting tetrazoles. The DMB group is inert to various conditions, including those for ruthenium-catalyzed C-H arylation, but is readily cleaved under mild conditions. The use of a DMB protecting group permitted a synthesis of highly functionalized olmesartan medoxomil in a few steps.	API Corp, Healthcare Business Div 2, Proc R&D Dept, Chiyoda Ku, Tokyo 1010047, Japan	Seki, M (reprint author), API Corp, Healthcare Business Div 2, Proc R&D Dept, Chiyoda Ku, Kaiteki Bldg,1-13-4 Uchikanda, Tokyo 1010047, Japan.	seki.masahiko@mm.api-corp.co.jp					Anderson N. G., 2000, PRACTICAL PROCESS RE; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; KUBO K, 1993, J MED CHEM, V36, P2343, DOI 10.1021/jm00068a011; Willis MC, 2010, CHEM REV, V110, P725, DOI 10.1021/cr900096x; Ackermann L, 2010, CHEM COMMUN, V46, P4866, DOI 10.1039/c0cc00778a; Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; Arockiam P, 2009, GREEN CHEM, V11, P1871, DOI 10.1039/b913115a; Peng HM, 2010, ANGEW CHEM INT EDIT, V49, P5826, DOI 10.1002/anie.201000799; Arockiam PB, 2010, ANGEW CHEM INT EDIT, V49, P6629, DOI 10.1002/anie.201002870; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Seki M, 2011, J ORG CHEM, V76, P10198, DOI 10.1021/jo202041e; BERNHART CA, 1993, J MED CHEM, V36, P3371, DOI 10.1021/jm00074a018; Seki M, 2014, ACS CATAL, V4, P4047, DOI 10.1021/cs501328x; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; CARINI DJ, 1991, J MED CHEM, V34, P2525, DOI 10.1021/jm00112a031; Wexler RR, 1996, J MED CHEM, V39, P625, DOI 10.1021/jm9504722; Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Arockiam PB, 2012, CHEM REV, V112, P5879, DOI [10.1021/cr300153j, 10.1021/cr300153J]; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Dudnik AS, 2010, ANGEW CHEM INT EDIT, V49, P2096, DOI 10.1002/anie.200906755; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Seki M, 2014, RSC ADV, V4, P29131, DOI 10.1039/c4ra03679d; Kurup A, 2001, CHEM REV, V101, P2727, DOI 10.1021/cr000025g; Seki M, 2011, ACS CATAL, V1, P607, DOI 10.1021/cs200044t; Dunn P. J., 2010, GREEN CHEM PHARM IND; Kocienski P, 2013, SYNFACTS, V9, P0006; Seki M, 2012, YUKI GOSEI KAGAKU KY, V70, P1295; Seki M, 2014, [No title captured], Patent No. [WO 2014034868, 2014034868]; Seki M, 2015, SYNTHESIS-STUTTGART, V47, P1423, DOI 10.1055/s-0034-1380159; Seki M, 2015, SCI SYNTHES IN PRESS, V1; Seki M, 2012, SYNTHESIS-STUTTGART, V44, P3231, DOI 10.1055/s-0032-1317131; Seki M., 2014, [No title captured], Patent No. [WO 2014051008, 2014051008]; Seki M., 2010, [No title captured], Patent No. [WO 2011061996, 2011061996]; Seki M, 2014, SYNTHESIS-STUTTGART, V46, P3249, DOI 10.1055/s-0034-1378585; Sun S.-L, 2010, CHEM COMMUN, V46, P677; Yasuda N., 2011, ART PROCESS CHEM	36	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	19					2985	2990		10.1055/s-0034-1378848		6	Chemistry, Organic	Chemistry	CT1OO	WOS:000362568400017		
J	Mimura, R; Kitamori, A; Ikeda, A; Masuda, T; Nakano, K; Kotsuki, H; Ichikawa, Y				Mimura, Rika; Kitamori, Ayumi; Ikeda, Akifumi; Masuda, Toshiya; Nakano, Keiji; Kotsuki, Hiyoshizo; Ichikawa, Yoshiyasu			Biomimetic Approaches Employing the Ugi Five-Center Four-Component Reaction for Synthesis of the Right-Hand Portion of Halichonadin Q and the Central Part of Halichonadin M	SYNTHESIS-STUTTGART			English	Article						Ugi reaction; multicomponent reaction; biomimetic synthesis; terpenes; isocyanides	ALPHA-AMINO-ACIDS; MARINE SPONGE; 1ST SYNTHESIS; THEONELLIN ISOCYANIDE; SESQUITERPENOIDS; ALLYLAMINE; ALDEHYDES; ALCOHOLS	One-pot syntheses of models of the right- hand portion and the central part of the respective structures of halichonadins Q and M, using the Ugi five-center four-component reaction (U-5C-4CR), were executed. The biomimetic strategy employed in these routes demonstrates the feasibility of pathways we have proposed for the biosynthesis of marine organisms.	[Mimura, Rika; Kitamori, Ayumi; Ikeda, Akifumi; Nakano, Keiji; Kotsuki, Hiyoshizo; Ichikawa, Yoshiyasu] Kochi Univ, Fac Sci, Akebono, Kochi 7808520, Japan; [Masuda, Toshiya] Univ Tokushima, Fac Integrated Arts & Sci, Tokushima 7708502, Japan	Ichikawa, Y (reprint author), Kochi Univ, Fac Sci, Akebono, Kochi 7808520, Japan.	ichikawa@kochi-u.ac.jp					SPEZIALE AJ, 1960, J ORG CHEM, V25, P728, DOI 10.1021/jo01075a014; UGI I, 1961, CHEM BER-RECL, V94, P2802, DOI 10.1002/cber.19610941032; Saito K, 2013, SYNLETT, V24, P757, DOI 10.1055/s-0032-1318305; Aviles E, 2010, ORG LETT, V12, P5290, DOI 10.1021/ol102351z; Demharter A, 1996, ANGEW CHEM INT EDIT, V35, P173, DOI 10.1002/anie.199601731; Saito K, 2013, EUR J ORG CHEM, V2013, P7041, DOI 10.1002/ejoc.201301206; Ichikawa Y, 2011, ORG LETT, V13, P2520, DOI 10.1021/ol200308m; Tanaka N, 2012, ORG LETT, V14, P3498, DOI 10.1021/ol3014705; Ugi I, 1996, TETRAHEDRON, V52, P11657, DOI 10.1016/0040-4020(96)00647-3; GARROHELION F, 1993, J ORG CHEM, V58, P6109, DOI 10.1021/jo00074a044; Suto S, 2011, TETRAHEDRON LETT, V52, P3470, DOI 10.1016/j.tetlet.2011.04.105; Domling A, 2000, ANGEW CHEM INT EDIT, V39, P3168, DOI 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U; ICHIKAWA Y, 1992, J CHEM SOC PERK T 1, P2135, DOI 10.1039/p19920002135; ICHIKAWA Y, 1990, CHEM LETT, P1347, DOI 10.1246/cl.1990.1347; ICHIKAWA Y, 1993, J CHEM SOC PERK T 1, P2429, DOI 10.1039/p19930002429; ICHIKAWA Y, 1991, SYNLETT, P715; Tanaka N, 2015, HETEROCYCLES, V90, P173, DOI 10.3987/COM-14-S(K)2	17	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	19					3043	3048		10.1055/s-0034-1380438		6	Chemistry, Organic	Chemistry	CT1OO	WOS:000362568400025		
J	Sakai, N; Asama, S; Konakahara, T; Ogiwara, Y				Sakai, Norio; Asama, Shun; Konakahara, Takeo; Ogiwara, Yohei			Indium(III)-Catalyzed Reduction of Nitrobenzenes to Anilines: Scope and Limitations	SYNTHESIS-STUTTGART			English	Article						indium; reduction; hydrosiloxanes; nitrobenzenes; anilines	CHEMOSELECTIVE HYDROGENATION; CARBOXYLIC-ACIDS; SELECTIVE REDUCTION; CATALYTIC-SYSTEM; ORGANIC HALIDES; NITRO-COMPOUNDS; REDUCING AGENT; ARYL HALIDES; NITROARENES; NANOPARTICLES	We have demonstrated that a combination of indium(III) iodide and 1,1,3,3-tetramethyldisiloxane (TMDS) effectively catalyzes the chemoselective reduction of nitrobenzenes with a variety of functional groups (halogens, alkyl, alkoxy, hydroxy, ester, amino, amide, cyanide, thiol, and an alkene moiety), producing the corresponding aniline derivatives.	[Sakai, Norio; Asama, Shun; Konakahara, Takeo; Ogiwara, Yohei] Tokyo Univ Sci RIKADAI, Dept Pure & Appl Chem, Fac Sci & Technol, Noda, Chiba 2788510, Japan	Sakai, N (reprint author), Tokyo Univ Sci RIKADAI, Dept Pure & Appl Chem, Fac Sci & Technol, Noda, Chiba 2788510, Japan.	sakachem@rs.noda.tus.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25410120]	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 25410120) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). We deeply thank Shin-Etsu Chemical Co., Ltd. for the gift of hydrosilanes.	Wang JY, 2009, POLYM INT, V58, P1234, DOI 10.1002/pi.2648; Huang L, 2012, ADV SYNTH CATAL, V354, P2689, DOI 10.1002/adsc.201200330; Rahaim RJ, 2005, ORG LETT, V7, P5087, DOI 10.1021/ol052120n; Sakai N, 2007, J ORG CHEM, V72, P5920, DOI 10.1021/jo070814z; SHIRLEY DA, 1952, J ORG CHEM, V17, P193, DOI 10.1021/jo01136a004; Sakai N, 2008, TETRAHEDRON LETT, V49, P6873, DOI 10.1016/j.tetlet.2008.09.086; de Noronha RG, 2009, J ORG CHEM, V74, P6960, DOI 10.1021/jo9008657; Junge K, 2010, CHEM COMMUN, V46, P1769, DOI 10.1039/b924228g; LIPOWITZ J, 1973, J ORG CHEM, V38, P162, DOI 10.1021/jo00941a039; Onishi Y, 2002, J AM CHEM SOC, V124, P13690, DOI 10.1021/ja0283246; Guha NR, 2014, TETRAHEDRON LETT, V55, P2912, DOI 10.1016/j.tetlet.2014.03.047; Samant BS, 2011, CHEM COMMUN, V47, P7236, DOI 10.1039/c1cc12098k; Takasaki M, 2008, ORG LETT, V10, P1601, DOI 10.1021/ol800277a; Sakai N, 2010, CHEM COMMUN, V46, P3173, DOI 10.1039/c000383b; Li LY, 2014, CHEM-EUR J, V20, P3050, DOI 10.1002/chem.201304046; Xu HJ, 2011, J ORG CHEM, V76, P2296, DOI 10.1021/jo102506x; Wu XH, 2007, J ORG CHEM, V72, P765, DOI 10.1021/jo061703n; Sakai N, 2014, TETRAHEDRON, V70, P2027, DOI 10.1016/j.tet.2014.01.048; Park S, 2013, ORG BIOMOL CHEM, V11, P395, DOI 10.1039/c2ob27025k; Lundgren RJ, 2010, ANGEW CHEM INT EDIT, V49, P4071, DOI 10.1002/anie.201000526; Velcicky J, 2011, J AM CHEM SOC, V133, P6948, DOI 10.1021/ja201743j; Ahammed S, 2011, J ORG CHEM, V76, P7235, DOI 10.1021/jo200915h; Yasuda M, 2001, J ORG CHEM, V66, P7741, DOI 10.1021/jo0158534; Reis PM, 2009, TETRAHEDRON LETT, V50, P949, DOI 10.1016/j.tetlet.2008.12.038; Shi QX, 2007, ADV SYNTH CATAL, V349, P1877, DOI 10.1002/adsc.200700070; Kim JH, 2012, ADV SYNTH CATAL, V354, P2412, DOI 10.1002/adsc.201200356; Shil AK, 2012, TETRAHEDRON LETT, V53, P4858, DOI 10.1016/j.tetlet.2012.06.132; Kubczyk TM, 2011, GREEN CHEM, V13, P2320, DOI 10.1039/c1gc15669a; MacNair AJ, 2014, ORG BIOMOL CHEM, V12, P5082, DOI 10.1039/c4ob00945b; Tsuchimoto T, 2009, ORG LETT, V11, P2129, DOI 10.1021/ol900651u; Liang J, 2011, TETRAHEDRON, V67, P8532, DOI 10.1016/j.tet.2011.08.091; Addis D, 2011, ANGEW CHEM INT EDIT, V50, P6004, DOI 10.1002/anie.201100145; Tao CZ, 2008, TETRAHEDRON LETT, V49, P70, DOI 10.1016/j.tetlet.2007.11.012; Sharma U, 2012, GREEN CHEM, V14, P2289, DOI 10.1039/c2gc35452g; Sakai N, 2012, ORG LETT, V14, P4366, DOI 10.1021/ol302109v; Sakai N, 2011, ADV SYNTH CATAL, V353, P3397, DOI 10.1002/adsc.201100524; Zhang FW, 2011, GREEN CHEM, V13, P1238, DOI 10.1039/c0gc00854k; Baba A, 2005, CHEM REC, V5, P323, DOI 10.1002/tcr.20055; Miura K, 2007, J ORG CHEM, V72, P787, DOI 10.1021/jo061880o; Moriya T, 2013, J ORG CHEM, V78, P10642, DOI 10.1021/jo401529j; Li ZL, 2014, CHEMCATCHEM, V6, P1333, DOI 10.1002/cctc.201301037; Larock R. C., 1999, COMPREHENSIVE ORGANI, P821; Miura K, 2004, SYNLETT, P1985, DOI 10.1055/s-2004-830862; Pehlivan L, 2012, EUR J ORG CHEM, P4689, DOI 10.1002/ejoc.201200727; Sakai N, 2015, EUR J ORG CHEM, P1591, DOI 10.1002/ejoc.201403539; Vasilikogiannaki E, 2013, ADV SYNTH CATAL, V355, P907, DOI 10.1002/adsc.201200983	46	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	20					3179	3185		10.1055/s-0034-1378850		7	Chemistry, Organic	Chemistry	CT1OP	WOS:000362568500009		
J	Umei, K; Nishigaya, Y; Kamiya, M; Kohno, Y; Seto, S				Umei, Kentaro; Nishigaya, Yosuke; Kamiya, Megumi; Kohno, Yasushi; Seto, Shigeki			Synthesis of 2-Arylpyrazolo[1,5-a]pyridines by Suzuki-Miyaura Cross-Coupling Reaction	SYNTHESIS-STUTTGART			English	Article						Suzuki-Miyaura cross-coupling reaction; 2-arylpyrazolo[1,5-a]pyridine; triflate; regioselectivity; medicinal chemistry	RECEPTOR; POTENT; CYCLIZATION; INHIBITORS; YLIDES	Convenient access to a variety of 2-arylated pyrazolo[1,5-a]pyridine via pyrazolo[1,5-a]pyridine-2-yl triflate using the Suzuki-Miyaura cross-coupling reaction is described. Fifteen 2-arylpyrazolo[1,5-a]pyridine derivatives were synthesized in 52-95% yields.	[Umei, Kentaro; Nishigaya, Yosuke; Kamiya, Megumi; Kohno, Yasushi; Seto, Shigeki] Kyorin Pharmaceut Co Ltd, Discovery Res Headquarters, Watarase Res Ctr, Nogi, Tochigi 3290114, Japan	Seto, S (reprint author), Kyorin Pharmaceut Co Ltd, Discovery Res Headquarters, Watarase Res Ctr, 1848 Nogi, Nogi, Tochigi 3290114, Japan.	shigeki.seto@mb.kyorin-pharm.co.jp					MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Gudmundsson KS, 2008, BIOORG MED CHEM LETT, V18, P1157, DOI 10.1016/j.bmcl.2007.11.120; Kettle JG, 2012, J MED CHEM, V55, P1261, DOI 10.1021/jm201394e; Stevens KL, 2005, ORG LETT, V7, P4753, DOI 10.1021/ol0519745; Ding ST, 2013, CHEM COMMUN, V49, P4250, DOI 10.1039/c2cc33706a; Takahashi Y, 2012, J MED CHEM, V55, P5255, DOI 10.1021/jm300259r; Hoashi Y, 2013, TETRAHEDRON LETT, V54, P2199, DOI 10.1016/j.tetlet.2013.02.078; Mousseau JJ, 2010, ORG LETT, V12, P516, DOI 10.1021/ol902710f; OCHI H, 1976, B CHEM SOC JPN, V49, P1980, DOI 10.1246/bcsj.49.1980; SATAKE N, 1992, PHARMACOLOGY, V44, P206, DOI 10.1159/000138920; Mousseau JJ, 2011, J ORG CHEM, V76, P8243, DOI 10.1021/jo201303x; Kato J, 2014, TETRAHEDRON, V70, P2766, DOI 10.1016/j.tet.2014.02.081; Elsner J, 2006, BIOORGAN MED CHEM, V14, P1949, DOI 10.1016/j.bmc.2005.10.042; Johns BA, 2003, TETRAHEDRON, V59, P9001, DOI 10.1016/j.tet.2003.02.003; ANDERSON PL, 1981, J HETEROCYCLIC CHEM, V18, P1149; Rudyanto M, 2008, ORG LETT, V10, P1921, DOI 10.1021/ol8004112; Jones P, 2009, J MED CHEM, V52, P7170, DOI 10.1021/jm901188v; Nishigaya Y, 2014, TETRAHEDRON LETT, V55, P5963, DOI 10.1016/j.tetlet.2014.08.087; Arcadi A, 1998, SYNLETT, P446; Bravi G., 2007, [No title captured], Patent No. [WO 2007039146, 2007039146]; MIKI Y, 1985, J CHEM SOC PERK T 1, P379, DOI 10.1039/p19850000379; Seto S., 2012, [No title captured], Patent No. [WO 2012102297, 2012102297]; TSUCHIYA T, 1980, J CHEM SOC CHEM COMM, P1109, DOI 10.1039/c39800001109; Wang XJ, 2008, BIOMED RES-TOKYO, V29, P105, DOI 10.2220/biomedres.29.105	24	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	20					3221	3230		10.1055/s-0034-1381025		10	Chemistry, Organic	Chemistry	CT1OP	WOS:000362568500015		
J	Kitamura, T; Muta, K; Oyamada, J				Kitamura, Tsugio; Muta, Kensuke; Oyamada, Juzo			A Convenient Synthesis of 2-Fluoro- and 2-Chloromalonic Esters Mediated by Hypervalent Iodine	SYNTHESIS-STUTTGART			English	Article						2-fluoromalonic esters; 2-chloromalonic esters; hydrogen fluoride; hydrochloric acid; iodosylbenzene	BETA-DICARBONYL COMPOUNDS; ELEMENTAL FLUORINE; IODOTOLUENE DIFLUORIDE; ALPHA-FLUORINATION; XENON DIFLUORIDE; EFFICIENT METHOD; FACILE SYNTHESIS; DERIVATIVES; HF; IODOSYLBENZENE	Direct fluorination of malonic esters with a reagent system of iodosylbenzene and Et3N center dot 5HF gave the corresponding 2-fluoromalonic esters in good to high yields. Direct chlorination using iodosylbenzene and hydrochloric acid also provided the 2-chloromalonates in high yields.	[Kitamura, Tsugio; Muta, Kensuke; Oyamada, Juzo] Saga Univ, Grad Sch Sci & Engn, Dept Chem Appl Chem, Saga 8408502, Japan	Kitamura, T (reprint author), Saga Univ, Grad Sch Sci & Engn, Dept Chem Appl Chem, Hojo Machi, Saga 8408502, Japan.	kitamura@cc.saga-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25410048]	This work was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25410048).	Kitamura T, 2012, SYNTHESIS-STUTTGART, V44, P1159, DOI 10.1055/s-0031-1290578; Chambers RD, 1998, J FLUORINE CHEM, V92, P45, DOI 10.1016/S0022-1139(98)00254-1; UMEMOTO T, 1990, J AM CHEM SOC, V112, P8563, DOI 10.1021/ja00179a047; Kitamura T, 2014, J ORG CHEM, V79, P5842, DOI 10.1021/jo500691b; PURRINGTON ST, 1990, J ORG CHEM, V55, P3423, DOI 10.1021/jo00297a090; DUBOIS J, 1991, TETRAHEDRON, V47, P1001, DOI 10.1016/S0040-4020(01)80939-X; Geary GC, 2013, CHEM COMMUN, V49, P9263, DOI 10.1039/c3cc44792h; Harsanyi A, 2014, ORG PROCESS RES DEV, V18, P981, DOI 10.1021/op500141c; SMALC A, 1992, INORG SYN, V29, P1; WEEKS JL, 1962, J AM CHEM SOC, V84, P4612, DOI 10.1021/ja00882a063; Chambers RD, 1996, J FLUORINE CHEM, V78, P165, DOI 10.1016/0022-1139(96)03422-7; Kitamura T, 2011, ORG LETT, V13, P2392, DOI 10.1021/ol200632d; Suzuki S, 2014, CHEM SCI, V5, P2754, DOI 10.1039/c3sc53107d; Duan XY, 2015, SYNTHESIS-STUTTGART, V47, P777, DOI 10.1055/s-0034-1379973; Bergmann F. D., 1961, CHEM IND-LONDON, P591; Braun M., 2002, PCT Int. Appl, Patent No. [WO 2002060838, 2002060838, W02002060838 A1]; Carey F.A., 2000, ADV ORGANIC CHEM; Chambers R. D., 1997, PCT Int. Appl, Patent No. [WO 9700848 A1 19970109, 9700848]; Chambers R. D., 1999, PCT Int. Appl, Patent No. [WO 9903802 A1 19990128, 9903802]; Guenther A., 2005, PCT Int. Appl, Patent No. [WO 2005019154, 2005019154, WO2005019154 A1]; Hara S, 1996, CHEM COMMUN, P1899, DOI 10.1039/cc9960001899; Hoppe R., 1962, ANGEW CHEM INT EDIT, V1, P599, DOI 10.1002/anie.196205992; ISHIKAWA N, 1981, CHEM LETT, P107, DOI 10.1246/cl.1981.107; Kitamura T, 2013, SYNTHESIS-STUTTGART, V45, P3125, DOI 10.1055/s-0033-1339672; LERMAN O, 1983, J ORG CHEM, V48, P724, DOI 10.1021/jo00153a021; Mueh T., 2002, PCT Int. Appl, Patent No. [WO 2002016304, 2002016304]; PATRICK TB, 1988, J FLUORINE CHEM, V39, P415, DOI 10.1016/S0022-1139(00)81611-5; PURRINGTON ST, 1983, J ORG CHEM, V48, P761, DOI 10.1021/jo00153a037; Umemoto T., 1990, ORG SYNTH, V69, P129; UMEMOTO T, 1986, TETRAHEDRON LETT, V27, P3271, DOI 10.1016/S0040-4039(00)84772-3; Yoshida M, 2003, ARKIVOC, P36; Zheng ZB, 2014, TETRAHEDRON, V70, P9814, DOI 10.1016/j.tet.2014.11.004	32	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	20					3241	3245		10.1055/s-0034-1378747		5	Chemistry, Organic	Chemistry	CT1OP	WOS:000362568500017		
J	Kanai, M; Shimizu, Y; Morita, Y; Yamamoto, T; Nagai, H				Kanai, Motomu; Shimizu, Yohei; Morita, Yuya; Yamamoto, Tomohiro; Nagai, Hideoki			Chemoselective Boron-Catalyzed Nucleophilic Activation of Carboxylic Acids for Mannich-Type Reactions	SYNTHESIS-STUTTGART			English	Editorial Material									[Kanai, Motomu] Osaka Univ, ISIR, Suita, Osaka 565, Japan; [Kanai, Motomu] Univ Wisconsin, Prof Laura L Kiesslings Lab, Madison, WI 53706 USA; [Kanai, Motomu] Univ Tokyo, Grad Sch Pharmaceut Sci, Prof Masakatsu Shibasakis Lab, Tokyo 1138654, Japan; [Kanai, Motomu] JST ERATO Kanai Life Sci Catalysis Project, Tokyo, Japan; [Shimizu, Yohei; Morita, Yuya] Prof Kanais Lab, Tokyo, Japan; [Nagai, Hideoki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1138654, Japan	Kanai, M (reprint author), Osaka Univ, ISIR, Suita, Osaka 565, Japan.							0	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	19					A140	A143				4	Chemistry, Organic	Chemistry	CT1OO	WOS:000362568400002		
J	Patil, NT				Patil, Nitin T.			Young Career Focus: Dr. Nitin T. Patil (CSIR - National Chemical Laboratory, India)	SYNTHESIS-STUTTGART			English	Editorial Material							REACTIVITY; SCAFFOLDS; CASCADE		[Patil, Nitin T.] CSIR, Natl Chem Lab, Pune, Maharashtra, India; [Patil, Nitin T.] Univ Gottingen, Gottingen, Germany; [Patil, Nitin T.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Patil, Nitin T.] Biopolis, KC Nicolaous Chem Synth Lab, Singapore, Singapore; [Patil, Nitin T.] Scripps Res Inst, La Jolla, CA USA; [Patil, Nitin T.] IICT, Hyderabad, Andhra Pradesh, India; [Patil, Nitin T.] CSIR NCL, Pune, Maharashtra, India; [Patil, Nitin T.] Indian Acad Sci, Bangalore, Karnataka, India	Patil, NT (reprint author), CSIR, Natl Chem Lab, Pune, Maharashtra, India.						Shinde VS, 2015, CHEM-EUR J, V21, P975, DOI 10.1002/chem.201405061; Patil NT, 2012, CHEM COMMUN, V48, P3094, DOI 10.1039/c2cc17450b; Patil NT, 2013, ANGEW CHEM INT EDIT, V52, P2251, DOI 10.1002/anie.201208738; Patil NT, 2013, CHEM COMMUN, V49, P570, DOI 10.1039/c2cc37623g; Patil NT, 2012, ORG BIOMOL CHEM, V10, P211, DOI 10.1039/c1ob06432k; Bagle PN, 2015, CHEM-EUR J, V21, P3580, DOI 10.1002/chem.201406045	6	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	OCT	2015	47	19					A146	A148				3	Chemistry, Organic	Chemistry	CT1OO	WOS:000362568400004		
J	Tajima, H				Tajima, Hiroyuki			Special issue: 5th Topical Meeting on Spins in Organic Semiconductors Preface	SYNTHETIC METALS			English	Editorial Material									Univ Hyogo, Grad Sch Mat Sci, Kamigori Cho, Hyogo 6781297, Japan	Tajima, H (reprint author), Univ Hyogo, Grad Sch Mat Sci, 3-2-1 Kohto, Kamigori Cho, Hyogo 6781297, Japan.	tajima@sci.u-hyogo.ac.jp						0	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	OCT	2015	208				SI		1	1		10.1016/j.synthmet.2015.08.028		1	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CT2GK	WOS:000362619800001		
J	Fujikura, K; Akutsu, H; Yamada, J; Nakatsuji, S; Satoh, M				Fujikura, Kouki; Akutsu, Hiroki; Yamada, Jun-ichi; Nakatsuji, Shin'ichi; Satoh, Masaharu			Structures and properties of diradical compounds containing disulfide and nitroxide groups	SYNTHETIC METALS			English	Article						Nitroxide; Disulfide; Redox property; Battery property; Magnetic property	FERROCENE DERIVATIVES; BATTERIES; STORAGE	In order to develop a kind of dual redox system with rechargeable battery property having potential high charge density, eight disulfide compounds carrying nitroxide radical have been prepared. Reflecting their multi-redox nature observed in their cyclic voltammetry data, they exhibit multi-step charge-discharge profiles with fairly large capacities over 200 Ah kg(-1) for the first discharging processes. The Curie-Weiss type behaviors or 1D Heisenberg type profiles found for the respective radical compounds could be understandable by investigating the clarified crystal structures of four compounds (3,4, 7, and 8) among them. (C) 2015 Elsevier B.V. All rights reserved.	[Fujikura, Kouki; Akutsu, Hiroki; Yamada, Jun-ichi; Nakatsuji, Shin'ichi] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan; [Satoh, Masaharu] Murata Mfg Co, Shiga 5202393, Japan	Nakatsuji, S (reprint author), Univ Hyogo, Grad Sch Mat Sci, 3-2-1 Kouto, Kamigori, Hyogo 6781297, Japan.	nakatuji@sci.u-hyogo.ac.jp					Janoschka T, 2012, NACHR CHEM, V60, P728; VISCO SJ, 1989, J ELECTROCHEM SOC, V136, P661, DOI 10.1149/1.2096706; Fujiwara K, 2011, TETRAHEDRON LETT, V52, P6655, DOI 10.1016/j.tetlet.2011.10.059; Nakatsuji S, 2013, NEW J CHEM, V37, P2468, DOI 10.1039/c3nj00343d; Nakahara K, 2002, CHEM PHYS LETT, V359, P351, DOI 10.1016/S0009-2614(02)00705-4; Poizot P, 2011, ENERG ENVIRON SCI, V4, P2003, DOI 10.1039/c0ee00731e; Nakahara K, 2011, CHEM LETT, V40, P222, DOI 10.1246/cl.2011.222; Shibata Y, 2010, CHEM LETT, V39, P671, DOI 10.1246/cl.2010.671; Nishide H, 2008, SCIENCE, V319, P737, DOI 10.1126/science.1151831; Akutsu H, 2011, CHEM MATER, V23, P762, DOI 10.1021/cm100984z; Nakatsuji S, 2009, J ORG CHEM, V74, P9345, DOI 10.1021/jo902007m; Armand Cf. M., 2008, NATURE, V451, P652; Chen C.H., 2008, CHEMSUSCHEM, V1, P348; Nishide H., 2005, Electrochemical Society Interface, V14	14	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	OCT	2015	208				SI		17	20		10.1016/j.synthmet.2015.03.009		4	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CT2GK	WOS:000362619800004		
J	Sakai, T; Kasahara, T; Hijii, K; Ohta, H; Nakano, H				Sakai, Toru; Kasahara, Toshihiro; Hijii, Keigo; Ohta, Hitoshi; Nakano, Hiroki			Spin nanotubes with the ring exchange interactions	SYNTHETIC METALS			English	Article						Quantum spin system; Spin nanotube; Frustration; Spin gap		The S = 1/2 three-leg spin nanotube with the ring exchange interaction at each plaquette is investigated using the numerical diagonalization of finite-size systems. The previous work suggested that the system without the ring exchange interaction has a spin excitation gap between the singlet ground state and the triplet excitation, because a spontaneous dimerization occurs in the ground state. The present study indicates that as the ring exchange increases, a quantum phase transition occurs at some critical value to another spin gap phase where the pattern of the dimerization is different from the initial one. The spin gap is revealed to vanish at the phase boundary. The ground state phase diagram is also presented. (C) 2015 Elsevier B.V. All rights reserved.	[Sakai, Toru] Japan Atom Energy Agcy, Sayo, Hyogo 6795148, Japan; [Sakai, Toru; Kasahara, Toshihiro; Nakano, Hiroki] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan; [Hijii, Keigo; Ohta, Hitoshi] Kobe Univ, Mol Photosience Res Ctr, Kobe, Hyogo 6578501, Japan	Sakai, T (reprint author), Japan Atom Energy Agcy, SPring 8, Sayo, Hyogo 6795148, Japan.	sakai@spring8.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [23340109, 24540348, 26400387]; Strategic Programs for Innovative Research, MEXT; Computational Materials Science Initiative, Japan	This work has been partly supported by Grants-in-Aids for Scientific Research (B) (No. 23340109) and (C) (Nos. 24540348 and 26400387) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). We further thank the Supercomputer Center, Institute for Solid State Physics, University of Tokyo; the Cyberscience Center, Tohoku University; and the Computer Room, Yukawa Institute for Theoretical Physics, Kyoto University; the Department of Simulation Science, National Institute for Fusion Science; Center for Computational Materials Science, Institute for Materials Research, Tohoku University; Supercomputing Division, Information Technology Center, The University of Tokyo for computational facilities. This work was partly supported by the Strategic Programs for Innovative Research, MEXT, and the Computational Materials Science Initiative, Japan. The authors would like to express their sincere thanks to the staff members of the Center for Computational Materials Science of the Institute for Materials Research, Tohoku University for their continuous support of the SR16000 supercomputing facilities.	Sato M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014411; Sakai T, 2014, J PHYS CONF SER, V568, DOI 10.1088/1742-6596/568/4/042024; Okunishi K, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054416; Kawano K, 1997, J PHYS SOC JPN, V66, P4001, DOI 10.1143/JPSJ.66.4001; Cabra DC, 1998, PHYS REV B, V58, P6241, DOI 10.1103/PhysRevB.58.6241; Sakai T, 2005, PHYSICA E, V29, P633, DOI 10.1016/j.physe.2005.06.044; Sakai T, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/40/403201; Schnack J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.174420; Hijii K, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134403; Nishimoto S, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.054421; Nakano H, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.053704; Fouet JB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014409; Nakano H, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.043715; Nakano H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.014003; Nakano H, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.104710; Okunishi K., 2005, PROG THEOR PHYS, P297, DOI 10.1143/PTPS.159.297; RICE TM, 1993, EUROPHYS LETT, V23, P445, DOI 10.1209/0295-5075/23/6/011; Sakai T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.184415; Schulz H.J., 1996, CORRELATED FERMIONS	19	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	OCT	2015	208				SI		26	28		10.1016/j.synthmet.2015.04.021		3	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CT2GK	WOS:000362619800006		
J	Ishikawa, R; Kawata, S				Ishikawa, Ryuta; Kawata, Satoshi			Synthesis and magnetic properties of a hybrid molecular salt [Fe(qsal)(2)][Fe(CA)(qsal)Cl]center dot MeNO2	SYNTHETIC METALS			English	Article						Iron(III); Crystal structures; Magnetic properties; Chloranilate anions	SPIN-CROSSOVER COMPOUNDS; CHLORANILIC ACID; INTERMOLECULAR INTERACTIONS; ELECTRICAL-CONDUCTIVITY; PROTON CONDUCTION; COMPLEXES; CRYSTAL; METAL; FERROMAGNETISM; COEXISTENCE	A new hybrid molecular salt [Fe-III(qsal)(2)][Fe-III(CA)(qsal)Cl]center dot MeNO2 (1), where qsal(-)=N-(8-quinolyl)salicylaldiminate and CA(2-) = chloranilate was synthesized and structurally characterized by single-crystal X-ray crystallography. Each cationic [Fe-III(qsal)(2)](+) and anionic [Fe-III(CA)(qsal)Cl](-) unit is self assembled through intermolecular pi-pi stacking interactions between qsal(-) ligands, which stabilize the supramolecular networks in the crystal lattice. Magnetic measurements for 1 revealed that both Fe-III ions were in HS spin states with a small contribution from ZFS over the whole temperature region. (C) 2015 Elsevier B.V. All rights reserved.	[Ishikawa, Ryuta; Kawata, Satoshi] Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, Fukuoka 8140180, Japan	Ishikawa, R (reprint author), Fukuoka Univ, Fac Sci, Dept Chem, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	ryutaishikawa@fukuoka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26888017]	This work was partly supported by the Grant-in-Aid for Young Scientist (Start-up program) (Grant No. 26888017) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	ANDERSEN EK, 1967, ACTA CRYSTALLOGR, V22, P191, DOI 10.1107/S0365110X67000337; Okawa H, 2009, J AM CHEM SOC, V131, P13516, DOI 10.1021/ja905368d; Jasimuddin S, 2004, INORG CHIM ACTA, V357, P2015, DOI 10.1016/j.ica.2003.11.040; Gupta P, 2005, INORG CHEM, V44, P2081, DOI 10.1021/ic049419s; Takahashi K, 2006, INORG CHEM, V45, P5739, DOI 10.1021/ic060852l; Bruijnincx PCA, 2008, CHEM-EUR J, V14, P5567, DOI 10.1002/chem.200701878; Ishikawa R, 2007, CHEM LETT, V36, P1116, DOI 10.1246/cl.2007.1116; Coronado E, 2004, CHEM REV, V104, P5419, DOI 10.1021/cr030641n; Kawahara M, 2004, INORG CHEM, V43, P92, DOI 10.1021/ic035044y; Dias JC, 2007, INORG CHIM ACTA, V360, P3843, DOI 10.1016/j.ica.2007.02.004; Takahashi K, 2008, J AM CHEM SOC, V130, P6688, DOI 10.1021/ja801585r; Takahashi K, 2005, CHEM LETT, V34, P1240, DOI 10.1246/cl.2005.1240; Halcrow MA, 2011, CHEM SOC REV, V40, P4119, DOI 10.1039/c1cs15046d; Faulmann C, 2007, INORG CHIM ACTA, V360, P3870, DOI 10.1016/j.ica.2007.03.022; Hayami S, 2009, CHEM-EUR J, V15, P3497, DOI 10.1002/chem.200802395; Clemente-Leon M, 2011, CHEM SOC REV, V40, P473, DOI 10.1039/c0cs00111b; Train C, 2009, J AM CHEM SOC, V131, P16838, DOI 10.1021/ja9061568; Coronado E, 2000, NATURE, V408, P447, DOI 10.1038/35044035; Li XM, 2009, J COORD CHEM, V62, P1544, DOI 10.1080/00958970802669222; Pardo E, 2011, J AM CHEM SOC, V133, P15328, DOI 10.1021/ja206917z; Train C, 2008, NAT MATER, V7, P729, DOI 10.1038/nmat2256; Takahashi K, 2009, POLYHEDRON, V28, P1776, DOI 10.1016/j.poly.2008.11.047; Takahashi K, 2012, HYPERFINE INTERACT, V206, P1, DOI 10.1007/s10751-011-0497-z; Nagayoshi K, 2003, J AM CHEM SOC, V125, P221, DOI 10.1021/ja027895v; Galan-Mascaros JR, 2010, J AM CHEM SOC, V132, P9271, DOI 10.1021/ja103147k; Train C, 2011, CHEM SOC REV, V40, P3297, DOI 10.1039/c1cs15012j; Hayami S, 2001, J AM CHEM SOC, V123, P11644, DOI 10.1021/ja0017920; Neves AIS, 2009, CRYSTENGCOMM, V11, P2160, DOI 10.1039/b906620a; BROZE M, 1967, J PHYS CHEM-US, V71, P3690, DOI 10.1021/j100870a056; Kitagawa S, 2002, COORDIN CHEM REV, V224, P11, DOI 10.1016/S0010-8545(01)00369-1; Min KS, 2006, J AM CHEM SOC, V128, P40, DOI 10.1021/ja0566984; Nihei M, 2007, COORDIN CHEM REV, V251, P2606, DOI 10.1016/j.ccr.2007.08.007; Ohkoshi S, 2010, J AM CHEM SOC, V132, P6620, DOI 10.1021/ja100385f; Sadakiyo M, 2012, J AM CHEM SOC, V134, P5472, DOI 10.1021/ja300122r; Coronado E, 2005, J MATER CHEM, V15, P66, DOI 10.1039/b415940n; Dias JC, 2009, INORG CHIM ACTA, V362, P2076, DOI 10.1016/j.ica.2008.09.009; Ohkoshi S, 2007, ANGEW CHEM INT EDIT, V46, P3238, DOI 10.1002/anie.200604452; Gamez P, 2009, DALTON T, P7845, DOI 10.1039/b908208e; Gutlich P., 2004, TOP CURR CHEM, V233-235; Kojima Y, 2010, ACTA CRYSTALLOGR E, V66, pM204, DOI 10.1107/S1600536810002783; Peters A, 2009, EUR J INORG CHEM, P3791, DOI 10.1002/ejic.200900399; Reinoso S., 1927, ACTA CRYSTALLOGR, VE61, pm1925; Takahashi K, 2010, PHYSICA B, V405, pS65, DOI 10.1016/j.physb.2009.10.029; Weber B, 2009, EUR J INORG CHEM, P465, DOI 10.1002/ejic.200800891	44	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	OCT	2015	208				SI		35	38		10.1016/j.synthmet.2015.05.009		4	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CT2GK	WOS:000362619800008		
J	Yoshida, R; Kodama, T; Kikuchi, K; Aoyagi, S; Fujita, W				Yoshida, Rei; Kodama, Takeshi; Kikuchi, Koichi; Aoyagi, Shinobu; Fujita, Wataru			Crystal structure and magnetic properties of the charge-transfer complex (BDTA)(2)(H3O)(2)[Fe(II)(CN)(6)]	SYNTHETIC METALS			English	Article						Cyclic thiazyl radicals; Crystal structure; Magnetic properties; Charge-transfer interactions	THIAZYL RADICALS; PHASE-TRANSITION; TEMPERATURE; PRESSURE; BISTABILITY; EVAPORATION; CONDUCTOR; SOLVENT; DRIVEN; UNIQUE	The crystal structure and magnetic properties of (BDTA)(2)(H3O)(2)[Fe(II)(CN)(6)] (I), a charge-transfer complex, were investigated. The charge transfer interaction works between BDTA(+) and Fe(CN)(6)(4-) in 1 from UV, IR spectra, and single crystal X-ray analyses, although the degree of charge transfer is quite small. Complex 1 forms dark green crystals and is composed of closed-shell ions BDTA(+), H3O+, and Fe (CN)(6)(4-), as deduced from X-ray analysis and magnetic measurements. Although complex 1 is diamagnetic, a paramagnetic material is irreversibly formed upon heating beyond 360K. The paramagnetic material thus formed remains in the paramagnetic state even upon cooling to 2K. DSC, TGA, and powder X-ray diffraction measurements revealed that the heating of 1 results in the evaporation of two water molecules per formula unit, leading to large structural changes and decomposition of 1. The diamagnetic-to-paramagnetic change in 1 may result from the formation of high-spin iron species due to changes in the coordination environment. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshida, Rei; Kodama, Takeshi; Kikuchi, Koichi] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Aoyagi, Shinobu; Fujita, Wataru] Nagoya City Univ, Dept Informat & Biol Sci, Mizuho Ku, Nagoya, Aichi 4678501, Japan	Fujita, W (reprint author), Nagoya City Univ, Dept Informat & Biol Sci, Mizuho Ku, 1 Yamanohata,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	fujitaw@nsc.nagoya-cu.ac.jp			SEI Group SCI Foundation	The authors thank the Institute for Molecular Science for magnetic measurements, and RI research center of Tokyo Metropolitan University for DSC and TGA measurements. The synchrotron radiation experiments were performed at SPring-8 with approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2014A0100 and 2014B0100). This study was partially supported by the SEI Group SCI Foundation.	AWERE EG, 1990, INORG CHEM, V29, P4821, DOI 10.1021/ic00348a044; Fujita W, 2006, J AM CHEM SOC, V128, P6016, DOI 10.1021/ja060979+; Fujita W, 2004, CHEM PHYS LETT, V388, P186, DOI [10.1016/j.cplett.2004.02.084, 10.1016/j.cplett.2007.02.084]; Okamoto K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075328; Wong JWL, 2014, J AM CHEM SOC, V136, P1070, DOI 10.1021/ja411057x; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Awaga K, 2006, B CHEM SOC JPN, V79, P25, DOI 10.1246/bcsj.79.25; Umezono Y, 2006, J AM CHEM SOC, V128, P1084, DOI 10.1021/ja057207i; Hase M, 1996, J PHYS SOC JPN, V65, P1392, DOI 10.1143/JPSJ.65.1392; Fujita W, 2002, CHEM PHYS LETT, V362, P97, DOI 10.1016/S0009-2614(02)01056-4; Matsuzaki H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017403; Fujita W, 1999, SCIENCE, V286, P261, DOI 10.1126/science.286.5438.261; Fujita W, 2011, CRYST GROWTH DES, V11, P575, DOI 10.1021/cg101481c; Mito M, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.124705; Fujita W, 2015, DALTON T, V44, P903, DOI 10.1039/c4dt03208j; Lekin K, 2014, J AM CHEM SOC, V136, P8050, DOI 10.1021/ja502753t; Fujita W, 2008, ANGEW CHEM INT EDIT, V47, P9480, DOI 10.1002/anie.200803249; Fujita W, 2002, CHEM PHYS LETT, V357, P385, DOI 10.1016/S0009-2614(02)00535-3; Suzuki K, 2010, CHEM LETT, V39, P1096, DOI 10.1246/cl.2010.1096; FANNING JC, 1972, J INORG NUCL CHEM, V34, P139, DOI 10.1016/0022-1902(72)80371-3; Fujita W, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064434; Lekin K, 2010, J AM CHEM SOC, V132, P16212, DOI 10.1021/ja106768z; Mito M, 2009, J AM CHEM SOC, V131, P16012, DOI 10.1021/ja908238w; Awaga K, 2014, B CHEM SOC JPN, V87, P234, DOI 10.1246/bcsj.20130248; Brusso JL, 2004, J AM CHEM SOC, V126, P14692, DOI 10.1021/ja044979q; Leitch AA, 2011, J AM CHEM SOC, V133, P6051, DOI 10.1021/ja200391j; Banister AJ, 1996, ANGEW CHEM INT EDIT, V35, P2533, DOI 10.1002/anie.199625331; Robertson CM, 2008, J AM CHEM SOC, V130, P14791, DOI [10.1021/ja8054436, 10.1021/ja8654436]; Fujita W, 2009, CHEM-ASIAN J, V4, P400, DOI 10.1002/asia.200800362; Awaga K, 2008, INORG CHIM ACTA, V361, P3761, DOI 10.1016/j.ica.2008.03.065; Shuku Y, 2013, INORG CHEM, V52, P9921, DOI 10.1021/ic401078z; Thomson RI, 2012, CHEM-EUR J, V18, P8629, DOI 10.1002/chem.201200760; SWANSON BI, 1974, INORG CHEM, V13, P1685, DOI 10.1021/ic50137a028; Carlin R., 1986, MAGNETOCHEMISTRY; Fujita W., 2014, EUR J INORG CHEM, P93; Gutlich P., 2004, SPIN CROSSOVER TRANS; Huheey J.E., 1993, INORGANIC CHEM PRINC; Jeffrey G. A., 1997, INTRO HYDROGEN BONDI; Leitch AA, 2007, CHEM COMMUN, P3368, DOI 10.1039/b708756j; Sheldrick G. M., 1997, PROGRAM REFINEMENT C; Sorai Michio, 2013, Chem Rev, V113, pPR41, DOI 10.1021/cr300156s; Staniland SS, 2005, CHEM COMMUN, P3204, DOI 10.1039/b502783g; Winter SM, 2009, CHEM COMMUN, P7306, DOI 10.1039/b917213k; WOLMERSHAUSER G, 1984, J CHEM SOC CHEM COMM, P573, DOI 10.1039/c39840000573	44	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	OCT	2015	208				SI		43	48		10.1016/j.synthmet.2015.05.011		6	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	CT2GK	WOS:000362619800010		
J	Noyes, AM; Ramu, B; Parker, MW; Underhill, D; Gluck, JA				Noyes, Adam M.; Ramu, Bhavadharini; Parker, Matthew W.; Underhill, David; Gluck, Jason A.			Extracorporeal Membrane Oxygenation as a Bridge to Surgery for Infective Endocarditis Complicated by Aorto-Atrial Fistula and Cardiopulmonary Collapse	TEXAS HEART INSTITUTE JOURNAL			English	Article						Aortic valve insufficiency/etiology/surgery; debridement; endocarditis; bacterial/complications/surgery; heart valve diseases/complications; extracorporeal membrane oxygenation/trends; infective endocarditis; shock, cardiogenic/therapy; shock, septic; substance abuse, intravenous/complications	MORTALITY; PATIENT	The timing of surgery for active infective endocarditis is challenging when patients exhibit mechanical dysfunction and hemodynamic compromise. Extracorporeal membrane oxygenation has been described in treating sepsis but not, insofar as we know, in treating the acute mechanical sequelae that arise from infective endocarditis. We report perhaps the first case that shows the usefulness of extracorporeal membrane oxygenation as a bridge to definitive treatment in a 35-year-old man who had infective endocarditis followed by aorto-atrial fistula and cardiopulmonary collapse.	[Noyes, Adam M.; Gluck, Jason A.] Univ Connecticut, Sch Med, Dept Med, Farmington, CT 06032 USA; [Ramu, Bhavadharini; Parker, Matthew W.; Gluck, Jason A.] Hartford Hosp, Div Cardiol, Ishikari, Hokkaido 06102, Japan; [Underhill, David] Hartford Hosp, Dept Cardiac Surg, Ishikari, Hokkaido 06102, Japan	Noyes, AM (reprint author), Brown Univ, Dept Cardiol, Warren Alpert Med Sch, 593 Eddy St,Main Bldg Rm 209, Providence, RI 02903 USA.	adam_noyes@brown.edu					Olaison L, 2002, INFECT DIS CLIN N AM, V16, P453, DOI 10.1016/S0891-5520(01)00006-X; Manne MB, 2012, ANN THORAC SURG, V93, P489, DOI 10.1016/j.athoracsur.2011.10.063; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Bruegger D, 2009, J HEART VALVE DIS, V18, P418; Thuny F, 2011, EUR HEART J, V32, P2027, DOI 10.1093/eurheartj/ehp089; Jault F, 1997, ANN THORAC SURG, V63, P1737, DOI 10.1016/S0003-4975(97)00117-3; Schuerer DJE, 2008, CHEST, V134, P179, DOI 10.1378/chest.07-2512; Huang HH, 2012, TRANSPL P, V44, P1171, DOI 10.1016/j.transproceed.2012.01.095; Anguera I, 2005, EUR HEART J, V26, P288, DOI 10.1093/eurheartj/ehi034; Maclaren Graeme, 2007, Crit Care Resusc, V9, P76	10	0	0	TEXAS HEART INST	HOUSTON	PO BOX 20345, HOUSTON, TX 77225-0345 USA	0730-2347	1526-6702		TEX HEART I J	Tex. Heart Inst. J.	OCT	2015	42	5					471	473				3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS9SD	WOS:000362430900015		
J	Imoto, Y				Imoto, Yutaka			Repair of Bland-White-Garland Syndrome via a Modified Technique	TEXAS HEART INSTITUTE JOURNAL			English	Letter									Kagoshima Univ, Dept Cardiovasc & Gastrointestinal Surg, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Imoto, Y (reprint author), Kagoshima Univ, Dept Cardiovasc & Gastrointestinal Surg, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.						SESE A, 1992, ANN THORAC SURG, V53, P527; Manoly I, 2014, TEX HEART I J, V41, P48, DOI 10.14503/THIJ-12-3112	2	0	0	TEXAS HEART INST	HOUSTON	PO BOX 20345, HOUSTON, TX 77225-0345 USA	0730-2347	1526-6702		TEX HEART I J	Tex. Heart Inst. J.	OCT	2015	42	5					507	507				1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CS9SD	WOS:000362430900025		
J	Yoshihara, A; Noh, JY; Watanabe, N; Mukasa, K; Ohye, H; Suzuki, M; Matsumoto, M; Kunii, Y; Suzuki, N; Kameda, T; Iwaku, K; Kobayashi, S; Sugino, K; Ito, K				Yoshihara, Ai; Noh, Jaeduk Yoshimura; Watanabe, Natsuko; Mukasa, Koji; Ohye, Hidemi; Suzuki, Miho; Matsumoto, Masako; Kunii, Yo; Suzuki, Nami; Kameda, Toshiaki; Iwaku, Kenji; Kobayashi, Sakiko; Sugino, Kiminori; Ito, Koichi			Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan	THYROID			English	Article							AMERICAN THYROID ASSOCIATION; BIRTH-DEFECTS; ANTITHYROID DRUGS; EARLY-PREGNANCY; MATERNAL HYPERTHYROIDISM; PROPYLTHIOURACIL; MANAGEMENT; EXPOSURE; POSTPARTUM; GUIDELINES	Background: To control hyperthyroidism due to Graves' disease, antithyroid drugs should be administered. Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy. Congenital anomalies associated with exposure to propylthiouracil (PTU) have also recently been reported. Methods: This study investigated whether substituting potassium iodide (KI) for MMI in the first trimester would result in a lower incidence of major congenital anomalies than continuing treatment with MMI alone. The cases of 283 women with Graves' disease (GD) were reviewed whose treatment was switched from MMI to KI in the first trimester (iodine group), as well as the cases of 1333 patients treated with MMI alone (MMI group) for comparison. Another major outcome of interest was the incidence of neonatal thyroid dysfunction. The subjects of the analysis of major congenital anomalies and neonatal thyroid dysfunction were live-born infants. Results: The incidence of major anomalies was 4/260 (1.53%) in the iodine group, which was significantly lower than the incidence of 47/1134 (4.14%) in the MMI group. Two neonates in the iodine group had anomalies consistent with MMI embryopathy (0.8%), as opposed to 18 neonates in the MMI group (1.6%). None of the neonates exposed to KI had thyroid dysfunction or goiter. Conclusions: Substituting KI for MMI as a means of controlling hyperthyroidism in GD patients during the first trimester may reduce the incidence of congenital anomalies, at least in iodine-sufficient regions.	[Yoshihara, Ai; Noh, Jaeduk Yoshimura; Watanabe, Natsuko; Mukasa, Koji; Ohye, Hidemi; Suzuki, Miho; Matsumoto, Masako; Kunii, Yo; Suzuki, Nami; Kameda, Toshiaki; Iwaku, Kenji; Kobayashi, Sakiko; Sugino, Kiminori; Ito, Koichi] Ito Hosp, Dept Internal Med, Tokyo 1508308, Japan	Yoshihara, A (reprint author), Ito Hosp, Shibuya Ku, 4-3-6 Jingumae, Tokyo 1508308, Japan.	a-yoshihara@ito-hospital.jp					Kurtoğlu Selim, 2009, J Clin Res Pediatr Endocrinol, V1, P275, DOI 10.4274/jcrpe.v1i6.275; Andersen SL, 2014, THYROID, V24, P1533, DOI 10.1089/thy.2014.0150; Andersen SL, 2014, EUR J ENDOCRINOL, V171, pC1, DOI 10.1530/EJE-14-0524; MOMOTANI N, 1992, J CLIN ENDOCR METAB, V75, P738, DOI 10.1210/jc.75.3.738; Aramaki M, 2005, AM J MED GENET A, V139A, P156, DOI 10.1002/ajmg.a.30917; Mestman JH, 2004, BEST PRACT RES CL EN, V18, P267, DOI 10.1016/j.beem.2004.03.005; Lazarus JH, 2000, CLIN ENDOCRINOL, V53, P265, DOI 10.1046/j.1365-2265.2000.01087.x; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Barbero P, 2004, AM J MED GENET A, V129A, P83, DOI 10.1002/ajmg.a.20668; Ecker JL, 1997, OBSTET GYN CLIN N AM, V24, P575, DOI 10.1016/S0889-8545(05)70323-5; Barbero P, 2008, AM J MED GENET A, V146A, P2390, DOI 10.1002/ajmg.a.32497; Luewan S, 2011, ARCH GYNECOL OBSTET, V283, P243, DOI 10.1007/s00404-010-1362-z; Cooper DS, 2009, J CLIN ENDOCR METAB, V94, P1881, DOI 10.1210/jc.2009-0850; HAYASHIDA CY, 1990, J ENDOCRINOL INVEST, V13, P937; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Yoshihara A, 2012, J CLIN ENDOCR METAB, V97, P2396, DOI 10.1210/jc.2011-2860; Clementi M, 2010, J CLIN ENDOCR METAB, V95, pE337, DOI 10.1210/jc.2010-0652; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Andersen SL, 2013, J CLIN ENDOCR METAB, V98, P4373, DOI 10.1210/jc.2013-2831; Connelly KJ, 2012, J PEDIATR-US, V161, P760, DOI 10.1016/j.jpeds.2012.05.057; Kontoleon P, 2002, Clin Exp Obstet Gynecol, V29, P304; Laurberg P, 2014, EUR J ENDOCRINOL, V171, pR13, DOI 10.1530/EJE-14-0135; NAGATAKI S, 1970, Endocrinology, V87, P1218; PARKER W A, 1982, Clinical Pharmacy, V1, P471; Phoojaroenchanachai M, 2001, CLIN ENDOCRINOL, V54, P365, DOI 10.1046/j.1365-2265.2001.01224.x; Sato S, 2015, THYROID, V25, P43, DOI 10.1089/thy.2014.0084; Taylor Peter, 2012, Eur Thyroid J, V1, P41, DOI 10.1159/000336071; Taylor Peter N, 2012, Eur Thyroid J, V1, P176, DOI 10.1159/000342920; Uchida T, 2014, ENDOCRINE, V47, P506, DOI 10.1007/s12020-014-0171-8	29	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	OCT 1	2015	25	10					1155	1161		10.1089/thy.2014.0581		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CS7LY	WOS:000362266300013		
J	Shudo, Y; Cohen, JE; MacArthur, JW; Goldstone, AB; Otsuru, S; Trubelja, A; Patel, J; Edwards, BB; Hung, G; Fairman, AS; Brusalis, C; Hiesinger, W; Atluri, P; Hiraoka, A; Miyagawa, S; Sawa, Y; Woo, YJ				Shudo, Yasuhiro; Cohen, Jeffrey E.; MacArthur, John W.; Goldstone, Andrew B.; Otsuru, Satoru; Trubelja, Alen; Patel, Jay; Edwards, Bryan B.; Hung, George; Fairman, Alexander S.; Brusalis, Christopher; Hiesinger, William; Atluri, Pavan; Hiraoka, Arudo; Miyagawa, Shigeru; Sawa, Yoshiki; Woo, Y. Joseph			A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy	TISSUE ENGINEERING PART A			English	Article							MECHANICAL-PROPERTIES; INFARCTION; CARTILAGE; TECHNOLOGY; ACTIVATION; REPAIR; ANALOG; HEART; MODEL	There exists a substantial body of work describing cardiac support devices to mechanically support the left ventricle (LV); however, these devices lack biological effects. To remedy this, we implemented a cell sheet engineering approach utilizing chondrocytes, which in their natural environment produce a relatively elastic extracellular matrix (ECM) for a cushioning effect. Therefore, we hypothesized that a chondrocyte cell sheet applied to infarcted and borderzone myocardium will biologically enhance the ventricular ECM and increase elasticity to augment cardiac function in a model of ischemic cardiomyopathy (ICM). Primary articular cartilage chondrocytes of Wistar rats were isolated and cultured on temperature-responsive culture dishes to generate cell sheets. A rodent ICM model was created by ligating the left anterior descending coronary artery. Rats were divided into two groups: cell sheet transplantation (1.0x10(7) cells/dish) and no treatment. The cell sheet was placed onto the surface of the heart covering the infarct and borderzone areas. At 4 weeks following treatment, the decreased fibrotic extension and increased elastic microfiber networks in the infarct and borderzone areas correlated with this technology's potential to stimulate ECM formation. The enhanced ventricular elasticity was further confirmed by the axial stretch test, which revealed that the cell sheet tended to attenuate tensile modulus, a parameter of stiffness. This translated to increased wall thickness in the infarct area, decreased LV volume, wall stress, mass, and improvement of LV function. Thus, the chondrocyte cell sheet strengthens the ventricular biomechanical properties by inducing the formation of elastic microfiber networks in ICM, resulting in attenuated myocardial stiffness and improved myocardial function.	[Shudo, Yasuhiro; Cohen, Jeffrey E.; MacArthur, John W.; Goldstone, Andrew B.; Patel, Jay; Edwards, Bryan B.; Woo, Y. Joseph] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Cohen, Jeffrey E.; MacArthur, John W.; Goldstone, Andrew B.; Trubelja, Alen; Hung, George; Fairman, Alexander S.; Brusalis, Christopher; Hiesinger, William; Atluri, Pavan; Hiraoka, Arudo] Univ Penn, Sch Med, Dept Surg, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Otsuru, Satoru] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH USA; [Shudo, Yasuhiro; Miyagawa, Shigeru; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka, Japan	Woo, YJ (reprint author), Stanford Univ, Sch Med, Dept Cardiothorac Surg, Falk Bldg CV-235,300 Pasteur Dr, Stanford, CA 94305 USA.	joswoo@stanford.edu			National Institutes of Health (NIH) [1R01HL089315-01]; Shinya Fund for International Exchange, Japan; Claude R. Joyner Fund for Young Medical Researchers [12POST12060567]; Uehara Memorial Foundation for Research Fellow, Japan	This study was supported by the National Institutes of Health (NIH) Grant 1R01HL089315-01 (Y.J.W.): American Heart Association Great Rivers Affiliate Postdoctoral Fellowship cosponsored by the Claude R. Joyner Fund for Young Medical Researchers (# 12POST12060567) (Y.S.): Uehara Memorial Foundation for Research Fellow, Japan (Y.S.): Shinya Fund for International Exchange, Japan (Y.S.).	Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Trubelja A, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027731; Shudo Y, 2013, CIRCULATION, V128, pS59, DOI 10.1161/CIRCULATIONAHA.112.000293; MacArthur JW, 2013, CIRCULATION, V128, pS79, DOI 10.1161/CIRCULATIONAHA.112.000343; GROSSMAN W, 1980, AM J MED, V69, P576, DOI 10.1016/0002-9343(80)90471-4; PFEFFER MA, 1990, CIRCULATION, V81, P1161; Hiesinger W, 2011, CIRCULATION, V124, pS18, DOI 10.1161/CIRCULATIONAHA.110.009431; MacArthur JW, 2013, J THORAC CARDIOV SUR, V145, P278, DOI 10.1016/j.jtcvs.2012.09.080; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517; Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd; Uchinaka A, 2012, MOL CELL BIOCHEM, V368, P203, DOI 10.1007/s11010-012-1361-4; Li AH, 2014, CIRC RES, V114, P916, DOI 10.1161/CIRCRESAHA.114.302819; Shudo Y, 2014, TISSUE ENG PT A, V20, P728, DOI 10.1089/ten.TEA.2012.0534; Blom AS, 2005, CIRCULATION, V112, P1274, DOI 10.1161/CIRCULATIONAHA.104.499202; Sawa Y, 2013, CURR PHARM BIOTECHNO, V14, P61; Atluri P, 2013, CIRCULATION, V128, pS95, DOI 10.1161/CIRCULATIONAHA.112.000368; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Yano F, 2013, BIOMATERIALS, V34, P5581, DOI 10.1016/j.biomaterials.2013.04.008; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Shudo Y, 2013, CIRC J, V77, P1063, DOI 10.1253/circj.CJ-12-0615; Miyagawa S, 2011, ANN THORAC SURG, V91, P320, DOI 10.1016/j.athoracsur.2010.09.080; Frederick JR, 2010, CIRCULATION, V122, pS107, DOI [10.1161/CIRCULATIONAHA.109.930404, 10.1161/C1RCULATIONAHA.109.930404]; Shudo Y, 2012, J THORAC CARDIOV SUR, V143, pS43, DOI 10.1016/j.jtcvs.2011.11.013; Mourouzis I, 2013, METABOLISM, V62, P1387, DOI 10.1016/j.metabol.2013.05.008; Shudo Y, 2011, J THORAC CARDIOV SUR, V142, P1188, DOI 10.1016/j.jtcvs.2011.07.002; Kokubo M., 2013, J TISSUE ENG REGEN M, DOI [10.1002/term.1764, DOI 10.1002/TERM.1764]; Philla J. J., 2002, CIRCULATION, V106, pI207; Zhang C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00650	31	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3341	1937-335X		TISSUE ENG PT A	Tissue Eng. Part A	OCT 1	2015	21	19-20					2515	2525		10.1089/ten.tea.2014.0155		11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	CT1GN	WOS:000362546100006		
J	Tsugo, K; Kashimura, A; Une, Y				Tsugo, Kosuke; Kashimura, Akane; Une, Yumi			Asbestosis in a Japanese Macaque (Macaca fuscata)	TOXICOLOGIC PATHOLOGY			English	Article						asbestos; asbestosis; tremolite; Japanese macaque	INDUCED DISEASES; MESOTHELIOMA; PNEUMOCONIOSIS; HEALTH	Asbestosis is a chronic lung disease caused by inhalation of asbestos, a fibrous mineral. It is one of the most severe diseases resulting from environmental contamination. We found asbestosis in a female Japanese macaque over 25 years of age that died from senility. Clear needle-like crystals were deposited throughout the lung lobes, particularly in the perivascular areas. Asbestos bodies were observed in some of these crystals. Fibrosis without inflammation was observed in the periarterial and peribronchiolar regions. The crystals were identified as tremolite, and a total of 16,633,968 asbestos bodies and 465,334,411 tremolite fibers were observed in 1 g of dry lung tissue. No tumors or pleural adhesions were seen. This is the first report of spontaneous asbestosis in a nonhuman animal.	[Tsugo, Kosuke; Kashimura, Akane; Une, Yumi] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa 2525201, Japan	Une, Y (reprint author), Azabu Univ, Sch Vet Med, Lab Vet Pathol, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan.	une@azabu-u.ac.jp					Shukla A, 2003, FREE RADICAL BIO MED, V34, P1117, DOI 10.1016/S0891-5849(03)00060-1; CHURG A, 1984, AM J PATHOL, V115, P437; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Huang SXL, 2011, J TOXICOL ENV HEAL B, V14, P179, DOI 10.1080/10937404.2011.556051; Cullinan P, 2013, PRIM CARE RESP J, V22, P249, DOI 10.4104/pcrj.2013.00055; PLATEK SF, 1985, FUND APPL TOXICOL, V5, P327, DOI 10.1016/0272-0590(85)90081-8; Yue F, 2014, NEUROBIOL AGING, V35, P1656, DOI 10.1016/j.neurobiolaging.2014.01.139; Hodgson JT, 2000, ANN OCCUP HYG, V44, P565, DOI 10.1016/S0003-4878(00)00045-4; BRAAK H, 1988, STAIN TECHNOL, V63, P197; SHIN ML, 1973, AM J PATHOL, V70, P291; Neumann V, 2013, DTSCH ARZTEBL INT, V110, P319, DOI 10.3238/arztebl.2013.0319; CRAIGHEAD JE, 1982, ARCH PATHOL LAB MED, V106, P544; Iuchi Y., 2009, JPN J LUNG CANC, V49, P83; KAMP DW, 1992, FREE RADICAL BIO MED, V12, P293, DOI 10.1016/0891-5849(92)90117-Y; Kishimoto Takumi, 2014, Nihon Rinsho, V72, P300; McNULTY J. C., 1962, MED JOUR AUSTRALIA, V49 II, P953	16	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	OCT	2015	43	7					1035	1039		10.1177/0192623315587594		5	Pathology; Toxicology	Pathology; Toxicology	CS9ZO	WOS:000362453500012		
J	Koh, S; Yamada, K; Nishimoto, M; Hayashi, Y; Koh, H; Nakashima, Y; Nakane, T; Hirose, A; Nakamae, M; Kakeya, H; Hino, M; Nakamae, H				Koh, S.; Yamada, K.; Nishimoto, M.; Hayashi, Y.; Koh, H.; Nakashima, Y.; Nakane, T.; Hirose, A.; Nakamae, M.; Kakeya, H.; Hino, M.; Nakamae, H.			Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation	TRANSPLANT INFECTIOUS DISEASE			English	Article						antibacterial prophylaxis; hematopoietic stem cell transplantation (HSCT); bacteremia; enterobacterial flora; polymyxin B; levofloxacin	ACUTE NONLYMPHOCYTIC LEUKEMIA; ANTIBIOTIC-PROPHYLAXIS; NEUTROPENIC PATIENTS; BACTERIAL-INFECTION; ANTIMICROBIAL AGENTS; FEBRILE NEUTROPENIA; CANCER; PREVENTION; COMPLICATIONS; METAANALYSIS	BackgroundFluoroquinolones are widely used for antibacterial prophylaxis during neutropenia following hematopoietic stem cell transplantation (HSCT). Nevertheless, data are inadequate as to whether fluoroquinolones decrease mortality rate compared with other antibiotics. MethodsWe retrospectively compared the efficacy of antibacterial prophylaxis using non-absorbable polymyxin B (PB) (n=106) or systemic levofloxacin (LVFX) (n=140) after allogeneic SCT at our institute between 2004 and 2013. ResultsNo significant difference was observed between the 2 groups in the cumulative incidences of failure of prophylaxis (P=0.21), clinically documented infections (P=0.70), or non-relapse mortality within the first 100days after transplantation (P=0.42). With bacteremia, the rate of resistance to LVFX was 82% in the PB group and 100% in the LVFX group (P=0.41). Also, no significant difference was found in overall survival between the 2 groups (P=0.78). ConclusionOur results indicate no difference in the effectiveness of antibacterial prophylaxis between systemic antibiotic LVFX and non-absorbable antibiotic PB.	[Koh, S.; Nishimoto, M.; Hayashi, Y.; Koh, H.; Nakashima, Y.; Nakane, T.; Hirose, A.; Nakamae, M.; Hino, M.; Nakamae, H.] Osaka City Univ, Hematol, Grad Sch Med, Osaka 5458585, Japan; [Yamada, K.; Kakeya, H.] Osaka City Univ, Infect Control Sci, Grad Sch Med, Osaka 5458585, Japan	Nakamae, H (reprint author), Osaka City Univ, Hematol, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	hirohisa@msic.med.osaka-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [23591423]	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant (Number 23591423).	Aimoto M, 2014, INFECTION, V42, P971, DOI 10.1007/s15010-014-0657-6; GLUCKMAN E, 1991, CHEMOTHERAPY, V37, P33; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Bjorklund A, 2007, BONE MARROW TRANSPL, V40, P1055, DOI 10.1038/sj.bmt.1705856; Masaoka T, 2004, CLIN INFECT DIS, V39, pS49, DOI 10.1086/383054; GUIOT HFL, 1983, J INFECT DIS, V147, P615; JEHN U, 1981, KLIN WOCHENSCHR, V59, P1093, DOI 10.1007/BF01746196; Baden LR, 2012, J NATL COMPR CANC NE, V10, P1412; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979; SCHIMPFF SC, 1975, ANN INTERN MED, V82, P351; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Kimura S, 2014, J INFECTION, V69, P13, DOI 10.1016/j.jinf.2014.02.013; Leiva M, 2005, INT J ANTIMICROB AG, V25, P252, DOI 10.1016/j.ijantimicag.2004.10.013; Dykewicz CA, 2001, CLIN INFECT DIS, V33, P139, DOI 10.1086/321805; NEWELL PM, 1988, J CLIN MICROBIOL, V26, P401; Guthrie KA, 2010, BONE MARROW TRANSPL, V45, P675, DOI 10.1038/bmt.2009.216; Kwa A, 2007, EXPERT REV ANTI-INFE, V5, P811, DOI 10.1586/14787210.5.5.811; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Engelhard D, 2009, BONE MARROW TRANSPL, V44, P467, DOI 10.1038/bmt.2009.257; Cullen M, 2005, NEW ENGL J MED, V353, P988, DOI 10.1056/NEJMoa050078; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Gafter-Gvili A, 2012, COCHRANE DB SYST REV, V1; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lucena CM, 2014, BONE MARROW TRANSPL, V49, P1293, DOI 10.1038/bmt.2014.151; Nakane T, 2015, J INFECT CHEMOTHER, V21, P16, DOI 10.1016/j.jiac.2014.08.026; Patel JB, 2014, PERFORMANCE STANDA S, V34	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	OCT	2015	17	5					647	654		10.1111/tid.12416		8	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	CT1YB	WOS:000362597900003		
J	Hamaguchi, Y; Mori, A; Uemura, T; Ogawa, K; Fujimoto, Y; Okajima, H; Kaido, T; Uemoto, S				Hamaguchi, Y.; Mori, A.; Uemura, T.; Ogawa, K.; Fujimoto, Y.; Okajima, H.; Kaido, T.; Uemoto, S.			Incidence and risk factors for herpes zoster in patients undergoing liver transplantation	TRANSPLANT INFECTIOUS DISEASE			English	Article						herpes zoster; liver transplantation; incidence rate; risk factors; mycophenolate mofetil	MYCOPHENOLATE-MOFETIL; POSTHERPETIC NEURALGIA; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; VARICELLA; METAANALYSIS; INFECTION; GRAFT; CYTOMEGALOVIRUS; COMPLICATIONS	BackgroundHerpes zoster (HZ) is the most common manifestation of latent varicella zoster virus reactivation, which occurs naturally as a result of aging or in immunocompromised patients. Solid organ transplant recipients are at increased risk for HZ owing to their chronic immunosuppression. Although several reports investigated risk factors for the development of HZ in heart or renal transplantation, data in liver transplantation (LT) are limited. MethodsWe evaluated clinical data retrospectively in 377 adult patients undergoing LT between January 2005 and December 2012 in our institution. We analyzed the incidence rate of HZ and the standardized incidence ratio (SIR) by comparing with the general Japanese population. We additionally investigated risk factors for HZ after LT. ResultsHZ developed in 27 (7.16%) of the 377 patients after LT. The incidence rate of HZ after LT was 17.83 per 1000 person-years, which was significantly higher than in the general Japanese population (SIR = 4.61; 95% confidence interval [CI], 4.13-5.14). Multivariate analysis showed that older age (hazard ratio [HR] = 3.95; P < 0.001) and exposure to mycophenolate mofetil (HR = 3.03; P = 0.007) were independent risk factors for HZ after LT. ConclusionsThis is the first and largest study, to our knowledge, to investigate the incidence rate of HZ and risk factors for development of HZ after LT in the Japanese population. Further investigations to focus on immunosuppressive regimens to reduce the risk for HZ incidence in this high-risk population could establish a new protocol of immunosuppression after LT.	[Hamaguchi, Y.; Mori, A.; Uemura, T.; Ogawa, K.; Fujimoto, Y.; Okajima, H.; Kaido, T.; Uemoto, S.] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg, Kyoto 6068507, Japan	Mori, A (reprint author), Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	akr@kuhp.kyoto-u.ac.jp					Chapman JR, 2011, AM J TRANSPLANT, V11, P693, DOI 10.1111/j.1600-6143.2011.03504.x; Zmonarski SC, 2003, TRANSPLANT P, V35, P2205, DOI 10.1016/S0041-1345(03)00764-4; Lauzurica R, 2003, TRANSPLANT P, V35, P1758, DOI 10.1016/S0041-1345(03)00684-5; Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599; Pourfarziani V, 2007, TRANSPL P, V39, P1237, DOI 10.1016/j.transproceed.2007.03.006; Yawn BP, 2013, NEUROLOGY, V81, P928, DOI 10.1212/WNL.0b013e3182a3516e; Fishman JA, 2013, AM J TRANSPLANT, V13, P1, DOI 10.1111/ajt.12002; Salah A, 2014, LIVER TRANSPLANT, V20, P200, DOI 10.1002/lt.23789; Herrero JI, 2004, LIVER TRANSPLANT, V10, P1140, DOI 10.1002/lt.20219; Manuel O, 2008, J HEART LUNG TRANSPL, V27, P11, DOI 10.1016/j.healun.2007.09.028; Levitsky J, 2005, LIVER TRANSPLANT, V11, P320, DOI 10.1002/lt.20356; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp013211; Morioka D, 2007, ANN SURG, V245, P315, DOI 10.1097/01.sla.0000236600.24667.a4; Xing S, 2014, CLIN BIOCHEM, V47, P663, DOI 10.1016/j.clinbiochem.2014.01.014; Textor SC, 2000, LIVER TRANSPLANT, V6, P521, DOI 10.1053/jlts.2000.9737; Moore J, 2009, TRANSPLANTATION, V87, P591, DOI 10.1097/TP.0b013e318195a421; Ogura Y, 2010, LIVER TRANSPLANT, V16, P718, DOI 10.1002/lt.22059; Nalamachu S, 2012, DRUG AGING, V29, P863, DOI 10.1007/s40266-012-0014-3; Hori T, 2012, CLIN TRANSPLANT, V26, pE324, DOI 10.1111/j.1399-0012.2012.01664.x; Pergam SA, 2011, TRANSPL INFECT DIS, V13, P15, DOI 10.1111/j.1399-3062.2010.00547.x; Ko GB, 2013, TRANSPL INFECT DIS, V15, P416, DOI 10.1111/tid.12091; McAlister VC, 2006, AM J TRANSPLANT, V6, P1578, DOI 10.1111/j.1600-6143.2006.01360.x; Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011; Satoh S, 2005, TRANSPL P, V37, P1751, DOI 10.1016/j.transproceed.2005.03.072; Ueda Y, 2014, TRANSPLANTATION, V97, P344, DOI 10.1097/01.TP.0000435702.61642.0a; Ito T, 2003, TRANSPLANTATION, V76, P158, DOI 10.1097/01.TP.0000072372.42396.47; Koo S, 2014, TRANSPL INFECT DIS, V16, P17, DOI 10.1111/tid.12149; Geissler EK, 2009, GUT, V58, P452, DOI 10.1136/gut.2008.163527; Miller GG, 2007, AM J TRANSPLANT, V7, P741, DOI 10.1111/j.1600-6143.2006.01718.x; Johnson RW, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-37; Oxman Michael N, 2009, J Am Osteopath Assoc, V109, pS13; tersMeulen CG, 2000, NEPHROL DIAL TRANSPL, V15, P711; Zuckerman RA, 2013, AM J TRANSPLANT, V13, P55, DOI 10.1111/ajt.12003	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	OCT	2015	17	5					671	678		10.1111/tid.12425		8	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	CT1YB	WOS:000362597900006		
J	Eriguchi, Y; Nakamura, K; Hashimoto, D; Shimoda, S; Shimono, N; Akashi, K; Ayabe, T; Teshima, T				Eriguchi, Y.; Nakamura, K.; Hashimoto, D.; Shimoda, S.; Shimono, N.; Akashi, K.; Ayabe, T.; Teshima, T.			Decreased secretion of Paneth cell -defensins in graft-versus-host disease	TRANSPLANT INFECTIOUS DISEASE			English	Article						graft-versus-host disease; hematopoietic stem cell transplantation; -defensins; cryptdin; mouse model; Paneth cells; fecal testing; microbiota	ALPHA-DEFENSINS; TRANSPLANTATION; DIVERSITY; MORTALITY; RISK	BackgroundIntestinal microbial ecology is actively regulated by Paneth cell-derived antimicrobial peptides, -defensins. Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (SCT). We previously demonstrated that Paneth cells are targeted by GVHD, and their expression of antimicrobial peptide -defensins is impaired, leading to a loss of physiological diversity among the microflora and development of bloodstream infection. Herein, we evaluated whether fecal levels of -defensins could be surrogate marker of intestinal dysbiosis. MethodsWe directly measured -defensin cryptdin-1 (Crp1) in fecal pellets of mice with GVHD by using a novel enzyme-linked immunosorbent assay. ResultsFecal levels of Crp1 were significantly decreased in mice with GVHD but unchanged in mice without GVHD after SCT. These were correlated with intestinal flora diversity. ConclusionWe demonstrate a link between reduced secretion of Paneth cell -defensins and dysbiosis of intestinal flora in GVHD. Fecal levels of -defensins could be surrogate markers for intestinal microbial homeostasis.	[Eriguchi, Y.; Shimoda, S.; Shimono, N.; Akashi, K.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Japan; [Nakamura, K.; Ayabe, T.] Hokkaido Univ, Dept Cell Biol Sci, Grad Sch Life Sci, Fac Adv Life Sci, Sapporo, Hokkaido 0608638, Japan; [Hashimoto, D.; Teshima, T.] Hokkaido Univ, Dept Hematol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Teshima, T (reprint author), Hokkaido Univ, Dept Hematol, Grad Sch Med, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	teshima@med.hokudai.ac.jp			JSPS KAKENHI [25293217, 26461438, 26462831]; Japan Agency for Medical Research and Development (AMED) [15Aek0510012h0001]; Health and Labor Science Research Grants; Promotion and Standardization of the Tenure-Track System; Center of Innovation Trial Program; Knowledge Cluster, Sapporo Bio-S from MEXT	This study was supported by grants from JSPS KAKENHI (25293217 to T.T., 26461438 to D.H., and 26462831 to K.N.), Japan Agency for Medical Research and Development (AMED, 15Aek0510012h0001 to T.T.), Health and Labor Science Research Grants (to T.T.), the Promotion and Standardization of the Tenure-Track System (to D.H.), the Center of Innovation Trial Program (to T.T., K.N.), and the Knowledge Cluster, Sapporo Bio-S from MEXT (to T.A.).	Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Levine JE, 2013, BLOOD, V122, P1505, DOI 10.1182/blood-2013-02-485813; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Masuda K, 2011, J INNATE IMMUN, V3, P315, DOI 10.1159/000322037; Kato K, 2010, BIOL BLOOD MARROW TR, V16, P751, DOI 10.1016/j.bbmt.2010.01.012; Nakamura K, 2013, ANAL BIOCHEM, V443, P124, DOI 10.1016/j.ab.2013.08.021; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; KORNGOLD R, 1990, J IMMUNOL, V145, P4079; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066; SHANNON CE, 1948, AT&T TECH J, V27, P623; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Qin J, 2010, NATURE, V464, P59, DOI DOI 10.1038/NATURE08821; Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725; vansBekkum D, 1961, INT J RADIAT BIOL, V3, P173; vansBekkum DW, 1974, JNCI-J NATL CANCER I, V52, P401	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	OCT	2015	17	5					702	706		10.1111/tid.12423		5	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	CT1YB	WOS:000362597900010		
J	Miura, H; Kawamura, Y; Kudo, K; Ihira, M; Ohye, T; Kurahashi, H; Kawashima, N; Miyamura, K; Yoshida, N; Kato, K; Takahashi, Y; Kojima, S; Yoshikawa, T				Miura, H.; Kawamura, Y.; Kudo, K.; Ihira, M.; Ohye, T.; Kurahashi, H.; Kawashima, N.; Miyamura, K.; Yoshida, N.; Kato, K.; Takahashi, Y.; Kojima, S.; Yoshikawa, T.			Virological analysis of inherited chromosomally integrated human herpesvirus-6 in three hematopoietic stem cell transplant patients	TRANSPLANT INFECTIOUS DISEASE			English	Article						inherited CIHHV-6; reactivation; HSCT; RT-PCR	HUMAN-HERPESVIRUS-6 REACTIVATION; CLINICAL-SIGNIFICANCE; RECIPIENTS; ENCEPHALITIS; TRANSMISSION; FEATURES; VIRUS	We analyzed 3 hematopoietic stem cell transplant (HSCT) recipients with inherited chromosomally integrated human herpesvirus-6 (inherited CIHHV-6). Cases 1 (inherited CIHHV-6A) and 2 (inherited CIHHV-6B) were inherited CIHHV-6 recipients. Case 3 received bone marrow from a donor with inherited CIHHV-6B. Following HSCT, HHV-6B was isolated from Case 1. HHV-6A and -6B messenger RNAs were detected in Cases 1 and 3.	[Miura, H.; Kawamura, Y.; Kudo, K.; Yoshikawa, T.] Fujita Hlth Univ, Dept Pediat, Sch Med, Toyoake, Aichi 4701192, Japan; [Ihira, M.] Fujita Hlth Univ, Fac Clin Engn, Sch Hlth Sci, Toyoake, Aichi 4701192, Japan; [Ohye, T.; Kurahashi, H.] Fujita Hlth Univ, Div Mol Genet, Toyoake, Aichi 4701192, Japan; [Kawashima, N.; Miyamura, K.] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Yoshida, N.; Kato, K.] Japanese Red Cross Nagoya First Hosp, Div Hematol Oncol, Childrens Med Ctr, Nagoya, Aichi, Japan; [Takahashi, Y.; Kojima, S.] Nagoya Univ, Sch Med, Dept Pediat, Nagoya, Aichi 466, Japan	Yoshikawa, T (reprint author), Fujita Hlth Univ, Dept Pediat, Sch Med, Toyoake, Aichi 4701192, Japan.	tetsushi@fujita-hu.ac.jp					Kato Y, 2014, J CLIN MICROBIOL, V52, P419, DOI 10.1128/JCM.02192-13; Ihira M, 2012, J MED VIROL, V84, P1388, DOI 10.1002/jmv.23350; Fujita A, 2008, J INFECTION, V57, P241, DOI 10.1016/j.jinf.2008.06.014; Yoshikawa T, 2002, J INFECT DIS, V185, P847, DOI 10.1086/339411; Endo A, 2014, CLIN INFECT DIS, V59, P545, DOI 10.1093/cid/ciu323; Strenger V, 2014, CLIN MICROBIOL INFEC, V20, P1027, DOI 10.1111/1469-0691.12639; Lee SO, 2011, TRANSPLANTATION, V92, P224, DOI 10.1097/TP.0b013e318222444a; Pellett PE, 2012, REV MED VIROL, V22, P144, DOI 10.1002/rmv.715; Clark DA, 2006, J INFECT DIS, V193, P912, DOI 10.1086/500838; Singh N, 2000, TRANSPLANTATION, V69, P2474, DOI 10.1097/00007890-200006270-00002; Seeley WW, 2007, NEUROLOGY, V69, P156, DOI 10.1212/01.wnl.0000265591.10200.d7; Kamble RT, 2007, BONE MARROW TRANSPL, V40, P563, DOI 10.1038/sj.bmt.1705780; Zerr DM, 2001, CLIN INFECT DIS, V33, P763, DOI 10.1086/322642; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Ogata M, 2006, J INFECT DIS, V193, P68, DOI 10.1086/498531; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273	1399-3062		TRANSPL INFECT DIS	Transpl. Infect. Dis.	OCT	2015	17	5					728	731		10.1111/tid.12419		4	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	CT1YB	WOS:000362597900015		
J	Tsuruta, M; Mukai, Y				Tsuruta, Momi; Mukai, Yuzuru			Hybrid seedling inviability locus (HIs1) mapped on linkage group 4 of the Japanese flowering cherry, Cerasus x yedoensis 'Somei-yoshino'	TREE GENETICS & GENOMES			English	Article						Flowering cherry; Hybrid inviability; Linkage map; Segregation distortion; Somei-yoshino	PRUNUS-PERSICA L.; MICROSATELLITE MARKERS; SSR MARKERS; SELF-INCOMPATIBILITY; GENETIC DIVERSITY; CHLOROPLAST DNA; RECESSIVE GENES; AVIUM NAPOLEON; PEACH; CROSS	Cerasus x yedoensis 'Somei-yoshino' (2n=16), one of the most popular cultivars of Japanese flowering cherry, is considered a hybrid between Cerasus spachiana and Cerasus speciosa. In the present study, we observed segregation of the trait for seedling growth in F-1 progenies of Somei-yoshino. In all three families crossed with ancestral wild species, C. spachiana, approximately half of the seedlings showed growth failure. To identify loci involved in seedling inviability, we constructed a genetic linkage map of Somei-yoshino. Both normal growth (N=77) and growth failure seedlings (N=101) of an F-1 progenies crossed between Somei-yoshino (CY) and C. spachiana (E750) were used for map construction. In accordance to pseudo-testcross strategy, female (CY) and male (E750) linkage maps were constructed. The CY map consists of eight linkage groups with 59 simple sequence repeat (SSR) and 17 amplified fragment length polymorphism (AFLP) markers. The map length is 574.9 cM. In contrast, the E750 map reached 196.8 cM and included 17 SSRs. Subsequently, we explored positions of loci associated to seedling inviability along with linkage maps. Results of segregation distortion of markers, association analysis, and interval mapping consistently showed that an inviability gene was located between two SSR markers, EMPaS13 and BPPCT005 in the fourth linkage group (LG4) of the Somei-yoshino map with 99.6 % explanations for the inviability trait but not present in LG4 of the E750 map. From the genotypes and expressions of seedling inviability, we named the locus Hybrid Inviability of seedlings 1 (HIs1). Finally, HIs1 was mapped to LG4 as Mendelian trait loci and was completely linked with an SSR, EMPaS13. Although the mechanisms of seedling inviability cannot be explained by only one locus model of HIs1, one of the candidate genes involved in hybrid incompatibility between Somei-yoshino and C. spachiana is certainly located on LG4 of the CY map.	[Tsuruta, Momi; Mukai, Yuzuru] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Tsuruta, M (reprint author), Gifu Univ, Fac Appl Biol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	m.tsuruta.lfme@gmail.com			Japan Science Society	This work was supported by the Sasakawa Scientific Research Grant from The Japan Science Society.	Ohta S, 2007, PLANT SYST EVOL, V263, P209, DOI 10.1007/s00606-006-0474-1; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; WATANABE K, 1967, BOT MAG TOKYO, V80, P257; Orr HA, 1996, GENETICS, V144, P1331; Tsuda Y, 2009, CONSERV GENET, V10, P685, DOI 10.1007/s10592-008-9615-0; INNAN H, 1995, JPN J GENET, V70, P185, DOI 10.1266/jjg.70.185; Moyle LC, 2008, GENETICS, V179, P1437, DOI 10.1534/genetics.107.083618; Matsubara K, 2007, THEOR APPL GENET, V115, P179, DOI 10.1007/s00122-007-0553-x; Mnejja M, 2004, MOL ECOL NOTES, V4, P163, DOI 10.1111/j.1471-8286.2004.00603.x; Vaughan SP, 2004, MOL ECOL NOTES, V4, P429, DOI 10.1111/j.1471-8286.2004.00673.x; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Clarke JB, 2009, TREE GENET GENOMES, V5, P41, DOI 10.1007/s11295-008-0166-9; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Iketani H, 2007, BREEDING SCI, V57, P1, DOI 10.1270/jsbbs.57.1; Cipriani G, 1999, THEOR APPL GENET, V99, P65, DOI 10.1007/s001220051209; Bliss FA, 2002, GENOME, V45, P520, DOI 10.1139/G02-011; Ohta S, 2005, BREEDING SCI, V55, P415, DOI 10.1270/jsbbs.55.415; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Joobeur T, 1998, THEOR APPL GENET, V97, P1034, DOI 10.1007/s001220050988; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Sweigart AL, 2006, GENETICS, V172, P2465, DOI 10.1534/genetics.105.053686; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Tsuruta Momi, 2012, Horticultural Research (Japan), V11, P321; Kato S, 2014, TREE GENET GENOMES, V10, P477, DOI 10.1007/s11295-014-0697-1; Ohta S, 2006, J JPN SOC HORTIC SCI, V75, P72, DOI 10.2503/jjshs.75.72; Yamamoto E, 2007, THEOR APPL GENET, V115, P187, DOI 10.1007/s00122-007-0554-9; Clarke JB, 2003, MOL ECOL NOTES, V3, P578, DOI 10.1046/j.1471-8286.2003.00517.x; Sosinski B, 2000, THEOR APPL GENET, V101, P421, DOI 10.1007/s001220051499; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Testolin R, 2000, GENOME, V43, P512, DOI 10.1139/gen-43-3-512; Aranzana MJ, 2002, PLANT BREEDING, V121, P87, DOI 10.1046/j.1439-0523.2002.00656.x; Moyle LC, 2005, GENETICS, V169, P355, DOI 10.1534/genetics.104.029546; Arus P, 2012, TREE GENET GENOMES, V8, P531; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Flower Association of Japan, 1982, MAN JAP FLOW CHERR; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Kato S., 2009, Journal of the Japanese Forest Society, V91, P354; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Miura K, 2008, BREEDING SCI, V58, P99, DOI 10.1270/jsbbs.58.99; OGINUMA K, 1976, Journal of Japanese Botany, V51, P104; Oginuma K, 1977, B BIOL SOC HIROSHIMA, V43, P53; Ohba H, 2007, FLOWERING CHERRIES J; Tsuruta M., 2012, Journal of the Japanese Forest Society, V94, P229, DOI 10.4005/jjfs.94.229; Wang S, 2012, WINDOWS QTL CARTOGRA; Wilson EH, 1916, CHERRIES JAPAN	50	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1614-2942	1614-2950		TREE GENET GENOMES	Tree Genet. Genomes	OCT	2015	11	5							88	10.1007/s11295-015-0910-x		11	Forestry; Genetics & Heredity; Horticulture	Forestry; Genetics & Heredity; Agriculture	CS9SJ	WOS:000362431600002		
J	Aboellail, MAM; Kanenishi, K; Mori, N; Kurobe, A; Hata, T				Aboellail, M. A. M.; Kanenishi, K.; Mori, N.; Kurobe, A.; Hata, T.			HDlive imaging of circumvallate placenta	ULTRASOUND IN OBSTETRICS & GYNECOLOGY			English	Editorial Material							DIAGNOSIS; ULTRASOUND		[Aboellail, M. A. M.; Kanenishi, K.; Mori, N.; Hata, T.] Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, Miki, Kagawa 7610739, Japan; [Kurobe, A.] Kurobe Clin, Dept Obstet & Gynecol, Kita Ku, Takamatsu, Kagawa, Japan	Hata, T (reprint author), Kagawa Univ, Grad Sch Med, Dept Perinatol & Gynecol, 1750-1 Ikenobe, Miki, Kagawa 7610739, Japan.	toshi28@med.kagawa-u.ac.jp					JAUNIAUX E, 1989, J CLIN ULTRASOUND, V17, P126, DOI 10.1002/jcu.1870170212; SISTROM CL, 1993, ULTRASOUND OBST GYN, V3, P249, DOI 10.1046/j.1469-0705.1993.03040249.x; Arlicot C, 2012, J ULTRAS MED, V31, P340; Kagan KO, 2011, ULTRASOUND OBST GYN, V38, P607, DOI 10.1002/uog.10112; MCCARTHY J, 1995, J ULTRAS MED, V14, P21	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7692	1469-0705		ULTRASOUND OBST GYN	Ultrasound Obstet. Gynecol.	OCT	2015	46	4					513	514		10.1002/uog.14839		2	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine & Medical Imaging	CS8XM	WOS:000362373200026		
J	Saito, K; Katada, T				Saito, Kota; Katada, Toshiaki			Mechanisms for exporting large-sized cargoes from the endoplasmic reticulum	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						COPII; Collagen; Chylomicron; TANGO1; cTAGE5	ER EXIT SITES; BBF2H7-MEDIATED SEC23A PATHWAY; CHYLOMICRON RETENTION DISEASE; LENTICULO-SUTURAL DYSPLASIA; EARLY SECRETORY PATHWAY; GTP-BINDING PROTEIN; COPII VESICLE COAT; ANEMIA TYPE-II; COLLAGEN SECRETION; SAR1 GTPASE	Cargo proteins exported from the endoplasmic reticulum to the Golgi apparatus are typically transported in coat protein complex II (COPII)-coated vesicles of 60-90 nm diameter. Several cargo molecules including collagens and chylomicrons form structures that are too large to be accommodated by these vesicles, but their secretion still requires COPII proteins. Here, we first review recent progress on large cargo secretions derived especially from animal models and human diseases, which indicate the importance of COPII proteins. We then discuss the recent isolation of specialized factors that modulate the process of COPII-dependent cargo formation to facilitate the exit of large-sized cargoes from the endoplasmic reticulum. Based on these findings, we propose a model that describes the importance of the GTPase cycle for secretion of oversized cargoes. Next, we summarize reports that describe the structures of COPII proteins and how these results provide insight into the mechanism of assembly of the large cargo carriers. Finally, we discuss what issues remain to be solved in the future.	[Saito, Kota; Katada, Toshiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, Tokyo 1130033, Japan	Saito, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ksaito@mol.f.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)	We thank members of the Katada Laboratory for valuable discussions. This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (K.S. and T.K.) and Japan Society for the Promotion of Science (JSPS; K.S. and T.K.).	Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; Kondo S, 2012, CELL DEATH DIFFER, V19, P1939, DOI 10.1038/cdd.2012.77; Saito K, 2011, MOL BIOL CELL, V22, P2301, DOI 10.1091/mbc.E11-02-0143; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Lord C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013367; Noble AJ, 2013, NAT STRUCT MOL BIOL, V20, P167, DOI 10.1038/nsmb.2467; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Adams EJ, 2014, J BIOL CHEM, V289, P20858, DOI 10.1074/jbc.M114.566687; Bianchi P, 2009, HUM MUTAT, V30, P1292, DOI 10.1002/humu.21077; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Copic A, 2012, SCIENCE, V335, P1359, DOI 10.1126/science.1215909; Bacia K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00017; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Steegmaier M, 2000, MOL BIOL CELL, V11, P2719; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Yorimitsu T, 2012, MOL BIOL CELL, V23, P2930, DOI 10.1091/mbc.E12-05-0356; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bhandari D, 2013, MOL BIOL CELL, V24, P2727, DOI 10.1091/mbc.E13-02-0114; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Hellerbrand C, 2008, GUT, V57, P243, DOI 10.1136/gut.2007.129544; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Gedeon AK, 1999, NAT GENET, V22, P400; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Lerner DW, 2013, DEV CELL, V24, P159, DOI [10.1016/j.devcel.2012.12.005, 10.1016/j.devce1.2012.12.005]; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Tao JY, 2012, P NATL ACAD SCI USA, V109, pE2001, DOI 10.1073/pnas.1209207109; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Kim SD, 2012, J BIOL CHEM, V287, P10134, DOI 10.1074/jbc.M111.283382; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Kuehn MJ, 1998, NATURE, V391, P187; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Levic D, 2015, J MOL MED, V93, P165, DOI 10.1007/s00109-014-1247-x; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; Garbes L, 2015, AM J HUM GENET, V96, P432, DOI 10.1016/j.ajhg.2015.01.002; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Shugrue CA, 1999, J CELL SCI, V112, P4547; Baines AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061114; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; BARLOWE C, 1993, J BIOL CHEM, V268, P873; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Bharucha N, 2013, MOL BIOL CELL, V24, P3406, DOI 10.1091/mbc.E13-04-0185; Bhattacharya N, 2012, J MOL BIOL, V420, P324, DOI 10.1016/j.jmb.2012.04.024; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Bosserhoff AK, 2003, J BIOL CHEM, V278, P15225, DOI 10.1074/jbc.M212639200; Boyadjiev SA, 2011, CLIN GENET, V80, P169, DOI 10.1111/j.1399-0004.2010.01550.x; Charcosset M, 2008, MOL GENET METAB, V93, P74, DOI 10.1016/j.ymgme.2007.08.120; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Comtesse N, 2002, ONCOGENE, V21, P239, DOI 10.1038/sj.onc.1205005; Comtesse N, 2001, GENOMICS, V75, P43, DOI 10.1006/geno.2001.6576; Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Guinn BA, 2006, BRIT J HAEMATOL, V134, P238, DOI 10.1111/j.1365-2141.2006.06135.x; Hariri H, 2014, J MOL BIOL, V426, P3811, DOI 10.1016/j.jmb.2014.08.023; Heckel D, 1997, HUM MOL GENET, V6, P2031; Hellerbrand C, 2005, LIVER INT, V25, P357, DOI 10.1111/j.1478-3231.2005.01099.x; Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200; Ishikawa Y, 2015, BBA-GEN SUBJECTS, V1850, P1983, DOI 10.1016/j.bbagen.2014.12.024; Ishikura-Kinoshita S, 2012, J INVEST DERMATOL, V132, P2010, DOI 10.1038/jid.2012.103; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; Johnson A, 2015, EMBO J, DOI 10.15252/embj.201489032; Kong B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08109; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; Kung LF, 2012, EMBO J, V31, P1014, DOI 10.1038/emboj.2011.444; Kurihara M, 2013, BRIT J CANCER, V108, P1460, DOI 10.1038/bjc.2013.27; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Lui WO, 2008, CANCER RES, V68, P7156, DOI 10.1158/0008-5472.CAN-08-1085; Malhotra V, 2015, BIOCHEM SOC T, V43, P104, DOI 10.1042/BST20140286; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mcmahon C, 2012, J BIOL CHEM, V287, P43599, DOI 10.1074/jbc.M112.420141; Melville DB, 2011, DIS MODEL MECH, V4, P763, DOI 10.1242/dmm.007625; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Montegna EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031156; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Niu XB, 2012, DEV BIOL, V367, P197, DOI 10.1016/j.ydbio.2012.05.004; Niu XB, 2014, J BIOL CHEM, V289, P11971, DOI 10.1074/jbc.M114.547190; Nogueira C, 2014, ELIFE, V3, DOI 10.7554/eLife.02784; O'Donnell J, 2011, J STRUCT BIOL, V173, P358, DOI 10.1016/j.jsb.2010.09.002; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Ong YS, 2010, J CELL BIOL, V190, P331, DOI 10.1083/jcb.201003005; Pagant S, 2015, CURR BIOL, V25, P403, DOI 10.1016/j.cub.2014.11.070; Peretti N, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-24; Pitman JL, 2011, J LIPID RES, V52, P1775, DOI 10.1194/jlr.M017277; SABESIN SM, 1977, J LIPID RES, V18, P496; Saito K, 2014, J CELL BIOL, V206, P751, DOI 10.1083/jcb.201312062; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schmidt K, 2013, BIOL OPEN, V2, P256, DOI 10.1242/bio.20133251; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200; Stephens DJ, 2002, J CELL SCI, V115, P1149; Stoll R, 2001, EMBO J, V20, P340, DOI 10.1093/emboj/20.3.340; Usener D, 2003, J INVEST DERMATOL, V121, P198, DOI 10.1046/j.1523-1747.2003.12318.x; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Whittle JRR, 2010, J CELL BIOL, V190, P347, DOI 10.1083/jcb.201003092; Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225; Yoshibori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040765; Zanetti G, 2013, ELIFE, V2, DOI 10.7554/eLife.00951	138	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	OCT	2015	72	19					3709	3720		10.1007/s00018-015-1952-9		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CR1FK	WOS:000361069800008		
J	Lin, YM; Li, B; Feng, ZB; Kim, YA; Endo, M; Su, DS				Lin, Yangming; Li, Bo; Feng, Zhenbao; Kim, Yoong Ahm; Endo, Morinobu; Su, Dang Sheng			Efficient Metal-Free Catalytic Reaction Pathway for Selective Oxidation of Substituted Phenols	ACS CATALYSIS			English	Article						onion-like carbon; molecular model catalysts; phenol; selective oxidation; metal-free	ONION-LIKE CARBON; HYDROGEN-PEROXIDE; P-BENZOQUINONES; ACTIVE-SITES; 2,6-DIMETHYLPHENOL; DEHYDROGENATION; NANOTUBES; REDUCTION; 2,6-DIMETHYL-1,4-BENZOQUINONE; HETEROPOLYCOMPOUNDS	Selective oxidation of substituted phenols to p-benzoquinones is known to be inefficient because of the competing C-O coupling reaction caused by phenoxy radicals. The poor stability of conventional metal-based catalysts represents another bottleneck for industrial application. Here, we describe a metal-free reaction pathway in which onion-like carbon (OLC) as a low-cost catalyst exhibits excellent catalytic activity and stability in the selective oxidation of mono-, di- and trisubstituted phenols to their corresponding p-benzoquinones, even better than the reported metal-based catalysts (e.g., yield, stability) and industrial catalysts for particular substrates. Together with XPS, Raman, DFT calculations, and a series of comparative experiments, we demonstrate that the zigzag configuration as a type of carbon defects may play a crucial role in these reactions by stabilizing the intermediate phenoxy radicals.	[Lin, Yangming; Li, Bo; Feng, Zhenbao; Su, Dang Sheng] Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China; [Lin, Yangming] Univ Sci & Technol China, Sch Chem & Mat Sci, Hefei 230001, Peoples R China; [Kim, Yoong Ahm] Chonnam Natl Univ, Sch Polymer Sci & Engn, Kwangju 500757, South Korea; [Endo, Morinobu] Shinshu Univ, Carbon Inst Sci & Technol, Nagano 3808553, Japan; [Su, Dang Sheng] Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, D-14195 Berlin, Germany	Su, DS (reprint author), Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China.	dssu@imr.ac.cn	Li, Bo /B-8847-2012		MOST [2011CBA00504]; NSFC of China [21133010, 51221264, 21261160487]; Chinese Academy of Sciences [XDA09030103]; Institute of Metal Research [Y3NBA211A1]	The authors thank Dr. Linhui Yu, Bingsen Zhang, Jia Wang, Rui Huang, and Kuang-Hsu Wu for their kind help during this study. The authors acknowledge financial support from MOST (2011CBA00504); NSFC of China (21133010, 51221264, 21261160487); and the "Strategic Priority Research Program" of the Chinese Academy of Sciences, Grant No. XDA09030103. Bo Li is grateful for a financial grant from the Institute of Metal Research (Y3NBA211A1). The computing time was partly allocated from ShenYang Branch, Supercomputing Center of CAS.	Cao YH, 2014, ACS CATAL, V4, P1617, DOI 10.1021/cs500187q; Wienhofer G, 2010, ADV SYNTH CATAL, V352, P1615, DOI 10.1002/adsc.201000137; Esguerra KVN, 2014, J AM CHEM SOC, V136, P7662, DOI 10.1021/ja501789x; Lin YM, 2014, ACS NANO, V8, P7823, DOI 10.1021/nn501286v; Ivanchikova ID, 2014, CATAL SCI TECHNOL, V4, P200, DOI 10.1039/c3cy00615h; Cheneviere Y, 2010, APPL CATAL A-GEN, V387, P129, DOI 10.1016/j.apcata.2010.08.018; Takaki K, 2002, B CHEM SOC JPN, V75, P311, DOI 10.1246/bcsj.75.311; Chen CM, 2012, J MATER CHEM, V22, P14076, DOI 10.1039/c2jm31426f; Kholdeeva OA, 2014, CATAL SCI TECHNOL, V4, P1869, DOI 10.1039/c4cy00087k; Zhang J, 2008, SCIENCE, V322, P73, DOI 10.1126/science.1161916; Song SQ, 2010, CATAL COMMUN, V11, P783, DOI 10.1016/j.catcom.2010.02.015; Lin Y, 2015, CHEM COMMUN, V51, P13086, DOI 10.1039/c5cc01963j; Su DS, 2013, CHEM REV, V113, P5782, DOI 10.1021/cr300367d; Qi W, 2014, ACS CATAL, V4, P3212, DOI 10.1021/cs500723v; Wu SC, 2014, CHEMCATCHEM, V6, P1558, DOI 10.1002/cctc.201402070; Enoki T, 2007, INT REV PHYS CHEM, V26, P609, DOI 10.1080/01442350701611991; Shenderova O, 2008, DIAM RELAT MATER, V17, P462, DOI 10.1016/j.diamond.2007.08.023; Gao YJ, 2013, ANGEW CHEM INT EDIT, V52, P2109, DOI 10.1002/anie.201207918; Kobayashi S, 2003, PROG POLYM SCI, V28, P1015, DOI 10.1016/S0079-6700(03)00014-5; Bogdanov K, 2014, CARBON, V73, P78, DOI 10.1016/j.carbon.2014.02.041; Murahashi S, 1996, J AM CHEM SOC, V118, P2509, DOI 10.1021/ja954009q; Lin YM, 2014, J MATER CHEM A, V2, P12475, DOI 10.1039/c4ta01611d; Saladino R, 2002, TETRAHEDRON, V58, P8493, DOI 10.1016/S0040-4020(02)01025-6; Li WJ, 2014, ACS CATAL, V4, P1261, DOI 10.1021/cs500062s; Villabrille P, 2008, APPL CATAL A-GEN, V334, P374, DOI 10.1016/j.apcata.2007.10.025; Holec D, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235403; Allen SE, 2013, CHEM REV, V113, P6234, DOI 10.1021/cr300527g; Yang JH, 2013, ENERG ENVIRON SCI, V6, P793, DOI 10.1039/c3ee23623d; Villabrille P, 2004, APPL CATAL A-GEN, V270, P101, DOI 10.1016/j.apcata.2004.04.028; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; Chai GL, 2014, J AM CHEM SOC, V136, P13629, DOI 10.1021/ja502646c; Li S, 2012, J PHYS CHEM LETT, V3, P2465, DOI 10.1021/jz3009387; Gupta KC, 2008, COORDIN CHEM REV, V252, P1420, DOI 10.1016/j.ccr.2007.09.005; SHELDON RA, 1994, CATAL TODAY, V19, P215, DOI 10.1016/0920-5861(94)80186-X; Keller N, 2002, ANGEW CHEM INT EDIT, V41, P1885, DOI 10.1002/1521-3773(20020603)41:11<1885::AID-ANIE1885>3.0.CO;2-5; Lee YE, 2014, J AM CHEM SOC, V136, P6782, DOI 10.1021/ja500183z; Moller K, 2010, CHEM-EUR J, V16, P10300, DOI 10.1002/chem.201001429; Pech D, 2010, NAT NANOTECHNOL, V5, P651, DOI [10.1038/nnano.2010.162, 10.1038/NNANO.2010.162]; Boldron C, 2005, CHEM COMMUN, P5808, DOI 10.1039/b510378a; Ivanchikova ID, 2014, ACS CATAL, V4, P2706, DOI 10.1021/cs500738e; Li Y, 2009, CHEM ENG J, V146, P270, DOI 10.1016/j.cej.2008.09.031; Mohapatra SK, 2003, CATAL COMMUN, V4, P57, DOI 10.1016/S1566-7367(02)00257-1; ZOMBECK A, 1981, J AM CHEM SOC, V103, P7580, DOI 10.1021/ja00415a027; Bohle A, 2006, ADV SYNTH CATAL, V348, P1011, DOI 10.1002/adsc.200505491; Braxton J. H. G., 1965, U. S. Patent, Patent No. [3,213,114, 3213114]; Costantini M., 1980, U. S. Patent, Patent No. [4,208,339, 4208339]; Died H. K., 1982, U. S. Patent, Patent No. [4,360,469, 4360469]; Finley K. T., 1988, QUINONOID COMPOUNDS, V1, P537; Fishwick C.W. G., 1988, QUINONOID COMPOUNDS, V1, P403; Frisch M.J., 2009, GAUSSIAN 09; Hay A., 1967, US Patent, Patent No. [3,306,874, 3306874]; Kholdeeva O. A., 2005, J CATAL, V236, P62; Mariarty R. M., 2004, ORG REACTIONS, P327; Michelet D., 1975, U. S. Patent, Patent No. [3,927,045, 3927045]; Molander G. A., 2014, COMPREHENSIVE ORGANI, V3, P56; Pommer H., 1972, U. S. Patent, Patent No. [3,658,852, 3658852]; Rappoport Z., 2003, OXIDATION OF PHENOLS, P1153, DOI [10.1002/0470857277.ch17, DOI 10.1002/0470857277.CH17]; Reilly E. L., 1981, U. S. Patent, Patent No. [4,257,968, 4257968]; Rutledge T., 1974, U. S. Patent, Patent No. [3,784,575, 3784575]; TANEV PT, 1994, NATURE, V368, P321, DOI 10.1038/368321a0	60	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	OCT	2015	5	10					5921	5926		10.1021/acscatal.5b01222		6	Chemistry, Physical	Chemistry	CS9EI	WOS:000362391500027		
J	Ichitsuka, T; Fujita, T; Ichikawa, J				Ichitsuka, Tomohiro; Fujita, Takeshi; Ichikawa, Junji			Nickel-Catalyzed Allylic C(sp(3))-F Bond Activation of Trifluoromethyl Groups via beta-Fluorine Elimination: Synthesis of Difluoro-1,4-dienes	ACS CATALYSIS			English	Article						C-F bond activation; nickel catalysis; trifluoromethylalkenes; alkynes; 1,4-dienes; beta-fluorine elimination	C-F ACTIVATION; GEM-DIFLUOROALKENES; REDUCTIVE COUPLINGS; OXIDATIVE-ADDITION; BUILDING-BLOCKS; ALKYNES; COMPLEXES; REGIOSELECTIVITY; SUBSTITUTION; CYCLIZATIONS	The nickel-catalyzed defluorinative coupling of 2-trifluoromethyl-1-alkenes and alkynes with the aid of Et3SiH provides 1,1-difluoro-1,4-dienes under mild reaction conditions. This reaction involves selective allylic C(sp(3))-F bond activation via beta-fluorine elimination from nickelacyclopentenes.	[Ichitsuka, Tomohiro; Fujita, Takeshi; Ichikawa, Junji] Univ Tsukuba, Fac Pure & Appl Sci, Div Chem, Tsukuba, Ibaraki 3058571, Japan	Ichikawa, J (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Chem, Tsukuba, Ibaraki 3058571, Japan.	junji@chem.tsukuba.ac.jp			JSPS [26870079];  [25288016]	This work was supported by the Grant-in-Aid for Scientific Research (B) (No. 25288016) and the Grant-in-Aid for Young Scientists (B) (No. 26870079) from JSPS. We acknowledge Tosoh F-Tech, Inc. for a generous gift of 2-bromo-3,3,3trifluoropropene.	Ahrens T, 2015, CHEM REV, V115, P931, DOI 10.1021/cr500257c; Amii H, 1999, CHEM COMMUN, P1323, DOI 10.1039/a903681d; Miura T, 2008, CHEM LETT, V37, P1006, DOI 10.1246/cl.2008.1006; Nakamura Y, 2012, ORG LETT, V14, P3316, DOI 10.1021/ol301195x; Ichikawa J, 2007, CHIM OGGI, V25, P54; Ichikawa J, 2002, SYNTHESIS-STUTTGART, P1917; IKEDA S, 1994, J AM CHEM SOC, V116, P5975, DOI 10.1021/ja00092a061; Fischer P, 2012, ORGANOMETALLICS, V31, P1374, DOI 10.1021/om2009815; Zhang ZK, 2015, ORG LETT, V17, P2474, DOI 10.1021/acs.orglett.5b00980; Ohashi M, 2014, ANGEW CHEM INT EDIT, V53, P13578, DOI 10.1002/anie.201408467; Burdeniuc J, 1997, CHEM BER-RECL, V130, P145, DOI 10.1002/cber.19971300203; Tobisu M, 2011, J AM CHEM SOC, V133, P19505, DOI 10.1021/ja207759e; Ichitsuka T, 2014, ANGEW CHEM INT EDIT, V53, P7564, DOI 10.1002/anie.201402695; Qiu XL, 2002, J ORG CHEM, V67, P7162, DOI 10.1021/jo0257400; Narumi T, 2007, ORG LETT, V9, P3465, DOI 10.1021/ol701627v; Tillack A, 1997, J ORGANOMET CHEM, V532, P117, DOI 10.1016/S0022-328X(96)06734-4; Liu P, 2011, J AM CHEM SOC, V133, P6956, DOI 10.1021/ja202007s; Zell T, 2011, DALTON T, V40, P1852, DOI 10.1039/c0dt01442g; Ichikawa J, 2000, PURE APPL CHEM, V72, P1685, DOI 10.1351/pac200072091685; Magueur G, 2006, J FLUORINE CHEM, V127, P637, DOI 10.1016/j.jfluchem.2005.12.013; Corberan R, 2011, ANGEW CHEM INT EDIT, V50, P7079, DOI 10.1002/anie.201102398; Iida T, 2012, ANGEW CHEM INT EDIT, V51, P9535, DOI 10.1002/anie.201203588; Montgomery J, 1996, J AM CHEM SOC, V118, P2099, DOI 10.1021/ja952026+; Kuhl S, 2003, ADV SYNTH CATAL, V345, P341, DOI 10.1002/adsc.200390036; Fuchibe K, 2015, ORG LETT, V17, P1126, DOI 10.1021/ol503759d; Kuehnel MF, 2013, ANGEW CHEM INT EDIT, V52, P3328, DOI 10.1002/anie.201205260; Montgomery J, 2004, ANGEW CHEM INT EDIT, V43, P3890, DOI 10.1002/anie.200300634; Moslin RM, 2007, CHEM COMMUN, P4441, DOI 10.1039/b707737h; Fuchibe K, 2012, ANGEW CHEM INT EDIT, V51, P12059, DOI 10.1002/anie.201206946; Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Hazari A, 2009, ANGEW CHEM INT EDIT, V48, P1296, DOI 10.1002/anie.200804310; Clot E, 2011, ACCOUNTS CHEM RES, V44, P333, DOI 10.1021/ar100136x; Hu MY, 2013, J AM CHEM SOC, V135, P17302, DOI 10.1021/ja409941r; Chaulagain MR, 2006, TETRAHEDRON, V62, P7560, DOI 10.1016/j.tet.2006.03.120; Fuchibe K, 2009, ANGEW CHEM INT EDIT, V48, P8070, DOI 10.1002/anie.200901986; Iluc VM, 2006, TETRAHEDRON, V62, P7577, DOI 10.1016/j.tet.2006.05.055; MOORE WR, 1992, J AM CHEM SOC, V114, P360, DOI 10.1021/ja00027a056; Gao B, 2015, ANGEW CHEM INT EDIT, V54, P638, DOI 10.1002/anie.201409705; Liu P, 2010, J AM CHEM SOC, V132, P2050, DOI 10.1021/ja909562y; Stahl T, 2013, ACS CATAL, V3, P1578, DOI 10.1021/cs4003244; Pigeon X, 2010, ANGEW CHEM INT EDIT, V49, P1123, DOI 10.1002/anie.200904747; LAPPERT MF, 1974, J ORGANOMET CHEM, V80, P329, DOI 10.1016/S0022-328X(00)80011-X; BOBEK M, 1987, J MED CHEM, V30, P1494, DOI 10.1021/jm00391a036; Dai WP, 2014, J ORG CHEM, V79, P10537, DOI 10.1021/jo5022234; Sun AD, 2011, ORG LETT, V13, P2750, DOI 10.1021/ol200860t; Jin Z, 2012, CHEM-EUR J, V18, P446, DOI 10.1002/chem.201103050; Hintermann L, 2006, EUR J INORG CHEM, P1397, DOI 10.1002/ejic.20500795; Ichikawa J., 2010, YUKI GOSEI KAGAKU KY, V68, P1175; Ichikawa J, 2006, CHEM COMMUN, P4425, DOI 10.1039/b610690k; Ikeda S, 2000, ACCOUNTS CHEM RES, V33, P511, DOI 10.1021/ar9901016; Montgomery J, 2000, ACCOUNTS CHEM RES, V33, P467, DOI 10.1021/ar990095d; Terao J, 2009, CHEM COMMUN, P6011, DOI 10.1039/b915620h; Unzner TA, 2015, TETRAHEDRON LETT, V56, P877, DOI 10.1016/j.tetlet.2014.12.145; Weaver J, 2014, TETRAHEDRON, V70, P7413, DOI 10.1016/j.tet.2014.06.004; Wu GJ, 2014, EUR J ORG CHEM, P4477, DOI 10.1002/ejoc.201402597	55	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	OCT	2015	5	10					5947	5950		10.1021/acscatal.5b01463		4	Chemistry, Physical	Chemistry	CS9EI	WOS:000362391500031		
J	Watarai, A; Schirmer, L; Thones, S; Freudenberg, U; Werner, C; Simon, JC; Anderegg, U				Watarai, Akira; Schirmer, Lucas; Thoenes, Stephan; Freudenberg, Uwe; Werner, Carsten; Simon, Jan C.; Anderegg, Ulf			TGF beta functionalized starPEG-heparin hydrogels modulate human dermal fibroblast growth and differentiation	ACTA BIOMATERIALIA			English	Article						starPEG; Heparin; Hydrogels; Wound healing; Myofibroblast; Alpha-smooth muscle actin (alpha SMA); Extracellular matrix (ECM); Metalloprotease (MMP)	MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-1; MECHANICAL-PROPERTIES; FACTOR DELIVERY; CELL-ADHESION; COLLAGEN I; PROTEIN; REGENERATION; TGF-BETA-1	Hydrogels are promising biomaterials that can adapt easily to complex tissue entities. Furthermore, chemical modifications enable these hydrogels to become an instructive biomaterial to a variety of cell types. Human dermal fibroblasts play a pivotal role during wound healing, especially for the synthesis of novel dermal tissue replacing the primary fibrin clot. Thus, the control of growth and differentiation of dermal fibroblasts is important to modulate wound healing. In here, we utilized a versatile starPEG-heparin hydrogel platform that can be independently adjusted with respect to mechanical and biochemical properties for cultivating human dermal fibroblasts. Cell-based remodeling of the artificial matrix was ensured by using matrix metalloprotease (MMP) cleavable crosslinker peptides. Attachment and proliferation of fibroblasts on starPEG-heparin hydrogels of differing stiffness, density of pro-adhesive RGD peptides and MMP cleavable peptide linkers were tested. Binding and release of human TGF beta(1) as well as biological effect of the pre-adsorbed growth factor on fibroblast gene expression and myofibroblast differentiation were investigated. Hydrogels containing RGD peptides supported fibroblast attachment, spreading, proliferation matrix deposition and remodeling compared to hydrogels without any modifications. Reversibly conjugated TGF beta(1) was demonstrated to be constantly released from starPEG-heparin hydrogels for several days and capable of inducing myofibroblast differentiation of fibroblasts as determined by induction of collagen type I, ED-A-Fibronectin expression and incorporation of alpha smooth muscle actin and palladin into F-actin stress fibers. Taken together, customized starPEG-heparin hydrogels could be of value to promote dermal wound healing by stimulating growth and differentiation of human dermal fibroblasts. Statement of Significance The increasing number of people of advanced age within the population results in an increasing demand for the treatment of non-healing wounds. Hydrogels are promising biomaterials for the temporary closure of large tissue defects: They can adapt to complex tissue geometry and can be engineered for specific tissue needs. We used a starPEG-heparin hydrogel platform that can be independently adjusted to mechanical and biochemical characteristics. We investigated how these hydrogels can support attachment, proliferation and differentiation of dermal fibroblasts. After introducing adhesive peptides these hydrogels support cell attachment and proliferation. Moreover, TGF beta - an essential growth and differentiation factor for fibroblasts - can be immobilized reversibly and functionally on these hydrogels. Thus, starPEG-heparin hydrogels could be developed to bioactive temporary wound dressings. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Watarai, Akira; Thoenes, Stephan; Simon, Jan C.; Anderegg, Ulf] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany; [Schirmer, Lucas; Freudenberg, Uwe; Werner, Carsten] Tech Univ Dresden, Leibniz Inst Polymer Res, Dresden, Germany; [Watarai, Akira] Kitasato Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Anderegg, U (reprint author), Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany.	ulf.anderegg@medizin.uni-leipzig.de	Werner, Carsten/F-8127-2010; Umlauf, Ursula/D-3356-2014; Schirmer, Lucas/P-9635-2015	Werner, Carsten/0000-0003-0189-3448; Schirmer, Lucas/0000-0003-1132-808X	Deutsche Forschungsgemeinschaft [TRR 67];  [TRR67]	Authors gratefully acknowledge the financial support of the Deutsche Forschungsgemeinschaft (TRR 67 collaborative research group (Projects B4 to UA, A10 to UF and CW, B3 to JS). AW received a TRR67 scholarship award. And, we like to thank Sibylle Vorberg and Armen Majok for excellent assistance, as well as Mikhail Tsurkan, Marcus Binner and Nelly Rein for their major support and providing the materials this study was based on.	Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441; Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021; Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Zieris A, 2011, J CONTROL RELEASE, V156, P28, DOI 10.1016/j.jconrel.2011.06.042; Tsurkan MV, 2010, MACROMOL RAPID COMM, V31, P1529, DOI 10.1002/marc.201000155; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; van der Smissen A, 2013, ACTA BIOMATER, V9, P7775, DOI 10.1016/j.actbio.2013.04.023; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; AGACHE PG, 1980, ARCH DERMATOL RES, V269, P221, DOI 10.1007/BF00406415; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002; Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002; Miyazaki K, 2012, EXP CELL RES, V318, P1716, DOI 10.1016/j.yexcr.2012.05.006; Webster R, 2009, MILESTONES DRUG THER, P127, DOI 10.1007/978-3-7643-8679-5_8; Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049; Freudenberg U, 2012, ADV FUNCT MATER, V22, P1391, DOI 10.1002/adfm.201101868; Tsurkan MV, 2013, J CONTROL RELEASE, V167, P248, DOI 10.1016/j.jconrel.2013.01.030; VINCENT S, 1993, NUCLEIC ACIDS RES, V21, P1498, DOI 10.1093/nar/21.6.1498; Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68; Chwalek K, 2011, BIOMATERIALS, V32, P9649, DOI 10.1016/j.biomaterials.2011.08.078; Weitz DS, 2010, J THROMB THROMBOLYS, V29, P199, DOI 10.1007/s11239-009-0411-6; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Zieris A, 2010, J MATER SCI-MATER M, V21, P915, DOI 10.1007/s10856-009-3913-z; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Zahouani H, 2009, SKIN RES TECHNOL, V15, P68, DOI 10.1111/j.1600-0846.2008.00329.x; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Boresi A.P., 2003, ADV MECH MAT, V6; Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414; Clark RAF, 1996, MOL CELLULAR BIOL WO; Fields G. B., 1996, PEPT SCI, V40, P399; Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012; van der Smissen A, 2011, BIOMATERIALS, V32, P8938, DOI 10.1016/j.biomaterials.2011.08.025	42	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	OCT 1	2015	25						65	75		10.1016/j.actbio.2015.07.036		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CS2WX	WOS:000361933800007		
J	Ito, A; Sogo, Y; Yamazaki, A; Aizawa, M; Osaka, A; Hayakawa, S; Kikuchi, M; Yamashita, K; Tanaka, Y; Tadokoro, M; de Sena, LA; Buchanan, F; Ohgushi, H; Bohner, M				Ito, Atsuo; Sogo, Yu; Yamazaki, Atsushi; Aizawa, Mamoru; Osaka, Akiyoshi; Hayakawa, Satoshi; Kikuchi, Masanori; Yamashita, Kimihiro; Tanaka, Yumi; Tadokoro, Mika; de Sena, Lidia Agata; Buchanan, Fraser; Ohgushi, Hajime; Bohner, Marc			Interlaboratory studies on in vitro test methods for estimating in vivo resorption of calcium phosphate ceramics	ACTA BIOMATERIALIA			English	Article						Dissolution; Calcium phosphate; Resorption; Round-robin test	BETA-TRICALCIUM PHOSPHATE; BONE-GRAFT SUBSTITUTES; PHAGOLYSOSOMAL PH; DISSOLUTION; MODEL; BEHAVIOR; HYDROXYAPATITE; MACROPHAGES; SOLUBILITY; ZINC	A potential standard method for measuring the relative dissolution rate to estimate the resorbability of calcium-phosphate-based ceramics is proposed. Tricalcium phosphate (TCP), magnesium-substituted TCP (MgTCP) and zinc-substituted TCP (ZnTCP) were dissolved in a buffer solution free of calcium and phosphate ions at pH 4.0, 5.5 or 7.3 at nine research centers. Relative values of the initial dissolution rate (relative dissolution rates) were in good agreement among the centers. The relative dissolution rate coincided with the relative volume of resorption pits of ZnTCP in vitro. The relative dissolution rate coincided with the relative resorbed volume in vivo in the case of comparison between microporous MgTCPs with different Mg contents and similar porosity. However, the relative dissolution rate was in poor agreement with the relative resorbed volume in vivo in the case of comparison between microporous TCP and MgTCP due to the superimposition of the Mg-mediated decrease in TCP solubility on the Mg-mediated increase in the amount of resorption. An unambiguous conclusion could not be made as to whether the relative dissolution rate is predictive of the relative resorbed volume in vivo in the case of comparison between TCPs with different porosity. The relative dissolution rate may be useful for predicting the relative amount of resorption for calcium-phosphate-based ceramics having different solubility under the condition that the differences in the materials compared have little impact on the resorption process such as the number and activity of resorbing cells. Statement of significance The evaluation and subsequent optimization of the resorbability of calcium phosphate are crucial in the use of resorbable calcium phosphates. Although the resorbability of calcium phosphates has usually been evaluated in vivo, establishment of a standard in vitro method that can predict in vivo resorption is beneficial for accelerating development and commercialization of new resorbable calcium phosphate materials as well as reducing use of animals. However, there are only a few studies to propose such an in vitro method within which direct comparison was carried out between in vitro and in vivo resorption. We propose here an in vitro method based on measuring dissolution rate. The efficacy and limitations of the method were evaluated by international round-robin tests as well as comparison with in vivo resorption studies for future standardization. This study was carried out as one of Versailles Projects on Advanced Materials and Standards (VAMAS). (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Ito, Atsuo; Sogo, Yu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan; [Yamazaki, Atsushi] Waseda Univ, Dept Resources & Environm Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Aizawa, Mamoru] Meiji Univ, Sch Sci & Technol, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Osaka, Akiyoshi; Hayakawa, Satoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med & Bioengn Sci, Okayama, Okayama 7008530, Japan; [Kikuchi, Masanori] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Yamashita, Kimihiro; Tanaka, Yumi] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; [Tadokoro, Mika; Ohgushi, Hajime] Natl Inst Adv Ind Sci & Technol, Amagasaki, Hyogo 6610974, Japan; [de Sena, Lidia Agata] Inst Nacl Metrol Qualidade & Tecnol Inmetro, Diretoria Metrol Cient & Ind Dimci, Div Metrol Mat Dimat, BR-25250020 Xerem Duque De Caxias, RJ, Brazil; [Buchanan, Fraser] Queens Univ, Sch Mech & Aerosp Engn, Belfast BT9 5AH, Antrim, North Ireland; [Bohner, Marc] RMS Fdn, CH-2544 Bettlach, Switzerland	Ito, A (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.	atsuo-ito@aist.go.jp	HAYAKAWA, Satoshi/B-2104-2011	HAYAKAWA, Satoshi/0000-0002-1097-8614	CNPq, Brazil [PROMETRO/CNPq 370823/2011-7]; JST, Japan	We acknowledge Koji Senda, Shu Ihara and Shunxin Guo at Waseda University; Tokoha Sakurai and Kazuko Yoshiyuki at National Institute of Advanced Industrial Science and Technology; Dr. Yasutaka Yamada at University of Tsukuba; Jun Fukasawa at Meiji University; and Reto Luginbuehl, Benjamin Andreatta and Dmitriy Alexeev at RMS Foundation for their technical assistance. Lidia Agata de Sena acknowledges CNPq, Brazil for the fellowship (PROMETRO/CNPq 370823/2011-7). Atsuo Ito and Hajime Ohgushi acknowledge JST, Japan for Special Coordination Funds for Promoting Science and Technology.	Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P837, DOI 10.1016/j.msec.2006.09.036; von Doernberg MC, 2006, BIOMATERIALS, V27, P5186, DOI 10.1016/j.biomaterials.2006.05.051; Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014; Chow LC, 2003, J BIOMED MATER RES B, V65B, P245, DOI 10.1002/jmb.b.10009; Schaefer S, 2011, ADV ENG MATER, V13, P342, DOI 10.1002/adem.201000267; Bloebaum RD, 1998, J BIOMED MATER RES, V40, P104, DOI 10.1002/(SICI)1097-4636(199804)40:1<104::AID-JBM12>3.0.CO;2-O; Yamada Y, 2008, J BIOMED MATER RES A, V84A, P344, DOI 10.1002/jbm.a.31265; Ito A, 2002, J BIOMED MATER RES, V60, P224, DOI 10.1002/jbm.10068; Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035; NYBERG K, 1992, ENVIRON HEALTH PERSP, V97, P149, DOI 10.2307/3431344; [Anonymous], F1926F1926M08 ASTM; Kalita SJ, 2006, J AM CERAM SOC, V89, P875, DOI 10.1111/j.1551-2916.2005.00854.x; Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112; Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032; Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663; DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105; Tang RK, 2003, J COLLOID INTERF SCI, V260, P379, DOI 10.1016/S0021-9797(03)00048-12; Li X, 2009, ACTA BIOMATER, V5, P508, DOI 10.1016/j.actbio.2008.06.010; KLEIN CPAT, 1986, BIOMATERIALS, V7, P144; Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J; Yokozeki H, 1998, J MATER SCI-MATER M, V9, P381, DOI 10.1023/A:1013279412600; del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432; Szpalski M, 2002, ORTHOPEDICS, V25, pS601; Bashoor-Zadeh M, 2011, BIOMATERIALS, V32, P6362, DOI 10.1016/j.biomaterials.2011.05.030; Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; VERBEECK RMH, 1986, B SOC CHIM BELG, V95, P455; Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; Chen ZT, 2014, BIOMATERIALS, V35, P8553, DOI 10.1016/j.biomaterials.2014.06.038; Winkler T, 2010, ACTA BIOMATER, V6, P4127, DOI 10.1016/j.actbio.2010.04.015; Tang RK, 2001, LANGMUIR, V17, P3480, DOI 10.1021/la001730n; Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010; Bohner M, 1997, J COLLOID INTERF SCI, V190, P37, DOI 10.1006/jcis.1997.4846; Zhang ZY, 2012, ACTA BIOMATER, V8, P13, DOI 10.1016/j.actbio.2011.09.020; Cameron Hugh U., 1992, Contemporary Orthopaedics, V25, P506; CECH P, 1984, BLOOD, V63, P88; Davison NL, 2014, BIOMATERIALS, V35, P5088, DOI 10.1016/j.biomaterials.2014.03.013; Herron Scott, 2003, Am J Orthop (Belle Mead NJ), V32, P581; McAndrew M P, 1988, J Orthop Trauma, V2, P333, DOI 10.1097/00005131-198802040-00011; Wu L., 2014, ACTA BIOMATER	42	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	OCT 1	2015	25						347	355		10.1016/j.actbio.2015.07.040		9	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CS2WX	WOS:000361933800032		
J	Koiso, M; Palmer, B; Piccione, P				Koiso, Miyuki; Palmer, Bennett; Piccione, Paolo			Bifurcation and symmetry breaking of nodoids with fixed boundary	ADVANCES IN CALCULUS OF VARIATIONS			English	Article						Delaunay surfaces; equivariant bifurcation; constant mean curvature surfaces	CONSTANT MEAN-CURVATURE; SURFACES; STABILITY	We prove bifurcation results for (compact portions of) nodoids in R-3, whose boundary consists of two fixed coaxial circles of the same radius lying in parallel planes. Degeneracy occurs at an infinite discrete sequence of instants, that are divided into four classes. Different types of bifurcation and break of symmetry occur at each instant of three of the four classes; bifurcation does not occur at the degeneracy instants of the fourth class.	[Koiso, Miyuki] Kyushu Univ, Inst Math Ind, Nishi Ku, Fukuoka 8190395, Japan; [Palmer, Bennett] Idaho State Univ, Dept Math, Pocatello, ID 83209 USA; [Piccione, Paolo] Univ Sao Paulo, Dept Matemat, Inst Matemat & Estat, BR-05508900 Sao Paulo, SP, Brazil	Koiso, M (reprint author), Kyushu Univ, Inst Math Ind, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	koiso@math.kyushu-u.ac.jp; palmbenn@isu.edu; piccione.p@gmail.com			Japan Society for the Promotion of Science [25287012]; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Fapesp, Brazil; CNPq, Brazil	The first author is partially supported by Grant-in-Aid for Scientific Research (B) No. 25287012 of the Japan Society for the Promotion of Science, and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development. The third author is partially supported by Fapesp and CNPq, Brazil.	Koiso M, 2005, INDIANA U MATH J, V54, P1817, DOI 10.1512/iumj.2005.54.2613; Slobozhanin LA, 1997, PHYS FLUIDS, V9, P1893, DOI 10.1063/1.869310; Koiso M, 2007, CALC VAR PARTIAL DIF, V29, P295, DOI 10.1007/s00526-006-0066-5; SMOLLER J, 1990, INVENT MATH, V100, P63, DOI 10.1007/BF01231181; Alias LJ, 1999, P AM MATH SOC, V127, P1195, DOI 10.1090/S0002-9939-99-04950-3; BARBOSA JL, 1988, MATH Z, V197, P123, DOI 10.1007/BF01161634; Koiso M, 2002, TOHOKU MATH J, V54, P145, DOI 10.2748/tmj/1113247184; Alias LJ, 2013, J GEOM ANAL, V23, P677, DOI 10.1007/s12220-011-9260-6; Rossman W, 2005, EXP MATH, V14, P331, DOI 10.1080/10586458.2005.10128929; Courant R., 1953, METHODS MATH PHYS, VI; Crandall Michael G., 1971, J FUNCT ANAL, V8, P321, DOI DOI 10.1016/0022-1236(71)90015-2; Delaunay C., 1841, J MATH PURES APPL 1, V5, P309; Gilbarg D., 2001, CLASSICS MATH; Grosse-Brauckmann K., PROGR SURF THEOR M, P29; Hirsch M. W., 1994, GRAD TEXTS MATH, V33; Kato T., 1995, CLASSICS MATH; Koiso M., STABILITY BIFU UNPUB; Mazzeo R., 2002, CONT MATH, V314, P169; Patnaik U., 1994, THESIS U TOLEDO; Rossman W., 2008, TOKYO J MATH, V31, P161, DOI 10.3836/tjm/1219844829	20	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1864-8258	1864-8266		ADV CALC VAR	Adv. Calc. Var.	OCT	2015	8	4					337	370		10.1515/acv-2014-0011		34	Mathematics, Applied; Mathematics	Mathematics	CS6WR	WOS:000362224600003		
J	Morino, Y; Nagashima, T; Sugata, S; Sato, K; Tanabe, K; Noguchi, T; Takami, A; Tanimoto, H; Ohara, T				Morino, Yu; Nagashima, Tatsuya; Sugata, Seiji; Sato, Kei; Tanabe, Kiyoshi; Noguchi, Tadayoshi; Takami, Akinori; Tanimoto, Hiroshi; Ohara, Toshimasa			Verification of Chemical Transport Models for PM2.5 Chemical Composition Using Simultaneous Measurement Data over Japan	AEROSOL AND AIR QUALITY RESEARCH			English	Article						Simulation models; Organic aerosol; Volatility basis set; Aging reactions; Aerosol nitrate	SECONDARY ORGANIC AEROSOL; BASIS-SET APPROACH; AIR-QUALITY; PERFORMANCE; EMISSIONS; SYSTEM; ASSUMPTIONS; SIMULATION; OXIDATION; FRAMEWORK	Evaluation of models for simulating temporal and spatial variations of PM2.5 chemical composition in Japan has been limited by the lack of observational data. In this study, we used PM2.5 chemical composition data measured simultaneously over several regions of Japan in winter, spring, and summer 2012 to evaluate three sensitivity simulations, one based on a secondary organic aerosol (SOA) yield model and two based on a volatility basis set (VBS) model. Concentrations of sulfate (SO42-), nitrate (NO3-), and ammonium (NH4+) were well reproduced by all the simulations in summer. However, in winter and spring, SO42- concentrations were underestimated and NO3- concentrations were overestimated by the standard simulation. NO3- concentrations were better reproduced by a model with dry-deposition velocities of nitric acid and ammonia enhanced by a factor of 5, as was done in a previous study. Observed concentrations of elemental carbon and organic aerosol (OA) were higher at urban sites than at the surrounding remote sites, and this behavior was not adequately reproduced by models with a grid size of 15 km. Further refinements of emission inventories and models are necessary for better simulations of PM2.5 chemical compositions. OA concentration was greatly underestimated by the simulation based on the SOA yield model over all the seasons but was better reproduced by the simulations based on the VBS model in spring and summer because aging reactions were considered in the VBS model-based simulations. The VBS model-based simulations reproduced the observations that primary OA predominated in winter and that the contribution of SOA was higher than that of primary OA in spring and summer. These contributions should be validated by means of observation-based source contributions of OA in future studies.	[Morino, Yu; Nagashima, Tatsuya; Sugata, Seiji; Sato, Kei; Tanabe, Kiyoshi; Noguchi, Tadayoshi; Takami, Akinori; Tanimoto, Hiroshi; Ohara, Toshimasa] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Morino, Y (reprint author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	morino.yu@nies.go.jp	Tanimoto, Hiroshi/E-6779-2010; Sato, Kei/A-7202-2012		Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [C-1001, 5-1408, 5B-1101, 5-1506, S12-1]; Ministry of Education, Culture, Sports, Science, and Technology [24310024]	This research was supported by the Environment Research and Technology Development Fund (C-1001, 5-1408, 5B-1101, 5-1506, and S12-1) of the Ministry of the Environment, Japan, and by a Grant-in-Aid for Scientific Research (24310024) from the Ministry of Education, Culture, Sports, Science, and Technology. The authors are grateful to all participants in the measurement campaign. The authors also thank K. Suto and M. Suto for their assistance with model simulations and analyses and S. Hasegawa for his comments on PM<INF>2.5</INF> measurements.	Murphy BN, 2009, ENVIRON SCI TECHNOL, V43, P4722, DOI 10.1021/es803168a; Byun D, 2006, APPL MECH REV, V59, P51, DOI 10.1115/1.2128636; Zhang X, 2013, ATMOS CHEM PHYS, V13, P5907, DOI 10.5194/acp-13-5907-2013; Aikawa M, 2010, ATMOS ENVIRON, V44, P381, DOI 10.1016/j.atmosenv.2009.10.025; Stroud CA, 2011, ATMOS CHEM PHYS, V11, P3107, DOI 10.5194/acp-11-3107-2011; Ikeda K, 2014, J AIR WASTE MANAGE, V64, P445, DOI 10.1080/10962247.2013.845618; Morino Y, 2014, J GEOPHYS RES-ATMOS, V119, P13489, DOI 10.1002/2014JD021937; Tessum CW, 2015, GEOSCI MODEL DEV, V8, P957, DOI 10.5194/gmd-8-957-2015; Foley KM, 2010, GEOSCI MODEL DEV, V3, P205; Sudo K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001113; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423; Zhang QJ, 2013, ATMOS CHEM PHYS, V13, P5767, DOI 10.5194/acp-13-5767-2013; Donahue NM, 2006, ENVIRON SCI TECHNOL, V40, P2635, DOI 10.1021/es052297c; CHOW JC, 1993, ATMOS ENVIRON A-GEN, V27, P1185, DOI 10.1016/0960-1686(93)90245-T; Appel KW, 2008, ATMOS ENVIRON, V42, P6057, DOI 10.1016/j.atmosenv.2008.03.036; Shimadera H, 2014, J AIR WASTE MANAGE, V64, P374, DOI 10.1080/10962247.2013.778919; Bergstrom R, 2012, ATMOS CHEM PHYS, V12, P8499, DOI 10.5194/acp-12-8499-2012; Shrivastava M, 2011, ATMOS CHEM PHYS, V11, P6639, DOI 10.5194/acp-11-6639-2011; Guenther AB, 2012, GEOSCI MODEL DEV, V5, P1471, DOI 10.5194/gmd-5-1471-2012; Lane TE, 2008, ATMOS ENVIRON, V42, P7439, DOI 10.1016/j.atmosenv.2008.06.026; Cappa CD, 2012, ATMOS CHEM PHYS, V12, P9505, DOI 10.5194/acp-12-9505-2012; Lang JL, 2013, AEROSOL AIR QUAL RES, V13, P943, DOI 10.4209/aaqr.2012.09.0242; Turpin BJ, 2001, AEROSOL SCI TECH, V35, P602, DOI 10.1080/02786820152051454; Matsui H, 2014, ATMOS CHEM PHYS, V14, P9513, DOI 10.5194/acp-14-9513-2014; Morino Y, 2010, ENVIRON SCI TECHNOL, V44, P8581, DOI 10.1021/es102392r; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155; Hayami H, 2008, ATMOS ENVIRON, V42, P3510, DOI 10.1016/j.atmosenv.2007.08.057; Neuman JA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005092; Diehl T, 2012, ATMOS CHEM PHYS DISC, V12, P24895, DOI DOI 10.5194/ACPD-12-24895-2012; Han Z, 2015, ATMOS ENV IN PRESS; JATOP (Japan Auto-Oil Program), 2012, JPEC2011AQ0207 JATOP; JATOP(Japan Auto-Oil Program), 2012, JPEC2011AQ0206 JATOP; Kazahaya K., 2001, J GEOGR, V110, P271; Kurokawa J., 2013, CHEM PHYS, V13, P11019; Ministry of Environment, 2014, REP SIT AIR POLL 201; Ministry of Land Infrastructure Transport and Tourism, 2012, SURV CURR STAT CIT P; Ministry of Land Infrastructure Transport and Tourism, 2013, NAT LAND NUM INF LAN; Morino Y., 2015, ATMOS ENV IN PRESS; Morino Y, 2010, ASIAN J ATMOS ENV, V4, P150; Shimadera Hikari, 2014, Asian Journal of Atmospheric Environment, V8, P25, DOI 10.5572/ajae.2014.8.1.025; Skamarock W. C., 2008, NCARTN475STR; Yarwood G., 2005, RT0400675 US EPA	43	0	0	TAIWAN ASSOC AEROSOL RES-TAAR	TAICHUNG COUNTY	CHAOYANG UNIV TECH, DEPT ENV ENG & MGMT, PROD CTR AAQR, NO 168, JIFONG E RD, WUFONG TOWNSHIP, TAICHUNG COUNTY, 41349, TAIWAN	1680-8584	2071-1409		AEROSOL AIR QUAL RES	Aerosol Air Qual. Res.	OCT	2015	15	5					2009	2023		10.4209/aaqr.2015.02.0120		15	Environmental Sciences	Environmental Sciences & Ecology	CS3KC	WOS:000361971500026		
J	Song, GJ; Hwang, SM; Koo, SJ; Kim, HR; Jang, HC; Hong, JH; Park, HY; Choi, E; Kim, JY; Noh, TY; Lee, E; Yoo, SK				Song, Gil Joo; Hwang, Sung Min; Koo, Soo Jong; Kim, Hyoung Ryeun; Jang, Hee Chang; Hong, Jeong Hoon; Park, Hyun Yul; Choi, Euiji; Kim, Jin Young; Noh, Tae Yong; Lee, Eungsun; Yoo, Seoung-Kyo			Evaluation of Hindrance to the Growth of SiN Passivation Layer by Contamination of Fluoride Ions in Front Opening Unified Pod (FOUP)	AEROSOL AND AIR QUALITY RESEARCH			English	Article						Airborne molecular contaminants (AMC); Cleanroom contamination; Front opening unified pod (FOUP); Fluoride ion; SiN layer	300 MM WAFER; MANUFACTURING PROCESSES; NITROGEN	We have investigated the hindrance to the deposition growth of silicon nitride (SiN) passivation layer from the contamination by airborne molecules in the front opening unified pod (FOUP). In particular, an artificial contamination of FOUP by fluoride ions as the source of the contaminants is utilized to elucidate the influence of contamination on the wafer surface. When the bare wafer surface is exposed to fluoride ions in the contaminated FOUP, the deposited thickness of the SiN layer is observed to decrease to a maximum of 11 angstrom from our experimental condition. On the other hand, there is no appreciable variation in the thickness of deposited SiN layer stored in the pre-cleaned FOUP. Based on the analytical results of wafer surfaces and FOUPs, we believe that the contamination of fluoride ions on wafer surfaces is originated from the contaminated surface of FOUP. Therefore, we conclude that it is necessary to clean and monitor the inside of FOUP on a regular basis, especially after wet or dry etching processes, which generates gaseous impurities.	[Song, Gil Joo; Hwang, Sung Min; Koo, Soo Jong; Kim, Hyoung Ryeun; Jang, Hee Chang; Hong, Jeong Hoon; Park, Hyun Yul] SK Hynix Semicond Inc, Contaminat Qual Engn Mfg & Technol Div, Icheon Si, Gyeonggi Do, South Korea; [Choi, Euiji; Kim, Jin Young] Korea Inst Sci & Technol, Fuel Cell Res Ctr, Seoul 136791, South Korea; [Choi, Euiji] Kyushu Univ, Dept Mat Sci & Engn, Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Noh, Tae Yong; Lee, Eungsun; Yoo, Seoung-Kyo] WITHTECH INC CO LTD, Daejeon 305510, South Korea	Yoo, SK (reprint author), WITHTECH INC CO LTD, 300 Techno 2Rd, Daejeon 305510, South Korea.	skyoo@withtech.co.kr			Ministry of Trade, Industry and Energy (MOTIE) Republic of Korea; Defense Acquisition Program Administration (DAPA); Civil-Military Technology Cooperation (CMTC) Program [14-SF-EB-12]	This work was supported by the Ministry of Trade, Industry and Energy (MOTIE) Republic of Korea, Defense Acquisition Program Administration (DAPA) and Civil-Military Technology Cooperation (CMTC) Program under grants no. 14-SF-EB-12.	Den W., 2006, Journal of the Electrochemical Society, V153, DOI 10.1149/1.2147286; Layadi N, 1999, BELL LABS TECH J, V4, P155, DOI 10.1002/bltj.2184; Frickinger J, 2000, IEEE T SEMICONDUCT M, V13, P427, DOI 10.1109/66.892628; Hu SC, 2006, JPN J APPL PHYS 1, V45, P5269, DOI 10.1143/JJAP.45.52691; Kamoshima T, 2008, IEEE T SEMICONDUCT M, V21, P573, DOI 10.1109/TSM.2008.2005343; SPIERINGS GACM, 1993, J MATER SCI, V28, P6261, DOI 10.1007/BF01352182; Wu BJ, 2012, AEROSOL AIR QUAL RES, V12, P104, DOI 10.4209/aaqr.2011.07.0107; Hu SC, 2009, AEROSOL AIR QUAL RES, V9, P139; Hsu CF, 2001, P SOC PHOTO-OPT INS, V4405, P131, DOI 10.1117/12.425248; Gonzalez-Aguirre P, 2013, MICROELECTRON ENG, V105, P113, DOI 10.1016/j.mee.2012.12.005; KIKYUAMA H, 1991, IEEE T SEMICONDUCT M, V4, P26, DOI 10.1109/66.75861; Hu SC, 2007, APPL THERM ENG, V27, P1386, DOI 10.1016/j.applthermaleng.2006.10.028; Iwamoto T, 1997, APPL SURF SCI, V117, P237, DOI 10.1016/S0169-4332(97)80086-4; Chang MB, 2006, IND ENG CHEM RES, V45, P4101, DOI 10.1021/ie051227b; Hu SC, 2005, AEROSOL SCI TECH, V39, P185, DOI 10.1080/027868290920115; Lin IK, 2010, AEROSOL AIR QUAL RES, V10, P245, DOI 10.4209/aaqr.2009.10.0065; Hua YN, 2014, IEEE INT SYMP PHYS, P90, DOI 10.1109/IPFA.2014.6898149; Iliescu C, 2005, SURF COAT TECH, V198, P314, DOI 10.1016/j.surfcoat.2004.10.094; Jansen H, 1996, J MICROMECH MICROENG, V6, P14, DOI 10.1088/0960-1317/6/1/002; Nguyena T. Q., 2012, MICROELECTRON ENG, V105, P124; Tokunaga K., 2003, P 2003 IEEE INT S SE, P463; Yoo S. K., 2012, ADV SCI LETT, V17, P280	22	0	0	TAIWAN ASSOC AEROSOL RES-TAAR	TAICHUNG COUNTY	CHAOYANG UNIV TECH, DEPT ENV ENG & MGMT, PROD CTR AAQR, NO 168, JIFONG E RD, WUFONG TOWNSHIP, TAICHUNG COUNTY, 41349, TAIWAN	1680-8584	2071-1409		AEROSOL AIR QUAL RES	Aerosol Air Qual. Res.	OCT	2015	15	5					2175	2183		10.4209/aaqr.2014.10.0238		9	Environmental Sciences	Environmental Sciences & Ecology	CS3KC	WOS:000361971500040		
J	Brandt, Y; Currier, L; Plante, TW; Kabban, CMS; Tvaryanas, AP				Brandt, Yvonne; Currier, Linda; Plante, Timothy W.; Kabban, Christine M. Schubert; Tvaryanas, Anthony P.			A Randomized Controlled Trial of Core Strengthening Exercises in Helicopter Crewmembers with Low Back Pain	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						disability; whole body vibration; ergonomics	CLINICAL-PREDICTION RULE; STABILIZATION EXERCISES; VIBRATION; AIRCREW; PILOTS	BACKGROUND: The purpose of this study was to determine if five core strengthening exercises would decrease pain severity and related disability in U.S. Air Force helicopter aircrew members with low back pain. METHODS: The study was a randomized control group repeated measures design. The experimental manipulation consisted of a set of five core strengthening exercises performed 4 d/wk for 12 wk. Self-reported pain severity and disability were ascertained at baseline and 12 wk using the Numerical Pain Rating Scale (NPRS) and Modified Oswestry Low Back Pain Disability Index (MODI), respectively. The NPRS was used to ascertain both daily pain (NPRSdaily) and in-flight pain (NPRSflight). Self-reported improvement or deterioration in low back pain was measured using the Global Rating of Change Scale (GRCS). RESULTS: There were 12 subjects enrolled and 5 were randomized to the intervention group. The mean NPRSflight score decreased 1.8 points vs. increasing 0.1 points during the trial for the intervention and control groups, respectively. The mean MODI score decreased 4.8 points vs. increasing 1.7 points during the trial for the intervention and control groups, respectively. The mean GRCS score at the end of the trial was 4.0 vs. 0 for the intervention and control groups, respectively. There was no difference between groups in terms of mean NPRSdaily scores. CONCLUSIONS: Core strengthening exercises were effective in reducing in-flight pain and led to a reduction in pain symptoms and disability over the 12-wk study period as compared to those subjects who maintained their regular exercise regimen.	[Tvaryanas, Anthony P.] Air Force Res Lab, Wright Patterson AFB, OH 45433 USA; [Currier, Linda] US Air Force, Med Grp 374, Yokota Air Base, Japan; [Plante, Timothy W.] US Air Force, Joint Base Pearl Harbor, Med Grp 15, Hickam, HI USA; [Kabban, Christine M. Schubert] Air Force Inst Technol, Wright Patterson AFB, OH USA	Tvaryanas, AP (reprint author), Air Force Res Lab, Wright Patterson AFB, OH 45433 USA.	anthony.tvaryanas@us.af.mil					Hicks GE, 2005, ARCH PHYS MED REHAB, V86, P1753, DOI 10.1016/j.apmr.2005.03.033; Childs JD, 2010, PHYS THER, V90, P1404, DOI 10.2522/ptj.20090389; Fritz JM, 2001, PHYS THER, V81, P776; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Currier LL, 2007, PHYS THER, V87, P1106, DOI 10.2522/ptj.20060066; Childs JD, 2009, MED SCI SPORT EXER, V41, P2072, DOI 10.1249/MSS.0b013e3181a84db2; BOWDEN T, 1987, AVIAT SPACE ENVIR MD, V58, P461; Chou R, 2007, ANN INTERN MED, V147, P478; Liddle SD, 2004, PAIN, V107, P176, DOI 10.1016/j.pain.2003.10.017; Nevin RL, 2009, AVIAT SPACE ENVIR MD, V80, P807, DOI 10.3357/ASEM.2236.2009; Gaydos SJ, 2012, AVIAT SPACE ENVIR MD, V83, P879, DOI 10.3357/ASEM.3274.2012; Dempsey PG, 1997, J OCCUP ENVIRON MED, V39, P748, DOI 10.1097/00043764-199708000-00010; Orsello CA, 2013, AVIAT SPACE ENVIR MD, V84, P32, DOI 10.3357/ASEM.3425.2013; BONGERS PM, 1990, ERGONOMICS, V33, P1007, DOI 10.1080/00140139008925309; Armentrout JJ, 2006, AVIAT SPACE ENVIR MD, V77, P963; DELITTO A, 1995, PHYS THER, V75, P470; Delitto A, 1995, PHYS THER, V75, P485; Harrer KL, 2005, WHOLE BODY VIBRATION; Jensen M.P., 2001, HDB PAIN ASSESSMENT, P15; Kadix Systems, 2010, BUS CAS AN IMPR NAV; Liebenson C, 1998, J BODYWORK MOVEMENT, V2, P218, DOI 10.1016/S1360-8592(98)80018-1; Norris Christopher, 2008, Complement Ther Clin Pract, V14, P255, DOI 10.1016/j.ctcp.2008.06.001; Pelham Thomas W, 2005, Work, V24, P101; SANDOVER J, 1986, CLIN BIOMECH, V1, P150, DOI 10.1016/0268-0033(86)90007-0; Thomae MK, 1998, AVIAT SPACE ENV MED, V69, P469	25	0	0	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	OCT	2015	86	10					889	894		10.3357/AMHP.4245.2015		6	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	CS4PF	WOS:000362057300006		
J	Nakamura, I; Fukushima, S; Hayakawa, T; Sekiya, K; Matsumoto, T				Nakamura, Itaru; Fukushima, Shinji; Hayakawa, Tsukako; Sekiya, Kentaro; Matsumoto, Tetsuya			The additional costs of catheter-related bloodstream infections in intensive care units	AMERICAN JOURNAL OF INFECTION CONTROL			English	Article						Costs analysis; CRBSI; Nonantimicrobial; Candida	RESISTANT STAPHYLOCOCCUS-AUREUS; CLINICAL-PRACTICE GUIDELINES; METHICILLIN-RESISTANT; HEALTH-CARE; DISEASES SOCIETY; HOSPITAL STAY; 2009 UPDATE; MORTALITY; MANAGEMENT; BACTEREMIA	Purpose: The additional costs of health care-associated infections vary depending on the reimbursement systems of different countries. We estimated the additional costs of central venous catheter-related bloodstream infections (CVC-CRBSI) in Japan, which has a universal health insurance system covering all citizens. Methods: We conducted a retrospective matched case-control study. Twenty-two patients with CVC-CRBSI were identified among 2,148 patients treated between October 2011 and May 2014 in the intensive care unit of Tokyo Medical University Hospital (1,015 beds). Twenty-two matched controls were selected on the basis of 5 criteria. The drug and medical material costs and technical fees incurred from the date of catheter insertion until hospital discharge were examined using a fee-for-service system. The additional costs of CVC-CRBSI were calculated as the difference between the costs of cases and controls. The contribution of antimicrobial drugs and the causative microorganism to the additional drug costs were also assessed. Results: The additional costs of CVC-CRBSI were estimated at $57,090 per case. Antimicrobial agents comprised only about 10% of the additional drug costs. The additional costs of Candida infection were almost twice those of CVC-CRBSI caused by other microorganisms. Conclusions: The additional costs of CVC-CRBSI in Japan were estimated at $57,090 per case. Copyright (C) 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.	[Nakamura, Itaru; Fukushima, Shinji; Hayakawa, Tsukako] Tokyo Med Univ Hosp, Dept Infect Control & Prevent, Tokyo 1600023, Japan; [Sekiya, Kentaro] Tokyo Med Univ Hosp, Dept Med Profess, Tokyo, Japan; [Matsumoto, Tetsuya] Tokyo Med Univ, Dept Microbiol, Tokyo 1608402, Japan	Nakamura, I (reprint author), Tokyo Med Univ Hosp, Dept Infect Control & Prevent, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	task300@tokyo-med.ac.jp					Anderson DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008305; Laupland KB, 2006, J HOSP INFECT, V63, P124, DOI 10.1019/j.jhin.2005.12.016; Fukuda H, 2011, INFECTION, V39, P185, DOI 10.1007/s15010-011-0095-7; Kim T, 2001, INFECT CONT HOSP EP, V22, P99, DOI 10.1086/501871; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160; Abramson MA, 1999, INFECT CONT HOSP EP, V20, P408, DOI 10.1086/501641; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Kashimura N, 2012, SURG TODAY, V42, P639, DOI 10.1007/s00595-012-0126-8; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Rosenthal VD, 2003, AM J INFECT CONTROL, V31, P475, DOI 10.1016/j.ajic.2003.03.002; Fridkin SK, 2005, CLIN INFECT DIS, V41, P1455, DOI 10.1086/497138; Neidell MJ, 2012, CLIN INFECT DIS, V55, P807, DOI 10.1093/cid/cis552	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-6553	1527-3296		AM J INFECT CONTROL	Am. J. Infect. Control	OCT 1	2015	43	10					1046	1049		10.1016/j.ajic.2015.05.022		4	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	CS5CL	WOS:000362093600006		
J	Egawa, T; Goto, A; Ohno, Y; Yokoyama, S; Ikuta, A; Suzuki, M; Sugiura, T; Ohira, Y; Yoshioka, T; Hayashi, T; Goto, K				Egawa, Tatsuro; Goto, Ayumi; Ohno, Yoshitaka; Yokoyama, Shingo; Ikuta, Akihiro; Suzuki, Miho; Sugiura, Takao; Ohira, Yoshinobu; Yoshioka, Toshitada; Hayashi, Tatsuya; Goto, Katsumasa			Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article						AMP-activated protein kinase; protein degradation; autophagy; ubiquitin-proteasome; microRNA; heat shock protein	ACTIVATED PROTEIN-KINASE; RAT SKELETAL-MUSCLE; FOXO TRANSCRIPTION FACTORS; NF-KAPPA-B; OVERLOAD-INDUCED HYPERTROPHY; SOLEUS MUSCLE; GLUCOSE-TRANSPORT; UBIQUITIN LIGASES; MESSENGER-RNA; COMPENSATORY GROWTH	AMPK is considered to have a role in regulating skeletal muscle mass. However, there are no studies investigating the function of AMPK in modulating skeletal muscle mass during atrophic conditions. In the present study, we investigated the difference in unloading-associated muscle atrophy and molecular functions in response to 2-wk hindlimb suspension between transgenic mice overexpressing the dominant-negative mutant of AMPK (AMPK-DN) and their wild-type (WT) littermates. Male WT (n = 24) and AMPK-DN (n = 24) mice were randomly divided into two groups: an untreated preexperimental control group (n = 12 in each group) and an unloading (n = 12 in each group) group. The relative soleus muscle weight and fiber cross-sectional area to body weight were decreased by similar to 30% in WT mice by hindlimb unloading and by similar to 20% in AMPK-DN mice. There were no changes in puromycin-labeled protein or Akt/70-kDa ribosomal S6 kinase signaling, the indicators of protein synthesis. The expressions of ubiquitinated proteins and muscle RING finger 1 mRNA and protein, markers of the ubiquitin-proteasome system, were increased by hindlimb unloading in WT mice but not in AMPK-DN mice. The expressions of molecules related to the protein degradation system, phosphorylated forkhead box class O3a, inhibitor of kappa B alpha, microRNA (miR)-1, and miR-23a, were decreased only in WT mice in response to hindlimb unloading, and 72-kDa heat shock protein expression was higher in AMPK-DN mice than in WT mice. These results imply that AMPK partially regulates unloading-induced atrophy of slow-twitch muscle possibly through modulation of the protein degradation system, especially the ubiquitin-proteasome system.	[Egawa, Tatsuro; Goto, Ayumi; Ikuta, Akihiro; Suzuki, Miho; Goto, Katsumasa] Toyohashi SOZO Univ, Grad Sch Hlth Sci, Dept Physiol, Toyohashi, Aichi 4408511, Japan; [Goto, Ayumi; Hayashi, Tatsuya] Kyoto Univ, Grad Sch Human & Environm Studies, Lab Sports & Exercise Med, Kyoto, Japan; [Ohno, Yoshitaka; Yokoyama, Shingo] Toyohashi SOZO Univ, Sch Hlth Sci, Physiol Lab, Toyohashi, Aichi 4408511, Japan; [Sugiura, Takao] Yamaguchi Univ, Dept Exercise & Sports Physiol, Fac Educ, Yamaguchi, Japan; [Ohira, Yoshinobu] Doshisha Univ, Grad Sch Hlth & Sports Sci, Kyoto 602, Japan; [Yoshioka, Toshitada] Hirosaki Gakuin Univ, Hirosaki, Aomori, Japan	Goto, K (reprint author), Toyohashi SOZO Univ, Grad Sch Hlth Sci, Dept Physiol, 20-1 Ushikawa Cho Matsushita, Toyohashi, Aichi 4408511, Japan.	gotok@sepia.ocn.ne.jp			JSPS; Nakatomi Foundation; Descente Foundation for the Promotion of Sports Science; Uehara Memorial Foundation; Naito Foundation; Graduate School of Health Sciences, Toyohashi SOZO University	This study was supported in part by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows (T. Egawa and A. Goto), Grants-in-Aid for Scientific Research from JSPS (Y. Ohno, Y. Ohira, T. Yoshioka, and K. Goto), a Research Grant from The Nakatomi Foundation (T. Egawa), the Descente Foundation for the Promotion of Sports Science (T. Egawa), the Uehara Memorial Foundation (K. Goto), the Naito Foundation (K. Goto), and the Graduate School of Health Sciences, Toyohashi SOZO University (K. Goto).	Kontani Y, 2002, J BIOCHEM, V132, P309; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Jaric S, 2005, J STRENGTH COND RES, V19, P467; Cannavino J, 2015, J PHYSIOL-LONDON, V593, P1981, DOI 10.1113/jphysiol.2014.286740; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; GOLDSPINK DF, 1983, BIOCHEM J, V210, P89; Egawa T, 2014, AM J PHYSIOL-ENDOC M, V306, pE344, DOI 10.1152/ajpendo.00495.2013; Sitnick M, 2006, J APPL PHYSIOL, V100, P286, DOI 10.1152/japplphysiol.00869.2005; Wirth M, 2013, SEMIN CANCER BIOL, V23, P301, DOI 10.1016/j.semcancer.2013.05.007; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Gwag T, 2009, CELL PHYSIOL BIOCHEM, V24, P537, DOI 10.1159/000257510; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; Morris CA, 2005, J APPL PHYSIOL, V99, P1719, DOI 10.1152/japplphysiol.01419.2004; Kukreti H, 2013, J BIOL CHEM, V288, P6663, DOI 10.1074/jbc.M112.390369; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Tong JF, 2009, J CELL BIOCHEM, V108, P458, DOI 10.1002/jcb.22272; Miura S, 2009, AM J PHYSIOL-ENDOC M, V296, pE47, DOI 10.1152/ajpendo.90690.2008; TSIKA RW, 1987, J APPL PHYSIOL, V63, P2111; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Thomson DM, 2005, J APPL PHYSIOL, V98, P557, DOI 10.1152/japplphysiol.00811.2004; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Goto K, 2003, J APPL PHYSIOL, V94, P897, DOI 10.1152/japplphysiol.00408.2002; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima Noboru, 2007, Autophagy, V3, P542; Liu J, 2012, IUBMB LIFE, V64, P901, DOI 10.1002/iub.1087; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gordon SE, 2008, EXERC SPORT SCI REV, V36, P179, DOI 10.1097/JES.0b013e3181877e13; WIGSTON DJ, 1992, J NEUROBIOL, V23, P61, DOI 10.1002/neu.480230107; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Kojima A, 2007, J ORTHOP SCI, V12, P74, DOI 10.1007/s00776-006-1083-0; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Stapleton D, 1996, J BIOL CHEM, V271, P611; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Ohno Y, 2010, GEN PHYSIOL BIOPHYS, V29, P234, DOI 10.4149/gpb_2010_03_234; Egawa T, 2011, J APPL PHYSIOL, V111, P1629, DOI 10.1152/japplphysiol.00249.2011; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Goldspink G, 1999, J ANAT, V194, P323, DOI 10.1046/j.1469-7580.1999.19430323.x; Ringholm S, 2011, AM J PHYSIOL-ENDOC M, V301, pE649, DOI 10.1152/ajpendo.00230.2011; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Paturi S, 2010, J APPL PHYSIOL, V108, P7, DOI 10.1152/japplphysiol.00330.2009; Brooks NE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00099; Cannavino J, 2014, J PHYSIOL-LONDON, V592, P4575, DOI 10.1113/jphysiol.2014.275545; Cohen J., 1988, STAT POWER ANAL BEHA; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081929; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Kano Y, 2011, AM J PHYSIOL-REG I, V301, pR1350, DOI 10.1152/ajpregu.00294.2011; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Machida M, 2013, ADV EXERC SPORTS PHY, V19, P39; Sakuma K, J CACHEXIA IN PRESS; Senf SM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00330; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1; Wu CL, 2014, AM J PHYSIOL-CELL PH, V306, pC762, DOI 10.1152/ajpcell.00361.2013	82	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1849	1522-1555		AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	OCT 1	2015	309	7					E651	E662		10.1152/ajpendo.00165.2015		12	Endocrinology & Metabolism; Physiology	Endocrinology & Metabolism; Physiology	CS7BF	WOS:000362237800005		
J	Madurga, A; Golec, A; Pozarska, A; Ishii, I; Mizikova, I; Nardiello, C; Vadasz, I; Herold, S; Mayer, K; Reichenberger, F; Fehrenbach, H; Seeger, W; Morty, RE				Madurga, Alicia; Golec, Anita; Pozarska, Agnieszka; Ishii, Isao; Mizikova, Ivana; Nardiello, Claudio; Vadasz, Istvan; Herold, Susanne; Mayer, Konstantin; Reichenberger, Frank; Fehrenbach, Heinz; Seeger, Werner; Morty, Rory E.			The H2S-generating enzymes cystathionine beta-synthase and cystathionine gamma-lyase play a role in vascular development during normal lung alveolarization	AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY			English	Article						lung development; gasotransmitter; hydrogen sulfide; H2S; alveolarization	BRONCHOPULMONARY DYSPLASIA; HYDROGEN-SULFIDE; PULMONARY-HYPERTENSION; ANIMAL-MODELS; INJURY; MICE; HYPEROXIA; RAT; H2S; DISEASE	The gasotransmitter hydrogen sulfide (H2S) is emerging as a mediator of lung physiology and disease. Recent studies revealed that H2S administration limited perturbations to lung structure in experimental animal models of bronchopulmonary dysplasia (BPD), partially restoring alveolarization, limiting pulmonary hypertension, limiting inflammation, and promoting epithelial repair. No studies have addressed roles for endogenous H2S in lung development. H2S is endogenously generated by cystathionine beta-synthase (Cbs) and cystathionine gamma-lyase (Cth). We demonstrate here that the expression of Cbs and Cth in mouse lungs is dynamically regulated during lung alveolarization and that alveolarization is blunted in Cbs(-/-) and Cth(-/-) mouse pups, where a 50% reduction in the total number of alveoli was observed, without any impact on septal thickness. Laser-capture microdissection and immunofluorescence staining indicated that Cbs and Cth were expressed in the airway epithelium and lung vessels. Loss of Cbs and Cth led to a 100-500% increase in the muscularization of small-and medium-sized lung vessels, which was accompanied by increased vessel wall thickness, and an apparent decrease in lung vascular supply. Ablation of Cbs expression using small interfering RNA or pharmacological inhibition of Cth using propargylglycine in lung endothelial cells limited angiogenic capacity, causing a 30-40% decrease in tube length and a 50% decrease in number of tubes formed. In contrast, exogenous administration of H2S with GYY4137 promoted endothelial tube formation. These data confirm a key role for the H2S-generating enzymes Cbs and Cth in pulmonary vascular development and homeostasis and in lung alveolarization.	[Madurga, Alicia; Golec, Anita; Pozarska, Agnieszka; Mizikova, Ivana; Nardiello, Claudio; Herold, Susanne; Mayer, Konstantin; Seeger, Werner; Morty, Rory E.] Univ Giessen, Dept Internal Med Pulmonol, D-35390 Giessen, Germany; [Madurga, Alicia; Golec, Anita; Pozarska, Agnieszka; Mizikova, Ivana; Nardiello, Claudio; Herold, Susanne; Mayer, Konstantin; Seeger, Werner; Morty, Rory E.] German Ctr Lung Res, Marburg Lung Ctr, Giessen, Germany; [Madurga, Alicia; Golec, Anita; Pozarska, Agnieszka; Mizikova, Ivana; Nardiello, Claudio; Vadasz, Istvan; Seeger, Werner; Morty, Rory E.] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Ishii, Isao] Keio Univ, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Reichenberger, Frank] Asklepios Lung Ctr, Dept Pulmonol, Munich, Germany; [Fehrenbach, Heinz] German Ctr Lung Res, Div Expt Pneumol, Airway Res Ctr North, Prior Area Asthma & Allergy, Borstel, Germany	Morty, RE (reprint author), Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, Parkstr 1, D-61231 Bad Nauheim, Germany.	rory.morty@mpi-bn.mpg.de	Fehrenbach, Heinz/A-9161-2008	Fehrenbach, Heinz/0000-0003-1935-9411	Max Planck Society; German Research Foundation [Mo 1789/1]; Excellence Cluster [147, 306]; Federal Ministry of Higher Education, Research and the Arts of the State of Hessen LOEWE Program; German Center for Lung Research (Deutsches Zentrum fur Lungenforschung); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25460072, 25220103]	This study was supported by the Max Planck Society (to A. Madurga, A. Golec, A. Pozarska, I. Mizikova, C. Nardiello, W. Seeger, and R. E. Morty), the German Research Foundation through Grant Mo 1789/1 (to R. E. Morty) and Excellence Cluster 147 "Cardio-Pulmonary System" (to W. Seeger and R. E. Morty), Excellence Cluster 306 "Inflammation at Interfaces" (to H. Fehrenbach), as well as the Federal Ministry of Higher Education, Research and the Arts of the State of Hessen LOEWE Program (to I. Vadasz, S. Herold, K. Mayer, W. Seeger, and R. E. Morty), the German Center for Lung Research (Deutsches Zentrum fur Lungenforschung; to A. Madurga, A. Golec, A. Pozarska, I. Mizikova, C. Nardiello, I. Vadasz, S. Herold, K. Mayer, H. Fehrenbach, W. Seeger, and R. E. Morty), and Grants-in-Aid for Scientific Research (25460072 and 25220103) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to I. Ishii).	Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Alejandre-Alcazar MA, 2007, DEV DYNAM, V236, P2825, DOI 10.1002/dvdy.21293; RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Perry MM, 2011, AM J RESP CELL MOL, V45, P746, DOI 10.1165/rcmb.2010-0304OC; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Witsch TJ, 2014, AM J PHYSIOL-LUNG C, V306, pL246, DOI 10.1152/ajplung.00109.2013; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Maciewicz Rose A, 2009, Proc Am Thorac Soc, V6, P614, DOI 10.1513/pats.200908-094RM; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534; Thebaud B, 2007, NEONATOLOGY, V91, P291, DOI 10.1159/000101344; Witsch TJ, 2014, EUR RESPIR J, V44, P109, DOI 10.1183/09031936.00075713; Meng QH, 2007, AM J PATHOL, V170, P1406, DOI 10.2353/ajpath.2007.060939; Kumarasamy A, 2009, AM J RESP CRIT CARE, V180, P1239, DOI 10.1164/rccm.200902-0215OC; Madurga A, 2014, AM J PHYSIOL-LUNG C, V306, pL684, DOI 10.1152/ajplung.00361.2013; Madurga A, 2013, AM J PHYSIOL-LUNG C, V305, pL893, DOI 10.1152/ajplung.00267.2013; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Roper MD, 1996, MAMM GENOME, V7, P754, DOI 10.1007/s003359900226; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Shi W, 2007, CHEST, V132, P651, DOI 10.1378/chest.06-2663; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yildirim AO, 2010, AM J RESP CRIT CARE, V181, P705, DOI 10.1164/rccm.200804-573OC; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Schwartze JT, 2014, J BIOL CHEM, V289, P3262, DOI 10.1074/jbc.M113.541052; Malczyk M, 2013, AM J RESP CRIT CARE, V188, P1451, DOI 10.1164/rccm.201307-1252OC; Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC; Ambalavanan N, 2005, PEDIATR RES, V57, P631, DOI 10.1203/01.PDR.0000159512.55862.69; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI 10.1089/ARS.2008.2253; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; Erb A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100971; Fernandez-Gonzalez A, 2012, AM J PHYSIOL-LUNG C, V302, pL775, DOI 10.1152/ajplung.00196.2011; Mizikova I, 2015, AM J PHYSIOL-LUNG C, V308, pL1145, DOI 10.1152/ajplung.00039.2015; O'Reilly M, 2014, AM J PHYSIOL-LUNG C, V307, pL948, DOI 10.1152/ajplung.00160.2014; Schneider JP, 2014, AM J PHYSIOL-LUNG C, V306, pL341, DOI 10.1152/ajplung.00329.2013; Mühlfeld Christian, 2013, Am J Physiol Lung Cell Mol Physiol, V305, pL205, DOI 10.1152/ajplung.00427.2012; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; Vadivel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090965	49	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1040-0605	1522-1504		AM J PHYSIOL-LUNG C	Am. J. Physiol.-Lung Cell. Mol. Physiol.	OCT 1	2015	309	7					L710	L724		10.1152/ajplung.00134.2015		15	Physiology; Respiratory System	Physiology; Respiratory System	CS7BN	WOS:000362238600008		
J	Iwamori, S; Sato, E; Saigusa, D; Yoshinari, K; Ito, S; Sato, H; Takahashi, N				Iwamori, Saki; Sato, Emiko; Saigusa, Daisuke; Yoshinari, Kouichi; Ito, Sadayoshi; Sato, Hiroshi; Takahashi, Nobuyuki			A novel and sensitive assay for heme oxygenase activity	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Article						heme oxygenase; LC-MS/MS; biliverdin	CARBON-MONOXIDE; INDUCTION; SYSTEM; RAT	Heme oxygenase (HO) is a renoprotective protein in the microsome that degrades heme and produces biliverdin. Biliverdin is then reduced to a potent antioxidant bilirubin by biliverdin reductase in the cytosol. Because HO activity does not necessarily correlate with HO mRNA or protein levels, a reliable assay is needed to determine HO activity. Spectrophotometric measurement is tedious and requires a relatively large amount of kidney samples. Moreover, bilirubin is unstable and spontaneously oxidized to biliverdin in vitro. We developed a novel and sensitive liquid chromatography-tandem mass spectrometry (LCMS/MS) method to quantify biliverdin to measure HO activity in mice. Biliverdin and its internal standard, a deuterated biliverdin-d4, have MS/MS fragments with m/z transitions of 583 to 297 and 587 to 299, respectively. We prepared lysates of mouse kidneys, and added excess hemin, NADPH, and bilirubin oxidase to convert all bilirubin produced to biliverdin. After 30-min incubation at 37 or 4 degrees C, the samples were analyzed by LC-MS/MS. The difference in the amount of biliverdin between the two temperatures is HO activity. Treating mice with cobalt protoporphyrin, which induces the expression of HO, increased HO activity as determined by biliverdin production. Measuring the production of biliverdin using LC-MS/MS is a more sensitive and specific way to determine HO activity than the spectrophotometric method and allows the detection of subtle changes in renal or other HO activity.	[Iwamori, Saki; Sato, Emiko; Sato, Hiroshi; Takahashi, Nobuyuki] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Clin Pharmacol & Therapeut, Sendai, Miyagi 9808578, Japan; [Sato, Emiko; Ito, Sadayoshi; Sato, Hiroshi; Takahashi, Nobuyuki] Tohoku Univ, Dept Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Saigusa, Daisuke] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi 980, Japan; [Yoshinari, Kouichi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Mol Toxicol, Shizuoka 4228526, Japan	Takahashi, N (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Div Clin Pharmacol & Therapeut, Sendai, Miyagi 9808578, Japan.	ntakaha@m.tohoku.ac.jp			Japan Society of Promotion of Science (JSPS) [24659409, 24790832]; Translational Research Network Program of Ministry of Education, Culture, Sports, Science and Technology of Japan [J140001192]; Naito Foundation; Ministry of Health, Labor and Welfare of Japan	Our work was supported by Grants-In-Aid from the Japan Society of Promotion of Science (JSPS, 24659409, 24790832), Translational Research Network Program of Ministry of Education, Culture, Sports, Science and Technology of Japan (J140001192), the Naito Foundation, and Grants-In-Aid for Diabetic Nephropathy Research from the Ministry of Health, Labor and Welfare of Japan.	Al-Kahtani MA, OXID MED CELL LONGEV; MAINES MD, 1988, FASEB J, V2, P2557; ABRAHAM RT, 1987, J BIOL CHEM, V262, P2719; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Kaide J, 2001, J CLIN INVEST, V107, P1163, DOI 10.1172/JCI11218; Vreman HJ, 1998, CAN J PHYSIOL PHARM, V76, P1057; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Abraham NG, 2005, FREE RADICAL BIO MED, V39, P1, DOI 10.1016/j.freeadbiomed.2005.03.010; Morimoto K, 2001, KIDNEY INT, V60, P1858, DOI 10.1046/j.1523-1755.2001.01000.x; George EM, 2011, AM J PHYSIOL-REG I, V301, pR1495, DOI 10.1152/ajpregu.00325.2011; Pirone Cary, 2010, AoB Plants, V2010, pplq020, DOI 10.1093/aobpla/plq020; US_Food_and_Drug_Administration, 2013, GUID IND BIOAN METH; Vera T, 2007, AM J PHYSIOL-REG I, V292, pR1472, DOI 10.1152/ajpregu.00601.2006; Zager RA, 2011, J AM SOC NEPHROL, V23, P1048	16	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	OCT 1	2015	309	7					F667	F671		10.1152/ajprenal.00210.2015		5	Physiology; Urology & Nephrology	Physiology; Urology & Nephrology	CS7BK	WOS:000362238300010		
J	Shiwaku, H; Masaki, H; Yasugi, D; Narushima, K				Shiwaku, Hiroki; Masaki, Hidekazu; Yasugi, Daisuke; Narushima, Kenji			A Case of a Depressed Patient With Major Titanium Cranial Base Reconstruction Successfully Treated by ECT	AMERICAN JOURNAL OF PSYCHIATRY			English	Letter							ELECTROCONVULSIVE-THERAPY		[Shiwaku, Hiroki; Masaki, Hidekazu; Yasugi, Daisuke; Narushima, Kenji] Tokyo Metropolitan Tama Med Ctr, Dept Psychiat, Fuchu, Tokyo, Japan	Shiwaku, H (reprint author), Tokyo Metropolitan Tama Med Ctr, Dept Psychiat, Fuchu, Tokyo, Japan.						Mortier P, 2013, J ECT, V29, P231, DOI 10.1097/YCT.0b013e31827f137b; Gahr M, 2014, J ECT, V30, P62, DOI 10.1097/YCT.0b013e318295e30f	2	0	0	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0002-953X	1535-7228		AM J PSYCHIAT	Am. J. Psychiat.	OCT	2015	172	10					1024	1025		10.1176/appi.ajp.2015.14121539		2	Psychiatry	Psychiatry	CS5XH	WOS:000362151100020		
J	Horikawa, M; Miyayama, S; Irie, T; Kaji, T; Arai, Y				Horikawa, Masahiro; Miyayama, Shiro; Irie, Toshiyuki; Kaji, Tatsumi; Arai, Yasuaki			Development of Conventional Transarterial Chemoembolization for Hepatocellular Carcinomas in Japan: Historical, Strategic, and Technical Review	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Review						conventional transarterial chemoembolization; drug-eluting beads; hepatocellular carcinoma; Japanese; transarterial chemoembolization	TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED-TRIAL; DOXORUBICIN-ELUTING BEADS; INFERIOR PHRENIC ARTERY; OILY CHEMOEMBOLIZATION; SYMPTOMATIC TREATMENT; IODIZED OIL; LIPIODOL CHEMOEMBOLIZATION; INFUSION CHEMOTHERAPY; LOCAL RECURRENCE	OBJECTIVE. This article reviews the development of transarterial chemoembolization (TACE) in Japan, particularly ethiodized oil-based conventional TACE, from historical, strategic, and technical points of view. We also present the current status of standardized conventional TACE. CONCLUSION. Conventional TACE has been developed toward a more-selective and hemodynamic-conscious method, along with technical innovation and knowledge accumulation. Standardization of this method is necessary for further scientific evaluation.	[Horikawa, Masahiro] Dotter Intervent Inst, Portland, OR 97239 USA; [Miyayama, Shiro] Fukuiken Saiseikai Hosp, Dept Diagnost Radiol, Fukui, Japan; [Irie, Toshiyuki] Hitachi Gen Hosp, Dept Radiol, Hitachi, Ibaraki, Japan; [Kaji, Tatsumi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 359, Japan; [Arai, Yasuaki] Natl Canc Ctr, Dept Diagnost Radiol, Tokyo, Japan	Horikawa, M (reprint author), Dotter Intervent Inst, 3181 SW Sam Jackson Pk Rd,L342, Portland, OR 97239 USA.	horikawaradivr@gmail.com					El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Kothary N, 2007, J VASC INTERV RADIOL, V18, P1517, DOI 10.1016/j.jvir.2007.07.035; Ikeda M, 2013, J VASC INTERV RADIOL, V24, P490, DOI 10.1016/j.jvir.2013.01.003; Katsumori T, 2006, CARDIOVASC INTER RAD, V29, P1077, DOI 10.1007/s00270-006-0059-y; Miyayama S, 2010, CARDIOVASC INTER RAD, V33, P513, DOI 10.1007/s00270-009-9697-1; Golfieri R, 2014, BRIT J CANCER, V111, P255, DOI 10.1038/bjc.2014.199; PELLETIER G, 1990, J HEPATOL, V11, P181, DOI 10.1016/0168-8278(90)90110-D; Song SY, 2001, J VASC INTERV RADIOL, V12, P313, DOI 10.1016/S1051-0443(07)61910-1; UCHIDA H, 1990, CARDIOVASC INTER RAD, V13, P140, DOI 10.1007/BF02575465; Miyayama S, 2003, J VASC INTERV RADIOL, V14, P1155, DOI 10.1097/01.RVI.0000086534.86489.10; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; Ikai I, 2010, HEPATOL RES, V40, P1043, DOI 10.1111/j.1872-034X.2010.00731.x; MATSUI O, 1991, RADIOLOGY, V178, P493; Takayasu K, 2010, AM J ROENTGENOL, V194, P830, DOI 10.2214/AJR.09.3308; Takayasu K, 2001, AM J ROENTGENOL, V176, P681; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Miyayama S, 2009, HEPATOL RES, V39, P374, DOI 10.1111/j.1872-034X.2008.00465.x; Miyayama S, 2001, J VASC INTERV RADIOL, V12, P497, DOI 10.1016/S1051-0443(07)61890-9; OHISHI H, 1985, RADIOLOGY, V154, P25; Demachi H, 2000, CARDIOVASC INTER RAD, V23, P285, DOI 10.1007/s002700010070; Tesdal IK, 2006, CARDIOVASC INTER RAD, V29, P778, DOI 10.1007/s00270-005-0063-7; Miyayama S, 2006, CARDIOVASC INTER RAD, V29, P39, DOI 10.1007/s00270-004-0287-y; Kiely JM, 2006, J VASC INTERV RADIOL, V17, P47, DOI 10.1097/01.RVI.0000195074.43474.2F; SOO CS, 1983, RADIOLOGY, V147, P45; Miyayama S, 2011, JPN J RADIOL, V29, P371, DOI 10.1007/s11604-011-0568-8; Kim HC, 2005, RADIOGRAPHICS, V25, pS25, DOI 10.1148/rg.25si055508; YAMADA R, 1983, RADIOLOGY, V148, P397; Miyayama S, 2012, JPN J RADIOL, V30, P798, DOI 10.1007/s11604-012-0123-2; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Golfieri R, 2011, HEPATOLOGY, V53, P1580, DOI 10.1002/hep.24246; NAKAKUMA K, 1983, CANCER, V52, P2193, DOI 10.1002/1097-0142(19831215)52:12<2193::AID-CNCR2820521203>3.0.CO;2-R; Miyayama S, 2007, J VASC INTERV RADIOL, V18, P365, DOI 10.1016/j.jvir.2006.12.004; Miyayama S, 2008, J VASC INTERV RADIOL, V19, P1769, DOI 10.1016/j.jvir.2008.08.024; Bruix J, 1998, HEPATOLOGY, V27, P1578, DOI 10.1002/hep.510270617; Irie T, 2013, CARDIOVASC INTER RAD, V36, P706, DOI 10.1007/s00270-012-0476-z; Ikeda M, 2004, ONCOLOGY-BASEL, V66, P24, DOI 10.1159/000076331; Miyayama S, 2013, J VASC INTERV RADIOL, V24, P501, DOI 10.1016/j.jvir.2012.12.022; Kiyosue H, 2004, J VASC INTERV RADIOL, V15, P641, DOI 10.1097/01.RVI.0000124953.24134.C2; Georgiades CS, 2005, J VASC INTERV RADIOL, V16, P1653, DOI 10.1097/01.RVI.0000182185.47500.7A; Shimohira M, 2011, BRIT J RADIOL, V84, P184, DOI 10.1259/bjr/26974088; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Gao S, 2013, HEPATO-GASTROENTEROL, V60, P813, DOI 10.5754/hge121025; MADDEN MV, 1993, GUT, V34, P1598, DOI 10.1136/gut.34.11.1598; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Yamakado K, 2012, JPN J RADIOL, V30, P560, DOI 10.1007/s11604-012-0088-1; KONNO T, 1983, EUR J CANCER CLIN ON, V19, P1053, DOI 10.1016/0277-5379(83)90028-7; Miyayama S, 2010, CARDIOVASC INTER RAD, V33, P53, DOI 10.1007/s00270-009-9595-6; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; [Anonymous], 2002, HEPATOLOGY, DOI [DOI 10.1053/JHEP.2002.33156, 10.1053/jhep.2002.33156]; Sacco R, 2011, J VASC INTERV RADIOL, V22, P1545, DOI 10.1016/j.jvir.2011.07.002; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; Song MJ, 2012, J HEPATOL, V57, P1244, DOI 10.1016/j.jhep.2012.07.017; Chung JW, 2006, KOREAN J RADIOL, V7, P257; NAKAMURA H, 1989, RADIOLOGY, V170, P783; HATANAKA Y, 1995, RADIOLOGY, V195, P747; Koganemaru M, 2012, JPN J RADIOL, V30, P870, DOI 10.1007/s11604-012-0128-x; MATSUI O, 1993, RADIOLOGY, V188, P79; Matsui O, 2010, J HEPATO-BIL-PAN SCI, V17, P407, DOI 10.1007/s00534-009-0234-z; Pelletier G, 1998, J HEPATOL, V29, P129, DOI 10.1016/S0168-8278(98)80187-6; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Maeda S, 2002, HEPATOL RES, V23, P202, DOI 10.1016/S1386-6346(01)00174-7; Miyayama S, 2004, J VASC INTERV RADIOL, V15, P815, DOI 10.1097/01.RVI.0000136989.34890.D7; Park JW, 2013, LIVER INT, V33, P327, DOI 10.1111/liv.12083; El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222; Llovet JM, 2012, J HEPATOL, V56, P908; OBERTI F, 1995, NEW ENGL J MED, V332, P1256; Kudo Masatoshi, 2014, Liver Cancer, V3, P458, DOI 10.1159/000343875; LU CD, 1994, CHINESE MED J-PEKING, V107, P209; Sakaguchi H, 1991, Gan To Kagaku Ryoho, V18, P1349; Vogl TJ, 2011, AM J ROENTGENOL, V197, pW562, DOI 10.2214/AJR.10.4379	72	0	0	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	OCT	2015	205	4					764	773		10.2214/AJR.15.14825		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CS1SF	WOS:000361847300025		
J	Zhou, M; Li, JB; Cheng, L; Egevad, L; Deng, FM; Kunju, LP; Magi-Galluzzi, C; Melamed, J; Mehra, R; Mendrinos, S; Osunkoya, AO; Paner, G; Shen, SS; Tsuzuki, T; Trpkov, K; Tian, W; Yang, XM; Shah, RB				Zhou, Ming; Li, Jianbo; Cheng, Liang; Egevad, Lars; Deng, Fang-Ming; Kunju, Lakshmi Priya; Magi-Galluzzi, Cristina; Melamed, Jonathan; Mehra, Rohit; Mendrinos, Savvas; Osunkoya, Adeboye O.; Paner, Gladell; Shen, Steve S.; Tsuzuki, Toyonori; Trpkov, Kiril; Tian, Wei; Yang, Ximing; Shah, Rajal B.			Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						Gleason grade; Gleason pattern 4; poorly formed glands; prostate cancer; prostate needle biopsy; interobserver reproducibility	2005 INTERNATIONAL-SOCIETY; OF-AMERICAN-PATHOLOGISTS; ACTIVE SURVEILLANCE; INTRAOBSERVER REPRODUCIBILITY; RADICAL PROSTATECTOMY; OBSERVER VARIABILITY; CONSENSUS STATEMENT; CRIBRIFORM PATTERN; ISUP CONSENSUS; CANCER	Accurate recognition of Gleason pattern (GP) 4 prostate carcinoma (PCa) on needle biopsy is critical for patient management and prognostication. Poorly formed glands are the most common GP4 subpattern. We studied the diagnostic reproducibility and the quantitative threshold of grading GP4 poorly formed glands and the criteria to distinguish them from tangentially sectioned GP3 glands. Seventeen urologic pathologists were first queried for the definition of poorly formed glands using cases representing a spectrum of PCa glandular differentiation. Cancer glands with no or rare lumens, elongated compressed glands, and elongated nests were considered poorly formed glands by consensus. Participants then graded a second set of 23 PCa cases that potentially contained poorly formed glands with a fair interobserver agreement (=0.34). The consensus diagnoses, defined as agreement by >70% participants, were then correlated with the quantitative (5, 6 to 10, >10) and topographic features of poorly formed glands (clustered, immediately adjacent to, and intermixed with other well-formed PCa glands) in each case. Poorly formed glands immediately adjacent to other well-formed glands regardless of their number and small foci of 5 poorly formed glands regardless of their location were not graded as GP4. In contrast, large foci of >10 poorly formed glands that were not immediately adjacent to well-formed glands were graded as GP4. Grading poorly formed glands is challenging. Some morphologic features are, however, reproducible for and against a GP4 diagnosis. This study represents an important step in standardization of grading of poorly formed glands based on quantitative and topographic morphologic features.	[Zhou, Ming; Deng, Fang-Ming; Melamed, Jonathan] NYU, Med Ctr, New York, NY 10016 USA; [Li, Jianbo; Magi-Galluzzi, Cristina] Cleveland Clin, Cleveland, OH 44106 USA; [Cheng, Liang] Indiana Univ, Indianapolis, IN 46204 USA; [Kunju, Lakshmi Priya; Mehra, Rohit] Univ Michigan, Ann Arbor, MI 48109 USA; [Mendrinos, Savvas; Tian, Wei; Shah, Rajal B.] Miraca Life Sci Res Inst, Div Urol Pathol, Irving, TX USA; [Shen, Steve S.] Houston Methodist Hosp, Houston, TX USA; [Osunkoya, Adeboye O.] Emory Univ, Sch Med, Atlanta, GA USA; [Paner, Gladell] Univ Chicago, Chicago, IL 60637 USA; [Yang, Ximing] Northwestern Med Ctr, Chicago, IL USA; [Egevad, Lars] Karolinska Inst, Stockholm, Sweden; [Tsuzuki, Toyonori] Japanese Red Cross Nagoya Daini Hosp, Nagoya, Aichi, Japan; [Trpkov, Kiril] Calgary Lab Serv, Calgary, AB, Canada; [Trpkov, Kiril] Univ Calgary, Calgary, AB, Canada	Zhou, M (reprint author), NYU, Med Ctr, Dept Pathol, 560 First Ave,TCH 461, New York, NY 10016 USA.	ming.zhou@nyumc.org		Melamed, Jonathan/0000-0003-2844-7990			Amin MB, 2014, ARCH PATHOL LAB MED, V138, P1387, DOI 10.5858/arpa.2014-0219-SA; GLEASON DF, 1974, J UROLOGY, V111, P58; Melia J, 2006, HISTOPATHOLOGY, V48, P644, DOI 10.1111/j.1365-2559.2006.02393.x; Iczkowski KA, 2011, AM J CLIN PATHOL, V136, P98, DOI 10.1309/AJCPZ7WBU9YXSJPE; Rodriguez-Urrego PA, 2011, HUM PATHOL, V42, P68, DOI 10.1016/j.humpath.2010.07.001; Allsbrook WC, 2001, HUM PATHOL, V32, P74, DOI 10.1053/hupa.2001.21134; Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; McKenney JK, 2011, J UROLOGY, V186, P465, DOI 10.1016/j.juro.2011.03.115; Egevad L, 2001, UROLOGY, V57, P291, DOI 10.1016/S0090-4295(00)00922-5; Helpap B, 2006, VIRCHOWS ARCH, V449, P622, DOI 10.1007/s00428-006-0310-6; Egevad L, 2011, VIRCHOWS ARCH, V459, P175, DOI 10.1007/s00428-011-1106-x; Helpap B, 2012, PATHOL ONCOL RES, V18, P615, DOI 10.1007/s12253-011-9484-6; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; Shah RB, 2009, ARCH PATHOL LAB MED, V133, P1810, DOI 10.1043/1543-2165-133.11.1810; Gottipati S, 2012, AM J SURG PATHOL, V36, P900, DOI 10.1097/PAS.0b013e3182495dee; Brimo F, 2013, EUR UROL, V63, P892, DOI 10.1016/j.eururo.2012.10.015; Delahunt B, 2010, PATHOLOGY, V42, P339, DOI 10.3109/00313021003787924; Zareba P, 2009, HISTOPATHOLOGY, V55, P384, DOI 10.1111/j.1365-2559.2009.03405.x; Ellis CL, 2013, J UROLOGY, V190, P2068, DOI 10.1016/j.juro.2013.05.056; Lessells AM, 1997, HUM PATHOL, V28, P646, DOI 10.1016/S0046-8177(97)90172-6; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Carlson GD, 1998, UROLOGY, V51, P525, DOI 10.1016/S0090-4295(98)00002-8; Danneman D, 2014, BJU INT, V115, P248; Dong F, 2013, AM J SURG PATHOL, V37, P1855, DOI 10.1097/PAS.0b013e3182a02169; Eble JN, 2004, WHO CLASSIFICATION T; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Kweldam CF, 2015, MODERN PATHOL, V28, P457, DOI 10.1038/modpathol.2014.116; Mellinger GT, 1977, RECENT RESULTS CANC, V60, P61; Tannenbaum M, 1977, UROLOGIC PATHOLOGY P, P171	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	OCT	2015	39	10					1331	1339		10.1097/PAS.0000000000000457		9	Pathology; Surgery	Pathology; Surgery	CS5IU	WOS:000362112400004		
J	Yoshida, A; Kamata, T; Iwasa, T; Watanabe, S; Tsuta, K				Yoshida, Akihiko; Kamata, Tsugumasa; Iwasa, Takeshi; Watanabe, Shun-ichi; Tsuta, Koji			Myocardial Sleeve Tissues in Surgical Lung Specimens	AMERICAN JOURNAL OF SURGICAL PATHOLOGY			English	Article						arrhythmia; cancer; lung; myocardial sleeve; surgery	ATRIAL-FIBRILLATION; PULMONARY VEINS; RISK-FACTORS; RADIOFREQUENCY ABLATION; THORACIC-SURGERY; ARRHYTHMIAS; RESECTION; JUNCTION; HEARTS	Left atrial myocardial extensions over the pulmonary veins (PVs), known as myocardial sleeves, are present in the physiological anatomy of most individuals. Although this structure has recently received clinical attention as a major origin of paroxysmal atrial fibrillation (AF), it has not been documented in surgical specimens. Here, we examine incidentally identified myocardial sleeve tissue in routinely processed lung resection specimens to determine its incidence and diagnostic implications. Among 694 lung resection specimens with evaluable PV margins, myocardial sleeve tissue was identified in 26 cases (3.7%). The tissue was located within the adventitia of the PVs, mostly in margin preparations, and existed outside the pericardium in the majority of cases. Carcinoma infiltration of the sleeves was evident in 6 cases. No heart injuries were observed, and no tumors invaded the heart. Preoperative electrocardiography showed sinus rhythm in all cases, whereas postoperative monitoring revealed sinus rhythm in all patients except one who showed AF and flutter. Myocardial sleeve tissue is an underrecognized incidental finding in lung resection specimens, and it is not indicative of heart injury. Cancer infiltration into this tissue indicates neither heart invasion nor, by itself, invasion into the pericardium. Although surgical transection of the myocardial sleeve did not evoke immediate arrhythmia in most cases, the overall influence of this procedure on the postsurgical risk of AF remains to be determined in further studies involving extensive rhythm assessment.	[Yoshida, Akihiko; Tsuta, Koji] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo 1040045, Japan; [Kamata, Tsugumasa; Watanabe, Shun-ichi] Natl Canc Ctr, Dept Thorac Surg, Tokyo 1040045, Japan; [Iwasa, Takeshi] Natl Canc Ctr, Dept Gen Internal Med, Tokyo 1040045, Japan	Yoshida, A (reprint author), Natl Canc Ctr, Dept Pathol & Clin Labs, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	akyoshid@ncc.go.jp					Kuwabara H, 2012, INDIAN J PATHOL MICR, V55, P513, DOI 10.4103/0377-4929.107794; Onaitis M, 2010, ANN THORAC SURG, V90, P368, DOI 10.1016/j.athoracsur.2010.03.100; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Tagawa M, 2001, PACE, V24, P1459, DOI 10.1046/j.1460-9592.2001.01459.x; NATHAN H, 1970, THORAX, V25, P317, DOI 10.1136/thx.25.3.317; ASAMURA H, 1993, J THORAC CARDIOV SUR, V106, P1104; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Ho SY, 2001, HEART, V86, P265, DOI 10.1136/heart.86.3.265; NATHAN H, 1966, CIRCULATION, V34, P412; Steiner I, 2006, VIRCHOWS ARCH, V449, P88, DOI 10.1007/s00428-006-0197-2; Rena O, 2001, EUR J CARDIO-THORAC, V20, P688, DOI 10.1016/S1010-7940(01)00890-9; Roux N, 2004, SURG RADIOL ANAT, V26, P285, DOI 10.1007/s00276-003-0219-6; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hassink RJ, 2003, J AM COLL CARDIOL, V42, P1108, DOI 10.1016/S0735-1097(03)00918-5; Saito T, 2000, J CARDIOVASC ELECTR, V11, P888, DOI 10.1111/j.1540-8167.2000.tb00068.x; Ivanovic J, 2014, INTERACT CARDIOV TH, V18, P340, DOI 10.1093/icvts/ivt520; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Vaporciyan AA, 2004, J THORAC CARDIOV SUR, V127, P779, DOI 10.1016/j.jtcvs.2003.07.011; Moubarak JB, 2000, PACE, V23, P1836; Weiss C, 2002, PACE, V25, P1352, DOI 10.1046/j.1460-9592.2002.01352.x; De Simone CV, 2012, J CARDIOVASC ELECTR, V23, P1304, DOI 10.1111/j.1540-8167.2012.02403.x; Silverman JF, 2006, AM J CLIN PATHOL, V125, P815, DOI 10.1309/RJD0MY829KE8R9K2; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022; Sobin LH, 2009, INT UNION CANC UICC; Westra W, 2003, SURG PATHOLOGY DISSE	25	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0147-5185	1532-0979		AM J SURG PATHOL	Am. J. Surg. Pathol.	OCT	2015	39	10					1427	1432		10.1097/PAS.0000000000000467		6	Pathology; Surgery	Pathology; Surgery	CS5IU	WOS:000362112400017		
J	Stiburkova, B; Stekrova, J; Nakamura, M; Ichida, K				Stiburkova, Blanka; Stekrova, Jitka; Nakamura, Makiko; Ichida, Kimiyoshi			Hereditary Renal Hypouricemia Type 1 and Autosomal Dominant Polycystic Kidney Disease	AMERICAN JOURNAL OF THE MEDICAL SCIENCES			English	Article						Renal hypouricemia; SLC22A12; URAT1; Uric acid transporters	URATE; MUTATION; TRANSPORTER; SLC22A12; SLC2A9; IDENTIFICATION; JAPANESE; GENE; GOUT	Background:Renal hypouricemia (RHUC) is a heterogeneous inherited disorder characterized by impaired tubular uric acid (UA) transport with severe complications, such as acute kidney injury. Type 1 is caused by a mutation in the SLC22A12 gene (URAT1) and type 2 in the SLC2A9 gene (GLUT9). In this article, the authors present a coexpression functional characterization of variants responsible for RHUC type 1 in a Czech family with polycystic kidney disease (PKD).Methods:The serum UA concentration in the proband was 1.1 mg/dL and was expressed as an increase in the fractional excretion of UA (43%). The URAT1 allelic variants were prepared and their urate uptake and subcellular localization were studied by Xenopus oocytes expression system. Linkage analysis using a panel of 4 CA-repeat flanking markers for chromosome 16 and a panel of 3 CA-repeat flanking markers for chromosome 4 was performed, which carry the PKD1 and PKD2 genes, respectively.Results:Coexpression results showed that p.G366R and p.R477H suppressed urate transport by wild types. Colocalization studies showed an accumulation of URAT1 in the endoplasmic reticulum of the p.G366R variant and mainly retention of wild-type protein by variants p.G366R and p.R477H.Conclusions:The findings suggest that not only loss-of-function mutation of URAT1 but also the dominant-negative effect cause RHUC through loss of UA absorption, partly due to protein misfolding caused by accumulation of URAT1 protein in the endoplasmic reticulum.	[Stiburkova, Blanka] Inst Rheumatol, Prague 12850 2, Czech Republic; [Stiburkova, Blanka] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic; [Stiburkova, Blanka] Gen Univ Hosp, Prague, Czech Republic; [Stekrova, Jitka] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Stekrova, Jitka] Gen Univ Hosp, Prague, Czech Republic; [Nakamura, Makiko] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Tokyo, Japan; [Nakamura, Makiko; Ichida, Kimiyoshi] Jikei Univ, Sch Med, Div Kidney & Hypertens, Tokyo, Japan	Stiburkova, B (reprint author), Inst Rheumatol, Slupi 4, Prague 12850 2, Czech Republic.	stiburkova@revma.cz			Czech Republic Ministry of Education, Youth and Sports [LH13245]; Charles University in Prague [PRVOUK-P25/LF1/2, P24/LF1/3]	Supported by grants from the Czech Republic Ministry of Education, Youth and Sports (LH13245) and by institutional support from a program at Charles University in Prague (PRVOUK-P25/LF1/2, P24/LF1/3).	Stiburkova B, 2012, PEDIATR NEPHROL, V27, P1411, DOI 10.1007/s00467-012-2174-0; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Enomoto A, 2002, NATURE, V417, P447; Sebesta I, 2011, NUCLEOS NUCLEOT NUCL, V30, P1112, DOI 10.1080/15257770.2011.611483; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Dinour D, 2011, NEPHROL DIAL TRANSPL, V26, P2175, DOI 10.1093/ndt/gfq722; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Stiburkova B, 2013, EUR J HUM GENET, V21, P1067, DOI 10.1038/ejhg.2013.3; Taniguchi A, 2005, ARTHRITIS RHEUM, V52, P2576, DOI 10.1002/art.21242; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Dinour D, 2010, J AM SOC NEPHROL, V21, P64, DOI 10.1681/ASN.2009040406; Ichida K, 2008, CLIN GENET, V74, P243, DOI 10.1111/j.1399-0004.2008.01021.x; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Shima Y, 2011, PEDIATRICS, V127, pE1621, DOI 10.1542/peds.2010-2592; Iwai N, 2004, KIDNEY INT, V66, P935, DOI 10.1111/j.1523-1755.2004.00839.x; Bhasin B, 2014, AM J MED, V127, pE3, DOI 10.1016/j.amjmed.2013.08.025; Gabrikova D, 2015, UROLITHIASIS, V43, P441, DOI 10.1007/s00240-015-0790-4; Obeidova L, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-41; Reiterova J, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-59; Stiburkova B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097646; Tasic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028641	22	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0002-9629	1538-2990		AM J MED SCI	Am. J. Med. Sci.	OCT	2015	350	4					268	271		10.1097/MAJ.0000000000000550		4	Medicine, General & Internal	General & Internal Medicine	CS6UM	WOS:000362218400006		
J	Yamazaki, S; Yamagishi, M; Nishida, K; Tamura, S; Monta, O; Numata, S; Tsutsumi, Y; Ohashi, H				Yamazaki, Sachiko; Yamagishi, Masaaki; Nishida, Kouichi; Tamura, Satoshi; Monta, Osamu; Numata, Satoshi; Tsutsumi, Yasushi; Ohashi, Hirokazu			Congenital Absence of One Pulmonary Valve Cusp With Other Hypoplastic Cusps	ANNALS OF THORACIC SURGERY			English	Editorial Material							NATURAL-HISTORY	Congenital absence of a single pulmonary valve cusp is extremely rare. We report a case of a 38-year-old woman with a confirmed congenital absence of a single pulmonary valve cusp associated with dextrocardia. The other 2 leaflets were moderately hypoplastic, and transthoracic echocardiography showed severe pulmonary regurgitation. This combination of lesions has not been reported previously. Pulmonary valve replacement using a composite biologic valved conduit was performed with an excellent outcome. (C) 2015 by The Society of Thoracic Surgeons	[Yamazaki, Sachiko] Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, Fukui 9100833, Japan; Kyoto Prefectural Univ Med, Childrens Med Ctr, Dept Pediat Cardiovasc Surg, Kyoto, Japan	Yamazaki, S (reprint author), Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, 2-228 Shimbo, Fukui 9100833, Japan.	rockyyamazaki@yahoo.co.jp					Zucker N, 2004, CARDIOL YOUNG, V14, P402, DOI 10.1017/S1047951104004093; TANABE Y, 1992, AM HEART J, V124, P526, DOI 10.1016/0002-8703(92)90627-8; ANSARI A, 1991, PROG CARDIOVASC DIS, V33, P329, DOI 10.1016/0033-0620(91)90024-G; SHIMAZAKI Y, 1984, THORAC CARDIOV SURG, V32, P257, DOI 10.1055/s-2007-1023399; Sayger P, 2000, PEDIATR CARDIOL, V21, P487, DOI 10.1007/s002460010118; Westaby S, 1997, ANN THORAC SURG, V64, P849, DOI 10.1016/S0003-4975(97)00687-5; Ficher DR, 1984, AM J CARDIOL, V53, P1433	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	OCT	2015	100	4					1450	1452		10.1016/j.athoracsur.2014.12.103		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CS7TE	WOS:000362288000061		
J	Kinoshita, T; Kamiyama, I; Hayashi, Y; Asakura, K; Ohtsuka, T; Kohno, M; Emoto, K; Nakayama, R; Morioka, H; Asamura, H				Kinoshita, Tomonari; Kamiyama, Ikuo; Hayashi, Yuichiro; Asakura, Keisuke; Ohtsuka, Takashi; Kohno, Mitsutomo; Emoto, Katsura; Nakayama, Robert; Morioka, Hideo; Asamura, Hisao			Spontaneous Regression of Metastatic Extraskeletal Myxoid Chondrosarcoma	ANNALS OF THORACIC SURGERY			English	Editorial Material							CANCER	Spontaneous regression of tumors is very unusual and is defined as a partial or complete disappearance of metastatic tumors without any treatment. This phenomenon has been reported in almost all types of cancer. The patient was a 25-year-old woman who presented with multiple pulmonary nodules on her bilateral lungs on the annual chest roentgenograph. Simultaneously, a swelling mass on her subcutaneous inguinal region was observed. The diagnosis of the inguinal mass was extraskeletal myxoid chondrosarcoma. The inguinal mass and pulmonary nodules spontaneously regressed without any treatment after biopsy. The patient was doing well without evidence of recurrence at 1 year after the operation without any additional therapy. Our case is the first clinical one that indicated a possibility of histologic regression of extraskeletal myxoid chondrosarcoma. (C) 2015 by The Society of Thoracic Surgeons	Keio Univ, Sch Med, Div Gen Thorac Surg, Dept Surg,Dept Pathol, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo 1608582, Japan	Kinoshita, T (reprint author), Keio Univ, Sch Med, Div Gen Thorac Surg, Dept Surg,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	t.kinoshita@a7.keio.jp					Kumar T, 2010, RESP MED, V104, P1543, DOI 10.1016/j.rmed.2010.04.026; Papac RJ, 1998, IN VIVO, V12, P571; Kawaguchi S, 2003, CANCER, V97, P1285, DOI 10.1002/cncr.11162; Martin JM, 2014, AM J DERMATOPATH, V36, pE183, DOI 10.1097/DAD.0000000000000033; STEPHENS.HE, 1971, SURG GYNECOL OBSTETR, V133, P649	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	OCT	2015	100	4					1465	1467		10.1016/j.athoracsur.2014.12.107		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CS7TE	WOS:000362288000068		
J	Mizuno, T; Hachimaru, T; Oi, K; Watanabe, T; Kuroki, H; Fujiwara, T; Sakurai, S; Takeshita, M; Kinoshita, R; Arai, H				Mizuno, Tomohiro; Hachimaru, Tsuyoshi; Oi, Keiji; Watanabe, Taiju; Kuroki, Hidehito; Fujiwara, Tatsuki; Sakurai, Shogo; Takeshita, Masashi; Kinoshita, Ryoji; Arai, Hirokuni			Easy and Safe Total Debranching of Arch Aneurysms Using Axilloaxillary Arterial Bypass	ANNALS OF THORACIC SURGERY			English	Article								Techniques used in hybrid repair of proximal aortic arch diseases are associated with perioperative complications such as cerebrovascular emboli. We present an easy and safe technique of total debranching thoracic endovascular aortic repair for arch diseases using axilloaxillary arterial bypass. The placement of the axilloaxillary arterial bypass enables perfusion of the brachiocephalic artery even when the artery is clamped. After reconstruction of the brachiocephalic artery and the left common carotid artery, the left subclavian artery is proximally ligated, and it is perfused through the bypass. This procedure is simple, safe, and useful for the prevention of neurologic complications. (C) 2015 by The Society of Thoracic Surgeons	[Mizuno, Tomohiro; Hachimaru, Tsuyoshi; Oi, Keiji; Watanabe, Taiju; Kuroki, Hidehito; Fujiwara, Tatsuki; Sakurai, Shogo; Takeshita, Masashi; Kinoshita, Ryoji; Arai, Hirokuni] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Surg, Tokyo 1138519, Japan	Mizuno, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	t-mizuno@yhc.att.ne.jp					Makaroun MS, 2008, J VASC SURG, V47, P912, DOI 10.1016/j.jvs.2007.12.006; Czerny M, 2012, ANN THORAC SURG, V94, P84, DOI 10.1016/j.athoracsur.2012.03.024; Antoniou GA, 2010, EUR J VASC ENDOVASC, V39, P683, DOI 10.1016/j.ejvs.2010.02.002	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	OCT	2015	100	4					1476	1478		10.1016/j.athoracsur.2015.04.045		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CS7TE	WOS:000362288000074		
J	Ishikawa, Y; Masuda, M; Ito, H; Nakayama, H				Ishikawa, Yoshihiro; Masuda, Munetaka; Ito, Hiroyuki; Nakayama, Haruhiko			What Really Affects Synchronous Pulmonary Adenocarcinoma Management? Reply	ANNALS OF THORACIC SURGERY			English	Letter									[Ishikawa, Yoshihiro; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa, Japan; [Ito, Hiroyuki; Nakayama, Haruhiko] Kanagawa Canc Ctr, Dept Thorac Surg, Yokohama, Kanagawa, Japan	Ishikawa, Y (reprint author), Yokohama City Univ, Dept Surg, Yokohama, Kanagawa, Japan.	y_ishikw@yokohama-cu.ac.jp					Gu B, 2013, ANN THORAC SURG, V96, P411, DOI 10.1016/j.athoracsur.2013.04.048; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Baisi A, 2015, ANN THORAC SURG, V100, P1506; Ishikawa Y, 2014, ANN THORAC SURG, V98, P1983	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	OCT	2015	100	4					1507	1507				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	CS7TE	WOS:000362288000083		
J	Yamazaki, H; Nakamura, S; Suzuki, G; Yoshida, K; Yoshioka, Y; Koizumi, M; Ogawa, K				Yamazaki, Hideya; Nakamura, Satoaki; Suzuki, Gen; Yoshida, Ken; Yoshioka, Yasuo; Koizumi, Masahiko; Ogawa, Kazuhiko			Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy	ANTICANCER RESEARCH			English	Review						Prostate cancer; radiotherapy; hypofractionation; high-dose-rate brachytherapy; stereotactic radiotherapy; particle therapy; review	DOSE-RATE BRACHYTHERAPY; RATE INTERSTITIAL BRACHYTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; STEREOTACTIC BODY RADIOTHERAPY; RELAPSE-FREE SURVIVAL; LATE RECTAL TOXICITY; QUALITY-OF-LIFE; RISK INDEX PRIX; RADIATION-THERAPY	Conventionally fractionated (CF) external-beam radiation therapy (1.8-2.0 Gy/fraction) is an established treatment modality for localized prostate cancer. Emerging evidence suggests that the alpha/beta ratio for prostate cancer is as low as 1.5, which has prompted investigators to explore hypofractionated (HF) radiation therapy. We reviewed the current status of hypofractionation and found that the accumulated outcomes reveal that dose escalation by moderate (2.5-4 Gy/fraction) hypofractionation (mHF) results in a better early biochemical outcome with acceptable complication rates, although there exist no marked advantages, other than the convenience of short treatment periods. Recently, hypofractionated external-beam radiotherapy has been challenged by accelerated hypofractionation (AHF), i.e., stereotactic body irradiation, particle therapy, and a high-doserate brachytherapy, using 5-10 Gy/fraction with a precise dose distribution and shorter treatment periods. Five-year biochemical control rates improved to >90%, even for high-risk groups, with a higher dose delivery using a safer technology. The overall survival rate reached nearly 100% at 5 years and was unaffected by prostate cancer, particularly in patients aged >80 years. Therefore, if maintaining the quality of life is the main purpose, short-term treatment is an attractive option from the socioeconomic perspective. Furthermore, CF and mHF regimens use equivalent doses at 2 Gy per fraction (EQD2) of 62-84 Gy, whereas AHF uses a higher EQD2 of 85 to 135 Gy if an alpha/beta ratio of 1.5 is applied. In the preliminary phase, AHF has theoretical advantages that not only reduce the treatment period but also potentially improve BC, particularly in high-risk groups using a higher EQD2.	[Yamazaki, Hideya; Nakamura, Satoaki; Suzuki, Gen] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Radiol, Kamigyo Ku, Kyoto, Kyoto 6028566, Japan; [Yoshida, Ken] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 569, Japan; [Yoshioka, Yasuo; Koizumi, Masahiko; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan	Yamazaki, H (reprint author), Kyoto Prefectural Univ Med, Dept Radiol, Kamigyo Ku, 465 Kajiicho Kawaramachi Hirokoji, Kyoto, Kyoto 6028566, Japan.	hideya10@hotmail.com					Yeoh EE, 2011, INT J RADIAT ONCOL, V81, P1271, DOI 10.1016/j.ijrobp.2010.07.1984; Zaorsky NG, 2013, CANCER TREAT REV, V39, P728, DOI 10.1016/j.ctrv.2013.01.008; Yoshida K, 2014, ANTICANCER RES, V34, P3077; Hoskin P, 2012, INT J RADIAT ONCOL, V82, P1376, DOI 10.1016/j.ijrobp.2011.04.031; Heemsbergen WD, 2010, INT J RADIAT ONCOL, V78, P19, DOI 10.1016/j.ijrobp.2009.07.1680; [Anonymous], 2012, NAT COMPR CANC NETW; Sun LB, 2014, TUMOR BIOL, V35, P9911, DOI 10.1007/s13277-014-2297-y; Proust-Lima C, 2011, INT J RADIAT ONCOL, V79, P195, DOI 10.1016/j.ijrobp.2009.10.008; Yoshioka Y, 2013, J RADIAT RES, V54, P781, DOI 10.1093/jrr/rrt027; Demanes DJ, 2011, INT J RADIAT ONCOL, V81, P1286, DOI [10.1016/j.ijrobp.2010.10.015, 10.1016/j.ifrobp.2010.10.015]; Yoshioka Y, 2007, STRAHLENTHER ONKOL, V183, P490, DOI 10.1007/s00066-007-1692-3; Kupelian PA, 2002, INT J RADIAT ONCOL, V53, P904, DOI 10.1016/S0360-3016(02)02836-5; Majewski W, 2004, INT J RADIAT ONCOL, V60, P60, DOI 10.1016/j.ijrobp.2004.02.056; Prada PJ, 2012, BRACHYTHERAPY, V11, P105, DOI 10.1016/j.brachy.2011.05.003; Tree AC, 2014, CLIN ONCOL-UK, V26, P216, DOI 10.1016/j.clon.2014.01.008; Ishikawa H, 2012, INT J UROL, V19, P296, DOI 10.1111/j.1442-2042.2012.02961.x; King CR, 2013, RADIOTHER ONCOL, V109, P217, DOI 10.1016/j.radonc.2013.08.030; Hoskin PJ, 2012, RADIOTHER ONCOL, V103, P217, DOI 10.1016/j.radonc.2012.01.007; Kim YJ, 2013, ACTA ONCOL, V52, P477, DOI 10.3109/0284186X.2013.764011; Yoshida K, 2014, ANTICANCER RES, V34, P2015; Brenner DJ, 2004, INT J RADIAT ONCOL, V60, P1013, DOI 10.1016/j.ijrobp.2004.04.014; Dasu A, 2012, ACTA ONCOL, V51, P963, DOI 10.3109/0284186X.2012.719635; Martinez AA, 2010, AM J CLIN ONCOL-CANC, V33, P481, DOI 10.1097/COC.0b013e3181b9cd2f; Hoffman KE, 2014, INT J RADIAT ONCOL, V88, P1074, DOI 10.1016/j.ijrobp.2014.01.015; Arcangeli S, 2012, INT J RADIAT ONCOL, V84, P1172, DOI 10.1016/j.ijrobp.2012.02.049; Pollack A, 2013, J CLIN ONCOL, V31, P3860, DOI 10.1200/JCO.2013.51.1972; Zhu Z, 2014, BRIT J CANCER, V110, P2396, DOI 10.1038/bjc.2014.197; Patel N, 2013, INT J RADIAT ONCOL, V86, P534, DOI 10.1016/j.ijrobp.2013.02.010; Lukka H, 2005, J CLIN ONCOL, V23, P6132, DOI 10.1200/JCO.2005.06.153; Ghilezan M, 2012, INT J RADIAT ONCOL, V83, P927, DOI 10.1016/j.ijrobp.2011.05.001; Yoshioka Y, 2009, STRAHLENTHER ONKOL, V185, P446, DOI 10.1007/s00066-009-1981-0; Yoshioka Y, 2011, INT J RADIAT ONCOL, V80, P469, DOI 10.1016/j.ijrobp.2010.02.013; Tucker SL, 2011, INT J RADIAT ONCOL, V81, P600, DOI 10.1016/j.ijrobp.2010.11.080; Kupelian PA, 2007, INT J RADIAT ONCOL, V68, P1424, DOI 10.1016/j.ijrobp.2007.01.067; Loblaw A, 2013, RADIOTHER ONCOL, V107, P153, DOI 10.1016/j.radonc.2013.03.022; Leborgne F, 2012, INT J RADIAT ONCOL, V82, P1200, DOI 10.1016/j.ijrobp.2010.12.040; Dearnaley D, 2012, LANCET ONCOL, V13, P43, DOI 10.1016/S1470-2045(11)70293-5; Zamboglou N, 2013, INT J RADIAT ONCOL, V85, P672, DOI 10.1016/j.ijrobp.2012.07.004; Brenner MJ, 2014, J CLIN ONCOL, V32, P1851, DOI 10.1200/JCO.2013.54.4247; Yeoh EEK, 2003, INT J RADIAT ONCOL, V55, P943, DOI 10.1016/S0360-3016(02)04146-9; Arcangeli G, 2011, INT J RADIAT ONCOL, V79, P1013, DOI 10.1016/j.ijrobp.2009.12.045; Botrel Tobias Engel Ayer, 2013, Core Evid, V8, P1, DOI 10.2147/CE.S41178; Demanes DJ, 2014, BRACHYTHERAPY, V13, P529, DOI 10.1016/j.brachy.2014.03.002; Galalae RM, 2014, BRACHYTHERAPY, V13, P117, DOI 10.1016/j.brachy.2013.11.002; Hoskin P, 2014, RADIOTHER ONCOL, V112, P63, DOI 10.1016/j.radonc.2014.06.007; Katz AJ, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-118; Koontz BF, 2014, EUR UROL; Kuban DA, 2010, INT J RADIAT ONCOL, V78, pS58; Marzi S, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-117; Michalski JM, 2014, INT J RADIAT ONCOL, V90, P1263, DOI 10.1016/j.ijrobp.2014.10.035; Miralbell Raymond, 2012, Int J Radiat Oncol Biol Phys, V82, pe17, DOI 10.1016/j.ijrobp.2010.10.075; Musunuru Hima Bindu, 2014, Front Oncol, V4, P313, DOI 10.3389/fonc.2014.00313; Yamazaki H, 2014, J RADIAT RES, V55, P1033, DOI 10.1093/jrr/rru061; Yoshida K, 2014, STRAHLENTHER ONKOL, V190, P1015, DOI 10.1007/s00066-014-0675-4	54	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5167	5177				11	Oncology	Oncology	CS1KM	WOS:000361823200002		
J	Kosaka, T; Davydova, J; Ono, HA; Akiyama, H; Hirai, SI; Ohno, S; Takeshita, F; Aoki, K; Ochiya, T; Yamamoto, M; Kunisaki, C; Endo, I				Kosaka, Takashi; Davydova, Julia; Ono, Hidetaka A.; Akiyama, Hirotoshi; Hirai, Shu-Ichi; Ohno, Shigeo; Takeshita, Fumitaka; Aoki, Kazunori; Ochiya, Takahiro; Yamamoto, Masato; Kunisaki, Chikara; Endo, Itaru			Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer Lesions	ANTICANCER RESEARCH			English	Article						Gastric cancer; peritoneal dissemination; conditionally replicative adenovirus; luminescent imaging	STAGING LAPAROSCOPY; FROZEN-SECTION; DIAGNOSTIC LAPAROSCOPY; PERITONEAL METASTASIS; PANCREATIC-CANCER; PHASE-II; VECTORS; CHEMOTHERAPY; CARCINOMA; GENE	Background: Long-term outcomes of patients with peritoneal dissemination of gastric cancer remain unsatisfactory despite advances in treatment modalities. Internal luminescence conditionally replicative adenovirus (CRAd) presents a novel approach for cancer treatment and imaging. Materials and Methods: 3CL is a modified cyclo-oxygenase-2 (COX2) promoter-driven CRAd which contains the luciferase expression gene for bioluminescence imaging. The visualizing and therapeutic effect of 3CL was evaluated in a mouse model of peritoneal dissemination. Results: Intraperitoneal injection of 3CL achieved the shrinkage and reduction of lesions of peritoneal dissemination. Six model mice treated with 3CL had a significantly longer mean survival time than 6 mock-treated mice (85.7 versus 34.3 days, p=0.0005). By whole-body bioluminescent imaging, the sensitivity and specificity of peritoneal dissemination detection through macroscopic inspection were 58.1% and 83.2%, respectively, whereas 3CL viral imaging modality yielded corresponding values of 78.8% and 99.3%. Peritoneal lesions detected by imaging histologically contained cancer cells and necrotic tissue, which originated from viral oncolytic effects. Conclusion: Cox2 CRAds with 5/3 chimeric-fiber modification, therefore, appear to be a promising imaging and therapeutic tools for peritoneal dissemination of gastric cancer.	[Kosaka, Takashi; Ono, Hidetaka A.; Akiyama, Hirotoshi; Kunisaki, Chikara; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Hirai, Shu-Ichi; Ohno, Shigeo] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Davydova, Julia; Yamamoto, Masato] Univ Minnesota, Dept Surg, Div Basic & Translat Res, Minneapolis, MN 55455 USA; [Takeshita, Fumitaka; Aoki, Kazunori; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Chuo Ku, Tokyo 104, Japan	Kosaka, T (reprint author), Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	yokotaka1026@yahoo.co.jp			Ministry of Education, Science, Sports, Culture, and Technology of Japan [18591477, 20500395]; Japanese Society of Strategies for Cancer Research and Therapy; US National Institute of Health [CA094084, DK63615]	We thank Long P. Le, Yoji Nagashima, Kenta Narumi, and Atsushi Kondoh for advice. This study was supported, in part, by Grants-in-Aid for Scientific Research 18591477 and 20500395 from the Ministry of Education, Science, Sports, Culture, and Technology of Japan (to CK), by a Grant-in-Aid from the Japanese Society of Strategies for Cancer Research and Therapy (to TK), as by grants CA094084 and DK63615 from the US National Institute of Health (to MY).	Davydova J, 2004, CANCER RES, V64, P4319, DOI 10.1158/0008-5472.CAN-04-0064; Younes M, 2005, ARCH PATHOL LAB MED, V129, P1558; Hecht JR, 2003, CLIN CANCER RES, V9, P555; Krasnykh VN, 1996, J VIROL, V70, P6839; Koopal SA, 2000, CANCER, V89, P1720, DOI 10.1002/1097-0142(20001015)89:8<1720::AID-CNCR11>3.0.CO;2-F; Tekant Y, 2005, SURGERY, V137, P527, DOI 10.1016/j.surg.2004.12.014; Karnam US, 2002, ENDOSCOPY, V34, P146, DOI 10.1055/s-2002-19847; Alvarez RD, 1997, HUM GENE THER, V8, P597, DOI 10.1089/hum.1997.8.5-597; Hoffman JM, 2007, RADIOLOGY, V244, P39, DOI 10.1148/radiol.2441060773; ALLUM WH, 1989, BRIT J SURG, V76, P535, DOI 10.1002/bjs.1800760604; Tanis PJ, 2001, ANN SURG ONCOL, V8, P222, DOI 10.1245/aso.2001.8.3.222; Chartier C, 1996, J VIROL, V70, P4805; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Umeoka T, 2004, CANCER RES, V64, P6259, DOI 10.1158/0008-5472.CAN-04-1335; Sugarbaker PH, 2000, ONCOLOGY-BASEL, V58, P96, DOI 10.1159/000012086; Ray Pritha, 2007, V411, P131, DOI 10.1007/978-1-59745-549-7_10; Dassen AE, 2009, EJSO-EUR J SURG ONC, V35, P449, DOI 10.1016/j.ejso.2008.11.010; Yamamoto M, 2003, GASTROENTEROLOGY, V125, P1203, DOI 10.1053/S0016-5085(03)01196-X; Ono HA, 2005, J GASTROENTEROL, V40, P31, DOI 10.1007/s00535-004-1490-y; Ristimaki A, 1997, CANCER RES, V57, P1276; Song KY, 2007, WORLD J SURG, V31, P1228, DOI 10.1007/s00268-007-9017-3; Rau B, 2005, LANGENBECK ARCH SURG, V390, P187, DOI 10.1007/s00423-004-0483-x; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Zinn KR, 2008, ILAR J, V49, P103; Chang L, 2009, SURG ENDOSC, V23, P231, DOI 10.1007/s00464-008-0099-2; Ono HA, 2005, CANCER RES, V65, P10154, DOI 10.1158/0008-5472.CAN-05-1871; Muntean V, 2009, J GASTROINTEST LIVER, V18, P189; Kurihara Y, 2009, CLIN CANCER RES, V15, P2335, DOI 10.1158/1078-0432.CCR-08-2690; Imano M, 2012, J GASTROINTEST SURG, V16, P2190, DOI 10.1007/s11605-012-2059-3; Okabe H, 2009, ANN SURG ONCOL, V16, P3227, DOI 10.1245/s10434-009-0706-z; Kimura J, 2013, CANCER SCI, V104, P1083, DOI 10.1111/cas.12196; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; DeWeese TL, 2001, CANCER RES, V61, P7476; Yonemura Y, 2012, INT J SURG ONCOL, V2012	36	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5201	5210				10	Oncology	Oncology	CS1KM	WOS:000361823200006		
J	Kunii, E; Ozasa, H; Oguri, T; Maeno, K; Fukuda, S; Uemura, T; Takakuwa, O; Ohkubo, H; Takemura, M; Niimi, A				Kunii, Eiji; Ozasa, Hiroaki; Oguri, Tetsuya; Maeno, Ken; Fukuda, Satoshi; Uemura, Takehiro; Takakuwa, Osamu; Ohkubo, Hirotsugu; Takemura, Masaya; Niimi, Akio			Reversal of c-MET-mediated Resistance to Cytotoxic Anticancer Drugs by a Novel c-MET Inhibitor TAS-115	ANTICANCER RESEARCH			English	Article						Lung cancer; drug resistance; c-MET inhibitor; TAS-115; anticancer drug combinations	CELL LUNG-CANCER; INVASIVE GROWTH; TUMOR-GROWTH; CARCINOMA; PATHWAY; KINASE; ANGIOGENESIS; EXPRESSION; THERAPY; EGFR	Background: The cellular N-methyl-N'-nitrosoguanidine human osteosarcoma transforming gene (c-MET) protein is the receptor tyrosine kinase for hepatocyte growth factor. We recently found that c-MET protein expression and activation were enhanced in the majority of small cell lung cancer cell lines with cytotoxic anticancer drug resistance, and that down-regulation of c-MET reduced resistance to these drugs. Materials and Methods: Expression of c-MET was studied in three non-small cell lung cancer (NSCLC) cell lines, including six resistant cell strains to cytotoxic anticancer drugs. To assess the effect of c-MET activation on drug resistance, we studied drug sensitivity in the presence of a novel c-MET inhibitor TAS-115. Results: c-MET expression and activation are also enhanced in some cytotoxic anticancer drug-resistant NSCLC cell lines, and inhibition of c-MET activation by TAS-115 reduced resistance of these cell lines to anticancer drugs. Conclusion: The mechanism of cellular resistance to anticancer drugs via hepatocyte growth factor/c-MET signal activation is not restricted to small cell lung cancer cell lines, and TAS-115 might be able to reverse the drug resistance of these cancer cells.	[Kunii, Eiji; Oguri, Tetsuya; Maeno, Ken; Fukuda, Satoshi; Uemura, Takehiro; Takakuwa, Osamu; Ohkubo, Hirotsugu; Takemura, Masaya; Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Ozasa, Hiroaki] Kyoto Univ, Grad Sch Med, Dept Multidisciplinary Canc Treatment, Sakyo Ku, Kyoto, Japan	Oguri, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Resp Med Allergy & Clin Immunol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	t-oguri@med.nagoya-cu.ac.jp			Nagoya City University	This study was supported by a grant-in-Aid for Research from the Nagoya City University.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Nakade J, 2014, J THORAC ONCOL, V9, P775, DOI 10.1097/JTO.0000000000000170; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Ozasa H, 2010, CANCER SCI, V101, P161, DOI 10.1111/j.1349-7006.2009.01358.x; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Masuya D, 2004, BRIT J CANCER, V90, P1555, DOI 10.1038/sj.bjc.6601718; Gasparini G, 1997, J NATL CANCER I, V89, P139, DOI 10.1093/jnci/89.2.139; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Ishii M, 2000, ANTI-CANCER DRUG, V11, P353, DOI 10.1097/00001813-200006000-00005; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Blumenschein GR, 2012, J CLIN ONCOL, V30, P3287, DOI 10.1200/JCO.2011.40.3774; Takeuchi S, 2012, AM J PATHOL, V181, P1034, DOI 10.1016/j.ajpath.2012.05.023; Kang YK, 2014, INVEST NEW DRUG, V32, P355, DOI 10.1007/s10637-013-0057-2; Ozasa H, 2014, CANCER SCI, V105, P1032, DOI 10.1111/cas.12447; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Fujita H, 2013, MOL CANCER THER, V12, P2685, DOI 10.1158/1535-7163.MCT-13-0459; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Jantus-Lewintre E, 2011, LUNG CANCER, V74, P326, DOI 10.1016/j.lungcan.2011.02.016; Arriola E, 2011, BRIT J CANCER, V105, P814, DOI 10.1038/bjc.2011.298; Bottaro DP, 1991, SCIENCE, V251, P8027	27	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5241	5247				7	Oncology	Oncology	CS1KM	WOS:000361823200011		
J	Uesawa, Y; Sakagami, H; Ishihara, M; Kagaya, H; Kanamoto, T; Terakubo, S; Nakashima, H; Yahagi, H; Takao, K; Sugita, Y				Uesawa, Yoshihiro; Sakagami, Hiroshi; Ishihara, Mariko; Kagaya, Hajime; Kanamoto, Taisei; Terakubo, Shigemi; Nakashima, Hideki; Yahagi, Hideaki; Takao, Koichi; Sugita, Yoshiaki			Quantitative Structure-Cytotoxicity Relationship of 3-Styryl-2H-chromenes	ANTICANCER RESEARCH			English	Article						3-styryl-2H-chromenes; QSAR analysis; cytotoxicity; tumor selectivity; anti-HIV activity	2H-CHROMENE DERIVATIVES; SEARCH; AGENTS	Background: Sixteen 3-styryl-2H-chromenes were subjected to quantitative structure-activity relationship analysis based on their cytotoxicity, tumor selectivity and anti-HIV activity, in order to find their new biological activities. Materials and Methods: Cytotoxicity against four human oral squamous cell carcinoma (OSCC) cell lines, three mesenchymal and two epithelial normal oral cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide method. Tumor-selectivity (TS) was evaluated by the ratio of the mean CC50 (50% cytotoxic concentration) against normal human oral cells to that against OSCC cell lines. Anti-HIV activity was evaluated by the ratio of CC50 to EC50 (50% cytoprotective concentration from HIV infection). Potency-selectivity expression (PSE) was determined by the ratio of TS/CC50 against OSCC. Physicochemical, structural and quantum-chemical parameters were calculated based on the conformations optimized by the LowModeMD method. Results: All 3-styryl-2H-chromene derivatives showed relatively high tumor selectivity. Especially, the compound that has a methoxy group at 7-position of the chromene ring and chlorine at 4'-position of phenyl group in styryl moiety [12] showed the highest TS and PSE values, exceeding those of resveratrol, doxorubicin and 5-FU. All compounds showed no anti-HIV activity. Among 330 chemical descriptors, 8, 74 and 16 descriptors significantly correlated to the cytotoxicity of normal and tumor cells, and tumor-specificity, respectively. Conclusion. Multivariate statistics with chemical descriptors for molecular shape and flatness may be useful for the evaluation of tumor-specificity of 3-styryl-2H-chromenes.	[Uesawa, Yoshihiro; Kagaya, Hajime] Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Kiyose, Tokyo 204858, Japan; [Sakagami, Hiroshi] Meikai Univ, Sch Dent, Div Pharmacol, Sakado, Saitama 35002, Japan; [Ishihara, Mariko] Meikai Univ, Sch Dent, Div Basic Chem, Sakado, Saitama 35002, Japan; [Kanamoto, Taisei; Terakubo, Shigemi; Nakashima, Hideki] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; [Yahagi, Hideaki; Takao, Koichi; Sugita, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 35002, Japan	Uesawa, Y (reprint author), Meiji Pharmaceut Univ, Dept Clin Pharmaceut, 2-522-1 Noshio, Kiyose, Tokyo 204858, Japan.	uesawa@my-pharm.ac.jp			KAKENHI from Japan Society for the Promotion of Science (JSPS) [15K08111]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by KAKENHI from the Japan Society for the Promotion of Science (JSPS) (15K08111). The annual license of the statistical software, JMP Pro, was supported by the grant-in-aid of the oncology specialists promotion program by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Patil SA, 2013, FUTURE MED CHEM, V5, P1647, DOI 10.4155/fmc.13.126; Ohno H, 2013, ANTICANCER RES, V33, P3061; Suzuki R, 2014, ANTICANCER RES, V34, P4117; Kantoh K, 2010, IN VIVO, V24, P843; Wildman SA, 1999, J CHEM INF COMP SCI, V39, P868, DOI 10.1021/ci990307l; Roy R, 2014, J ORG CHEM, V79, P6603, DOI 10.1021/jo5011125; Batista JM, 2008, BIOL PHARM BULL, V31, P538, DOI 10.1248/bpb.31.538; NAKASHIMA H, 1992, ANTIVIR RES, V18, P91, DOI 10.1016/0166-3542(92)90008-S; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Conti C, 2010, BIOORGAN MED CHEM, V18, P6480, DOI 10.1016/j.bmc.2010.06.103; Conti C, 2014, BIOORGAN MED CHEM, V22, P1201, DOI 10.1016/j.bmc.2013.11.054; Conti C, 2011, BIOORGAN MED CHEM, V19, P7357, DOI 10.1016/j.bmc.2011.10.060; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17; Das S, 2012, J MED CHEM, V51, P193; Gramza AW, 2013, J CLIN ONCOL, V31, P6074; Hall LH, 1991, REV COMPUTATIONAL CH, V2; Horikoshi M, 1974, JPN J ORAL SURG, V20, P100	17	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5299	5307				9	Oncology	Oncology	CS1KM	WOS:000361823200018		
J	Liu, LT; Ito, S; Nishio, N; Sun, Y; Chen, NN; Tanaka, Y; Isobe, K				Liu, Lintao; Ito, Sachiko; Nishio, Naomi; Sun, Yang; Chen, Nana; Tanaka, Yuriko; Isobe, Ken-ichi			GADD34 Facilitates Cell Death Resulting from Proteasome Inhibition	ANTICANCER RESEARCH			English	Article						GADD34; proteasome inhibition; cell death; eIF2 alpha; autophagy	LUNG-CANCER CELLS; ER STRESS; PROTEIN-SYNTHESIS; APOPTOSIS; AUTOPHAGY; BORTEZOMIB; EIF2-ALPHA; MECHANISMS; GENERATION; THERAPY	Background: Proteasome inhibition has been proven to be a promising therapeutic strategy in cancer clinical treatment. Inhibition of proteasome leads to failure of amino acid homeostasis, which causes cell death via activation of various mechanisms. Materials and Methods: To investigate the role of GADD34 in cell death following proteasome inhibition, we treated WT MEF and GADD34 KO MEF with MG132 and various analyses were performed, including PI staining, western blot, immunofluorescence and ROS production. Results: Expression of GADD34 dramatically enhanced MG132-induced cell death via protein synthesis. GADD34 decreased phosphorylated eIF2 alpha and increased ROS production and the levels of ubiquinated protein. Importantly, we found that accumulation of autophagy following MG132-treatment facilitated cell death in MEF. Conclusion: GADD34 plays a vital role in promoting cell death following proteasome inhibition via enhancing protein synthesis to activate death-associated mechanisms, including ER stress, ROS production and autophagy formation.	[Liu, Lintao; Ito, Sachiko; Nishio, Naomi; Sun, Yang; Chen, Nana; Tanaka, Yuriko; Isobe, Ken-ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi 4648601, Japan; [Isobe, Ken-ichi] Nagoya Womens Univ, Dept Food Sci & Nutr, Nagoya, Aichi 4678610, Japan	Isobe, K (reprint author), Nagoya Womens Univ, Dept Food Sci & Nutr, Mizuho Ku, 3-40 Shioji Cho, Nagoya, Aichi 4678610, Japan.	isobe@nagoya-wu.ac.jp			Japan Society for the Promotion of Science [25293166]	The Authors thank M. Tanaka for technical assistance with flow cytometric experiments (Laboratory of Division for Medical Research Engineering, Nagoya University Graduate School of Medicine), as well as N. Oiwa for administrative assistance. This work was supported by 25293166 Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science.	Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JC126390; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Scagliotti G, 2006, CRIT REV ONCOL HEMAT, V58, P177, DOI 10.1016/j.critrevonc.2005.12.001; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Yuan BZ, 2009, ONCOGENE, V28, P3775, DOI 10.1038/onc.2009.240; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Uddin MN, 2011, BIOCHEM BIOPH RES CO, V407, P692, DOI 10.1016/j.bbrc.2011.03.077; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Bunn PA, 2004, CLIN CANCER RES, V10, p4263S, DOI 10.1158/1078-0432.CCR-040011; Ito S, SCI REPORTS; Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896	26	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5317	5324				8	Oncology	Oncology	CS1KM	WOS:000361823200020		
J	Sakagami, H; Uesawa, Y; Ishihara, M; Kagaya, H; Kanamoto, T; Terakubo, S; Nakashima, H; Takao, K; Sugita, Y				Sakagami, Hiroshi; Uesawa, Yoshihiro; Ishihara, Mariko; Kagaya, Hajime; Kanamoto, Taisei; Terakubo, Shigemi; Nakashima, Hideki; Takao, Koichi; Sugita, Yoshiaki			Quantitative Structure-Cytotoxicity Relationship of Oleoylamides	ANTICANCER RESEARCH			English	Article						Oleoylamides; QSAR analysis; cytotoxicity; tumor selectivity; anti-HIV activity	SLEEP; OLEAMIDE; SEARCH; LIPIDS	Eighteen oleoylamides were subjected to quantitative structure-activity relationship analysis based on their cytotoxicity, tumor selectivity and anti-HIV activity, in order to assess their biological activities. Cytotoxicity against four human oral squamous cell carcinoma (OSCC) cell lines and five human oral normal cells (gingival fibroblast, periodontal ligament fibroblast, pulp cell, oral keratinocyte, primary gingival epithelial cells) was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. Tumor-selectivity (TS) was evaluated by the ratio of the mean 50% cytotoxic concentration (CC50) against normal human oral cells to that against OSCC cell lines. Potency-selectivity expression (PSE) was determined by the ratio of TS to CC50 against OSCC. Anti-HIV activity was evaluated by the ratio of CC50 to the concentration leading to 50% cytoprotection from HIV infection (EC50). Physicochemical, structural and quantum-chemical parameters were calculated based on the conformations optimized by the LowModeMD method. Among 18 derivatives, compounds 8 with a catechol group) and 18 with a (2-pyridyl) amino group) had the highest TS. On the other hand, doxorubicin and 5-fluorouracil (5-FU) were more highly cytotoxic to normal epithelial cells, displaying unexpectedly lower TS and PSE values. None of the compounds had anti-HIV activity. Among 330 chemical descriptors, 75, 73 and 19 descriptors significantly correlated to the cytotoxicity to normal and tumor cells, and TS, respectively. Multivariate statistics with chemical descriptors for molecular polarization and hydrophobicity may be useful for the evaluation of cytotoxicity and TS of oleoylamides.	[Sakagami, Hiroshi] Meikai Univ, Sch Dent, Div Pharmacol, Sakado, Saitama 3500283, Japan; [Ishihara, Mariko] Meikai Univ, Sch Dent, Div Basic Chem, Sakado, Saitama 3500283, Japan; [Uesawa, Yoshihiro; Kagaya, Hajime] Meiji Pharmaceut Univ, Dept Clin Pharmaceut, Kiyose, Japan; [Kanamoto, Taisei; Terakubo, Shigemi; Nakashima, Hideki] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa, Japan; [Takao, Koichi; Sugita, Yoshiaki] Josai Univ, Fac Pharmaceut Sci, Dept Pharmaceut & Hlth Sci, Bioorgan Chem Lab, Sakado, Saitama 35002, Japan	Sakagami, H (reprint author), Meikai Univ, Sch Dent, Dept Diagnost & Therapeut Sci, Div Pharmacol, Sakado, Saitama 3500283, Japan.	sakagami@dent.meikai.ac.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [15K08111]; Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by KAKENHI from the Japan Society for the Promotion of Science (JSPS) (15K08111). The annual license of the statistical software, JMP Pro, was supported by the grant-in-aid of the oncology specialists promotion program by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Andreiuk GM, 1978, UKR BIOKHIM ZH, V69, P32; Uchiyama N, 2010, FORENSIC SCI INT, V198, P31, DOI 10.1016/j.forsciint.2010.01.004; Fedorova I, 2001, J PHARMACOL EXP THER, V299, P332; Ohno H, 2013, ANTICANCER RES, V33, P3061; Suzuki R, 2014, ANTICANCER RES, V34, P4117; Mechoulam R, 1997, NATURE, V389, P25, DOI 10.1038/37891; Zorko M, 2005, ANTIMICROB AGENTS CH, V49, P2307, DOI 10.1128/;AAC.49.6.2307-2313.2005; Pearlman RS, 1998, PERSPECT DRUG DISCOV, V9-11, P339, DOI 10.1023/A:1027232610247; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; Kantoh K, 2010, IN VIVO, V24, P843; Akimov MG, 2015, ANTICANCER RES, V35, P2657; Dang HT, 2011, BIOORGAN MED CHEM, V19, P1520, DOI 10.1016/j.bmc.2010.12.046; Wildman SA, 1999, J CHEM INF COMP SCI, V39, P868, DOI 10.1021/ci990307l; Chu CJ, 2003, J BIOL CHEM, V278, P13633, DOI 10.1074/jbc.M211231200; NAKASHIMA H, 1992, ANTIVIR RES, V18, P91, DOI 10.1016/0166-3542(92)90008-S; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Huitron-Resendiz S, 2001, EXP NEUROL, V172, P235, DOI 10.1006/exnr.2001.7792; McDonald GR, 2008, SCIENCE, V322, P917, DOI 10.1126/science.1162395; Ezzili C, 2010, BIOORG MED CHEM LETT, V20, P5959, DOI 10.1016/j.bmcl.2010.08.048; Das S, 2012, EUR J MED CHEM, V51, P193, DOI 10.1016/j.ejmech.2012.02.042; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17; Hall LH, 1991, REV COMPUTATIONAL CH, V2; PETITJEAN M, 1992, J CHEM INF COMP SCI, V32, P331, DOI 10.1021/ci00008a012; Slatis K, 2012, LIPIDS, V47, P355; Stewart J. J. P., 1993, MOPAC MANUAL; Takao K, 2015, CHEM PHARM BULL, V63, P278, DOI 10.1248/cpb.c14-00881	26	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5341	5351				11	Oncology	Oncology	CS1KM	WOS:000361823200023		
J	Tamura, T; Ohira, M; Tanaka, H; Muguruma, K; Toyokawa, T; Kubo, N; Sakurai, K; Amano, R; Kimura, K; Shibutani, M; Maeda, K; Hirakawa, K				Tamura, Tatsuro; Ohira, Masaichi; Tanaka, Hiroaki; Muguruma, Kazuya; Toyokawa, Takahiro; Kubo, Naoshi; Sakurai, Katsunobu; Amano, Ryosuke; Kimura, Kenjiro; Shibutani, Masatsune; Maeda, Kiyoshi; Hirakawa, Kosei			Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer	ANTICANCER RESEARCH			English	Article						Programmed cell death-1 (PD1); programmed death-1 ligand-1 (PDL1); gastric cancer	MHC CLASS-I; CLINICAL-SIGNIFICANCE; IMMUNE EVASION; POOR-PROGNOSIS; CELL-CARCINOMA; B7-H1; ANTIBODY; SAFETY; PD-1	Background/Aim: The cell surface receptor programmed death-1 (PD1) and its ligand (PDL1) have been detected in various cancer types. It has been reported that expression of PDL1 and PD1 in a tumor is associated with poor prognosis of the patient. In the present study, we retrospectively examined tumor expression of PDL1 and intratumoral PD1(+) cell infiltration, and assessed their relationship with patient prognosis according to the pathological stage of gastric cancer. Materials and Methods: PDL1 and PD1 expression in primary tumors from 431 patients was evaluated using immuno histochemistry. The association between the expression of PDL1/PD1 and clinicopathological features was assessed. Results: High expression of PDL1 was observed in 128 (29.6%) patients. PDL1 expression was correlated with tumor infiltration of PD1(+) cells. In multivariate analysis, PDL1 expression was associated with worse overall survival. In subset analysis, PDL1 expression was significantly associated with survival in patients with stage II/III gastric cancer. In conclusion, PDL1 was an independent prognostic factor for patients with stage II/III gastric cancer. Our results suggested that patients with stage II/III gastric cancer might be appropriate for PD1/PDL1targeted therapy.	[Tamura, Tatsuro; Ohira, Masaichi; Tanaka, Hiroaki; Muguruma, Kazuya; Toyokawa, Takahiro; Kubo, Naoshi; Sakurai, Katsunobu; Amano, Ryosuke; Kimura, Kenjiro; Shibutani, Masatsune; Maeda, Kiyoshi; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan	Ohira, M (reprint author), 1-4-3 Asahi Machi,Abeno Ku, Osaka 5458585, Japan.	masaichi@med.osaka-cu.ac.jp					Saito H, 2013, J SURG ONCOL, V107, P517, DOI 10.1002/jso.23281; Bang YJ, 2010, LANCET, V376, P1302; Geng YT, 2015, INT J CLIN ONCOL, V20, P273, DOI 10.1007/s10147-014-0701-7; Ito G, 2012, EXP THER MED, V3, P925, DOI 10.3892/etm.2012.537; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Yoshii M, 2013, HEPATO-GASTROENTEROL, V60, P611, DOI 10.5754/hge12433; Wang LC, 2010, WORLD J SURG, V34, P1059, DOI 10.1007/s00268-010-0448-x; Yoshii M, 2012, BRIT J CANCER, V106, P1668, DOI 10.1038/bjc.2012.141; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Iwauchi T, 2011, CANCER SCI, V102, P683, DOI 10.1111/j.1349-7006.2010.01843.x; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Muenst S, 2014, BREAST CANCER RES TR, V146, P15, DOI 10.1007/s10549-014-2988-5; Garon EB, 2015, NEW ENGLAND J MED; Japanese Gastric Cancer Association, 2011, GASTRIC CANCER, V14, P113, DOI [10.1007/s10120-011-0042-4, DOI 10.1007/S10120-011-0042-4]]; Topalian SL, CURRENT OPINION IMMU, V24, P207	20	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5369	5376				8	Oncology	Oncology	CS1KM	WOS:000361823200026		
J	Naemura, M; Murasaki, C; Inoue, Y; Okamoto, H; Kotake, Y				Naemura, Madoka; Murasaki, Chihiro; Inoue, Yasutoshi; Okamoto, Haruna; Kotake, Yojiro			Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells	ANTICANCER RESEARCH			English	Article						Long noncoding RNA; ANRIL; p15; p16; cell cycle	TUMOR-SUPPRESSOR; INDUCED SENESCENCE; CDK INHIBITORS; LOCUS; P53; MDM2; P16(INK4A); EXPRESSION; PATHWAYS; DELETION	Background: Long noncoding RNA ANRIL (antisense non-coding RNA in the INK4 locus) represses p15 and p16, which induce cell-cycle arrest at G(1) phase, leading to enhanced cell proliferation of normal fibroblasts. Herein we report that ANRIL is also involved in the regulation of cancer-cell proliferation. Materials and Methods: HeLa and H1299 cells were transfected with ANRIL siRNAs. At 72 h post-transfection, cells were subjected to quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and cell-cycle analysis. Results: qRT-PCR showed that ANRIL is highly expressed in these cancer cells compared to normal fibroblasts. Depletion of ANRIL increased p15 expression, with no impact on p16 or ARF (alternative reading frame) expression, and caused cell-cycle arrest at the G(2)/M phase, leading to inhibition of proliferation of H1299 and HeLa cells. Conclusion: ANRIL positively regulates the proliferation of cancer cells, such as H1299 and HeLa cells, via regulating p15 and other genes related to G(2)/M phase control.	[Naemura, Madoka; Murasaki, Chihiro; Inoue, Yasutoshi; Okamoto, Haruna; Kotake, Yojiro] Kinki Univ, Fac Humanity Oriented Sci & Engn, Dept Biol & Environm Chem, Fukuoka, Japan	Kotake, Y (reprint author), Kinki Univ, Fac Humanity Oriented Sci & Engn, Dept Biol & Environm Chem, 11-6 Kayanomori, Iizuka, Fukuoka 8208555, Japan.	ykotake@fuk.kindai.ac.jp			JSPS KAKENHI [26430127]; Takeda Science Foundation	The Authors thank the members of the Kotake Laboratory for their technical assistance and helpful discussions. This work was supported by JSPS KAKENHI grant number 26430127 (to YK) and the Takeda Science Foundation (to YK).	Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Kitagawa M, 2012, CURR DRUG TARGETS, V13, P1616; Congrains A, 2012, BIOCHEM BIOPH RES CO, V419, P612, DOI 10.1016/j.bbrc.2012.02.050; Ruas M, 1998, BBA-REV CANCER, V1378, pF115; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Wan GH, 2013, CELL SIGNAL, V25, P1086, DOI 10.1016/j.cellsig.2013.02.006; Aravidis C, 2012, ANTICANCER RES, V32, P5309; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sato K, 2010, ONCOL REP, V24, P701, DOI 10.3892/or_00000910; Zhang EB, 2014, ONCOTARGET, V5, P2276; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Kitagawa M, 2013, CELL MOL LIFE SCI, V70, P4785, DOI 10.1007/s00018-013-1423-0; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Boukhari A, 2015, ANTICANCER RES, V35, P149; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Kotake Y, 2015, CYTOTECHNOL IN PRESS	27	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5377	5382				6	Oncology	Oncology	CS1KM	WOS:000361823200027		
J	Iriyama, N; Hatta, Y; Kobayashi, S; Uchino, Y; Miura, K; Kurita, D; Kodaira, H; Takahashi, H; Iizuka, Y; Inoue, M; Takei, M				Iriyama, Noriyoshi; Hatta, Yoshihiro; Kobayashi, Sumiko; Uchino, Yoshihito; Miura, Katsuhiro; Kurita, Daisuke; Kodaira, Hitomi; Takahashi, Hiromichi; Iizuka, Yoshikazu; Inoue, Mitsuru; Takei, Masami			Higher Red Blood Cell Distribution Width Is an Adverse Prognostic Factor in Chronic-phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors	ANTICANCER RESEARCH			English	Article						Red blood cell distribution width; chronic myeloid leukemia; prognosis	EUTOS SCORE; EUROPEAN TREATMENT; TREATMENT RESPONSE; IMATINIB; RECOMMENDATIONS; DASATINIB; OUTCOMES; NILOTINIB	The significance of red blood cell distribution width (RDW) was evaluated in patients with chronic myeloid leukemia (CML) in the chronic phase (CP). Eighty-four patients with newly-diagnosed CML-CP treated with any tyrosine kinase inhibitor (TKI) were analyzed. Patients were divided into two groups: a low-RDW group (RDW values <= 15%, n=31) and a high-RDW group (RDW values >15%, n=53). The 5-year event-free survival (EFS) and transformation-free survival (TFS) rates differed significantly between the low-and high-RDW groups (100% and 68%, respectively, in EFS, p=0.0071 and 100% and 81%, respectively, in TFS, p=0.039). The stratification by RDW had an impact on overall 5-year survival (100% in the low and 77% in the high RDW groups, p=0.047). We conclude that the RDW has a critical role in risk stratification of CML-CP patients for predicting treatment responses and outcomes.	[Iriyama, Noriyoshi; Hatta, Yoshihiro; Kobayashi, Sumiko; Uchino, Yoshihito; Miura, Katsuhiro; Kurita, Daisuke; Kodaira, Hitomi; Takahashi, Hiromichi; Iizuka, Yoshikazu; Takei, Masami] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol,Itabashi Ku, Tokyo 1738610, Japan; [Inoue, Mitsuru] Nihon Univ, Sch Med, Dept Clin Lab, Itabashi Ku, Tokyo 1738610, Japan	Iriyama, N (reprint author), Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol,Itabashi Ku, 30-1 Oyaguchi Kami Cho, Tokyo 1738610, Japan.	iriyama.noriyoshi@nihon-u.ac.jp; hatta.yoshihiro@nihon-u.ac.jp			Bristol; Novartis	M.T. received research grants from Bristol and Novartis. N.I. received honoraria and lecture fees from Bristol and Novartis. Y.H. also received honoraria from Bristol and Novartis. The other authors declare no competing financial interests.	Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Langabeer SE, 2002, LEUKEMIA, V16, P393, DOI 10.1038/sj/leu/2402392; Jabbour E, 2012, BLOOD, V119, P4524, DOI 10.1182/blood-2011-10-388967; Yamamoto E, 2014, CANCER SCI, V105, P105, DOI 10.1111/cas.12321; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; DAINIAK N, 1984, BRIT J HAEMATOL, V56, P507, DOI 10.1111/j.1365-2141.1984.tb03980.x; Bonifacio M, 2014, ANN HEMATOL, V93, P163, DOI 10.1007/s00277-013-1974-z; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Tiribelli M, 2013, LEUKEMIA RES, V37, P1457, DOI 10.1016/j.leukres.2013.07.037; Iriyama N, 2015, AM J HEMATOL, V90, P282, DOI 10.1002/ajh.23923; Kantarjian H, 2011, J CLIN ONCOL, V29, P3173, DOI 10.1200/JCO.2010.33.4169; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Ohnishi K, 2012, CANCER SCI, V103, P1071, DOI 10.1111/j.1349-7006.2012.02253.x; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Makishima H, 2011, BLOOD, V117, pE198, DOI 10.1182/blood-2010-06-292433; Tauchi T, 2011, LEUKEMIA RES, V35, P585, DOI 10.1016/j.leukres.2010.10.027; Hughes TP, 2014, BLOOD, V123, P1353, DOI 10.1182/blood-2013-06-510396; Iriyama N, 2014, INT J HEMATOL, V100, P379, DOI 10.1007/s12185-014-1649-0; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Schmidt M, 2014, LEUKEMIA, V28, P2292, DOI 10.1038/leu.2014.272; Yagasaki Fumiharu, 2009, Rinsho Ketsueki, V50, P481	23	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5473	5478				6	Oncology	Oncology	CS1KM	WOS:000361823200039		
J	Sasaki, Y; Osada, S; Matsui, S; Imai, H; Tanahashi, T; Tanaka, Y; Matsuhashi, N; Okumura, N; Yamaguchi, K; Yoshida, K				Sasaki, Yoshiyuki; Osada, Shinji; Matsui, Satoshi; Imai, Hisashi; Tanahashi, Toshiyuki; Tanaka, Yoshihiro; Matsuhashi, Nobuhisa; Okumura, Naoki; Yamaguchi, Kazuya; Yoshida, Kazuhiro			Preoperative Chemotherapy Can Change the Surgical Procedure for Hepatectomy in Patients with Liver Metastasis of Colorectal Cancer	ANTICANCER RESEARCH			English	Article							MAJOR INTRAHEPATIC VESSELS; NEOADJUVANT TREATMENT; COLON-CANCER; OXALIPLATIN; RESECTION; TRIAL; CAPECITABINE; BEVACIZUMAB; ATTACHMENT; REVERSAL	Aim: The benefit of preoperative chemotherapy is evaluated in order to clarify the relationship of tumor site with hepatic vessels for hepatectomy. Tumor location in relation to intrahepatic vessels is critical in the decision to operate, but the argument for this concept remains insufficient. Currently, the response rate is evaluated by the decrease in size or number of tumors but not by hepatic resection range. Patients and Methods: We evaluated 32 patients who underwent hepatectomy after chemotherapy for liver metastases from colorectal cancer (CLM). Tumor diameter was defined by contrast computed tomographic imaging before both chemotherapy and surgery. The targeted vessels were those in the main Glisson capsule and hepatic vein and were indicated to change in the resected area by their treatment. Results: Tumor size decreased, increased or remained unchanged in 62 (68.9%), 27 (30.0%) and one (1.1%) tumor, respectively. Out of the 29 tumors, reduced resection volume was achieved in 12 (37.9%), and the difference in volume was 17.4 +/- 4.15 ml. A significant positive correlation was found between tumor shrinkage rate and final distance from the attached vessels (p=0.017), and a shrinkage rate of 63.6 +/- 12.4% was necessary for a tumor to be separated from an attached vessel. The final distance was significantly positively correlated with tumor shrinkage speed (p=0.0027), and a shrinkage speed of 0.64 +/- 0.12%/day was expected to enable a a tumor to be separated from its attached vessel. Conclusion: Chemotherapy, especially by favorable combination with molecular targeting agents, even for resectable CLM appears to be acceptable and may lead to increased performance of radical surgical resection.	[Sasaki, Yoshiyuki; Imai, Hisashi; Tanahashi, Toshiyuki; Tanaka, Yoshihiro; Matsuhashi, Nobuhisa; Okumura, Naoki; Yamaguchi, Kazuya; Yoshida, Kazuhiro] Gifu Univ, Grad Sch Med, Surg Oncol, Gifu 5011194, Japan; [Osada, Shinji; Matsui, Satoshi] Gifu Univ, Grad Sch Med, Multidisciplinary Therapy Hepatobiliary Pancreat, Gifu 5011194, Japan	Osada, S (reprint author), Gifu Univ, Grad Sch Med, Multidisciplinary Therapy Hepatobiliary Pancreat, 1-1 Yanagido, Gifu 5011194, Japan.	sting@gifu-u.ac.jp					Leone F, 2013, CANCER-AM CANCER SOC, V119, P3429, DOI 10.1002/cncr.28223; Nuzzo G, 2008, SURGERY, V143, P384, DOI 10.1016/j.surg.2007.09.038; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Nagashima I, 2006, WORLD J GASTROENTERO, V12, P6961; Kataoka K, 2014, WORLD J SURG, V38, P936, DOI 10.1007/s00268-013-2305-1; Tanaka K, 2014, SURGERY, V155, P936, DOI 10.1016/j.surg.2013.12.030; Poston GJ, 2005, J CLIN ONCOL, V23, P7125, DOI 10.1200/JCO.2005.08.722; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Ribero D, 2007, CANCER, V110, P2761, DOI 10.1002/cncr.23099; Nakano H, 2008, ANN SURG, V247, P118, DOI 10.1097/SLA.0b013e31815774de; Wong R, 2011, ANN ONCOL, V22, P2042, DOI 10.1093/annonc/mdq714; Haraldsdottir S, 2013, THER ADV MED ONCOL, V5, P221, DOI 10.1177/1758834013485111; Folprecht G, 2005, ANN ONCOL, V16, P1311, DOI 10.1093/annonc/mdi246; Osada S, 2005, J AM COLL SURGEONS, V201, P405, DOI 10.1016/j.jamcollsurg.2005.05.015; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ye LC, 2013, J CLIN ONCOL, V31, P1931, DOI 10.1200/JCO.2012.44.8308; Sasaki Y, 2013, INT J MED SCI, V10, P1231, DOI 10.7150/ijms.6244; Osada S, 2014, HEPATO-GASTROENTEROL, V61, P722, DOI 10.5754/hge11510; Mochizuki I, 2012, BRIT J CANCER, V106, P1268, DOI 10.1038/bjc.2012.86; Tanaka K, 2012, CANCER-AM CANCER SOC, V118, P2443, DOI 10.1002/cncr.26563; Adam R, 2009, J CLIN ONCOL, V27, P1829, DOI 10.1200/JCO.2008.19.9273; Dexiang Zhu, 2012, Ann Surg Oncol, V19, P2860, DOI 10.1245/s10434-012-2356-9; Osada Shinji, 2012, Oncol Rev, V6, pe9, DOI 10.4081/oncol.2012.e9; Zhu DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086543	24	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5485	5489				5	Oncology	Oncology	CS1KM	WOS:000361823200041		
J	Ishikawa, H; Katoh, H; Kaminuma, T; Kawamura, H; Ito, K; Matsui, H; Hirato, J; Shimizu, N; Takezawa, Y; Tsuji, H; Suzuki, K; Ohno, T; Nakano, T				Ishikawa, Hitoshi; Katoh, Hiroyuki; Kaminuma, Takuya; Kawamura, Hidemasa; Ito, Kazuto; Matsui, Hiroshi; Hirato, Junko; Shimizu, Nobuaki; Takezawa, Yutaka; Tsuji, Hiroshi; Suzuki, Kazuhiro; Ohno, Tatsuya; Nakano, Takashi		Gunma Heavy Ion Medical Ctr	Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life	ANTICANCER RESEARCH			English	Article						Carbon-ion therapy; prostate cancer; toxicity; quality of life; hypofractionation	ANDROGEN-DEPRIVATION THERAPY; LONG-TERM OUTCOMES; RADIATION-THERAPY; MEN; JAPAN; BEAM; GY; BRACHYTHERAPY; IRRADIATION; EXPERIENCE	Aim: To prospectively evaluate the feasibility of carbon-ion radiotherapy (C-ion RT) for prostate cancer using a new compact-sized accelerator. Patients and Methods: Seventy-six patients underwent C-ion RT at our center using a recommended dose fractionation of 57.6 GyE in 16 fractions established at the National Institute of Radiological Sciences. Health-related Quality of Life (HRQOL) assessment was also performed using the Medical Outcome Study 8-items Short Form Health Survey (SF-8) questionnaire. Results: The median follow-up time was 51 months (range=8-58 months). Grade 2 gastrointestinal and genitourinary complications developed in 1 (1.3%) and 5 (6.6%) patients, respectively. Recurrences occurred in 4 patients, and the 4-year biochemical relapse-free rate was 94.6%. The HRQOL scores after C-ion RT were objectively well-maintained. Conclusion: Irrespective of the small number of patients of the study, C-ion RT for prostate cancer using the first commercial-based accelerator reproduced the toxicity outcomes at the NIRS.	[Ishikawa, Hitoshi] Univ Tsukuba, Fac Med, Dept Radiat Oncol, Ibaraki, Japan; [Katoh, Hiroyuki; Kaminuma, Takuya; Kawamura, Hidemasa; Suzuki, Kazuhiro; Ohno, Tatsuya; Nakano, Takashi] Gunma Univ, Heavy Ion Med Res Ctr, Gunma, Japan; [Ito, Kazuto; Matsui, Hiroshi] Gunma Univ, Grad Sch Med, Dept Urol, Gunma, Japan; [Hirato, Junko] Gunma Univ, Grad Sch Med, Dept Pathol, Gunma, Japan; [Shimizu, Nobuaki] Gunma Canc Ctr, Dept Urol, Gunma, Japan; [Takezawa, Yutaka] Isesaki City Hosp, Dept Urol, Isesaki, Gunma, Japan; [Tsuji, Hiroshi] Natl Inst Radiol Sci, Res Ctr Hosp Charged Particle Therapy, Chiba 260, Japan	Ishikawa, H (reprint author), Univ Tsukuba, Fac Med, Dept Radiat Oncol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hishikawa@pmrc.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591832]	This work was supported by Grants-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (24591832) of Japan.	Nomiya T, 2014, BRIT J CANCER, V110, P2389, DOI 10.1038/bjc.2014.191; Okada T, 2012, INT J RADIAT ONCOL, V84, P968, DOI 10.1016/j.ijrobp.2012.01.072; Kupelian PA, 2005, INT J RADIAT ONCOL, V63, P1463, DOI 10.1016/j.ijrobp.2005.05.054; Vicini FA, 2003, SEMIN RADIAT ONCOL, V13, P98, DOI 10.1053/srao.2003.50009; Ishikawa H, 2006, INT J RADIAT ONCOL, V66, P1084, DOI 10.1016/j.ijrobp.2006.06.056; FOWLER JF, 1984, INT J RADIAT BIOL, V46, P103, DOI 10.1080/09553008414551181; Ishikawa H, 2008, INT J RADIAT ONCOL, V72, P78, DOI 10.1016/j.ijrobp.2007.12.044; Ishikawa H, 2012, INT J UROL, V19, P296, DOI 10.1111/j.1442-2042.2012.02961.x; Lee WR, 2001, INT J RADIAT ONCOL, V51, P614, DOI 10.1016/S0360-3016(01)01707-2; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Katoh H, 2014, INT J UROL, V21, P370, DOI 10.1111/iju.12294; Esper P, 1997, UROLOGY, V50, P920, DOI 10.1016/S0090-4295(97)00459-7; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Kanai T, 1997, RADIAT RES, V147, P78, DOI 10.2307/3579446; Akakura K, 2004, PROSTATE, V58, P252, DOI 10.1002/pros.10328; Slater JD, 2004, INT J RADIAT ONCOL, V59, P348, DOI 10.1016/j.ijrobp.2003.10.011; Sugimoto M, 2008, INT J UROL, V15, P524, DOI 10.1111/j.1442-2042.2008.02046.x; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Ishikawa H, 2006, RADIOTHER ONCOL, V81, P57, DOI 10.1016/j.radonc.2006.08.015; Sevilla C, 2012, PROSTATE CANCER P D, V15, P237, DOI 10.1038/pcan.2011.71; Wakatsuki M, 2008, INT J RADIAT ONCOL, V72, P1010, DOI 10.1016/j.ijrobp.2008.02.035; Patel N, 2013, INT J RADIAT ONCOL, V86, P534, DOI 10.1016/j.ijrobp.2013.02.010; Tsuji H, 2005, INT J RADIAT ONCOL, V63, P1153, DOI 10.1016/j.ijrobp.2005.04.022; Dacal K, 2006, J AM GERIATR SOC, V54, P85, DOI 10.1111/j.1532-5415.2005.00567.x; Bruner DW, 2015, CANCER-AM CANCER SOC, V121, P2422, DOI 10.1002/cncr.29362; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Feigenberg SJ, 2005, INT J RADIAT ONCOL, V62, P397, DOI 10.1016/j.ijrobp.2004.10.021; Monga U, 2005, J REHABIL RES DEV, V42, P391, DOI 10.1682/JRRD.2004.06.0071; Suzuki M, 2000, INT J RADIAT ONCOL, V48, P241, DOI 10.1016/S0360-3016(00)00568-X; Cahlon O, 2008, INT J RADIAT ONCOL, V71, P330, DOI 10.1016/j.ijrobp.2007.10.004; Kamada T, 2015, LANCET ONCOL, V16, pE93, DOI 10.1016/S1470-2045(14)70412-7; Marshall RA, 2014, UROL ONCOL, V32, pe1; Ohno Tatsuya, 2011, Cancers (Basel), V3, P4046, DOI 10.3390/cancers3044046; Okamoto Masahiko, 2012, Int J Radiat Oncol Biol Phys, V82, pe211, DOI 10.1016/j.ijrobp.2011.03.041; Pugh TJ, 2014, CANCER J, V20, P415, DOI 10.1097/PPO.0000000000000083; Sobin LH, 2010, TNM CLASSIFICATION M, P237; The National Cancer Institute, 2010, COMM TERM CRIT ADV E; Ware JE, 2001, SCORE INTERPRET SING; Ware JE, 1996, QUALITY LIFE PHARMAC, P337	39	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5559	5566				8	Oncology	Oncology	CS1KM	WOS:000361823200054		
J	Uratani, R; Toiyama, Y; Shimura, T; Mori, K; Fujikawa, H; Hiro, J; Ohi, M; Inoue, Y; Tanaka, K; Araki, T; Mohri, Y; Kusunoki, M				Uratani, Ryo; Toiyama, Yuji; Shimura, Tadanobu; Mori, Koichiro; Fujikawa, Hiroyuki; Hiro, Jyunichiro; Ohi, Masaki; Inoue, Yasuhiro; Tanaka, Koji; Araki, Toshimitsu; Mohri, Yasuhiko; Kusunoki, Masato			Preoperative Lower Body Mass Index Correlates with Poorer Prognosis in Patients Undergoing Curative Laparoscopic Surgery for Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Colorectal cancer; laparoscopic surgery; body mass index; prognosis; recurrence	FATTY-ACID SYNTHASE; COLON-CANCER; LYMPHOCYTE RATIO; RANDOMIZED-TRIAL; METAANALYSIS; NEUTROPHIL; SURVIVAL; OBESITY; RECURRENCE; OVERWEIGHT	Aim: The aim of this study was to investigate the correlations between clinicopathological findings, laboratory data and survival outcome in patients undergoing curative laparoscopic surgery for colorectal cancer (CRC). Patients and Methods: Clinicopathological findings and laboratory data, including tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) and systemic inflammatory response indicators, neutrophil-to-lymphocyte ratio (NLR) and modified Glasgow prognosis score (mGPS), for 204 patients (tumor stage I-III) undergoing laparoscopic curative surgery for CRC were collected. Results: Elevated CA19-9 and mGPS, and body mass index (BMI) <20 kg/m(2) were significant indicators of poorer overall survival, while CA19-9 and BMI were validated as independent predictors of overall survival. In addition, BMI <20 kg/m(2) was a significant independent factor predictive of poorer disease-free survival. BMI significantly negatively correlated with NLR, which reflects the patients' immune response. Conclusion: Lower BMI is a promising predictor of recurrence and poor prognosis in patients treated by laparoscopic surgery for CRC with curative intent.	[Uratani, Ryo; Toiyama, Yuji; Shimura, Tadanobu; Mori, Koichiro; Fujikawa, Hiroyuki; Hiro, Jyunichiro; Ohi, Masaki; Inoue, Yasuhiro; Tanaka, Koji; Araki, Toshimitsu; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Inst Life Sci, Grad Sch Med, Dept Gastrointestinal & Pediat Surg,Div Reparat M, Tsu, Mie 5148507, Japan	Toiyama, Y (reprint author), Mie Univ, Inst Life Sci, Grad Sch Med, Dept Gastrointestinal & Pediat Surg,Div Reparat M, Tsu, Mie 5148507, Japan.	ytoi0725@clin.medic.mie-u.ac.jp					Yamamoto S, 2014, ANN SURG, V260, P23, DOI 10.1097/SLA.0000000000000499; OWNBY HE, 1983, CANCER, V52, P126, DOI 10.1002/1097-0142(19830701)52:1<126::AID-CNCR2820520123>3.0.CO;2-Y; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P1528, DOI 10.1002/cncr.27938; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Lin PC, 2012, INT J COLORECTAL DIS, V27, P1333, DOI 10.1007/s00384-012-1447-1; Kuchiba A, 2012, JNCI-J NATL CANCER I, V104, P415, DOI 10.1093/jnci/djr542; Hu HK, 2011, SEMIN ONCOL, V38, P500, DOI 10.1053/j.seminoncol.2011.05.004; Toiyama Y, 2011, EXP THER MED, V2, P95, DOI 10.3892/etm.2010.175; Faeh D, 2011, EUR J EPIDEMIOL, V26, P647, DOI 10.1007/s10654-011-9593-2; Inoue Y, 2013, ONCOLOGY-BASEL, V84, P100, DOI 10.1159/000343822; Nissan A, 2006, J CLIN ONCOL, V24, P4078, DOI 10.1200/JCO.2006.06.2968; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Shibutani M, 2014, ANTICANCER RES, V34, P3753; Mallappa S, 2013, COLORECTAL DIS, V15, P323, DOI 10.1111/codi.12008; Hung HY, 2011, INT J COLORECTAL DIS, V26, P1059, DOI 10.1007/s00384-011-1192-x; Castillo JJ, 2012, LEUKEMIA RES, V36, P868, DOI 10.1016/j.leukres.2011.12.020; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Wu SJ, 2014, CANCER CAUSE CONTROL, V25, P1489, DOI 10.1007/s10552-014-0450-y	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5639	5648				10	Oncology	Oncology	CS1KM	WOS:000361823200065		
J	Yamaguchi, Y; Deng, DW; Sato, Y; Hou, YT; Watanabe, R; Sasaki, K; Kawabe, M; Hirano, E; Morinaga, T				Yamaguchi, Yoshie; Deng, Dawei; Sato, Yoshinori; Hou, Yung-Te; Watanabe, Rie; Sasaki, Kohei; Kawabe, Masaaki; Hirano, Eiichi; Morinaga, Tetsuo			Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer (vol 35, pg 4641, 2015)	ANTICANCER RESEARCH			English	Correction									[Yamaguchi, Yoshie; Deng, Dawei; Sato, Yoshinori; Hou, Yung-Te; Hirano, Eiichi; Morinaga, Tetsuo] Japan Bio Prod Co Ltd, Kurume, Fukuoka, Japan; [Watanabe, Rie; Sasaki, Kohei; Kawabe, Masaaki] Japan Vilene Co Ltd, Ibaraki, Japan; [Yamaguchi, Yoshie] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan	Yamaguchi, Y (reprint author), Japan Bio Prod Co Ltd, Kurume, Fukuoka, Japan.						Zhang Y, 2015, ANTICANCER RES, V35, P4641	1	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	OCT	2015	35	10					5705	5705				1	Oncology	Oncology	CS1KM	WOS:000361823200075		
J	Tawara, M; Sakatoku, A; Tiodjio, RE; Tanaka, D; Nakamura, S				Tawara, Mika; Sakatoku, Akihiro; Tiodjio, Rosine E.; Tanaka, Daisuke; Nakamura, Shogo			Cloning and Characterization of a Novel Agarase from a Newly Isolated Bacterium Simiduia sp Strain TM-2 Able to Degrade Various Seaweeds	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						Simiduia; Degradation; Seaweeds; Agarase	ALGINATE LYASE GENES; BETA-AGARASE; ENZYMATIC-PROPERTIES; MOLECULAR-CLONING; HATCHERY DIET; MARINE; AGARIVORANS; VIBRIO; POLYSACCHARIDES; PURIFICATION	A new bacterial strain capable of reducing thalli of various seaweeds (red, green, and brown algae) was isolated from marine sediments of Uozu in Toyama Prefecture, Japan. We designated the strain Simiduia sp. TM-2 based on analyses of the 16S rRNA gene and gyrB gene sequences and its biochemical and morphological characteristics. Zymography methods revealed numerous active bands of alginate lyases, cellulases, and agarases in the cells and culture supernatants of TM-2, showing that the strain possessed multiple polysaccharide lyases. A novel agarase gene (agaTM2) was cloned from TM-2 and expressed in Escherichia coli. The resulting DNA sequence contained an open reading frame of 1764 bp that encoded a protein of 587 amino acids with an estimated molecular mass of 64 kDa and pI of 4.62. The deduced amino acid sequence, AgaTM2, had a typical signal peptide followed by a glycoside hydrolase family 16 catalytic domain and two carbohydrate-binding modules 6. A BLAST search indicated that AgaTM2 shared 75.5 % amino acid sequence identity with agarase from Simiduia agarivorans SA1. The cloned and purified AgaTM2 protein showed optimal activity at 35 A degrees C and pH 8.0, and its thermostability increased in the presence of calcium ions. AgaTM2 degraded agarose to tetraose and hexaose.	[Tawara, Mika; Sakatoku, Akihiro; Tiodjio, Rosine E.; Tanaka, Daisuke; Nakamura, Shogo] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan; [Sakatoku, Akihiro] Toyama Univ, Fac Earth & Environm Syst, Dept Environm & Energy Sci, Grad Sch Sci & Engn, Toyama 9308555, Japan	Sakatoku, A (reprint author), Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan.	sakatoku@sci.u-toyama.ac.jp			Ministry of Education, Science and Culture in Japan [25340121]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 25340121) from the Ministry of Education, Science and Culture in Japan (to SN).	Nelson N, 1944, J BIOL CHEM, V153, P375; Fukahori S, 2008, MOL MED REP, V1, P537; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; de Souza MCR, 2007, J APPL PHYCOL, V19, P153, DOI 10.1007/s10811-006-9121-z; SZYBALSKI W, 1993, GENE, V135, P279, DOI 10.1016/0378-1119(93)90078-H; Kang YQ, 2009, MYCOPATHOLOGIA, V167, P95, DOI 10.1007/s11046-008-9151-y; Fu XT, 2008, APPL MICROBIOL BIOT, V78, P265, DOI 10.1007/s00253-007-1303-3; Wakabayashi M, 2012, BIODEGRADATION, V23, P93, DOI 10.1007/s10532-011-9489-6; Wu SC, 2005, FISHERIES SCI, V71, P1149, DOI 10.1111/j.1444-2906.2005.01075.x; Kawamoto H, 2006, MAR BIOTECHNOL, V8, P481, DOI 10.1007/s10126-005-6157-z; Tanaka D, 2010, CURR MICROBIOL, V60, P203, DOI 10.1007/s00284-009-9525-5; HIGASHIHARA T, 1978, B JPN SOC SCI FISH, V44, P1127; Uchimura K, 2010, MAR BIOTECHNOL, V12, P526, DOI 10.1007/s10126-009-9237-7; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Shieh WY, 2008, INT J SYST EVOL MICR, V58, P895, DOI 10.1099/ijs.0.65371-0; UCHIDA M, 1995, FISHERIES SCI, V61, P117; Lee DG, 2006, BIOTECHNOL LETT, V28, P1925, DOI 10.1007/s10529-006-9171-y; Kumagai Y, 2012, BIOCHIMIE, V94, P2783, DOI 10.1016/j.biochi.2012.09.012; Kim DY, 2011, BIORESOURCE TECHNOL, V102, P9185, DOI 10.1016/j.biortech.2011.06.073; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Fu WD, 2008, J IND MICROBIOL BIOT, V35, P915, DOI 10.1007/s10295-008-0365-2; YOUNG KS, 1978, CARBOHYD RES, V66, P207, DOI 10.1016/S0008-6215(00)83253-X; Ohta Y, 2004, APPL MICROBIOL BIOT, V64, P505, DOI 10.1007/s00253-004-1573-y; Camacho P, 2004, MAR BIOTECHNOL, V6, P642, DOI 10.1007/s10126-004-2901-0; AOKI T, 1990, EUR J BIOCHEM, V187, P461, DOI 10.1111/j.1432-1033.1990.tb15326.x; Giordano Assurita, 2006, Biotechnology Journal, V1, P511, DOI 10.1002/biot.200500036; Oh C, 2010, BRAZ J MICROBIOL, V41, P876, DOI 10.1590/S1517-83822010000400006; Rhee YJ, 2010, J MICROBIOL BIOTECHN, V20, P1378, DOI 10.4014/jmb.1007.07010; Wang JX, 2006, APPL MICROBIOL BIOT, V71, P833, DOI 10.1007/s00253-005-0207-3; Kim BC, 2012, INT J SYST EVOL MICR, V62, P906, DOI 10.1099/ijs.0.031153-0; Uchida M, 1997, J APPL PHYCOL, V9, P541, DOI 10.1023/A:1007940005528; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Dhargalkar V. K., 2005, SCI CULTURE, V71, P60; DUCKWORT.M, 1971, ANAL BIOCHEM, V44, P636, DOI 10.1016/0003-2697(71)90253-3; Hom S. J., 2000, J IND MICROBIOL BIOT, V25, P249; Howard O., 1988, GENETICS, V120, P621; Woo-Jung K, 2008, J MICROBIOL BIOTECHN, V18, P616; Youngdeuk L, 2013, J MICROBIOL BIOTECHN, V23, P913, DOI 10.4014/jmb.1209.09009; Lin S. Y., 2013, GENOME ANNOUNCEMENTS, V1; Sakatoku A, 2012, MICROBIOLOGYOPEN, V1, P2, DOI 10.1002/mbo3.10	41	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0273-2289	1559-0291		APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	OCT	2015	177	3					610	623		10.1007/s12010-015-1765-1		14	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	CS2HM	WOS:000361889900003		
J	Suzuki, S; Inohara, T				Suzuki, Shinji; Inohara, Takehiro			Mathematical definitions of enclave and exclave, and applications	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Enclave; Exclave; Graph theory; Districting; Voting game		This paper offers mathematical definitions of enclave and exclave using a graph theoretical framework, and gives some applications of the definitions. Some basic properties of enclave and exclave are also verified by using the definitions. Though there are numerous enclaves and exclaves in the world, they have not been analyzed mathematically so far. Giving them mathematical definitions is useful for the problems of political boundaries, e.g the drawing of the boundaries of single member electoral districts and the economic analysis of political integration. (C) 2015 Elsevier Inc. All rights reserved.	[Suzuki, Shinji; Inohara, Takehiro] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528550, Japan	Suzuki, S (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	suzuki.s.cd@m.titech.ac.jp; inohara@valdes.titech.ac.jp					Alesina A., 2003, NUMBER SIZE NATIONS; NIEMI RG, 1990, J POLIT, V52, P1155, DOI 10.2307/2131686; ROBINSON GWS, 1959, ANN ASSOC AM GEOGR, V49, P283, DOI 10.1111/j.1467-8306.1959.tb01614.x; Shapley LS, 1954, AM POLIT SCI REV, V48, P787, DOI 10.2307/1951053; Banzhaf J.F., 1965, RUTGERS LAW REV, V19, P317; Bolton P, 1997, Q J ECON, V112, P1057, DOI 10.1162/003355300555420; Crocker R., 2012, C RES SERVICE REPORT; Dubey P., 1979, Mathematics of Operations Research, V4, DOI 10.1287/moor.4.2.99; Myerson B., 1977, MATH OPER RES, V12, P225; Shapley L. S., 1953, ANN MATH STUD, V28, p[307, 307]; Suzuki S, 2005, SOCIOL THEOR METHOD, V20, P197; Yokomichi K., 2007, COSLOG UP TO DATE DO, V1, P1	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	OCT 1	2015	268						728	742		10.1016/j.amc.2015.06.114		15	Mathematics, Applied	Mathematics	CS0RD	WOS:000361769000064		
J	Du, WB; Gao, Y; Liu, C; Zheng, Z; Wang, Z				Du, Wen-Bo; Gao, Yang; Liu, Chen; Zheng, Zheng; Wang, Zhen			Adequate is better: particle swarm optimization with limited-information	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Particle swarm optimization; Limited information; Motion consensus	CONVERGENCE	Based on the interaction of individuals, particle swarm optimization (PSO) is a well recognized algorithm to find optima in search space. In its canonical version, the trajectory of each particle is usually influenced by the best performer among its neighborhood, which thus ignores some useful information from other neighbors. To capture information of all the neighbors, the fully informed PSO is proposed, which, however, may bring redundant information into the search process. Motivated by both scenarios, here we present a particle swarm optimization with limited information, which provides each particle adequate information yet avoids the waste of information. By means of systematic analysis for the widely-used standard test functions, it is unveiled that our new algorithm outperforms both canonical PSO and fully informed PSO, especially for multimodal test functions. We further investigate the underlying mechanism from a microscopic point of view, revealing that moderate velocity, moderate diversity and best motion consensus facilitate a good balance between exploration and exploitation, which results in the good performance. (C) 2015 Elsevier Inc. All rights reserved.	[Du, Wen-Bo; Gao, Yang; Liu, Chen] Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China; [Du, Wen-Bo; Gao, Yang; Liu, Chen] Beijing Key Lab Network Based Cooperat Air Traff, Beijing 100191, Peoples R China; [Du, Wen-Bo; Gao, Yang; Liu, Chen] Beijing Lab Gen Aviat Technol, Beijing 100191, Peoples R China; [Zheng, Zheng] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing 100191, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka, Japan	Du, WB (reprint author), Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China.	wenbodu@buaa.edu.cn			National Natural Science Foundation of China [61201314, 61221061, 61231013]; Key Project in the National Science & Technology Pillar Program [2012BAG04B01]; Beijing Higher Education Young Elite Teacher Project [YETP1072]	This work is supported by the National Natural Science Foundation of China (Grant nos. 61201314, 61221061 and 61231013), Key Project in the National Science & Technology Pillar Program (Grant no. 2012BAG04B01), and Beijing Higher Education Young Elite Teacher Project (Grant no. YETP1072).	KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Mendes R, 2004, IEEE T EVOLUT COMPUT, V8, P204, DOI [10.1109/TEVC.2004.826074, 10.1109/tevc.2004.826074]; Qi J, 2013, PHYSICA A, V392, P1522, DOI 10.1016/j.physa.2012.11.054; Zhan ZH, 2009, IEEE T SYST MAN CY B, V39, P1362, DOI 10.1109/TSMCB.2009.2015956; Kennedy J, 2006, IEEE T SYST MAN CY C, V36, P515, DOI 10.1109/TSMCC.2006.875410; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Bratton D., 2007, P IEEE SWARM INT S, P120; Eberhart R., 1995, P 6 INT S MICR HUM S, P39, DOI DOI 10.1109/MHS.1995.494215; Eigen M., 1973, INGO RECHENBERG EVOL; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Kennedy J., 1995, P IEEE INT C NEUR NE, P1942, DOI DOI 10.1109/ICNN.1995.488968; Kennedy J., 2002, IEEE P C EVOL COMPUT, V2, P1671, DOI [10.1109/CEC.2002.1004493, DOI 10.1109/CEC.2002.1004493]; Kennedy J., 1999, P IEEE C EV COMP, V3; Liang J. J., 2005, P IEEE SWARM INT S, P68, DOI 10.1109/SIS.2005.1501604; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Mendes R., 2014, THESIS U MINHO; Poli Riccardo, 2007, Swarm Intelligence, V1, DOI 10.1007/s11721-007-0002-0; Rarnaweera A., 2004, IEEE T EVOLUT COMPUT, V8, P240; Shi Y., 2001, P 2001 C EV COMP, V1, P101; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7	22	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	OCT 1	2015	268						832	838		10.1016/j.amc.2015.06.062		7	Mathematics, Applied	Mathematics	CS0RD	WOS:000361769000073		
J	Fang, YC; Liang, CW; Koshel, J; Sasian, J; Yatagai, T; Wang, YT; Zavisian, JM				Fang, Yi Chin; Liang, Chao-Wen; Koshel, John; Sasian, Jose; Yatagai, Toyohiko; Wang, Yongtian; Zavisian, James M.			Optical design and testing: introduction	APPLIED OPTICS			English	Editorial Material								Optical design and testing have numerous applications in industrial, military, consumer, and bio-medical settings. This issue features original research ranging from the optical design of image and nonimage optical stimuli for human perception, optics applications, bio-optics applications, displays, and solar energy systems to novel imaging modalities from deep UV to infrared spectral imaging, a systems perspective to imaging, as well as optical measurement. In addition, new concepts and trends for optics and further optical systems will be especially highlighted in this special issue. (C) 2015 Optical Society of America	[Fang, Yi Chin] Natl First Kaohsiung Univ Sci & Technol, Kaohsiung 807, Taiwan; [Liang, Chao-Wen] Natl Cent Univ, Dept Opt & Photon, Taoyuan, Taiwan; [Koshel, John; Sasian, Jose] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Yatagai, Toyohiko] Utsunomiya Univ, Ctr Opt Res & Educ, Utsunomiya, Tochigi 3218585, Japan; [Wang, Yongtian] Beijing Inst Technol, Beijing 100081, Peoples R China; [Zavisian, James M.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA	Fang, YC (reprint author), Natl First Kaohsiung Univ Sci & Technol, Kaohsiung 807, Taiwan.	yfang@ccms.nkfust.edu.tw						0	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	OCT 1	2015	54	28								10.1364/AO.54.00ODT1		2	Optics	Optics	CS7BA	WOS:000362237300038		
J	Zhang, S; Yang, Y; Hanson, SG; Takeda, M; Wang, W				Zhang, Shun; Yang, Yi; Hanson, Steen G.; Takeda, Mitsuo; Wang, Wei			Statistics of the derivatives of complex signal derived from Riesz transform and its application to pseudo-Stokes vector correlation for speckle displacement measurement	APPLIED OPTICS			English	Article							PATTERN; REPRESENTATION; PHOTOGRAPHY; ACCURACY	As an improvement of the well-known intensity correlation used in conventional electronic speckle photography, we have proposed a new technique, to the best of our knowledge, for displacement measurement referred to as pseudo-Stokes vector correlation (PSVC). To provide a theoretical background for the superiority of the proposed PSVC technique, we study the statistical properties of the spatial derivatives of the complex signal representation generated from the Riesz transform. Under the assumption of a Gaussian random process, a theoretical analysis for the pseudo Stokes vector correlation has been provided. Based on these results, we show mathematically that PSVC has a performance advantage over conventional intensity-based correlation technique. (C) 2015 Optical Society of America	[Zhang, Shun; Yang, Yi; Wang, Wei] Heriot Watt Univ, Sch Engn & Phys Sci, Inst Photon & Quantum Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Hanson, Steen G.] DTU Foton, Dept Photon Engn, DK-4000 Roskilde, Denmark; [Takeda, Mitsuo] Utsunomiya Univ, CORE, Utsunomiya, Tochigi 3218585, Japan	Wang, W (reprint author), Heriot Watt Univ, Sch Engn & Phys Sci, Inst Photon & Quantum Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	w.wang@hw.ac.uk			Engineering and Physical Sciences Research Council (EPSRC) [EP/K03643/1]; JSPS KAKENHI Grant [25390090]; Scottish Universities Physics Alliance (SUPA) [SSG040]	Engineering and Physical Sciences Research Council (EPSRC) (EP/K03643/1); JSPS KAKENHI Grant (25390090); Scottish Universities Physics Alliance (SUPA) (SSG040).	Abramowitz M., 1974, HDB MATH FUNCTIONS F; Egorov YA, 2004, J OPT A-PURE APPL OP, V6, pS217, DOI 10.1088/1464-4258/6/5/014; CHU TC, 1985, EXP MECH, V25, P232, DOI 10.1007/BF02325092; CHEN DJ, 1993, APPL OPTICS, V32, P1839, DOI 10.1364/AO.32.001839; Wang W, 2006, OPT EXPRESS, V14, P120, DOI 10.1364/OPEX.14.000120; SJODAHL M, 1993, APPL OPTICS, V32, P2278, DOI 10.1364/AO.32.002278; Pan B, 2010, APPL OPTICS, V49, P5501, DOI 10.1364/AO.49.005501; Berry MV, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/9/094001; Larkin KG, 2001, J OPT SOC AM A, V18, P1862, DOI 10.1364/JOSAA.18.001862; Riesz M, 1928, MATH Z, V27, P218, DOI 10.1007/BF01171098; SJODAHL M, 1994, APPL OPTICS, V33, P6667, DOI 10.1364/AO.33.006667; Wang W, 2010, STRAIN, V46, P12, DOI 10.1111/j.1475-1305.2009.00672.x; Bekshaev A. Y., 2011, ADV OPT TECHNOL, V2011; Bracewell R. N., 1999, FOURIER TRANSFORM IT; Dennis MR, 2004, J OPT A-PURE APPL OP, V6, pS202, DOI 10.1088/1464-4258/6/5/011; Goodman J. W., 1985, STAT OPTICS; Goodman J. W., 2010, SPECKLE PHENOMENA IN; Papoulis A., 1965, PROBABILITY RANDOM V; Plaskowski A., 1987, CROSS CORRELATION FL; Rastogi P. K., 2000, PHOTOMECHANICS; Sirohi R. S., 1993, SPECKLE METROLOGY; Sutton MA, 2009, IMAGE CORRELATION FOR SHAPE, MOTION AND DEFORMATION MEASUREMENTS: BASIC CONCEPTS, THEORY AND APPLICATIONS, P1, DOI 10.1007/978-0-387-78747-3; Wang W, 2014, APPL OPTICS, V53, pB147, DOI 10.1364/AO.53.00B147	23	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	OCT 1	2015	54	28					8561	8565		10.1364/AO.54.008561		5	Optics	Optics	CS7BA	WOS:000362237300083		
J	Tanaka, Y; Tominaka, S; Kurokawa, T				Tanaka, Yosuke; Tominaka, Seiji; Kurokawa, Takashi			Precision distance measurement using a two-photon absorption process in a silicon avalanche photodiode with saw-tooth phase modulation	APPLIED OPTICS			English	Article							CONTINUOUS-WAVE LADAR; 20 M RANGE; CHIRP LINEARIZATION; FREQUENCY COMB; FIBER-LASER; DIODE-LASER; LONG-RANGE; INTERFEROMETRY; RESOLUTION; ACCURACY	We present a novel configuration of a precision laser distance measurement based on the two-photon absorption (TPA) photocurrent from a silicon avalanche photodiode (Si-APD). The proposed system uses saw-tooth phase modulation, known as serrodyne modulation, in order to shift the frequency of the reference light from that of the probe light. It suppresses the coherent interference noise between the probe and the reference. The serrodyne modulation also enables lock-in detection of the TPA photocurrent. Furthermore, it contributes to the reduction of the system components. The precision measurement is experimentally demonstrated by measuring a fiber length difference of 2.6 m with a standard deviation of 27 mu m under constant temperature. The high-precision displacement measurement is also demonstrated by measuring the temperature-induced change in the optical path length difference of a fiber interferometer. (C) 2015 Optical Society of America	[Tanaka, Yosuke; Tominaka, Seiji; Kurokawa, Takashi] Tokyo Univ Agr & Technol, Inst Engn, Div Adv Elect & Elect Engn, Fuchu, Tokyo 183, Japan	Tanaka, Y (reprint author), Tokyo Univ Agr & Technol, Inst Engn, Div Adv Elect & Elect Engn, Fuchu, Tokyo 183, Japan.	tyosuke@cc.tuat.ac.jp	Tanaka, Yosuke/C-8806-2013		Japan Society for the Promotion of Science (JSPS) [25630170]	Japan Society for the Promotion of Science (JSPS) (25630170).	Koshikiya Y, 2008, J LIGHTWAVE TECHNOL, V26, P3287, DOI 10.1109/JLT.2008.928916; Minoshima K, 2000, APPL OPTICS, V39, P5512, DOI 10.1364/AO.39.005512; Tanaka Y, 2005, IEEE PHOTONIC TECH L, V17, P2682, DOI 10.1109/LPT.2005.859120; Roos PA, 2009, OPT LETT, V34, P3692, DOI 10.1364/OL.34.003692; Doloca NR, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/11/115302; AMMON G, 1970, APPL OPTICS, V9, P2256, DOI 10.1364/AO.9.002256; Yang RT, 2014, OPT LETT, V39, P5834, DOI 10.1364/OL.39.005834; Coddington I, 2009, NAT PHOTONICS, V3, P351, DOI 10.1038/NPHOTON.2009.94; Fujima I, 1998, MEAS SCI TECHNOL, V9, P1049, DOI 10.1088/0957-0233/9/7/007; Satyan N, 2009, OPT EXPRESS, V17, P15991, DOI 10.1364/OE.17.015991; Lay OP, 2003, OPT LETT, V28, P890, DOI 10.1364/OL.28.000890; Barber ZW, 2011, OPT LETT, V36, P1152, DOI 10.1364/OL.36.001152; PARTHASARATHY S, 1982, P SOC PHOTO-OPT INST, V336, P2; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Barber ZW, 2010, APPL OPTICS, V49, P213, DOI 10.1364/AO.49.000213; Tanaka Y, 2003, OPT LETT, V28, P402, DOI 10.1364/OL.28.000402; Baumann E, 2013, OPT LETT, V38, P2026, DOI 10.1364/OL.38.002026; Pollinger F, 2009, APPL OPTICS, V48, P6188, DOI 10.1364/AO.48.006188; Dale J, 2014, OPT EXPRESS, V22, P24869, DOI 10.1364/OE.22.024869; Tanaka Y, 2007, JPN J APPL PHYS 1, V46, P5331, DOI 10.1143/JJAP.46.5331; Kikuchi K, 1998, ELECTRON LETT, V34, P123, DOI 10.1049/el:19980008; EARNSHAW KB, 1972, APPL OPTICS, V11, P749, DOI 10.1364/AO.11.000749; Azouigui S, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3428729; LAGAKOS N, 1981, APPL OPTICS, V20, P2305, DOI 10.1364/AO.20.002305; Bickel G., 1985, OPT ENG, V24; DANDLIKER R, 1988, OPT LETT, V13, P339, DOI 10.1364/OL.13.000339; Floch S. L., 2008, APPL OPTICS, V47, P3027; JACKSON DA, 1982, ELECTRON LETT, V18, P1081, DOI 10.1049/el:19820740; Jalkio J. A., 1985, OPTICAL ENG, V24; Kinder T, 2002, J OPT A-PURE APPL OP, V4, pS364, DOI 10.1088/1464-4258/4/6/381; Stone J. A., 1999, APPL OPTICS, V38, P5981; Tanaka Y, 2015, MEAS SCI TECHNOL, V26, DOI 10.1088/0957-0233/26/2/025205; van den Berg SA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.183901; Zheng J, 2006, APPL OPTICS, V45, P2723, DOI 10.1364/AO.45.002723	34	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	OCT 1	2015	54	28					E35	E40		10.1364/AO.54.000E35		6	Optics	Optics	CS7BA	WOS:000362237300007		
J	Suzuki, K; Takahashi, M; Li, CY; Lin, SP; Tomari, M; Shing, CM; Fang, SH				Suzuki, Katsuhiko; Takahashi, Masaki; Li, Chia-Yang; Lin, Shiuan-Pey; Tomari, Miki; Shing, Cecilia M.; Fang, Shih-Hua			The acute effects of green tea and carbohydrate coingestion on systemic inflammation and oxidative stress during sprint cycling	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM			English	Article						carbohydrate; green tea; leukocyte; cytokine; testosterone; anti-oxidation	HIGH-INTENSITY; FAT OXIDATION; EXTRACT SUPPLEMENTATION; SUBSTRATE METABOLISM; CAFFEINE INGESTION; HORMONAL RESPONSES; ORAL GLUCOSE; PERFORMANCE; EXERCISE; TESTOSTERONE	Green tea (Camellia sinensis) has anti-oxidative and anti-inflammatory effects, which may be beneficial to athletes performing high-intensity exercise. This study investigated the effects of carbohydrate and green tea coingestion on sprint cycling performance and associated oxidative stress and immunoendocrine responses to exercise. In a crossover design, 9 well-trained male cyclists completed 3 sets of 8 repetitions of 100-m uphill sprint cycling while ingesting green tea and carbohydrate (TEA) (22 mg/kg body mass catechins, 6 mg/kg body mass caffeine, 230 mg/kg glucose, and 110 mg/kg fructose) or carbohydrate only (CHO) (230 mg/kg body mass glucose and 110 mg/kg body mass fructose) during each 10-min recovery period between sets. Blood samples were collected before exercise, 10 min after exercise, and 14 h after exercise. There was no effect of acute TEA ingestion on cycling sprint performance (p = 0.29), although TEA maintained postexercise testosterone and lymphocyte concentrations, which decreased significantly in the CHO group (p < 0.001). While there was a trend for lower postexercise neutrophil count with TEA (p = 0.05), there were no significant differences between TEA and CHO for circulating cytokines (p > 0.20), markers of oxidative stress and antioxidant capacity (p > 0.17), adiponectin concentration (p = 0.60), or muscle damage markers (p > 0.64). While acute green tea ingestion prevents the postexercise decrease in testosterone and lymphocytes, it does not appear to benefit cycling sprint performance or reduce markers of oxidation and inflammation when compared with carbohydrate alone.	[Suzuki, Katsuhiko; Takahashi, Masaki; Tomari, Miki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Li, Chia-Yang] Kaohsiung Med Univ, Coll Med, Dept Genome Med, Kaohsiung, Taiwan; [Li, Chia-Yang] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Lin, Shiuan-Pey] China Med Univ, Sch Pharm, Taichung, Taiwan; [Shing, Cecilia M.] Univ Tasmania, Sch Hlth Sci, Launceston, Tas 7250, Australia; [Fang, Shih-Hua] Natl Taiwan Univ Sport, Inst Athlet, Taichung 40404, Taiwan	Fang, SH (reprint author), Natl Taiwan Univ Sport, Inst Athlet, 16,Sec 1,Shuan Shih Rd, Taichung 40404, Taiwan.	shfang@ntupes.edu.tw		Lin, Shiuan-Pey/0000-0002-6186-2101	National Science Council (NSC) - National Science Council, Republic of China [101-2628-H-028-002-MY3]; Waseda Institute of Sports Nutrition; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23240097-15H01833]	We warmly thank the coach, Jui-Te Hsu, and all the cyclic athletes for their patience and participation in this study. This study was supported by a grant from National Science Council (NSC) 101-2628-H-028-002-MY3 granted by National Science Council, Republic of China; from the Waseda Institute of Sports Nutrition; and a Grant-in Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23240097-15H01833). We thank Pei-Yu Shih for expert technical assistance.	Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130; Ferreira LF, 2008, J APPL PHYSIOL, V104, P853, DOI 10.1152/japplphysiol.00953.2007; Phillips SM, 2014, J SPORT SCI MED, V13, P252; Hoffman JR, 1997, EUR J APPL PHYSIOL O, V75, P83; Jowko E, 2015, EUR J NUTR, V54, P783, DOI 10.1007/s00394-014-0757-1; Gant N, 2010, INT J SPORT NUTR EXE, V20, P191; Ichinose T, 2011, SCAND J MED SCI SPOR, V21, P598, DOI 10.1111/j.1600-0838.2009.01077.x; VANBREDA E, 1993, PFLUG ARCH EUR J PHY, V424, P294; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; DILL DB, 1974, J APPL PHYSIOL, V37, P247; Cooper R, 2014, EUR J SPORT SCI, V14, P353, DOI 10.1080/17461391.2013.813972; Yu PL, 2010, J CELL BIOCHEM, V110, P333, DOI 10.1002/jcb.22541; Pedersen DJ, 2008, J APPL PHYSIOL, V105, P7, DOI 10.1152/japplphysiol.01121.2007; COSTILL DL, 1992, SPORTS MED, V13, P86; Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007; Venables MC, 2008, AM J CLIN NUTR, V87, P778; KREZOWSKI PA, 1986, AM J CLIN NUTR, V44, P847; Fung ST, 2013, BRIT J NUTR, V109, P2199, DOI 10.1017/S0007114512004370; Conger SA, 2011, INT J SPORT NUTR EXE, V21, P71; Paton CD, 2010, EUR J APPL PHYSIOL, V110, P1243, DOI 10.1007/s00421-010-1620-6; Warren GL, 2010, MED SCI SPORT EXER, V42, P1375, DOI 10.1249/MSS.0b013e3181cabbd8; Beaven CM, 2013, APPL PHYSIOL NUTR ME, V38, P633, DOI 10.1139/apnm-2012-0333; Rumpler W, 2001, J NUTR, V131, P2848; Astorino TA, 2012, NUTR RES, V32, P78, DOI 10.1016/j.nutres.2011.12.001; Roberts SP, 2010, J SPORT SCI, V28, P833, DOI 10.1080/02640414.2010.484069; Hulston CJ, 2008, MED SCI SPORT EXER, V40, P2096, DOI 10.1249/MSS.0b013e318182a9c7; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Haramizu S, 2013, MED SCI SPORT EXER, V45, P1694, DOI 10.1249/MSS.0b013e31828de99f; Lee CL, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-17; Currell K, 2008, MED SCI SPORT EXER, V40, P275, DOI 10.1249/mss.0b013e31815adf19; Yiannakopoulou EC, 2013, FREE RADICAL RES, V47, P667, DOI 10.3109/10715762.2013.819975; Tanner AV, 2014, J SPORT SCI, V32, P680, DOI 10.1080/02640414.2013.850594; Glaister M, 2012, J STRENGTH COND RES, V26, P1001, DOI 10.1519/JSC.0b013e31822ba300; Jowko E, 2011, NUTR RES, V31, P813, DOI 10.1016/j.nutres.2011.09.020; Lee CL, 2014, EUR J APPL PHYSIOL, V114, P1533, DOI 10.1007/s00421-014-2888-8; Caronia LM, 2013, CLIN ENDOCRINOL, V78, P291, DOI 10.1111/j.1365-2265.2012.04486.x; Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381; SUTTON JR, 1973, BRIT MED J, V1, P520; Glaister M, 2008, MED SCI SPORT EXER, V40, P1835, DOI 10.1249/MSS.0b013e31817a8ad2; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Goldstein ER, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-5; HAKKINEN K, 1993, J APPL PHYSIOL, V74, P882; Jeukendrup AE, 2011, J SPORT SCI, V29, pS91, DOI 10.1080/02640414.2011.610348; Jowko E, 2012, INT J SPORT NUTR EXE, V22, P486; Lin SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087580; Murakami S, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-23; NEWBY FD, 1990, AM J PHYSIOL, V259, pE865; Peake JM, 2014, AM J PHYSIOL-ENDOC M, V307, pE539, DOI 10.1152/ajpendo.00276.2014; Takahashi M, 2014, BRIT J NUTR, V112, P1542, DOI 10.1017/S0007114514002530	49	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	1715-5312	1715-5320		APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	OCT	2015	40	10					997	1003		10.1139/apnm-2015-0123		7	Nutrition & Dietetics; Physiology; Sport Sciences	Nutrition & Dietetics; Physiology; Sport Sciences	CS5LK	WOS:000362119400004		
J	Takano, A; Kawakami, N; Miyamoto, Y; Matsumoto, T				Takano, Ayumi; Kawakami, Norito; Miyamoto, Yuki; Matsumoto, Toshihiko			A Study of Therapeutic Attitudes Towards Working With Drug Abusers: Reliability and Validity of the Japanese Version of the Drug and Drug Problems Perception Questionnaire	ARCHIVES OF PSYCHIATRIC NURSING			English	Article							ALCOHOL-RELATED PROBLEMS; MENTAL-HEALTH PROBLEMS; GENERAL-PRACTITIONERS; WORKFORCE DEVELOPMENT; ROLE LEGITIMACY; HELPING AGENTS; WORKERS; NURSES; CARE; ILLNESS	Positive therapeutic attitudes from healthcare professionals are important when providing medical services. The Drug and Drug Problems Perception Questionnaire (DDPPQ) measures healthcare professionals' attitudes towards working with drug abusers. We developed a Japanese version (J-DDPPQ) and examined its reliability and validity among Japanese nurses. The J-DDPPQshowed good internal consistency (Cronbach's alpha = 0.92). Using exploratory factor analysis, the five-factor structure was found to be identical to the original structure. Construct validity was supported by significant positive correlations with experience working with drug abusers, a high level of knowledge and skills, receiving education and training, and optimistic perception about people with drug dependence. The results show that the J-DDPPQ has acceptable reliability and validity and will contribute to investigating the effect of education and training on drug abuse. (C) 2015 Elsevier Inc. All rights reserved.	[Takano, Ayumi; Miyamoto, Yuki] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Psychiat Nursing,Bunkyo Ku, Tokyo 1130033, Japan; [Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Matsumoto, Toshihiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Drug Dependence Res, Kodaira, Tokyo, Japan	Takano, A (reprint author), Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Psychiat Nursing,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ayumi-takano@umin.ac.jp; kawakami@m.u-tokyo.ac.jp; yyuki-tky@umin.ac.jp; tmatsu@ncnp.go.jp			Japanese Health Labour Science Research Grant	The author gratefully acknowledges Hazel Watson, the developer of the DDPPQ, who checked the back translation of the J-DDPPQ. This study was partly supported by the Japanese Health Labour Science Research Grant. The authors declare no conflict of interest associated with this manuscript.	Link B, 2008, SOC SCI MED, V67, P409, DOI 10.1016/j.socscimed.2008.03.015; Ronzani TM, 2009, SOC SCI MED, V69, P1080, DOI 10.1016/j.socscimed.2009.07.026; Johansson K, 2002, ALCOHOL ALCOHOLISM, V37, P38, DOI 10.1093/alcalc/37.1.38; LIGHTFOOT PJC, 1986, BRIT J ADDICT, V81, P749; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Jacka D, 1999, DRUG ALCOHOL REV, V18, P287, DOI 10.1080/09595239996428; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Friedmann PD, 2000, J GEN INTERN MED, V15, P84, DOI 10.1046/j.1525-1497.2000.03379.x; Allsop SJ, 2009, DRUG ALCOHOL REV, V28, P541, DOI 10.1111/j.1465-3362.2009.00110.x; Munro A, 2007, INT J NURS STUD, V44, P1430, DOI 10.1016/j.ijnurstu.2006.07.024; Baker JA, 2005, J ADV NURS, V49, P522, DOI 10.1111/j.1365-2648.2004.03325.x; Edward KL, 2009, INT J NURS PRACT, V15, P74, DOI 10.1111/j.1440-172X.2009.01731.x; Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003; Howard V, 2010, J PSYCHIATR MENT HLT, V17, P862, DOI 10.1111/j.1365-2850.2010.01620.x; Watson H, 2007, ADDICTION, V102, P206, DOI 10.1111/j.1360-0443.2006.01686.x; BUSH RA, 1988, DRUG ALCOHOL DEPEN, V22, P105, DOI 10.1016/0376-8716(88)90044-0; GORMAN DM, 1991, BRIT J ADDICT, V86, P327; Albery IP, 2003, ADDICT BEHAV, V28, P995, DOI 10.1016/S0306-4603(01)00288-X; Adams MW, 2008, J PSYCHIATR MENT HLT, V15, P101, DOI 10.1111/j.1365-2850.2007.01210.x; CHAPPEL JN, 1985, J STUD ALCOHOL, V46, P48; Room R, 2005, DRUG ALCOHOL REV, V24, P143, DOI 10.1080/0959230500102434; Loughran H, 2010, BRIT J SOC WORK, V40, P239, DOI 10.1093/bjsw/bcn106; Roche AM, 2009, DRUG ALCOHOL REV, V28, P550, DOI 10.1111/j.1465-3362.2009.00111.x; WELLER L, 1988, BRIT J MED PSYCHOL, V61, P277; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Rao H, 2009, J PSYCHIATR MENT HLT, V16, P279, DOI 10.1111/j.1365-2850.2008.01369.x; Fitzgerald N, 2009, PHARM WORLD SCI, V31, P149, DOI 10.1007/s11096-009-9284-1; TAYLOR SM, 1979, SOC SCI MED-MED GEOG, V13, P281, DOI 10.1016/0160-8002(79)90051-0; Tominaga M, 2009, SOC PSYCH PSYCH EPID, V44, P777, DOI 10.1007/s00127-009-0499-1; Ford R, 2008, J CLIN NURS, V17, P2452, DOI 10.1111/j.1365-2702.2007.02266.x; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Berger M, 2005, SOC SCI MED, V61, P1821, DOI 10.1016/j.socsimed.2005.03.025; Cartwright A., 2000, HANDSCORING ALCOHOL; CARTWRIGHT AKJ, 1980, BRIT J ADDICT, V75, P413; Hooper D., 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.1016/J.INFBEH.2006.11.010; Hunot V., 1998, BRIT J GUID COUNS, V26, P353, DOI 10.1080/03069889808253848; Kelleher S., 2007, ACCIDENT EMERGENCY N, P161; Roe A. R, 2010, ASS CERTIFIED REHABI; Selleck C S, 1998, J Obstet Gynecol Neonatal Nurs, V27, P70, DOI 10.1111/j.1552-6909.1998.tb02593.x; Wada K, 2009, YAKUBUTSU SHIYOUNI K; Watson H., 2010, INVOLVEMENT NURSES M; World Health Organization, 2008, PRINC DRUG DEP TREAT; World Health Organization, 2010, ATLAS SUBST US 2010	44	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9417	1532-8228		ARCH PSYCHIAT NURS	Arch. Psychiatr. Nurs.	OCT	2015	29	5					302	308		10.1016/j.apnu.2015.05.002		7	Nursing; Psychiatry	Nursing; Psychiatry	CS5ZB	WOS:000362155700008		
J	Fujie, F				Fujie, Futaba			On traceable and upper traceable numbers of graphs	ARS COMBINATORIA			English	Article						Hamiltonian graphs; traceable graphs; traceable number; upper traceable number	HAMILTONIAN WALK	For a connected graph G of order n >= 2 and a linear ordering s: v(1), v(2), ..., v(n) of V(G), define d(s) = Sigma(n-1)(i=1) d(v(i), v(i+1)). The traceable number t(G) and upper traceable number t(+)(G) of G are defined by t(G) = min{d(s)} and t(+) (G) = max{d(s)}, respectively, where the minimum and maximum are taken over all linear orderings s of V(G). Consequently, t(G) <= t(+)(G). It is known that n - 1 <= t(G) <= 2n - 4' and n - 1 <= t(+)(G) <= left perpendicularn(2)/2left perpendicular - 1 for every connected graph G of order n >= 3 and, furthermore, for every pair n, A of integers with 2 <= n - 1 <= A <= 2n - 4 there exists a graph of order n whose traceable number equals A. In this work we determine all pairs A, B of positive integers with A <= B that are realizable as the traceable number and upper traceable number, respectively, of some graph. It is also determined for which pairs n,B of integers with n - 1 <= B <= left perpendicularn(2)/2left perpendicular - 1 there exists a graph whose order equals n and upper traceable number equals B.	Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan	Fujie, F (reprint author), Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan.	futaba@math.nagoya-u.ac.jp					ASANO T, 1980, J GRAPH THEOR, V4, P315, DOI 10.1002/jgt.3190040310; NEBESKY L, 1976, CZECH MATH J, V26, P596; Okamoto F, 2008, CZECH MATH J, V58, P271, DOI 10.1007/s10587-008-0016-9; NISHIZEKI T, 1983, DISCRETE APPL MATH, V5, P211, DOI 10.1016/0166-218X(83)90042-2; Bermond J. C., 1976, C NUMER, V15, P41; Chartrand G., 2010, GRAPHS DIGRAPHS; Chartrand G., 2004, B I COMBIN APPL, V42, P37; Goodman S. E., 1974, SIAM Journal on Computing, V3, DOI 10.1137/0203017; Okamoto F., 2006, MATH BOHEM, V131, P63; Okamoto F., 2008, MATH BOHEM, V133, P389; Vacek P., 1991, ARCH MATH BRNO A, V27, P105; Vacek P., 1992, ARCH MATH, V28, P11	12	0	0	CHARLES BABBAGE RES CTR	WINNIPEG	PO BOX 272 ST NORBERT POSTAL STATION, WINNIPEG, MB R3T 2N2, CANADA	0381-7032			ARS COMBINATORIA	ARS Comb.	OCT	2015	123						97	114				18	Mathematics	Mathematics	CS8BE	WOS:000362309900009		
J	Morita, D; Sawada, H; Ogawa, W; Miyachi, H; Kuroda, T				Morita, Daichi; Sawada, Hiromi; Ogawa, Wakano; Miyachi, Hiroyuki; Kuroda, Teruo			Riccardin C derivatives cause cell leakage in Staphylococcus aureus	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Riccardin C; MRSA; Cell leakage; Mesosome; Macrocyclic bis(bibenzyl)	MULTIDRUG EFFLUX PUMP; SWISS-MODEL; TRICLOSAN RESISTANCE; GENE CLONING; PROTEIN; INHIBITION; MECHANISM; MRSA; ENVIRONMENT; REDUCTASE	Methicillin-resistant Staphylococcus aureus (MRSA) is a major problem in clinical settings, and because it is resistant to most antimicrobial agents, MRSA infections are difficult to treat. We previously reported that synthetic macrocyclic bis(bibenzyl) derivatives, which were originally discovered in liverworts, had anti-MRSA activity. However, the action mechanism responsible was unclear. In the present study, we elucidated the action mechanism of macrocyclic bis(bibenzyl) RC-112 and its partial structure, IDPO-9 (2-phenoxyphenol). Survival experiments demonstrated that RC-112 had a bactericidal effect on MRSA, whereas IDPO-9 had bacteriostatic effects. IDPO-9-resistant mutants exhibited cross-resistance to triclosan, but not to RC-112. The mutation was identified in the fabI, enoyl-acyl carrier protein reductase gene, a target of triclosan. We have not yet isolated the RC-112-resistant mutant. On the other hand, the addition of RC-112, unlike IDPO-9, caused the inflow of ethidium and propidium into S. aureus cells. RC-112-dependent ethidium outflow was observed in ethidium-loaded S. aureus cells. Transmission electron microscopy also revealed that S. aureus cells treated with RC-112 had intracellular lamellar mesosomal-like structures. Intracellular Na+ and K+ concentrations were significantly changed by the RC-112 treatment. These results indicated that RC-112 increased membrane permeability to ethidium, propidium, Na+, and K+, and also that the action mechanism of IDPO-9 was different from those of the other compounds. (C) 2015 Elsevier B.V. All rights reserved.	[Morita, Daichi; Ogawa, Wakano; Kuroda, Teruo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, Okayama 7008530, Japan; [Sawada, Hiromi; Miyachi, Hiroyuki] Okayama Univ, Med & Bioorgan Chem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Kuroda, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Microbiol, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	ph18039@s.okayama-u.ac.jp; ph20116@s.okayama-u.ac.jp; wogawa@daiichi-cps.ac.jp; miyachi@pharm.okayama-u.ac.jp; tkuroda@cc.okayama-u.ac.jp			Drug Discovery Project for Intractable Infectious Diseases of Okayama University (IIDPO)	This work was supported in part by Drug Discovery Project for Intractable Infectious Diseases of Okayama University (IIDPO). We gratefully thank the Division of Instrumental Analysis, Department of Instrumental Analysis & Cryogenics, Advanced Science Research Center, Okayama University for the ICP-OES analysis.	Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; SOMMA S, 1984, ANTIMICROB AGENTS CH, V26, P917; Yamada Y, 2006, BIOL PHARM BULL, V29, P801, DOI 10.1248/bpb.29.801; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.1143-3347.2002; Shenkarev ZO, 2002, BIOPHYS J, V82, P762; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; REUSCH VM, 1973, BIOCHIM BIOPHYS ACTA, V300, P79, DOI 10.1016/0304-4157(73)90012-9; Brenwald NP, 2003, J HOSP INFECT, V55, P141, DOI 10.1016/S0195-6701(03)00222-6; Xu AH, 2010, ACTA PHARMACOL SIN, V31, P609, DOI 10.1038/aps.2010.37; Xiong YQ, 1999, ANTIMICROB AGENTS CH, V43, P1111; ASAKAWA Y, 1982, PHYTOCHEMISTRY, V21, P2143, DOI 10.1016/0031-9422(82)83073-2; Bouhdid S, 2009, J APPL MICROBIOL, V106, P1558, DOI 10.1111/j.1365-2672.2008.04124.x; Yamada Y, 2006, BIOL PHARM BULL, V29, P554, DOI 10.1248/bpb.29.554; Yoshida T, 1996, TETRAHEDRON, V52, P14487, DOI 10.1016/0040-4020(96)00889-7; Sawada H, 2013, BIOORG MED CHEM LETT, V23, P6563, DOI 10.1016/j.bmcl.2013.10.069; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Floyd JL, 2010, ANTIMICROB AGENTS CH, V54, P5406, DOI 10.1128/AAC.00580-10; SHIMODA M, 1995, INFECT IMMUN, V63, P2886; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; DeMarco CE, 2007, ANTIMICROB AGENTS CH, V51, P3235, DOI 10.1128/AAC.00430-07; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Truong-Bolduc QC, 2005, J BACTERIOL, V187, P2395, DOI 10.1128/JB.187.7.2395-2405.2005; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Tamehiro N, 2005, FEBS LETT, V579, P5299, DOI 10.1016/j.febslet.2005.08.054; de Leon L, 2010, MICROBIOL RES, V165, P617, DOI 10.1016/j.micres.2009.12.004; UMEDA A, 1980, J GEN MICROBIOL, V118, P215; NEYFAKH AA, 1993, ANTIMICROB AGENTS CH, V37, P128; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; PERKINS HR, 1969, BIOCHEM J, V111, P195; TANAKA N, 1983, ANTIMICROB AGENTS CH, V24, P797; Gupta S, 2014, ENVIRON SCI POLLUT R, V21, P10186, DOI 10.1007/s11356-014-2951-3; Sawada H, 2012, BIOORG MED CHEM LETT, V22, P7444, DOI 10.1016/j.bmcl.2012.10.052; Asakawa Y, 2000, SPECTROSC-INT J, V14, P149; Horiuchi Y., 2001, J ELECT MICROSC TECH, V16; Peitsch M. C., 1995, NAT BIOTECHNOL, V13, P658, DOI DOI 10.1038/NBT0795-658	42	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	OCT	2015	1848	10	A				2057	2064		10.1016/j.bbamem.2015.05.008		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS5YE	WOS:000362153400013		
J	Ekman, P; Maula, T; Yamaguchi, S; Yamamoto, T; Nyholm, TKM; Katsumura, S; Slotte, JP				Ekman, Peik; Maula, Terhi; Yamaguchi, Shou; Yamamoto, Tetsuya; Nyholm, Thomas K. M.; Katsumura, Shigeo; Slotte, J. Peter			Formation of an ordered phase by ceramides and diacylglycerols in a fluid phosphatidylcholine bilayer - Correlation with structure and hydrogen bonding capacity	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Phase separation; Hydrogen bonding; Fluorescence life time analysis; Trans-parinaric acid	ENRICHED MEMBRANE DOMAINS; ACYL-CHAIN LENGTH; BIOPHYSICAL PROPERTIES; PHOSPHOLIPID MEMBRANE; CHOLESTEROL; SPHINGOLIPIDS; VESICLES; MIXTURES; REORGANIZATION; 2ND-MESSENGER	Ceramides and diacylglycerols are lipids with a large hydrophobic part (acyl chains and long-chain base) whereas their polar function (hydroxyl group) is small. They need colipids with large head groups to coexist in bilayer membranes. In this study, we have determined how saturated and unsaturated ceramides and acyl-chain matched diacylglycerols form ordered domains in 1-palmitoy1-2-oleoyl-sn-glycero-3-phosphocholine bilayers as a function of bilayer concentration. The formation of ordered domains was determined from lifetime analysis of trans-parinaric acid. Ceramides formed ordered domains with equal average tPA lifetime at lower bilayer concentration when compared to acyl-chain matched diacylglycerols. This was true for both saturated (16:0) and mono-unsaturated (18:1) species. This finding suggested that hydrogen bonding among ceramides contributed to their more efficient ordered phase formation, since diacylglycerols do not form similar hydrogen bonding networks. The role of hydrogen bonding in ordered domain formation was further verified by using palmitoyl ceramide analogs with 2N and 3OH methylated long-chain bases. These analogs do not form hydrogen bonds from the 2NH or the 3OH, respectively. While methylation of the 3OH did not affect ordered phase formation compared to native palmitoyl ceramide, 2NH methylation markedly attenuated ceramide ordered phase formation. We conclude that in addition to acyl chain length, saturation, molecular order, and lack of large head group, also hydrogen bonding involving the 2NH is crucial for efficient formation of ceramide-rich domains in fluid phosphatidylcholine bilayers. (C) 2015 Elsevier B.V. All rights reserved.	[Ekman, Peik; Maula, Terhi; Nyholm, Thomas K. M.; Slotte, J. Peter] Abo Akad Univ, Fac Engn Sci, Biochem, FIN-20520 Turku, Finland; [Yamaguchi, Shou; Yamamoto, Tetsuya; Katsumura, Shigeo] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda City, Hyogo 6691337, Japan	Slotte, JP (reprint author), Abo Akad Univ, Fac Engn Sci, Biochem, FIN-20520 Turku, Finland.	jpslotte@abo.fi			Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Abo Akademi Foundation	We thank Dr. Tomi Airenne for help with Maestro software and molecular dimension measurements. The study was funded by generous grants from the Sigrid Juselius Foundation, the Magnus Ehrnrooth Foundation, and the Abo Akademi Foundation.	Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamen.2005.10.009; Riske KA, 2003, BIOPHYS J, V85, P2351, DOI 10.1016/S0006-3495(03)74659-1; Almeida PFF, 2009, BBA-BIOMEMBRANES, V1788, P72, DOI 10.1016/j.bbamem.2008.08.007; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Nagashima T, 2015, LANGMUIR, V31, P1479, DOI 10.1021/la503906m; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Chiantia S, 2007, LANGMUIR, V23, P7659, DOI 10.1021/la7010919; Kuklev DV, 2004, CHEM PHYS LIPIDS, V131, P215, DOI 10.1016/j.chemphyslip.2004.06.001; COHEN R, 1984, CHEM PHYS LIPIDS, V35, P371, DOI 10.1016/0009-3084(84)90079-3; Gulbins E, 2004, J MOL MED-JMM, V82, P357, DOI 10.1007/s00109-004-0539-y; Sot J, 2014, BIOPHYS J, V107, P2828, DOI 10.1016/j.bpj.2014.10.063; Silva L, 2006, MOL MEMBR BIOL, V23, P137, DOI 10.1080/09687860500439474; Ahyayauch H, 2015, BIOPHYS J, V108, P1672, DOI 10.1016/j.bpj.2015.02.020; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Silva L, 2006, BBA-BIOMEMBRANES, V1758, P452, DOI 10.1016/j.bbamem.2006.03.008; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; PASCHER I, 1976, BIOCHIM BIOPHYS ACTA, V455, P433, DOI 10.1016/0005-2736(76)90316-3; Hsueh YW, 2002, BIOPHYS J, V82, P3089; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Veiga MP, 1999, BIOPHYS J, V76, P342; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Maula T, 2011, BIOPHYS J, V101, P2948, DOI 10.1016/j.bpj.2011.11.007; Castro BM, 2007, BIOPHYS J, V93, P1639, DOI 10.1529/biophysj.107.107714; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Zhang Y, 2009, BBA-BIOMEMBRANES, V1788, P178, DOI 10.1016/j.bbamem.2008.07.030; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; Pinto SN, 2011, BBA-BIOMEMBRANES, V1808, P2753, DOI 10.1016/j.bbamem.2011.07.023; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Ali MR, 2006, BIOCHEMISTRY-US, V45, P12629, DOI 10.1021/bi060610x; Johnston I, 2008, BBA-BIOMEMBRANES, V1778, P185, DOI 10.1016/j.bbamem.2007.09.021; Huang HW, 1996, BIOCHEM BIOPH RES CO, V220, P834, DOI 10.1006/bbrc.1996.0490; Castro BM, 2009, J BIOL CHEM, V284, P22978, DOI 10.1074/jbc.M109.026567; Jimenez-Monreal AM, 1998, BBA-BIOMEMBRANES, V1373, P209, DOI 10.1016/S0005-2736(98)00106-0; BONOSI F, 1990, LANGMUIR, V6, P1769, DOI 10.1021/la00102a011; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P819, DOI 10.1021/bi00624a002; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Artetxe I, 2013, BIOPHYS J, V104, P604, DOI 10.1016/j.bpj.2012.12.026; Mendelsohn R, 2014, J PHYS CHEM B, V118, P4378, DOI 10.1021/jp501003c; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Bjorkbom A, 2011, BBA-BIOMEMBRANES, V1808, P1179, DOI 10.1016/j.bbamem.2011.01.009; Björkqvist Y J E, 2008, Biochim Biophys Acta, V1778, P954, DOI 10.1016/j.bbamem.2007.12.016; HABERLAN.ME, 1973, P NATL ACAD SCI USA, V70, P2313, DOI 10.1073/pnas.70.8.2313; Ira S. Zou, 2009, J STRUCT BIOL, V168, P78; WELTI R, 1982, BIOCHEMISTRY-US, V21, P5685, DOI 10.1021/bi00265a045	52	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	OCT	2015	1848	10	A				2111	2117		10.1016/j.bbamem.2015.06.019		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS5YE	WOS:000362153400019		
J	Tadokoro, S; Inoh, Y; Nakanishi, M; Hirashima, N				Tadokoro, Satoshi; Inoh, Yoshikazu; Nakanishi, Mamoru; Hirashima, Naohide			Effects of PIP2 on membrane fusion between mast cell SNARE liposomes mediated by synaptotagmin 2	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Synaptotagmin; SNARE; Exocytosis; Liposome; Membrane fusion; Mast cell	CA2+-TRIGGERED EXOCYTOSIS; CA2+-ACTIVATED SECRETION; PLASMA-MEMBRANE; RBL-2H3 CELLS; DEGRANULATION; RELEASE; CA2+; MICROTUBULES; COMPARTMENT; SYNTAXIN-3	Recent studies have revealed that SNARE proteins are involved in exocytotic release in mast cells. Previously, we reported that mast cell SNARE proteins induce membrane fusion between liposomes. Moreover, we found that synaptotagmin 2, a candidate Ca2+ sensor for mast cell exocytosis, enhanced SNARE-mediated membrane fusion via Ca2+ and phosphatidylserine. Phosphatidylinositol 4,5-bisphosphate (PIP2) is an acidic phospholipid like phosphatidylserine. In the present study, we investigated whether PIP2 is involved in the enhancement effect of synaptotagmin 2 on SNARE-mediated membrane fusion. PIP2 did not show any significant effect on SNARE-mediated membrane fusion by itself. In the presence of Ca2+, synaptotagmin 2 enhanced SNARE-mediated membrane fusion between liposomes containing PIP2. However, even in the presence of Ca2+, when we used 100% PC liposomes, synaptotagmin 2 did not show any significant effect on SNARE-mediated membrane fusion. These results indicated that PIP2 is involved in the enhancement effect of synaptotagmin 2 on membrane fusion between liposomes containing mast cell SNARE proteins. (C) 2015 Elsevier B.V. All rights reserved.	[Tadokoro, Satoshi; Hirashima, Naohide] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Inoh, Yoshikazu; Nakanishi, Mamoru] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Hirashima, N (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	hirashim@phar.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23770181, 25840051, 26460041]	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant 23770181 and 25840051 to S.T. and grant 26460041 to N.H.).	James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Paumet F, 2000, J IMMUNOL, V164, P5850; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Lippert U, 2007, FEBS LETT, V581, P3479, DOI 10.1016/j.febslet.2007.06.057; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Tadokoro S, 2005, J CELL SCI, V118, P2239, DOI 10.1242/jcs.02338; Nagai Y, 2011, BBA-BIOMEMBRANES, V1808, P2435, DOI 10.1016/j.bbamem.2011.07.003; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; Tadokoro S, 2007, MOL IMMUNOL, V44, P3427, DOI 10.1016/j.molimm.2007.02.013; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Benhamou M, 2010, FEBS LETT, V584, P4941, DOI 10.1016/j.febslet.2010.09.023; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; FOREMAN JC, 1972, J PHYSIOL-LONDON, V224, P753; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Sakiyama H, 2009, INFLAMM RES, V58, P139, DOI 10.1007/s00011-008-7173-z; FOREMAN JC, 1977, J PHYSIOL-LONDON, V271, P233; Kishimoto T, 2001, J PHYSIOL-LONDON, V533, P627, DOI 10.1111/j.1469-7793.2001.t01-1-00627.x; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Haberman Y, 2003, J CELL SCI, V116, P4307, DOI 10.1242/jcs.00719; Holgate ST, 1999, NATURE, V402, pB2; Tadokoro S, 2010, CELL IMMUNOL, V261, P51, DOI 10.1016/j.cellimm.2009.10.011; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	OCT	2015	1848	10	A				2290	2294		10.1016/j.bbamem.2015.06.016		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS5YE	WOS:000362153400038		
J	Ikari, A; Taga, S; Watanabe, R; Sato, T; Shimobaba, S; Sonoki, H; Endo, S; Matsunaga, T; Sakai, H; Yamaguchi, M; Yamazaki, Y; Sugatani, J				Ikari, Akira; Taga, Saeko; Watanabe, Ryo; Sato, Tomonari; Shimobaba, Shun; Sonoki, Hiroyuki; Endo, Satoshi; Matsunaga, Toshiyuki; Sakai, Hideki; Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Sugatani, Junko			Clathrin-dependent endocytosis of claudin-2 by DFYSP peptide causes lysosomal damage in lung adenocarcinoma A549 cells	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Adenocarcinoma; Claudin-2; Lung; Lysosomal damage	CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; EPITHELIAL-CELLS; TIGHT JUNCTIONS; CANCER-CELLS; EXPRESSION; PERMEABILITY; APOPTOSIS; PROMOTES; PATHWAY; PROTEIN	Claudins are tight junctional proteins and comprise a family of over 20 members. Abnormal expression of claudins is reported to be involved in tumor progression. Claudin-2 is highly expressed in lung adenocarcinoma tissues and increases cell proliferation, whereas it is not expressed in normal tissues. Claudin-2-targeting molecules such as peptides and small molecules may be novel anti-cancer drugs. The short peptide with the sequence DFYSP, which mimics the second extracellular loop of claudin-2, decreased claudin-2 content in the cytoplasmic fraction of A549 cells. In contrast, it did not affect the content in the nuclear fraction. The decrease in claudin-2 content was inhibited by chloroquine (CQ), a lysosomal inhibitor, but not by MG-132, a proteasome inhibitor. In the presence of DFYSP peptide and CQ claudin-2 was co-localized with LAMP-I, a lysosomal marker. The DFYSP peptide-induced decrease in claudin-2 content was inhibited by monodancylcadaverine (MDC), an inhibitor of clathrin-dependent endocytosis. DFYSP peptide increased lysosome content and cathepsin B release, and induced cellular injury, which were inhibited by MDC. Cellular injury induced by DFYSP peptide was inhibited by necrostatin-1, an inhibitor of necrotic cell death, but not by Z-VAD-FMK, an inhibitor of apoptotic cell death. Our data indicate that DFYSP peptide increases the accumulation of the peptide and claudin-2 into the lysosome, resulting in lysosomal damage. Claudin-2 may be a new target for lung cancer therapy. (c) 2015 Elsevier B.V. All rights reserved.	[Ikari, Akira; Taga, Saeko; Shimobaba, Shun; Sonoki, Hiroyuki; Endo, Satoshi; Matsunaga, Toshiyuki] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, Gifu 5011196, Japan; [Watanabe, Ryo; Sato, Tomonari; Sakai, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Yamaguchi, Masahiko; Yamazaki, Yasuhiro; Sugatani, Junko] Univ Shizuoka, Shizuoka 4228526, Japan	Ikari, A (reprint author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp			JSPS KAKENHI [15H04657, 25293047]; Takeda Science Foundation; Nakatomi Foundation; Ichiro Kanehara Foundation; Sagawa Foundation for Promotion of Cancer Research	This work was supported in part by JSPS KAKENHI Grant Number 15H04657 (A.I.) and 25293047 (H.S. and A.I.), and grants from the Takeda Science Foundation, the Nakatomi Foundation, the Ichiro Kanehara Foundation, and the Sagawa Foundation for Promotion of Cancer Research (A.I.).	Baumgartner HK, 2011, CHEM BIOL DRUG DES, V77, P124, DOI 10.1111/j.1747-0285.2010.01061.x; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Ikari A, 2006, J CELL SCI, V119, P1781, DOI 10.1242/jcs.02901; Aung PP, 2006, VIRCHOWS ARCH, V448, P428, DOI 10.1007/s00428-005-0120-2; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Dabrowski S, 2015, ANTIOXID REDOX SIGN, V22, P1, DOI 10.1089/ars.2013.5706; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Ikari A, 2011, LIFE SCI, V88, P628, DOI 10.1016/j.lfs.2011.02.002; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Turksen K, 2004, J CELL SCI, V117, P2435, DOI 10.1242/jcs.01235; Tabaries S, 2012, MOL CELL BIOL, V32, P2979, DOI 10.1128/MCB.00299-12; Lu RF, 2014, MOL BIOL CELL, V25, P1744, DOI 10.1091/mbc.E13-12-0724; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Cong X, 2015, J CELL SCI, V128, P2271, DOI 10.1242/jcs.165878; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Tian RL, 2010, INT J CLIN EXP MED, V3, P293; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Mima S, 2008, CARCINOGENESIS, V29, P1994, DOI 10.1093/carcin/bgn134; Li Y, 2011, CANCER RES, V71, P7481, DOI 10.1158/0008-5472.CAN-11-0940; Halasz J, 2006, HUM PATHOL, V37, P555, DOI 10.1016/j.humpath.2005.12.015; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Mandel I, 2012, J CELL BIOCHEM, V113, P2415, DOI 10.1002/jcb.24118; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wong CH, 2007, FASEB J, V21, P438, DOI 10.1096/fj.05-4144com; Ikari A, 2012, BBA-MOL CELL RES, V1823, P1110, DOI 10.1016/j.bbamcr.2012.04.005; Zwanziger D, 2012, ANN NY ACAD SCI, V1257, P29, DOI 10.1111/j.1749-6632.2012.06567.x; Beeman NE, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-85; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195; Daugherty BL, 2004, AM J PHYSIOL-LUNG C, V287, pL1266, DOI 10.1152/ajplung.00423.2003; Ding Lei, 2013, Cancer Manag Res, V5, P367, DOI 10.2147/CMAR.S38294; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	OCT	2015	1848	10	A				2326	2336		10.1016/j.bbamem.2015.07.003		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS5YE	WOS:000362153400042		
J	van Waarde, A; Rybczynska, AA; Ramakrishnan, NK; Ishiwata, K; Elsinga, PH; Dierckx, RAJO				van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Ishiwata, Kiichi; Elsinga, Philip H.; Dierckx, Rudi A. J. O.			Potential applications for sigma receptor ligands in cancer diagnosis and therapy	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Review						Antitumor agents; Chemotherapy; Drug targeting; Positron emission tomography; Sigma-1 receptor; Sigma-2 receptor	MEMBRANE COMPONENT 1; PROGESTERONE-BINDING SITE(S); TUMOR-CELL DEATH; IN-VITRO; PHARMACOLOGICAL EVALUATION; BIOLOGICAL EVALUATION; POTASSIUM CHANNELS; STEALTH LIPOSOMES; SYSTEMIC DELIVERY; SIRNA DELIVERY	Sigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their endogenous ligands may include the hallucinogen N,N-dimethyltryptamine (DMT) and sphingolipid-derived amines which interact with sigma-1 receptors, besides steroid hormones (e.g., progesterone) which bind to both sigma receptor sub-populations. The sigma-1 receptor is a ligand-regulated molecular chaperone with various ion channels and G-protein-coupled membrane receptors as clients. The sigma-2 receptor was identified as the progesterone receptor membrane component 1 (PGRMC1). Although sigma receptors are over-expressed in tumors and up-regulated in rapidly dividing normal tissue, their ligands induce significant cell death only in tumor tissue. Sigma ligands may therefore be used to selectively eradicate tumors. Multiple mechanisms appear to underlie cell killing after administration of sigma ligands, and the signaling pathways are dependent both on the type of ligand and the type of tumor cell. Recent evidence suggests that the sigma-2 receptor is a potential tumor and serum biomarker for humaniung cancer and an important target for inhibiting tumor invasion and cancer progression. Current radiochemical efforts are focused on the development of subtype-selective radioligands for positron emission tomography (PET) imaging. Right now, the mostpromising tracers are [F-18]fluspidine and [F-18]FTC-146 for sigma-1 receptors and [C-11]RHM-1 and [F-18]ISO-1 for the sigma-2 subtype. Nanoparticles coupled to sigma ligands have shown considerable potential for targeted delivery of antitumor drugs in animal models of cancer, but clinical studies exploring this strategy in cancer patients have not yet been reported. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers. (C) 2014 Elsevier B.V. All rights reserved.	[van Waarde, Aren; Rybczynska, Anna A.; Ramakrishnan, Nisha K.; Elsinga, Philip H.; Dierckx, Rudi A. J. O.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9713 GZ Groningen, Netherlands; [Ishiwata, Kiichi] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Tokyo 1730015, Japan; [Dierckx, Rudi A. J. O.] Univ Ghent, Univ Hosp, B-9000 Ghent, Belgium	van Waarde, A (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	a.van.waarde@umcg.nl			Ubbo Emmius Bursary Position	During their PhD research on sigma receptors, AAR and NKR were supported by University funding (Ubbo Emmius Bursary Position).	Mach RH, 2013, J MED CHEM, V56, P7137, DOI 10.1021/jm301545c; Huang YS, 2014, MED RES REV, V34, P532, DOI 10.1002/med.21297; Zeng C, 2013, BRIT J CANCER, V109, P2368, DOI 10.1038/bjc.2013.593; Kim FJ, 2012, BIOCHEM BIOPH RES CO, V426, P177, DOI 10.1016/j.bbrc.2012.08.052; Do W, 2013, BIOCHEM BIOPH RES CO, V439, P215, DOI 10.1016/j.bbrc.2013.08.057; Meyer C, 1998, EUR J PHARMACOL, V347, P293, DOI 10.1016/S0014-2999(98)00103-4; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Niso M, 2013, CHEMMEDCHEM, V8, P2026, DOI 10.1002/cmdc.201300291; Berardi F, 2001, BIOORGAN MED CHEM, V9, P1325, DOI 10.1016/S0968-0896(01)00011-6; Kim SK, 2012, J CONTROL RELEASE, V157, P279, DOI 10.1016/j.jconrel.2011.08.014; Wang W, 2011, SCI CHINA CHEM, V54, P1, DOI 10.1007/s11426-010-4212-8; Rybczynska AA, 2013, J NUCL MED, V54, P1613, DOI 10.2967/jnumed.113.122655; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Ogawa K, 2013, NUCL MED BIOL, V40, P445, DOI 10.1016/j.nucmedbio.2013.02.008; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Azzariti A, 2011, EUR J PHARMACOL, V670, P74, DOI 10.1016/j.ejphar.2011.08.025; Johannessen M, 2009, AM J PHYSIOL-CELL PH, V296, pC1049, DOI 10.1152/ajpcell.00431.2008; Brimson JM, 2011, BRIT J PHARMACOL, V164, P772, DOI 10.1111/j.1476-5381.2011.01417.x; Piergentili A, 2010, J MED CHEM, V53, P1261, DOI 10.1021/jm901542q; Peluso JJ, 2012, ENDOCRINOLOGY, V153, P3929, DOI 10.1210/en.2011-2096; Yarim M, 2011, CHEM BIOL DRUG DES, V78, P869, DOI 10.1111/j.1747-0285.2011.01215.x; Ramakrishnan NK, 2013, J NUCL MED, V54, P1377, DOI 10.2967/jnumed.112.115931; Chevallier N, 2011, J PSYCHOPHARMACOL, V25, P960, DOI 10.1177/0269881111400648; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Maisonial A, 2012, BIOORGAN MED CHEM, V20, P257, DOI 10.1016/j.bmc.2011.11.002; Tu ZD, 2010, APPL RADIAT ISOTOPES, V68, P2268, DOI 10.1016/j.apradiso.2010.06.004; Riganas S, 2012, J MED CHEM, V55, P10241, DOI 10.1021/jm3013008; Pal K, 2011, J MED CHEM, V54, P2378, DOI 10.1021/jm101530j; Johannessen M, 2011, AM J PHYSIOL-CELL PH, V300, pC328, DOI 10.1152/ajpcell.00383.2010; Colabufo Nicola Antonio, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P161; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Zeng C, 2012, BRIT J CANCER, V106, P693, DOI 10.1038/bjc.2011.602; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Marrazzo A, 2011, EUR J MED CHEM, V46, P433, DOI 10.1016/j.ejmech.2010.10.012; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Ha YJ, 2011, INVEST OPHTH VIS SCI, V52, P7749, DOI 10.1167/iovs.11-8169; Dehdashti F, 2013, J NUCL MED, V54, P350, DOI 10.2967/jnumed.112.111948; Chen YC, 2010, J INVEST DERMATOL, V130, P2790, DOI 10.1038/jid.2010.222; Li J, 2012, J CONTROL RELEASE, V158, P108, DOI 10.1016/j.jconrel.2011.10.020; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Gerdes D, 1998, BIOL CHEM, V379, P907; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P4993, DOI 10.1167/iovs.08-1867; Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585; HELLEWELL SB, 1994, EUR J PHARM-MOLEC PH, V268, P9, DOI 10.1016/0922-4106(94)90115-5; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Guo JF, 2012, BIOMATERIALS, V33, P7775, DOI 10.1016/j.biomaterials.2012.07.012; James ML, 2014, J NUCL MED, V55, P147, DOI 10.2967/jnumed.113.120261; Abate C, 2011, J MED CHEM, V54, P1022, DOI 10.1021/jm1013133; Zhang HL, 2005, J PHARMACOL EXP THER, V313, P1387, DOI 10.1124/jpet.105.084152; Jonhede S, 2010, MOL VIS, V16, P819; Chu UB, 2014, BIOCHEMISTRY-US, V53, P2956, DOI 10.1021/bi500175p; Frecska E, 2013, J NEURAL TRANSM, V120, P1295, DOI 10.1007/s00702-013-1024-y; Weber F, 2014, J MED CHEM, V57, P2884, DOI 10.1021/jm401707t; Li SD, 2006, MOL PHARMACEUT, V3, P579, DOI 10.1021/mp060039w; Crottes D, 2011, J BIOL CHEM, V286, P27947, DOI 10.1074/jbc.M111.226738; Chen X, 2012, BIOORG MED CHEM LETT, V22, P6352, DOI 10.1016/j.bmcl.2012.08.083; Brune S, 2012, ASSAY DRUG DEV TECHN, V10, P365, DOI 10.1089/adt.2011.0376; Xu QX, 2012, J HISTOCHEM CYTOCHEM, V60, P457, DOI 10.1369/0022155412443542; Mir SUR, 2012, J BIOL CHEM, V287, P14494, DOI 10.1074/jbc.M111.324921; Moreno E, 2014, J NEUROSCI, V34, P3545, DOI 10.1523/JNEUROSCI.4147-13.2014; Spirkoski J, 2012, BIOCHEM PHARMACOL, V84, P1671, DOI 10.1016/j.bcp.2012.09.028; Wang X, 2013, BIOORGAN MED CHEM, V21, P215, DOI 10.1016/j.bmc.2012.10.038; Schrock JM, 2013, MOL PHARMACOL, V84, P751, DOI 10.1124/mol.113.087809; Hajipour AR, 2010, BIOORGAN MED CHEM, V18, P4397, DOI 10.1016/j.bmc.2010.04.078; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Aydar E, 2004, CANCER RES, V64, P5029, DOI 10.1158/0008-5472.CAN-03-2329; Zhang YF, 2012, INT J NANOMED, V7, P4473, DOI 10.2147/IJN.S31981; Cozzi NV, 2009, J NEURAL TRANSM, V116, P1591, DOI 10.1007/s00702-009-0308-8; Banerjee R, 2004, INT J CANCER, V112, P693, DOI 10.1002/ijc.20452; James ML, 2012, J MED CHEM, V55, P8272, DOI 10.1021/jm300371c; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; Yang Y, 2012, MOL THER, V20, P609, DOI 10.1038/mt.2011.270; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; Nakagawa O, 2010, J AM CHEM SOC, V132, P8848, DOI 10.1021/ja102635c; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Korpis K, 2014, BIOORGAN MED CHEM, V22, P221, DOI 10.1016/j.bmc.2013.11.033; Vitale AA, 2011, J NUCL MED, V52, P970, DOI 10.2967/jnumed.110.083246; Mir SUR, 2013, AUTOPHAGY, V9, P1566, DOI 10.4161/auto.25889; Yang Y, 2012, MOL PHARMACEUT, V9, P2280, DOI 10.1021/mp300152v; Ha YJ, 2012, MOL VIS, V18, P2860; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Mavlyutov TA, 2011, MOL VIS, V17, P1034; Holl K, 2013, CHEMMEDCHEM, V8, P2047, DOI 10.1002/cmdc.201300322; Li SD, 2008, MOL THER, V16, P942, DOI 10.1038/mt.2008.51; Abate C, 2011, CHEMMEDCHEM, V6, P73, DOI 10.1002/cmdc.201000371; Abate C, 2011, EUR J MED CHEM, V46, P4733, DOI 10.1016/j.ejmech.2011.05.057; van Waarde A, 2010, CURR PHARM DESIGN, V16, P3519, DOI 10.2174/138161210793563365; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Sun TM, 2014, ADV HEALTHC MATER, V3, P1283, DOI 10.1002/adhm.201400026; Balasuriya D, 2013, J NEUROSCI, V33, P18219, DOI 10.1523/JNEUROSCI.3360-13.2013; Colabufo NA, 2004, N-S ARCH PHARMACOL, V370, P106, DOI 10.1007/s00210-004-0961-2; Mavlyutov TA, 2012, NEUROSCIENCE, V206, P60, DOI 10.1016/j.neuroscience.2011.12.040; Falkenstein E, 1996, BIOCHEM BIOPH RES CO, V229, P86, DOI 10.1006/bbrc.1996.1761; Mukherjee A, 2005, J BIOL CHEM, V280, P15619, DOI 10.1074/jbc.M409723200; Schepmann D, 2011, J PHARMACEUT BIOMED, V55, P1136, DOI 10.1016/j.jpba.2011.03.044; Sunnam SK, 2010, ORG BIOMOL CHEM, V8, P5525, DOI 10.1039/c0ob00402b; Abate C, 2013, EUR J MED CHEM, V69, P920, DOI 10.1016/j.ejmech.2013.09.018; Fischer S, 2011, EUR J NUCL MED MOL I, V38, P540, DOI 10.1007/s00259-010-1658-z; Abate C, 2010, CHEMMEDCHEM, V5, P268, DOI 10.1002/cmdc.200900402; Renaudo A, 2004, J PHARMACOL EXP THER, V311, P1105, DOI 10.1124/jpet.104.072413; Toyohara J, 2012, NUCL MED BIOL, V39, P1049, DOI 10.1016/j.nucmedbio.2012.03.002; Tsai SY, 2012, SYNAPSE, V66, P42, DOI 10.1002/syn.20984; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Cesen MH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.361; Crottes D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00175; de Bruyn M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-301; Garg G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-50; Haller J.L, 2011, MOL IMAGING BIOL, V14, P325; Homick J.R., 2012, SURGERY, V152, pS152; Hornick JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-298; Hornick JR, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-41; Megalizzi V., 2010, MED RES REV, V32, P410; Mir S.U., 2011, INT J CANCER, V131, pE1; Navarro G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061245; Nguyen VH, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-80; Ogawa K, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-54; Pabba M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00050; Shoghi KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074188; Spitzer D., 2011, CANCER RES, V72, P201; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Zeng C, 2013, ANAL BIOCH C, V448C, P68	122	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	OCT	2015	1848	10	B		SI		2703	2714		10.1016/j.bbamem.2014.08.022		12	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS5YH	WOS:000362153700020		
J	Zhao, YM; Ogawa, H; Yonekura, SI; Mitsuhashi, H; Mitsuhashi, S; Nishino, I; Toyoshima, C; Ishiura, S				Zhao, Yimeng; Ogawa, Haruo; Yonekura, Shin-Ichiro; Mitsuhashi, Hiroaki; Mitsuhashi, Satomi; Nishino, Ichizo; Toyoshima, Chikashi; Ishiura, Shoichi			Functional analysis of SERCA1b, a highly expressed SERCA1 variant in myotonic dystrophy type 1 muscle	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						SERCA1a; SERCA1b; Myotonic dystrophy; P-type ATPase; Alternative splicing	RETICULUM CA2+ ATPASE; SARCOPLASMIC-RETICULUM; BINDING PROTEIN; STEADY-STATE; CA2+-ATPASE; CELLS; PUMP; HOMEOSTASIS; TRANSPORT; MUTATION	Myotonic dystrophy type 1 (DM1) is a genetic disorder in which multiple genes are aberrantly spliced. Sarco/endoplasmic reticulum Ca2+-ATPase 1 (SERCA1) is one of these genes, and it encodes a P-type ATPase. SERCA1 transports Ca2+ from the cytosol to the lumen, and is involved in muscular relaxation. It has two splice variants (SERCA1a and SERCA1b) that differ in the last eight amino adds, and the contribution of these variants to DM1 pathology is unclear. Here, we show that SERCA1b protein is highly expressed in DM1 muscle tissue, mainly localised at fast twitch fibres. Additionally, when SERCA1a and SERCA1b were overexpressed in cells, we found that the ATPase and Ca2+ uptake activity of SERCA1a was almost double that of SERCA1b. Although the affinity for both ATP and Ca2+ was similar between the two variants, SERCA1b was more sensitive to the inner microsomal environment. Thus, we hypothesise that aberrant expression of SERCA1b in DM1 patients is the cause of abnormal intracellular Ca2+ homeostasis. (C) 2015 Elsevier B.V. All rights reserved.	[Zhao, Yimeng; Mitsuhashi, Hiroaki; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Ogawa, Haruo; Yonekura, Shin-Ichiro; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Mitsuhashi, Satomi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878551, Japan	Ishiura, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cishiura@mail.eccu-tokyo.ac.jp			JSPS [13J08957]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [26-8]; Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare (MHLW) [H26-Sinkeikinn-ippan-004]; MHLW of Japan	We would like to thank Dr. Yukiko Hayashi for providing DM patients' biopsies. We also thank Dr. Yoshiki Kabashima for valuable discussions. This work was supported by JSPS Grant-in-Aid for JSPS Fellows, grant no. 13J08957. This work was also supported in part by an Intramural Research Grant (26-8) for Neurological and Psychiatric Disorders of NCNP, a research grant for Comprehensive Research on Disability Health and Welfare from the Ministry of Health, Labour and Welfare (MHLW; H26-Sinkeikinn-ippan-004) and a Grant-in-Aid from the MHLW of Japan (to S.l.).	Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Sharov VS, 2006, BIOCHEM J, V394, P605, DOI 10.1042/BJ20051214; Wootton LL, 2006, J BIOL CHEM, V281, P6970, DOI 10.1074/jbc.M510978200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Koebis M, 2011, GENES CELLS, V16, P961, DOI 10.1111/j.1365-2443.2011.01542.x; Zador E, 2007, CELL CALCIUM, V41, P379, DOI 10.1016/j.ceca.2006.08.001; Kino Y, 2009, NUCLEIC ACIDS RES, V37, P6477, DOI 10.1093/nar/gkp681; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Zhao YM, 2012, BIOCHEM BIOPH RES CO, V423, P212, DOI 10.1016/j.bbrc.2012.05.033; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Ji Y, 1999, AM J PHYSIOL-HEART C, V276, pH89; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Santoro M, 2014, NEUROPATH APPL NEURO, V40, P464, DOI 10.1111/nan.12076; Botta A, 2013, GENES-BASEL, V4, P275, DOI 10.3390/genes4020275; Dode L, 2002, J BIOL CHEM, V277, P45579, DOI 10.1074/jbc.M207778200; JACOBS AEM, 1990, BIOCHIM BIOPHYS ACTA, V1096, P14, DOI 10.1016/0925-4439(90)90006-B	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	OCT	2015	1852	10	A				2042	2047		10.1016/j.bbadis.2015.07.006		6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CS2TK	WOS:000361924700004		
J	Shiba, N; Miyazaki, D; Yoshizawa, T; Fukushima, K; Shiba, Y; Inaba, Y; Imamura, M; Takeda, S; Koike, K; Nakamura, A				Shiba, Naoko; Miyazaki, Daigo; Yoshizawa, Takahiro; Fukushima, Kazuhiro; Shiba, Yuji; Inaba, Yuji; Imamura, Michihiro; Takeda, Shin'ichi; Koike, Kenichi; Nakamura, Akinori			Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Dystrophin; Fibrosis; MMP-9; MIP-2; MCP-1; Osteopontin	REGENERATING SKELETAL-MUSCLE; DEFICIENT MDX MICE; MATRIX METALLOPROTEINASES; BETA-DYSTROGLYCAN; ALTERED INFLAMMATION; EXTRACELLULAR-MATRIX; TGF-BETA; IN-VITRO; OSTEOPONTIN; MATRIX-METALLOPROTEINASE-9	Matrix metalloprotease (MMP)-9 is an endopeptidase associated with the pathogenesis of Duchenne muscular dystrophy (DMD). The precise function of MMP-9 in DMD has not been elucidated to date. We investigated the effect of genetic ablation of MMP-9 in the mdx mouse model (mdx/Mmp9(-/-)). At the early disease stage, the muscles of mdx/Mmp9(-/-) mice showed reduced necrosis and neutrophil invasion, accompanied by downregulation of chemokine MIP-2. In addition, muscle regeneration was enhanced, which coincided with increased macrophage infiltration and upregulation of MCP-1, and resulted in increased muscle strength. The mdx/Mmp9(-/-) mice also displayed accelerated upregulation of osteopontin expression in skeletal muscle at the acute onset phase of dystrophy. However, at a later disease stage, the mice exhibited muscle growth impairment through altered expression of myogenic factors, and increased fibroadipose tissue. These results showed that MMP-9 might have multiple functions during disease progression. Therapy targeting MMP-9 may improve muscle pathology and function at the early disease stage, but continuous inhibition of this protein may result in the accumulation of fibroadipose tissues and reduced muscle strength at the late disease stage. (C) 2015 Elsevier B.V. All rights reserved.	[Shiba, Naoko; Inaba, Yuji; Koike, Kenichi] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano 3908621, Japan; [Miyazaki, Daigo] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 3908621, Japan; [Yoshizawa, Takahiro] Shinshu Univ, Res Ctr Human & Environm Sci, Div Lab Anim Res, Matsumoto, Nagano 3908621, Japan; [Fukushima, Kazuhiro; Nakamura, Akinori] Shinshu Univ Hosp, Intractable Dis Care Ctr, Matsumoto, Nagano 3908621, Japan; [Shiba, Yuji] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Imamura, Michihiro; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878561, Japan	Nakamura, A (reprint author), Shinshu Univ Hosp, Intractable Dis Care Ctr, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	anakamu@shinshu-u.ac.jp			JSPS KAKENHI [21300157, 26860792]	This research was supported by JSPS KAKENHI (21300157 to AN and 26860792 to NS).	Miyazaki D, 2011, HUM MOL GENET, V20, P1787, DOI 10.1093/hmg/ddr062; Yu Q, 2000, GENE DEV, V14, P163; Mehan RS, 2011, CELLS TISSUES ORGANS, V194, P510, DOI 10.1159/000323654; Van den Steen PE, 2000, BLOOD, V96, P2673; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Tomasek JJ, 1997, J BIOL CHEM, V272, P7482; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; Christoffersson G, 2012, BLOOD, V120, P4653, DOI 10.1182/blood-2012-04-421040; Uaesoontrachoon K, 2013, DIS MODEL MECH, V6, P197, DOI 10.1242/dmm.009993; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Dahiya S, 2011, HUM MOL GENET, V20, P4345, DOI 10.1093/hmg/ddr362; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Zanotti S, 2011, HISTOPATHOLOGY, V59, P1215, DOI 10.1111/j.1365-2559.2011.04051.x; Dahiya S, 2011, J IMMUNOL, V187, P2723, DOI 10.4049/jimmunol.1101342; Kumar A, 2010, AM J PATHOL, V177, P248, DOI 10.2353/ajpath.2010.091176; Romanic AM, 2002, CARDIOVASC RES, V54, P549, DOI 10.1016/S0008-6363(02)00254-7; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-54; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; De Paiva CS, 2006, EXP EYE RES, V83, P526, DOI 10.1016/j.exer.2006.02.004; Massova I, 1998, FASEB J, V12, P1075; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Alameddine HS, 2012, NEUROBIOL DIS, V48, P508, DOI 10.1016/j.nbd.2012.07.023; Carlson CG, 2010, J NEUROSCI METH, V186, P226, DOI 10.1016/j.jneumeth.2009.11.006; Matsumura K, 2005, NEUROMUSCULAR DISORD, V15, P336, DOI 10.1016/j.nmd.2005.01.007; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Amalfitano A, 1996, MUSCLE NERVE, V19, P1549, DOI 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Hoffman EP, 2013, MED SCI SPORT EXER, V45, P1060, DOI 10.1249/MSS.0b013e31828093c1; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Yamada H, 2001, HUM MOL GENET, V10, P1563, DOI 10.1093/hmg/10.15.1563; Nakamura A, 2005, BBA-MOL BASIS DIS, V1740, P326, DOI 10.1016/j.bbadis.2004.12.003; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; Massa R, 1997, BASIC APPL MYOL, V7, P387; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Peterson JM, 2009, J APPL PHYSIOL, V106, P130, DOI 10.1152/japplphysiol.90584.2008; Nguyen HX, 2005, J PHYSIOL-LONDON, V565, P403, DOI 10.1113/jphysiol.2005.085506; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Nico B, 2009, NEUROSCIENCE, V161, P1057, DOI 10.1016/j.neuroscience.2009.04.028; Zhong D, 2006, BIOCHEM BIOPH RES CO, V345, P867, DOI 10.1016/j.bbrc.2006.05.004; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Toumi H, 2003, BRIT J SPORT MED, V37, P284, DOI 10.1136/bjsm.37.4.284; Pagel CN, 2014, J CELL COMMUN SIGNAL, V8, P95, DOI 10.1007/s12079-013-0217-3; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Hindi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072121; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Myśliwiec Janusz, 2007, Endokrynol Pol, V58, P105; Nakamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02183; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356	66	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	OCT	2015	1852	10	A				2170	2182		10.1016/j.bbadis.2015.07.008		13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CS2TK	WOS:000361924700017		
J	Nishioka, T; Shohag, MH; Amano, M; Kaibuchi, K				Nishioka, Tomoki; Shohag, Md. Hasanuzzaman; Amano, Mutsuki; Kaibuchi, Kozo			Developing novel methods to search for substrates of protein kinases such as Rho-kinase	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Review						Protein phosphorylation; Protein kinase; Mass spectrometry	MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; PHOSPHORYLATION; PHOSPHOPROTEOMICS; REVEALS; IDENTIFICATION; CHROMATOGRAPHY; SPECIFICITY; INHIBITORS; DYNAMICS	Protein phosphoiylation is a major and essential post-translational modification in eukaryotic cells that plays a critical role in various cellular processes. Recent progresses in mass spectrometry techniques have enabled the effective identification and analysis of protein phosphorylation. Mass spectrometry-based approaches in investigating protein phosphorylation are very powerful and informative and can further improve our understanding of protein phosphorylation as a whole, but they cannot determine the upstream kinases involved. We introduce several studies that attempted to uncover the relationships between various kinases of interest and substrates, including two methods we developed: an in vitro approach termed the kinase-interacting substrate screening (KISS) method and an in vivo approach termed the phosphatase inhibitor and kinase inhibitor substrate screening (PIKISS) method. This article is part of a Special Issue entitled: Inhibitors of Protein Kinases. (C) 2015 Elsevier B.V. All rights reserved.	[Nishioka, Tomoki; Shohag, Md. Hasanuzzaman; Amano, Mutsuki; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, Nagoya, Aichi 4668550, Japan	Kaibuchi, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	kaibuchi@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology ofJapan [25251021]	This research was supported in part by Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology ofJapan (25251021). A portion of this study is the result of "Bioinformatics for Brain Sciences" conducted under the Strategic Research Program for Brain Sciences, and Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) by MEXT.	Amano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008704; Kettenbach AN, 2012, CHEM BIOL, V19, P608, DOI 10.1016/j.chembiol.2012.04.011; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Xue L, 2013, MOL CELL PROTEOMICS, V12, P2969, DOI 10.1074/mcp.O113.027722; Trost M, 2010, MASS SPECTROM REV, V29, P962, DOI 10.1002/mas.20297; Imamura H, 2014, J PROTEOME RES, V13, P3410, DOI 10.1021/pr500319y; Bian YY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03460; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Salazar C, 2006, ANN NY ACAD SCI, V1091, P517, DOI 10.1196/annals.1378.093; Wang CL, 2013, J PROTEOME RES, V12, P3813, DOI 10.1021/pr4002965; Silva AMN, 2013, FREE RADICAL BIO MED, V65, P925, DOI 10.1016/j.freeradbiomed.2013.08.184; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Hennrich ML, 2013, J PROTEOME RES, V12, P2214, DOI 10.1021/pr400074f; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Cohen P, 2006, BIOCHEM J, V393, P1, DOI 10.1042/BJ20051545; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Nishioka T, 2012, CELL STRUCT FUNCT, V37, P39; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; Huang SY, 2007, J PROTEOME RES, V6, P2674, DOI 10.1021/pr070134c; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; Croft D., 2014, NUCLEIC ACIDS RES, V42, P472, DOI DOI 10.1093/NAR/GICT1102; Franceschini A., 2013, NUCLEIC ACIDS RES, V41, pD 808, DOI DOI 10.1093/NAR/GKS1094; Hamaguchi T., 2014, CELL STRUCT FUNCT; Iesmantavicius V, 2014, MOL CELL PROTEOMICS, V13, P1979, DOI 10.1074/mcp.O113.035683; Kanehisa M., 2014, NUCLEIC ACIDS RES, V42, P199, DOI DOI 10.1093/NAR/GKT1076; Knight JDR, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-5; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Yang C., 2014, ELECTROPHORESIS, P1	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	OCT	2015	1854	10	B				1663	1666		10.1016/j.bbapap.2015.03.001		4	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CS8AK	WOS:000362307900014		
J	Jiang, JJ; Li, LY; Xie, MC; Fuji, R; Liu, SF; Yin, XB; Li, GL; Wang, Z				Jiang, Junjun; Li, Liyuan; Xie, Mingchao; Fuji, Ryosuke; Liu, Shangfeng; Yin, Xiaobei; Li, Genlin; Wang, Zhao			SPATA4 Counteracts Etoposide-Induced Apoptosis via Modulating Bcl-2 Family Proteins in He La Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						spermatogenesis associated 4 (SPATA4); apoptosis; Bcl-2 family; etoposide	CYTOCHROME-C RELEASE; MOLECULAR-CLONING; CANDIDATE ONCOGENE; DEATH; MITOCHONDRIA; GENE; BAX; CRYPTORCHIDISM; PERMEABILITY; ACTIVATION	Spermatogenesis associated 4 (SPATA4) is a testis-specific gene first cloned by our laboratory, and plays an important role in maintaining the physiological function of germ cells. Accumulated evidence suggests that SPATA4 might be associated with apoptosis. Here we established HeLa cells that stably expressed SPATA4 to investigate the function of SPATA4 in apoptosis. SPATA4 protected HeLa cells from etoposide-induced apoptosis through the mitochondrial apoptotie pathway, in the way that SPATA4 suppressed decrease of the mitochondrial membrane potential, the release of cytochrome c, and subsequent activation of easpase-9 and -3. We further demonstrated that SPATA4 upregulated anti-apoptotic members of Bcl-2 family proteins, Bcl-2, and downregulated the pro-apoptotic member of Bcl-2 family proteins, Bax. Knockdown of SPATA4 in HeLa/SPATA4 cells could partially rescue expression levels of bcl-2 and bax. In conclusion, SPATA4 protects HeLa cells against etoposide-induced apoptosis through the mitochondrial apoptotic pathway. Our findings provide further evidence that SPATA4 plays a role in regulating apoptosis.	[Jiang, Junjun; Li, Liyuan; Xie, Mingchao; Fuji, Ryosuke; Liu, Shangfeng; Wang, Zhao] Tsinghua Univ, Sch Med, Dept Pharmacol, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Fuji, Ryosuke] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Bioengn, Tokyo 2268051, Japan; [Yin, Xiaobei; Li, Genlin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing 100730, Peoples R China	Wang, Z (reprint author), Tsinghua Univ, Sch Med, Dept Pharmacol, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn			National Basic Research Program (973 Project) of China [2007CB507406, 2013CB530802]; National Natural Science Foundation of China [81270425]	This work was financially supported by the National Basic Research Program (973 Project) of China (No. 2007CB507406, 2013CB530802) and the National Natural Science Foundation of China (No. 81270425).	Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1073/jbc.M110629200; Liu SF, 2005, J BIOCHEM MOL BIOL, V38, P739; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Robertson JD, 2000, J BIOL CHEM, V275, P32438, DOI 10.1074/jbc.C000518200; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Zhang ZH, 2003, CONTRACEPTION, V68, P297, DOI 10.1016/S0010-7824(03)00176-8; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Petit PX, 1996, FEBS LETT, V396, P7, DOI 10.1016/0014-5793(96)00988-X; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; Liu SF, 2004, BIOCHEM BIOPH RES CO, V319, P32, DOI 10.1016/j.bbrc.2004.04.160; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Tan XJ, 2005, ACTA BIOCH BIOPH SIN, V37, P396, DOI 10.1111/j.1745-7270.2005.00057.x; Liu SF, 2002, ACTA BIOCH BIOPH SIN, V34, P796; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Kaufmann SH, 1998, BBA-GENE STRUCT EXPR, V1400, P195, DOI 10.1016/S0167-4781(98)00136-5; Fulda S, 2010, INT J CELL BIOL, V2010, DOI DOI 10.1155/2010/214074; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132	30	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1458	1463				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200003		
J	Kakizuka, S; Takeda, T; Komiya, Y; Koba, A; Uchi, H; Yamamoto, M; Furue, M; Ishii, Y; Yamada, H				Kakizuka, Saki; Takeda, Tomoki; Komiya, Yukiko; Koba, Akihiko; Uchi, Hiroshi; Yamamoto, Midori; Furue, Masutaka; Ishii, Yuji; Yamada, Hideyuki			Dioxin-Produced Alteration in the Profiles of Fecal and Urinary Metabolomes: A Change in Bile Acids and Its Relevance to Toxicity	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						2,3,7,8-tetrachlorodibenzo-p-dioxin; bile acid; metabolome; aryl hydrocarbon receptor	ARYL-HYDROCARBON RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; RAT-LIVER; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; FEEDBACK-REGULATION; MASS-SPECTROMETRY; EXPRESSION; MICE; EXPOSURE; TRANSPORTER	This study investigated dioxin-induced changes in metabolomes in pubertal rat excrement. The administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or restricting dietary intake (pair-fed group) markedly altered the metabolomic profile including lipids, hormones, and vitamins in the urine and feces. TCDD caused an increase in the fecal chenodeoxycholic acid and taurocholic acid content and in urinary adrenaline and 17 beta-estradiol, while the urinary melatonin level was reduced by TCDD. These changes were not observed in the pair-fed group. In accordance with the elevated level of fecal bile acids, TCDD reduced the intestinal expression of the apical sodium-dependent bile salt transporter, which plays a role in resorbing bile acids from the bile duct. In addition, CYP7A1, a rate-limiting enzyme for bile acid biosynthesis, was attenuated by TCDD treatment, although TCDD induced hepatic CYP8B1, an enzyme essential for cholic acid synthesis. Supplying cholic acid or chenodeoxycholic acid to TCDD-exposed rats tended to restore the TCDD-produced reduction in serum triglycerides, whereas no similar trend was observed in wasting syndrome and lipid accumulation in the liver. These results suggest that: 1) TCDD alters the circulating levels of bile acids and hormones via a mechanism distinct from an attenuation in dietary intake, although the majority of TCDD-induced changes in nutrient contents in the excrement is due to a reduction in food intake; and 2) TCDD facilitates the excretion of bile acids and disrupts their biosynthesis, resulting in the disturbance of lipid homeostasis.	[Kakizuka, Saki; Takeda, Tomoki; Komiya, Yukiko; Koba, Akihiko; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Higashi Ku, Fukuoka 8128582, Japan; [Uchi, Hiroshi; Furue, Masutaka] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Higashi Ku, Fukuoka 8128582, Japan; [Yamamoto, Midori] Coll Healthcare Management, Miyama, Fukuoka 8350018, Japan; [Furue, Masutaka] Kyushu Univ, Res & Clin Ctr Yusho & Dioxin, Higashi Ku, Fukuoka 8128582, Japan	Yamada, H (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hyamada@phar.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24659053]; Ministry of Health, Labour and Welfare of Japan [H24-Designated Research-014]	This work was supported by Grants from the Japan Society for the Promotion of Science [Exploratory Research 24659053], and the Ministry of Health, Labour and Welfare of Japan [Research on Food Safety (H24-Designated Research-014)].	Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; THUNBERG T, 1979, ARCH TOXICOL, V42, P265, DOI 10.1007/BF00334840; GREIG JB, 1973, FOOD COSMET TOXICOL, V11, P585, DOI 10.1016/S0015-6264(73)80329-3; Takeda T, 2014, MOL PHARMACOL, V85, P74, DOI 10.1124/mol.113.088575; Duane WC, 2007, BBA-MOL CELL BIOL L, V1771, P1380, DOI 10.1016/j.bbalip.2007.09.003; Lin SH, 2014, TALANTA, V118, P45, DOI 10.1016/j.talanta.2013.09.019; Diani-Moore S, 2013, J BIOL CHEM, V288, P21514, DOI 10.1074/jbc.M113.458067; HOLT PR, 1972, ARCH INTERN MED, V130, P574, DOI 10.1001/archinte.130.4.574; Lin SH, 2011, MOL BIOSYST, V7, P1956, DOI 10.1039/c1mb05057e; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Harrill JA, 2013, TOXICOL APPL PHARM, V272, P503, DOI 10.1016/j.taap.2013.06.024; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Kakiyama G, 2014, J LIPID RES, V55, P978, DOI 10.1194/jlr.D047506; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Thomas C, 2006, GUT, V55, P1321, DOI 10.1136/gut.2005.085555; Mitro N, 2007, HEPATOLOGY, V46, P885, DOI 10.1002/hep.21819; Forgacs AL, 2012, TOXICOL SCI, V125, P41, DOI 10.1093/toxsci/kfr262; Matsusue K, 1997, TOXICOL LETT, V91, P99, DOI 10.1016/S0378-4274(97)03881-2; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Neimark E, 2004, HEPATOLOGY, V40, P149, DOI 10.1002/hep.20295; Fan F, 1997, TOXICOLOGY, V116, P9, DOI 10.1016/S0300-483X(96)03514-7; Matsusue K, 1999, CHEM RES TOXICOL, V12, P1158, DOI 10.1021/tx990104r; Takeda T, 2012, J BIOL CHEM, V287, P18440, DOI 10.1074/jbc.M111.335158; ALBRO PW, 1978, CHEM-BIOL INTERACT, V23, P315, DOI 10.1016/0009-2797(78)90093-5; Huang M, 2010, RAPID COMMUN MASS SP, V24, P729, DOI 10.1002/rcm.4434; Murata T, 1997, NATURE, V388, P678; Linden J, 2010, FRONT NEUROENDOCRIN, V31, P452, DOI 10.1016/j.yfrne.2010.07.002; Slezak BP, 2000, TOXICOL SCI, V54, P390, DOI 10.1093/toxsci/54.2.390; Alrefai WA, 2005, AM J PHYSIOL-GASTR L, V288, pG978, DOI 10.1152/ajpgi.00379.2004; Berge P, 2011, ENVIRON SCI TECHNOL, V45, P6584, DOI 10.1021/es200747h; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; O'Kane AA, 2013, ENVIRON SCI TECHNOL, V47, P5409, DOI 10.1021/es305345u; Uno S, 2004, TOXICOL APPL PHARM, V196, P410, DOI 10.1016/j.taap.2004.01.014; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; Frueh FW, 2001, TOXICOL LETT, V122, P189, DOI 10.1016/S0378-4274(01)00364-2; Harstad EB, 2006, MOL PHARMACOL, V69, P1534, DOI 10.1124/mol.105.020107; Matsumoto Y, 2010, J TOXICOL SCI, V35, P365; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Lu CF, 2010, TOXICOL APPL PHARM, V248, P178, DOI 10.1016/j.taap.2010.07.020; Lin SH, 2011, TALANTA, V85, P1007, DOI 10.1016/j.talanta.2011.05.007; WILSON JD, 1972, ARCH INTERN MED, V130, P493, DOI 10.1001/archinte.130.4.493; DAWSON AM, 1967, GUT, V8, P1, DOI 10.1136/gut.8.1.1; Fletcher N, 2005, TOXICOL APPL PHARM, V207, P1, DOI 10.1016/j.taap.2004.12.003; BADLEY BWD, 1970, CAN MED ASSOC J, V102, P159; FORDHUTCHINSON AW, 1981, J ROY SOC MED, V74, P831; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Chiang JY, COMPR PHYSL, V3; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gasiewicz TA., 1991, HDB PESTICIDE TOXICO, V3, P1217; HARRIS M W, 1973, Environmental Health Perspectives, V5, P101, DOI 10.2307/3428118; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040322; Little RD, 1949, HISTOPATHOLOGIC TECH, P156; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251	59	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1484	1495				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200007		
J	Yamada, T; Mino, Y; Yagi, T; Naito, T; Kawakami, J				Yamada, Takahiro; Mino, Yasuaki; Yagi, Tatsuya; Naito, Takafumi; Kawakami, Junichi			Saturated Metabolism of Voriconazole N-Oxidation Resulting in Non linearity of Pharmacokinetics of Voriconazole at Clinical Doses	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						voriconazole; metabolite; nonlinear pharmacokinetics; N-oxidation; CYP2C19	HELICOBACTER-PYLORI; INVASIVE ASPERGILLOSIS; CYP2C19 GENOTYPE; ANTIFUNGAL; EFFICACY; SAFETY; ERADICATION; OXIDE	Metabolic saturation of voriconazole based on the trough plasma concentrations of voriconazole and its major metabolite N-oxide were evaluated according to CYP2C19 genotypes in 58 Japanese patients receiving voriconazole (median dose; 200 mg twice daily) for prophylaxis or treatment. Predose trough plasma concentrations of voriconazole and N-oxide were monitored on day 5d or later after initiation of voriconazole treatment. Large interindividual variations in trough plasma concentrations of voriconazole and N-oxide were observed. Dose-normalized trough plasma concentrations of voriconazole were strongly correlated with its absolute trough concentrations, and the straight regression line between them intersected close to the origin of the coordinates. No significant correlation was observed between the trough plasma concentrations of voriconazole and N-oxide. The inverse value of the metabolic ratio of N-oxide to voriconazole was strongly correlated with the absolute trough voriconazole concentrations. No significant differences in the trough plasma concentrations of voriconazole and N-oxide or the metabolic ratio of N-oxide to voriconazole between the CYP2C19 genotypes were observed. Saturated metabolism of voriconazole N-oxidation rather than CYP2C19 genotypes contributed to the nonlinear pharmacokinetics. The metabolic process converting voriconazole to N-oxide was saturated at the clinical dose.	[Yamada, Takahiro; Mino, Yasuaki; Yagi, Tatsuya; Naito, Takafumi; Kawakami, Junichi] Hamamatsu Univ, Sch Med, Dept Hosp Pharm, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Naito, T (reprint author), Hamamatsu Univ, Sch Med, Dept Hosp Pharm, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	naitou@hama-med.ac.jp					Justenhoven C, 2009, BREAST CANCER RES TR, V115, P391, DOI 10.1007/s10549-008-0076-4; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Sugimoto K, 2008, BRIT J CLIN PHARMACO, V65, P437, DOI 10.1111/j.1365-2125.2007.03057.x; Hamada Y, 2012, J INFECT CHEMOTHER, V18, P501, DOI 10.1007/s10156-011-0363-6; Mizutani T, 2003, DRUG METAB REV, V35, P99, DOI 10.1081/DMR-120023681; Mikus G, 2006, CLIN PHARMACOL THER, V80, P126, DOI 10.1016/j.clpt.2006.04.004; Ueda K, 2009, INT J HEMATOL, V89, P592, DOI 10.1007/s12185-009-0296-3; Zonios D, 2014, J INFECT DIS, V209, P1941, DOI 10.1093/infdis/jiu017; Roffey SJ, 2003, DRUG METAB DISPOS, V31, P731, DOI 10.1124/dmd.31.6.731; Miyakis S, 2010, CLIN MICROBIOL INFEC, V16, P927, DOI 10.1111/j.1469-0691.2009.02990.x; Matsumoto K, 2009, INT J ANTIMICROB AG, V34, P91, DOI 10.1016/j.ijantimicag.2009.01.008; Eiden C, 2010, XENOBIOTICA, V40, P701, DOI 10.3109/00498254.2010.503814; Furuta T, 2007, CLIN PHARMACOL THER, V81, P521, DOI 10.1038/sj.clpt.6100043; Smith J, 2006, ANTIMICROB AGENTS CH, V50, P1570, DOI 10.1128/AAC.50.4.1570-1572.2006; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Pascual A, 2008, CLIN INFECT DIS, V46, P201, DOI 10.1086/524669; Myrianthefs P, 2010, INT J ANTIMICROB AG, V35, P468, DOI 10.1016/j.ijantimicag.2009.12.021; Kurzawski M, 2006, EUR J CLIN PHARMACOL, V62, P877, DOI 10.1007/s00228-006-0183-2; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS157, DOI 10.1086/376523; Yamada T, 2012, CLIN BIOCHEM, V45, P134, DOI 10.1016/j.clinbiochem.2011.11.004; Goodwin ML, 2008, J ANTIMICROB CHEMOTH, V61, P17, DOI 10.1093/jac/dkm389; Denning DW, 2002, CLIN INFECT DIS, V34, P563, DOI 10.1086/324620; Wang G, 2009, EUR J CLIN PHARMACOL, V65, P281, DOI 10.1007/s00228-008-0574-7; Jeu L, 2003, CLIN THER, V25, P1321, DOI 10.1016/S0149-2918(03)80126-1; Scholz I, 2009, BRIT J CLIN PHARMACO, V68, P906, DOI 10.1111/j.1365-2125.2009.03534.x; MARTIN E, 1977, J PHARMACOKINET BIOP, V5, P579, DOI 10.1007/BF01059685; Tanigawara Y, 1999, CLIN PHARMACOL THER, V66, P528, DOI 10.1016/S0009-9236(99)70017-2; Pemán Javier, 2006, Ther Clin Risk Manag, V2, P129; Purkins L, 2002, ANTIMICROB AGENTS CH, V46, P2546, DOI 10.1128/AAC.46.8.2546-2553.2002	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1496	1503				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200008		
J	Matsuo, H; Kondo, Y; Kawasaki, T; Tokuyama, S; Imamura, N				Matsuo, Hirotaka; Kondo, Yoshiyuki; Kawasaki, Takashi; Tokuyama, Shinji; Imamura, Nobutaka			Borrelidin Isolated from Streptomyces sp Inhibited Adipocyte Differentiation in 3T3-L1 Cells via Several Factors Including GATA-Binding Protein 3	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						borrelidin; 3T3-L1 cell; adipocyte differentiation; GATA binding protein; Kruppel-like factor	TRANSFER-RNA SYNTHETASE; TRANSCRIPTION FACTORS; PPAR-GAMMA; ADIPOGENESIS; GENE; PREADIPOCYTE; EXPRESSION; FAMILY; MICE	An inhibitor of 3T3-L1 adipocyte differentiation was isolated from Streptomyces sp. TK08330 and identified by spectroscopy as the 18-membered macrolide borrelidin. Treatment with 1.0 mu m borrelidin suppressed intracellular lipid accumulation by 80% and inhibited the expression of adipocyte-specific genes. Borrelidin suppressed the mRNA expression of two master regulators of adipocyte differentiation, peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT/enhancer binding protein (C/EBP alpha). Studies on well-known upstream regulators of PPAR gamma revealed that borrelidin down-regulated C/EBP delta mRNA expression but did not affect expression of C/EBP beta. Borrelidin increased mRNA expression of negative regulators of differentiation such as GATA-binding protein (GATA) 3, Kriippel-like factor (KLF) 3 and KLF7, as well as positive regulators, KLF4, KLF6 and KLF15, at early stages of differentiation. To elucidate a primary mediator of borrelidin differentiation inhibitory activity, small interfering RNA (siRNA) transfection experiments were performed. The mRNA expression of PPAR gamma, which was down-regulated by borrelidin, was not changed by KLF3 and KLF7 siRNA treatment. In contrast, expression of PPAR gamma in GATA-3 siRNA-treated cells was not significantly different from that of control siRNA-treated cells. Borrelidin significantly inhibited lipid accumulation in control siRNA-treated cells, and treatment with GATA-3 siRNA slightly reduced the inhibitory effect of borrelidin. These results indicate that borrelidin inhibited adipocyte differentiation partially via GATA-3.	[Matsuo, Hirotaka; Kondo, Yoshiyuki; Imamura, Nobutaka] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan; [Matsuo, Hirotaka; Kawasaki, Takashi; Imamura, Nobutaka] Ritsumeikan Univ, Dept Pharm, Kusatsu, Shiga 5258577, Japan; [Tokuyama, Shinji] Shizuoka Univ, Dept Appl Biol Chem, Suruga Ku, Shizuoka 4228529, Japan	Matsuo, H (reprint author), Ritsumeikan Univ, Grad Sch Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	matsu-h@fc.ritsumei.ac.jp					Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; MAEHR H, 1987, J ANTIBIOT, V40, P1455; NASS G, 1976, MOL GEN GENET, V147, P39, DOI 10.1007/BF00337933; Mead JR, 2002, J MOL MED-JMM, V80, P753, DOI 10.1007/s00109-002-0384-9; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Gao YM, 2012, J AGR FOOD CHEM, V60, P9874, DOI 10.1021/jf302857x; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Kawamura Y, 2006, MOL ENDOCRINOL, V20, P844, DOI 10.1210/me.2005-0138; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Prinsen CFM, 1997, GENOMICS, V40, P207, DOI 10.1006/geno.1996.4534; Liu CX, 2012, J AGR FOOD CHEM, V60, P1251, DOI 10.1021/jf2044982; BERGER J, 1949, ARCH BIOCHEM, V22, P476; Nagamitsu T, 2007, J ORG CHEM, V72, P2744, DOI 10.1021/jo062089i; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Ishiyama A, 2011, J ANTIBIOT, V64, P381, DOI 10.1038/ja.2011.6; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Hu Y, 2009, PHYTOMEDICINE, V16, P864, DOI 10.1016/j.phymed.2009.03.002; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Fang PF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7402; Morrison R. F., 2000, J NUTR, V130, p3116S; Ntambi JM, 2000, J NUTR, V130, P3122; Wang PJ, 2014, CELL PHYSIOL BIOCHEM, V34, P288, DOI 10.1159/000362999	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1504	1511				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200009		
J	Masuda, Y; Yazawa, J; Makino, Y; Takada, K				Masuda, Yutaka; Yazawa, Jun; Makino, Yuuka; Takada, Kimihiko			PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						thrombin-activatable fibrinolysis inhibitor (TAFI); carboxypeptidase; LY294002; Akt; HepG2 cell	PLASMA CARBOXYPEPTIDASE-B; MESSENGER-RNA STABILITY; ISCHEMIC-STROKE; PROCARBOXYPEPTIDASE-B; TRANSCRIPT STABILITY; TISSUE FACTOR; ACUTE-PHASE; GENE; PROTEIN; RISK	Thrombin-activatable fibrinolysis inhibitor (TAFI) is a carboxypeptidase B-like proenzyme biosynthesized in the liver and released into the blood circulation. Activated TAFI (TAFIa) has been implicated as an important player in maintaining the balance between blood coagulation and fibrinolysis. In the present study, regulation of TAFI (CPB2) gene expression was investigated using cultured human hepatoma HepG2 cells. HepG2 cells were treated with the phosphoinositide 3-kinase (PI3K) inhibitor LY294002, and the levels of TAFI antigen and CPB2 mRNA were measured. HepG2 cells treated with LY29400 decreased their release of TAFI antigen into the conditioned medium (CM). In parallel, there were decreased levels of CPB2 mRNA and TAFI antigen in the cells. However, CPB2 gene promoter activity was not influenced by treatment of the cells with LY294002. The half-life of the CPB2 transcript was shortened by treatment with LY294002 compared with control. The present results suggest that the PI3K inhibitor LY294002 suppresses expression of TAFI, a prothrombotic factor, by decreasing the stability of CPB2 transcripts.	[Masuda, Yutaka; Yazawa, Jun; Makino, Yuuka; Takada, Kimihiko] Showa Pharmaceut Univ, Lab Clin Pharm, Machida, Tokyo 1948543, Japan	Masuda, Y (reprint author), Showa Pharmaceut Univ, Lab Clin Pharm, Machida, Tokyo 1948543, Japan.	ymasuda@ac.shoyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors would also like to thank all of the researchers who were involved in the research.	WILSON GM, 1995, PLASMID, V33, P198, DOI 10.1006/plas.1995.1021; Wang W, 1998, J BIOL CHEM, V273, P27176, DOI 10.1074/jbc.273.42.27176; de Bruijne ELE, 2011, THROMB RES, V127, P254, DOI 10.1016/j.thromres.2010.11.026; Zorio E, 2003, BRIT J HAEMATOL, V122, P958, DOI 10.1046/j.1365-2141.2003.04549.x; Eichinger S, 2004, BLOOD, V103, P3773, DOI 10.1182/blood-2003-10-3422; Tanno S, 2001, CANCER RES, V61, P589; Tregouet DA, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2008.03221.x; Suzuki K, 2004, J PHARMACOL EXP THER, V309, P607, DOI 10.1124/jpet.103.062729; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Boffa MB, 2003, J BIOL CHEM, V278, P9250, DOI 10.1074/jbc.M209588200; REDLITZ A, 1995, J CLIN INVEST, V96, P2534, DOI 10.1172/JCI118315; DANI C, 1984, EUR J BIOCHEM, V145, P299, DOI 10.1111/j.1432-1033.1984.tb08552.x; Hori Y, 2005, INT J MOL MED, V15, P265; Maret D, 2004, J THROMB HAEMOST, V2, P1969, DOI 10.1111/j.1538-7836.2004.00971.x; Bouma BN, 2001, THROMB RES, V101, P329, DOI 10.1016/S0049-3848(00)00411-4; Campbell W, 2001, IMMUNOL REV, V180, P162, DOI 10.1034/j.1600-065X.2001.1800114.x; Montaner J, 2003, STROKE, V34, P1038, DOI 10.1161/01.STR.0000063139.06585.45; Wu CL, 2003, THROMB HAEMOSTASIS, V90, P414, DOI 10.1160/TH02-09-0104; Muto Y, 2003, EUR J PHARMACOL, V461, P181, DOI 10.1016/S0014-2999(03)01297-4; Grille SJ, 2003, CANCER RES, V63, P2172; Leebeek FWG, 2005, J THROMB HAEMOST, V3, P2211, DOI 10.1111/j.1538-7836.2005.01484.x; Hori Y, 2002, J CLIN ENDOCR METAB, V87, P660, DOI 10.1210/jc.87.2.660; Garand M, 2007, BRIT J HAEMATOL, V138, P231, DOI 10.1111/j.1365-2141.2007.06640.x; Boffa MB, 2002, J BIOL CHEM, V277, P25329, DOI 10.1074/jbc.M203688200; Barrett NE, 2008, BRIT J PHARMACOL, V154, P918, DOI 10.1038/bjp.2008.151; ISHII H, 1992, BLOOD, V80, P2556; Santamaria A, 2003, STROKE, V34, P2387, DOI 10.1161/01.STR.0000088642.07691.15; Ladenvall C, 2007, ARTERIOSCL THROM VAS, V27, P955, DOI 10.1161/01.ATV.0000259354.93789.a6; Ishii H, 2009, THROMB HAEMOSTASIS, V102, P1204, DOI 10.1160/TH09-03-0194; Sakharov DV, 1997, J BIOL CHEM, V272, P14477, DOI 10.1074/jbc.272.22.14477; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Masuda Y, 2012, THROMB HAEMOSTASIS, V108, P74, DOI 10.1160/TH12-02-0101; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234; Broze GJ, 1996, BLOOD, V88, P3815; TAN AK, 1995, BIOCHEMISTRY-US, V34, P5811, DOI 10.1021/bi00017a012	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1529	1535				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200012		
J	Mori, A; Suzawa, H; Sakamoto, K; Nakahara, T; Ishii, K				Mori, Asami; Suzawa, Hironori; Sakamoto, Kenji; Nakahara, Tsutomu; Ishii, Kunio			Vasodilator Effects of Elcatonin, a Synthetic Eel Calcitonin, on Retinal Blood Vessels in Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						adenylyl cyclase; cyclooxygenase; nitric oxide; prostaglandin; retinal blood vessel	ENDOTHELIUM-DEPENDENT RELAXATION; INDUCED DIABETIC-RATS; SALMON-CALCITONIN; NITRIC-OXIDE; ARTERIOLES; RETINOPATHY; RECEPTORS; ABNORMALITIES; ACETYLCHOLINE; OSTEOCLASTS	The aim of this study was to examine the effects of elcatonin, a synthetic derivative of eel calcitonin, on rat retinal blood vessels, and to determine how diabetes affects the retinal vascular responses. Ocular fundus images were captured with an original high-resolution digital fundus camera in vivo. The retinal vascular responses were evaluated by measuring the diameter of retinal blood vessels contained in the digital images. Both systemic blood pressure and heart rate were continuously recorded. Elcatonin increased the diameter of retinal blood vessels but decreased mean blood pressure in a dose-dependent manner, whereas it had no significant effect on heart rate. A diminished retinal vasodilator response and significant pressor response to elcatonin were observed in rats injected intravenously with N-G-nitro-L-arginine methyl ester, a nitric oxide (NO) synthase inhibitor. Intravitreal injection of indomethacin, a non-selective cyclooxygenase (COX) inhibitor, and SQ22536, an adenylyl cyclase inhibitor, markedly attenuated the vasodilator effects of elcatonin on retinal blood vessels. The retinal vasodilator responses to elcatonin were unaffected 2 weeks after the induction of diabetes by a combination of streptozotocin treatment and D-glucose feeding. These results suggest that elcatonin dilates rat retinal blood vessels via NO- and COX-dependent mechanisms and that the adenylyl cyclase-adenosine 3',5'-cyclic monophosphate system plays a major role in the vasodilator mechanisms. The retinal vasodilatory effects of elcatonin seem to be preserved at early stages of diabetes.	[Mori, Asami; Suzawa, Hironori; Sakamoto, Kenji; Nakahara, Tsutomu; Ishii, Kunio] Kitasato Univ, Dept Mol Pharmacol, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan	Nakahara, T (reprint author), Kitasato Univ, Dept Mol Pharmacol, Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nakaharat@pharm.kitasato-u.ac.jp			Kitasato University Research Grant for Young Researchers; JSPS KAKENHI [21590102, 24790261, 24590122]; MEXT KAKENHI [25122712]	This study was supported by the Kitasato University Research Grant for Young Researchers (A. M.), JSPS KAKENHI (Grant Numbers: 21590102 K. I., 24790261 A. M. and 24590122 K. I.), and MEXT KAKENHI (Grant Number: 25122712, T. N.).	Mori A, 2011, EUR J PHARMACOL, V669, P94, DOI 10.1016/j.ejphar.2011.07.042; Yoshimura T, 2012, FUND CLIN PHARMACOL, V26, P315, DOI 10.1111/j.1472-8206.2011.00934.x; Takeyama M, 1996, J PHARM PHARMACOL, V48, P657; Ogawa N, 2007, N-S ARCH PHARMACOL, V375, P323, DOI 10.1007/s00210-007-0165-7; FRANCHI F, 1983, INT J CLIN PHARM RES, V3, P115; Ghirlanda G, 1997, DIABETES METAB REV, V13, P15, DOI 10.1002/(SICI)1099-0895(199703)13:1<15::AID-DMR176>3.0.CO;2-M; WEGENER LL, 1988, PEPTIDES, V9, P1191, DOI 10.1016/0196-9781(88)90106-4; Suzuki H, 1996, ENDOCRINOLOGY, V137, P4685, DOI 10.1210/en.137.11.4685; Shibata K, 1998, PHARMACOL BIOCHEM BE, V60, P371, DOI 10.1016/S0091-3057(98)00015-X; NICHOLSON GC, 1986, J CLIN INVEST, V78, P355, DOI 10.1172/JCI112584; QUATRARO A, 1992, LANCET, V339, P746, DOI 10.1016/0140-6736(92)90647-L; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; Chigurupati S, 2005, CANCER RES, V65, P8519, DOI 10.1158/0008-5472.CAN-05-0848; CLEMENTI G, 1986, NEUROSCI LETT, V66, P351, DOI 10.1016/0304-3940(86)90674-9; TAYLOR PD, 1992, BRIT J PHARMACOL, V107, P393; Mori A, 2007, EUR J PHARMACOL, V570, P135, DOI 10.1016/j.ejphar.2007.05.052; FORCE T, 1992, AM J PHYSIOL, V262, pF1110; SILVA OL, 1973, ARCH INTERN MED, V132, P337, DOI 10.1001/archinte.132.3.337; Mori A, 2009, J PHARMACOL SCI, V110, P160, DOI 10.1254/jphs.08320FP; MORIKAWA T, 1976, EXPERIENTIA, V32, P1104, DOI 10.1007/BF01927568; Mori A, 2011, N-S ARCH PHARMACOL, V383, P27, DOI 10.1007/s00210-010-0570-1; JIMENEZ FE, 1995, CURR THER RES CLIN E, V56, P385, DOI 10.1016/0011-393X(95)85007-4; PONTIROLI AE, 1994, AGING-CLIN EXP RES, V6, P459; Kaneko Y, 2006, J OCUL PHARMACOL TH, V22, P317, DOI 10.1089/jop.2006.22.317; Schmetterer L, 1999, DIABETOLOGIA, V42, P387, DOI 10.1007/s001250051171; OYAMA Y, 1986, EUR J PHARMACOL, V132, P75, DOI 10.1016/0014-2999(86)90013-0; Ogawa N, 2009, AM J PHYSIOL-REG I, V297, pR968, DOI 10.1152/ajpregu.91005.2008; Mori A, 2010, N-S ARCH PHARMACOL, V382, P119, DOI 10.1007/s00210-010-0526-5; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Fujimoto S, 2001, ACTA PHARMACOL SIN, V22, P595; Aoki M, 2012, EUR J PHARMACOL, V696, P62, DOI 10.1016/j.ejphar.2012.09.007; De La Cruz MDJP, 2004, DIABETES-METAB RES, V20, P91; EDWARDS I R, 1972, Clinical Endocrinology, V1, P337, DOI 10.1111/j.1365-2265.1972.tb00403.x; FEKE GT, 1994, INVEST OPHTH VIS SCI, V35, P2968; Ito A, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-42; Masi Laura, 2007, Clin Cases Miner Bone Metab, V4, P117; MONCADA S, 1991, PHARMACOL REV, V43, P109; Orimo H, 1996, J BONE MINER METAB, V14, P73, DOI 10.1007/BF01768835	38	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1536	1541				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200013		
J	Min, KS; Sano, E; Ueda, H; Sakazaki, F; Yamada, K; Takano, M; Tanaka, K				Min, Kyong-Son; Sano, Erika; Ueda, Hidenori; Sakazaki, Fumitoshi; Yamada, Keita; Takano, Masaoki; Tanaka, Keiichi			Dietary Deficiency of Calcium and/or Iron, an Age-Related Risk Factor for Renal Accumulation of Cadmium in Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cadmium; age-related risk factor; essential metal-deficiency; intestinal metal transporter	METALLOTHIONEIN; TRANSPORTER; ABSORPTION; RATS; CLONING; METALS; KIDNEY; GENES; LIVER; CD	The major route of cadmium (Cd) intake by non-smokers is through food ingestion. Cd is a non-essential metal absorbed through one or more transporters of essential metal ions. Expression of these transporters is affected by nutritional status. To investigate the risk factors for Cd toxicity, the effects of deficiency of essential metals on hepatic and renal accumulation of Cd were studied in mice of different ages. Mice were administered a control diet or one of the essential metal-deficient diets, administered Cd by gavage for 6 weeks, and killed; then, Cd accumulation was evaluated. Iron deficiency (FeDF) or calcium deficiency (CaDF) resulted in remarkable increases in hepatic and renal Cd accumulation compared with control-diet mice and other essential metal-deficient mice. Cd accumulation in hepatic and renal tissue was increased significantly at all ages tested in FeDF and CaDF mice. Renal Cd concentrations were higher in 4-week-old mice than in 8- and 25-week-old mice. Increase in intestinal mRNA expression of calcium transporter (CaT)1, divalent metal ion transporter-1, and metallothionein (MT)1 was also higher in 4-week-old mice than in other mice. Renal accumulation of Cd showed strong correlation with intestinal mRNA expression of CaT1 and MT1. These data suggest that CaDF and FeDF at younger ages can be a risk factor for Cd toxicity.	[Min, Kyong-Son; Sano, Erika; Ueda, Hidenori; Sakazaki, Fumitoshi; Yamada, Keita; Tanaka, Keiichi] Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka 5848540, Japan; [Takano, Masaoki] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan	Sakazaki, F (reprint author), Osaka Ohtani Univ, Fac Pharm, 3-11-1 Nishikiori Kita, Tondabayashi, Osaka 5848540, Japan.	sakazato@osaka-ohtani.ac.jp			Japan Society for the Promotion of Science [C-22510077]	The present study was supported by a Grant-in-Aid for Scientific Research (No. C-22510077) from the Japan Society for the Promotion of Science.	MIN KS, 1991, TOXICOL APPL PHARM, V109, P7, DOI 10.1016/0041-008X(91)90186-I; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; [Anonymous], 2014, DIET REF INT JAP 201; Eklund G, 2001, ARCH TOXICOL, V75, P522, DOI 10.1007/s00204-001-0280-z; Youn P, 2009, TOXICOL LETT, V184, P151, DOI 10.1016/j.toxlet.2008.11.002; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Song YR, 2003, ENDOCRINOLOGY, V144, P3885, DOI 10.1210/en.2003-0314; Crews HM, 2000, TOXICOL LETT, V112, P201, DOI 10.1016/S0378-4274(99)00284-2; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Park JD, 2002, TOXICOL SCI, V68, P288, DOI 10.1093/toxsci/68.2.288; Suzuki T, 2008, TOXICOL APPL PHARM, V227, P462, DOI 10.1016/j.taap.2007.10.026; MIN KS, 1987, TOXICOL APPL PHARM, V88, P294, DOI 10.1016/0041-008X(87)90014-7; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Kimura T, 1998, TOXICOL LETT, V99, P85, DOI 10.1016/S0378-4274(98)00129-5; Min KS, 2008, TOXICOL LETT, V176, P85, DOI 10.1016/j.toxlet.2007.10.011; Reeves PG, 2004, ENVIRON RES, V96, P311, DOI 10.1016/j.envres.2004.02.013; Min KS, 2008, TOXICOL SCI, V106, P284, DOI 10.1093/toxsci/kfn146; Friberg L., 1974, CADMIUM ENV; Ohrvik H, 2013, ISRN TOXICOLOGY, p[2013, 1]; ONOSAKA S, 1982, TOXICOL APPL PHARM, V63, P270, DOI 10.1016/0041-008X(82)90049-7; The Ministry of Health Labor and Welfare of Japan, 2014, 2012 NAT HLTH NUTR S	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1557	1563				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200016		
J	Nagai, N; Tanino, T; Ito, Y				Nagai, Noriaki; Tanino, Tadatoshi; Ito, Yoshimasa			Excessive Interleukin 18 Relate the Aggravation of Indomethacin-Induced Intestinal Ulcerogenic Lesions in Adjuvant-Induced Arthritis Rat	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						interleukin (IL)-18; intestinal ulcerogenic lesion; indomethacin; rheumatoid arthritis; interferon-gamma	NITRIC-OXIDE SYNTHASE; INTERFERON-GAMMA; BINDING-PROTEIN; EPITHELIAL-CELLS; INDUCTION; EXPRESSION; LIPOPOLYSACCHARIDE; INHIBITION; ACTIVATION; RECEPTOR	It is well known that rheumatoid arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) are more susceptible to NSAIDs-induced gastroenteropathy in comparison with other patients. In this study we demonstrate that expression levels of interleukin (IL)-18 are related to aggravation of intestinal ulcerogenic lesions in adjuvant-induced arthritis (AA) rats following oral administration of indomethacin. AA rats were administered oral indomethacin (40 mg/kg) and killed under deep isoflurane anesthesia after 24 h. The small intestinal mucosa was then examined. Oral administration of indomethacin caused hemorrhagic lesions in the small intestinal mucosa of AA rats, and the lesion score of AA rats 24 h after indomethacin treatment was approximately 5.6-fold higher than for normal rats administered indomethacin. IL-18 expression in the small intestinal mucosa of AA rats administered indomethacin was also higher in comparison with normal rats receiving indomethacin. In addition, interferon-gamma and nitric oxide levels in the small intestinal mucosa of AA rats were increased following oral administration of indomethacin. It is possible that IL-18 expression in AA rats renders the small intestinal mucosa more sensitive to indomethacin, and that IL-18 may play a role in aggravating intestinal ulcerogenic lesions in AA rats treated with this drug.	[Nagai, Noriaki; Ito, Yoshimasa] Kinki Univ, Fac Pharm, Higashiosaka, Osaka 5778502, Japan; [Tanino, Tadatoshi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Tokushima, Tokushima 7708514, Japan	Nagai, N (reprint author), Kinki Univ, Fac Pharm, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	nagai_n@phar.kindai.ac.jp					Aizawa Y, 1999, FEBS LETT, V445, P338, DOI 10.1016/S0014-5793(99)00148-9; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; FRIES JF, 1989, GASTROENTEROLOGY, V96, P647; WHITTLE BJR, 1995, BRIT J PHARMACOL, V116, P2286; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; YAMADA T, 1993, INFLAMMATION, V17, P641, DOI 10.1007/BF00920471; BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P1189; Escandell JM, 2007, J PHARMACOL EXP THER, V320, P581, DOI 10.1124/jpet.106.107003; WEISSENBORN U, 1985, PHARMACOLOGY, V30, P32, DOI 10.1159/000138047; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Kim SH, 2001, J IMMUNOL, V166, P148; Sakuma S, 2001, INFLAMM RES, V50, P509, DOI 10.1007/PL00000227; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Tanaka A, 1999, J PHYSIOL PHARMACOL, V50, P405; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Nagai N, 2009, TOXICOLOGY, V255, P124, DOI 10.1016/j.tox.2008.10.005; WHITTLE BJR, 1981, GASTROENTEROLOGY, V80, P94; ASAKO H, 1992, AM J PHYSIOL, V262, pG903; Sugawara S, 2001, J IMMUNOL, V167, P6568; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Hoshino K, 1999, J IMMUNOL, V162, P5041; Chen CW, 2003, J IMMUNOL, V171, P979; Kato N, 2009, DIGEST DIS SCI, V54, P2346, DOI 10.1007/s10620-008-0646-7; Kato S, 2002, JPN J PHARMACOL, V89, P1, DOI 10.1254/jjp.89.1; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; Kato S, 2007, LIFE SCI, V81, P1309, DOI 10.1016/j.lfs.2007.08.036; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Nagai N, 2006, BIOL PHARM BULL, V29, P2077, DOI 10.1248/bpb.29.2077; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; BILLINGHAM MEJ, 1983, PHARMACOL THERAPEUT, V21, P389, DOI 10.1016/0163-7258(83)90062-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Hultqvist M, 2006, PLOS MED, V3, P1625, DOI 10.1371/journal.pmed.0030348; VANE JR, 1971, NATURE-NEW BIOL, V231, P232	35	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1580	1590				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200019		
J	Sato, T; Kaneko, YK; Sawatani, T; Noguchi, A; Ishikawa, T				Sato, Taiji; Kaneko, Yukiko K.; Sawatani, Toshiaki; Noguchi, Akiko; Ishikawa, Tomohisa			Obligatory Role of Early Ca2+ Responses in H2O2-Induced beta-Cell Apoptosis	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						pancreatic beta-cell; apoptosis; hydrogen peroxide; calcium; inositol 1,4,5-trisphosphate (IP3) receptor	MITOCHONDRIAL CALCIUM UNIPORTER; INSULIN-PRODUCING CELLS; HYDROGEN-PEROXIDE; EXPRESSION; DEATH; PROTEIN; STRESS; GENE; INVOLVEMENT; MEDIATORS	Our previous study using apoptosis analysis suggested that Ca2+ release through inositol 1,4,5-trisphosphate (IP3) receptors and the subsequent Ca2+ influx through store-operated channels (SOCs) constitute a triggering signal for H2O2-induced beta-cell apoptosis. In the present study, we further examined the obligatory role of early Ca2+ responses in beta-cell apoptosis induction. H2O2 induced elevation of the cytosolic Ca2+ concentration ([Ca2+](c)) consisting of two phases: an initial transient [Ca2+](c) elevation within 30 mm and a slowly developing one thereafter. The first phase was almost abolished by 2-aminoethoxydiphenylborate (2-APB), which blocks IP3 receptors and cation channels including SOCs, while the second phase was only partially inhibited by 2-APB. The inhibition by 2-APB of the second phase was not observed when 2-APB was added 30 min after the treatment with H2O2. 2-APB also largely inhibited elevation of the mitochondrial Ca2+ concentration ([Ca2+](m)) induced by H2O2 when 2-APB was applied simultaneously with H2O2, but not when applied 30 min after H2O2 application. In addition, 2-APB inhibited the release of mitochondrial cytochrome c to the cytosol induced by H2O2 when 2-APB was applied simultaneously with H2O2 but not 30 mm post-treatment. H2O2-induced [Ca2+](m) elevation and cell death were not inhibited by Ru360, an inhibitor of the mitochondrial calcium uniporter (MCU). These results suggest that the H2O2-induced initial [Ca2+](c) elevation, occurring within 30 mm and mediated by Ca2+ release through IP3 receptors and subsequent Ca2+ influx through SOCs, leads to [Ca2+](m) elevation, possibly through a mechanism independent of MCU, thereby inducing cytochrome c release and consequent apoptosis.	[Sato, Taiji; Kaneko, Yukiko K.; Sawatani, Toshiaki; Noguchi, Akiko; Ishikawa, Tomohisa] Univ Shizuoka, Dept Pharmacol, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan	Ishikawa, T (reprint author), Univ Shizuoka, Dept Pharmacol, Grad Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	ishikat@u-shizuoka-ken.ac.jp			Japan Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science. The authors thank Mr. M. Takada and Mrs. Y. Sayama for their technical assistance. Some materials were supplied by Chugai Pharmaceutical Co., Ltd.	Takada M, 2011, BIOL PHARM BULL, V34, P954; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Rosado JA, 2004, J BIOL CHEM, V279, P1665, DOI 10.1074/jbc.M307963200; Marchi S, 2014, J PHYSIOL-LONDON, V592, P829, DOI 10.1113/jphysiol.2013.268235; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Nakazaki M, 2000, CELL STRUCT FUNCT, V25, P187, DOI 10.1247/csf.25.187; Bogeski I, 2006, CELL CALCIUM, V40, P1, DOI 10.1016/j.ceca.2006.03.003; Benhamou PY, 1998, DIABETOLOGIA, V41, P1093, DOI 10.1007/s001250051035; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Tamareille S, 2006, CELL CALCIUM, V39, P47, DOI 10.1016/j.ceca.2005.09.008; Verma G, 2013, MOL BIOL CELL, V24, P2058, DOI 10.1091/mbc.E12-12-0885; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Choi SE, 2006, EUR J PHARMACOL, V547, P1, DOI 10.1016/j.ejphar.2006.06.016; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Wang XL, 2004, DIABETES, V53, P129; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Brown GC, 2008, BBA-BIOENERGETICS, V1777, P877, DOI 10.1016/j.bbabio.2008.03.024; Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Rasilainen S, 2002, BIOCHEM PHARMACOL, V63, P1297, DOI 10.1016/S0006-2952(02)00864-X; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Hajnóczky György, 2006, Cell Calcium, V40, P553, DOI 10.1016/j.ceca.2006.08.016	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1599	1605				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200021		
J	Taguchi, K; Nagao, S; Yamasaki, K; Sakai, H; Seo, H; Maruyama, T; Otagiri, M				Taguchi, Kazuaki; Nagao, Saori; Yamasaki, Keishi; Sakai, Hiromi; Seo, Hakaru; Maruyama, Toru; Otagiri, Masaki			Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						hemoglobin; hemoglobin-vesicle (HbV); liposome; artificial blood; hyperlipidemia	ARTIFICIAL OXYGEN CARRIER; RATS; COMPLEMENT; BLOOD; BINDING; PROTEIN; SURFACE; CELLS	The hemoglobin-vesicle (HbV), a vesicle in which a concentrated human hemoglobin solution is encapsulated, was developed as an artificial oxygen carrier. Although HbV has a favorable safety, metabolic, and excretion performance in healthy animals, the effect of a massive amount of HbV, which also contains a large amount of a lipid component including cholesterol, on physiological response and metabolic performance under hyperlipidemic conditions is unclear. The aim of this study was to evaluate whether administration of HbN causes toxicity in apolipoprotein E-deficient mice (hyperlipidemic model mice). Apolipoprotein E-deficient mice were given a single injection of HbV (2000 mg hemoglobin/kg), and physiological responses and metabolic profiles were monitored for 14d thereafter. All the mice tolerated the massive amount of HbV and survived, and adequate biocompatibility was observed. Serum biochemical parameters indicate that liver and kidney function were not remarkably affected, and morphological changes in the liver and spleen were negligible. Lipid parameters in serum were significantly increased until 3d after HbV administration, but recovered within 7d after the administration. In a pharmacokinetic study, HbV was mainly found distributed in the liver and spleen, and disappeared from the body within 14d. In conclusion, even under conditions of hyperlipidemia, a massive dose of HbV and its components resulted in favorable biological compatibility, metabolic, and excretion profiles. These findings provide further support for the safety of HbV for clinical use.	[Taguchi, Kazuaki; Yamasaki, Keishi; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600082, Japan; [Nagao, Saori; Maruyama, Toru; Otagiri, Masaki] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, Kumamoto 8620973, Japan; [Yamasaki, Keishi; Seo, Hakaru; Otagiri, Masaki] Sojo Univ, DDS Res Inst, Nishi Ku, Kumamoto 8600082, Japan; [Sakai, Hiromi] Nara Med Univ, Dept Chem, Kashihara, Nara 6348521, Japan; [Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan	Otagiri, M (reprint author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	otagirim@ph.sojo-u.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science (JSPS) [KAKENHI 26860121]	We wish to thank the members of the RI Center in Kumamoto University for their important contributions to pharmacokinetic experiments. This work was supported in part by Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan and by a Grant-in-Aid for Young Scientist (B) from the Japan Society for the Promotion of Science (JSPS) (KAKENHI 26860121).	LOUGHREY HC, 1990, THROMB HAEMOSTASIS, V64, P172; Taguchi K, 2010, TOXICOL APPL PHARM, V248, P234, DOI 10.1016/j.taap.2010.08.006; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; HAVEL RJ, 1988, HEPATOLOGY, V8, P1689, DOI 10.1002/hep.1840080637; Sakai H, 2004, BIOMATERIALS, V25, P4317, DOI 10.1016/j.biomaterials.2003.11.005; Sou K, 2005, J PHARMACOL EXP THER, V312, P702, DOI 10.1124/jpet.104.074534; Uchegbu IF, 2013, J PHARM SCI-US, V102, P305, DOI 10.1002/jps.23377; Sakai H, 2003, CLIN CHEM LAB MED, V41, P222, DOI 10.1515/CCLM.2003.036; Abe H, 2007, ARTIF CELL BLOOD SUB, V35, P157, DOI 10.1080/10731190601188224; Phillips WT, 1997, EXP HEMATOL, V25, P1347; Taguchi K, 2011, J PHARM SCI-US, V100, P775, DOI 10.1002/jps.22286; KUIPERS F, 1986, BIOCHIM BIOPHYS ACTA, V876, P559, DOI 10.1016/0005-2760(86)90044-5; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Nagao S, 2014, BIOMATERIALS, V35, P6553, DOI 10.1016/j.biomaterials.2014.04.049; Abe H, 2006, ARTIF CELL BLOOD SUB, V34, P1, DOI 10.1080/00207450500428204; Grone EF, 2008, NAT CLIN PRACT NEPHR, V4, P424, DOI 10.1038/ncpneph0863; Taguchi K, 2009, DRUG METAB DISPOS, V37, P1456, DOI 10.1124/dmd.109.027094; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Balla J, 2005, MOL NUTR FOOD RES, V49, P1030, DOI 10.1002/mnfr.200500076; Tsuchida E, 2009, BIOCONJUGATE CHEM, V20, P1419, DOI 10.1021/bc800431d; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Yamaguchi M, 2009, J BIOMED MATER RES A, V88A, P34, DOI 10.1002/jbm.a.31857; Sakai H, 2007, ARTIF CELL BLOOD SUB, V35, P81, DOI 10.1080/10731190600974582; Araki J, 2015, TRANSPLANTATION, V99, P687, DOI 10.1097/TP.0000000000000528; Sou K, 2008, BBA-BIOMEMBRANES, V1778, P1035, DOI 10.1016/j.bbamem.2008.01.006; Sakai H, 1997, BIOCONJUGATE CHEM, V8, P23, DOI 10.1021/bc960069p; Sakai H, 2009, SHOCK, V31, P192, DOI 10.1097/SHK.0b013e31817d4066; Sakai H, 2001, AM J PATHOL, V159, P1079, DOI 10.1016/S0002-9440(10)61783-X; Komatsu H, 2007, NEUROSCI LETT, V421, P121, DOI 10.1016/j.neulet.2007.04.080; Parry E., 1988, BLOOD SUBSTITUTE PRE; Taguchi K, 2012, J DRUG METAB TOXICOL, V3, P128	31	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1606	1616				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200022		
J	Ueda, N; Umetsu, R; Abe, J; Kato, Y; Nakayama, Y; Kato, Z; Kinosada, Y; Nakamura, M				Ueda, Natsumi; Umetsu, Ryogo; Abe, Junko; Kato, Yamato; Nakayama, Yoko; Kato, Zenichiro; Kinosada, Yasutomi; Nakamura, Mitsuhiro			Analysis of Neuropsychiatric Adverse Events in Patients Treated with Oseltamivir in Spontaneous Adverse Event Reports	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						oseltamivir; abnormal behavior; adverse event report	DRUG-REACTIONS; GENDER-DIFFERENCES; ABNORMAL-BEHAVIOR; INFLUENZA; DISPROPORTIONALITY; PHARMACOVIGILANCE; ENCEPHALOPATHY; CHILDREN; DATABASE; SYSTEM	There have been concerns that oseltamivir causes neuropsychiatric adverse events (NPAEs). We analyzed the association of age and gender with NPAEs in patients treated with oseltamivir using a logistic regression model. NPAE data were obtained from the U.S. Food and Drug Administration Adverse Event Reporting System (2004 to 2013). The lower limit of the reporting odds ratio (ROR) 95% confidence interval (CI) of "abnormal behavior" in Japan, Singapore, and Taiwan was >= 1 The effects of the interaction terms for oseltamivir in male patients aged 10-19 years were statistically significant. The adjusted ROR of "abnormal behavior" was 96.4 (95% CI, 77.5-119.9) in male patients aged 10-19 years treated with osletamivir. In female patients, the results of the likelihood ratio test for "abnormal behavior" were not statistically significant. The adjusted NPAE RORs were increased in male and female patients under the age of 20 years. Oseltamivir use could be associated with "abnormal behavior" in males aged 10-19 years. After considering the causality restraints of the current analysis, further epidemiological studies are recommended.	[Ueda, Natsumi; Umetsu, Ryogo; Abe, Junko; Kato, Yamato; Nakayama, Yoko; Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu 5011196, Japan; [Abe, Junko] Med Database Co Ltd, Shibuya Ku, Tokyo 1500011, Japan; [Kato, Zenichiro] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011194, Japan; [Kinosada, Yasutomi] Gifu Univ, Grad Sch Med, Dept Biomed Informat, Gifu 5011194, Japan	Nakamura, M (reprint author), Gifu Pharmaceut Univ, Lab Drug Informat, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	mnakamura@gifu-pu.ac.jp			JSPS KAKENHI Grant [24390126]	This research was partially supported by JSPS KAKENHI Grant Number, 24390126.	Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; van Puijenbroek EP, 2001, BRIT J CLIN PHARMACO, V52, P579, DOI 10.1046/j.0306-5251.2001.01501.x; van Puijenbroek EP, 2000, EUR J CLIN PHARMACOL, V56, P733, DOI 10.1007/s002280000215; Takashima T, 2011, J NUCL MED, V52, P950, DOI 10.2967/jnumed.110.083949; Yorifuji T, 2009, EPIDEMIOLOGY, V20, P619, DOI 10.1097/EDE.0b013e3181a3d3f6; Yorifuji T, 2010, EPIDEMIOLOGY, V21, P916, DOI 10.1097/EDE.0b013e3181f32842; Jefferson T, 2009, LANCET, V374, P1312, DOI 10.1016/S0140-6736(09)61804-3; Nakai Y, 2003, ACTA NEUROPATHOL, V105, P233, DOI 10.1007/s00401-002-0605-x; Hasson R, 2012, J ATTEN DISORD, V16, P190, DOI 10.1177/1087054711427398; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Chung S, 2010, PSYCHIAT INVEST, V7, P302, DOI 10.4306/pi.2010.7.4.302; Gaub M, 1997, J AM ACAD CHILD PSY, V36, P1036, DOI 10.1097/00004583-199708000-00011; Hatori A, 2011, NEUROSCI LETT, V495, P187, DOI 10.1016/j.neulet.2011.03.055; Pariente A, 2007, DRUG SAFETY, V30, P891; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Greene SK, 2013, PHARMACOEPIDEM DR S, V22, P335, DOI 10.1002/pds.3363; Peng MM, 2010, EPIDEMIOLOGY, V21, P915, DOI 10.1097/EDE.0b013e3181f3544c; Montastruc JL, 2011, BRIT J CLIN PHARMACO, V72, P905, DOI 10.1111/j.1365-2125.2011.04037.x; Ho LNL, 2010, AM J PSYCHIAT, V167, P350, DOI 10.1176/appi.ajp.2009.09101421; Egberts ACG, 2002, DRUG SAFETY, V25, P453, DOI 10.2165/00002018-200225060-00010; Fujita T, 2010, JPN J PHARMACOEPIDEM, V15, P73; Hirota Y, 2009, RES EVIDENCE METHODS; Hoffman K. B., 2013, BRIT MED J, V347, pf4656; Jefferson T, 2014, NEURAMINIDASE INHIBI; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; The Metabolomics Innovation Centre (TMIC), DRUGBANK; Urushihara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028483; U.S. Department of Health and Human Services, 2005, HHS PAND INFL PLAN 2; US Food and Drug Administration, FDA ADV EV REP SYST	31	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1638	1644				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200025		
J	Iino, H; Fujii, M; Fujino, M; Koizumi, N; Watanabe, Y				Iino, Hayato; Fujii, Makiko; Fujino, Manami; Koizumi, Naoya; Watanabe, Yoshiteru			Penetration of Ufenamate into Intact, Stripped, or Delipidized Skin Using Different Vehicles	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						skin penetration; ufenamate; stripped skin; delipidized skin; oil vehicle; water vehicle	STRATUM-CORNEUM; MICROPIG SKIN; PERMEATION; MODEL	The purpose of this study was to clarify the effect of skin condition on skin penetration of the very high lipophilic drug, ufenamate (UF). UF was applied to stripped or delipidized skin using liquid paraffin (LP) or purified water containing polysorbate 80 at a dose of 2 mu L/cm(2). We found that UF penetration into intact and stripped skin using a water vehicle was respectively 5 and 10 times higher than that using LP. UF is freely soluble in oil and insoluble in water; thus, activity in water is higher than that in LP. Therefore, it is useful to use a water-based vehicle for both intact sites and those with defective stratum corneum (SC). Conversely, we found that delipidization of SC decreased the penetration of UF significantly with both LP and water, and the amount measured in the epidermis was 1 mu g/cm(2) with both vehicles. This indicates that UF is not suitable for so-called "dry skin." This study revealed clinically relevant differences in the penetration of UF into intact, stripped, or delipidized skin conditions.	[Iino, Hayato; Fujii, Makiko; Fujino, Manami; Koizumi, Naoya; Watanabe, Yoshiteru] Showa Pharmaceut Univ, Dept Pharmaceut & Biopharmaceut, Tokyo 1948543, Japan; [Iino, Hayato] Yuskin Pharmaceut Co Ltd, Dept Res & Dev, Kawasaki Ku, Kawasaki, Kanagawa 2100014, Japan	Fujii, M (reprint author), Nihon Univ, Sch Pharm, 7-7-1 Narashi Nodai, Funabashi, Chiba 2748555, Japan.	fujii.makiko@nihon-u.ac.jp					IMOKAWA G, 1986, J INVEST DERMATOL, V87, P758, DOI 10.1111/1523-1747.ep12456950; Fujii M, 1997, BIOL PHARM BULL, V20, P249; Kikuchi K, 2002, DERMATOLOGY, V205, P378, DOI 10.1159/000066432; LAVKER RM, 1991, AM J PATHOL, V138, P687; KLIGMAN AM, 1963, ARCH DERMATOL, V88, P702; Inoue K, 2000, DRUG DEV IND PHARM, V26, P45; Bekersky I, 2001, J AM ACAD DERMATOL, V44, pS17, DOI 10.1067/mjd.2001.109816; Gujjar M, 2014, INT J PHARMACEUT, V472, P362, DOI 10.1016/j.ijpharm.2014.06.050; Surber C, 2005, DERMATOLOGY, V210, P157, DOI 10.1159/000082572; Higuchi T., 1960, J SOC COSMET CHEM, V11, P85; Iju M, 1981, NISHINIHON J DERMATO, V43, P256; Kazama T, 1981, NISHINIHON J DERMATO, V43, P264; Kubo H, 1981, NISHINIHON J DERMATO, V43, P261; Sasaki R, 1997, J PEDIAT DERMATOL, V16, P47; Smith EW, 2002, TOPICAL ABSORPTION D, P457; Takahara Y, 1982, PHARMACOMETRICS, V24, P691; Uchiyama M, 1981, NISHINIHON J DERMATO, V43, P268	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1645	1648				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200026		
J	Tagami, T; Yanai, H; Terada, Y; Ozeki, T				Tagami, Tatsuaki; Yanai, Hiroshi; Terada, Yuka; Ozeki, Tetsuya			Evaluation of Phosphatidylserine-Specific Peptide-Conjugated Liposomes Using a Model System of Malaria-Infected Erythrocytes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						liposome; malaria; eryptosis; phosphatidylserine; targeting		Malaria is one of the most prevalent parasitic diseases and is most widespread in tropical regions. The malarial parasite grows and reproduces in erythrocytes during its life cycle, resulting in programmed erythrocyte death, termed eryptosis. Lipid scrambling, which occurs following the exposure of anionic lipids such as phosphatidylserine (PS) on the outer surface of erythrocytes, is a characteristic physical change that occurs early during eryptosis. Here, we prepared "PS specific peptide (PSP)"-conjugated liposomes (PSP-liposomes) and investigated whether PSP-liposomes hold promise as a novel strategy for actively targeting eryptosis. Eryptosis was induced by exposing red blood cells (RBCs) to ionomycin, a known calcium ionophore. When PSP liposomes were mixed with either RBCs or RBCs undergoing eryptosis (E-RBCs), the amount of PSP-liposome bound to E-RBCs was much higher than the amount bound to RBCs. However, the amount of PSP-liposome bound to E-RBCs was significantly inhibited by the presence of annexin V protein, which binds specifically to PS. These results suggest that PSP-liposomes could be an effective drug nanocarrier for treating E-RBCs and malaria-infected erythrocytes.	[Tagami, Tatsuaki; Yanai, Hiroshi; Terada, Yuka; Ozeki, Tetsuya] Nagoya City Univ, Grad Sch Pharmaceut Sci, Drug Delivery & Nano Pharmaceut, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Ozeki, T (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Drug Delivery & Nano Pharmaceut, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	ozekit@phar.nagoya-cu.ac.jp			SENSHIN Medical Research Foundation; Nagoya City University, Japan	This research was supported in part by a Grant from SENSHIN Medical Research Foundation and by a Grant-in-Aid for Research from Nagoya City University, Japan. According to the measurement of zeta potentials of liposomes, we express our appreciation to Dr. Noriko Ogawa, Dr. Chisato Takahashi who are the members of Dr. Hiromitsu Yamamoto's lab (Aichi-Gakuin University).	Lang KS, 2005, CELL PHYSIOL BIOCHEM, V15, P195, DOI 10.1159/000086406; Tagami T, 2011, BIOMATERIALS, V32, P6570, DOI 10.1016/j.biomaterials.2011.05.029; Dekkers DWC, 2002, BIOCHEM J, V362, P741, DOI 10.1042/0264-6021:3620741; Brand VB, 2003, CELL PHYSIOL BIOCHEM, V13, P347, DOI 10.1159/000075122; OWAIS M, 1995, ANTIMICROB AGENTS CH, V39, P180; Thapa N, 2008, J CELL MOL MED, V12, P1649, DOI 10.1111/j.1582-4934.2008.00305.x; Moreira JN, 2002, PHARMACEUT RES, V19, P265, DOI 10.1023/A:1014434732752; Santos-Magalhaes NS, 2010, ADV DRUG DELIVER REV, V62, P560, DOI 10.1016/j.addr.2009.11.024	8	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1649	1651				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200027		
J	Saita, T; Yamamoto, Y; Shin, M; Nakano, Y				Saita, Tetsuya; Yamamoto, Yuta; Shin, Masashi; Nakano, Yukitaka			Preparation of Antibodies and Development of an Enzyme-Linked Immunosorbent Assay for the Tyrosine Kinase Inhibitors Lapatinib and Nilotinib	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						lapatinib; nilotinib; tyrosine kinase inhibitor; enzyme-linked immunosorbent assay	CHRONIC MYELOID-LEUKEMIA; EXPOSURE-RESPONSE ANALYSIS; BCR-ABL; IMATINIB-RESISTANT; ORAL ABSORPTION; BREAST-CANCER; HUMAN PLASMA; PHARMACOKINETICS; QUANTIFICATION; GEFITINIB	In this paper, we describe the production of the first specific antibodies against the tyrosine kinase inhibitors lapatinib and nilotinib. Anti-lapatinib antibody was obtained by immunizing rabbits with an antigen conjugated with bovine serum albumin using 3-chloro-4((3-fluorobenzyl)oxy)aniline. Anti-nilotinib antibody was produced by immunizing mice with an antigen conjugated with bovine serum albumin using 2-(5-amino-2-methylanilino)-4-(3-pyridyl)pyrimidine. The generated antibodies were used to develop highly sensitive and specific enzyme-linked immunosorbent assays (ELISAs) for lapatinib and nilotinib in human serum. The assays were capable of detecting lapatinib and nilotinib at serum concentrations as low as 40 and 8 ng/mL, respectively. Using the two ELISAs, drugs levels were easily measured in the serum of rats after a single dose oral administration of lapatinib or nilotinib. The assays are therefore expected be valuable tools for therapeutic drug monitoring in the clinical setting and pharmacokinetic studies of lapatinib and nilotinib.	[Saita, Tetsuya; Yamamoto, Yuta; Shin, Masashi] Sojo Univ, Fac Biotechnol & Life Sci, Appl Life Sci Dept, Kumamoto 8600082, Japan; [Nakano, Yukitaka] Kyushu Cent Hosp, Dept Pharm, Minami Ku, Fukuoka 8158588, Japan	Saita, T (reprint author), Sojo Univ, Fac Biotechnol & Life Sci, Appl Life Sci Dept, 4-22-1 Ikeda, Kumamoto 8600082, Japan.	sait1102@life.sojo-u.ac.jp					Teng WC, 2010, MOL PHARMACOL, V78, P693, DOI 10.1124/mol.110.065839; Golemovic M, 2005, CLIN CANCER RES, V11, P4941, DOI 10.1158/1078-0432.CCR-04-2601; Koch KM, 2009, J CLIN ONCOL, V27, P1191, DOI 10.1200/JCO.2008.18.3285; Pirro E, 2011, J CHROMATOGR SCI, V49, P753; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Yin OQP, 2010, J CLIN PHARMACOL, V50, P960, DOI 10.1177/0091270009346061; Saita T, 2013, BIOL PHARM BULL, V36, P1964; Castellino S, 2012, DRUG METAB DISPOS, V40, P139, DOI 10.1124/dmd.111.040949; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Giles FJ, 2013, EUR J CLIN PHARMACOL, V69, P813, DOI 10.1007/s00228-012-1385-4; Gotze L, 2012, CLIN CHIM ACTA, V413, P143, DOI 10.1016/j.cca.2011.09.012; DeRemer DL, 2008, CLIN THER, V30, P1956, DOI 10.1016/j.clinthera.2008.11.014; Larson RA, 2012, EUR J CLIN PHARMACOL, V68, P723, DOI 10.1007/s00228-011-1200-7; Lankheet NAG, 2013, BIOMED CHROMATOGR, V27, P466, DOI 10.1002/bmc.2814; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; HOSODA H, 1981, CHEM PHARM BULL, V29, P170; Saita T, 2005, BIOL PHARM BULL, V28, P1833, DOI 10.1248/bpb.28.1833; Xia BF, 2012, BIOPHARM DRUG DISPOS, V33, P536, DOI 10.1002/bdd.1821; Fumoleau P, 2014, BREAST, V23, P663, DOI 10.1016/j.breast.2014.07.003; Ohgami M, 2013, JPN J THER DRUG MONI, V30, P125	21	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1652	1657				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200028		
J	Yagi-Utsumi, M; Dobson, CM				Yagi-Utsumi, Maho; Dobson, Christopher M.			Conformational Effects of the A21G Flemish Mutation on the Aggregation of Amyloid beta Peptide	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						amyloid beta; familial Alzheimer's disease; NMR spectroscopy; fibrillization; secondary structure	ALZHEIMERS-DISEASE; SECONDARY STRUCTURE; CEREBRAL-HEMORRHAGE; CIRCULAR-DICHROISM; PROTEIN; NUCLEATION; VARIANTS; NMR; NEUROTOXICITY; GANGLIOSIDES	Among the various hereditary mutants of amyloid beta (A beta) in familial Alzheimer's disease (AD), the A21G Flemish-type mutant has unique properties showing a low aggregation propensity but progressive deposition in vascular walls. Moreover, in contrast to other familial AD cases that show extensive A beta(1-42) deposition in the brain, patients with Flemish AD predominantly exhibit the deposition of the A beta(1-40) isoform. Here we report the structural characterization of the Flemish-type mutant (A21G) in comparison with the wild-type A beta(1-40) peptide to examine the possible effects of the A21G mutation on the conformation of the A beta(1-40) isoform. The kinetic analysis of the aggregation of the peptides monitored by thioflavin T fluorescence measurement indicates that the mutation precludes the initial nucleation process of amyloid fibril formation by A beta(1-40). Spectroscopic data indicate that the Flemish-type mutant bound to aqueous micelles composed of lyso-GM1, in which the mobile N-terminal segment is tethered through the C-terminal helical segment, has reduced alpha-helical structure compared to the wild-type peptide. Our findings suggest that the mutational perturbation to the membrane binding properties is coupled with the changes in nucleation behavior of A beta during its fibril formation.	[Yagi-Utsumi, Maho; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Yagi-Utsumi, M (reprint author), Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	mahoyagi@ims.ac.jp; cmd44@cam.ac.uk			JSPS/the Ministry of Eduction, Culture, Sports, Science and Technology (MEXT) KAKENHI [15K21680]; National Center for Geriatrics and Gerontology, the Nanotechnology Platform Program of MEXT of Japan [25-19]; Okazaki ORION project; Naito Foundation	We thank Drs. Tuomas Knowles (University of Cambridge) and Koichi Kato (National Institutes of Natural Sciences) for valuable discussions. We are also grateful to Georg Meisl and Dr. Celine Galvagnion for helpful advice. This work was supported in part by a JSPS/the Ministry of Eduction, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant-in-Aid for Yong Scientists (B) (15K21680 to M.Y.-U.), Research Funding for Longevity Sciences (25-19) from the National Center for Geriatrics and Gerontology, the Nanotechnology Platform Program of MEXT of Japan, and the Okazaki ORION project. M. Y.-U. is a recipient of the Naito Foundation Grant for Studying Overseas.	Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Meinhardt J, 2007, PROTEIN SCI, V16, P1214, DOI 10.1110/ps.062734207; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Huet A, 2006, BIOPHYS J, V91, P3829, DOI 10.1526/biophysj.106.090993; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Kumar-Singh S, 2002, AM J PATHOL, V161, P507, DOI 10.1016/S0002-9440(10)64207-1; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Juszczyk P, 2005, ACTA BIOCHIM POL, V52, P425; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Fawzi NL, 2008, BIOPHYS J, V94, P2007, DOI 10.1529/biophysj.107.121467; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Fantini J, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001602; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/nchembio.1750, 10.1038/NCHEMBIO.1750]; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Rodziewicz-Motowidlo S, 2007, BIOPOLYMERS, V87, P23, DOI 10.1002/bip.20768; Yagi-Utsumi M, 2010, INT J ALZHEIMERS DIS, V2011	36	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1668	1672				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200031		
J	Mukai, Y; Toda, T; Takeuchi, S; Senda, A; Yamashita, M; Eliasson, E; Rane, A; Inotsume, N				Mukai, Yuji; Toda, Takaki; Takeuchi, Satoya; Senda, Asuna; Yamashita, Miki; Eliasson, Erik; Rane, Anders; Inotsume, Nobuo			Simultaneous Determination Method of Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids by LC-MS/MS System	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						epoxyeicosatrienoic acid; dihydroxyeicosatrienoic acid; arachidonic acid; LC-MS/MS	TANDEM MASS-SPECTROMETRY; CYTOSOLIC EPOXIDE HYDROLASE; ARACHIDONIC-ACID; CYTOCHROME-P450 METABOLITES; ENDOTHELIAL-CELLS; LINOLEIC ACIDS; EICOSANOIDS; HYPERTENSION; ROLES; MONOOXYGENASES	Epoxyeicosatrienoic acids (EETs) are produced primarily by CYPs from arachidonic acid (AA) and then further metabolized to the corresponding dihydroxyeicosatrienoic acids (DHETs). EETs play important roles in physiological processes such as regulating vasodilation and inflammation. Thus, the drug inhibition of CYP-mediated AA metabolism could reduce production of EETs, potentially resulting in adverse cardiovascular events. The aim of this study was to develop a simple method to simultaneously determine the concentrations of both EETs and DHETs using a conventional LC-MS/MS system to evaluate drug-endogenous substance interactions, including eicosanoids. Eight eicosanoids (5,6-EET, 8,9-EET, 11,12-EET, 14,15-EET, 5,6-DHET, 8,9-DHET, 11,12-DHET, and 14,15-DHET) were detected with their corresponding deuterium-labeled eicosanoids as internal standards. The samples were purified by solid-phase extraction columns. Liquid chromatographic separation was achieved on a C18 column. DHETs and EETs were eluted at 4-7 and 18-26 mm, respectively. The weighted (1/y(2)) calibration curves were linear over a range of 5-2000nmol/L for EETs and 2-2000nmol/L for DHETs. In quality control (QC) samples, the recoveries of eicosanoids were 95.2-118%. The intra-day precisions were within 6% in all three QC samples, and the inter-day precisions were <16.7% at 50nmol/L, <8.6% at 200nmol/L, and <9.8% at 1000nmol/L. We have applied this method for the determination of the eicosanoid levels in samples from incubation studies of AA by using human recombinant CYP enzyme (rCYP), and confirmed that the method has sensitivity sufficient for assessment of rCYP incubation study.	[Mukai, Yuji; Toda, Takaki; Takeuchi, Satoya; Senda, Asuna; Inotsume, Nobuo] Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmacol, Sapporo, Hokkaido 0068590, Japan; [Yamashita, Miki] Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmaceut, Sapporo, Hokkaido 0068590, Japan; [Eliasson, Erik; Rane, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Pharmacol, SE-14186 Stockholm, Sweden	Toda, T (reprint author), Hokkaido Pharmaceut Univ, Sch Pharm, Div Clin Pharmacol, 7 Jo,15-4-1 Maeda, Sapporo, Hokkaido 0068590, Japan.	toda@hokuyakudai.ac.jp			JSPS [22590141]	This work was supported by JSPS KAKENHI Grant No. 22590141.	Fleming I, 2007, TRENDS PHARMACOL SCI, V28, P448, DOI 10.1016/j.tips.2007.08.002; ROSOLOWSKY M, 1990, CIRC RES, V66, P608; Nakamura T, 1997, J MASS SPECTROM, V32, P888, DOI 10.1002/(SICI)1096-9888(199708)32:8<888::AID-JMS548>3.0.CO;2-W; Nithipatikom K, 2001, ANAL BIOCHEM, V298, P327, DOI 10.1006/abio.2001.5395; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Gauthier KM, 2007, J CARDIOVASC PHARM, V50, P601; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Zhang JH, 2007, ANAL BIOCHEM, V365, P40, DOI 10.1016/j.ab.2007.03.001; Roman RJ, 2002, PHYSIOL REV, V82, P131; Edpuganti V, 2014, J CHROMATOGR B, V964, P153, DOI 10.1016/j.jchromb.2013.08.008; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; Blewett AJ, 2008, J PHARMACEUT BIOMED, V46, P653, DOI 10.1016/j.jpba.2007.11.047; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Imig JD, 2010, J CARDIOVASC PHARM, V56, P329, DOI 10.1097/FJC.0b013e3181e96e0c; Shinde DD, 2012, J CHROMATOGR B, V911, P113, DOI 10.1016/j.jchromb.2012.11.004; Williams JM, 2010, J CARDIOVASC PHARM, V56, P336, DOI 10.1097/FJC.0b013e3181f04b1c; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; VanRollins M, 1996, J BIOL CHEM, V271, P14001; SMITH WL, 1989, BIOCHEM J, V259, P315; Martin-Venegas R, 2014, J CHROMATOGR B, V964, P41, DOI 10.1016/j.jchromb.2014.05.024; Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Martin-Venegas R, 2011, J PHARMACEUT BIOMED, V56, P976, DOI 10.1016/j.jpba.2011.06.018; Yue HF, 2007, J PHARMACEUT BIOMED, V43, P1122, DOI 10.1016/j.jpba.2006.10.009; Zeldin DC, 1996, ARCH BIOCHEM BIOPHYS, V330, P87, DOI 10.1006/abbi.1996.0229; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478; Nithipatikom K, 2006, AM J PHYSIOL-HEART C, V290, pH500, DOI 10.1152/ajphcart.00918.2005; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200	32	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2015	38	10					1673	1679				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CS4LL	WOS:000362047200032		
J	Uju; Wijayanta, AT; Goto, M; Kamiya, N				Uju; Wijayanta, Agung Tri; Goto, Masahiro; Kamiya, Noriho			Great potency of seaweed waste biomass from the carrageenan industry for bioethanol production by peracetic acid-ionic liquid pretreatment	BIOMASS & BIOENERGY			English	Article						Enzymatic saccharification; Ionic liquids; Peracetic acid; Pretreatment; Carrageenan industry seaweed waste biomass	CELLULOSE; EXTRACTION; WOOD; HYDROLYSIS; FEEDSTOCKS; MECHANISM; LIGNIN	Seaweed waste biomass from the carrageenan industry (SWBC) is a potential biomass feedstock for producing sustainable biofuel because it increases the product value and reduces the pollutant risk. Peracetic acid (PAA) followed by ionic liquid (IL) pretreatment has been used to increase the enzymatic saccharification of pretreated SWBC. The SWBC cellulose content was comparable with that of terrestrial biomasses. PAA + 1-hexylpyridinium chloride [(Hpy][Cl]), and PAA + 1-ethyl-3-methylimidazolium diethylphosphate ([Emim][DEP]) pretreatments produced saccharide and unknown oligosaccharide fractions in regenerated water (similar to 4-6% SWBC cellulose content). For 48 h of saccharification, the untreated SWBC and the SWBC pretreated using PAA followed by [Hpy][Cl], [Emim][DEP] or 1-ethyl-3-methylimidazole acetate ([Emim][OAc]) produced cellulose conversions of 77, 91, 84 and 62%, respectively. The untreated SWBC had a high cellulose conversion, which may be caused by the low lignin and hemicellulose contents of the SWBC. PAA + IL pretreatment could yield pretreated SWBCs with more amorphous cellulose structures, which lead to an almost-complete cellulose conversion. (c) 2015 Elsevier Ltd. All rights reserved.	[Uju] Bogor Agr Univ, Dept Aquat Prod Technol, Bogor 16680, Indonesia; [Uju] Bogor Agr Univ, Surfactant & Bioenergy Res Ctr, Bogor 16144, Indonesia; [Wijayanta, Agung Tri] Sebelas Maret Univ, Dept Mech Engn, Fac Engn, Surakarta 57126, Indonesia; [Goto, Masahiro; Kamiya, Noriho] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Goto, Masahiro; Kamiya, Noriho] Kyushu Univ, Ctr Future Chem, Nishi Ku, Fukuoka 8190395, Japan	Uju (reprint author), Bogor Agr Univ, Dept Aquat Prod Technol, J1 Lingkar Akad Kampus IPB Darmaga, Bogor 16680, Indonesia.	ujusadi@ipb.ac.id					Yasuno S, 1997, BIOSCI BIOTECH BIOCH, V61, P1944; Bixler HJ, 2011, J APPL PHYCOL, V23, P321, DOI 10.1007/s10811-010-9529-3; Wijayanta AT, 2012, BIORESOURCE TECHNOL, V110, P645, DOI 10.1016/j.biortech.2012.01.068; Siddhanta AK, 2009, BIORESOURCE TECHNOL, V100, P6669, DOI 10.1016/j.biortech.2009.07.047; Sen M, 2010, FOOD RES INT, V43, P1361, DOI 10.1016/j.foodres.2010.03.021; Lee SH, 2009, BIOTECHNOL BIOENG, V102, P1368, DOI 10.1002/bit.22179; Casas A, 2012, J CHEM TECHNOL BIOT, V87, P472, DOI 10.1002/jctb.2724; Jung KA, 2013, BIORESOURCE TECHNOL, V135, P182, DOI 10.1016/j.biortech.2012.10.025; Alvira P, 2010, BIORESOURCE TECHNOL, V101, P4851, DOI 10.1016/j.biortech.2009.11.093; Azevedo G, 2013, FOOD HYDROCOLLOID, V31, P94, DOI 10.1016/j.foodhyd.2012.10.010; Oh SY, 2005, CARBOHYD RES, V340, P2376, DOI 10.1016/j.carres.2005.08.007; Stromme M, 2002, MATER LETT, V57, P569, DOI 10.1016/S0167-577X(02)00831-5; Adams JM, 2009, J APPL PHYCOL, V21, P569, DOI 10.1007/s10811-008-9384-7; Chang VS, 2000, APPL BIOCHEM BIOTECH, V84-6, P5, DOI 10.1385/ABAB:84-86:1-9:5; Wu H, 2011, BIOTECHNOL BIOENG, V108, P2865, DOI 10.1002/bit.23266; Freile-Pelegrin Y, 2006, BOT MAR, V49, P65, DOI 10.1515/BOT.2006.008; Banerjee S, 2010, BIOFUEL BIOPROD BIOR, V4, P77, DOI 10.1002/bbb.188; Hayes DJ, 2009, CATAL TODAY, V145, P138, DOI 10.1016/j.cattod.2008.04.017; EVANS PD, 1992, WOOD SCI TECHNOL, V26, P151; REVOL JF, 1981, J APPL POLYM SCI, V26, P1275, DOI 10.1002/app.1981.070260419; Wijayanta AT, 2014, FUEL PROCESS TECHNOL, V117, P53, DOI 10.1016/j.fuproc.2013.01.012; Hoffmann RA, 1995, FOOD HYDROCOLLOID, V9, P281; Daroch M, 2013, APPL ENERG, V102, P1371, DOI 10.1016/j.apenergy.2012.07.031; Conde-Mejia C, 2012, PROCESS SAF ENVIRON, V90, P189, DOI 10.1016/j.psep.2011.08.004; Ge L, 2009, RENEW ENERG, V36, P84; Nelson M. L., 1964, J APPL POLYM SCI, V8, P1311, DOI DOI 10.1002/APP.1964.070080322; [OECD FAO], 2014, OECD FAO AGR OUTL, DOI [http://dx.doi.org/10.1787/agr_outlook-2014-en, DOI 10.1787/AGR_0UTL00K-2014-EN]; Uju A., 2013, BIORESOURCE TECHNOL, V135, P103, DOI DOI 10.1016/J.BI0RTECH.2012.06.096; Uju K., 2013, BIORESOURCE TECHNOL, V138, P87; Uju Y., 2012, BIORESOURCE TECHNOL, V103, P446; Van Soest P. J., 1970, AGR HDB, V379	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0961-9534	1873-2909		BIOMASS BIOENERG	Biomass Bioenerg.	OCT	2015	81						63	69		10.1016/j.biombioe.2015.05.023		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CS5QZ	WOS:000362134400010		
J	Tan, L; Sun, ZY; Okamoto, S; Takaki, M; Tang, YQ; Morimura, S; Kida, K				Tan, Li; Sun, Zhao-Yong; Okamoto, Shinpei; Takaki, Masatoshi; Tang, Yue-Qin; Morimura, Shigeru; Kida, Kenji			Production of ethanol from raw juice and thick juice of sugar beet by continuous ethanol fermentation with flocculating yeast strain KF-7	BIOMASS & BIOENERGY			English	Article						Beta vulgaris; Continuous fermentation; Flocculating yeast; Two-stage fermentation with fresh yeast cells feed; High ethanol concentration	SWEET SORGHUM JUICE; FUEL	Sugar beet juice can serve as feedstock for ethanol product due to its high content of fermentable sugars and high energy output/input ratio. Batch ethanol fermentation of raw juice and thick juice proved that addition of mineral nutrients could not improve ethanol concentration, but could accelerate the fermentation rate. Fermentation of thick juice with an initial pH of 9.1 did not affect the fermentation process. The continuous ethanol fermentation of raw juice was performed at 35 degrees C with a dilution rate of 0.3 h(-1), resulting in ethanol concentration, ethanol yield and productivity of 70.7 g L-1, 89.8% and 21.2 g L-1 h(-1), respectively. A two-stage reactor was used in the continuous ethanol fermentation of thick juice by feeding fresh yeast cells into the second reactor. This process was stable at a total process dilution rate of 0.11 h(-1) with an overall sugar concentration of 190 g L-1 in the influent. The ethanol concentration was kept at approximately 80 g L-1, corresponding to ethanol yield of 82.5% and productivity of 8.8 g L-1 h(-1). (c) 2015 Elsevier Ltd. All rights reserved.	[Tan, Li; Sun, Zhao-Yong; Tang, Yue-Qin; Kida, Kenji] Sichuan Univ, Coll Architecture & Environm, Chengdu 610065, Peoples R China; [Okamoto, Shinpei; Takaki, Masatoshi; Morimura, Shigeru; Kida, Kenji] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Sun, ZY (reprint author), Sichuan Univ, Coll Architecture & Environm, 24 South Sect 1,First Ring Rd, Chengdu 610065, Peoples R China.	szy198306@hotmail.com					Koga N, 2008, AGR ECOSYST ENVIRON, V125, P101, DOI 10.1016/j.agee.2007.12.002; KIDA K, 1991, J FERMENT BIOENG, V72, P54, DOI 10.1016/0922-338X(91)90146-8; Andrzejewski B, 2013, IND CROP PROD, V49, P648, DOI 10.1016/j.indcrop.2013.06.027; [Anonymous], 88 STAT YB MIN AGR F; Takaki M, 2015, IND CROP PROD, V63, P329, DOI 10.1016/j.indcrop.2014.10.009; Balat M, 2008, PROG ENERG COMBUST, V34, P551, DOI 10.1016/j.pecs.2007.11.001; Grahovac J, 2012, FUEL, V93, P221, DOI 10.1016/j.fuel.2011.10.019; KIDA K, 1990, J FERMENT BIOENG, V69, P39, DOI 10.1016/0922-338X(90)90161-O; Tang Y, 2006, PROCESS BIOCHEM, V41, P909, DOI 10.1016/j.procbio.2005.09.008; Dodic S, 2009, BIOMASS BIOENERG, V33, P822, DOI 10.1016/j.biombioe.2009.01.002; Kawa-Rygielska J, 2013, BIORESOURCE TECHNOL, V133, P134, DOI 10.1016/j.biortech.2013.01.070; Balat M, 2011, ENERG CONVERS MANAGE, V52, P858, DOI 10.1016/j.enconman.2010.08.013; Zabed H, 2014, SCI WORLD J, DOI 10.1155/2014/957102; Razmovski R, 2012, FUEL, V92, P1, DOI 10.1016/j.fuel.2011.07.046; KIDA K, 1992, J FERMENT BIOENG, V74, P169, DOI 10.1016/0922-338X(92)90078-9; Vargas-Ramirez JM, 2013, BIOMASS BIOENERG, V59, P362, DOI 10.1016/j.biombioe.2013.07.014; Tang YQ, 2010, J BIOSCI BIOENG, V109, P41, DOI 10.1016/j.jbiosc.2009.07.002; Miyagawa H, 2011, J I BREWING, V117, P91; Ogbonna JC, 2001, BIORESOURCE TECHNOL, V76, P1, DOI 10.1016/S0960-8524(00)00084-5; Muthaiyan A, 2011, PROG ENERG COMBUST, V37, P351, DOI 10.1016/j.pecs.2010.06.005; Tang YQ, 2008, BIOMASS BIOENERG, V32, P1037, DOI 10.1016/j.biombioe.2008.01.027; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; Dziugan P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-158; Vucurovic DG, 2012, BIORESOURCE TECHNOL, V104, P367, DOI 10.1016/j.biortech.2011.10.085; Vučurovic´ V. M., 2013, Acta Periodica Technologica, V44, P313; Zhang NN, 2014, BIORESOURCE TECHNOL, V155, P189, DOI 10.1016/j.biortech.2013.12.081	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0961-9534	1873-2909		BIOMASS BIOENERG	Biomass Bioenerg.	OCT	2015	81						265	272		10.1016/j.biombioe.2015.07.019		8	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CS5QZ	WOS:000362134400034		
J	Soda, S; Ohchi, T; Piradee, J; Takai, Y; Ike, M				Soda, Satoshi; Ohchi, Takeshi; Piradee, Jusakulvijit; Takai, Yuichiro; Ike, Michihiko			Duckweed biomass as a renewable biorefinery feedstock: Ethanol and succinate production from Wolffia globosa	BIOMASS & BIOENERGY			English	Article						Duckweed; Chemical constituent; Ethanol; Succinate	LEMNA-MINOR; NUTRIENT REMOVAL; WASTE-WATER; BIOETHANOL; CONVERSION; LETTUCE; ARRHIZA; GROWTH; ACID	For evaluating duckweed biomass as a bioresource, the specific growth rate and the chemical constituents of duckweed of four kinds were investigated. Spirodela polyrrhiza, Lemna minor, Wolffia arrhiza, and Wolffia globosa commonly showed high specific growth rates of 0.22-0.30 d(-1) with initial concentrations of nitrogen >3.0 kg m(-3) and phosphorus >5.0 kg m(-3). All duckweeds had high sugar contents greater than 300 g kg(-1) of dry mass. Especially, vegetative fronds of W. globosa showed the highest sugar content of 410 g kg(-1) of dry mass. The duckweed biomass was pretreated easily by heating at 121 degrees C for saccharification using a-amylase and amyloglucosidase. The ethanol yield of W. globosa biomass in the simultaneous saccharification and fermentation (SSF) using the enzymes and dry yeast was 170 g kg(-1) of dry mass, whereas the succinate yield in the SSF using the enzymes and Actinobacillus succinogenes was 200 g kg(-1) of dry mass. The production rates of ethanol and succinate from the W. globosa biomass were estimated as 0.58 kg m(-2) y(-1) and 0.68 kg m(2) y(-1), respectively. The biomass of duckweed, with its high growth rate and high starch content, can be an excellent renewable feedstock for the production of ethanol and succinate as building block chemicals for the replacement of petrochemicals. (C) 2015 Elsevier Ltd. All rights reserved.	[Soda, Satoshi; Ohchi, Takeshi; Piradee, Jusakulvijit; Takai, Yuichiro; Ike, Michihiko] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan	Soda, S (reprint author), Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	soda@see.eng.osaka-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST)	This study was partly supported by Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency (JST). We appreciate Prof. M. Morikawa (Hokkaido University) for providing us L. minor, Dr. K. Mori (University of Yamanashi) for providing us W. globosa, Prof. E. Landolt for providing us W. globosa (Swiss Federal Institute for Technology), and Mr. T. Yahara (Osaka University) for preliminary trials of succinate fermentation.	Zhao X, 2012, BIOMASS BIOENERG, V47, P354, DOI 10.1016/j.biombioe.2012.09.025; Peng JF, 2007, ECOL MODEL, V206, P147, DOI 10.1016/j.ecolmodel.2007.03.029; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Fujita M, 1999, J BIOSCI BIOENG, V87, P194, DOI 10.1016/S1389-1723(99)89012-4; Mishima D, 2008, BIORESOURCE TECHNOL, V99, P2495, DOI 10.1016/j.biortech.2007.04.056; Witty Michael, 2009, International Journal of Botany, V5, P307, DOI 10.3923/ijb.2009.307.313; Ge XM, 2012, BIORESOURCE TECHNOL, V124, P485, DOI 10.1016/j.biortech.2012.08.050; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; Xu JL, 2011, BIOSYST ENG, V110, P67, DOI 10.1016/j.biosystemseng.2011.06.007; Soda S, 2013, ECOL ENG, V57, P210, DOI 10.1016/j.ecoleng.2013.04.023; Soda S, 2013, WATER SCI TECHNOL, V67, P2637, DOI 10.2166/wst.2013.188; Zeikus JG, 1999, APPL MICROBIOL BIOT, V51, P545, DOI 10.1007/s002530051431; ORON G, 1988, WATER RES, V22, P179, DOI 10.1016/0043-1354(88)90076-0; Oslaj M, 2010, BIOMASS BIOENERG, V34, P1538, DOI 10.1016/j.biombioe.2010.04.016; Cheng JJ, 2009, CLEAN-SOIL AIR WATER, V37, P17, DOI 10.1002/clen.200800210; Suzuki W, 2014, J BIOSCI BIOENG, V118, P41, DOI 10.1016/j.jbiosc.2013.12.007; ORON G, 1994, AGR WATER MANAGE, V26, P27, DOI 10.1016/0378-3774(94)90022-1; Lasfar S, 2007, WATER RES, V41, P2333, DOI 10.1016/j.watres.2007.01.059; Campanella A., 2008, BIORESOURCE TECHNOL, V109, P154; Chanda S., 1992, AQUAT BOT, V42, P81; Hoagland D. R., 1940, SOIL SCI, V60, P463; Japanese Standard Association, 1993, TEST METH IND WAST, pK0102; Leng RA, 1995, LIVEST RES RURAL DEV, V7, P1; Mori K., 2005, JPN J WATER TREAT BI, V41, P129, DOI 10.2521/jswtb.41.129; Sluiter A., 2011, TP51042618 NAT REN E, P18; Sluiter A., 2008, TP51042622 NAT REN E, P5; Takai Y., 2014, JPN J WATER TREAT BI, V50, P133; Takai Y., 2012, J WATER WASTE, V54, P613	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0961-9534	1873-2909		BIOMASS BIOENERG	Biomass Bioenerg.	OCT	2015	81						364	368		10.1016/j.biombioe.2015.07.020		5	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CS5QZ	WOS:000362134400045		
J	Tanaka, Y; Wakida, S				Tanaka, Yoshio; Wakida, Shin-ichi			Time-shared optical tweezers with a microlens array for dynamic microbead arrays	BIOMEDICAL OPTICS EXPRESS			English	Article							BEAD ARRAYS; MANIPULATION; TRAP; DESIGN	Dynamic arrays of microbeads and cells offer great flexibility and potential as platforms for sensing and manipulation applications in various scientific fields, especially biology and medicine. Here, we present a simple method for assembling and manipulating dense dynamic arrays based on time-shared scanning optical tweezers with a microlens array. Three typical examples, including the dynamic and simultaneous bonding of microbeads in real-time, are demonstrated. The optical design and the hardware setup for our approach are also described. (C) 2015 Optical Society of America	[Tanaka, Yoshio; Wakida, Shin-ichi] Natl Inst Adv Ind Sci & Technol, Takamatsu, Kagawa 7610395, Japan	Tanaka, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Takamatsu, Kagawa 7610395, Japan.	yo-tanaka@aist.go.jp			JSPS KAKENHI Grant [15K05921]	We would like to thank Dr. Shigeyuki Takahara of Kagawa Prefectural Industrial Technology Center for 3D-printing of a microlens array folder. This work was partly supported by JSPS KAKENHI Grant No. 15K05921.	Tanaka Y, 2009, OPT EXPRESS, V17, P24102, DOI 10.1364/OE.17.024102; Manesse M, 2013, LAB CHIP, V13, P2153, DOI 10.1039/c3lc00044c; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Rodrigo PJ, 2009, OPT EXPRESS, V17, P6578, DOI 10.1364/OE.17.006578; Mio C, 2000, REV SCI INSTRUM, V71, P2196, DOI 10.1063/1.1150605; Terray A, 2002, SCIENCE, V296, P1841, DOI 10.1126/science.1072133; Chiou PY, 2005, NATURE, V436, P370, DOI 10.1038/nature03831; Tanaka Y, 2011, OPT EXPRESS, V19, P15445, DOI 10.1364/OE.19.015445; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; SASAKI K, 1991, JPN J APPL PHYS 2, V30, pL907, DOI 10.1143/JJAP.30.L907; Fallman E, 1997, APPL OPTICS, V36, P2107, DOI 10.1364/AO.36.002107; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Arneborg N, 2005, FEMS MICROBIOL LETT, V245, P155, DOI 10.1016/j.femsle.2005.03.008; Tanaka Y, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/2/025708; Sinclair G, 2004, OPT EXPRESS, V12, P5475, DOI 10.1364/OPEX.12.005475; Gluckstad J., 2009, GEN PHASE CONTRAST; Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104	17	1	1	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	OCT 1	2015	6	10					3670	3677		10.1364/BOE.6.003670		8	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CS7AT	WOS:000362236600001		
J	Dudzic, JP; Kondo, S; Ueda, R; Bergman, CM; Lemaitre, B				Dudzic, Jan P.; Kondo, Shu; Ueda, Ryu; Bergman, Casey M.; Lemaitre, Bruno			Drosophila innate immunity: regional and functional specialization of prophenoloxidases	BMC BIOLOGY			English	Article						Drosophila; Prophenoloxidase; Melanization; Gene family; Immunity; Duplication	MELANIZATION REACTION; GENE DUPLICATION; CRYSTAL CELLS; BLOOD-CELLS; EVOLUTION; PHENOLOXIDASE; MELANOGASTER; INFECTION; SYSTEM; RESPONSES	Background: The diversification of immune systems during evolution involves the expansion of particular gene families in given phyla. A better understanding of the metazoan immune system requires an analysis of the logic underlying such immune gene amplification. This analysis is now within reach due to the ease with which we can generate multiple mutations in an organism. In this paper, we analyze the contribution of the three Drosophila prophenoloxidases (PPOs) to host defense by generating single, double and triple mutants. PPOs are enzymes that catalyze the production of melanin at the site of infection and around parasites. They are the rate-limiting enzymes that contribute to the melanization reaction, a major immune mechanism of arthropods. The number of PPO-encoding genes is variable among insects, ranging from one in the bee to ten in the mosquito. Results: By analyzing mutations alone and in combination, we ascribe a specific function to each of the three PPOs of Drosophila. Our study confirms that two PPOs produced by crystal cells, PPO1 and PPO2, contribute to the bulk of melanization in the hemolymph, upon septic or clean injury. In contrast, PPO3, a PPO restricted to the D. melanogaster group, is expressed in lamellocytes and contributes to melanization during the encapsulation process. Interestingly, another overlapping set of PPOs, PPO2 and PPO3, achieve melanization of the capsule upon parasitoid wasp infection. Conclusions: The use of single or combined mutations allowed us to show that each PPO mutant has a specific phenotype, and that knocking out two of three genes is required to abolish fully a particular function. Thus, Drosophila PPOs have partially overlapping functions to optimize melanization in at least two conditions: following injury or during encapsulation. Since PPO3 is restricted to the D. melanogaster group, this suggests that production of PPO by lamellocytes emerged as a recent defense mechanism against parasitoid wasps. We conclude that differences in spatial localization, immediate or late availability, and mode of activation underlie the functional diversification of the three Drosophila PPOs, with each of them having non-redundant but overlapping functions.	[Dudzic, Jan P.; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Kondo, Shu; Ueda, Ryu] Natl Inst Genet, Genet Strains Res Ctr, Invertebrate Genet Lab, Mishima, Shizuoka 4118540, Japan; [Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Lemaitre, B (reprint author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland.	bruno.lemaitre@epfl.ch	Bergman, Casey/F-7854-2010	Bergman, Casey/0000-0002-5462-9854			Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Palmer WJ, 2015, MOL BIOL EVOL, V32, P2111, DOI 10.1093/molbev/msv093; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; Chen Y, 2012, DEV COMP IMMUNOL, V38, P88, DOI 10.1016/j.dci.2012.04.007; Chen ZX, 2014, GENOME RES, V24, P1209, DOI 10.1101/gr.159384.113; Markus R, 2015, J INNATE IMMUN, V7, P340, DOI 10.1159/000369618; Scannell DR, 2008, GENOME RES, V18, P137, DOI 10.1101/gr.6341207; Ferjoux G, 2007, DEV BIOL, V305, P726, DOI 10.1016/j.ydbio.2007.03.010; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Nam HJ, 2008, MOL CELLS, V26, P606; Keebaugh ES, 2014, DEV COMP IMMUNOL, V42, P111, DOI 10.1016/j.dci.2013.06.001; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Nam HJ, 2012, EMBO J, V31, P1253, DOI 10.1038/emboj.2011.476; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Castillejo-Lopez C, 2005, BIOCHEM BIOPH RES CO, V338, P1075, DOI 10.1016/j.bbrc.2005.10.042; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Tang HP, 2009, FLY, V3, P105; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Vlisidou I, 2015, FEBS J, V282, P1368, DOI 10.1111/febs.13235; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Neyen C, 2014, METHODS, V68, P116, DOI 10.1016/j.ymeth.2014.02.023; Gascuel O, 1997, MOL BIOL EVOL, V14, P685; Bretscher AJ, 2015, BIOL OPEN, V4, P355, DOI 10.1242/bio.201410595; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Hauling T, 2014, BIOL OPEN, V3, P250, DOI 10.1242/bio.20146494; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; Kacsoh BZ, 2012, THESIS EMORY U; Leitao AB, 2015, ELIFE, V4, DOI 10.7554/eLife.06166; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Neyen C, 2015, DEV COMP IMMUNOL, V50, P166, DOI 10.1016/j.dci.2014.12.011; Rizki T.M., 1984, P579; Salazar-Jaramillo L, 2014, GENOME BIOL EVOL, V6, P273, DOI 10.1093/gbe/evu012; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94	60	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1741-7007			BMC BIOL	BMC Biol.	OCT 1	2015	13								81	10.1186/s12915-015-0193-6		16	Biology	Life Sciences & Biomedicine - Other Topics	CS7QN	WOS:000362280000001		
J	Kawakatsu, Y; Sugishita, T; Tsutsui, J; Oruenjo, K; Wakhule, S; Kibosia, K; Were, E; Honda, S				Kawakatsu, Yoshito; Sugishita, Tomohiko; Tsutsui, Junya; Oruenjo, Kennedy; Wakhule, Stephen; Kibosia, Kennedy; Were, Eric; Honda, Sumihisa			Individual and contextual factors associated with community health workers' performance in Nyanza Province, Kenya: a multilevel analysis	BMC HEALTH SERVICES RESEARCH			English	Article						Community health workers; Human resource; Performance; Multilevel analysis; Contextual factor; Rural area; Kenya	DHAKA URBAN SLUMS; CHILDHOOD ILLNESSES; MANAGEMENT; RETENTION; BANGLADESH; DISTRICT; ACHIEVE; QUALITY; SIAYA; GOALS	Background: Several African and South Asian countries are currently investing in new cadres of community health workers (CHWs) as a major part of strategies aimed at reaching the Millennium Development Goals. However, one review concluded that community health workers did not consistently provide services likely to have substantial effects on health and that quality was usually poor. The objective of this research was to assess the CHWs' performance in Western Kenya and describe determinants of that performance using a multilevel analysis of the two levels, individual and supervisor/community. Methods: This study conducted three surveys between August and September 2011 in Nyanza Province, Kenya. The participants of the three surveys were all 1,788 active CHWs, all their supervisors, and 2,560 randomly selected mothers who had children aged 12 to 23 months. CHW performance was generated by three indicators: reporting rate, health knowledge and household coverage. Multilevel analysis was performed to describe the determinants of that performance. Results: The significant factors associated with the CHWs' performance were their marital status, educational level, the size of their household, their work experience, personal sanitation practice, number of supervisions received and the interaction between their supervisors' better health knowledge and the number of supervisions. Conclusion: A high quality of routine supervisions is one of the key interventions in sustaining a CHW's performance. In addition, decreasing the dropout rate of CHWs is important both for sustaining their performance and for avoiding the additional cost of replacing them. As for the selection criteria of new CHWs, good educational status, availability of supporters for household chores and good sanitation practices are all important in selecting CHWs who can maintain their high performance level.	[Kawakatsu, Yoshito; Sugishita, Tomohiko] JICA SEMAH Project, Kisumu, Kenya; [Kawakatsu, Yoshito; Honda, Sumihisa] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Tsutsui, Junya] Ritsumeikan Univ, Coll Social Sci, Kyoto, Japan; [Oruenjo, Kennedy; Wakhule, Stephen; Kibosia, Kennedy; Were, Eric] Minist Publ Hlth & Sanitat, Nairobi, Kenya	Kawakatsu, Y (reprint author), JICA SEMAH Project, Kisumu, Kenya.	y.kawakatsu.0829@gmail.com			JICA SEMAH Project	The JICA SEMAH Project supported and funded this survey as part of their project activities. DHMT members in our research area also supported this study. The authors would like to thank everyone who assisted with this research, with special thanks to the Ministry of Health, Kenya and all participants.	Ahmed SM, 2008, BRAC U J, V1, P39; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alam K, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-29; Kalyango JN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-282; Amare Y., 2009, 1 JSI RES TRAIN I IN; Amoran O E, 2005, Niger J Med, V14, P195; Anand PS, 2004, LANCET, V364, P1603; Rowe SY, 2006, INT J QUAL HEALTH C, V18, P299, DOI 10.1093/intqhc/mzl009; BERMAN PA, 1987, SOC SCI MED, V25, P443, DOI 10.1016/0277-9536(87)90168-7; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Olang'o CO, 2010, HEALTH POLICY, V97, P232, DOI 10.1016/j.healthpol.2010.05.004; Ande O, 2004, HEALTH EDUC RES, V19, P110, DOI 10.1093/her/cyg004; Puett C, 2012, FOOD NUTR BULL, V33, P273; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Alam K, 2012, SOC SCI MED, V75, P511, DOI 10.1016/j.socscimed.2012.03.039; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; Kawakatsu Y, 2012, VACCINE, V30, P7588, DOI 10.1016/j.vaccine.2012.10.037; Guo G, 2000, ANNU REV SOCIOL, V26, P441, DOI 10.1146/annurev.soc.26.1.441; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Rowe SY, 2007, TROP MED INT HEALTH, V12, P651, DOI 10.1111/j.1365-3156.2007.01824.x; Stekelenburg J, 2003, HEALTH POLICY, V65, P109, DOI 10.1016/S0168-8510(02)00207-5; Gilroy K, 2006, MANAGEMENT SICK CHIL; Gopalan SS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001557; Kawakatsu Y, 2012, PRIMARY HLTH CARE RE, V13, P1; Kenya MoH, 2005, REV TRENDS 2 NAT HLT; Kok MC, 2014, HLTH POLICY PLAN, V11; Lopes SC, 2014, GUINEA BISSAU HUMAN, V12, P8; Ministry of Health, 2007, KEN LINK COMM HLTH S; Ministry of public health and sanitation AH, 2008, MIN PUBL HLTH SAN ST; Perez F, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-28; Rabe-Hesketh S, 2002, STATA J, V2, P1; Rahman SM, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-12; SPECTOR PE, 1985, AM J COMMUN PSYCHOL, V13, P693, DOI 10.1007/BF00929796; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; World Health Organization, 2006, WORK TOG HLTH WORLD; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340	37	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6963			BMC HEALTH SERV RES	BMC Health Serv. Res.	OCT 1	2015	15								442	10.1186/s12913-015-1117-4		10	Health Care Sciences & Services	Health Care Sciences & Services	CS4WP	WOS:000362077100001		
J	Suzuki, R				Suzuki, Ritsuro			Treatment of extranodal NK and T-cell lymphoma	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Suzuki, Ritsuro] Shimane Univ Hosp, Dept Hematol & Oncol, Izumo, Shimane, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	17	11	11				1	Hematology	Hematology	CS9QG	WOS:000362425300016		
J	Mellgren, K; Chiang, A; Abla, O; Alexander, S; Plat, G; Myakova, N; Meyer-Wentrup, F; Kobayashi, R; Pillon, M; Bubanska, E; Kabickova, E; Krenova, Z; Fedorova, A; Wrobel, G; Klapper, W; Williams, D; Attarbaschi, A; Kontny, U				Mellgren, K.; Chiang, A.; Abla, O.; Alexander, S.; Plat, G.; Myakova, N.; Meyer-Wentrup, F.; Kobayashi, R.; Pillon, M.; Bubanska, E.; Kabickova, E.; Krenova, Z.; Fedorova, A.; Wrobel, G.; Klapper, W.; Williams, D.; Attarbaschi, A.; Kontny, U.		EICNHL I-BFM Study Grp	Non-anaplastic peripheral T-cell lymphoma in children and adolescents - International review	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Mellgren, K.] Queen Silvia Hosp Children, Gothenburg, Sweden; [Chiang, A.] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Abla, O.; Alexander, S.] Hosp Sick Children, Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Plat, G.] Children Pediat Oncol Hematol Unit, Toulouse, France; [Myakova, N.] Fed Ctr Pediat Hem Onc Immunol, Moscow, Russia; [Meyer-Wentrup, F.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Kobayashi, R.] Sapporo Hokuyu Hosp, Dept Paediat, Sapporo, Hokkaido, Japan; [Pillon, M.] Clin Pediat Hematooncol, Padua, Italy; [Bubanska, E.] Comenius Univ, Dept Pediat Hematol & Oncol, Bratislava, Slovakia; [Kabickova, E.] Charles Univ Prague, Prague, Czech Republic; [Kabickova, E.] Univ Hosp Motol, Prague, Czech Republic; [Krenova, Z.] Children Pediat Oncol Hematol Clin, Brno, Czech Republic; [Fedorova, A.] Belarusian Res Ctr Pediat Oncol Hematol & Immunol, Minsk, Byelarus; [Wrobel, G.] Med Univ, Wroclaw, Poland; [Klapper, W.] Univ Kiel, Dept Pathol, Kiel, Germany; [Williams, D.] Addenbrookes Hosp, CUHFT, Cambridge, England; [Attarbaschi, A.] Med Univ Vienna, St Anna Childrens Hosp, Vienna, Austria; [Kontny, U.] Univ Med Ctr Aachen, Div Pediat Hematol Oncol & Stem Cell Transplantat, Aachen, Germany								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	19	13	13				1	Hematology	Hematology	CS9QG	WOS:000362425300018		
J	Ueyama, J; Kobayashi, R; Tanaka, F; Sunami, S; Mitsui, T; Koga, Y; Mori, T; Osumi, T; Fukano, R; Ohki, K; Sekimizu, M; Mori, T; Inoue, M; Kikuta, A; Goto, H; Sakamaki, H; Sawada, A; Kato, K; Suzuki, R; Atuta, Y				Ueyama, Jun-ichi; Kobayashi, Ryoji; Tanaka, Fumiko; Sunami, Shosuke; Mitsui, Tetsuo; Koga, Yuhki; Mori, Takeshi; Osumi, Tomoo; Fukano, Reiji; Ohki, Kentaro; Sekimizu, Masahiro; Mori, Tetsuya; Inoue, Masami; Kikuta, Atushi; Goto, Hiroaki; Sakamaki, Hisashi; Sawada, Akihisa; Kato, Koji; Suzuki, Rituro; Atuta, Yoshiko			Incidence and risk factors of pediatric post-transplant lymphoproliferative disorder following allogenic hematopoietic stem cell transplantation: Japan Society for Hematopoietic Cell Transplantation (JSHCT) collaborative study	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Ueyama, Jun-ichi; Kobayashi, Ryoji; Tanaka, Fumiko; Sunami, Shosuke; Mitsui, Tetsuo; Koga, Yuhki; Mori, Takeshi; Osumi, Tomoo; Fukano, Reiji; Ohki, Kentaro; Sekimizu, Masahiro; Mori, Tetsuya] Japanese Pediat Leukemia Lymphoma Study Grp, Lymphoma Comm, Yonago, Tottori, Japan; [Inoue, Masami; Kikuta, Atushi; Goto, Hiroaki; Sakamaki, Hisashi; Sawada, Akihisa; Kato, Koji; Suzuki, Rituro; Atuta, Yoshiko] JSHCT, Yonago, Tottori, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	49	31	31				1	Hematology	Hematology	CS9QG	WOS:000362425300047		
J	Fukano, R; Kobayashi, R; Mori, T; Fujita, N; Mitsui, T; Kato, K; Suzuki, R; Suzumiya, J				Fukano, Reiji; Kobayashi, Ryoji; Mori, Tetsuya; Fujita, Naoto; Mitsui, Tetsuo; Kato, Koji; Suzuki, Ritsuro; Suzumiya, Junji			Hematopoietic stem cell transplantation using reduced-intensity conditioning regimen for relapsed or refractory anaplastic large cell lymphoma: 11 cases of children, adolescents and young adults in Japan	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Fukano, Reiji] Kyushu Natl Canc Ctr, Dept Pediat, Fukuoka, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Mori, Tetsuya] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Fujita, Naoto] Hiroshima Red Cross Hosp, Dept Pediat, Hiroshima, Japan; [Fujita, Naoto] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Mitsui, Tetsuo] Yamagata Univ Hosp, Dept Pediat, Yamagata, Japan; [Kato, Koji] Kyushu Univ, Grad Sch Med, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Suzuki, Ritsuro; Suzumiya, Junji] Shimane Univ Hosp, Ctr Canc, Dept Oncol Hematol, Izumo, Shimane, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	58	34	35				2	Hematology	Hematology	CS9QG	WOS:000362425300056		
J	Yasui, M; Sato, M; Sawada, A; Inoue, M				Yasui, Masahiro; Sato, Maho; Sawada, Akihisa; Inoue, Masami			Two patients of avascular necrosis of the bone after an autologous bone marrow transplantation and multi-drug chemotherapy in adolescent and young adult generations with Non-Hodgkin lymphoma	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						Osaka Med Ctr, Dept Hematol Oncol, Izumi, Osaka, Japan; Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	91	51	51				1	Hematology	Hematology	CS9QG	WOS:000362425300087		
J	Lavoine, N; Le Deley, MC; Woessmann, W; Pillon, M; Williams, D; Horibe, K; Wrobel, G; Attarbaschi, A; Bezhuisen, A; Uyttebroeck, A; Mellgren, K; Brugieres, L				Lavoine, Noemie; Le Deley, Marie-Cecile; Woessmann, Wilhelm; Pillon, Marta; Williams, Denise; Horibe, Keizo; Wrobel, Grazyna; Attarbaschi, Andishe; Bezhuisen, Auke; Uyttebroeck, Anne; Mellgren, Karen; Brugieres, Laurence		European Intergrp Childhood; Japanese Pediat Leukemia Lymphoma; Austrian BFM Grp	Second and subsequent relapses of ALCL: EICNHL experience	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Lavoine, Noemie; Le Deley, Marie-Cecile; Brugieres, Laurence] Inst Gustave Roussy, Villejuif, France; [Woessmann, Wilhelm] Univ Giessen, D-35390 Giessen, Germany; [Pillon, Marta] Univ Hosp, Padua, Italy; [Williams, Denise] Cambridge Univ Hosp NHS Trust, Cambridge, England; [Horibe, Keizo] Nagoya Med Ctr, Nagoya, Aichi, Japan; [Wrobel, Grazyna] Med Univ, Wroclaw, Poland; [Attarbaschi, Andishe] St Anna Childrens Hosp, A-1090 Vienna, Austria; [Bezhuisen, Auke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Uyttebroeck, Anne] Univ Hosp, Leuven, Belgium; [Mellgren, Karen] Gothenburg Univ, Gothenburg, Sweden								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	102	55	55				1	Hematology	Hematology	CS9QG	WOS:000362425300098		
J	Damm-Welk, C; Yamashita, Y; Bench, A; Turner, S; Lamant, L; Verge, V; Tosato, E; Schieferstein, J; Mussolin, L				Damm-Welk, C.; Yamashita, Y.; Bench, A.; Turner, S.; Lamant, L.; Verge, V.; Tosato, E.; Schieferstein, J.; Mussolin, L.			Quality control of standardized methods for NPM-ALK RT-PCR and anti-ALK-Antibody-Measurement for anaplastic large cell lymphoma - a report of the EICNHL Reference Laboratory Group	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Damm-Welk, C.; Schieferstein, J.] Univ Giessen, Dept Pediat Hematol & Oncol, D-35390 Giessen, Germany; [Damm-Welk, C.; Schieferstein, J.] Univ Giessen, NHL BFM Study Ctr, D-35390 Giessen, Germany; [Yamashita, Y.] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Bench, A.] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England; [Turner, S.] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 1QP, England; [Lamant, L.] Inst Univ Canc Toulouse Oncopole, Serv Anat & Cytol Pathol, Toulouse, France; [Verge, V.] Gustave Roussy, Lab Rech Translat Hematol, Villejuif, France; [Tosato, E.; Mussolin, L.] Univ Padua, Dept Womens & Childrens Hlth, Clin Pediat Hematooncol, Padua, Italy								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	104	56	56				1	Hematology	Hematology	CS9QG	WOS:000362425300100		
J	Tanaka, F; Kobayashi, R; Nakazawa, A; Ueyama, J; Osumi, T; Sunami, S; Mitsui, T; Koga, Y; Mori, T; Fukano, R; Ohki, K; Sekimizu, M; Mori, T				Tanaka, Fumiko; Kobayashi, Ryoji; Nakazawa, Atsuko; Ueyama, Junichi; Osumi, Tomoo; Sunami, Shosuke; Mitsui, Tetsuo; Koga, Yuhki; Mori, Takeshi; Fukano, Reiji; Ohki, Kentaro; Sekimizu, Masahiro; Mori, Tetsuya		Japanese Pediat Leukemia Lymphoma	Primary cutaneous lymphomas of childhood in Japan	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Tanaka, Fumiko] Saiseikai Yokohamashi Nanbu Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Ueyama, Junichi] Tottori Univ, Dept Pediat, Tottori 680, Japan; [Osumi, Tomoo] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan; [Sunami, Shosuke] Japanese Red Cross Narita Hosp, Dept Pediat, Narita, Japan; [Mitsui, Tetsuo] Yamagata Univ, Dept Pediat, Yamagata 990, Japan; [Koga, Yuhki] Kyushu Univ Hosp, Dept Pediat, Fukuoka 812, Japan; [Mori, Takeshi] Kobe Univ, Dept Pediat, Kobe, Hyogo 657, Japan; [Fukano, Reiji] Kyushu Canc Ctr, Natl Hosp Org, Dept Pediat, Fukuoka, Japan; [Ohki, Kentaro] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Sekimizu, Masahiro] Nagoya Med Ctr, Natl Hosp Org, Dept Pediat, Nagoya, Aichi, Japan; [Mori, Tetsuya] St Marianna Univ, Sch Med, Dept Pediat, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	106	57	57				1	Hematology	Hematology	CS9QG	WOS:000362425300102		
J	Osumi, T; Tanaka, F; Mori, T; Fukano, R; Tsurusawa, M; Oshima, K; Nakazawa, A; Kobayashi, R				Osumi, Tomoo; Tanaka, Fumiko; Mori, Tetsuya; Fukano, Reiji; Tsurusawa, Masahito; Oshima, Koichi; Nakazawa, Atsuko; Kobayashi, Ryoji			Pediatric primary mediastinal large B-cell lymphoma in Japan	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Osumi, Tomoo] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan; [Tanaka, Fumiko] Saiseikai Yokohama City South Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Mori, Tetsuya] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan; [Fukano, Reiji] Kyushu Natl Canc Ctr, Dept Pediat, Fukuoka, Japan; [Tsurusawa, Masahito] Ama City Hosp, Dept Pediat, Jimokuji, Aichi, Japan; [Oshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	110	58	58				1	Hematology	Hematology	CS9QG	WOS:000362425300106		
J	Kobayashi, R; Tanaka, F; Nakazawa, A; Ueyama, JI; Sunami, S; Mitsui, T; Koga, Y; Mori, T; Osumi, T; Fukano, R; Ohki, K; Sekimizu, M; Mori, T				Kobayashi, Ryoji; Tanaka, Fumiko; Nakazawa, Atsuko; Ueyama, Jun-Ichi; Sunami, Shosuke; Mitsui, Tetsuo; Koga, Yuhki; Mori, Takeshi; Osumi, Tomoo; Fukano, Reiji; Ohki, Kentaro; Sekimizu, Masahiro; Mori, Tetsuya			Follicular lymphoma of children in Japan	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Kobayashi, Ryoji; Tanaka, Fumiko; Nakazawa, Atsuko; Ueyama, Jun-Ichi; Sunami, Shosuke; Mitsui, Tetsuo; Koga, Yuhki; Mori, Takeshi; Osumi, Tomoo; Fukano, Reiji; Ohki, Kentaro; Sekimizu, Masahiro; Mori, Tetsuya] Japanese Pediat Leukemia Lymphoma Study Grp, Lymphoma Comm, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	112	59	59				1	Hematology	Hematology	CS9QG	WOS:000362425300108		
J	Hori, D; Kobayashi, R; Suzuki, D; Sano, H; Kishimoto, K; Yasuda, K; Kobayashi, K				Hori, Daiki; Kobayashi, Ryoji; Suzuki, Daisuke; Sano, Hirozumi; Kishimoto, Kenji; Yasuda, Kazue; Kobayashi, Kunihiko			Pediatric nodal marginal zone lymphoma in a Japanese boy	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Hori, Daiki; Kobayashi, Ryoji; Suzuki, Daisuke; Sano, Hirozumi; Kishimoto, Kenji; Yasuda, Kazue; Kobayashi, Kunihiko] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	115	60	60				1	Hematology	Hematology	CS9QG	WOS:000362425300111		
J	Koga, Y; Tsurusawa, M; Watanabe, T; Gosho, M; Mori, T; Mitsui, T; Sunami, S; Kobayashi, R; Fukano, R; Tanaka, F; Fujita, N; Inada, H; Sekimizu, M; Koh, K; Kosaka, Y; Komada, Y; Saito, AM; Nakazawa, A; Horibe, K				Koga, Yuhki; Tsurusawa, Masahito; Watanabe, Tomoyuki; Gosho, Masahiko; Mori, Tetsuya; Mitsui, Tetsuo; Sunami, Shosuke; Kobayashi, Ryoji; Fukano, Reiji; Tanaka, Fumiko; Fujita, Naoto; Inada, Hiroko; Sekimizu, Masahiro; Koh, Katsuyoshi; Kosaka, Yoshiyuki; Komada, Yoshihiro; Saito, Akiko M.; Nakazawa, Atsuko; Horibe, Keizo		Japanese Pediat Leukemia Lymphoma	Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia/lymphoma study Group B-NHL03 study	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Koga, Yuhki; Tsurusawa, Masahito; Watanabe, Tomoyuki; Gosho, Masahiko; Mori, Tetsuya; Mitsui, Tetsuo; Sunami, Shosuke; Kobayashi, Ryoji; Fukano, Reiji; Tanaka, Fumiko; Fujita, Naoto; Inada, Hiroko; Sekimizu, Masahiro; Koh, Katsuyoshi; Kosaka, Yoshiyuki; Komada, Yoshihiro; Saito, Akiko M.; Nakazawa, Atsuko; Horibe, Keizo; Japanese Pediat Leukemia Lymphoma] Kyushu Univ Hosp, Dept Pediat, Fukuoka 812, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	125	63	64				2	Hematology	Hematology	CS9QG	WOS:000362425300121		
J	Nakazawa, A; Osumi, T; Tsurusawa, M; Kobayashi, R; Iwafuchi, H; Ohshima, K; Tamaru, JI; Nakamine, H; Nakamura, S; Fujimoto, JI; Hojo, H; Matsuno, Y; Yoshino, T; Klapper, W				Nakazawa, Atsuko; Osumi, Tomoo; Tsurusawa, Masahito; Kobayashi, Roji; Iwafuchi, Hideto; Ohshima, Kouich; Tamaru, Jun-Ichi; Nakamine, Hirokazu; Nakamura, Shigeo; Fujimoto, Jun-Ichiro; Hojo, Hiroshi; Matsuno, Yoshihiro; Yoshino, Tadashi; Klapper, Wolfram			Pediatric diffuse large B-cell lymphoma in Japan	BRITISH JOURNAL OF HAEMATOLOGY			English	Meeting Abstract	5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma	OCT 22, 2015	Varese, ITALY						[Nakazawa, Atsuko; Osumi, Tomoo; Iwafuchi, Hideto] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Nakazawa, Atsuko; Osumi, Tomoo; Tsurusawa, Masahito; Kobayashi, Roji; Iwafuchi, Hideto; Ohshima, Kouich; Tamaru, Jun-Ichi; Nakamine, Hirokazu; Nakamura, Shigeo; Fujimoto, Jun-Ichiro; Hojo, Hiroshi; Matsuno, Yoshihiro; Yoshino, Tadashi] Japanese Pediat Leukemia Lymphoma Study Grp, Pathol & Lymphoma Comm, Sapporo, Hokkaido, Japan; [Klapper, Wolfram] Univ Kiel, Dept Pathol, Hematopathol Sect, Kiel, Germany; [Klapper, Wolfram] Lymph Node Registry, Kiel, Germany			Nakamura, Shigeo/I-1571-2012					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	OCT	2015	171			1	SI	127	64	64				1	Hematology	Hematology	CS9QG	WOS:000362425300123		
J	Malik, JN; Sahoo, S; Satuluri, S; Okumura, K				Malik, Javed N.; Sahoo, Santiswarup; Satuluri, S.; Okumura, Koji			Active Fault and Paleoseismic Studies in Kangra Valley: Evidence of Surface Rupture of a Great Himalayan 1905 Kangra Earthquake (M-w 7.8), Northwest Himalaya, India	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							NW HIMALAYA; OBLIQUE CONVERGENCE; TECTONIC MODEL; FRONTAL THRUST; COLLISION ZONE; SEISMIC HAZARD; 2005 KASHMIR; CAL BP; SEISMOTECTONICS; RECURRENCE	Our findings suggest that interseismic strain accumulated south of the fault ramp under the Higher Himalayas was not only released periodically along the Himalayan frontal thrust (HFT) during large-magnitude earthquakes, but also along the active faults in the hinterland. The 4 April 1905 Kangra earthquake (M-w 7.8) killed more than 20,000 people and destroyed the towns of Kangra and Dharamsala in northwest Himalaya. In spite of its large magnitude, with a maximum intensity X on the Rossi-Forel intensity scale recorded in the epicentral area, no surface rupture was reported, and no focal mechanism is available. This article uses satellite imagery and field mapping to identify an active rightlateral strike-slip fault, named the Kangra Valley fault (KVF). We infer that the KVF represents the surface rupture of the 1905 Kangra earthquake, extending west-northwest-east-southeast and east-west for similar to 60 km. It cuts through the Kangra and Sihunta Valleys and is capable of producing M-w >= 7.2 earthquakes. Existence of the KVF in the Kangra re-entrant is indicative of oblique convergence and slip partitioning between the Main Boundary thrust in the north, the Jawalamukhi thrust in the south, and a strike-slip fault in the northwest Himalaya. Paleoseismic investigations revealed evidence of at least four earthquakes on the KVF. Event I (oldest) occurred before 900 B.C. or between 900 B.C. and 2500 B.C.; Event II occurred between 100 B.C. and 80 B.C.; penultimate Event III occurred around A.D. 800 and A.D. 1000; and, the most recent event, Event IVoccurred after A.D. 1620 and before A.D. 1940 and is likely the 1905 Kangra earthquake (M-w 7.8). A longer recurrence along the KVF is inferred between older paleoearthquake Events I and II, and a shorter interval of 1050 +/- 150 years is inferred between younger events (II, III, and IV). Because the strain during the 1905 Kangra earthquake was released along the KVF, potential for large-magnitude earthquakes in northwest Himalaya along the HFT still remains.	[Malik, Javed N.; Sahoo, Santiswarup; Satuluri, S.] Indian Inst Technol, Dept Civil Engn, Kanpur 208016, Uttar Pradesh, India; [Okumura, Koji] Hiroshima Univ, Fac Letters, Dept Geog, Higashihiroshima, Hiroshima 7398522, Japan	Malik, JN (reprint author), Indian Inst Technol, Dept Civil Engn, Kanpur 208016, Uttar Pradesh, India.	javed@iitk.ac.in; swarups@iitk.ac.in; sravisri@iitk.ac.in; kojiok@hiroshima-u.ac.jp			Japan International Cooperation Agency (JICA); Japan Science and Technology (JST); Ministry of Earth Sciences (MoES), New Delhi	We are thankful to Japan International Cooperation Agency (JICA) and Japan Science and Technology (JST) for funding project SATREPS-DISA-NET to J. N. M. and K. O. Partial financial support received from the Ministry of Earth Sciences (MoES), New Delhi, is duly acknowledged. We would also like to thank the Master-ji from Pathiyar-Dadh village and all the people who helped us during the field survey and trenching. Help provided by Asmita Mohanty, Sambit P. Naik, and Sumanta Pasari during the field studies is duly acknowledged. We are grateful to A. Lin, an anonymous referee, and Associate Editor Brian Sherrod for providing valuable suggestions and comments, which helped in bringing more clarity to our article. We would also like to thank Brian Atwater, U.S. Geological Survey for his valuable suggestions. J. N. M. would like to thank his wife Vasima, daughter Zulfiya, and son Tabrez for their constant support throughout this work.	[Anonymous], 2004, GEOPHYS J INT; Kayal JR, 2010, GEOMAT NAT HAZ RISK, V1, P51, DOI 10.1080/19475701003625752; STUIVER M, 1977, RADIOCARBON, V19, P355; Kayal JR, 2001, TECTONOPHYSICS, V339, P331, DOI 10.1016/S0040-1951(01)00129-9; PANTOSTI D, 1993, J GEOPHYS RES-SOL EA, V98, P6561, DOI 10.1029/92JB02277; Powers PM, 1998, GEOL SOC AM BULL, V110, P1010, DOI 10.1130/0016-7606(1998)110<1010:SASOTK>2.3.CO;2; Kaneda H, 2008, B SEISMOL SOC AM, V98, P521, DOI 10.1785/0120070073; Ambraseys N, 2000, CURR SCI INDIA, V79, P45; Malik JN, 2003, ANN GEOPHYS-ITALY, V46, P917; McCaffrey R, 1998, GEOLOGY, V26, P691, DOI 10.1130/0091-7613(1998)026<0691:ROOCIT>2.3.CO;2; Malik JN, 2010, TECTONOPHYSICS, V483, P327, DOI 10.1016/j.tecto.2009.10.028; NI J, 1984, J GEOPHYS RES, V89, P1147, DOI 10.1029/JB089iB02p01147; Srivastava P, 2009, CATENA, V76, P135, DOI 10.1016/j.catena.2008.10.004; Thakur VC, 2000, TECTONOPHYSICS, V326, P289, DOI 10.1016/S0040-1951(00)00126-8; Malik JN, 2010, J STRUCT GEOL, V32, P350, DOI 10.1016/j.jsg.2010.01.005; Lave J, 2005, SCIENCE, V307, P1302, DOI 10.1126/science.1104804; Bilham R, 2001, SCIENCE, V293, P1442, DOI 10.1126/science.1062584; Styron RH, 2011, GEOSPHERE, V7, P582, DOI 10.1130/GES00606.1; Sherrod BL, 2013, GEOSPHERE, V9, P827, DOI 10.1130/GES00880.1; Ramsey CB, 2013, RADIOCARBON, V55, P2021; Reimer PJ, 2013, RADIOCARBON, V55, P1869; NAKATA T, 1990, TECTONOPHYSICS, V181, P83, DOI 10.1016/0040-1951(90)90009-W; Kondo H, 2008, GEOLOGY, V36, P731, DOI 10.1130/G25028A.1; Dubey AK, 2004, J ASIAN EARTH SCI, V24, P245, DOI 10.1016/j.jseaes.2003.11.002; Rockwell TK, 2013, NAT GEOSCI, V6, P19, DOI 10.1038/ngeo1673; Wallace K, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022906; QUITTMEYER RC, 1979, B SEISMOL SOC AM, V69, P773; Malik JN, 2008, HIMAL GEOL, V29, P109; Lave J, 2000, J GEOPHYS RES-SOL EA, V105, P5735, DOI 10.1029/1999JB900292; LYONCAEN H, 1983, J GEOPHYS RES, V88, P8171, DOI 10.1029/JB088iB10p08171; Hough SE, 2005, CURR SCI INDIA, V88, P1632; Sapkota SN, 2013, NAT GEOSCI, V6, P71, DOI [10.1038/ngeo1669, 10.1038/NGEO1669]; Kumar S, 2001, TECTONOPHYSICS, V331, P359, DOI 10.1016/S0040-1951(00)00293-6; Malik JN, 2007, J ASIAN EARTH SCI, V29, P604, DOI 10.1016/j.jseaes.2006.03.010; Banerjee P., 2002, Geophysical Research Letters, V29, DOI 10.1029/2002GL015184; Gansser A., 1964, GEOLOGY HIMALAYA; Iyengar R., 1999, INDIAN J HIST SCI, V34, P181; Kumar S., 2006, J GEOPHYS RES, V111, P1; Kumar S, 2001, SCIENCE, V294, P2328, DOI 10.1126/science.1066195; Kundu B., 2014, TECTONICS, V33, P1; McCalpin J.P., 2009, PALEOSEISMOLOGY; Middlemiss C. S., 1910, MEM GEOL SURV INDIA, V38, P405; Nakata T., 1991, SPECIAL PUBLICATION, V21; Personius S. F., 2014, WASHINGTON GEOSPHERE, V10, P1482, DOI [10.1130/GES01067.1, DOI 10.1130/GES01067.1]; Raiverman V., 1994, HIMAL GEOL, V15, P263; Seeber L., 1981, Zagros - Hindu Kush - Himalaya - Geodynamic evolution; Seeber L., 1981, M EWING SERIES, V4, P259, DOI DOI 10.1029/ME004P0259; Yeats R S, 1997, GEOLOGY EARTHQUAKES	48	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	OCT	2015	105	5					2325	2342		10.1785/0120140304		18	Geochemistry & Geophysics	Geochemistry & Geophysics	CS5MP	WOS:000362122600001		
J	Nakata, N; Tanaka, W; Oda, Y				Nakata, Nori; Tanaka, Wataru; Oda, Yoshiya			Damage Detection of a Building Caused by the 2011 Tohoku-Oki Earthquake with Seismic Interferometry	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							MULTIDIMENSIONAL DECONVOLUTION; IMPULSE-RESPONSE; MILLIKAN LIBRARY; WAVE; VELOCITY; NET	We apply seismic interferometry based on deconvolution to earthquake data observed in a building at Tokyo Metropolitan University to extract building response and estimate velocities and frequencies of traveling waves inside the building. The building is a 10-story reinforced concrete structure in Tokyo, Japan. The earthquake data were recorded 2 months before, 6 months after, and 16 months after the M-w 9.0 Tohoku-Oki earthquake (11 March 2011). The observation period of each acquisition was 20-30 days. We analyze more than 300 earthquakes recorded in these time periods, and we find significant reduction (similar to 20%) in wave velocities and fundamental-mode frequencies after the Tohoku-Oki earthquake. Because deconvolution interferometry separates the response of the building from the effect of complicated wave propagation outside the building, we interpret that this reduction is mostly related to the building. We can also estimate frequencies of the fundamental mode from observed data, and these frequencies contain the responses of building and the ray paths from hypocenters. Therefore, as we find from the data, the frequencies estimated from observed data are generally lower than those from deconvolved waveforms due to the effects of wave propagation. Although the velocities in the building decrease similar to 20% after the ohoku-Oki earthquake, we cannot find significant reduction in the S-wave velocities at the near surface (depth shallower than 100 m). This fact indicates the decrease in velocities is mainly related to the building, and hence, with deconvolution interferometry, we can detect damages to the building caused by the Tohoku-Oki earthquake.	[Nakata, Nori] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Tanaka, Wataru; Oda, Yoshiya] Tokyo Metropolitan Univ, Dept Civil & Environm Engn, Hachioji, Tokyo 1920397, Japan	Nakata, N (reprint author), Stanford Univ, Dept Geophys, 397 Panama Mall, Stanford, CA 94305 USA.	nnakata@stanford.edu; w.27bononchi@gmail.com; oda@tmu.ac.jp			George Thompson Fellowship at Stanford University; Long-Term Safety for Aging Infrastructure Constructions at the Tokyo Metropolitan University	We thank the Tokyo Metropolitan University for the permission to acquire the seismic data. This study is supported by the Long-Term Safety for Aging Infrastructure Constructions at the Tokyo Metropolitan University. We are grateful to Maria I. Todorovska for her thorough review and useful comments. Nori Nakata thanks the financial support of the George Thompson Fellowship at Stanford University.	Ruigrok E, 2010, GEOPHYS J INT, V183, P339, DOI 10.1111/j.1365-246X.2010.04724.x; Vasconcelos I, 2008, GEOPHYSICS, V73, pS129, DOI 10.1190/1.2904985; Ebrahimian M, 2015, J ENG MECH, V141, DOI 10.1061/(ASCE)EM.1943-7889.0000933; Prieto GA, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006067; Sawazaki K, 2009, B SEISMOL SOC AM, V99, P352, DOI 10.1785/0120080058; Nakata N, 2013, B SEISMOL SOC AM, V103, P3073, DOI 10.1785/0120130101; Nakata N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048800; Nakata N, 2015, J GEOPHYS RES-SOL EA, V120, P1159, DOI 10.1002/2015JB011870; Kohler MD, 2007, B SEISMOL SOC AM, V97, P1334, DOI 10.1785/0120060148; Pech A, 2012, SOIL DYN EARTHQ ENG, V39, P128, DOI 10.1016/j.soildyn.2012.03.009; Nakata N, 2014, GEOPHYS J INT, V199, P1125, DOI 10.1093/gji/ggu316; Snieder R, 2006, B SEISMOL SOC AM, V96, P586, DOI 10.1785/0120050109; Todorovska M, 2008, STRUCT CONTROL HLTH, V15, P90, DOI 10.1002/stc.208; Trifunac MD, 2001, J STRUCT ENG-ASCE, V127, P517, DOI 10.1061/(ASCE)0733-9445(2001)127:5(517); Miyazawa M, 2008, GEOPHYSICS, V73, pD35, DOI 10.1190/1.2937172; Nakata N, 2013, B SEISMOL SOC AM, V103, P1662, DOI 10.1785/0120120291; Nakata N, 2014, B SEISMOL SOC AM, V104, P204, DOI 10.1785/0120130050; Wapenaar K, 2008, GEOPHYSICS, V73, pA51, DOI 10.1190/1.2976118; Bulmer M. G., 1979, PRINCIPLES STAT; CLAERBOU.JF, 1968, GEOPHYSICS, V33, P264, DOI 10.1190/1.1439927; Ebrahimian M, 2014, J ENG MECH, V140, DOI 10.1061/(ASCE)EM.1943-7889.0000720; Menke W., 2012, GEOPHYS DATA ANAL DI, V3; Prieto GA, 2010, B SEISMOL SOC AM, V100, P2322, DOI 10.1785/0120090285; Rahmani M, 2015, EARTHQ ENG STRUCT D, V44, P317, DOI 10.1002/eqe.2454; Snieder R, 2004, GUIDED TOUR MATH MET; Snieder R., 2006, PHYS REV E, V73, DOI [10.1103/Phys-RevE.73.066620, DOI 10.1103/PHYS-REVE.73.066620]; Snieder R. K., 2004, PHYS REV E, V69, P610; Todorovska MI, 2009, B SEISMOL SOC AM, V99, P611, DOI 10.1785/0120080191; Todorovska MI, 2009, B SEISMOL SOC AM, V99, P626, DOI 10.1785/0120080333; Trifunac MD, 1972, EARTHQ ENG STRUCT D, V1, P133, DOI DOI 10.1002/EQE.4290010203; Wapenaar K, 2004, PHYS REV LETT, V93, DOI DOI 10.1103/PHYSREVLETT.87.134301	31	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	OCT	2015	105	5					2411	2419		10.1785/0120140220		9	Geochemistry & Geophysics	Geochemistry & Geophysics	CS5MP	WOS:000362122600007		
J	Nakano, K; Matsushima, S; Kawase, H				Nakano, Kenichi; Matsushima, Shinichi; Kawase, Hiroshi			Statistical Properties of Strong Ground Motions from the Generalized Spectral Inversion of Data Observed by K-NET, KiK-net, and the JMA Shindokei Network in Japan	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							2003 TOKACHI-OKI; SOURCE MODEL; STRESS-DROP; ATTENUATION CHARACTERISTICS; TOHOKU EARTHQUAKE; SOURCE PARAMETERS; BOREHOLE; RECORDS; SURFACE; RANGE	The objective of this study is to investigate in detail the characteristics of strong ground motions separated from acceleration Fourier spectra of ground motions observed by K-NET, KiK-net, and the Japan Meteorological Agency (JMA) Shindokei network in Japan using the generalized spectral inversion method. The separation method used here is the same as that proposed by Kawase and Matsuo (2004), with the same reference bedrock site at YMGH01. We include events with magnitude equal to or larger than 4.5 observed from 1996 to 2011. Our results are in good agreement with previous results regarding source, path, and site characteristics, but with higher stability thanks to the increased amount of data. We obtain site amplification factors common to all source types but with different Q-values for three source categories: crustal earthquakes (type C), subducting plate-boundary earthquakes (type B), and intraplate earthquakes (type I). We find that our frequency-dependent Q-values are comparable to those of previous studies, and that the obtained Q-values depend on the traveling regions. As for the geometric spreading factor n, we find that for type B and type I earthquakes, the value is close to 1.0 as expected, but type C earthquakes show apparent frequency dependence. From the corner frequencies of source spectra, we calculate Brune's stress parameters and find a clear magnitude dependence, in which smaller events tend to spread over a wider range while maintaining the same maximum value. This means that stress drops for larger events would be maximal. We confirm that this is exactly the case for several mainshock-aftershock sequences. The average stress parameters are 5.1 and 6.0 MPa for types B and I, and 0.8 MPa for type C. This large difference between types B and I and type C can be explained primarily by the depth dependence of stress parameters.	[Nakano, Kenichi] HAZAMA ANDO CORP, Tech Res Inst, Tsukuba, Ibaraki 3050822, Japan; [Matsushima, Shinichi; Kawase, Hiroshi] Kyoto Univ, Disaster Prevent Res Inst, Div Disaster Management Safe & Secure Soc, Uji, Kyoto 6110011, Japan	Nakano, K (reprint author), HAZAMA ANDO CORP, Tech Res Inst, 515-1 Karima, Tsukuba, Ibaraki 3050822, Japan.	kawase@zeisei.dpri.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21241044, 26242034]	We express our special thanks to Hidenori Matsuo of Hitachi System and Service for his efforts devoted to the spectral inversion code used in this study, and to Hiroo Kanamori, John Anderson, Fabrice Cotton, and Annemarie Baltay for their enlightening discussions. We extend our gratitude to John Zhao and Stephane Drouet for their constructive review comments. We also thank Toshimi Satoh of Shimizu Corp. for information on her achievements. A part of this study was supported by a Grant-in-Aid for Basic Research (A) by Ministry of Education, Culture, Sports, Science and Technology, Japan (P. I. Hiroshi Kawase, No. 21241044 and No. 26242034). The free distribution of strong-motion data as well as the PS logging data of K-NET operated by National Research Institute for Earth Science and Disaster Prevention is highly appreciated. We used Generic Mapping Tools software by Wessel and Smith (1998) to plot several figures.	AKI K, 1967, J GEOPHYS RES, V72, P1217, DOI 10.1029/JZ072i004p01217; Andrews D. J., 1986, EARTHQUAKE SOURCE ME, DOI [10.1029/GM037p0259, DOI 10.1029/GM037P0259]; Andrews D. J., 1982, P WORKSH 16 DYN CHAR, V82-591, P437; Ye LL, 2013, B SEISMOL SOC AM, V103, P1221, DOI 10.1785/0120120115; Kamae K, 2004, EARTH PLANETS SPACE, V56, P323; IWATA T, 1988, J PHYS EARTH, V36, P155; Asano K, 2012, EARTH PLANETS SPACE, V64, P1111, DOI 10.5047/eps.2012.05.003; Drouet S, 2010, GEOPHYS J INT, V182, P880, DOI 10.1111/j.1365-246X.2010.04626.x; Anderson JG, 2013, B SEISMOL SOC AM, V103, P1935, DOI 10.1785/0120120252; KATO K, 1992, J PHYS EARTH, V40, P175; Oth A, 2011, B SEISMOL SOC AM, V101, P652, DOI 10.1785/0120100134; Zhao JX, 2010, B SEISMOL SOC AM, V100, P712, DOI 10.1785/0120090070; Cotton F, 2013, SEISMOL RES LETT, V84, P42, DOI 10.1785/0220120087; BRUNE JN, 1971, J GEOPHYS RES, V76, P5002; Kurahashi S, 2011, EARTH PLANETS SPACE, V63, P571, DOI 10.5047/eps.2011.06.044; Karim KR, 2002, EARTHQUAKE ENG STRUC, V31, P1191, DOI 10.1002/eqe.158; Drouet S, 2011, GEOPHYS J INT, V187, P1625, DOI 10.1111/j.1365-246X.2011.05219.x; Baltay AS, 2013, B SEISMOL SOC AM, V103, P211, DOI 10.1785/0120120161; Bindi D, 2006, B SEISMOL SOC AM, V96, P200, DOI 10.1785/0120050038; BRUNE JN, 1970, J GEOPHYS RES, V75, P4997, DOI 10.1029/JB075i026p04997; Oth A, 2011, B SEISMOL SOC AM, V101, P667, DOI 10.1785/0120100135; Satoh T, 1997, B SEISMOL SOC AM, V87, P446; Aoi S., 2000, EOS T AGU, V81, P329; BOORE DM, 1984, B SEISMOL SOC AM, V74, P1615; BOORE DM, 1983, B SEISMOL SOC AM, V73, P1865; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; Fukuyama E., 1998, ZISIN, V51, P149; Hazewinkel M., 2001, ENCY MATH; Ho H., 2006, 1 EUR C EARTHQ ENG S; Honda R, 2004, EARTH PLANETS SPACE, V56, P317; Ikeda T., 2004, J STRUCT CONSTR ENG, V586, P53; Irikura K., 1994, ANN GEOFIS, VXXXVII, P1721; Kato K., 1998, ZISIN, V51, P123; Kawabe H., 2012, 15 WORLD C EARTHQ EN; Kawase H., 2004, 13 WORLD C EARTHQ EN; Kawase H., 2000, 6 INT C SEISM ZON PA; Kawase H., 2006, B EARTHQ RES I TOKYO, V81, P309; Kawase H., 2012, AIJ PRELIMINARY RECO; Kinoshita S, 1998, SEISMOL RES LETT, V69, P309; Nozu A, 2007, J JAPAN ASS EARTHQUA, V7, P215; Okada Y, 2004, EARTH PLANETS SPACE, V56, pXV; Sasatani T., 2006, GEOPHYS B HOKKAIDO U, P123; Satoh T., 2008, 14 WORLD C EARTHQ EN; Satoh T., 2002, J STRUCT CONSTR ENG, V556, P15; SATOH T., 2006, STRUCT ENG EARTHQ EN, V23-1, P125; Somei K, 2014, PURE APPL GEOPHYS, V171, P2747, DOI 10.1007/s00024-014-0774-2; TAKEMURA M., 1990, J SEISMOL SOC JPN, V43, P257; Ueno H., 2002, Q J SEISMOL, V65, P123; WESSEL P, 1998, EOS T AGU, V0079	50	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	OCT	2015	105	5					2662	2680		10.1785/0120140349		19	Geochemistry & Geophysics	Geochemistry & Geophysics	CS5MP	WOS:000362122600024		
J	Marrero-Diaz, R; Lopez, D; Perez, NM; Custodio, E; Sumino, H; Melian, GV; Padron, E; Hernandez, PA; Calvo, D; Barrancos, J; Padilla, G; Sortino, F				Marrero-Diaz, Rayco; Lopez, Dina; Perez, Nemesio M.; Custodio, Emilio; Sumino, Hirochika; Melian, Gladys V.; Padron, Eleazar; Hernandez, Pedro A.; Calvo, David; Barrancos, Jose; Padilla, German; Sortino, Francesco			Carbon dioxide and helium dissolved gases in groundwater at central Tenerife Island, Canary Islands: chemical and isotopic characterization	BULLETIN OF VOLCANOLOGY			English	Article						Helium; Carbon dioxide; Dissolved gases; Volcanic aquifer; Tenerife	TEIDE VOLCANO; THERMAL WATERS; NATURAL-WATERS; HE-3 EMISSION; SHIELD-STAGE; SPAIN; CO2; EVOLUTION; CALDERA; GEOCHEMISTRY	Seismic-volcanic unrest was detected between 2004 and 2005 in the central and northwest zones of Tenerife Island (Canary Islands, Spain). With the aim of strengthening the program of geochemical and seismic-volcanic surveillance, a study of the origin, characteristics, and spatial distribution of dissolved carbon dioxide (CO2) and helium (He) gases in the volcanic aquifer of central Tenerife Island and around Teide volcano was carried out. This work also improves the hydrogeological and hydrogeochemical conceptual model of groundwater flow. Dissolved CO2 concentrations in sampled groundwater are several orders of magnitude higher than that of air-saturated water (ASW) suggesting a significant contribution of non-atmospheric CO2, mainly magmatic, confirmed through measurement of isotopic compositions (delta C-13(TDIC)) and total dissolved inorganic carbon (TDIC) concentrations. A vertical stratification of dissolved CO2 and delta C-13(TDIC) values was observed in the volcanic aquifer at the eastern region of Las Canadas Caldera. Stratification seems to be controlled by both degree of magmatic CO2-water interaction and CO2 degassing and the original delta C-13(co2(g)) isotopic composition. The highest dissolved helium (He-4) concentrations in groundwater seem to be related to radiogenic contributions resulting from water-rock interactions, and increase with residence time, instead of with endogenous magmatic inputs. Isotopic systematics show that the dissolved gases in groundwater of central Tenerife are variable mixtures of CO2-He-3-rich fluids of volcanic-hydrothermal origin with both organic and atmospheric components. The results suggest that the eastern area of Las Canadas Caldera, the South Volcanic Ridge, and the Teide summit cone are the areas most affected by degassing of the volcanic-hydrothermal system, and they are therefore the most suitable zones for future geochemical monitoring.	[Marrero-Diaz, Rayco; Perez, Nemesio M.; Melian, Gladys V.; Padron, Eleazar; Hernandez, Pedro A.; Calvo, David; Barrancos, Jose; Padilla, German] ITER, Div Environm Res, Tenerife 38611, Canary Islands, Spain; [Marrero-Diaz, Rayco; Lopez, Dina; Perez, Nemesio M.; Melian, Gladys V.; Padron, Eleazar; Hernandez, Pedro A.; Calvo, David; Barrancos, Jose; Padilla, German] Inst Volcanol Canarias INVOLCAN, Tenerife, Canary Islands, Spain; [Lopez, Dina] Ohio Univ, Dept Geol Sci, Clippinger Labs 316, Athens, OH 45701 USA; [Custodio, Emilio] Univ Politecn Cataluna, Dept Ingn Terreno Cartog & Geofis, ES-08034 Barcelona, Spain; [Sumino, Hirochika] Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Sortino, Francesco] INGV, Sez Palermo, I-90146 Palermo, Italy; [Marrero-Diaz, Rayco] LNEG, P-2610999 Lisbon, Portugal	Marrero-Diaz, R (reprint author), ITER, Div Environm Res, Tenerife 38611, Canary Islands, Spain.	rayco.diaz@lneg.pt	LNEG, Producao Cientifica/D-2212-2012; 	Sumino, Hirochika/0000-0002-4689-6231	Cabildo Insular de Tenerife; Gobierno de Canarias under the project Vigilancia Volcanica de Tenerife; Interreg IIIB Azores-Madeira-Canarias community initiative under the project Alerta; Interreg IIIB Azores-Madeira-Canarias community initiative under the project Alerta II	The authors are grateful to the different Water Communities of Tenerife for their invaluable collaboration and support in the field work. We are grateful to two anonymous reviewers and the editors Dr. Clive Oppenheimer and Dr. James White for their positive reviews and suggestions. This work was partially supported by the Cabildo Insular de Tenerife and the Gobierno de Canarias under the project Vigilancia Volcanica de Tenerife, as well as by the Interreg IIIB Azores-Madeira-Canarias community initiative under the projects Alerta and Alerta II.	ANCOCHEA E, 1990, J VOLCANOL GEOTH RES, V44, P231, DOI 10.1016/0377-0273(90)90019-C; Jean-Baptiste P, 2009, EARTH PLANET SC LETT, V281, P70, DOI 10.1016/j.epsl.2009.02.009; SANO Y, 1985, J GEOPHYS RES-SOLID, V90, P8729, DOI 10.1029/JB090iB10p08729; Capasso G, 1998, APPL GEOCHEM, V13, P631, DOI 10.1016/S0883-2927(97)00109-1; Perez NM, 1996, GEOPHYS RES LETT, V23, P3531, DOI 10.1029/96GL03470; Marrero R, 2008, PURE APPL GEOPHYS, V165, P147, DOI 10.1007/s00024-007-0287-3; SANO Y, 1985, GEOCHEM J, V19, P135; Perez NM, 2013, J GEOL SOC LONDON, V170, P585, DOI 10.1144/jgs2012-125; Caliro S, 1999, J VOLCANOL GEOTH RES, V90, P219, DOI 10.1016/S0377-0273(99)00027-X; Chiodini G, 2006, PURE APPL GEOPHYS, V163, P759, DOI 10.1007/s00024-006-0037-y; Pina-Varas P, 2014, SURV GEOPHYS, V35, P1045, DOI 10.1007/s10712-014-9280-4; SANO Y, 1984, SCIENCE, V224, P150, DOI 10.1126/science.224.4645.150; ALBERTBELTRAN JF, 1990, J VOLCANOL GEOTH RES, V43, P321, DOI 10.1016/0377-0273(90)90059-O; Marrero-Diaz R, 2015, WATER-SUI, V7, P2451, DOI 10.3390/w7052451; Hernandez P, 2000, J VOLCANOL GEOTH RES, V103, P425, DOI 10.1016/S0377-0273(00)00235-3; GIGGENBACH WF, 1988, GEOCHIM COSMOCHIM AC, V52, P2749, DOI 10.1016/0016-7037(88)90143-3; ABLAY GJ, 1995, B VOLCANOL, V57, P337, DOI 10.1007/BF00301292; Marti J, 2009, J VOLCANOL GEOTH RES, V182, P23, DOI 10.1016/j.jvolgeores.2009.01.028; Inguaggiato S, 2005, J VOLCANOL GEOTH RES, V141, P91, DOI 10.1016/j.volgeores.2004.09.006; GIGGENBACH WF, 1992, EARTH PLANET SC LETT, V113, P495, DOI 10.1016/0012-821X(92)90127-H; Carracedo JC, 2007, GEOL SOC AM BULL, V119, P1027, DOI 10.1130/B26087.1; Guillou H, 2004, EARTH PLANET SC LETT, V222, P599, DOI 10.1016/j.epsl.2004.03.012; Ablay GJ, 2000, J VOLCANOL GEOTH RES, V103, P175, DOI 10.1016/S0377-0273(00)00224-9; Soler V, 2004, PURE APPL GEOPHYS, V161, P1519, DOI 10.1007/s00024-004-2518-1; STANLEY CR, 1989, J GEOCHEM EXPLOR, V32, P355, DOI 10.1016/0375-6742(89)90076-9; Allard P, 1997, EARTH PLANET SC LETT, V148, P501, DOI 10.1016/S0012-821X(97)00052-6; Federico C, 2002, GEOCHIM COSMOCHIM AC, V66, P963, DOI 10.1016/S0016-7037(01)00813-4; Inguaggiato S, 2000, J VOLCANOL GEOTH RES, V99, P151, DOI 10.1016/S0377-0273(00)00158-X; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; Hernandez P, 2004, J VOLCANOL GEOTH RES, V131, P59, DOI 10.1016/S0377-0273(03)00316-0; Aiuppa A, 2000, GEOCHIM COSMOCHIM AC, V64, P1827, DOI 10.1016/S0016-7037(00)00345-8; Grassa F, 2006, PURE APPL GEOPHYS, V163, P781, DOI 10.1007/s00024-006-0043-0; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Kusakabe M, 2001, GEOCHEM J, V35, P459; Morikawa N, 2008, J VOLCANOL GEOTH RES, V175, P218, DOI 10.1016/j.jvolgeores.2008.03.038; BENSON BB, 1976, J CHEM PHYS, V64, P689, DOI 10.1063/1.432215; Padron E, 2013, GEOLOGY, V41, P539, DOI 10.1130/G34027.1; Cardellini C, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002165; Thirlwall MF, 2000, J VOLCANOL GEOTH RES, V103, P247, DOI 10.1016/S0377-0273(00)00227-4; Evans WC, 2002, J VOLCANOL GEOTH RES, V114, P291, DOI 10.1016/S0377-0273(01)00268-2; Ablay G, 2000, J VOLCANOL GEOTH RES, V103, P135, DOI 10.1016/S0377-0273(00)00220-1; Melian G, 2012, B VOLCANOL, V74, P1465, DOI 10.1007/s00445-012-0613-1; Perez NM, 2007, PURE APPL GEOPHYS, V164, P2431, DOI 10.1007/s00024-007-0280-x; Seisdedos J, 2012, J VOLCANOL GEOTH RES, V239, P92, DOI 10.1016/j.jvolgeores.2012.06.013; Pous J, 2002, EARTH PLANET SC LETT, V204, P249, DOI 10.1016/S0012-821X(02)00956-1; Cerdena ID, 2011, J VOLCANOL GEOTH RES, V206, P15, DOI 10.1016/j.jvolgeores.2011.06.005; VALENTIN A, 1990, J VOLCANOL GEOTH RES, V44, P251, DOI 10.1016/0377-0273(90)90020-G; Caliro S, 2005, APPL GEOCHEM, V20, P1060, DOI 10.1016/j.apgeochem.2005.02.002; STOLPER E, 1988, EARTH PLANET SC LETT, V87, P397, DOI 10.1016/0012-821X(88)90004-0; Appelo C.A.J., 2005, GEOCHEMISTRY GROUNDW; Carracedo JC, 2006, EOS T AM GEOPHYS UN, V87, P2005, DOI [10.1029/2006EO430003, DOI 10.1029/2006E0430003]; Custodio E, 2012, WAT AGR ENV SPAIN CA, P281; Custodio E, 2007, GROUNDW VOLC HARD RO; Custodio E, 2013, 7 ASAMBLEA HISPANO P, P435; Custodio E., 1987, HIDROGEOLOGIA RECURS, V12, P263; Deutsch C. V., 1998, GSLIB GEOSTATISTICAL; Faure G., 1986, PRINCIPLES ISOTOPE G; Fritz P., 1997, ENV ISOTOPES HYDROGE; Galindo I, 2005, ESTRUCTURA VOLCANO T; Garcia A, 2006, EOS, V87, P61, DOI [10.1029/2006EO060001, DOI 10.1029/2006EO060001]; Hoefs J., 2009, STABLE ISOTOPE GEOCH; Iribarren I, 2014, MODELOS GEOLOGICOS 3; Jenkins AC, 1961, ARGON HELIUM RARE GA; Marrero R, 2010, MODELO HIDROGEOQUIMI; Mook WG, 2002, ENV ISOT HYDROL CYCL, VI, P281; Navarro JM, 1995, GEOLOGIA HIDROGEOLOG; Navarro JM, 1989, ESF M CAN VOLC LANZ, P150; Ozima M., 2002, NOBLE GAS GEOCHEMIST; Perez NM, 1992, 3 C GEOL ESP 8 C LAT, P463; Perez NM, 2007, EOS T AM GEOPHYS UN, V88, P488, DOI 10.1029/2007EO460008; Petratherm Limited, 2013, TEN MAGN SURV ID GEO; Romero C., 1991, MANIFESTACIONES VOLC; Sakamoto M, 1992, GEOCHEM J, V26, P85; Sano Y, 1995, CHEM GEOL, V119, P260; Schopphoff A, 2003, GIT LABOR FACHZ, V10, P996; Sinclair A., 1974, J GEOCHEM EXPLOR, V3, P129, DOI DOI 10.1016/0375-6742(74)90030-2; Sumino H, 2001, J MASS SPECTROM SOC, V49, P61; Villasante-Marcos V, 2014, J VOLCANOL GEOTH RES, V272, P59, DOI 10.1016/j.jvolgeores.2013.12.007	78	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0258-8900	1432-0819		B VOLCANOL	Bull. Volcanol.	OCT	2015	77	10							86	10.1007/s00445-015-0969-0		18	Geosciences, Multidisciplinary	Geology	CS7RJ	WOS:000362282600004		
J	Mine, K; Yamashita, A				Mine, Kotaro; Yamashita, Atsushi			Metric Compactifications and Coarse Structures	CANADIAN JOURNAL OF MATHEMATICS-JOURNAL CANADIEN DE MATHEMATIQUES			English	Article						coarse geometry; Higson corona; continuously controlled coarse structure; uniform continuity; boundary at infinity	GROMOV HYPERBOLIC SPACES; K-THEORY; GEOMETRY; BOUNDARY	Let TB be the category of totally bounded, locally compact metric spaces with the C-0 coarse structures. We show that if X and Y are in TB, then X and Y are coarsely equivalent if and only if their Higson coronas are homeomorphic. In fact, the Higson corona functor gives an equivalence of categories TB -> K, where K is the category of compact metrizable spaces. We use this fact to show that the continuously controlled coarse structure on a locally compact space X induced by some metrizable compactification (X) over tilde is determined only by the topology of the remainder (X) over tilde \ X.	[Mine, Kotaro] Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan; [Yamashita, Atsushi] Chiba Inst Technol, Narashino, Chiba 2750023, Japan	Mine, K (reprint author), Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan.	mine@ms.u-tokyo.ac.jp; ayamashita@p.chibakoudai.jp					Jordi J, 2010, GEOMETRIAE DEDICATA, V149, P129, DOI 10.1007/s10711-010-9472-0; Bonk M, 2000, GEOM FUNCT ANAL, V10, P266, DOI 10.1007/s000390050009; Rosenthal D, 2004, K-THEORY, V32, P139, DOI 10.1023/B:KTHE.0000037563.35102.0d; Paulin F, 1996, J LOND MATH SOC, V54, P50; Wright N, 2003, J FUNCT ANAL, V197, P469, DOI 10.1016/S0022-1236(02)00025-3; CARLSSON G, 1995, TOPOLOGY, V34, P731, DOI 10.1016/0040-9383(94)00033-H; Cuchillo-Ibanez E, 2008, T AM MATH SOC, V360, P5229, DOI 10.1090/S0002-9947-08-04603-5; Higson N, 1997, K-THEORY, V11, P209, DOI 10.1023/A:1007705726771; Woods RG, 1995, FUND MATH, V147, P39; Bridson M. R., 1999, GRUNDLEHREN MATH WIS, V319; Buyalo S., 2007, EMS MONOGRAPHS MATH; Engelking R., 1989, SIGMA SERIES PURE MA, V6; Roe J., CORRECTIONS LECT COA; Roe J., 2003, U LECT SERIES, V31	14	0	0	CANADIAN MATHEMATICAL SOC	OTTAWA	209-1725 ST LAURENT BLVD, OTTAWA, ONTARIO K1G 3V4, CANADA	0008-414X	1496-4279		CAN J MATH	Can. J. Math.-J. Can. Math.	OCT	2015	67	5					1091	1108		10.4153/CJM-2015-029-8		18	Mathematics	Mathematics	CS5XW	WOS:000362152600006		
J	Nohara, Y; Ueda, K				Nohara, Yuichi; Ueda, Kazushi			Goldman Systems and Bending Systems	CANADIAN JOURNAL OF MATHEMATICS-JOURNAL CANADIEN DE MATHEMATIQUES			English	Article						toric degeneration	FLAT CONNECTIONS; MODULI SPACE; PARABOLIC BUNDLES; RIEMANN SURFACE; SYMPLECTIC-GEOMETRY; TORIC DEGENERATIONS; POLYGONS; REPRESENTATIONS; CURVES	We show that the moduli space of parabolic bundles on the projective line and the polygon space are isomorphic, both as complex manifolds and as symplectic manifolds equipped with structures of completely integrable systems, if the stability parameters are small.	[Nohara, Yuichi] Kagawa Univ, Fac Educ, Takamatsu, Kagawa 7608522, Japan; [Ueda, Kazushi] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Nohara, Y (reprint author), Kagawa Univ, Fac Educ, Saiwai Cho 1-1, Takamatsu, Kagawa 7608522, Japan.	nohara@ed.kagawa-u.ac.jp; kazushi@ms.u-tokyo.ac.jp			Korea Institute for Advanced Study	We thank Shinnosuke Okawa for valuable discussions, and the anonymous referee for suggesting improvements. A part of this paper was written while K. U. was visiting the Korea Institute for Advanced Study, whose hospitality and financial support are gratefully acknowledged.	Kapovich M, 1996, J DIFFER GEOM, V44, P479; Thaddeus M, 1996, J AM MATH SOC, V9, P691, DOI 10.1090/S0894-0347-96-00204-4; Jeffrey L, 1997, MATH ANN, V307, P93, DOI 10.1007/s002080050024; JEFFREY LC, 1994, MATH ANN, V298, P667, DOI 10.1007/BF01459756; Dolgachev IV, 1998, IHES PUBL MATH, P5; Nohara Y, 2014, NAGOYA MATH J, V214, P125, DOI 10.1215/00277630-2643839; WEITSMAN J, 1992, COMMUN MATH PHYS, V145, P425, DOI 10.1007/BF02099391; Kamiyama Y, 2002, GEOMETRIAE DEDICATA, V93, P25, DOI 10.1023/A:1020393910472; Howard B, 2011, CAN J MATH, V63, P878, DOI 10.4153/CJM-2011-021-0; JEFFREY LC, 1994, ADV MATH, V106, P151, DOI 10.1006/aima.1994.1054; BAUER S, 1991, MATH ANN, V290, P509, DOI 10.1007/BF01459257; Nishinou T, 2010, ADV MATH, V224, P648, DOI 10.1016/j.aim.2009.12.012; GOLDMAN WM, 1986, INVENT MATH, V85, P263, DOI 10.1007/BF01389091; Alekseev A, 1998, J DIFFER GEOM, V48, P445; Speyer D, 2004, ADV GEOM, V4, P389, DOI 10.1515/advg.2004.023; Treloar T, 2002, CAN J MATH, V54, P30, DOI 10.4153/CJM-2002-002-1; Hurtubise JC, 2000, CAN J MATH, V52, P1235, DOI 10.4153/CJM-2000-052-4; Guruprasad K, 1997, DUKE MATH J, V89, P377, DOI 10.1215/S0012-7094-97-08917-1; Foth P., 2005, TRAV MATH, VXVI, P87; GEIGLE W, 1987, LECT NOTES MATH, V1273, P265; GUILLEMIN V., 1984, MATH PHYS STUDIES, V6, P161; Hausmann J.-C., 1997, ENSEIGN MATH, V43, P173; JEFFREY LC, 1992, COMMUN MATH PHYS, V150, P593, DOI 10.1007/BF02096964; KLYACHKO AA, 1994, A MATHEMAT, V25, P67; Lenzing H., 2011, EMS SER C REP, P153; Manon C. A., ARXIV09100577; Marle C.-M., 1985, RENDICONTI SEMINARIO, V43, P227; MEHTA VB, 1980, MATH ANN, V248, P205, DOI 10.1007/BF01420526; Millson JJ, 2001, COMMUN MATH PHYS, V218, P315, DOI 10.1007/PL00005557	29	0	0	CANADIAN MATHEMATICAL SOC	OTTAWA	209-1725 ST LAURENT BLVD, OTTAWA, ONTARIO K1G 3V4, CANADA	0008-414X	1496-4279		CAN J MATH	Can. J. Math.-J. Can. Math.	OCT	2015	67	5					1109	1143		10.4153/CJM-2015-004-2		35	Mathematics	Mathematics	CS5XW	WOS:000362152600007		
J	Sekino, S; Kashiwagi, Y; Kanazawa, H; Takada, K; Baba, T; Sato, S; Inoue, H; Kojima, M; Tani, K				Sekino, Saki; Kashiwagi, Yuriko; Kanazawa, Hitoshi; Takada, Kazuki; Baba, Takashi; Sato, Seiichi; Inoue, Hiroki; Kojima, Masaki; Tani, Katsuko			The NESH/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based WAVE2 complex	CELL COMMUNICATION AND SIGNALING			English	Article						c-Abl; Abi-1; NESH/Abi-3; WAVE2; Imatinib mesylate; Membrane protrusions	ABL TYROSINE KINASE; TRANSFORMING ACTIVITY; INVADOPODIA FORMATION; STRUCTURE PREDICTION; SIGNALING COMPLEX; PROTEIN; ABI1; PHOSPHORYLATION; NESH; LAMELLIPODIA	Background: Abl interactor (Abi) family proteins play significant roles in actin cytoskeleton organization through participation in the WAVE complex. Mammals possess three Abi proteins: Abi-1, Abi-2, and NESH/Abi-3. Abi-1 and Abi-2 were originally identified as Abl tyrosine kinase-binding proteins. It has been disclosed that Abi-1 acts as a bridge between c-Abl and WAVE2, and c-Abl-mediated WAVE2 phosphorylation promotes actin remodeling. We showed previously that NESH/Abi-3 is present in the WAVE2 complex, but neither binds to c-Abl nor promotes c-Abl-mediated phosphorylation of WAVE2. Results: In this study, we characterized NESH/Abi-3 in more detail, and compared its properties with those of Abi-1 and Abi-2. NESH/Abi-3 was ectopically expressed in NIH3T3 cells, in which Abi-1, but not NESH/Abi-3, is expressed. The expression of NESH/Abi-3 caused degradation of endogenous Abi-1, which led to the formation of a NESH/Abi-3-based WAVE2 complex. When these cells were plated on fibronectin-coated dishes, the translocation of WAVE2 to the plasma membrane was significantly reduced and the formation of peripheral lamellipodial structures was disturbed, suggesting that the NESH/Abi-3-based WAVE2 complex was unable to help produce lamellipodial protrusions. Next, Abi-1, Abi-2, or NESH/Abi-3 was expressed in v-src-transformed NIH3T3 cells. Only in NESH/Abi-3-expressed cells did treatment with an Abl kinase inhibitor, imatinib mesylate, or siRNA-mediated knockdown of c-Abl promote the formation of invadopodia, which are ventral membrane protrusions with extracellular matrix degradation activity. Structural studies showed that a linker region between the proline-rich regions and the Src homology 3 (SH3) domain of Abi-1 is crucial for its interaction with c-Abl and c-Abl-mediated phosphorylation of WAVE2. Conclusions: The NESH/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based one, and NESH/Abi-3 may be involved in the formation of ventral protrusions under certain conditions.	[Sekino, Saki; Kashiwagi, Yuriko; Kanazawa, Hitoshi; Takada, Kazuki; Baba, Takashi; Sato, Seiichi; Inoue, Hiroki; Kojima, Masaki; Tani, Katsuko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan	Tani, K (reprint author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan.	tani@toyaku.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science of Ministry of Education, Culture, Sports, Science and Technology, Japan [26440105]	We thank Ms. S. Seino, Mr. K. Sudo, Mr. R. Asano and Ms. A. Suga for their technical assistance. We are very grateful to Dr. H. Yamaguchi for his helpful advice on the invadopodia assay. We are also grateful to Dr. D. Baltimore, Dr. B. Mayer, Dr. T. Takenawa, Dr. D. Yamazaki, and Dr. T. Akagi for the kind gifts of reagents. We also thank Dr. T. Shishido for critical reading of the manuscript. This work was supported in part by a Grant-in-aid for Scientific Research, 26440105 (to K. T.), from, and by the Platform for Drug Discovery, Informatics, and Structural Life Science (to M. K) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin TY, 2004, J BIOMED SCI, V11, P902, DOI 10.1159/000081837; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Xiong XL, 2008, BBA-MOL CELL RES, V1783, P737, DOI 10.1016/j.bbamcr.2008.01.028; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Maruoka M, 2005, FEBS LETT, V579, P2986, DOI 10.1016/j.febslet.2005.04.052; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Panjarian S, 2013, J BIOL CHEM, V288, P5443, DOI 10.1074/jbc.R112.438382; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Singh A, 2013, J BIOL CHEM, V288, P14135, DOI 10.1074/jbc.M112.445643; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; McShea MA, 2013, DEV BIOL, V373, P1, DOI 10.1016/j.ydbio.2012.09.017; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Ichigotani Y, 2002, INT J MOL MED, V9, P591; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Suzuki J, 2004, ONCOGENE, V23, P8527, DOI 10.1038/sj.onc.1207894; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Stuart JR, 2006, J BIOL CHEM, V281, P31290, DOI 10.1074/jbc.M602389200; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Hirao N, 2006, FEBS LETT, V580, P6464, DOI 10.1016/j.febslet.2006.10.065; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Ichigotani Y, 2002, CANCER RES, V62, P2215; Fan PD, 2003, CANCER RES, V63, P873; Hayes KE, 2013, ONCOGENE, V32, P4766, DOI 10.1038/onc.2012.513; Matsuda S, 2008, MOL ONCOL, V2, P16, DOI 10.1016/j.molonc.2008.03.003; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Miyazaki K, 2000, BBA-GENE STRUCT EXPR, V1493, P237, DOI 10.1016/S0167-4781(00)00158-5; Dubielecka PM, 2011, P NATL ACAD SCI USA, V108, P7022, DOI 10.1073/pnas.1016811108; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Bae J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034514; Bae J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034677; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Dubielecka PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010430; Dubielecka PM, 2011, FEBS LETT, V584, P3279; Hossain Sajjad, 2012, Genes Cancer, V3, P402, DOI 10.1177/1947601912460051; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626	49	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1478-811X			CELL COMMUN SIGNAL	Cell Commun. Signal.	OCT 1	2015	13								41	10.1186/s12964-015-0119-5		15	Cell Biology	Cell Biology	CS7EF	WOS:000362246200001		
J	Asai, S; Yabe, Y; Goto, R; Nagata, S; Monguchi, Y; Kita, Y; Sajiki, H; Sawama, Y				Asai, Shota; Yabe, Yuki; Goto, Ryota; Nagata, Saori; Monguchi, Yasunari; Kita, Yasuyuki; Sajiki, Hironao; Sawama, Yoshinari			Gold-Catalyzed Benzylic Azidation of Phthalans and Isochromans and Subsequent FeCl3-Catalyzed Nucleophilic Substitutions	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						azidation; gold catalyst; phthalan; isochroman; iron-catalyzed nucleophilic substitution	INHIBITORS; 1,4-EPOXY-1,4-DIHYDRONAPHTHALENES; BIS(INDOLYL)METHANES; AZIDONATION; ANNULATION; ARYLATION; ETHERS; AZIDES	The benzylic positions of the phthalan and isochroman derivatives (1) as benzene-fused cyclic ethers effectively underwent gold-catalyzed direct azidation using trimethylsilylazide (TMSN3) to give the corresponding 1-azidated products (2) possessing the N,O-acetal partial structure. The azido group of the N,O-acetal behaved as a leaving group in the presence of catalytic iron(III) chloride, and 1-aryl or allyl phthalan and isochroman derivatives were obtained by nucleophilic arylation or allylation, respectively. Meanwhile, a double nucleophilic substitution toward the 1-azidated products (2) occurred at the 1-position using indole derivatives as a nucleophile accompanied by elimination of the azido group and subsequent ring opening of the cyclic ether nucleus produced the bisindolylarylmethane derivatives.	[Asai, Shota; Yabe, Yuki; Goto, Ryota; Nagata, Saori; Monguchi, Yasunari; Sajiki, Hironao; Sawama, Yoshinari] Gifu Pharmaceut Univ, Gifu 5011196, Japan; [Kita, Yasuyuki] Ritsumeikan Univ, Coll Pharmaceut Sci, Shiga 5258577, Japan	Sajiki, H (reprint author), Gifu Pharmaceut Univ, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	sajiki@gifu-pu.ac.jp; sawama@gifu-pu.ac.jp			Japan Society for the Promotion of Science (JSPS); Ritsumeikan Global Innovation Research Organization (R-GIRO) project	This work was supported by Grand-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) and Ritsumeikan Global Innovation Research Organization (R-GIRO) project.	Magnus P, 1998, J AM CHEM SOC, V120, P12486, DOI 10.1021/ja9829564; Pedersen CM, 2005, ORG BIOMOL CHEM, V3, P816, DOI 10.1039/b500037h; SCRIVEN EFV, 1988, CHEM REV, V88, P297, DOI 10.1021/cr00084a001; de Groot MJ, 2002, J MED CHEM, V45, P1983, DOI 10.1021/jm0110791; Muramatsu W, 2014, ORG LETT, V16, P2042, DOI 10.1021/ol5006399; Sawama Y, 2013, ANGEW CHEM INT EDIT, V52, P1515, DOI 10.1002/anie.201207315; MARTIN P, 1976, SCIENCE, V194, P965, DOI 10.1126/science.982057; Xu XL, 2004, J NAT PROD, V67, P1661, DOI 10.1021/np0400609; Yang YD, 2010, MOL INFORM, V29, P421, DOI 10.1002/minf.201000034; DALTERIO S, 1977, SCIENCE, V196, P1472, DOI 10.1126/science.867048; Shiri M, 2010, CHEM REV, V110, P2250, DOI 10.1021/cr900195a; Sivaprasad G, 2006, BIOORG MED CHEM LETT, V16, P6302, DOI 10.1016/j.bmcl.2006.09.019; Sawama Y, 2012, CHEM-EUR J, V18, P16608, DOI 10.1002/chem.201202984; Panda G, 2007, EUR J MED CHEM, V42, P410, DOI 10.1016/j.ejmech.2006.09.020; Sawama Y, 2009, ORG LETT, V11, P5034, DOI 10.1021/ol902005e; Sawama Y, 2013, ADV SYNTH CATAL, V355, P517, DOI 10.1002/adsc.201200771; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Otomo M, 2008, BIOL PHARM BULL, V31, P1489, DOI 10.1248/bpb.31.1489; Sawama Y, 2015, CHEM-EUR J, V21, P2222, DOI 10.1002/chem.201405558; Sawama Y, 2014, CHEM-EUR J, V20, P2631, DOI 10.1002/chem.201303910; Viuf C, 2001, ANGEW CHEM INT EDIT, V40, P623, DOI 10.1002/1521-3773(20010202)40:3<623::AID-ANIE623>3.3.CO;2-7; Xie J, 2012, ANGEW CHEM INT EDIT, V51, P1252, DOI 10.1002/anie.201107605; Pedersen H, 2004, ORG BIOMOL CHEM, V2, P2861, DOI 10.1039/b405768f; Yamaori S, 2010, BIOCHEM PHARMACOL, V79, P1691, DOI 10.1016/j.bcp.2010.01.028; Sawama Y, 2013, ORG LETT, V15, P5282, DOI 10.1021/ol402511r; Khan R, 2010, CHEM NAT COMPD+, V46, P722, DOI 10.1007/s10600-010-9725-z; Kamal A, 2009, J ENZYM INHIB MED CH, V24, P559, DOI 10.1080/14756360802292974 ; Sujatha K, 2009, INDIAN J CHEM B, V48, P267; Sawama Y, 2015, ORG LETT, V17, P434, DOI 10.1021/acs.orglett.5b00106; MARGOSIAN D, 1981, J ORG CHEM, V46, P877, DOI 10.1021/jo00318a011; Benabadji SH, 2004, ACTA PHARMACOL SIN, V25, P666; Sawama Y, 2014, CHEM-EUR J, V20, P510, DOI 10.1002/chem.201302862; Baruah M., 2002, J CHEM SOC P1, V2002, P509; Huisgen R., 1963, ANGEW CHEM INT EDIT, V2, P565, DOI DOI 10.1002/ANIE.196305651; Murali A, 2011, EUR J ORG CHEM, P5297, DOI 10.1002/ejoc.201100674; Sawama Y., 2010, SYNLETT, V14, P2151; Zang Y., 2012, ORG BIOMOL CHEM, V10, P9137; Zhi L, 1998, J MED CHEM, V41, P291, DOI 10.1021/jm9705768	38	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					757	761				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000001		
J	Toyo'oka, T; Kikura-Hanajiri, R				Toyo'oka, Toshimasa; Kikura-Hanajiri, Ruri			A Reliable Method for the Separation and Detection of Synthetic Cannabinoids by Supercritical Fluid Chromatography with Mass Spectrometry, and Its Application to Plant Products	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						cannabinoid; supercritical fluid chromatography; mass spectrometry; plant product; isomer separation	LC-MS/MS; NAPHTHALEN-1-YL-(1-PENTYLINDOL-3-YL)METHANONE JWH-018; HUMAN URINE; METABOLITES; IDENTIFICATION; TOXICOLOGY; AGONIST; DRUGS; BLOOD	A reliable method using supercritical fluid chromatography with mass spectrometry (SFC-MS) was developed for cannabinoids using compressed carbon dioxide (CO2) and methanol as the mobile-phase. The cannabinoids, i.e., cannabicyclohexanol (CCH: cis-isomer), trans-CCH, 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47497), 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)-cyclohexyl]-phenol (CP-55940), 3-(1,1'-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol (HU-210), 2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol (CBD), (1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-018), (1-butyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-073) and 1-(1-pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)-ethanone (JWH-250), were determined within 12 mm using a conventional column (2-EP) for SFC. Furthermore, two optical isomers of CCH and trans-CCH were completely and rapidly separated by a chiral stationary phase column (AMY1). A highly sensitive detection (0.002-3.75ppb) was also obtained by these methods using 2-EP and AMY1 columns. These methods were applied to the qualitative and quantitative determination of cannabinoids in dried plant products. Although the concentration and species were different in the products, JWH-018, JWH-073 and CCH, including the cis-isomer, trans-isomer and the optical isomers, were detected in the products. Therefore, the proposed SFC-MS method seems to be useful as an alternative method to GC-MS and LC-MS for illegal drugs, such as cannabinoids.	[Toyo'oka, Toshimasa] Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Suruga Ku, Shizuoka 4228526, Japan; [Kikura-Hanajiri, Ruri] Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, Tokyo 1588501, Japan	Toyo'oka, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	toyooka@u-shizuoka-ken.ac.jp			Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan	The authors thank Ms. Sachiko Shindo and Mr. Hidaka Ikeda, Nihon Waters Co., for technical assistance with the SFC-MS analysis. This study was supported in part by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan.	Lindigkeit R, 2009, FORENSIC SCI INT, V191, P58, DOI 10.1016/j.forsciint.2009.06.008; Uchiyama N, 2010, FORENSIC SCI INT, V198, P31, DOI 10.1016/j.forsciint.2010.01.004; Marquet P, 1999, J CHROMATOGR B, V733, P93, DOI 10.1016/S0378-4347(99)00147-4; Teske J, 2010, J CHROMATOGR B, V878, P2659, DOI 10.1016/j.jchromb.2010.03.016; Poklis JL, 2012, BIOMED CHROMATOGR, V26, P1393, DOI 10.1002/bmc.2710; Uchiyama N, 2011, YAKUGAKU ZASSHI, V131, P1141; Uchiyama N, 2009, CHEM PHARM BULL, V57, P439, DOI 10.1248/cpb.57.439; Bogusz MJ, 1999, J CHROMATOGR B, V733, P65, DOI 10.1016/S0378-4347(98)00520-9; Li XW, 2013, J CHROMATOGR A, V1302, P95, DOI 10.1016/j.chroma.2013.06.028; Yanes EG, 2012, J CHROMATOGR B, V909, P42, DOI 10.1016/j.jchromb.2012.10.013; [Anonymous], 2009, UNDERSTANDING SPICE; Temerdashev AZ, 2014, J ANAL CHEM+, V69, P817, DOI 10.1134/S1061934814090111; De Backer B, 2009, J CHROMATOGR B, V877, P4115, DOI 10.1016/j.jchromb.2009.11.004; Iwasaki Y, 2011, J CHROMATOGR B, V879, P1159, DOI 10.1016/j.jchromb.2011.02.008; Mercolini L, 2013, J CHROMATOGR A, V1271, P33, DOI 10.1016/j.chroma.2012.11.030; Fischedick JT, 2009, PHYTOCHEM ANALYSIS, V20, P421, DOI 10.1002/pca.1143; de Jager AD, 2012, J CHROMATOGR B, V897, P22, DOI 10.1016/j.jchromb.2012.04.002; Niessen WMA, 1998, J CHROMATOGR A, V794, P407, DOI 10.1016/S0021-9673(97)01112-6; Kim JY, 2007, RAPID COMMUN MASS SP, V21, P1339, DOI 10.1002/rcm.2956; Zhang Q, 2006, ANAL BIOANAL CHEM, V386, P1345, DOI 10.1007/s00216-006-0717-6; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Raharjo TJ, 2004, PHYTOCHEM ANALYSIS, V15, P79, DOI 10.1002/pca.753; Toyo'oka T, 2008, J CHROMATOGR SCI, V46, P233; Uchiyama N, 2009, FORENSIC TOXICOL, V27, P61, DOI 10.1007/s11419-009-0069-y; Montesano C, 2014, J PHARMACEUT BIOMED, V91, P169, DOI 10.1016/j.jpba.2013.12.035; Huffman J. W., 2009, CANNABINOID RECEPTOR; WEISSMAN A, 1982, J PHARMACOL EXP THER, V223, P516	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					762	769				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000002		
J	Uchino, T; Miyazaki, Y; Ohkawa, T; Yamazaki, T; Yanagihara, Y; Yoshimori, T; Komatsu, M; Suzuki, H; Kagawa, Y				Uchino, Tomonobu; Miyazaki, Yasunori; Ohkawa, Tomoyo; Yamazaki, Takuto; Yanagihara, Yoshitsugu; Yoshimori, Takayuki; Komatsu, Mamoru; Suzuki, Hiroshi; Kagawa, Yoshiyuki			Reconstitution of L-Asparaginase in Siliconized Syringes with Shaking and Headspace Air Induces Protein Aggregation	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						protein aggregation; silicone oil; L-asparaginase (L-ASP); sub-visible particle; flow cytometry; Raman microscopy	ACUTE LYMPHOBLASTIC-LEUKEMIA; MONOCLONAL-ANTIBODY; SUBVISIBLE PARTICLES; WATER-INTERFACE; FLOW-CYTOMETRY; OIL; STABILITY; FORMULATIONS; SPECTROSCOPY; IMPACT	The aim of this study was to characterize protein aggregation during reconstitution of a highly concentrated solution of lyophilized L-asparaginase (L-ASP). The effect of the preparation method on L-ASP aggregation using siliconized or non-siliconized syringes and the effect of storage after preparation were evaluated by far-UV circular dichroism spectroscopy, Raman microscopy, flow cytometry, and flow particle image analysis. To investigate the effect of syringe type in combination with shaking and headspace air on L-ASP aggregation, four kinds of L-ASP in 5% glucose solutions were prepared (in the presence or absence of silicon oil and headspace air). Slight differences in L-ASP secondary structure were observed between the siliconized and non-siliconized syringe systems before shaking. Large numbers of sub-visible (0.1-100 mu m) and submicron (0.1-1 mu m) particles were formed by preparation with siliconized syringes and the combination of shaking and headspace air. The number of aggregated particles was not decreased with increased storage time. The Raman microscopy, flow cytometry and flow particle image results suggested that L-ASP interacted with silicone oil, which induced aggregation. Nevertheless, sub-visible and submicron particles were also formed with non-siliconized syringes. However, using non-siliconized syringes, the number of aggregated particles decreased with storage. No changes in particle character were observed before or after shaking with headspace air in non-siliconized syringes, indicating that soluble aggregates formed and dissolved with storage. Silicone oil in syringes, in combination with shaking and headspace air, strongly affected the aggregation of lyophilized L-ASP formulations during preparation.	[Uchino, Tomonobu; Miyazaki, Yasunori; Ohkawa, Tomoyo; Yamazaki, Takuto; Kagawa, Yoshiyuki] Univ Shizuoka, Sch Pharmaceut Sci, Dept Clin Pharmaceut, Suruga Ku, Shizuoka 4228526, Japan; [Uchino, Tomonobu; Miyazaki, Yasunori; Kagawa, Yoshiyuki] Shizuoka Prefectural Gen Hosp, Clin Pharmacokinet Lab, Aoi Ku, Shizuoka 4208527, Japan; [Yanagihara, Yoshitsugu; Suzuki, Hiroshi] Tokyo Univ Hosp, Fac Med, Dept Pharm, Bunkyo Ku, Tokyo 1138655, Japan; [Yoshimori, Takayuki] TKY Create Inc, Nerima Ku, Tokyo 1780061, Japan; [Komatsu, Mamoru] Thermo Fisher Sci KK, CAD Mol Sales Dept, Applicat Grp, Kanagawa Ku, Yokohama, Kanagawa 2210022, Japan	Uchino, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Clin Pharmaceut, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	uchinot@u-shizuoka-ken.ac.jp					Singh SK, 2010, J PHARM SCI-US, V99, P3302, DOI 10.1002/jps.22097; CASTAMAN G, 1990, HAEMATOLOGICA, V75, P567; Jayes L, 2003, ANAL CHEM, V75, P742, DOI 10.1021/ac026012f; Torosantucci R, 2011, J PHARM SCI-US, V100, P2574, DOI 10.1002/jps.22523; Li CH, 2009, CURR PHARM BIOTECHNO, V10, P391; Liu L, 2011, INVEST OPHTH VIS SCI, V52, P1023, DOI 10.1167/iovs.10-6431; Kueltzo LA, 2008, J PHARM SCI-US, V97, P1801, DOI 10.1002/jps.21110; BELL BA, 1986, DEV PHARMACOL THERAP, V9, P145; Auge KB, 2011, J PHARM SCI-US, V100, P5100, DOI 10.1002/jps.22704; Sharma B, 2007, BIOTECHNOL ADV, V25, P318, DOI 10.1016/j.biotechadv.2007.01.006; Promeyrat A, 2010, FOOD CHEM, V121, P412, DOI 10.1016/j.foodchem.2009.12.057; Strambini GB, 1996, BIOPHYS J, V70, P971; Zolls S, 2012, J PHARM SCI-US, V101, P914, DOI 10.1002/jps.23001; Wiesbauer J, 2013, LANGMUIR, V29, P15240, DOI 10.1021/la4028223; Majumdar S, 2011, J PHARM SCI-US, V100, P2563, DOI 10.1002/jps.22515; Kumru OS, 2012, J PHARM SCI-US, V101, P3636, DOI 10.1002/jps.23224; Narhi LO, 2012, J PHARM SCI-US, V101, P493, DOI 10.1002/jps.22790; Promeyrat A, 2010, MEAT SCI, V85, P625, DOI 10.1016/j.meatsci.2010.03.015; Boven K, 2005, KIDNEY INT, V67, P2346, DOI 10.1111/j.1523-1755.2005.00340.x; Wacker P, 2007, J PEDIAT HEMATOL ONC, V29, P627, DOI 10.1097/MPH.0b013e3181483df1; Tyagi AK, 2009, J PHARM SCI-US, V98, P94, DOI 10.1002/jps.21419; de Campos RPS, 2013, SPECTROCHIM ACTA A, V100, P67, DOI 10.1016/j.saa.2012.03.054; Albertsen BK, 2005, PEDIATR BLOOD CANCER, V44, P255, DOI 10.1002/pbc.20214; Ryan MH, 2006, INT IMMUNOPHARMACOL, V6, P647, DOI 10.1016/j.intimp.2005.10.001; Das TK, 2012, AAPS PHARMSCITECH, V13, P732, DOI 10.1208/s12249-012-9793-4; Woo MH, 2000, J CLIN ONCOL, V18, P1525; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Wen ZQ, 2007, J PHARM SCI-US, V96, P2861, DOI 10.1002/jps.20895; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Nishi H, 2014, J PHARM SCI-US, V103, P90, DOI 10.1002/jps.23782; Mach H, 2011, J PHARM SCI-US, V100, P1671, DOI 10.1002/jps.22414; Jones LS, 2005, J PHARM SCI-US, V94, P918, DOI 10.1002/jps.20321; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Thirumangalathu R, 2009, J PHARM SCI-US, V98, P3167, DOI 10.1002/jps.21719; Vazquez-Rey M, 2011, BIOTECHNOL BIOENG, V108, P1494, DOI 10.1002/bit.23155; Ludwig DB, 2011, ANAL BIOCHEM, V410, P191, DOI 10.1016/j.ab.2010.12.008; Cram L. Scott, 2002, Methods in Cell Science, V24, P1, DOI 10.1023/A:1024198904819; Liu Wei, 2010, PDA J Pharm Sci Technol, V64, P11; Kyowahakko Kirin Co. L, 2013, LEUNASE INJ INT FORM; Ludwig DB, 2010, J PHARM SCI-US, V99, P1721, DOI 10.1002/jps.21982; Rosenberg Amy S, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359	41	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					770	779				10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000003		
J	Yamada, K; Iwao, Y; Bani-Jaber, A; Noguchi, S; Itai, S				Yamada, Kyohei; Iwao, Yasunori; Bani-Jaber, Ahmad; Noguchi, Shuji; Itai, Shigeru			Preparation and Evaluation of Newly Developed Chitosan Salt Coating Dispersions for Colon Delivery without Requiring Overcoating	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						chitosan derivative; acid stability; colonic delivery; coating dispersion; film	DRUG-DELIVERY; ACETAMINOPHEN TABLETS	Although chitosan (CS) has been recognized as a good material for colon-specific drug delivery systems, an overcoating with an enteric coating polymer on the surface of CS is absolutely necessary because CS is soluble in acidic conditions before reaching the colon. In the present study, to improve its stability in the presence of acid, a newly developed CS-laurate (CS-LA) material was evaluated as a coating dispersion for the development of colon-specific drug delivery systems. Two types of CS with different molecular weights, CS250 and CS600, were used to prepare CS-LA films by the casting method. The CS250-LA films had smooth surfaces, whereas the surfaces of the CS600-LA films were rough, indicating that the CS250-LA dispersion could form a denser film than CS600-LA. Both of these CS-LA films maintained a constant shape over 22 h in a pH 1.2 HCl/NaCl buffer, where the corresponding CS films rapidly disintegrated. In addition, the CS250-LA film showed specific colon degradability in a pH 6.0 phosphate buffered solution containing 1.0% (w/v) beta-glucosidase. As a result of tensile strength and elongation at the break, both CS-LA films were found to have flexible film properties. Finally, the release of acetaminophen from disks coated with CS250-LA dispersions was significantly suppressed in fluids at pH 1.2 and 6.8, whereas disks coated with CS solution rapidly released the drug in pH 1.2 fluids. Taken together, this study shows that LA modification could be a useful approach in preparing CS films with acid stability and colonic degradability properties without requiring overcoating.	[Yamada, Kyohei; Iwao, Yasunori; Noguchi, Shuji; Itai, Shigeru] Univ Shizuoka, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan; [Bani-Jaber, Ahmad] Univ Jordan, Fac Pharm, Amman, Jordan	Itai, S (reprint author), Univ Shizuoka, Grad Sch Pharmaceut Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	s-itai@u-shizuoka-ken.ac.jp					Rekha MR, 2009, J CONTROL RELEASE, V135, P144, DOI 10.1016/j.jconrel.2009.01.011; Macleod GS, 1999, INT J PHARM, V187, P251, DOI 10.1016/S0378-5173(99)00196-9; Ribeiro LNM, 2014, INT J PHARMACEUT, V463, P1, DOI 10.1016/j.ijpharm.2013.12.035; Sako K, 1996, PHARMACEUT RES, V13, P594, DOI 10.1023/A:1016006423601; Bani-Jaber A, 2015, INT J PHARMACEUT, V483, P49, DOI 10.1016/j.ijpharm.2015.02.014; Bernkop-Schnurch A, 2012, EUR J PHARM BIOPHARM, V81, P463, DOI 10.1016/j.ejpb.2012.04.007; Bani-Jaber A, 2012, ARCH PHARM RES, V35, P1159, DOI 10.1007/s12272-012-0706-6; Omwancha WS, 2013, INT J PHARMACEUT, V441, P343, DOI 10.1016/j.ijpharm.2012.11.022; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g; Zhang H, 2002, BIOMATERIALS, V23, P2761, DOI 10.1016/S0142-9612(02)00011-X; He W, 2009, EUR J PHARM BIOPHARM, V72, P266, DOI 10.1016/j.ejpb.2008.10.017; Furukawa K., 2010, PHARM TECH JPN, V26, P71; Furukawa K., 2009, PHARM TECH JPN, V25, P63	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					799	806				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000006		
J	Morimoto, K; Ogawa, R; Koseki, D; Takahashi, Y; Dohi, T; Kita, Y				Morimoto, Koji; Ogawa, Ryosuke; Koseki, Daichi; Takahashi, Yusuke; Dohi, Toshifumi; Kita, Yasuyuki			Clean Synthesis of N-Pyrrolyl Azoles by Metal-Free Oxidative Cross-Coupling Using Recyclable Hypervalent Iodine Reagent	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						oxidative coupling; hypervalent iodine reagent; recycle; pyrrole; azole; C-N bond formation	HIGHLY SELECTIVE OXIDATION; H BOND FUNCTIONALIZATION; FLUOROUS ALKYL IODIDES; CATALYZED C-N; CARBONYL-COMPOUNDS; IONIC LIQUID; BIS(TRIFLUOROACETATE) ADDUCTS; INDOLES; EFFICIENT; CHEMISTRY	The facile and clean oxidative coupling reaction of pyrroles with azoles has been achieved using the recyclable hypervalent iodine(III) reagents having adamantane structures. These iodine(III) reagents could be recovered from the reaction mixtures by a simple solid-liquid separation, i.e., filtration, for reuse.	[Morimoto, Koji; Ogawa, Ryosuke; Koseki, Daichi; Takahashi, Yusuke; Dohi, Toshifumi; Kita, Yasuyuki] Ritsumeikan Univ, Coll Pharmaceut Sci, Shiga 5258577, Japan	Kita, Y (reprint author), Ritsumeikan Univ, Res Org Sci & Technol, 1-1-1 Nojihigashi, Shiga 5258577, Japan.	kita@ph.ritsumei.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; JSPS	This work was partially supported by Grants-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research on Innovative Areas "Advanced Molecular Transformation by Organocatalysts" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. K. M. also acknowledges support from the Grant-in-Aid for Young Scientists (B) from the JSPS.	Qian WX, 2005, ANGEW CHEM INT EDIT, V44, P952, DOI 10.1002/anie.200461889; Duschek A, 2011, ANGEW CHEM INT EDIT, V50, P1524, DOI 10.1002/anie.201000873; Togo H, 2002, SYNLETT, P1966, DOI 10.1055/s-2002-35575; Rocaboy C, 2003, CHEM-EUR J, V9, P88, DOI 10.1002/chem.200390034; Dohi T, 2012, GREEN CHEM, V14, P1493, DOI 10.1039/c2gc16632a; Ma DW, 2008, ACCOUNTS CHEM RES, V41, P1450, DOI 10.1021/ar8000298; Zhdankin VV, 2009, ARKIVOC, P1; Evano G, 2008, CHEM REV, V108, P3054, DOI 10.1021/cr8002505; Beck EM, 2006, J AM CHEM SOC, V128, P2528, DOI 10.1021/ja058141u; Merritt EA, 2009, ANGEW CHEM INT EDIT, V48, P9052, DOI 10.1002/anie.200904689; Liu C, 2004, J AM CHEM SOC, V126, P10250, DOI 10.1021/ja046810i; Tohma H, 2001, TETRAHEDRON, V57, P345, DOI 10.1016/S0040-4020(00)00941-8; Novak P, 1997, CHEM REV, V97, P207, DOI 10.1021/cr941181o; Potavathri S, 2008, TETRAHEDRON LETT, V49, P4050, DOI 10.1016/j.tetlet.2008.04.073; Baran PS, 2005, ANGEW CHEM INT EDIT, V44, P609, DOI 10.1002/anie.200462048; Gonzalez DF, 2012, CHEMCATCHEM, V4, P955, DOI 10.1002/cctc.201200116; Beletskaya IP, 2004, COORDIN CHEM REV, V248, P2337, DOI 10.1016/j.ccr.2004.09.014; Handy ST, 2005, J ORG CHEM, V70, P2874, DOI 10.1021/jo047807k; Stuart DR, 2007, SCIENCE, V316, P1172, DOI 10.1126/science.1141956; Moroda A, 2006, TETRAHEDRON, V62, P12408, DOI 10.1016/j.tet.2006.09.112; Ferreira EM, 2003, J AM CHEM SOC, V125, P9578, DOI 10.1021/ja035054y; Morimoto K, 2014, ASIAN J ORG CHEM, V3, P382, DOI 10.1002/ajoc.201400027; Wen J, 2014, CHEM-EUR J, V20, P974, DOI 10.1002/chem.201302761; Podgorsek A, 2009, J ORG CHEM, V74, P3133, DOI 10.1021/jo900233h; Grimster NP, 2005, ANGEW CHEM INT EDIT, V44, P3125, DOI 10.1002/anie.200500468; Fan H, 2008, CHEM REV, V108, P264, DOI 10.1021/cr078199m; Bellina F, 2010, ADV SYNTH CATAL, V352, P1223, DOI 10.1002/adsc.201000144; Tohma H, 2004, ADV SYNTH CATAL, V346, P111, DOI 10.1002/adsc.200303203; Dohi T, 2010, ANGEW CHEM INT EDIT, V49, P3334, DOI 10.1002/anie.200907281; Tesevic V, 2006, J ORG CHEM, V71, P7433, DOI 10.1021/jo0612067; Poirier M, 2010, ORG LETT, V12, P2334, DOI 10.1021/ol100685p; Tesevic V, 2005, GREEN CHEM, V7, P833, DOI 10.1039/b511951k; Monnier F, 2009, ANGEW CHEM INT EDIT, V48, P6954, DOI 10.1002/anie.200804497; Morimoto K, 2010, ORG LETT, V12, P3804, DOI 10.1021/ol101498r; Ley SV, 2003, ANGEW CHEM INT EDIT, V42, P5400, DOI 10.1002/anie.200300594; Tohma H, 2004, ANGEW CHEM INT EDIT, V43, P3595, DOI 10.1002/anie.200454234; Abe S, 2001, J ORG CHEM, V66, P6174, DOI 10.1021/jo010333u; Kita Y, 2009, J AM CHEM SOC, V131, P1668, DOI 10.1021/ja808940n; Yusubov MS, 2010, MENDELEEV COMMUN, V20, P185, DOI 10.1016/j.mencom.2010.06.001; Gabriel S, 2007, CHEM MATER, V19, P2364, DOI 10.1021/cm062450h; Yusubov MS, 2012, CURR ORG SYNTH, V9, P247; Potavathri S, 2010, J AM CHEM SOC, V132, P14676, DOI 10.1021/ja107159b; Stuart DR, 2007, J AM CHEM SOC, V129, P12072, DOI 10.1021/ja0745862; Baran PS, 2004, J AM CHEM SOC, V126, P7450, DOI 10.1021/ja047874w; Zhdankin VV, 2008, CHEM REV, V108, P5299, DOI 10.1021/cr800332c; Dohi T., 2009, CHEM COMMUN, V2009, P2073; Fan W. Q., 1996, COMPREHENSIVE HETERO, V2; Katritzky A. R., 2000, ARKIVOC, V2000, P471; Kita Y., 2011, J SYNTH ORG CHEM JPN, V2011, P1241; Kunz K, 2003, SYNLETT, P2428, DOI 10.1055/s-2003-42473; Ley S. V., 1999, J CHEM SOC PERK T, V1999, P1251; Ley S. V., 1999, J CHEM SOC PERK T, V1999, P669; Merritt E. A., 2011, SYNTHESIS-STUTTGART, V2011, P517; Morimoto K, 2011, EUR J ORG CHEM, P6326, DOI 10.1002/ejoc.201100969; Qian WX, 2006, SYNLETT, P709, DOI 10.1055/s-2006-933109; Shang YJ, 2007, SYNLETT, P67, DOI 10.1055/s-2006-958450; Suzuki Y, 2010, SYNTHESIS-STUTTGART, P2355, DOI 10.1055/s-0029-1218795; Togo H, 1998, SYNLETT, P534	58	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					819	824				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000009		
J	Takahashi, B; Funami, H; Shibata, M; Maruoka, H; Koyama, M; Kanki, S; Muto, T				Takahashi, Bitoku; Funami, Hideaki; Shibata, Makoto; Maruoka, Hiroshi; Koyama, Makoto; Kanki, Satomi; Muto, Tsuyoshi			Structural Optimization of Ghrelin Receptor Inverse Agonists to Improve Lipophilicity and Avoid Mechanism-Based CYP3A4 Inactivation	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						ghrelinR; inverse agonist; obesity; mechanism-based inactivation; ligand-lipophilicity efficiency	HORMONE SECRETAGOGUE RECEPTOR; CYTOCHROME-P450 ENZYMES; DISCOVERY; OBESITY	Structural optimization of 2-aminonicotinamide derivatives as ghrelin receptor inverse agonists is reported. So as to avoid mechanism-based inactivation (MBI) of CYP3A4, 1,3-benzodioxol ring of the lead compound was modified. Improvement of the main activity and lipophilicity was achieved simultaneously, leading to compound 18a, which showed high lipophilic ligand efficiency (LLE) and low MBI activity.	[Takahashi, Bitoku; Funami, Hideaki; Shibata, Makoto; Maruoka, Hiroshi; Koyama, Makoto; Kanki, Satomi; Muto, Tsuyoshi] Asubio Pharma Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan	Takahashi, B (reprint author), Asubio Pharma Co Ltd, Chuo Ku, 6-4-3 Minatojima Minamunachi, Kobe, Hyogo 6500047, Japan.	takahashi.bitoku.cz@asubio.co.jp					Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; Takahashi B, 2015, BIOORGAN MED CHEM, V23, P4792, DOI 10.1016/j.bmc.2015.05.047; Carpino PA, 2008, EXPERT OPIN THER PAT, V18, P1253, DOI 10.1517/13543770802513859; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kalgutkar AS, 2007, CURR DRUG METAB, V8, P407; Orr STM, 2012, J MED CHEM, V55, P4896, DOI 10.1021/jm300065h; FIFE WK, 1983, J ORG CHEM, V48, P1375, DOI 10.1021/jo00156a053; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Tong J, 2010, DIABETES, V59, P2145, DOI 10.2337/db10-0504; Hoist B., 2003, MOL ENDOCRINOL, V17, P2201; Mannhold R., 2008, J PHARM SCI, V98, P861; Takahashi B, 2015, BIOORG MED CHEM LETT, V25, P2707, DOI 10.1016/j.bmcl.2015.04.040	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					825	832				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000010		
J	Fuchino, H; Yazawa, A; Kiuchi, F; Kawahar, N; Takahashi, Y; Satake, M				Fuchino, Hiroyuki; Yazawa, Aya; Kiuchi, Fumiyuki; Kawahar, Nobuo; Takahashi, Yutaka; Satake, Motoyoshi			Novel Monoterpene Lactones from Cinnamomum inunctum	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Cinnamomum inunctum; Lauraceae; monoterpene	ALPHA-LEVANTENOLIDE; BETA-LEVANTENOLIDE; DITERPENES	Four new monoterpene lactones, 5-(2,3-dihydroxy-3-methylbutyl)-4-hydroxy-4-methyldihydrofuran-2(3H)-one (1), 5-(2,3-dihydroxy-3-methylbutyl)-4-methylfuran-2(5H)-one (2), 8-hydroxy-4,7,7-trimethyl-1,6-dioxaspiro[4.4]non-3-en-2-one (3) and 8-hydroxy-4,7,7-trimethyl-1,6-dioxaspiro[4.4]non-3-en-2-one (4), were isolated from the methanolic extract of the fruit of Cinnamomum inunctum, a folk medicine in Myanmar, together with a known compound, 3-hydroxy-4,4-dimethyl-4-butyrolactone (5). Their chemical structures were determined by spectral methods. Among these, 3 and 4 possessed unique spirolactone moieties.	[Fuchino, Hiroyuki; Kawahar, Nobuo] Natl Inst Biomed Innovat, Res Ctr Med Plant Resources, Hlth & Nutr, Tsukuba, Ibaraki 3050843, Japan; [Yazawa, Aya; Satake, Motoyoshi] Ochanomizu Univ, Inst Environm Sci Human Life, Bunkyo Ku, Tokyo 1128610, Japan; [Kiuchi, Fumiyuki] Keio Univ, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Takahashi, Yutaka] MS Solut, Kodaira, Tokyo 1870035, Japan	Fuchino, H (reprint author), Natl Inst Biomed Innovat, Res Ctr Med Plant Resources, Hlth & Nutr, 1-2 Hachimandai, Tsukuba, Ibaraki 3050843, Japan.	fuchino@nibiohn.go.jp			Health and Labour Sciences Research Grant (Ministry of Health, Labour and Welfare of Japan)	This research was financially supported by the Health and Labour Sciences Research Grant (Ministry of Health, Labour and Welfare of Japan).	URONES JG, 1992, TETRAHEDRON, V48, P10389, DOI 10.1016/S0040-4020(01)88343-5; Ahmed AA, 2004, PHYTOCHEMISTRY, V65, P2539, DOI 10.1016/j.phytochem.2004.08.002; PETTERSSON T, 1993, J AGR FOOD CHEM, V41, P2097, DOI 10.1021/jf00035a052; Thantsin K, 2008, NAT PROD RES, V22, P576, DOI 10.1080/14786410701592802; Awale S., 2006, Journal of Traditional Medicines, V23, P47; GONZALEZ AG, 1976, TETRAHEDRON LETT, P1897	6	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					833	836				4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000011		
J	Nohara, T; Fujiwara, Y; Zhou, JR; Urata, J; Ikeda, T; Murakami, K; El-Aasr, M; Ono, M				Nohara, Toshihiro; Fujiwara, Yukio; Zhou, Jian-Rong; Urata, Jun; Ikeda, Tsuyoshi; Murakami, Kotaro; El-Aasr, Mona; Ono, Masateru			Saponins, Esculeosides B-1 and B-2, in Tomato Juice and Sapogenol, Esculeogenin B-1	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Solanum lycopersicum; tomato juice; tomato saponin; esculeoside B-1; esculeoside B-2; esculeogenin B-1	GLYCOSIDES; FRUITS	It has been shown that commercial tomato juice packaged in 900 g plastic bottles contains rare, naturally occurring steroidal solanocapsine-type tomato glycosides in which the saponins consist of esculeosides B-1 (2) and B-2 (3) in 0.041% as major components lacking esculeoside A. We suggest that these saponins are derived from esculeoside A (1) when the juice in plastic bottles is prepared by treatment with boiling water, similar to the process used in preparing canned tomatoes. Herein, the obtained tomato saponins (2) and (3) provided sapogenols esculeogenin B-1 (4) and B-2 (5), respectively, by acid hydrolysis. The former was identical to esculeogenin B previously reported, and the latter was a new sapogenol characterized to be (5 alpha,22S,23S,25S)-22,26-epimino-16 beta,23-epoxy-3 beta,23,27-trihydroxycholestane.	[Nohara, Toshihiro; Zhou, Jian-Rong; Urata, Jun; Ikeda, Tsuyoshi; Murakami, Kotaro] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Ikeda, Kumamoto 8600082, Japan; [Fujiwara, Yukio] Kumamoto Univ, Fac Life Sci, Grad Sch Med Sci, Chuo Ku, Kumamoto 8608556, Japan; [El-Aasr, Mona] Tanta Univ, Fac Pharm, Tanta 31111, Egypt; [Ono, Masateru] Tokai Univ, Sch Agr, Kumamoto 8691404, Japan	Nohara, T (reprint author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1, Ikeda, Kumamoto 8600082, Japan.	none@ph.sojo-u.ac.jp					Manabe H, 2011, J NAT MED-TOKYO, V65, P176, DOI 10.1007/s11418-010-0443-4; Manabe H, 2013, CHEM PHARM BULL, V61, P764; SCHREIBER K, 1962, LIEBIGS ANN CHEM, V655, P114; DEMARCO PV, 1968, J AM CHEM SOC, V90, P5480, DOI 10.1021/ja01022a027; Fujiwara Y, 2004, TETRAHEDRON, V60, P4915, DOI 10.1016/j.tet.2004.03.088; Nohara T, 2007, J NAT MED, V61, P1, DOI 10.1007/s11418-006-0021-y; Fujiwara Y, 2007, ARTERIOSCL THROM VAS, V27, P2400, DOI 10.1161/ATVBAHA.107.147405; Nohara T, 2010, J NAT PROD, V73, P1734, DOI 10.1021/np100311t; Yoshizaki M, 2005, CHEM PHARM BULL, V53, P839, DOI 10.1248/cpb.53.839; Fujiwara Y, 2003, CHEM PHARM BULL, V51, P234, DOI 10.1248/cpb.51.234; Nohara T., 2014, 8 JSP CCTCNM KSP JOI, P141	11	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2015	63	10					848	850				3	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS4LJ	WOS:000362047000014		
J	Sato, H; Yajima, T; Yamagishi, A				Sato, Hisako; Yajima, Tomoko; Yamagishi, Akihiko			Chiroptical Studies on Supramolecular Chirality of Molecular Aggregates	CHIRALITY			English	Review						vibrational circular dichroism; supramoelcular; chiral gelator; sol-gel transformation; perfluoroalkyl	VIBRATIONAL CIRCULAR-DICHROISM; N-ALKYL PERFLUOROALKANAMIDES; OPTICAL-ACTIVITY; AMYLOID SUPERSTRUCTURES; 12-HYDROXYOCTADECANOIC ACID; MACROMOLECULAR HELICITY; ABSOLUTE-CONFIGURATIONS; VCD SPECTROSCOPY; BINARY-MIXTURES; BIS-UREA	The attempts of applying chiroptical spectroscopy to supramolecular chirality are reviewed with a focus on vibrational circular dichroism (VCD). Examples were taken from gels, solids, and monolayers formed by low-molecular mass weight chiral gelators. Particular attention was paid to a group of gelators with perfluoroalkyl chains. The effects of the helical conformation of the perfluoroalkyl chains on the formation of chiral architectures are reported. It is described how the conformation of a chiral gelator was determined by comparing the experimental and theoretical VCD spectra together with a model proposed for the molecular aggregation in fibrils. The results demonstrate the potential utility of the chiroptical method in analyzing organized chiral aggregates. Chirality 27:659-666, 2015. (c) 2015 Wiley Periodicals, Inc.	[Sato, Hisako] Ehime Univ, Grad Sci & Engn, Matsuyama, Ehime, Japan; [Yajima, Tomoko] Ochanomizu Univ, Dept Chem, Tokyo, Japan; [Yamagishi, Akihiko] Toho Univ, Dept Chem, Chiba 2748510, Japan	Sato, H (reprint author), Ehime Univ, Grad Sci & Engn, 2-5 Bunkyo Cho, Matsuyama, Ehime, Japan.	sato.hisako.my@ehime-u.ac.jp			JSPS KAKENHI [26620068]	This work was supported by JSPS KAKENHI Grant Number 26620068.	Dzwolak W, 2013, LANGMUIR, V29, P365, DOI 10.1021/la304374q; Afrasiabi R, 2013, CHEM-EUR J, V19, P15862, DOI 10.1002/chem.201303116; van Esch JH, 2000, ANGEW CHEM INT EDIT, V39, P2263; Iavicoli P, 2010, J AM CHEM SOC, V132, P9350, DOI 10.1021/ja101533j; Setnicka V, 2006, CHEM-EUR J, V12, P8735, DOI 10.1002/chem.200500973; Sato H, 2011, CHEM COMMUN, V47, P3736, DOI 10.1039/c0cc05802e; Loiseau J, 2002, TETRAHEDRON, V58, P4049, DOI 10.1016/S0040-4020(02)00271-5; Yamamoto S, 2012, CHIRALITY, V24, P97, DOI 10.1002/chir.21029; Sato H, 2012, ORG BIOMOL CHEM, V10, P1581, DOI 10.1039/c1ob06460f; NAFIE LA, 1976, J AM CHEM SOC, V98, P2715, DOI 10.1021/ja00426a007; Welch WRW, 2013, J PHYS CHEM B, V117, P10343, DOI 10.1021/jp4056126; Kawauchi T, 2008, ANGEW CHEM INT EDIT, V47, P515, DOI 10.1002/anie.200703655; Cho MH, 2008, CHEM REV, V108, P1331, DOI 10.1021/cr078377b; Formaggio F, 2010, CHIRALITY, V22, pE30, DOI 10.1002/chir.20858; Vijay R, 2012, J PHYS CHEM A, V116, P10759, DOI 10.1021/jp308134m; Stephens PJ, 2008, CHIRALITY, V20, P643, DOI 10.1002/chir.20477; Rhee H, 2012, CHEM SOC REV, V41, P4457, DOI 10.1039/c2cs15336j; Sato H, 2008, CHEM PHYS LETT, V467, P140, DOI 10.1016/j.cplett.2008.11.024; Marty R, 2014, J PHYS CHEM B, V118, P11152, DOI 10.1021/jp506837c; Polavarapu PL, 2014, CHIRALITY, V26, P539, DOI 10.1002/chir.22316; Sato H, 2014, RSC ADV, V4, P25867, DOI 10.1039/c4ra02526a; He YA, 2011, APPL SPECTROSC, V65, P699, DOI 10.1366/11-06321; Polavarapu PL, 2012, CHIRALITY, V24, P909, DOI 10.1002/chir.22015; Monde K, 2006, J AM CHEM SOC, V128, P6000, DOI 10.1021/ja0602041; Smulders MMJ, 2008, CHIRALITY, V20, P1016, DOI 10.1002/chir.20568; Schwartz E, 2013, CHEM-EUR J, V19, P13168, DOI 10.1002/chem.201300073; Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Hase Y, 2009, J AM CHEM SOC, V131, P10719, DOI 10.1021/ja904128d; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; Poopari MR, 2015, J ORG CHEM, V80, P428, DOI 10.1021/jo502438a; Kudo M, 2009, J ORG CHEM, V74, P8154, DOI 10.1021/jo901934r; Sato H, 2014, RSC ADV, V4, P1659, DOI 10.1039/c3ra44070b; TACHIBANA T, 1979, NATURE, V278, P578, DOI 10.1038/278578a0; Piepenbrock MOM, 2010, CHEM REV, V110, P1960, DOI 10.1021/cr9003067; Zhang DW, 2012, CHEM REV, V112, P5271, DOI 10.1021/cr300116k; Rhee HJ, 2009, NATURE, V458, P310, DOI 10.1038/nature07846; Nieto-Ortega B, 2012, CHEM COMMUN, V48, P9147, DOI 10.1039/c2cc34374f; Novotna J, 2012, CHIRALITY, V24, P432, DOI 10.1002/chir.22045; Andrushchenko V, 2010, CHIRALITY, V22, pE96, DOI 10.1002/chir.20872; Kral V, 2005, TETRAHEDRON, V61, P5499, DOI 10.1016/j.tet.2005.03.134; Sadlej J, 2010, CHEM SOC REV, V39, P1478, DOI 10.1039/b915178h; Raghavanpillai A, 2012, J FLUORINE CHEM, V135, P187, DOI 10.1016/j.jfluchem.2011.10.015; Sato H, 2013, INT J MOL SCI, V14, P964, DOI 10.3390/ijms14010964; Zweep N, 2009, LANGMUIR, V25, P8802, DOI 10.1021/la9004714; Jyothish K, 2007, CHEM-EUR J, V13, P5944, DOI 10.1002/chem.200700130; Yang GC, 2011, TOP CURR CHEM, V298, P189, DOI 10.1007/128_2010_86; Babenko V, 2013, FEBS LETT, V587, P625, DOI 10.1016/j.febslet.2013.02.010; Babenko V, 2013, LANGMUIR, V29, P5271, DOI 10.1021/la400612w; Measey TJ, 2011, J AM CHEM SOC, V133, P1066, DOI 10.1021/ja1089827; Ma SL, 2007, J AM CHEM SOC, V129, P12364, DOI 10.1021/ja074188z; de Loos M, 2001, ANGEW CHEM INT EDIT, V40, P613, DOI 10.1002/1521-3773(20010202)40:3<613::AID-ANIE613>3.0.CO;2-K; Ruther A, 2014, CHIRALITY, V26, P490, DOI 10.1002/chir.22307; Monde K, 2004, J AM CHEM SOC, V126, P9496, DOI 10.1021/ja0484461; Kohno K, 2012, CHEM COMMUN, V48, P3860, DOI 10.1039/c2cc18164a; George M, 2005, LANGMUIR, V21, P9970, DOI 10.1021/la050371z; Tamoto R, 2015, CHEM COMMUN, V51, P3518, DOI 10.1039/c4cc07972h; Polavarapu PL, 2008, CHIRALITY, V20, P664, DOI 10.1002/chir.20475; Kurouski D, 2013, FEBS LETT, V587, P1638, DOI 10.1016/j.febslet.2013.03.038; Geiger HC, 2014, LANGMUIR, V30, P13979, DOI 10.1021/la503954b; Ajayaghosh A, 2007, ACCOUNTS CHEM RES, V40, P644, DOI 10.1021/ar7000364; Hanabusa K, 1996, ANGEW CHEM INT EDIT, V35, P1949, DOI 10.1002/anie.199619491; George M, 2003, J AM CHEM SOC, V125, P10275, DOI 10.1021/ja0362407; Hernandez FE, 2011, MOLECULES, V16, P3315, DOI 10.3390/molecules16043315; Yang GC, 2008, PHYS CHEM CHEM PHYS, V10, P6787, DOI 10.1039/b810886b; Farkas V, 2013, EUR J ORG CHEM, P3513, DOI 10.1002/ejoc.201300071; Harada N, 2008, CHIRALITY, V20, P691, DOI 10.1002/chir.20478; Hembury GA, 2008, CHEM REV, V108, P1, DOI 10.1021/cr050005k; Qing GY, 2014, ANGEW CHEM INT EDIT, V53, P2124, DOI 10.1002/anie.201308554; Merten C, 2010, MACROMOLECULES, V43, P8373, DOI 10.1021/ma101272b; Giugliarelli A, 2013, J PHYS CHEM B, V117, P2645, DOI 10.1021/jp311268x; Fu L, 2011, INT J MOL SCI, V12, P9404, DOI 10.3390/ijms12129404; Taniguchi T, 2006, MOL CRYST LIQ CRYST, V460, P107, DOI 10.1080/15421400600914916; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Xue PC, 2009, CHEM-EUR J, V15, P9824, DOI 10.1002/chem.200900732; Bieri M, 2007, PHYS CHEM CHEM PHYS, V9, P671, DOI 10.1039/b609930k; Tejedor RM, 2013, CHEM-EUR J, V19, P6044, DOI 10.1002/chem.201204197; Setnicka V, 2008, LANGMUIR, V24, P7520, DOI 10.1021/la800611h; MILLER KJ, 1990, J AM CHEM SOC, V112, P8533, DOI 10.1021/ja00179a044; Chi H, 2013, BIOMACROMOLECULES, V14, P3880, DOI 10.1021/bm401015f; Faggi E, 2010, TETRAHEDRON, V66, P5190, DOI 10.1016/j.tet.2010.04.086; Sato H, 2011, CHEM LETT, V40, P25, DOI 10.1246/cl.2011.25; Raghavanpillai A, 2009, J FLUORINE CHEM, V130, P410, DOI 10.1016/j.jfluchem.2009.01.006; Mennucci B, 2011, CHIRALITY, V23, P717, DOI 10.1002/chir.20984; Nieto-Ortega B, 2012, J PHYS CHEM LETT, V3, P2120, DOI 10.1021/jz300725d; Wu T, 2015, COORDIN CHEM REV, V284, P1, DOI 10.1016/j.ccr.2014.09.012; TWIEG RJ, 1985, MACROMOLECULES, V18, P1361, DOI 10.1021/ma00148a060; Aparicio F, 2014, ANGEW CHEM INT EDIT, V53, P1373, DOI 10.1002/anie.201309172; Berova N, 2012, COMPREHENSIVE CHIROP; Dzwolak W, 2014, CHIRALITY, V26, P220; Fages F., 2005, LOW MOL MASS GELATOR; Fisch MJ, 2009, GAUSSIAN 09; Gan J, 2009, CHEM COMMUN, V34, P5133; Hasegawa T, 2014, CHEMPLUSCHEM, V79, P1421, DOI 10.1002/cplu.201402156; Hudecova J, 2012, CHEMPHYSCHEM, V13, P2748, DOI 10.1002/cphc.201200201; KRAFFT MP, 1994, ANGEW CHEM INT EDIT, V33, P1100, DOI 10.1002/anie.199411001; Liu CX, 2014, CHEM COMMUN, V50, P3702, DOI 10.1039/c4cc00311j; Parachanskyy V, 2014, RSC ADV, V4, P57125; Rodriguez-Llansola F, 2012, CHEM-EUR J, V18, P14725, DOI 10.1002/chem.201200707; Sasaki T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2756; Scwartz E, 2010, MACROMOLECULES, V43, P7931; Stenicka V, 2002, TETRAHEDRON-ASYMMETR, V13, P2661; STEPHENS PJ, 1985, J PHYS CHEM-US, V89, P748, DOI 10.1021/j100251a006; Stephens P. J., 2012, VCD SPECTROSCOPY ORG; Yamanaka M, 2006, CHEM COMMUN, P2248, DOI 10.1039/b601485b	104	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	OCT	2015	27	10					659	666		10.1002/chir.22482		8	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CS6AZ	WOS:000362160700001		
J	Kobayashi, T; Singer, ML; Orendurff, MS; Gao, F; Daly, WK; Foreman, KB				Kobayashi, Toshiki; Singer, Madeline L.; Orendurff, Michael S.; Gao, Fan; Daly, Wayne K.; Foreman, K. Bo			The effect of changing plantarflexion resistive moment of an articulated ankle-foot orthosis on ankle and knee joint angles and moments while walking in patients post stroke	CLINICAL BIOMECHANICS			English	Article						AFO; Gait disorders; Orthotic devices; Stiffness; Kinetics; Kinematics	OIL DAMPER; GAIT; INDIVIDUALS; KINEMATICS; STIFFNESS; PERFORMANCE; HEMIPLEGIA; MOBILITY; ROCKER; 1ST	Background: The adjustment of plantarflexion resistive moment of an articulated ankle-foot orthosis is considered important in patients post stroke, but the evidence is still limited. Therefore, the aim of this study was to investigate the effect of changing the plantarflexion resistive moment of an articulated ankle-foot orthosis on ankle and knee joint angles and moments in patients post stroke. Methods: Gait analysis was performed on 10 subjects post stroke under four different plantarflexion resistive moment conditions using a newly designed articulated ankle-foot orthosis. Data were recorded using a Bertec split-belt instrumented treadmill in a 3-dimensional motion analysis laboratory. Findings: The ankle and knee sagittal joint angles and moments were significantly affected by the amount of plantarflexion resistive moment of the ankle-foot orthosis. Increasing the plantarflexion resistive moment of the ankle-foot orthosis induced significant decreases both in the peak ankle plantarflexion angle (P < 0.01) and the peak knee extension angle (P < 0.05). Also, the increase induced significant increases in the internal dorsiflexion moment of the ankle joint (P < 0.01) and significantly decreased the internal flexion moment of the knee joint (P< 0.01). Interpretation: These results suggest an important link between the kinematic/kinetic parameters of the lower-limb joints and the plantarflexion resistive moment of an articulated ankle-foot orthosis. A future study should be performed to clarify their relationship further so that the practitioners may be able to use these parameters as objective data to determine an optimal plantarflexion resistive moment of an articulated ankle-foot orthosis for improved orthotic care in individual patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Kobayashi, Toshiki; Orendurff, Michael S.; Daly, Wayne K.] Orthocare Innovat, Mountlake Terrace, WA USA; [Kobayashi, Toshiki] Hokkaido Univ Sci, Fac Hlth Sci, Dept Prosthet & Orthot, Sapporo, Hokkaido 0068585, Japan; [Singer, Madeline L.; Foreman, K. Bo] Univ Utah, Dept Phys Therapy, Salt Lake City, UT USA; [Gao, Fan] Univ Texas SW Med Ctr Dallas, Sch Hlth Profess, Dept Hlth Care Sci, Dallas, TX 75390 USA	Kobayashi, T (reprint author), Hokkaido Univ Sci, Fac Hlth Sci, Dept Prosthet & Orthot, 7-15-4-1 Maeda, Sapporo, Hokkaido 0068585, Japan.	kobayashi-t@hus.ac.jp			National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health & Human Development [2R44HD069095]	This study was supported by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health & Human Development, Grant Number 2R44HD069095. We would like to thank Mr. David E. Hensley of Seattle O&P for his technical support in designing the articulated AFO.	Kobayashi T, 2012, TOP STROKE REHABIL, V19, P338, DOI 10.1310/tsr1904-338; de Wit DCM, 2004, CLIN REHABIL, V18, P550, DOI 10.1191/0269215504cr770oa; Gok H, 2003, CLIN REHABIL, V17, P137, DOI 10.1191/0269215503cr605oa; Yamamoto S, 2013, PROSTHET ORTHOT INT, V37, P212, DOI 10.1177/0309364612460266; Nolan KJ, 2011, CLIN BIOMECH, V26, P655, DOI 10.1016/j.clinbiomech.2011.03.011; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Cappozzo A, 1996, CLIN BIOMECH, V11, P90, DOI 10.1016/0268-0033(95)00046-1; Cruz TH, 2009, GAIT POSTURE, V30, P312, DOI 10.1016/j.gaitpost.2009.05.018; [Anonymous], 1993, GAIT POSTURE, DOI 10.1016/0966-6362(93)90040-8; Owen E, 2010, PROSTHET ORTHOT INT, V34, P254, DOI 10.3109/03093646.2010.485597; Kobayashi T, 2010, J BIOMECH, V43, P1831, DOI 10.1016/j.jbiomech.2010.02.024; Kobayashi T, 2011, GAIT POSTURE, V33, P721, DOI 10.1016/j.gaitpost.2011.02.005; Yamamoto S, 2005, PROSTHET ORTHOT INT, V29, P209, DOI 10.1080/03093640500199455; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Singer ML, 2014, CLIN BIOMECH, V29, P1077, DOI 10.1016/j.clinbiomech.2014.09.001; Wang RY, 2007, AM J PHYS MED REHAB, V86, P556, DOI 10.1097/PHM.0b013e31806dd0d3; Kobayashi T, 2013, GAIT POSTURE, V37, P457, DOI 10.1016/j.gaitpost.2012.07.028; Kobayashi T, 2011, J REHABIL RES DEV, V48, P565, DOI 10.1682/JRRD.2010.10.0193; TUKEY JW, 1985, BIOMETRICS, V41, P295, DOI 10.2307/2530666; Yamamoto S, 2009, PROSTHET ORTHOT INT, V33, P307, DOI 10.3109/03093640903176563; Gao F, 2011, PROSTHET ORTHOT INT, V35, P181, DOI 10.1177/0309364611409617; Bregman DJJ, 2010, PROSTHET ORTHOT INT, V34, P293, DOI 10.3109/03093646.2010.495969; Esposito ER, 2014, CLIN ORTHOP RELAT R, V472, P3026, DOI 10.1007/s11999-014-3661-3; Bohannon R. W., 1987, PHYS THER, V67, P206; Harper NG, 2014, CLIN BIOMECH, V29, P877, DOI 10.1016/j.clinbiomech.2014.07.005; Kendall F.P., 1993, MUSCLES TESTING FUNC; Persson CU, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-83; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Winter D. A., 2005, BIOMECHANICS MOTOR C	29	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	OCT	2015	30	8					775	780		10.1016/j.clinbiomech.2015.06.014		6	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	CS5VH	WOS:000362145900002		
J	Tamura, S; Higuchi, K; Tamaki, M; Inoue, C; Awazawa, R; Mitsuki, N; Nakazawa, Y; Mishima, H; Takahashi, K; Kondo, O; Imai, K; Mono, T; Ohara, O; Ogi, T; Furukawa, F; Inoue, M; Yoshiura, KI; Kanazawa, N				Tamura, Shinobu; Higuchi, Kohei; Tamaki, Masaharu; Inoue, Chizuko; Awazawa, Ryoko; Mitsuki, Noriko; Nakazawa, Yuka; Mishima, Hiroyuki; Takahashi, Kenzo; Kondo, Osamu; Imai, Kohsuke; Mono, Tomohiro; Ohara, Osamu; Ogi, Tomoo; Furukawa, Fukumi; Inoue, Masami; Yoshiura, Koh-Ichiro; Kanazawa, Nobuo			Novel compound heterozygous DNA ligase IV mutations in an adolescent with a slowly-progressing radiosensitive-severe combined immunodeficiency	CLINICAL IMMUNOLOGY			English	Article						DNA ligase IV; Hematopoietic stem cell transplantation; LIG4 syndrome; Severe combined immunodeficiency; TREC/KREC; Whole exome sequencing	STEM-CELL TRANSPLANTATION; HYPOMORPHIC MUTATIONS; EXCISION CIRCLES; SEQUENCING DATA; REPAIR; DEFICIENCY; RECEPTOR; IDENTIFICATION; LYMPHOCYTE; PATIENT	We herein describe a case of a 17-year-old boy with intractable common warts, short stature, microcephaly and slowly-progressing pancytopenia. Simultaneous quantification of T-cell receptor recombination excision circles (TREC) and immunoglobulin kappa-deleting recombination excision circles (KREC) suggested very poor generation of both T-cells and B-cells. By whole exome sequencing, novel compound heterozygous mutations were identified in the patient's DNA ligase IV (LIG4) gene. The diagnosis of LIG4 syndrome was confirmed by delayed DNA double-strand break repair kinetics in gamma-irradiated fibroblasts from the patient and their restoration by an introduction of wild-type LIG4. Although the patient received allogeneic hematopoietic stem cell transplantation from his haploidentical mother, he unfortunately expired due to an insufficiently reconstructed immune system. An earlier definitive diagnosis using TREC/KREC quantification and whole exome sequencing would thereby allow earlier intervention, which would be essential for improving long-term survival in similar cases with slowly-progressing LIG4 syndrome masked in adolescents. (C) 2015 Elsevier Inc. All rights reserved.	[Tamura, Shinobu; Tamaki, Masaharu] Kinan Hosp, Dept Hematol & Oncol, Wakayama, Japan; [Higuchi, Kohei; Kondo, Osamu; Inoue, Masami] Osaka Med Ctr, Dept Hematol & Oncol, Osaka, Japan; [Inoue, Chizuko] Sarashi Clin, Wakayama, Japan; [Awazawa, Ryoko; Takahashi, Kenzo] Univ Ryukyus, Dept Dermatol, Okinawa, Japan; [Mitsuki, Noriko; Imai, Kohsuke; Mono, Tomohiro] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Nakazawa, Yuka; Ogi, Tomoo] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, Nagasaki 852, Japan; [Nakazawa, Yuka; Ogi, Tomoo] Nagasaki Univ, Dept Genome Repair, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Nakazawa, Yuka; Ogi, Tomoo] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 4648601, Japan; [Mishima, Hiroyuki; Yoshiura, Koh-Ichiro] Nagasaki Univ, Dept Human Genet, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dev Technol Dept, Kisarazu, Japan; [Furukawa, Fukumi; Kanazawa, Nobuo] Wakayama Med Univ, Dept Dermatol, Wakayama, Japan	Kanazawa, N (reprint author), Wakayama Med Univ, Dept Dermatol, 811-1 Kimiidera, Wakayama, Japan.	nkanazaw@wakayama-med.acjp		Ogi, Tomoo/0000-0002-5492-9072	Japan Ministry of Health, Labor and Welfare [201324076A]; Cooperative Research Grant from the Atomic Bomb Disease Institute at Nagasaki University	This work was supported in part by a grant from the Japan Ministry of Health, Labor and Welfare (201324076A) and the Cooperative Research Grant from the Atomic Bomb Disease Institute at Nagasaki University.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Grunebaum E, 2008, J ALLERGY CLIN IMMUN, V122, P1219, DOI 10.1016/j.jaci.2008.08.031; O'Driscoll M, 2008, BONE MARROW TRANSPL, V41, P983, DOI 10.1038/bmt.2008.18; Buck D, 2006, EUR J IMMUNOL, V36, P224, DOI 10.1002/eji.200535401; Toita N, 2007, AM J MED GENET A, V143A, P742, DOI 10.1002/ajmg.a.31644; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Kamae C, 2013, J ALLERGY CLIN IMMUN, V131, P1437, DOI 10.1016/j.jaci.2012.10.059; Moshous D, 2003, J CLIN INVEST, V111, P381, DOI 10.1172/JCI200316774; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Nijnik A, 2009, J CLIN INVEST, V119, P1696, DOI 10.1172/JCI32743; Booth C, 2013, BRIT J HAEMATOL, V162, P177, DOI 10.1111/bjh.12400; Tilgner K, 2013, CELL DEATH DIFFER, V20, P1089, DOI 10.1038/cdd.2013.44; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Enders A, 2006, J IMMUNOL, V176, P5060; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Gatz SA, 2011, J NEUROSCI, V31, P10088, DOI 10.1523/JNEUROSCI.1324-11.2011; Murray JE, 2014, HUM MUTAT, V35, P76, DOI 10.1002/humu.22461; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; Unal S, 2009, PEDIATR BLOOD CANCER, V53, P482, DOI 10.1002/pbc.22031; Leiding JW, 2012, J ALLERGY CLIN IMMUN, V130, P1030, DOI 10.1016/j.jaci.2012.07.049; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Bertaina A, 2014, BLOOD, V124, P822, DOI 10.1182/blood-2014-03-563817; Difilippantonio M.J., 2008, J EXP MED, V205; Gaspar HB, 2013, BLOOD, V122, P3749, DOI 10.1182/blood-2013-02-380105; Gruhn B., 2007, ORPHANET J RARE DIS, V2, P1; Jia N, 2015, NAT PROTOC, V10, P12, DOI 10.1038/nprot.2014.194; Mishima Hiroyuki, 2011, BMC Res Notes, V4, P331, DOI 10.1186/1756-0500-4-331; Morinishi Y, 2009, J PEDIATR-US, V155, P829, DOI 10.1016/j.jpeds.2009.05.026; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	OCT	2015	160	2					255	260		10.1016/j.clim.2015.07.004		6	Immunology	Immunology	CS5XL	WOS:000362151500014		
J	Shimizu, M; Nakagishi, Y; Inoue, N; Mizuta, M; Ko, G; Saikawa, Y; Kubota, T; Yamasaki, Y; Takei, S; Yachie, A				Shimizu, Masaki; Nakagishi, Yasuo; Inoue, Natsumi; Mizuta, Mao; Ko, Giyo; Saikawa, Yutaka; Kubota, Tomohiro; Yamasaki, Yuichi; Takei, Syuji; Yachie, Akihiro			Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis	CLINICAL IMMUNOLOGY			English	Article						Interleukin-18 (IL-18); Prediction of macrophage activation syndrome; Systemic juvenile idiopathic arthritis	ONSET STILLS-DISEASE; KILLER-CELL DYSFUNCTION; RHEUMATOID-ARTHRITIS; ADULT-ONSET; DIAGNOSTIC-SIGNIFICANCE; CYTOKINE PROFILES; GAMMA PRODUCTION; PATHOGENESIS; TOCILIZUMAB; IL-18	To assess the role of IL-6/IL-18 in the pathogenesis of systemic juvenile idiopathic arthritis (s-JIA) and to investigate the clinical significance of serum IL-18 levels for predicting macrophage activation syndrome (MAS) development, we measured the serum IL-6/IL-18 levels in 76 s-JIA patients, including 15 with MAS, and compared them with the clinical features. We identified 2 distinct subsets on the basis of serum IL-6/IL-18 levels. The IL-18-dominant subset had more patients who developed MAS. Serum IL-18 levels during active phase in patients with MAS were significantly higher than those without MAS. The cutoff value of serum IL-18 levels for predicting MAS development was 47750 pg/ml. The patients with IL-18 dominant subset at their disease onset were significantly more likely to develop MAS after TCZ therapy started. IL-18 might have a key role in the pathogenesis of MAS. Serum IL-18 levels >47750 pg/ml might be useful to predict MAS development. (C) 2015 Elsevier Inc. All rights reserved.	[Shimizu, Masaki; Inoue, Natsumi; Yachie, Akihiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, Kanazawa, Ishikawa 9208641, Japan; [Nakagishi, Yasuo; Mizuta, Mao] Hyogo Prefectural Kobe Childrens Hosp, Dept Pediat Rheumatol, Kobe, Hyogo, Japan; [Ko, Giyo; Saikawa, Yutaka] Kanazawa Med Univ, Sch Med, Dept Pediat, Uchinada, Ishikawa 92002, Japan; [Kubota, Tomohiro; Yamasaki, Yuichi; Takei, Syuji] Kagoshima Univ, Fac Med, Sch Med, Dept Pediat, Kagoshima 890, Japan	Shimizu, M (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	shimizum@staff.kanazawa-u.ac.jp					Maeno N, 2002, ARTHRITIS RHEUM, V46, P2539, DOI 10.1002/art.10389; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Macaubas C, 2010, CLIN IMMUNOL, V134, P206, DOI 10.1016/j.clim.2009.09.010; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; Gracie JA, 2004, CLIN EXP IMMUNOL, V136, P402, DOI 10.1111/j.1365-2249.2004.02475.x; Ramanan AV, 2003, J RHEUMATOL, V30, P401; Fitzgerald AA, 2005, ARTHRITIS RHEUM, V52, P1794, DOI 10.1002/art.21061; Ravelli A, 2012, GENES IMMUN, V13, P289, DOI 10.1038/gene.2012.3; Shimizu M, 2013, CYTOKINE, V61, P345, DOI 10.1016/j.cyto.2012.11.025; Grom AA, 2004, ARTHRITIS RHEUM, V50, P689, DOI 10.1002/art.20198; Macaubas C, 2012, CLIN IMMUNOL, V142, P362, DOI 10.1016/j.clim.2011.12.008; Petty RE, 2004, J RHEUMATOL, V31, P390; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Grom AA, 2003, J PEDIATR-US, V142, P292, DOI 10.1067/mpd.2003.110; Villanueva J, 2005, ARTHRITIS RES THER, V7, pR30, DOI 10.1186/ar1453; Strippoli R, 2012, ARTHRITIS RHEUM-US, V64, P1680, DOI 10.1002/art.33496; Shimizu M, 2012, CYTOKINE, V58, P287, DOI 10.1016/j.cyto.2012.02.006; Bleesing J, 2007, ARTHRITIS RHEUM, V56, P965, DOI 10.1002/art.22416; Kawaguchi Y, 2001, ARTHRITIS RHEUM, V44, P1716, DOI 10.1002/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I; Grom AA, 2010, CURR OPIN RHEUMATOL, V22, P561, DOI 10.1097/01.bor.0000381996.69261.71; Frosch M, 2008, RHEUMATOLOGY, V47, P121, DOI 10.1093/rheumatology/kem271; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Shimizu M, 2012, CLIN IMMUNOL, V143, P273, DOI 10.1016/j.clim.2012.03.004; Bruck N, 2015, CLIN IMMUNOL, V159, P72, DOI 10.1016/j.clim.2015.04.018; Behrens EM, 2007, J RHEUMATOL, V34, P1133; de Jager W, 2009, ARTHRITIS RHEUM, V60, P2782, DOI 10.1002/art.24750; Sawhney S, 2001, ARCH DIS CHILD, V85, P421, DOI 10.1136/adc.85.5.421; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Ravelli A, 2002, CURR OPIN RHEUMATOL, V14, P548, DOI 10.1097/01.BOR.0000020666.29529.57; Ravelli A, 2005, J PEDIATR-US, V146, P598, DOI 10.1016/j.jpeds.2004.12.016; Yokota S, 2014, J RHEUMATOL, V41, P759, DOI 10.3899/jrheum.130690; Verbsky JW, 2004, J RHEUMATOL, V31, P2071; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Shimizu M, 2012, CYTOKINE, V60, P226, DOI 10.1016/j.cyto.2012.05.003; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Athreya BH, 2002, CLIN EXP RHEUMATOL, V20, P121; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; OKAMURA H, 1995, INFECT IMMUN, V63, P3966; Ramanan AV, 2003, J RHEUMATOL, V30, P2513; CABANE J, 1990, ANN RHEUM DIS, V49, P283, DOI 10.1136/ard.49.5.283; Stephan JL, 2001, RHEUMATOLOGY, V40, P1285, DOI 10.1093/rheumatology/40.11.1285; Ichida H, 2014, ARTHRIT CARE RES, V66, P642, DOI 10.1002/acr.22194; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Jager W. de, 2007, ANN RHEUM DIS, V66, P588; Kawashima M., 2005, ARTHRITIS RHEUM, V52, P1794; Put K., 2015, RHEUMATOLOG IN PRESS; Ravelli A, 2014, ARTHRITIS RHEUMATOL, V66, pS83, DOI 10.1002/art.38472; Shigemura T, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-15	51	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1521-6616	1521-7035		CLIN IMMUNOL	Clin. Immunol.	OCT	2015	160	2					277	281		10.1016/j.clim.2015.06.005		5	Immunology	Immunology	CS5XL	WOS:000362151500016		
J	Toyoshima, T; Tanaka, H; Ayukawa, Y; Howashi, M; Masuzaki, T; Kiyosue, T; Koyano, K; Nakamura, S				Toyoshima, Takeshi; Tanaka, Hideaki; Ayukawa, Yasunori; Howashi, Miori; Masuzaki, Tomohiro; Kiyosue, Takahiro; Koyano, Kiyoshi; Nakamura, Seiji			Primary Stability of a Hybrid Implant Compared with Tapered and Cylindrical Implants in an Ex Vivo Model	CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH			English	Article						animal model; dental implant; implant stability quotient; maximum insertion torque; primary stability; push-out test	OSSEOINTEGRATED TITANIUM IMPLANTS; ENDOSSEOUS IMPLANTS; BONE THICKNESS; IN-VITRO; SURFACE; VALUES; DOG	BackgroundHybrid implants are thought to offer good stability and bone-implant contact. PurposeThis study sought to evaluate the primary stability of a hybrid implant compared with tapered and cylindrical implants in an ex vivo model and compare undersized drilling with standard drilling in attaining primary stability. Materials and MethodsHybrid (Straumann (R) Bone Level; BL), tapered (Straumann (R) Tapered Effect; TE), and cylindrical (Straumann (R) Standard Plus; SP) implants were inserted into 15 mm-thick porcine iliac crest blocks using standard (corticocancellous or cancellous bone) or undersized (cancellous bone only) drilling (n=7). Stability was evaluated using maximum insertion torque (MIT), implant stability quotient (ISQ), and push-out tests. ResultsThe mean MIT for BL and TE was significantly higher than that for SP (p<0.05). With standard drilling in corticocancellous bone, the mean ISQ for TE was significantly higher than that for SP (p<.05). The mean MIT, ISQ, and push-out test scores for BL, TE, and SP with standard drilling in corticocancellous bone were significantly higher than those with undersized or standard drilling in cancellous bone (p<.05). ConclusionsIn this ex vivo model, the hybrid implant demonstrated promising primary stability compared with the cylindrical implant. The improved stability of the hybrid implant was especially evident in cancellous bone. The influence of the cortical layer should be recognized when selecting implants for primary stability.	[Toyoshima, Takeshi; Tanaka, Hideaki; Kiyosue, Takahiro; Nakamura, Seiji] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Fukuoka 8128582, Japan; [Ayukawa, Yasunori; Howashi, Miori; Masuzaki, Tomohiro; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Fukuoka 8128582, Japan; [Kiyosue, Takahiro; Koyano, Kiyoshi] Kyushu Univ, Regenerat Dent & Implant Ctr, Fukuoka 8128582, Japan	Toyoshima, T (reprint author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takesea@dent.kyushu-u.ac.jp					Abuhussein H, 2010, CLIN ORAL IMPLAN RES, V21; Palattella P, 2008, CLIN ORAL IMPLAN RES, V19, P1148, DOI 10.1111/j.1600-0501.2008.01578.x; Divac M, 2013, INT J ORAL MAX IMPL, V28, P84, DOI 10.11607/jomi.2587; Orsini E, 2012, INT J ORAL MAX IMPL, V27, P383; Merheb J, 2010, CLIN ORAL IMPLAN RES, V21, P612, DOI 10.1111/j.1600-0501.2009.01880.x; Lekholm U, 1998, J PROSTHET DENT, V79, P43, DOI 10.1016/S0022-3913(98)70192-1; Meredith N, 1998, INT J PROSTHODONT, V11, P269; Sakoh J, 2006, INT J ORAL MAX IMPL, V21, P560; Li JG, 1997, BIO-MED MATER ENG, V7, P379; Motoyoshi M, 2005, CLIN ORAL IMPLAN RES, V16, P480, DOI 10.1111/j.1600-0501.2005.01130.x; Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x; ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; Martinez H, 2001, CLIN ORAL IMPLAN RES, V12, P423, DOI 10.1034/j.1600-0501.2001.120501.x; ROBERTS WE, 1984, AM J ORTHOD DENTOFAC, V86, P95, DOI 10.1016/0002-9416(84)90301-4; Chung SH, 2008, J ORAL REHABIL, V35, P229, DOI 10.1111/j.1365-2842.2006.01653.x; O'Sullivan D, 2004, CLIN ORAL IMPLAN RES, V15, P474, DOI 10.1111/j.1600-0501.2004.01041.x; Chun HJ, 2002, J ORAL REHABIL, V29, P565, DOI 10.1046/j.1365-2842.2002.00891.x; Nedir R, 2009, INT J ORAL MAX IMPL, V24, P727; WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213; Glauser Roland, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P47, DOI 10.1111/j.1708-8208.2003.tb00015.x; Lekholm U, 1985, TISSUE INTEGRATED PR, P199; Romanos GE, 2014, CLIN IMPLANT DENT R, V16, P166, DOI 10.1111/j.1708-8208.2012.00470.x; Romanos GE, 2014, CLIN IMPLANT DENT R, V16, P89, DOI 10.1111/j.1708-8208.2012.00464.x; Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1523-0899	1708-8208		CLIN IMPLANT DENT R	Clin. Implant Dent. Relat. Res.	OCT	2015	17	5					950	956		10.1111/cid.12205		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CS9SV	WOS:000362432900014		
J	Uchino, H; Ito, M; Fujima, N; Kazumata, K; Yamazaki, K; Nakayama, N; Kuroda, S; Houkin, K				Uchino, Haruto; Ito, Masaki; Fujima, Noriyuki; Kazumata, Ken; Yamazaki, Kazuyoshi; Nakayama, Naoki; Kuroda, Satoshi; Houkin, Kiyohiro			A novel application of four-dimensional magnetic resonance angiography using an arterial spin labeling technique for noninvasive diagnosis of Moyamoya disease	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Arterial spin labeling; Cerebrovascular; Four-dimensional magnetic resonance; angiography; Moyamoya disease; Postoperative hyperperfusion	ALTERNATING RADIOFREQUENCY; MRI; REVASCULARIZATION; VESSELS; SURGERY; TIME; FLOW	Background: Noncontrast-enhanced time-resolved four-dimensional magnetic resonance angiography using an arterial spin labeling technique (ASL-4D MRA) is emerging as a next generation angiography for the management of neurovascular diseases. This study evaluated the feasibility of ASL-4D MRA for the diagnosis of Moyamoya disease (MMD) and MMD staging by using digital subtraction angiography (DSA) and time-of-flight MRA (TOF MRA) as current standards. Methods: Eleven consecutive non-operated patients who underwent DSA for the diagnosis of MMD were recruited. Two independent observers evaluated the three tests. The data were analyzed for inter-observer and inter-modality agreements on MMD stage. Nine of 22 hemispheres underwent surgical revascularization and ASL-4D MRA was repeated postoperatively. Results: Time-resolved inflow of blood through the cerebral vessels, including moyamoya vessels, was visualized in all the 22 non-operated hemispheres. MMD stages assessed by DSA and ASL-4D MRA were completely matched in 18 hemispheres, with a significant positive correlation between these modalities (r=0.93, P<0.001). Inter-observer agreement with ASL-4D MRA (K=0.91 +/- 0.04, P<0.001) and inter-modality agreement between ASL-4D MRA and DSA (K = 0.93 +/- 0.04, P<0.001) were both excellent. MMD stages assessed by ASL-4D MRA have also a significant positive correlation with those assessed by TOF MRA (r=0.68, P=0.004). Repeated ASL-4D MRA clearly demonstrated the bypassed arteries and changes in the dynamic flow patterns of cerebral arteries in all the nine hemispheres after surgical revascularization. Of these, postoperative focal hyperperfusion was detected by single photon emission tomography in 7 hemispheres. In five of the seven hemispheres (71%) with postoperative hyperperfusion, ASL-4D MRA demonstrated focal hyperintense signals in the bypassed arteries, although TOF MRA did not. Conclusions: Noninvasive ASL-4D MRA is feasible for the diagnosis of MMD staging. This next generation angiography may be useful for monitoring disease evolution and treatment response in cerebral arteries after revascularization surgery in MMD. (C) 2015 Elsevier B.V. All rights reserved.	[Uchino, Haruto; Ito, Masaki; Kazumata, Ken; Yamazaki, Kazuyoshi; Nakayama, Naoki; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Fujima, Noriyuki] Hokkaido Univ, Grad Sch Med, Dept Radiol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kuroda, Satoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neurosurg, Toyama 9300914, Japan	Ito, M (reprint author), Stanford Univ, Sch Med, Dept Neurosurg, 1201 Welch Rd,MSLS P320, Stanford, CA 94305 USA.	masakiitou-nsu@umin.ac.jp					Sawada T, 2012, NEURORADIOLOGY, V54, P1089, DOI 10.1007/s00234-012-1020-1; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288; Wu HM, 2014, J MAGN RESON IMAGING, V39, P1320, DOI 10.1002/jmri.24279; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; Houkin K, 1997, CHILD NERV SYST, V13, P24, DOI 10.1007/s003810050034; Cloft HJ, 1999, STROKE, V30, P317; Wang R, 2014, EUR RADIOL, V24, P1135, DOI 10.1007/s00330-014-3098-9; Kuroda S, 2010, NEUROSURGERY, V66, P1093, DOI 10.1227/01.NEU.0000369606.00861.91; Yan LR, 2010, RADIOLOGY, V256, P270, DOI 10.1148/radiol.10091543; Mikami T, 2013, J STROKE CEREBROVASC, V22, P862, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.010; EDELMAN RR, 1994, RADIOLOGY, V192, P513; Uchino H, 2012, STROKE, V43, P2610, DOI 10.1161/STROKEAHA.112.654723; GREITZ T, 1968, ACTA RADIOL DIAGN, V7, P331; Look D. C., 1970, Review of Scientific Instruments, V41, DOI 10.1063/1.1684482; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Mildner T, 2003, MAGNET RESON MED, V49, P791, DOI 10.1002/mrm.10438; Reinacher PC, 2007, NEURORADIOLOGY, V49, pS3, DOI 10.1007/s00234-007-1468-6; Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, NEUROL MED CHIR TOKY, V52, P245	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2015	137						105	111		10.1016/j.clineuro.2015.07.003		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CS2SD	WOS:000361921000022		
J	Taira, T; Yanagisawa, S; Nagano, T; Zhu, YB; Kuroiwa, T; Koumura, N; Kitamoto, D; Imura, T				Taira, Toshiaki; Yanagisawa, Satohiro; Nagano, Takuto; Zhu, Yanbei; Kuroiwa, Takayoshi; Koumura, Nagatoshi; Kitamoto, Dai; Imura, Tomohiro			Selective encapsulation of cesium ions using the cyclic peptide moiety of surfactin: Highly efficient removal based on an aqueous giant micellar system	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Biosurfactant; Surfactin; Micelle; Cyclic peptide; Cesium	BACILLUS-SUBTILIS; COMPLEXATION; VALINOMYCIN; CATION; DFT; BIOSURFACTANT; EXTRACTION; CS+; RB+	Cyclic peptide of surfactin (SF) is one of the promising environment-friendly biosurfactants abundantly produced by microorganisms such as Bacillus subtilis. SF is also known to act as an ionophore, wherein alkali metal ions can be trapped in the cyclic peptide. Especially, SF is expected to show high affinity for Cs+ because of the distinctive cavity size and coordination number. In this study, we reported the specific interaction between SF and Cs+ and succeeded in the highly efficient removal of Cs+ from water using giant SF micelles as a natural sorbent. The specific interaction between SF and Cs+ to form their inclusion complex was revealed by nuclear magnetic resonance (NMR) and Fourier transform infrared (FT-IR) spectroscopy. We found that SF micelles selectively encapsulate Cs+, which was suggested by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS). A highly effective separation of Cs+ immobilized on the surface of the SF micelles was also achieved through facile centrifugal ultrafiltration in 91% even in coexisting with other alkali metal ions such as Na+ and K+. Thus, the use of the giant micellar system of SF with its high Cs+ affinity and distinctive assembling properties would be a new approach for the treatment of contaminated soil and water. (C) 2015 Elsevier B.V. All rights reserved.	[Taira, Toshiaki; Imura, Tomohiro] Natl Inst Adv Ind Sci & Technol, Res Inst Chem Proc Technol, Tsukuba, Ibaraki 3058565, Japan; [Yanagisawa, Satohiro; Nagano, Takuto] Kaneka Corp, New Business Dev Div, Kita Ku, Osaka 5308288, Japan; [Zhu, Yanbei; Kuroiwa, Takayoshi] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Koumura, Nagatoshi; Kitamoto, Dai] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan	Imura, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Chem Proc Technol, Cent 5-2,1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	t-imura@aist.go.jp					Imura T, 2013, J OLEO SCI, V62, P499, DOI 10.5650/jos.62.499; Jauregi P, 2013, SEP PURIF TECHNOL, V104, P175, DOI 10.1016/j.seppur.2012.11.017; ROSE MC, 1974, BIOCHIM BIOPHYS ACTA, V372, P426, DOI 10.1016/0304-4165(74)90204-9; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; THIMON L, 1993, COLLOID SURFACE B, V1, P57, DOI 10.1016/0927-7765(93)80018-T; Arutchelvi J, 2014, COLLOID SURFACE B, V116, P396, DOI 10.1016/j.colsurfb.2013.12.034; BYSTROV VF, 1977, EUR J BIOCHEM, V78, P63, DOI 10.1111/j.1432-1033.1977.tb11714.x; THIMON L, 1992, BIOTECHNOL LETT, V14, P713, DOI 10.1007/BF01021648; Li Y, 2009, J PHYS CHEM B, V113, P15272, DOI 10.1021/jp9062862; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Dejugnat C, 2011, CHEMPHYSCHEM, V12, P2138, DOI 10.1002/cphc.201100094; Pichierri F, 2013, DALTON T, V42, P6083, DOI 10.1039/c2dt32180g; Armentrout PB, 2013, J PHYS CHEM B, V117, P3771, DOI 10.1021/jp401366g; GRELL E, 1973, EUR J BIOCHEM, V34, P415, DOI 10.1111/j.1432-1033.1973.tb02774.x; MAGETDANA R, 1992, J COLLOID INTERF SCI, V153, P285, DOI 10.1016/0021-9797(92)90319-H; HOOD SL, 1953, ARCH BIOCHEM BIOPHYS, V45, P423, DOI 10.1016/S0003-9861(53)80018-4; Mulligan CN, 2001, J HAZARD MATER, V85, P111, DOI 10.1016/S0304-3894(01)00224-2; Makrlik E, 2013, J RADIOANAL NUCL CH, V298, P2065, DOI 10.1007/s10967-013-2686-5; Shaligram NS, 2010, FOOD TECHNOL BIOTECH, V48, P119; MATSUDA H, 1989, J PHYSIOL-LONDON, V413, P139; Makrlik E, 2013, J RADIOANAL NUCL CH, V295, P615, DOI 10.1007/s10967-012-1871-2; Zou AH, 2010, J PHYS CHEM B, V114, P2712, DOI 10.1021/jp908675s; Huczynski A, 2012, BIOORG MED CHEM LETT, V22, P7002, DOI 10.1016/j.bmcl.2012.09.046; Kitajima A, 2012, CHEM LETT, V41, P1473, DOI 10.1246/cl.2012.1473; Bade R, 2011, J WATER SUSTAIN, V1, P85; Cotton F.A., 1995, BASIC INORGANIC CHEM; Krane K S, 1987, INTRO NUCL PHYS; MISSEL PJ, 1989, J PHYS CHEM-US, V93, P8354, DOI 10.1021/j100363a014; Sewald N., 2009, PEPTIDES CHEM BIOL; Taira T, 2014, J OLEO SCI, V63, P407, DOI 10.5650/jos.ess13138	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	OCT 1	2015	134						59	64		10.1016/j.colsurfb.2015.06.034		6	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CS5TU	WOS:000362142000008		
J	Nagahashi, K; Teramura, Y; Takai, M				Nagahashi, Koji; Teramura, Yuji; Takai, Madoka			Stable surface coating of silicone elastomer with phosphorylcholine and organosilane copolymer with cross-linking for repelling proteins	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						Polydimethylsiloxane (PDMS); 2-Methacryloyloxyethylphosphorylcholine (MPC); Surface modification; Blood compatibility; Copolymer	TRANSFER RADICAL POLYMERIZATION; BIOMEDICAL APPLICATIONS; ADSORPTION-RESISTANCE; PHOSPHOLIPID POLYMER; PLATELET-ADHESION; PLASMA; BLOOD; HEMOCOMPATIBILITY; BIOMATERIALS; DENSITY	Poly(dimethylsiloxane) (PDMS)-based polymers are widely used in blood-contacting medical devices. However, the hydrophobic property causes adsorption of plasma proteins and activates blood clotting. There are several techniques for PDMS surface modification. However, the efficacy is limited to short duration due to the low glass transition temperature of PDMS. The goal of this study is to fabricate a highly stable polymer membrane with blood-compatibility on PDMS. Here, we synthesized random copolymer of 2-methacryloyloxyethyl phosphorylcholine (MPC),3-methacryloxypropyl trimethoxysilane (MPTMSi) and 3-(methacryloyloxy) propyl-tris(trimethylsilyloxy) silane (MPTSSi). These copolymers are covalently and physically immobilized on PDMS surface by silane coupling (cross-linking) and hydrophobic interaction. Protein adsorption was significantly reduced on MPC copolymer-coated PDMS surface. In particular, copolymer containing 50% MPC unit was the most effective and maintained the effect for the longest duration (84 days). From analyses of X-ray reflectometry (XRR) and X-ray photoelectron spectroscopy (XPS), it is determined that the density of the polymer membrane is an important factor for the long-term stability. In addition, the coating of PDMS with MPC copolymer does not influence on oxygen permeability. (C) 2015 Elsevier B.V. All rights reserved.	[Nagahashi, Koji; Teramura, Yuji; Takai, Madoka] Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan	Takai, M (reprint author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	takai@bis.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT	This work was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Soft-Interface Science," and Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). A part of this work was conducted in Research Hub for Advanced Nano Characterization, The University of Tokyo, supported by MEXT. The authors thank Mr. K. Sato, and Mr. R. Yokoi from Fuji Systems, Inc., as well as Dr. T. Isoyama and Dr. K. Kushiro from the University of Tokyo, for helpful discussion and comments.	Larson BJ, 2013, LANGMUIR, V29, P12990, DOI 10.1021/la403077q; Maeda T, 2000, ASAIO J, V46, P426, DOI 10.1097/00002480-200007000-00011; Innis-Samson VA, 2009, X-RAY SPECTROM, V38, P376, DOI 10.1002/xrs.1182; Futamura K, 2008, LANGMUIR, V24, P10340, DOI 10.1021/la801017h; Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006; Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014; Jin ZL, 2010, J BIOMAT SCI-POLYM E, V21, P1331, DOI 10.1163/092050609X12517190417713; van der Lee A, 2001, LANGMUIR, V17, P7664, DOI 10.1021/la010811w; Yamasaki A, 2003, COLLOID SURFACE B, V28, P53, DOI 10.1016/S0927-7765(02)00130-3; Wang JH, 2005, J MICROSC-OXFORD, V217, P216, DOI 10.1111/j.1365-2818.2005.01453.x; Watanabe J, 2008, COLLOID SURFACE B, V65, P155, DOI 10.1016/j.colsurfb.2008.04.006; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Wang P, 2008, LANGMUIR, V24, P13496, DOI 10.1021/la8028066; Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046; Seo JH, 2011, SOFT MATTER, V7, P2968, DOI 10.1039/c0sm01292k; Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3; Kyomoto M, 2010, BIOMATERIALS, V31, P658, DOI 10.1016/j.biomaterials.2009.09.083; Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x; Wu ZG, 2009, LAB CHIP, V9, P1500, DOI 10.1039/b901651a; Nii K, 2013, MICROFLUID NANOFLUID, V14, P951, DOI 10.1007/s10404-012-1102-8; Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783; Yoshikawa C, 2006, MACROMOLECULES, V39, P2284, DOI 10.1021/ma0520242; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202; Kovach KM, 2014, J BIOMED MATER RES A, V102, P4195, DOI 10.1002/jbm.a.35090; Multanen V, 2014, COLLOID SURFACE A, V461, P225, DOI 10.1016/j.colsurfa.2014.07.047; Robert-Nicoud G, 2014, POLYM CHEM-UK, V5, P6687, DOI 10.1039/c4py00941j; Sadahiro Tomohito, 2012, Gen Thorac Cardiovasc Surg, V60, P192, DOI 10.1007/s11748-011-0868-z; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Xiong XH, 2015, J MATER CHEM B, V3, P629, DOI 10.1039/c4tb01600a; Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765	1873-4367		COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	OCT 1	2015	134						384	391		10.1016/j.colsurfb.2015.07.040		8	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	CS5TU	WOS:000362142000048		
J	Wang, Q; Hu, LH; Yoon, SH; Lu, SX; Delichatsios, M; Chung, SH				Wang, Qiang; Hu, Longhua; Yoon, Sung Hwan; Lu, Shouxiang; Delichatsios, Michael; Chung, Suk Ho			Blow-out limits of nonpremixed turbulent jet flames in a cross flow at atmospheric and sub-atmospheric pressures	COMBUSTION AND FLAME			English	Article						Nonpremixed turbulent jet flame; Cross flow; Blow-out limit; Pressure effect	DIRECT NUMERICAL-SIMULATION; DIFFUSION FLAMES; TRANSVERSE JETS; LIFTED FLAMES; BURNING VELOCITIES; ELEVATED PRESSURES; PREMIXED FLAMES; COFLOW JETS; AIR; STABILIZATION	The blow-out limits of nonpremixed turbulent jet flames in cross flows were studied, especially concerning the effect of ambient pressure, by conducting experiments at atmospheric and sub-atmospheric pressures. The combined effects of air flow and pressure were investigated by a series of experiments conducted in an especially built wind tunnel in Lhasa, a city on the Tibetan plateau where the altitude is 3650 m and the atmospheric pressure condition is naturally low (64 kPa). These results were compared with results obtained from a wind tunnel at standard atmospheric pressure (100 kPa) in Hefei city (altitude 50 m). The size of the fuel nozzles used in the experiments ranged from 3 to 8 mm in diameter and propane was used as the fuel. It was found that the blow-out limit of the air speed of the cross flow first increased ("cross flow dominant" regime) and then decreased ("fuel jet dominant" regime) as the fuel jet velocity increased in both pressures; however, the blow-out limit of the air speed of the cross flow was much lower at sub-atmospheric pressure than that at standard atmospheric pressure whereas the domain of the blow-out limit curve (in a plot of the air speed of the cross flow versus the fuel jet velocity) shrank as the pressure decreased. A theoretical model was developed to characterize the blow-out limit of nonpremixed jet flames in a cross flow based on a Damkohler number, defined as the ratio between the mixing time and the characteristic reaction time. A satisfactory correlation was obtained at relative strong cross flow conditions ("cross flow dominant" regime) that included the effects of the air speed of the cross flow, fuel jet velocity, nozzle diameter and pressure. (C) 2015 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Wang, Qiang; Hu, Longhua; Lu, Shouxiang] Univ Sci & Technol China, State Key Lab Fire Sci, Hefei 230026, Anhui, Peoples R China; [Yoon, Sung Hwan] Hokkaido Univ, Grad Sch Engn, Div Mech & Space Engn, Sapporo, Hokkaido, Japan; [Delichatsios, Michael] Univ Ulster, Sch Built Environm, FireSERT, Newtownabbey BT38 8GQ, North Ireland; [Chung, Suk Ho] King Abdullah Univ Sci & Technol, Clean Combust Res Ctr, Thuwal 239556900, Saudi Arabia	Hu, LH (reprint author), Univ Sci & Technol China, State Key Lab Fire Sci, Hefei 230026, Anhui, Peoples R China.	hlh@ustc.edu.cn	Wang, Qiang/P-6329-2015; 	Chung, Suk Ho/0000-0001-8782-312X	Excellent Young Scientist Fund of National Natural Science Foundation of China [51422606]; NSFC-RS Newton Advanced Fellowship [51561130158]; National Basic Research Program of China [2012CB719702]; Fundamental Research Funds for the Central Universities; KAUST	This work was supported by the Excellent Young Scientist Fund of National Natural Science Foundation of China (grant no. 51422606) and NSFC-RS Newton Advanced Fellowship (grant no. 51561130158) to Longhua Hu, the National Basic Research Program of China (grant no. 2012CB719702), and Fundamental Research Funds for the Central Universities. Suk Ho Chung was supported by KAUST.	ANDREWS GE, 1972, COMBUST FLAME, V19, P275, DOI 10.1016/S0010-2180(72)80218-9; Kim KN, 2007, P COMBUST INST, V31, P1591, DOI 10.1016/j.proci.2006.07.236; Lee WJ, 2003, APPL ENERG, V76, P257, DOI 10.1016/S0306-2619(03)00066-7; Karagozian AR, 2010, PROG ENERG COMBUST, V36, P531, DOI 10.1016/j.pecs.2010.01.001; Wang Q, 2014, COMBUST FLAME, V161, P1125, DOI 10.1016/j.combustflame.2013.10.021; KALGHATGI GT, 1983, COMBUST FLAME, V52, P91, DOI 10.1016/0010-2180(83)90123-2; Tieszen SR, 1996, COMBUST FLAME, V106, P442, DOI 10.1016/0010-2180(96)00008-9; Grout RW, 2012, J FLUID MECH, V706, P351, DOI 10.1017/jfm.2012.257; Hu LH, 2013, COMBUST FLAME, V160, P295, DOI 10.1016/j.combustflame.2012.10.016; Lee J, 2003, COMBUST FLAME, V135, P449, DOI 10.1016/S0010-2180(03)00182-2; Kumar S, 2007, COMBUST SCI TECHNOL, V179, P2219, DOI 10.1080/00102200701407887; Qin X, 2005, P COMBUST INST, V30, P233, DOI 10.1016/j.proci.2004.08.251; DAHM WJA, 1990, AIAA J, V28, P1157, DOI 10.2514/3.25186; Muppidi S, 2005, J FLUID MECH, V530, P81, DOI 10.1017/S0022112005003514; Lyons KM, 2007, PROG ENERG COMBUST, V33, P211, DOI 10.1016/j.pecs.2006.11.001; Kostiuk LW, 2000, P COMBUST INST, V28, P553; Chung SH, 2007, P COMBUST INST, V31, P877, DOI 10.1016/j.proci.2006.08.117; Choi BC, 2013, FUEL, V103, P956, DOI 10.1016/j.fuel.2012.07.022; Cho ES, 2006, COMBUST SCI TECHNOL, V178, P1559, DOI 10.1080/00102200500536175; Wu XS, 2011, COMBUST FLAME, V158, P539, DOI 10.1016/j.combustflame.2010.10.006; Kolla H, 2012, COMBUST FLAME, V159, P2755, DOI 10.1016/j.combustflame.2012.01.012; Hasselbrink EF, 2001, J FLUID MECH, V443, P1; EGOLFOPOULOS FN, 1990, COMBUST FLAME, V80, P7, DOI 10.1016/0010-2180(90)90049-W; Hu LH, 2013, FUEL, V106, P779, DOI 10.1016/j.fuel.2012.10.051; KALGHATGI GT, 1981, COMBUST SCI TECHNOL, V26, P241, DOI 10.1080/00102208108946965; Hu XK, 2011, P COMBUST INST, V33, P2607, DOI 10.1016/j.proci.2010.07.025; Hasselbrink EF, 2001, J FLUID MECH, V443, P27; Moore NJ, 2011, FLOW TURBUL COMBUST, V87, P525, DOI 10.1007/s10494-011-9334-3; Grout RW, 2011, P COMBUST INST, V33, P1629, DOI 10.1016/j.proci.2010.06.013; KALGHATGI GT, 1981, COMBUST SCI TECHNOL, V26, P233, DOI 10.1080/00102208108946964; Broadwell J.E., 1985, S INT COMBUST, V20, P303, DOI 10.1016/S0082-0784(85)80515-4; Cha M.S., 1996, S INT COMBUST, V26, P121, DOI 10.1016/S0082-0784(96)80208-6; Comes J. N., 2012, J COMBUST, V2012, DOI [10.1155/2012/21891, DOI 10.1155/2012/21891]; Dahm W. J. A., 1988, P COMBUST INST, V22, P801; Delichatsios M.A., 1987, 50852601137 GRI; Montgomery C.J., 1998, S INT COMBUST, V27, P1175, DOI 10.1016/S0082-0784(98)80520-1; Moore N. J., 2008, INT J REACTING SYST, V2, P811; Turns S. R., 1996, INTRO COMBUSTION; VANQUICK.L, 1966, COMBUST FLAME, V10, P59, DOI 10.1016/0010-2180(66)90028-9	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	OCT	2015	162	10					3562	3568		10.1016/j.combustflame.2015.06.012		7	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CS2TT	WOS:000361925600009		
J	Nakaya, S; Tsue, M; Kono, M; Imamura, O; Tomioka, S				Nakaya, Shinji; Tsue, Mitsuhiro; Kono, Michikata; Imamura, Osamu; Tomioka, Sadatake			Effects of thermally cracked component of n-dodecane on supersonic combustion behaviors in a scramjet model combustor	COMBUSTION AND FLAME			English	Article						Supersonic combustion; Hydrocarbon fuels; Thermal cracking; Scramjet	KEROSENE COMBUSTION; FLAME STABILIZATION; SELF-IGNITION; PLASMA-JET; FUELS; FLOW; MIXTURES; HYDROGEN	Supersonic combustion ramjet technology using liquid hydrocarbon fuels is invaluable due to great benefits of the energy density per unit volume and handling. This study carried out experiments to investigate the effects of the components in thermally cracked n-dodecane on ignition and supersonic combustion behavior at supersonic speeds (Mach 2.0) and at stagnation temperatures between 1800 K and 2400 K in a supersonic model combustor with a cavity flame holder. Components of the thermally cracked n-dodecane at 1.0 MPa in a flow reactor were experimentally measured by using a gas chromatograph. Based on the measured components, surrogate fuels consisting of main components of cracked n-dodecane, hydrogen, methane, ethane and ethylene were defined, and fractions of the component was varied at less than 10%. Ignition and supersonic combustion behaviors were tested for single component and surrogate fuels. In all cases where supersonic combustions were achieved, ignitions were firstly observed in the boundary layer at the expanding cross section zone. The flames, then, propagated upstream and were held at the cavity. Two combustion modes, jet wake stabilized and cavity stabilized flames were observed based on the distribution of rise in pressure and OH chemiluminescence. In cases of pure fuel injections, ignitions for ethylene injections could be observed at a stagnation temperature of 1800 K. On the other hand, ignitions for methane and ethane injections could be observed above a stagnation temperature of 2200 K. Ignitions for surrogate fuel injections were also investigated. These ignition limits were also validated by a simple estimation of chemical reaction and residence times. It was also found that an increase in fuel temperature improved the ignition limits although the effect of the dynamic pressure ratio between the fuel injection and the main flow was rather limited in the present study. (C) 2015 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Nakaya, Shinji; Tsue, Mitsuhiro; Kono, Michikata] Univ Tokyo, Dept Aeronaut & Astronaut, Tokyo 1138656, Japan; [Imamura, Osamu] Nihon Univ, Coll Ind Technol, Tokyo 102, Japan; [Tomioka, Sadatake] Japan Aerosp Explorat Agcy, Tokyo, Japan	Nakaya, S (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tsnakaya@mail.ecc.u-tokyo.ac.jp					Fan XJ, 2007, J PROPUL POWER, V23, P317, DOI 10.2514/1.26402; BURCAT A, 1972, COMBUST FLAME, V18, P115, DOI 10.1016/S0010-2180(72)80232-3; Takahashi S, 2000, P COMBUST INST, V28, P705; Edwards T, 2003, J PROPUL POWER, V19, P1089, DOI 10.2514/2.6946; Marinov NM, 1998, COMBUST FLAME, V114, P192, DOI 10.1016/S0010-2180(97)00275-7; KIMURA I, 1981, COMBUST FLAME, V42, P297, DOI 10.1016/0010-2180(81)90164-4; Jacobsen LS, 2008, J PROPUL POWER, V24, P641, DOI 10.2514/1.27358; Ryan M, 2009, P COMBUST INST, V32, P2429, DOI 10.1016/j.proci.2008.06.209; Ben-Yakar A, 2001, J PROPUL POWER, V17, P869, DOI 10.2514/2.5818; Hsu KY, 1998, J PROPUL POWER, V14, P57, DOI 10.2514/2.5266; Fan XJ, 2006, J PROPUL POWER, V22, P103, DOI 10.2514/1.15427; JU YG, 1995, COMBUST FLAME, V102, P462, DOI 10.1016/0010-2180(95)00047-A; Takita K, 2011, P COMBUST INST, V33, P2383, DOI 10.1016/j.proci.2010.07.078; Mathur T, 2001, J PROPUL POWER, V17, P1305, DOI 10.2514/2.5879; Edwards T, 2006, COMBUST SCI TECHNOL, V178, P307, DOI 10.1080/00102200500294346; Rasmussen CC, 2005, P COMBUST INST, V30, P2825, DOI 10.1016/j.proci.2004.08.185; Do H, 2010, COMBUST FLAME, V157, P1783, DOI 10.1016/j.combustflame.2010.03.009; Leylegian JC, 2012, J PROPUL POWER, V28, P412, DOI 10.2514/1.B34118; VINOGRADOV VA, 1995, J PROPUL POWER, V11, P130, DOI 10.2514/3.23850; Micka DJ, 2009, P COMBUST INST, V32, P2397, DOI 10.1016/j.proci.2008.06.192; Huang H, 2004, J ENG GAS TURB POWER, V126, P284, DOI 10.1115/1.1689361; Sun MB, 2012, EXP THERM FLUID SCI, V43, P90, DOI 10.1016/j.expthermflusci.2012.03.028; Owens M, 1997, J PROPUL POWER, V13, P525, DOI 10.2514/2.5198; Colket MB, 2001, J PROPUL POWER, V17, P315, DOI 10.2514/2.5744; Yu G, 2001, J PROPUL POWER, V17, P1263, DOI 10.2514/2.5874; Tsue M, 2011, P COMBUST INST, V33, P2391, DOI 10.1016/j.proci.2010.07.070; Arai T., 2000, P 2000 ANN M, P305; Bonghi L, 1995, 950730 AIAA; BROWN PN, 1989, SIAM J SCI STAT COMP, V10, P1038, DOI 10.1137/0910062; Cheng S., 1989, PROG ENERGY COMB SCI, V15, P181; Davis D.L., 1997, 973274 AIAA; Lander H.R., 1971, J AIRCRAFT, V8, P200, DOI DOI 10.2514/3.44255; Wang H., 1998, INTERNAL REPORT	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	OCT	2015	162	10					3847	3853		10.1016/j.combustflame.2015.07.021		7	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CS2TT	WOS:000361925600033		
J	Saiki, Y; Fan, Y; Suzuki, Y				Saiki, Yu; Fan, Yong; Suzuki, Yuji			Radical quenching of metal wall surface in a methane-air premixed flame	COMBUSTION AND FLAME			English	Article						Flame-wall interaction; Chemical quenching effect; Surface reaction; Metal surface; Planar laser induced fluorescence	MICROSCALE COMBUSTION; OH-PLIF; CHANNELS; EXTINCTION; SPECTROSCOPY; PROPAGATION; PROFILES; IGNITION; QUARTZ	In order to quantify chemical quenching effect of metal wall surfaces, a methane-air premixed flame formed in narrow quartz plate channels is investigated. Stainless steel321 (SUS321) and Incone1600 are chosen as the surface materials for their high oxidation/heat resistivity. Thin films of SUS321 and InconeI600 are deposited on the quartz plates using a vacuum arc plasma gun to realize equivalent thermal boundary condition with different surface reactions. In addition, two types of alumina thin films are prepared using atomic layer deposition (ALD) and sputtering techniques to explore the surface roughness effect. Microscopic OH-PLIF and numerical simulation with detailed chemistry are employed to examine the near-wall flame structures. When the wall temperature T-w >= 1073 K, OH concentrations near the SUS321/Incone1600 surfaces are significantly lower than that near the quartz surface. Based on the PLIF data, the initial sticking coefficient S-0 associated with radical adsorption is estimated to be 0.1 and 0.01 for the 5US321/InconeI600 and quartz surfaces, respectively, indicating stronger radical quenching effect on these metal surfaces. On the other hand, OH profile near the sputtered-alumina surface, which has larger roughness, is in good accordance with that near the ALD-alumina surface. This implies that the radical adsorption is independent on surface roughness. (C) 2015 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Saiki, Yu] Nagoya Inst Technol, Dept Mech Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; [Fan, Yong; Suzuki, Yuji] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan	Saiki, Y (reprint author), Nagoya Inst Technol, Dept Mech Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	saiki.yu@nitech.ac.jp; fan@mesl.t.u-tokyo.ac.jp; ysuzuki@mesl.t.u-tokyo.ac.jp		Saiki, Yu/0000-0001-7877-1735	Tanigawa foundation, Japan	This work is supported by Tanigawa foundation, Japan.	Fernandez-Pello AC, 2002, P COMBUST INST, V29, P883, DOI 10.1016/S1540-7489(02)80113-4; VLACHOS DG, 1994, AICHE J, V40, P1005, DOI 10.1002/aic.690400611; Saiki Y, 2013, P COMBUST INST, V34, P3395, DOI 10.1016/j.proci.2012.06.095; POINSOT TJ, 1993, COMBUST FLAME, V95, P118, DOI 10.1016/0010-2180(93)90056-9; Maruta K, 2004, COMBUST EXPLO SHOCK+, V40, P516, DOI 10.1023/B:CESW.0000041403.16095.a8; Prakash S, 2005, COMBUST SCI TECHNOL, V177, P793, DOI 10.1080/00102200590917275; Raimondeau S, 2002, P COMBUST INST, V29, P901, DOI 10.1016/S1540-7489(02)80114-6; Fan Y, 2009, P COMBUST INST, V32, P3083, DOI 10.1016/j.proci.2008.06.219; VLACHOS DG, 1993, COMBUST FLAME, V95, P313, DOI 10.1016/0010-2180(93)90135-P; Aghalayam P, 1998, AICHE J, V44, P2025, DOI 10.1002/aic.690440910; Maruta K, 2011, P COMBUST INST, V33, P125, DOI 10.1016/j.proci.2010.09.005; Zhang HW, 2013, COMBUST THEOR MODEL, V17, P682, DOI 10.1080/13647830.2013.792393; VLACHOS DG, 1995, COMBUST FLAME, V103, P59, DOI 10.1016/0010-2180(95)00072-E; Boust B, 2007, COMBUST FLAME, V149, P286, DOI 10.1016/j.combustflame.2006.12.019; Brambilla A, 2015, P COMBUST INST, V35, P3429, DOI 10.1016/j.proci.2014.06.131; Egolfopoulos FN, 1997, COMBUST FLAME, V109, P237, DOI 10.1016/S0010-2180(96)00152-6; Bai B, 2013, COMBUST FLAME, V160, P2810, DOI 10.1016/j.combustflame.2013.07.008; Popp P, 1997, COMBUST FLAME, V108, P327, DOI 10.1016/S0010-2180(96)00144-7; Yang HL, 2013, P COMBUST INST, V34, P3379, DOI 10.1016/j.proci.2012.07.038; Kim KT, 2006, COMBUST FLAME, V146, P19, DOI 10.1016/j.combustflame.2006.04.012; Andrae J, 2002, COMBUST FLAME, V128, P165, DOI 10.1016/S0010-2180(01)00342-X; Maruta K, 2005, P COMBUST INST, V30, P2429, DOI 10.1016/j.proci.2004.08.245; ALLEN MG, 1993, AIAA J, V31, P505, DOI 10.2514/3.11358; Fan Y, 2011, P COMBUST INST, V33, P3267, DOI 10.1016/j.proci.2010.05.041; Saiki Y, 2011, COMBUST FLAME, V158, P1391, DOI 10.1016/j.combustflame.2010.09.025; Andrae J, 2002, P COMBUST INST, V29, P789, DOI 10.1016/S1540-7489(02)80101-8; Bohlin A, 2015, P COMBUST INST, V35, P3723, DOI 10.1016/j.proci.2014.05.124; Kizaki Y, 2015, P COMBUST INST, V35, P3389, DOI 10.1016/j.proci.2014.07.030; Dreizler A, 2015, P COMBUST INST, V35, P37, DOI 10.1016/j.proci.2014.08.014; Ju YG, 2011, PROG ENERG COMBUST, V37, P669, DOI 10.1016/j.pecs.2011.03.001; Masel R.L, 1996, PRINCIPLES ADSORPTIO; Miesse C. M., 2004, AICHE J, V50, P3205; Popp R, 1996, P COMBUST INST, V16, P2693; Yang HL, 2011, COMBUST SCI TECHNOL, V183, P444, DOI 10.1080/00102202.2010.530323	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	OCT	2015	162	10					4036	4045		10.1016/j.combustflame.2015.07.043		10	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CS2TT	WOS:000361925600049		
J	Ijioma, ER; Izuhara, H; Mimura, M; Ogawa, T				Ijioma, Ekeoma R.; Izuhara, Hirofumi; Mimura, Masayasu; Ogawa, Toshiyuki			Homogenization and fingering instability of a microgravity smoldering combustion problem with radiative heat transfer	COMBUSTION AND FLAME			English	Article						Multiscale modeling; Homogenization; Smoldering combustion; Radiative heat transfer; Fingering instability	PATTERN-FORMATION; FILTRATION COMBUSTION; MODEL; NONEQUILIBRIUM; PROPAGATION; FLAMES	The present study concerns the homogenization and fingering instability of a microgravity smoldering combustion problem with radiative heat transfer. The major premise of the homogenization procedure is the slow exothermic fuel oxidation of a reactive porous medium at the pore level. The porous medium consists of epsilon - periodically distributed cells, with epsilon a suitable scale parameter. A nonlinear reaction rate of Arrhenius type accounts for the relationship between the reactants and the heat that sustains the smoldering process. At the gas-solid interface, the balance of thermal fluxes is given by the heat production rate due to the reaction and the radiative heat losses at the interface. Since the size of the inclusions is small with respect to e, we derive a kinetic model for fuel conversion in the region occupied by the solid inclusions and hence complete the description of a single-step chemical kinetics. The derived macroscopic model shows a close correspondence to a previous phenomenological reaction-diffusion model, within a suitable choice of parameters. We perform numerical simulations on the microscopic and homogenized models in order to verify the efficiency of the homogenization process in the slow smoldering regime. We show that the results of the macroscopic model capture the distinct fingering states reminiscent of microgravity smoldering combustion. We also show qualitative results that confirm the close relationship between the radiative heat losses and the characteristic length scales of the instability. (C) 2015 The Combustion Institute. Published by Elsevier Inc. All rights reserved.	[Ijioma, Ekeoma R.; Mimura, Masayasu; Ogawa, Toshiyuki] Meiji Univ, Meiji Inst Adv Study Math Sci MIMS, Nakano Ku, Tokyo 1648525, Japan; [Mimura, Masayasu; Ogawa, Toshiyuki] Meiji Univ, Grad Sch Adv Math Sci, Nakano Ku, Tokyo 1648525, Japan; [Ijioma, Ekeoma R.; Mimura, Masayasu; Ogawa, Toshiyuki] Meiji Univ, CMMA, Nakano Ku, Tokyo 1648525, Japan; [Izuhara, Hirofumi] Miyazaki Univ, Fac Engn, Miyazaki 8892192, Japan	Ijioma, ER (reprint author), Meiji Univ, Meiji Inst Adv Study Math Sci MIMS, Nakano Ku, 4-21-1 Nakano, Tokyo 1648525, Japan.	e.r.ijioma@gmail.com; hiro.izuhara@gmail.com; mimura.masayasu@gmail.com; tshogw@gmail.com		Ijioma, Ekeoma/0000-0002-5631-2500	Mathematical Institute for Advanced Study of Mathematical Sciences (MIMS), Center for Mathematical Modeling and Applications (CMMA), Meiji University	This work was supported by the Mathematical Institute for Advanced Study of Mathematical Sciences (MIMS), Center for Mathematical Modeling and Applications (CMMA), Meiji University.	ALLAIRE G, 1992, SIAM J MATH ANAL, V23, P1482, DOI 10.1137/0523084; Kagan L, 2008, COMBUST THEOR MODEL, V12, P269, DOI 10.1080/13647830701639462; OHLEMILLER TJ, 1983, COMBUST FLAME, V54, P131, DOI 10.1016/0010-2180(83)90027-5; ROGERS FE, 1980, COMBUST SCI TECHNOL, V24, P129, DOI 10.1080/00102208008952431; Olson SL, 2009, COMBUST FLAME, V156, P1214, DOI 10.1016/j.combustflame.2009.01.015; Ijioma ER, 2015, INT J HEAT MASS TRAN, V81, P924, DOI 10.1016/j.ijheatmasstransfer.2014.11.021; SCHULT DA, 1995, COMBUST FLAME, V101, P471, DOI 10.1016/0010-2180(94)00239-O; Ijioma ER, 2013, COMBUST THEOR MODEL, V17, P185, DOI 10.1080/13647830.2012.734860; Zik O, 1998, PHYS REV LETT, V81, P3868, DOI 10.1103/PhysRevLett.81.3868; Zik O, 1999, PHYS REV E, V60, P518, DOI 10.1103/PhysRevE.60.518; Aldushin AP, 2006, COMBUST FLAME, V145, P579, DOI 10.1016/j.combustflame.2005.12.009; Leach SV, 2000, COMBUST FLAME, V120, P346, DOI 10.1016/S0010-2180(99)00089-9; Kuwana K, 2014, COMBUST SCI TECHNOL, V186, P466, DOI 10.1080/00102202.2014.883220; Allaire G, 2009, MULTISCALE MODEL SIM, V7, P1148, DOI 10.1137/080714737; Allaire G, 2013, SIAM J MATH ANAL, V45, P1136, DOI 10.1137/110849821; Olson SL, 2006, COMBUST THEOR MODEL, V10, P323, DOI 10.1080/13647830600565446; Ikeda K, 2008, HIROSHIMA MATH J, V38, P349; AURIAULT JL, 1994, INT J HEAT MASS TRAN, V37, P2885, DOI 10.1016/0017-9310(94)90342-5; Kagan L, 1997, COMBUST FLAME, V108, P220, DOI 10.1016/S0010-2180(96)00108-3; Wahle CW, 2003, COMBUST SCI TECHNOL, V175, P1389, DOI 10.1080/00102200390218921; Oliveira AAM, 2001, PROG ENERG COMBUST, V27, P523, DOI 10.1016/S0360-1285(00)00030-7; Uchida Y, 2015, COMBUST FLAME, V162, P1957, DOI 10.1016/j.combustflame.2014.12.014; Bakhvalov N., 1989, MATH ITS APPL SOVIET, V36; Bensoussan A., 1978, STUDIES MATH ITS APP, V5; Fakheri A., 1989, AIAA J, V89-0504; Fasano A., 2009, MATH METHOD APPL SCI, P1; Fatima T, 2014, NETW HETEROG MEDIA, V9, P709, DOI 10.3934/nhm.2014.9.709; Hornung U., 1997, INTERDISCIPLINARY AP, V6; Hu LN, 2015, MATH MOD METH APPL S, V25, P685, DOI 10.1142/S0218202515500165; Ijioma E.R., 2014, THESIS MEIJI U TOKYO; Kagan L, 1996, PHYS REV E, V53, P6021, DOI 10.1103/PhysRevE.53.6021; Lu CA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036201; Monsurro S., 2003, ADV MATH SCI APPL, V13, P43; Olson S., 1998, 27 S INT COMB, V27, P2525; Sanchez-Palencia E., 1985, LECT NOTES PHYS, V272; Turns S. R., 2000, INTRO COMBUSTION CON; Whitaker S., 1998, THEORY APPL TRANSPOR, V13; Yuan F.-p., 2013, APPL MATH MECH-ENGL, P1; Zik O., 1998, P COMBUST INST, V27, P2815	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0010-2180	1556-2921		COMBUST FLAME	Combust. Flame	OCT	2015	162	10					4046	4062		10.1016/j.combustflame.2015.07.044		17	Thermodynamics; Energy & Fuels; Engineering, Multidisciplinary; Engineering, Chemical; Engineering, Mechanical	Thermodynamics; Energy & Fuels; Engineering	CS2TT	WOS:000361925600050		
J	Watanabe, M; Yonezawa, T; Shobu, T; Shoji, T				Watanabe, Masashi; Yonezawa, Toshio; Shobu, Takahisa; Shoji, Tetsuo			In Situ X-Ray Diffraction Measurement Method for Investigating the Oxides Films on Austenitic Stainless Steel in Simulated Pressurized Water Reactor Primary Water	CORROSION			English	Article						hydrogen; oxide film layer structure; oxides; pressurized water reactor; stainless steels; stress corrosion cracking; x-ray diffraction	HIGH-TEMPERATURE WATER; STRESS-CORROSION CRACKING; PWR PRIMARY WATER; ELECTRICAL-RESISTANCE; PURE WATER; SURFACE; ALLOYS; 316L; IRON; DIFFRACTOMETRY	Synchrotron x-ray diffraction analytical techniques have been used to investigate the structure of oxide films formed on Type 316L (UNS S31603) austenitic stainless steel in simulated pressurized water reactor primary water. An in situ technique for investigating the layer structures of oxide films has been developed using this measurement method. The observed layer structures of the oxide films changed depending on the dissolved hydrogen concentration (DH) in PWR primary water. In two cases, where DH = 5 cm(3)/kg (H2O) or 30 cm(3)/kg (H2O), a (NixFe(1-x))Fe2O4-type spinel oxide was observed as the outer oxide, and a FeCr2O4-type spinel oxide was detected as the thin inner oxide. When DH = 30 cm(3)/kg (H2O), the Fe:Ni ratio in the (NixFe(1-x))Fe2O4 outer spinel oxide was much larger than when DH = 5 cm(3)/kg (H2O). In addition, sequential in situ measurements when the hydrogen concentration varied from 5 cm(3)/kg (H2O) to 30 cm(3)/kg (H2O) also demonstrated that the oxide layer structure seemed to adjust its characteristic composition as a function of the DH. The oxide layer structure could also be reversed to that of the initial state with DH = 5 cm(3)/kg (H2O) when the DH was switched back from 30 cm(3)/kg (H2O) to 5 cm(3)/kg (H2O).	[Watanabe, Masashi; Yonezawa, Toshio; Shoji, Tetsuo] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808577, Japan; [Shobu, Takahisa] Japan Atom Energy Agcy, Sayoh 6795184, Japan	Watanabe, M (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808577, Japan.	m-wat@fri.niche.tohoku.ac.jp			Electric Power Research Institute; Kansai Electric Power Co., Inc.; Tohoku Electric Power Co., Inc.; Mitsubishi Heavy Industries, Ltd.; EDF-SEPTEN; Chubu Electric Power Co., Inc.; JSPS KAKENHI [25289348]	Part of this study was performed as a part of the POLIM research program which is financially supported by the Electric Power Research Institute, the Kansai Electric Power Co., Inc., Tohoku Electric Power Co., Inc., Mitsubishi Heavy Industries, Ltd., EDF-SEPTEN, and Chubu Electric Power Co., Inc. The remaining part of this study was supported by JSPS KAKENHI Grant Number 25289348. The authors would like to acknowledge their financial support. The authors would also like to acknowledge technical discussions with Dr. Peter Scott and experimental support from Dr. Osami Sakata (NIMS) and Dr. Hiroo Tajiri (JASRI).	Ahluwalia K., 2007, 1015427 EPRI; Akiniwa Y., 2003, ZAIRYOU, V52, P764; Andresen P. L., 2004, CORROSION 2004; Terachi T, 2008, J NUCL SCI TECHNOL, V45, P975, DOI 10.3327/jnst.45.975; LISTER DH, 1987, CORROS SCI, V27, P113, DOI 10.1016/0010-938X(87)90068-0; Ishida K, 2012, J NUCL SCI TECHNOL, V49, P1078, DOI 10.1080/00223131.2012.730899; CUBICCIOTTI D, 1993, J NUCL MATER, V201, P176, DOI 10.1016/0022-3115(93)90173-V; Kautek W, 1998, ELECTROCHIM ACTA, V43, P2979, DOI 10.1016/S0013-4686(98)00038-3; HAYES KF, 1987, SCIENCE, V238, P783, DOI 10.1126/science.238.4828.783; Peterson AA, 2008, J SUPERCRIT FLUID, V43, P490, DOI 10.1016/j.supflu.2007.08.003; Arioka K, 2006, CORROSION, V62, P74; Bojinov M, 1999, CORROS SCI, V41, P1557, DOI 10.1016/S0010-938X(99)00003-7; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; Andresen PL, 2008, J NUCL MATER, V383, P97, DOI 10.1016/j.jnucmat.2008.08.005; Terachi T, 2005, J NUCL SCI TECHNOL, V42, P225, DOI 10.3327/jnst.42.225; Saario T, 1995, MATER SCI FORUM, V185-, P621; Liu XH, 2014, CORROS SCI, V78, P200, DOI 10.1016/j.corsci.2013.09.017; Maslar JE, 2001, J NUCL MATER, V298, P239, DOI 10.1016/S0022-3115(01)00657-2; Kai A, 2004, KEY ENG MAT, V261-263, P913; [Anonymous], 2008, CRACKS INN SURF WELD; Belo MD, 1998, CORROS SCI, V40, P447, DOI 10.1016/S0010-938X(97)00158-3; [Anonymous], 2002, WERKST KORROS; Jensen KMO, 2014, CHEMSUSCHEM, V7, P1594, DOI 10.1002/cssc.201301042; Sennour M, 2010, J NUCL MATER, V402, P147, DOI 10.1016/j.jnucmat.2010.05.010; Watanabe M, 2013, J NUCL MATER, V434, P189, DOI 10.1016/j.jnucmat.2012.10.049; Takeda Y, 2006, APPL SURF SCI, V252, P8580, DOI 10.1016/j.apsusc.2005.11.073; Raja KS, 2001, J MATER SCI LETT, V20, P965, DOI 10.1023/A:1010909723426; Kim JH, 2005, NUCL ENG DES, V235, P1029, DOI 10.1016/j.nucengdes.2004.12.002; Beverskog B, 1996, CORROS SCI, V38, P2121, DOI 10.1016/S0010-938X(96)00067-4; Bamford W., 2003, P 11 INT C ENV DEGR, P1071; Bojinov M, 1999, ELECTROCHIM ACTA, V44, P4331, DOI 10.1016/S0013-4686(99)00149-8; Couvant T., 2006, P INT S FONT, P6; Fukumura T., THESIS U FUKUI; Gao Y. C., 1981, ADV FRACTURE RES, V2, P669; KIM YJ, 1995, CORROSION, V51, P849; Kunig R. H., 1986, NP4248 EPRI WEST EL; Lister D. H., 1987, CORROS SCI, V27, P125; Miyajima K., TOOO4 CENTR RES I EL, P5; Da Fonseca JQ, 2005, J MICROSC-OXFORD, V218, P9, DOI 10.1111/j.1365-2818.2005.01461.x; Sathiyanarayanan S, 1999, CORROS SCI, V41, P1899, DOI 10.1016/S0010-938X(99)00021-9; Scott P. M., 2003, 11 INT S ENV DEGR MA; Scott P. M., 2001, 10 INT S ENV DEGR MA; Shoji T., 2003, P 11 INT S ENV DEGR, P588; Shoji T., 2003, P 11 INT C ENV DEGR; Suzuki S., 2004, MAINTENOLOGY, V3, P65; Takemura K., 1979, High Temperatures - High Pressures, V11; Terachi T., 2003, INSS J, V10, P151; Thomas LE, 1999, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON ENVIRONMENTAL DEGRADATION OF MATERIALS IN NUCLEAR POWER SYSTEMS-WATER REACTORS, P41; Yildiz B., 2007, 212 ECS M; Young L. M., 2001, CORROSION 2001	50	0	0	NATL ASSOC CORROSION ENG	HOUSTON	1440 SOUTH CREEK DRIVE, HOUSTON, TX 77084-4906 USA	0010-9312	1938-159X		CORROSION-US	Corrosion	OCT	2015	71	10					1224	1236		10.5006/1690		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CS5MX	WOS:000362123400006		
J	Ohtani, T; Bouix, S; Lyall, AE; Hosokawa, T; Saito, Y; Melonakos, E; Westin, CF; Seidman, LJ; Goldstein, J; Mesholam-Gately, R; Petryshen, T; Wojcik, J; Kubicki, M				Ohtani, Toshiyuki; Bouix, Sylvain; Lyall, Amanda E.; Hosokawa, Taiga; Saito, Yukiko; Melonakos, Eric; Westin, Carl-Fredrik; Seidman, Larry J.; Goldstein, Jill; Mesholam-Gately, Raquelle; Petryshen, Tracey; Wojcik, Joanne; Kubicki, Marek			Abnormal white matter connections between medial frontal regions predict symptoms in patients with first episode schizophrenia	CORTEX			English	Article						White matter; Fractional anisotropy; Orbitofrontal cortex; Anterior cingulate cortex; First episode schizophrenia	ANTERIOR CINGULATE CORTEX; RECENT-ONSET SCHIZOPHRENIA; DIFFUSION TENSOR; 1ST-EPISODE SCHIZOPHRENIA; ORBITOFRONTAL CORTEX; CORPUS-CALLOSUM; AUDITORY HALLUCINATIONS; FUNCTIONAL NEUROANATOMY; NONVERBAL TASK; PSYCHOSIS	Introduction: The medial orbitofrontal cortex (mOFC) and rostral part of anterior cingulate cortex (rACC) have been suggested to be involved in the neural network of salience and emotional processing, and associated with specific clinical symptoms in schizophrenia. Considering the schizophrenia dysconnectivity hypothesis, the connectivity abnormalities between mOFC and rACC might be associated with clinical characteristics in first episode schizophrenia patients (FESZ). Methods: After parcellating mOFC into the anterior and posterior part, diffusion properties of the mOFC-rACC white matter connections for 21 patients with FESZ and 21 healthy controls (HCs) were examined using stochastic tractography, one of the most effective Diffusion Tensor Imaging (DTI) methods for examining tracts between adjacent gray matter (GM) regions. Results: Fractional anisotropy (FA) reductions were observed in bilateral posterior, but not anterior mOFC-rACC connections (left: p < .0001; right: p < .0001) in FESZ compared to HCs. In addition, reduced FA in the left posterior mOFC-rACC connection was associated with more severe anhedonia-asociality (rho = -.633, p = .006) and total score (rho = -.520, p = .032) in the Scale for the Assessment of Negative Symptoms (SANS); reduced FA in the right posterior mOFC-rACC connection was associated with more severe affective flattening (rho = -.644, p = .005), total score (rho = -.535, p = .027) in SANS, hallucinations (rho = -.551, p = .018), delusions (rho = -.632, p = .005) and total score (rho = -.721, p = .001) in the Scale for the Assessment of Positive Symptoms (SAPS) in FESZ. Conclusions: The observed white matter abnormalities within the connections between mOFC and rACC might be associated with the psychopathology of the early stage of schizophrenia. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohtani, Toshiyuki; Bouix, Sylvain; Lyall, Amanda E.; Hosokawa, Taiga; Saito, Yukiko; Melonakos, Eric; Kubicki, Marek] Harvard Univ, Brigham & Womens Hosp, Sch Med, Psychiat Neuroimaging Lab,Dept Psychiat, Boston, MA 02115 USA; [Ohtani, Toshiyuki; Hosokawa, Taiga; Kubicki, Marek] VA Boston Healthcare Syst, Boston, MA USA; [Seidman, Larry J.; Mesholam-Gately, Raquelle] Harvard Univ, Beth Israel Deaconess Med Ctr, Massachusetts Mental Hlth Ctr, Publ Psychiat Div,Dept Psychiat,Sch Med, Boston, MA 02215 USA; [Seidman, Larry J.; Goldstein, Jill; Wojcik, Joanne] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Petryshen, Tracey] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Boston, MA USA; [Petryshen, Tracey] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Westin, Carl-Fredrik] Harvard Univ, Brigham & Womens Hosp, Sch Med, Surg Planning Lab,MRI Div,Dept Radiol, Boston, MA 02115 USA; [Ohtani, Toshiyuki] Chiba Univ, Safety & Hlth Org, Chiba, Chiba, Japan; [Hosokawa, Taiga] Tsuchida Hosp, Tokyo, Japan; [Saito, Yukiko] Kansai Med Univ, Dept Neuropsychiat, Moriguchi, Osaka 570, Japan	Kubicki, M (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Psychiat Neuroimaging Lab,Dept Psychiat, Boston, MA 02115 USA.	kubicld@bwh.harvard.edu			National Institute of Health [K05 MH070047, R01AG042512, R01MH102377, R01 MH 50740, R01 MH 40799, R01 MH 082918, R01MH 074794, P50MH 080272, 1P50MH080272-01]; VA Schizophrenia Center Grant; National Alliance for Medical Image Computing (NAMIC); National Institutes of Health through the NIH Roadmap for Medical Research [U54 EB005149]; NIH [P41 RR013218]; Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award	We gratefully acknowledge the support of the National Institute of Health (K05 MH070047, R01AG042512, R01MH102377, R01 MH 50740, R01 MH 40799, R01 MH 082918, R01MH 074794, P50MH 080272, 1P50MH080272-01, the VA Schizophrenia Center Grant. This work is also part of the National Alliance for Medical Image Computing (NAMIC), funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant U54 EB005149, and is also supported by NIH Grant P41 RR013218 to the Neuroimage Analysis Center. In addition, the work has been supported by the Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award.	Andreasen N., 1981, SCALE ASSESSMENT NEG; Andreasen N.C., 1984, SCALE ASSESSMENT POS; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Rotarska-Jagiela A, 2008, NEUROIMAGE, V39, P1522, DOI 10.1016/j.neuroimage.2007.10.063; Cui LQ, 2011, PSYCHIAT RES-NEUROIM, V194, P347, DOI 10.1016/j.pscychresns.2011.03.010; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Diekhof EK, 2011, NEUROPSYCHOLOGIA, V49, P984, DOI 10.1016/j.neuropsychologia.2011.01.032; Kubicki M, 2007, J PSYCHIAT RES, V41, P15, DOI 10.1016/j.jspychires.2005.05.005; Price G, 2007, NEUROIMAGE, V35, P458, DOI 10.1016/j.neuroimage.2006.12.019; Bjornemo M, 2002, LECT NOTES COMPUT SC, V2488, P435; Zou LQ, 2008, ACAD RADIOL, V15, P285, DOI 10.1016/j.acra.2007.09.026; Peters BD, 2008, NEUROPSYCHOBIOLOGY, V58, P19, DOI 10.1159/000154476; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; Buchy L, 2012, PSYCHIAT RES-NEUROIM, V203, P6, DOI 10.1016/j.pscychresns.2011.09.009; Kanaan R, 2009, BRIT J PSYCHIAT, V194, P236, DOI 10.1192/bjp.bp.108.054320; Gladsjo JA, 1999, J INT NEUROPSYCH SOC, V5, P247; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Liu XY, 2013, BEHAV BRAIN RES, V252, P157, DOI 10.1016/j.bbr.2013.05.061; Allen P, 2007, BRIT J PSYCHIAT, V190, P162, DOI 10.1192/bjp.bp.106.025700; Zhang XC, 2010, BIOL PSYCHIAT, V68, P674, DOI 10.1016/j.biopsych.2010.06.018; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Seok JH, 2007, PSYCHIAT RES-NEUROIM, V156, P93, DOI 10.1016/j.pseychresns.2007.02.002; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Pettersson-Yeo W, 2011, NEUROSCI BIOBEHAV R, V35, P1110, DOI 10.1016/j.neubiorev.2010.11.004; Peters BD, 2010, J PSYCHIATR RES, V44, P993, DOI 10.1016/j.jpsychires.2010.05.003; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Caligiuri MP, 2005, SCHIZOPHR RES, V80, P151, DOI 10.1016/j.schres.2005.07.030; CLEGHORN JM, 1992, AM J PSYCHIAT, V149, P1062; Federspiel A, 2006, NEUROBIOL DIS, V22, P702, DOI 10.1016/j.nbd.2006.01.015; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Konrad A, 2008, SCHIZOPHRENIA BULL, V34, P72, DOI 10.1093/schbul/sbm034; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Liu JX, 2010, J AFFECT DISORDERS, V127, P309, DOI 10.1016/j.jad.2010.05.026; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Lahti AC, 2006, NEUROPSYCHOPHARMACOL, V31, P221, DOI 10.1038/sj.npp.1300837; Allman JM, 2001, ANN NY ACAD SCI, V935, P107; Cheung V, 2008, PSYCHOL MED, V38, P877, DOI 10.1017/S0033291707001808; Whitford TJ, 2011, NEUROIMAGE, V54, P2318, DOI 10.1016/j.neuroimage.2010.10.048; Foucher JR, 2005, NEUROIMAGE, V26, P374, DOI 10.1016/j.neuroimage.2005.01.042; Segal D, 2007, INT J NEUROPSYCHOPH, V10, P503, DOI 10.1017/S14611570600722X; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Kawashima T, 2009, SCHIZOPHR RES, V110, P119, DOI 10.1016/j.schres.2009.01.014; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Gasparotti R, 2009, SCHIZOPHR RES, V108, P41, DOI 10.1016/j.schres.2008.11.015; Mitelman SA, 2007, SCHIZOPHR RES, V92, P211, DOI 10.1016/j.schres.2006.12.029; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Fitzsimmons J, 2014, SCHIZOPHR RES, V156, P157, DOI 10.1016/j.schres.2014.04.022; Erkwoh R, 1997, ACTA PSYCHIAT SCAND, V96, P51, DOI 10.1111/j.1600-0447.1997.tb09904.x; Ohtani T, 2014, SCHIZOPHR RES, V157, P190, DOI 10.1016/j.schres.2014.05.016; Perez-Iglesias R, 2010, AM J PSYCHIAT, V167, P451, DOI 10.1176/appi.ajp.2009.09050716; Dekker N, 2010, PSYCHIAT RES-NEUROIM, V181, P51, DOI 10.1016/j.pscychresns.2009.06.003; Hughes BL, 2012, CEREB CORTEX, V22, P1372, DOI 10.1093/cercor/bhr213; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Shad MU, 2006, PSYCHIAT RES-NEUROIM, V146, P35, DOI 10.1016/j.pscychresns.2005.11.001; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Oishi K, 2009, J NEUROIMAGING, V19, P127, DOI 10.1111/j.1552-6569.2008.00262.x; Duda JT, 2010, LECT NOTES COMPUT SC, V6362, P282; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Uranova NA, 2007, INT J NEUROPSYCHOPH, V10, P537, DOI 10.1017/S1461145707007626; de Marco G, 2006, NEUROIMAGE, V30, P1030, DOI 10.1016/j.neuroimage.2005.10.001; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Palaniyappan L, 2011, PSYCHOL MED, V41, P1701, DOI 10.1017/S0033291710002205; Hao YH, 2006, NEUROREPORT, V17, P23, DOI 10.1097/01.wnr.0000195664.15090.46; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Kubicki M, 2011, NEUROIMAGE, V55, P1657, DOI 10.1016/j.neuroimage.2011.01.047; Parellada E, 2008, NUCL MED COMMUN, V29, P894, DOI 10.1097/MNM.0b013e328302cd10; Blackwood NJ, 2004, PSYCHOL MED, V34, P591, DOI 10.1017/S0033291703008997; Brune M, 2008, NEUROPSYCHOLOGIA, V46, P1992, DOI 10.1016/j.neuropsychologia.2008.01.023; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Tang JS, 2010, BRAIN RES, V1343, P199, DOI 10.1016/j.brainres.2010.04.083; Alexander AL, 1997, MAGNET RESON MED, V38, P1016, DOI 10.1002/mrm.1910380623; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663; First M. B., 2002, STRUCTURED CLIN INTE; Heid O., 2000, P INT SOC MAG RESON, V38, p[799, 1016]; Hien D., 1994, STRUCTURED CLIN INTE; Kapur S, 2003, AM J PSYCHIAT, V160, P12; Mori S, 2005, MRI ATLAS HUMAN WHIT	82	1	1	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	OCT	2015	71						264	276		10.1016/j.cortex.2015.05.028		13	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CS5PV	WOS:000362131300024		
J	Minamoto, T; Yaoi, K; Osaka, M; Osaka, N				Minamoto, Takehiro; Yaoi, Ken; Osaka, Mariko; Osaka, Naoyuki			The rostral prefrontal cortex underlies individual differences in working memory capacity: An approach from the hierarchical model of the cognitive control	CORTEX			English	Article						Working memory capacity; Individual differences; Prefrontal cortex; Executive function; Hierarchical model	GENERAL FLUID INTELLIGENCE; LATENT-VARIABLE APPROACH; NEURAL MECHANISMS; FRONTAL-LOBE; TERM-MEMORY; ATTENTION; INTERFERENCE; SPAN; TASK; BEHAVIOR	Neuroimaging and behavioral evidence has suggested that the lateral prefrontal cortex is involved in individual differences in working memory capacity (WMC). However, few studies have localized the neural structures that differentiate high and low WMC individuals, considering the functional architecture of the prefrontal cortex. The present study aimed to identify a frontal region that underlies individual differences from the perspective of the hierarchical architecture of the frontal cortex. By manipulating an episodic factor of cognitive control (control in selecting an appropriate task set according to a temporal context) and using a parametric modulation analysis, we found that both highand low- WMC individuals have similar activation patterns in the premotor cortex (BA6, 8), caudal prefrontal cortex (BA44, 45), and frontopolar cortex (BA10, 11), but differed in the rostral part of the prefrontal cortex (BA46/47); high WMC individuals showed greater activation in the higher episodic control condition, whereas low WMC individuals showed reduced activation when episodic control was required. Similar patterns of activation were found in the right inferior parietal and middle/inferior temporal cortices. These results indicate that the rostral prefrontal cortex, which supports episodic cognitive control, possibly by sending a weighting signal toward the inferior parietal and middle/inferior temporal cortices that modulate saliency and sensory processing, underlies individual differences in WMC. Episodic control account, which considers the organization of the prefrontal cortex, fits well with previous findings of individual differences in WMC. (C) 2015 Elsevier Ltd. All rights reserved.	[Minamoto, Takehiro] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka 5650871, Japan; [Yaoi, Ken; Osaka, Naoyuki] Kyoto Univ, Fac Letters, Dept Psychol, Kyoto, Japan; [Osaka, Mariko] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan	Minamoto, T (reprint author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, 1-4 Yamadaoka, Suita, Osaka 5650871, Japan.	txminamoto@nict.go.jp			Japan Society for the Promotion of Science [22220003, 23240036]	This study was supported by the Japan Society for the Promotion of Science [grant numbers 22220003 (to NO) and 23240036 (to MO)]. We thank Dr. Takanori Kochiyama for technical advice in analyzing neuro-imaging data.	Burgess GC, 2011, J EXP PSYCHOL GEN, V140, P674, DOI 10.1037/a0024695; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665; Botvinick MM, 2007, PHILOS T R SOC B, V362, P1615, DOI 10.1098/rstb.2007.2056; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Unsworth N, 2007, J EXP PSYCHOL LEARN, V33, P1020, DOI 10.1037/0278-7393.33.6.1020; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Colom R, 2007, COGN NEUROPSYCHOL, V24, P867, DOI 10.1080/02643290701781557; Badre D, 2009, NAT NEUROSCI, V12, P515, DOI 10.1038/nn.2277; Minamoto T, 2010, BRAIN RES, V1335, P63, DOI 10.1016/j.brainres.2010.03.088; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Ackerman PL, 2002, J EXP PSYCHOL GEN, V131, P567, DOI 10.1037//0096-3445.131.4.567; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Unsworth N, 2004, J EXP PSYCHOL LEARN, V30, P1302, DOI 10.1037/0278-7393.30.6.1302; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Mrazek MD, 2013, PSYCHOL SCI, V24, P776, DOI 10.1177/0956797612459659; Osaka N, 2004, NEUROIMAGE, V21, P623, DOI 10.1016/j.neuroimaging.2003.09.069; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Osaka M, 2002, MEM COGNITION, V30, P562, DOI 10.3758/BF03194957; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Fuster JM, 2004, TRENDS COGN SCI, V8, P143, DOI 10.1016/j.tics.2004.02.004; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Egner T, 2005, J COGNITIVE NEUROSCI, V17, P1774, DOI 10.1162/089892905774589226; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; [Anonymous], 1995, NATURE, DOI DOI 10.1038/378279A0; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Shimamura Arthur P., 1995, P803; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; Conway ARA, 1999, MEM COGNITION, V27, P1042, DOI 10.3758/BF03201233; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Braver T. S., 2002, PRINCIPLES FRONTAL L, P428, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0027; Brett M., 8 INT C FUNCT MAPP H; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; Fuster J. M., 1990, ANN NY ACAD SCI, V608, P330, DOI 10.1111q.1749-6632.1990.tb48901.x; Lister J. M., 1997, PREFRONTAL CORTEX AN; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; OSAKA M, 1994, JPN J PSYCHOL, V65, P339; Passingham R.E., 2002, PRINCIPLES FRONTAL L, P221; Shipstead Z., 2012, J EXPT PSYCHOL LEARN, V39, P277	56	0	0	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	OCT	2015	71						277	290		10.1016/j.cortex.2015.07.025		14	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CS5PV	WOS:000362131300025		
J	Chasombat, J; Nagai, T; Pampai, R; Vongpralub, T				Chasombat, Jakkhaphan; Nagai, Takashi; Pampai, Rangsun; Vongpralub, Thevin			Pretreatment of in vitro matured bovine oocytes with docetaxel before vitrification: Effects on cytoskeleton integrity and developmental ability after warming	CRYOBIOLOGY			English	Article						Docetaxel; Bovine oocytes; Vitrification; Cytoskeleton fibers	EMBRYO DEVELOPMENT; MOUSE OOCYTES; PRECLINICAL PHARMACOLOGY; MEIOTIC MATURATION; CORTICAL GRANULES; CYTOCHALASIN-B; TAXOL; FERTILIZATION; MICROTUBULES; TAXOTERE	The stabilization of spindle fibersis important for successful vitrification of bovine oocytes because micro-tubules and other cytoskeleton fibers (CSF) can be damaged during vitrification, resulting in failure of fertilization after thawing. Docetaxel, a stabilizing agent, could potentially reduce CSF damage of bovine oocytes induced during vitrification. However, there have been no reports on the effects of docetaxel on their vitrification. Experiment I was conducted to investigate the effects of various doses of docetaxel (0.0, 0.05, 0.5, 5.0 and 50 mu M) in preincubation medium of in vitro matured (IVM) bovine oocytes on their developmental ability after in vitro fertilization (IVF). The results show that 0.05)110 docetaxel had no adverse effect on embryo development, while docetaxel at a concentration of >= 0.5 mu M inhibited development. Experiments 2 and 3 were conducted to investigate the effects of preincubation of IVM bovine oocytes with 0.05 mu M docetaxel for 30 min prior to vitrification-warming on CSF integrity (Experiment 2), and on oocyte survival and viability after IVF (Experiment 3). When preincubated with 0.05 mu M docetaxel for 30 min before vitrification, post-thawed oocytes had less CSF damage and higher survival rates compared with those untreated with docetaxel before vitrification. Surviving oocytes also had higher rates of cleavage and development to the blastocyst stage after IVF. In conclusion, preincubation of IVM bovine oocytes with 0.05 mu M docetaxel for 30 min before vitrification was effective at preventing CSF damage during vitrification, and improving oocyte viability after warming and subsequent cleavage and blastocyst formation after IVF. (C) 2015 Elsevier Inc. All rights reserved.	[Chasombat, Jakkhaphan; Vongpralub, Thevin] Khon Kaen Univ, Fac Agr, Dept Anim Sci, Khon Kaen 40002, Thailand; [Nagai, Takashi] Food & Fertilizer Technol Ctr, Taipei 10648, Taiwan; [Nagai, Takashi] NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Pampai, Rangsun] Suranaree Univ Technol, Embryo Technol & Stem Cell Res Ctr, Nakhon Ratchasima 30000, Thailand; [Pampai, Rangsun] Suranaree Univ Technol, Sch Biotechnol, Nakhon Ratchasima 30000, Thailand	Vongpralub, T (reprint author), Khon Kaen Univ, Fac Agr, Dept Anim Sci, Khon Kaen 40002, Thailand.	vthevi@kku.ac.th					Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Fuchinoue K, 2004, J ASSIST REPROD GEN, V21, P307, DOI 10.1023/B:JARG.0000043705.63523.68; Silvestre MA, 2006, ANIM REPROD SCI, V93, P176, DOI 10.1016/j.anireprosci.2005.08.006; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Sinou V, 1996, ANTIMICROB AGENTS CH, V40, P358; MOHR LR, 1980, J REPROD FERTIL, V58, P189; Dinnyes A, 2000, BIOL REPROD, V63, P513, DOI 10.1095/biolreprod63.2.513; BOUQUET M, 1992, HUM REPROD, V7, P76; Parrish JJ, 2014, THERIOGENOLOGY, V81, P67, DOI 10.1016/j.theriogenology.2013.08.005; Velilla E, 2004, MOL REPROD DEV, V68, P507, DOI 10.1002/mrd.20111; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; Katayama M, 2006, DEV BIOL, V299, P206, DOI 10.1016/j.ydbio.2006.07.022; Park SE, 2001, FERTIL STERIL, V75, P1177, DOI 10.1016/S0015-0282(01)01809-X; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Schmidt DW, 2004, FERTIL STERIL, V82, pS26, DOI 10.1016/j.fertnstert.2004.07.071; Dobrinsky JR, 2000, BIOL REPROD, V62, P564, DOI 10.1095/biolreprod62.3.564; VANBLERKOM J, 1991, P NATL ACAD SCI USA, V88, P5031; Adona PR, 2008, ANIM REPROD SCI, V108, P49, DOI 10.1016/j.anireprosci.2007.07.002; Vacca A, 2002, J HEMATOTH STEM CELL, V11, P103, DOI 10.1089/152581602753448577; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; Morato R, 2008, CRYOBIOLOGY, V57, P137, DOI [10.1016/j.cryobiol.2008.07.003, 10.1016/j.cryobio1.2008.07.003]; Shi WQ, 2006, REPRODUCTION, V131, P795, DOI 10.1530/rep.1.00899; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Devillard L, 2008, MOL CELL BIOCHEM, V307, P149, DOI 10.1007/s11010-007-9594-3; Connors SA, 1998, DEV BIOL, V200, P103, DOI 10.1006/dbio.1998.8945; Mao LN, 2014, REPROD BIOMED ONLINE, V28, P284, DOI 10.1016/j.rbmo.2013.10.016; ANDREU JM, 1994, J BIOL CHEM, V269, P31785; Morato R, 2008, MOL REPROD DEV, V75, P191, DOI 10.1002/mrd.20725; Gligorov J, 2004, ONCOLOGIST, V9, P3, DOI 10.1634/theoncologist.9-suppl_2-3; Domanska UM, 2012, NEOPLASIA, V14, P709, DOI 10.1593/neo.12324; Ratto MH, 2011, ANIM REPROD SCI, V129, P1, DOI 10.1016/j.anireprosci.2011.10.001; Jimenez-Trigos E, 2013, REPROD DOMEST ANIM, V48, P15, DOI 10.1111/j.1439-0531.2012.02018.x; CHERR GN, 1988, J EXP ZOOL, V246, P81, DOI 10.1002/jez.1402460111; SCHREVEL J, 1994, P NATL ACAD SCI USA, V91, P8472, DOI 10.1073/pnas.91.18.8472; Van Blerkom J, 2007, MOL HUM REPROD, V13, P759, DOI 10.1093/molehr/gam068; Boiso I, 2002, HUM REPROD, V17, P1885, DOI 10.1093/humrep/17.7.1885; Ward F, 2002, THERIOGENOLOGY, V57, P2105, DOI 10.1016/S0093-691X(02)00696-9; Mailhes JB, 1999, MUTAT RES-FUND MOL M, V423, P79, DOI 10.1016/S0027-5107(98)00228-0; Sripunya N, 2010, J REPROD DEVELOP, V56, P176, DOI 10.1262/jrd.09-108H; BISSERY MC, 1995, EUR J CANCER, V31A, pS1, DOI 10.1016/0959-8049(95)00357-O; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Fromes Y., 1992, P AM ASSOC CANC RES, P3055; GUERITTEVOEGELEIN F, 1991, J MED CHEM, V34, P992, DOI 10.1021/jm00107a017; Inoue S., 1981, Journal of Cell Biology, V91, P131; Prentice JR, 2011, THERIOGENOLOGY, V75, P602, DOI 10.1016/j.theriogenology.2010.09.027; RINGEL I, 1991, J NATL CANCER I, V83, P288, DOI 10.1093/jnci/83.4.288; Sparreboom A, 1998, ANTI-CANCER DRUG, V9, P1, DOI 10.1097/00001813-199801000-00001; Thouas G. A., 2001, REPROD BIOMED ONLINE, V3, P25, DOI [10.1016/S1472-6483(10)61960-8, DOI 10.1016/S1472-6483(10)61960-8]; Vieira AD, 2002, CRYOBIOLOGY, V45, P91, DOI 10.1016/S0011-2240(02)00109-8	50	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0011-2240	1090-2392		CRYOBIOLOGY	Cryobiology	OCT	2015	71	2					216	223		10.1016/j.cryobiol.2015.07.002		8	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	CS8BU	WOS:000362311500004		
J	Lee, Y; Ikeuchi, M				Lee, Yoonseok; Ikeuchi, Masamitsu			Experimental study of laminar natural convection heat transfer from a vertical cylinder to slush nitrogen under constant heat flux conditions	CRYOGENICS			English	Article						Slush nitrogen; Natural convection; Heat transfer coefficient	PIPE-FLOW	Natural convection heat transfer from a vertical cylinder immersed in slush and subcooled liquid nitrogen and subjected to constant heat fluxes was investigated in order to determine the relative merits of slush nitrogen (SIN2) for immersion cooling. A glass dewar was used as a test vessel in which a cylindrical heater was mounted vertically, and heat transfer measurements were carried out for SIN2 and subcooled liquid nitrogen (LN2) in the laminar flow range. The results revealed advantages of SIN2 over subcooled LN2 in natural convection cooling. The local temperatures of the heated surface surrounded by solid nitrogen particles are measured to increase at much slower rates than in subcooled LN2, which is due to the latent heat of fusion of solid nitrogen. Even after the solid nitrogen particles surrounding the heater are apparently depleted, the average heat transfer coefficients for SIN2 are still found to be greater than those for LN2 with the improvement in heat transfer being larger for lower Grashof number regime. Our analysis also indicates that solid nitrogen particles in close proximity to heated surface do not discourage local convection due to the porous nature of SIN2, making the heat transfer in SIN2 more effective than in the case of solid-liquid phase change of nitrogen involving melting and conduction processes. (C) 2015 Elsevier Ltd. All rights reserved.	[Lee, Yoonseok; Ikeuchi, Masamitsu] Mayekawa Mfg Co Ltd, Moriya City, Ibaraki 3020118, Japan	Ikeuchi, M (reprint author), Mayekawa Mfg Co Ltd, 2000 Tatsuzawa, Moriya City, Ibaraki 3020118, Japan.						Alexiades V, 1992, MATH MODELING MELTIN; Ohira K, 2011, CRYOGENICS, V51, P563, DOI 10.1016/j.cryogenics.2011.07.008; Ohira K, 2012, CRYOGENICS, V52, P428, DOI 10.1016/j.cryogenics.2012.04.006; [Anonymous], 1999, GASPAK V3 32; FUJII T, 1970, INT J HEAT MASS TRAN, V13, P753, DOI 10.1016/0017-9310(70)90125-0; Matsuo K, 2006, AIP CONF PROC, V823, P1033; Fuchino S., 2009, 5133 NAT CONV REC IE; Gebhart B., 1970, HEAT TRANSFER; Globe S, 1959, T AM SOC MECH ENGR C, V81, P24; Haberbusch MS, 1996, COMP CONTINUOUS FREE, P10732; Holman JP, 1981, HEAT TRANSFER; Ikeuchi M, 2007, TEION KOGAKU, V42, P96, DOI 10.2221/jcsj.42.96; Metais B, 1964, T ASME J HEAT TRANSF, V86, P295; Momotari H, 2009, 5135 NAT CONV REC IE; Press WH, 1994, NUMERICAL RECIPES C; Schwenterly B, 2010, DOE PEER REV JUN 30; Takakoshi T, 2006, ADV CRYOGEN ENG, V51, P1025; Uryu T, 2009, 5134 NAT CONV REC IE	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0011-2275	1879-2235		CRYOGENICS	Cryogenics	OCT	2015	71						76	81		10.1016/j.cryagenics.2015.05.008		6	Thermodynamics; Physics, Applied	Thermodynamics; Physics	CS5QE	WOS:000362132200010		
J	Aoki, I; Mori, I				Aoki, Ichiro; Mori, Ikue			Molecular biology of thermosensory transduction in C. elegans	CURRENT OPINION IN NEUROBIOLOGY			English	Article							NUCLEOTIDE-GATED CHANNEL; NEMATODE CAENORHABDITIS-ELEGANS; TRP CHANNELS; THERMOTACTIC BEHAVIOR; OLFACTORY NEURON; SENSORY NEURONS; AFD NEURON; TEMPERATURE; PLASTICITY; PATHWAY	As the environmental temperature prominently influences diverse biological aspects of the animals, thermosensation and the subsequent information processing in the nervous system has attracted much attention in biology. Thermotaxis in the nematode Caenorhabditis elegans is an ideal behavioral paradigm by which to address the molecular mechanism underlying thermosensory transduction. Molecular genetic analysis in combination with other physiological and behavioral studies revealed that sensation of ambient temperature is mediated mainly by cyclic guanosine monophosphate (cGMP) signaling in thermosensory neurons. The information of the previously perceived temperature is also stored within the thermosensory neurons, and the consequence of the comparison between the past and the present temperature is conveyed to the downstream interneurons to further regulate the motor-circuits that encode the locomotion.	[Aoki, Ichiro; Mori, Ikue] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Grp Mol Neurobiol, Nagoya, Aichi 4648602, Japan	Mori, I (reprint author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Grp Mol Neurobiol, Nagoya, Aichi 4648602, Japan.	m46920a@nucc.cc.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22123010]	IM is a Scholar of Institute for Advanced Research in Nagoya University. This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas 'Neural Diversity and Neocortical Organization' (Grant number 22123010), the Strategic Research Program for Brain Sciences 'Bioinformatics for Brain Sciences' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Murayama T, 2013, CURR BIOL, V23, P1007, DOI 10.1016/j.cub.2013.04.052; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Conti B, 2008, CELL MOL LIFE SCI, V65, P1626, DOI 10.1007/s00018-008-7536-1; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Xiong WH, 1998, NAT NEUROSCI, V1, P359; Luo LJ, 2014, P NATL ACAD SCI USA, V111, P2776, DOI 10.1073/pnas.1315205111; Wang D, 2013, J GEN PHYSIOL, V142, P437, DOI 10.1085/jgp.201310959; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Smith HK, 2013, GENETICS, V194, P885, DOI 10.1534/genetics.113.152660; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Nishida Y, 2011, EMBO REP, V12, P855, DOI 10.1038/embor.2011.120; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Morgan A, 2005, BIOCHEM SOC T, V33, P1341; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Narayan A, 2011, P NATL ACAD SCI USA, V108, P9667, DOI 10.1073/pnas.1106617108; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; Sugi T, 2011, NAT NEUROSCI, V14, P984, DOI 10.1038/nn.2854; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Wasserman SM, 2011, CURR BIOL, V21, P353, DOI 10.1016/j.cub.2011.01.053; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Satterlee JS, 2004, CURR BIOL, V14, P62, DOI 10.1016/j.cub.2003.12.030; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Samuel ADT, 2003, J NEUROSCI, V23, P373; Edwards MR, 2012, J NEUROSCI, V32, P7042, DOI 10.1523/JNEUROSCI.4029-11.2012; Oda S, 2011, J NEUROPHYSIOL, V106, P301, DOI 10.1152/jn.01029.2010; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Glauser DA, 2011, GENETICS, V188, P91, DOI 10.1534/genetics.111.127100; Chao Y, 2014, EMBO J; Kuhara A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1352; Liu S, 2012, PLOS ONE, P7; Ohta A, 2014, NAT COMMUN, V5; Russell J, 2014, P NATL ACAD SCI US; Savory FR, 2011, PLOS ONE; Schild LC, 2014, NEURON; WHITE JG, 1986, PHILOS T ROY SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu YV, 2014, NEURON	56	0	1	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-4388	1873-6882		CURR OPIN NEUROBIOL	Curr. Opin. Neurobiol.	OCT	2015	34						117	124		10.1016/j.conb.2015.03.011		8	Neurosciences	Neurosciences & Neurology	CS5SU	WOS:000362139300018		
J	Weitzel, T; Sugiyama, H; Yamasaki, H; Ramirez, C; Rosas, R; Mercado, R				Weitzel, Thomas; Sugiyama, Hiromu; Yamasaki, Hiroshi; Ramirez, Cristian; Rosas, Reinaldo; Mercado, Ruben			Human Infections with Pseudoterranova cattani Nematodes, Chile	EMERGING INFECTIOUS DISEASES			English	Letter							ANISAKIDAE; ASCARIDOIDEA; PARASITE; COMPLEX		[Weitzel, Thomas; Rosas, Reinaldo] Clin Alemana Univ Desarrollo, Santiago, Chile; [Sugiyama, Hiromu; Yamasaki, Hiroshi] Natl Inst Infect Dis, Tokyo, Japan; [Ramirez, Cristian] Univ Mayor, Santiago, Chile; [Mercado, Ruben] Univ Chile, Santiago 7, Chile	Mercado, R (reprint author), Univ Chile, Fac Med, Unidad Docente Parasitol, Av Palmeras 299,Parque Quinta Normal, Santiago 7, Chile.	rmercado@med.uchile.cl		Weitzel, Thomas/0000-0002-9804-2123			Torres P, 2007, J PARASITOL, V93, P440, DOI 10.1645/GE-946R.1; Chai JY, 2005, INT J PARASITOL, V35, P1233, DOI 10.1016/j.ijpara.2005.07.013; Mattiucci S, 2014, J PARASITOL, V100, P199, DOI 10.1645/12-120.1; Arizono N, 2011, EMERG INFECT DIS, V17, P555, DOI 10.3201/eid1703.101350; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; Hochberg NS, 2010, CLIN INFECT DIS, V51, P806, DOI 10.1086/656238; Zhu XQ, 2002, PARASITOLOGY, V124, P615, DOI 10.1017/S0031182002001579; SAKANARI JA, 1989, CLIN MICROBIOL REV, V2, P278; George-Nascimento M, 2000, REV CHIL HIST NAT, V73, P93; Jofre L, 2008, REV CHIL INFECTOL, V25, P200, DOI [/S0716-10182008000300010, 10.4067/S0716-10182008000300010]	10	0	0	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1080-6040	1080-6059		EMERG INFECT DIS	Emerg. Infect. Dis	OCT	2015	21	10					1874	1875		10.3201/eid2110.141848		2	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CS5ZY	WOS:000362158000032		
J	Grandjean, P; Barouki, R; Bellinger, DC; Casteleyn, L; Chadwick, LH; Cordier, S; Etzel, RA; Gray, KA; Ha, EH; Junien, C; Karagas, M; Kawamoto, T; Lawrence, BP; Perera, FP; Prins, GS; Puga, A; Rosenfeld, CS; Sherr, DH; Sly, PD; Suk, W; Sun, Q; Toppari, J; van den Hazel, P; Walker, CL; Heindel, JJ				Grandjean, Philippe; Barouki, Robert; Bellinger, David C.; Casteleyn, Ludwine; Chadwick, Lisa H.; Cordier, Sylvaine; Etzel, Ruth A.; Gray, Kimberly A.; Ha, Eun-Hee; Junien, Claudine; Karagas, Margaret; Kawamoto, Toshihiro; Lawrence, B. Paige; Perera, Frederica P.; Prins, Gail S.; Puga, Alvaro; Rosenfeld, Cheryl S.; Sherr, David H.; Sly, Peter D.; Suk, William; Sun, Qi; Toppari, Jorma; van den Hazel, Peter; Walker, Cheryl L.; Heindel, Jerrold J.			Life-Long Implications of Developmental Exposure to Environmental Stressors: New Perspectives	ENDOCRINOLOGY			English	Article							EPIGENETIC TRANSGENERATIONAL INHERITANCE; HEALTH; ORIGINS; RISK; ESTROGENS; CHEMICALS	The Developmental Origins of Health and Disease (DOHaD) paradigm is one of the most rapidly expanding areas of biomedical research. Environmental stressors that can impact on DOHaD encompass a variety of environmental and occupational hazards as well as deficiency and oversupply of nutrients and energy. They can disrupt early developmental processes and lead to increased susceptibility to disease/dysfunctions later in life. Presentations at the fourth Conference on Prenatal Programming and Toxicity in Boston, in October 2014, provided important insights and led to new recommendations for research and public health action. The conference highlighted vulnerable exposure windows that can occur as early as the preconception period and epigenetics as a major mechanism than can lead to disadvantageous "reprogramming" of the genome, thereby potentially resulting in transgenerational effects. Stem cells can also be targets of environmental stressors, thus paving another way for effects that may last a lifetime. Current testing paradigms do not allow proper characterization of risk factors and their interactions. Thus, relevant exposure levels and combinations for testing must be identified from human exposure situations and outcome assessments. Testing of potential underpinning mechanisms and biomarker development require laboratory animal models and in vitro approaches. Only few large-scale birth cohorts exist, and collaboration between birth cohorts on a global scale should be facilitated. DOHaD-based research has a crucial role in establishing factors leading to detrimental outcomes and developing early preventative/remediation strategies to combat these risks.	[Grandjean, Philippe; Bellinger, David C.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Sun, Qi] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Grandjean, Philippe] Univ Southern Denmark, Inst Publ Hlth, Dept Environm Med, DK-5000 Odense, Denmark; [Barouki, Robert] Univ Paris 05, Hop Necker Enfants Malad, AP HP, INSERM Unit 1124, F-75015 Paris, France; [Casteleyn, Ludwine] Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Chadwick, Lisa H.; Gray, Kimberly A.; Suk, William; Heindel, Jerrold J.] NIEHS, Div Extramural Res & Training, Res Triangle Pk, NC 27709 USA; [Cordier, Sylvaine] Univ Rennes 1, INSERM, Unit 1085, F-35000 Rennes, France; [Etzel, Ruth A.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Ha, Eun-Hee] Ewha Womans Univ, Sch Med, Dept Prevent Med, Seoul 158710, South Korea; [Junien, Claudine] INRA, MR Unite Mixte Rech Biol Dev & Reprod 1198, F-78350 Jouy En Josas, France; [Junien, Claudine] Univ Versailles St Quentin, F-78000 Versailles, France; [Karagas, Margaret] Geisel Sch Med Dartmouth, Childrens Environm Hlth & Dis Prevent Res Ctr, Hanover, NH 03766 USA; [Karagas, Margaret] Geisel Sch Med Dartmouth, Dept Epidemiol, Hanover, NH 03766 USA; Univ Occupat & Environm Hlth, Dept Environm Hlth, Kitakyushu, Fukuoka 8078555, Japan; [Lawrence, B. Paige] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA; [Perera, Frederica P.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA; [Perera, Frederica P.] Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY 10032 USA; [Prins, Gail S.] Univ Illinois, Dept Urol, Chicago, IL 60612 USA; [Puga, Alvaro] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Rosenfeld, Cheryl S.] Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Bond Life Sci Ctr, Genet Area Program,Biomed Sci, Columbia, MO 65211 USA; [Sherr, David H.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Sly, Peter D.] Univ Queensland, Royal Childrens Hosp, Queensland Childrens Med Res Inst, Brisbane, Qld 4006, Australia; [Toppari, Jorma] Univ Turku, Dept Physiol, Turku 20014, Finland; [Toppari, Jorma] Univ Turku, Dept Pediat, Turku 20014, Finland; [Toppari, Jorma] Turku Univ Hosp, Turku 20014, Finland; [van den Hazel, Peter] Int Network Childrens Hlth Environm & Safety, NL-6955 Ellecom, Netherlands; [Walker, Cheryl L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Grandjean, P (reprint author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr 3E-110,401 Pk Dr, Boston, MA 02115 USA.	pgrand@hsph.harvard.edu	Cordier, Sylvaine/F-7919-2013		European Commission; National Institute of Environmental Health Sciences (NIEHS/National Institutes of Health); United States Environmental Protection Agency; Boston University Superfund Research Program; Geisel School of Medicine at Dartmouth; Harvard T.H. Chan School of Public Health; International Network on Children's Health, Environment and Safety; International Society for Children's Health and the Environment; International Society for Environmental Epidemiology; World Health Organization	The PPTOX IV conference was supported by the European Commission, the National Institute of Environmental Health Sciences (NIEHS/National Institutes of Health), the United States Environmental Protection Agency, the Boston University Superfund Research Program, Geisel School of Medicine at Dartmouth, and Harvard T.H. Chan School of Public Health.; The PPTOX IV conference was sponsored by the International Network on Children's Health, Environment and Safety, the International Society for Children's Health and the Environment, the International Society for Environmental Epidemiology, and the World Health Organization.	Somers EC, 2014, LUPUS, V23, P568, DOI 10.1177/0961203313499419; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Szyf M, 2013, J GENET GENOMICS, V40, P331, DOI 10.1016/j.jgg.2013.06.004; Greathouse KL, 2012, MOL CANCER RES, V10, P546, DOI 10.1158/1541-7786.MCR-11-0605; Rippey C, 2013, AM J HUM GENET, V93, P697, DOI 10.1016/j.ajhg.2013.09.004; DeWitt JC, 2012, TOXICOL PATHOL, V40, P230, DOI 10.1177/0192623311427709; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Lioy PJ, 2011, ENVIRON HEALTH PERSP, V119, pA466, DOI 10.1289/ehp.1104387; Patel CJ, 2013, HUM GENET, V132, P495, DOI 10.1007/s00439-012-1258-z; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Stel J, 2015, ENDOCRINOLOGY, V156, P3466, DOI 10.1210/en.2015-1434; Mitchell C, 2014, P NATL ACAD SCI USA, V111, P5944, DOI 10.1073/pnas.1404293111; Heindel JJ, 2015, ENDOCRINOLOGY, V156, P3416, DOI 10.1210/EN.2015-1394; Schug TT, 2013, TOXICOL SCI, V131, P343, DOI 10.1093/toxsci/kfs267; Hu WY, 2012, MOL CELL ENDOCRINOL, V354, P63, DOI 10.1016/j.mce.2011.08.032; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Barrett ES, 2015, ENDOCRINOLOGY, V156, P3435, DOI 10.1210/en.2015-1335; Birnbaum LS, 2015, ENDOCRINOLOGY, V156, P3405, DOI 10.1210/en.2015-1458; Brisken C, 2015, ENDOCRINOLOGY, V156, P3442, DOI 10.1210/en.2015-1392; Broen JCA, 2014, NAT REV RHEUMATOL, V10, P671, DOI 10.1038/nrrheum.2014.128; Cao-Lei L, 2015, Transl Psychiatry, V5, pe515, DOI 10.1038/tp.2015.13; Fullston T, 2015, PHYSL REP, P3; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Knower KC, 2014, ENDOCR-RELAT CANCER, V21, pT33, DOI 10.1530/ERC-13-0513; Laiosa MD, 2015, ENDOCRINOLOGY, V156, P3458, DOI 10.1210/en.2015-1347; Prins GS, 2015, ENDOCRINOLOGY, V156, P3451, DOI 10.1210/en.2015-1357; Rosenfeld CS, 2015, ENDOCRINOLOGY, V156, P3422, DOI 10.1210/en.2015-1227; Skinner MK, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0153-y; Suades-Gonzalez E, 2015, ENDOCRINOLOGY, V156, P3473, DOI 10.1210/en.2015-1403; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401	31	1	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2015	156	10					3408	3415		10.1210/EN.2015-1350		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CS7AG	WOS:000362235300003		
J	Shimoda, Y; Okada, S; Yamada, E; Pessin, JE; Yamada, M				Shimoda, Yoko; Okada, Shuichi; Yamada, Eijiro; Pessin, Jeffrey E.; Yamada, Masanobu			Tctex1d2 Is a Negative Regulator of GLUT4 Translocation and Glucose Uptake	ENDOCRINOLOGY			English	Article							DYNEIN LIGHT-CHAIN; 3T3L1 ADIPOCYTES; INSULIN; PHOSPHORYLATION; MUNC18C; PROTEIN; SYNIP	Tctex1d2 (Tctex1 domain containing 2) is an open reading frame that encodes for a functionally unknown protein that contains a Tctex1 domain found in dynein light chain family members. Examination of gene expression during adipogenesis demonstrated a marked increase in Tctex1d2 protein expression that was essentially undetectable in preadipocytes and markedly induced during 3T3-L1 adipocyte differentiation. Tctex1d2 overexpression significantly inhibited insulin-stimulated glucose transporter 4 (GLUT4) translocation and 2-deoxyglucose uptake. In contrast, Tctex1d2 knockdown significantly increased insulin-stimulated GLUT4 translocation and 2-deoxyglucose uptake. However, acute insulin stimulation (up to 30 min) in 3T3-L1 adipocytes with overexpression or knockdown of Tctex1d2 had no effect on Akt phosphorylation, a critical signal transduction target required for GLUT4 translocation. Although overexpression of Tctex1d2 had no significant effect on GLUT4 internalization, Tctex1d2 was found to associate with syntaxin 4 in an insulin-dependent manner and inhibit Doc2b binding to syntaxin 4. In addition, glucose-dependent insulinotropic polypeptide rescued the Tctex1d2 inhibition of insulin-stimulated GLUT4 translocation by suppressing the Tctex1d2-syntaxin 4 interaction and increasing Doc2b-Synatxin4 interactions. Taking these results together, we hypothesized that Tctex1d2 is a novel syntaxin 4 binding protein that functions as a negative regulator of GLUT4 plasma membrane translocation through inhibition of the Doc2b-syntaxin 4 interaction.	[Shimoda, Yoko; Okada, Shuichi; Yamada, Eijiro; Yamada, Masanobu] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma 3718511, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Okada, S (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, 3-39-15 Showa Machi, Maebashi, Gumma 3718511, Japan.	okadash@gunma-u.ac.jp					Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Fukuda N, 2009, DIABETES, V58, P377, DOI 10.2337/db08-0303; Freitas MJ, 2014, OMICS, V18, P242, DOI 10.1089/omi.2013.0133; Yamada E, 2014, ENDOCR J, V61, P523; Mohammad S, 2011, J BIOL CHEM, V286, P43062, DOI 10.1074/jbc.M111.289009; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Kao AMW, 2000, AM J PHYSIOL-ENDOC M, V278, pE825; Umahara M, 2008, ENDOCRINOLOGY, V149, P40, DOI 10.1210/en.2006-1549; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Asante D, 2014, J CELL SCI, V127, P4774, DOI 10.1242/jcs.159038; Govers R, 2014, DIABETES METAB, V40, P400, DOI 10.1016/j.diabet.2014.01.005; Grusovin J, 2003, FRONT BIOSCI, V8, P620; Okada Shuichi, 2003, Methods Mol Med, V83, P93; Ramalingam L, 2014, TRENDS ENDOCRIN MET, V25, P601, DOI 10.1016/j.tem.2014.06.010	18	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2015	156	10					3548	3558		10.1210/en.2015-1120		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CS7AG	WOS:000362235300023		
J	Nomoto, H; Kondo, T; Miyoshi, H; Nakamura, A; Hida, Y; Yamashita, K; Sharma, AJ; Atsumi, T				Nomoto, Hiroshi; Kondo, Takuma; Miyoshi, Hideaki; Nakamura, Akinobu; Hida, Yoko; Yamashita, Ken-ichiro; Sharma, Arun J.; Atsumi, Tatsuya			Inhibition of Small Maf Function in Pancreatic beta-Cells Improves Glucose Tolerance Through the Enhancement of Insulin Gene Transcription and Insulin Secretion	ENDOCRINOLOGY			English	Article							MOLECULE GLUCOKINASE ACTIVATOR; CHRONIC EXPOSURE; TRANSGENIC MICE; EXPRESSION; PROTEINS; RIPE3B1; BINDING; DIFFERENTIATION; PROLIFERATION; HETERODIMER	The large-Maf transcription factor v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA) has been found to be crucial for insulin transcription and synthesis and for pancreatic beta-cell function and maturation. However, insights about the effects of small Maf factors on beta-cells are limited. Our goal was to elucidate the function of small-Maf factors on beta-cells using an animal model of endogenous small-Maf dysfunction. Transgenic (Tg) mice with beta-cell-specific expression of dominant-negative MafK (DN-MafK) experiments, which can suppress the function of all endogenous small-Mafs, were fed a high-fat diet, and their in vivo phenotypes were evaluated. Phenotypic analysis, glucose tolerance tests, morphologic examination of beta-cells, and islet experiments were performed. DN-MafK-expressed MIN6 cells were also used for in vitro analysis. The results showed that DN-MafK expression inhibited endogenous small-Maf binding to insulin promoter while increasing MafA binding. DN-MafK Tg mice under high-fat diet conditions showed improved glucose metabolism compared with control mice via incremental insulin secretion, without causing changes in insulin sensitivity or MafA expression. Moreover, up-regulation of insulin and glucokinase gene expression was observed both in vivo and in vitro under DN-MafK expression. We concluded that endogenous small-Maf factors negatively regulates beta-cell function by competing for MafA binding, and thus, the inhibition of small-Maf activity can improve beta-cell function.	[Nomoto, Hiroshi; Kondo, Takuma; Miyoshi, Hideaki; Nakamura, Akinobu; Hida, Yoko; Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido 0608638, Japan; [Yamashita, Ken-ichiro] Hokkaido Univ, Grad Sch Med, Dept Transplant Surg, Sapporo, Hokkaido 0608638, Japan; [Sharma, Arun J.] Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, Boston, MA 02215 USA; [Sharma, Arun J.] MedImmune LLC, Gaithersburg, MD 20878 USA	Kondo, T (reprint author), Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	takkondo@med.hokudai.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, Technology Foundation; Suzuken Memorial Foundation; National Institutes of Health [RO1 DK60127]	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, Technology Foundation and the Suzuken Memorial Foundation (H.M.) and by the National Institutes of Health Grant RO1 DK60127 (to A.J.S.).	Moates JM, 2003, DIABETES, V52, P403; Nakamura A, 2012, DIABETOLOGIA, V55, P1745, DOI 10.1007/s00125-012-2521-5; Kumaki I, 2006, LIFE SCI, V78, P1760, DOI 10.1016/j.lfs.2005.08.030; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; Kim JW, 2009, ENDOCRINOLOGY, V150, P4074, DOI 10.1210/en.2009-0241; OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596; Ferre T, 1996, FASEB J, V10, P1213; Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Shimokawa N, 2000, MOL CELL BIOCHEM, V203, P135, DOI 10.1023/A:1007017902194; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Toki T, 1997, ONCOGENE, V14, P1901, DOI 10.1038/sj.onc.1201024; Panakanti R, 2009, MOL PHARMACEUT, V6, P274, DOI 10.1021/mp800183b; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Shimohata H, 2009, BIOCHEM BIOPH RES CO, V389, P235, DOI 10.1016/j.bbrc.2009.08.124; Shimohata H, 2006, BIOCHEM BIOPH RES CO, V346, P671, DOI 10.1016/j.bbrc.2006.05.184; Shimokawa N, 2005, J CELL PHYSIOL, V205, P77, DOI 10.1002/jcp.20369; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Nakamura A, 2009, ENDOCRINOLOGY, V150, P1147, DOI 10.1210/en.2008-1183; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; Poitout V, 1996, J CLIN INVEST, V97, P1041, DOI 10.1172/JCI118496; Hino S, 2004, DIABETOLOGIA, V47, P1819, DOI 10.1007/s00125-004-1522-4; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Watanabe M, 2013, TRANSPLANTATION, V96, P454, DOI 10.1097/TP.0b013e31829b077f	33	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2015	156	10					3570	3580		10.1210/en.2014-1906		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CS7AG	WOS:000362235300025		
J	Tamaki, M; Hagiwara, A; Miyashita, K; Wakino, S; Inoue, H; Fujii, K; Fujii, C; Sato, M; Mitsuishi, M; Muraki, A; Hayashi, K; Doi, T; Itoh, H				Tamaki, Masanori; Hagiwara, Aika; Miyashita, Kazutoshi; Wakino, Shu; Inoue, Hiroyuki; Fujii, Kentaro; Fujii, Chikako; Sato, Masaaki; Mitsuishi, Masanori; Muraki, Ayako; Hayashi, Koichi; Doi, Toshio; Itoh, Hiroshi			Improvement of Physical Decline Through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6Nx CKD Model Mice	ENDOCRINOLOGY			English	Article							DES-ACYL GHRELIN; CHRONIC KIDNEY-DISEASE; HUMAN SKELETAL-MUSCLE; CORONARY-HEART-DISEASE; GROWTH-FACTOR-I; EXERCISE ENDURANCE; DIETARY-PROTEIN; GHS-R; MEN; TISSUE	Because a physical decline correlates with an increased risk of a wide range of disease and morbidity, an improvement of physical performance is expected to bring significant clinical benefits. The primary cause of physical decline in 5/6 nephrectomized (5/6Nx) chronic kidney disease model mice has been regarded as a decrease in muscle mass; however, our recent study showed that a decrease in muscle mitochondria plays a critical role. In the present study, we examined the effects of a gastric hormone ghrelin, which has been reported to promote muscle mitochondrial oxidation, on the physical decline in the chronic kidney disease model mice, focusing on the epigenetic modulations of a mitochondrial activator gene, peroxisome proliferator- activated receptor-gamma coactivator-1 alpha (PGC-1 alpha). Ghrelin treatment improved a decline in exercise endurance of 5/6Nx mice, associated with an increase in both of the muscle mass and mitochondrial amount. The expression level of PGC-1 alpha was decreased in the skeletal muscle of 5/6Nx mice, which was associated with an increase in the methylation ratio of the cytosine residue at 260 base pairs upstream of the initiation point. Conversely, ghrelin treatment demethylated the cytosine residue and increased the expression of PGC-1 alpha. A representative muscle anabolic factor, IGF-1, did not affect the expression of PGC-1 alpha and muscle mitochondrial amount, although it increased muscle mass. As a result, IGF-1 treatment in 5/6Nx mice did not increase the decreased exercise endurance as effectively as ghrelin treatment did. These findings indicate an advantage of ghrelin treatment for a recovery of physical decline.	[Tamaki, Masanori; Hagiwara, Aika; Miyashita, Kazutoshi; Wakino, Shu; Inoue, Hiroyuki; Fujii, Kentaro; Fujii, Chikako; Sato, Masaaki; Mitsuishi, Masanori; Muraki, Ayako; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Tamaki, Masanori; Doi, Toshio] Tokushima Univ Hosp, Dept Nephrol, Tokushima 7708503, Japan	Miyashita, K (reprint author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	miyakaz@z6.keio.jp			Japan Society for the Promotion of Science [26860644, 26460920]	This work was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science 26860644 (for M.T.) and 26460920 (for K.M.).	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; DeBoer MD, 2008, ENDOCRINOLOGY, V149, P827, DOI 10.1210/en.2007-1046; SUTER E, 1995, INT J SPORTS MED, V16, P160, DOI 10.1055/s-2007-972985; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P345, DOI 10.1046/j.1365-201X.1997.00222.x; Donath MY, 1996, J CLIN ENDOCR METAB, V81, P4089, DOI 10.1210/jc.81.11.4089; Mitsuishi M, 2013, AM J PHYSIOL-ENDOC M, V305, pE776, DOI 10.1152/ajpendo.00145.2013; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; Gershon E, 2014, OBESITY, V22, P380, DOI 10.1002/oby.20535; SLATTERY ML, 1988, AM J EPIDEMIOL, V127, P571; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Tamaki M, 2014, KIDNEY INT, V85, P1330, DOI 10.1038/ki.2013.473; Barazzoni R, 2010, KIDNEY INT, V77, P23, DOI 10.1038/ki.2009.411; Koshinaka K, 2011, BIOCHEM BIOPH RES CO, V412, P296, DOI 10.1016/j.bbrc.2011.07.086; Sheriff S, 2012, MOL CELL ENDOCRINOL, V351, P286, DOI 10.1016/j.mce.2011.12.021; Porporato PE, 2013, J CLIN INVEST, V123, P611, DOI 10.1172/JCI39920; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P335; Heppner KM, 2014, DIABETES, V63, P122, DOI 10.2337/db13-0414; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Sugiyama M, 2012, REGUL PEPTIDES, V178, P21, DOI 10.1016/j.regpep.2012.06.003; Tureckova J, 2001, J BIOL CHEM, V276, P39264, DOI 10.1074/jbc.M104991200; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JC1200421134; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Remels AHV, 2010, FASEB J, V24, P5052, DOI 10.1096/fj.09-150714; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Yamamoto D, 2008, LIFE SCI, V82, P460, DOI 10.1016/j.lfs.2007.11.019; Adams GR, 1998, J APPL PHYSIOL, V84, P1716; Barazzoni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026224; Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Riddoch-Contreras J, 2009, EXP NEUROL, V215, P281, DOI 10.1016/j.expneurol.2008.10.014; Sakata I, 2010, INT J PEPT, V2010, DOI [DOI 10.1155/2010/945056, 10.1155/2010/945056]; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290	43	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2015	156	10					3638	3648		10.1210/en.2015-1353		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CS7AG	WOS:000362235300030		
J	Tang, LJ; Okamoto, S; Shiuchi, T; Toda, C; Takagi, K; Sato, T; Saito, K; Yokota, S; Minokoshi, Y				Tang, Lijun; Okamoto, Shiki; Shiuchi, Tetsuya; Toda, Chitoku; Takagi, Kazuyo; Sato, Tatsuya; Saito, Kumiko; Yokota, Shigefumi; Minokoshi, Yasuhiko			Sympathetic Nerve Activity Maintains an Anti-Inflammatory State in Adipose Tissue in Male Mice by Inhibiting TNF-alpha Gene Expression in Macrophages	ENDOCRINOLOGY			English	Article							DIET-INDUCED THERMOGENESIS; ACTIVATED PROTEIN-KINASE; AGOUTI-RELATED PROTEIN; INSULIN-RESISTANCE; NEUROPEPTIDE-Y; BROWN ADIPOCYTES; LIPID-METABOLISM; IN-VITRO; KAPPA-B; OBESITY	Adipose tissue macrophages (ATMs) play an important role in the inflammatory response in obese animals. How ATMs are regulated in lean animals has remained elusive, however. We now show that the sympathetic nervous system (SNS) is necessary to maintain the abundance of the mRNA for the proinflammatory cytokine TNF-alpha at a low level in ATMs of lean mice. Intracerebroventricular injection of agouti-related neuropeptide increased the amount of TNF-alpha mRNA in epididymal (epi) white adipose tissue (WAT), but not in interscapular brown adipose tissue (BAT), through inhibition of sympathetic nerve activity in epiWAT. The surgical denervation and beta-adrenergic antagonist propranolol up-regulated TNF-alpha mRNA in both epiWAT and BAT in vivo. Signaling by the beta(2)-adrenergic receptor (AR) and protein kinase A down-regulated TNF-alpha mRNA in epiWAT explants and suppressed lipopolysaccharide-induced up-regulation of TNF-alpha mRNA in the stromal vascular fraction of this tissue. beta-AR-deficient (beta-less) mice manifested an increased plasma TNF-alpha concentration and increased TNF-alpha mRNA abundance in epiWAT and BAT. TNF-alpha mRNA abundance was greater in ATMs (CD11b(+) cells of the stromal vascular fraction) from epiWAT or BAT of wild-type mice than in corresponding CD11b(+) cells, and beta(2)-AR mRNA abundance was greater in ATMs than in CD11b(+) cells of epiWAT. Our results show that the SNS and beta(2)-AR-protein kinase A pathway maintain an anti-inflammatory state in ATMs of lean mice in vivo, and that the brain melanocortin pathway plays a role in maintaining this state in WAT of lean mice via the SNS.	[Tang, Lijun; Okamoto, Shiki; Takagi, Kazuyo; Sato, Tatsuya; Saito, Kumiko; Yokota, Shigefumi; Minokoshi, Yasuhiko] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Okamoto, Shiki; Shiuchi, Tetsuya; Minokoshi, Yasuhiko] Grad Univ Adv Studies, Sokendai, Dept Physiol Sci, Hayama, Kanagawa 2400193, Japan; [Shiuchi, Tetsuya] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Integrat Physiol, Tokushima, Tokushima 7708503, Japan; [Toda, Chitoku] Yale Univ, Sch Med, New Haven, CT 06520 USA	Minokoshi, Y (reprint author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Endocrinol & Metab, Dept Dev Physiol, 38 Nishigonaka Myodaiji, Okazaki, Aichi 4448585, Japan.	minokosh@nips.ac.jp			Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22126005, 25126728]; Specific Research Fund of the National Institutes of Natural Sciences;  [21390067];  [24390058];  [20790656];  [22790875];  [23790282]	This work was supported by Grants-in-Aid for Scientific Research (B) 21390067 and 24390058 (to Y.M.), Grants-in-Aid for Young Scientists (B) 20790656 and 22790875 (to S.O.) and 23790282 (to C.T.), the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (Y.M.), and a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Basis and Disorders of Control of Appetite and Fat Accumulation" 22126005 (to Y.M.) and 25126728 (to S.O.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, as well as by The Specific Research Fund of the National Institutes of Natural Sciences (Y.M.).	Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Mory G, 2001, INT J OBESITY, V25, P1592, DOI 10.1038/sj.ijo.0801811; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Rayner DV, 2001, P NUTR SOC, V60, P357; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; CORRELL JW, 1963, SCIENCE, V140, P387, DOI 10.1126/science.140.3565.387; GEPPERT TD, 1994, MOL MED, V1, P93; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Shrestha YB, 2010, AM J PHYSIOL-REG I, V299, pR140, DOI 10.1152/ajpregu.00535.2009; MINOKOSHI Y, 1988, J PHYSIOL-LONDON, V398, P361; Carter AB, 1999, AM J RESP CELL MOL, V20, P751; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JC131743; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Swantek JL, 1997, MOL CELL BIOL, V17, P6274; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Ellacott KLJ, 2007, ENDOCRINOLOGY, V148, P6186, DOI 10.1210/en.2007-0699; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Trevaskis JL, 2007, OBESITY, V15, P2664, DOI 10.1038/oby.2007.318; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Hahn TM, 1998, NAT NEUROSCI, V1, P271; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Fujimoto W, 2007, P NATL ACAD SCI USA, V104, P15514, DOI 10.1073/pnas.0707328104; Ishii T, 2007, BRAIN RES, V1144, P91, DOI 10.1016/j.brainres.2007.01.086; Valladares A, 2001, FEBS LETT, V493, P6, DOI 10.1016/S0014-5793(01)02264-5; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; SEVERN A, 1992, J IMMUNOL, V148, P3441; EGAWA M, 1991, AM J PHYSIOL, V260, pR328; Khoo JC, 1972, BIOCHEM BIOPH RES CO, V4, P407; MINOKOSHI Y, 1986, AM J PHYSIOL, V251, P1005; Perez DM, 2006, ADRENERGIC RECEPTORS; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Zhang W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-27	49	1	1	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2015	156	10					3680	3694		10.1210/EN.2015-1096		15	Endocrinology & Metabolism	Endocrinology & Metabolism	CS7AG	WOS:000362235300034		
J	Hsu, CF; Lee, TT; Tanaka, K				Hsu, Chun-Fei; Lee, Tsu-Tian; Tanaka, Kazuo			Intelligent nonsingular terminal sliding-mode control via perturbed fuzzy neural network	ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE			English	Article						Intelligent control; Sliding-mode control; Fuzzy neural network; Perturbed membership function	NONLINEAR-SYSTEMS; ARTICULATION CONTROLLER; TRACKING PERFORMANCE; DESIGN; MANIPULATORS; CONVERTERS; MOTOR	In this paper, an intelligent nonsingular terminal sliding-mode control (INTSMC) system, which is composed of a terminal neural controller and a robust compensator, is proposed for an unknown nonlinear system. The terminal neural controller including a perturbed fuzzy neural network (PFNN) is the main controller and the robust compensator is designed to eliminate the effect of the approximation error introduced by the PFNN upon the system stability. The PFNN is used to approximate an unknown nonlinear term of the system dynamics and perturbed asymmetric membership functions are used to handle rule uncertainties when it is hard to exactly determine the grade of membership functions. In additional, Lyapunov stability theory is used to discuss the parameter learning and system stability of the INTSMC system. Finally, the proposed INTSMC system is applied to an inverted pendulum and a voice coil motor actuator. The simulation and experimental results show that the proposed INTSMC system can achieve favorable tracking performance and is robust against parameter variations in the plant. (C) 2015 Elsevier Ltd. All rights reserved.	[Hsu, Chun-Fei; Lee, Tsu-Tian] Tamkang Univ, Dept Elect Engn, New Taipei City 25137, Taiwan; [Tanaka, Kazuo] Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Tokyo, Japan	Hsu, CF (reprint author), Tamkang Univ, Dept Elect Engn, 151 Yingzhuan Rd, New Taipei City 25137, Taiwan.	fei@ee.tku.edu.tw; ttlee@ee.tku.edu.tw; ktanaka@mce.uec.ac.jp			Ministry of Science and Technology of Republic of China [MOST 103-2221-E-032-063-MY2]	The authors are grateful to the associate editor and the reviewers for their valuable comments. The authors appreciate the partial financial support from the Ministry of Science and Technology of Republic of China under Grant MOST 103-2221-E-032-063-MY2.	Na J, 2013, IEEE T NEUR NET LEAR, V24, P370, DOI 10.1109/TNNLS.2012.2225845; Kayacan E, 2012, IEEE T IND ELECTRON, V59, P3510, DOI 10.1109/TIE.2011.2182017; Lin CM, 2013, IEEE T FUZZY SYST, V21, P1044, DOI 10.1109/TFUZZ.2013.2241769; Abiyev RH, 2010, IEEE T IND ELECTRON, V57, P4147, DOI 10.1109/TIE.2010.2043036; Kayacan E, 2015, IEEE T IND ELECTRON, V62, P1716, DOI 10.1109/TIE.2014.2345353; Kim N, 2007, IEEE T NEURAL NETWOR, V18, P482, DOI 10.1109/TNN.2006.885120; Juang CF, 2013, IEEE T CYBERNETICS, V43, P1781, DOI 10.1109/TSMCB.2012.2230253; Yang J, 2013, AUTOMATICA, V49, P2287, DOI 10.1016/j.automatica.2013.03.026; Nayeripour M, 2011, APPL SOFT COMPUT, V11, P4766, DOI 10.1016/j.asoc.2011.07.006; Li SH, 2013, IEEE T IND INFORM, V9, P1879, DOI 10.1109/TII.2012.2226896; Tan CP, 2010, AUTOMATICA, V46, P1401, DOI 10.1016/j.automatica.2010.05.010; Zhao D, 2011, P I MECH ENG I-J SYS, V225, P1136, DOI 10.1177/0959651811401303; Lin FJ, 2013, IEEE T POWER ELECTR, V28, P3557, DOI 10.1109/TPEL.2012.2224888; Mon YJ, 2012, NEURAL COMPUT APPL, V21, P2163, DOI 10.1007/s00521-012-1098-8; Cheng KH, 2007, IEEE T IND ELECTRON, V54, P1528, DOI 10.1109/TIE.2007.894717; Lee LW, 2012, IET CONTROL THEORY A, V6, P1699, DOI 10.1049/iet-cta.2011.0434; Karakose M, 2010, IEEE SYS MAN CYBERN, P3628; Seok JK, 2012, IET ELECTR POWER APP, V6, P575, DOI 10.1049/iet-epa.2011.0237; Feng Y, 2013, AUTOMATICA, V49, P1715, DOI 10.1016/j.automatica.2013.01.051; Komurcugil H, 2013, CONTROL ENG PRACT, V21, P321, DOI 10.1016/j.conengprac.2012.11.006; Chen CH, 2010, NEURAL COMPUT APPL, V19, P1089, DOI 10.1007/s00521-010-0347-y; Chen CL, 2012, NONLINEAR DYNAM, V70, P2015, DOI 10.1007/s11071-012-0593-x; Yang J, 2014, IEEE T IND INFORM, V10, P604, DOI 10.1109/TII.2013.2279232; Wu S, 2014, IEEE-ASME T MECH, V19, P932, DOI 10.1109/TMECH.2013.2264218; Hsu CF, 2012, ENG APPL ARTIF INTEL, V25, P997, DOI 10.1016/j.engappai.2012.03.014; Castillo O, 2012, APPL SOFT COMPUT, V12, P1267, DOI 10.1016/j.asoc.2011.12.010; Juang CF, 2013, IEEE T FUZZY SYST, V21, P477, DOI 10.1109/TFUZZ.2012.2230179; Juang CF, 2014, IEEE T NEUR NET LEAR, V25, P216, DOI 10.1109/TNNLS.2013.2253799; Yu SH, 2005, AUTOMATICA, V41, P1957, DOI 10.1016/j.automatica.2005.07.001; Lin FJ, 2012, IEEE T FUZZY SYST, V20, P971, DOI 10.1109/TFUZZ.2012.2191412; Lou CW, 2012, ENG APPL ARTIF INTEL, V25, P1567, DOI 10.1016/j.engappai.2012.07.006; Chang YH, 2014, IEEE T CYBERNETICS, V44, P293, DOI 10.1109/TCYB.2013.2253548; Chen SY, 2011, IEEE T CONTR SYST T, V19, P636, DOI 10.1109/TCST.2010.2050484; Gennaro S. D., 2014, IEEE T IND ELECTRON, V61, P2678; Hsu CF, 2014, APPL SOFT COMPUT, V23, P355, DOI 10.1016/j.asoc.2014.06.008; Lin CK, 2006, IEEE T FUZZY SYST, V14, P849, DOI 10.1109/TFUZZ.2006.879982; Lin CM, 2015, IEEE T CONTR SYST T, V23, P693, DOI 10.1109/TCST.2014.2325897; Mendel J.M., 2001, UNCERTAIN RULE BASED; Wang L.-X., 1994, ADAPTIVE FUZZY SYSTE; Zhang X., 2014, IEEE T POWER ELECTR, V28, P1358	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0952-1976	1873-6769		ENG APPL ARTIF INTEL	Eng. Appl. Artif. Intell.	OCT	2015	45						339	349		10.1016/j.engappai.2015.07.014		11	Automation & Control Systems; Computer Science, Artificial Intelligence; Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Automation & Control Systems; Computer Science; Engineering	CS5PO	WOS:000362130500026		
J	Wakai, T; Machida, H; Yoshida, S; Yanagihara, S; Suzuki, R; Matsubara, M; Enuma, Y				Wakai, Takashi; Machida, Hideo; Yoshida, Shinji; Yanagihara, Seiji; Suzuki, Ryosuke; Matsubara, Masaaki; Enuma, Yasuhiro			Development of an unstable failure analysis procedure considering change of compliance at a crack part of SFR pipes	ENGINEERING FAILURE ANALYSIS			English	Article						Sodium-cooled fast reactor; Leak-before-break; Unstable failure; Secondary stress; Mod.9Cr-1Mo steel		This paper describes a failure analysis procedure used in Leak Before Break (LBB) assessment of large sodium pipes in Japan Sodium cooled Fast Reactor (JSFR) made of modified 9Cr-1Mo steel. Since the steel has small thermal expansion rate and excellent high temperature strength, a simplified piping layout can be achieved. However, the fracture toughness of the steel is relatively smaller than that of the austenitic stainless steel used for many former fast reactor (FR) pipes. For this reason, a sophisticated LBB assessment is required for the pipes made of modified 9Cr-1Mo steel. Since the internal pressure of the pipes of JSFR is small, the thermal load caused by thermal expansion is predominant. Supposing a through wall crack in such piping system, the stiffness of the crack part will decrease with crack extension. The rational failure analysis procedure, evaluating the loading conditions at a crack part considering change of compliance of the piping system with crack extension, was proposed. The loading conditions at a crack part are evaluated by a Finite Element Analysis (FEA) in which the stiffness of a cracked pipe is modeled (1), and critical crack size is estimated by the 2-parameter method (2). The stiffness of a crack part is evaluated using the critical crack size and loading condition (3), and the stiffness of the crack part is reflected into the FEA model (4). The critical crack size can be achieved reasonably by repeating from (1) to (4). Using some experimental results, the validity of the analysis procedure was verified. Finally, the critical crack size was calculated for designed JSFR pipes. It was clarified that the proposed procedure was much effective to loosen LBB conditions for JSFR piping system. For the verification of the method, calculated results were compared to some experimental results. (C) 2014 Elsevier Ltd. All rights reserved.	[Wakai, Takashi] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan; [Machida, Hideo; Yoshida, Shinji] TEPCO Syst Corp, Koto Ku, Tokyo 1350034, Japan; [Yanagihara, Seiji; Suzuki, Ryosuke; Matsubara, Masaaki] Gunma Univ, Kiryu, Gumma 3768515, Japan; [Enuma, Yasuhiro] Mitsubishi FBR Syst Inc, Shibuya Ku, Tokyo 1500001, Japan	Wakai, T (reprint author), Japan Atom Energy Agcy, 4002 Narita Cho, Oarai, Ibaraki 3111393, Japan.						Robertson A, 2005, INT J PRES VES PIP, V82, P407, DOI 10.1016/j.ijpvp.2004.09.005; Japan Atomic Energy Agency and ITOCHU Techno-Solutions Corporation, 2008, FINAS VER 19 US MAN; Matsubara M., 2003, P ICPVT 10, P481; Milne I, 1987, BACKGROUND VALIDATIO; RCC-MR Edition, 2002, PVP201025243 ASME; Wakai T., 2010, PVP201025243 ASME; Zahoor A., 1989, DUCTILE FRACTURE HDB, V1	7	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1350-6307	1873-1961		ENG FAIL ANAL	Eng. Fail. Anal.	OCT	2015	56						484	500		10.1016/j.engfailanal.2014.11.021		17	Engineering, Mechanical; Materials Science, Characterization & Testing	Engineering; Materials Science	CS1NF	WOS:000361832300048		
J	Wijewardana, NS; Kawamoto, K; Moldrup, P; Komatsu, T; Kurukulasuriya, LC; Priyankara, NH				Wijewardana, N. Senani; Kawamoto, Ken; Moldrup, Per; Komatsu, Toshiko; Kurukulasuriya, L. Chandana; Priyankara, Nadeej H.			Characterization of water repellency for hydrophobized grains with different geometries and sizes	ENVIRONMENTAL EARTH SCIENCES			English	Article						Water repellency; Hydrophobized grains; Capillary barrier cover system; Grain size	CAPILLARY BARRIER PERFORMANCE; CONTACT-ANGLE; DIVERSION CAPACITY; PARTICLE-SIZE; SANDY SOILS; COVER; WETTABILITY; FRACTIONS; SEVERITY; DESIGN	Capillary barrier cover systems (CBCSs) are useful and low-cost earthen cover systems for preventing water infiltration and controlling seepage at solid waste landfills. A possible technique to enhance the impermeable properties of CBCSs is to make water repellent grains by mixing the earthen cover material with a hydrophobic agent (HA). In this study, six different grains with different geometries and sizes were used to prepare dry hydrophobized grains by mixing with different contents of oleic acid as a HA. Wet hydrophobized grains were prepared by adjusting the water content (theta(g); kg kg(-1)) of dry hydrophobized grains. To characterize the water repellency (WR) of dry and wet hydrophobized grains, initial solidwater contact angles (alpha(i)) were measured using the sessile drop method (SDM). Based on SDM results from the aiHA content and alpha(i)-theta(g) curves, useful WR indices were introduced as "Area_(dry)'' and "Area_(wet)'' (areas under the alpha(i)-HA content and alpha(i)-theta(g) curves, respectively), "HA_(zica)'' and "theta(g)_(zica)'' (maximum HA content and theta(g) at which WR disappears, respectively), and "alpha(i,peak)'' and "HA_alpha(i,peak)'' (peak alpha(i) in the alpha(i)-HA content curve and corresponding HA content to alpha(i),(peak), respectively). Pearson correlation analysis was performed to identify correlations between proposed WR indices and basic grain properties. Results showed that WR indices correlated well to d(50) and coefficient of uniformity (C-u) and regression equations for WR indices were obtained as functions of d(50) and C-u (r(2) > 0.7).	[Wijewardana, N. Senani; Kawamoto, Ken; Komatsu, Toshiko] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Kawamoto, Ken] Saitama Univ, Int Inst Resilient Soc, Sakura Ku, Saitama 3388570, Japan; [Moldrup, Per] Aalborg Univ, Dept Civil Engn, Aalborg, Denmark; [Kurukulasuriya, L. Chandana] Univ Peradeniya, Fac Engn, Peradeniya, Sri Lanka; [Priyankara, Nadeej H.] Univ Ruhuna, Dept Civil & Environm Engn, Fac Engn, Matara, Sri Lanka	Wijewardana, NS (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	senaniwijewardana@gmail.com			Science and Technology Research Partnership for Sustainable Development ("SATREPS") Project	This research project was supported by a Grant from the Science and Technology Research Partnership for Sustainable Development ("SATREPS") Project. We gratefully acknowledge Dr. S. Subedi, Department of Civil Engineering, Himalayan Institute of Science and Technology, Purbanchal University, Kathmandu, Nepal, and Dr. Tusheng Ren, Department of Soil and Water Sciences, China Agricultural University, Beijing, China, for providing us published data.	STORMONT JC, 1995, WATER RESOUR RES, V31, P783, DOI 10.1029/94WR03001; Bachmann J, 2000, SOIL SCI SOC AM J, V64, P564; Chau HW, 2014, GEODERMA, V221, P113, DOI 10.1016/j.geoderma.2013.12.025; Diehl D, 2013, COLLOID SURFACE A, V432, P8, DOI 10.1016/j.colsurfa.2013.05.011; Roy JL, 2002, SOIL SCI, V167, P83, DOI 10.1097/00010694-200202000-00001; KOERNER RM, 1992, CIVIL ENG, V62, P55; Leelamanie DAL, 2008, SOIL SCI PLANT NUTR, V54, P179, DOI 10.1111/j.1747-0765.2007.00232.x; Wijewardana YNS, 2014, UNSATURATED SOILS: RESEARCH & APPLICATIONS, VOLS 1 AND 2, P255; Leelamanie DAL, 2007, SOIL SCI PLANT NUTR, V53, P711, DOI 10.1111/j.1747-0765.2007.00199.x; Simon FG, 2004, ENVIRON SCI POLICY, V7, P277, DOI 10.1016/j.envsci.2004.04.002; Tidwell VC, 2003, J CONTAM HYDROL, V62-3, P287, DOI 10.1016/S0169-7722(02)00164-X; Regalado CM, 2005, SOIL SCI SOC AM J, V69, P1955, DOI 10.2136/sssaj2005.0060; Ellerbrock RH, 2005, SOIL SCI SOC AM J, V69, P57; Karunarathna AK, 2010, VADOSE ZONE J, V9, P719, DOI 10.2136/vzj2009.0124; Graber ER, 2009, SOIL SCI SOC AM J, V73, P541, DOI 10.2136/sssaj2008.0131; FINK DH, 1970, SOIL SCI SOC AM PRO, V34, P189; Dell'Avanzi E, 2010, UNSATURATED SOILS: EXPERIMENTAL STUDIES IN UNSATURATED SOILS AND EXPANSIVE SOILS, P461; de Jonge LW, 1999, SOIL SCI SOC AM J, V63, P437; Khire MV, 2000, J GEOTECH GEOENVIRON, V126, P695, DOI 10.1061/(ASCE)1090-0241(2000)126:8(695); Scanlon BR, 2005, VADOSE ZONE J, V4, P55; Liu H, 2012, SOIL SCI SOC AM J, V76, P342, DOI [10.2136/sssaj11.0081, 10.2136/sssaj2011.0081]; Alexandrova L, 2011, COLLOID SURFACE A, V382, P88, DOI 10.1016/j.colsurfa.2010.12.008; Kawamoto K, 2007, SOIL SCI SOC AM J, V71, P1658, DOI 10.2136/sssaj2006.0284; Bachmann J, 2000, J HYDROL, V231, P66, DOI 10.1016/S0022-1694(00)00184-0; Lamparter A, 2010, SOIL SCI SOC AM J, V74, P2010, DOI 10.2136/sssaj2010.0082N; Subedi S, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0055; Yanful EK, 2006, J ENVIRON MANAGE, V81, P72, DOI 10.1016/j.jenvman.2005.10.006; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Bozkurt S, 2001, SCI TOTAL ENVIRON, V271, P145, DOI 10.1016/S0048-9697(00)00840-8; Buczko U, 2006, SOIL SCI SOC AM J, V70, P718, DOI 10.2136/sssaj2005.0183; STEENHUIS TS, 1991, WATER RESOUR RES, V27, P2155, DOI 10.1029/91WR01366; [Anonymous], 1990, CATENA S; Benson CH, 1995, ASCE SPECIAL PUBLICA, V201-217; Gonzalez-Penaloza FA, 2013, GEODERMA, V209, P31, DOI 10.1016/j.geoderma.2013.05.022; KING PM, 1981, AUST J SOIL RES, V19, P275, DOI 10.1071/SR9810275; Koerner R.M., 1997, FINAL COVERS SOLID W; Morris C.E., 1998, GEOTECHNICAL GEOLOGI, V16, P201, DOI [10.1023/A:1008853710339, DOI 10.1023/A:1008853710339]; Naveed M, 2011, SOIL SCI SOC AM J, V76, P845; Pease RE, 1996, P HSRC WERC JOINT C; Purdy SCEG, 1999, P SARD 7 INT WAST MA; ROSS B, 1990, WATER RESOUR RES, V26, P2625, DOI 10.1029/WR026i010p02625; Sharma HD, 2004, GEOENVIRONMENTAL ENG; Subedi S, 2011, AM GEOPH UN FALL M 2; Youd TL, 1973, EVALUATION RELATIVE, P98, DOI 10.1520/STP37866S	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	OCT	2015	74	7					5525	5539		10.1007/s12665-015-4565-6		15	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CS4AD	WOS:000362016100006		
J	Mori, K; Tada, K; Tawara, Y; Ohno, K; Asami, M; Kosaka, K; Tosaka, H				Mori, Koji; Tada, Kazuhiro; Tawara, Yasuhiro; Ohno, Koichi; Asami, Mari; Kosaka, Koji; Tosaka, Hiroyuki			Integrated watershed modeling for simulation of spatiotemporal redistribution of post-fallout radionuclides: Application in radiocesium fate and transport processes derived from the Fukushima accidents	ENVIRONMENTAL MODELLING & SOFTWARE			English	Article						Watershed modeling; Sediment transport; Fallout radionuclides; Fukushima Dai-ichi; GETFLOWS	SEDIMENT TRANSPORT; RIVER-BASIN; GROUNDWATER INTERACTIONS; NUMERICAL-MODELS; SUBSURFACE FLOW; OVERLAND-FLOW; SOIL-EROSION; CESIUM-137; ADSORPTION; DESORPTION	Simulation of the watershed-scale fate and transport of radionuclides is required in order to predict the consequences of contamination redistribution. Integrated watershed modeling is a suitable technique for this task, but it requires fully coupled investigation of radionuclide behavior in surface water, suspended sediment and subsurface aquifers. We developed a novel simulator for computing the spatiotemporal redistribution of fallout radionuclides in watersheds. The simulator was applied to an actual reservoir basin contaminated by fallout radionuclides from the Fukushima Dai-Ichi Nuclear Power Plant accident in 2011. As a result, the simulated Cs-137 concentration in bottom sediment showed a reasonably close match with the measurement data. The distribution coefficient of Cs-137 consistent with the latest measurement data was identified as being at least 400,000 L/kg, and it was estimated that more than 90% of the total Cs-137 distributed in the fallout remains in the catchment area. (C) 2015 Elsevier Ltd. All rights reserved.	[Mori, Koji; Tada, Kazuhiro; Tawara, Yasuhiro] Geosphere Environm Technol Corp, Chiyoda Ku, Tokyo 1010063, Japan; [Ohno, Koichi; Asami, Mari; Kosaka, Koji] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Tosaka, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Syst Innovat, Bunkyo Ku, Tokyo 1138656, Japan	Mori, K (reprint author), Geosphere Environm Technol Corp, Chiyoda Ku, 2-1 Kanda Awajicho, Tokyo 1010063, Japan.	mori@getc.co.jp; tada@getc.co.jp; tawara@getc.co.jp; ohno-k@niph.go.jp; asami@niph.go.jp; kosaka@niph.go.jp; tosaka@sys.t.u-tokyo.ac.jp					Poreba GJ, 2006, GEOCHRONOMETRIA, V25, P37; Heppner CS, 2006, ADV WATER RESOUR, V29, P930, DOI 10.1016/j.advwatres.2005.08.003; Kollet SJ, 2006, ADV WATER RESOUR, V29, P945, DOI 10.1016/j.advwatres.2005.08.006; Ewen J, 2000, J HYDROL ENG, V5, P250, DOI 10.1061/(ASCE)1084-0699(2000)5:3(250); Borah DK, 2003, T ASAE, V46, P1553; Sulis M, 2010, ADV WATER RESOUR, V33, P456, DOI 10.1016/j.advwatres.2010.01.010; Loffredo N, 2014, SCI TOTAL ENVIRON, V493, P701, DOI 10.1016/j.scitotenv.2014.06.059; Meili M, 1996, APPL GEOCHEM, V11, P311, DOI 10.1016/0883-2927(95)00098-4; Tosaka H, 2000, HYDROL PROCESS, V14, P449, DOI 10.1002/(SICI)1099-1085(20000228)14:3<449::AID-HYP948>3.0.CO;2-9; Furman A, 2008, VADOSE ZONE J, V7, P741, DOI 10.2136/vzj2007.0065; Centeri C, 2009, J PLANT NUTR SOIL SC, V172, P789, DOI 10.1002/jpln.200900009; Kabir MA, 2011, HYDROL EARTH SYST SC, V15, P1307, DOI 10.5194/hess-15-1307-2011; Yoshimura K, 2015, J ENVIRON RADIOACTIV, V139, P362, DOI 10.1016/j.jenvrad.2014.07.019; Sadat-Helbar SM, 2009, MA COMPUT SCI ENG, P39; Chiang PN, 2010, J ENVIRON RADIOACTIV, V101, P472, DOI 10.1016/j.jenvrad.2008.10.013; Mehl S, 2006, GROUND WATER, V44, P792, DOI 10.1111/j.1745-6584.2005.00192.x; GELHAR LW, 1992, WATER RESOUR RES, V28, P1955, DOI 10.1029/92WR00607; Ebel BA, 2009, HYDROL PROCESS, V23, P1949, DOI 10.1002/hyp.7279; LAFLEN JM, 1991, J SOIL WATER CONSERV, V46, P34; ITAKURA T, 1980, J HYDR ENG DIV-ASCE, V106, P1325; Rubey WW, 1933, AM J SCI, V25, P325; Sanford W, 2011, HYDROGEOL J, V19, P13, DOI 10.1007/s10040-010-0637-6; Hosono T, 2013, WATER RES, V47, P2661, DOI 10.1016/j.watres.2013.02.020; Panday S, 2004, ADV WATER RESOUR, V27, P361, DOI 10.1016/j.advwatres.2004.02.016; Prosser IP, 2000, PROG PHYS GEOG, V24, P179, DOI 10.1191/030913300669852483; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; Goldberg S, 2007, VADOSE ZONE J, V6, P407, DOI 10.2136/vzj2006.0085; Golosov V, 2000, IAHS-AISH P, P49; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Ran Q, 2007, HYDROL PROCESS, V21, P1522, DOI 10.1002/hyp.6642; Ashida K., 1972, J CIVIL ENG JPN SOC, V206, P59; Balonov M., 2010, IAEA TECH REP SER, V472; Bear J., 1972, DYNAMICS FLUIDS PORO; Bixio A.C., 2000, SURFACE WATER SYSTEM, V2, P115; Brandt CJ, 1989, 4 BEN C GEOM PROC, V16, P507, DOI [10.1016/0341-8162(89)90032-5, DOI 10.1016/0341-8162(89)90032-5]; Camporese M, 2010, WATER RESOUR RES, V46, DOI 10.1029/2008WR007536; CORNELL RM, 1993, J RADIOAN NUCL CH AR, V171, P483, DOI 10.1007/BF02219872; Daniel E. B., 2011, The Open Hydrology Journal, V5, P26, DOI 10.2174/1874378101105010026; Danish Hydraulic Institute, 2007, MIKE SHE US MAN, V2; Ding Y., 1995, SOC PET ENG, P451; Dongguang W., 2009, B GEOL SURV JPN, V60, P5; Firestone R. B., 1997, P 9 INT S CAPT GAMM, V2; Foster GR, 1987, USER REQUIREMENTS US; Gabet EJ, 2003, WATER RESOUR RES, V39, P1; Govers G., 1990, IAHS PUBL, V189, P45; Graham D. N., 2005, WATERSHED MODELS, P245; Hamon W.R., 1961, J HYDRAULICS DIVISIO, V87, P107; IAEA, 2013, ISOTOPE METHODS DATI; IAEA, 2014, FOLLOW UP IAEA INT M; IAEA, 2010, IAEA TECHN REP SER, V472, P1; Ichiyanagi K., 2012, IAH2012 C NIAG FALLS; Julien P. Y., 1985, AM SOC AGR ENG, V28, P755, DOI 10.13031/2013.32333; Kinsel W.G., 1980, 26 USDA, VI; Kitamura A., 2014, EGU GEN ASS C, V16, P11456; Margvelashvilii M., 1996, WG4RP9604; Meyer-Peter E., 1948, P 2 C INT ASS HYDR R, P39; Ministry of Education Culture Sports Science and Technology (MEXT), 2014, EXT SIT DISTR MAP RA; Ministry of the Environment Government of Japan, 2013, MON DAT AQ ENV; Morgan R.P.C., 1998, EUROPEAN SOIL EROSIO; Mori K., 2006, 11 INT HIGH LEV RAD; Mori K., 2011, J JPN SOC CIV ENG B1, V67, p1_739; Morris D.A., 1967, SUMMARY HYDROLOGIC P; Nagao S., 2013, BIOGEOSCI DISCUSS, V10, P2767, DOI DOI 10.5194/BGD-10-2767-2013; Onishi Y., 2013, PNNL22364; Owens PN, 1996, J ENVIRON RADIOACTIV, V32, P169, DOI 10.1016/0265-931X(96)84941-1; Pruess K, 1991, TOUGH2 GEN PURPOSE N; Riverfront Research Center Geosphere environmental technology and Yachiyo engineering corporation, 2014, MULTI WAT MOD FUK DE; Shimada J., 2012, IAH2012 C NIAG FALLS, P232; Shimada J., 2012, EFFECT ARTFICIAL REC, P59; Sugawara M., 1984, RES NOTES NATL RES C; Takahashi J., 2014, J ENVIRON RADIOACTIV, V139, P351; Tenma N., 2005, GEOTHERM RESOUR COUC, P81; Therrien R., 2010, HYDROGEOSPHERE 3 DIM; TORRI D, 1987, CATENA, V14, P149, DOI 10.1016/S0341-8162(87)80013-9; Tosaka H., 2010, IAHR INT GROUNDW S 2; U.S. Department of the Interior Bureau of Reclamation, 2006, ER SED MAN; van der Heijde P.K., 1990, MODELCARE 90 CALIBRA, P195; VanderKwaak J.E., 1999, THESIS U WATERLOO WA; Woolhiser D.A., 1990, ARS, V77, P130; Yamaguchi Noriko, 2012, Bulletin of the National Institute of Agro-Environmental Sciences, V31, P75; Yamashiki Y., 2014, SCI REP, V4; Zheleznyak M., 2003, WG4TN97 RODOS, V5, P48; Zheleznyak M.J., 1997, CONDENS MATTER PHYS, V12, P37; Zyvoloski G.A., 1997, SUMMARY MODELS METHO	84	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1364-8152	1873-6726		ENVIRON MODELL SOFTW	Environ. Modell. Softw.	OCT	2015	72						126	146		10.1016/j.envsoft.2015.06.012		21	Computer Science, Interdisciplinary Applications; Engineering, Environmental; Environmental Sciences	Computer Science; Engineering; Environmental Sciences & Ecology	CS2MX	WOS:000361906400012		
J	Jagiello, K; Mostrag-Szlichtyng, A; Gajewicz, A; Kawai, T; Imaizumi, Y; Sakurai, T; Yamamoto, H; Tatarazako, N; Mizukawa, K; Aoki, Y; Suzuki, N; Watanabe, H; Puzyn, T				Jagiello, Karolina; Mostrag-Szlichtyng, Aleksandra; Gajewicz, Agnieszka; Kawai, Toru; Imaizumi, Yoshitaka; Sakurai, Takeo; Yamamoto, Hiroshi; Tatarazako, Norihisa; Mizukawa, Kaoruko; Aoki, Yasunobu; Suzuki, Noriyuki; Watanabe, Haruna; Puzyn, Tomasz			Towards modelling of the environmental fate of pharmaceuticals using the QSPR-MM scheme	ENVIRONMENTAL MODELLING & SOFTWARE			English	Article						Multimedia mass-balance models; Quantitative structure-property relationship models; Pharmaceuticals; Drug-like compounds	PERSISTENT ORGANIC POLLUTANTS; STRUCTURE-PROPERTY RELATIONSHIP; AQUEOUS SOLUBILITY PREDICTION; MASS-BALANCE MODELS; DRUG-LIKE COMPOUNDS; RISK-ASSESSMENT; MOLECULAR DESCRIPTORS; POLYHALOGENATED POPS; SURFACE WATERS; GREAT-ER	Pharmaceuticals are considered as a new, important group of pollutants. These compounds can enter the environment via several routes and can disturb the natural balance of ecosystems. Factors affecting the environmental fate of medical substances can be determined with computational modelling. The routine application of the modelling methodology in the environmental risk assessment for newly designed pharmaceuticals would enable prediction of their important physical/chemical properties and forecasting their long-range transport and fate. In this contribution, we present the existing state-of-the-art and review the currently available modelling tools of two groups: Quantitative Structure-Property Relationship techniques and Multimedia Mass-balance models. We discuss the current research needs in the context of extending the applicability of the existing tools onto pharmaceuticals, being a more structurally diversified group of contaminants than persistence organic pollutants, for which the majority of the existing models have been originally developed. (C) 2015 Elsevier Ltd. All rights reserved.	[Jagiello, Karolina; Mostrag-Szlichtyng, Aleksandra; Gajewicz, Agnieszka; Puzyn, Tomasz] Univ Gdansk, Fac Chem, Lab Environm Chemometr, PL-80308 Gdansk, Poland; [Kawai, Toru; Imaizumi, Yoshitaka; Sakurai, Takeo; Tatarazako, Norihisa; Aoki, Yasunobu; Suzuki, Noriyuki; Watanabe, Haruna] Natl Inst Environm Studies, Ctr Environm Risk Res, Tsukuba, Ibaraki 3058506, Japan; [Yamamoto, Hiroshi] Univ Tokushima, Inst Socioarts & Sci, Tokushima 7708502, Japan; [Mizukawa, Kaoruko] Tokyo Univ Agr & Technol, Lab Organ Geochem, Fuchu, Tokyo 1838509, Japan	Puzyn, T (reprint author), Univ Gdansk, Fac Chem, Lab Environm Chemometr, Ul Wita Stwosza 63, PL-80308 Gdansk, Poland.	t.puzyn@qsar.eu.org	Sakurai, Takeo/D-6384-2011	Sakurai, Takeo/0000-0002-4263-3469	Japanese Society for the Promotion of Science (JSPS); Polish Academy of Science (PAN); Polish Ministry of Science and Higher Education [DS 530-8637-D510-14]; Foundation for Polish Science; European Social Fund by Human Capital Operational Programme, Action 4.3, Strengthening of didactic potential of universities in key areas in the context of the goals of the Europe strategy [UDA - POKL.04.03.00-00-047/12]	This work was supported by the Japanese Society for the Promotion of Science (JSPS) and the Polish Academy of Science (PAN) as part of the joint project: "Developing QSPR-MM combined model to predict persistence and long-range transport potential of PPCPs". The authors thank the Polish Ministry of Science and Higher Education (grant no. DS 530-8637-D510-14 and the Foundation for Polish Science (FOCUS 2010 Programme) for the financial support. KJ thanks the European Social Fund for granting her with a fellowship in frame of the project "Development Program of the University of Gdansk in areas of Europe 2020 (UG 2020)" supported by Human Capital Operational Programme, Action 4.3, Strengthening of didactic potential of universities in key areas in the context of the goals of the Europe 2020 strategy (Grant No. UDA - POKL.04.03.00-00-047/12).	Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Prevedouros K, 2004, ENVIRON POLLUT, V128, P251, DOI 10.1016/j.envpol.2003.08.041; Duchowicz PR, 2009, INT J MOL SCI, V10, P2558, DOI 10.3390/ijms10062558; GOMIS R, 1984, RES COMMUN CHEM PATH, V46, P331; van Wezel AP, 2002, CHEMOSPHERE, V47, P1113, DOI 10.1016/S0045-6535(02)00048-6; Tauxe-Wuersch A, 2005, WATER RES, V39, P1761, DOI 10.1016/j.watres.2005.03.003; Cooper ER, 2008, SCI TOTAL ENVIRON, V398, P26, DOI 10.1016/j.scitotenv.2008.02.061; MacLeod M, 2001, ENVIRON SCI POLLUT R, V8, P156, DOI 10.1007/BF02987379; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Anderson PD, 2004, ENVIRON SCI TECHNOL, V38, P838, DOI 10.1021/es034430b; Cao DS, 2010, J CHEMOMETR, V24, P584, DOI 10.1002/cem.1321; ANSELL B, 1956, BRIT MED J, V1, P650; Schowanek D, 2002, TOXICOL LETT, V131, P39, DOI 10.1016/S0378-4274(02)00064-4; MACKAY D, 1985, J PHARM SCI, V74, P1236, DOI 10.1002/jps.2600741120; Jagiello K, 2014, STRUCT CHEM, V25, P997, DOI 10.1007/s11224-014-0419-1; Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; MACKAY D, 1979, ENVIRON SCI TECHNOL, V13, P1218, DOI 10.1021/es60158a003; Puzyn T, 2011, STRUCT CHEM, V22, P873, DOI 10.1007/s11224-011-9764-5; Vermeire TG, 1997, CHEMOSPHERE, V34, P1823, DOI 10.1016/S0045-6535(97)00017-9; Bhhatarai B, 2011, WATER RES, V45, P1463, DOI 10.1016/j.watres.2010.11.006; Sosnowska A, 2014, ATMOS ENVIRON, V87, P10, DOI 10.1016/j.atmosenv.2013.12.036; Puzyn T, 2008, ENVIRON SCI TECHNOL, V42, P5189, DOI 10.1021/es8002348; Chen XQ, 2002, J PHARM SCI, V91, P1838, DOI 10.1002/jps.10178; Hawker DW, 2011, WATER RES, V45, P768, DOI 10.1016/j.watres.2010.08.053; Papa E, 2007, CHEMOSPHERE, V67, P351, DOI 10.1016/j.chemosphere.2006.09.079; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Kar S, 2010, J INDIAN CHEM SOC, V87, P1455; Yap CW, 2006, J MOL GRAPH MODEL, V24, P383, DOI 10.1016/j.jmgm.2005.10.004; Carlsson C, 2006, SCI TOTAL ENVIRON, V364, P67, DOI 10.1016/j.scitotenv.2005.06.035; DIAMOND ML, 1992, CHEMOSPHERE, V25, P1907, DOI 10.1016/0045-6535(92)90030-U; Suzuki N, 2004, ENVIRON SCI TECHNOL, V38, P5682, DOI 10.1021/es049261p; Carlsson C, 2006, SCI TOTAL ENVIRON, V364, P88, DOI 10.1016/h.scitotenv.2005.06.036; Nash JP, 2004, ENVIRON HEALTH PERSP, V112, P1725, DOI 10.1289/ehp.7209; Ghasemi J, 2007, CHEM PHARM BULL, V55, P669, DOI 10.1248/cpb.55.669; Puzyn T, 2008, ATMOS ENVIRON, V42, P6627, DOI 10.1016/j.atmosenv.2008.04.048; Bergstrom CAS, 2004, J CHEM INF COMP SCI, V44, P1477, DOI 10.1021/ci049909h; Gajewicz A, 2010, ATMOS ENVIRON, V44, P1428, DOI 10.1016/j.atmosenv.2010.01.041; Daughton CG, 2009, ENVIRON TOXICOL CHEM, V28, P2495, DOI 10.1897/08-382.1; Csiszar SA, 2011, ENVIRON INT, V37, P821, DOI 10.1016/j.envint.2011.02.001; Puzyn T, 2011, J HAZARD MATER, V192, P970, DOI 10.1016/j.jhazmat.2011.05.078; Watts MM, 2003, ECOTOX ENVIRON SAFE, V54, P207, DOI 10.1016/S0147-6513(02)00029-5; Luckenbach T, 2005, ENVIRON HEALTH PERSP, V113, P17; Modi S, 2012, DRUG DISCOV TODAY, V17, P135, DOI 10.1016/j.drudis.2011.10.022; MACKAY D, 1989, CHEMOSPHERE, V18, P1343, DOI 10.1016/0045-6535(89)90027-1; Hansen NT, 2006, J CHEM INF MODEL, V46, P2601, DOI 10.1021/ci600292q; Zukowska B, 2006, SCI TOTAL ENVIRON, V359, P177, DOI 10.1016/j.scitotenv.2005.05.033; Schowanek D, 2001, WATER SCI TECHNOL, V43, P179; WEST MG, 1945, P SOC EXP BIOL MED, V60, P363; Modarresi H, 2006, J CHEM INF MODEL, V46, P930, DOI 10.1021/ic050307n; Du-Cuny L, 2008, EUR J MED CHEM, V43, P501, DOI 10.1016/j.ejmech.2007.04.009; Wania F, 1999, ENVIRON POLLUT, V100, P223, DOI 10.1016/S0269-7491(99)00093-7; Kawai T, 2014, ENVIRON SCI TECHNOL, V48, P3245, DOI 10.1021/es4026003; Boeije G., 1997, WATER SCI TECHNOL, V36, P254; CSTEE, 2001, ENV RISK ASS MED PRO; Daughton Christian G, 2011, Expert Rev Clin Pharmacol, V4, P211, DOI 10.1586/ecp.11.6; Gramatica Paola, 2013, Methods Mol Biol, V930, P499, DOI 10.1007/978-1-62703-059-5_21; Kawai T., 2009, ORGANOHALOGEN COMPD, V71, P1610; Koratege S., 2010, J PHARMACOL TOX MET, V61, P67; Kormann F., 2006, ENVIRON MODELL SOFTW, V21, P925; McKone T. E., 1993, CALTOX MULTIMEDIA TO; OECD, 2002, OECD UNEP WORKSH US; Puzyn T., 2010, CHALLENGES ADV COMPU; Roncaglioni A, 2013, CURR OPIN PHARMACOL, V13, P802, DOI 10.1016/j.coph.2013.06.001; Tripathi K. D., 2006, PHARM CLASSIFICATION; UNEP, 2001, STOCKH CONV PERS ORG	66	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1364-8152	1873-6726		ENVIRON MODELL SOFTW	Environ. Modell. Softw.	OCT	2015	72						147	154		10.1016/j.envsoft.2015.06.013		8	Computer Science, Interdisciplinary Applications; Engineering, Environmental; Environmental Sciences	Computer Science; Engineering; Environmental Sciences & Ecology	CS2MX	WOS:000361906400013		
J	Nakata, H; Nakayama, SMM; Ikenaka, Y; Mizukawa, H; Ishii, C; Yohannes, YB; Konnai, S; Darwish, WS; Ishizuka, M				Nakata, Hokuto; Nakayama, Shouta M. M.; Ikenaka, Yoshinori; Mizukawa, Hazuki; Ishii, Chihiro; Yohannes, Yared B.; Konnai, Satoru; Darwish, Wageh Sobhy; Ishizuka, Mayumi			Metal extent in blood of livestock from Dandora dumping site, Kenya: Source identification of Pb exposure by stable isotope analysis	ENVIRONMENTAL POLLUTION			English	Article						Dandora; Dumping site; Livestock; Metal contamination; Stable Pb isotopes	HAZARDOUS-WASTE LANDFILL; LEAD-ZINC MINE; HEAVY-METALS; NW SPAIN; CATTLE; POLLUTION; CADMIUM; CONTAMINATION; VICINITY; HEALTH	Nairobi city in Kenya produces 2000 tons/day of garbage, and most of it is dumped onto the Dandora dumping site, home to a quarter-million residents. This study was conducted (1) to assess the contamination levels of nine metals and a metalloid (arsenic) in the blood of pigs, goats, sheep and cattle from Dandora, and (2) to identify a possible source of lead (Pb) pollution. Cadmium (Cd, 0.17-435 mu g/kg, dry-wt) and Pb (90-2710 mu g/kg) levels in blood were generally high, suggesting human exposure to Cd through livestock consumption and Pb poisoning among pigs (2600 mu g/kg) and cattle (354 mu g/kg). Results of Pb isotope ratios indicated that the major exposure route might differ among species. Our results also suggested a possibility that the residents in Dandora have been exposed to the metals through livestock consumption. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakata, Hokuto; Nakayama, Shouta M. M.; Ikenaka, Yoshinori; Ishii, Chihiro; Yohannes, Yared B.; Darwish, Wageh Sobhy; Ishizuka, Mayumi] Hokkaido Univ, Toxicol Lab, Dept Environm Vet Sci, Grad Sch Vet Med,Kita ku, Sapporo, Hokkaido 0600818, Japan; [Ikenaka, Yoshinori] North West Univ, Water Res Grp, Unit Environm Sci & Management, Potchefstroom, South Africa; [Mizukawa, Hazuki] Hokkaido Univ, Dept Environm Vet Sci, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Yohannes, Yared B.] Univ Gondar, Dept Chem, Coll Nat & Computat Sci, Gondar, Ethiopia; [Konnai, Satoru] Hokkaido Univ, Infect Dis Lab, Dept Dis Control, Grad Sch Vet Med,Kita Ku, Sapporo, Hokkaido 0600818, Japan; [Darwish, Wageh Sobhy] Zagazig Univ, Food Control Dept, Fac Vet Med, Zagazig, Egypt	Ishizuka, M (reprint author), Hokkaido Univ, Toxicol Lab, Dept Environm Vet Sci, Grad Sch Vet Med,Kita ku, Kita 18 Nishi 9, Sapporo, Hokkaido 0600818, Japan.	ishizum@vetmed.hokudai.ac.jp		Darwish, Wageh/0000-0002-4399-1401	Ministry of Education, Culture, Sports, Science and Technology of Japan [24405004, 24248056, 26304043]; JSPS; Mitsui & Co., Ltd. Environment Fund	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan awarded to M. Ishizuka (No. 24405004 and 24248056) and Y. Ikenaka (No. 26304043), and the foundation of JSPS Core to Core Program (AA Science Platforms) and Bilateral Joint Research Project. We also acknowledge financial support from The Mitsui & Co., Ltd. Environment Fund. The analyses of element concentrations were technically supported by Mr. Takahiro Ichise.	Abu-Rukah Y, 2001, J ARID ENVIRON, V49, P615, DOI 10.1006/jare.2001.0796; Yabe J, 2011, ENVIRON TOXICOL CHEM, V30, P1892, DOI 10.1002/etc.580; Yohannes YB, 2013, CHEMOSPHERE, V91, P857, DOI 10.1016/j.chemosphere.2013.01.047; RICE DA, 1987, B ENVIRON CONTAM TOX, V39, P622; WIKSE SE, 1992, J AM VET MED ASSOC, V200, P1625; Machado W, 2002, ENVIRON POLLUT, V120, P455, DOI 10.1016/S0269-7491(02)00108-2; ASTRIN KH, 1987, ANN NY ACAD SCI, V514, P23, DOI 10.1111/j.1749-6632.1987.tb48757.x; Minagawa M, 2005, CHEM GEOL, V218, P91, DOI 10.1016/j.chemgeo.2005.01.019; Patra RC, 2006, J VET MED A, V53, P511; Nakayama SMM, 2013, ENVIRON MONIT ASSESS, V185, P4907, DOI 10.1007/s10661-012-2912-6; Alonso ML, 2000, SCI TOTAL ENVIRON, V246, P237, DOI 10.1016/S0048-9697(99)00461-1; CHOW TJ, 1965, SCIENCE, V147, P502, DOI 10.1126/science.147.3657.502; Mor S, 2006, ENVIRON MONIT ASSESS, V118, P435, DOI 10.1007/s10661-006-1505-7; Benvenuti M, 1997, ENVIRON GEOL, V30, P238; Miranda M, 2005, ENVIRON INT, V31, P543, DOI 10.1016/j.envint.2004.09.025; Alonso ML, 2000, FOOD ADDIT CONTAM, V17, P447, DOI 10.1080/02652030050034028; Briggs D, 2003, BRIT MED BULL, V68, P1, DOI 10.1093/bmb/ldg019; Yabe J, 2015, CHEMOSPHERE, V119, P941, DOI 10.1016/j.chemosphere.2014.09.028; Monna F, 1998, SPECTROCHIM ACTA B, V53, P1317, DOI 10.1016/S0584-8547(98)00164-5; Dolgopolova A, 2006, APPL GEOCHEM, V21, P563, DOI 10.1016/j.apgeochem.2005.12.014; Pareja-Carrera J, 2014, ECOTOX ENVIRON SAFE, V108, P210, DOI 10.1016/j.ecoenv.2014.07.014; Borga K, 2005, ENVIRON POLLUT, V134, P397, DOI 10.1016/j.envpol.2004.09.016; Ikenaka Y, 2012, ENVIRON TOXICOL CHEM, V31, P2300, DOI 10.1002/etc.1951; Ogundiran OO, 2008, INT J ENVIRON SCI TE, V5, P243, DOI 10.1007/BF03326018; GULSON BL, 1981, ENVIRON SCI TECHNOL, V15, P691, DOI 10.1021/es00088a008; ROJAS MA, 1965, J ANIM SCI, V24, P664; Mari M, 2009, ENVIRON INT, V35, P1034, DOI 10.1016/j.envint.2009.05.004; LINK RP, 1966, AM J VET RES, V27, P759; Liu ZP, 2003, SCI TOTAL ENVIRON, V309, P117, DOI 10.1016/S0048-9697(03)00011-1; Blacksmith Institute, 2007, BLACKSM I PAP ANN RE, P1; Henderson Jr C.R., 2003, NEW ENGL J MED, V348, P1517; Huang Y.D., 2001, TOXICOPATHY NUTR DIS, P194; Liu J., 2007, METAL TOXICOLOGY CAS, P931; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mutune A. N., 2014, African Journal of Environmental Science and Technology, V8, P66, DOI 10.5897/AJEST2013.1573; Puls R., 1994, MINERAL LEVELS ANIMA; RABINOWI.MB, 1972, ENVIRON SCI TECHNOL, V6, P705, DOI 10.1021/es60067a003; Iglesias M, 2010, International Journal of Environment and Waste Management, V5, DOI 10.1504/IJEWM.2010.029687; SAS Institute, 2007, JMP STAT GRAPH GUID; United Nations Environment Programme (UNEP), 2007, ENV POLL IMP PUBL HL; Vrijheid M, 2000, ENVIRON HEALTH PERSP, V108, P101, DOI 10.2307/3454635	41	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	OCT	2015	205						8	15		10.1016/j.envpol.2015.05.003		8	Environmental Sciences	Environmental Sciences & Ecology	CS8AM	WOS:000362308100002		
J	Lohwacharin, J; Takizawa, S; Punyapalakul, R				Lohwacharin, J.; Takizawa, S.; Punyapalakul, R.			Carbon black retention in saturated natural soils: Effects of flow conditions, soil surface roughness and soil organic matter	ENVIRONMENTAL POLLUTION			English	Article						Atomic force microscopy (AFM); Carbon black; Soil organic matter; Surface roughness; Two-site transport	COLLOID FILTRATION THEORY; POROUS-MEDIA; FULLERENE NANOPARTICLES; PARTICLE-SIZE; TRANSPORT; DEPOSITION; SAND; ATTACHMENT; CHEMISTRY; DYNAMICS	We evaluated factors affecting the transport, retention, and re-entrainment of carbon black nanoparticles (nCBs) in two saturated natural soils under different flow conditions and input concentrations using the two-site transport model and Kelvin probe force microscopy (KPFM). Soil organic matter (SOM) was found to create unfavorable conditions for the retention. Despite an increased flow velocity, the relative stability of the estimated maximum retention capacity in soils may suggest that flow-induced shear stress forces were insufficient to detach nCB. The KPFM observation revealed that nCBs were retained at the grain boundary and on surface roughness, which brought about substantial discrepancy between theoretically-derived attachment efficiency factors and the ones obtained by the experiments using the two-site transport model. Thus, decreasing ionic strength and increasing solution pH caused re-entrainment of only a small fraction of retained nCB in the soil columns. (C) 2015 Elsevier Ltd. All rights reserved.	[Lohwacharin, J.; Takizawa, S.] Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Punyapalakul, R.] Chulalongkorn Univ, Dept Environm Engn, Bangkok 10330, Thailand	Lohwacharin, J (reprint author), Univ Tokyo, Grad Sch Engn, Dept Urban Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	jenyuk@env.t.u-tokyo.ac.jp; takizawa@env.t.u-tokyo.ac.jp; patipam.p@eng.chula.ac.th			JSPS Post-doctoral Fellowship by the Japan Society for the Promotion of Science [21-09290]	We thank three anonymous reviewers for their constructive and valuable comments. This study was supported by a JSPS Post-doctoral Fellowship (#21-09290) provided by the Japan Society for the Promotion of Science.	JOHNSON PR, 1995, LANGMUIR, V11, P801, DOI 10.1021/la00003a023; Yoon JS, 2006, WATER RESOUR RES, V42, DOI 10.1029/2004WR003660; Fang J, 2009, ENVIRON POLLUT, V157, P1101, DOI 10.1016/j.envpol.2008.11.006; Pantea D, 2001, CARBON, V39, P1147, DOI 10.1016/S0008-6223(00)00239-6; Kasel D, 2013, WATER RES, V47, P933, DOI 10.1016/j.watres.2012.11.019; Kretzschmar R, 1997, WATER RESOUR RES, V33, P1129, DOI 10.1029/97WR00298; Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P210, DOI 10.1021/es030416n; Wang DJ, 2013, ENVIRON SCI TECHNOL, V47, P821, DOI 10.1021/es303794d; Zhang LL, 2012, ENVIRON SCI TECHNOL, V46, P7230, DOI 10.1021/es301234m; BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0; Goldberg E, 2014, ENVIRON SCI TECHNOL, V48, P12732, DOI 10.1021/es502044k; Torkzaban S, 2007, LANGMUIR, V23, P9652, DOI 10.1021/1a700995e; Wang DJ, 2013, ENVIRON SCI TECHNOL, V47, P5154, DOI 10.1021/es305337r; Tufenkji N, 2005, LANGMUIR, V21, P841, DOI 10.1021/la048102g; Jaisi DP, 2009, ENVIRON SCI TECHNOL, V43, P9161, DOI 10.1021/es901927y; Wang YG, 2010, J ENVIRON QUAL, V39, P1925, DOI 10.2134/jeq2009.0411; Bradford SA, 2003, ENVIRON SCI TECHNOL, V37, P2242, DOI 10.1021/es025899u; Torkzaban S, 2013, ENVIRON SCI TECHNOL, V47, P11528, DOI 10.1021/es402075f; LIU DL, 1995, ENVIRON SCI TECHNOL, V29, P2963, DOI 10.1021/es00012a012; Li YS, 2008, ENVIRON SCI TECHNOL, V42, P7174, DOI 10.1021/es801305y; Hahn MW, 2004, ENVIRON SCI TECHNOL, V38, P5915, DOI 10.1021/es049746d; Sagee O, 2012, CHEMOSPHERE, V88, P670, DOI 10.1016/j.chemosphere.2012.03.055; Shellenberger K, 2002, ENVIRON SCI TECHNOL, V36, P184, DOI 10.1021/es015515k; Johnson WP, 2010, WATER RES, V44, P1158, DOI 10.1016/j.watres.2009.12.014; Torkzaban S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006541; Tong MP, 2010, WATER RES, V44, P1094, DOI 10.1016/j.watres.2009.09.040; Tong MP, 2006, ENVIRON SCI TECHNOL, V40, P7725, DOI 10.1021/es061201r; Plaza I, 2015, SOIL TILL RES, V146, P148, DOI 10.1016/j.still.2014.10.013; Barth C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.136804; Melitz W, 2011, SURF SCI REP, V66, P1, DOI 10.1016/j.surfrep.2010.10.001; Bradford SA, 2006, J CONTAM HYDROL, V82, P99, DOI 10.1016/j.jconhyd.2005.09.006; Wang C, 2012, ENVIRON SCI TECHNOL, V46, P7151, DOI 10.1021/es300314n; Wang DJ, 2012, SOIL SCI SOC AM J, V76, P375, DOI 10.2136/sssaj2011.0203; Koike E, 2006, CHEMOSPHERE, V65, P946, DOI 10.1016/j.chemosphere.2006.03.078; Bertsch PM, 1999, P NATL ACAD SCI USA, V96, P3350, DOI 10.1073/pnas.96.7.3350; Tufenkji N, 2004, LANGMUIR, V20, P10818, DOI 10.1021/la0486638; Brow CN, 2005, COLLOID SURFACE A, V253, P125, DOI 10.1016/j.colsurfa.2004.11.005; Bradford SA, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012468; Ceresana, 2013, ADDIT POLYM, V2013, P10; Donnet J.-B., 1976, CARBON BLACK; Johnson W.P., 2005, EOS, V86, P179, DOI DOI 10.1029/2005EO180002; Ley T.W., 1994, SOIL WATER MONITORIN; SPOSITO G., 2008, CHEM SOILS; Swift R.S., 1996, METHODS SOIL ANAL 3, V5	44	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0269-7491	1873-6424		ENVIRON POLLUT	Environ. Pollut.	OCT	2015	205						131	138		10.1016/j.envpol.2015.05.036		8	Environmental Sciences	Environmental Sciences & Ecology	CS8AM	WOS:000362308100016		
J	Watanabe, KP; Kawata, M; Ikenaka, Y; Nakayama, SMM; Ishii, C; Darwish, WS; Saengtienchai, A; Mizukawa, H; Ishizuka, M				Watanabe, Kensuke P.; Kawata, Minami; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Ishii, Chihiro; Darwish, Wageh Sobhi; Saengtienchai, Aksorn; Mizukawa, Hazuki; Ishizuka, Mayumi			Cytochrome P450-mediated warfarin metabolic ability is not a critical determinant of warfarin sensitivity in avian species: In vitro assays in several birds and in vivo assays in chicken	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						Avian; Cytochrome P450; Species difference; Warfarin; Pharmacokinetics	2ND-GENERATION ANTICOAGULANT RODENTICIDES; CLINICAL-CHEMISTRY; PHARMACOKINETICS; RATS; ENANTIOMERS; EXPOSURE; WILDLIFE; PLASMA; CYP2C9; CANADA	Coumarin-derivative anticoagulant rodenticides used for rodent control are posing a serious risk to wild bird populations. For warfarin, a classic coumarin derivative, chickens have a high median lethal dose (LD50), whereas mammalian species generally have much lower LD50. Large interspecies differences in sensitivity to warfarin are to be expected. The authors previously reported substantial differences in warfarin metabolism among avian species; however, the actual in vivo pharmacokinetics have yet to be elucidated, even in the chicken. In the present study, the authors sought to provide an in-depth characterization of warfarin metabolism in birds using in vivo and in vitro approaches. A kinetic analysis of warfarin metabolism was performed using liver microsomes of 4 avian species, and the metabolic abilities of the chicken and crow were much higher in comparison with those of the mallard and ostrich. Analysis of in vivo metabolites from chickens showed that excretions predominantly consisted of 4-hydroxywarfarin, which was consistent with the in vitro results. Pharmacokinetic analysis suggested that chickens have an unexpectedly long half-life despite showing high metabolic ability in vitro. The results suggest that the half-life of warfarin in other bird species could be longer than that in the chicken and that warfarin metabolism may not be a critical determinant of species differences with respect to warfarin sensitivity. Environ Toxicol Chem 2015;34:2328-2334. (c) 2015 SETAC	[Watanabe, Kensuke P.; Kawata, Minami; Ikenaka, Yoshinori; Nakayama, Shouta M. M.; Ishii, Chihiro; Darwish, Wageh Sobhi; Saengtienchai, Aksorn; Mizukawa, Hazuki; Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Toxicol Lab, Sapporo, Hokkaido, Japan; [Ikenaka, Yoshinori] North West Univ, Unit Environm Sci & Management, Water Res Grp, Potchefstroom, South Africa; [Darwish, Wageh Sobhi] Zagazig Univ, Fac Vet Med, Food Control Dept, Zagazig, Egypt; [Saengtienchai, Aksorn] Kasetsart Univ, Lat Yao Chatuchak, Fac Vet Med, Dept Pharmacol, Bangkok, Thailand	Ishizuka, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Toxicol Lab, Sapporo, Hokkaido, Japan.	ishizum@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24405004, 24248056, 26304043, 15H0282505, 15K1221305]	We are grateful to T. Ichise for his helpful dedication. The present study was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan awarded to M. Ishizuka (nos. 24405004 and 24248056) and Y. Ikenaka (nos. 26304043, 15H0282505, and 15K1221305). One of the authors (K.P. Watanabe) is a research fellow at the Japan Society for the Promotion of Science (no. 2300186400).	SPANO JS, 1987, AVIAN DIS, V31, P800, DOI 10.2307/1591034; Fukui E, 2008, ANIM SCI J, V79, P158, DOI 10.1111/j.1740-0929.2008.00512.x; DECKERT FW, 1973, DRUG METAB DISPOS, V1, P704; PAMPORI NA, 1993, BIOCHEM PHARMACOL, V46, P885, DOI 10.1016/0006-2952(93)90498-L; Smith SA, 2000, J VET PHARMACOL THER, V23, P329, DOI 10.1046/j.1365-2885.2000.00269.x; OMURA T, 1964, J BIOL CHEM, V239, P2370; SAWADA Y, 1985, J PHARMACOKINET BIOP, V13, P477, DOI 10.1007/BF01059331; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; VESELL ES, 1974, SCIENCE, V184, P466, DOI 10.1126/science.184.4135.466; BACHMANN KA, 1975, J PHARM PHARMACOL, V27, P832; Langford KH, 2013, SCI TOTAL ENVIRON, V450, P205, DOI 10.1016/j.scitotenv.2013.01.100; Eason CT, 1999, J APPL TOXICOL, V19, P157, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<157::AID-JAT559>3.0.CO;2-K; Gage BF, 2000, AM J MED, V109, P481, DOI 10.1016/S0002-9343(00)00545-3; BAI KM, 1986, B ENVIRON CONTAM TOX, V37, P544; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; SCOTT AK, 1984, BRIT J CLIN PHARMACO, V17, P559; Harr KE, 2002, VET CLIN PATH, V31, P140, DOI 10.1111/j.1939-165X.2002.tb00295.x; Jones DR, 2010, CHEM RES TOXICOL, V23, P939, DOI 10.1021/tx1000283; Sanchez-Barbudo IS, 2012, SCI TOTAL ENVIRON, V420, P280, DOI 10.1016/j.scitotenv.2012.01.028; YACOBI A, 1974, J PHARMACOKINET BIOP, V2, P239, DOI 10.1007/BF01059764; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z; OREILLY RA, 1974, CLIN PHARMACOL THER, V16, P348; Watanabe KP, 2010, COMP BIOCHEM PHYS C, V152, P114, DOI 10.1016/j.cbpc.2010.03.006; Zhu X, 2005, BIOPHARM DRUG DISPOS, V26, P147, DOI 10.1002/bdd.442; Ishizuka M, 2007, DRUG METAB DISPOS, V35, P62, DOI 10.1124/dmd.106.011775; Hughes J, 2013, ECOTOXICOLOGY, V22, P974, DOI 10.1007/s10646-013-1074-9; Khalil WF, 2001, J VET PHARMACOL THER, V24, P343, DOI 10.1046/j.1365-2885.2001.00349.x; Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1; Jones DR, 2011, J CHROMATOGR B, V879, P1056, DOI 10.1016/j.jchromb.2011.03.022; Thomas PJ, 2011, ENVIRON INT, V37, P914, DOI 10.1016/j.envint.2011.03.010; Hu SX, 2013, POULTRY SCI, V92, P1283, DOI 10.3382/ps.2012-02911; Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n; Erickson WA, 2004, POTENTIAL RISKS RODE; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Walker L, 2013, ANTICOAGULANT RODENT; Watanabe KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075689	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	OCT	2015	34	10					2328	2334		10.1002/etc.3062		7	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CS6VW	WOS:000362222200018		
J	Tanaka, M; Takeuchi, H; Osaki, Y; Hiraiwa, K; Nakamura, R; Oyama, T; Takahashi, T; Wada, N; Kawakubo, H; Saikawa, Y; Omori, T; Kitagawa, Y				Tanaka, Motomu; Takeuchi, Hiroya; Osaki, Yoshiki; Hiraiwa, Kunihiko; Nakamura, Rieko; Oyama, Takashi; Takahashi, Tsunehiro; Wada, Norihito; Kawakubo, Hirofumi; Saikawa, Yoshiro; Omori, Tai; Kitagawa, Yuko			Prognostic significance of circulating tumor cells in patients with advanced esophageal cancer	ESOPHAGUS			English	Article						Circulating tumor cells; Esophageal cancer; CellSearch system	METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; PROSTATE-CANCER; CLINICAL-SIGNIFICANCE; DIGITAL MICROSCOPY; COLORECTAL-CANCER; PROGRESSION-FREE; CARCINOMA-CELLS; SOLID TUMORS; SURVIVAL	The purpose of this study was to establish the clinicopathological significance of circulating tumor cells (CTCs) in patients with advanced or recurrent esophageal cancer who received either chemotherapy or chemoradiotherapy. CTCs from 38 patients with advanced or recurrent esophageal cancer were quantified using the CellSearch system before and approximately 3-5 weeks after the initiation of a new line of chemotherapy or chemoradiotherapy. The correlation between CTC counts and clinicopathological variables was examined. Of the 38 patients, 15 (39 %) had recurrent esophageal cancer, and 23 patients (61 %) had primary advanced esophageal cancer. The mean age was 63 years (range 43-87 years). One patient (2.6 %) had a complete response to treatment, 16 (42.1 %) had a partial response, 12 (31.6 %) showed stable disease, and nine (23.7 %) showed signs of progressive disease. The overall survival of patients with a parts per thousand yen2 CTCs was significantly shorter than that of patients with < 2 CTCs both at baseline and at first follow-up (p = 0.047 and p = 0.011, respectively). Significant correlation was found between the change in CTC counts and the response to treatment (p = 0.036). The overall survival in patients with a parts per thousand yen2 CTCs both at baseline and at first follow-up was significantly shorter than patients with < 2 CTCs both at baseline and at first follow-up (p = 0.002). Patients with a reduction rate in the CTC value < 80 % experienced significantly shorter survival than patients with a reduction rate of a parts per thousand yen80 % (p = 0.035). The CTC counts at first follow-up served as an independent prognostic factor (p = 0.011). Our results suggest that measuring the number of CTCs in patients with advanced or recurrent esophageal cancer can be useful for predicting the survival of patients and for monitoring the response to cancer treatments.	[Tanaka, Motomu; Takeuchi, Hiroya; Osaki, Yoshiki; Hiraiwa, Kunihiko; Nakamura, Rieko; Oyama, Takashi; Takahashi, Tsunehiro; Wada, Norihito; Kawakubo, Hirofumi; Saikawa, Yoshiro; Omori, Tai; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan	Takeuchi, H (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	htakeuchi@a6.keio.jp					Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Gaforio JJ, 2003, INT J CANCER, V107, P984, DOI 10.1002/ijc.11479; Moreno JG, 2001, UROLOGY, V58, P386, DOI 10.1016/S0090-4295(01)01191-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fehm T, 2002, CLIN CANCER RES, V8, P2073; Witzig TE, 2002, CLIN CANCER RES, V8, P1085; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; FUJITA H, 1995, ANN SURG, V222, P654, DOI 10.1097/00000658-199511000-00008; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Hiraiwa K, 2008, ANN SURG ONCOL, V15, P3092, DOI 10.1245/s10434-008-0122-9; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Shariat SF, 2003, CANCER RES, V63, P4662; Straub B, 2003, ONCOLOGY-BASEL, V65, P12, DOI 10.1159/000072486; Seeberg LT, 2015, ANN SURG, V261, P164, DOI 10.1097/SLA.0000000000000580	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					352	359		10.1007/s10388-014-0482-0		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800002		
J	Kawano, H; Morita, M; Otsu, H; Ando, K; Hiyoshi, Y; Ito, S; Saeki, H; Oki, E; Maehara, Y				Kawano, Hiroyuki; Morita, Masaru; Otsu, Hajime; Ando, Koji; Hiyoshi, Yukiharu; Ito, Shuhei; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko			Pharyngo-laryngo-esophagectomy and reconstruction with a gastric tube for corrosive pharyngoesophagitis	ESOPHAGUS			English	Article						Corrosive esophagitis; Pharyngo-laryngo-esophagectomy; Gastric conduit	STRICTURES; ESOPHAGUS; MANAGEMENT; INGESTION; ADULTS; INTERPOSITION; REPLACEMENT; EXPERIENCE; SURGERY; INJURY	We herein present the case of a 44-year-old male who was successfully treated with pharyngo-laryngo-esophagectomy for severe corrosive esophagitis associated with pharyngitis. He accidentally ingested an unidentified liquid and subsequently developed esophagitis and progressive pharyngolaryngitis. Since he also developed dyspnea, he initially underwent a tracheotomy at an emergency hospital. Afterward, dysphagia due to hypopharingoesophageal stricture gradually developed, and the patient was referred to our hospital. Therefore, under laparotomy, a feeding tube was inserted into the jejunostomy, and the gastroendoscope inserted via the anterior gastric wall revealed that the gastric mucosa along the greater curvature was intact. Based on this information, it was concluded that the patient could undergo reconstruction with a gastric tube following pharyngo-laryngo-esophagectomy, and this was successfully accomplished 3 months later.	[Kawano, Hiroyuki; Morita, Masaru; Otsu, Hajime; Ando, Koji; Hiyoshi, Yukiharu; Ito, Shuhei; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan	Kawano, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kawahiro@surg2.med.kyushu-u.ac.jp					Okonta KE, 2012, INTERACT CARDIOV TH, V15, P713, DOI 10.1093/icvts/ivs320; Zhou JH, 2005, J THORAC CARDIOV SUR, V130, P449, DOI 10.1016/j.jtcvs.2005.02.029; Harlak A, 2013, INT J SURG, V11, P164, DOI 10.1016/j.ijsu.2012.12.010; Choi RS, 1997, J PEDIATR SURG, V32, P1083, DOI 10.1016/S0022-3468(97)90404-8; Chou SH, 2010, WORLD J SURG, V34, P2383, DOI 10.1007/s00268-010-0646-6; Ramasamy K, 2003, J CLIN GASTROENTEROL, V37, P119, DOI 10.1097/00004836-200308000-00005; GERZIC ZB, 1990, ANN SURG, V211, P329, DOI 10.1097/00000658-199003000-00004; Sikorszki L, 2012, EUR SURG, V44, P299, DOI 10.1007/s10353-012-0156-x; Knezevic JD, 2007, DIS ESOPHAGUS, V20, P530, DOI 10.1111/j.1442-2050.2007.00694.x; Javed A, 2011, ANN SURG, V254, P62, DOI 10.1097/SLA.0b013e3182125ce7; HUY PTB, 1988, ANN SURG, V207, P439; Ruol A, 2010, EUR J CARDIO-THORAC, V38, P659, DOI 10.1016/j.ejcts.2010.03.057; Kim YT, 2001, EUR J CARDIO-THORAC, V20, P1, DOI 10.1016/S1010-7940(01)00747-3; HOPKINS RA, 1981, ANN SURG, V194, P146, DOI 10.1097/00000658-198108000-00005; Wu MH, 2001, EUR J CARDIO-THORAC, V19, P400, DOI 10.1016/S1010-7940(01)00614-5; Mansour KA, 1997, ANN THORAC SURG, V64, P752, DOI 10.1016/S0003-4975(97)00616-4; Chaudhary A, 1996, WORLD J SURG, V20, P703; GUMASTE VV, 1992, AM J GASTROENTEROL, V87, P1	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					360	364		10.1007/s10388-014-0466-0		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800003		
J	Urabe, M; Mori, K; Nishida, M; Yagi, K; Yamagata, Y; Aikou, S; Yamashita, H; Nomura, S; Shinozaki-Ushiku, A; Fukayama, M; Seto, Y				Urabe, Masayuki; Mori, Kazuhiko; Nishida, Masato; Yagi, Koichi; Yamagata, Yukinori; Aikou, Susumu; Yamashita, Hiroharu; Nomura, Sachiyo; Shinozaki-Ushiku, Aya; Fukayama, Masashi; Seto, Yasuyuki			Primary adenocarcinoma in the middle thoracic esophagus, which revealed scirrhous-like growth	ESOPHAGUS			English	Article						Esophageal neoplasms; Adenocarcinoma; Scirrhous; Middle thoracic esophagus	ECTOPIC GASTRIC-MUCOSA; LINITIS PLASTICA; CELL-CARCINOMA; CANCER	A 63-year-old man presented with a protruded tumor in the middle thoracic esophagus demonstrated by endoscopy. The tumor showed diffuse submucosal infiltrations, and the biopsy yielded a pathological diagnosis of adenocarcinoma. As an initial treatment, definitive chemoradiotherapy was performed. Although subsequent evaluations by endoscopy showed a good response, the lesion presented stenotic change. Positron emission tomography showed abnormally increased accumulation of 18F-fluorodeoxyglucose in the primary lesion suspicious for remnant disease. Therefore, the patient underwent salvage esophagectomy. On the resected specimen, the tumor was localized within the middle third of the esophagus: Its anal side was lined by non-cancerous squamous cell epithelium. The tumor was pathologically diagnosed as moderate to poorly differentiated adenocarcinoma. The tumor accompanied a circular stricture and a prominent fibrosis, a histologic finding known as scirrhous-type growth. Here, we report a case of scirrhous-like adenocarcinoma arising from middle thoracic esophagus successfully operated on after definitive chemoradiotherapy.	[Urabe, Masayuki; Mori, Kazuhiko; Nishida, Masato; Yagi, Koichi; Yamagata, Yukinori; Aikou, Susumu; Yamashita, Hiroharu; Nomura, Sachiyo; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Bunkyo Ku, Tokyo 1138655, Japan; [Shinozaki-Ushiku, Aya; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan	Urabe, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	urabe-tky@umin.ac.jp					Lauwers GY, 1998, DIGEST DIS SCI, V43, P901, DOI 10.1023/A:1018855223225; Yamashita H, 2006, DIS ESOPHAGUS, V19, P15, DOI 10.1111/j.1442-2050.2006.00531.x; Usui A, 2013, SURG TODAY, V43, P794, DOI 10.1007/s00595-012-0400-9; Honda M, 2010, ESOPHAGUS-TOKYO, V7, P225, DOI 10.1007/s10388-010-0248-2; Maezato K, 2007, SURG TODAY, V37, P1096, DOI 10.1007/s00595-007-3533-5; YOSHIDA M, 1986, ENDOSCOPY, V18, P44, DOI 10.1055/s-2007-1018441; CHEJFEC G, 1983, CANCER, V51, P2139, DOI 10.1002/1097-0142(19830601)51:11<2139::AID-CNCR2820511131>3.0.CO;2-Y; PAZDUR R, 1988, AM J GASTROENTEROL, V83, P1395; CHRISTENSEN WN, 1987, AM J SURG PATHOL, V11, P397, DOI 10.1097/00000478-198705000-00009; Endoh Y, 1999, PATHOL INT, V49, P156, DOI 10.1046/j.1440-1827.1999.00838.x; Noguchi T, 2001, J GASTROENTEROL, V36, P704, DOI 10.1007/s005350170035; Japanese Society for Esophageal Disease, 2008, JAP CLASS ES CANC; Jonhson FP, 1910, AM J ANAT, V10, P521; Kikuchi T, 1995, GASTROENTEROL ENDOSC, V37, P2446; LORTATJA.JL, 1968, SURGERY, V64, P535; AZZOPARDI JG, 1962, BRIT J SURG, V49, P497, DOI 10.1002/bjs.18004921703; RAPHAEL HA, 1966, ANN SURG, V164, P785, DOI 10.1097/00000658-196611000-00002; Tachimori Y, 2014, ESOPHAGUS-TOKYO, V11, P21, DOI 10.1007/s10388-013-0393-5; Takubo K, 1996, PATHOLOGY ESOPHAGUS, P23; Yamanaka H, 1998, Jpn J Thorac Cardiovasc Surg, V46, P943	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					365	369		10.1007/s10388-014-0467-z		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800004		
J	Ozawa, Y; Fujishima, F; Ito, K; Okamoto, H; Teshima, J; Kamei, T; Miyata, G; Ohuchi, N; Sasano, H				Ozawa, Yohei; Fujishima, Fumiyoshi; Ito, Ken; Okamoto, Hiroshi; Teshima, Jin; Kamei, Takashi; Miyata, Go; Ohuchi, Noriaki; Sasano, Hironobu			Superficial esophageal carcinoma composed of basaloid, adenocarcinomatous, and squamous components	ESOPHAGUS			English	Article						Esophageal carcinoma; Basaloid squamous carcinoma; Adenocarcinoma; Histological variety	CELL-CARCINOMA	A 60-year-old man diagnosed with esophageal cancer of the lower thoracic esophagus was referred for curative operation. Thoracoscopic esophagectomy with two-field lymph node dissection was performed without neoadjuvant therapy. Histopathological findings revealed three different components of carcinoma in the same tumor specimen: basaloid, adenocarcinomatous and squamous components. These different components of the tumor histological subtypes existed separately with clear borderline, but the histological transition among these components was partially appreciated. All of components were associated with different patterns in immunohistochemistry. The patient was well without recurrence 24 months after operation. It is well known that esophageal carcinoma have histological variety and variant types of esophageal carcinoma frequently colocalized with squamous component. However, the presence of three components which occupied the same proportion of the lesion in the superficial carcinoma has not been reported to the best of our knowledge. We finally interpreted this tumor as a composite tumor arising from squamous epithelium and differentiated into three different histologic phenotypes. Because of the various morphological features of esophageal carcinoma, detailed histopathological analysis of surgical specimens plays pivotal roles in obtaining their clinicopathological features.	[Ozawa, Yohei; Ito, Ken; Okamoto, Hiroshi; Teshima, Jin; Kamei, Takashi; Miyata, Go; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Div Adv Surg Sci & Technol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Ozawa, Yohei; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Fujishima, Fumiyoshi; Ito, Ken; Sasano, Hironobu] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan	Ozawa, Y (reprint author), Tohoku Univ, Grad Sch Med, Div Adv Surg Sci & Technol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	ozawa.youhei@opal.plala.or.jp					Hishida T, 2002, PATHOL INT, V52, P313, DOI 10.1046/j.1440-1827.2002.01346.x; Ohashi K, 2003, PATHOL RES PRACT, V199, P713, DOI 10.1078/0344-0338-00487; TAKUBO K, 1989, ACTA PATHOL JAPON, V39, P180; Arai T, 2011, ESOPHAGUS-TOKYO, V8, P169, DOI 10.1007/s10388-011-0280-x; Sarbia M, 1997, CANCER, V79, P1871, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1871::AID-CNCR5>3.0.CO;2-J; Imamhasan A, 2012, HUM PATHOL, V43, P2012, DOI 10.1016/j.humpath.2012.02.010; Chen SB, 2012, J CANCER RES CLIN, V138, P1165, DOI 10.1007/s00432-012-1180-8; Bhagat Vishal, 2003, Int J Gastrointest Cancer, V34, P139, DOI 10.1385/IJGC:34:2-3:139; Hoichi K, 2005, STOMACH INTEST TOKYO, V40, P355; Ide Hiroko, 2005, Stomach and Intestine (Tokyo), V40, P279; Japanese Society for Esophageal Diseases, 2007, GUID CLIN PATH STUD; Kobayashi Yutaka, 2005, Stomach and Intestine (Tokyo), V40, P371; Kozu T, 2005, STOMACH INTEST TOKYO, V40, P337; Makuuchi Hiroyasu, 2005, Stomach and Intestine (Tokyo), V40, P320; Nambu K, 2008, JPN J GASTROENTEROL, V41, P1404; Yao Takashi, 2005, Stomach and Intestine (Tokyo), V40, P288; Zuguchi M, 2012, JPN J GASTROENTEROL, V45, P826	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					370	376		10.1007/s10388-014-0471-3		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800005		
J	Hasegawa, H; Oshikiri, T; Yasuda, T; Sumi, Y; Fujino, Y; Tominaga, M; Kakeji, Y				Hasegawa, Hiroshi; Oshikiri, Taro; Yasuda, Takashi; Sumi, Yasuo; Fujino, Yasuhiro; Tominaga, Masahiro; Kakeji, Yoshihiro			Colonic metastasis after resection of primary esophageal squamous cell carcinoma: report of a case	ESOPHAGUS			English	Article						Esophageal carcinoma; Colonic metastasis; Squamous cell carcinoma	LUNG; CANCER	Colonic metastasis of esophageal squamous cell carcinoma (SCC) is extremely rare. A 77-year-old male patient was diagnosed with primary middle thoracic esophageal carcinoma and subsequently underwent subtotal esophagectomy. The pathological TNM classification was SCC of the esophagus, T3N1M0 stage IIIA. Twenty months later, he underwent emergency surgery due to acute abdomen. Exploratory laparotomy revealed diffuse peritonitis, as well as increased wall thickness and a pinhole perforation at the hepatic flexure of the transverse colon. He underwent right hemicolectomy, and pathological investigation demonstrated metastatic SCC of the colon from the esophageal carcinoma. The postoperative course was uneventful, and he was discharged 14 days after surgery. However, computed tomography scans performed 2 weeks after discharge showed carcinomatous peritonitis. The patient declined chemotherapy and died 2 months later.	[Hasegawa, Hiroshi; Oshikiri, Taro; Yasuda, Takashi; Fujino, Yasuhiro; Tominaga, Masahiro] Hyogo Canc Ctr, Dept Surg Gastroenterol, Akashi, Hyogo 6738558, Japan; [Sumi, Yasuo; Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan	Hasegawa, H (reprint author), Hyogo Canc Ctr, Dept Surg Gastroenterol, 13-70 Kitaoji Cho, Akashi, Hyogo 6738558, Japan.	hase@hp.pref.hyogo.jp					Ichida H, 2013, WORLD J SURG, V37, P398, DOI 10.1007/s00268-012-1830-7; Sawada T, 2013, HEPATOB PANCREAT DIS, V12, P103, DOI 10.1016/S1499-3872(13)60015-6; Singla M, 2011, INDIAN J CANCER, V48, P267, DOI 10.4103/0019-509X.82893; Hsu PK, 2011, J GASTROINTEST SURG, V15, P558, DOI 10.1007/s11605-011-1458-1; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Teyton P, 2009, J GASTROINTEST SURG, V13, P451, DOI 10.1007/s11605-008-0749-7; Karaosmanoglu AD, 2012, DIAGN INTERV RADIOL, V18, P171, DOI 10.4261/1305-3825.DIR.4309-11.1; Hirasaki S, 2008, WORLD J GASTROENTERO, V14, P5481, DOI 10.3748/wjg.14.5481; Vyas SJ, 2002, EUR J CARDIO-THORAC, V22, P1011, DOI 10.1016/S1010-7940(02)00580-8; Carroll D, 2001, EUR J CARDIO-THORAC, V19, P719, DOI 10.1016/S1010-7940(01)00646-7; Iwase Hiroaki, 2004, Int J Clin Oncol, V9, P398, DOI 10.1007/s10147-004-0412-6; Karwasra R K, 2002, Indian J Gastroenterol, V21, P207; Kuwano Hiroyuki, 2003, Ann Thorac Cardiovasc Surg, V9, P6; Sakai H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-127; Shimada Y, 2014, J SURG CASE REP, DOI [10.1093/jscr/rjt117, DOI 10.1093/JSCR/RJT117]	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					383	386		10.1007/s10388-014-0473-1		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800007		
J	Okamura, A; Kawakubo, H; Takeuchi, H; Shimogawara, T; Matsubara, K; Obara, H; Oyama, T; Hoshikawa, T; Nakamaru, M; Sotome, K; Morozumi, K; Hachiya, T; Shimizu, H; Kitagawa, Y				Okamura, Akihiko; Kawakubo, Hirofumi; Takeuchi, Hiroya; Shimogawara, Tatsuya; Matsubara, Kentaro; Obara, Hideaki; Oyama, Takashi; Hoshikawa, Tatsuhiko; Nakamaru, Makoto; Sotome, Keiichi; Morozumi, Kyoei; Hachiya, Takashi; Shimizu, Hideyuki; Kitagawa, Yuko			Successful treatment of aortogastric fistula after esophagectomy	ESOPHAGUS			English	Article						Aortogastric fistula; Endovascular stent graft repair; Esophagectomy; Peptic ulcer	PEPTIC-ULCER; GASTROAORTIC FISTULA; COMPLICATION; CARCINOMA; ESOPHAGUS; RESECTION	Aortogastric fistula is a rare and lethal complication after esophagectomy. We report a case of an aortogastric fistula due to a peptic ulcer after esophagectomy for esophageal carcinoma, in which treatment with surgery and endovascular stent graft repair was successful. A 67-year-old woman underwent esophagectomy for esophageal carcinoma and reconstruction with a gastric tube through the posterior mediastinal route. Eleven years later, she experienced massive hematemesis and severe shock due to an aortogastric fistula, although there was no evidence of cancer recurrence. The fistula was obliterated surgically and the perforated aorta was directly closed. However, a pseudoaneurysm located at the closure site on the aortic wall developed postoperatively. An endovascular thoracic aortic stent graft was placed successfully, and she was discharged after intensive care. Thus, we present the very rare case of an aortogastric fistula formed following esophagectomy that was successfully treated with surgery and endovascular stent graft repair.	[Okamura, Akihiko; Kawakubo, Hirofumi; Takeuchi, Hiroya; Shimogawara, Tatsuya; Matsubara, Kentaro; Obara, Hideaki; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Oyama, Takashi; Hoshikawa, Tatsuhiko; Nakamaru, Makoto; Sotome, Keiichi; Morozumi, Kyoei] Fussa Hosp, Dept Surg, Fussa, Tokyo 1978511, Japan; [Hachiya, Takashi; Shimizu, Hideyuki] Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo 1608582, Japan	Kawakubo, H (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hkawakubo@z3.keio.jp					RASULI P, 1990, J CAN ASSOC RADIOL, V41, P151; BEGIN LR, 1992, ANN THORAC SURG, V54, P564; MAGUIRE WC, 1947, SURGERY, V22, P842; MERENDINO KA, 1950, J THORAC SURG, V19, P405; Katsoulis IE, 2001, DIS ESOPHAGUS, V14, P76, DOI 10.1046/j.1442-2050.2001.00156.x; Antoniou GA, 2009, J VASC SURG, V49, P782, DOI 10.1016/j.jvs.2008.08.068; Sato O, 1999, SURG TODAY, V29, P431; Molina-Navarro C, 2001, ANN THORAC SURG, V72, P1783, DOI 10.1016/S0003-4975(00)02569-8; BROOKES VS, 1952, THORAX, V7, P167, DOI 10.1136/thx.7.2.167; Takebayashi T, 2004, SURG TODAY, V34, P777, DOI 10.1007/s00595-004-2826-1; ULLMANN AS, 1961, CAN MED ASSOC J, V85, P27; Deutsch A A, 1978, Arch Surg, V113, P537; LAU OJ, 1983, BRIT J SURG, V70, P504, DOI 10.1002/bjs.1800700816; Mochizuki Yoshinari, 2003, Jpn J Thorac Cardiovasc Surg, V51, P448, DOI 10.1007/BF02719601	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					387	391		10.1007/s10388-014-0476-y		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800008		
J	Inoue, T; Yachida, S; Kashiwagi, H; Otani, T; Ishimura, K; Kushida, Y; Okano, K; Usuki, H; Wakabayashi, H; Suzuki, Y				Inoue, Tatsushi; Yachida, Shinichi; Kashiwagi, Hirotaka; Otani, Tsuyosi; Ishimura, Ken; Kushida, Yoshio; Okano, Keiichi; Usuki, Hisashi; Wakabayashi, Hisao; Suzuki, Yasuyuki			A case of Barrett's Esophageal Adenocarcinoma associated with heterotopic pancreas	ESOPHAGUS			English	Article						Barrett's esophagus; Esophageal adenocarcinoma; Heterotopic pancreas	ATRESIA; REFLUX	A 56-year-old man was referred to our hospital because of the detection of esophageal adenocarcinoma at a local hospital. Endoscopy showed an elevated lesion in the lower esophagus. We diagnosed this lesion as early esophageal carcinoma and performed video-assisted distal esophagectomy. On microscopic examination, a 6.0-cm irregular elevated lesion with a cavity lesion was identified at the lower esophagus. This lesion corresponded to well- to moderately differentiated adenocarcinoma with invasion to the submucosa. In the cavity lesion, mucosal glands and pancreatic tissue were detected. The surrounding esophageal mucosa showed Barrett's epithelium with high-grade intraepithelial neoplasia and adenocarcinoma. The lesion was diagnosed as Barrett's esophageal adenocarcinoma at T1b, N2, M0: Stage II. The patient is alive and well without recurrence 5 years after surgery. Esophageal heterotopic pancreas is a congenital condition that is exceedingly rare. In this case, heterotopic pancreas and its surrounding cavity lesion were considered to have led to the onset of Barrett's esophagus and its progression to adenocarcinoma.	[Inoue, Tatsushi; Yachida, Shinichi; Kashiwagi, Hirotaka; Okano, Keiichi; Usuki, Hisashi; Suzuki, Yasuyuki] Kagawa Univ, Fac Med, Dept Surg Gastroenterol, Miki, Kagawa 7610793, Japan; [Inoue, Tatsushi; Otani, Tsuyosi; Ishimura, Ken; Wakabayashi, Hisao] Kagawaken Saiseikai Hosp, Dept Surg, Takamatsu, Kagawa, Japan; [Kushida, Yoshio] Kagawa Univ, Fac Med, Dept Diagnost Pathol, Miki, Kagawa 7610793, Japan	Inoue, T (reprint author), Kagawa Univ, Fac Med, Dept Surg Gastroenterol, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	GZT04437@nifty.ne.jp					Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Park J, 2010, J PEDIATR SURG, V45, pE25, DOI 10.1016/j.jpedsurg.2009.12.018; MATHUR M, 1991, AM J GASTROENTEROL, V86, P1419; Phillips WA, 2011, J GASTROEN HEPATOL, V26, P639, DOI 10.1111/j.1440-1746.2010.06602.x; Shanbhogue AKP, 2009, RADIOGRAPHICS, V29, P1003, DOI 10.1148/rg.294085748; Emerson L, 2004, J SURG ONCOL, V87, P53, DOI 10.1002/jso.20087; Dixon MF, 2001, GUT, V49, P359, DOI 10.1136/gut.49.3.359; Ozcan C, 2002, J PEDIATR SURG, V37, P116, DOI 10.1053/jpsu.2002.29442; Playford RJ, 2006, GUT, V55, P442, DOI 10.1136/gut.2005.083600; Mizuno Y, 2007, SURG TODAY, V37, P704, DOI 10.1007/s00595-006-3384-5; Caidwell MT, 1995, BRIT J SURG, V82, P657; Japanese Esophageal Society, 2009, ESOPHAGUS, V6, P1, DOI DOI 10.1007/S10388-009-0169-0; Karpińska Marta Strutyńska, 2011, Pol Przegl Chir, V83, P171, DOI 10.2478/v10035-011-0026-4; Patrick Lyn, 2011, Altern Med Rev, V16, P116	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					392	397		10.1007/s10388-014-0479-8		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800009		
J	Kajiyama, Y; Iwanuma, Y; Tomita, N; Amano, T; Isayama, F; Saita, M; Ozaki, A; Shibamoto, M; Kitano, H; Uchida, T				Kajiyama, Yoshiaki; Iwanuma, Yoshimi; Tomita, Natsumi; Amano, Takayuki; Isayama, Fuyumi; Saita, Masayuki; Ozaki, Asako; Shibamoto, Misako; Kitano, Hiromi; Uchida, Takayuki			Relational topographical anatomy between right bronchial artery and thoracic duct	ESOPHAGUS			English	Article						Right bronchial artery; Thoracic duct; Topographical anatomy; Anomaly	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CHYLOTHORAX; ESOPHAGECTOMY; MANAGEMENT; CARCINOMA; RESECTION	Thoracic duct injury leads to "chylothorax". We found a close relationship of topographical anatomy between right bronchial artery and thoracic duct from esophageal cancer operations. We retrospectively analyzed topographical anatomy of right bronchial artery and location of thoracic duct in 124 cases operated in 2012. Of 124 cases, we recognized 8 cases of anomalous right bronchial artery. In these cases, the right bronchial artery originated directly from descending aorta without connections with third intercostal artery. When the right bronchial artery has a connection with third intercostal artery, the thoracic duct was located within the loop of the right bronchial artery. However, in these 8 anomalous cases, thoracic duct was located dorsally outside the loop of the right bronchial artery without exceptions. We have to be very careful in exploring the thoracic duct when we notice the anomalous right bronchial artery during esophageal cancer operation.	[Kajiyama, Yoshiaki; Iwanuma, Yoshimi; Tomita, Natsumi; Amano, Takayuki; Isayama, Fuyumi; Saita, Masayuki; Ozaki, Asako; Shibamoto, Misako; Kitano, Hiromi; Uchida, Takayuki] Juntendo Univ, Sch Med, Dept Esophageal & Gastroenterol Surg, Bunkyo Ku, Tokyo 1138421, Japan	Kajiyama, Y (reprint author), Juntendo Univ, Sch Med, Dept Esophageal & Gastroenterol Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kaji@juntendo.ac.jp					Hematti H, 2011, THORAC SURG CLIN, V21, P229, DOI 10.1016/j.thorsurg.2011.01.002; Battal B, 2011, J COMPUT ASSIST TOMO, V35, P253, DOI 10.1097/RCT.0b013e3182073c27; Dugue L, 1998, BRIT J SURG, V85, P1147; Merrigan BA, 1997, BRIT J SURG, V84, P15, DOI 10.1002/bjs.1800840107; Wemyss-Holden SA, 2001, BRIT J SURG, V88, P1442, DOI 10.1046/j.0007-1323.2001.01896.x; Phang K, 2014, CLIN ANAT, V27, P637, DOI 10.1002/ca.22337; Rizk NP, 2004, J AM COLL SURGEONS, V198, P42, DOI 10.1016/j.jamcollsurg.2003.08.007; Morita Y, 2010, RADIOLOGY, V255, P934, DOI 10.1148/radiol.10081220; Mishra PK, 2013, WORLD J SURG, V37, P141, DOI 10.1007/s00268-012-1811-x; KASAI T, 1979, ANAT ANZEIGER, V145, P166; Wada T, 2013, DIS ESOPHAGUS, V26, P616, DOI 10.1111/dote.12012; Funami Y, 1996, SURGERY, V119, P67, DOI 10.1016/S0039-6060(96)80216-9; BOLGER C, 1991, BRIT J SURG, V78, P587, DOI 10.1002/bjs.1800780521; DOUGENIS D, 1992, SURG GYNECOL OBSTET, V174, P501; Nair SK, 2007, EUR J CARDIO-THORAC, V32, P362, DOI 10.1016/j.ejcts.2007.04.024	15	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1612-9059	1612-9067		ESOPHAGUS-TOKYO	Esophagus	OCT	2015	12	4					398	400		10.1007/s10388-014-0450-8		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CS7WN	WOS:000362297800010		
